<SEC-DOCUMENT>0001124140-21-000097.txt : 20211102
<SEC-HEADER>0001124140-21-000097.hdr.sgml : 20211102
<ACCEPTANCE-DATETIME>20211102170948
ACCESSION NUMBER:		0001124140-21-000097
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		106
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211102
DATE AS OF CHANGE:		20211102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXACT SCIENCES CORP
		CENTRAL INDEX KEY:			0001124140
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				204782291
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35092
		FILM NUMBER:		211372426

	BUSINESS ADDRESS:	
		STREET 1:		5505 ENDEAVOR LANE
		CITY:			MADISON
		STATE:			WI
		ZIP:			53719
		BUSINESS PHONE:		608-284-5700

	MAIL ADDRESS:	
		STREET 1:		5505 ENDEAVOR LANE
		CITY:			MADISON
		STATE:			WI
		ZIP:			53719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXACT CORP
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>exas-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:62297662-2bfb-41ec-9bf7-9eb144772313,g:499e252f-fe94-4d47-8333-c3acba229b0e,d:fd942d9caf664925b961fb4f8d8f685d--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:exas="http://www.exactsciences.com/20210930" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exas-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV8zLTEtMS0xLTE_f3999791-f229-42d2-9ad2-e47748d2c94a">2021</ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV80LTEtMS0xLTE_3e8dde2d-b4e1-431e-9235-1dba81f0bd0b">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV81LTEtMS0xLTE_00357081-893f-4ded-8be2-b686b23378a4">0001124140</ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV82LTEtMS0xLTE_d2245361-1186-4f5c-8daf-43779e1a45b8">false</ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGV4dHJlZ2lvbjo3ZGUwZmVkNzFlYWY0Y2M3OWQ4ZDE0MTE4NmVkMjA1OF80Mg_bfae8c5f-0fb2-425f-8952-f57db9870ba9">--12-31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81OC9mcmFnOmNkODljMWIwZDEzNTRkYzU5ZWRiN2U2MDMwODA2YWViL3RleHRyZWdpb246Y2Q4OWMxYjBkMTM1NGRjNTllZGI3ZTYwMzA4MDZhZWJfMjQy_e181e8c0-7a3d-42ea-83d1-789d5ee50987">0.1326</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81OC9mcmFnOmNkODljMWIwZDEzNTRkYzU5ZWRiN2U2MDMwODA2YWViL3RleHRyZWdpb246Y2Q4OWMxYjBkMTM1NGRjNTllZGI3ZTYwMzA4MDZhZWJfMjQ1_08f6b0ce-bc50-4c94-b93a-d7f05ab60dd6">0.0896</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81OC9mcmFnOmNkODljMWIwZDEzNTRkYzU5ZWRiN2U2MDMwODA2YWViL3RleHRyZWdpb246Y2Q4OWMxYjBkMTM1NGRjNTllZGI3ZTYwMzA4MDZhZWJfMjQ4_9244d8e2-6708-44cf-94ac-96a946f5af23">0.0821</ix:nonFraction><ix:nonNumeric contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NA_a63abb75-8298-4289-82ca-d79cd14f64fc">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NQ_a7a5c01b-96cc-4030-a445-b85e4c06296f">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI1MA_7ed6786f-7aa1-4913-ad46-9c4fe5b019bf">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" name="exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" name="exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb">P4Y</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMTk3L2ZyYWc6ZGM5YzdkYmIwMmNjNDZjNWE0YmJiNjMzZDdhNjgyNTUvdGV4dHJlZ2lvbjpkYzljN2RiYjAyY2M0NmM1YTRiYmI2MzNkN2E2ODI1NV8yMTk5MDIzMjU1NTU3_4d5562d8-8c6b-45a7-a707-cabb69d0386d">1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="exas-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i4345381fdd3249c7b09e4950af6f50d7_I20211101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="icaadbb616eae41fa90b155f9198a61f3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i551c655f93e84ff688983bbc818b9b24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5b879da246b14941a83322faaeed6793_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a089c68d2054e71ae53dbe33acb46e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2d218d7eeae48b689178b021a2d9641_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d1a5e4e4fb3441dbfac2e16747f0f82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f71ee0084e4eadb1fad7a7287abf77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06acbbeed575445bb4555931be715a61_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35f5f3b14daf4545b117801527f11480_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i094f6b20548e406aa1288c2f7bb503ce_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01dccf0f1cd74d4b9ba6b84dc1db95d1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8ec01d6b22540e381cef4d704dbefdd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i037dafa9fcb1448595787e22be1373a3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4239b36587d47b9b67ceb074d0de230_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id326b3d6f1254686955c693689f8d7d8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0baa301bd4a2483fb87ec3ff4678d7b3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d78ab3ef424e599d850c44805a1ce8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7570a7ca68604ab193ddcc503f407047_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c13f47ff92f4d38a48f563ec039cca7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a00307d8ec84b5e91e63fb7f9ff072e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6d6c8e24a154e2298c770d5ede9849a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae0e894a4a7f44789a730dae8d02a80e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1875021431d84ba4b5c921b34aa74aff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60304b507d2d47a4beae13dd19cd021e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ed5f3ef270f4beca6bc7c118222f3e6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f46968c2ac4412d8f9620137a8c6374_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7040c10b7747fcbcec17982a4d2f4e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48f2732f724e456a9642ca5734eae6e1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e10d3514844641a53eb38bf634cf5b_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c52981677ce4a888854fe6b6b0ffe08_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a62efea1c4b4dad930fa573b6c99563_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d558258814f4878ba1f82b61916b08e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64bfc16e556a449a831b1c4af0089d2e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f2b2bb1c864e00920956c21f816e20_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01c96c9ab7c14967920412b87f32b6c0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5c4e6487434fdbb1a622f0080871e0_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dfef23d60d041dcb2e5ff139b68bed4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73256ccbde6a4a12845c25b8d6a836c2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4ddaf31e8724905808d6d26fb1d3e98_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f129d90bdeb408e8087ee20a8683ffc_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01e9c8f772ad4932a0753e9678189d1b_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieba75542757243c48c1903c54053e34f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0912a5984f84bb28a27c9b48d9742d0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0ad06284f6547c3a757c9097601bd0a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c72990efe38423c885bc80777b5d195_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96986827f84947af8d4abfe56c07628f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e6ccfede314e49b1285af649de49da_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id99a4512c1d64749be5a8a8315d2d519_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab125bbe3464831934cae09e63392a9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c3768e6733343e298c844be52e6b227_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c5d0a1031244da98e1f497d05696a9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c26ea4630974c43a74423ba696c884d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92f563c0ffb417f938fb6903a548c40_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia53cf4692f7a499a8f9f2bb58f1edb6f_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic260e91a22f64d36ace033eed2e0ebe6_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5fd31d1a4c54db49806dc7819602dcb_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d44e865abb4a51a5b5501e0a448a8d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b178d75514549ce8ea66ebbd555a8f3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7670af9c955a4e8faf887308db05e979_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id444aec802554b8bb1365dce26fea270_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d9018de7fac4dc190a8367b24291c0c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib05f381693e64b0dab8d73252c93ac05_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3905df4105f94399ab1bfd44d6526587_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaded02e3fc3944cb80ece4c9df2ccde3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2207747f21754338966e914ce4f44b7a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd243860e9749e797d0fa40c030a984_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:SharesIssuedUponAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b8fefa7fe2141829ad68e0d413c03d3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:SharesIssuedUponAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied784b899fd94614a96d000bcd733b92_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab5607dd7295462cb8c90861fc743def_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ff017345e814e08bfa7d77cb58912c7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7b3a687e0214f13b567a2e97a426191_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3a1712ede2942bc8705b2381ed4bde8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137c30961fc947dda5c83f8077cb708d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib679c506439a443bb2d06e9eb73f7433_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7297a2895984854bde48ce5c1058f91_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dcafd136a464463a18bf7d7a0aabc1b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8379dfc1c2554ffab184de397af796d4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic581a41a228c4ae7ae63d34ea421cced_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f0651ae9954de988ac49c1cec0c010_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f57ca6a167a43b4bd33c0535aa347d5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9fc6aab4d3f47f7afa8fdee107a4a60_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia505fd74c0704dd78a15cd07d6bec4f2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i667d454b548144cc8245d44ab0448111_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc3607a1c09473eb6ba098ff05bad78_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ff09f5adfd24b298edc56009dd65975_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00444e24ec1241f3b7ce26b81f6319cb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c87ea0590d04f828df277e02be7dbce_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063bc72fa7ab4cb6a8c9a466fe5aa116_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec34b3d38ad47c3a8c65d21d6a37b56_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3ffbd8983c4f1ba70c98a0ab97ef7d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb4b44207d9466993c79d22ca6e06eb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e1d778217746d0a4ed93e318426779_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9528b0d3873149b0baaa0af2498e1789_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59324a5c86a042f18bd9bf5e533238e0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0871846c6e044d0289f2d41819e1fb31_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib39277e0ee7649f4a508d3e2c9863dd3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb79758603984bad872062ffd7af29a2_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8d8fb26ece45a69d29c95350219e5e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4915188f99d42a6b86eca6320118435_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7b5bb29d0e4ce08e610464b1b71b37_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i992eec5c1e0a4469b393b751d5eb9389_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i661a0097adc94c5c86868c8e52fb1c00_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f52f7ff969c485b96ea18039cc813cd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i707df04e45c244bdb2753eb7ff65444b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i016c8264c60a431a8ecf3ae449c720c8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f4fa3ff2f042ec8152cfdd2a41b981_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id13f5ee7c3f641fc979fe7a4a3c4e208_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9955c3ab73c746da927a0a812a044811_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie52257ef670146a09f3d526496fbd69f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a45ebc0ee824d3b8b9a76338253a1ae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe7fefd1dd334af09a0b944eb61e0372_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f37da1b5f84e8d9f2274f6ca39cf9e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie93b05b8539f41c1840428f39ff69a20_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a76a46842ae4cf493ed92d239b12b86_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf18cbd6240143d7b12639b8d3688bda_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4090efeb29b94b56a6aad380d6c19370_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8250c7f4f5e4113adb46384c985cf13_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96884d3335c9474d85d0a0151047b3c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i248f0aaf5ff64f5aaee08b667c06b387_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0cca153dbb14b2f99d14ed4101de2af_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">exas:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d988dcef79447dcb20227b33fd68679_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">exas:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b42a57edea48f5924650bda9e8458a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">exas:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cfebb799f1944df980320a2b810292b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:CashAndMoneyMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056bbdc3f35d4f1c97c9eaf225f5e67d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:CashAndMoneyMarketMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13be9f7dfe5045bfa40c514789b1321c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83467d26f5bd4aea9d91d6b5d120f225_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c8a7f6ee43e472892b140b9fd2a1a53_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id26cf57382b64fdab7bfd9aa29ea248c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb18575cb9a44b4daebf27decd1b5840_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73e374a0bd147d2b769746796b11924_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152dab5324a1480c9feaec96cfb9608b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7d5f7437ec646d18e769f045a314e6a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i832a3ecaa8474916bdc09a1251d24703_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7300a597044b329c0be127d20807ba_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1df2197ee3ca4faba476f8e618d26e98_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e5244a5f34475e816a12b0991473e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i046c9bf82f9d4d84afc8bdb4fbc09ee4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2603c42ca166450aa67a6456c7aac5f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib565421c7a9e4cee80899653950911dd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee71fa70c5840f2aa66cb1886e4e1e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if97c19b0ff2e426c8ff2e5e5c8c9ba5b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5d1f9f305b34febb42e7ec0e7aea18f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c709a9c228d4975bf362e7fbdbaf15d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1eea2a1fc8048b3886f462bacd90918_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eaf3d04e6d54cb69c0bcb15abf59ad3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f34accaeb4c4b69bd008a1a7025ae7c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26037492e0b347dc8fb448751d76c11a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c7eb1cd63614c76a69d6c2265857e45_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:OfficeEquipmentAndComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73857043c37b41f9baaed76bd0a2da45_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:OfficeEquipmentAndComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a9cb213c64b4411bef4a6f840992c57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:OfficeEquipmentAndComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17efc5443e29495c96dd26eb9db272fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8206c44cfe3d480d87b647d39baa233b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08e3529a89e4d289e1bef68ce7d0fcc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e40593098e345db94df0524569e9818_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d059ff1b2e4031ad7a352239b93fa2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if185d20192144383ad067c44e7be1c5a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8e88e6baa0f4bb08fcee1ef175222e9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7428b7f6a341495982fc6f8d0cd2b254_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00a10169cbd94256abf1a671f2b87341_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850e8485ac9b4874afcdcf9edc86f702_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i397f9e5032ae4722a80dcb17bdcc41dc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if702705143d144ad941b197bde5db8a0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a88eba861f4e4192b519eeccb19ef6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2991de22736346499f93730cc6444632_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb98b0ac54b84d199190275ac41818ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42836131dcd845d9b7d67c233c57a9e5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b0a3bd4a6c42c2898767451b09fa3b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie377b2d58e75450081174518661faffc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice576d710d154504bb423eb18f1ad591_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09917a07a99c400e9b8821622e9f4348_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie999f144ca6d42a8945ed5489734beaf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7453ee4e20e44478b0b8848dde011f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2500b0e4387f476185dd50c36f479490_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic730c612567f459fb5f4f0a35a23f7aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6157347e1860457c9ba2688f1f242d19_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3520dd0084974b7b9d074b11858f9955_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02b8ec43328475895f430cbf7c3fe17_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d3648998024a2caf8410e3d681a404_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ae3fe6eee984352a3ff41b1d601ab3a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e3951d25ef84754a2744cec75114754_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fde4bcaab504180ae894941003778cc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890d82d4d1c74eb0bd114be1fd3387da_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ff8b0693ba14e6a8ba588d8c68f9d36_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">exas:ArmuneBiosciencesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icce105c6a6b64d718e4502a0b7aa92d7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">exas:ArmuneBiosciencesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6599b9ca619946ee95551b50bc36454a_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">exas:ArmuneBiosciencesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i501c7f9788854b61a82cd861d37a75db_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4920c4a12554781a0baa0e8b7a2a4ca_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:GenomicHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6653408e966412f9580bd258009d9e9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7670aee13835456b9ef946cbf5090d2c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i076cccc3ea454a719579e19eb576403a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7735b48d36ff44b29b0a466a9b6c6a03_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eaa44b39d5645a9a0faf988680be02a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if36c23e4f0c64b8892c737ae997e1b21_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice75a7198c9c4189b63219eac0c1032e_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4330edc45cf84441a4cd9cf3d6dc4379_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec3596c0cce347588c0c90b759253721_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71ac0875363d44f48e9a998b50b03693_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5b310b00e484dcf83114f26ed4d03ab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1edbf863623a4583b670e04195a560f2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f071db6d26f4417836a89ae4bf9dc13_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae353c40c869427d99501cfd0e428d16_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47e1dca476854604bbc32c5a07963ffa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia30980f5ef444b3490f4789bea8f12fb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2629689a88b443dc8d9888f5eef1bd71_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5f1a09055054f3d8d1946791967fc77_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29cb011245734390b34548e0994a1a0b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i556b2b7061a84128a4bcc29752f8e922_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e1cdf0f1387456c89946289c26f60e8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6d0406051014646b0970f3d9130bbb7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i108006d8fdb74103b198303365a9bc58_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic730ed990e6644239b3ae1d4cb5eb387_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee052d8326c94ffda0d8f89f13146d06_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f1f3c7b2e624156a85733d1e95e2f04_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6d569e7074a40b4b3e6f21fdc68efdc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabdd7005af4546f38d23f679ee216c45_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79793c0a6b4a40bfbc8f7bd09705a9e1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c347bb18e4e44cd93e616e79b51eadc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaab539435c7a481aaed99f701cafa053_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6179574a6404661adb02cdfd4ecac70_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f5eb5cb806f46a3a282ece9ae9e05a6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02062cfc353a43feb126d3f904610723_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0332bd716b34f80bbba08e250974a9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e4418e3f444936ae782784aaf5154c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f358e0fdb3422f93412305ec8ee504_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ae36a17c1b640618068686e33ff1802_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456b35ed51ac45b18c17b51e6d86e854_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07629df4ca2c4cbf803a8e9b3e8c6908_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0802092f5404859b5da28c255e698c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70d1e5476c5e4d07af802800933a510b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e245a53d37346bf907516b3ea304801_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31c943c8a77e42589005bd95b10382ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672fb690c6e24a47821c2ddc8a90fabb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e24063fca9740369d367ba93027918e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d60b555b44746d6b68f5fe0334c3ca9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c3a663e94eb4a27bd5c65ba03cacf87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i247aaad53c6245ccbbd5ec147d4988da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib403eea329ef416a8a24ac2287f97a62_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd7d357017eb4157a5f470172d3e0487_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dd8f93b52f5442291314fe4545a7ec8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i043e843eab1c434d95629465a45eab9a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43309733f4814ee09bbc83df1d2962fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c5970ee82644e25bb734b992dd63362_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8e8f57f6c664ec39d5d416a45042a81_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ee94b86157f48f68658ceb0b86089f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7735ebc6072e4844a77d8a37da54e9e3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveAndAshionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibd2c2b55dd8e4b4a8baccd8dfe9fabf8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:ProductDevelopmentAndOtherMilestoneBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">exas:MeasurementInputProbabilityOfSuccessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3f1b003917c4eb2b6290a35759a68ab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">exas:MeasurementInputPresentValueFactorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:ProductDevelopmentAndOtherMilestoneBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f9bc02d95f4a8d88d901e1d36b8857_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:RevenueAndOtherPerformanceBasedPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:BiomatricaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1df4e2f14a42828145784edc81d152_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7e54c98df5e425386007ce202a5cdaa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i423735ec2fa04dc998bc308ebb5ebaa2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46c3a28bcdca48689179ee81c50f41d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875166f2ce66407bbd9156c0c0b38938_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3202fd2c10d4c7398235b5e85235b84_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">exas:OneMonthLondonInterbankOfferRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadfa6d5584e64d8d96cf57f8ef06f8c5_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e094585ad64a8dbf6962da458f2b91_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f3368f21e3f45b08bdf3abf7718904a_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafe6aabe3c26422ba3568068ffeae6b5_I20171130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1c80baca1f84cf0b348fa500c7ac519_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cd6211d49ce40f2a37e553096ffe101_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3bd705add894d9cbb688ee5e9a40dbf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e9cb3ad90c4a5d82d4288d4e770a53_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d7390258e4a4b2ba37dcee40cdf5250_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i797d752f32bf41b5a68518c097333f71_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agreement"><xbrli:measure>exas:agreement</xbrli:measure></xbrli:unit><xbrli:context id="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">exas:TaxIncrementFinancingLoanAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife7a525df7ca4926bdd7bd3c78f5a6bd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">exas:TaxIncrementFinancingLoanAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>exas:employee</xbrli:measure></xbrli:unit><xbrli:context id="i215a2290155b49189167351e504e7ec6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">exas:TaxIncrementFinancingLoanAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a521727e1e2422195adff75e2af975a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib556532666a843ffaa7ac89ce011921f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if16b3c6f1e4a4d1489f70faed335b68d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbba114462ea45e2925e5dd96d8f6ec2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50e1ec8fda6643ce82eee56046acd62b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfddf1183e2348268bfa21947a0c2519_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if11cabfe62874386b5321d2d3c18173d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7019a92c504448ceac52c088b3629b1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3877e40a0f249069cae9a5fc123fb01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d10c4091ef4bb88a8442da98f2e144_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d45eaa6f404347bac96339127fc805_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38025f781a304faeaa4d5be06d555c28_I20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:JanuaryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2e12ba29e1148cc92200e3f802d478d_I20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f6e4612ba6042b3a41b0a3a22cc1a08_D20180101-20180131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i130815bcac064cb9a769f10dde0d717f_I20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:JuneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i321e09355b9344bb8c1ddfb4873b74c4_D20180601-20180630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:JuneNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i374446ae108740e8b3d011f480573480_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:AggregateConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cedb49083ec46b7819b0b36b95fd866_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:AggregateConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bfcc0d5558a40d4bbafe59948477390_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b1067f298de48eca8c19edda276d2ed_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0a237027f04c40b0f9753f4982f052_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41663aac7c7a4e50bbe228b3f6df07a4_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5de4fa457232460eb415263a8948799a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:AggregateConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i124fcfaa5c2844ba9a7f3648437e97a4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:January2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icebfd363a27a407f91529aaa90ed0971_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:June2025NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd02d60e985347cca760b9cee3c1553f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11ab2964ac5a4d30ab3e51e81e533a19_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i558d42ab543b48d1bd82a3e120ac356d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c6f646df40d4090b3421105d8392a38_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25bccea148c24ef3b5882a544e0cc76f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62e976ba77074ce9b9fe3a0c91204d9f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie533365c1c7a49cfa488f532fa22ddb8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i096f0478568e4ab3ba5831ff5cf0ff8b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09b705cb560e427b94fb986c5efcc8fa_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:MAYOFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7687d156b5064d39b98d15068b794c79_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b58a8bac9c14347b1a5e677d4bd4071_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4940cc012454056b02ad98f6edbda80_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38df5143fb9f471eaadf9f61fcdb461a_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5315ee1596b6499d88299026c527248b_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08569ff75b9f4fb89d6962ce95f8760d_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie431846077ce465aaa2deb9090c42f3d_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id60aa524dd6844bfab317842fa27f753_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i073a3afe3259475fa47b27b5734849c0_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib66de190a3114ea390108d37accaf4be_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e581abbb2e45fb9d0f5e111ecb424d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie75cea8f115f4394bd4c6369824b83e6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f8d48835a0141b7a3d9e3c2af436ca5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-14</xbrli:startDate><xbrli:endDate>2021-04-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fa41ad8e71d4dd28f502802045906ae_I20210414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i376b181ad07a407cbb2ac71cfb91c79f_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-11</xbrli:startDate><xbrli:endDate>2021-01-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-03</xbrli:startDate><xbrli:endDate>2020-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i440309922a2844d8b7f20c86821d414f_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i949e45cbfa8f4affa83a6c86d26dc895_D20200303-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-03</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if11e689b7b1c49b3a07b24b28aee69ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6189b240ae4709b0cb6a53b24b5529_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb78c2ffc7a24797b5f3efdbf143d558_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9728265290ae4d62bae3395eaa6b09a9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc090024fb42477da472a7b389554c39_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032fd22b30fc4740afe82de8e068942e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350ab28dcf6f4361a935ff5ed1b2d4e0_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id526869db3114853b21ef6d57b0d6023_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e5ec3803d9c47489d2b8976b93ba9cd_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i871bb8ae36f4481b94f202bc81915ae8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b935f915cf4d8284af4012ec5af1fc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820542840d28423db7a2ed962f5b4151_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibed0ef19bdd64427a77d040d96302174_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46963a5244634b8a9cb4bede92e87e7c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd69de72c3544263ada7167dc7802735_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0149388bcc174e008d48d4ce24ecd34b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icecddaccecae455d8964c306f1d3197d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f3ebdda81e4395b4fdf88ad090c5ca_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e812e1e60a444187707448c6487230_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f69879b003347d9ad2b403f9773eef5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4a70c95a2c047f2bdceaeba16fb36a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27d111df7c824f28b43805bf4020f417_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ad627bc9d74b5d9d01292c752d08e0_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i980b2917c57c435eae9dc611d50ee893_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6945ebb4ad9454887ade5b79a893636_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e2d9caa00d941178a209e6942f90740_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e95c6cd79cc4d7a935971ea5e1e6e8e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ead48ecd8c495a8083ab6bde044c3d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie99e0e805c704e9eb1ceeca30b976339_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a8ee4db1a042719bcde877f5d252ea_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i558be5b82da24f16af1d8a52684e9d6d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f932abf713e4c43a93cd801959cce5e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c9ab0eda5440bd9d65a69c85ab0eb7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39ccbffede514c3292129dae5bcde954_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b0e97ffe0040889b3f8b090462e327_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:FacilityInLaJollaCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb129685ec824606a9235abe6526a5d3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">exas:DOSRuleInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d998ca81b55400f81d638f38b49779c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">exas:DOSRuleInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">exas:NewMarketTaxCreditProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>exas:facility</xbrli:measure></xbrli:unit><xbrli:context id="i107170d7fed64652982d166e0b941437_I20150331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc1f54843b74a68949920da70be0d63_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a07478702f74507bc6501dba1c86d9d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i233731ca43664d2c93c9d490bf6d67d5_I20210414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:CommercialLaunchMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i990575d7a2fe4594870c1692af08e8f6_I20210414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:MRDProductRevenueMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70acbbc0dbc5483ab952ef2d524cf18b_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b131fa1d864ac79567f3577788ccc1_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:FDAApprovalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55deacfe7ea94c7488107e4687d0d7e9_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:CenterForMedicareAndMedicaidServicesCMSCoverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434a63ff04d349ca9dd0cd31f8dbd3fe_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a0e991fc3574513b998b53a404cbd4d_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:AllocatedToConsiderationTransferredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic720ba1718c741998617bf85bd1369ef_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:AllocatedToPreviousOwnershipInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e00c316ed7d4743b9ae72c32d1ea634_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:AllocatedToCompensationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72248a0ae06a4828857001f7eb06939a_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:CompensationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3b489bbf63f4c70a052049910386070_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2212887fcb4485932c6ca7b57bac3b_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37a4ec695a024e4e80da4d3494beed97_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9248689114b34d9bb59ac32e2ea4d2fe_I20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i739d95546ece4d0bb7484bec638b1ce3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-06</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1bb5f00a7bb444381ab380f445719b4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2de807b6ca3d4e4a86f20612c5808594_D20210106-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-06</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4af871727fe246d883797ebcafb803cf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie231f4fa3d2943ffbe7fe72b6feb6e16_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2208e7b3dafd4734ad1c448f7ee2ebd2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">exas:EmployeesWithQualifyingTerminationEventsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b29593c68434f2699b1a75adf89a7cf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i836f2fc064cf4745a2df3a6dffded766_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68687c83ee8c49eb85c072bb07c29656_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie959531369c94b0683d868dc39af4087_I20200303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53102950ca084ca68b3b328343165ec8_D20200304-20210303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-04</xbrli:startDate><xbrli:endDate>2021-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i660d9c31964046fd8f0829d2e58f4405_I20210303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i236fa5e8e1614dad9327b02436f9e492_D20200303-20200303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-03</xbrli:startDate><xbrli:endDate>2020-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5084f90d66dc4b7ebb62ead28ea222fe_D20200303-20200303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-03</xbrli:startDate><xbrli:endDate>2020-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98ec76a50c654b3286dda25e4ae5e185_I20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:PFSGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584d1f57791b47d7842344882f5499e3_I20210623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:PFSGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:PFSGenomicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-23</xbrli:startDate><xbrli:endDate>2021-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80ac638840f440a7904d59afcbea3cc5_I20210111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifabaf4b7e254465dbc76f19d64a783d8_I20210111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f31a307e874ce8afdd82c892892230_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice171bffc87a4afd95cc52b6534e2776_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8253dc31a74450a8053d46842c3eb1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f486f15d984c8ab5076786cc04e07f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11e90247f0d444a48ddf485761f1c6bc_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c6bcdbe518418186b36093e716a0e5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6260119aed2d44219f06bcf7f78466ff_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5a40758325f4f10ba85a4d7f63cc106_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia01c094882504b1680c962a4508c16f1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0745308ee7374949b866802826027f90_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124140</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>exas:segment</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ifd942d9caf664925b961fb4f8d8f685d_1"></div><div style="min-height:31.5pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;border-top:2.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.881%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU2_7eb2e827-9e03-4e6e-8fda-b9640b494cec">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU3_0b7927ad-a414-41af-989f-a4ba9e4241f8">&#9746;</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMTM_eae0c5ae-02bb-4cc8-8506-849211fc2b9b">September&#160;30, 2021</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU4_dfc36e0f-46d4-4752-ae5d-3de2e3fa7501">&#9744;</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUy_5ba84d3a-0b5e-43b9-b489-68862060d8a1">001-35092</ix:nonNumeric></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDQ5_46017015-cd79-44d6-b473-5548a96a706a">EXACT SCIENCES CORPORATION</ix:nonNumeric></span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8wLTAtMS0xLTE_be028e2e-2831-401d-a1db-e4648621b539">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8wLTEtMS0xLTE_f946856f-94e2-4905-bfbe-698d11e514a6">02-0478229</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(State or other jurisdiction of</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(I.R.S. Employer</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Identification Number)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTAtMS0xLTEvdGV4dHJlZ2lvbjo5OTFiNDMzZmEyNTU0MDRkODhmMWZiYTFhOTg3ZmE0Ml80_63c20cd3-09b4-4d10-a699-92c850f71ea6">5505 Endeavor Lane</ix:nonNumeric>, <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTAtMS0xLTEvdGV4dHJlZ2lvbjo5OTFiNDMzZmEyNTU0MDRkODhmMWZiYTFhOTg3ZmE0Ml84_dbf5f70f-06a4-4605-8e31-c2c009cb262a">Madison</ix:nonNumeric> <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTAtMS0xLTEvdGV4dHJlZ2lvbjo5OTFiNDMzZmEyNTU0MDRkODhmMWZiYTFhOTg3ZmE0Ml8xMQ_b04baed5-4615-4a20-a0fe-e5d5b841b739">WI</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTEtMS0xLTE_524e47f0-0f02-4e63-a4e1-ce1b243a98e4">53719</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUz_79af6e8e-da5d-4d1c-8e92-f34aa33b10b1">608</ix:nonNumeric>) <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU0_7b0e0c56-a4a5-4d9e-b04a-2a82c5073dec">535-8815</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">)</span></div><div style="margin-bottom:6pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.731%"><tr><td style="width:1.0%"></td><td style="width:31.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.784%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title&#160;of&#160;each&#160;class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading&#160;Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6MzExYzdhYjAyMjUzNDViNzg1MzZjYzQzOWI5Y2VhMDkvdGFibGVyYW5nZTozMTFjN2FiMDIyNTM0NWI3ODUzNmNjNDM5YjljZWEwOV8xLTAtMS0xLTE_eb54aad6-10af-40ad-9efa-9b72072f1619">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6MzExYzdhYjAyMjUzNDViNzg1MzZjYzQzOWI5Y2VhMDkvdGFibGVyYW5nZTozMTFjN2FiMDIyNTM0NWI3ODUzNmNjNDM5YjljZWEwOV8xLTItMS0xLTE_91ae4607-7e5d-4308-8fc2-406f579d664d">EXAS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6MzExYzdhYjAyMjUzNDViNzg1MzZjYzQzOWI5Y2VhMDkvdGFibGVyYW5nZTozMTFjN2FiMDIyNTM0NWI3ODUzNmNjNDM5YjljZWEwOV8xLTQtMS0xLTE_18d26a0e-943a-45a6-8f17-6a94d56291a8">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU1_149eacaa-9591-4a36-9a90-542f219f35e6">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9744;</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUw_f1a61bbd-5a2c-4877-bf4c-fa823172e612">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.387%"><tr><td style="width:1.0%"></td><td style="width:46.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODk4NjM4NDFiNDMyNGQyMDk2YTEyNmZlNDk2YWVlZDQvdGFibGVyYW5nZTo4OTg2Mzg0MWI0MzI0ZDIwOTZhMTI2ZmU0OTZhZWVkNF8wLTAtMS0xLTE_332333ad-567c-46e3-91f5-1fd8866cde0a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODk4NjM4NDFiNDMyNGQyMDk2YTEyNmZlNDk2YWVlZDQvdGFibGVyYW5nZTo4OTg2Mzg0MWI0MzI0ZDIwOTZhMTI2ZmU0OTZhZWVkNF8xLTMtMS0xLTE_7675e349-7e0a-4543-b727-d450a1680939">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODk4NjM4NDFiNDMyNGQyMDk2YTEyNmZlNDk2YWVlZDQvdGFibGVyYW5nZTo4OTg2Mzg0MWI0MzI0ZDIwOTZhMTI2ZmU0OTZhZWVkNF8yLTEtMS0xLTE_c8f897e7-467e-4f58-a87e-e27e54967b35">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt;text-indent:18pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#9744;</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUx_273f14c6-1cb3-45f0-b741-8629b0f33314">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9746;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of November 1, 2021, the registrant had <ix:nonFraction unitRef="shares" contextRef="i4345381fdd3249c7b09e4950af6f50d7_I20211101" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDA5_cb4d1ca2-3d8c-45b9-be5c-f08f114a9a7f">172,318,821</ix:nonFraction> shares of common stock outstanding.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page<br/>Number</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_10">Part&#160;I - Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_10">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_10">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_13">Condensed Consolidated Balance Sheets (unaudited) as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_13">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_13"> 30, 2021 and December&#160;31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_16">Condensed Consolidated Statements of Operations (unaudited) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_16">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_16"> Months Ended&#160;</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_16">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_16"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_19">Condensed Consolidated Statements of Comprehensive Loss (unaudited) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_19">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_19"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_19">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_19"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_22">Condensed Consolidated Statements of Stockholders&#8217; Equity (unaudited) for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_22">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_22"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_22"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_25">Condensed Consolidated Statements of Cash Flows (unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_25">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_25"> 30, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_25">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_28">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_28">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_91">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_91">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_91">43</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_94">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_94">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_94">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_97">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_97">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_97">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_100">Part&#160;II - Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_103">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_103">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_103">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_106">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_106">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_106">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_109">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_109">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_109">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_112">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_112">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_112">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_115">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_115">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_115">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_118">Item 5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_118">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_118">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_121">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_121">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_121">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_124">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ifd942d9caf664925b961fb4f8d8f685d_124">62</a></span></div></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share data - unaudited)</span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Part&#160;I &#8212; Financial Information</span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_13"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMy0xLTEtMS0x_f52d52f6-c2d9-4528-bd4e-0fa8243eeb82">273,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMy0zLTEtMS0x_08e9a446-371a-413c-8c45-b1056f4512f9">1,491,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNC0xLTEtMS0x_8697c8ab-0552-403a-be6b-f9ab48ad6065">944,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNC0zLTEtMS0x_2738c95d-cc67-4cf0-a812-8aa0ee5921c8">348,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNS0xLTEtMS0x_2777dae2-10bd-4b78-ba21-49bcbb527b92">249,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNS0zLTEtMS0x_93e149a2-79fd-4d6f-8208-dd1ae1b56375">233,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNi0xLTEtMS0x_930f744a-4856-4695-9c6f-18a99fc88e00">95,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNi0zLTEtMS0x_0e9aedae-ca86-45e1-ab15-404ee908b5f8">92,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNy0xLTEtMS0x_bff82d3b-8c28-4b3a-af6b-ae1fda1242b4">52,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNy0zLTEtMS0x_e32d3770-6e2f-4153-a741-4367d4072113">33,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfOC0xLTEtMS0x_95c91bd5-ae6c-47a9-811b-4a47c1fb2abd">1,615,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfOC0zLTEtMS0x_c79cdc7a-2eea-4e8e-8cfc-2e5638500812">2,198,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTAtMS0xLTEtMQ_b9e9a0b4-0b7a-4543-bb80-72ef7be2a054">524,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTAtMy0xLTEtMQ_ee0c9769-02d7-472b-b50f-332dbc3abd56">451,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTEtMS0xLTEtMQ_1340ee9b-fb1b-46d9-917d-031c0f984c0b">167,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTEtMy0xLTEtMQ_2ab32944-fe16-405b-b8e1-707f1a1bfb47">125,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTItMS0xLTEtMQ_7f2f7132-4d8b-4382-9496-7ecf07f5a545">2,242,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTItMy0xLTEtMQ_90bc7ddf-8bd5-4b79-9654-bbb3ab080dd8">1,237,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTMtMS0xLTEtMQ_23088bbf-3b03-441b-bb71-e3dc256a48c0">2,044,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTMtMy0xLTEtMQ_8ce40ab5-e3a0-4307-85da-d5fc342bb658">847,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTQtMS0xLTEtMQ_8cf858a4-3647-4b1d-be00-e4a787c90760">59,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTQtMy0xLTEtMQ_787e6c16-2256-40f3-9121-e37784c84436">63,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTUtMS0xLTEtMQ_d014c4f8-b7ef-450e-ba28-dbb422fa4df5">6,654,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTUtMy0xLTEtMQ_a8bde2ed-30c1-415a-8ff8-e18929329d91">4,925,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTgtMS0xLTEtMQ_a8273ba5-b17c-486b-baa7-add1e1e1ae71">41,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTgtMy0xLTEtMQ_15db7078-9eda-42fd-a808-4e013971f892">35,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTktMS0xLTEtMQ_42847e61-b0e3-4b24-9c56-d46e0689ab68">304,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTktMy0xLTEtMQ_2f90a0b8-0991-4f50-aaaf-5cfe6c2a2017">233,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjAtMS0xLTEtMQ_177d39ea-940f-4457-b7cc-059aae799add">19,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjAtMy0xLTEtMQ_1bbc880f-91e8-4bab-a3c4-9cfc06e35876">11,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjEtMS0xLTEtMQ_04379deb-0efb-4178-b680-787145877fae">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjEtMy0xLTEtMQ_91e778e5-c290-49a2-a11e-ac46a513fe2f">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes, net, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjItMS0xLTEtMQ_a7b55e45-7a5c-41fc-aa9c-77925b69b2f9">313,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjItMy0xLTEtMQ_5f226618-6c34-4b20-85a8-cd0ebe76bc3c">312,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjMtMS0xLTEtMQ_2dc4b53b-c208-4da0-a3b6-d5c2b39aec9d">30,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjMtMy0xLTEtMQ_3680e6c3-0ce9-4d05-ae6b-24ee7e4138f2">38,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjQtMS0xLTEtMQ_a94c1a98-b066-4a63-8f8c-000813171927">710,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjQtMy0xLTEtMQ_796e30b2-7c6c-433c-93ca-e970f3d63677">633,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes, net, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjYtMS0xLTEtMQ_6a45b7f1-aa7c-4ba2-9907-990935c45580">1,865,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjYtMy0xLTEtMQ_2e9d17c9-e04b-4792-8b54-ef58118a9c17">1,861,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermLoansPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjctMS0xLTEtMQ_ec5b56f4-7b9e-47a8-b62f-c00b768c07df">21,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermLoansPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjctMy0xLTEtMQ_c9ee753b-cd39-4944-9ac6-05f1fb35d3b0">22,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjgtMS0xLTEtMQ_4b39b1a3-a8be-4f23-807a-06180eddfed6">436,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjgtMy0xLTEtMQ_b52d2d3b-b7c2-40c2-a0cd-d392b7f5586b">51,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjktMS0xLTEtMQ_e18e05e3-0459-42e0-8e94-05d4e8737e28">162,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjktMy0xLTEtMQ_54529b53-ef24-412f-bfea-2f7a00752166">121,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzAtMS0xLTEtMQ_1a6b2b78-31e9-438c-bdb5-9bc7e8c418fc">3,196,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzAtMy0xLTEtMQ_7be107be-0aec-4a94-9c06-911922cbcb15">2,689,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 14)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzEtMS0xLTEtMQ_50178a73-b658-4731-abab-5ee3a40cd82f"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzEtMy0xLTEtMQ_b9c7d0ea-85df-4668-968e-0b74a0929874"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzIx_4729dc42-c72a-451e-927e-82f2f9c3f4c7"><ix:nonFraction unitRef="usdPerShare" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzIx_b5e50a23-15ef-4d75-8a28-07bec760c034">0.01</ix:nonFraction></ix:nonFraction> par value Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzQ1_6ddfc6b5-36fe-4fe8-84e4-035dfa32c65c"><ix:nonFraction unitRef="shares" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzQ1_8c2ac30f-d145-40d9-9042-f91ed6a0ade3">5,000,000</ix:nonFraction></ix:nonFraction> shares issued and outstanding&#8212;<ix:nonFraction unitRef="shares" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_2f22bd15-2d39-4ff1-a036-d5779de3364a"><ix:nonFraction unitRef="shares" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_36f0bd7b-cd10-4e87-8971-46184fa51ee4"><ix:nonFraction unitRef="shares" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_c6842332-3c3b-4ea0-ae2c-1cb119a67d69"><ix:nonFraction unitRef="shares" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_e8808c23-1e55-4ca7-bca7-14b4fff035ad">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMS0xLTEtMQ_f010729d-dfad-457d-a575-46b5a0597a33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PreferredStockValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMy0xLTEtMQ_0e2b7e43-9296-4f87-9ed7-d4d991431c31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzE4_ae545512-7843-4614-b8a9-69dccb228782"><ix:nonFraction unitRef="usdPerShare" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzE4_ba07ba65-2c7a-4255-8da5-33f57161e74f">0.01</ix:nonFraction></ix:nonFraction> par value Authorized&#8212;<ix:nonFraction unitRef="shares" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzQy_d136cd03-90af-4c99-8482-49ed4842fad7"><ix:nonFraction unitRef="shares" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzQy_df49bc6e-75da-423a-945e-474bcb6997ef">400,000,000</ix:nonFraction></ix:nonFraction> shares issued and outstanding&#8212;<ix:nonFraction unitRef="shares" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzc1_62b4f3fc-fe25-4102-acba-9145cdf6ea59"><ix:nonFraction unitRef="shares" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzc1_8b741d5d-e934-4f02-8ddf-fd4669689147">172,242,798</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzgy_a27a92be-4a7c-4ed8-b2a6-5b17a98e4204"><ix:nonFraction unitRef="shares" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzgy_a91465d9-2929-431f-9b78-aa122b1200d3">159,423,410</ix:nonFraction></ix:nonFraction> shares at September&#160;30, 2021 and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMS0xLTEtMQ_ae3828cc-f74f-409b-bc2e-46dcc2ef98ad">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMy0xLTEtMQ_3aa4cf7e-7c23-43fc-8cc3-cd2efcbce51c">1,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzUtMS0xLTEtMQ_d23ac330-f95a-4e29-92d8-a1a5af30b08f">5,876,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzUtMy0xLTEtMQ_93046777-359d-49c2-b55b-80675329c3b8">4,279,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzYtMS0xLTEtMQ_fd02b4e5-fdf3-4b5a-83ff-120a2ac96b40">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzYtMy0xLTEtMQ_b6c0e077-887b-4f85-84ba-2a0f373cc87b">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzctMS0xLTEtMQ_2d33a8f7-9bef-4bb8-be9b-f5b8b0d0f25e">2,420,910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzctMy0xLTEtMQ_cb2caab5-575f-4c7c-989c-8c67e4d24837">2,045,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzgtMS0xLTEtMQ_59087cb5-afd9-40a6-bb40-cd3437439c06">3,457,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzgtMy0xLTEtMQ_1f138f15-20b9-44e8-8250-a946a15428af">2,235,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzktMS0xLTEtMQ_046e8c50-4ac9-49b8-890d-a4abb616af63">6,654,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzktMy0xLTEtMQ_51e83a2a-4d55-4523-b84e-c34eb32ca1b0">4,925,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except per share data - unaudited)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi0xLTEtMS0x_910e3e84-c4a0-4f04-996e-17f88b175242">456,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi0zLTEtMS0x_6bfccf7e-b357-4c58-8e60-c2e69e6ce784">408,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi01LTEtMS0x_61d7356b-8ed5-4ee0-8c1e-ce00ea8b831c">1,293,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi03LTEtMS0x_4d57ed78-4591-49be-a01c-f9c75ce99c7b">1,025,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales (exclusive of amortization of acquired intangible assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS0xLTEtMS0x_c260cf2c-2c76-43b5-8ca8-21a17483f39c">115,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS0zLTEtMS0x_84a85724-dd09-42c5-9860-9ce97a70b8bb">95,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS01LTEtMS0x_584f82d6-5921-4c5a-9fcd-e2d1f204f94c">339,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS03LTEtMS0x_1dff9146-c916-45fe-b0ff-bc8c3317629f">254,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi0xLTEtMS0x_149ba1fd-ea59-44ed-a550-ca7fdb8a3515">75,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi0zLTEtMS0x_d214096d-3eec-44b9-85e8-07338b0f1aa7">31,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi01LTEtMS0x_cf200368-93f2-475e-946e-5fa0e4402f5c">297,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi03LTEtMS0x_62ff423f-fada-46c8-9bd9-0065dfb90b48">107,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy0xLTEtMS0x_7bf28736-e3b6-4ae4-ba41-cc269ed797b8">196,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy0zLTEtMS0x_e01a69ae-ebad-4903-ada2-55202bc9d7dc">136,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy01LTEtMS0x_81a388d2-34b6-4754-a176-accdd8992a1f">577,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy03LTEtMS0x_6b8e149e-b25c-4fdb-a6bd-36fac90127b2">423,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC0xLTEtMS0x_7e62c179-f8e9-4b82-9088-fcde9a612327">186,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC0zLTEtMS0x_87384eff-367e-4546-a29f-ca07f770429f">115,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC01LTEtMS0x_c2c674d9-e44a-4899-90e6-4908efec29df">621,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC03LTEtMS0x_360586bb-0cf6-4408-8611-814f80b42641">336,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS0xLTEtMS0x_0b31d47f-da48-483b-b503-3fc59b2ad769">23,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS0zLTEtMS0x_2f881637-adfb-41a9-bdd4-09f8ce04ccfe">23,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS01LTEtMS0x_ab197447-d9af-4361-8c77-baf5980dd260">70,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS03LTEtMS0x_2d201873-5026-4e83-9e52-70ec33608e05">70,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMS0xLTEtMjY2_a31931cc-92ca-48ec-bb89-c48160ebd1f8">20,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMy0xLTEtMjY2_b4aefd6b-aee9-4f03-a358-b8a1f44cce24">209,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNS0xLTEtMjY2_126b0d9e-841f-44c2-a91f-5d02dc3e6a18">20,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNy0xLTEtMjY2_6f1e0f95-94fa-4146-a6e5-5e6560a31347">209,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMS0xLTEtMQ_60176d86-3fc4-4c3e-a83f-a14e58ea4f6c">618,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMy0xLTEtMQ_9cddff02-8e30-4813-9883-e45aabde1411">611,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNS0xLTEtMQ_3035c30e-680f-48d2-8fa9-c30cf51bc6fb">1,927,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNy0xLTEtMQ_15395e56-a7f1-4819-a9c9-b03139ee4a51">1,401,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItMS0xLTEtMQ_6c33dec3-9e33-43c6-99c3-e05e0601599c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItMy0xLTEtMQ_cecce2eb-528e-4a83-a5d0-04df68e77bea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItNS0xLTEtMQ_a6f1b107-56bc-4965-81e6-930a7fa057ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherOperatingIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItNy0xLTEtMQ_7886bd71-0e86-4128-9b88-d9eac3e178f6">23,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtMS0xLTEtMQ_48b33144-b4e6-44dc-8677-fafa4398dda6">162,023</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtMy0xLTEtMQ_5e290d06-d1ef-4191-a236-5445a089ad37">203,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtNS0xLTEtMQ_d675ed0f-8f9a-487e-9e9d-22185f67406c">634,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtNy0xLTEtMQ_2b4369c9-ccc5-458b-abba-067e5dc712a6">352,717</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:InvestmentIncomeExpenseNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtMS0xLTEtMQ_0522a94f-f458-4950-a9d5-98746f582e37">4,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="exas:InvestmentIncomeExpenseNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtMy0xLTEtMQ_a6f6c130-2d18-491d-9645-824717b1d086">2,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:InvestmentIncomeExpenseNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtNS0xLTEtMQ_ae1b2881-b4aa-4956-8171-84f12e0b11bc">30,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="exas:InvestmentIncomeExpenseNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtNy0xLTEtMQ_c1327de1-af0e-4634-b46c-68d00d6d11a8">5,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctMS0xLTEtMQ_e7824e4f-be34-4c1a-8286-f93003a41a81">4,680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctMy0xLTEtMQ_b726c87b-5eab-4bf7-b60b-7ef64e36dabf">4,478</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctNS0xLTEtMQ_8a3edd55-d15a-43f4-8237-9423135bade1">13,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctNy0xLTEtMQ_b8fb6c96-f9e9-4f30-9f7e-12619e5cfd5a">63,382</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtMS0xLTEtMQ_7d65c683-4def-4d48-af65-ffb6e278b2e2">8,773</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtMy0xLTEtMQ_6fbe277b-8e85-46fd-8044-334c8934e20b">1,955</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtNS0xLTEtMQ_782b3c29-5a1c-48ad-a0e0-1433c62414b5">16,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtNy0xLTEtMQ_3518816e-2b21-451a-95ae-825a698d794c">57,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtMS0xLTEtMQ_331bf4d8-4c91-48cf-b970-ad8a82d1e6e1">170,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtMy0xLTEtMQ_ca9cfbf6-01bb-419f-9391-3465cf5d7830">205,290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtNS0xLTEtMQ_0031e5c9-826a-4360-b2f2-995e1b3a152f">617,652</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtNy0xLTEtMQ_4cf912b0-e285-4e82-a7da-3824ed00ea67">410,567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItMS0xLTEtMQ_c2a3d349-0a44-4f83-bddc-7cea2a0267d8">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItMy0xLTEtMQ_b809f1b0-57d2-4376-b082-14397248f9f1">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItNS0xLTEtMQ_d4520d8a-3f3f-465f-87cb-750e7c68abfa">242,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItNy0xLTEtMQ_50ea01a6-678c-4a05-b452-16d5fb9476f5">5,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtMS0xLTEtMQ_cb35a3ba-2d92-4b41-ad52-faa0c97e8d32">166,938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtMy0xLTEtMQ_a3846831-3fdd-4897-ae46-d87820c86c3e">202,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtNS0xLTEtMQ_997c8cd0-cff7-47a0-a8d6-73c9d9d352ed">375,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtNy0xLTEtMQ_806ef33b-1d23-4f0a-8007-725aba3d255d">405,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share&#8212;basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMS0xLTEtMQ_c6786d09-ee94-4679-a830-a2e2522f2ec3"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMS0xLTEtMQ_fcb0cf58-2d9e-47b1-9751-1b0ae5d574d1">0.97</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMy0xLTEtMQ_7aac35e9-22a5-4ad8-b242-691175451a07"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMy0xLTEtMQ_b4d4425d-cfa4-4715-bc20-30dea812c703">1.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNS0xLTEtMQ_4fb72e39-7a8c-4d6d-a89a-9a70e0d21d93"><ix:nonFraction unitRef="usdPerShare" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNS0xLTEtMQ_9dd1389b-f882-4a22-a96f-5b07c3d8d8dc">2.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNy0xLTEtMQ_17b45bf9-2ad0-41f0-aaf3-33468e8dc28a"><ix:nonFraction unitRef="usdPerShare" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNy0xLTEtMQ_fe225dc5-baa9-4c71-ba2d-5ff62713d6ac">2.71</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding&#8212;basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMS0xLTEtMQ_0c399f13-5978-45af-ac3c-9dff62b54dec"><ix:nonFraction unitRef="shares" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMS0xLTEtMQ_928ee9c5-705b-4741-ad51-442a8647ca09">171,978</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMy0xLTEtMQ_1e91f91a-f5d4-4c63-868b-41a578e3d09a"><ix:nonFraction unitRef="shares" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMy0xLTEtMQ_2bd7d3af-6a56-44e6-a3c0-150e786647cf">150,155</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNS0xLTEtMQ_08d978a3-731f-41e6-b770-c133bed1aadc"><ix:nonFraction unitRef="shares" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNS0xLTEtMQ_c7cee06b-0822-4704-81ee-48cc26974453">170,978</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNy0xLTEtMQ_1692dc23-1143-4f30-9d9b-8cc80cd094ce"><ix:nonFraction unitRef="shares" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNy0xLTEtMQ_a3064940-6100-4967-955e-d4a6059560d8">149,346</ix:nonFraction></ix:nonFraction></span></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands - unaudited)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.726%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi0xLTEtMS0x_5972c2e1-ea4a-4354-8de8-c2cd4e867100">166,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi0zLTEtMS0x_5d06adbe-ef31-445c-9569-dc7400de0bec">202,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi01LTEtMS0x_e273ca00-847b-4bed-ac02-d5f3d6d5138f">375,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi03LTEtMS0x_0892e237-a6d3-4fcc-937c-c9ac6d06749f">405,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), before tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on available-for-sale investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC0xLTEtMS0x_45a3498a-f9c6-4d6d-8448-c1d3bbca4011">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC0zLTEtMS0x_c3fe8f3f-2d19-4837-a68a-c034041aff5b">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC01LTEtMS0x_e221c5fd-6c3d-4466-9ae3-7c3ce6e476ff">563</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC03LTEtMS0x_ff8edf18-5208-40c7-80d4-8918a6d93319">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS0xLTEtMS0x_06f36e19-25e2-4fdc-853e-68960c60183b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS0zLTEtMS0x_c8474a02-3408-46d8-9f19-5c8c5210cb97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS01LTEtMS0x_fb4e8ebb-d6a1-4c37-8c7d-2b100dce46d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS03LTEtMS0x_3b88b3da-c12d-44ce-afd5-eea3bd141a39">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss, before tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:ComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi0xLTEtMS0x_673c7681-a228-41e8-86fd-a65c2de225db">166,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:ComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi0zLTEtMS0x_556acb65-9a7a-42eb-ae80-cd3dda8c38d8">202,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:ComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi01LTEtMS0x_5cfd8529-546c-4d70-abdf-c2fce1b24e58">375,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:ComprehensiveIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi03LTEtMS0x_7b47f698-f162-4b78-92de-643a161feefc">404,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense related to items of other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy0xLTEtMS0x_7333849b-f421-4b7f-8ea3-de9682b11cfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy0zLTEtMS0x_c4ad724d-1413-4652-884e-90f4048292b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy01LTEtMS0x_23c2e80c-4af9-497d-9f21-2f6ccf464440">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy03LTEtMS0x_14811270-7045-4ff5-8fb3-576b867d56d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC0xLTEtMS0x_f5534830-7826-4c65-8a26-385986cf21f8">166,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC0zLTEtMS0x_57dce947-5431-44fd-a454-b0ac51e6a302">202,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC01LTEtMS0x_b5e228fb-4816-459c-8cb4-d900b72f51bb">375,407</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC03LTEtMS0x_537b7514-7d53-4fdd-aede-8f2e2ebd937d">404,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share data - unaudited)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.354%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional <br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive <br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMS0zLTEtMS0xL3RleHRyZWdpb246Yjg4ZGZjMjZmNmNkNDQ2M2E3ZTIwMjEwNzRjYmY2ZDRfNA_2b2eeeb8-e56f-401c-8039-c03fa289b37f">0.01</ix:nonFraction></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a089c68d2054e71ae53dbe33acb46e3_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi0xLTEtMS0x_178308bd-7f5d-4689-a584-1920b2ebb993">159,423,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a089c68d2054e71ae53dbe33acb46e3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi0zLTEtMS0x_d3c7747f-eb40-4af0-af63-de91a984b4af">1,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d218d7eeae48b689178b021a2d9641_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi01LTEtMS0x_cf230bb1-f933-4a46-88af-53e86deb5813">4,279,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1a5e4e4fb3441dbfac2e16747f0f82_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi03LTEtMS0x_ff6c37d6-60c4-4983-9042-88e78320a8e0">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41f71ee0084e4eadb1fad7a7287abf77_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi05LTEtMS0x_f9d1d21a-7d15-4fee-9432-9c850522f0f8">2,045,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi0xMS0xLTEtMQ_c60e5db4-5da0-439b-8a2e-9ca83a91da6c">2,235,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of convertible notes, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMy0xLTEtMS0x_8df259af-d6c5-4317-bf55-47f6e0a3b2c9">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMy01LTEtMS0x_67fb6231-b2a1-4289-8205-3b39f9d54b51">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMy0xMS0xLTEtMQ_c7246442-0a93-4a8d-ac27-7e55f6b02939">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC0xLTEtMS0x_62e05936-c5a1-45a4-997d-15cb4a53df83">967,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC0zLTEtMS0x_68dbd0e8-e04d-43a9-90cc-1efacd5c85ba">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC01LTEtMS0x_9a39fdb1-1d20-4aee-b00e-8b7e0d048f6d">8,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC0xMS0xLTEtMQ_7027d726-a6ac-48b2-8bf7-11995c0da33b">8,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock to fund the Company&#8217;s 2020 401(k) match</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS0xLTEtMS0x_dc968b31-baf3-467a-a355-12c062ccc6b3">162,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS0zLTEtMS0x_c2f83e10-209b-4943-8389-16d9c840f7e9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS01LTEtMS0x_93f594b5-5224-4aa4-94f8-2f6e656b86b5">22,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS0xMS0xLTEtMQ_143c00b7-713a-4353-99ce-15a42baac12d">22,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense related to issuance of stock options and restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi0xLTEtMS0x_e0cfad6d-2516-4dcf-9b47-ecad1b8bebe7">1,355,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi0zLTEtMS0x_814a9965-5b8c-4e35-906f-73e9d54345cf">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi01LTEtMS0x_a0ec84a7-6386-4f2d-918b-da79fe83bc1b">158,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi0xMS0xLTEtMQ_c5949474-3ac9-4b24-9d35-3e807a82283a">158,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for business combination and asset acquisition </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy0xLTEtMS0x_de1c0726-a258-45f8-8294-9d62c803a515">9,384,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy0zLTEtMS0x_9fa16f3b-dc0b-404a-a9d1-a8f7d2da933d">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy01LTEtMS0x_d454d425-f700-44dc-8439-277a71cfa1e3">1,254,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy0xMS0xLTEtMQ_0b1bd94d-710c-4fc4-82f4-eac336a3a225">1,254,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35f5f3b14daf4545b117801527f11480_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOC05LTEtMS0x_16535c89-a06e-430c-a32c-32f0a56a88bc">31,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOC0xMS0xLTEtMQ_bd0831d9-c358-4b83-a0ee-63b7119e33e0">31,164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i094f6b20548e406aa1288c2f7bb503ce_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOS03LTEtMS0x_8a7bd4cd-ccde-4563-aa61-b30f769bea70">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOS0xMS0xLTEtMQ_9fcba27e-91a7-44d8-b167-d2960acd0c48">162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01dccf0f1cd74d4b9ba6b84dc1db95d1_I20210331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtMS0xLTEtMQ_ce8767c1-7b43-4fdb-80e7-aa5de6f3da29">171,293,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01dccf0f1cd74d4b9ba6b84dc1db95d1_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtMy0xLTEtMQ_7ab8ebcc-35ea-4135-aae9-6f677a61d8fc">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ec01d6b22540e381cef4d704dbefdd_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtNS0xLTEtMQ_dfd488ae-bc59-4096-b543-9ccf01324634">5,723,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037dafa9fcb1448595787e22be1373a3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtNy0xLTEtMQ_dbb97aae-2e98-4990-95f1-2b5d9f03e4aa">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4239b36587d47b9b67ceb074d0de230_I20210331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtOS0xLTEtMQ_afb7e520-8f2e-44d1-894a-2defc81ff505">2,077,060</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id326b3d6f1254686955c693689f8d7d8_I20210331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtMTEtMS0xLTE_d8cadfb4-78c2-4719-9585-e0c864068e6a">3,648,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of convertible notes, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTEtMS0xLTEtMQ_2d23ce99-bf4b-4526-b411-260e154ebfea">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTEtNS0xLTEtMQ_c154430f-ed9b-4656-bf40-e9ae7610f265">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTEtMTEtMS0xLTE_3e775822-1f89-4d2e-9466-c5f49f9f3dbb">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItMS0xLTEtMQ_ff7855d7-6b6b-487c-9c0d-91622a75704a">140,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItMy0xLTEtMQ_a4635c99-4add-4663-a4a1-98192dbda977">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItNS0xLTEtMQ_6eba08c2-a9ba-4e34-951d-0e62283751e6">2,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItMTEtMS0xLTE_e0a91d02-36fd-450c-9301-063ec3d48fed">2,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense related to issuance of stock options and restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtMS0xLTEtMQ_cca7378d-f246-41e3-9bd6-91c54d70841f">121,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtMy0xLTEtMQ_30470d4c-db35-4ac5-93d9-06d0ac0e7ec7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtNS0xLTEtMQ_bf748b5e-1571-40f4-a4fe-20e6098a7434">56,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtMTEtMS0xLTE_b87b62b7-b1fa-4bc5-b2c2-caf41e2013fa">56,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtMS0xLTEtMQ_550beb61-6ff1-43b9-8a5e-8abe0bbb2ef6">126,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtMy0xLTEtMQ_12bda5f8-55a8-4ed9-aec5-e19cdd5739c4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtNS0xLTEtMQ_53074e79-0176-4419-9d6a-c5d5241528b1">16,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtMTEtMS0xLTE_398e9a28-9cfc-4629-9c03-dcd2009d0540">16,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtMS0xLTEtMQ_ca30cbb1-7064-4ccd-8670-5de8a3b6c777">173,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtMy0xLTEtMQ_9ab29389-0721-427a-88f4-b398af9c3b6a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtNS0xLTEtMQ_7f38a83d-3a22-43ed-ae27-af511bd307ea">12,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtMTEtMS0xLTE_09fdf85e-4748-4cb0-a898-c4f76e37f82a">12,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0baa301bd4a2483fb87ec3ff4678d7b3_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTYtOS0xLTEtMQ_a0697525-1814-4229-973e-da5522419656">176,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTYtMTEtMS0xLTE_1c10746b-2e02-4885-9602-c818f0a7ab14">176,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19d78ab3ef424e599d850c44805a1ce8_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTctNy0xLTEtMQ_19949b5d-9fae-40d0-878e-1b36fd665ecd">297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTctMTEtMS0xLTE_7cada29c-b5bc-4e6e-8db1-29ab24558399">297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7570a7ca68604ab193ddcc503f407047_I20210630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtMS0xLTEtMQ_81e260de-ab6d-4e86-9008-6c607786b270">171,855,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7570a7ca68604ab193ddcc503f407047_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtMy0xLTEtMQ_4eb038b2-808c-4355-8843-8f9bedd1d458">1,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c13f47ff92f4d38a48f563ec039cca7_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtNS0xLTEtMQ_2ba2e2a1-ef4b-4acc-a85c-b9f446af2749">5,811,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a00307d8ec84b5e91e63fb7f9ff072e_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtNy0xLTEtMQ_b057de3c-3c1b-4999-b7ba-2e9010df6cfc">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6d6c8e24a154e2298c770d5ede9849a_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtOS0xLTEtMQ_8ad6ac54-ff83-4a07-b4b5-d68f8a37c578">2,253,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae0e894a4a7f44789a730dae8d02a80e_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtMTEtMS0xLTE_64892cc6-7cbd-43ff-8885-bb09aa8d754a">3,559,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of convertible notes, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMS0xLTEtMjY2MTY_a28455ea-fc1b-40cc-82d5-4765b151fb12">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktNS0xLTEtMjY2MTY_f3ba3824-e9a1-4091-bf65-66aa5a6060a0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMTEtMS0xLTI2NjE2_0c72874e-3831-4299-aa99-b23bdbe2054b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMS0xLTEtMzc5_ed00bb7f-2f3f-4d61-9544-6edefb22d920">100,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMy0xLTEtMzc5_b11fd16f-d9ae-4754-b3d6-29f4401bc721">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktNS0xLTEtMzc5_c37db1ea-1c41-4202-a17c-a4f864053c2f">1,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMTEtMS0xLTM3OQ_ac45374e-4a57-4744-a282-3a8e91c79a5e">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense related to issuance of stock options and restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtMS0xLTEtMzc5_623b7e04-7bd7-43cc-9c27-046313737a6e">286,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtMy0xLTEtMzc5_c30b98d2-c8e4-4e96-9454-712da55b80ef">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtNS0xLTEtMzc5_a2312d02-59cc-43fb-945a-15f1b08d84ed">63,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtMTEtMS0xLTM3OQ_fe22fb11-4c91-4255-8d4b-dcaaffda583f">63,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1875021431d84ba4b5c921b34aa74aff_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjItOS0xLTEtMzc5_08d9654b-bf1e-4905-b141-1a800b7ab2d5">166,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjItMTEtMS0xLTM3OQ_b817f8dc-e422-4724-8b40-0f74e4b69cbd">166,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60304b507d2d47a4beae13dd19cd021e_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjMtNy0xLTEtMzc5_e23c0e04-0c40-4cb2-b063-a5535063689c">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjMtMTEtMS0xLTM3OQ_f5e216c5-8824-420f-8ef4-354dbbb82018">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ed5f3ef270f4beca6bc7c118222f3e6_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtMS0xLTEtMzc5_cf73ac44-f39b-4b35-bee2-362b692ccd4d">172,242,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed5f3ef270f4beca6bc7c118222f3e6_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtMy0xLTEtMzc5_a8b5400a-cec4-4bd3-8854-2ad7b52ee6cf">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f46968c2ac4412d8f9620137a8c6374_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtNS0xLTEtMzc5_7764787c-e8a7-4501-9bce-bfd47d5d974a">5,876,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7040c10b7747fcbcec17982a4d2f4e_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtNy0xLTEtMzc5_20a918d8-5a61-4efe-8cf2-8bbb0fb92f3e">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48f2732f724e456a9642ca5734eae6e1_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtOS0xLTEtMzc5_a08b548b-2c10-448e-8dcf-bafa3f77c140">2,420,910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtMTEtMS0xLTM3OQ_15a24e0f-4d00-481b-bd23-023e8ca03fad">3,457,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands, except share data - unaudited)</span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.378%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.354%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional  Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other<br/>Comprehensive <br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMS0zLTEtMS0xL3RleHRyZWdpb246ZjdhZWYzOTk5ZjcwNDQwOThkMjNiYzc0ZTk3M2E3M2JfNA_859e9744-39db-45f8-aea8-58ef3c87490b">0.01</ix:nonFraction></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c52981677ce4a888854fe6b6b0ffe08_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi0xLTEtMS0x_cd6ecce8-76aa-4b70-ad2e-b80964ac2609">147,625,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c52981677ce4a888854fe6b6b0ffe08_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi0zLTEtMS0x_e016f740-85d6-4330-96bd-454b5e22d034">1,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a62efea1c4b4dad930fa573b6c99563_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi01LTEtMS0x_3fe85569-c68b-4d93-a668-da12ac3f8f0d">3,178,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d558258814f4878ba1f82b61916b08e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi03LTEtMS0x_1c3c901c-fb76-47f9-89e2-d171deace886">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64bfc16e556a449a831b1c4af0089d2e_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi05LTEtMS0x_68c49ab4-d069-42d5-8cf1-6785688763ee">1,222,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f2b2bb1c864e00920956c21f816e20_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi0xMS0xLTEtMQ_c26fb7ff-f176-4f22-887c-421b5c427449">1,957,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy0xLTEtMS0x_e182e08a-291f-4c8b-8a4b-d2b1a5cfd2b6">160,286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy0zLTEtMS0x_0c4a0d37-a125-47b2-a278-b27cd57257b3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy01LTEtMS0x_89e85d08-ebd3-4463-b938-5abad97bb114">4,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy0xMS0xLTEtMQ_2847b1e1-9180-4946-ac64-b596e11a714a">4,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock to fund the Company&#8217;s 2019 401(k) match</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC0xLTEtMS0x_73a3f11d-a137-480f-898b-5a71cdf7c621">136,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC0zLTEtMS0x_2dbb703b-f81b-4d40-95f8-b67e1ccc3215">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC01LTEtMS0x_8baa105c-ff8e-4602-af66-989f5353d83f">12,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC0xMS0xLTEtMQ_b6a7cdc7-6bdc-4b96-b18c-be3583c442c5">12,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense related to issuance of stock options and restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS0xLTEtMS0x_fc99c7cc-7849-40e5-a02f-ba7f61b35549">1,141,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS0zLTEtMS0x_8527b9f6-aa46-4e96-9339-bf91ea775b7c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS01LTEtMS0x_9b433732-1160-4a76-9b30-a53b7ebe6673">29,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS0xMS0xLTEtMQ_b1bef25b-e4fc-4092-b2a7-0499c4093af3">29,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi0xLTEtMS0x_43eeee68-114e-442b-a1e8-df504669d35b">382,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi0zLTEtMS0x_bd982de7-dde6-4ff2-81fb-46e043f42f3d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi01LTEtMS0x_26149505-7ffa-4de4-a019-1cab7aa1f470">28,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi0xMS0xLTEtMQ_283b9efd-c2bf-4033-9d2b-192286a65036">28,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01c96c9ab7c14967920412b87f32b6c0_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNy05LTEtMS0x_58139571-7731-4173-9289-371de77b5069">134,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNy0xMS0xLTEtMQ_3f6831d4-b00a-4eae-9af6-100f241ef2b9">134,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb5c4e6487434fdbb1a622f0080871e0_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOC03LTEtMS0x_41940b15-bcce-4b00-8a77-a8aab23b307e">1,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOC0xMS0xLTEtMQ_4421107e-365c-4320-a2f4-08108e920773">1,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0dfef23d60d041dcb2e5ff139b68bed4_I20200331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS0xLTEtMS0x_cc8ec5e7-701d-42a1-b81f-54491a41511b">149,446,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dfef23d60d041dcb2e5ff139b68bed4_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS0zLTEtMS0x_2ca04661-427f-4133-b34f-095bec8c0c92">1,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73256ccbde6a4a12845c25b8d6a836c2_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS01LTEtMS0x_48c0af79-a6ef-4719-aa77-fe0cb4addaab">3,252,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4ddaf31e8724905808d6d26fb1d3e98_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS03LTEtMS0x_1ab1354b-e51e-4123-ab4c-daa7a6ea9074">1,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f129d90bdeb408e8087ee20a8683ffc_I20200331" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS05LTEtMS0x_0f96324c-4344-4caa-948c-19e2a618879e">1,356,933</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01e9c8f772ad4932a0753e9678189d1b_I20200331" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS0xMS0xLTEtMQ_fd8fdeeb-e268-4015-9b5f-58f28e67b823">1,895,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtMS0xLTEtMQ_d900d50f-3dbc-41e2-8c95-39f11633c50d">208,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtMy0xLTEtMQ_3a1a5c3b-5073-4efa-bca1-0a0b84ebf95d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtNS0xLTEtMQ_67989827-5d54-492c-bb05-6950df51c5d5">6,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtMTEtMS0xLTE_96529842-8092-428e-b034-9b2790d1f60c">6,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense related to issuance of stock options and restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtMS0xLTEtMQ_ba62b858-6c1e-467d-87ed-c2e592e84f5f">157,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtMy0xLTEtMQ_aa71be46-e2a1-40d8-ba9b-1fe2b9b81235">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtNS0xLTEtMQ_dd2762e1-efe0-42a4-ba5b-ae4436234c9b">40,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtMTEtMS0xLTE_d5f73bd0-4958-4878-a331-b92e1229a624">40,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of employee stock purchase plan shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItMS0xLTEtMQ_313407c7-ae03-422d-b472-b9a802ae4ccd">167,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItMy0xLTEtMQ_a009da2f-9094-47fe-9d25-b0176bcf08ab">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItNS0xLTEtMQ_3132dc99-2097-4e92-9502-2bff95e0f9e0">9,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItMTEtMS0xLTE_79403497-a89f-4a5c-b99e-f8a0731b9d18">9,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0912a5984f84bb28a27c9b48d9742d0_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTMtOS0xLTEtMQ_30980b8a-2c8c-4ba3-875d-f0360364bc51">68,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTMtMTEtMS0xLTE_364d634e-daa0-4410-9b6a-d55bd486da13">68,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0ad06284f6547c3a757c9097601bd0a_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTQtNy0xLTEtMQ_7b4a1c87-0d9c-4404-b6c7-8f94d4a25065">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTQtMTEtMS0xLTE_3aec23bd-d260-489b-8852-aeca9b1b584c">3,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, June 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c72990efe38423c885bc80777b5d195_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtMS0xLTEtMQ_0932b8b5-0733-4e0c-bfd4-8a487f2b90d3">149,980,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c72990efe38423c885bc80777b5d195_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtMy0xLTEtMQ_3b59cd38-7f5a-4d2e-906d-5fa89d8067d4">1,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96986827f84947af8d4abfe56c07628f_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtNS0xLTEtMQ_11915756-8720-46d6-adad-49b3309ee936">3,309,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e6ccfede314e49b1285af649de49da_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtNy0xLTEtMQ_0fb50e85-e2bd-4f41-a716-d5fd1185fec5">1,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id99a4512c1d64749be5a8a8315d2d519_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtOS0xLTEtMQ_56b85d69-1094-4ba6-98e2-83c28c606ff4">1,425,025</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab125bbe3464831934cae09e63392a9_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtMTEtMS0xLTE_34b839a3-bba7-433d-9dc3-c255b72b2ff7">1,887,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtMS0xLTEtMzM4_917e73c6-1701-48b1-afbd-9a8545c2776a">140,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtMy0xLTEtMzM4_30e8734c-db33-436a-8860-930c4788d4c3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3768e6733343e298c844be52e6b227_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtNS0xLTEtMzM4_8f684902-432b-4036-bb14-e14eb52ec7e2">4,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtMTEtMS0xLTMzOA_72a18406-8efc-447d-855d-949f98c84608">4,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation expense related to issuance of stock options and restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctMS0xLTEtMzM4_e515791c-d7d5-42b5-a23d-959541467568">249,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctMy0xLTEtMzM4_81a9ac8f-584b-4e15-8f72-a61470236e4c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3768e6733343e298c844be52e6b227_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctNS0xLTEtMzM4_87063394-352e-44e6-930f-f461d7308b8b">41,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctMTEtMS0xLTMzOA_97e99aa3-a2cb-4610-bf3d-f761fa06fadc">41,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock for business combinations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtMS0xLTEtMzM4_a8074cda-692c-4040-9efe-c6a4f2f4f390">3,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtMy0xLTEtMzM4_2b031a96-5a00-43b4-b434-d160e8b07b8e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3768e6733343e298c844be52e6b227_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtNS0xLTEtMzM4_f30562cd-60f9-40a8-bb11-f8b20407cb8c">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtMTEtMS0xLTMzOA_976252ed-15d0-4798-9bd4-01d6b42a88d9">250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26c5d0a1031244da98e1f497d05696a9_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTktOS0xLTEtMzM4_b72ff91c-4aa0-45d4-a623-d56251133251">202,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTktMTEtMS0xLTMzOA_f09d53e2-fa81-4ce9-a097-2de1de218a4c">202,538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c26ea4630974c43a74423ba696c884d_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjAtNy0xLTEtMzM4_ca5fc2f4-1e95-403f-ad7f-06539ef5316d">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjAtMTEtMS0xLTMzOA_e6c86969-c5f8-4cee-8d43-8b20a7a0fa94">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie92f563c0ffb417f938fb6903a548c40_I20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtMS0xLTEtMzM4_c727310a-ae10-4277-a805-02707fe2ab75">150,373,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92f563c0ffb417f938fb6903a548c40_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtMy0xLTEtMzM4_f5a3a321-dac5-47fd-a2fe-6f000bf438b0">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia53cf4692f7a499a8f9f2bb58f1edb6f_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtNS0xLTEtMzM4_7659bb6a-4a26-4226-9600-48ef1f44d116">3,355,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic260e91a22f64d36ace033eed2e0ebe6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtNy0xLTEtMzM4_70b77d08-bd64-47df-a4b5-96ab32e10af8">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5fd31d1a4c54db49806dc7819602dcb_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtOS0xLTEtMzM4_32d2b6da-6b42-4072-ad5c-f94e9f77a4cd">1,627,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtMTEtMS0xLTMzOA_a32ae2fd-bd90-4c1b-92ef-c90751c4f682">1,730,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_25"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands - unaudited)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMy0xLTEtMS0x_076f3e16-6b5a-485f-8d72-1219086b118c">375,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMy0zLTEtMS0x_ac9463b4-b019-455e-a176-39b0db7845a4">405,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNS0xLTEtMS0x_292877ab-4c1d-4dfe-9e1c-accdea28d13a">64,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNS0zLTEtMS0x_fc5c99b6-80d7-47ce-8e9b-53b19cd41ed6">53,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNi0xLTEtMS0x_73c6bde9-cd67-4228-9f3d-0ad6d56de43a">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNi0zLTEtMS0x_a7440d49-5e24-4634-b001-270f66db4d6c">930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (gain) loss on equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNy0xLTEtMS0x_c15aa2b3-a251-4e52-a972-5cba031b3554">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNy0zLTEtMS0x_114c8da9-d36f-41f0-afce-77bcaeea44c2">1,183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOC0xLTEtMS0x_55cc5924-66be-4ac4-89ca-7a7e157a850b">248,716</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOC0zLTEtMS0x_32e8bbf3-dcc8-49cd-9a96-d172963af2dd">6,161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOS0xLTEtMS0x_524e53f2-2825-498e-95b3-6ea97c6651e6">197,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOS0zLTEtMS0x_fea5f8c9-a120-48cc-8d20-73034b2380e8">111,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Post-combination expense for acceleration of unvested equity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:PostCombinationExpenseForAccelerationOfUnvestedEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTAtMS0xLTEtMQ_5260291e-b0f1-47c6-a0a6-cbc732673fe0">80,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="exas:PostCombinationExpenseForAccelerationOfUnvestedEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTAtMy0xLTEtMQ_469a8cf7-4240-4895-9f10-ec3b12170d4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gain on preferred stock investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTEtMS0xLTEtMQ_3c36f353-1b9e-4414-ad15-619262bc6edb">30,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTEtMy0xLTEtMQ_66591f2e-ad46-440a-8403-ff5f3a1e50d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on settlement of convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTItMS0xLTEtMQ_28a1bacd-7831-4f79-85c2-b6bbf13f8356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTItMy0xLTEtMQ_805ca576-81f6-4932-80a3-54e639209db2">50,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred financing costs, convertible note debt discount and issuance costs, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTMtMS0xLTEtMQ_2579fac8-eb7d-4489-aba6-45a61c7e1db2">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" name="exas:AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTMtMy0xLTEtMQ_8dda291c-b8e4-4d02-912d-42f0fe3701ba">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of premium on short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTQtMS0xLTEtMQ_af0e8a98-a6bf-41d1-b156-b3ae2edd650a">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="exas:IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTQtMy0xLTEtMQ_5cd7ae57-4c1e-4b01-9b6b-f5ddd51a8209">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTUtMS0xLTEtMQ_ee1f5e65-dd85-4225-a4d8-4eb51add3d77">70,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTUtMy0xLTEtMQ_e1287b8c-5e8e-45e0-b3fb-bd6402534a73">70,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMS0xLTEtMzAw_2c72588f-8e32-4458-915a-0393066782ba">20,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMy0xLTEtMzAw_009edf92-8223-4b2b-8873-e7f337177b06">209,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset acquisition IPR&amp;D expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMS0xLTEtMQ_e38e8da9-5715-4b70-a796-2b78c8f2e260">85,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ResearchAndDevelopmentInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMy0xLTEtMQ_238be780-368d-43be-b844-1c1b74f70b54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTctMS0xLTEtMQ_67285b77-2431-4075-ad66-8a4fca4c2526">10,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTctMy0xLTEtMQ_8d9a73a3-7e2a-49cf-930f-01ab78381ca4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTgtMS0xLTEtMQ_cfb03e15-05a5-42b8-b4ea-c59dd6d53ab9">18,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTgtMy0xLTEtMQ_19a270d1-206f-4de1-823a-714130f020d2">11,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjAtMS0xLTEtMQ_4771484c-140c-4f46-a17a-3b571ab254af">14,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjAtMy0xLTEtMQ_8b81ab37-48b0-4675-9ece-27b59f04b66f">73,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjEtMS0xLTEtMQ_d4bf8689-6741-4cee-9d0f-12454b840a33">1,091</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjEtMy0xLTEtMQ_14e5e587-a348-453d-b112-3fdd3643f5aa">18,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjItMS0xLTEtMQ_4b55f8ca-9f75-4975-b766-aedba75b768c">11,834</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjItMy0xLTEtMQ_a99b8183-366f-4d5c-9ccb-3de8cb16a670">6,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjMtMS0xLTEtMQ_4a5bc1bc-92a2-465d-b46d-e59d49c39986">64,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjMtMy0xLTEtMQ_49b08561-876d-477a-9b1c-e8fa0a2833a9">7,608</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjQtMS0xLTEtMQ_8564ca60-3caa-4f27-9cdc-20d41c10cae1">20,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjQtMy0xLTEtMQ_0351a4b4-e010-4055-aa7a-1bbed5b7c781">35,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjUtMS0xLTEtMQ_3b00b198-e73e-489e-b5ae-537dabb04e1d">77,664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjUtMy0xLTEtMQ_ecc9db1b-a120-4e38-b045-1106d4cec57f">25,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjctMS0xLTEtMQ_118985f6-9d36-4ef5-9ff7-b7e9a266c8a9">1,021,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjctMy0xLTEtMQ_5b971a61-0f82-416a-ae2c-1f34845e5e97">890,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities and sales of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjgtMS0xLTEtMQ_dd5b0e45-5719-40bd-ba4a-75ece35a284e">424,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjgtMy0xLTEtMQ_4d95f075-d585-479b-aa8e-dbe2e07823b2">559,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjktMS0xLTEtMQ_72b66ee4-ea84-4afa-bdef-ba5af6c97ab1">76,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjktMy0xLTEtMQ_563438b6-9c5b-42e0-9f4f-62b31e8f3478">48,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combination, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzAtMS0xLTEtMQ_1765fa03-9f3f-4369-8bf3-4e188ab1a221">415,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzAtMy0xLTEtMQ_8ecde97d-d47f-4c28-aa4a-e0b4bbab0555">6,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset acquisition</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzEtMS0xLTEtMQ_f6ef8789-434e-47ce-a3e8-139323c25780">58,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzEtMy0xLTEtMQ_4f40d902-2844-42ee-b438-1aec5fa290a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in privately held companies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzItMS0xLTEtMQ_1b7638d2-6c83-487c-a8a0-a9f1e98f74e0">13,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzItMy0xLTEtMQ_192a05ec-a8b9-4cae-88a1-9994542841ee">10,610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzMtMS0xLTEtMQ_1beb0377-603f-4037-aee3-ae567976a332">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzMtMy0xLTEtMQ_6283a739-bab6-4052-bc7e-34d2d40653ee">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzQtMS0xLTEtMQ_636ff13b-c383-405b-9399-dbc1671cb69f">1,160,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzQtMy0xLTEtMQ_59f4b875-eb6d-4652-842b-d3a77a002277">395,399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible notes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzYtMS0xLTEtMQ_dc0d39fd-e581-4456-8d8e-2d2fb86f6cbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzYtMy0xLTEtMQ_a7f73c7f-1f30-435d-bff7-db8370130efb">1,125,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzctMS0xLTEtMQ_bd185379-9bc4-4498-833e-104534479b91">13,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzctMy0xLTEtMQ_0a726b13-c28e-4cb6-a0b6-6d59cd238d6e">15,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds in connection with the Company&#8217;s employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzgtMS0xLTEtMQ_4b853cc2-3b5e-4972-b2f4-a3233339022a">12,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzgtMy0xLTEtMQ_c569e94d-845f-48c8-bd9a-141503641ff4">9,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on settlement of convertible notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RepaymentsOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzktMS0xLTEtMQ_6025e57c-1f78-49d6-b81b-732c849822e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfConvertibleDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzktMy0xLTEtMQ_0f36f5ea-15aa-4245-b28b-4ea4759c4f09">150,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDAtMS0xLTEtMQ_075b1067-6789-4a4d-936f-fe1ca6bdeafd">4,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDAtMy0xLTEtMQ_9398e9e7-6dff-4728-929b-494436f9c4ab">938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDEtMS0xLTEtMQ_96499f26-9820-4c51-b080-7ed7ef6d0881">20,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDEtMy0xLTEtMQ_945f615c-6d85-428d-b3a1-44f27ed075c2">999,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDItMS0xLTEtMQ_3e448482-6c1f-4a45-bd85-c595a227317e">1,217,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDItMy0xLTEtMQ_b2f7b079-46b6-42da-b57d-c8c252d8eb78">629,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDMtMS0xLTEtMQ_c14e8ed4-673e-4e50-a880-f5d56283afca">1,491,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f2b2bb1c864e00920956c21f816e20_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDMtMy0xLTEtMQ_98f71d78-d497-4cbf-bf0f-a8d54204f62f">177,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDQtMS0xLTEtMQ_0c834c04-57b1-4f0c-909b-180fadb52077">274,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDQtMy0xLTEtMQ_6417a45f-eb10-4767-a43c-7e5e29381306">806,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in thousands - unaudited)</span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosure of non-cash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment acquired but not paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfMy0xLTEtMS0x_99ea1b8a-9c9a-4919-954f-90fc2a08a99b">21,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfMy0zLTEtMS0x_38ea1ca8-3d4d-49ab-b406-db27c32b48bf">7,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on available-for-sale investments, before tax</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNC0xLTEtMS0x_77e0bd95-ed7e-4c2c-94b4-4ae773446d7c">563</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNC0zLTEtMS0x_08111f94-6f8d-42e8-92ff-94c49b3022c1">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of <ix:nonFraction unitRef="shares" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0wLTEtMS0xL3RleHRyZWdpb246NDRlZDY0ODk3ZWU4NDI1MWFjM2VkMmM5ZjViZmVjYTNfMTY_b53d0d25-5fc7-4e9c-bbec-88e53cb13d22">162,606</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0wLTEtMS0xL3RleHRyZWdpb246NDRlZDY0ODk3ZWU4NDI1MWFjM2VkMmM5ZjViZmVjYTNfMjM_1bc393c6-778a-42b8-a07c-a118a92b297f">136,559</ix:nonFraction> shares of common stock to fund the Company&#8217;s 401(k) matching contribution for 2020 and 2019, respectively</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:IssuanceOfStockToFundMatchingContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0xLTEtMS0x_5d64032c-4fe1-4288-8714-a22ae217b176">22,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="exas:IssuanceOfStockToFundMatchingContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0zLTEtMS0x_6ada2aca-5493-4f2f-8b62-0572dd54552d">12,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of <ix:nonFraction unitRef="shares" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0wLTEtMS0xL3RleHRyZWdpb246ZDE4YzBjNDUzNmExNGZhMGI4YzQ2NDJhMjY4ZmY5MGFfMTY_acb2ec06-258f-49d6-bc25-d6780feb03ef">9,510,436</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0wLTEtMS0xL3RleHRyZWdpb246ZDE4YzBjNDUzNmExNGZhMGI4YzQ2NDJhMjY4ZmY5MGFfMjM_406f6f21-f02b-4fc0-8f4a-cb1663707a20">382,947</ix:nonFraction> shares of common stock for business combinations and asset acquisition for 2021 and 2020, respectively</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0xLTEtMS0x_9ca5023c-849f-44af-9b34-cfb3160d0332">1,270,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0zLTEtMS0x_937b6f3f-9b08-4831-b293-3c6b3eaa3d7f">28,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business combination contingent consideration liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNy0xLTEtMS0x_0823bb27-f8a9-48ca-b550-eda3a0a3cc6c">350,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNy0zLTEtMS0x_264a0a5f-3bfc-41c3-bc32-290085f9ae91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfOS0xLTEtMS0x_a257de4e-9721-4721-8785-653d24a105fe">10,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfOS0zLTEtMS0x_ca1f4731-83f8-4e01-8e35-7a4f179f1d8f">9,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_28"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_31"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjY_a231a143-30f5-4ecd-bff1-ce29419135c7" continuedAt="i66143c527aa94f89bd4a38a87a50e0e1" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i66143c527aa94f89bd4a38a87a50e0e1" continuedAt="ie01c175db99b4d3e899d628230dbaca4"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exact Sciences Corporation (together with its subsidiaries, &#8220;Exact,&#8221; or the &#8220;Company&#8221;) was incorporated in February 1995. Exact is a leading global cancer diagnostics company. It has developed some of the most impactful brands in cancer screening and diagnostics, including Cologuard&#174; and Oncotype DX&#174;. Exact is currently working on the development of additional tests, with the goal of bringing new, innovative cancer tests to patients throughout the world.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjc_7cd93f90-f42c-497c-bf8a-ffaf27256572" continuedAt="i58b83536039348918d38319ab501e4aa" escape="true">Basis of Presentation and Principles of Consolidation</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i58b83536039348918d38319ab501e4aa">The accompanying condensed consolidated financial statements, which include the accounts of Exact Sciences Corporation and those of its wholly owned subsidiaries and variable interest entities, are unaudited and have been prepared on a basis substantially consistent with the Company&#8217;s audited financial statements and notes as of and for the year ended December&#160;31, 2020 included in the Company&#8217;s Annual Report on Form 10-K (the &#8220;2020 Form 10-K&#8221;). All intercompany transactions and balances have been eliminated upon consolidation. These condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and follow the requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of adjustments of a normal and recurring nature) considered necessary for a fair statement of its financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet at December&#160;31, 2020 has been derived from audited financial statements, but does not contain all of the footnote disclosures from the 2020 Form 10-K. The results of the Company&#8217;s operations for any interim period are not necessarily indicative of the results of the Company&#8217;s operations for any other interim period or for a full fiscal year. The statements should be read in conjunction with the audited financial statements and related notes included in the 2020 Form 10-K.</ix:continuation> </span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMzA_90cb8a02-336a-4b7e-a5cf-48f4ffa05327" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company&#8217;s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company&#8217;s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2020 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of the coronavirus (&#8220;COVID-19&#8221;) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic impacted the Company's revenues and operating results for the three and nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of COVID-19 depends on factors beyond the Company&#8217;s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ie01c175db99b4d3e899d628230dbaca4" continuedAt="i51fdca6b3fc84197bcddb30e31151248"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, there were no changes to the Company&#8217;s significant accounting policies as described in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, except as described in the Recently Adopted Accounting Pronouncements section below. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjg_eb6cd40a-550c-467b-ba3b-7a00c915f29b" continuedAt="ia0400c20cc7c4e159a551054545b14f5" escape="true">Reclassifications</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia0400c20cc7c4e159a551054545b14f5">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.</ix:continuation> </span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMzM_a893840a-97da-494e-b7e1-b60acbb81838" continuedAt="ieb1222f6695d48c5991285cdcec23f03" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, The Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update simplifies the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the update, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. This standard may be adopted through either a modified retrospective method of transition or a full retrospective method of transition. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the standard on January 1, 2021 through application of the full retrospective method of transition. This method of adoption was applied to enhance comparability between the periods presented in the Company&#8217;s financial statements. The Company applied the standard to convertible notes outstanding as of the date of the first offering of the Company&#8217;s outstanding convertible notes as discussed in Note 9. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s convertible debt instruments will be accounted for as a single liability measured at its amortized cost. The notes are no longer bifurcated between debt and equity, rather accounted for entirely as debt at face value net of any discount or premium and issuance costs. Interest expense is comprised of (1) cash interest payments, (2) amortization of any debt discounts or premiums based on the original offering, and (3) amortization of any debt issuance costs. Gain or loss on extinguishment of convertible notes is calculated as the difference between the (i) fair value of the consideration transferred and (ii) the sum of the carrying value of the debt at the time of repurchase. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i51fdca6b3fc84197bcddb30e31151248" continuedAt="i73d260290d884969a67ca6ad2f4d5d8a"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieb1222f6695d48c5991285cdcec23f03">As of January 1, 2019, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $<ix:nonFraction unitRef="usd" contextRef="ic9d44e865abb4a51a5b5501e0a448a8d_I20181231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfNzk5NQ_32ec3580-909d-4183-ab84-19a0d759ca61">260.2</ix:nonFraction>&#160;million, a decrease in accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i5b178d75514549ce8ea66ebbd555a8f3_I20181231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODAzNg_77ffd746-b326-407c-83f4-45945c85c25c">26.6</ix:nonFraction>&#160;million, and an increase to net deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i7670af9c955a4e8faf887308db05e979_I20181231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODA4Ng_82fd6b06-4655-4f37-be53-1275ac060e21">55.7</ix:nonFraction>&#160;million offset by a corresponding increase of $<ix:nonFraction unitRef="usd" contextRef="i7670af9c955a4e8faf887308db05e979_I20181231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODEyNw_ebd1e9f5-88f0-41fc-8848-a9b4ee611e31">55.7</ix:nonFraction>&#160;million in the valuation allowance. As of January 1, 2020, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $<ix:nonFraction unitRef="usd" contextRef="id444aec802554b8bb1365dce26fea270_I20191231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODI3MQ_e3980d96-69ff-4627-a238-1cfd42ef5dea">227.8</ix:nonFraction>&#160;million, an increase in accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i4d9018de7fac4dc190a8367b24291c0c_I20191231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODMxMw_f465a344-b652-4cb1-9b83-95b7265ea4d9">102.6</ix:nonFraction>&#160;million, and an increase to the net deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="ib05f381693e64b0dab8d73252c93ac05_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODM2Nw_97287778-238a-46b5-93f7-b89b25ce598c">83.2</ix:nonFraction>&#160;million offset by a corresponding increase of $<ix:nonFraction unitRef="usd" contextRef="ib05f381693e64b0dab8d73252c93ac05_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODQwOA_7af3587c-6ad0-4650-aa35-c3b2f9b86186">74.7</ix:nonFraction>&#160;million in the valuation allowance resulting in a net decrease of $<ix:nonFraction unitRef="usd" contextRef="ib05f381693e64b0dab8d73252c93ac05_I20191231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODQ2OQ_7d4d104a-ea36-48cd-8dd3-b41aec11f27d">8.5</ix:nonFraction>&#160;million in recorded deferred tax liabilities. As of December 31, 2020, the cumulative effect of adoption resulted in an increase in the net carrying amount of convertible notes, net, current portion of $<ix:nonFraction unitRef="usd" contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODY2Ng_d11ad513-2880-4301-a2a7-db0f540e0ccb">57.3</ix:nonFraction>&#160;million and convertible notes, net, less current portion of $<ix:nonFraction unitRef="usd" contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleLongTermNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODcyMQ_aff4dba3-35be-40b5-9506-ad0be3bda335">540.9</ix:nonFraction>&#160;million, a decrease in additional-paid-in-capital of $<ix:nonFraction unitRef="usd" contextRef="i3905df4105f94399ab1bfd44d6526587_I20201231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODc2OQ_02f8c2b1-bcdd-45b9-89bb-588e31a4c8d4">510.3</ix:nonFraction>&#160;million, an increase in accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="iaded02e3fc3944cb80ece4c9df2ccde3_I20201231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODgxMQ_38944a19-6240-4a78-b5a5-a018710c393b">77.7</ix:nonFraction>&#160;million, and an increase to net deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODg2MQ_d15ce257-32b5-4a97-9340-115fccff2c78">146.0</ix:nonFraction>&#160;million offset by a corresponding increase of $<ix:nonFraction unitRef="usd" contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODkwMg_5678aa08-0b23-443e-b6cb-6d77c70bda67">135.8</ix:nonFraction>&#160;million in the valuation allowance resulting in a net decrease of $<ix:nonFraction unitRef="usd" contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODk2Mw_ba1aeb5d-fb6a-44c2-a39b-78594d379ddd">10.2</ix:nonFraction>&#160;million in recorded deferred tax liabilities. For the three months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $<ix:nonFraction unitRef="usd" contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTEwMA_b89617f2-1289-4f3c-86f0-b7e9c57b14ee">19.1</ix:nonFraction>&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs, income tax benefit decreased by $<ix:nonFraction unitRef="usd" contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTIyNg_32818f68-6528-4415-a000-70a943b1e7a8">1.8</ix:nonFraction>&#160;million and net loss per share, basic and diluted, decreased by $<ix:nonFraction unitRef="usdPerShare" contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTI4NQ_1efcf78c-28c7-48a5-93f4-a87409ef8928"><ix:nonFraction unitRef="usdPerShare" contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTI4NQ_58df4bcf-cfda-4639-8218-0db60fda9c1f">0.12</ix:nonFraction></ix:nonFraction> per share. For the nine months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $<ix:nonFraction unitRef="usd" contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTM5NQ_51defc1c-f925-40f4-9c2f-9af8daed824d">8.3</ix:nonFraction>&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMzI5ODUzNDg5NDIzNg_6f87762f-97d2-43b5-b140-091009b0e809">51.2</ix:nonFraction>&#160;million, which was offset by an increase in loss on extinguishment of $<ix:nonFraction unitRef="usd" contextRef="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMzI5ODUzNDg5NDI1OA_ef280ede-7870-4aca-85cc-4acf4657f508">42.9</ix:nonFraction>&#160;million in connection with the extinguishment of $<ix:nonFraction unitRef="usd" contextRef="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMzI5ODUzNDg5NDI4MA_236163f1-1d2f-4113-a62a-ad13ecb4403f">100.0</ix:nonFraction>&#160;million face value of 2025 Notes. Income tax benefit decreased by $<ix:nonFraction unitRef="usd" contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTY3OQ_94afd2e6-e244-4d20-a882-cb5b16edc1f1">1.8</ix:nonFraction>&#160;million and net loss per share, basic and diluted, increased by $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTczOA_b3b4b3f9-ffc5-4022-a5b6-1f266a34c559"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTczOA_b80cbeb4-cff8-401c-82fc-977e06acf3d0">0.04</ix:nonFraction></ix:nonFraction> per share.</ix:continuation>  </span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjk_d3517d26-646a-4683-a5a0-81cd4afaba4b" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share is the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive as a result of the Company&#8217;s losses.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMzI_f05af164-56f2-4232-94a7-5075b27f51b4" continuedAt="iec007600467643f8b664e78d9512b171" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses for each period:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable in connection with acquisitions (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idcd243860e9749e797d0fa40c030a984_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMi0yLTEtMS0x_10c756bd-0fef-47fd-97f4-41d3e6ae5a2b">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b8fefa7fe2141829ad68e0d413c03d3_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMi00LTEtMS0x_5a6d3ab1-611a-48ca-a717-92a4a2d8d791">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied784b899fd94614a96d000bcd733b92_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMy0yLTEtMS0x_4c0e0e15-cbdb-417c-977e-d914a4d4b506">2,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab5607dd7295462cb8c90861fc743def_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMy00LTEtMS0x_81431558-8e1c-438e-a15d-4bfa272b14ba">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the release of restricted stock awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ff017345e814e08bfa7d77cb58912c7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNC0yLTEtMS0x_0db3e27e-5098-4f4a-a5b3-cebcec41c62f">4,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7b3a687e0214f13b567a2e97a426191_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNC00LTEtMS0x_18c15c39-0130-4f13-b7e2-bb69bdc07448">4,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the release of performance share units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3a1712ede2942bc8705b2381ed4bde8_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNS0yLTEtMS0x_a7a3ae69-d534-48b2-aeba-1ddb3637f0b6">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i137c30961fc947dda5c83f8077cb708d_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNS00LTEtMS0x_7e6def39-ff42-487e-8017-80172046ae32">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon conversion of convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib679c506439a443bb2d06e9eb73f7433_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNi0yLTEtMS0x_0be87935-55a3-4125-9dc3-73db421f7b9f">20,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7297a2895984854bde48ce5c1058f91_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNi00LTEtMS0x_4f5d528c-f691-4e25-a549-e13bfd52587d">20,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNy0yLTEtMS0x_248933f9-b6fe-435d-bc81-40d5819650ef">27,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNy00LTEtMS0x_fdb37511-2249-43a8-8230-f3df4053f5e6">27,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i73d260290d884969a67ca6ad2f4d5d8a" continuedAt="i15e4ef2db4e14ab8ba8d949c24830cef"><ix:continuation id="iec007600467643f8b664e78d9512b171" continuedAt="i7a3b2abbe71d4207a9c8899f47fbb51b">(1)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i15e4ef2db4e14ab8ba8d949c24830cef"><ix:continuation id="i7a3b2abbe71d4207a9c8899f47fbb51b">During the third quarter of 2021, shares were issued related to holdback amounts on the previously closed acquisition of Viomics, Inc. (&#8220;Viomics&#8221;). The remaining issuable shares relate to the previously closed acquisition of Paradigm Diagnostics, Inc. (&#8220;Paradigm&#8221;).</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:12pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_34"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjI2NA_b63c8d04-aec7-4afa-8227-2bbed2c05d20" continuedAt="i2cdf6c13031c41b6b4b0b5a836ff53bc" escape="true">REVENUE </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2cdf6c13031c41b6b4b0b5a836ff53bc" continuedAt="i6c5e2aa8c7764825a979dcad7ddcadd4">The Company&#8217;s revenue is primarily generated by its laboratory testing services utilizing its Cologuard, Oncotype DX, and COVID-19 tests. The services are completed upon release of a patient&#8217;s test result to the ordering healthcare provider.  </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i6c5e2aa8c7764825a979dcad7ddcadd4"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjI2NQ_0b730ac4-f870-4465-9c08-023485cce018" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s revenues disaggregated by revenue source:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:18pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Screening</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Parts B &amp; C</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dcafd136a464463a18bf7d7a0aabc1b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy0yLTEtMS0x_7e7fefa4-a6de-41bd-8267-ab638784bada">116,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8379dfc1c2554ffab184de397af796d4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy00LTEtMS0x_61b7c6c8-dc87-42c3-aafe-4fc82b66e502">98,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic581a41a228c4ae7ae63d34ea421cced_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy02LTEtMS0x_06def5b9-56de-4cc2-b1a6-1e3e30cdfd7c">329,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f0651ae9954de988ac49c1cec0c010_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy04LTEtMS0x_3483a191-dd67-44e3-8b04-c4559035df4c">256,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1f57ca6a167a43b4bd33c0535aa347d5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC0yLTEtMS0x_85cc4e24-6077-4a38-8c95-3e1ca9441715">151,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id9fc6aab4d3f47f7afa8fdee107a4a60_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC00LTEtMS0x_b2b4e8f4-727d-4bc2-9273-23999d9fa613">106,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia505fd74c0704dd78a15cd07d6bec4f2_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC02LTEtMS0x_ad46de51-8415-4bc5-83df-aa5aa1a35a06">419,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i667d454b548144cc8245d44ab0448111_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC04LTEtMS0x_f4506c1a-9749-4245-8b42-c023f31a9005">280,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iccc3607a1c09473eb6ba098ff05bad78_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS0yLTEtMS0x_49e711a4-f726-4bab-96fa-62e6deaec3e5">13,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8ff09f5adfd24b298edc56009dd65975_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS00LTEtMS0x_9af83ed1-c77a-4229-83cb-f54dccf67cbf">9,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00444e24ec1241f3b7ce26b81f6319cb_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS02LTEtMS0x_ef4b237c-bcff-4478-9be1-12e362edd8d1">36,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7c87ea0590d04f828df277e02be7dbce_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS04LTEtMS0x_9c6b6635-6141-410d-b3f3-80c3528185df">28,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Screening</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i063bc72fa7ab4cb6a8c9a466fe5aa116_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi0yLTEtMS0x_f013e12d-a83d-41ae-ad8c-469625237576">280,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieec34b3d38ad47c3a8c65d21d6a37b56_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi00LTEtMS0x_df13a5df-ba93-4869-a54e-6d69218df7c0">214,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iaa3ffbd8983c4f1ba70c98a0ab97ef7d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi02LTEtMS0x_97e9ec01-6099-41f1-a496-96de1c3ba096">784,643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifcb4b44207d9466993c79d22ca6e06eb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi04LTEtMS0x_0678a547-ac94-444c-a735-482fb53cde2e">565,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precision Oncology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Parts B &amp; C</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04e1d778217746d0a4ed93e318426779_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC0yLTEtMS0x_849fc732-3697-4c4e-9ca8-3bab47e5572b">51,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9528b0d3873149b0baaa0af2498e1789_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC00LTEtMS0x_33740e99-c5d6-47eb-857e-6a8446d9ad30">33,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59324a5c86a042f18bd9bf5e533238e0_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC02LTEtMS0x_e474f503-8f1b-439b-bfb2-d226d1d8b787">142,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0871846c6e044d0289f2d41819e1fb31_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC04LTEtMS0x_f9a59f7d-002c-47f8-a407-62a2292b2991">114,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib39277e0ee7649f4a508d3e2c9863dd3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS0yLTEtMS0x_664e9bfb-b9ba-4f6a-b4ce-f6cc4bf9d9d4">42,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifb79758603984bad872062ffd7af29a2_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS00LTEtMS0x_84f4732b-0fcf-4476-b8ca-9cfb41b6ce24">37,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifd8d8fb26ece45a69d29c95350219e5e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS02LTEtMS0x_241c3398-c3d1-4f09-966a-49fee539eee6">145,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia4915188f99d42a6b86eca6320118435_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS04LTEtMS0x_f85ef790-da90-4f3d-b458-8d377b3c64dc">137,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f7b5bb29d0e4ce08e610464b1b71b37_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtMi0xLTEtMQ_0de15209-1a61-4078-9bba-176b4bc0b5ac">27,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i992eec5c1e0a4469b393b751d5eb9389_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtNC0xLTEtMQ_2659b570-dcbb-45a8-9fb4-3beb308540c0">16,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i661a0097adc94c5c86868c8e52fb1c00_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtNi0xLTEtMQ_15012e52-2a4f-4854-9422-437ec1e578f4">80,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2f52f7ff969c485b96ea18039cc813cd_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtOC0xLTEtMQ_45fcc54b-48e3-42c3-900c-f329ca61a97b">56,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i707df04e45c244bdb2753eb7ff65444b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtMi0xLTEtMQ_05579ce4-59f1-4693-a679-7236a3106784">23,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i016c8264c60a431a8ecf3ae449c720c8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtNC0xLTEtMQ_59a7fb8a-b2bb-4802-8210-4bf56cae9d61">3,989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i53f4fa3ff2f042ec8152cfdd2a41b981_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtNi0xLTEtMQ_8a0730f7-53cd-4459-8994-4a464d1466df">44,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id13f5ee7c3f641fc979fe7a4a3c4e208_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtOC0xLTEtMQ_f4931ef0-33f8-4a45-93e5-3b76745e05af">14,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Precision Oncology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9955c3ab73c746da927a0a812a044811_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItMi0xLTEtMQ_34fc7579-33a8-4be4-9f08-e412b9e3b4ca">145,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie52257ef670146a09f3d526496fbd69f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItNC0xLTEtMQ_c3b89236-293b-462a-93bc-eee8149f370a">91,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6a45ebc0ee824d3b8b9a76338253a1ae_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItNi0xLTEtMQ_d429ecf8-6d40-419b-805a-82aae9c9e1f8">412,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe7fefd1dd334af09a0b944eb61e0372_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItOC0xLTEtMQ_3de5ae74-3c28-4509-ae6e-b46e40527dd5">322,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 Testing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42f37da1b5f84e8d9f2274f6ca39cf9e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtMi0xLTEtMQ_b14d01eb-b543-4eb8-b477-fe077db727a0">30,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie93b05b8539f41c1840428f39ff69a20_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtNC0xLTEtMQ_7b22961f-ec29-4aaa-8453-81865e66e37a">102,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a76a46842ae4cf493ed92d239b12b86_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtNi0xLTEtMQ_243bc9dc-5cf5-4220-80ac-9bb8b0c0271d">96,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf18cbd6240143d7b12639b8d3688bda_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtOC0xLTEtMQ_bd655adf-eba8-42de-ac2c-64df85f7a42a">136,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtMi0xLTEtMQ_1116e21b-55bc-4c14-91bf-95eb8378119a">456,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtNC0xLTEtMQ_82e1603a-7ddd-4b7b-911a-ad5d0bedfbcf">408,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtNi0xLTEtMQ_969e5f5f-7411-4b39-bfc0-2c909c0aa954">1,293,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtOC0xLTEtMQ_08d7b94b-dc99-4191-baab-fd5a52b142ef">1,025,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Screening revenue primarily includes laboratory service revenue from the Cologuard test while Precision Oncology revenue primarily includes laboratory service revenue from global Oncotype DX products. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The downward adjustment to revenue from changes in transaction price was $<ix:nonFraction unitRef="usd" contextRef="i4090efeb29b94b56a6aad380d6c19370_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfNjUy_f4d932cd-09d9-4116-8b45-8eca0be1af6c">0.2</ix:nonFraction> million for the three months ended September 30, 2021 and revenue recognized from changes in transaction price was $<ix:nonFraction unitRef="usd" contextRef="ib8250c7f4f5e4113adb46384c985cf13_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfNzI3_450bbbf7-b0a8-415a-b335-2a69f5a4f0a8">0.5</ix:nonFraction> million for the three months ended September 30, 2020. The downward adjustment to revenue from changes in transaction price was $<ix:nonFraction unitRef="usd" contextRef="i96884d3335c9474d85d0a0151047b3c5_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfODE2_0320fe25-4f2d-4ab3-aa03-b386220a55bb">13.2</ix:nonFraction> million for the nine months ended September 30, 2021 and revenue recognized from changes in transaction price was $<ix:nonFraction unitRef="usd" contextRef="i248f0aaf5ff64f5aaee08b667c06b387_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfODkx_bbf6b7a1-2aac-41f4-8f0d-928ba4eb2ca6">9.1</ix:nonFraction> million for the nine months ended September 30, 2020. At each reporting period end, the Company conducts an analysis of the estimates used to calculate the transaction price to determine whether any new information available impacts those estimates made in prior reporting periods. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue balances are reported in other current liabilities in the Company&#8217;s condensed consolidated balance sheets and were $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTQyOA_ce4864cf-af4d-4b50-a9a4-8f8560349772">18.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTQzNQ_f0048ea0-437e-492c-967b-2498eb5238ca">25.0</ix:nonFraction>&#160;million as of September&#160;30, 2021 and December&#160;31, 2020, respectively. As of September&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="ia0cca153dbb14b2f99d14ed4101de2af_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTQ3OQ_f5e89775-9003-412a-bf37-f7fbaddd4a11">17.8</ix:nonFraction>&#160;million of the Company&#8217;s deferred revenue balance is a result of the billing terms pursuant to the existing COVID-19 laboratory service agreements (&#8220;LSAs&#8221;) with customers. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized for the three months ended September 30, 2021 and 2020, which was included in the deferred revenue balance at the beginning of each period, was $<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTc3Mg_e81f810b-a323-4b44-a5d3-644288eea821">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTc3OQ_2bcb8e70-f715-44e7-8120-5a094bb1255c">5,000</ix:nonFraction>, respectively. Of the $<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTgwNA_e81f810b-a323-4b44-a5d3-644288eea821">0.2</ix:nonFraction>&#160;million of revenue recognized for the three months ended September 30, 2021, which was included in the deferred revenue balance at the beginning of the period, $<ix:nonFraction unitRef="usd" contextRef="i8d988dcef79447dcb20227b33fd68679_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTkyNA_05bd24d0-43e5-4bb0-bbc7-d8e15281012b">0.1</ix:nonFraction>&#160;million related to COVID-19 testing. Revenue recognized for the nine months ended September 30, 2021 and 2020, which was included in the deferred revenue balance at the beginning of each period, was $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjA4MQ_e0468337-f011-41ff-abed-3fdf7429ca05">24.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjA4OA_b481fdfa-96d6-4cc7-859a-5ad2818acefd">0.2</ix:nonFraction>&#160;million, respectively. Of the $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjExMw_e0468337-f011-41ff-abed-3fdf7429ca05">24.6</ix:nonFraction>&#160;million of revenue recognized for the nine months ended September 30, 2021, which was included in the deferred revenue balance at the beginning of the period, $<ix:nonFraction unitRef="usd" contextRef="i11b42a57edea48f5924650bda9e8458a_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjIzMw_6e68b430-e594-4a72-84cd-08f29790d880">24.3</ix:nonFraction>&#160;million related to COVID-19 testing.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_37"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_0f7de33e-5a92-431b-8579-1573e4d6c238" continuedAt="i162268cbd38f44c88a398269e1743d64" escape="true"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_460b9c45-5d6e-4882-94f1-519934e581f1" continuedAt="i21283a845f8f4b2dbea03450338c0ceb" escape="true"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_c384d141-2fee-4891-a462-a7a7af30f930" continuedAt="iad127c073fe04e9d921a6608eed180b4" escape="true"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_ee4969f4-43e3-47c1-b71e-3bdc7a110f5e" continuedAt="i71e0d119abf8434b930fe7fda6ab7d33" escape="true"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_efa067b1-920d-4dbe-bdf6-0f1e6bdce14e" continuedAt="i5e1589f3b03e4b80a6c932a06c66a6ad" escape="true">MARKETABLE SECURITIES</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i162268cbd38f44c88a398269e1743d64" continuedAt="i08055f2a49554150aedce830a685089c"><ix:continuation id="i21283a845f8f4b2dbea03450338c0ceb" continuedAt="i3a90a9e09a0f4f418c30113631a004a9"><ix:continuation id="iad127c073fe04e9d921a6608eed180b4" continuedAt="i7ea3901097a7479cb0fc226a9bcdd2c1"><ix:continuation id="i71e0d119abf8434b930fe7fda6ab7d33" continuedAt="i6064438f69a7452e81d71c7b5dc1e990"><ix:continuation id="i5e1589f3b03e4b80a6c932a06c66a6ad" continuedAt="i51c4d48388c5457ab0b89aae642b5106"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxOA_2b6baeec-7437-4da6-845d-a91d7a2e20f4" escape="true"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxOA_f745b35c-d4ae-456c-88c7-6ddd8873bcac" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cfebb799f1944df980320a2b810292b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMi0yLTEtMS0x_c71efc7e-a2e5-455a-bbd1-594866245dbb">273,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056bbdc3f35d4f1c97c9eaf225f5e67d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMi00LTEtMS0x_d3d91e95-8c89-4563-8fb7-5e18b53fe64a">901,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i13be9f7dfe5045bfa40c514789b1321c_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMy0yLTEtMS0x_3b4425c9-2ffa-4139-b3db-07ba7a98a293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMy00LTEtMS0x_8fc1e90e-122c-43f2-bf97-37fb2862a416">589,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4c8a7f6ee43e472892b140b9fd2a1a53_I20210930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNC0yLTEtMS0x_a0186f3a-f501-42f2-a368-f9fd1b8ae9fa">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id26cf57382b64fdab7bfd9aa29ea248c_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNC00LTEtMS0x_4486bcb2-aa63-46dd-b2f8-86500113e33e">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNS0yLTEtMS0x_3d85e641-3b17-4000-9f5e-2b2b98a5c5c2">274,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNS00LTEtMS0x_9a6f69df-18fa-48af-84ff-a96e00542438">1,491,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb18575cb9a44b4daebf27decd1b5840_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNy0yLTEtMS0x_e0a8d57d-14bc-43eb-8ddc-33e2a4cb417d">941,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e374a0bd147d2b769746796b11924_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNy00LTEtMS0x_8c714d7f-1f34-45c6-bc30-300089312a91">347,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOC0yLTEtMS0x_0429ce1e-7195-4fe9-b523-2745f1c612e2">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOC00LTEtMS0x_c2983df1-fae4-4b19-8c79-3644910cc766">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOS0yLTEtMS0x_e6e86ad3-f338-4768-905e-90fe0674a9d7">944,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOS00LTEtMS0x_e3bafb0b-845e-453c-8871-bb921a9da4b2">348,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents, restricted cash and marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMTAtMi0xLTEtMQ_f16b0c43-2c36-4087-83fb-78757d96d27d">1,218,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMTAtNC0xLTEtMQ_291c8e38-430f-4636-8189-a7c6e79ef15c">1,840,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgyMQ_bc73721b-b562-4622-ae38-d513f7be1dc4" continuedAt="ia9b25f2114064b00bd57993e615903ea" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.527%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS0yLTEtMS0x_e62c6f58-30d2-43e6-b7a3-7216afc43d38">368,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS00LTEtMS0x_f6af8f7e-c553-4503-965d-c0db0f8b2cc8">213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS02LTEtMS0x_2d697a89-e1ab-4ee6-bfc5-b95474c229b3">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS04LTEtMS0x_078f8300-ace1-4c53-9c03-7325fb5e5221">368,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi0yLTEtMS0x_3ab74a8b-c5d8-4569-aa3d-ecc4a682b175">276,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi00LTEtMS0x_81c3cd58-c994-483d-addc-258eb00e93e6">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi02LTEtMS0x_4f3ce667-2373-4f97-ab04-2e7c6b9bee10">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi04LTEtMS0x_af50d4a9-c462-466e-bce9-c58178b8e3a9">276,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy0yLTEtMS0x_ebc23680-8467-4a7c-b454-9ddfc1860686">175,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy00LTEtMS0x_4be9203f-8cf7-4522-9aba-359319d45ddc">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy02LTEtMS0x_8a610ae5-8927-48c7-bb20-66cf2a89a4c5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy04LTEtMS0x_3a3efc27-df34-48cf-bd69-c9122c2c8b76">175,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC0yLTEtMS0x_a42cc00b-d73a-49d9-a64d-f403d58bc7b2">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC00LTEtMS0x_7e19544d-2c64-4597-9257-14bcb0298232">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC02LTEtMS0x_3a6cf887-bdeb-4280-b880-894acb964daa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC04LTEtMS0x_90e87fac-92d5-4c2e-8761-34b4623bb99a">10,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS0yLTEtMS0x_806967fe-394f-489d-b2c1-0a5ee8616a2f">111,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS00LTEtMS0x_5ac402eb-d87d-4b7b-860d-44216a89c6c2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS02LTEtMS0x_e498c5d7-2bbe-4b21-ae1b-91c996cd4b2f">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS04LTEtMS0x_8ae58e50-21ce-461b-a415-f63df41ec200">111,164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtMi0xLTEtMQ_9e35607f-96f1-4676-86b4-5c1148184c5e">941,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtNC0xLTEtMQ_76b6d7b9-91e0-4f20-8556-5a368c8d2518">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtNi0xLTEtMQ_537f4232-12fa-4a4d-bb60-9045a4ad5fe0">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtOC0xLTEtMQ_2a34fb54-f2c9-4f98-8e68-e69f87c06f22">941,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Gains and losses in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) are reported before tax impact.</span></div></ix:nonNumeric></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i08055f2a49554150aedce830a685089c" continuedAt="ic592d12e5f3d4063bc8a2df0fbec301d"><ix:continuation id="i3a90a9e09a0f4f418c30113631a004a9" continuedAt="ibfdfc391537f48588d4f93ba1fca49d9"><ix:continuation id="i7ea3901097a7479cb0fc226a9bcdd2c1" continuedAt="iaa8e3d153c344d878a6e42ad1e83c921"><ix:continuation id="i6064438f69a7452e81d71c7b5dc1e990" continuedAt="i932032cae2ed4fe794bded9828e8120f"><ix:continuation id="i51c4d48388c5457ab0b89aae642b5106" continuedAt="i7e0d3d541cce4759b5611613f3965639"><ix:continuation id="ia9b25f2114064b00bd57993e615903ea"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.527%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi0yLTEtMS0x_9c0c3bd9-893f-412f-8c92-94427523f397">589,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi00LTEtMS0x_403f6cef-5c34-4663-9a09-e04160d57ded">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi02LTEtMS0x_28dba6a7-0098-4d18-acd8-eb2884c88c83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi04LTEtMS0x_ca80af7a-5ca3-4a14-a1e9-66d435f8d1b4">589,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy0yLTEtMS0x_92afcd93-6c41-47dd-a0f7-fb055826c1a5">589,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy00LTEtMS0x_64fe4220-33dc-4e4a-acc0-614a522f65c7">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy02LTEtMS0x_606f8f19-99c5-419e-b6a0-ac655b1f7fca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy04LTEtMS0x_4daaaa69-e845-4568-9b3c-b3d4c7d6d220">589,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS0yLTEtMS0x_68c245e5-0cb0-4dda-9edd-c587d4123ff9">207,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS00LTEtMS0x_ea87e509-b89c-4446-8d0c-b348386cc9fc">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS02LTEtMS0x_7a18285c-7d85-4e1f-953d-d564e7e50fde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS04LTEtMS0x_83bc7bb1-f37f-4172-8cde-43e23d3d870c">207,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi0yLTEtMS0x_481fe329-9a3f-4894-874c-43ce1e3bc213">7,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi00LTEtMS0x_afac5aa5-3bb7-4190-a017-c55ac6905209">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi02LTEtMS0x_2800cd30-e9a9-4aa9-ac49-3545291dba97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi04LTEtMS0x_7277973e-2eee-465c-99f4-6846ea41a2ed">7,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy0yLTEtMS0x_fdaf901c-2fbe-40b4-9872-9d7c2d0b8317">132,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy00LTEtMS0x_898eca5f-9834-4dff-afa0-eb709cd93456">612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy02LTEtMS0x_b77e15ff-eba1-4671-a604-51a6f6e46133">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy04LTEtMS0x_c9a63577-6b9c-438e-9052-b1f0f999b3af">132,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e374a0bd147d2b769746796b11924_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC0yLTEtMS0x_909db683-6e1c-4c58-a0df-e9285cf77a1e">346,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e374a0bd147d2b769746796b11924_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC00LTEtMS0x_fe0408b2-2126-4369-ab23-ccff1f1e175e">688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e374a0bd147d2b769746796b11924_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC02LTEtMS0x_68b517ce-582e-44a0-86eb-dd30333597a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia73e374a0bd147d2b769746796b11924_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC04LTEtMS0x_56b55002-71cf-4c54-b050-e79e7392f652">347,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS0yLTEtMS0x_55174a64-8e08-4789-b438-c37aefd9e2b8">936,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS00LTEtMS0x_98c93bff-9d6e-4082-997e-9d3d202a8e5b">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS02LTEtMS0x_b107dca6-ddd4-41d1-9a2b-5e1e318393be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS04LTEtMS0x_4c8bc821-8de0-486c-93ab-a9a75bb1f78a">937,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Gains and losses in AOCI are reported before tax impact.</span></div></ix:continuation><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgyMg_046c3989-8735-4b9f-9110-165137bd73d5" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contractual underlying maturities of the Company&#8217;s available-for-sale debt securities at September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.527%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Due one year or less</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Due after one year through five&#160;years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi0yLTEtMS0x_8863d461-7cc8-4810-99b8-defa21dae1f1">7,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi00LTEtMS0x_1b413079-566b-4eab-8825-98c6a217e855">7,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi02LTEtMS0x_bd439a0d-86d1-44c1-ace7-6251029dfa0e">269,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi04LTEtMS0x_8446acf2-b584-4655-a154-696c6395e4f0">269,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy0yLTEtMS0x_1f2d134f-b646-4fda-90ba-1bb57bb9ec43">235,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy00LTEtMS0x_f7a2f6fe-4756-48c3-a65a-bcc4649287dd">236,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy02LTEtMS0x_19df5e2e-5dad-4512-acd9-5822616dab85">132,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy04LTEtMS0x_edad1aee-2661-45e6-a0b7-5ad02b04f4c4">132,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC0yLTEtMS0x_b4be9772-7a34-43c7-b969-b168c285d2ac">175,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC00LTEtMS0x_efad0a45-aaed-4915-8607-c9b23ebbcfdb">175,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC02LTEtMS0x_83570965-9c42-4eba-a298-1d4f6c98a456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC04LTEtMS0x_44311414-42e6-41d8-8217-1e7af65856d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS0yLTEtMS0x_11093627-4b23-4af1-a772-d1f14f1f9a08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS00LTEtMS0x_2baa2e76-22e8-4aec-bf5d-02277d9517c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS02LTEtMS0x_6e8e2607-00e0-47ee-b8b3-3b0e655e07c3">111,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS04LTEtMS0x_a1f0d5e1-c9a5-49cf-94af-cbb5a6d3a2f1">111,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtMi0xLTEtMQ_25103347-fd44-4638-8993-42de7ae9a82c">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtNC0xLTEtMQ_30c1ef34-9733-4235-9ab5-dfd253d2b0f4">10,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtNi0xLTEtMQ_e6441e98-8d3f-429b-9645-c69649f9a79d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtOC0xLTEtMQ_7a910748-b62b-4088-9c2c-7ad0cd3a5ffe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItMi0xLTEtMQ_b7f61864-dfe0-4a56-9fb5-b1b484392994">428,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItNC0xLTEtMQ_6b8e4e42-fccb-4f59-a1dc-ce9143dbcd44">428,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItNi0xLTEtMQ_8b68596a-7e9d-41af-b866-931aa006f26d">512,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItOC0xLTEtMQ_b23b46b5-5d2b-453c-bf2e-18d3cda34524">512,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxOQ_72783cb8-1b9d-4a06-828e-f4362bce0648" escape="true"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.414%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:18pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less than one year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">One year or greater</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy0yLTEtMS0x_93bc9bda-59ec-410c-a66f-f2c7641edc5a">155,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy00LTEtMS0x_f69a4bd7-8518-484b-a451-a8fe7750c86e">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy02LTEtMS0x_6b319ba8-eb5b-433c-978a-794c2fda68fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy04LTEtMS0x_f5a261a8-c874-4f9d-b1ab-d601c6920674">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy0xMC0xLTEtMQ_e1f70ad8-01b8-473b-8287-5327098e0f80">155,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy0xMi0xLTEtMQ_0d68eec3-8ade-47fc-ae41-a9892a5a36e4">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC0yLTEtMS0x_d82dbdc6-a89d-4363-8bad-4f3372358940">15,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC00LTEtMS0x_d470e3c6-86ae-4e95-9f0a-a47539535e7a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC02LTEtMS0x_e30713bb-0495-4087-9511-5e85ca571b58">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC04LTEtMS0x_d69cb8ec-6fb8-4766-ab15-8c5db5689c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC0xMC0xLTEtMQ_29bb7718-fd71-4847-8ee4-e21831dfc2ff">15,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC0xMi0xLTEtMQ_d7c93ecc-d10e-49dc-98c9-4b41fd6766e4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS0yLTEtMS0x_f37cdf79-678c-42cb-b8fc-a1651027125f">81,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS00LTEtMS0x_6c38b288-a008-4b4d-80d4-dce521582585">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS02LTEtMS0x_5b4abc12-cf35-40e2-a85d-bc733bef3a27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS04LTEtMS0x_12f45549-7dab-43e4-aa29-80b468a3c979">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS0xMC0xLTEtMQ_cedfefc9-3129-4c73-8f15-ebc0795cf456">81,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f7300a597044b329c0be127d20807ba_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS0xMi0xLTEtMQ_d6052ec3-05f5-4a65-8d91-17828e1baf00">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi0yLTEtMS0x_92ab45aa-dda6-4614-bdfa-c705144b1017">259,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi00LTEtMS0x_84829eb6-248c-40f2-aaa5-f35c1e342132">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi02LTEtMS0x_af2d6c5f-772a-45fe-9b09-17e685c66443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi04LTEtMS0x_002a031c-4946-4949-974c-bd15c27b1630">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi0xMC0xLTEtMQ_7a8aeaad-81b1-40ce-a834-92a89e8b57f9">259,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi0xMi0xLTEtMQ_d71c9bc1-2c50-42f2-a1c6-81f371dbfc14">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC0yLTEtMS0x_12c839e9-af66-4fc3-b132-a0a02d7de2b1">511,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC00LTEtMS0x_311ef9d9-575d-488e-ad5b-f1b90260d7f8">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC02LTEtMS0x_8129d31f-dbd6-4844-a1c5-a86d44750d5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC04LTEtMS0x_28de6cac-7b5f-4d61-a959-6fa30bad6005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC0xMC0xLTEtMQ_b7cd9197-7827-44ee-830f-9900968d96fd">511,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC0xMi0xLTEtMQ_94648ad7-74b8-4cd0-ac96-7ae165d37650">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ic592d12e5f3d4063bc8a2df0fbec301d"><ix:continuation id="ibfdfc391537f48588d4f93ba1fca49d9"><ix:continuation id="iaa8e3d153c344d878a6e42ad1e83c921"><ix:continuation id="i932032cae2ed4fe794bded9828e8120f"><ix:continuation id="i7e0d3d541cce4759b5611613f3965639"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTU0NQ_16ca4911-92cf-4278-b9d9-a4d131dfda83">4.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTU1Mg_c4b758d2-5625-4d85-a645-9d47d46f1a50">1.9</ix:nonFraction>&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTYzNA_24e09a9c-5a5a-4ada-a0c9-29fd11de868d">33,000</ix:nonFraction> and a loss of $<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTY1MQ_397dbc13-d705-4c5e-b6d5-e0779e6e365a">0.3</ix:nonFraction>&#160;million for the three and nine months ended September&#160;30, 2020.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses recorded are included in investment income (expense), net in the Company&#8217;s condensed consolidated statements of operations.</span></div></ix:continuation></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_40"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RleHRyZWdpb246Y2FjNGI3NzQ1ZDZkNDlhNGJjZGViZWM3NzVlM2RkYzlfNTg_73da5953-e0ba-4a18-b450-209d7f6425af" continuedAt="ia96d993ccdbe4bd28cfed565c9818b3c" escape="true">INVENTORY</ix:nonNumeric></span></div><ix:continuation id="ia96d993ccdbe4bd28cfed565c9818b3c"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RleHRyZWdpb246Y2FjNGI3NzQ1ZDZkNDlhNGJjZGViZWM3NzVlM2RkYzlfNTk_3b0c6e0d-9070-412d-a228-5e7570eec85d" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMS0yLTEtMS0x_300dc8d9-05a8-40d4-ac31-643326bddc70">47,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMS00LTEtMS0x_e9d2d005-0e1b-44a4-8207-bc2131fd2aa6">43,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished and finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:InventoryFinishedAndSemiFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMi0yLTEtMS0x_e1e74851-5223-48ca-99d3-559f3b4e3e22">47,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="exas:InventoryFinishedAndSemiFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMi00LTEtMS0x_50a06c85-4417-4c11-8156-49f8bffe2346">49,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMy0yLTEtMS0x_af6b817e-f70a-4b6d-9f90-6bdde01d0c03">95,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMy00LTEtMS0x_3bddee4c-badf-4410-9086-2b9a7389a8eb">92,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_43"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNjYy_bf69472f-860d-449f-8c6f-d098856769ac" continuedAt="iff9f021577b84bbdbbcc7218f55145f4" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="iff9f021577b84bbdbbcc7218f55145f4" continuedAt="i37e125eb0f6e43f488c8c8a89cad82d7"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNjYz_2718205a-0432-46cd-8e15-3c199965609e" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated useful lives of property, plant and equipment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046c9bf82f9d4d84afc8bdb4fbc09ee4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMi00LTEtMS0x_a92c1d71-9ec9-4d28-8bff-343cf99d153d">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2603c42ca166450aa67a6456c7aac5f0_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMi02LTEtMS0x_ba4896ad-e542-4574-b7f5-b22506ae7a1d">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib565421c7a9e4cee80899653950911dd_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMy00LTEtMS0x_1f312172-bd31-4a4d-929b-1419345d1427">142,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee71fa70c5840f2aa66cb1886e4e1e9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMy02LTEtMS0x_6f342414-22ee-47a2-96f4-6c85f214b9f6">117,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if97c19b0ff2e426c8ff2e5e5c8c9ba5b_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNC0yLTEtMS0x_4d7ff02b-7997-4569-8a23-25a5468d273c">15</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5d1f9f305b34febb42e7ec0e7aea18f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNC00LTEtMS0x_1da7ea96-1154-405f-b714-69720f11d5d1">4,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c709a9c228d4975bf362e7fbdbaf15d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNC02LTEtMS0x_587ee410-0103-4266-8426-44c5cca8a6a4">4,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id1eea2a1fc8048b3886f462bacd90918_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS0yLTEtMS0xL3RleHRyZWdpb246MTY3OTA4ZDQzMTA5NDg1N2I2NTZjMjBmOGMxODMxZWRfNA_5a69329a-5f4d-4335-a4cb-232197c338b6">30</ix:nonNumeric> - <ix:nonNumeric contextRef="i1eaf3d04e6d54cb69c0bcb15abf59ad3_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS0yLTEtMS0xL3RleHRyZWdpb246MTY3OTA4ZDQzMTA5NDg1N2I2NTZjMjBmOGMxODMxZWRfOQ_a48150a8-ef4d-46bf-b880-25b5e62381de">40</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f34accaeb4c4b69bd008a1a7025ae7c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS00LTEtMS0x_46d762ec-4990-4abe-ad35-54bf9f37bb93">201,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26037492e0b347dc8fb448751d76c11a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS02LTEtMS0x_966f125a-bfe6-47d2-bf26-77a96a1a8762">200,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and computer software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5c7eb1cd63614c76a69d6c2265857e45_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNi0yLTEtMS0x_92e4ffdd-d1e0-4fbe-996e-b851cd8f914e">3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73857043c37b41f9baaed76bd0a2da45_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNi00LTEtMS0x_dcd7563e-db8b-4bbc-bea7-b634f0e2623c">99,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a9cb213c64b4411bef4a6f840992c57_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNi02LTEtMS0x_db919726-e652-49c5-8b2b-1066e0d54ac7">75,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i17efc5443e29495c96dd26eb9db272fd_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy0yLTEtMS0xL3RleHRyZWdpb246NGQyZDc2Yzc4ZGZjNGQ3ODlkMGU1MjU0YTIwYzY1NTdfNA_2438ba25-e3aa-4935-88b8-9de1c7ca7a32">3</ix:nonNumeric> - <ix:nonNumeric contextRef="i8206c44cfe3d480d87b647d39baa233b_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy0yLTEtMS0xL3RleHRyZWdpb246NGQyZDc2Yzc4ZGZjNGQ3ODlkMGU1MjU0YTIwYzY1NTdfOQ_29ef3db0-ad80-4da7-a75a-1f832ac7e20f">10</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib08e3529a89e4d289e1bef68ce7d0fcc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy00LTEtMS0x_a5ebff72-ea7a-42cb-9554-d9895c4bf2a2">175,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e40593098e345db94df0524569e9818_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy02LTEtMS0x_a11c75e3-812b-49e9-a740-364afa62d0ae">142,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i84d059ff1b2e4031ad7a352239b93fa2_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC0yLTEtMS0xL3RleHRyZWdpb246MjMyNTIyMzNiNTE0NDc3Y2I1ZDRmOThhY2Y1Y2EyYmRfNA_f329d5eb-cd9b-4e72-8b60-61529efeb94c">3</ix:nonNumeric> - <ix:nonNumeric contextRef="if185d20192144383ad067c44e7be1c5a_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC0yLTEtMS0xL3RleHRyZWdpb246MjMyNTIyMzNiNTE0NDc3Y2I1ZDRmOThhY2Y1Y2EyYmRfOQ_2f741b8e-bfac-4131-b966-f0fd3e1de462">10</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8e88e6baa0f4bb08fcee1ef175222e9_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC00LTEtMS0x_8ef17c09-75ae-4e48-bfae-f4ef693a4a7f">27,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7428b7f6a341495982fc6f8d0cd2b254_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC02LTEtMS0x_9fb94222-dad6-4d59-81eb-ca347ad0dce2">24,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a10169cbd94256abf1a671f2b87341_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOS00LTEtMS0x_abf4e376-faf1-439a-90d1-5aae5e26f7ec">64,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850e8485ac9b4874afcdcf9edc86f702_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOS02LTEtMS0x_6b772146-50d6-4c8f-8e34-33155a4908a5">18,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTAtNC0xLTEtMQ_c88b2c99-dc59-46d0-bc9b-8b37b2b54d9d">719,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTAtNi0xLTEtMQ_5c7581d2-59f1-4d00-9a87-34b8e95998d0">589,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTEtNC0xLTEtMQ_0ee31b72-64c6-4e6a-9211-487a8e745a08">195,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTEtNi0xLTEtMQ_3da88ec4-1172-4688-9f80-c5f343db8eb7">137,538</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTItNC0xLTEtMQ_6865e551-c7ab-42b1-8177-54100bc90864">524,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTItNi0xLTEtMQ_33cdd47a-2207-4620-9fba-7a98a861e555">451,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Lesser of remaining lease term, building life, or estimated useful life.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the three months ended September 30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMjQ5_c79f50bd-c64f-4ea1-be41-ce2c36d74042">22.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMjU2_212a4b0d-6d1d-4fea-b4cd-c1d52765edb2">19.7</ix:nonFraction>&#160;million, respectively. Depreciation expense for the nine months ended September 30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMzE3_e4206426-71f0-4254-9370-f106793f772e">64.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMzI0_49e9ae64-8475-45d1-9683-76c9b7287987">53.3</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i37e125eb0f6e43f488c8c8a89cad82d7">At September&#160;30, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i00a10169cbd94256abf1a671f2b87341_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMzY1_5551bab3-5641-4f58-9d46-a26f8d7e1c93">64.2</ix:nonFraction> million of assets under construction which consisted of $<ix:nonFraction unitRef="usd" contextRef="ib08e3529a89e4d289e1bef68ce7d0fcc_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNDE2_c5565cb7-cf2a-4b84-a82c-cde5004b9a5f">11.8</ix:nonFraction> million in laboratory equipment, $<ix:nonFraction unitRef="usd" contextRef="ib565421c7a9e4cee80899653950911dd_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNDQ0_4e7a71df-2a09-4b72-bfa5-361b0c1d9e37">40.6</ix:nonFraction> million related to building and leasehold improvements, $<ix:nonFraction unitRef="usd" contextRef="i397f9e5032ae4722a80dcb17bdcc41dc_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNDk5_8adaa183-b8a2-4d0e-aa4e-63061c58f1a1">11.6</ix:nonFraction> million in capitalized costs related to software projects, and $<ix:nonFraction unitRef="usd" contextRef="ie5d1f9f305b34febb42e7ec0e7aea18f_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMTA5OTUxMTYyODUyMg_8e9175fe-20e9-457d-923f-5199e9f9faf4">0.2</ix:nonFraction> million related to land improvements. Depreciation will begin on these assets once they are placed into service upon completion between 2021 and 2023.</ix:continuation> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_46"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2OA_c8c0a654-c00b-412f-84ac-e9078cc76a1c" continuedAt="ic70633916985440d9223cdaaf32df280" escape="true">INTANGIBLE ASSETS AND GOODWILL</ix:nonNumeric></span></div><ix:continuation id="ic70633916985440d9223cdaaf32df280" continuedAt="idf862151f565462286186d9dd27b1911"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2OQ_53ce1cec-9dcd-42fe-acd9-4b8f07ad50c4" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net-book-value and estimated remaining life of the Company&#8217;s intangible assets as of September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if702705143d144ad941b197bde5db8a0_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi0yLTEtMS0x_7bcda72b-a7ed-47ae-9213-517b8f313f53">14.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi00LTEtMS0x_aa34ca28-fd5c-43b8-8de3-d0c3dd1c146b">100,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi02LTEtMS0x_070cf94e-c2a2-4994-8801-434df975b722">11,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi04LTEtMS0x_f700aac9-f68b-41a1-965d-20ec991ac017">88,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id4a88eba861f4e4192b519eeccb19ef6_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy0yLTEtMS0x_3cbd0ead-b7af-4a13-b091-7b43cfa79f01">12.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2991de22736346499f93730cc6444632_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy00LTEtMS0x_403c8083-1986-4264-a698-9016c8de19a8">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2991de22736346499f93730cc6444632_I20210930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy02LTEtMS0x_a83bac04-c327-4d43-a346-10df3c8a81bd">539</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2991de22736346499f93730cc6444632_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy04LTEtMS0x_1fc4e9bd-4f73-4071-b68f-ca6b7e9d5bd2">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icb98b0ac54b84d199190275ac41818ce_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC0yLTEtMS0x_35083f2c-2b45-4c43-994f-111390b1f589">3.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42836131dcd845d9b7d67c233c57a9e5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC00LTEtMS0x_20ecd967-a732-46db-951f-fc07300f68c0">10,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42836131dcd845d9b7d67c233c57a9e5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC02LTEtMS0x_e58931ee-7042-4715-81cd-eccc2c1a5469">6,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42836131dcd845d9b7d67c233c57a9e5_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC04LTEtMS0x_42bae61e-3674-437d-8a86-056dca659a1b">4,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i23b0a3bd4a6c42c2898767451b09fa3b_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS0yLTEtMS0x_79fddee0-5337-479f-9ff0-b16696a80c4c">8.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS00LTEtMS0x_68079843-a108-43b3-aaac-eb4c9059a975">853,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS02LTEtMS0x_9984777b-00e6-4c7d-bebe-8f3e217a7f99">155,404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS04LTEtMS0x_7b69f879-71e2-42a5-b430-cf75f2ae7194">697,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie377b2d58e75450081174518661faffc_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi0yLTEtMS0x_6637daa5-82a3-45ce-a6f5-af83a4e1c1c9">5.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi00LTEtMS0x_c20d8c8c-c5f6-4bb2-9704-0d67cb5def68">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi02LTEtMS0x_e9171206-d7b1-4f99-9f48-bc5cd3462181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi04LTEtMS0x_03b8ceb0-cd5a-4ea0-9722-1ff01429795c">2,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNy00LTEtMS0x_ebf9da56-2945-4fe4-b9dc-f6550e7cff38">969,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNy02LTEtMS0x_d7e37b2a-63f5-4904-b943-bd4b890446a9">174,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNy04LTEtMS0x_ec568fa3-0a3d-411b-9fc3-a26520967e7d">794,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOC00LTEtMS0x_44bdcff1-5ab5-4136-b821-8ab096543ae8">1,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOC04LTEtMS0x_b3bfd602-68c4-4e27-92bb-5aab1aaddfae">1,250,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOS00LTEtMS0x_588e33b8-fcb0-4180-87e2-0f0ea2eca6e8">2,219,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOS02LTEtMS0x_e2ad6141-7c54-4a08-98af-270c2194e60a">174,350</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOS04LTEtMS0x_9b2655bf-c9e2-473d-81ba-b74d7375b4ea">2,044,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net-book-value and estimated remaining life of the Company&#8217;s intangible assets as of December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Remaining Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ice576d710d154504bb423eb18f1ad591_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi0yLTEtMS0x_b7bc840e-051e-419b-9ff1-da2d2653a538">14.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09917a07a99c400e9b8821622e9f4348_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi00LTEtMS0x_0b4befa1-da87-4625-bbc4-bb1349f45f9c">100,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09917a07a99c400e9b8821622e9f4348_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi02LTEtMS0x_57d868bf-78ee-4981-a71b-66c51970da3c">7,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09917a07a99c400e9b8821622e9f4348_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi04LTEtMS0x_f57fa1a9-186e-4347-99d5-3cb135a8822e">93,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie999f144ca6d42a8945ed5489734beaf_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy0yLTEtMS0x_f77b552c-1e9d-486a-91ff-dc4ca1de223c">12.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib7453ee4e20e44478b0b8848dde011f2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy00LTEtMS0x_d31e6cc5-e292-4f35-ae26-e088bce93dce">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib7453ee4e20e44478b0b8848dde011f2_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy02LTEtMS0x_9b75624d-57eb-460b-b1ba-e9a6dd4f871d">404</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib7453ee4e20e44478b0b8848dde011f2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy04LTEtMS0x_68985ad3-0052-4f95-bf09-dd3eaad1bdc3">2,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2500b0e4387f476185dd50c36f479490_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC0yLTEtMS0x_bb99e9f3-fea8-435c-ac26-f58a103d8c63">3.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic730c612567f459fb5f4f0a35a23f7aa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC00LTEtMS0x_75f9f4e7-dafe-4b41-a58b-54586bd053d4">10,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic730c612567f459fb5f4f0a35a23f7aa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC02LTEtMS0x_390a69cc-b71c-44ab-93a0-ce715aa38ced">5,422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic730c612567f459fb5f4f0a35a23f7aa_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC04LTEtMS0x_f3f07f5f-2b38-434b-a045-7363e84e12da">5,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6157347e1860457c9ba2688f1f242d19_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS0yLTEtMS0x_4b9b5f49-3156-4d3a-b74e-a79c6c3ffb49">9.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3520dd0084974b7b9d074b11858f9955_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS00LTEtMS0x_6db0e054-f49d-48b9-8fb0-1d9def2ff810">814,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3520dd0084974b7b9d074b11858f9955_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS02LTEtMS0x_79a35ec1-aff0-49ec-a02d-97070a1de80d">93,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3520dd0084974b7b9d074b11858f9955_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS04LTEtMS0x_add9027d-caa3-4558-af13-73716804a7f8">720,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib02b8ec43328475895f430cbf7c3fe17_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi0yLTEtMS0x_0c7632d6-e559-42d8-b81b-691b3fff5460">6.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18d3648998024a2caf8410e3d681a404_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi00LTEtMS0x_cea5a3e3-d51e-4cd6-8094-7d88a889853e">30,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i18d3648998024a2caf8410e3d681a404_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi02LTEtMS0x_88e7fce4-1c5d-463d-9483-2e51b5dceaf9">4,527</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18d3648998024a2caf8410e3d681a404_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi04LTEtMS0x_6553af44-aa1d-45f8-963e-e8d53bea6f8b">25,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNy00LTEtMS0x_05d37905-c3dc-41f0-9d1d-7fe9ecab8e09">958,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNy02LTEtMS0x_dc339e18-c45c-443e-817e-3683ce79e1bc">110,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNy04LTEtMS0x_441a120a-981a-4817-9bb2-9a8b54d41396">847,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2Ng_6ad346ac-8e01-4ed1-b092-511c20413c8b" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the estimated future amortization expense associated with the Company&#8217;s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfMS0yLTEtMS0x_457d9a26-d7f3-4df3-b190-87200d05119c">23,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfMi0yLTEtMS0x_b32b23be-c460-40af-bb94-8abeeb3d35db">92,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfMy0yLTEtMS0x_85027660-ef10-45d8-8ff2-ae47c3c0319e">92,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNC0yLTEtMS0x_d8b94f15-fae3-46ac-9c23-6138cdabb10e">91,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNS0yLTEtMS0x_d344958c-1393-4ec3-80e6-d286c64b3977">90,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNi0yLTEtMS0x_9ee95cfb-43fa-4476-a158-7e5c1f6221cd">404,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNy0yLTEtMS0x_a1c334a1-0f49-4544-927e-d4f499fcd2e2">794,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquired intangible assets are being amortized on a straight-line basis over the estimated useful life. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="idf862151f565462286186d9dd27b1911"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021 and in connection with the preparation of the financial statements, the Company recorded a non-cash, pre-tax impairment loss of $<ix:nonFraction unitRef="usd" contextRef="i7ae3fe6eee984352a3ff41b1d601ab3a_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMjAzNg_20e4c49c-b52e-4d8e-bb9d-70a60cc6f05a"><ix:nonFraction unitRef="usd" contextRef="i8e3951d25ef84754a2744cec75114754_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMjAzNg_cb94a5f5-d2d5-454b-9936-13543006351c">20.2</ix:nonFraction></ix:nonFraction> million related to the supply agreement intangible asset that was initially recorded as part of the combination with Genomic Health due to lower than anticipated performance of the underlying product. The Company utilized the income approach to measure the fair value of the supply agreement, which involves significant unobservable inputs (Level 3 inputs). The impairment is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company began discussions with Biocartis regarding the termination of its agreements with Biocartis related to the development of an in vitro diagnostic (&#8220;IVD&#8221;) version of the Oncotype DX Breast Recurrence Score&#174; test. As a result, and in connection with the preparation of the financial statements included in the Company&#8217;s Form 10-Q for the period ended September&#160;30, 2020, the Company recorded a non-cash, pre-tax impairment loss of $<ix:nonFraction unitRef="usd" contextRef="i0fde4bcaab504180ae894941003778cc_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDY1MA_749e3c9f-fdfc-40bf-a314-d9643ae09c0c"><ix:nonFraction unitRef="usd" contextRef="i890d82d4d1c74eb0bd114be1fd3387da_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDY1MA_c4bc1fd6-3c1f-470b-974b-a48b0c5428e7">200.0</ix:nonFraction></ix:nonFraction> million related to the in-process research and development intangible asset that was initially recorded as part of the combination with Genomic Health. The impairment is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company abandoned certain research and development assets acquired through an asset purchase agreement with Armune Biosciences, Inc. in 2017. These assets were expected to complement the Company&#8217;s product pipeline and were expected to have alternative future uses at the time of acquisition; however, due to changes in strategic priorities and efforts during the third quarter of 2020, these assets are no longer expected to be utilized to advance the Company&#8217;s product pipeline. As a result, and in connection with the preparation of the financial statements included in the Company&#8217;s Form 10-Q for the period ended September&#160;30, 2020, the Company wrote-off the gross cost basis of the intangible asset of $<ix:nonFraction unitRef="usd" contextRef="i8ff8b0693ba14e6a8ba588d8c68f9d36_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDc1OQ_de017243-2c49-4dba-8ab7-c91cb1433646">12.2</ix:nonFraction> million and accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i8ff8b0693ba14e6a8ba588d8c68f9d36_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDc3OA_08d47590-0b7c-4227-a747-d8bf8b8af6f1">2.5</ix:nonFraction> million as of September&#160;30, 2020. This write-off resulted in a non-cash, pre-tax impairment loss of $<ix:nonFraction unitRef="usd" contextRef="icce105c6a6b64d718e4502a0b7aa92d7_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDgxOA_99338ed3-2659-4ad1-aa03-004ce805c3d8"><ix:nonFraction unitRef="usd" contextRef="i6599b9ca619946ee95551b50bc36454a_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDgxOA_e2fda415-1f55-4619-b2a6-0a0076a01502">9.7</ix:nonFraction></ix:nonFraction> million, which is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2Nw_d18a073d-6b23-4730-9466-5de12e0e058b" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the periods ended September&#160;30, 2021 and December&#160;31, 2020 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3f2b2bb1c864e00920956c21f816e20_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfMS0yLTEtMS0x_9162c5d3-e79d-412b-9985-73b709a7d497">1,203,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paradigm &amp; Viomics acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i501c7f9788854b61a82cd861d37a75db_D20200101-20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfMi0yLTEtMS0x_a0df9799-3606-4c7d-93df-119ffceea00e">30,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genomic Health acquisition adjustment (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4920c4a12554781a0baa0e8b7a2a4ca_D20200101-20201231" decimals="-3" format="ixt:num-dot-decimal" name="exas:GoodwillAcquiredAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfMy0yLTEtMS0x_090d023f-7418-4526-a456-c23dfadfa6e3">4,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNC0yLTEtMS0x_0101f7a2-fe5d-4590-aeaf-b71e7edbfad6">1,237,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thrive acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNS0yLTEtMS0x_09ff5d37-ad97-4ac3-8b61-b98c38a49c4a">948,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ashion Acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6653408e966412f9580bd258009d9e9_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNi0yLTEtMS0x_253268ef-a531-4b22-828a-ed7d386975a5">56,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNy0yLTEtMS0x_8dc95897-cb75-4ee9-b20d-8e516f832acd">2,242,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company recognized a measurement period adjustment to goodwill related to an increase in Genomic Health&#8217;s pre-acquisition deferred tax liability due to finalization of certain income-tax related items.</span></div></ix:nonNumeric><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_131abee0-545d-4ce4-901b-672aecc3fc86"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_23cc76ea-24f7-4ab8-895c-cd69be1e07cb"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_921c9516-094e-49e6-9ce0-af7265b8b057"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_9c564678-0775-436d-9d1c-be24994dd942">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses for the three and nine months ended September&#160;30, 2021 and 2020.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_49"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNjM3OQ_a5b5b6d7-bb8f-4bd7-b067-2f467cd582dd" continuedAt="i76bc127e2de74ac689ed4ce6c0734137" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><ix:continuation id="i76bc127e2de74ac689ed4ce6c0734137" continuedAt="i910c67b83d324412a400b2757e9dbc99"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three levels of the fair value hierarchy established are as follows:</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i910c67b83d324412a400b2757e9dbc99" continuedAt="i20f601a3459d47c69a43c2b961854ca6"><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unobservable inputs that reflect the Company&#8217;s assumptions about the assumptions that market participants would use in pricing the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNjM4MA_f2a3711d-4ca9-4219-b340-1869de883e57" continuedAt="i643e849128824370b60a548fb638acb8" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value measurements as of September&#160;30, 2021 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active Markets<br/>for Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7670aee13835456b9ef946cbf5090d2c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi0yLTEtMS0x_b06e5f05-615b-420b-b56f-796740c4ccb8">273,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i076cccc3ea454a719579e19eb576403a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi00LTEtMS0x_9d051123-9c59-438c-8fe4-dafe13044a7d">273,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7735b48d36ff44b29b0a466a9b6c6a03_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi02LTEtMS0x_ef5a9149-046b-4589-ba86-cb0a7bfbaaec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eaa44b39d5645a9a0faf988680be02a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi04LTEtMS0x_395f3b2a-b64e-4d3f-b26c-f25faaa3815d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36c23e4f0c64b8892c737ae997e1b21_I20210930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC0yLTEtMS0x_4271bd5a-95d1-486a-bd10-fdbf53573df7">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice75a7198c9c4189b63219eac0c1032e_I20210930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC00LTEtMS0x_34854242-a310-4e4c-a233-98d32e51100c">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4330edc45cf84441a4cd9cf3d6dc4379_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC02LTEtMS0x_0a2117b7-9ff6-4500-9c30-6c3922209f8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3596c0cce347588c0c90b759253721_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC04LTEtMS0x_ff49cc8d-08d4-41ee-93dd-0f794d160eeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71ac0875363d44f48e9a998b50b03693_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi0yLTEtMS0x_ebae1b06-0c0d-4ede-95f5-397aa6c3c5ca">368,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5b310b00e484dcf83114f26ed4d03ab_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi00LTEtMS0x_7d08ea61-25b0-4ea7-8845-f0e7117fd287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edbf863623a4583b670e04195a560f2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi02LTEtMS0x_f369cce0-5aaf-43eb-a6b5-05f7e345483f">368,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f071db6d26f4417836a89ae4bf9dc13_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi04LTEtMS0x_bb626bd4-bb55-4e49-ade9-6326942c8616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae353c40c869427d99501cfd0e428d16_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy0yLTEtMS0x_ee7f3cb2-bd15-44be-bc8e-09dd2a6ca295">175,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e1dca476854604bbc32c5a07963ffa_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy00LTEtMS0x_39504433-f07d-4315-96d8-0e79b7d4eb93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia30980f5ef444b3490f4789bea8f12fb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy02LTEtMS0x_3fedd29d-9a4b-485e-9a28-14de3b7cb5a0">175,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2629689a88b443dc8d9888f5eef1bd71_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy04LTEtMS0x_4e8f9805-307a-4c6e-b0f6-86bbffa8abcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5f1a09055054f3d8d1946791967fc77_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC0yLTEtMS0x_2c855bf9-dcc2-4ea9-90fc-b6b6f09c2750">10,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29cb011245734390b34548e0994a1a0b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC00LTEtMS0x_18a2f283-0484-45d2-b364-045e19054a6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556b2b7061a84128a4bcc29752f8e922_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC02LTEtMS0x_b15c8586-e76f-4fbb-ba4f-c341c29069b7">10,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e1cdf0f1387456c89946289c26f60e8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC04LTEtMS0x_aed422d2-a404-451a-9981-634b66e40b27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d0406051014646b0970f3d9130bbb7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS0yLTEtMS0x_452860b5-b8e5-4832-ad97-3ade55026fc9">276,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i108006d8fdb74103b198303365a9bc58_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS00LTEtMS0x_23416ef5-9da2-4712-b042-9e2a09cbea4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic730ed990e6644239b3ae1d4cb5eb387_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS02LTEtMS0x_7fbe3582-fa2c-4fc4-9d31-42861c5cf5a3">276,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee052d8326c94ffda0d8f89f13146d06_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS04LTEtMS0x_e7a1b06e-7758-4bee-9ee6-c8d9aae206c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1f3c7b2e624156a85733d1e95e2f04_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtMi0xLTEtMQ_88829785-ab7f-45ab-bdce-2a682a053328">111,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6d569e7074a40b4b3e6f21fdc68efdc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtNC0xLTEtMQ_d1ac569e-c9a5-424c-9c14-52f5c5ee90c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdd7005af4546f38d23f679ee216c45_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtNi0xLTEtMQ_b8eea1c4-5bfb-4f2e-a688-c1d3ebf0583e">111,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79793c0a6b4a40bfbc8f7bd09705a9e1_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtOC0xLTEtMQ_bde68c07-df37-4c72-891b-4e9a66293401">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtMi0xLTEtMQ_4bafef81-6b09-4060-9f8f-84148ee12116">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtNC0xLTEtMQ_fed21869-776c-47c7-b28e-c01f78629606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtNi0xLTEtMQ_52748ce5-f542-4f92-b184-a45693bfc258">3,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtOC0xLTEtMQ_a93148c6-89eb-456a-a6ed-a5522f09d6ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedNotReadilyMarketableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItMi0xLTEtMjU0MjU_783f8ddd-434b-4d9c-a1eb-7e3c65cb7dc4">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:SecurityOwnedNotReadilyMarketableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItNC0xLTEtMjU0MjU_21969dcb-0263-456b-b853-56163c187e44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:SecurityOwnedNotReadilyMarketableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItNi0xLTEtMjU0MjU_9c4e069f-ed10-444b-9876-6c61e91fcc43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedNotReadilyMarketableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItOC0xLTEtMjU0MjU_7fbdeac9-d6ae-4c5e-9f56-b2ddfa11eda7">2,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtMi0xLTEtMQ_0d01c6e9-07ea-46c9-80c1-c613642ba0ae">363,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtNC0xLTEtMQ_b8d0bff5-bf28-4138-a46f-2b77e4809c80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtNi0xLTEtMQ_417cb40e-0ee6-4155-a1f4-351806024327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtOC0xLTEtMQ_f5e9ef68-fd91-4cca-a4b8-7081280ee3f0">363,647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtMi0xLTEtMQ_e70740cd-87c5-4f70-9c53-260b09614485">857,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtNC0xLTEtMQ_681bc1f9-2bb3-4741-852c-228682b5207a">274,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtNi0xLTEtMQ_f30e4061-0c4d-4b33-8561-bb850c9c6a14">944,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtOC0xLTEtMQ_cd61b54a-ff15-4a9d-b83f-57e311a270d3">361,107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The equity securities held are classified as Level 2 as they are subject to a short-term lock-up restriction and have been discounted from the observable market prices of the similar unrestricted equity securities. </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i20f601a3459d47c69a43c2b961854ca6" continuedAt="i3338faf60faa4221a796fccfcdb4910f"><ix:continuation id="i643e849128824370b60a548fb638acb8"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value measurements as of December&#160;31, 2020 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active Markets<br/>for Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaab539435c7a481aaed99f701cafa053_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi0yLTEtMS0x_7ba5fe0b-bf33-4883-bf0d-2be21025216a">901,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6179574a6404661adb02cdfd4ecac70_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi00LTEtMS0x_57852b4a-18cb-479d-b16e-76c6861d27b0">901,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f5eb5cb806f46a3a282ece9ae9e05a6_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi02LTEtMS0x_8f6ad36d-9c60-4ece-a2eb-cf8d0ab98a63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02062cfc353a43feb126d3f904610723_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi04LTEtMS0x_5be94350-6aa2-443c-b013-4a9842c49b75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0332bd716b34f80bbba08e250974a9d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy0yLTEtMS0x_bcbcb0b5-cbff-4112-9230-fe04ba1a091a">589,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e4418e3f444936ae782784aaf5154c_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy00LTEtMS0x_794ce6d6-bd4e-48f7-90a8-0f537a27ce81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f358e0fdb3422f93412305ec8ee504_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy02LTEtMS0x_b48057f2-22ac-47df-9ba4-799f2da77ef1">589,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ae36a17c1b640618068686e33ff1802_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy04LTEtMS0x_9f3917ff-cfd0-4653-864c-8d100c738e06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i456b35ed51ac45b18c17b51e6d86e854_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC0yLTEtMS0x_605fbfcc-a5e0-4a40-9288-85dd54140a8e">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07629df4ca2c4cbf803a8e9b3e8c6908_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC00LTEtMS0x_939b4594-fa81-4061-85aa-136bd400cee8">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0802092f5404859b5da28c255e698c9_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC02LTEtMS0x_677e629a-2389-478a-89b0-75aa67231ed5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d1e5476c5e4d07af802800933a510b_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC04LTEtMS0x_75f4b997-542c-417e-95c8-e90612a1e6fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e245a53d37346bf907516b3ea304801_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi0yLTEtMS0x_d8cf4989-4340-44e5-8288-fa2af52824da">207,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31c943c8a77e42589005bd95b10382ce_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi00LTEtMS0x_ce89b2ad-6623-4e1d-bbe6-d555f6dae6a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672fb690c6e24a47821c2ddc8a90fabb_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi02LTEtMS0x_d7c6bcae-78f7-4779-8a2b-63a09ec24b0c">207,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e24063fca9740369d367ba93027918e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi04LTEtMS0x_97f1c7fd-eb08-4528-b6f8-0c4b325033ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d60b555b44746d6b68f5fe0334c3ca9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy0yLTEtMS0x_31c9adc0-db9c-45ba-a1e5-de65c31921b0">132,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3a663e94eb4a27bd5c65ba03cacf87_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy00LTEtMS0x_27e2dace-8dec-4c3e-ade6-5f40f051d848">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i247aaad53c6245ccbbd5ec147d4988da_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy02LTEtMS0x_63a4525a-270a-4a4d-a5db-f264a41bf6e4">132,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib403eea329ef416a8a24ac2287f97a62_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy04LTEtMS0x_c5724ff9-710e-40a6-b1a2-b722fa707805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7d357017eb4157a5f470172d3e0487_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC0yLTEtMS0x_f0faee91-b1fe-4b91-96da-eee08da48468">7,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dd8f93b52f5442291314fe4545a7ec8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC00LTEtMS0x_853ba83d-8f1f-4405-9f74-475d2232b70e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i043e843eab1c434d95629465a45eab9a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC02LTEtMS0x_2686416d-8ee8-41c0-8d6f-5770a2d123f9">7,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43309733f4814ee09bbc83df1d2962fc_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC04LTEtMS0x_2b936902-c1c1-450e-bac1-2ea2a73b9559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5970ee82644e25bb734b992dd63362_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS0yLTEtMS0x_00fbc04e-a8a6-4c61-bc9d-5f71e6146ce5">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e8f57f6c664ec39d5d416a45042a81_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS00LTEtMS0x_6f85a738-7f83-41b5-9b17-b50c2d147cd3">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS02LTEtMS0x_7bbe420c-5312-440e-a6a8-3861875a6e59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee94b86157f48f68658ceb0b86089f8_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS04LTEtMS0x_485f300b-cf7c-4193-ac10-88f23895987d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c5970ee82644e25bb734b992dd63362_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtMi0xLTEtMQ_ca314894-77c6-4a84-9f01-f8606569b614">2,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e8f57f6c664ec39d5d416a45042a81_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtNC0xLTEtMQ_bd3f7d2d-a6f9-4ced-b0b2-f95ef8b5c462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtNi0xLTEtMQ_f9d24682-45ba-4e83-a1c7-d5a9b26f05f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee94b86157f48f68658ceb0b86089f8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtOC0xLTEtMQ_0e154d64-1874-4ca7-a9f9-7b2b25160a07">2,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5970ee82644e25bb734b992dd63362_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItMi0xLTEtMQ_4ab53de2-d57a-461f-a5c9-d930803fdec9">1,837,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8e8f57f6c664ec39d5d416a45042a81_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItNC0xLTEtMQ_9fea2c1f-5544-4f59-95c4-994fd7a7699f">903,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItNi0xLTEtMQ_367093f6-2da5-467f-bdf8-af46b459168b">937,172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee94b86157f48f68658ceb0b86089f8_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:FairValueNetAssetLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItOC0xLTEtMQ_5dbf21d2-ef6e-42ef-b8f7-eb979d09e096">2,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in valuation techniques or transfers between fair value measurement levels during the periods ended September&#160;30, 2021 and December&#160;31, 2020. The fair value of Level 2 instruments classified as cash equivalents and marketable debt securities are valued using a third-party pricing agency where the valuation is based on observable inputs including pricing for similar assets and other observable market factors. The Company&#8217;s marketable equity security investment in Biocartis held as of December&#160;31, 2020 was classified as a Level 1 instrument prior to being sold in the first quarter of 2021.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain regulatory and product revenue milestones being achieved. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within general and administrative expenses on the Company&#8217;s condensed consolidated statements of operations. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration as of September&#160;30, 2021 and December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfMjg4OA_6615b8ef-a7ff-4c06-b90b-100cffc367b8">363.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfMjg5NQ_d3693199-9590-48e5-91a0-b8e6d19204ac">2.5</ix:nonFraction>&#160;million, respectively, which was recorded in other long-term liabilities in the condensed consolidated balance sheets.</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNjM3Nw_3d09d587-d67c-41aa-9deb-0b175cdcd676" continuedAt="id884de1c31ff4c8f8a5098a06ab7b938" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfMS0yLTEtMS0x_68abf171-98be-4a81-996c-d88e55df9d3d">2,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfMi0yLTEtMS0x_3e2af4d3-2eec-4232-910d-8b1d9a097dd7">350,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfMy0yLTEtMS0x_bcd16c9c-924d-48b4-9334-0aaf96744130">10,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfNC0yLTEtMS0x_6ca34b8d-2686-4991-845c-dcd29869bdc3">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance, September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfNS0yLTEtMS0x_cfa42e7f-f89d-4fb1-b417-8f2eaaa6a84c">363,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id884de1c31ff4c8f8a5098a06ab7b938" continuedAt="id2423ec6cd584af99d0e78aabcec2cfd">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="id2423ec6cd584af99d0e78aabcec2cfd">The increase in the contingent consideration liability is due to the contingent consideration associated with the acquisitions of Ashion Analytics, LLC (&#8220;Ashion&#8221;) and Thrive Earlier Detection Corporation (&#8220;Thrive&#8221;). Refer to Note 17 for further information.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i3338faf60faa4221a796fccfcdb4910f"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This fair value measurement of contingent consideration is categorized as a Level 3 liability, as the measurement amount is based primarily on significant inputs not observable in the market. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration liability recorded related to regulatory and product development milestones associated with the Thrive and Ashion acquisitions was $<ix:nonFraction unitRef="usd" contextRef="i7735ebc6072e4844a77d8a37da54e9e3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfMzc2OQ_c4c15050-9c65-4d1a-80b4-5416a08e7cf8">361.3</ix:nonFraction>&#160;million as of September&#160;30, 2021. The Company evaluates the fair value of the regulatory and product development contingent consideration liabilities using the probability-weighted scenario based discounted cash flow model, which is consistent with the initial measurement of the expected contingent consideration liabilities. Probabilities of success are applied to each potential scenario and the resulting values are discounted using a rate that considers a present-value factor. The passage of time in addition to changes in projected milestone achievement timing, present-value factor, the degree of achievement if applicable, and probabilities of success may result in adjustments to the fair value measurement. The fair value measurements of contingent consideration for which a liability is recorded include significant unobservable inputs. As of September&#160;30, 2021, the fair value of the contingent consideration liability recorded related to regulatory and product development milestones was determined using a weighted average probability of success of <ix:nonFraction unitRef="number" contextRef="ibd2c2b55dd8e4b4a8baccd8dfe9fabf8_I20210930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNDg0NA_b7730a62-c9b6-4d7e-aad9-6433d746f06f">90.5</ix:nonFraction>% and a weighted average present-value factor of <ix:nonFraction unitRef="number" contextRef="ib3f1b003917c4eb2b6290a35759a68ab_I20210930" decimals="3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNDg5NA_4914fa2b-348d-4bb4-9419-9b4cbd55a3f7">2.0</ix:nonFraction>%. The projected fiscal year of payment range is from 2024 to 2027. Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration earnout liability related to certain revenue milestones associated with the Biomatrica acquisition was $<ix:nonFraction unitRef="usd" contextRef="i63f9bc02d95f4a8d88d901e1d36b8857_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTIxNA_48dbbe6c-f163-47de-b4f9-db9daa9a7f01">2.3</ix:nonFraction>&#160;million as of September&#160;30, 2021. The revenue milestone associated with the Ashion acquisition is not expected to be achieved and therefore no liability has been recorded for this milestone. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Marketable Equity Investments</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the aggregate carrying amounts of the Company&#8217;s non-marketable equity securities without readily determinable fair values were $<ix:nonFraction unitRef="usd" contextRef="i0a1df4e2f14a42828145784edc81d152_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTU2Mw_6edda2b9-1f69-49cc-81c0-9a0e16407d37">22.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if7e54c98df5e425386007ce202a5cdaa_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTU3MA_83d1bafa-b047-488d-84cd-fc22460b9537">29.1</ix:nonFraction>&#160;million, respectively, which are classified as a component of other long-term assets in the Company&#8217;s condensed consolidated balance sheets. There have been no downward or upward adjustments made on these investments since initial recognition. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company had open foreign currency forward contracts with notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i423735ec2fa04dc998bc308ebb5ebaa2_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTk0MQ_4002bc2d-863d-408b-a5c2-32c2d852108c">29.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i46c3a28bcdca48689179ee81c50f41d2_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTk0OA_65471b5e-4354-45e4-aac8-fcc3d768a656">22.4</ix:nonFraction>&#160;million, respectively. The Company's foreign exchange derivative instruments are classified as Level 2 within the fair value hierarchy as they are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data. The fair value of the foreign currency forward contracts was zero at September&#160;30, 2021 and December&#160;31, 2020, and there were no gains or losses recorded for the three and nine months ended September&#160;30, 2021 and 2020.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_52"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDI5Nw_5bf6b140-e6b9-4cdb-a197-38ac8b2a37a6" continuedAt="i640b17918dcb4a37a818c6cbf2c5d320" escape="true">LONG-TERM DEBT</ix:nonNumeric></span></div><ix:continuation id="i640b17918dcb4a37a818c6cbf2c5d320" continuedAt="i21b4cdaed2214ce9b17d9cfbe9ff9aaf"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Construction Loan Agreement</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2017, the Company entered into a loan agreement with Fifth Third Bank (formerly MB Financial Bank, N.A.) (the &#8220;Construction Loan Agreement&#8221;), which provides the Company with a non-revolving construction loan (the &#8220;Construction Loan&#8221;) of $<ix:nonFraction unitRef="usd" contextRef="i875166f2ce66407bbd9156c0c0b38938_I20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzA1_4f1ac2d7-0bcd-45dc-928c-22d1acf3a062">25.6</ix:nonFraction> million. The Company used the Construction Loan proceeds to finance the construction of an additional clinical laboratory and related facilities in Madison, Wisconsin. The Construction Loan is collateralized by the additional clinical laboratory and related facilities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Construction Loan Agreement, funds drawn will bear interest at a rate equal to the sum of the 1-month LIBOR rate plus <ix:nonFraction unitRef="number" contextRef="if3202fd2c10d4c7398235b5e85235b84_D20171201-20171231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNzA4_ea6d00cd-fad3-4a78-86cf-7cd7723a5b87">2.25</ix:nonFraction> percent. Regular monthly payments are interest-only for the first <ix:nonNumeric contextRef="iadfa6d5584e64d8d96cf57f8ef06f8c5_D20171201-20171231" format="ixt-sec:durmonth" name="exas:DebtInstrumentPeriodicPaymentInterestTerm" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNzY5_991a733c-e811-418c-a482-fd2355f7b795">24</ix:nonNumeric> months, with further payments based on a <ix:nonNumeric contextRef="i37e094585ad64a8dbf6962da458f2b91_D20171201-20171231" format="ixt-sec:durwordsen" name="exas:DebtInstrumentRemainingAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDI5OA_24dfb51f-75a5-4f8b-a6ad-ad305fd1cfd4">20-year</ix:nonNumeric> amortization schedule. Amounts borrowed pursuant to the Construction Loan Agreement may be prepaid at any time without penalty. The maturity date of the Construction Loan Agreement is December 10, 2022.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Fifth Third Bank, on behalf of the Company, issued an Irrevocable Standby Letter of Credit in the amount of $<ix:nonFraction unitRef="usd" contextRef="i9f3368f21e3f45b08bdf3abf7718904a_I20171130" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTE0Mw_fee8f0c0-7e37-43f0-8639-67a1aae14924">0.6</ix:nonFraction> million in favor of the City of Madison, Wisconsin (the &#8220;City Letter of Credit&#8221;). The City Letter of Credit is deemed to have been issued pursuant to the Construction Loan Agreement. The amount of the City Letter of Credit will reduce, dollar for dollar, the amount available for borrowing under the Construction Loan Agreement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i21b4cdaed2214ce9b17d9cfbe9ff9aaf" continuedAt="ib0fec8ca880849b89e0c9108a042a31e"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition to Fifth Third Bank&#8217;s initial advance of loan proceeds under the Construction Loan Agreement, the Company was required to first invest at least $<ix:nonFraction unitRef="usd" contextRef="iafe6aabe3c26422ba3568068ffeae6b5_I20171130" decimals="-5" format="ixt:num-dot-decimal" name="exas:MinimumOwnInvestmentToBeMadeInConstructionProject" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTYyNg_e376e52b-2ebb-4f2b-b1c9-67a3a28a595e">16.4</ix:nonFraction> million of its own cash into the construction project. The Company fulfilled its required initial investment and made its first draw on the Construction Loan in June 2018. In December 2019, the Company began making monthly payments towards the outstanding principal balance plus accrued interest. As of September&#160;30, 2021 and December&#160;31, 2020, the outstanding balance was $<ix:nonFraction unitRef="usd" contextRef="ib1c80baca1f84cf0b348fa500c7ac519_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongtermConstructionLoanCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTk2Mw_79f40498-2068-47c3-8b5d-5c8592a16999">22.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0cd6211d49ce40f2a37e553096ffe101_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LongtermConstructionLoanCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTk3MA_7c518d04-3c77-44e2-8a8b-d08a7ffe1b8b">23.8</ix:nonFraction> million, respectively, from the Construction Loan, including $<ix:nonFraction unitRef="usd" contextRef="id3bd705add894d9cbb688ee5e9a40dbf_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjAyNg_123df39c-169b-497d-8bc3-352e6fd921be"><ix:nonFraction unitRef="usd" contextRef="i75e9cb3ad90c4a5d82d4288d4e770a53_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjAyNg_dff608cd-fb14-4d1e-a33a-d160c942ca6d">0.7</ix:nonFraction></ix:nonFraction> million of interest incurred, which is accrued for as an interest reserve and represents a portion of the loan balance. The Company capitalized the $<ix:nonFraction unitRef="usd" contextRef="i1d7390258e4a4b2ba37dcee40cdf5250_D20191201-20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InterestCostsCapitalized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjE2OQ_752839d9-0d80-442b-9aab-e45e06ffc813">0.7</ix:nonFraction> million of interest to the construction project. The Company incurred approximately $<ix:nonFraction unitRef="usd" contextRef="iafe6aabe3c26422ba3568068ffeae6b5_I20171130" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjI0OA_f3aa151e-17dd-48a6-b856-4388641874bb">0.2</ix:nonFraction> million of debt issuance costs related to the Construction Loan, which are recorded as a direct deduction from the liability. The debt issuance costs are being amortized over the life of the Construction Loan.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Construction Loan approximates fair value due to the short maturity of this instrument. The Construction Loan is privately held with no public market for this debt and therefore is classified as a Level 3 fair value measurement. The change in the fair value during the three and nine months ended September&#160;30, 2021 was due to payments made on the loan resulting in a decrease in the liability.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Construction Loan Agreement was amended effective June 30, 2020 to include a financial covenant to maintain a minimum liquidity of $<ix:nonFraction unitRef="usd" contextRef="i797d752f32bf41b5a68518c097333f71_I20200630" decimals="INF" format="ixt:num-dot-decimal" name="exas:DebtInstrumentCovenantLiquidityRequiredMinimum" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjk4Mg_23bb994e-be61-4155-a0da-7fef5e73fe96">250</ix:nonFraction>&#160;million and remove the minimum tangible net worth covenant. As of September&#160;30, 2021, the Company is in compliance with the covenant included in the amended agreement. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Increment Financing Loan Agreements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into <ix:nonFraction unitRef="agreement" contextRef="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="exas:NumberOfAgreementsEntered" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzE5NQ_a8e584f8-1121-483d-89df-a699ae071d94">two</ix:nonFraction> separate Tax Increment Financing Loan Agreements (&#8220;TIFs&#8221;) in February 2019 and June 2019 with the City of Madison, Wisconsin. The TIFs provide for $<ix:nonFraction unitRef="usd" contextRef="ife7a525df7ca4926bdd7bd3c78f5a6bd_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzM0NQ_50e7dcfd-4dd4-447c-99ba-a45560b85163">4.6</ix:nonFraction> million of financing in the aggregate. In return for the loans, the Company is obligated to create and maintain <ix:nonFraction unitRef="employee" contextRef="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930" decimals="0" name="exas:NumberOfJobsRequiredToCreatedAndMaintained" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzQ1Mg_f5ec0675-e93f-4daa-b54e-459a230eaad5">500</ix:nonFraction> full-time jobs over a <ix:nonNumeric contextRef="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDI5OQ_509eb210-8ad1-46a5-b5ed-2d5c7ad12a56">five-year</ix:nonNumeric> period, starting on the date of occupancy of the buildings constructed. In the event that the job creation goals are not met, the Company would be required to pay a penalty.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the earned financial incentives as the full-time equivalent positions are filled. The amount earned is recorded as a liability and amortized as a reduction of operating expenses over a <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" format="ixt-sec:durwordsen" name="us-gaap:RegulatoryLiabilityAmortizationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDMwMA_0d667748-a81b-4977-ba95-1a37210b4fec">two-year</ix:nonNumeric> period, which is the timeframe when the TIFs will be repaid through property taxes.</span></div></ix:continuation><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib0fec8ca880849b89e0c9108a042a31e">As of December 31, 2019, the Company had earned and received payment of the full $<ix:nonFraction unitRef="usd" contextRef="i215a2290155b49189167351e504e7ec6_I20191231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDAzNw_10491c68-80f4-4e23-ada6-e7f0f0257568">4.6</ix:nonFraction> million from the City of Madison, and the corresponding liability became fully amortized in October 2020. In May 2021 the City of Madison confirmed that the Company had repaid the TIFs in full and released the Company from the loans and the related property lien.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_55"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:ConvertibleNotesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3Nw_d7adf332-63eb-4195-8ce8-b216f8245b02" continuedAt="id7dc867e5afa44d583740a7293b47baa" escape="true">CONVERTIBLE NOTES</ix:nonNumeric></span></div><ix:continuation id="id7dc867e5afa44d583740a7293b47baa" continuedAt="ia27e39870df94e9cb5ce7c98a2181dcc"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3NA_ae64efdb-7c36-4cda-88d3-08731f7f9f12" continuedAt="i0fdd37ac143f4f6f919a0ad3327da161" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (2)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Discount and Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leveling</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Convertible notes - <ix:nonFraction unitRef="number" contextRef="i6a521727e1e2422195adff75e2af975a_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi0wLTEtMS0xL3RleHRyZWdpb246YjNiODIxNGNjNDQzNDg1YThhZDY0M2ZkMWU5ODFkNGFfMjk_c5e42f2d-e09d-46a9-b940-4a5bc0179783">0.375</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a521727e1e2422195adff75e2af975a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:ConvertibleNotesPayableGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi0yLTEtMS0x_bdeb3b38-931e-4a10-823b-a7de6e33df26">1,150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a521727e1e2422195adff75e2af975a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi00LTEtMS0x_ccce53a0-050a-4ed6-bf98-8e3065deba42">19,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a521727e1e2422195adff75e2af975a_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi02LTEtMS0x_34e993ab-6ad8-4f54-b2f2-6d59e40003c5">1,130,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib556532666a843ffaa7ac89ce011921f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi04LTEtMS0x_c2c88ea7-2cbd-4bbc-b89c-401d4831efac">1,222,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible notes - <ix:nonFraction unitRef="number" contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy0wLTEtMS0xL3RleHRyZWdpb246NTU1NDFmNDZjMDU3NGI1MzkwNmQ1NGE4MzE2NzkyZDlfMjk_e9178604-d295-422b-86c7-07221805f526">0.375</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:ConvertibleNotesPayableGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy0yLTEtMS0x_72297702-e6dc-45fc-bc13-26f59605d393">747,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy00LTEtMS0x_c4696128-6f43-4bc6-b4d7-08152668edd8">12,257</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy02LTEtMS0x_a577ac22-4a8c-4394-bda8-2453d79ce216">735,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbba114462ea45e2925e5dd96d8f6ec2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy04LTEtMS0x_01546038-385d-4448-978e-9df31fa17589">834,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Convertible notes - <ix:nonFraction unitRef="number" contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC0wLTEtMS0xL3RleHRyZWdpb246MWViNzdjMGY4YWU5NGNmNTg5ODkwZWExYTUxZDg3ZWJfMjk_270fdd87-7f4f-4a05-85bd-4912054b8b81">1.000</ix:nonFraction>% (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:ConvertibleNotesPayableGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC0yLTEtMS0x_d0fbdf66-3f6b-4fb3-a3ed-fbbe85c2645a">315,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC00LTEtMS0x_0f00b3ae-c1fa-4020-ba88-cee8d821df18">1,901</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC02LTEtMS0x_5e073693-756b-4563-adde-a4495f1c037d">313,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfddf1183e2348268bfa21947a0c2519_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC04LTEtMS0x_4bc5fc02-55e5-444f-b953-1ebb829de77d">455,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ia27e39870df94e9cb5ce7c98a2181dcc" continuedAt="idfbc63fd3cd041e8b275c488dc11c5a1"><ix:continuation id="i0fdd37ac143f4f6f919a0ad3327da161" continuedAt="ic0ab7690825a4d15a21c54926f15a9b3"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of December&#160;31, 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (2)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Discount and Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leveling</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Convertible notes - <ix:nonFraction unitRef="number" contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi0wLTEtMS0xL3RleHRyZWdpb246NzkxZjIwZjYyOGVlNDA3OTg4YjViNzNhMzZjNzVjNzlfMjk_c75a7bac-8b61-499b-8eb3-042748e5658d">0.375</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="exas:ConvertibleNotesPayableGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi0yLTEtMS0x_bfc74a95-4c46-463a-9ff4-ea2f9ad21fb5">1,150,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi00LTEtMS0x_2d34c2f9-022e-4b03-a356-0f40fd8b1288">21,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi02LTEtMS0x_cbb8ae2e-c3c3-464b-9a07-ac3d0f1a3da6">1,128,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if11cabfe62874386b5321d2d3c18173d_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi04LTEtMS0x_e9709911-fe10-4c16-ae98-0da9f3905b6a">1,526,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible notes - <ix:nonFraction unitRef="number" contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy0wLTEtMS0xL3RleHRyZWdpb246MGU1ODdmMTk0NDEwNDEzNmE3ODlhOTRhY2Q2NDI2MGRfMjk_7bc2ccaa-34eb-42a3-af7a-f135ee4bd0a5">0.375</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="exas:ConvertibleNotesPayableGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy0yLTEtMS0x_5eab7c70-2679-4af9-9612-a1ddfaa60f83">747,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy00LTEtMS0x_7c84f74a-fd64-4477-b931-69a037fd5d54">13,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy02LTEtMS0x_b2ff15f1-dffb-4d91-825c-07414907c018">733,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3877e40a0f249069cae9a5fc123fb01_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy04LTEtMS0x_0f68f735-6575-4a3b-ba19-925b525f5688">992,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Convertible notes - <ix:nonFraction unitRef="number" contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC0wLTEtMS0xL3RleHRyZWdpb246OTIwNTdjMDc2ZGJjNDVlZGFjOTZmYmRlZWEzMzIzMWVfMjk_a7042f75-988d-4417-a568-c7b9ea2dae5d">1.000</ix:nonFraction>% (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="exas:ConvertibleNotesPayableGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC0yLTEtMS0x_3d9cc925-3aa0-4c7a-9b10-786df7f995d8">315,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC00LTEtMS0x_a83cea98-b2b8-4eff-ab69-303453d5e42a">2,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC02LTEtMS0x_9fa0625d-72f1-4130-9c33-fa19212fce7a">312,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d45eaa6f404347bac96339127fc805_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtFairValueDisclosures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC04LTEtMS0x_842ce6b5-609a-4e2a-8aef-b9ff84e62ef9">601,744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the Company&#8217;s share price on the days leading up to September&#160;30, 2021 and December 31, 2020, holders of the 2025 Convertible Notes have the right to convert their debentures. As a result, the 2025 Convertible Notes are included within convertible notes, net, current portion on the condensed consolidated balance sheets. Some holders did convert their debentures, resulting in a decrease of the principal amount of the 2025 Convertible Notes. </span></div></ix:continuation><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic0ab7690825a4d15a21c54926f15a9b3" continuedAt="i0cbb0dd7e6104f6d97c0c901a887bc79">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i0cbb0dd7e6104f6d97c0c901a887bc79">The fair values are based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement.</ix:continuation> </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuances and Settlements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Company issued and sold $<ix:nonFraction unitRef="usd" contextRef="i38025f781a304faeaa4d5be06d555c28_I20180131" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODQy_dc6d05bb-a540-42ef-bc67-d1a633e619ae">690.0</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i38025f781a304faeaa4d5be06d555c28_I20180131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODc4_ab7878f2-94ab-4e92-879f-dfa22b32896e">1.0</ix:nonFraction>% Convertible Notes (the &#8220;January 2025 Notes&#8221;) with a maturity date of January 15, 2025. The January 2025 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="ic2e12ba29e1148cc92200e3f802d478d_I20180131" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTAyNg_d7f14ba4-8fdb-4631-966e-36d786116f02">1.0</ix:nonFraction>% per year, payable semi-annually in arrears on January 15 and July 15 of each year, beginning on July 15, 2018. The net proceeds from the issuance of the January 2025 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i2f6e4612ba6042b3a41b0a3a22cc1a08_D20180101-20180131" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTIyMA_aafa8a7b-4722-46d8-804f-e46737205e8e">671.1</ix:nonFraction> million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company issued and sold an additional $<ix:nonFraction unitRef="usd" contextRef="i130815bcac064cb9a769f10dde0d717f_I20180630" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTM4Ng_06279e5d-9944-4126-9880-29edf01f5bb8">218.5</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i130815bcac064cb9a769f10dde0d717f_I20180630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTQyMg_4a1653f1-4ba4-4723-9cd4-7d9ad0d77ee7">1.0</ix:nonFraction>% Convertible Notes (the &#8220;June 2025 Notes&#8221;). The June 2025 Notes were issued under the same indenture pursuant to which the Company previously issued the January 2025 Notes (the &#8220;Indenture&#8221;). The January 2025 Notes and the June 2025 Notes (collectively, the &#8220;2025 Notes&#8221;) have identical terms (including the same January 15, 2025 maturity date) and are treated as a single series of securities. The net proceeds from the issuance of the June 2025 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i321e09355b9344bb8c1ddfb4873b74c4_D20180601-20180630" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTg5NQ_18895944-051c-41d1-b70b-091feadc6280">225.3</ix:nonFraction> million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company issued and sold $<ix:nonFraction unitRef="usd" contextRef="i374446ae108740e8b3d011f480573480_I20190331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjA0OA_8b78f216-7c1d-4de4-bc81-9214d5eef76b">747.5</ix:nonFraction> million in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i374446ae108740e8b3d011f480573480_I20190331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjA4NA_a30a4746-cc14-4317-8768-605680da9121">0.375</ix:nonFraction>% Convertible Notes (the &#8220;2027 Notes&#8221;) with a maturity date of March 15, 2027. The 2027 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i374446ae108740e8b3d011f480573480_I20190331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjIxNA_a30a4746-cc14-4317-8768-605680da9121">0.375</ix:nonFraction>% per year, payable semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2019. The net proceeds from the issuance of the 2027 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i2cedb49083ec46b7819b0b36b95fd866_D20190301-20190331" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjQwOA_23726a71-7c85-4a13-8c97-937da5baeb4c">729.5</ix:nonFraction> million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized a portion of the proceeds from the issuance of the 2027 Notes to settle a portion of the 2025 Notes in privately negotiated transactions. In March 2019, the Company used cash of $<ix:nonFraction unitRef="usd" contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjcxNw_a92a622b-d22b-4517-a9a6-2276a8802a17">494.1</ix:nonFraction> million and an aggregate of <ix:nonFraction unitRef="shares" contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331" decimals="-5" name="us-gaap:ConversionOfStockSharesIssued1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjc0MA_1de0e043-0334-463d-ba05-c06a2d9b46f2">2.2</ix:nonFraction> million shares of the Company&#8217;s common stock valued at $<ix:nonFraction unitRef="usd" contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjc5MA_280cb609-7566-497b-9d96-1eb09bb7c9eb">182.4</ix:nonFraction> million for total consideration of $<ix:nonFraction unitRef="usd" contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331" decimals="-5" name="exas:RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjgyMA_49aba912-551f-4699-b4bb-8310bdfff623">676.5</ix:nonFraction> million to settle $<ix:nonFraction unitRef="usd" contextRef="i8bfcc0d5558a40d4bbafe59948477390_D20190301-20190331" decimals="-5" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjgzMw_f37a6084-7170-4f75-9f66-bebfade4a2e4">493.4</ix:nonFraction> million of the 2025 Notes, of which $<ix:nonFraction unitRef="usd" contextRef="i8bfcc0d5558a40d4bbafe59948477390_D20190301-20190331" decimals="-5" name="exas:DebtInstrumentConvertibleEquityComponentInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjg2NA_13be7379-942c-4e5a-9e60-429c8b52d0d0">0.7</ix:nonFraction> million was used to pay off interest accrued on the 2025 Notes. The transaction resulted in a loss on settlement of convertible notes of $<ix:nonFraction unitRef="usd" contextRef="i7b1067f298de48eca8c19edda276d2ed_D20190301-20190331" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjk5Ng_dcbafecf-2e4d-49f1-b96f-c56d5ceeb55d">187.7</ix:nonFraction> million, which is reflected in accumulated deficit in the Company&#8217;s condensed consolidated balance sheets. The loss represents the difference between (i) the fair value of the consideration transferred and (ii) the carrying value of the debt at the time of repurchase.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company issued and sold $<ix:nonFraction unitRef="usd" contextRef="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzMwNg_36ab4216-484d-40a2-87ae-12972a881a2b">1.15</ix:nonFraction> billion in aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzM0Mg_f695a10d-19c7-4675-a78e-dcf6cad6b9f8">0.375</ix:nonFraction>% Convertible Notes (the &#8220;2028 Notes&#8221; and, collectively with the 2025 Notes and the 2027 Notes, the &#8220;Notes&#8221;) with a maturity date of March 1, 2028. The 2028 Notes accrue interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzU0MQ_f695a10d-19c7-4675-a78e-dcf6cad6b9f8">0.375</ix:nonFraction>% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2020. The net proceeds from the issuance of the 2028 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="ida0a237027f04c40b0f9753f4982f052_D20200201-20200229" decimals="-7" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromConvertibleDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzczMg_84189d5a-c92d-4db4-bf34-8fc1af8956ef">1.13</ix:nonFraction> billion, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="idfbc63fd3cd041e8b275c488dc11c5a1" continuedAt="iac2ab65d772444c7a01c8eb6a323d6fa"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company used $<ix:nonFraction unitRef="usd" contextRef="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzg3Nw_8aaa4fa8-b5f1-4aa6-b035-49ad61c41cca">150.1</ix:nonFraction> million of the proceeds from the issuance of the 2028 Notes to settle $<ix:nonFraction unitRef="usd" contextRef="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229" decimals="-5" name="exas:DebtInstrumentAmountSettledInExtinguishment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzk0Mg_0a691880-7a0f-4396-a3e4-431cf9c67841">100.0</ix:nonFraction> million of the 2025 Notes, of which $<ix:nonFraction unitRef="usd" contextRef="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229" decimals="-5" name="exas:DebtInstrumentConvertibleEquityComponentInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzk3Mw_057f81b3-3b82-4497-9dc8-0bdb4c571347">0.1</ix:nonFraction> million was used to pay off interest accrued on the 2025 Notes. The transaction resulted in a loss on settlement of convertible notes of $<ix:nonFraction unitRef="usd" contextRef="i41663aac7c7a4e50bbe228b3f6df07a4_D20200201-20200229" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNDEwNQ_8abea08b-56eb-4870-b715-a0632a77af8a">50.8</ix:nonFraction> million, which is recorded in interest expense in the Company&#8217;s condensed consolidated statement of operations. The loss represents the difference between (i) the fair value of the consideration transferred and (ii) the carrying value of the debt at the time of repurchase.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Conversion Features</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the six-months immediately preceding the maturity date of the applicable series of Notes, each series of Notes is convertible only upon the occurrence of certain events and during certain periods, as set forth in the Indentures filed at the time of the original offerings. On or after the date that is six-months immediately preceding the maturity date of the applicable series of Notes until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert such Notes at any time. The Notes will be convertible into cash, shares of the Company&#8217;s common stock (plus, if applicable, cash in lieu of any fractional share), or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s election.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company&#8217;s intent and policy to settle all conversions through combination settlement. The initial conversion rate is&#160;13.26, 8.96, and 8.21 shares of common stock per&#160;$1,000&#160;principal amount for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively, which is equivalent to an initial conversion price of&#160;approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTUwMQ_a05b6c6c-80a5-4a86-9f6e-b61b9a3400a1">75.43</ix:nonFraction>,&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTUwNQ_c357e03b-cf00-48fd-ab2a-a1fd99dffac8">111.66</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="i6a521727e1e2422195adff75e2af975a_I20210930" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTUxMw_7a98ab20-7cb7-4a01-94b1-c3696bddce1d">121.84</ix:nonFraction> per share of the Company&#8217;s common stock for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively. The 2025 Notes, 2027 Notes, and 2028 Notes may be convertible in up to <ix:nonFraction unitRef="shares" contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTY4OQ_e256101e-fbb7-4d5a-a9db-17fe81cfa7e2">4.2</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="shares" contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTY5Mw_909320ff-9488-4a82-ba87-8397fd3cc4ef">6.7</ix:nonFraction>&#160;million, and <ix:nonFraction unitRef="shares" contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTcwMQ_182e2ae1-86ed-4df0-a602-de906df6329d">9.4</ix:nonFraction>&#160;million shares, respectively. The conversion rate is subject to adjustment upon the occurrence of certain specified events as set forth in the Indentures filed at the time of the original offerings but will not be adjusted for accrued and unpaid interest. In addition, holders of the Notes who convert their Notes in connection with a &#8220;make-whole fundamental change&#8221; (as defined in the Indenture), will, under certain circumstances, be entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a &#8220;fundamental change&#8221; (as defined in the Indenture), holders of the Notes may require the Company to repurchase for cash all or part of their Notes at a repurchase price equal to&#160;<ix:nonFraction unitRef="number" contextRef="i5de4fa457232460eb415263a8948799a_D20210101-20210930" decimals="INF" name="exas:DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNjM4Ng_e1e3d4e7-0910-4208-9a7e-5f65c351bd4e">100</ix:nonFraction>%&#160;of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the closing price of the Company&#8217;s common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNjU0MQ_15672a6c-20ab-46d4-9d1a-5f81aac5c6d5">95.45</ix:nonFraction> on September&#160;30, 2021, the if-converted values on the Company&#8217;s 2025 Notes exceed the principal amount by $<ix:nonFraction unitRef="usd" contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNjYwNg_6d7d5f79-1255-4c28-866f-3f5b4ba7f38c">83.6</ix:nonFraction> million and the 2027 Notes and 2028 Notes do not exceed the principal amount.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ranking of Convertible Notes</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are the Company&#8217;s senior unsecured obligations and (i) rank senior in right of payment to all of its future indebtedness that is expressly subordinated in right of payment to the Notes; (ii) rank equal in right of payment to each outstanding series thereof and to all of the Company&#8217;s future liabilities that are not so subordinated, unsecured indebtedness; (iii) are effectively junior to all of the Company&#8217;s existing and future secured indebtedness and other secured obligations, to the extent of the value of the assets securing that indebtedness and other secured obligations; and (iv) are structurally subordinated to all indebtedness and other liabilities of the Company&#8217;s subsidiaries.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance costs are amortized to interest expense over the term of the Notes. <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3NQ_e1304415-b731-4bbd-b10c-91cea10a1710" continuedAt="i5e0833aea2304037b144710b9c188a00" escape="true">The following table summarizes the original issuance costs at the time of issuance for each set of Notes:</ix:nonNumeric></span></div><div><ix:continuation id="i5e0833aea2304037b144710b9c188a00"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i124fcfaa5c2844ba9a7f3648437e97a4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:DebtInstrumentConvertibleTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfMS0yLTEtMS0x_ae88a4d5-b6c9-4af8-8c39-5c93343532d6">10,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icebfd363a27a407f91529aaa90ed0971_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:DebtInstrumentConvertibleTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfMi0yLTEtMS0x_f07e7330-3cdf-4aaf-895a-040a4f71051f">7,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:DebtInstrumentConvertibleTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfMy0yLTEtMS0x_be1953a2-95f5-4fd7-99da-22ae60f795b2">14,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:DebtInstrumentConvertibleTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfNC0yLTEtMS0x_7ef18dde-6905-4791-8272-e518831b5189">24,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="iac2ab65d772444c7a01c8eb6a323d6fa"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:InterestExpenseDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3OQ_13f361bf-c58f-4cf1-99e6-2d5d6446e5e3" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi0yLTEtMS0x_c7174701-55bf-42b3-a049-e1b6b13cdc31">1,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi00LTEtMS0x_41fb1cc6-adc7-420b-b08d-4e20603bc734">1,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi02LTEtMS0x_befe4347-a8dc-4a01-a824-cbffa150c250">4,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi04LTEtMS0x_e27ada19-60d5-4e41-a95d-0026d1ca8532">3,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy0yLTEtMS0x_472865d6-66b7-4b54-8f23-e6962694edb9">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy00LTEtMS0x_0e28cce2-c00b-4e3c-bae4-ba965770549f">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy02LTEtMS0x_0c3cb799-6041-403c-b5ca-ce082fa0796b">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy04LTEtMS0x_d2f221b9-413a-4b70-8483-862bc2c6cc2d">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on settlement of convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC0yLTEtMS0x_5ee9c6f0-0e10-49ba-abce-11b96c0b0e36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC00LTEtMS0x_30c4cbcf-b75f-48f1-af64-e369cb5677eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC02LTEtMS0x_ceeb8aa0-d108-4635-9245-18f276cf3fd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC04LTEtMS0x_c11e7901-cf76-4971-970c-48059b6c3d63">50,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coupon interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS0yLTEtMS0x_5a457c08-61f6-4d1a-87cf-340f4e9fb691">2,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="exas:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS00LTEtMS0x_e478bb5b-fcae-414b-bbcd-9095b23b4b33">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS02LTEtMS0x_808d477d-edd2-4be2-abe0-95c5f6109983">7,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="exas:CouponInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS04LTEtMS0x_45e8aa47-c525-43a9-933d-15873a0450bb">7,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense on convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi0yLTEtMS0x_c7357dce-f877-4c24-886a-eb7781888c6d">4,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi00LTEtMS0x_26bf13aa-2462-4851-b563-faf4ad6f5835">4,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi02LTEtMS0x_60391218-32ae-461b-9608-e941df8a5240">12,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi04LTEtMS0x_dc5ba4fd-bf1f-49b0-b9be-fe7811c0d12e">61,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy0yLTEtMS0x_d42618db-bb6c-4628-b321-eafd8d226ead">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" name="us-gaap:InterestExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy00LTEtMS0x_03d1dc22-49b5-4b5e-b010-2e09629afdca">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy02LTEtMS0x_8f44098d-c101-475b-9022-3e36e526957d">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy04LTEtMS0x_215b698d-369f-401d-b886-d2a96aa3cefb">1,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC0yLTEtMS0x_b93498cc-bd12-4b63-9e24-089f9392c922">4,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC00LTEtMS0x_57a19d47-40d9-4850-8535-9711ca0c563c">4,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC02LTEtMS0x_0553f15e-dd6a-40c0-9b56-fbc56d5a76bf">13,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC04LTEtMS0x_7ffff758-8d3b-4131-818f-2779e4d7256e">63,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rates on the 2025 Notes, 2027 Notes, and 2028 Notes for the three months ended September&#160;30, 2021 and 2020 were <ix:nonFraction unitRef="number" contextRef="ibd02d60e985347cca760b9cee3c1553f_D20210701-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk3Mg_b8246562-7598-4af9-87c0-61185410b757">1.18</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i11ab2964ac5a4d30ab3e51e81e533a19_D20210701-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk3Ng_5c972224-934b-4982-9b71-1597d8e0900b">0.68</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i558d42ab543b48d1bd82a3e120ac356d_D20210701-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk4NA_06e949f6-f203-4de3-afa8-1aea6e75b9ec">0.64</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i1c6f646df40d4090b3421105d8392a38_D20200701-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk5MQ_57c4293e-3e05-4527-80c5-9c11da04f1f6">1.18</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i25bccea148c24ef3b5882a544e0cc76f_D20200701-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk5NQ_563585d1-63eb-4c81-813c-3c460dabe33f">0.68</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i62e976ba77074ce9b9fe3a0c91204d9f_D20200701-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODAwMw_04b4fe4f-c663-4978-bc02-88ab3309ff86">0.64</ix:nonFraction>%, respectively. The effective interest rates on the 2025 Notes, 2027 Notes, and 2028 Notes for the nine months ended September&#160;30, 2021 and 2020 were <ix:nonFraction unitRef="number" contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODEzNQ_9c697fa6-5cdb-447c-a0cd-18f803cd706f">1.18</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODEzOQ_0d2c57f6-74c0-4c3d-b841-1123cb0dff16">0.67</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE0Nw_b1d22572-e9dc-45c6-8f59-30cfde73f433">0.64</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE1NA_798b5c2c-546c-494e-8062-0eb6735b3127">1.21</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ie533365c1c7a49cfa488f532fa22ddb8_D20200101-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE1OA_eab29878-5362-40f5-9b99-40f746cee048">0.68</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i096f0478568e4ab3ba5831ff5cf0ff8b_D20200101-20200930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE2Ng_c9692e9b-a9b1-46d9-b777-2a0bef38501f">0.63</ix:nonFraction>%, respectively. The remaining period over which the unamortized debt discount will be recognized as non-cash interest expense is <ix:nonNumeric contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODI5Nw_cd6b4be7-6171-4149-9acf-9c59115671bc">3.30</ix:nonNumeric>, <ix:nonNumeric contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODMwMQ_e5926725-a9c4-426f-b19a-d398f8901d90">5.46</ix:nonNumeric>, and <ix:nonNumeric contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODMwOQ_9b3e7db0-dbc7-45ea-adec-2ffc9fd3aa73">6.42</ix:nonNumeric> years for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_61"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) <ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:LicensingAgreementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQzMQ_b73aeb1f-783f-4e07-9c40-5e061b94776d" continuedAt="ib5627acaaf7148e2b5422888f56ab224" escape="true">LICENSE AND COLLABORATION AGREEMENTS</ix:nonNumeric></span></div><ix:continuation id="ib5627acaaf7148e2b5422888f56ab224" continuedAt="icb776bf10845488b87fc59b9e724e2fa"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses certain technologies that are, or may be, incorporated into its technology under several license agreements, as well as the rights to commercialize certain diagnostic tests through collaboration agreements. Generally, the license agreements require the Company to pay low single-digit royalties based on net revenues received using the technologies and may require minimum royalty amounts or maintenance fees.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mayo</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June&#160;2009 the Company entered into a license agreement with Mayo Foundation for Medical Education and Research (&#8220;Mayo&#8221;). The Company&#8217;s license agreement with Mayo was most recently amended and restated in September 2020. Under the license agreement, Mayo granted the Company an exclusive, worldwide license to certain Mayo patents and patent applications, as well as a non-exclusive, worldwide license with regard to certain Mayo know-how. The scope of the license covers any screening, surveillance or diagnostic test or tool for use in connection with any type of cancer, pre-cancer, disease or condition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The licensed Mayo patents and patent applications contain both method and composition claims that relate to sample processing, analytical testing and data analysis associated with nucleic acid screening for cancers and other diseases. The jurisdictions covered by these patents and patent applications include the U.S., Australia, Canada, the European Union, China, Japan and Korea. Under the license agreement, the Company assumed the obligation and expense of prosecuting and maintaining the licensed Mayo patents and is obligated to make commercially reasonable efforts to bring to market products using the licensed Mayo intellectual property.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant&#160;to the Company&#8217;s&#160;agreement with Mayo,&#160;the Company is&#160;required to pay Mayo a low-single-digit royalty on the Company&#8217;s net sales of current and future products using the licensed Mayo intellectual property&#160;each year during the term of the Mayo agreement. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the most recent amendment, the Company agreed to pay Mayo an additional $<ix:nonFraction unitRef="usd" contextRef="i09b705cb560e427b94fb986c5efcc8fa_I20200930" decimals="-5" format="ixt:num-dot-decimal" name="exas:LicenseAgreementFeesCommitment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMjA3Mg_9d39adc5-84df-40be-aefc-5a0b5cb1361f">6.3</ix:nonFraction> million, payable in five equal annual installments through 2024. The annual installments are recorded in research and development expenses in the Company&#8217;s condensed consolidated statements of operations.  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="icb776bf10845488b87fc59b9e724e2fa"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The license agreement will remain in effect, unless earlier terminated by the parties in accordance with the agreement, until the last of the licensed patents expires in 2038 (or later, if certain licensed patent applications are issued). However, if the Company is still using the licensed Mayo know-how or certain Mayo-provided biological specimens or their derivatives on such expiration date, the term shall continue until the earlier of the date the Company stops using such know-how and materials and the date that is five years after the last licensed patent expires. The license agreement contains customary termination provisions and permits Mayo to terminate the license agreement if the Company sues Mayo or its affiliates, other than any such suit claiming an uncured material breach by Mayo of the license agreement.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to granting the Company a license to the covered Mayo intellectual property, Mayo provides the Company with product development and research and development assistance pursuant to the license agreement and other collaborative arrangements. In September 2020, Mayo also agreed to make available certain personnel to provide such assistance through January 2025. In connection with this collaboration, the Company incurred charges of $<ix:nonFraction unitRef="usd" contextRef="i7687d156b5064d39b98d15068b794c79_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzU0OA_9fc136ce-d2ea-42ad-9635-75f09e4c3c33">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4b58a8bac9c14347b1a5e677d4bd4071_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzU1NQ_2b5d9ebf-1c11-4f7b-95ac-2e244b17f0bc">0.9</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $<ix:nonFraction unitRef="usd" contextRef="ia4940cc012454056b02ad98f6edbda80_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzYyMw_80d54e38-d6d3-4d11-9874-0f9133de2d55">3.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i38df5143fb9f471eaadf9f61fcdb461a_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzYzMA_681bc5d7-bd0e-47f0-9875-3149fd4cfebb">2.8</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively. The charges incurred in connection with this collaboration are recorded in research and development expenses in the Company&#8217;s condensed consolidated statements of operations. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Johns Hopkins University (&#8220;JHU&#8221;)</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the acquisition of Thrive, the Company acquired a worldwide exclusive license agreement with JHU for use of several JHU patents and licensed know-how. The license is designed to enable the Company to leverage JHU proprietary data in the development and commercialization of a blood-based, multi-cancer early detection test. The agreement terms include single-digit sales-based royalties and sales-based milestone payments of $<ix:nonFraction unitRef="usd" contextRef="i5315ee1596b6499d88299026c527248b_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:PaymentsContingentOnMilestonesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDMwMg_3b91f3c4-f998-4563-8dac-b45816243fec">10.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i08569ff75b9f4fb89d6962ce95f8760d_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:PaymentsContingentOnMilestonesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDMwNg_d191d699-c94f-4cd8-a6c1-e829b292733a">15.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie431846077ce465aaa2deb9090c42f3d_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:PaymentsContingentOnMilestonesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDMxMA_acbff61a-55a1-4a3d-8680-4f6e6f7b23c6">20.0</ix:nonFraction> million upon achieving calendar year licensed product revenue using JHU proprietary data of $<ix:nonFraction unitRef="usd" contextRef="id60aa524dd6844bfab317842fa27f753_D20210105-20210105" decimals="-7" format="ixt:num-dot-decimal" name="exas:CollaborativeArrangementsSalesMilestoneAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQwMQ_814813cb-643d-4677-bf9c-72bb4c95a641">0.50</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i073a3afe3259475fa47b27b5734849c0_D20210105-20210105" decimals="-7" format="ixt:num-dot-decimal" name="exas:CollaborativeArrangementsSalesMilestoneAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQwNQ_9b51fb87-995c-4750-b213-bbdd6dc7b6fe">1.00</ix:nonFraction> billion, and $<ix:nonFraction unitRef="usd" contextRef="ib66de190a3114ea390108d37accaf4be_D20210105-20210105" decimals="-7" format="ixt:num-dot-decimal" name="exas:CollaborativeArrangementsSalesMilestoneAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQxMw_1a5514f4-f861-4b57-877f-6aad3fd12ac3">1.50</ix:nonFraction> billion, respectively.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_64"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMjE4MQ_c0cb22f0-8613-4fc3-bdff-3b50405c4209" continuedAt="ib28044a604ca42a6b5cee52b8063b1cd" escape="true">PFIZER PROMOTION AGREEMENT</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib28044a604ca42a6b5cee52b8063b1cd" continuedAt="ic69cd4cda5594a919821c4dea1873252">In August 2018, the Company entered into a Promotion Agreement (the &#8220;Original Promotion Agreement&#8221;) with Pfizer Inc. (&#8220;Pfizer&#8221;), which was amended and restated in October 2020 (the &#8220;Restated Promotion Agreement&#8221;). The Restated Promotion Agreement extends the relationship between the Company and Pfizer and restructures the manner in which the Company compensates Pfizer for promotion of the Cologuard test through a service fee, and provision of certain other sales and marketing services related to the Cologuard test. The Restated Promotion Agreement includes fixed and performance-related fees, some of which retroactively went into effect on April 1, 2020. All payments to Pfizer are recorded in sales and marketing expenses in the Company&#8217;s condensed consolidated statements of operations. </ix:continuation></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic69cd4cda5594a919821c4dea1873252">Under the Original Promotion Agreement, the service fee was calculated based on incremental gross profits over specified baselines during the term. Under the Restated Promotion Agreement, the service fee provides a fee-for-service model that includes certain fixed fees and performance-related bonuses. The performance-related bonuses are contingent upon the achievement of certain annual performance criteria with any applicable expense being recognized ratably upon achievement of the payment becoming probable. The Company incurred charges of $<ix:nonFraction unitRef="usd" contextRef="i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTM4MA_91fb215a-0f5e-43b8-b2ad-7ba807290b4e">16.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id0e581abbb2e45fb9d0f5e111ecb424d_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTM4Nw_38f3895d-ece8-4eea-80f2-f723297c51b1">18.0</ix:nonFraction>&#160;million for the service fee for the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $<ix:nonFraction unitRef="usd" contextRef="ie75cea8f115f4394bd4c6369824b83e6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTQ3NQ_9cd05edf-b4a3-4cba-9a2b-864e765c76f4">63.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9f8d48835a0141b7a3d9e3c2af436ca5_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTQ4Mg_6ac37d30-5c32-4d44-bb85-b591c0e194a7">39.7</ix:nonFraction> million for the service fee for the nine months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $<ix:nonFraction unitRef="usd" contextRef="i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTU3MA_1c4828dc-fa52-461e-8033-e39709203750">30.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id0e581abbb2e45fb9d0f5e111ecb424d_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTU3Nw_1943d2d1-58ba-46e6-9e19-3783cf1afae8">15.8</ix:nonFraction> million for promotion, sales and marketing services performed by Pfizer on behalf of the Company during the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $<ix:nonFraction unitRef="usd" contextRef="ie75cea8f115f4394bd4c6369824b83e6_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTczNw_e3eaf8ee-7436-4896-ab04-1c2297369aff">88.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i9f8d48835a0141b7a3d9e3c2af436ca5_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:MarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTc0NA_bd39b233-cc82-4c5e-bc0d-dc5a8925b770">56.3</ix:nonFraction> million for promotion, sales and marketing services performed by Pfizer on behalf of the Company during the nine months ended September 30, 2021 and 2020, respectively. During 2022, and contingent upon the achievement of certain Cologuard test revenue metrics during 2021, the Company will pay Pfizer a royalty based on a low single-digit royalty rate applied to actual 2022 Cologuard test revenues. The term of the Restated Promotion Agreement runs through December 31, 2022.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_67"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTg5MA_4f6af421-719b-4ba1-96a3-9ea8cf3bd340" continuedAt="i81e6ee1a44e14cceae765fc39f7e70fb" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i81e6ee1a44e14cceae765fc39f7e70fb" continuedAt="i101024dbc1e44c33a01b8e9b8662e9ee"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ashion Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021 the Company completed its acquisition of Ashion. In connection with the acquisition, which is further described in Note 17, the Company issued <ix:nonFraction unitRef="shares" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMjIy_d3d8d016-3ab1-482b-93d3-39ba468b9da5">0.1</ix:nonFraction>&#160;million common shares that had a fair value of $<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMjY0_0b6c75e1-15d9-44b1-9850-03f8b542cac6">16.2</ix:nonFraction> million.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i101024dbc1e44c33a01b8e9b8662e9ee" continuedAt="if998da76f80a42d0963ccd51162a7a94"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Thrive Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company completed its acquisition of Thrive. In connection with the acquisition, which is further described in Note 17, the Company issued <ix:nonFraction unitRef="shares" contextRef="i376b181ad07a407cbb2ac71cfb91c79f_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfNDYy_d1a3866c-2b2b-4cf3-987d-74dd045b5d7b">9.3</ix:nonFraction>&#160;million common shares that had a fair value of $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-7" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfNTA0_1a2bb007-bdf9-4d1d-be02-9eaf3508e374">1.19</ix:nonFraction> billion.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Targeted Digital Sequencing (&#8220;TARDIS&#8221;) License Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company acquired a worldwide exclusive license to the TARDIS technology from The Translational Genomics Research Institute (&#8220;TGen&#8221;), which is further described in Note 17. As part of the consideration transferred, the Company issued <ix:nonFraction unitRef="shares" contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111" decimals="-5" format="ixt:num-dot-decimal" name="exas:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfODM4_32658dfc-544a-4358-a36c-c980add3c68e">0.2</ix:nonFraction>&#160;million shares that had a fair value of $<ix:nonFraction unitRef="usd" contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfODcz_83d69112-4740-43a7-9087-a5a46af2a59e">27.3</ix:nonFraction> million. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paradigm Diagnostics, Inc. and Viomics, Inc. Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company completed the acquisitions of Paradigm and Viomics. The purchase price for these acquisitions consisted of cash and stock with a fair value of $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTE0NQ_bacaabba-2334-408f-ba6f-8d62554b8ab1">40.4</ix:nonFraction> million. Of the $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTE1Ng_bacaabba-2334-408f-ba6f-8d62554b8ab1">40.4</ix:nonFraction> million purchase price, $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTE3NQ_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc">32.2</ix:nonFraction>&#160;million is expected to be settled through the issuance of <ix:nonFraction unitRef="shares" contextRef="i440309922a2844d8b7f20c86821d414f_D20200301-20200331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTIyOA_2535c692-5c0d-42a7-85b8-6964ce5c226d">0.4</ix:nonFraction>&#160;million shares of common stock. Of the $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTI2Mg_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc">32.2</ix:nonFraction>&#160;million that will be settled through the issuance of common stock, $<ix:nonFraction unitRef="usd" contextRef="i949e45cbfa8f4affa83a6c86d26dc895_D20200303-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTMyNA_c8cea121-5732-449d-9a84-0931aaa0e99e">28.8</ix:nonFraction>&#160;million was issued as of September&#160;30, 2021, and the remainder was withheld and may become issuable as additional merger consideration subject to the terms and conditions of the acquisition agreements. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Accumulated Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTg4OQ_6b36eabd-929e-408a-9210-3f4fae146f5c" continuedAt="i62f42e7e34594543a4d5b66fdcc26cc7" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount recognized in AOCI for the nine months ended September&#160;30, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gain (Loss)<br/>on Marketable<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if11e689b7b1c49b3a07b24b28aee69ce_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMS0yLTEtMS0x_251e2276-0d25-4c9d-a542-3da207cd1123">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1a5e4e4fb3441dbfac2e16747f0f82_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMS00LTEtMS0x_4bd55d7d-8d50-4f4b-a9bc-4c2c8bd125a8">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMi0yLTEtMS0x_4e16378a-76d9-4840-889e-533fa0603fef">292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMi00LTEtMS0x_77e3be87-16d5-4dcf-8e47-faa4cc4351cf">292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMy0yLTEtMS0x_12125f9f-6b23-42ef-90b7-3635680e4674">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMy00LTEtMS0x_4b4f3343-c297-4ad3-b130-9156d8736ea0">271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period change in accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNC0yLTEtMS0x_24e74b6e-bd24-4529-968e-e9be4e71476f">563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNC00LTEtMS0x_3754e330-0204-4e52-9f8d-166e6562126a">563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense related to items of other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNS0yLTEtMS0x_4bee3881-af49-406e-94aa-096a7bbdec19">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNS00LTEtMS0x_f1fad145-d3f0-4261-b599-f651f4f6f2be">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6189b240ae4709b0cb6a53b24b5529_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNi0yLTEtMS0x_6224d3ec-9e8c-4104-a14d-3d3710dfb4bf">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7040c10b7747fcbcec17982a4d2f4e_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNi00LTEtMS0x_13bad597-6b35-47ee-954e-730ccf2d397b">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in AOCI for the nine months ended September 30, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gain (Loss)<br/>on Marketable<br/>Securities (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb78c2ffc7a24797b5f3efdbf143d558_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMS0yLTEtMS0x_51c4a77c-7066-4166-bbc9-777d10746164">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9728265290ae4d62bae3395eaa6b09a9_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMS00LTEtMS0x_e7e5d1a3-eec7-4820-8af6-f5c230a1504f">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d558258814f4878ba1f82b61916b08e_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMS02LTEtMS0x_845e3db4-644d-44d4-83c3-3dee16539f10">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMi0yLTEtMS0x_a14d54bc-de06-4df3-bed0-ea7ff765a11c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc090024fb42477da472a7b389554c39_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMi00LTEtMS0x_d8160b1d-9dd2-4e7f-ad8e-55827579b17b">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMi02LTEtMS0x_8f7bfff9-a810-440f-a1dc-ea4be7bdbf7f">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMy0yLTEtMS0x_aa7286ae-27b5-4848-a5b8-a5fe8caf982f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc090024fb42477da472a7b389554c39_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMy00LTEtMS0x_18c6e2e0-8f4c-49fe-8fd9-50d7bc8932a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMy02LTEtMS0x_63319e80-7113-4d17-a608-6592c18b33f6">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period change in accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNC0yLTEtMS0x_61010fb1-4db2-4b58-80a3-2c556a2a1811">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc090024fb42477da472a7b389554c39_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNC00LTEtMS0x_e47f45f0-8ac1-42d0-ac18-896a23f8c1ce">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNC02LTEtMS0x_5401d135-ae8e-47d7-aed3-7fd15bb237b6">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032fd22b30fc4740afe82de8e068942e_I20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNS0yLTEtMS0x_0d66d6bd-d39d-4a5f-9f96-01ef3ab097ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i350ab28dcf6f4361a935ff5ed1b2d4e0_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNS00LTEtMS0x_f20e923f-f33d-4069-b784-33a8cecba680">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic260e91a22f64d36ace033eed2e0ebe6_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNS02LTEtMS0x_e52415b6-e092-4907-8990-a4b32ca96dac">1,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i62f42e7e34594543a4d5b66fdcc26cc7" continuedAt="i57fd9715d5d64d17a3e8702dd61bd21b">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i57fd9715d5d64d17a3e8702dd61bd21b">There was no tax impact from the amounts recognized in AOCI for the three and nine months ended September&#160;30, 2020.</ix:continuation> </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="if998da76f80a42d0963ccd51162a7a94"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTg4OA_717dd838-47c7-4cbc-988f-88b4e8cc8a2f" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI for the nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.970%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the<br/>Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about AOCI Components (In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of available-for-sale investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id526869db3114853b21ef6d57b0d6023_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfMy00LTEtMS0x_ef2f794c-3f5a-44fe-b33e-56bb83798618">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5ec3803d9c47489d2b8976b93ba9cd_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:InvestmentIncomeNonoperating" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfMy02LTEtMS0x_73edc913-7369-4c6f-a265-697d6fd0d975">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i871bb8ae36f4481b94f202bc81915ae8_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNC00LTEtMS0x_37f43c7f-f491-489e-9bf0-459d6cd23fb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b935f915cf4d8284af4012ec5af1fc_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNC02LTEtMS0x_57abeb1c-9610-4ac7-b49f-97ab609c2ac6">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820542840d28423db7a2ed962f5b4151_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNS00LTEtMS0x_2d84926d-ebf5-4bd2-8754-dbe70dfec84e">271</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibed0ef19bdd64427a77d040d96302174_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNS02LTEtMS0x_b70de358-1c4b-4ee3-9dd5-c77a573aa0f3">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_70"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYyOA_95988f84-75d8-4977-b87a-3a13972aba6a" continuedAt="i3d0374ebf40948ac8cc3dd8369026548" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i3d0374ebf40948ac8cc3dd8369026548" continuedAt="ie3f3b5f0fec242f4b5c14dd582ff8c94"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Plans</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the 2010 Omnibus Long-Term Incentive Plan (As Amended and Restated Effective July 27, 2017), the 2019 Omnibus Long-Term Incentive Plan, the 2010 Employee Stock Purchase Plan, and the 2016 Inducement Award Plan (collectively, the &#8220;Stock Plans&#8221;). </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records stock-based compensation expense in connection with the amortization of restricted stock and restricted stock unit awards (&#8220;RSUs&#8221;), stock purchase rights granted under the Company&#8217;s employee stock purchase plan and stock options granted to employees, non-employee consultants and non-employee directors. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNzEy_d19f2c8b-af04-4ba1-944d-4b95bdca86d1">63.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNzE5_db96fadc-79ca-4ae5-b055-1bbcad335487">41.5</ix:nonFraction> million in stock-based compensation expense during the three months ended September 30, 2021 and 2020, respectively. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfODE1_73cf6077-35f1-4314-ad19-0e650ab688d5">283.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfODIy_636c0f47-09a5-4ae6-a3d2-ef6278ecd3a0">111.1</ix:nonFraction> million in stock-based compensation expense during the nine months ended September 30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfOTE3_b1a8b50e-e399-4e52-95f9-469f5d77afd0">401.6</ix:nonFraction> million of expected total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under all equity compensation plans. The Company expects to recognize that cost over a weighted average period of <ix:nonNumeric contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTE1MQ_34be96b3-8633-41f4-943f-d6a7abf9d920">2.8</ix:nonNumeric> years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Thrive, the Company accelerated the vesting of shares of previously unvested stock options and restricted stock units for employees with qualifying termination events. During the three months ended September 30, 2021, the Company accelerated <ix:nonFraction unitRef="shares" contextRef="icd69de72c3544263ada7167dc7802735_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTQwMA_41813b55-881e-49be-87d1-e2901965702c">34,167</ix:nonFraction> shares of previously unvested stock options and <ix:nonFraction unitRef="shares" contextRef="i0149388bcc174e008d48d4ce24ecd34b_D20210701-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTQ1MQ_5e02b566-684d-448b-991f-82d257eff95d">24,865</ix:nonFraction> shares of previously unvested restricted stock awards and restricted stock units and recorded $<ix:nonFraction unitRef="usd" contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTU0OA_d2a8a282-c0be-46a3-8135-a2e8263ce194">4.5</ix:nonFraction> million of non-cash stock-based compensation for the accelerated awards. During the nine months ended September 30, 2021, the Company accelerated <ix:nonFraction unitRef="shares" contextRef="icecddaccecae455d8964c306f1d3197d_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTY1NQ_ad81b946-6543-4086-870c-6297406ea2bb">138,163</ix:nonFraction> shares of previously unvested stock options and <ix:nonFraction unitRef="shares" contextRef="i92f3ebdda81e4395b4fdf88ad090c5ca_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTcwNg_dd9507d1-2b0b-46da-9f8f-7d7ce5aae445">58,171</ix:nonFraction> shares of previously unvested restricted stock awards and restricted stock units and recorded $<ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTgwMw_288a95cc-80d5-479f-ab11-236317dfbae2">19.0</ix:nonFraction> million of non-cash stock-based compensation for the accelerated awards. As further discussed in Note 17, the Company also recorded $<ix:nonFraction unitRef="usd" contextRef="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTkzMA_a1b0204b-fd59-4aa9-9a63-b5c1c407ef05">86.2</ix:nonFraction> million in stock-based compensation related to accelerated vesting of awards held by Thrive employees in connection with the acquisition. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ie3f3b5f0fec242f4b5c14dd582ff8c94" continuedAt="i7b55900c45a744a8b4067e1c8c43f645"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYzMA_5e294ecc-7833-4f84-a04f-0ac4b503bc4a" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of each service-based option award on the date of grant using the Black-Scholes option-pricing model, which utilizes several key assumptions which are disclosed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Plan Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfMy04LTEtMS0xL3RleHRyZWdpb246MmZiY2RmYTE0ZGY0NGM4ZmI1YTFkZjRiZWFmNDIwOTlfNA_28e1ae33-3753-481c-a077-84f25ec2c436">0.11</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfMy04LTEtMS0xL3RleHRyZWdpb246MmZiY2RmYTE0ZGY0NGM4ZmI1YTFkZjRiZWFmNDIwOTlfOQ_c5366da1-d97a-4cfd-b180-b681f6ba5f53">1.47</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80e812e1e60a444187707448c6487230_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNC04LTEtMS0xL3RleHRyZWdpb246MzEyZWVhM2FjNDNmNDU2YmFhYmE1NGUwY2FiNGQ4MDJfNA_1a504138-1eb8-4db2-87e0-e32606828354">0.25</ix:nonNumeric> - <ix:nonNumeric contextRef="i9f69879b003347d9ad2b403f9773eef5_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNC04LTEtMS0xL3RleHRyZWdpb246MzEyZWVhM2FjNDNmNDU2YmFhYmE1NGUwY2FiNGQ4MDJfOQ_aa06d6bb-486f-4c15-8c2a-adc9a9064c64">6.15</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNS04LTEtMS0xL3RleHRyZWdpb246ZDc2ZDFhNmM2MmJjNGJhZmI4YTlkNWVhNDk1NzcyN2FfNA_76649f5d-2f3a-4c9f-b33a-593000b3c6f1">44.19</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNS04LTEtMS0xL3RleHRyZWdpb246ZDc2ZDFhNmM2MmJjNGJhZmI4YTlkNWVhNDk1NzcyN2FfOQ_1fad88c5-58b6-48d1-a147-b6b8e600b21b">77.51</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNi04LTEtMS0x_31f577ad-2028-4ec7-953f-84cd03c296a7">&#8212;</ix:nonFraction>%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company did not grant stock options under its 2010 Omnibus Long-Term Incentive Plan or 2019 Omnibus Long-Term Incentive Plan during the period. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under the Stock Plans is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Aggregate intrinsic value in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4a70c95a2c047f2bdceaeba16fb36a9_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMi0yLTEtMS0x_4a26ed6b-b56d-47b5-b393-c2969946c713">2,231,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib4a70c95a2c047f2bdceaeba16fb36a9_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMi00LTEtMS0x_07f8b319-98a6-4130-9844-404e428b8ef9">39.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i27d111df7c824f28b43805bf4020f417_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMi02LTEtMS0x_d99f8deb-6ab9-438d-a2f8-6409c8559266">6.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMy0yLTEtMS0x_36626cc2-c980-4c87-aa87-eff93c441522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMy00LTEtMS0x_1511bb35-f2f6-4cf0-bbb7-05a99099f64b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed through acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNC0yLTEtMS0x_0b35b83f-5c22-4d56-b5bf-706dd479eebd">1,393,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="2" name="exas:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNC00LTEtMS0x_9f22b5f1-1a27-4b3d-bf4b-f5d5ec3008ab">5.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNS0yLTEtMS0x_9fc899bb-f3c2-4856-8e8f-eb962a1b5e20">1,208,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNS00LTEtMS0x_9f5ddd85-f1d7-4221-bc7c-b3fad58f212a">11.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNi0yLTEtMS0x_3cdb8ec2-3f76-4fd2-92a2-a07361225765">36,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNi00LTEtMS0x_0e2ac1ff-9b95-4b12-a44f-d506a2518d4d">62.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy0yLTEtMS0x_36642ee6-1390-4f5f-8335-06f51299370d">2,379,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy00LTEtMS0x_9b8e17ce-c5f9-4e62-824d-037c2457067d">33.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy02LTEtMS0x_7a43c0b3-4d2b-40a1-9337-c37dbd90d5e3">5.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy04LTEtMS0x_ea5af069-f5b6-4064-ab3e-7e380780d1f1">147,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC0yLTEtMS0x_0ef96152-1566-4b75-9f5e-97f5d1b83222">2,379,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC00LTEtMS0x_24b35668-03c1-490d-a4b7-7d5f1d6a6f07">33.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC02LTEtMS0x_9adb8d0d-29c5-44ea-922c-fd6ebd588450">5.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC04LTEtMS0x_560d59ef-f2a0-4371-8f26-a781ee7485d6">147,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS0yLTEtMS0x_8bea02a2-9b89-47dc-bee1-16bca4e9e69b">1,816,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS00LTEtMS0x_ec067b61-6651-4241-b643-8e6ecd01a988">25.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS02LTEtMS0x_4476656f-0713-45f5-8606-3dd605a383b5">4.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS04LTEtMS0x_fb60f298-6339-4543-9634-453426d18511">127,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of options granted during the nine months ended September&#160;30, 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjY1NA_18a88b94-7e8d-4db3-aa78-f7f625b36263">58.57</ix:nonFraction>. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The total intrinsic value of options exercised during the nine months ended September&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjc0Nw_1e4d7c7a-aee8-4de7-96f1-187c140d2270">148.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i82ad627bc9d74b5d9d01292c752d08e0_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjc1NA_798e744d-e9e2-4439-bd0a-b32a812e4d6d">29.0</ix:nonFraction> million, respectively, determined as of the date of exercise.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received approximately $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjg0Ng_38bd8a34-be4a-4a27-a72f-6953d3358a48">13.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjg1Mw_ca073d31-e3ea-4d89-8a66-ee1ce794656e">15.4</ix:nonFraction> million from stock option exercises during the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock and Restricted Stock Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock and restricted stock units is determined on the date of grant using the closing stock price on that day. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i7b55900c45a744a8b4067e1c8c43f645" continuedAt="i495159c16c6245a29d18a81d2bf36bef"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYzNA_b2adcc49-e1bf-44a9-9a3a-566b86215883" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock and restricted stock unit activity during the nine months ended September&#160;30, 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted stock and restricted stock units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average Grant<br/>Date Fair Value (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i980b2917c57c435eae9dc611d50ee893_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMS0yLTEtMS0x_19deb479-9fbc-4ac5-b368-e2c5419eda18">3,968,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i980b2917c57c435eae9dc611d50ee893_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMS00LTEtMS0x_dcf8d42e-fbe1-4050-83fc-b071731ef8b7">79.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMi0yLTEtMS0x_84dfb192-9fcf-486e-87de-7408160ffa03">2,084,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMi00LTEtMS0x_4eb9f185-16c0-4f19-9203-a5d9ed38a2e6">133.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed through acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMy0yLTEtMS0x_b8c4e975-6135-49b5-96cc-3fd41ea9c8a9">242,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="2" name="exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMy00LTEtMS0x_58bbe70e-8a90-44b4-ac2e-0c07c6d88978">127.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNC0yLTEtMS0x_28d08921-a2bb-4bb6-b875-3d68f9a25777">1,582,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNC00LTEtMS0x_53c527c2-3751-4dd6-9c9a-536303ec50e7">72.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNS0yLTEtMS0x_dad7b905-514f-457a-af2a-743b72024179">406,201</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNS00LTEtMS0x_737160ed-c627-443a-a99b-a2cd95cf17c3">99.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6945ebb4ad9454887ade5b79a893636_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNi0yLTEtMS0x_ac81d178-124b-41fd-aaea-be8f8b7d8e86">4,306,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia6945ebb4ad9454887ade5b79a893636_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNi00LTEtMS0x_c83f5fc8-ca3a-4e51-867b-9ab6469d1757">109.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The fair value of restricted stock units vested and converted to shares of the Company&#8217;s common stock was $<ix:nonFraction unitRef="usd" contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMzM1NQ_52329d22-5e21-4026-9283-8087e56716fc">114.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8e2d9caa00d941178a209e6942f90740_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMzM2Mg_5bd74847-1d94-4173-8724-ffffafe8df7a">79.1</ix:nonFraction> million during the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of the restricted stock units granted during the nine months ended September&#160;30, 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i0e95c6cd79cc4d7a935971ea5e1e6e8e_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMzUzMw_4a1c626a-8bc9-41cc-964c-ba7c1cbbd0d2">90.95</ix:nonFraction>.</span></div></ix:nonNumeric><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Share Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued performance-based equity awards to certain employees which vest upon the achievement of certain performance goals, including financial performance targets and operational milestones. </span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYzMg_02f38bba-a2e6-4c1f-9fc4-6753f4d035d6" continuedAt="i9607bedaa7f848e58dc3b58506741f0f" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of performance share-based compensation arrangements granted under all equity compensation unit activity is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance share units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average Grant<br/>Date Fair Value (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1ead48ecd8c495a8083ab6bde044c3d_I20201231" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMS0yLTEtMS0x_c3a25449-fb6c-438a-864d-3351954d8f91">618,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id1ead48ecd8c495a8083ab6bde044c3d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMS00LTEtMS0x_5f2416b8-ba0f-4a19-9b8f-1491ff3bca92">93.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMi0yLTEtMS0x_d13fdc7b-4434-43a8-a972-c3b89c576b2b">253,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMi00LTEtMS0x_414040da-2193-4715-bef3-98d115e27ffe">140.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMy0yLTEtMS0x_8e7eaaaf-d987-402b-a58c-549b211549c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930" decimals="2" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMy00LTEtMS0x_9bf233f7-ff3a-4329-b61c-8a2bdcfea35b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNC0yLTEtMS0x_8180257e-1b46-4091-a395-fc6a29169bfa">8,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNC00LTEtMS0x_b23cd4d6-4303-4587-9a3b-38bfcfc7242f">68.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie99e0e805c704e9eb1ceeca30b976339_I20210930" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNS0yLTEtMS0x_90af025f-0516-4345-9544-53270e5f8a57">862,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie99e0e805c704e9eb1ceeca30b976339_I20210930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNS00LTEtMS0x_2f38f4d1-b66c-4a38-9bd0-69786ccdefb0">107.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The performance share units listed above assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding performance share units as of September&#160;30, 2021 was <ix:nonFraction unitRef="shares" contextRef="ie99e0e805c704e9eb1ceeca30b976339_I20210930" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDM3OQ_a6e3a998-6fca-4735-851d-e15ed70785b3">249,695</ix:nonFraction>. </span></div></ix:nonNumeric><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9607bedaa7f848e58dc3b58506741f0f" continuedAt="i013db96b02b84fd9b91e930b79faef9c">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i013db96b02b84fd9b91e930b79faef9c">The weighted average grant date fair value of the performance share units granted during the nine months ended September&#160;30, 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i75a8ee4db1a042719bcde877f5d252ea_D20200101-20200930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDUwMA_6e701599-d746-4c2b-ab0d-c1926e53698b">90.17</ix:nonFraction>.</ix:continuation>  </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i495159c16c6245a29d18a81d2bf36bef" continuedAt="ic545bf1a61d34701a924c9697110fece"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYyOQ_b360ed4b-baa9-4c63-8efd-2d0e92d19c41" continuedAt="i79ea2464c20b4788930b829cd504a33f" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of ESPP shares is based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy02LTEtMS0xL3RleHRyZWdpb246NzlhYTExMjQ4NWY2NDNiOWE2ZTFhZWNlYTI3ZGMxM2VfNA_09a0785b-5018-4b97-a0d0-9eae42f26121">0.04</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy02LTEtMS0xL3RleHRyZWdpb246NzlhYTExMjQ4NWY2NDNiOWE2ZTFhZWNlYTI3ZGMxM2VfOQ_4187f3d3-4bd4-47ac-a34f-57f7575a9dcb">0.16</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy04LTEtMS0xL3RleHRyZWdpb246Y2ViZjljZTZjMmFmNDhlNDhhYzllNmY0N2RiY2JjNzJfNA_0e11ba49-e102-4752-9f48-86d56487db78">0.12</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy04LTEtMS0xL3RleHRyZWdpb246Y2ViZjljZTZjMmFmNDhlNDhhYzllNmY0N2RiY2JjNzJfOQ_68c68a8b-6162-4038-b66f-9c0fcbb98302">0.20</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i558be5b82da24f16af1d8a52684e9d6d_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC02LTEtMS0xL3RleHRyZWdpb246YjdiNWE5ODgyNzY0NGU1MTgxM2I5NThmNjQ2MjFhNzZfNA_83261c1a-a5b9-4478-8d5c-aa30f94ac653">0.5</ix:nonNumeric> - <ix:nonNumeric contextRef="i1f932abf713e4c43a93cd801959cce5e_D20210101-20210930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC02LTEtMS0xL3RleHRyZWdpb246YjdiNWE5ODgyNzY0NGU1MTgxM2I5NThmNjQ2MjFhNzZfOQ_7bf95734-736d-4395-8593-bce783b099d1">2</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91c9ab0eda5440bd9d65a69c85ab0eb7_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC04LTEtMS0xL3RleHRyZWdpb246YmRmMDZhMDAyMDRjNDdiMDgwMTQ1NWMzYTQ5MjVkZTNfNA_57c8ded7-50da-4b6c-9d8b-ebbb0bc9befa">0.5</ix:nonNumeric> - <ix:nonNumeric contextRef="i39ccbffede514c3292129dae5bcde954_D20200101-20200930" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC04LTEtMS0xL3RleHRyZWdpb246YmRmMDZhMDAyMDRjNDdiMDgwMTQ1NWMzYTQ5MjVkZTNfOQ_2818c919-6b5c-4f18-bf17-6e98a8ea4e5a">2</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS02LTEtMS0xL3RleHRyZWdpb246YzkzNzZhM2NjNTg4NDM1YmIwODA2OTJjZDJjNWJkMDJfNA_d97468a3-e5bb-4d62-8ea4-f8dd40be5bb8">48.38</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS02LTEtMS0xL3RleHRyZWdpb246YzkzNzZhM2NjNTg4NDM1YmIwODA2OTJjZDJjNWJkMDJfOQ_b45c4797-559c-49bd-93a8-32035234a1c6">68.51</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS04LTEtMS0xL3RleHRyZWdpb246ODg5OTdkMDA2NmM3NDJhNjgzZmE2OTJjMDJlMTE3NWZfNA_1729d2fb-df6b-46a2-a819-df48706fde2b">63.67</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS04LTEtMS0xL3RleHRyZWdpb246ODg5OTdkMDA2NmM3NDJhNjgzZmE2OTJjMDJlMTE3NWZfOQ_792988d4-c2ba-427e-9eda-9b0ee870ed2f">89.04</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930" decimals="4" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNi02LTEtMS0xL3RleHRyZWdpb246N2I2YWJhZWMwOTdiNDEyNmExZDYxNjBlMTY0Y2Q5MjZfNA_fd220cb5-b2c6-4908-a36c-c118c6b826e6">&#8212;</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNi04LTEtMS0xL3RleHRyZWdpb246MTNkNDQ0MzFmNDI4NGE0ZGFkMTAyYzk3ZDA0NzU3MWVfNA_8f85ac28-3f87-4840-a1a0-31e96bb0b69d">&#8212;</ix:nonFraction>%</span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic545bf1a61d34701a924c9697110fece" continuedAt="i7befaa8d9aaf4bf2b7a8a2f2d7e629b1"><ix:continuation id="i79ea2464c20b4788930b829cd504a33f" continuedAt="i4c963db442544071983f201a6a80a856">(1)</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i7befaa8d9aaf4bf2b7a8a2f2d7e629b1"><ix:continuation id="i4c963db442544071983f201a6a80a856">The Company did not issue stock purchase rights under its 2010 Employee Stock Purchase Plan during the three months ended September&#160;30, 2021 and 2020, respectively.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_73"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0Ng_a56b6683-54b2-4d66-b90d-589a6cbcbbf6" continuedAt="i0e6cd50b485140af8b17130d7c5b8dbc" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i0e6cd50b485140af8b17130d7c5b8dbc" continuedAt="ie7ac92e127004b87838a3eb0b696060b"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0Nw_7b119d2c-09f7-47f4-9e1e-2909f2787901" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental disclosure of cash flow information related to the Company&#8217;s cash and non-cash activities with its leases are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMy0yLTEtMS0x_bc3a5851-921a-42d9-9dd3-1f685113918b">19,835</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMy00LTEtMS0x_85f4808a-11e6-4c99-b0a9-6911fcffccf5">12,827</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNC0yLTEtMS0x_75382ae0-495b-4112-812d-9eaa78204756">723</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNC00LTEtMS0x_fb39b5ec-b571-4e79-8e17-8c33bbd1fa7e">125</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNS0yLTEtMS0x_250f3e37-0497-48a5-88b3-e8bad323caac">3,805</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNS00LTEtMS0x_dbcf8c2d-7a15-4235-85cd-987d0152d6e3">620</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNy0yLTEtMS0x_b1cdaa13-44eb-46b2-9b81-371dc3a37a2d">60,480</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNy00LTEtMS0x_a2bee913-19e7-4aa1-b513-20911d8d371e">13,662</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOC0yLTEtMS0x_64c4a63c-fd39-4597-b7aa-8836d4bc8947">4,296</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOC00LTEtMS0x_0db4cfb2-4853-487e-a7f9-7d4b1a858556">17,420</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOS0yLTEtMS0x_f0a9b988-e18d-4f55-9a96-0bd00a0251a7">8.14</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOS00LTEtMS0x_84bc52a6-ebbc-4c62-a4a1-4ddd8a8a8831">8.95</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTAtMi0xLTEtMQ_fd267518-04dc-4c03-be33-c3a577e7c03b">3.13</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTAtNC0xLTEtMQ_e9274acd-f0e8-4f83-91b4-9854fbb48d7c">3.86</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTEtMi0xLTEtMQ_112be9bd-632a-4d7e-9a85-1f5fbc726a0c">6.28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTEtNC0xLTEtMQ_1dc5e1e5-e960-4eea-ad0f-09a2f8219110">6.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTItMi0xLTEtMQ_7b05fade-727b-4124-8a14-ba969fe8e27d">5.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTItNC0xLTEtMQ_cbf32df5-2db8-49e7-9048-afb162362199">5.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the nine months ended September&#160;30, 2021, this includes right-of-use assets acquired as part of the business combinations described in Note 17 of $<ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMzMx_64f5ff75-91e5-44cd-9080-9efe37a4a5f1">39.6</ix:nonFraction> million.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company&#8217;s right-of-use assets from operating leases are $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNDEy_f031430a-4a36-4ca5-bb52-aaa308000ac4">167.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNDE5_400d27fd-3984-49ed-8fb5-533f68c73167">125.9</ix:nonFraction> million, respectively, which are reported in operating lease right-of-use assets in the Company&#8217;s condensed consolidated balance sheets. As of September&#160;30, 2021, the Company has outstanding operating lease obligations of $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNjIw_bcb342d3-2de9-4e4f-b5c9-23f8886b5675">182.2</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNjMz_8c7c01fe-d6f7-4c1a-a5e0-48ce93f8bb51">19.2</ix:nonFraction> million is reported in operating lease liabilities, current portion and $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNzAw_aa3fea45-2854-4ee7-87e8-e5dc98c9672b">163.0</ix:nonFraction> million is reported in operating lease liabilities, less current portion in the Company&#8217;s condensed consolidated balance sheets. As of December&#160;31, 2020, the Company had outstanding operating lease obligations of $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfODkz_63d3cea3-4f75-4429-b1cc-35258dca46a6">132.6</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTA2_adba0d60-d8d9-4621-a08b-5f3ae4fd82a0">11.5</ix:nonFraction> million is reported in operating lease liabilities, current portion and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTcz_fd087be6-1471-4d0a-a6f3-9979f239bf48">121.1</ix:nonFraction> million is reported in operating lease liabilities, less current portion in the Company&#8217;s condensed consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#8217;s rating for operating leases. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ie7ac92e127004b87838a3eb0b696060b" continuedAt="i84ae9f51e1f3423b80fb233fc34fdd2d"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company&#8217;s right-of-use assets from finance leases are $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTM4OQ_c6d23b87-53e8-489b-8531-333d2de77cf2">18.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTM5Ng_43cd97b6-857d-4759-9ca9-3b1f40d06054">18.6</ix:nonFraction> million, respectively, which are reported in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NA_a63abb75-8298-4289-82ca-d79cd14f64fc">other long-term assets</span>, net in the Company&#8217;s condensed consolidated balance sheets. As of September&#160;30, 2021, the Company has outstanding finance lease obligations of $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTU4Nw_ce43d5c8-fcd8-444a-9f5a-43cace2d4918">19.1</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTYwMA_9c3bba38-1818-4faf-b5e3-251953ac05c6">5.9</ix:nonFraction> million is reported in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NQ_a7a5c01b-96cc-4030-a445-b85e4c06296f">other current liabilities</span> and $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTY0OA_466f32d9-8bd0-495a-8954-dbc256c87959">13.2</ix:nonFraction> million is reported in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI1MA_7ed6786f-7aa1-4913-ad46-9c4fe5b019bf">other long-term liabilities</span> in the Company&#8217;s condensed consolidated balance sheets. As of December&#160;31, 2020, the Company had outstanding finance lease obligations of $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTgxNw_44e5232b-e353-45e2-b62a-391c90ae1691">18.7</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTgzMA_173f4334-2e1f-414f-bf20-bd7002a4dfdb">4.7</ix:nonFraction> million is reported in other current liabilities and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTg3OA_cc54f06e-de71-49c3-bd22-0a61442a4c68">14.0</ix:nonFraction> million is reported in other long-term liabilities in the Company&#8217;s condensed consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#8217;s rating for finance leases. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed a lease agreement for a new facility in La Jolla, California, which the Company is expecting to commence in the fourth quarter of 2021. The Company anticipates that it will recognize $<ix:nonFraction unitRef="usd" contextRef="i26b0e97ffe0040889b3f8b090462e327_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:LesseeOperatingLeaseLeaseNotYetCommencedAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMjM1Mg_df12070b-f1d8-4ef8-b13b-69bf0a9489cc">22.9</ix:nonFraction> million in operating lease right-of-use assets and $<ix:nonFraction unitRef="usd" contextRef="i26b0e97ffe0040889b3f8b090462e327_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:LesseeOperatingLeaseLeaseNotYetCommencedLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMjM5OA_4644097f-f459-4f66-becb-76599442ab2d">22.9</ix:nonFraction> million in operating lease liabilities in the condensed consolidated balance sheet, respectively, upon commencement of the lease. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company&#8217;s best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Quarterly Report on Form 10-Q, amounts accrued for legal proceedings and regulatory matters were not material except for the amounts accrued related to the Medicare Date of Service Rule Investigation (the &#8220;DOS Rule Investigation&#8221;) discussed below. However, it is possible that in a particular quarter or annual period the Company&#8217;s financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of, or development in, legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow or liquidity.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently responding to civil investigative demands and administrative subpoenas issued pursuant to the Health Insurance Portability and Accountability Act of 1996 by the United States Department of Justice (&#8220;DOJ&#8221;) concerning Genomic Health&#8217;s compliance with the Medicare Date of Service billing regulations. The Company has been cooperating with these inquiries and has produced documents in response thereto.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, as part of ongoing discussions between the DOJ and the Company regarding the DOS Rule Investigation, the DOJ presented an estimate of civil damages in the amount of $<ix:nonFraction unitRef="usd" contextRef="icb129685ec824606a9235abe6526a5d3_I20210630" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNTExOA_de28e0a0-4606-40d8-b50a-a45ab3482a92">48.2</ix:nonFraction> million relating to alleged non-compliance with the Medicare Date of Service billing regulations from 2007 to 2020. The civil damages estimate does not include potential treble damages, civil or criminal penalties or other remedies that the DOJ could seek against the Company. Based on the Company&#8217;s review and analysis of the DOJ presentation, civil damages estimate, and range of potential exposure, the Company recorded an accrual of approximately $<ix:nonFraction unitRef="usd" contextRef="i0d998ca81b55400f81d638f38b49779c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTA5OTUxMTYzODg2OQ_7c642901-7fb2-46f9-87d9-dbd402121e16">10</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, litigation outcomes are difficult to predict, and the estimation of probable losses requires an analysis of multiple possible outcomes that often depend on judgments about potential actions by third parties. Accordingly, the recorded accrual of approximately $<ix:nonFraction unitRef="usd" contextRef="i0d998ca81b55400f81d638f38b49779c_I20210930" decimals="-6" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTA5OTUxMTYzOTg1Nw_7c642901-7fb2-46f9-87d9-dbd402121e16">10</ix:nonFraction> million for the three and nine months ended September&#160;30, 2021 is based on several factors, considerations, and judgments, and the ultimate resolution of this matter could result in a loss in excess of the recorded accrual.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i84ae9f51e1f3423b80fb233fc34fdd2d"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2019, Niles Rosen M.D. filed a sealed ex parte qui tam lawsuit against the Company in the United States District Court for the Middle District of Florida, that alleged a violation of the Federal Anti-Kickback Statute and False Claims Act for offering gift cards to patients in exchange for returning the Cologuard screening test (the &#8220;Qui Tam Suit&#8221;). Dr. Rosen seeks on behalf of the U.S. government and himself an award of civil penalties, treble damages and fees and costs. On February 25, 2020, the Company received a civil investigative demand by the DOJ related to the Company&#8217;s gift card program. The Company produced documents in response thereto. On March 25, 2021, the DOJ filed a notice of its election to decline intervention in the Qui Tam Suit. This election does not prevent Dr. Rosen from continuing the Qui Tam Suit. On April 12, 2021, Dr. Rosen filed an amended complaint against the Company, alleging violations of the Federal Anti-Kickback Statute and False Claims Act. The Company first learned of the Qui Tam Suit and the DOJ&#8217;s election to decline intervention in July 2021.  The Company intends to vigorously defend itself against Dr. Rosen's claims and seek, among other things, the Company&#8217;s attorneys' fees and costs incurred in defending this action. Although the Company denies Dr. Rosen's allegations and believes that it has meritorious defenses to his False Claims Act claims, neither the outcome of the litigation nor can a reasonable estimate or an estimated range of loss associated with the litigation be determined at this time.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse outcomes from the DOS Rule Investigation and the Qui Tam Suit could include the Company being required to pay treble damages, incur civil and criminal penalties, paying attorneys&#8217; fees, entering into a corporate integrity agreement, being excluded from participation in government healthcare programs, including Medicare and Medicaid, and other adverse actions that could materially affect the Company&#8217;s business, financial condition, and results of operation.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company's combination with Genomic Health, on June 22, 2020, Suzanne Flannery, a purported former stockholder of Genomic Health, filed a Verified Individual and Class Action Complaint in the Delaware Court of Chancery, captioned Flannery v. Genomic Health, Inc., et al., C.A. No. 2020-0492. Flannery amended her complaint on November 23, 2020. The amended complaint asserts individual and class action claims, including: (i) a violation of 8 Del. C. &#167; 203 by Genomic Health, Exact Sciences and a purported controlling group of former Genomic Health stockholders; (ii) conversion by Genomic Health, Exact Sciences and Spring Acquisition Corp.; (iii) breach of fiduciary duty by Genomic Health's former directors; (iv) breach of fiduciary duty by the purported controlling group; and (v) aiding and abetting breach of fiduciary duty against Exact Sciences, Spring Acquisition and Goldman Sachs &amp; Co. LLC, Genomic Health's financial advisor in the combination. The amended complaint seeks, among other things, declaratory relief, unspecified monetary damages and attorneys' fees and costs. All defendants moved to dismiss the amended complaint. Oral argument on defendants&#8217; motions to dismiss the amended complaint occurred in May 2021, and in September 2021 the case was officially dismissed by the court.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_76"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:NewMarketTaxCreditTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83Ni9mcmFnOjQ1YTNlZmY3NmU3MTRmNmU4ZTg2ZGUwYjgwZDk3MGNlL3RleHRyZWdpb246NDVhM2VmZjc2ZTcxNGY2ZThlODZkZTBiODBkOTcwY2VfMjI5Mg_5591fd68-ac9e-42e2-8de2-8c732bbae605" continuedAt="i67a18786ac7047e985b23c5656df525b" escape="true">NEW MARKET TAX CREDIT</ix:nonNumeric></span></div><ix:continuation id="i67a18786ac7047e985b23c5656df525b" continuedAt="i110aaae6ca5e4129b0e06608e05bdaf7"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2014, the Company received approximately $<ix:nonFraction unitRef="usd" contextRef="ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231" decimals="-5" format="ixt:num-dot-decimal" name="exas:NetProceedsFromFinancingArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83Ni9mcmFnOjQ1YTNlZmY3NmU3MTRmNmU4ZTg2ZGUwYjgwZDk3MGNlL3RleHRyZWdpb246NDVhM2VmZjc2ZTcxNGY2ZThlODZkZTBiODBkOTcwY2VfMTAy_581f0459-c9f5-4ffa-b228-742e4134ea7c">2.4</ix:nonFraction> million in net proceeds from financing agreements related to working capital and capital improvements at <ix:nonFraction unitRef="facility" contextRef="ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231" decimals="INF" format="ixt-sec:numwordsen" name="exas:NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83Ni9mcmFnOjQ1YTNlZmY3NmU3MTRmNmU4ZTg2ZGUwYjgwZDk3MGNlL3RleHRyZWdpb246NDVhM2VmZjc2ZTcxNGY2ZThlODZkZTBiODBkOTcwY2VfMjAy_f639daec-c12f-44ec-908f-158fc2490be7">one</ix:nonFraction> of its Madison, Wisconsin facilities.&#160;This financing arrangement was structured with an unrelated third-party financial institution (the &#8220;Investor&#8221;), an investment fund, and its majority owned community development entity in connection with the Company&#8217;s participation in transactions qualified under the federal New Markets Tax Credit (&#8220;NMTC&#8221;) program, pursuant to Section 45D of the Internal Revenue Code of 1986, as amended. The Company is required to be in compliance through December 2021 with various regulations and contractual provisions that apply to the NMTC arrangement. Noncompliance with applicable requirements could result in the Investor&#8217;s projected tax benefits not being realized and, therefore, require the Company to indemnify the Investor for any loss or recapture of NMTC related to the financing until such time as the recapture provisions have expired under the applicable statute of limitations. The Company does not anticipate any credit recapture will be required in connection with this financing arrangement.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor and its majority owned community development entity are considered Variable Interest Entities (&#8220;VIEs&#8221;) and the Company is the primary beneficiary of the VIEs. This conclusion was reached based on the following:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing activities of the VIEs &#8212; collecting and remitting interest and fees and NMTC compliance &#8212; were all considered in the initial design and are not expected to significantly affect performance throughout the life of the VIE;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual arrangements obligate the Company to comply with NMTC rules and regulations and provide various other guarantees to the Investor and community development entity;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Investor lacks a material interest in the underlying economics of the project; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company is obligated to absorb losses of the VIEs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i110aaae6ca5e4129b0e06608e05bdaf7">Because the Company is the primary beneficiary of the VIEs, they have been included in the consolidated financial statements. There are no other assets, liabilities or transactions in these VIEs outside of the financing transactions executed as part of the NMTC arrangement.</ix:continuation></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_79"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="exas:WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyMw_df0370a1-c649-40b2-ae1e-af98b97988c1" continuedAt="i7c6a0a00aa004e78af1a1d2f51e96ffa" escape="true">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</ix:nonNumeric></span></div><ix:continuation id="i7c6a0a00aa004e78af1a1d2f51e96ffa" continuedAt="ic39a4c9915a9471a9c8264118182f734"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2015, the Company entered into an agreement with the Wisconsin Economic Development Corporation (&#8220;WEDC&#8221;) to earn $<ix:nonFraction unitRef="usd" contextRef="i107170d7fed64652982d166e0b941437_I20150331" decimals="-5" format="ixt:num-dot-decimal" name="exas:RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTk0_d4a4b67a-8b77-4298-a28b-1c2e8eb76359">9.0</ix:nonFraction> million in refundable tax credits on the condition that the Company expends $<ix:nonFraction unitRef="usd" contextRef="i107170d7fed64652982d166e0b941437_I20150331" decimals="-5" format="ixt:num-dot-decimal" name="exas:CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjY1_c2c18206-6360-4415-b231-b2997080019f">26.3</ix:nonFraction> million in capital investments and establishes and maintains <ix:nonFraction unitRef="employee" contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331" decimals="INF" name="exas:NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMzIx_f654749e-22f1-4672-a545-4959466b7b5a">758</ix:nonFraction> full-time positions over a <ix:nonNumeric contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331" format="ixt-sec:durwordsen" name="exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyNA_9b841fb8-0d8d-4288-8790-a4f047e50c77">seven-year</ix:nonNumeric> period. The tax credits earned are first applied against the tax liability otherwise due, and if there is no such liability present, the claim for tax credits will be reimbursed in cash to the Company. The maximum amount of the refundable tax credit to be earned for each year is fixed, and the Company earns the credits by meeting certain capital investment and job creation thresholds over the <ix:nonNumeric contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331" format="ixt-sec:durwordsen" name="exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyNQ_e12da41b-ff3a-44d1-bf2a-34d8c67c17a9">seven-year</ix:nonNumeric> period. Should the Company earn and receive the job creation tax credits but not maintain those full-time positions through the end of the agreement, the Company may be required to pay those credits back to the WEDC.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the earned tax credits as job creation and capital investments occur. The amount of tax credits earned is recorded as a liability and amortized as a reduction of operating expenses over the expected period of benefit. The tax credits earned from capital investment are recognized as an offset to depreciation expense over the expected life of the acquired capital assets. The tax credits earned related to job creation are recognized as an offset to operational expenses over the life of the agreement, as the Company is required to maintain the minimum level of full-time positions through the <ix:nonNumeric contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331" format="ixt-sec:durwordsen" name="exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyNg_69c96266-56b9-41fa-b892-a2539f6717a6">seven-year</ix:nonNumeric> period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company has earned all $<ix:nonFraction unitRef="usd" contextRef="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:RefundableTaxCreditEarnedToDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTY0OQ_73beba8a-0e0c-475c-a2f6-be95d2db0e15">9.0</ix:nonFraction> million of the refundable tax credits and has received payment of $<ix:nonFraction unitRef="usd" contextRef="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:RefundableTaxCreditReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTcxMA_95a92184-3bd4-4ecc-b1c8-0dd3267c967c">7.5</ix:nonFraction> million from the WEDC. The unpaid portion is $<ix:nonFraction unitRef="usd" contextRef="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:RefundableTaxCreditReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTc1MA_a3a1546c-e36b-4fb4-b401-bfd710d2fcb1">1.5</ix:nonFraction> million, which is reported in prepaid expenses and other current assets, reflecting when collection of the refundable tax credits is expected to occur. As of September&#160;30, 2021 and December&#160;31, 2020, the corresponding liability, which reflected when the expected benefit of tax credit amortization would reduce future operating expenses, has been fully amortized. </span></div></ix:continuation><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic39a4c9915a9471a9c8264118182f734">During the three and nine months ended September&#160;30, 2020, the Company amortized $<ix:nonFraction unitRef="usd" contextRef="i1bc1f54843b74a68949920da70be0d63_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="exas:AmortizationOfRefundableTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjEzMw_7580e2e9-1e17-4742-96be-3c6e8a449374">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9a07478702f74507bc6501dba1c86d9d_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="exas:AmortizationOfRefundableTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjE0MA_28fdbc5b-1207-4767-85f0-66d60e8b5262">1.7</ix:nonFraction> million, respectively, of the tax credits earned as a reduction of operating expenses.</ix:continuation> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_82"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:AssetAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDI_21c1a71a-5f3f-44aa-ad2f-c0ee767f6096" continuedAt="i93a4c15c8c07427dae0a1f9b3fd11090" escape="true"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNTE_6698e803-7468-4ffa-9151-fc83e242ff44" continuedAt="iabc787a2af5247cd949d36a39f6c680b" escape="true">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i93a4c15c8c07427dae0a1f9b3fd11090" continuedAt="if717570d09d540b9b712f6306891aa17"><ix:continuation id="iabc787a2af5247cd949d36a39f6c680b" continuedAt="ib773872325d545daa4737218c42c0e23"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ashion Analytics, LLC</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2021, the Company completed the acquisition (&#8220;Ashion Acquisition&#8221;) of all of the outstanding equity interests of Ashion from PMed Management, LLC (&#8220;PMed&#8221;), which is a subsidiary of TGen. The Ashion Acquisition provided the Company a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;) certified and College of American Pathologists (&#8220;CAP&#8221;) accredited sequencing lab based in Phoenix, Arizona. Ashion developed GEMExTra&#174;, a comprehensive genomic cancer test, and provides access to whole exome, matched germline, and transcriptome sequencing capabilities. The Company has included the financial results of Ashion in the consolidated financial statements from the date of the combination.  </span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDk_02408839-2f61-4391-b160-51735b9ecfcb" continuedAt="i774ba0263fe84130811b3db84ea22bab" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Ashion was approximately $<ix:nonFraction unitRef="usd" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODk1_cf5159ea-833c-4b84-a64c-1ab86a3d49a2">110.0</ix:nonFraction> million, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfMS0yLTEtMS0x_a144d927-bc18-47a0-9a43-7a5382c48774">74,775</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfMi0yLTEtMS0x_ccd5687c-f432-4728-84c6-ffe0a018dc28">16,224</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfMy0yLTEtMS0x_3e78c2a9-67e1-469c-b7f8-54f98b1c7e5b">19,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfNC0yLTEtMS0x_ae91b779-b8d9-4475-ba13-22b47213851b">109,999</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the <ix:nonFraction unitRef="shares" contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfOTU3_e5bd93b9-c1e3-4bec-85b2-5c28b410e44a">125,444</ix:nonFraction> common shares issued as part of consideration transferred was determined on the basis of the average of the high and low market price of the Company's shares on the acquisition date, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTE1Mw_3b725b6e-f6ca-4c56-bab5-5ac1dd95fbb7">129.33</ix:nonFraction>. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="if717570d09d540b9b712f6306891aa17" continuedAt="i403e96a22d0b4bce8c7c1dfbea6f78db"><ix:continuation id="ib773872325d545daa4737218c42c0e23" continuedAt="i4d57ea20d8204db8b973076c8c2aba22"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration arrangement requires the Company to pay $<ix:nonFraction unitRef="usd" contextRef="i233731ca43664d2c93c9d490bf6d67d5_I20210414" decimals="-5" name="exas:BusinessCombinationContingentConsiderationAdditionalPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTIyNw_df79c089-6766-4f46-8478-defe8b1c785e">20.0</ix:nonFraction> million of additional cash consideration to PMed upon the Company&#8217;s commercial launch, on or before the tenth anniversary of the Ashion Acquisition, of a test for minimal residual disease (&#8220;MRD&#8221;) detection and/or treatment (the &#8220;Commercial Launch Milestone&#8221;). The fair value of the Commercial Launch Milestone at the acquisition date was $<ix:nonFraction unitRef="usd" contextRef="i233731ca43664d2c93c9d490bf6d67d5_I20210414" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU2MA_0e6a2bf0-5ed5-449e-8149-28bd777ff82e">19.0</ix:nonFraction> million. The contingent consideration arrangement also requires the Company to pay $<ix:nonFraction unitRef="usd" contextRef="i990575d7a2fe4594870c1692af08e8f6_I20210414" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTYzOA_685d204f-016b-4e0d-870a-fc340804b0df">30.0</ix:nonFraction> million of additional cash upon the Company&#8217;s achievement, on or before the fifth anniversary of the Ashion Acquisition, of cumulative revenues from MRD products of $<ix:nonFraction unitRef="usd" contextRef="i990575d7a2fe4594870c1692af08e8f6_I20210414" decimals="-5" name="exas:BusinessCombinationContingentConsiderationRevenueMilestone" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc5OA_24a1ad22-02b5-45aa-adb4-060968020d25">500.0</ix:nonFraction> million (the &#8220;MRD Product Revenue Milestone&#8221;). No value was ascribed to the MRD Product Revenue Milestone based on probability assessments as of the acquisition date. The fair value of the Commercial Launch Milestone and MRD Product Revenue Milestone was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in Accounting Standards Codification (&#8220;ASC&#8221;) 820. The key assumptions are described in Note 7. </span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDc_df766310-d0d8-4d38-b0fa-8c209ecde26a" continuedAt="i682b46e3ff584b778c365d5bc8d65473" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMS0yLTEtMS0x_ba32279f-9291-4c51-8a4c-245b579d96e7">2,474</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMi0yLTEtMS0x_40956055-8d9a-40c3-be2b-1c8f7a00a894">2,349</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMy0yLTEtMS0x_0541b508-ea33-47d1-9a1c-662546862f78">1,811</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNC0yLTEtMS0x_7c9a9028-783a-44ce-be05-8fe380f70b23">425</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNS0yLTEtMS0x_942befb3-9f24-4a92-a5b4-877c9d395456">9,947</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNi0yLTEtMS0x_2ac10a6f-7aca-4c6b-8296-982a33acefcb">548</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNy0yLTEtMS0x_94438ed9-f755-49b6-b729-b976d1b95fac">39,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfOC0yLTEtMS0x_2ec4122f-d3d4-4724-bb76-193e88b5d3a9">56,554</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTAtMi0xLTEtMQ_98540516-763d-4759-8def-f31822d999b5">1,477</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTEtMi0xLTEtMQ_10092310-1b96-42a1-8028-f4ad29692962">1,190</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTItMi0xLTEtMQ_0113894b-ab0a-4f77-b844-9b5c844dc18b">343</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTMtMi0xLTEtMQ_6540a601-c114-4248-b110-9ec04db2c1f8">98</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTQtMi0xLTEtMQ_0f34f8d7-639e-4a14-a430-85581e4561c3">205</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTUtMi0xLTEtMQ_2ea276bf-73cc-42c0-bdda-3ac2ddbc609c">3,313</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTYtMi0xLTEtMQ_bb3ca788-a1a5-40d8-b98c-4a603a2cb62c">53,241</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTgtMi0xLTEtMQ_76527105-dddb-4219-b1a5-bddfc9481c84">56,758</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTktMi0xLTEtMQ_05406cbc-a031-41d4-a653-235342d85d19">109,999</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjUyMA_9ac162b8-ba7a-433c-bbbc-df3d91b7a09b">39.0</ix:nonFraction> million of identifiable intangible assets related to the developed technology associated with GEMExTra. Developed technology represents purchased technology that had reached technological feasibility and for which Ashion had substantially completed development as of the date of combination. The fair value of the developed technology has been determined using the income approach multi-period excess earnings method, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, and required rate of return and tax rate. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of <ix:nonNumeric contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMzI1Mw_87224285-61c0-4458-b8f8-8d2462651578">13</ix:nonNumeric> years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the acquired workforce expertise, the capabilities in the advancement of creating and launching new products, including an MRD product, and expected sales force synergies related to the developed technology. The total goodwill related to this combination is deductible for tax purposes.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i403e96a22d0b4bce8c7c1dfbea6f78db" continuedAt="i24fd188d205640fb8080817346d0d623"><ix:continuation id="i4d57ea20d8204db8b973076c8c2aba22" continuedAt="id74e72c4363740d7920a76ceeb6daed1"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the developed technology intangible asset.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma impact and results of operations disclosures have not been included due to immateriality.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ie6653408e966412f9580bd258009d9e9_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNDMyMg_81c316e6-80c1-4136-8ba7-bca449ccdf04">1.6</ix:nonFraction>&#160;million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations, respectively. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thrive Earlier Detection Corporation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2021, the Company completed the acquisition (&#8220;Thrive Merger&#8221;) of all of the outstanding capital stock of Thrive. Thrive, headquartered in Cambridge, Massachusetts, is a healthcare company dedicated to incorporating earlier cancer detection into routine medical care. The Company expects that combining Thrive's early-stage screening test, CancerSEEK, with the Company&#8217;s scientific platform, clinical organization and commercial infrastructure will establish the Company as a leading competitor in blood-based, multi-cancer early detection. The Company has included the financial results of Thrive in the consolidated financial statements from the date of the combination.  </span></div><ix:continuation id="i774ba0263fe84130811b3db84ea22bab"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Thrive was approximately $<ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-7" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTQwNg_9a76361d-51aa-4204-b7a2-912820870f5b">2.19</ix:nonFraction> billion, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfMS0yLTEtMS0x_34c39c67-f51f-4479-bd3a-944fc6e80645">1,175,431</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfMi0yLTEtMS0x_6102558c-ecad-49a3-b40c-2c6ec0f3a341">584,996</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfMy0yLTEtMS0x_55999b82-9ba4-4349-b0d2-a4572813fae3">331,348</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of replaced equity awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationFairValueOfReplacedEquityAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfNC0yLTEtMS0x_5df7880e-f7c4-40c1-8f37-41c3273e8bdc">52,245</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously held equity investment fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfNS0yLTEtMS0x_64041345-1e24-4858-aa6c-74100183814f">43,034</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfNi0yLTEtMS0x_c6b17785-5b26-4ce7-91df-4594a7956643">2,187,054</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued <ix:nonFraction unitRef="shares" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTQ2NQ_d9a1ee1e-e329-44ee-b2f8-b9b4efc85f53">9,323,266</ix:nonFraction> common shares that had a fair value of $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-7" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTUwNw_1a2bb007-bdf9-4d1d-be02-9eaf3508e374">1.19</ix:nonFraction> billion based on the average of the high and low market price of the Company's shares on the acquisition date, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTYyMw_736c09a7-cf49-47e8-a00d-cc5345c07dcc">127.79</ix:nonFraction>. Of the total consideration for common stock issued, $<ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-7" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTY3OQ_6fdb2f29-279c-41a0-91af-3d8d6911795f">1.18</ix:nonFraction> billion was allocated to the purchase consideration and $<ix:nonFraction unitRef="usd" contextRef="i70acbbc0dbc5483ab952ef2d524cf18b_D20210105-20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTczMA_078d9c88-be26-4e3a-9d75-0b42d3cb6fed">16.0</ix:nonFraction> million was recorded as compensation within general and administrative expenses in the condensed consolidated statement of operations on the acquisition date due to accelerated vesting of legacy Thrive restricted stock awards (&#8220;RSA&#8221;) and RSU awards in connection with the acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $<ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjAyNw_d6c9bae6-d78e-4a8f-86b9-a0eaf4eac301">590.2</ix:nonFraction> million in cash on the acquisition date. Of the total consideration for cash, $<ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjEwMA_8b00fe87-e25d-4f01-808a-8eb9a41dc99d">585.0</ix:nonFraction> million was allocated to the purchase consideration and $<ix:nonFraction unitRef="usd" contextRef="i70acbbc0dbc5483ab952ef2d524cf18b_D20210105-20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjE1MQ_3fd51d05-36c9-4ad2-a408-d07f3b95df0c">5.2</ix:nonFraction> million was recorded as compensation within general and administrative expenses on the acquisition date due to accelerated vesting of legacy Thrive RSU and RSA awards that were cash-settled in connection with the acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration arrangement requires the Company to pay up to $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjQ0Nw_da8b9f08-8a3f-480f-beb6-0ada933175ff">450.0</ix:nonFraction> million of additional cash consideration to Thrive&#8217;s former shareholders upon the achievement of two discrete events, U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval and Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) coverage, for $<ix:nonFraction unitRef="usd" contextRef="ib2b131fa1d864ac79567f3577788ccc1_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjY3OA_7274cdad-ad94-4115-ba42-133f33b8b26a">150.0</ix:nonFraction> million and up to $<ix:nonFraction unitRef="usd" contextRef="i55deacfe7ea94c7488107e4687d0d7e9_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjY5MQ_d7548152-f779-4819-8b65-11f8ac9dbd46">300.0</ix:nonFraction> million, respectively. The fair value of the contingent consideration arrangement at the acquisition date was $<ix:nonFraction unitRef="usd" contextRef="i434a63ff04d349ca9dd0cd31f8dbd3fe_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjc5Ng_76393d90-c249-42a9-a722-554f4dcb490b">352.0</ix:nonFraction> million. The fair value of the contingent consideration was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. The key assumptions are described in Note 7. Of the total fair value of the contingent consideration, $<ix:nonFraction unitRef="usd" contextRef="i0a0e991fc3574513b998b53a404cbd4d_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzE4OA_ac9d2b78-f0f6-4f6f-bfea-8cde77c5423a">331.3</ix:nonFraction> million was allocated to the consideration transferred, $<ix:nonFraction unitRef="usd" contextRef="ic720ba1718c741998617bf85bd1369ef_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzIzOQ_5cad8dc3-8c11-4e0d-bbb8-267ba5da7314">6.4</ix:nonFraction> million was allocated to the Company&#8217;s previous ownership interest in Thrive, and $<ix:nonFraction unitRef="usd" contextRef="i9e00c316ed7d4743b9ae72c32d1ea634_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzMxNg_bb7bdc6c-4435-4d9a-9947-c6b93c4d7dc2">14.3</ix:nonFraction> million was deemed compensatory as participation is dependent on replaced unvested equity awards vesting which requires future service. Compensation expense related to the milestones could be up to $<ix:nonFraction unitRef="usd" contextRef="i72248a0ae06a4828857001f7eb06939a_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzUwOQ_c3ae78e7-ec17-4d64-ad78-0fdba6679543">18.2</ix:nonFraction> million undiscounted and will be recognized in the future once probable and payable.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i24fd188d205640fb8080817346d0d623" continuedAt="ib3380069bcf44e09b4726791abb162d4"><ix:continuation id="id74e72c4363740d7920a76ceeb6daed1" continuedAt="i15090390c8594baaa731d470d7d8b657"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company replaced unvested stock options, RSUs, and RSAs and vested stock options with a combination-date fair value of $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzcxMg_7980d842-f620-49b0-a331-9b19558c30c3">197.0</ix:nonFraction> million. Of the total consideration for replaced equity awards, $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzc3MQ_92a8c785-532c-4393-8b9d-c7a4f650357c">52.2</ix:nonFraction> million was allocated to the consideration transferred and $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzgyNQ_e37e1f39-db0f-408c-9c86-fe70a912f706">144.8</ix:nonFraction> million was deemed compensatory as it was attributable to post acquisition vesting. Of the total compensation related to replaced awards, $<ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzk1OA_227b1689-7752-46f6-81dd-22e3ec998473">65.0</ix:nonFraction> million was expensed on the acquisition date due to accelerated vesting of stock options in connection with the acquisition and $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODA4MQ_be092424-529c-4574-bc2b-784f0c4e86a1">79.8</ix:nonFraction> million relates to future services and will be expensed over the remaining service periods of the unvested stock options, RSUs, and RSAs on a straight-line basis. Including expense recognized for accelerated vesting of RSUs and RSAs described above, total expected stock-based compensation expense is $<ix:nonFraction unitRef="usd" contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODM3Nw_65f46b59-b411-4d3e-981e-162d0328bc52">166.0</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODM5MA_a1b0204b-fd59-4aa9-9a63-b5c1c407ef05">86.2</ix:nonFraction> million was recognized immediately to general and administrative expenses in the condensed consolidated statement of operations due to accelerated vesting. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the stock options assumed by the Company was determined using the Black-Scholes option pricing model. The fair value of the RSA and RSUs assumed by the Company was determined based on the average of the high and low market price of the Company's shares on the acquisition date. The share conversion ratio of <ix:nonFraction unitRef="number" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="5" name="exas:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODg2OA_7d8269af-713c-4f3b-b027-ea2abd17f800">0.06216</ix:nonFraction> was applied to convert Thrive&#8217;s outstanding equity awards for Thrive&#8217;s common stock into equity awards for shares of the Company&#8217;s common stock.</span></div><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDY_bf71f285-8978-40a0-b490-c6b3d7fa44ef" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options assumed were based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.794%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Plan Shares Assumed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMS0yLTEtMS0xL3RleHRyZWdpb246MGM0N2VlODI4MzYzNGUyZTg0YzQ1OTk5ZDcyZTBlMmVfNA_c92391af-f618-44ae-8c01-e84c4182bd11">0.11</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMS0yLTEtMS0xL3RleHRyZWdpb246MGM0N2VlODI4MzYzNGUyZTg0YzQ1OTk5ZDcyZTBlMmVfOQ_c2da5270-8354-4b16-973c-6f1d9643405e">0.12</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f2212887fcb4485932c6ca7b57bac3b_D20210105-20210105" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMi0yLTEtMS0xL3RleHRyZWdpb246YTE0MjJhZjY5ZDhjNDk3NGE0OGEyMDI1Nzc4ZmRlYWNfNA_d3865607-b3d3-4db7-8d7d-23f476f94233">1.26</ix:nonNumeric> - <ix:nonNumeric contextRef="i37a4ec695a024e4e80da4d3494beed97_D20210105-20210105" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMi0yLTEtMS0xL3RleHRyZWdpb246YTE0MjJhZjY5ZDhjNDk3NGE0OGEyMDI1Nzc4ZmRlYWNfOQ_3b423f4a-5a31-457f-8edb-57ab113b5edd">1.57</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMy0yLTEtMS0xL3RleHRyZWdpb246Nzc3MzM3YTIzM2NjNGMwYmIwOTNlZDYyZjQzOGEzOTRfNA_0d998a18-15d6-41af-a2a0-5750ca1930d3">65.54</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMy0yLTEtMS0xL3RleHRyZWdpb246Nzc3MzM3YTIzM2NjNGMwYmIwOTNlZDYyZjQzOGEzOTRfOQ_931821b7-d3eb-4c6f-8e70-75b18f08c87f">71.00</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfNC0yLTEtMS0xL3RleHRyZWdpb246YzMyNWM3NWVlYmM2NGRmNmIxYjRiNDVlYWQ4ZDZmYzVfNA_d2651266-bb15-46b6-a9e8-7d0df2f8fb1b">&#8212;</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share of options assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i1f2212887fcb4485932c6ca7b57bac3b_D20210105-20210105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfNS0yLTEtMS0xL3RleHRyZWdpb246NjJmNDVmZjk2ZjIzNGE0MGIxN2M2NDM1NjY2MjM1YzZfNA_93c8b00d-53fe-4a71-8bdd-b3e28f1234a5">109.74</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i37a4ec695a024e4e80da4d3494beed97_D20210105-20210105" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfNS0yLTEtMS0xL3RleHRyZWdpb246NjJmNDVmZjk2ZjIzNGE0MGIxN2M2NDM1NjY2MjM1YzZfOQ_6f33bb3a-420d-4413-b558-e59fd495b4c4">124.89</ix:nonFraction></span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously held a preferred stock investment of $<ix:nonFraction unitRef="usd" contextRef="i9248689114b34d9bb59ac32e2ea4d2fe_I20210105" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfOTE2Ng_8a7cb1b3-cfcf-497a-b036-bdf378b4536c">12.5</ix:nonFraction> million in Thrive and recognized a gain of approximately $<ix:nonFraction unitRef="usd" contextRef="i739d95546ece4d0bb7484bec638b1ce3_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfOTIxOA_7ba103c0-1901-4dcb-904b-df8cb19d9703">30.5</ix:nonFraction> million on the transaction within investment income (expense), net on the Company&#8217;s condensed consolidated statement of operations, which represented the adjustment of the Company&#8217;s historical investment to the acquisition date fair value. The fair value of the Company&#8217;s previous ownership in Thrive was determined based on the pro-rata share payout applied to the Company&#8217;s interest combined with the fair value of the Company&#8217;s share of the contingent consideration arrangement, as discussed above.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ib3380069bcf44e09b4726791abb162d4" continuedAt="i5c3262b41baa4cf6a735e5b0ae567ba6"><ix:continuation id="i15090390c8594baaa731d470d7d8b657" continuedAt="iedcc9f7ec19b43ffb6648e2be5cae707"><ix:continuation id="i682b46e3ff584b778c365d5bc8d65473" continuedAt="i8d8b54291dc34506bcb47b20033edd78"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>January 5, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allocation as of September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMS0yLTEtMS0x_07d0ffde-fbc8-45b8-84ce-55b07256e4f4">241,748</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMS00LTEtMS0x_7959c382-8dba-4856-86ff-996757b6503b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMS02LTEtMS0x_a6d92526-9f22-46e8-959e-2ffea9f90108">241,748</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMi0yLTEtMS0x_76f70eba-9c65-4987-9f8e-07252d255837">3,939</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMi00LTEtMS0x_06765495-0cb2-42ce-85ba-756598e1d66b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMi02LTEtMS0x_59e9802b-ad55-4609-aef3-d1062b5c903d">3,939</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMy0yLTEtMS0x_ada94f8e-3636-4cfa-9aaf-10fe55d03584">29,977</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMy00LTEtMS0x_fe163426-8f90-4b65-bc1c-0a2aae86a4ca">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMy02LTEtMS0x_8ed2d7eb-e4f3-482a-96a8-ebdc00876265">29,977</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNC0yLTEtMS0x_19482561-3fe8-40ca-b3e2-52a158411342">39,027</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNC00LTEtMS0x_e2696d47-7bc5-41b8-87c9-5d5b976f96c6">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNC02LTEtMS0x_e23ded04-905f-4488-8c97-12fbfb7cd429">39,027</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNS0yLTEtMS0x_ff9229ee-b011-479e-8969-df08983b3020">67</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNS00LTEtMS0x_c460b1ed-16c5-4021-ae25-8e9bf3418942">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNS02LTEtMS0x_a987cce5-6664-4332-b573-ca69c5adc820">67</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNi0yLTEtMS0x_a8d8767b-bcdb-4017-8ac0-f7dbd09b3278">1,250,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNi00LTEtMS0x_8b5b3364-c297-4afe-8d2e-46608a80cfdd">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNi02LTEtMS0x_d3f15e00-9511-47cc-9b00-0a5cba4f4a92">1,250,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNy0yLTEtMS0x_97c6e276-5b74-417d-a09c-cb852676b887">1,564,758</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNy00LTEtMS0x_c32b868c-2f4c-4bfe-bdad-bf43f731a95c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNy02LTEtMS0x_dd86a968-ad9e-4085-8a6a-600966e6d02a">1,564,758</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfOS0yLTEtMS0x_24ba94a9-5701-4298-9e69-a9683161f38a">3,222</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfOS00LTEtMS0x_e667ed3a-4d5c-4a8c-bba0-717e0429d1ad">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfOS02LTEtMS0x_3d3b3fcd-e344-4d69-bf6f-470059fa590f">3,222</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTAtMi0xLTEtMQ_1f1f938c-49ab-4057-92c2-297ceb92a502">6,218</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTAtNC0xLTEtMQ_a460069d-7a58-4d54-a602-53964d656afe">1,862</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTAtNi0xLTEtMQ_e663d6bc-5c92-4a7f-8886-22769d407be4">8,080</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTEtMi0xLTEtMQ_bca4b715-c5c1-4f32-9ad0-ae3e6146357e">2,980</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTEtNC0xLTEtMQ_8aca44d2-dc3e-4e39-9b9b-303c569c525c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTEtNi0xLTEtMQ_d398d72c-8d0d-44f4-bbb8-58e5135929a1">2,980</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTItMi0xLTEtMQ_b26d1c1e-3f7b-40c4-8fae-b71d08fb7010">38,622</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTItNC0xLTEtMQ_a43f2eb7-65a8-403f-8d9d-f7ec226a6cf2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTItNi0xLTEtMQ_ad2127e5-9367-4d9b-a5de-d1fb3da6db4e">38,622</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTMtMi0xLTEtMQ_2a1bc57a-6d43-4103-96bd-ef7a70c62c01">272,905</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTMtNC0xLTEtMQ_03764e62-4de7-44eb-9e5f-186ca7f46fa6">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTMtNi0xLTEtMQ_74e82d3a-a9d9-4162-9387-d9d76c852b73">272,905</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTQtMi0xLTEtMQ_84dc0f28-7b8d-466c-9902-e99ff3252a2f">323,947</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTQtNC0xLTEtMQ_2b1d3d4e-dab1-49d9-b226-d8b1891e88af">1,862</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTQtNi0xLTEtMQ_c7a4587b-21c5-4916-bda9-9ea10dd9172b">325,809</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTUtMi0xLTEtMQ_69abdd11-992f-4080-a543-032f2d6ea4e0">1,240,811</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTUtNC0xLTEtMQ_8b3b7a78-efd7-4fb2-b549-1e4e5cc097b0">1,862</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTUtNi0xLTEtMQ_54e298f8-f811-4182-82aa-32047941186e">1,238,949</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTctMi0xLTEtMQ_d1a528ad-61a9-4ad3-91ff-46c7c804a472">946,243</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTctNC0xLTEtMQ_2c978936-7760-483d-916f-013b40eca0dc">1,862</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTctNi0xLTEtMQ_27a7c140-5f6c-4f4b-bf64-73ca860e57af">948,105</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTgtMi0xLTEtMQ_7eed6723-e889-4cd3-968f-843034201428">2,187,054</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930" decimals="-3" format="ixt:fixed-zero" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTgtNC0xLTEtMQ_0cabcac0-c54b-4c7f-a815-b333c04f9516">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTgtNi0xLTEtMQ_866de75b-45f4-40b0-a430-65537b270081">2,187,054</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D represents the fair value assigned to research and development assets that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying product and expected commercial release. The amounts capitalized are accounted for as indefinite-lived intangible assets, subject to impairment testing, until completion or abandonment of the research and development efforts associated with the projects. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105" decimals="-7" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTAzNjQ_3fcc2902-70ce-49eb-9db7-39d02837c034">1.25</ix:nonFraction> billion of IPR&amp;D related to a project associated with the development of an FDA approved blood-based, multi cancer screening test. The IPR&amp;D asset was valued using the multiple-period excess earnings method approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, required rate of return and tax rate, as well as estimates of achievement probability and timing related to the royalty and milestone obligations due to JHU, as described in Note 10. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the research and development workforce expertise, next generation sequencing capabilities and expected synergies. The total goodwill related to this combination is not deductible for tax purposes.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the IPR&amp;D asset, as well as finalization of the pre-combination income tax returns.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net loss before tax of Thrive included in the Company&#8217;s condensed consolidated statement of operations from the combination date of January 5, 2021 to September&#160;30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i2de807b6ca3d4e4a86f20612c5808594_D20210106-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTE4OTE_ff4f9ba0-2cd7-407e-8ecf-57e53dc1a7c6">219.6</ix:nonFraction> million. The net loss before tax of Thrive included in the Company&#8217;s condensed consolidated statement of operations for the three months ended September 30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTIwMTc_cf995977-f296-4589-9059-572471b45dec">39.6</ix:nonFraction> million.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i5c3262b41baa4cf6a735e5b0ae567ba6" continuedAt="ia57f3ec7e6a94fb1967b27bdf0b7a572"><ix:continuation id="iedcc9f7ec19b43ffb6648e2be5cae707" continuedAt="if7a1e41281324447b510c52c65072e89"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDA_d116c2a0-98a6-4cab-8928-82cde0226d18" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.537%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi0yLTEtMS0x_b971cb79-a79c-416f-b465-fba7d3612e3f">456,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4af871727fe246d883797ebcafb803cf_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi00LTEtMS0x_1db480bc-a7cf-41d3-9ada-44284fbce9e1">408,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi02LTEtMS0x_dd632d9d-0c76-47c0-92f9-78bb1a01efe3">1,293,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie231f4fa3d2943ffbe7fe72b6feb6e16_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi04LTEtMS0x_0479f575-8284-4da8-ab56-298d7b9d05c6">1,025,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessAcquisitionProFormaIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy0yLTEtMS0x_f2414629-61b4-44a0-bfd4-9865ffef86ef">170,797</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4af871727fe246d883797ebcafb803cf_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessAcquisitionProFormaIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy00LTEtMS0x_91aafe16-0776-40b8-beaf-f7824ab71bca">224,860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessAcquisitionProFormaIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy02LTEtMS0x_5798abb5-0cce-4eb9-9ab3-735f5c15a229">536,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie231f4fa3d2943ffbe7fe72b6feb6e16_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="exas:BusinessAcquisitionProFormaIncomeLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy04LTEtMS0x_81cbc6b3-d74e-4b46-b374-75e626acff7e">575,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information for all periods presented above has been calculated after adjusting the results of Thrive to reflect the business combination accounting effects resulting from this combination. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTI0NzY_a1b0204b-fd59-4aa9-9a63-b5c1c407ef05">86.2</ix:nonFraction> million of stock-based compensation expense related to accelerated vesting in connection with the acquisition, $<ix:nonFraction unitRef="usd" contextRef="i2208e7b3dafd4734ad1c448f7ee2ebd2_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTI1ODI_6a1fb986-5793-4ea5-9f55-06b077db2a1b">13.5</ix:nonFraction> million of stock-based compensation expense related to accelerated vesting for employees with qualifying termination events, and $<ix:nonFraction unitRef="usd" contextRef="i6b29593c68434f2699b1a75adf89a7cf_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTI3MDY_c205ddc8-dc15-4631-a794-586b57145a03">10.3</ix:nonFraction> million of transaction costs incurred to execute the acquisition during the first quarter of 2021. These expenses are included in general and administrative expenses on the condensed consolidated statement of operations for the nine months ended September 30, 2021 and are reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a realized gain of $<ix:nonFraction unitRef="usd" contextRef="i739d95546ece4d0bb7484bec638b1ce3_D20210101-20210331" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTMwNDM_7ba103c0-1901-4dcb-904b-df8cb19d9703">30.5</ix:nonFraction> million during the first quarter of 2021 in investment income (expense), net on the Company&#8217;s condensed consolidated statement of operations relating to the Company&#8217;s pre-acquisition investment in Thrive. This gain has been reduced to $<ix:nonFraction unitRef="usd" contextRef="i836f2fc064cf4745a2df3a6dffded766_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTMyNjM_d4962a14-5ca9-432e-8ed7-fb54d3d83980">7.6</ix:nonFraction>&#160;million due to the Company&#8217;s smaller ownership interest in Thrive on January 1, 2020, and is reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a remeasurement of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i836f2fc064cf4745a2df3a6dffded766_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTM0ODI_b430891c-452b-4a71-b287-b83c08043b89">10.5</ix:nonFraction> million related to Thrive in general and administrative expenses in the condensed consolidated statement of operations for the nine months ended September 30, 2021. This expense is reflected in the nine months ended September 30, 2020 in the table above. The historical consolidated financial statements have been adjusted in the unaudited pro forma combined financial information to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The unaudited pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the combination had taken place as of January 1, 2020.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTA5OTUxMTY0OTAwMg_2e2ce333-73bb-47b9-beb7-dec1251635d4">10.3</ix:nonFraction> million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with acquisition-related severances, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ0ODQ_d2a8a282-c0be-46a3-8135-a2e8263ce194">4.5</ix:nonFraction> million of expense related to vesting of previously unvested equity awards and $<ix:nonFraction unitRef="usd" contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PostemploymentBenefitsPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ1NTg_5773c971-6880-4c84-8367-d2d0dbcb59d4">1.2</ix:nonFraction> million of additional benefit charges for the three months ended September 30, 2021. The Company recorded $<ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ2MjM_288a95cc-80d5-479f-ab11-236317dfbae2">19.0</ix:nonFraction> million of expense related to vesting of previously unvested equity awards and $<ix:nonFraction unitRef="usd" contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PostemploymentBenefitsPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ2OTc_951949d9-7a00-4bfb-b862-6537f0d90252">3.9</ix:nonFraction> million of additional benefit charges for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paradigm Diagnostics, Inc. and Viomics, Inc.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2020, the Company acquired all of the outstanding capital stock of Paradigm and Viomics, two related party companies of one another headquartered in Phoenix, Arizona, in transactions that were deemed to be a single business combination in accordance with ASC 805, Business Combinations, (&#8220;the Paradigm Acquisition&#8221;). Paradigm provides comprehensive genomic-based profiling tests that assist in the diagnosis and therapy recommendations for late-stage cancer. Viomics provides a platform for identification of biomarkers.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into this acquisition to enhance its product portfolio in cancer diagnostics and to enhance its capabilities for biomarker identification.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ia57f3ec7e6a94fb1967b27bdf0b7a572" continuedAt="icfe51c9056594f8387585e9a49442388"><ix:continuation id="if7a1e41281324447b510c52c65072e89" continuedAt="i9aeb98e878024134ae70e20931cc6515"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of the consideration to be transferred for Paradigm and Viomics was $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU1Nzk_bacaabba-2334-408f-ba6f-8d62554b8ab1">40.4</ix:nonFraction> million, which consists of $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU2MDE_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc">32.2</ix:nonFraction>&#160;million payable in shares of the Company&#8217;s common stock and $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU2NTY_a59c853b-1073-4a2d-ae3f-547930927f3b">8.2</ix:nonFraction>&#160;million which was settled through a cash payment. Of the $<ix:nonFraction unitRef="usd" contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU3MDg_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc">32.2</ix:nonFraction>&#160;million to be settled through the issuance of common stock, $<ix:nonFraction unitRef="usd" contextRef="i949e45cbfa8f4affa83a6c86d26dc895_D20200303-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU3NjM_c8cea121-5732-449d-9a84-0931aaa0e99e">28.8</ix:nonFraction>&#160;million was issued as of September&#160;30, 2021, and the remaining $<ix:nonFraction unitRef="usd" contextRef="i68687c83ee8c49eb85c072bb07c29656_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="exas:BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU4MDU_2ca81f87-1083-4186-b153-b470750c8dc5">3.4</ix:nonFraction>&#160;million, which was withheld and may become payable as additional merger consideration, is included in other current liabilities in the condensed consolidated balance sheet as of September&#160;30, 2021. <ix:continuation id="i8d8b54291dc34506bcb47b20033edd78" continuedAt="ic01b8cd33bf84052ac2702358cbc8b9e">The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:</ix:continuation></span></div><div><ix:continuation id="ic01b8cd33bf84052ac2702358cbc8b9e" continuedAt="i6087e6232e7d4536b111806a49f4d6a2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>March 3, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Allocation<br/>March 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie959531369c94b0683d868dc39af4087_I20200303" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMS0yLTEtMS0x_5dd4e9d4-8024-4d3d-9e20-4c1645de34c5">6,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303" decimals="-3" sign="-" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMS00LTEtMS0x_39bafc06-a4f3-405f-8d7c-aba134f7eccc">760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303" decimals="-3" format="ixt:num-dot-decimal" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMS02LTEtMS0x_516cf305-9c04-4244-9f60-086ad70c3f3a">5,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie959531369c94b0683d868dc39af4087_I20200303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMi0yLTEtMS0x_9475e4bf-7ec9-4b21-b9d6-2bf00f809fdc">29,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303" decimals="-3" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMi00LTEtMS0x_d3fa2811-18f9-4e4b-853e-38f9163130f2">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMi02LTEtMS0x_bb9df23a-3173-4eb7-a7ad-dc018b583712">30,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie959531369c94b0683d868dc39af4087_I20200303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMy0yLTEtMS0x_961e84a2-48e4-447d-a265-0f93e53f4e45">7,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303" decimals="-3" format="ixt:fixed-zero" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMy00LTEtMS0x_1ba9ea6a-91ba-42c8-8c12-28b95d4610c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMy02LTEtMS0x_2d21f0b1-9ef6-4046-8477-ac79281b5c47">7,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie959531369c94b0683d868dc39af4087_I20200303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNC0yLTEtMS0x_da29598a-79bc-41b2-817d-3d67dcbdf337">3,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303" decimals="-3" name="exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNC00LTEtMS0x_af22d89a-a3f9-48e5-bfdc-f8c6e48af261">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNC02LTEtMS0x_2990c717-ca51-4617-b973-2d061b31f642">3,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie959531369c94b0683d868dc39af4087_I20200303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNS0yLTEtMS0x_462bd314-6505-40ef-83dc-79bc24cd5674">40,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303" decimals="-3" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNS00LTEtMS0x_883bdbfd-ee61-4497-84bb-ba4613d391ec">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNS02LTEtMS0x_6a5620f1-da7d-4182-9398-a897ad3f8a71">40,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measurement period adjustments primarily related to accounts receivable valuation and working capital adjustments.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of identifiable intangible assets has been determined using the income approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, weighted average cost of capital and tax rate.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology represents purchased technology that had reached technological feasibility and for which development had been completed as of the acquisition date. Fair value was determined using future discounted cash flows related to the projected income stream of the developed technology for a discrete projection period. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of <ix:nonNumeric contextRef="i236fa5e8e1614dad9327b02436f9e492_D20200303-20200303" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTY5OTc_afa068b9-8c7f-497a-a112-10f2a9ebd80a">15</ix:nonNumeric> years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the assembled workforce, and expected synergies. The total goodwill related to this acquisition is not deductible for tax purposes.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company agreed to issue to the previous investors in Viomics equity interests with an acquisition-date fair value of up to $<ix:nonFraction unitRef="usd" contextRef="i5084f90d66dc4b7ebb62ead28ea222fe_D20200303-20200303" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc0NjE_7be4a1c5-a7b8-45ff-bec0-963b6477ad63">8.4</ix:nonFraction>&#160;million in Viomics, vesting over <ix:nonNumeric contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303" format="ixt-sec:duryear" name="exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc0ODk_be290d9b-1b83-4c99-8517-2779a24af94d">4</ix:nonNumeric> years based on certain retention arrangements. Payment is contingent upon continued employment with the Company over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb">four</span></span> year vesting period and is recognized as stock-based compensation expense in general and administrative expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Acquisitions</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PFS Genomics Inc. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 3, 2021, the Company acquired <ix:nonFraction unitRef="number" contextRef="i98ec76a50c654b3286dda25e4ae5e185_I20210503" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc4NTI_7f587832-3fdd-4973-9494-88373cc57b4f">90</ix:nonFraction>% of the outstanding capital stock of PFS Genomics Inc. (&#8220;PFS&#8221;). On June 23, 2021, the Company completed the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i584d1f57791b47d7842344882f5499e3_I20210623" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc5OTE_90ccc202-5956-4b3f-9034-6daee240f685">10</ix:nonFraction>% interest in PFS. The Company paid cash of $<ix:nonFraction unitRef="usd" contextRef="i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTgwMzY_79247e02-a68d-4089-9319-bc563d741ff5">33.6</ix:nonFraction> million for <ix:nonFraction unitRef="number" contextRef="i584d1f57791b47d7842344882f5499e3_I20210623" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTgwNDM_7fcb1a8b-98a1-4069-b055-d7d9e47bbee4">100</ix:nonFraction>% of the outstanding capital stock in PFS. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PFS is a healthcare company focused on personalizing treatment for breast cancer patients to improve outcomes and reduce unnecessary treatment. The Company expects this acquisition to expand its ability to help guide early-stage breast cancer treatment through individualized radiotherapy treatment decisions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was treated as an asset acquisition under GAAP because substantially all of the fair value of the gross assets acquired were deemed to be associated with the acquired technology.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets acquired and liabilities assumed were substantially comprised of the IPR&amp;D asset as shown in the table below. The IPR&amp;D asset acquired was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="icfe51c9056594f8387585e9a49442388"><ix:continuation id="i9aeb98e878024134ae70e20931cc6515"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the total purchase price was allocated to the acquired net tangible and intangible assets based on their estimated fair values as of the closing date. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related costs were not material in this asset acquisition. </span></div><ix:continuation id="i6087e6232e7d4536b111806a49f4d6a2"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisition of PFS Genomics outstanding shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfMi0yLTEtMS0x_c1829602-7071-46a9-971d-f1db2d5b18d6">33,569</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584d1f57791b47d7842344882f5499e3_I20210623" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNC0yLTEtMS0x_267140cc-6b40-478a-8521-f2f013331797">496</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584d1f57791b47d7842344882f5499e3_I20210623" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNS0yLTEtMS0x_dcd71f07-d384-40fe-ade1-825ecb6c07e7">33,074</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i584d1f57791b47d7842344882f5499e3_I20210623" decimals="-3" sign="-" name="exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNi0yLTEtMS0x_d1451a63-2ef5-4665-8360-a4e2d9e69c33">1</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i584d1f57791b47d7842344882f5499e3_I20210623" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNy0yLTEtMS0x_c9484aec-e507-4046-ac4c-472ba57eb03c">33,569</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TARDIS License Agreement </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2021, the Company entered into a worldwide exclusive license to the proprietary TARDIS technology from TGen, an affiliate of City of Hope. Under the agreement, the Company acquired a royalty-free, worldwide exclusive license to proprietary TARDIS patents and know-how. The Company intends to develop and commercialize the TARDIS technology as a minimal residual disease test. The Company accounted for this transaction as an asset acquisition. In connection with the asset acquisition, the Company paid upfront fair value consideration of $<ix:nonFraction unitRef="usd" contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxMDA_d71eaa5e-6b89-44d4-952a-2636ba0322e7">52.3</ix:nonFraction> million comprised of $<ix:nonFraction unitRef="usd" contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxMTY_0700de9f-4f68-4155-9705-1f1a4be84a5b">25.0</ix:nonFraction> million in cash and issuance of <ix:nonFraction unitRef="shares" contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111" decimals="-5" format="ixt:num-dot-decimal" name="exas:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxNDM_32658dfc-544a-4358-a36c-c980add3c68e">0.2</ix:nonFraction>&#160;million shares of common stock valued at $<ix:nonFraction unitRef="usd" contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxNzk_83d69112-4740-43a7-9087-a5a46af2a59e">27.3</ix:nonFraction> million based on the average of the high and low market price of the Company&#8217;s shares on the acquisition date. In addition, the Company is obligated to make milestone payments to TGen of $<ix:nonFraction unitRef="usd" contextRef="i80ac638840f440a7904d59afcbea3cc5_I20210111" decimals="-5" format="ixt:num-dot-decimal" name="exas:PaymentsContingentOnMilestonesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAzNjE_18254b5d-6947-441b-9bf3-1dfd17cb15c5">10.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifabaf4b7e254465dbc76f19d64a783d8_I20210111" decimals="-5" format="ixt:num-dot-decimal" name="exas:PaymentsContingentOnMilestonesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAzNjg_f5dd57b4-ee78-4c2f-9f40-5ebfe6d17d10">35.0</ix:nonFraction> million upon achieving cumulative product revenue related to MRD detection and/or treatment totaling $<ix:nonFraction unitRef="usd" contextRef="i94f31a307e874ce8afdd82c892892230_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" name="exas:CollaborativeArrangementsSalesMilestoneAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjA0NjQ_d79fc603-c761-47dc-be7b-3bd960efea12">100.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ice171bffc87a4afd95cc52b6534e2776_D20210101-20210131" decimals="-5" format="ixt:num-dot-decimal" name="exas:CollaborativeArrangementsSalesMilestoneAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjA0NzE_aac68e12-6d0b-4b2f-9e87-955370a801e8">250.0</ix:nonFraction> million, respectively. These payments are contingent upon achievement of these cumulative revenues on or before December 31, 2030. The upfront consideration was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. The Company will record the sales milestones once achievement is deemed probable. No acquisition related costs were incurred in this asset acquisition during the three and nine months ended September&#160;30, 2021.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_85"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RleHRyZWdpb246OTdlNzljZTRlZTY0NDhlODk3OWRkZGZiOWRkYjg1MzdfMTAxMA_1af68960-51d0-4c4e-8a60-d05fa2c1197d" continuedAt="i3da173d3bb6143f3b12e09772386a179" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3da173d3bb6143f3b12e09772386a179" continuedAt="id85499d48c0748888ea17e75bd784b80">Management determined that the Company functions as a single operating segment, and thus reports as a single reportable segment. This operating segment is focused on the development and global commercialization of clinical laboratory services allowing healthcare providers and patients to make individualized treatment decisions. Management assessed the discrete financial information routinely reviewed by the Company's Chief Operating Decision Maker, its President and Chief Executive Officer, to monitor the Company's operating performance and support decisions regarding allocation of resources to its operations. Performance is continuously monitored at the consolidated level to timely identify deviations from expected results. </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXACT SCIENCES CORPORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="id85499d48c0748888ea17e75bd784b80"><ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RleHRyZWdpb246OTdlNzljZTRlZTY0NDhlODk3OWRkZGZiOWRkYjg1MzdfMTAxMQ_65a7c41a-5b05-4e3d-a3ee-929821b56ebe" escape="true"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total revenue from customers by geographic region. Product revenues are attributed to countries based on ship-to location.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c8253dc31a74450a8053d46842c3eb1_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi0yLTEtMS0x_b8369c6a-1430-4103-9440-ba7ea0aae8c3">429,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f486f15d984c8ab5076786cc04e07f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi00LTEtMS0x_743a0f20-4aa5-493c-baed-da4849428d0c">392,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11e90247f0d444a48ddf485761f1c6bc_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi02LTEtMS0x_0ff96660-b880-411b-b3d3-4f0b7f76304d">1,213,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c6bcdbe518418186b36093e716a0e5_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi04LTEtMS0x_bc20878a-ab38-4863-bfcb-0bbbc3364627">968,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6260119aed2d44219f06bcf7f78466ff_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy0yLTEtMS0x_7e6d63e7-e189-497a-b349-f9049ef6fc7f">27,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5a40758325f4f10ba85a4d7f63cc106_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy00LTEtMS0x_66b7327b-fa95-4c89-b01c-1b0667bf68c4">16,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia01c094882504b1680c962a4508c16f1_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy02LTEtMS0x_9729bd36-7456-440b-aa84-561288f0f30c">80,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0745308ee7374949b866802826027f90_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy04LTEtMS0x_b2e9ee4e-49b0-40f8-b801-1b808e8ce291">56,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC0yLTEtMS0x_cbbb52cc-0b14-48bf-8090-0b4d9849decc">456,379</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC00LTEtMS0x_07f3d762-5259-48e4-9e65-94c825ea7274">408,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC02LTEtMS0x_27408603-de79-455a-a095-dc68ab993a34">1,293,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC04LTEtMS0x_f22d0001-08b6-4a7e-961d-087affd5f107">1,025,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets located in countries outside of the United States are not significant.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_88"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19)&#160;<ix:nonNumeric contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMjAzNg_409ae580-3957-44fe-b1c4-c8e0cf9d655e" continuedAt="i10c6cfa6b5ac4ba2a2a2a9608e61dda5" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i10c6cfa6b5ac4ba2a2a2a9608e61dda5"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfNjk_f5fd7481-aca6-4543-ad4b-0ca6be8961c9">3.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfODk_ddf095a9-9d37-4c48-bc02-6cbd5a664759">2.8</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, respectively. The Company recorded an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTcx_b2216c4b-22e3-43f8-86ab-065b342fc52b">242.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTkx_50b69731-284c-481b-bf6e-cbc82fc003ed">5.3</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively. The Company&#8217;s income tax expense recorded during the three months ended September 30, 2021 is primarily related to foreign tax expense, as well as the future limitations on and expiration of certain Federal and State deferred tax assets. The Company&#8217;s income tax benefit recorded during the nine months ended September 30, 2021 is primarily related to an income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfNTgy_534cb324-9872-4ddf-9457-6bbeba35774c">239.2</ix:nonFraction> million recorded as a result of the change in the deferred tax asset valuation allowance resulting from the Thrive Merger. A deferred tax liability of approximately $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfNzQy_e5e0b595-9839-4938-b536-064e1da29b47">32.7</ix:nonFraction> million was recorded as of September&#160;30, 2021, which is included in other long-term liabilities on the Company&#8217;s condensed consolidated balance sheet. The Company continues to maintain a full valuation allowance against its deferred tax assets based on management&#8217;s determination that it is more likely than not the benefit will not be realized.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $<ix:nonFraction unitRef="usd" contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTA4Mw_58cc5179-15f0-4b18-97af-0b0d19aaa887">17.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTA5MA_738c9a32-63e9-482d-8375-c55a62be1442">16.6</ix:nonFraction> million of unrecognized tax benefits at September&#160;30, 2021 and December&#160;31, 2020, respectively. These amounts have been recorded as a reduction to the Company&#8217;s deferred tax asset, if recognized they would not have an impact on the effective tax rate due to the existing valuation allowance. Certain of the Company's unrecognized tax benefits could change due to activities of various tax authorities, including possible settlement of audits, or through normal expiration of various statutes of limitations. The Company does not expect a material change in unrecognized tax benefits in the next twelve months.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, due to the carryforward of unutilized net operating losses and research and development credits, the Company is subject to U.S. federal income tax examinations for the tax years 2001 through 2021, and to state income tax examinations for the tax years 2001 through 2021. No interest or penalties related to income taxes have been accrued or recognized as of September&#160;30, 2021.</span></div></ix:continuation><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_91"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations should be read in conjunction with the condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements and notes thereto and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020, which has been filed with the SEC (the &#8220;2020 Form 10-K&#8221;).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form&#160;10-Q contains forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the &#8220;safe harbor&#8221; created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;seek,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;goal,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate&#8221; or other comparable terms. All statements other than statements of historical facts included in this Quarterly Report on Form 10-Q regarding our strategies, prospects, expectations, financial condition, operations, costs, plans and objectives are forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding expected future operating results; our strategies, positioning, resources, capabilities and expectations for future events or performance; and the anticipated benefits of our acquisitions, including estimated synergies and other financial impacts. Forward-looking statements are neither historical facts nor assurances of future performance or events. Instead, they are based only on current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Actual results, conditions and events may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results, conditions and events to differ materially from those indicated in the forward-looking statements include, among others, the following: uncertainties associated with the coronavirus (&#8220;COVID-19&#8221;) pandemic, including its possible effects on our operations, including our supply chain and clinical studies, and the demand for our cancer and COVID-19 testing products and services; our ability to efficiently and flexibly manage our business amid uncertainties related to COVID-19; our ability to successfully and profitably market our products and services; our ability to realize the benefits of our recently hired sales representatives and our promotion agreement with Pfizer;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover our products and services and adequately reimburse us for such products and services; the amount and nature of competition for our products and services; the effects of any judicial, executive or legislative action affecting us or the healthcare system; recommendations, guidelines and quality metrics issued by various organizations regarding cancer screening or our products and services; our ability to successfully develop new products and services and assess potential market opportunities; our ability to effectively enter into and utilize strategic partnerships and acquisitions; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to obtain and maintain regulatory approvals and comply with applicable regulations; our ability to manage an international business and our expectations regarding our international expansion and opportunities; the potential effects of foreign currency exchange rate fluctuations and our efforts to hedge such effects; the possibility that the anticipated benefits from our business acquisitions will not be realized in full or at all or may take longer to realize than expected; the possibility that costs or difficulties related to the integration of acquired businesses&#8217; operations will be greater than expected and the possibility that integration efforts will disrupt our business and strain management time and resources; the outcome of any litigation, government investigations, enforcement actions or other legal proceedings, including in connection with acquisitions;  our ability to retain and hire key personnel, including employees at businesses we acquire. The risks included above are not exhaustive.  Other important risks and uncertainties are described in the Risk Factors and in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations sections of the 2020 Form 10-K and subsequently filed Quarterly Reports on Form 10-Q. You are further cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exact Sciences Corporation (together with its subsidiaries, &#8220;Exact,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or the &#8220;Company&#8221;) is a leading global cancer diagnostics company. We have developed some of the most impactful brands in cancer diagnostics, and we are currently working on the development of additional tests, with the goal of bringing new innovative cancer tests to patients throughout the world.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 17 of our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for full discussion of acquisitions completed during the year. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Cologuard Test</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Colorectal cancer is the second leading cause of cancer deaths in the United States and the leading cause of cancer deaths in the United States among non-smokers. In 2020 in the United States there was estimated to be approximately 148,000 new cases of colorectal cancer and 53,000 deaths from colorectal cancer. It is widely accepted that colorectal cancer is among the most preventable, yet least prevented cancers.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Cologuard&#174; test is a non-invasive stool-based DNA (&#8220;sDNA&#8221;) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Upon approval by the U.S. Food and Drug Administration (&#8220;FDA&#8221;) in August 2014, our Cologuard test became the first and only FDA-approved sDNA non-invasive colorectal cancer screening test. Our Cologuard test is now indicated for average risk adults 45 years of age and older.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Oncotype Tests</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply our world-class scientific and commercial expertise and infrastructure to lead the translation of clinical and genomic data into clinically actionable results for treatment planning throughout the cancer patient&#8217;s journey, from diagnosis to treatment selection and monitoring. Our Oncotype tests include our flagship line of Oncotype DX&#174; gene expression tests for breast, prostate and colon cancer, as well as Oncotype DX AR-V7 Nucleus Detect&#174; test, a liquid-based test for advanced stage prostate cancer.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we announced the introduction of the Oncotype MAP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pan-Cancer Tissue (&#8220;Oncotype MAP&#8221;) test, which is a rapid, comprehensive tumor profiling panel that aids therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Business Background and Products</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We commercialize our Oncotype tests internationally through employees in Canada, Japan and six European countries, as well as through exclusive distribution agreements. We have provided our Oncotype tests in more than 90 countries outside of the United States. We do not offer our Cologuard test or COVID-19 testing outside of the United States.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pipeline Research and Development</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development efforts are focused on developing new products and enhancing existing products to address new cancer areas and expand the clinical utility and addressable patient populations for our existing tests. We expect to advance liquid biopsy through biomarker discovery and validation in tissue, blood, or other fluids and to leverage recent business development activities to accelerate our leadership in earlier cancer detection and treatment guidance. We are pursuing the following opportunities:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Colon Cancer Screening</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are seeking opportunities to improve upon our Cologuard test&#8217;s performance characteristics. In October 2019, we and Mayo presented at the American College of Gastroenterology&#8217;s 2019 Annual Scientific Meeting findings from a blinded-case control study showing enhanced colorectal cancer and advanced adenoma detection using newly discovered methylation biomarkers. To establish the performance of an enhanced multi-target stool DNA test, we expect to enroll more than 10,000 patients 40 years of age and older in our multi-center, prospective BLUE-C study. The timing of any such enhancements to our Cologuard test is unknown and would be subject to FDA approval. We are also working to develop a blood-based screening test for colorectal cancer.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Multi-Cancer Early Detection (&#8220;MCED&#8221;) Test Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are currently seeking to develop a blood-based, MCED test. In January 2021, we completed the acquisition of Thrive Earlier Detection Corporation (&#8220;Thrive&#8221;), a healthcare company dedicated to developing a blood-based, MCED test. An early version of Thrive&#8217;s test has achieved promising results in a 10,000-patient, prospective, interventional study detecting 10 different types of cancer, including seven with no current recommended screening guidelines, with very few false positives. We intend to combine Thrive's expertise with our scientific capabilities, clinical organization and commercial infrastructure to establish us as a leading competitor in blood-based, multi-cancer early detection.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hepatocellular Carcinoma (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HCC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">) Test Development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently developing a blood-based biomarker test to serve as an alternative to ultrasound and alpha-fetoprotein (&#8220;AFP&#8221;) for use in HCC testing. HCC is the most common type of liver cancer. Our goal is to provide a patient-friendly test that performs better than the current guideline-recommended testing options. In August 2021, the performance of our Oncoguard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Liver liquid biopsy test was published in the peer-reviewed journal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Gastroenterology and Hepatology</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The test delivers 82% early-stage sensitivity and an overall 88% sensitivity for HCC at 87% specificity with a novel combination of six blood-based biomarkers for HCC. The study compared performance to the AFP test, which demonstrated 45% sensitivity at 90% specificity for early stage HCC. Our test was made available on a limited basis beginning in the second quarter of 2021.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Minimal Residual Disease (&#8220;MRD&#8221;) Test Development. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021 we acquired an exclusive license to The Translational Genomics Research Institute (&#8220;TGen&#8221;) proprietary Targeted Digital Sequencing (&#8220;TARDIS&#8221;) technology. We are currently seeking to utilize this compelling and technically distinct approach to develop a test to detect small amounts of tumor DNA that may remain in patients&#8217; blood after they have undergone initial treatment. In a study published in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Science Translational Medicine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, TARDIS demonstrated high accuracy in assessing molecular response and residual disease during neoadjuvant therapy to treat breast cancer. TARDIS achieved up to 100-fold improvement beyond the current limit of circulating tumor DNA detection. We intend to expand our precision oncology business to become a leader in minimal residual disease testing, which will leverage our existing foundation to deliver better solutions to patients navigating cancer. </span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Development Studies for Oncotype DX Products. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also conduct or fund clinical studies that could support additional opportunities for our Oncotype DX products. For example, we are exploring clinical studies to expand the use of genomic testing to address additional populations, including higher-risk patients. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also use a number of other technologies across various development programs and product implementations. While early-stage cancer continues to be our main focus, we believe we also have an opportunity to expand our business further along the patient&#8217;s cancer journey, both through our research and development process and strategic collaborations.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, which includes our clinical study programs, accounts for a material portion of our operating expenses. As we seek to enhance our current product portfolio and expand our product pipeline by developing additional cancer screening and diagnostic tests, we expect that our research and development expenditures will continue to increase.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Testing Business</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In late March 2020, we began providing COVID-19 testing. We have partnered with various customers, including the State of Wisconsin Department of Health Services, to administer testing. Customers are responsible for employing trained personnel to collect specimens. Specimens are sent to our laboratory in Madison, Wisconsin, where we run the assay in our laboratories and provide test results to ordering providers. In light of the uncertainty surrounding the COVID-19 pandemic, we intend to periodically reassess our COVID-19 testing business. Although we expect that demand for our COVID-19 testing services will decline over time as the pandemic abates, as discussed below,  demand for these services remained relatively strong during the quarter ended September 30, 2021, in part due to increased COVID-19 cases in certain areas of the country during the quarter.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Priorities</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our top priorities for 2021 are to (1) get more people tested, (2) advance new solutions, and (3) enhance our customer experience.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Get More People Tested</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to delivering critical answers to patients by getting more people tested with our Cologuard and Oncotype tests. Depending on the course of the COVID-19 pandemic, we expect to continue to provide COVID-19 testing. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Advance New Solutions</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we are focused on advancing new solutions to provide answers to patients throughout their cancer journeys. We plan to continue investing in ongoing and additional clinical trials to support our product development efforts in enhancing existing products. We also plan to bring new products to patients and providers as further discussed in the Pipeline Research and Development section above.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enhance Our Customer Experience</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another priority for 2021 is to enhance our customer experience. To establish long-term relationships with patients and providers, we plan to improve customer communications and create new ways to personalize their experiences. Our goal is to become the cancer diagnostic provider of choice for providers and patients. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19 has affected many segments of the global economy, including the cancer screening and diagnostics industry. The pandemic and related precautionary measures have materially disrupted our business since March 2020 and have significantly impacted, and may continue to impact, our testing volumes, revenues, margins and cash utilization, among other measures. The level and nature of the disruption caused by COVID-19 is unpredictable, may be cyclical and long-lasting and may vary from location to location. As a result of the pandemic, we continue to provide COVID-19 testing, the revenue from which has partially offset the pandemic&#8217;s impact on our Screening and Precision Oncology testing revenue. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to social distancing, stay-at-home orders, and other actions taken in response to COVID-19, there was a significant and widespread decline in standard wellness visits and preventive services beginning at the end of the first quarter of 2020. We took steps to limit exposure to COVID-19 based on recommendations from government and health agencies, including limiting field-based, face-to-face interactions by our sales force. The pandemic negatively impacted both our Screening and Precision Oncology businesses in 2020. We began to see orders recovering towards the end of 2020 to near pre-pandemic levels.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Cologuard test orders have increased from the early pandemic lows, the growth has been slower than expected due to continuing restrictions on patients&#8217; and our and Pfizer Inc.&#8217;s (&#8220;Pfizer&#8221;) sales representatives&#8217; access to healthcare provider offices and additional outbreaks of COVID-19 and its variants during 2021, which further diminished access to healthcare provider offices. Our Cologuard test is promotionally responsive, and preventive health and wellness visits continue to be deprioritized due to the risk of COVID-19. The COVID-19 pandemic has also reduced well-patient access to healthcare providers, which has contributed to, and may continue to contribute to, delays to clinical studies that are critical to the launch of future products and services. Even after the pandemic subsides, some healthcare providers and health systems may limit the extent and type of sales representatives&#8217; access to their facilities and personnel. We have not seen the impact to our Precision Oncology business as it relates to the COVID-19 variants like we have with our Cologuard test. This is mostly due to the fact that patients are already diagnosed with cancer and there is greater urgency to access healthcare providers and our Oncotype tests. We could see a delayed impact in our Precision Oncology business from the COVID-19 variants if patients deprioritize preventive services, including mammograms and prostate cancer screening. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although health and safety precautions loosened in many jurisdictions during the quarter ended June 30, 2021 as the number of COVID-19 cases began to decline and vaccination rates increased, beginning in late July 2021, COVID-19 cases, including cases associated with the highly contagious delta variant, increased significantly in the United States. With the recent resurgence of COVID-19 cases, mask mandates, social-distancing, and other protective measures were reinstated in many parts of the country. Although infection rates have begun to fall in some parts of the country, cases are continuing to climb in other regions, and public health officials and medical professionals have warned that COVID-19 cases may spike again nationally, particularly if vaccination rates do not quickly increase or if additional, potent disease variants emerge. It is unclear how long any future resurgences may last, how severe they may be, and what safety measures governments may impose in response. It is also unclear how long individuals will remain cautious about resuming activities such as preventive-care medical visits or how long medical practices will remain cautious about allowing individuals, such as sales representatives, into their offices. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we completed an expedited hiring process and onboarded approximately 400 former Pfizer sales representatives to increase adoption of our Cologuard test and our pipeline of innovative screening tests. Prior to late August 2021, when Pfizer announced a decrease in the number of sales positions supporting its Internal Medicine therapeutic area, these employees had been promoting our Cologuard test under our promotion agreement with Pfizer (the &#8220;Promotion Agreement&#8221;). </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are uncertain how many or what type of sales details Pfizer&#8217;s sales representatives will contribute during the remainder of 2021 and beyond. In October 2020, we amended and restated our Promotion Agreement with Pfizer to, among other things, address changes to the operational landscape resulting from the COVID-19 pandemic, and we are in the process of discussing further amendments to the Promotion Agreement. Those discussions could result in material changes to the Promotion Agreement. If we are unable to manage our relationships with Pfizer and Pfizer&#8217;s sales representatives, or if we or Pfizer fail to optimally or effectively promote, market and sell our Cologuard test, our results of operation could be adversely affected.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adjusted, and expect to continue to adjust, our COVID-19 precautionary measures at our various locations based on local recovery levels and applicable governmental regulations. During the third quarter of 2021, we announced that anyone working onsite at an Exact Sciences&#8217; U.S. facility and anyone going into a healthcare setting to perform their job in the U.S. must be fully vaccinated. As part of this announcement, we provided information to help educate and encourage our employees to receive the COVID-19 vaccination. We have also authorized more employees to work on-site and expect more teams to return onsite in the fourth quarter of 2021. Our business could be negatively affected if we take excessive, ineffective or inadequate precautions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to plan for future growth through investing in our existing operations and through the acquisitions further discussed in our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have generated significant losses since inception and, as of September&#160;30, 2021, we had an accumulated deficit of approximately $2.42 billion. We expect to continue to incur losses for the near future, and it is possible we may never achieve profitability.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue is primarily generated by our laboratory testing services from our Cologuard, Oncotype, and COVID-19 tests. Our Screening revenue, which primarily includes laboratory service revenue from our Cologuard test, was $280.4&#160;million and $214.6&#160;million for the three months ended September 30, 2021 and 2020, respectively. Screening revenue was $784.6 million and $565.4 million for nine months ended September 30, 2021 and 2020, respectively. The increase for the three and nine months ended September&#160;30, 2021 was primarily due to an increase in the number of completed Cologuard tests, partially offset by a decrease in transaction price as discussed below. Relative recovery from the COVID-19 pandemic and increases in electronic ordering rates, screening of patients in the 45 to 49 age group, and screening of patients that previously completed a Cologuard test contributed to the increase in completed Cologuard tests for the three and nine months ended September&#160;30, 2021. Our Precision Oncology revenue, which primarily includes laboratory service revenue from our global Oncotype products, was $145.4&#160;million and $91.6&#160;million for the three months ended September 30, 2021 and 2020, respectively. Precision Oncology revenue was $412.6 million and $322.9 million for the nine months ended September 30, 2021 and 2020, respectively. The increase for the three and nine months ended September&#160;30, 2021 was primarily due to an increase in the number of completed Oncotype tests. In the third quarter of 2020, Oncotype test revenue was negatively impacted as a result of the COVID-19 pandemic. During the third quarter of 2021, we saw an increase in Oncotype DX breast test orders, both domestically and internationally. Additionally, in 2021 we had revenue from new products as a result of our recent acquisitions that we did not have for the three and nine months ended September 30, 2020. For the three months ended September 30, 2021 and 2020, we also generated revenue from our COVID-19 testing of $30.6&#160;million and $102.2 million, respectively. For the nine months ended September 30, 2021 and 2020, we generated revenue from our COVID-19 testing of $96.0 million and $136.7 million, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September&#160;30, 2021, we recorded a downward adjustment to revenue of $0.2 million and $13.2 million, respectively, on completed tests from the prior year after identifying a lower realized reimbursement rate on a portion of our laboratory testing services. This change in transaction price is primarily driven by certain prior claims not being submitted to insurance timely. We are working to address these issues, and are more broadly working on improvements to our billing systems to prevent recurrence. Pursuant to our contracts with payers and standards within the industry, claims submitted outside of specified timeframes may not be reimbursed. Successful reimbursement for our laboratory testing services will continue to depend on our ability to execute our order to cash operations efficiently. At each reporting period-end, we monitor our estimates of transaction price to ensure reflection of conditions that exist at each reporting date, and while we strive to restrict volatility in our realized reimbursement rates, changes in transaction price can occur. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our cost structure.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our selling, general and administrative expenses consist primarily of non-research personnel salaries, office expenses, professional fees, sales and marketing expenses incurred in support of our commercialization efforts and non-cash stock-based compensation.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes costs related to inventory production and usage, shipment of collection kits and tissue samples, royalties and the cost of services to process tests and provide results to healthcare providers. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that revenue and cost of sales for our services will continue to fluctuate and be affected by the test volume of our products, our operating efficiencies, patient adherence rates, payer mix, the levels of reimbursement, and payment patterns of payers and patients.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales (exclusive of amortization of acquired intangible assets).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of sales (exclusive of amortization of acquired intangible assets) increased to $115.7&#160;million for the three months ended September 30, 2021 compared to $95.1&#160;million for the three months ended September 30, 2020. Cost of sales (exclusive of amortization of acquired intangible assets) increased to $339.7 million for the nine months ended September 30, 2021 compared to $254.6 million for the nine months ended September 30, 2020. The increase in cost of sales is primarily due to an increase in production costs, which is a direct result of an increase in completed Cologuard and Oncotype tests. The increase was partially offset by a reduction in the number of COVID-19 tests completed year over year. </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Production costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other cost of sales expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost of sales expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Production costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personnel expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other cost of sales expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased to $75.4&#160;million for the three months ended September 30, 2021 compared to $31.5&#160;million for the three months ended September 30, 2020. Research and development expenses increased to $297.2 million for the nine months ended September 30, 2021 compared to $107.7 million for the nine months ended September 30, 2020. The increase for the three and nine months ended September&#160;30, 2021 is primarily a result of the acquisition of Thrive in January 2021, which resulted in increased direct research and development expenses, as well as an increase in personnel and stock-based compensation expenses due to the increase in headcount. We also saw an increase in clinical trial related expenses, which were driven by the BLUE-C study as enrollment increased in 2021 following a slowdown in 2020 due to the COVID-19 pandemic and cost cutting measures that we put in place. Specific to the nine months ended September 30, 2021, direct research and development expenses increased year over year due to our acquisition of the license to the TARDIS technology in January 2021 and our acquisition of PFS Genomics in May 2021, which resulted in an expense of $52.3&#160;million and $33.1&#160;million upon acquisition, respectively. The acquisitions are further described in Note 17 of our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and support services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personnel expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased to $186.5&#160;million for the three months ended September 30, 2021 compared to $115.6&#160;million for the three months ended September 30, 2020. General and administrative expenses increased to $621.9 million for the nine months ended September 30, 2021 compared to $336.3 million for the nine months ended September 30, 2020. The increase in general and administrative expenses was in part due to $10.2 million and $141.4 million in acquisition and integration related costs incurred during the three and nine months ended September&#160;30, 2021 as part of our acquisitions completed during the year, which primarily consists of integration related stock-based compensation and professional and legal fees incurred. The acquisition and integration related costs also include the remeasurement of the contingent consideration liabilities recorded from our acquisitions, which are included in other general and administrative expenses. The contingent consideration liability is further discussed in Note 7 of our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. Personnel expenses and stock-based compensation also increased due to an increase in headcount to prepare for future growth in our operations and from our recent acquisitions. Due to the COVID-19 pandemic and the protective measures put in place in the first half of 2020, we experienced lower spend in our personnel and professional fees. As our business began to recover in the third quarter of 2020, personnel expenses and stock-based compensation increased due to additional headcount. These factors account for a portion of the increase that we see for the three and nine months ended September&#160;30, 2021 when compared to the prior year. </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and support services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.6&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and support services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total general and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and marketing expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Sales and marketing expenses increased to $196.6&#160;million for the three months ended September 30, 2021 compared to $136.5&#160;million for the three months ended September 30, 2020. Sales and marketing expenses increased to $577.6 million for the nine months ended September 30, 2021 compared to $423.1 million for the nine months ended September 30, 2020. The increase in sales and marketing expenses was primarily due to an increase in direct marketing spend to support the future growth of our products and increased personnel expenses and stock-based compensation as a result of an increase in headcount including the approximately 400 former Pfizer sales representatives that were onboarded in the third quarter of 2021. In addition, professional fees increased during the three and nine months ended September&#160;30, 2021 primarily due to an increase in costs incurred related to our Promotion Agreement with Pfizer during the second and third quarters of 2021 as compared to 2020, which were reduced due to cost saving measures as a result of the COVID-19 pandemic. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct marketing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and support services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other sales and marketing expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total sales and marketing expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amounts&#160;in&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personnel expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.0&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct marketing costs </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional and legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility and support services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other sales and marketing expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total sales and marketing expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of acquired intangible assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Amortization of acquired intangible assets increased to $23.9&#160;million for the three months ended September 30, 2021 compared to $23.4 million for the three months ended September 30, 2020. Amortization of acquired intangible assets increased to $71.0&#160;million for the nine months ended September 30, 2021 compared to $70.2&#160;million for the nine months ended September 30, 2020. The increase in amortization of acquired intangible assets was primarily due to the amortization of intangible assets acquired as part of our acquisition of Ashion Analytics, LLC.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible asset impairment charge.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Intangible asset impairment charge decreased to $20.2 million for the three and nine months ended September&#160;30, 2021 compared to $209.7 million for the three and nine months ended September&#160;30, 2020. The impairment recorded during the three and nine months ended September&#160;30, 2021 relates to the impairment of the supply agreement intangible asset acquired as part of the combination with Genomic Health. The impairment recorded during the three and nine months ended September 30, 2020 primarily relates to the impairment of the in-process research and development intangible asset acquired as part of the combination with Genomic Health.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other operating income.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other operating income decreased to zero for the three and nine months ended September&#160;30, 2021 compared to zero and $23.7 million for the three and nine months ended September&#160;30, 2020, respectively. The income generated during the three and nine months ended September&#160;30, 2020 represents the funding received under the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) Provider Relief Fund, which was accepted from the Department of Health &amp; Human Services in May 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment income (expense), net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Investment income (expense), net decreased to an expense of $4.1&#160;million for the three months ended September 30, 2021 compared to income of $2.5&#160;million for the three months ended September 30, 2020. Investment income (expense), net increased to $30.5&#160;million for the nine months ended September 30, 2021 compared to $5.5&#160;million for the nine months ended September 30, 2020. The decrease in investment income (expense), net for the three months ended September 30, 2021 was primarily due to losses recorded on our equity securities. The increase in investment income, net for the nine months ended September 30, 2021 was primarily due to the realized gain of $30.5 million that was recorded on our preferred stock investment in Thrive at closing in January 2021, which represented the adjustment to our historical investment to its fair value prior to our acquisition of Thrive. Our acquisition of Thrive is further described in Note 17 of our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Interest expense increased to $4.7&#160;million for the three months ended September 30, 2021 compared to $4.5&#160;million for the three months ended September 30, 2020. Interest expense recorded from our outstanding convertible notes totaled $4.0&#160;million during each of the three months ended September 30, 2021 and 2020. Interest expense decreased to $13.9&#160;million for the nine months ended September 30, 2021 compared to $63.4&#160;million for the nine months ended September 30, 2020. Interest expense recorded from our outstanding convertible notes totaled $12.1&#160;million and $61.8&#160;million during the nine months ended September 30, 2021 and 2020, respectively. Of the interest expense recorded on our outstanding convertible notes for the nine months ended September 30, 2020, $50.8&#160;million is due to the loss on settlement of convertible notes. The convertible notes are further described in Note 9 of our condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. In addition, we recognized an immaterial amount of interest expense relating to stated interest expense on our construction loan and finance leases for the three and nine months ended September&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax benefit. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit increased to $3.9&#160;million for the three months ended September 30, 2021 compared to $2.8&#160;million for the three months ended September 30, 2020. Income tax benefit increased to $242.6&#160;million for the nine months ended September 30, 2021 compared to $5.3&#160;million for the nine months ended September 30, 2020. This increase in income tax benefit is primarily due to an income tax benefit of $239.2&#160;million recorded during the nine months ended September 30, 2021, as a result of the change in the deferred tax asset valuation allowance resulting from the acquisition of Thrive.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have financed our operations since inception primarily through public offerings of our common stock and convertible debt and through revenue generated by the sale of our laboratory testing services. As of September&#160;30, 2021, we had approximately $273.8&#160;million in unrestricted cash and cash equivalents and approximately $944.7&#160;million in marketable securities. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our investments in marketable securities consist of fixed income investments, and all are deemed available-for-sale. The objectives of this portfolio are to provide liquidity and safety of principal while striving to achieve the highest rate of return. Our investment policy limits investments to certain types of instruments issued by institutions with investment grade credit ratings and places restrictions on maturities and concentration by type and issuer.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $77.7&#160;million for the nine months ended September 30, 2021 compared to cash provided by operations of $25.1&#160;million for the nine months ended September 30, 2020. The increase in cash used in operating activities for the nine months ended September 30, 2021 was primarily due to an increase in cash payments made related to expenses necessary to process our tests and an increase in operating expenses to prepare for future growth of our operations. This was partially offset by an increase in revenue, which was driven by an increase in completed Cologuard and Oncotype tests.   </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $1.16&#160;billion for the nine months ended September 30, 2021 compared to cash use of $395.4&#160;million for the nine months ended September 30, 2020. The increase in cash used in investing activities for the nine months ended September 30, 2021 compared to the same period in 2020 was primarily the result of the timing of purchases, sales, and maturities of marketable securities. Excluding the impact of purchases, sales, and maturities of marketable securities, net cash used in investing activities was $563.8&#160;million for the nine months ended September 30, 2021 compared to $65.3&#160;million for the nine months ended September 30, 2020. Cash use consisted primarily of our acquisition of Thrive of $343.2&#160;million, our acquisition of Ashion of $72.3&#160;million, our asset acquisition of PFS Genomics of $33.1&#160;million, and our TARDIS license asset acquisition of $25.0&#160;million, purchases of property and equipment of $76.4&#160;million, and investments in privately held companies of $13.6&#160;million for the nine months ended September 30, 2021. Cash use primarily consisted of purchase of property and equipment of $48.4&#160;million, investments in privately held companies of $10.6&#160;million, and business combinations of $6.7&#160;million for the nine months ended September 30, 2020.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $20.7&#160;million for the nine months ended September 30, 2021 compared to $999.8&#160;million for the nine months ended September 30, 2020. The cash provided by financing activities during the nine months ended September 30, 2021 consisted of proceeds of $13.4&#160;million from the exercise of stock options and $12.0&#160;million in connection with our employee stock purchase plan, which was partially offset by cash outflows of $4.7&#160;million for other financing activities. The cash provided by financing activities for the nine months ended September 30, 2020 was primarily the result of proceeds of $1.13&#160;billion from our issuance of Convertible Notes with a maturity date of March 1, 2028 (the &#8220;2028 Notes&#8221;), and we used $150.1&#160;million of cash to settle a portion of the 2025 Notes. In addition, during the nine months ended September 30, 2020 we received proceeds of $15.4&#160;million from the exercise of stock options and $9.8&#160;million in connection with our employee stock purchase plan. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash and cash equivalents and marketable securities on hand at September&#160;30, 2021 will be sufficient to fund our current operations for at least the next twelve months based on current operating plans. However, we may need to raise additional capital to fully fund our current strategic plan, which includes successfully commercializing our Cologuard test and Oncotype products and developing a pipeline of future products. Additionally, we may enter into transactions to acquire other businesses, products, services, or technologies as part of our strategic plan. If we are unable to obtain sufficient additional funds to enable us to fund our operations through the completion of such plan, our results of operations and financial condition would be materially adversely affected, and we may be required to delay the implementation of our plan and otherwise scale back our operations. Even if we successfully raise sufficient funds to complete our plan, there is no certainty that we will be successful in generating sufficient cash flow from operations or achieving and maintaining profitable operations in the future to enable us to meet our obligations as they come due.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A table reflecting certain of our specified contractual obligations as of December&#160;31, 2020 was provided in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operation of our 2020 Form 10-K. There were no material changes outside the ordinary course of our business in our specified contractual obligations during the nine months ended September 30, 2021.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;GAAP&#8221;). The preparation of these financial statements requires us to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that are believed to be appropriate under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are more fully described in Note&#160;1 of our financial statements included in our 2020 Form&#160;10-K, as well as our Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations on our 2020 Form 10-K, we believe that the following accounting policies and judgments are most critical to aid in fully understanding and evaluating our reported financial results. Other than the adoption of Accounting Standards Update 2020-06 fully discussed in Note 9 of our condensed consolidated financial statements in this Quarterly Report on Form 10-Q, there have not been any significant changes to our critical accounting policies and estimates during the nine months ended September 30, 2021.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenues are recognized when we release a result to the ordering healthcare provider, in an amount that reflects the consideration we expect to collect in exchange for those services. The amount of revenue we recognize is based on the established billing rates less contractual and other adjustments, which yields the unconstrained amount that we expect to ultimately collect. We determine the amount we expect to ultimately collect, using historical collections, established reimbursement rates and other adjustments. The expected amount is typically lower than, if applicable, the agreed-upon reimbursement amount due to several factors, such as the amount of any patient co-payments, out-of-network payers, the existence of secondary payers and claim denials. The consideration derived from our contracts is fixed when we contract with a direct bill payer. Our ability to collect is not contingent on the customer&#8217;s ability to collect through their downstream billing efforts. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of some of our laboratory service agreements (&#8220;LSAs&#8221;) with various organizations, the right to bill and collect exists prior to the receipt of a specimen and release of a test result to the ordering healthcare provider, which results in deferred revenue. The deferred revenue balance is generally relieved upon the release of the applicable patient&#8217;s test result to the ordering healthcare provider or as of the date the customer has surpassed the window of time in which they are able to exercise their rights for testing services. We believe these points in time represent our fulfillment of our obligations to the customer. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quality of our billing operations, most notably those activities that relate to obtaining the correct information in order to bill effectively for services provided, directly impacts the collectability of our receivables and revenue estimates. As such, we continually assess the state of our order to cash operations in order to identify areas of risk and opportunity that allow us to appropriately estimate receivables and revenue. Upon ultimate collection, the aggregate amount received from payers and patients where reimbursement was estimated is compared to previous collection estimates and, if necessary, the transaction price is adjusted. Finally, should we later determine the judgments underlying estimated collections change, our financial results could be negatively impacted in future quarters. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations and Asset Acquisitions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business Combinations are accounted for under the acquisition method in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 805, Business Combinations. The acquisition method requires identifiable assets acquired and liabilities assumed and any non-controlling interest in the business acquired be recognized and measured at fair value on the acquisition date, which is the date that the acquirer obtains control of the acquired business. The amount by which the fair value of consideration transferred as the purchase price exceeds the net fair value of assets acquired and liabilities assumed is recorded as goodwill. Acquisitions that do not meet the definition of a business combination under the ASC are accounted for as asset acquisitions. Asset acquisitions are accounted for by allocating the cost of the acquisition to the individual assets acquired and liabilities assumed on a relative fair value basis. Goodwill is not recognized in an asset acquisition with any consideration in excess of net assets acquired allocated to acquired assets on a relative fair value basis. Transaction costs are expensed in a business combination and are considered a component of the cost of the acquisition in an asset acquisition. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We evaluate the fair value of long-lived assets, which include property, plant and equipment, intangible assets, and investments in privately held companies, for impairment whenever events or changes in circumstances indicate that the carrying amounts of the assets may not be fully recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 in the Notes to Condensed Consolidated Financial Statements for the discussion of Recent Accounting Pronouncements.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, we had no off-balance sheet arrangements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_94"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to market risk is principally confined to our cash, cash equivalents and marketable securities. We invest our cash, cash equivalents, and marketable securities in securities of the U.S. governments and its agencies and in investment-grade, highly liquid investments consisting of commercial paper, bank certificates of deposit, and corporate bonds, which as of September&#160;30, 2021 and December&#160;31, 2020 were classified as available-for-sale. We place our cash, cash equivalents, restricted cash, and marketable securities with high-quality financial institutions, limit the amount of credit exposure to any one institution, and have established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on a hypothetical ten percent adverse movement in interest rates, the potential losses in future earnings, fair value of risk-sensitive financial instruments, and cash flows are immaterial, although the actual effects may differ materially from the hypothetical analysis. While we believe our cash, cash equivalents, restricted cash, and marketable securities do not contain excessive risk, we cannot provide absolute assurance that, in the future, our investments will not be subject to adverse changes in market value. In addition, we maintain significant amounts of cash, cash equivalents, restricted cash, and marketable securities at one or more financial institutions that are in excess of federally insured limits. Given the potential instability of financial institutions, we cannot provide assurance that we will not experience losses on these deposits. We do not utilize interest rate hedging agreements or other interest rate derivative instruments.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical ten percent change in interest rates would not have a material adverse impact on our future operating results or cash flows. All of our significant interest-bearing liabilities bear interest at fixed rates and therefore are not subject to fluctuations in market interest rates; however, because these interest rates are fixed, we may be paying a higher interest rate, relative to market, in the future if circumstances change.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Risk</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our revenues are recognized in U.S. dollars, although a small portion is denominated in foreign currency as we continue to expand into markets outside of the U.S. Certain expenses related to our international activities are payable in foreign currencies. As a result, factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets will affect our financial results.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into forward contracts to mitigate the impact of adverse movements in foreign exchange rates related to the re-measurement of monetary assets and liabilities and hedge our foreign currency exchange rate exposure. As of September&#160;30, 2021, we had open foreign currency forward contracts with notional amounts of $29.5&#160;million. Although the impact of currency fluctuations on our financial results has been immaterial in the past, there can be no guarantee that the impact of currency fluctuations related to our international activities will not be material in the future.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_97"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls and procedures, as defined in Rule&#160;13a-15(e)&#160;promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Based upon that evaluation, our principal executive officer and our principal financial officer concluded that, as of September&#160;30, 2021, our disclosure controls and procedures were effective. Disclosure controls and procedures enable us to record, process, summarize and report information required to be included in our Exchange Act filings within the required time period. Our disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed by us in the periodic reports filed with the SEC is accumulated and communicated to our management, including our principal executive, financial and accounting officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we acquired all of the outstanding capital stock of Thrive (see Note 17 of the accompanying condensed consolidated financial statements for additional information). As of September&#160;30, 2021, management is in the process of evaluating and integrating the internal controls of Thrive into our existing operations. Other than the controls enhanced or implemented to integrate the Thrive business, there have been no significant changes in internal control over financial reporting during the quarter ended September&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_100"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part&#160;II - Other Information</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_103"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we are a party to various legal proceedings arising in the ordinary course of our business. Legal proceedings, including litigation, government investigations and enforcement actions could result in material costs, occupy significant management resources and entail civil and criminal penalties. The information called for by this item is incorporated by reference to the information in Note 14 of the Notes to Condensed Consolidated Financial Statements included in Part I of this Quarterly Report on Form 10-Q. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_106"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a rapidly changing environment that involves a number of risks that could materially affect our business, financial condition or future results, some of which are beyond our control. In addition to the other information set forth in this report, the risks and uncertainties that we believe are most important for you to consider are discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in the 2020 Form 10-K and in Part II, &#8220;Item 1A. Risk Factors&#8221; in our subsequently filed Quarterly Reports on Form 10-Q.  Other than the factors set forth below, there have been no material changes to the risk factors described in the 2020 Form 10-K. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to realize the anticipated benefits of our newly hired sales representatives or our Pfizer Promotion Agreement.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we completed an expedited hiring process and onboarded approximately 400 former Pfizer sales representatives. Prior to late August 2021, when Pfizer announced a decrease in the number of sales positions supporting its Internal Medicine therapeutic area, these employees had been promoting our Cologuard test under the Promotion Agreement between Exact Sciences and Pfizer. The newly hired representatives increased the size of our primary care field sales team to more than 850 representatives. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain risks may exist that may prevent us from realizing the anticipated benefits of our newly hired sales representatives, including, among others:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may encounter potential unknown liabilities or unforeseen increased expenses or delays in connection with the integration of the new representatives into our workforce and their deployment into the field;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cultural and other differences between Pfizer and us could delay or prevent the successful integration and subsequent retention of these new sales personnel;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Healthcare providers may be more reluctant to allocate time for meetings with Exact sales representatives offering a more limited product portfolio as compared to the product portfolio offered by those representatives when at Pfizer; </span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our management&#8217;s attention may be diverted by the integration and deployment process;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Precautionary measures taken in response to the COVID-19 pandemic, together with changing policies at healthcare providers offices and hospitals, may limit our sales representatives&#8217; interactions with healthcare providers for an unknown period of time; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Depending on the course of the COVID-19 pandemic, we may need to once again withdraw all or a portion of our sales representatives from the field.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully realize the anticipated benefits of our new sales personnel, our business and operating results could be harmed.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Promotion Agreement to be successful, we will need to effectively coordinate sales and marketing activities among our and Pfizer&#8217;s teams. We are in discussions with Pfizer that could result in material changes to our relationship with Pfizer. Pfizer continues to promote our Cologuard test under the Promotion Agreement through a smaller sales team, but the changing dynamics of our and Pfizer&#8217;s sales teams may reduce or otherwise alter the benefits of the Promotion Agreement. We are uncertain how many or what type of sales details Pfizer&#8217;s sales representatives will contribute during the fourth quarter of 2021 and beyond.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 outbreak has and may further materially and adversely affect our business and financial results.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, together with related precautionary measures, has materially disrupted our business since March 2020 and may continue to disrupt our business for an unknown period of time. COVID-19 has significantly impacted, and may continue to significantly impact, our operating results including our revenues, margins, and cash utilization, among other measures. The territories in which we market, sell, distribute and perform our tests have attempted to address the COVID-19 pandemic in varying ways, including stay-at-home orders, temporarily closing businesses, restricting gatherings, restricting travel, and mandating social distancing and face coverings. Certain jurisdictions have begun re-opening only to return to restrictions due to increases in new COVID-19 cases. Although health and safety precautions loosened in many jurisdictions over the past several months as the number of COVID-19 cases declined and vaccination rates increased, beginning in early July 2021, COVID-19 cases, including cases associated with the highly contagious delta variant, have increased significantly in the United States. Although, infection rates have begun to fall in some parts of the country, cases are continuing to climb in other regions, and public health officials and medical professionals have warned that COVID-19 cases may spike again nationally, particularly if vaccination rates do not quickly increase or if additional, potent disease variants emerge. It is unclear how long any resurgence will last, how severe it will be, and what safety measures governments will impose in response to it. Mask mandates, social-distancing, travel restrictions and stay-at-home orders are in force in many areas of the country and could be reinstated elsewhere. Even before the recent increase in cases, many individuals remained cautious about resuming activities such as preventive-care medical visits and many medical practices remained cautious about allowing individuals, such as sales representatives, into their offices. The level and nature of the disruption caused by COVID-19 is unpredictable, may be cyclical and long-lasting and may vary from location to location. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has materially impacted our business, and may continue to impact our business for an unknown period of time. Such impacts may include the following:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Both our and Pfizer&#8217;s sales teams have been, and for an extended period of time may continue to be, limited in their in-person interactions with healthcare providers, and therefore, also limited in their ability to engage in various types of healthcare provider education activities as contemplated by our and Pfizer&#8217;s Cologuard Promotion Agreement;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Healthcare providers or patients have canceled or delayed scheduling, and for an extended period of time may continue to cancel or delay scheduling, standard wellness visits and other non-emergency appointments and procedures (including mammograms and prostate cancer screenings), contributing to a decline in orders for our products or services;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restrictions on travel, commerce and shipping may prevent patients and pathologists from shipping samples to our clinical laboratories;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pandemic-related supply chain disruptions (whether caused by restrictions, congestion, or slowdowns in shipping or logistics, increases in demand for certain goods used on our operations, or otherwise) may hinder, or even force us to suspend, operations at some or all of our clinical laboratories;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Illnesses, quarantines, financial hardships, restrictions on travel, commerce and shipping, or other consequences of the pandemic, may disrupt our business relationships, and we or other parties may assert rights under force majeure clauses to excuse performance;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have experienced, and for an extended period of time may continue to experience, reduced volumes at our clinical laboratories and we may need to suspend operations at some or all of our clinical laboratories;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our efforts to manage our operations through a volatile and cyclical pandemic, which efforts may include cost cutting measures, may hinder our efforts to commercialize our products or delay the development of future products and services;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our partners have postponed or cancelled clinical studies, which may delay or prevent our launch of future products and services and increase the opportunity for competitors to develop products and services that compete with ours;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our workforce may be infected by the virus or otherwise distracted;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A combination of factors, including infection from the virus, supply shortfalls or disruptions, and inability to obtain or maintain equipment, could increase our operating expenses and adversely affect our lab capacity and our ability to meet the demand for our testing services;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have adjusted, and expect to continue to adjust, our precautionary measures at our various locations based on our perception of local recovery levels and applicable governmental regulations; our business could be negatively affected if we take excessive, ineffective or inadequate precautions; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may inaccurately estimate the duration or severity of the COVID-19 pandemic, which could cause us to misalign our staffing, spending, activities and precautionary measures with current or future market conditions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts, the ultimate impact of COVID-19 depends on factors beyond our knowledge or control, including the duration and severity of the outbreak, third-party actions taken to contain its spread and mitigate its public health effects and short- and long-term changes in the behaviors of medical professionals and patients resulting from the pandemic.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We heavily rely upon certain suppliers, including suppliers that are the sole source of certain products; the loss or interruption of supply from our suppliers could have a disruptive effect on our business.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain supplies from third-party suppliers and manufacturers. In some cases, due to the unique attributes of products that are incorporated into our tests, we maintain either a single-source supplier relationship or a very limited set of supplier relationships. Certain of our third-party suppliers possess exclusive intellectual property or otherwise may be the only party with the rights or expertise to provide us critical supplies. These third parties are independent entities subject to their own unique operational, regulatory compliance, and financial risks that are outside our control. These third parties may not be willing to enter or renew long-term supply arrangements with us or continue to supply us at all. Additionally, they may not perform their obligations in a timely and cost-effective manner and they may be unwilling or unable to increase production capacity commensurate with demand for our tests or future products or services. Our relationships with suppliers may also be negatively affected by general supply chain material shortages worldwide, as suppliers struggle to keep pace with demand and manage their own supply chains. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may become dependent on additional single- or limited-source suppliers, or become increasingly dependent on existing suppliers, as we expand and develop our product and service pipeline. For example, our Oncotype MAP and GEMExTra&#174; tests are currently only validated to be performed on Illumina&#8217;s sequencing platform and we are not aware of any other platform that we could use in the near future as a commercially viable alternative. Further, Illumina may become the sole supplier of certain equipment and reagents necessary for future tests we may develop, including MCED, minimal residual disease, and recurrence monitoring tests. We currently procure Illumina equipment and reagents on a purchase order basis, without any long-term supply agreement. In August 2021, Illumina completed its acquisition of GRAIL, which is commercializing a MCED test against which certain of our planned tests would compete. Illumina&#8217;s ownership of GRAIL could incentivize Illumina to offer its sequencing products in a manner that advantages GRAIL over us and other competitors, including the potential that Illumina may be unwilling or unable to supply, or commit to supplying, us with sequencing equipment and reagents on commercially acceptable terms, or at all. Although Illumina has made an irrevocable standing offer to supply any customer with its sequencing products on certain terms, that offer may not provide pricing or other terms necessary for us or others to successfully compete against GRAIL, including outside of the U.S. Although we expect to continue our efforts to validate alternative sequencing platforms on which we could run our Oncotype MAP or GEMExTra tests or other future tests in a commercially viable manner, we may expend considerable time and efforts, endure delays to our test development and commercialization timelines, and be ultimately unsuccessful in our efforts to validate alternatives. Even if we validate an alternative sequencing platform, we may become substantially dependent on the supplier of that platform.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, as an additional example, we rely on Hamilton Company to provide us laboratory equipment and related supplies (such as racking and pipette tips) necessary to perform certain critical DNA analysis steps in our clinical laboratory tests, including our Cologuard, Oncotype DX and COVID-19 tests. Although other companies may offer viable alternative platforms, we have invested significant capital, time and expertise to procure Hamilton machines and to optimize their use in our tests. Industry demand for Hamilton supplies has increased significantly since the onset of the COVID-19 pandemic, and although we have a long-term supply agreement with Hamilton, it is possible that Hamilton could become unable or unwilling to continue to provide us with certain equipment and supplies on commercially acceptable terms, if at all. Hamilton may require us to exclusively use Hamilton consumables and components in connection with certain Hamilton laboratory equipment. Therefore, if our access to certain Hamilton consumables and components became impacted, we may need to completely replace the Hamilton platform. Validating alternative vendors&#8217; offerings could be expensive, time-consuming, and unsuccessful. Further, because our Cologuard test is regulated by the FDA, we may also need FDA clearance or approval to replace certain Hamilton equipment and supplies with another vendor&#8217;s offerings. FDA approval or clearance may entail extensive new clinical and material costs and delays and may be ultimately unsuccessful.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of a critical supplier, the failure to perform by a critical supplier, the deterioration of our relationship with a critical supplier or any unilateral modification to the contractual terms under which we are supplied materials could have a disruptive effect on our business, and could adversely affect our results of operations for an extended period of time, particularly if we are required to validate an alternative supplier.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our results of operations can be adversely affected by labor shortages, turnover and labor cost increases.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labor is a significant component of operating our business. A number of factors may adversely affect the labor force available to us or increase labor costs, including high employment levels, federal unemployment subsidies, including unemployment benefits offered in response to the COVID-19 pandemic, increased wages offered by other employers, vaccine mandates and other government regulations and our responses thereto. As more employers offer remote work, we may have more difficulty recruiting for jobs that require on-site attendance, such as certain clinical laboratory and sales roles. Although we have not experienced any material labor shortage to date, we have recently observed an overall tightening and increasingly competitive labor market. A sustained labor shortage or increased turnover rates within our employee base, caused by COVID-19 or as a result of general macroeconomic factors, could lead to increased costs, such as increased overtime or financial incentives to meet demand and increased wage rates to attract and retain employees, and could negatively affect our ability to efficiently operate our clinical laboratories and overall business. If we are unable to hire and retain employees capable of performing at a high-level, or if mitigation measures we may take to respond to a decrease in labor availability have unintended negative effects, our business could be adversely affected. An overall labor shortage, lack of skilled labor, increased turnover or labor inflation, caused by COVID-19 or as a result of general macroeconomic factors, could have a material adverse impact on our business and operating results.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be a party to litigation in the normal course of business or otherwise, which could affect our business and financial position.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are a party to or otherwise involved in legal proceedings, claims and government investigations and other legal matters, both inside and outside the United States, arising in the ordinary course of our business or otherwise. We are currently involved in various legal proceedings and claims that have not yet been fully resolved, and additional claims may arise in the future. Legal proceedings can be complex and take many months, or even years, to reach resolution, with the final outcome depending on a number of variables, some of which are not within our control. Litigation is subject to significant uncertainty and may be expensive, time-consuming, and disruptive to our operations. Although we will vigorously defend ourselves in such legal proceedings, their ultimate resolution and potential financial and other impacts on us are uncertain. For these and other reasons, we may choose to settle legal proceedings and claims, regardless of their actual merit. If a legal proceeding is resolved against us, it could result in significant compensatory damages, and in certain circumstances punitive or trebled damages, disgorgement of revenue or profits, remedial corporate measures or injunctive relief imposed on us. If our existing insurance does not cover the amount or types of damages awarded, or if other resolution or actions taken as a result of a legal proceeding were to restrain our ability to operate, our financial position, results of operations or cash flows could be materially adversely affected. In addition, legal proceedings, and any adverse resolution thereof, can result in adverse publicity and damage to our reputation, which could adversely impact our business. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts we record for legal contingencies can result from a complex series of judgments about future events and uncertainties and can rely heavily on estimates and assumptions. While we have accrued for certain potential legal liabilities, there is no guarantee that additional costs will not be incurred beyond the amounts accrued. Additional information regarding certain legal matters in which we are involved can be found in Note 14 to our Condensed Consolidated Financial Statements in Part I, Item 1.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_109"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_112"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_115"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div id="ifd942d9caf664925b961fb4f8d8f685d_118"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_121"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="-sec-extract:summary;text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this Form 10-Q.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed<br/>with<br/>This<br/>Report</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>herein&#160;from<br/>Form&#160;or<br/>Schedule</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing<br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SEC&#160;File /<br/>Registration<br/>Number</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1124140/000091205700046284/a2027577zex-3_3.txt">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sixth Amended and Restated Certificate of Incorporation of the Registrant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1 (Exhibit&#160;3.3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/4/2000</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-48812</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1124140/000112414020000044/exhibit31.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Sixth Amended and Restated Certificate of Incorporation of the Registrant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K (Exhibit&#160;3.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/24/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35092</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1124140/000112414021000035/exas-20210303xexx31.htm">3.3</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fifth Amended and Restated By-Laws of the Registrant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K (Exhibit&#160;3.1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-35092</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exas-20210930xexx311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to Rule 13(a)-14(a) or Rule 15d-14(a) of Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exas-20210930xexx312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to Rule&#160;13(a)-14(a)&#160;or Rule&#160;15d-14(a)&#160;of Securities Exchange Act of 1934</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exas-20210930xexx321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the Quarterly Report on Form 10-Q of Exact Sciences Corporation for the quarter ended September&#160;30, 2021 filed on November&#160;2, 2021, formatted in Inline eXtensible Business Reporting Language (&#8220;iXBRL&#8221;): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statement of Changes in Stockholders&#8217; Equity, (iv) Condensed Consolidated Statements of Cash Flows and (v) related notes to these financial statements</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from our Quarterly Report for the period ended September&#160;30, 2021, filed with the Securities and Exchange Commission on November&#160;2, 2021, is formatted in Inline Extensible Business Reporting Language (&#8220;iXBRL&#8221;)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="ifd942d9caf664925b961fb4f8d8f685d_124"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="text-indent:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ifd942d9caf664925b961fb4f8d8f685d_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXACT SCIENCES CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November&#160;2, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kevin T. Conroy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin T. Conroy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November&#160;2, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey T. Elliott</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey T. Elliott</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Chief Operating Officer </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial and Accounting Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exas-20210930xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idf10b8bd4d8d456ca8f9ebdb99743be3_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin T. Conroy, certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form&#160;10-Q of Exact Sciences Corporation (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.665%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;2, 2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin T. Conroy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin T. Conroy</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exas-20210930xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i698e6e42aec442f08f4023876559df32_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey T. Elliott, certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form&#160;10-Q of Exact Sciences Corporation (the &#8220;registrant&#8221;)&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.665%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;2, 2021</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey T. Elliott</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey T. Elliott</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Chief Operating Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exas-20210930xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i77237b05101b4354be50a6b6470d316d_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002&#160;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Exact Sciences Corporation (the &#8220;Company&#8221;) on Form&#160;10-Q for the quarter ended September&#160;30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), we, Kevin T. Conroy, President and Chief Executive Officer of the Company and Jeffrey T. Elliott, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, to our knowledge, that&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:24pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.339%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.690%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November&#160;2, 2021</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kevin T. Conroy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin T. Conroy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; November&#160;2, 2021</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey T. Elliott</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey T. Elliott</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Chief Operating Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>exas-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:62297662-2bfb-41ec-9bf7-9eb144772313,g:499e252f-fe94-4d47-8333-c3acba229b0e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exas="http://www.exactsciences.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exactsciences.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exas-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exas-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exas-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exas-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.exactsciences.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityParenthetical" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Stockholders Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsParenthetical" roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical">
        <link:definition>1008009 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2303301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails" roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails">
        <link:definition>2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent Accounting Pronouncements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails" roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails">
        <link:definition>2405402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUE" roleURI="http://www.exactsciences.com/role/REVENUE">
        <link:definition>2106102 - Disclosure - REVENUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUETables" roleURI="http://www.exactsciences.com/role/REVENUETables">
        <link:definition>2307302 - Disclosure - REVENUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEScheduleofDisaggregationofRevenueDetails" roleURI="http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails">
        <link:definition>2408403 - Disclosure - REVENUE - Schedule of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUENarrativeDetails" roleURI="http://www.exactsciences.com/role/REVENUENarrativeDetails">
        <link:definition>2409404 - Disclosure - REVENUE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIES" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIES">
        <link:definition>2110103 - Disclosure - MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESTables" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESTables">
        <link:definition>2311303 - Disclosure - MARKETABLE SECURITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails">
        <link:definition>2412405 - Disclosure - MARKETABLE SECURITIES - Schedule of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails">
        <link:definition>2413406 - Disclosure - MARKETABLE SECURITIES - Schedule of Available For Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails">
        <link:definition>2414407 - Disclosure - MARKETABLE SECURITIES - Schedule of Underlying Maturities of AFS Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails">
        <link:definition>2415408 - Disclosure - MARKETABLE SECURITIES - Schedule of Gross Unrealized Losses And Fair Value of Available For Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MARKETABLESECURITIESNarrativeDetails" roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESNarrativeDetails">
        <link:definition>2416409 - Disclosure - MARKETABLE SECURITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORY" roleURI="http://www.exactsciences.com/role/INVENTORY">
        <link:definition>2117104 - Disclosure - INVENTORY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYTables" roleURI="http://www.exactsciences.com/role/INVENTORYTables">
        <link:definition>2318304 - Disclosure - INVENTORY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYDetails" roleURI="http://www.exactsciences.com/role/INVENTORYDetails">
        <link:definition>2419410 - Disclosure - INVENTORY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>2120105 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>2321305 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails">
        <link:definition>2422411 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Schedule of Estimated Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTNarrativeDetails" roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails">
        <link:definition>2423412 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILL" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL">
        <link:definition>2124106 - Disclosure - INTANGIBLE ASSETS AND GOODWILL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILLTables" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables">
        <link:definition>2325306 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails">
        <link:definition>2426413 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1">
        <link:definition>2426413 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails">
        <link:definition>2427414 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILLNarrativeDetails" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails">
        <link:definition>2428415 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails" roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails">
        <link:definition>2429416 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2130107 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2331307 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails">
        <link:definition>2432417 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2433418 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails" roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails">
        <link:definition>2434419 - Disclosure - FAIR VALUE MEASUREMENTS - Fair Value of Contingent Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBT" roleURI="http://www.exactsciences.com/role/LONGTERMDEBT">
        <link:definition>2135108 - Disclosure - LONG-TERM DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LONGTERMDEBTDetails" roleURI="http://www.exactsciences.com/role/LONGTERMDEBTDetails">
        <link:definition>2436420 - Disclosure - LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONVERTIBLENOTES" roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTES">
        <link:definition>2137109 - Disclosure - CONVERTIBLE NOTES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONVERTIBLENOTESTables" roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESTables">
        <link:definition>2338308 - Disclosure - CONVERTIBLE NOTES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONVERTIBLENOTESScheduleofConvertibleNotesDetails" roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails">
        <link:definition>2439421 - Disclosure - CONVERTIBLE NOTES - Schedule of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONVERTIBLENOTESAdditionalinformationDetails" roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails">
        <link:definition>2440422 - Disclosure - CONVERTIBLE NOTES - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONVERTIBLENOTESScheduleofTransactionCostsDetails" roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails">
        <link:definition>2441423 - Disclosure - CONVERTIBLE NOTES - Schedule of Transaction Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONVERTIBLENOTESSummaryofInterestExpenseDetails" roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails">
        <link:definition>2442424 - Disclosure - CONVERTIBLE NOTES - Summary of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEANDCOLLABORATIONAGREEMENTS" roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS">
        <link:definition>2143110 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails" roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails">
        <link:definition>2444425 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS - Mayo (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails" roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails">
        <link:definition>2445426 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS - John Hopkins University (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PFIZERPROMOTIONAGREEMENT" roleURI="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT">
        <link:definition>2146111 - Disclosure - PFIZER PROMOTION AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PFIZERPROMOTIONAGREEMENTDetails" roleURI="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails">
        <link:definition>2447427 - Disclosure - PFIZER PROMOTION AGREEMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2148112 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2349309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>2450428 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofOCIDetails" roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails">
        <link:definition>2451429 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of OCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails" roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails">
        <link:definition>2452430 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of amounts reclassified from AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2153113 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2354310 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2455431 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONFairValueandActivityDetails" roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails">
        <link:definition>2456432 - Disclosure - STOCK-BASED COMPENSATION - Fair Value and Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2157114 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESTables" roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESTables">
        <link:definition>2358311 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails" roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails">
        <link:definition>2459433 - Disclosure - COMMITMENTS AND CONTINGENCIES - Supplemental Disclosure of Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails">
        <link:definition>2460434 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NEWMARKETTAXCREDIT" roleURI="http://www.exactsciences.com/role/NEWMARKETTAXCREDIT">
        <link:definition>2161115 - Disclosure - NEW MARKET TAX CREDIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NEWMARKETTAXCREDITDetails" roleURI="http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails">
        <link:definition>2462435 - Disclosure - NEW MARKET TAX CREDIT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WISCONSINECONOMICDEVELOPMENTTAXCREDITS" roleURI="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS">
        <link:definition>2163116 - Disclosure - WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails" roleURI="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails">
        <link:definition>2464436 - Disclosure - WISCONSIN ECONOMIC DEVELOPMENT TAX CREDIT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONS" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS">
        <link:definition>2165117 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables">
        <link:definition>2366312 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails">
        <link:definition>2467437 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Business Combinations Textual (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails">
        <link:definition>2468438 - Disclosure - BUSINESS COMBINATIONS - Schedule of Consideration Transferred for Ashion Analytics (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails">
        <link:definition>2469439 - Disclosure - BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, Ashion Analytics (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails">
        <link:definition>2470440 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Consideration Transferred, Thrive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails">
        <link:definition>2471441 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Assumptions on Fair Value of Options Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails">
        <link:definition>2472442 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed, Thrive (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails">
        <link:definition>2473443 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Pro Forma Thrive Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails">
        <link:definition>2474444 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed From Paradigm Diagnostics Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails">
        <link:definition>2475445 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails" roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails">
        <link:definition>2476446 - Disclosure - BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, PFS Genomics (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATION">
        <link:definition>2177118 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATIONTables">
        <link:definition>2378313 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONDetails" roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails">
        <link:definition>2479447 - Disclosure - SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.exactsciences.com/role/INCOMETAXES">
        <link:definition>2180119 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.exactsciences.com/role/INCOMETAXESDetails">
        <link:definition>2481448 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="exas_TARDISTechnologyMember" abstract="true" name="TARDISTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" abstract="false" name="RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" abstract="false" name="DebtInstrumentConvertibleEquityComponentInterestAccrued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" abstract="false" name="BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="exas_IssuanceOfStockToFundMatchingContributions" abstract="false" name="IssuanceOfStockToFundMatchingContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" abstract="true" name="WisconsinEconomicDevelopmentTaxCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ComprehensiveIncomeLossBeforeTax" abstract="false" name="ComprehensiveIncomeLossBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_LicenseAgreementFeesCommitment" abstract="false" name="LicenseAgreementFeesCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" abstract="false" name="IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_GenomicHealthIncMember" abstract="true" name="GenomicHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_ArmuneBiosciencesAgreementMember" abstract="true" name="ArmuneBiosciencesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_ScreeningMember" abstract="true" name="ScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationFairValueOfReplacedEquityAwards" abstract="false" name="BusinessCombinationFairValueOfReplacedEquityAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_OneMonthLondonInterbankOfferRateMember" abstract="true" name="OneMonthLondonInterbankOfferRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_InternationalSalesMember" abstract="true" name="InternationalSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" abstract="false" name="NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" abstract="false" name="AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="exas_ThriveAndAshionMember" abstract="true" name="ThriveAndAshionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_DebtInstrumentConvertibleTransactionCosts" abstract="false" name="DebtInstrumentConvertibleTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" abstract="false" name="CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CompensationExpenseMember" abstract="true" name="CompensationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_PaymentsContingentOnMilestonesPayable" abstract="false" name="PaymentsContingentOnMilestonesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_ConvertibleNotesPayable2027Member" abstract="true" name="ConvertibleNotesPayable2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_AggregateConvertibleNotesMember" abstract="true" name="AggregateConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_RestrictedCashMember" abstract="true" name="RestrictedCashMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="exas_NewMarketTaxCreditTextBlock" abstract="false" name="NewMarketTaxCreditTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_BuildingsAndLeaseholdImprovementsMember" abstract="true" name="BuildingsAndLeaseholdImprovementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" abstract="false" name="PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_MeasurementInputPresentValueFactorMember" abstract="true" name="MeasurementInputPresentValueFactorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ConvertibleNotesTextBlock" abstract="false" name="ConvertibleNotesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" abstract="false" name="NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" abstract="false" name="ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" abstract="false" name="DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="exas_EmployeeAndNonEmployeesStockOptionMember" abstract="true" name="EmployeeAndNonEmployeesStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_MRDProductRevenueMilestoneMember" abstract="true" name="MRDProductRevenueMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_NumberOfJobsRequiredToCreatedAndMaintained" abstract="false" name="NumberOfJobsRequiredToCreatedAndMaintained" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="exas_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_NewMarketTaxCreditAbstract" abstract="true" name="NewMarketTaxCreditAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CollaborativeArrangementsSalesMilestoneAxis" abstract="true" name="CollaborativeArrangementsSalesMilestoneAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="exas_OfficeEquipmentAndComputerSoftwareMember" abstract="true" name="OfficeEquipmentAndComputerSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CashAndMoneyMarketMember" abstract="true" name="CashAndMoneyMarketMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" abstract="false" name="WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_InventoryFinishedAndSemiFinishedGoods" abstract="false" name="InventoryFinishedAndSemiFinishedGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_SharesIssuedUponAcquisitionMember" abstract="true" name="SharesIssuedUponAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ServiceOrProductTypeAxis" abstract="true" name="ServiceOrProductTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="exas_DebtInstrumentAmountSettledInExtinguishment" abstract="false" name="DebtInstrumentAmountSettledInExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" abstract="false" name="PostCombinationExpenseForAccelerationOfUnvestedEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_ConvertibleNotesPayable2028Member" abstract="true" name="ConvertibleNotesPayable2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" abstract="false" name="ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_JanuaryNotesMember" abstract="true" name="JanuaryNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_AllocatedToCompensationMember" abstract="true" name="AllocatedToCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" abstract="true" name="CenterForMedicareAndMedicaidServicesCMSCoverageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_TaxIncrementFinancingLoanAgreementsMember" abstract="true" name="TaxIncrementFinancingLoanAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ConvertibleNotesPayable2025Member" abstract="true" name="ConvertibleNotesPayable2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_AmortizationOfRefundableTaxCredits" abstract="false" name="AmortizationOfRefundableTaxCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_EmployeesWithQualifyingTerminationEventsMember" abstract="true" name="EmployeesWithQualifyingTerminationEventsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_SalesMilestoneRangeOneMember" abstract="true" name="SalesMilestoneRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_RevenueAndOtherPerformanceBasedPaymentsMember" abstract="true" name="RevenueAndOtherPerformanceBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_RefundableTaxCreditReceived" abstract="false" name="RefundableTaxCreditReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CONVERTIBLENOTESAbstract" abstract="true" name="CONVERTIBLENOTESAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_January2025NotesMember" abstract="true" name="January2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_AllocatedToConsiderationTransferredMember" abstract="true" name="AllocatedToConsiderationTransferredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" abstract="false" name="PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_RefundableTaxCreditEarnedToDate" abstract="false" name="RefundableTaxCreditEarnedToDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" abstract="true" name="WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_StockBasedCompensationPlansMember" abstract="true" name="StockBasedCompensationPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" abstract="false" name="BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="exas_RefundableTaxCreditReceivable" abstract="false" name="RefundableTaxCreditReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_MinimumOwnInvestmentToBeMadeInConstructionProject" abstract="false" name="MinimumOwnInvestmentToBeMadeInConstructionProject" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationContingentConsiderationRevenueMilestone" abstract="false" name="BusinessCombinationContingentConsiderationRevenueMilestone" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_DebtInstrumentPeriodicPaymentInterestTerm" abstract="false" name="DebtInstrumentPeriodicPaymentInterestTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="exas_DebtInstrumentRemainingAmortizationPeriod" abstract="false" name="DebtInstrumentRemainingAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="exas_NewMarketTaxCreditProgramMember" abstract="true" name="NewMarketTaxCreditProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_NetProceedsFromFinancingArrangement" abstract="false" name="NetProceedsFromFinancingArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_PFSGenomicsMember" abstract="true" name="PFSGenomicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_MeasurementInputProbabilityOfSuccessMember" abstract="true" name="MeasurementInputProbabilityOfSuccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_DOSRuleInvestigationMember" abstract="true" name="DOSRuleInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_NumberOfAgreementsEntered" abstract="false" name="NumberOfAgreementsEntered" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="exas_LicensingAgreementDisclosureTextBlock" abstract="false" name="LicensingAgreementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_SalesMilestoneRangeTwoMember" abstract="true" name="SalesMilestoneRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_PfizerIncMember" abstract="true" name="PfizerIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" abstract="false" name="BusinessCombinationContingentConsiderationGainLossChangeInFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_JuneNotesMember" abstract="true" name="JuneNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_VariablePriceContractMember" abstract="true" name="VariablePriceContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="exas_COVID19Member" abstract="true" name="COVID19Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_InterestExpenseDebtTableTextBlock" abstract="false" name="InterestExpenseDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" abstract="true" name="RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_CouponInterestExpense" abstract="false" name="CouponInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BiomatricaIncMember" abstract="true" name="BiomatricaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CollaborativeArrangementsSalesMilestoneAmount" abstract="false" name="CollaborativeArrangementsSalesMilestoneAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_PrecisionOncologyMember" abstract="true" name="PrecisionOncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ThriveEarlierDetectionCorporationMember" abstract="true" name="ThriveEarlierDetectionCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_COVID19TestingMember" abstract="true" name="COVID19TestingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ParadigmViomicsMember" abstract="true" name="ParadigmViomicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ConvertibleNotesPayableGross" abstract="false" name="ConvertibleNotesPayableGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_SalesMilestoneRangeThreeMember" abstract="true" name="SalesMilestoneRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_FDAApprovalMember" abstract="true" name="FDAApprovalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ScheduleOfConvertibleNotesTable" abstract="true" name="ScheduleOfConvertibleNotesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="exas_AllocatedToPreviousOwnershipInterestMember" abstract="true" name="AllocatedToPreviousOwnershipInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationContingentConsiderationAdditionalPayment" abstract="false" name="BusinessCombinationContingentConsiderationAdditionalPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="exas_DebtInstrumentCovenantLiquidityRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRequiredMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" abstract="false" name="BusinessAcquisitionProFormaIncomeLossBeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CollaborativeArrangementsSalesMilestoneDomain" abstract="true" name="CollaborativeArrangementsSalesMilestoneDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_June2025NotesMember" abstract="true" name="June2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_FacilityInLaJollaCAMember" abstract="true" name="FacilityInLaJollaCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_PromotionAgreementDisclosureAbstract" abstract="true" name="PromotionAgreementDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_LICENSEAGREEMENTSAbstract" abstract="true" name="LICENSEAGREEMENTSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="exas_GoodwillAcquiredAdjustment" abstract="false" name="GoodwillAcquiredAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_MAYOFoundationMember" abstract="true" name="MAYOFoundationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_AshionAnalyticsMember" abstract="true" name="AshionAnalyticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_InvestmentIncomeExpenseNonoperating" abstract="false" name="InvestmentIncomeExpenseNonoperating" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" abstract="true" name="ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" abstract="false" name="AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_CommercialLaunchMilestoneMember" abstract="true" name="CommercialLaunchMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ServiceOrProductTypeDomain" abstract="true" name="ServiceOrProductTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" abstract="false" name="RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>exas-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:62297662-2bfb-41ec-9bf7-9eb144772313,g:499e252f-fe94-4d47-8333-c3acba229b0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d9af60a8-1c91-46e4-ad25-222ccf4828ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_43ed6e7d-dc41-4a0e-8019-50698b1218c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d9af60a8-1c91-46e4-ad25-222ccf4828ad" xlink:to="loc_us-gaap_LiabilitiesCurrent_43ed6e7d-dc41-4a0e-8019-50698b1218c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_ec8fd4ce-66da-4743-90a3-1a3f03d3e7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d9af60a8-1c91-46e4-ad25-222ccf4828ad" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_ec8fd4ce-66da-4743-90a3-1a3f03d3e7ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_bdb2ad32-2880-48e2-9523-160139345e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d9af60a8-1c91-46e4-ad25-222ccf4828ad" xlink:to="loc_us-gaap_LongTermLoansPayable_bdb2ad32-2880-48e2-9523-160139345e04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_eefcc028-967c-4f7f-8383-1899eb48bc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d9af60a8-1c91-46e4-ad25-222ccf4828ad" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_eefcc028-967c-4f7f-8383-1899eb48bc4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7c8161eb-8059-4976-9d60-f0103af9bc54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d9af60a8-1c91-46e4-ad25-222ccf4828ad" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7c8161eb-8059-4976-9d60-f0103af9bc54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_9ea35665-55e6-4d34-86bf-c7e8496c06ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_9ea35665-55e6-4d34-86bf-c7e8496c06ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_82c057d2-0856-4864-b784-83b69dcfaf40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_82c057d2-0856-4864-b784-83b69dcfaf40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f9fd66ee-4733-4b81-8198-f9a1ef200ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:to="loc_us-gaap_AccountsPayableCurrent_f9fd66ee-4733-4b81-8198-f9a1ef200ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d5a4c946-a864-429b-82c7-9cfa4f300858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d5a4c946-a864-429b-82c7-9cfa4f300858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b9c4e226-9f6f-47ad-82e8-82aeb7eac3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b9c4e226-9f6f-47ad-82e8-82aeb7eac3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_2a84ef60-38a9-4143-8380-823a2021326c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_3a321758-8748-404d-8f3b-d31d4ca07e16" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_2a84ef60-38a9-4143-8380-823a2021326c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9c9395b-e14a-45d6-8a21-b5d7fa2399ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0b850807-78e4-4536-8b4c-80056d055262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9c9395b-e14a-45d6-8a21-b5d7fa2399ce" xlink:to="loc_us-gaap_Liabilities_0b850807-78e4-4536-8b4c-80056d055262" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d06e1f3d-cfd8-4f4b-9aca-419b3c9ae830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9c9395b-e14a-45d6-8a21-b5d7fa2399ce" xlink:to="loc_us-gaap_StockholdersEquity_d06e1f3d-cfd8-4f4b-9aca-419b3c9ae830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d5028485-8c73-41a8-bd78-c8fef4800459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e9c9395b-e14a-45d6-8a21-b5d7fa2399ce" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d5028485-8c73-41a8-bd78-c8fef4800459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_873e3937-1d8b-4c3e-bfdd-c1c26ff269ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:to="loc_us-gaap_AssetsCurrent_873e3937-1d8b-4c3e-bfdd-c1c26ff269ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8de82b4d-898a-4d8b-866a-abdad18089b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8de82b4d-898a-4d8b-866a-abdad18089b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_22ad697e-81fa-465b-91c2-3e35f9bac063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_22ad697e-81fa-465b-91c2-3e35f9bac063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_df4ff6ae-07cb-4ee3-aecd-a9e5f6ed02dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_df4ff6ae-07cb-4ee3-aecd-a9e5f6ed02dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8cf33869-ad15-4a06-9d9c-d2291c426250" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:to="loc_us-gaap_Goodwill_8cf33869-ad15-4a06-9d9c-d2291c426250" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a015f9be-cd3d-4e9b-8e47-fb0090104432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eb9aef0a-0f12-4bce-95fa-4c011fd51120" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a015f9be-cd3d-4e9b-8e47-fb0090104432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b8dd570-ba6a-4c6e-9f7c-d6e336c8343d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9e828586-a9df-4d38-a561-78805485aefe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8b8dd570-ba6a-4c6e-9f7c-d6e336c8343d" xlink:to="loc_us-gaap_PreferredStockValue_9e828586-a9df-4d38-a561-78805485aefe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c1edc8ee-6788-464f-a9a1-93346c1b9b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8b8dd570-ba6a-4c6e-9f7c-d6e336c8343d" xlink:to="loc_us-gaap_CommonStockValue_c1edc8ee-6788-464f-a9a1-93346c1b9b01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c703f375-7d87-4f37-9c79-51a7421b407f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8b8dd570-ba6a-4c6e-9f7c-d6e336c8343d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c703f375-7d87-4f37-9c79-51a7421b407f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cde50dc3-5a36-43b3-b020-a3ae1549cfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8b8dd570-ba6a-4c6e-9f7c-d6e336c8343d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cde50dc3-5a36-43b3-b020-a3ae1549cfdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_00633f45-af2a-4648-9e54-7c470b8c6bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8b8dd570-ba6a-4c6e-9f7c-d6e336c8343d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_00633f45-af2a-4648-9e54-7c470b8c6bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5b17684b-015c-4fe5-a3ec-44759a1cdb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_eefa116a-5ae2-485f-b19f-f488c7d26636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5b17684b-015c-4fe5-a3ec-44759a1cdb8c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_eefa116a-5ae2-485f-b19f-f488c7d26636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_12e2a989-ed09-4cdd-8525-b05aeb23b2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5b17684b-015c-4fe5-a3ec-44759a1cdb8c" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_12e2a989-ed09-4cdd-8525-b05aeb23b2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6fb96132-c366-4dde-9ed1-0385c13fef85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5b17684b-015c-4fe5-a3ec-44759a1cdb8c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6fb96132-c366-4dde-9ed1-0385c13fef85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_eeda7659-adfc-4727-8e58-ea34a70bf4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5b17684b-015c-4fe5-a3ec-44759a1cdb8c" xlink:to="loc_us-gaap_InventoryNet_eeda7659-adfc-4727-8e58-ea34a70bf4e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e6a34ce7-6e3b-4d34-9aa9-3474cacfbccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5b17684b-015c-4fe5-a3ec-44759a1cdb8c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e6a34ce7-6e3b-4d34-9aa9-3474cacfbccc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae0316b2-4f0a-47e0-bea8-f122c037eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_66a60008-5809-4cc2-a3d6-f17774e6b5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae0316b2-4f0a-47e0-bea8-f122c037eee6" xlink:to="loc_us-gaap_OperatingIncomeLoss_66a60008-5809-4cc2-a3d6-f17774e6b5a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_81b50b7f-db7d-4ed4-9069-62633f3efb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ae0316b2-4f0a-47e0-bea8-f122c037eee6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_81b50b7f-db7d-4ed4-9069-62633f3efb63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_fd2f42ec-33a5-4949-85de-12e8e1b19720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InvestmentIncomeExpenseNonoperating_2feb98b4-a8b5-4079-8c76-cc99c4d789e7" xlink:href="exas-20210930.xsd#exas_InvestmentIncomeExpenseNonoperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_fd2f42ec-33a5-4949-85de-12e8e1b19720" xlink:to="loc_exas_InvestmentIncomeExpenseNonoperating_2feb98b4-a8b5-4079-8c76-cc99c4d789e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_747324fe-efd3-4abb-aa01-b7d92bdfee8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_fd2f42ec-33a5-4949-85de-12e8e1b19720" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_747324fe-efd3-4abb-aa01-b7d92bdfee8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fa3e24f8-1d16-4da5-95b5-98206e09d691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4679035a-c31d-4432-a07d-6aeef3ad9d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fa3e24f8-1d16-4da5-95b5-98206e09d691" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4679035a-c31d-4432-a07d-6aeef3ad9d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_20854230-2988-48fb-9e6f-cb02a028faca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fa3e24f8-1d16-4da5-95b5-98206e09d691" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_20854230-2988-48fb-9e6f-cb02a028faca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_08837fa1-a07a-477f-bebd-38b5d37fabee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5109b4ca-7d02-402f-be48-84c9697fd3bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_08837fa1-a07a-477f-bebd-38b5d37fabee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5109b4ca-7d02-402f-be48-84c9697fd3bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7d19966c-fa4b-4e1f-9e5a-960a073fbad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_08837fa1-a07a-477f-bebd-38b5d37fabee" xlink:to="loc_us-gaap_CostsAndExpenses_7d19966c-fa4b-4e1f-9e5a-960a073fbad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_7100d607-0ee9-4059-ba6f-086cad864d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_08837fa1-a07a-477f-bebd-38b5d37fabee" xlink:to="loc_us-gaap_OtherOperatingIncome_7100d607-0ee9-4059-ba6f-086cad864d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_29b0a56c-cff9-4eeb-a180-e6a3c610fea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:to="loc_us-gaap_CostOfRevenue_29b0a56c-cff9-4eeb-a180-e6a3c610fea5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9ac4f15d-e3d3-4c44-946e-4bef9dab2a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9ac4f15d-e3d3-4c44-946e-4bef9dab2a20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_4784974d-e750-44f7-aedf-15e10a603734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_4784974d-e750-44f7-aedf-15e10a603734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_3855e043-1ec8-455f-a27f-f2585f45a00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:to="loc_us-gaap_SellingAndMarketingExpense_3855e043-1ec8-455f-a27f-f2585f45a00e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b6e9c8e8-2e03-4d82-b475-e3b914311672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b6e9c8e8-2e03-4d82-b475-e3b914311672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27bf1413-8b4f-4428-b729-9d79d0840901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7a91da93-9742-4ffa-a6ff-e04c2a179078" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_27bf1413-8b4f-4428-b729-9d79d0840901" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_ComprehensiveIncomeLossBeforeTax_db0a9b46-bb25-4755-adf2-3549fdc7d9bf" xlink:href="exas-20210930.xsd#exas_ComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_590d3539-1a66-4c47-87e5-5f6000b9fbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exas_ComprehensiveIncomeLossBeforeTax_db0a9b46-bb25-4755-adf2-3549fdc7d9bf" xlink:to="loc_us-gaap_NetIncomeLoss_590d3539-1a66-4c47-87e5-5f6000b9fbb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_fb0de29a-bbe9-4be4-a5c0-c7c39463896c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exas_ComprehensiveIncomeLossBeforeTax_db0a9b46-bb25-4755-adf2-3549fdc7d9bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_fb0de29a-bbe9-4be4-a5c0-c7c39463896c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_dc521388-cac0-441e-9c2d-4b5992c24c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_exas_ComprehensiveIncomeLossBeforeTax_db0a9b46-bb25-4755-adf2-3549fdc7d9bf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_dc521388-cac0-441e-9c2d-4b5992c24c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_75141d7c-b05b-4a78-b6df-38ede7fca22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ComprehensiveIncomeLossBeforeTax_efcd15ca-5734-486e-87cf-b3cf29e4bf69" xlink:href="exas-20210930.xsd#exas_ComprehensiveIncomeLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_75141d7c-b05b-4a78-b6df-38ede7fca22c" xlink:to="loc_exas_ComprehensiveIncomeLossBeforeTax_efcd15ca-5734-486e-87cf-b3cf29e4bf69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_9547c191-fab7-44c5-86e9-54aaf68c126a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_75141d7c-b05b-4a78-b6df-38ede7fca22c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_9547c191-fab7-44c5-86e9-54aaf68c126a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a6f7819f-2fa3-4fbe-ba1c-31151c7aa8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1a19fb27-05ec-46cb-9b0a-ab05110b89d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a6f7819f-2fa3-4fbe-ba1c-31151c7aa8e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1a19fb27-05ec-46cb-9b0a-ab05110b89d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b7e40999-e111-4ce3-aafd-760a750bd8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a6f7819f-2fa3-4fbe-ba1c-31151c7aa8e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b7e40999-e111-4ce3-aafd-760a750bd8dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f260c808-e5fa-4047-9cc4-13b605979c71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a6f7819f-2fa3-4fbe-ba1c-31151c7aa8e1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f260c808-e5fa-4047-9cc4-13b605979c71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0031883-bd18-42fa-aa70-58e2b31dbbba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b3411602-d893-4e09-9a5a-ab68369966a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0031883-bd18-42fa-aa70-58e2b31dbbba" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b3411602-d893-4e09-9a5a-ab68369966a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_320f2862-1516-4185-9cd1-bee988b15599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0031883-bd18-42fa-aa70-58e2b31dbbba" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_320f2862-1516-4185-9cd1-bee988b15599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_bb1e0fd0-88e9-4acf-9d01-f1cc186e2794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0031883-bd18-42fa-aa70-58e2b31dbbba" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_bb1e0fd0-88e9-4acf-9d01-f1cc186e2794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_df1b9017-06c0-4d61-905d-11efea08a589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0031883-bd18-42fa-aa70-58e2b31dbbba" xlink:to="loc_us-gaap_ProceedsFromStockPlans_df1b9017-06c0-4d61-905d-11efea08a589" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_b2c1f7b2-9289-4819-ad2f-5878dd9c39a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a0031883-bd18-42fa-aa70-58e2b31dbbba" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_b2c1f7b2-9289-4819-ad2f-5878dd9c39a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_464be5cd-b744-4452-acf6-1293407dd488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_464be5cd-b744-4452-acf6-1293407dd488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_388c1761-c4ab-4ef4-8513-3823a299e788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_388c1761-c4ab-4ef4-8513-3823a299e788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_55febaa9-939e-4cb9-b80e-fc83de215a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_55febaa9-939e-4cb9-b80e-fc83de215a47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_67445b96-e45d-48e4-80ff-15ef4fd34013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_67445b96-e45d-48e4-80ff-15ef4fd34013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6e38e145-a67a-440d-95fa-228096693c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6e38e145-a67a-440d-95fa-228096693c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_6d8d53df-9b1f-4cba-83b9-db9db2e92a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_6d8d53df-9b1f-4cba-83b9-db9db2e92a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_4c5051f4-31d7-47ac-92d0-199fcf718621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_54ce62d3-d2d0-4593-b579-51fb24ea7b7d" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_4c5051f4-31d7-47ac-92d0-199fcf718621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f8ae8eb1-89a3-4052-8c03-9901566cbffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_f8ae8eb1-89a3-4052-8c03-9901566cbffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8b953df1-1489-4ef5-ba08-e4e18f968faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8b953df1-1489-4ef5-ba08-e4e18f968faf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_912afd18-c759-4d58-8959-6a90744066f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_912afd18-c759-4d58-8959-6a90744066f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_6699ccb6-ebfc-4372-95f1-31877524c14b" xlink:href="exas-20210930.xsd#exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_6699ccb6-ebfc-4372-95f1-31877524c14b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_4a66dc71-b415-4063-8a72-a9e2c84d16c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_OperatingLeaseExpense_4a66dc71-b415-4063-8a72-a9e2c84d16c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4c847964-e060-471e-9ceb-340ff833987b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4c847964-e060-471e-9ceb-340ff833987b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_eb928f6f-b63e-4e46-80d6-1a12b5ee2083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_eb928f6f-b63e-4e46-80d6-1a12b5ee2083" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7f2687fe-3e1c-417d-9bc5-ef54392df981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7f2687fe-3e1c-417d-9bc5-ef54392df981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_d97f88cb-51fc-43a2-b138-eb027b75090c" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_d97f88cb-51fc-43a2-b138-eb027b75090c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0a2f1ba1-16fd-4181-ba55-ece1155e21fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0a2f1ba1-16fd-4181-ba55-ece1155e21fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8b83ca97-be03-4bcb-bdc2-4b98c534a913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_ProfitLoss_8b83ca97-be03-4bcb-bdc2-4b98c534a913" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_19646fc2-9200-4e58-a19c-8eb0a90f7606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_19646fc2-9200-4e58-a19c-8eb0a90f7606" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_fac3468a-6172-4fa7-ab6e-76a7a33c7ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_fac3468a-6172-4fa7-ab6e-76a7a33c7ea8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_21c29a94-eeb7-4903-9ba4-893484e0e0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_21c29a94-eeb7-4903-9ba4-893484e0e0f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_11801c7a-4e1e-4b43-bd98-ea70443afbef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_ShareBasedCompensation_11801c7a-4e1e-4b43-bd98-ea70443afbef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_461b707c-1573-46d6-84b0-3f12a611a027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_461b707c-1573-46d6-84b0-3f12a611a027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e834ec40-5348-418e-af9c-3ba36e7c75b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e834ec40-5348-418e-af9c-3ba36e7c75b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IncreaseDecreaseInOperatingLeaseLiabilities_90798b3e-4a8a-4ed8-80b7-93101c76a2b5" xlink:href="exas-20210930.xsd#exas_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_exas_IncreaseDecreaseInOperatingLeaseLiabilities_90798b3e-4a8a-4ed8-80b7-93101c76a2b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_5a10dc02-9d9d-4905-a326-b4d0aa3e785c" xlink:href="exas-20210930.xsd#exas_PostCombinationExpenseForAccelerationOfUnvestedEquity"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_5a10dc02-9d9d-4905-a326-b4d0aa3e785c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_f0de7339-42c4-44ad-a5dd-dced48b1b2a0" xlink:href="exas-20210930.xsd#exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_f0de7339-42c4-44ad-a5dd-dced48b1b2a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e08ed0f6-35f7-4071-8c3f-d9bf416ba90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4d2c2dfc-80f2-4c8a-83ff-4ca34fef4eb4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_e08ed0f6-35f7-4071-8c3f-d9bf416ba90e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3c1c781d-ef8b-49c6-a42e-9324d8ae63b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_22abcdc3-1132-4df5-a310-af10c5a33baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3c1c781d-ef8b-49c6-a42e-9324d8ae63b9" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_22abcdc3-1132-4df5-a310-af10c5a33baf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_fbe03d12-1976-4aba-8cb6-4a2c0327af9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_3c1c781d-ef8b-49c6-a42e-9324d8ae63b9" xlink:to="loc_us-gaap_MarketableSecurities_fbe03d12-1976-4aba-8cb6-4a2c0327af9e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0376491-0282-4634-80ee-8ec11194a3de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_da234eb6-5bf7-4d6a-85e5-6dde5d332369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0376491-0282-4634-80ee-8ec11194a3de" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_da234eb6-5bf7-4d6a-85e5-6dde5d332369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4388f0dc-c3d1-4048-8d61-7bf5f3e7997b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0376491-0282-4634-80ee-8ec11194a3de" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4388f0dc-c3d1-4048-8d61-7bf5f3e7997b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cda70a8b-2a8d-478a-a42b-101a3945f46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d0376491-0282-4634-80ee-8ec11194a3de" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_cda70a8b-2a8d-478a-a42b-101a3945f46b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_3481ecf8-91f4-4950-aa47-136c3f8550ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_12c5f945-cdd7-4709-932b-9cf91063b221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_3481ecf8-91f4-4950-aa47-136c3f8550ad" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_12c5f945-cdd7-4709-932b-9cf91063b221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_262f4218-c119-4265-a2d0-eef81b313ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_3481ecf8-91f4-4950-aa47-136c3f8550ad" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_262f4218-c119-4265-a2d0-eef81b313ad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d0a1cc0b-14a4-4e51-85ea-096c5f4dad2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_eaa79cc4-a562-49ef-b1d4-1e6afc566ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d0a1cc0b-14a4-4e51-85ea-096c5f4dad2c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_eaa79cc4-a562-49ef-b1d4-1e6afc566ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6a0ce8d9-2ab1-4c2f-9dec-65e012151319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_d0a1cc0b-14a4-4e51-85ea-096c5f4dad2c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_6a0ce8d9-2ab1-4c2f-9dec-65e012151319" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INVENTORYDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_deebdf62-ba44-4942-851d-0ccb9c3a06fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InventoryFinishedAndSemiFinishedGoods_eea22086-4925-4485-8188-622d2dd074d6" xlink:href="exas-20210930.xsd#exas_InventoryFinishedAndSemiFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_deebdf62-ba44-4942-851d-0ccb9c3a06fa" xlink:to="loc_exas_InventoryFinishedAndSemiFinishedGoods_eea22086-4925-4485-8188-622d2dd074d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_e53dfb43-3e59-44b8-b69b-9acfa01f0af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_deebdf62-ba44-4942-851d-0ccb9c3a06fa" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_e53dfb43-3e59-44b8-b69b-9acfa01f0af1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9742783d-d899-471e-957e-49e59d6fc1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_beb116cc-5dcf-4d17-99a8-c5559ba36791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9742783d-d899-471e-957e-49e59d6fc1c8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_beb116cc-5dcf-4d17-99a8-c5559ba36791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fd11e3f8-7819-4d74-9877-283ddb08bc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_9742783d-d899-471e-957e-49e59d6fc1c8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_fd11e3f8-7819-4d74-9877-283ddb08bc69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25afab1a-2aee-48c6-b1dc-37fcb3fe3418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2818963d-f388-48ce-a4ea-1f846b3b5a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25afab1a-2aee-48c6-b1dc-37fcb3fe3418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2818963d-f388-48ce-a4ea-1f846b3b5a56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8448688e-9107-4107-8ce6-9b0e9c5dc9a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_25afab1a-2aee-48c6-b1dc-37fcb3fe3418" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8448688e-9107-4107-8ce6-9b0e9c5dc9a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_935688ac-8a07-4fad-9d8c-c3b8cbd5cdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1aee7534-7e87-42bf-98c7-993eddade92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_935688ac-8a07-4fad-9d8c-c3b8cbd5cdd6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_1aee7534-7e87-42bf-98c7-993eddade92c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5c66ddb-7989-4785-8078-e9a4a9fda87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_935688ac-8a07-4fad-9d8c-c3b8cbd5cdd6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5c66ddb-7989-4785-8078-e9a4a9fda87d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_43973b02-9445-4b24-ba8b-d37518285dab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7556b070-a87f-4b5f-8044-b49de3d79141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_43973b02-9445-4b24-ba8b-d37518285dab" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7556b070-a87f-4b5f-8044-b49de3d79141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5a93cb61-5a3a-4575-ae3c-7e37010ce292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_43973b02-9445-4b24-ba8b-d37518285dab" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_5a93cb61-5a3a-4575-ae3c-7e37010ce292" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d3691afa-4ed8-4bb0-aa21-ceb2e6bb9465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_334f55d8-0529-45b6-b40c-8f4e48d00d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d3691afa-4ed8-4bb0-aa21-ceb2e6bb9465" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_334f55d8-0529-45b6-b40c-8f4e48d00d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_14abc632-aa0b-4535-b9a9-39ac729464f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d3691afa-4ed8-4bb0-aa21-ceb2e6bb9465" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_14abc632-aa0b-4535-b9a9-39ac729464f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c5a49bcb-b288-4bd3-b9aa-49f8ffcb5cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c5a49bcb-b288-4bd3-b9aa-49f8ffcb5cc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b7785207-11bf-4352-b0ea-c7556ff7cacc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_b7785207-11bf-4352-b0ea-c7556ff7cacc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5dba721a-d2eb-4007-affb-bbfba504f0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_5dba721a-d2eb-4007-affb-bbfba504f0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_17c47ebf-537b-42e9-a3fd-e39a9f069bd6" xlink:href="exas-20210930.xsd#exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:to="loc_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_17c47ebf-537b-42e9-a3fd-e39a9f069bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2f96420b-8fd9-42cd-be29-f14a38e01474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2f96420b-8fd9-42cd-be29-f14a38e01474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_947dc00f-8e58-4540-81e4-a6a32acf0b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dee16451-e130-4a1b-8ae1-97ab777a2a9b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_947dc00f-8e58-4540-81e4-a6a32acf0b8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_3aa9de4e-d882-4d32-a1ab-fd53ecb97996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_311970ed-e5c8-4bb3-80a2-ec0c87552c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_3aa9de4e-d882-4d32-a1ab-fd53ecb97996" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_311970ed-e5c8-4bb3-80a2-ec0c87552c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7d34f377-42d9-400c-a260-18efdb250a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_3aa9de4e-d882-4d32-a1ab-fd53ecb97996" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_7d34f377-42d9-400c-a260-18efdb250a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eaed7fda-4b2e-415d-b368-4249c6d7ca2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_3aa9de4e-d882-4d32-a1ab-fd53ecb97996" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_eaed7fda-4b2e-415d-b368-4249c6d7ca2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7f56356f-e5a9-43fd-bb77-c9ec67162bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_3aa9de4e-d882-4d32-a1ab-fd53ecb97996" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7f56356f-e5a9-43fd-bb77-c9ec67162bf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_d4f2a73d-d1e1-4764-9e36-875b972a571c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityOwnedNotReadilyMarketableFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueNetAssetLiability_3aa9de4e-d882-4d32-a1ab-fd53ecb97996" xlink:to="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_d4f2a73d-d1e1-4764-9e36-875b972a571c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESScheduleofConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_c7abab51-68bf-42a3-b586-860bd91dfb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayableGross_e5e7682b-7d09-4c40-9241-d6056351a681" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_c7abab51-68bf-42a3-b586-860bd91dfb01" xlink:to="loc_exas_ConvertibleNotesPayableGross_e5e7682b-7d09-4c40-9241-d6056351a681" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_921ce83d-0eb6-4fa0-9a7f-1eec1de3db88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_c7abab51-68bf-42a3-b586-860bd91dfb01" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_921ce83d-0eb6-4fa0-9a7f-1eec1de3db88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESSummaryofInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_5830ea1d-0754-4663-868d-7fd4d3e28a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f2d51b21-92f5-4092-98cf-3e2a552551da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_5830ea1d-0754-4663-868d-7fd4d3e28a4f" xlink:to="loc_us-gaap_InterestExpenseDebt_f2d51b21-92f5-4092-98cf-3e2a552551da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_c3056370-22f8-435b-9af3-a6c2fc4b11db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOther"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_5830ea1d-0754-4663-868d-7fd4d3e28a4f" xlink:to="loc_us-gaap_InterestExpenseOther_c3056370-22f8-435b-9af3-a6c2fc4b11db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_f7a1ee18-7109-47ec-8a5c-f6669d66c6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_857287b8-346d-46ce-815e-02473d143a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_f7a1ee18-7109-47ec-8a5c-f6669d66c6b3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_857287b8-346d-46ce-815e-02473d143a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CouponInterestExpense_e7d61751-a0fb-476e-be8e-c24b680ff861" xlink:href="exas-20210930.xsd#exas_CouponInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_f7a1ee18-7109-47ec-8a5c-f6669d66c6b3" xlink:to="loc_exas_CouponInterestExpense_e7d61751-a0fb-476e-be8e-c24b680ff861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_95516a2f-d710-449c-b84c-41b320584f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_f7a1ee18-7109-47ec-8a5c-f6669d66c6b3" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_95516a2f-d710-449c-b84c-41b320584f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f3be16e7-aad2-4cb7-8f50-42141486a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_f7a1ee18-7109-47ec-8a5c-f6669d66c6b3" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f3be16e7-aad2-4cb7-8f50-42141486a1fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYScheduleofOCIDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_2296af92-d2f7-45a0-b37e-531b7b67e4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_a5836c7b-a78e-4312-a18f-11ea93b95706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_2296af92-d2f7-45a0-b37e-531b7b67e4ac" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_a5836c7b-a78e-4312-a18f-11ea93b95706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_7ec7c817-4f81-485e-bd31-89b66ae379a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_2296af92-d2f7-45a0-b37e-531b7b67e4ac" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_7ec7c817-4f81-485e-bd31-89b66ae379a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96664d8e-ae77-4c48-a13c-1443db853176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_17ad4f46-f80c-4b1d-babb-09b69a8951fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96664d8e-ae77-4c48-a13c-1443db853176" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_17ad4f46-f80c-4b1d-babb-09b69a8951fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_67ab9e6a-3b55-4657-9dcc-888bb52dc416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_96664d8e-ae77-4c48-a13c-1443db853176" xlink:to="loc_us-gaap_Goodwill_67ab9e6a-3b55-4657-9dcc-888bb52dc416" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5a679981-a060-467b-8a10-c848b763556c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e715ff0c-51bd-4901-a813-bb8eb5255fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5a679981-a060-467b-8a10-c848b763556c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_e715ff0c-51bd-4901-a813-bb8eb5255fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_227dc69a-d6c4-420d-a491-b855d3b2c432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5a679981-a060-467b-8a10-c848b763556c" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_227dc69a-d6c4-420d-a491-b855d3b2c432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards_799b8a1a-03f1-4c49-a64d-93246c5b046b" xlink:href="exas-20210930.xsd#exas_BusinessCombinationFairValueOfReplacedEquityAwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5a679981-a060-467b-8a10-c848b763556c" xlink:to="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards_799b8a1a-03f1-4c49-a64d-93246c5b046b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a6a4bee1-f8ea-47e5-a98b-b2ea65583680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5a679981-a060-467b-8a10-c848b763556c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a6a4bee1-f8ea-47e5-a98b-b2ea65583680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c54b120a-e935-4044-a5af-4d955f3712d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_5a679981-a060-467b-8a10-c848b763556c" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c54b120a-e935-4044-a5af-4d955f3712d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_124a11b9-c1d9-4da2-b2df-db34021321b4" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_124a11b9-c1d9-4da2-b2df-db34021321b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_de703cc8-dd98-49ba-8745-759401b819a4" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_de703cc8-dd98-49ba-8745-759401b819a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_80285935-c1a5-40af-905e-b3083f6c9ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_80285935-c1a5-40af-905e-b3083f6c9ef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d876f03b-0fc9-4c8a-a0c8-5ff28d1f3653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d876f03b-0fc9-4c8a-a0c8-5ff28d1f3653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_55dd0096-9eba-49ee-beb0-76c55d308c7e" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_55dd0096-9eba-49ee-beb0-76c55d308c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_21f07900-4d59-4159-947f-a3c8720578c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_93b5771f-8279-45d7-a93f-d14fb0bad4a0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_21f07900-4d59-4159-947f-a3c8720578c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0a335bcb-c501-483a-952a-186deec8a3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d7051c3-3e4d-4a6c-ae8f-58f2cf037810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0a335bcb-c501-483a-952a-186deec8a3e1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5d7051c3-3e4d-4a6c-ae8f-58f2cf037810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cc1b5c8c-3ce6-4a66-b265-f6762347c03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_0a335bcb-c501-483a-952a-186deec8a3e1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cc1b5c8c-3ce6-4a66-b265-f6762347c03b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_554e184a-9569-4bf1-9623-4c25e6c142e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_554e184a-9569-4bf1-9623-4c25e6c142e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c0770d91-df6c-41f8-9829-71d97ce94de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c0770d91-df6c-41f8-9829-71d97ce94de3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c2dbafa9-b942-4bc2-92a2-6aef31c54ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c2dbafa9-b942-4bc2-92a2-6aef31c54ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_fb82dfbb-ae57-41ca-8e79-585d35b95e10" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_fb82dfbb-ae57-41ca-8e79-585d35b95e10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b48665bd-273d-4690-bb4e-1f227efee8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_b48665bd-273d-4690-bb4e-1f227efee8c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_82ad2699-0ca5-4e0e-8473-a38aba2d1861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_82ad2699-0ca5-4e0e-8473-a38aba2d1861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_229d8fa3-e198-47b4-8728-dec100cafbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_229d8fa3-e198-47b4-8728-dec100cafbf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_db78ee7e-25f2-4076-9612-1c1663b9c5c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_db78ee7e-25f2-4076-9612-1c1663b9c5c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_94d7c0ef-b522-49b4-834f-08d8cc908fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_cf10d756-dd0a-4a49-aef1-271454b13397" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_94d7c0ef-b522-49b4-834f-08d8cc908fdf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ba6f6408-b62b-4af4-90a3-8ff14e81f242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_2aaf6d5d-98ae-47e3-8a02-9eafb6a1b95b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ba6f6408-b62b-4af4-90a3-8ff14e81f242" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_2aaf6d5d-98ae-47e3-8a02-9eafb6a1b95b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_1f47282e-9822-407c-9e90-91a4ed106df2" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ba6f6408-b62b-4af4-90a3-8ff14e81f242" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_1f47282e-9822-407c-9e90-91a4ed106df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_1d9b9fa3-7218-4ddc-9c74-b6fbff12249f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ba6f6408-b62b-4af4-90a3-8ff14e81f242" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_1d9b9fa3-7218-4ddc-9c74-b6fbff12249f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_949c6041-63b6-4559-99ac-3c38e18917f7" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_ba6f6408-b62b-4af4-90a3-8ff14e81f242" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_949c6041-63b6-4559-99ac-3c38e18917f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ba5ebfbb-c3c0-4f39-b4a3-99f3b2110b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8f9902f3-e0b7-4ce1-a8bd-217b6b6d98ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ba5ebfbb-c3c0-4f39-b4a3-99f3b2110b0b" xlink:to="loc_us-gaap_Goodwill_8f9902f3-e0b7-4ce1-a8bd-217b6b6d98ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_56e552ad-fc28-438d-941a-dfbf5734f584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ba5ebfbb-c3c0-4f39-b4a3-99f3b2110b0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_56e552ad-fc28-438d-941a-dfbf5734f584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_1dff9a2b-1816-4b17-a38e-c2ee6ed1fbc7" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ba5ebfbb-c3c0-4f39-b4a3-99f3b2110b0b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_1dff9a2b-1816-4b17-a38e-c2ee6ed1fbc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_542d382b-fc93-456c-bd0b-08764f48014b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ba5ebfbb-c3c0-4f39-b4a3-99f3b2110b0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_542d382b-fc93-456c-bd0b-08764f48014b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>exas-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:62297662-2bfb-41ec-9bf7-9eb144772313,g:499e252f-fe94-4d47-8333-c3acba229b0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i74bca52e153a4d2492988bb179215fe9_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_58330c29-e9db-42ef-948f-e48be9feea7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_58330c29-e9db-42ef-948f-e48be9feea7c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2e2e8d1b-57e1-4f86-99d9-f99267cb7652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2e2e8d1b-57e1-4f86-99d9-f99267cb7652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f798b9e-5918-4def-bc4d-11933608f3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockholdersEquity_8f798b9e-5918-4def-bc4d-11933608f3fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ee35f1b2-56de-49a3-acad-f71c9b5722a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ee35f1b2-56de-49a3-acad-f71c9b5722a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4bbf0711-67fa-42e3-a6b4-d6380060902a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4bbf0711-67fa-42e3-a6b4-d6380060902a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6746afc7-b354-4fb4-af31-704977b92bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6746afc7-b354-4fb4-af31-704977b92bd5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_73ca6e06-afb5-43ad-9f88-8c2cd1d963e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_73ca6e06-afb5-43ad-9f88-8c2cd1d963e3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_3629cc3a-d5b7-4fce-a107-879274828dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_3629cc3a-d5b7-4fce-a107-879274828dea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_c94f960d-681b-4546-9f61-38c8adffab02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_c94f960d-681b-4546-9f61-38c8adffab02" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14ac64d8-4b68-4542-b7aa-5a75ce574001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14ac64d8-4b68-4542-b7aa-5a75ce574001" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6fde136a-db13-4512-b938-aea257cd48c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6fde136a-db13-4512-b938-aea257cd48c3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_812beed0-8b31-4179-b61d-feb7718c3a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_812beed0-8b31-4179-b61d-feb7718c3a6e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fa4c2d9f-420b-4c82-9593-b1b589681fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fa4c2d9f-420b-4c82-9593-b1b589681fd0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2ace3ead-882d-450c-9fe3-3f161e9d019c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2ace3ead-882d-450c-9fe3-3f161e9d019c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cd4e8302-3cc5-497d-a33d-78618bff82f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cd4e8302-3cc5-497d-a33d-78618bff82f7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42ddf73b-912c-4f6a-8ff5-7d8c7df6e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_NetIncomeLoss_42ddf73b-912c-4f6a-8ff5-7d8c7df6e8d6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_afe367ba-e89b-4712-bb80-b40e7fd5aeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_afe367ba-e89b-4712-bb80-b40e7fd5aeab" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_56fdf455-8a8a-46d2-9550-0573c608d789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dd1a7c14-f72d-43e9-9996-c514febf29ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_58330c29-e9db-42ef-948f-e48be9feea7c" xlink:to="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:to="loc_us-gaap_EquityComponentDomain_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:to="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_82b9a31f-3066-4910-bae5-ed8b71f62761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_CommonStockMember_82b9a31f-3066-4910-bae5-ed8b71f62761" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a263ba04-094e-4672-8aa1-b08ef81eb36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a263ba04-094e-4672-8aa1-b08ef81eb36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_53f8f08f-94b0-483c-9358-f666d1606867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_53f8f08f-94b0-483c-9358-f666d1606867" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_80ad239d-13ce-4f01-a47f-e369920dd42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_RetainedEarningsMember_80ad239d-13ce-4f01-a47f-e369920dd42f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails" xlink:type="extended" id="i9e41025bacbb4e14962156f1774b4517_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_03fa65d2-05dc-4c13-8759-d5bade9140b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_StockholdersEquity_03fa65d2-05dc-4c13-8759-d5bade9140b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2d110fdf-8fbd-44ad-ad79-a29af65110d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2d110fdf-8fbd-44ad-ad79-a29af65110d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a5cb8672-80d7-4aa7-8d98-5b77342a1489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a5cb8672-80d7-4aa7-8d98-5b77342a1489" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38d17065-d742-409b-a8af-68d2f06200ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38d17065-d742-409b-a8af-68d2f06200ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_0a11bc35-9f55-4c96-b5c1-82babc255bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_0a11bc35-9f55-4c96-b5c1-82babc255bb7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_018f5e6b-0e66-4e37-865e-bd7426b38c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_018f5e6b-0e66-4e37-865e-bd7426b38c22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ad40b4e6-2196-42ab-b155-b3d7da1c4c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ad40b4e6-2196-42ab-b155-b3d7da1c4c0e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8626d7c0-5535-4953-b23d-9925c5c0f052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8626d7c0-5535-4953-b23d-9925c5c0f052" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3072dd46-e70c-4d0a-9f48-de202a359cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_EarningsPerShareBasic_3072dd46-e70c-4d0a-9f48-de202a359cbb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_104c94d6-021e-427a-9284-4be73556748e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_EarningsPerShareDiluted_104c94d6-021e-427a-9284-4be73556748e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8f2c18a6-8c24-4017-9ac1-ceeafc57f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8f2c18a6-8c24-4017-9ac1-ceeafc57f6fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_34675378-4bd0-438c-a09d-85a101ad72e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_34675378-4bd0-438c-a09d-85a101ad72e1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_d91ad599-19e4-4e7e-83b9-62208cf425bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_d91ad599-19e4-4e7e-83b9-62208cf425bc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ab4ab502-d9c9-4b61-9dc4-dda772501844" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ab4ab502-d9c9-4b61-9dc4-dda772501844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_fcafa693-4050-4828-a933-f6106d89ff18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ab4ab502-d9c9-4b61-9dc4-dda772501844" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_fcafa693-4050-4828-a933-f6106d89ff18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7a930936-9c8f-40ca-a6fe-2572f10057da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7a930936-9c8f-40ca-a6fe-2572f10057da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b094c848-eaac-49d8-866b-43e5648e29be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b094c848-eaac-49d8-866b-43e5648e29be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member_1f7f1ad3-fa6e-43c6-9f71-344e3984fe02" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b094c848-eaac-49d8-866b-43e5648e29be" xlink:to="loc_exas_ConvertibleNotesPayable2025Member_1f7f1ad3-fa6e-43c6-9f71-344e3984fe02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5fd01905-e825-4f64-b0e9-28a6ccc7ed19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:to="loc_us-gaap_EquityComponentDomain_5fd01905-e825-4f64-b0e9-28a6ccc7ed19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:to="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_94393617-601c-40f2-b239-f7c8528e7309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_94393617-601c-40f2-b239-f7c8528e7309" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a5fb015e-f51d-4796-b23d-bdbbda929a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:to="loc_us-gaap_RetainedEarningsMember_a5fb015e-f51d-4796-b23d-bdbbda929a25" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails" xlink:type="extended" id="i03d8cec5e5c54ad1b73e0a4a73d82e0a_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6c9880f8-0bc2-4524-99ca-47f134358286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0bdb23b1-f8d5-497f-bcec-a0f668570d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6c9880f8-0bc2-4524-99ca-47f134358286" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0bdb23b1-f8d5-497f-bcec-a0f668570d18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6c9880f8-0bc2-4524-99ca-47f134358286" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c71758a-02b0-4c14-90d1-6b18af27832c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c71758a-02b0-4c14-90d1-6b18af27832c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SharesIssuedUponAcquisitionMember_a0c1a74c-14db-4c0d-bb6e-a482d7462bd1" xlink:href="exas-20210930.xsd#exas_SharesIssuedUponAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_exas_SharesIssuedUponAcquisitionMember_a0c1a74c-14db-4c0d-bb6e-a482d7462bd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember_154b51b2-4124-4e18-b9aa-a0e5025d86e2" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_exas_EmployeeAndNonEmployeesStockOptionMember_154b51b2-4124-4e18-b9aa-a0e5025d86e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_878665d0-ecd2-426f-acfb-283fc9e33d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_us-gaap_RestrictedStockMember_878665d0-ecd2-426f-acfb-283fc9e33d7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_eb81a226-cc3f-4b98-9b49-8952b1e270d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_us-gaap_PerformanceSharesMember_eb81a226-cc3f-4b98-9b49-8952b1e270d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_fb17e467-e5d0-4f54-b00c-1a2513581acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_fb17e467-e5d0-4f54-b00c-1a2513581acc" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#REVENUEScheduleofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="extended" id="icfb27bcbf0654c61a8ea11721f3ce21a_REVENUEScheduleofDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_475561c1-6e96-4993-92a4-088c8b8edf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b5dde5d-45cf-4a60-9a88-8ad0c5c13b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_475561c1-6e96-4993-92a4-088c8b8edf83" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b5dde5d-45cf-4a60-9a88-8ad0c5c13b51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_475561c1-6e96-4993-92a4-088c8b8edf83" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:to="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeDomain_4c8bbba3-6ce8-42a7-9833-beea848a7284_default" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:to="loc_exas_ServiceOrProductTypeDomain_4c8bbba3-6ce8-42a7-9833-beea848a7284_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:to="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScreeningMember_7c8d5ec3-23e2-44db-ac96-5632bd0dcd9e" xlink:href="exas-20210930.xsd#exas_ScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:to="loc_exas_ScreeningMember_7c8d5ec3-23e2-44db-ac96-5632bd0dcd9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PrecisionOncologyMember_712df447-2ee0-4aad-871c-ef4471957131" xlink:href="exas-20210930.xsd#exas_PrecisionOncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:to="loc_exas_PrecisionOncologyMember_712df447-2ee0-4aad-871c-ef4471957131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_COVID19TestingMember_14a18d32-8e5b-4a8e-97b1-20fb64780fa0" xlink:href="exas-20210930.xsd#exas_COVID19TestingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:to="loc_exas_COVID19TestingMember_14a18d32-8e5b-4a8e-97b1-20fb64780fa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:to="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_db59d9d9-2d8e-45e4-8b03-b9c30de08581_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:to="loc_srt_ProductsAndServicesDomain_db59d9d9-2d8e-45e4-8b03-b9c30de08581_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:to="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_6dbd38a7-c3ed-4f7b-8c9f-6be8b1c1b238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_us-gaap_ProductMember_6dbd38a7-c3ed-4f7b-8c9f-6be8b1c1b238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ebb35ce5-bf9b-46d4-8ebe-fe21e87ea157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_us-gaap_ServiceMember_ebb35ce5-bf9b-46d4-8ebe-fe21e87ea157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InternationalSalesMember_96fd6ed6-a860-4c76-b692-30cf8ae2dfb4" xlink:href="exas-20210930.xsd#exas_InternationalSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_exas_InternationalSalesMember_96fd6ed6-a860-4c76-b692-30cf8ae2dfb4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_c3733701-62f4-4d73-af3a-1daddd7d1a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_c3733701-62f4-4d73-af3a-1daddd7d1a4e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/REVENUENarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#REVENUENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/REVENUENarrativeDetails" xlink:type="extended" id="i72d2b968af2d406b81cf182632199c03_REVENUENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ad28b8f8-8b14-474a-8cb0-5dbef957c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ad28b8f8-8b14-474a-8cb0-5dbef957c2e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a8453447-eeeb-423c-a79b-c09b3f7cdede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a8453447-eeeb-423c-a79b-c09b3f7cdede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3c611666-5b89-416f-963f-9c9e659e3014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3c611666-5b89-416f-963f-9c9e659e3014" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1270f0dc-8562-4624-9a8b-9b0795e32e72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_1270f0dc-8562-4624-9a8b-9b0795e32e72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ae8981d5-9379-412c-9b6a-aafc671dcbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ae8981d5-9379-412c-9b6a-aafc671dcbfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_VariablePriceContractMember_0b971477-7b03-45d5-96af-cf83ca32b546" xlink:href="exas-20210930.xsd#exas_VariablePriceContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ae8981d5-9379-412c-9b6a-aafc671dcbfe" xlink:to="loc_exas_VariablePriceContractMember_0b971477-7b03-45d5-96af-cf83ca32b546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_90b7cb67-a218-49d5-a94d-b408de9c6471_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_90b7cb67-a218-49d5-a94d-b408de9c6471_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_54f610de-88e4-40a0-a751-e2f986b290e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_54f610de-88e4-40a0-a751-e2f986b290e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_COVID19Member_17b977fb-0f7e-473a-88e2-45030657c815" xlink:href="exas-20210930.xsd#exas_COVID19Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_54f610de-88e4-40a0-a751-e2f986b290e0" xlink:to="loc_exas_COVID19Member_17b977fb-0f7e-473a-88e2-45030657c815" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" xlink:type="extended" id="if5f1c199fa364a4b82a0afd025d9f212_MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5070bdd5-e8ea-40f6-865a-1f08a75ab06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5070bdd5-e8ea-40f6-865a-1f08a75ab06c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2f12871a-1ac0-4598-a5ac-c7f7f9832044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2f12871a-1ac0-4598-a5ac-c7f7f9832044" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_62cd86c9-6539-4561-9093-c5844ad3c267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_62cd86c9-6539-4561-9093-c5844ad3c267" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_6953b16c-af7b-40b6-ab2e-de82485ecaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_MarketableSecurities_6953b16c-af7b-40b6-ab2e-de82485ecaa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_be041511-3c01-4559-9c3f-bb9bfa249942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_be041511-3c01-4559-9c3f-bb9bfa249942" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_94abc9a2-1cdf-4b38-824d-622627801bc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_94abc9a2-1cdf-4b38-824d-622627801bc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CashAndMoneyMarketMember_5dbd639f-9d66-4a18-bf5d-f89e6c494161" xlink:href="exas-20210930.xsd#exas_CashAndMoneyMarketMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:to="loc_exas_CashAndMoneyMarketMember_5dbd639f-9d66-4a18-bf5d-f89e6c494161" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_3b95f410-743b-4513-8e3b-490a027fad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_3b95f410-743b-4513-8e3b-490a027fad2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedCashMember_08fd7aee-234c-46a8-8e0c-efff28eef637" xlink:href="exas-20210930.xsd#exas_RestrictedCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:to="loc_exas_RestrictedCashMember_08fd7aee-234c-46a8-8e0c-efff28eef637" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_86cbf448-05cf-4d7d-b731-38ece312daa6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_86cbf448-05cf-4d7d-b731-38ece312daa6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7a3bc6dc-da4f-4d5f-a3f6-93616989a2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7a3bc6dc-da4f-4d5f-a3f6-93616989a2d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ec8da510-9b8c-4be2-8db6-dcf3d25b6117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ec8da510-9b8c-4be2-8db6-dcf3d25b6117" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended" id="ibaf7168fcca34bc1812f5e70a122b6e1_MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06359762-402e-4229-9e56-162e372baa88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06359762-402e-4229-9e56-162e372baa88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c9784b16-78db-49a4-b38a-ef3aaaea9bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c9784b16-78db-49a4-b38a-ef3aaaea9bb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ebe175d-fe1b-4039-84c5-c8148af7064e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ebe175d-fe1b-4039-84c5-c8148af7064e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3f7d8fa0-78d2-412e-99a8-c04867e0ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3f7d8fa0-78d2-412e-99a8-c04867e0ad94" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d54c45f7-9b05-4028-8548-3ed8116004fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d54c45f7-9b05-4028-8548-3ed8116004fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_34207ff8-7c0f-42aa-90f2-52214d113be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_34207ff8-7c0f-42aa-90f2-52214d113be6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f00ebe53-42d0-430e-a7db-4877662f6463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f00ebe53-42d0-430e-a7db-4877662f6463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1be67557-c62f-486c-a3d0-7752c4b682c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1be67557-c62f-486c-a3d0-7752c4b682c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_555022f8-d36f-4802-8efe-b756c15798c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_CommercialPaperMember_555022f8-d36f-4802-8efe-b756c15798c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f697fe31-a9f3-4735-b7ec-95849d23050a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f697fe31-a9f3-4735-b7ec-95849d23050a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_f0644239-4232-4ced-b341-cd0ad69d75e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_f0644239-4232-4ced-b341-cd0ad69d75e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_eb880d50-cc3a-4dd5-b4c4-04005e50b9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_eb880d50-cc3a-4dd5-b4c4-04005e50b9b0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails" xlink:type="extended" id="i73fd23a083c54945803c090ddcaeb201_MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_ef5e9ee3-6a7b-4208-93e1-442cd857ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_ef5e9ee3-6a7b-4208-93e1-442cd857ef4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_23cd6337-fcc5-4fb4-a893-5db94bf91a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_23cd6337-fcc5-4fb4-a893-5db94bf91a6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_f60a7aed-77df-44d1-9c31-86a45178e735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_f60a7aed-77df-44d1-9c31-86a45178e735" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_35b133df-ceb4-4f19-ad50-44422741fd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_35b133df-ceb4-4f19-ad50-44422741fd5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2786d8a2-3588-44c2-bdf4-9293fce4439f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2786d8a2-3588-44c2-bdf4-9293fce4439f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_b714cd5e-dd78-4282-9bfc-f123c1f7f925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2786d8a2-3588-44c2-bdf4-9293fce4439f" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_b714cd5e-dd78-4282-9bfc-f123c1f7f925" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca39bb11-5c63-40bc-a418-a7bc94b212ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca39bb11-5c63-40bc-a418-a7bc94b212ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b615fff-1a0d-41f5-913b-1b5e23184c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b615fff-1a0d-41f5-913b-1b5e23184c2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_1cc46085-adef-4f68-a484-2c8827ea9a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_1cc46085-adef-4f68-a484-2c8827ea9a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_7191d8b3-c41a-4a45-95f4-9df27bcd893f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_CertificatesOfDepositMember_7191d8b3-c41a-4a45-95f4-9df27bcd893f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_5a3b378f-833e-4dce-8832-b5fbb09556c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_5a3b378f-833e-4dce-8832-b5fbb09556c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_254ca6e6-1d09-46c7-ae99-aa084fb47942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_CommercialPaperMember_254ca6e6-1d09-46c7-ae99-aa084fb47942" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" xlink:type="extended" id="i544090f3cec346f2a529020822cdfd1a_MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c3e5ea89-ca91-4f90-ac43-f6fc6d82089f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c3e5ea89-ca91-4f90-ac43-f6fc6d82089f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e8042b4e-3e7b-460e-aae1-bf17a4b449f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e8042b4e-3e7b-460e-aae1-bf17a4b449f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_da7f524b-0ccd-45f0-8fc7-c366b23fcf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_da7f524b-0ccd-45f0-8fc7-c366b23fcf7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1efedd54-5c22-411d-b603-8abb13690bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1efedd54-5c22-411d-b603-8abb13690bb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_fbdaa6e0-5a41-4c62-95f3-2cdfe5dc5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_fbdaa6e0-5a41-4c62-95f3-2cdfe5dc5359" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3e0303b-9727-432e-8948-31c0e871499d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3e0303b-9727-432e-8948-31c0e871499d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7be1b207-dd4c-4b87-881f-405b53eaa79f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7be1b207-dd4c-4b87-881f-405b53eaa79f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_4c323835-72d9-472e-90b2-7cf29f7afbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_4c323835-72d9-472e-90b2-7cf29f7afbb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_b5e5f2d7-add9-4764-b1b0-92a0197301c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_CertificatesOfDepositMember_b5e5f2d7-add9-4764-b1b0-92a0197301c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_88f0b2b1-b6e5-4ac1-92d3-914ce58f9e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_88f0b2b1-b6e5-4ac1-92d3-914ce58f9e2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6f3bd9f-23c0-4672-aa72-c7c14c995db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6f3bd9f-23c0-4672-aa72-c7c14c995db0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_68249dfe-b0de-447a-9415-6b8c8e3fcf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_68249dfe-b0de-447a-9415-6b8c8e3fcf63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e01a258c-9766-4e67-9515-828491ecb0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68249dfe-b0de-447a-9415-6b8c8e3fcf63" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e01a258c-9766-4e67-9515-828491ecb0bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" xlink:type="extended" id="i34133124264f4323ae104f1b5bc51aee_PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_29c67dac-1111-4bc7-9f54-7d1d4b9ef592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_29c67dac-1111-4bc7-9f54-7d1d4b9ef592" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4e73336f-1b38-42e6-a67a-d4448e829873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4e73336f-1b38-42e6-a67a-d4448e829873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ed11828-696e-43fe-b3cd-fb5a6c476330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ed11828-696e-43fe-b3cd-fb5a6c476330" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a591dc46-55c0-46ef-875d-e0d4ba50b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a591dc46-55c0-46ef-875d-e0d4ba50b27e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:to="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2117624d-95f9-4c75-a3be-ddb16a967ce5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:to="loc_srt_RangeMember_2117624d-95f9-4c75-a3be-ddb16a967ce5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:to="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_093c91ca-8932-4f4a-9c76-326c32068d3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:to="loc_srt_MinimumMember_093c91ca-8932-4f4a-9c76-326c32068d3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8fb29ba7-e1fa-4102-99ba-2d4e7ad606d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:to="loc_srt_MaximumMember_8fb29ba7-e1fa-4102-99ba-2d4e7ad606d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9dc48f77-471b-48b5-bddc-69ebadfe52f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9dc48f77-471b-48b5-bddc-69ebadfe52f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_daf8e8c3-6140-434c-8a44-80a9a66f8b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_LandMember_daf8e8c3-6140-434c-8a44-80a9a66f8b3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BuildingsAndLeaseholdImprovementsMember_9366f80a-54e5-498f-bf84-fd28955ca822" xlink:href="exas-20210930.xsd#exas_BuildingsAndLeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_exas_BuildingsAndLeaseholdImprovementsMember_9366f80a-54e5-498f-bf84-fd28955ca822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_511a52b8-9b68-4481-957e-2845eb0dd640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_LandImprovementsMember_511a52b8-9b68-4481-957e-2845eb0dd640" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_6becece3-249b-4b15-9243-fe3570cd2bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_BuildingMember_6becece3-249b-4b15-9243-fe3570cd2bbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_OfficeEquipmentAndComputerSoftwareMember_59ce9d26-dc86-4d70-beec-ec96d030b8fe" xlink:href="exas-20210930.xsd#exas_OfficeEquipmentAndComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_exas_OfficeEquipmentAndComputerSoftwareMember_59ce9d26-dc86-4d70-beec-ec96d030b8fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_fadd1266-2e46-430e-9264-13835be9ec03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_EquipmentMember_fadd1266-2e46-430e-9264-13835be9ec03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d7d35e4a-6b70-4004-beab-87b71d4ed6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d7d35e4a-6b70-4004-beab-87b71d4ed6dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_fb56a357-d394-4ebc-851d-7ba742bb8104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_AssetUnderConstructionMember_fb56a357-d394-4ebc-851d-7ba742bb8104" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails" xlink:type="extended" id="ic095efe0ae7a402d8d674ffb3bdd373c_PROPERTYPLANTANDEQUIPMENTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_560cb401-7240-4dfe-a56c-160e319e6bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_Depreciation_560cb401-7240-4dfe-a56c-160e319e6bd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_818193a0-8ed7-4520-9aab-f081959634a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_818193a0-8ed7-4520-9aab-f081959634a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_60faa33e-1cd9-4f6d-91ee-e59840b019b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_ConstructionInProgressGross_60faa33e-1cd9-4f6d-91ee-e59840b019b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63ba4f63-c54b-4ac1-857e-78236c8a6eeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63ba4f63-c54b-4ac1-857e-78236c8a6eeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_42f6f04d-e409-40e1-b3de-8a4cfd5165bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_AssetUnderConstructionMember_42f6f04d-e409-40e1-b3de-8a4cfd5165bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_73c245b6-1511-4e99-944b-e66d6074e458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_EquipmentMember_73c245b6-1511-4e99-944b-e66d6074e458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BuildingsAndLeaseholdImprovementsMember_1c7f82a1-221a-4924-8ac7-8168d541fa50" xlink:href="exas-20210930.xsd#exas_BuildingsAndLeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_exas_BuildingsAndLeaseholdImprovementsMember_1c7f82a1-221a-4924-8ac7-8168d541fa50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_a2b2a1cd-6feb-4459-9262-2ce9e8659942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_a2b2a1cd-6feb-4459-9262-2ce9e8659942" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_db588228-7bc9-4d57-be2d-e73f5ee55bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_LandImprovementsMember_db588228-7bc9-4d57-be2d-e73f5ee55bb9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" xlink:type="extended" id="i5fb61d4ae34b401c852e82957d3c1671_INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7afebc09-5e59-4dfa-be6f-88bf9fef16f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7afebc09-5e59-4dfa-be6f-88bf9fef16f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_40e2ddb4-076e-4e99-a6db-08b83f09de3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_40e2ddb4-076e-4e99-a6db-08b83f09de3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fcd3ffbf-ccb3-4711-8897-d32d8d962703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fcd3ffbf-ccb3-4711-8897-d32d8d962703" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2551e062-c646-43c3-9583-e435a45f1aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2551e062-c646-43c3-9583-e435a45f1aad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4681f475-382b-41ba-98bc-6687e8347d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4681f475-382b-41ba-98bc-6687e8347d70" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8872e8e2-2e7e-41bf-8e79-487a7c289a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8872e8e2-2e7e-41bf-8e79-487a7c289a95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8588a4a-3d7b-441f-beaf-24b5e8876939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8588a4a-3d7b-441f-beaf-24b5e8876939" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_623948a2-f32f-415f-bff4-3aa038e24c87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_623948a2-f32f-415f-bff4-3aa038e24c87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_64a24bb8-d5f0-4b26-baec-ea3a7a781c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_TradeNamesMember_64a24bb8-d5f0-4b26-baec-ea3a7a781c18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_952dde4d-91ab-4e60-8ddf-798bec5e204a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_952dde4d-91ab-4e60-8ddf-798bec5e204a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_f34c2804-faf0-41f3-93e4-e7ded22d09f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_PatentsMember_f34c2804-faf0-41f3-93e4-e7ded22d09f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_5a44e481-98cd-466d-af57-bd66e1250e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_5a44e481-98cd-466d-af57-bd66e1250e71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_08dff7ae-47e8-4ccb-9b30-aab906d5d906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_ServiceAgreementsMember_08dff7ae-47e8-4ccb-9b30-aab906d5d906" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails" xlink:type="extended" id="ia958be04933d4fc4bc55448869bd20b5_INTANGIBLEASSETSANDGOODWILLNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2163ef5d-b2e7-40f9-99d9-3b6cf42db1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2163ef5d-b2e7-40f9-99d9-3b6cf42db1e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a361ff49-3d3b-4464-96a1-1edb6100fa91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a361ff49-3d3b-4464-96a1-1edb6100fa91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64e5b55f-a28f-41ce-ae79-b41ae6560a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64e5b55f-a28f-41ce-ae79-b41ae6560a72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66030d92-4690-4540-912c-a121bc2013e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66030d92-4690-4540-912c-a121bc2013e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b09f480f-f6e0-488c-ab3c-391b9593faca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b09f480f-f6e0-488c-ab3c-391b9593faca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_800643d3-e9b7-4dbe-8f29-c18cd6241866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b09f480f-f6e0-488c-ab3c-391b9593faca" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_800643d3-e9b7-4dbe-8f29-c18cd6241866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d7af28c-9695-4f15-933d-85dc37f0f337_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4d7af28c-9695-4f15-933d-85dc37f0f337_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b210214-06b3-49a1-9ecb-5129f3ffbfd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b210214-06b3-49a1-9ecb-5129f3ffbfd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ArmuneBiosciencesAgreementMember_c3205072-4e6a-4b71-ba3e-2b484494b190" xlink:href="exas-20210930.xsd#exas_ArmuneBiosciencesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b210214-06b3-49a1-9ecb-5129f3ffbfd9" xlink:to="loc_exas_ArmuneBiosciencesAgreementMember_c3205072-4e6a-4b71-ba3e-2b484494b190" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails" xlink:type="extended" id="i34bcf48b7342456788b6e67707797c43_INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fc6f9271-503f-4f29-9e6e-0f0e1e12d36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_fc6f9271-503f-4f29-9e6e-0f0e1e12d36b" xlink:to="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_57ccb650-f9c8-416a-a459-0d0f1064dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_us-gaap_Goodwill_57ccb650-f9c8-416a-a459-0d0f1064dc3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dcf28143-0b54-49e1-a849-6f4bacad3f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dcf28143-0b54-49e1-a849-6f4bacad3f69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_GoodwillAcquiredAdjustment_ae720ed8-2c0f-4800-8a2c-c34fdee04581" xlink:href="exas-20210930.xsd#exas_GoodwillAcquiredAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_exas_GoodwillAcquiredAdjustment_ae720ed8-2c0f-4800-8a2c-c34fdee04581" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1312c43-7508-436c-a095-6f2eff18093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_fc6f9271-503f-4f29-9e6e-0f0e1e12d36b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2041714-32ce-4eed-bcc7-6ab42638b17d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2041714-32ce-4eed-bcc7-6ab42638b17d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_d5d06729-061d-4289-9217-720feea7cfef" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_ParadigmViomicsMember_d5d06729-061d-4289-9217-720feea7cfef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_GenomicHealthIncMember_2354fe6a-377e-4a21-a564-5282ec103cb4" xlink:href="exas-20210930.xsd#exas_GenomicHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_GenomicHealthIncMember_2354fe6a-377e-4a21-a564-5282ec103cb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_19fd671a-db5c-40d8-81a6-f176b8679169" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_19fd671a-db5c-40d8-81a6-f176b8679169" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_992f9eb4-f5c7-48ef-93f0-42d8b500ac76" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_AshionAnalyticsMember_992f9eb4-f5c7-48ef-93f0-42d8b500ac76" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" xlink:type="extended" id="i59550f8ca0ae4c79b73462dfd2c82c85_FAIRVALUEMEASUREMENTSScheduleofFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a09abc70-66bd-4ae8-8f66-fe932740936a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a09abc70-66bd-4ae8-8f66-fe932740936a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f23ab1c2-55a8-4da8-975a-ca56a8a2727a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f23ab1c2-55a8-4da8-975a-ca56a8a2727a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_50d5023a-be0b-45c5-93ca-df9f4f2e81df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_50d5023a-be0b-45c5-93ca-df9f4f2e81df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_3705a8bd-79b1-4959-9364-ec2f805d5417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityOwnedNotReadilyMarketableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_3705a8bd-79b1-4959-9364-ec2f805d5417" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3e8fc267-7e27-4de5-9028-b5cb9612bc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3e8fc267-7e27-4de5-9028-b5cb9612bc01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_f0465b42-5505-4e92-9134-ff30d0fb7f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_FairValueNetAssetLiability_f0465b42-5505-4e92-9134-ff30d0fb7f01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6daedf5a-1410-48dd-868f-9c9537275697_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6daedf5a-1410-48dd-868f-9c9537275697_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_98d517c8-2788-40b9-9929-c1395785672e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_98d517c8-2788-40b9-9929-c1395785672e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c6d1f29c-6bab-42e6-9023-5942f340d000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c6d1f29c-6bab-42e6-9023-5942f340d000" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_30361b05-7ba8-4763-921c-5d1e5c6e4f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_30361b05-7ba8-4763-921c-5d1e5c6e4f82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_876c6273-f6d1-4a59-8a89-0f30ec24debf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_876c6273-f6d1-4a59-8a89-0f30ec24debf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_47b55fda-b383-4ae2-8148-6b119774713e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_47b55fda-b383-4ae2-8148-6b119774713e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f0528c5a-23c8-491b-a8fc-871a9f72c3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_47b55fda-b383-4ae2-8148-6b119774713e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f0528c5a-23c8-491b-a8fc-871a9f72c3c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_90457a82-58fe-437b-9527-03958643599a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_90457a82-58fe-437b-9527-03958643599a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_6bc02fac-4e71-4b1a-b9dc-2d97da214367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:to="loc_us-gaap_MoneyMarketFundsMember_6bc02fac-4e71-4b1a-b9dc-2d97da214367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedCashMember_fb055f99-59c6-4c90-bd3b-bb56d692085f" xlink:href="exas-20210930.xsd#exas_RestrictedCashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:to="loc_exas_RestrictedCashMember_fb055f99-59c6-4c90-bd3b-bb56d692085f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b81976b-2b08-4307-8589-42bb8a0be0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b81976b-2b08-4307-8589-42bb8a0be0fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ed21d1fe-bfd6-4951-8326-5bb89da535e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ed21d1fe-bfd6-4951-8326-5bb89da535e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_e3a361bd-533e-4106-b45b-ce6765f627b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_e3a361bd-533e-4106-b45b-ce6765f627b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_c1f4dd4c-174f-4636-981d-52ab8465966d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_CertificatesOfDepositMember_c1f4dd4c-174f-4636-981d-52ab8465966d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b3a4840d-f1d9-4d4e-87ba-1d09668fa856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_CommercialPaperMember_b3a4840d-f1d9-4d4e-87ba-1d09668fa856" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1abcc25c-c549-47cf-8b05-cb49ba51c40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1abcc25c-c549-47cf-8b05-cb49ba51c40a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_c7a759d2-3ed8-404b-b29b-f2dd3c39835a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_c7a759d2-3ed8-404b-b29b-f2dd3c39835a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i804cb77ef46c4122849879b2d3c98eb0_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c532862-02fa-4b69-8489-1d408e95b12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c532862-02fa-4b69-8489-1d408e95b12d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_79b11235-ff98-412c-ab43-f69be2843f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_79b11235-ff98-412c-ab43-f69be2843f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_87e7045a-52a5-4856-bd28-c89d0f375faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_87e7045a-52a5-4856-bd28-c89d0f375faa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_912f14f6-6178-4fcf-9807-a5b1b1b9a8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_DerivativeNotionalAmount_912f14f6-6178-4fcf-9807-a5b1b1b9a8f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_257dc960-95cd-45b2-b20c-54622d3a3b5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_257dc960-95cd-45b2-b20c-54622d3a3b5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveAndAshionMember_0e6b211b-cd2b-46be-ab11-74e31f01e0b8" xlink:href="exas-20210930.xsd#exas_ThriveAndAshionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:to="loc_exas_ThriveAndAshionMember_0e6b211b-cd2b-46be-ab11-74e31f01e0b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BiomatricaIncMember_092f6edd-e6c2-46af-8578-a2b492f5db09" xlink:href="exas-20210930.xsd#exas_BiomatricaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:to="loc_exas_BiomatricaIncMember_092f6edd-e6c2-46af-8578-a2b492f5db09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0571f8c2-ac0f-4a6e-b245-bc99697b467e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0571f8c2-ac0f-4a6e-b245-bc99697b467e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54c7959a-7457-45a1-a5b3-ab8387b67aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54c7959a-7457-45a1-a5b3-ab8387b67aca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a1820e1f-aa9c-46b9-86ef-e320baad728c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54c7959a-7457-45a1-a5b3-ab8387b67aca" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a1820e1f-aa9c-46b9-86ef-e320baad728c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_114b6d24-33f1-4f51-bfd0-419cce620e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_114b6d24-33f1-4f51-bfd0-419cce620e10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f101fefd-5637-435e-a19d-1ff299c358f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_114b6d24-33f1-4f51-bfd0-419cce620e10" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f101fefd-5637-435e-a19d-1ff299c358f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1eea35a7-e370-47d5-9f38-d5025d7bdfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1eea35a7-e370-47d5-9f38-d5025d7bdfdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_56463792-c82c-4596-b7d8-f000a0d4ac68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1eea35a7-e370-47d5-9f38-d5025d7bdfdd" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_56463792-c82c-4596-b7d8-f000a0d4ac68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_ee5e3e77-a752-4151-8232-df5661150f49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_ee5e3e77-a752-4151-8232-df5661150f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_a2cba1b8-76a6-4fa5-8a9e-5a7dc8ae1d93" xlink:href="exas-20210930.xsd#exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:to="loc_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_a2cba1b8-76a6-4fa5-8a9e-5a7dc8ae1d93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RevenueAndOtherPerformanceBasedPaymentsMember_fa3032ca-8875-4fc3-ae9a-974278a8c3ed" xlink:href="exas-20210930.xsd#exas_RevenueAndOtherPerformanceBasedPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:to="loc_exas_RevenueAndOtherPerformanceBasedPaymentsMember_fa3032ca-8875-4fc3-ae9a-974278a8c3ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3d6baa0b-e56f-4df0-a11e-879e543cb8f9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:to="loc_srt_RangeMember_3d6baa0b-e56f-4df0-a11e-879e543cb8f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c661d43-1711-4323-8694-af687f43cfba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:to="loc_srt_RangeMember_0c661d43-1711-4323-8694-af687f43cfba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_ced818be-543b-4a53-bd9a-e64e1b0ab3f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0c661d43-1711-4323-8694-af687f43cfba" xlink:to="loc_srt_WeightedAverageMember_ced818be-543b-4a53-bd9a-e64e1b0ab3f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cd36a4a3-52f2-4137-b44e-5adddca0d842_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_cd36a4a3-52f2-4137-b44e-5adddca0d842_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_a539adab-4a38-4d5e-9897-c64f55c86693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_a539adab-4a38-4d5e-9897-c64f55c86693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_de0e48b4-0b55-41ba-a1d5-7c13fb0aa06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_a539adab-4a38-4d5e-9897-c64f55c86693" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_de0e48b4-0b55-41ba-a1d5-7c13fb0aa06a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc6bd01f-6eb5-40da-be7a-6ce2b519c641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_de0e48b4-0b55-41ba-a1d5-7c13fb0aa06a" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc6bd01f-6eb5-40da-be7a-6ce2b519c641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_cde67302-4ace-4f4f-9598-fe6ac7b13426_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_cde67302-4ace-4f4f-9598-fe6ac7b13426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MeasurementInputProbabilityOfSuccessMember_0ae6a1f9-bc6b-4ca4-994b-875cd3471df9" xlink:href="exas-20210930.xsd#exas_MeasurementInputProbabilityOfSuccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:to="loc_exas_MeasurementInputProbabilityOfSuccessMember_0ae6a1f9-bc6b-4ca4-994b-875cd3471df9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MeasurementInputPresentValueFactorMember_503026dd-13ca-417d-b6e9-0a4b6702c3d6" xlink:href="exas-20210930.xsd#exas_MeasurementInputPresentValueFactorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:to="loc_exas_MeasurementInputPresentValueFactorMember_503026dd-13ca-417d-b6e9-0a4b6702c3d6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#LONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/LONGTERMDEBTDetails" xlink:type="extended" id="i237a77f639f9484ea938883e6b70584f_LONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_86bdfc17-3bce-424b-8e7f-94cdad78c679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_86bdfc17-3bce-424b-8e7f-94cdad78c679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_49b7b9b8-dda8-4853-bbf3-5efa8ffe30d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_49b7b9b8-dda8-4853-bbf3-5efa8ffe30d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentPeriodicPaymentInterestTerm_5338900d-1fb6-4b0c-9db0-417103efc863" xlink:href="exas-20210930.xsd#exas_DebtInstrumentPeriodicPaymentInterestTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_DebtInstrumentPeriodicPaymentInterestTerm_5338900d-1fb6-4b0c-9db0-417103efc863" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentRemainingAmortizationPeriod_925c430d-e858-434c-bb0e-5bf7fdb72512" xlink:href="exas-20210930.xsd#exas_DebtInstrumentRemainingAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_DebtInstrumentRemainingAmortizationPeriod_925c430d-e858-434c-bb0e-5bf7fdb72512" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6700e6c6-dbeb-457a-b360-7cc4781624f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6700e6c6-dbeb-457a-b360-7cc4781624f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_62f05084-4146-4e4a-ab93-5651f4018087" xlink:href="exas-20210930.xsd#exas_MinimumOwnInvestmentToBeMadeInConstructionProject"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_62f05084-4146-4e4a-ab93-5651f4018087" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent_40886f85-2a91-4ae9-8826-ee152e3dc4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermConstructionLoanCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent_40886f85-2a91-4ae9-8826-ee152e3dc4c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred_9fc2c66e-209b-41a3-8586-4ca419529523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_InterestCostsIncurred_9fc2c66e-209b-41a3-8586-4ca419529523" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_5356e9b2-a4a1-4c08-82f4-d9fd0b68185d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_InterestCostsCapitalized_5356e9b2-a4a1-4c08-82f4-d9fd0b68185d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_ad5482d0-3919-4e46-81fb-b062832e1bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_ad5482d0-3919-4e46-81fb-b062832e1bfe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_33e53d6d-fda1-46b6-91d8-84eb73ae1a0b" xlink:href="exas-20210930.xsd#exas_DebtInstrumentCovenantLiquidityRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_33e53d6d-fda1-46b6-91d8-84eb73ae1a0b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfAgreementsEntered_95790b68-847a-45c0-8277-4226216dd0e5" xlink:href="exas-20210930.xsd#exas_NumberOfAgreementsEntered"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_NumberOfAgreementsEntered_95790b68-847a-45c0-8277-4226216dd0e5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfJobsRequiredToCreatedAndMaintained_ecc7e6d8-1765-4e3d-81ed-d06a6a9359da" xlink:href="exas-20210930.xsd#exas_NumberOfJobsRequiredToCreatedAndMaintained"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_NumberOfJobsRequiredToCreatedAndMaintained_ecc7e6d8-1765-4e3d-81ed-d06a6a9359da" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_114db150-01b8-45ed-b3fe-131cc83d1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentTerm_114db150-01b8-45ed-b3fe-131cc83d1dc4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RegulatoryLiabilityAmortizationPeriod_59492048-592f-4fe7-a969-1a0bd1b41a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatoryLiabilityAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_RegulatoryLiabilityAmortizationPeriod_59492048-592f-4fe7-a969-1a0bd1b41a68" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9ca59d9d-d221-4a8d-837f-93b525c7b6b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:to="loc_us-gaap_CreditFacilityDomain_9ca59d9d-d221-4a8d-837f-93b525c7b6b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3bce057c-eeea-4736-9214-c4b3dca36fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:to="loc_us-gaap_CreditFacilityDomain_3bce057c-eeea-4736-9214-c4b3dca36fc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_05db5ccc-c40f-49c8-acf8-531b5dfa4547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_3bce057c-eeea-4736-9214-c4b3dca36fc5" xlink:to="loc_us-gaap_LetterOfCreditMember_05db5ccc-c40f-49c8-acf8-531b5dfa4547" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0bedcf8c-6d58-45a1-b155-79fb0543f30b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0bedcf8c-6d58-45a1-b155-79fb0543f30b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoansMember_565de808-80e1-4f5f-8632-93c47011c051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:to="loc_us-gaap_ConstructionLoansMember_565de808-80e1-4f5f-8632-93c47011c051" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TaxIncrementFinancingLoanAgreementsMember_9cefac29-34cc-4814-9ab2-0284c2b2ff19" xlink:href="exas-20210930.xsd#exas_TaxIncrementFinancingLoanAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:to="loc_exas_TaxIncrementFinancingLoanAgreementsMember_9cefac29-34cc-4814-9ab2-0284c2b2ff19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f44431a4-0f24-4433-9ce0-76bc429376b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:to="loc_us-gaap_VariableRateDomain_f44431a4-0f24-4433-9ce0-76bc429376b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e06ea348-4337-4019-bff9-b19b08d9a1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:to="loc_us-gaap_VariableRateDomain_e06ea348-4337-4019-bff9-b19b08d9a1ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_OneMonthLondonInterbankOfferRateMember_29c65e39-f02e-4b1e-8a39-6310d91fedf7" xlink:href="exas-20210930.xsd#exas_OneMonthLondonInterbankOfferRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e06ea348-4337-4019-bff9-b19b08d9a1ce" xlink:to="loc_exas_OneMonthLondonInterbankOfferRateMember_29c65e39-f02e-4b1e-8a39-6310d91fedf7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESScheduleofConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails" xlink:type="extended" id="i7a46f226787e4c6ab2018296d2984ae2_CONVERTIBLENOTESScheduleofConvertibleNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4922496f-8e78-4644-bb9c-7b3101e17c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4922496f-8e78-4644-bb9c-7b3101e17c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayableGross_e9484616-e057-4733-a96f-ce0f420d6a2a" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_exas_ConvertibleNotesPayableGross_e9484616-e057-4733-a96f-ce0f420d6a2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4894070a-dbf5-4ff8-8740-07912278f6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4894070a-dbf5-4ff8-8740-07912278f6d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_e41cd0be-e97f-411e-a692-673d1c159c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_ConvertibleNotesPayable_e41cd0be-e97f-411e-a692-673d1c159c74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fd0513d-e7ca-4ee5-a12b-e01f6e6ce2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fd0513d-e7ca-4ee5-a12b-e01f6e6ce2bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:href="exas-20210930.xsd#exas_ScheduleOfConvertibleNotesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7f005bbd-aa88-4017-ad39-61adc029fea2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7f005bbd-aa88-4017-ad39-61adc029fea2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d0a9f56-4797-473f-8564-32921570012b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d0a9f56-4797-473f-8564-32921570012b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_7995de6f-ff1f-4a7a-a2ef-a81d928b1b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d0a9f56-4797-473f-8564-32921570012b" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_7995de6f-ff1f-4a7a-a2ef-a81d928b1b49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:href="exas-20210930.xsd#exas_AggregateConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember_7995de6f-ff1f-4a7a-a2ef-a81d928b1b49" xlink:to="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member_c86b4abc-257c-4808-8167-8ad1d560593e" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:to="loc_exas_ConvertibleNotesPayable2028Member_c86b4abc-257c-4808-8167-8ad1d560593e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member_8bc59764-e589-4a5e-a63d-5a05cd989c6f" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:to="loc_exas_ConvertibleNotesPayable2027Member_8bc59764-e589-4a5e-a63d-5a05cd989c6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member_2a160149-8fa2-4029-bdd7-c4cbf3def48a" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:to="loc_exas_ConvertibleNotesPayable2025Member_2a160149-8fa2-4029-bdd7-c4cbf3def48a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75b35011-892e-4252-882d-dc0b4472461d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_75b35011-892e-4252-882d-dc0b4472461d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_194bd5ac-a639-451e-8afe-728729f13e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_194bd5ac-a639-451e-8afe-728729f13e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9837ec25-9b29-49f6-a586-e3d965c2986e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_194bd5ac-a639-451e-8afe-728729f13e84" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9837ec25-9b29-49f6-a586-e3d965c2986e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f1c96043-5786-4987-aff1-bd0f7ce89d70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_f1c96043-5786-4987-aff1-bd0f7ce89d70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4d5c5ee1-7ef2-424a-86a7-87b3a9f6c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4d5c5ee1-7ef2-424a-86a7-87b3a9f6c70e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f92d56c2-d060-4779-93c5-4f3f4a42adf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f92d56c2-d060-4779-93c5-4f3f4a42adf2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESAdditionalinformationDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails" xlink:type="extended" id="ia82d46fad7b744f8942dbb1dcf2ef56a_CONVERTIBLENOTESAdditionalinformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b5180499-535b-46ba-abd7-a61f0c15fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b5180499-535b-46ba-abd7-a61f0c15fb57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_68afac09-c7e8-4350-8154-326fde4b7423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_68afac09-c7e8-4350-8154-326fde4b7423" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3662768f-dc2c-4af3-9fee-686d23d38d49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3662768f-dc2c-4af3-9fee-686d23d38d49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_0a8ebdcb-e31d-48a3-bf58-6e29274a0421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_0a8ebdcb-e31d-48a3-bf58-6e29274a0421" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_a6e426c5-4c08-4848-92b2-9485f9470272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_a6e426c5-4c08-4848-92b2-9485f9470272" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_17131fe5-b34b-4c11-98f7-d459536ed6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_17131fe5-b34b-4c11-98f7-d459536ed6c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_41d04474-8760-42ce-9f66-0127d656e819" xlink:href="exas-20210930.xsd#exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_41d04474-8760-42ce-9f66-0127d656e819" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_3f0c2340-171e-4f23-ac83-d8dc19d26970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_RepaymentsOfDebt_3f0c2340-171e-4f23-ac83-d8dc19d26970" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_3ed74ca3-bbc9-41ce-b75d-aa4d7eab8ad6" xlink:href="exas-20210930.xsd#exas_DebtInstrumentConvertibleEquityComponentInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_3ed74ca3-bbc9-41ce-b75d-aa4d7eab8ad6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_66c275e0-ae6d-43d0-b539-1629e1687f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_66c275e0-ae6d-43d0-b539-1629e1687f36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentAmountSettledInExtinguishment_58b8a473-b9cb-40a7-9529-8e518aa9052d" xlink:href="exas-20210930.xsd#exas_DebtInstrumentAmountSettledInExtinguishment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_DebtInstrumentAmountSettledInExtinguishment_58b8a473-b9cb-40a7-9529-8e518aa9052d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c91946d9-6f9e-44a5-982a-182ce4fb107c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c91946d9-6f9e-44a5-982a-182ce4fb107c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f609a790-50a3-4dd0-ac91-6fbadac40122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f609a790-50a3-4dd0-ac91-6fbadac40122" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_13f0f8ff-05b8-4712-8d86-d64f4aeba515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_13f0f8ff-05b8-4712-8d86-d64f4aeba515" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_f0dd8218-9619-41f5-a28e-b00c88618c67" xlink:href="exas-20210930.xsd#exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_f0dd8218-9619-41f5-a28e-b00c88618c67" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_ed51260e-71aa-4e9f-951d-1ce68fda2b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_SharePrice_ed51260e-71aa-4e9f-951d-1ce68fda2b4a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_59445a9f-845c-4b0b-8bfc-41eba5002bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_59445a9f-845c-4b0b-8bfc-41eba5002bc6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_33e907ed-03c0-4e8e-a46c-3992668b4b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_33e907ed-03c0-4e8e-a46c-3992668b4b30" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_48813ae2-db85-4709-bfef-8f56769959cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_48813ae2-db85-4709-bfef-8f56769959cc" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:to="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_99299173-ccd2-44d0-844a-d6e7316e45c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_99299173-ccd2-44d0-844a-d6e7316e45c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0f9de16e-2912-41d2-9815-baf2c769765d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0f9de16e-2912-41d2-9815-baf2c769765d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_b128302e-5c30-4453-9cbc-6aad0d5b6964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0f9de16e-2912-41d2-9815-baf2c769765d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_b128302e-5c30-4453-9cbc-6aad0d5b6964" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:href="exas-20210930.xsd#exas_AggregateConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember_b128302e-5c30-4453-9cbc-6aad0d5b6964" xlink:to="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_JanuaryNotesMember_876ae152-c54f-4d42-995d-5b88b6cfa876" xlink:href="exas-20210930.xsd#exas_JanuaryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_JanuaryNotesMember_876ae152-c54f-4d42-995d-5b88b6cfa876" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_JuneNotesMember_99fa140a-ce9b-4317-bc38-e8026d52af86" xlink:href="exas-20210930.xsd#exas_JuneNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_JuneNotesMember_99fa140a-ce9b-4317-bc38-e8026d52af86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member_f21f24df-0a10-4663-ac92-29420a3746d7" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_ConvertibleNotesPayable2025Member_f21f24df-0a10-4663-ac92-29420a3746d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member_60157730-b8ef-4883-b80f-45e13ad55af2" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_ConvertibleNotesPayable2027Member_60157730-b8ef-4883-b80f-45e13ad55af2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member_aefb389c-4d36-4c11-ab95-db08faa166ca" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_ConvertibleNotesPayable2028Member_aefb389c-4d36-4c11-ab95-db08faa166ca" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESScheduleofTransactionCostsDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails" xlink:type="extended" id="i449242f836584e8f97200b0a259d61d2_CONVERTIBLENOTESScheduleofTransactionCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4483401d-14fb-452c-873e-f93d853ba8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentConvertibleTransactionCosts_bbafb3c6-6f01-4b8c-a6d7-a087d7471134" xlink:href="exas-20210930.xsd#exas_DebtInstrumentConvertibleTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4483401d-14fb-452c-873e-f93d853ba8fe" xlink:to="loc_exas_DebtInstrumentConvertibleTransactionCosts_bbafb3c6-6f01-4b8c-a6d7-a087d7471134" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:href="exas-20210930.xsd#exas_ScheduleOfConvertibleNotesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4483401d-14fb-452c-873e-f93d853ba8fe" xlink:to="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:to="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_January2025NotesMember_e5445b7e-88a0-4c65-9698-cda739c34c23" xlink:href="exas-20210930.xsd#exas_January2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_January2025NotesMember_e5445b7e-88a0-4c65-9698-cda739c34c23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_June2025NotesMember_1136b78b-af4c-4702-9d6c-aa0c599beb83" xlink:href="exas-20210930.xsd#exas_June2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_June2025NotesMember_1136b78b-af4c-4702-9d6c-aa0c599beb83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member_447034e2-5fc4-47e3-961d-281ae44a247f" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_ConvertibleNotesPayable2027Member_447034e2-5fc4-47e3-961d-281ae44a247f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member_3e756f82-f69f-43af-ab4c-de5fbab6cad3" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_ConvertibleNotesPayable2028Member_3e756f82-f69f-43af-ab4c-de5fbab6cad3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails" xlink:type="extended" id="i70c20967eab64d93828ec85c5d113e14_LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LicenseAgreementFeesCommitment_0d1eae56-2171-4a52-8f48-e45e41a6608d" xlink:href="exas-20210930.xsd#exas_LicenseAgreementFeesCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:to="loc_exas_LicenseAgreementFeesCommitment_0d1eae56-2171-4a52-8f48-e45e41a6608d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_29770fae-b8cf-4c22-bc4e-000ce9aff839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_29770fae-b8cf-4c22-bc4e-000ce9aff839" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e7680e66-88d9-436a-bbea-3ae376d586ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e7680e66-88d9-436a-bbea-3ae376d586ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1b5f4e05-9cfa-496c-8db0-1d3c25d10cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1b5f4e05-9cfa-496c-8db0-1d3c25d10cd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_a8948d61-e13c-4a3f-b2ce-ff7ec3bc62ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1b5f4e05-9cfa-496c-8db0-1d3c25d10cd3" xlink:to="loc_us-gaap_LicensingAgreementsMember_a8948d61-e13c-4a3f-b2ce-ff7ec3bc62ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e7116111-1343-456e-b769-8a6707d9255b_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:to="loc_dei_EntityDomain_e7116111-1343-456e-b769-8a6707d9255b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cbdd944e-d9f7-4879-9d51-cb39be8a259f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:to="loc_dei_EntityDomain_cbdd944e-d9f7-4879-9d51-cb39be8a259f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MAYOFoundationMember_ee45b212-fe9c-4ae6-848a-476349fa629c" xlink:href="exas-20210930.xsd#exas_MAYOFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_cbdd944e-d9f7-4879-9d51-cb39be8a259f" xlink:to="loc_exas_MAYOFoundationMember_ee45b212-fe9c-4ae6-848a-476349fa629c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_263c89ac-4416-4341-ac71-99cdb16faaed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_263c89ac-4416-4341-ac71-99cdb16faaed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e04eb3a9-4a03-4d54-a2a0-d5fc5fb2324f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e04eb3a9-4a03-4d54-a2a0-d5fc5fb2324f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MAYOFoundationMember_eb4c807b-1257-476f-9209-90d77e5f7c38" xlink:href="exas-20210930.xsd#exas_MAYOFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e04eb3a9-4a03-4d54-a2a0-d5fc5fb2324f" xlink:to="loc_exas_MAYOFoundationMember_eb4c807b-1257-476f-9209-90d77e5f7c38" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails" xlink:type="extended" id="i29cc77e0e347484395f0339811736021_LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsContingentOnMilestonesPayable_e83819ef-8119-41f1-920e-8438c941fd0c" xlink:href="exas-20210930.xsd#exas_PaymentsContingentOnMilestonesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:to="loc_exas_PaymentsContingentOnMilestonesPayable_e83819ef-8119-41f1-920e-8438c941fd0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_48a23349-816e-4b2a-823a-49512fa8dc8f" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_48a23349-816e-4b2a-823a-49512fa8dc8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_c281ba92-593c-4568-8ca8-afda75f8ee3c_default" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_c281ba92-593c-4568-8ca8-afda75f8ee3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeOneMember_64a6c311-65f3-436b-a7cf-102efe1466c8" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:to="loc_exas_SalesMilestoneRangeOneMember_64a6c311-65f3-436b-a7cf-102efe1466c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeTwoMember_7df613ec-e977-4a5a-8484-1294b294f0f3" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:to="loc_exas_SalesMilestoneRangeTwoMember_7df613ec-e977-4a5a-8484-1294b294f0f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeThreeMember_89a25eed-5b36-40a4-abcf-cfd837e74060" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:to="loc_exas_SalesMilestoneRangeThreeMember_89a25eed-5b36-40a4-abcf-cfd837e74060" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f987c38f-bfe3-4801-b9ee-4c2be8017ff3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f987c38f-bfe3-4801-b9ee-4c2be8017ff3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62e3081b-7cee-496c-85c2-9ba0fad40158" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62e3081b-7cee-496c-85c2-9ba0fad40158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_4594a00d-37e2-420c-b353-02c4edc54e4b" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62e3081b-7cee-496c-85c2-9ba0fad40158" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_4594a00d-37e2-420c-b353-02c4edc54e4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8227553f-a890-45e8-b181-199977d334aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8227553f-a890-45e8-b181-199977d334aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a982cf0d-d041-4382-b88a-0d661bed891b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a982cf0d-d041-4382-b88a-0d661bed891b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_f2f5c762-f1fb-46ee-97a1-3aae27fa7544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a982cf0d-d041-4382-b88a-0d661bed891b" xlink:to="loc_us-gaap_LicensingAgreementsMember_f2f5c762-f1fb-46ee-97a1-3aae27fa7544" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PFIZERPROMOTIONAGREEMENTDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails" xlink:type="extended" id="i09e212ca0a9a4b8599ebc61121eb9a3d_PFIZERPROMOTIONAGREEMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_9a26b87d-b3a2-45a0-9e43-d4fdc58bdd67" xlink:href="exas-20210930.xsd#exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:to="loc_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_9a26b87d-b3a2-45a0-9e43-d4fdc58bdd67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense_a9851f8e-74ac-416a-968b-bdd3d016cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:to="loc_us-gaap_MarketingExpense_a9851f8e-74ac-416a-968b-bdd3d016cad6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:to="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_422f677e-9992-4664-a510-95a5388a79c3_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:to="loc_dei_EntityDomain_422f677e-9992-4664-a510-95a5388a79c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_93ce06a9-8a19-4b87-98c3-735a01c9b3b6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:to="loc_dei_EntityDomain_93ce06a9-8a19-4b87-98c3-735a01c9b3b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PfizerIncMember_7ada2000-debb-4ede-979b-66448e6e4bf4" xlink:href="exas-20210930.xsd#exas_PfizerIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_93ce06a9-8a19-4b87-98c3-735a01c9b3b6" xlink:to="loc_exas_PfizerIncMember_7ada2000-debb-4ede-979b-66448e6e4bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ef0db40a-d130-4ebd-8c79-faabc5e42e81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ef0db40a-d130-4ebd-8c79-faabc5e42e81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b853fd2d-7fdc-4ea2-96f6-74db7d25cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b853fd2d-7fdc-4ea2-96f6-74db7d25cc2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember_4cf4134c-f644-4ada-8324-1e5055aacaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b853fd2d-7fdc-4ea2-96f6-74db7d25cc2b" xlink:to="loc_us-gaap_ManufacturedProductOtherMember_4cf4134c-f644-4ada-8324-1e5055aacaf0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="i9dcc9dda83444b17b513517d59389967_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f2153d51-f6da-45b6-b8e5-05418d6cf387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f2153d51-f6da-45b6-b8e5-05418d6cf387" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_afd6ea65-55ca-4d06-b5db-7e7bfd1e45ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_afd6ea65-55ca-4d06-b5db-7e7bfd1e45ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_31f0cffe-2208-4568-a46c-312a4f7641d7" xlink:href="exas-20210930.xsd#exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_31f0cffe-2208-4568-a46c-312a4f7641d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_8bb4420a-0a2f-4f87-8e74-191f5b8e2144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_8bb4420a-0a2f-4f87-8e74-191f5b8e2144" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e04808c2-95c3-44c5-a486-8fb82e48a744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e04808c2-95c3-44c5-a486-8fb82e48a744" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1f720d61-be5e-4b5d-9f49-45754167bed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1f720d61-be5e-4b5d-9f49-45754167bed4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d35e6f-901f-48d5-8205-cbd8658acf61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d35e6f-901f-48d5-8205-cbd8658acf61" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_be62fb59-7fc1-454a-a328-c2b3be71e139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_be62fb59-7fc1-454a-a328-c2b3be71e139" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_d1a5327c-9539-400a-aa95-286120209e95" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:to="loc_exas_AshionAnalyticsMember_d1a5327c-9539-400a-aa95-286120209e95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_623ab6bd-8c1d-4729-b6b6-db0f8facf3e1" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_623ab6bd-8c1d-4729-b6b6-db0f8facf3e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_dfc4b103-6239-4ee5-94a1-43849c8ef3b2" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:to="loc_exas_ParadigmViomicsMember_dfc4b103-6239-4ee5-94a1-43849c8ef3b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:to="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_b96d084c-2113-405d-a8a0-dce716e35c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_b96d084c-2113-405d-a8a0-dce716e35c72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TARDISTechnologyMember_0aa0de88-7179-4a3e-8cec-493a6a5fe482" xlink:href="exas-20210930.xsd#exas_TARDISTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_b96d084c-2113-405d-a8a0-dce716e35c72" xlink:to="loc_exas_TARDISTechnologyMember_0aa0de88-7179-4a3e-8cec-493a6a5fe482" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYScheduleofOCIDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails" xlink:type="extended" id="i4a69c587d65d448bb34f15ccd4a484b6_STOCKHOLDERSEQUITYScheduleofOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_860e89c7-2b51-4495-96f5-98a71463e6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_860e89c7-2b51-4495-96f5-98a71463e6bc" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_01d63e68-5366-4266-ab7c-aea099949b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_StockholdersEquity_01d63e68-5366-4266-ab7c-aea099949b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_78823277-498a-4808-91ac-5f9e173d352e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_78823277-498a-4808-91ac-5f9e173d352e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_24160e05-df74-4f4e-9913-18110f3c8185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_24160e05-df74-4f4e-9913-18110f3c8185" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1e78cf8a-cb7a-4057-919b-8c24339d6390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1e78cf8a-cb7a-4057-919b-8c24339d6390" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_27df58db-bf42-463d-9259-8835724f4abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_27df58db-bf42-463d-9259-8835724f4abd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16ac6194-2f0a-4cd0-a396-174ce967827b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_860e89c7-2b51-4495-96f5-98a71463e6bc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9a18f55e-69a1-4acb-8217-3409328e5bd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:to="loc_us-gaap_EquityComponentDomain_9a18f55e-69a1-4acb-8217-3409328e5bd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:to="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ad65573-7d66-4403-ad80-2613c0576963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ad65573-7d66-4403-ad80-2613c0576963" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_de96ee27-fd2a-49f3-815e-5675cebc7b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_de96ee27-fd2a-49f3-815e-5675cebc7b50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d5febe82-d861-41d1-af2d-2fbd0d8c2fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d5febe82-d861-41d1-af2d-2fbd0d8c2fb5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails" xlink:type="extended" id="i9d6ebf0937ec4684b2da3390e4afe09a_STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_3de2d7bc-b794-478d-9e55-c7dfec60c96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_3de2d7bc-b794-478d-9e55-c7dfec60c96a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1ad23cb1-8276-4696-bd41-c6ba62349aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1ad23cb1-8276-4696-bd41-c6ba62349aba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b05d9166-cb34-4db5-b740-68b13af50309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b05d9166-cb34-4db5-b740-68b13af50309" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_48643877-ffc0-44ef-b792-9705a1958b73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_48643877-ffc0-44ef-b792-9705a1958b73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bad41ecf-2634-4365-a032-dd84d767ec7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bad41ecf-2634-4365-a032-dd84d767ec7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_a87ba4f5-4542-4c3f-ad23-f4196f1a84b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bad41ecf-2634-4365-a032-dd84d767ec7f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_a87ba4f5-4542-4c3f-ad23-f4196f1a84b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_af1182fa-e865-4667-a271-b14fc36b9183_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:to="loc_us-gaap_EquityComponentDomain_af1182fa-e865-4667-a271-b14fc36b9183_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:to="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_68c65bf9-9f18-4e33-b36e-47aa24031b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_68c65bf9-9f18-4e33-b36e-47aa24031b50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4b281882-ba9f-476c-abb8-0b6fdcbfc647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4b281882-ba9f-476c-abb8-0b6fdcbfc647" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="i9159e21bb791405c97c40566ce9ba8ba_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_be7f43ba-6ddf-4122-b310-f2338926cf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_be7f43ba-6ddf-4122-b310-f2338926cf3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0014e3ae-d9c4-4a0c-ad83-8dd2b74e294f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0014e3ae-d9c4-4a0c-ad83-8dd2b74e294f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d541832-f150-4eb5-9312-b01281ab8f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d541832-f150-4eb5-9312-b01281ab8f42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_5b8efa62-1de5-4283-b821-8b8eb6e98a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_5b8efa62-1de5-4283-b821-8b8eb6e98a6b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9659d109-a365-4a4e-bba6-6d1df3e92bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ShareBasedCompensation_9659d109-a365-4a4e-bba6-6d1df3e92bf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_78b9a738-8e90-4a0f-8187-d7f5ab475e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_78b9a738-8e90-4a0f-8187-d7f5ab475e02" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9aa7460e-f856-4bb3-bc0a-aa445de34932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9aa7460e-f856-4bb3-bc0a-aa445de34932" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3545ac0f-0952-4707-975e-d2d8bc8bd321_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3545ac0f-0952-4707-975e-d2d8bc8bd321_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember_6444e4b8-fd80-4016-9842-09c48201d73c" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:to="loc_exas_EmployeeAndNonEmployeesStockOptionMember_6444e4b8-fd80-4016-9842-09c48201d73c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_074bd722-6a9a-4121-a13e-bb33f2f0900f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_074bd722-6a9a-4121-a13e-bb33f2f0900f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a720cc30-683d-4151-87af-d80faebef122_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a720cc30-683d-4151-87af-d80faebef122_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_637544f3-0f3b-42ba-8dc7-b79f70b71d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_637544f3-0f3b-42ba-8dc7-b79f70b71d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_bbed7414-afd4-4830-a688-f5277c4fb5bd" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_637544f3-0f3b-42ba-8dc7-b79f70b71d3d" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_bbed7414-afd4-4830-a688-f5277c4fb5bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:to="loc_us-gaap_PlanNameDomain_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_af02b9d8-df4c-4499-8ef1-92d488bae62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:to="loc_us-gaap_PlanNameDomain_af02b9d8-df4c-4499-8ef1-92d488bae62d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_StockBasedCompensationPlansMember_65e9ab96-a72c-4079-b385-d44544b1f6aa" xlink:href="exas-20210930.xsd#exas_StockBasedCompensationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_af02b9d8-df4c-4499-8ef1-92d488bae62d" xlink:to="loc_exas_StockBasedCompensationPlansMember_65e9ab96-a72c-4079-b385-d44544b1f6aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ba9a6999-5afd-47f2-b696-7bef7d2a7870_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ba9a6999-5afd-47f2-b696-7bef7d2a7870_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d0769a58-aad5-4068-8cc3-bafc1c773596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d0769a58-aad5-4068-8cc3-bafc1c773596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4abc2c2a-7f63-4a13-8c6b-0c00f3af38fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d0769a58-aad5-4068-8cc3-bafc1c773596" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4abc2c2a-7f63-4a13-8c6b-0c00f3af38fd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKBASEDCOMPENSATIONFairValueandActivityDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails" xlink:type="extended" id="ica0ac84f674346a3aae1ac7560d33fb6_STOCKBASEDCOMPENSATIONFairValueandActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_36d29e56-8846-499a-bd1c-8f1a30265e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_36d29e56-8846-499a-bd1c-8f1a30265e83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d6892062-4012-48bb-b852-155863b073b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d6892062-4012-48bb-b852-155863b073b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a5a8a930-eda1-4129-b49b-f4fbafe24743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a5a8a930-eda1-4129-b49b-f4fbafe24743" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5f5362a0-60af-4cd0-be9f-f864a01b00f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5f5362a0-60af-4cd0-be9f-f864a01b00f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_9d721448-a946-4f77-9fb7-f2b427a59310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_9d721448-a946-4f77-9fb7-f2b427a59310" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cdb86395-d9ac-4012-99a6-b9dc9d77bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cdb86395-d9ac-4012-99a6-b9dc9d77bc44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ef9c7251-710f-4746-bdce-cbad78a89857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ef9c7251-710f-4746-bdce-cbad78a89857" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_597c8f34-9c7f-4c5a-a131-2ff6ace9c62f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_597c8f34-9c7f-4c5a-a131-2ff6ace9c62f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_ad5b589f-b9f9-4028-b820-2f83ec7c34f6" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_ad5b589f-b9f9-4028-b820-2f83ec7c34f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4773232-fb62-47d5-bf99-ffdc1f0d4114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4773232-fb62-47d5-bf99-ffdc1f0d4114" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8229f088-51bb-4708-9086-c898ba865a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8229f088-51bb-4708-9086-c898ba865a32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1c1872d6-c7ef-49b9-99a5-eb1a428ecdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_94895410-0ed8-4760-9115-8a1c155bf908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_94895410-0ed8-4760-9115-8a1c155bf908" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b0fb4a9-1e09-44ff-8744-7c6ab800966a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b0fb4a9-1e09-44ff-8744-7c6ab800966a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6626eb3b-9a40-48ef-aac4-a7aa03244047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6626eb3b-9a40-48ef-aac4-a7aa03244047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bc9d883f-161d-44e9-b935-136ea72b2144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bc9d883f-161d-44e9-b935-136ea72b2144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_e0f8cef6-8a02-4a30-be4b-02bba016d1bd" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_e0f8cef6-8a02-4a30-be4b-02bba016d1bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a388422c-dbf1-4fcd-af53-23be7c1ec5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a388422c-dbf1-4fcd-af53-23be7c1ec5c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c0426886-b7db-427d-9ba8-fca31ed38559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c0426886-b7db-427d-9ba8-fca31ed38559" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_611fb478-82c8-4ad3-a52f-c3464811e2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_98398a52-bc99-46d1-8694-aba5288b9a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_98398a52-bc99-46d1-8694-aba5288b9a8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d26482b6-b2c3-4476-9301-930d0227beb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d26482b6-b2c3-4476-9301-930d0227beb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a809a8c0-9c18-4af8-b2d9-380d592d6adc" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a809a8c0-9c18-4af8-b2d9-380d592d6adc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dbe4bb95-ce80-4e22-a3a5-45b550c3c287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a809a8c0-9c18-4af8-b2d9-380d592d6adc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dbe4bb95-ce80-4e22-a3a5-45b550c3c287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dd1a8b07-1481-4b72-b6ce-f3fbf0a99bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dd1a8b07-1481-4b72-b6ce-f3fbf0a99bb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a5086402-2df2-4549-a41d-cd6f0072337f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a5086402-2df2-4549-a41d-cd6f0072337f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_11417408-46cc-4667-b27f-f3dda4ef57f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_11417408-46cc-4667-b27f-f3dda4ef57f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_11384a73-a2cb-4e50-8d64-d7d8b1a5f267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_11384a73-a2cb-4e50-8d64-d7d8b1a5f267" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_454f0f6e-523e-4d5d-a86a-be8a4f03f05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_454f0f6e-523e-4d5d-a86a-be8a4f03f05d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e2bd0239-4e64-4b87-89e6-3c0ad467fb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e2bd0239-4e64-4b87-89e6-3c0ad467fb30" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_79b66b33-0ca4-4927-b525-3ce11199c9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_79b66b33-0ca4-4927-b525-3ce11199c9a3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81780f3d-caee-4cb4-a159-60de9653c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81780f3d-caee-4cb4-a159-60de9653c3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_735185a6-79e1-46a3-9849-937b54bffda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_735185a6-79e1-46a3-9849-937b54bffda9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_fa19176f-dd3f-41c4-a09f-a312aff68eb3" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_fa19176f-dd3f-41c4-a09f-a312aff68eb3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23b0ea87-34d7-40a0-89db-cf27cbe35eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23b0ea87-34d7-40a0-89db-cf27cbe35eb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ea43c96f-0ee9-49cd-ae7a-243eee03ad53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ea43c96f-0ee9-49cd-ae7a-243eee03ad53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7820b4b8-fe97-4782-928c-5ba1f08ee2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_75e45f9f-eea1-47e4-9526-218c47adb94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_75e45f9f-eea1-47e4-9526-218c47adb94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_601857bd-74f7-4999-b76a-568522a19deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_601857bd-74f7-4999-b76a-568522a19deb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_397cefe1-1567-4377-b165-a7dbf34bd793" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_397cefe1-1567-4377-b165-a7dbf34bd793" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0128dd33-ad97-4bed-ac71-861a5682e44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0128dd33-ad97-4bed-ac71-861a5682e44f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a93fe2f-0eff-45ee-b1b6-45d3e8332cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a93fe2f-0eff-45ee-b1b6-45d3e8332cbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7aecb443-b73f-4b8e-9027-445de26dcfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_83ff885b-f01d-48de-b1be-fd9c5b87ed34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_83ff885b-f01d-48de-b1be-fd9c5b87ed34" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_17b13a38-ceda-40bc-ba90-ad24e8e99828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_17b13a38-ceda-40bc-ba90-ad24e8e99828" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_da2d0c18-cd05-4b11-9255-aec67bad6281_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:to="loc_us-gaap_PlanNameDomain_da2d0c18-cd05-4b11-9255-aec67bad6281_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2334fa44-a62b-4b47-96ad-f43f637291fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:to="loc_us-gaap_PlanNameDomain_2334fa44-a62b-4b47-96ad-f43f637291fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_StockBasedCompensationPlansMember_194f1cc4-6b0a-4d79-ac53-10c899234508" xlink:href="exas-20210930.xsd#exas_StockBasedCompensationPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_2334fa44-a62b-4b47-96ad-f43f637291fa" xlink:to="loc_exas_StockBasedCompensationPlansMember_194f1cc4-6b0a-4d79-ac53-10c899234508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4d545def-1c57-4cf9-bbe6-39955c735366_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4d545def-1c57-4cf9-bbe6-39955c735366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember_1e9c1dd0-93c8-40e2-b4af-3bc7ad6ee5d2" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_exas_EmployeeAndNonEmployeesStockOptionMember_1e9c1dd0-93c8-40e2-b4af-3bc7ad6ee5d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_c9c89168-c8f6-49fa-a1d9-5c3a7fc13f14" xlink:href="exas-20210930.xsd#exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_c9c89168-c8f6-49fa-a1d9-5c3a7fc13f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_799044a2-d348-41ea-bd7f-42d94045e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_799044a2-d348-41ea-bd7f-42d94045e4dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_34b667e2-75e5-4ec8-83a6-9df0b76bd2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_us-gaap_PerformanceSharesMember_34b667e2-75e5-4ec8-83a6-9df0b76bd2eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a7eae26a-14f4-4327-b4b8-c2c53e808a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_us-gaap_EmployeeStockMember_a7eae26a-14f4-4327-b4b8-c2c53e808a20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:to="loc_srt_RangeMember_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:to="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_800344b5-d962-4aa8-8176-410d61938408" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:to="loc_srt_MinimumMember_800344b5-d962-4aa8-8176-410d61938408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4a7f013d-70be-4ab2-ae23-282f45aeaa14" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:to="loc_srt_MaximumMember_4a7f013d-70be-4ab2-ae23-282f45aeaa14" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails" xlink:type="extended" id="id9b17cf11eb049b2a1269e1083c19189_COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7b1e19eb-6191-48e7-b872-9b71903b0688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:to="loc_us-gaap_OperatingLeasePayments_7b1e19eb-6191-48e7-b872-9b71903b0688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_5523728d-a614-4fc0-a7cf-3273957d8478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_5523728d-a614-4fc0-a7cf-3273957d8478" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_248105d6-db1d-4ec5-b9c2-9e4710dc08d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_248105d6-db1d-4ec5-b9c2-9e4710dc08d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7b67c9e6-2aec-4881-b53a-69b6b802c61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7b67c9e6-2aec-4881-b53a-69b6b802c61f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ef2616e1-d524-414d-82d8-00ea84552f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ef2616e1-d524-414d-82d8-00ea84552f0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4b356db5-8394-47b3-a798-54696b39c55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4b356db5-8394-47b3-a798-54696b39c55f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66f29438-df0d-4246-b110-8069666c168a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66f29438-df0d-4246-b110-8069666c168a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f9455bbf-bf1c-4e68-978a-c56a9858a1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f9455bbf-bf1c-4e68-978a-c56a9858a1cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ba3e1128-ece4-40aa-b218-403c1a23b586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ba3e1128-ece4-40aa-b218-403c1a23b586" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2a4f5fb-d994-49bc-9725-22fa2cc57a34_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2a4f5fb-d994-49bc-9725-22fa2cc57a34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8c4f118-73fe-4716-8510-6537642f3825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8c4f118-73fe-4716-8510-6537642f3825" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_5e698e4d-b178-41df-82e9-da129259c64e" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8c4f118-73fe-4716-8510-6537642f3825" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_5e698e4d-b178-41df-82e9-da129259c64e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" xlink:type="extended" id="i10e34137da3d4c3989eed73c2a77367b_COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8422672e-26f5-474e-8b0a-c315a83c57dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8422672e-26f5-474e-8b0a-c315a83c57dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_88f78c11-8884-4831-8161-c3693a778c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseLiability_88f78c11-8884-4831-8161-c3693a778c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d767ae2a-6f43-4540-8c6d-1ee67180f2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d767ae2a-6f43-4540-8c6d-1ee67180f2c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3abaa8e6-5348-4897-87b9-8f5f05ba8b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3abaa8e6-5348-4897-87b9-8f5f05ba8b5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ed80a1e3-5238-4113-a82e-95f061dba384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ed80a1e3-5238-4113-a82e-95f061dba384" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7cb1ded6-d1d0-4e5f-8945-245d6ec7436c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7cb1ded6-d1d0-4e5f-8945-245d6ec7436c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ccd60e60-bffb-44b2-92da-bfc96d671de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiability_ccd60e60-bffb-44b2-92da-bfc96d671de8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b79f54a2-42dd-40d2-bc4f-012c28fb18e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b79f54a2-42dd-40d2-bc4f-012c28fb18e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1f8247a5-b253-4cb3-a563-8805f70e0146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1f8247a5-b253-4cb3-a563-8805f70e0146" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8113ad43-3fb2-492e-adec-2185a02d3dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8113ad43-3fb2-492e-adec-2185a02d3dce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_77a94634-5966-48e2-af17-fe1308423c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_77a94634-5966-48e2-af17-fe1308423c44" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_8d9260cd-0343-4604-bce3-577592bbd32b" xlink:href="exas-20210930.xsd#exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_8d9260cd-0343-4604-bce3-577592bbd32b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_cadde35a-7319-40fa-8c3e-53d3f233f64e" xlink:href="exas-20210930.xsd#exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_cadde35a-7319-40fa-8c3e-53d3f233f64e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_423288de-263f-435e-956b-a2759d1fc2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_LitigationReserve_423288de-263f-435e-956b-a2759d1fc2d1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_43ecb68c-8eb0-4e9b-9e7e-06f8d12d770b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_43ecb68c-8eb0-4e9b-9e7e-06f8d12d770b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d55e3360-27c0-400a-a3de-6d9be9edbc11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d55e3360-27c0-400a-a3de-6d9be9edbc11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb47d7e-11da-46cc-b30a-dd86648a404a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb47d7e-11da-46cc-b30a-dd86648a404a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FacilityInLaJollaCAMember_10f33cf0-a0aa-4c68-96af-7ef83c25a1ef" xlink:href="exas-20210930.xsd#exas_FacilityInLaJollaCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb47d7e-11da-46cc-b30a-dd86648a404a" xlink:to="loc_exas_FacilityInLaJollaCAMember_10f33cf0-a0aa-4c68-96af-7ef83c25a1ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:to="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9ca30bb3-c382-41ce-b060-94b54ab6cfcb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:to="loc_srt_LitigationCaseTypeDomain_9ca30bb3-c382-41ce-b060-94b54ab6cfcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_30e16a99-3f0a-4d55-88d5-6172926e151e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:to="loc_srt_LitigationCaseTypeDomain_30e16a99-3f0a-4d55-88d5-6172926e151e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DOSRuleInvestigationMember_bb67b6c9-b316-4071-886e-eea4669b9ab2" xlink:href="exas-20210930.xsd#exas_DOSRuleInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_30e16a99-3f0a-4d55-88d5-6172926e151e" xlink:to="loc_exas_DOSRuleInvestigationMember_bb67b6c9-b316-4071-886e-eea4669b9ab2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#NEWMARKETTAXCREDITDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails" xlink:type="extended" id="i8080940b77164b5aa332ee412485b69d_NEWMARKETTAXCREDITDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NetProceedsFromFinancingArrangement_05eca71d-3b66-4521-aa04-065a852a0fe7" xlink:href="exas-20210930.xsd#exas_NetProceedsFromFinancingArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:to="loc_exas_NetProceedsFromFinancingArrangement_05eca71d-3b66-4521-aa04-065a852a0fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_539b75d6-db89-4240-afd6-f538471463c9" xlink:href="exas-20210930.xsd#exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:to="loc_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_539b75d6-db89-4240-afd6-f538471463c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:to="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_0cc00180-ff53-489a-aaf9-b4b11c0216dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:to="loc_us-gaap_TransactionDomain_0cc00180-ff53-489a-aaf9-b4b11c0216dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_8f683a65-3af1-4b7e-84de-e920e76a2207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:to="loc_us-gaap_TransactionDomain_8f683a65-3af1-4b7e-84de-e920e76a2207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditProgramMember_205d889f-e1b2-436a-94ca-c1dd30396897" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_8f683a65-3af1-4b7e-84de-e920e76a2207" xlink:to="loc_exas_NewMarketTaxCreditProgramMember_205d889f-e1b2-436a-94ca-c1dd30396897" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails" xlink:type="extended" id="id5e149e6c1f64386ba5c7ef5c0820398_WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_d9752d82-b6fa-4338-a182-a5929a0d578e" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_d9752d82-b6fa-4338-a182-a5929a0d578e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_33d6f054-e91d-4bf3-90e5-132935576c0a" xlink:href="exas-20210930.xsd#exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_33d6f054-e91d-4bf3-90e5-132935576c0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_ea202d58-6f57-4bc6-b97e-ef9884c335b0" xlink:href="exas-20210930.xsd#exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_ea202d58-6f57-4bc6-b97e-ef9884c335b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_54a68e9b-8cd3-4340-b29a-a23c1702f8d5" xlink:href="exas-20210930.xsd#exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_54a68e9b-8cd3-4340-b29a-a23c1702f8d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditEarnedToDate_86463db5-9966-48d8-8d27-2a52474c8e1d" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditEarnedToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditEarnedToDate_86463db5-9966-48d8-8d27-2a52474c8e1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditReceived_759f599a-7341-4426-a76f-416e64aedba0" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditReceived_759f599a-7341-4426-a76f-416e64aedba0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditReceivable_718a8e15-2f04-4f4e-903a-f7a4535f174f" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditReceivable_718a8e15-2f04-4f4e-903a-f7a4535f174f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AmortizationOfRefundableTaxCredits_ffef112f-285e-4415-bbed-7c9a3706cb9f" xlink:href="exas-20210930.xsd#exas_AmortizationOfRefundableTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_AmortizationOfRefundableTaxCredits_ffef112f-285e-4415-bbed-7c9a3706cb9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e3e6330e-954e-4797-8307-4867a7643dc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e3e6330e-954e-4797-8307-4867a7643dc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bababee2-2ba7-4f96-86f6-4419d41e8654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bababee2-2ba7-4f96-86f6-4419d41e8654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_20c859f8-d4f1-48a0-95d8-7b3725b6de60" xlink:href="exas-20210930.xsd#exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bababee2-2ba7-4f96-86f6-4419d41e8654" xlink:to="loc_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_20c859f8-d4f1-48a0-95d8-7b3725b6de60" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails" xlink:type="extended" id="i80ecd0431f59414a98231785e5b6c715_BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7ed81b52-7d4d-487b-ab86-5f2abfe81483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7ed81b52-7d4d-487b-ab86-5f2abfe81483" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d00981dc-a1c1-4d4f-bfde-b2391eac630d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d00981dc-a1c1-4d4f-bfde-b2391eac630d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_f5a828e9-6ab1-463c-aa69-1c0c26cedd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_f5a828e9-6ab1-463c-aa69-1c0c26cedd63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationAdditionalPayment_c1f1f144-a69a-439c-8bad-dbb901b18042" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationAdditionalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationContingentConsiderationAdditionalPayment_c1f1f144-a69a-439c-8bad-dbb901b18042" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3472eda2-91cb-41f6-8e40-0677b50c5957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3472eda2-91cb-41f6-8e40-0677b50c5957" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationRevenueMilestone_71eb56d3-6a52-4668-b636-ddee6f8d6d68" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationRevenueMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationContingentConsiderationRevenueMilestone_71eb56d3-6a52-4668-b636-ddee6f8d6d68" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5f0d3168-bdbb-4208-b852-c14e49c7071a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5f0d3168-bdbb-4208-b852-c14e49c7071a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f64ef704-f2da-4dd1-915a-566c32530514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f64ef704-f2da-4dd1-915a-566c32530514" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6c85589e-56bb-4deb-bdb9-2d4e30b4b31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6c85589e-56bb-4deb-bdb9-2d4e30b4b31f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dffdfbaa-1d22-439b-a353-2efef9b4ca12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dffdfbaa-1d22-439b-a353-2efef9b4ca12" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18f48534-bbd4-4710-b259-65b619c86856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18f48534-bbd4-4710-b259-65b619c86856" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_cba88286-86c9-40f0-aa17-d767e22f6d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_cba88286-86c9-40f0-aa17-d767e22f6d99" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_20d159f5-7b0c-4bae-b708-5cfcfb50d485" xlink:href="exas-20210930.xsd#exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_20d159f5-7b0c-4bae-b708-5cfcfb50d485" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8dee9e4c-5f32-463a-8785-48d3f18ad99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8dee9e4c-5f32-463a-8785-48d3f18ad99f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3dc30683-188e-4832-a116-e3075cc90d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3dc30683-188e-4832-a116-e3075cc90d0d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8be657e8-d1b2-4015-8521-16ea4eed928a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8be657e8-d1b2-4015-8521-16ea4eed928a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_326a98a8-bea0-4890-9160-3873433795c6" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_326a98a8-bea0-4890-9160-3873433795c6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_00bc94c3-0a31-4c82-8327-def927101388" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_00bc94c3-0a31-4c82-8327-def927101388" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_999ae443-747d-40d5-947b-85cbf2303f4f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_999ae443-747d-40d5-947b-85cbf2303f4f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1ca8f1fc-0dad-4faf-92cd-c385f3bfb92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1ca8f1fc-0dad-4faf-92cd-c385f3bfb92d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_61a61240-e5d4-4002-b3d2-a2563acb5e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_61a61240-e5d4-4002-b3d2-a2563acb5e7f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_17b59ccf-3f4c-4418-8305-42e729300baa" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_17b59ccf-3f4c-4418-8305-42e729300baa" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_56953dfa-6ad6-4360-8377-df3e28f630ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_56953dfa-6ad6-4360-8377-df3e28f630ec" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c5287794-016f-43f4-8288-bcc592c23725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c5287794-016f-43f4-8288-bcc592c23725" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_0c210cbd-f4ea-4d98-9c99-f768ae35e334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_0c210cbd-f4ea-4d98-9c99-f768ae35e334" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f4a107a-7685-4718-90e5-9f1b10a963d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f4a107a-7685-4718-90e5-9f1b10a963d9" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_635675b7-9966-4816-a1b0-afe6f2bfff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ShareBasedCompensation_635675b7-9966-4816-a1b0-afe6f2bfff4e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsPeriodExpense_a1c584f4-4f01-4773-9367-c6d4218f20d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_PostemploymentBenefitsPeriodExpense_a1c584f4-4f01-4773-9367-c6d4218f20d2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6d6ccfda-e66d-4621-a3d3-485e72155dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6d6ccfda-e66d-4621-a3d3-485e72155dfd" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_bc7212b0-a35f-4fae-afb9-0f2022ba0a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_bc7212b0-a35f-4fae-afb9-0f2022ba0a05" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_b35f8dcd-ffa9-45c1-99b5-f84398cd759d" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_b35f8dcd-ffa9-45c1-99b5-f84398cd759d" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_61947136-6dcc-45e1-9862-6ede0200de87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_61947136-6dcc-45e1-9862-6ede0200de87" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_379b5591-cd05-4db9-9151-09028a8fe505" xlink:href="exas-20210930.xsd#exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_379b5591-cd05-4db9-9151-09028a8fe505" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92e83665-2684-4601-aa35-3919dc5ad6f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92e83665-2684-4601-aa35-3919dc5ad6f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_c3f308e6-dc8e-466c-80e5-5d7605886537" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_AshionAnalyticsMember_c3f308e6-dc8e-466c-80e5-5d7605886537" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_02f65c10-f04f-4494-b026-00ab19698df1" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_02f65c10-f04f-4494-b026-00ab19698df1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_10e949f6-d17b-467e-b35d-aadfcce4d8fe" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_ParadigmViomicsMember_10e949f6-d17b-467e-b35d-aadfcce4d8fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember_25c4a66a-abe6-4753-8330-6182c146cd86" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_PFSGenomicsMember_25c4a66a-abe6-4753-8330-6182c146cd86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_f50e0028-67ed-4c61-bf68-6741f77dcf2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_f50e0028-67ed-4c61-bf68-6741f77dcf2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CommercialLaunchMilestoneMember_d652d66c-552c-482b-92f6-847af4de6ac6" xlink:href="exas-20210930.xsd#exas_CommercialLaunchMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_CommercialLaunchMilestoneMember_d652d66c-552c-482b-92f6-847af4de6ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MRDProductRevenueMilestoneMember_5b3dce41-f117-4657-8489-e3c0885c5057" xlink:href="exas-20210930.xsd#exas_MRDProductRevenueMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_MRDProductRevenueMilestoneMember_5b3dce41-f117-4657-8489-e3c0885c5057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FDAApprovalMember_fc2af115-bdad-46ec-8bd6-87562c80fea5" xlink:href="exas-20210930.xsd#exas_FDAApprovalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_FDAApprovalMember_fc2af115-bdad-46ec-8bd6-87562c80fea5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_85c8f301-da4b-4cda-904f-493d2bdd5fc3" xlink:href="exas-20210930.xsd#exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_85c8f301-da4b-4cda-904f-493d2bdd5fc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToConsiderationTransferredMember_be78c489-8aa2-479b-b780-808ca5163834" xlink:href="exas-20210930.xsd#exas_AllocatedToConsiderationTransferredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_AllocatedToConsiderationTransferredMember_be78c489-8aa2-479b-b780-808ca5163834" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToPreviousOwnershipInterestMember_436b14c6-093f-4981-9393-97b4a25041ff" xlink:href="exas-20210930.xsd#exas_AllocatedToPreviousOwnershipInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_AllocatedToPreviousOwnershipInterestMember_436b14c6-093f-4981-9393-97b4a25041ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToCompensationMember_4e14a38c-d7af-42db-a4ed-3e2da0cc1bb1" xlink:href="exas-20210930.xsd#exas_AllocatedToCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_AllocatedToCompensationMember_4e14a38c-d7af-42db-a4ed-3e2da0cc1bb1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CompensationExpenseMember_6358e49e-96e3-4505-af46-9da9db6136ab" xlink:href="exas-20210930.xsd#exas_CompensationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_CompensationExpenseMember_6358e49e-96e3-4505-af46-9da9db6136ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_54da8275-09f1-43d1-bb0b-0d04a7b943af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_54da8275-09f1-43d1-bb0b-0d04a7b943af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d3f98d2-60d7-4dfd-ab3e-515618483212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d3f98d2-60d7-4dfd-ab3e-515618483212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_5409cb7f-3c74-4f08-8a22-172664bbc19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:to="loc_us-gaap_InvestmentIncomeMember_5409cb7f-3c74-4f08-8a22-172664bbc19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_19563e47-1203-415f-8e17-d0aa60429745_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_19563e47-1203-415f-8e17-d0aa60429745_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_869a4508-c5f3-4aea-a882-37d7d2c86729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_869a4508-c5f3-4aea-a882-37d7d2c86729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7df086-8ca6-4110-87df-2a7d6b5c4a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_869a4508-c5f3-4aea-a882-37d7d2c86729" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7df086-8ca6-4110-87df-2a7d6b5c4a92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_46ca8484-d9dc-4980-92e8-3c4d4aa6f361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7df086-8ca6-4110-87df-2a7d6b5c4a92" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_46ca8484-d9dc-4980-92e8-3c4d4aa6f361" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e2a9810c-2d73-4d36-a70a-f1c6318bce6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e2a9810c-2d73-4d36-a70a-f1c6318bce6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_3b0c3080-edeb-4b54-a399-a272e66bb52d" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e2a9810c-2d73-4d36-a70a-f1c6318bce6b" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_3b0c3080-edeb-4b54-a399-a272e66bb52d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a2fff00-ff25-48c5-b5c1-ad0fe69b366f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a2fff00-ff25-48c5-b5c1-ad0fe69b366f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeesWithQualifyingTerminationEventsMember_873fd08e-99b2-463b-b3d5-cd6bc33fa9eb" xlink:href="exas-20210930.xsd#exas_EmployeesWithQualifyingTerminationEventsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a2fff00-ff25-48c5-b5c1-ad0fe69b366f" xlink:to="loc_exas_EmployeesWithQualifyingTerminationEventsMember_873fd08e-99b2-463b-b3d5-cd6bc33fa9eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1817ae2d-0c4c-4aa2-9619-9104cefc56c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1817ae2d-0c4c-4aa2-9619-9104cefc56c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3a6301dd-09fe-4610-83e5-a41f393be5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1817ae2d-0c4c-4aa2-9619-9104cefc56c9" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3a6301dd-09fe-4610-83e5-a41f393be5df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails" xlink:type="extended" id="i5782d9c4c6d343efa2a6d58b63af83b9_BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_b1cb0e4a-cd54-4b8b-ac97-e044391abb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_b1cb0e4a-cd54-4b8b-ac97-e044391abb59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8216c1d7-6309-4bba-8742-f7ecea683893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8216c1d7-6309-4bba-8742-f7ecea683893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_f9f0f537-60cd-4f07-9b60-26bd74f854b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_f9f0f537-60cd-4f07-9b60-26bd74f854b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d3676a1-892d-41e2-942e-056d843d815f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d3676a1-892d-41e2-942e-056d843d815f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7e06509-346e-4747-9d53-55af1ab2f155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7e06509-346e-4747-9d53-55af1ab2f155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_9423d9e1-e338-4839-b9e8-e2a8cceeb744" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7e06509-346e-4747-9d53-55af1ab2f155" xlink:to="loc_exas_AshionAnalyticsMember_9423d9e1-e338-4839-b9e8-e2a8cceeb744" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" xlink:type="extended" id="i8f370a0392ea47db9092acb420043972_BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_061c1ac8-2d30-42f0-90be-09561a1e21a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_061c1ac8-2d30-42f0-90be-09561a1e21a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a654e3db-2303-468f-9591-464eb82338b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a654e3db-2303-468f-9591-464eb82338b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fd6b5fd6-8fce-4074-a137-97be0bab4c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fd6b5fd6-8fce-4074-a137-97be0bab4c0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_583a2092-7ec6-4f06-8b21-553e34e57f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_583a2092-7ec6-4f06-8b21-553e34e57f47" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bfc406ca-df63-4546-ae5c-25e6a911106e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bfc406ca-df63-4546-ae5c-25e6a911106e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_4c88ae22-d7f6-4644-993a-6e0750631543" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_4c88ae22-d7f6-4644-993a-6e0750631543" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_563e1ceb-6320-4f6a-913f-7cfe2d2f7b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_563e1ceb-6320-4f6a-913f-7cfe2d2f7b53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_78e585c8-b338-487c-b924-ac9d4cf43bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_78e585c8-b338-487c-b924-ac9d4cf43bc2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a57f93b6-7b21-4087-9b5a-9425d2c57f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a57f93b6-7b21-4087-9b5a-9425d2c57f66" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_64bc9e1b-aa9d-42ad-b1f7-d044c4d7e794" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_64bc9e1b-aa9d-42ad-b1f7-d044c4d7e794" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_63429298-5516-4c5c-b0fc-5c5082f880f7" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_63429298-5516-4c5c-b0fc-5c5082f880f7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7007e838-c6c7-4718-ac68-14f498b833ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7007e838-c6c7-4718-ac68-14f498b833ce" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_d27bcd9c-17f1-4c00-b4d8-f4b240d53a33" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_d27bcd9c-17f1-4c00-b4d8-f4b240d53a33" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d490dde-195e-4dae-9234-a98d91f912d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d490dde-195e-4dae-9234-a98d91f912d1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c3ac7217-7a9d-4846-b7ea-5bafafde4324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c3ac7217-7a9d-4846-b7ea-5bafafde4324" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97632de4-c5f0-4208-9fbb-f1df9efec0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_Goodwill_97632de4-c5f0-4208-9fbb-f1df9efec0ac" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0fffb1f3-3eb9-4ade-aa76-55ed68e98480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0fffb1f3-3eb9-4ade-aa76-55ed68e98480" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e086991-ee92-4149-b37d-90440e5e39d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5e086991-ee92-4149-b37d-90440e5e39d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fcfd34-a0f5-4f40-b18c-8bbb2e130e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fcfd34-a0f5-4f40-b18c-8bbb2e130e0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_b2e1fa02-5518-4455-871a-d5ed5e9e929a" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fcfd34-a0f5-4f40-b18c-8bbb2e130e0b" xlink:to="loc_exas_AshionAnalyticsMember_b2e1fa02-5518-4455-871a-d5ed5e9e929a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" xlink:type="extended" id="iaee2549a307943fa969387786d95716e_BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b08a336f-18c8-4343-940d-022179479e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b08a336f-18c8-4343-940d-022179479e8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c287b915-b1e3-440f-9935-bda18fc7ffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c287b915-b1e3-440f-9935-bda18fc7ffaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_6596f431-53bc-438e-aec4-d68cadd5005e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_6596f431-53bc-438e-aec4-d68cadd5005e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards_4ee1a3d0-5741-4f96-93e6-817bf5e63eb6" xlink:href="exas-20210930.xsd#exas_BusinessCombinationFairValueOfReplacedEquityAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards_4ee1a3d0-5741-4f96-93e6-817bf5e63eb6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_71c1fa95-2d7b-48c2-ac0d-d0fad34f81c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_71c1fa95-2d7b-48c2-ac0d-d0fad34f81c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c7d19944-f9f3-4029-884b-9b85df6800f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c7d19944-f9f3-4029-884b-9b85df6800f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7d1123e7-9393-456b-933a-1a7356ed6bf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7d1123e7-9393-456b-933a-1a7356ed6bf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d92989e5-67b3-46c2-b9bf-c09c5eaf649e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d92989e5-67b3-46c2-b9bf-c09c5eaf649e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_00907da7-7fbe-4f7f-b925-ae5ae203ce34" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d92989e5-67b3-46c2-b9bf-c09c5eaf649e" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_00907da7-7fbe-4f7f-b925-ae5ae203ce34" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails" xlink:type="extended" id="i51c9317bb6ad41ab9bbd5730b50c1207_BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5b9456cf-083e-408c-bcd1-0fd2334b5934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5b9456cf-083e-408c-bcd1-0fd2334b5934" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3a4afe0d-1376-43f7-9206-e7da34756257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3a4afe0d-1376-43f7-9206-e7da34756257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f335df72-8f1f-4b42-a953-e51972071ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f335df72-8f1f-4b42-a953-e51972071ff0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c4f52d5e-6569-4281-9e67-6c89eab0b06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c4f52d5e-6569-4281-9e67-6c89eab0b06d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_a6ac2910-4d75-4f05-9cff-f2c91137988e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_a6ac2910-4d75-4f05-9cff-f2c91137988e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bfb86e28-210f-4ca0-aa84-78f099ddbe15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bfb86e28-210f-4ca0-aa84-78f099ddbe15" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c66542fb-1adf-4e22-8e7d-99a005a27d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c66542fb-1adf-4e22-8e7d-99a005a27d14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4835de7-76f2-463c-acee-ee3afb47470b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4835de7-76f2-463c-acee-ee3afb47470b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_459ef7d1-2378-4ef5-99cc-07ba08c3cde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4835de7-76f2-463c-acee-ee3afb47470b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_459ef7d1-2378-4ef5-99cc-07ba08c3cde0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_50d77ce9-660e-487a-994f-d404902aa8f5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:to="loc_srt_RangeMember_50d77ce9-660e-487a-994f-d404902aa8f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:to="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b83145a1-2f39-4ed8-b4b5-720ef03b10ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:to="loc_srt_MinimumMember_b83145a1-2f39-4ed8-b4b5-720ef03b10ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4278ce3b-cb13-4632-a132-b5aaac526636" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:to="loc_srt_MaximumMember_4278ce3b-cb13-4632-a132-b5aaac526636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_795536d0-9959-4d2c-a6bd-1eabef7c83a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_795536d0-9959-4d2c-a6bd-1eabef7c83a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a3ab886-2c9b-49c7-87b8-910afe3e05e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a3ab886-2c9b-49c7-87b8-910afe3e05e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_dae0f6f6-7d92-4d19-a372-f829e0ab7b64" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a3ab886-2c9b-49c7-87b8-910afe3e05e4" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_dae0f6f6-7d92-4d19-a372-f829e0ab7b64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" xlink:type="extended" id="ied60cccf70204c068ab3bf1efc24ad62_BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_df6a1d13-dff4-4ecb-843c-c17a2d446542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_df6a1d13-dff4-4ecb-843c-c17a2d446542" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_00f78aa6-070e-4f3f-b5c5-bffa4bf40b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_00f78aa6-070e-4f3f-b5c5-bffa4bf40b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_fc512447-abce-4362-bc34-03709dd70085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_fc512447-abce-4362-bc34-03709dd70085" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6888c4e8-679f-4780-8208-535dc3aee144" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6888c4e8-679f-4780-8208-535dc3aee144" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dc94f59-c12d-4908-906c-a95b92916196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dc94f59-c12d-4908-906c-a95b92916196" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_608e9f0a-1cf0-4d67-9b85-03d2dc76097c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_608e9f0a-1cf0-4d67-9b85-03d2dc76097c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5dfb05b8-3ddf-4d80-bf23-fb8ba25ea724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5dfb05b8-3ddf-4d80-bf23-fb8ba25ea724" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_191e4657-0bf7-41ac-b157-665af9e1ea8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_191e4657-0bf7-41ac-b157-665af9e1ea8b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_99453cb9-489d-439a-b01e-7c3c0d8e8bd1" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_99453cb9-489d-439a-b01e-7c3c0d8e8bd1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_108e702c-8c1e-45bd-ae13-ebb3ecfebc7d" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_108e702c-8c1e-45bd-ae13-ebb3ecfebc7d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_e73c54ca-5fcf-4935-9350-b2c7977e569b" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_e73c54ca-5fcf-4935-9350-b2c7977e569b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f67d9f76-c34c-48dd-b837-69d8f3bfb0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f67d9f76-c34c-48dd-b837-69d8f3bfb0de" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6e90f056-5c81-4540-9d17-d0d6d490f6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6e90f056-5c81-4540-9d17-d0d6d490f6d7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_dc3eee05-c48e-438c-9559-de69d756cf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_dc3eee05-c48e-438c-9559-de69d756cf6d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_68ca5e00-50bb-4efb-bfbc-2ef58b8c4841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_Goodwill_68ca5e00-50bb-4efb-bfbc-2ef58b8c4841" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_324558f1-c9fc-4579-8819-f1ff92896860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_324558f1-c9fc-4579-8819-f1ff92896860" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_836437b9-d318-4864-a3af-4041885761f2" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_836437b9-d318-4864-a3af-4041885761f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_80f365f9-4140-4879-8b12-bb7406756a30" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_80f365f9-4140-4879-8b12-bb7406756a30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_e3199096-0206-4ed6-bc6f-581d0c4ef1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_e3199096-0206-4ed6-bc6f-581d0c4ef1a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_19810135-2d90-4495-b1f6-87b557269c03" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_19810135-2d90-4495-b1f6-87b557269c03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_2c5ae7c1-eb32-483e-a330-9d7002152863" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_2c5ae7c1-eb32-483e-a330-9d7002152863" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_205cfc31-2319-4ffe-97c2-7cbedd94814d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_205cfc31-2319-4ffe-97c2-7cbedd94814d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_4f2be099-0d55-4fd2-965b-bbef143bb70f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_4f2be099-0d55-4fd2-965b-bbef143bb70f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_9e6c66c9-bbec-43f1-bc55-342edeb85e86" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_9e6c66c9-bbec-43f1-bc55-342edeb85e86" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_b2dadbf0-35c1-4ac0-abab-f5ddc6e6e3dc" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_b2dadbf0-35c1-4ac0-abab-f5ddc6e6e3dc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_4d99416c-9abc-4491-bf02-f40cdf5898e0" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_4d99416c-9abc-4491-bf02-f40cdf5898e0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_634ea05a-328d-4692-8a3c-2b7222abf180" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_634ea05a-328d-4692-8a3c-2b7222abf180" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_d2e1d772-26dc-4e61-9910-1b56dfe87966" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_d2e1d772-26dc-4e61-9910-1b56dfe87966" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_cb786bcb-abc1-4278-9c59-8480be0cd439" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_cb786bcb-abc1-4278-9c59-8480be0cd439" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_bda300ed-d802-4a6a-9fc4-88f97e400e78" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_bda300ed-d802-4a6a-9fc4-88f97e400e78" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_55b8926c-8f31-4f75-bc49-b7c50ab5949b" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_55b8926c-8f31-4f75-bc49-b7c50ab5949b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_8d3908b0-46c7-4b2a-ac75-0fb4b3e44094" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_8d3908b0-46c7-4b2a-ac75-0fb4b3e44094" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cdd4e99e-fbea-4537-84dc-68e1ca0639e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cdd4e99e-fbea-4537-84dc-68e1ca0639e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a9e3ec5-c328-4fc6-8faf-bf998fc09572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a9e3ec5-c328-4fc6-8faf-bf998fc09572" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_bd5c0fc5-ef31-405a-985d-dd11fc848eaf" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a9e3ec5-c328-4fc6-8faf-bf998fc09572" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_bd5c0fc5-ef31-405a-985d-dd11fc848eaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails" xlink:type="extended" id="i5a007f928a234d60a9baf33123cf1fc2_BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_20270665-4ac9-407c-a411-ca40ddab6a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_20270665-4ac9-407c-a411-ca40ddab6a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_8837d088-4e1e-444c-a37d-aa850a645cc8" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionProFormaIncomeLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:to="loc_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_8837d088-4e1e-444c-a37d-aa850a645cc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a2e0b14-dd98-4a4a-ad3c-83b549285896_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0a2e0b14-dd98-4a4a-ad3c-83b549285896_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d60e4b16-255e-4a1c-83b0-a425bfef05aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d60e4b16-255e-4a1c-83b0-a425bfef05aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_fff3652e-3992-4f5a-8d41-71eb9238b582" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d60e4b16-255e-4a1c-83b0-a425bfef05aa" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_fff3652e-3992-4f5a-8d41-71eb9238b582" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" xlink:type="extended" id="ic82679500e3f409486f16a7fe8d2567b_BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_dfc8c4ca-de91-4616-af77-f7ecdb37321f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_dfc8c4ca-de91-4616-af77-f7ecdb37321f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5262fd15-8f9b-4317-8fd7-9ac193288c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_Goodwill_5262fd15-8f9b-4317-8fd7-9ac193288c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6afcac0d-14ab-4588-8bfb-c974091367f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6afcac0d-14ab-4588-8bfb-c974091367f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_200b4d5e-ea0b-4927-bf6e-333a989c7cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_200b4d5e-ea0b-4927-bf6e-333a989c7cda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f6625e86-d707-4f6b-9927-ef4ea725175e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f6625e86-d707-4f6b-9927-ef4ea725175e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_36a04b61-a579-4eb6-a481-97d71d92dac8" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_36a04b61-a579-4eb6-a481-97d71d92dac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_629f6e0f-0346-449d-8e6f-d22fd245cb55" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_629f6e0f-0346-449d-8e6f-d22fd245cb55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_c0cad0c0-0bee-4b35-94e0-f85eeee37d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_c0cad0c0-0bee-4b35-94e0-f85eeee37d11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_b8924ae7-b5be-4b02-aa2f-48620b1d5aea" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_b8924ae7-b5be-4b02-aa2f-48620b1d5aea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_f0f9f7a6-d4ac-4d1c-9b0b-11425edfd541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_f0f9f7a6-d4ac-4d1c-9b0b-11425edfd541" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511d0684-8009-44ed-8958-fa13c88b72fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_511d0684-8009-44ed-8958-fa13c88b72fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44b30286-3172-4a2b-a634-a3c813107402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44b30286-3172-4a2b-a634-a3c813107402" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_748baf81-1c7a-4b6f-8b34-651b2f05ff9d" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44b30286-3172-4a2b-a634-a3c813107402" xlink:to="loc_exas_ParadigmViomicsMember_748baf81-1c7a-4b6f-8b34-651b2f05ff9d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails" xlink:type="extended" id="ie6c3e73e6555467b85a97b770a224ad8_BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98e92e4a-cd65-4703-932d-279cc69b1277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98e92e4a-cd65-4703-932d-279cc69b1277" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c699a856-9994-4c8f-96bc-6f1747c1263c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c699a856-9994-4c8f-96bc-6f1747c1263c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_1b7e8588-0596-4419-a03e-b0760a0d792c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_1b7e8588-0596-4419-a03e-b0760a0d792c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7307e56d-e93f-4c95-ad84-1fd3a03a739f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7307e56d-e93f-4c95-ad84-1fd3a03a739f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_145443d2-9044-46fa-8688-bc404e84e8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_145443d2-9044-46fa-8688-bc404e84e8f8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_54597acd-9726-4515-ba2c-838c06b6a97d" xlink:href="exas-20210930.xsd#exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_54597acd-9726-4515-ba2c-838c06b6a97d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_13605954-7b50-4df4-a42e-addd0010056f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_13605954-7b50-4df4-a42e-addd0010056f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsContingentOnMilestonesPayable_4c5a3213-5919-4c3b-be0a-56ec81baf5e4" xlink:href="exas-20210930.xsd#exas_PaymentsContingentOnMilestonesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_exas_PaymentsContingentOnMilestonesPayable_4c5a3213-5919-4c3b-be0a-56ec81baf5e4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_71bf12bb-98ca-4404-8382-075a548c5d33" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_71bf12bb-98ca-4404-8382-075a548c5d33" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7_default" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeOneMember_403c3e4e-8c38-46f8-af46-32060ffb718f" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:to="loc_exas_SalesMilestoneRangeOneMember_403c3e4e-8c38-46f8-af46-32060ffb718f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeTwoMember_0e673c28-9786-4d05-921e-151c4d517897" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:to="loc_exas_SalesMilestoneRangeTwoMember_0e673c28-9786-4d05-921e-151c4d517897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_7a66fbdf-3e47-440a-9ccf-c7dabc952237_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:to="loc_us-gaap_AssetAcquisitionDomain_7a66fbdf-3e47-440a-9ccf-c7dabc952237_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_9382533b-9e36-4389-885b-60011bf67a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:to="loc_us-gaap_AssetAcquisitionDomain_9382533b-9e36-4389-885b-60011bf67a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TARDISTechnologyMember_aa66ac9a-e7a3-4fd1-80e9-e0c0a3327e3a" xlink:href="exas-20210930.xsd#exas_TARDISTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_9382533b-9e36-4389-885b-60011bf67a96" xlink:to="loc_exas_TARDISTechnologyMember_aa66ac9a-e7a3-4fd1-80e9-e0c0a3327e3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c74f24d-c33c-42a5-969a-0454cb1e4c29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c74f24d-c33c-42a5-969a-0454cb1e4c29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37d94f13-bdd7-4075-9dbd-9e27962a6b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37d94f13-bdd7-4075-9dbd-9e27962a6b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember_067586bb-084c-4ca2-b3a6-937a87a22a35" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37d94f13-bdd7-4075-9dbd-9e27962a6b32" xlink:to="loc_exas_PFSGenomicsMember_067586bb-084c-4ca2-b3a6-937a87a22a35" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails" xlink:type="extended" id="i363ae31058e24067bce4c395f5c3f6c8_BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_91b74750-8932-4c91-99c5-555b112fc070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_91b74750-8932-4c91-99c5-555b112fc070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_9aba7353-2320-4d53-b7dd-b96b3c28bc63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_9aba7353-2320-4d53-b7dd-b96b3c28bc63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4e14d32e-3b99-4807-8783-0e3abb865aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4e14d32e-3b99-4807-8783-0e3abb865aa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_13d76436-cb34-4b13-bfa0-e0154c2d536f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_13d76436-cb34-4b13-bfa0-e0154c2d536f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_128d2466-1819-4594-a0fb-c429df987f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_128d2466-1819-4594-a0fb-c429df987f56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b72f46d6-4def-4bc0-bd35-c9f279501e42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b72f46d6-4def-4bc0-bd35-c9f279501e42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50b50163-97cf-4d50-8bb0-380f4b3f3f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50b50163-97cf-4d50-8bb0-380f4b3f3f51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember_0d08c677-6069-4afc-a96b-13f9a3b10497" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50b50163-97cf-4d50-8bb0-380f4b3f3f51" xlink:to="loc_exas_PFSGenomicsMember_0d08c677-6069-4afc-a96b-13f9a3b10497" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#SEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="extended" id="ic4a2591653bb4fecbabba174f62299c9_SEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5b786de9-8ec3-4b1d-aa51-d3ca5d00ae69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5b786de9-8ec3-4b1d-aa51-d3ca5d00ae69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01eda3ba-5b48-48b2-a2a9-b5ccdfda7b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01eda3ba-5b48-48b2-a2a9-b5ccdfda7b95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:to="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_74fb158e-c092-4352-bce7-2f908141d92f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:to="loc_srt_SegmentGeographicalDomain_74fb158e-c092-4352-bce7-2f908141d92f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:to="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_832c023e-22f0-4b64-bc00-7735a0f80cb7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:to="loc_country_US_832c023e-22f0-4b64-bc00-7735a0f80cb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_aab06f64-e9b0-4ccd-ae8e-dec2d5fdc504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:to="loc_us-gaap_NonUsMember_aab06f64-e9b0-4ccd-ae8e-dec2d5fdc504" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>exas-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:62297662-2bfb-41ec-9bf7-9eb144772313,g:499e252f-fe94-4d47-8333-c3acba229b0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent_4b44e459-1a57-41e6-bf5a-7fd49f058e40_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount drawn from loan</link:label>
    <link:label id="lab_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Construction Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermConstructionLoanCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent" xlink:to="lab_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_0e11b5e0-c024-45b7-b22d-472e0f74e527_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_cb3f5822-bce0-4c99-8e54-4ecb3f62f306_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d1006cf2-2e4d-41d8-9e3a-de62942d6368_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AllocatedToCompensationMember_a187734e-39b5-4deb-b115-f56ac2a18b55_terseLabel_en-US" xlink:label="lab_exas_AllocatedToCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Compensation</link:label>
    <link:label id="lab_exas_AllocatedToCompensationMember_label_en-US" xlink:label="lab_exas_AllocatedToCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Compensation [Member]</link:label>
    <link:label id="lab_exas_AllocatedToCompensationMember_documentation_en-US" xlink:label="lab_exas_AllocatedToCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToCompensationMember" xlink:href="exas-20210930.xsd#exas_AllocatedToCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AllocatedToCompensationMember" xlink:to="lab_exas_AllocatedToCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_3893d4a2-f0eb-4303-a151-465913a151d6_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_ccf9ca6a-65e7-4efb-a6d3-d8a627f93abf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_924ab9b1-33e6-4d0e-8336-fd353beac21e_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_662c635b-a4f2-4640-9c92-5daf6e88d04b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_65f2fb4f-1a82-4941-b568-db426e712095_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5f33f12b-db98-4340-9f60-6f992fbd8bb7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_StockBasedCompensationPlansMember_64181b42-345a-4bb5-9afa-3cf42f43dcfa_terseLabel_en-US" xlink:label="lab_exas_StockBasedCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plans</link:label>
    <link:label id="lab_exas_StockBasedCompensationPlansMember_label_en-US" xlink:label="lab_exas_StockBasedCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Based Compensation Plans [Member]</link:label>
    <link:label id="lab_exas_StockBasedCompensationPlansMember_documentation_en-US" xlink:label="lab_exas_StockBasedCompensationPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company maintains the 2010 Omnibus Long-Term Incentive Plan (As Amended and Restated Effective July 27, 2017), the 2010 Employee Stock Purchase Plan, the 2015 Inducement Award Plan, the 2016 Inducement Award Plan and the 2000 Stock Option and Incentive Plan (collectively, the "Stock Plans").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_StockBasedCompensationPlansMember" xlink:href="exas-20210930.xsd#exas_StockBasedCompensationPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_StockBasedCompensationPlansMember" xlink:to="lab_exas_StockBasedCompensationPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_3145bdb7-1627-4087-9e2e-d8df520a9bbc_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_3e1c82a1-cb2d-435d-a5c5-3165ad52c7e2_terseLabel_en-US" xlink:label="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin Economic Development Tax Credit Agreement</link:label>
    <link:label id="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_label_en-US" xlink:label="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin Economic Development Tax Credit Agreement [Member]</link:label>
    <link:label id="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_documentation_en-US" xlink:label="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information relating to the agreement with the Wisconsin Economic Development Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" xlink:href="exas-20210930.xsd#exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" xlink:to="lab_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c05686f1-1cc2-46d7-ad78-c1f64e62954b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_639930fb-1966-4ce6-8655-5642b883f33a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of business acquisitions, by acquisition</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_4c7eb6ee-e4dd-4490-a350-d7babd428105_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_8f1b0522-9a8b-4935-8e74-e7767beca720_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_3c7a07a2-17e2-439a-b86b-32186f49e941_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentAmountSettledInExtinguishment_8279a090-b104-4687-99bb-b7eb1499c2b6_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentAmountSettledInExtinguishment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt extinguished</link:label>
    <link:label id="lab_exas_DebtInstrumentAmountSettledInExtinguishment_label_en-US" xlink:label="lab_exas_DebtInstrumentAmountSettledInExtinguishment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Amount Settled In Extinguishment</link:label>
    <link:label id="lab_exas_DebtInstrumentAmountSettledInExtinguishment_documentation_en-US" xlink:label="lab_exas_DebtInstrumentAmountSettledInExtinguishment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, Amount Settled In Extinguishment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentAmountSettledInExtinguishment" xlink:href="exas-20210930.xsd#exas_DebtInstrumentAmountSettledInExtinguishment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentAmountSettledInExtinguishment" xlink:to="lab_exas_DebtInstrumentAmountSettledInExtinguishment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_58d24044-13d2-4d7b-abd7-85c0bb940816_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_61abf481-6f9a-4d92-95fa-4bd27b25f7e7_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f465780d-45a7-4781-a775-a852ac1bac6f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_45e83a40-7cfd-41d2-b0e6-08984cc04c6c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_715111fe-8523-441c-9cb4-3acf8dc8e8f6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_LicensingAgreementDisclosureTextBlock_835bae4f-c5d5-4023-9d2d-d0429b1f45ae_terseLabel_en-US" xlink:label="lab_exas_LicensingAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LICENSE AND COLLABORATION AGREEMENTS</link:label>
    <link:label id="lab_exas_LicensingAgreementDisclosureTextBlock_label_en-US" xlink:label="lab_exas_LicensingAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreement Disclosure [Text Block]</link:label>
    <link:label id="lab_exas_LicensingAgreementDisclosureTextBlock_documentation_en-US" xlink:label="lab_exas_LicensingAgreementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the entire disclosure related to licensing agreement entered by an entity during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LicensingAgreementDisclosureTextBlock" xlink:href="exas-20210930.xsd#exas_LicensingAgreementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_LicensingAgreementDisclosureTextBlock" xlink:to="lab_exas_LicensingAgreementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_be7e83ac-0dda-4aca-82a0-31ec548881ce_verboseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable assets acquired</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_a5cc41db-9467-4c55-ac22-f2eddd6bb93b_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_80f3ad9f-5bb5-479e-b7fe-f89b2b5fa4bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_1c0bb980-dc9b-4e99-b7f9-9f1496ecd550_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_485eb822-fa2f-4a64-a58b-99027745e4f7_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_80257920-66aa-46b6-81ba-6667e332c67f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_dc884e46-ef97-4103-8e36-68270c1748bb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_abc6eb3a-c008-455a-8ee4-6420f957edd5_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_a3f7f7b6-03e0-458b-970b-cf1e16b8ef0c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cd483332-fd2b-48bd-830b-d13d58a8ada8_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f7fe1bb4-5dca-4aa0-9d2d-f1eef2afeba4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average lease term remaining</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_54c050fa-45cd-488e-bb01-11b39c03b506_terseLabel_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through acquisition (in shares)</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_label_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Assumed in Period Through Acquisitions</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_documentation_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Assumed in Period Through Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" xlink:to="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DOSRuleInvestigationMember_53272414-9a57-471b-a25c-d907aa3196c1_terseLabel_en-US" xlink:label="lab_exas_DOSRuleInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOS Rule Investigation</link:label>
    <link:label id="lab_exas_DOSRuleInvestigationMember_label_en-US" xlink:label="lab_exas_DOSRuleInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOS Rule Investigation [Member]</link:label>
    <link:label id="lab_exas_DOSRuleInvestigationMember_documentation_en-US" xlink:label="lab_exas_DOSRuleInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DOS Rule Investigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DOSRuleInvestigationMember" xlink:href="exas-20210930.xsd#exas_DOSRuleInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DOSRuleInvestigationMember" xlink:to="lab_exas_DOSRuleInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a1007764-7203-46be-9b2b-29d74b24a75f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_72384013-cc56-4576-8221-bcf41443be64_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current period change in accumulated other comprehensive loss, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_c8dbdad2-4387-4c49-86d3-9d24b7a5c4fe_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment acquired but not paid</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d956e8be-903f-42d9-ae59-6067a3f6fdd2_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ad7b9e96-b5e2-4820-a00f-9625d3f2746a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8b5454be-103c-4d15-9ec7-b89f0fe5924d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_f5728bef-135b-4057-a551-65089d59822e_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_48cc12ed-bfd8-4f3b-8ed5-6f899335383f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsPeriodExpense_8fef5bd5-4fa7-4fa2-aaa6-442c6b131d90_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional benefit charges</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitsPeriodExpense_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits, Period Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsPeriodExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsPeriodExpense" xlink:to="lab_us-gaap_PostemploymentBenefitsPeriodExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_8185bd33-6c02-4c13-b60a-08566f66839f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt, if-converted (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Number of Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:to="lab_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_218a644e-bd7c-4046-96b6-68c5534fe3ba_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d35aa399-4dee-479f-8185-541a412f0da6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_8f98962c-41c7-4d04-81c5-bfba2cd0f5df_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount used to pay off interest accrued</link:label>
    <link:label id="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_label_en-US" xlink:label="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Equity Component, Interest Accrued</link:label>
    <link:label id="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_documentation_en-US" xlink:label="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents amount used to pay off interest accrued.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" xlink:href="exas-20210930.xsd#exas_DebtInstrumentConvertibleEquityComponentInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" xlink:to="lab_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_da4c858e-55b8-48fe-8a84-8670dce895c3_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_a30f9763-187c-446b-bbc9-ca5f33bc43c5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_4191ddab-792c-4110-8487-dc460bc1040d_negatedTerseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_792f2640-bfca-4de7-bdfd-f86482e1630b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AshionAnalyticsMember_5af86a8c-6016-47b3-83c7-7e7a45c575d2_terseLabel_en-US" xlink:label="lab_exas_AshionAnalyticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ashion Analytics</link:label>
    <link:label id="lab_exas_AshionAnalyticsMember_label_en-US" xlink:label="lab_exas_AshionAnalyticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ashion Analytics [Member]</link:label>
    <link:label id="lab_exas_AshionAnalyticsMember_documentation_en-US" xlink:label="lab_exas_AshionAnalyticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ashion Analytics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AshionAnalyticsMember" xlink:to="lab_exas_AshionAnalyticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_481d0e2a-7d1e-44d8-b144-1dce070c4584_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_484850e4-be22-469e-9df9-3b3ed8a88b5e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3ac70012-92af-42ef-99e8-6ff04079cfff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_fd790d69-f7fc-4b5e-a3a4-48469dee0a48_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Long-term Assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Long-term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2d6b1ab0-6e6c-42cd-b5b4-31c2c8ed8a34_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_88c76453-027b-4c53-8f7c-18b42a166d96_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2d0f5495-9718-41de-a375-04e34bcc86d7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c9c37a7f-1e2c-4c64-b6f6-9c5b49ca9ac0_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining useful life of finite-lived intangible asset (in years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_January2025NotesMember_8d032c06-c005-4084-84f1-65e1a7f23fd6_terseLabel_en-US" xlink:label="lab_exas_January2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2025 Notes</link:label>
    <link:label id="lab_exas_January2025NotesMember_label_en-US" xlink:label="lab_exas_January2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2025 Notes [Member]</link:label>
    <link:label id="lab_exas_January2025NotesMember_documentation_en-US" xlink:label="lab_exas_January2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_January2025NotesMember" xlink:href="exas-20210930.xsd#exas_January2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_January2025NotesMember" xlink:to="lab_exas_January2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_c69799ff-5573-46b4-9876-a04d5bd10ca8_verboseLabel_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination contingent consideration liability</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_b98db1de-6e7f-4b9e-8411-5cf3d40b81ee_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price contingent consideration</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_label_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Increase Due to Acquisition</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_documentation_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Increase Due to Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:to="lab_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f399f537-bf18-4cf3-9eeb-1e9260621fa1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d9a0ad1c-b778-4d39-948d-b9e804bc806b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_218e0aa1-4c85-4f5d-bb55-ea7b75ed3c31_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f0811b55-c6cf-4593-a9cd-11b8c0945a18_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, revenue recognized during period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_dfb49f69-9d9e-4888-a8b5-343f16a94fe9_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_29e9dfea-f8d8-4814-baaf-a8a314dfc682_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, pro forma loss</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_91f693c9-05a3-4be7-a420-5e5308fa37f3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_ef34ba43-d08d-46d6-bf41-707acec022a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of equity instruments other than options vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cccc1d63-3803-476d-8e84-54911d90cd8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_000c80b3-3b72-4289-b9ea-cdf2e125061c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_2dbeee05-fab1-4116-9abe-970ae1c58a64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, performance shares, activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_97f55d34-0bd0-4c44-9dd7-e284a238122b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_OneMonthLondonInterbankOfferRateMember_0b7b5492-a2b0-4b95-bd7d-7a32fbd4246f_terseLabel_en-US" xlink:label="lab_exas_OneMonthLondonInterbankOfferRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1-month LIBOR</link:label>
    <link:label id="lab_exas_OneMonthLondonInterbankOfferRateMember_label_en-US" xlink:label="lab_exas_OneMonthLondonInterbankOfferRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Month London Interbank Offer Rate [Member]</link:label>
    <link:label id="lab_exas_OneMonthLondonInterbankOfferRateMember_documentation_en-US" xlink:label="lab_exas_OneMonthLondonInterbankOfferRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at which a bank borrows funds from other banks in the one-month London interbank market.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_OneMonthLondonInterbankOfferRateMember" xlink:href="exas-20210930.xsd#exas_OneMonthLondonInterbankOfferRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_OneMonthLondonInterbankOfferRateMember" xlink:to="lab_exas_OneMonthLondonInterbankOfferRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CommercialLaunchMilestoneMember_1427f878-b693-4180-84c1-8b776c77891d_terseLabel_en-US" xlink:label="lab_exas_CommercialLaunchMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Launch Milestone</link:label>
    <link:label id="lab_exas_CommercialLaunchMilestoneMember_label_en-US" xlink:label="lab_exas_CommercialLaunchMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Launch Milestone [Member]</link:label>
    <link:label id="lab_exas_CommercialLaunchMilestoneMember_documentation_en-US" xlink:label="lab_exas_CommercialLaunchMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Launch Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CommercialLaunchMilestoneMember" xlink:href="exas-20210930.xsd#exas_CommercialLaunchMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CommercialLaunchMilestoneMember" xlink:to="lab_exas_CommercialLaunchMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_9c9c3884-01d1-461e-a2b6-1205eff239de_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_InventoryFinishedAndSemiFinishedGoods_f0dfc0cc-e71a-4e59-98ff-0d0219b182f7_terseLabel_en-US" xlink:label="lab_exas_InventoryFinishedAndSemiFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Semi-finished and finished goods</link:label>
    <link:label id="lab_exas_InventoryFinishedAndSemiFinishedGoods_label_en-US" xlink:label="lab_exas_InventoryFinishedAndSemiFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished and Semi Finished Goods</link:label>
    <link:label id="lab_exas_InventoryFinishedAndSemiFinishedGoods_documentation_en-US" xlink:label="lab_exas_InventoryFinishedAndSemiFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before valuation and LIFO reserves of completed merchandise/goods and merchandise/goods expected to be completed within one year of operating cycle that are expected to be sold within one year or operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InventoryFinishedAndSemiFinishedGoods" xlink:href="exas-20210930.xsd#exas_InventoryFinishedAndSemiFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_InventoryFinishedAndSemiFinishedGoods" xlink:to="lab_exas_InventoryFinishedAndSemiFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4edf9bc-937d-4413-9fd1-b595104f3b3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_c5c5f5f9-2e47-4ad0-afeb-8f7125b1e0f3_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cologuard promotion agreement</link:label>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_label_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufactured Product, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturedProductOtherMember" xlink:to="lab_us-gaap_ManufacturedProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_7e87fb20-9809-416b-b0ff-d22fce3e63d1_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of convertible note obligations included in the condensed consolidated balance sheets</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_39d4a09f-44cb-4226-9164-fe81728b9cd1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_340a4ad1-c6bc-43f0-8252-367cc7b3cbb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b82d0a68-5a11-4b41-a240-210f9eb073b6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_OfficeEquipmentAndComputerSoftwareMember_36ad4142-f667-44af-8dc3-4f6f79782b82_terseLabel_en-US" xlink:label="lab_exas_OfficeEquipmentAndComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and computer software</link:label>
    <link:label id="lab_exas_OfficeEquipmentAndComputerSoftwareMember_label_en-US" xlink:label="lab_exas_OfficeEquipmentAndComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment And Computer Software [Member]</link:label>
    <link:label id="lab_exas_OfficeEquipmentAndComputerSoftwareMember_documentation_en-US" xlink:label="lab_exas_OfficeEquipmentAndComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information relating to office equipment and computer software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_OfficeEquipmentAndComputerSoftwareMember" xlink:href="exas-20210930.xsd#exas_OfficeEquipmentAndComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_OfficeEquipmentAndComputerSoftwareMember" xlink:to="lab_exas_OfficeEquipmentAndComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_fa3f5bdf-e781-4fd2-ab3c-15f92d5b1050_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_c028d1d6-de4c-41e1-bdf8-dac530807a08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b6f8d1c4-87af-4b21-a47c-73050277dc21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_8ead0134-c86b-45e6-b101-49d5f43ff938_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_d7838574-205a-40f9-b29b-7fa1f170ecc2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingExpense_29848fa6-d138-4371-a6df-1da6b7f254ac_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges for promotion, sales and marketing</link:label>
    <link:label id="lab_us-gaap_MarketingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingExpense" xlink:to="lab_us-gaap_MarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_bf436020-9a3c-4313-9964-cfa349986ff2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of contractual maturities of available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fcdd3a52-b480-48c4-b1c5-0c022a50897f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fe76cb9f-d0dd-473e-bccd-05a4277f2750_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7c8e20d7-d4e4-4c56-a439-6fe4a3edec34_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS AND GOODWILL</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_c2cf0eef-a15e-4df5-8207-033a244b112e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value Authorized&#8212;5,000,000 shares issued and outstanding&#8212;no shares at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_5e40d50d-a208-4964-b65d-27b59ebb52b6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of common stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_a6dad76f-7347-474d-baeb-82313e921ec0_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a2b4f6ba-3a34-48a8-a9ee-f6d5d58e2afc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30bd473d-6312-4681-a664-3b260d58cace_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e3fe4962-bab8-4869-a1b9-ec3f8d755a21_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_3b7394fa-b315-4e12-8177-5c88105ad844_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued, price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_June2025NotesMember_f0c8237a-e2b0-4240-83f4-c75f3b9233ed_terseLabel_en-US" xlink:label="lab_exas_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:label id="lab_exas_June2025NotesMember_label_en-US" xlink:label="lab_exas_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes [Member]</link:label>
    <link:label id="lab_exas_June2025NotesMember_documentation_en-US" xlink:label="lab_exas_June2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_June2025NotesMember" xlink:href="exas-20210930.xsd#exas_June2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_June2025NotesMember" xlink:to="lab_exas_June2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_c4390b62-176a-4632-b0a1-457150214cab_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, liability, noncurrent, statement of financial position, extensible list</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_da83e65d-99b8-4cbb-aaab-f3ffc5a1f8ad_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_6d25e3b8-4d74-416c-bfc5-e78d53c070e4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit&#8203;</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RefundableTaxCreditReceivable_8ac21917-05a9-463a-9664-88dafbac322a_terseLabel_en-US" xlink:label="lab_exas_RefundableTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable tax credit receivable</link:label>
    <link:label id="lab_exas_RefundableTaxCreditReceivable_label_en-US" xlink:label="lab_exas_RefundableTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Tax Credit Receivable</link:label>
    <link:label id="lab_exas_RefundableTaxCreditReceivable_documentation_en-US" xlink:label="lab_exas_RefundableTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of refundable tax credit receivable as of the end of the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditReceivable" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RefundableTaxCreditReceivable" xlink:to="lab_exas_RefundableTaxCreditReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_921a7b12-8c74-4dc3-a831-99d0602b50ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_04ce12ea-80d6-47c4-9aee-a363318ac01c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_118d5dd5-dcb3-467c-aa6f-8d5488d82d35_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards_a8c467f5-23ed-4a51-90f5-427011f3c786_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replaced equity awards</link:label>
    <link:label id="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards_label_en-US" xlink:label="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Fair value of Replaced Equity Awards</link:label>
    <link:label id="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards_documentation_en-US" xlink:label="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Fair value of Replaced Equity Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards" xlink:href="exas-20210930.xsd#exas_BusinessCombinationFairValueOfReplacedEquityAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards" xlink:to="lab_exas_BusinessCombinationFairValueOfReplacedEquityAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_180f5f20-a767-4df6-84f4-4f3af46fc07a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible notes, net of tax</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_b6790a54-50c6-400c-b616-bca88e459b28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CashAndMoneyMarketMember_cac4cd38-c679-4b13-b43a-b18fcd6bb9cd_terseLabel_en-US" xlink:label="lab_exas_CashAndMoneyMarketMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and money market</link:label>
    <link:label id="lab_exas_CashAndMoneyMarketMember_label_en-US" xlink:label="lab_exas_CashAndMoneyMarketMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Money Market [Member]</link:label>
    <link:label id="lab_exas_CashAndMoneyMarketMember_documentation_en-US" xlink:label="lab_exas_CashAndMoneyMarketMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding cash and money market balances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CashAndMoneyMarketMember" xlink:href="exas-20210930.xsd#exas_CashAndMoneyMarketMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CashAndMoneyMarketMember" xlink:to="lab_exas_CashAndMoneyMarketMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_GenomicHealthIncMember_e83f0683-67bc-4fe1-ae2b-900439f9a25a_terseLabel_en-US" xlink:label="lab_exas_GenomicHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Agreement with Genomic Health, Inc.</link:label>
    <link:label id="lab_exas_GenomicHealthIncMember_label_en-US" xlink:label="lab_exas_GenomicHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genomic Health Inc [Member]</link:label>
    <link:label id="lab_exas_GenomicHealthIncMember_documentation_en-US" xlink:label="lab_exas_GenomicHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to Genomic Health, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_GenomicHealthIncMember" xlink:href="exas-20210930.xsd#exas_GenomicHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_GenomicHealthIncMember" xlink:to="lab_exas_GenomicHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_860ed97c-842f-4981-8b97-257a322e6f6e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of gross unrealized losses and fair values of investments in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_0fe4e7b5-5d29-4604-af0e-fa2464b51fc9_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_89ccd405-0339-48c5-a198-43f8f04859f8_terseLabel_en-US" xlink:label="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</link:label>
    <link:label id="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_label_en-US" xlink:label="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS [Abstract]</link:label>
    <link:label id="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_documentation_en-US" xlink:label="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin Economic Development Tax Credit Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" xlink:href="exas-20210930.xsd#exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" xlink:to="lab_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_8fd8226e-75c9-44ec-aabc-a6362729273b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_b6759d1e-7c7e-47e0-ace5-07f89c1ea456_terseLabel_en-US" xlink:label="lab_us-gaap_SecurityOwnedNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-marketable securities</link:label>
    <link:label id="lab_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_label_en-US" xlink:label="lab_us-gaap_SecurityOwnedNotReadilyMarketableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Owned Not Readily Marketable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityOwnedNotReadilyMarketableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue" xlink:to="lab_us-gaap_SecurityOwnedNotReadilyMarketableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9d8f034f-8a50-416d-ba5d-fd0fdd1e96ae_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeMember_c223a644-94e8-490e-8886-b85fd37aed4f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeMember_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeMember" xlink:to="lab_us-gaap_InvestmentIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3997a6ae-b5a9-4565-a9fe-296a94f1e2c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_71198434-d7d6-4854-9f92-38ef1580ca39_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_f01d4487-25a0-4049-9a80-322262a4cf06_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree after subsequent acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_7a996d6f-9736-4cc2-971e-b63ac475e6e7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, pro forma information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_2fe24adb-1791-4768-a3c1-003808156b23_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income (expense), net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNonoperating" xlink:to="lab_us-gaap_InvestmentIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_47ccbddc-55a1-4c9f-877b-cb84064d8cf8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RestrictedCashMember_e98fcd61-6613-4801-9465-03ae48f00739_terseLabel_en-US" xlink:label="lab_exas_RestrictedCashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_exas_RestrictedCashMember_label_en-US" xlink:label="lab_exas_RestrictedCashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash [Member]</link:label>
    <link:label id="lab_exas_RestrictedCashMember_documentation_en-US" xlink:label="lab_exas_RestrictedCashMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedCashMember" xlink:href="exas-20210930.xsd#exas_RestrictedCashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RestrictedCashMember" xlink:to="lab_exas_RestrictedCashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1f278c85-686c-4f13-851e-a632d5ad1e4b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_8c1def82-dc3e-4ad7-894d-bf76ab4d9510_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b62e4c46-ca6c-444e-9113-fb14d82fe91c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5c090c92-f64c-43cd-92b9-e457150632ed_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_9ba4422b-7ed9-4cad-9a03-97c3b2ccec06_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ThriveEarlierDetectionCorporationMember_2ecf2e0a-bb8e-45ca-9f6c-76cc9e526243_terseLabel_en-US" xlink:label="lab_exas_ThriveEarlierDetectionCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thrive</link:label>
    <link:label id="lab_exas_ThriveEarlierDetectionCorporationMember_label_en-US" xlink:label="lab_exas_ThriveEarlierDetectionCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thrive Earlier Detection Corporation [Member]</link:label>
    <link:label id="lab_exas_ThriveEarlierDetectionCorporationMember_documentation_en-US" xlink:label="lab_exas_ThriveEarlierDetectionCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thrive Earlier Detection Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ThriveEarlierDetectionCorporationMember" xlink:to="lab_exas_ThriveEarlierDetectionCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_06a68adf-e44d-4738-9194-a745aa61ca89_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d8a665e4-0ba2-4f91-ab1c-586494212c63_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in net loss per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_03a09c88-fee0-4b72-b78c-216de2a186b0_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, realized gain (loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_747ca0e9-894c-4d3b-b2cf-0ef42c0e789c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_1cc9ad29-ca6c-4cfc-a23c-0e125b8c6056_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_MeasurementInputProbabilityOfSuccessMember_3ac3b040-8eae-4a1c-8f41-8aac467c6ecc_terseLabel_en-US" xlink:label="lab_exas_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Success</link:label>
    <link:label id="lab_exas_MeasurementInputProbabilityOfSuccessMember_label_en-US" xlink:label="lab_exas_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Success [Member]</link:label>
    <link:label id="lab_exas_MeasurementInputProbabilityOfSuccessMember_documentation_en-US" xlink:label="lab_exas_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Success</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MeasurementInputProbabilityOfSuccessMember" xlink:href="exas-20210930.xsd#exas_MeasurementInputProbabilityOfSuccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_MeasurementInputProbabilityOfSuccessMember" xlink:to="lab_exas_MeasurementInputProbabilityOfSuccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d4cc322b-5281-4285-ae7d-65d84a1443a9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_90a9a1fa-04ab-4751-913e-04fd24cf8ebd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_bd34ef61-c208-45ab-a356-2bf58273edb3_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_87008218-a656-495c-97f6-289c75ca76aa_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_1decfec0-12f2-4bdf-a03d-7dc13ffe5398_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentDisclosureAbstract_2e47a52f-fc25-4087-aa53-752d094c5aa6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Adjustment Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Adjustment Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract" xlink:to="lab_us-gaap_FairValueAdjustmentDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_febb91c9-5da4-42c3-a32e-9368233d7195_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_bff2808a-3299-4599-813f-b93045e9669b_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense on convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_31236883-dee9-4b77-87ca-884ea70cbfa7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7eb14d19-d4f2-4883-8369-61cec109b2dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares, RSUs, and Performance Share Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_78e617f7-7789-4dad-8864-d1331a261b5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_c52e1cc0-245c-4d8a-b28c-3cb985e10cc6_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_0ee26ac7-7d82-41e8-9bd4-73400c939ec3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_b45e6f21-8403-4da1-8c5f-8d97491c4aac_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on settlement of convertible notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_61649545-d129-4fcf-a2cb-a28a5090153e_verboseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt in cash</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_f4e76610-6b25-431f-ad64-21fddd6d9641_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_029a44c7-502c-4398-a906-38311143044a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_671972bc-4e0f-4057-8e1a-5f44ed47387c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of equity acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_a89c3c49-85a2-42b3-be9e-7c276d5b7153_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionLoansMember_aa48d0cd-9d1e-408f-94a6-778e706f6bfa_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan Agreement</link:label>
    <link:label id="lab_us-gaap_ConstructionLoansMember_label_en-US" xlink:label="lab_us-gaap_ConstructionLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoansMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionLoansMember" xlink:to="lab_us-gaap_ConstructionLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_ed812b1e-e27a-45de-87ec-5d6b6b8270dd_terseLabel_en-US" xlink:label="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration</link:label>
    <link:label id="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_label_en-US" xlink:label="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Convertible Debt In Cash And By Issuance Of Shares</link:label>
    <link:label id="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_documentation_en-US" xlink:label="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total consideration for repayments of convertible debt by way of cash and shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" xlink:href="exas-20210930.xsd#exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" xlink:to="lab_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_639e875e-2029-46cd-a620-f3aaee12bdff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized (downward adjustments) from changes in transaction prices</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock_70a3fb4b-eb26-45ea-8cff-3a346c5c1d0e_verboseLabel_en-US" xlink:label="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</link:label>
    <link:label id="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock_label_en-US" xlink:label="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin Economic Development Tax Credit Disclosure [Text Block]</link:label>
    <link:label id="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock_documentation_en-US" xlink:label="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure relating to the Wisconsin Economic Development Tax Credit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" xlink:href="exas-20210930.xsd#exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" xlink:to="lab_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_183eb75f-dd8b-4ebb-996c-edeb111033d6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">If-converted value of debt in excess of principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_549c899f-6ba9-48d6-9152-d63e3e8d1df9_terseLabel_en-US" xlink:label="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing costs, convertible note debt discount and issuance costs, and other liabilities</link:label>
    <link:label id="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_label_en-US" xlink:label="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization (Deferred Amortization) of Deferred Financing Costs, Debt Discounts (Premiums) and Issuance Costs, Other Liabilities</link:label>
    <link:label id="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_documentation_en-US" xlink:label="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization (Deferred Amortization) of Deferred Financing Costs, Debt Discounts (Premiums) and Issuance Costs, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" xlink:href="exas-20210930.xsd#exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" xlink:to="lab_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_65c5a82b-a8c8-4700-979b-d388b3c45049_terseLabel_en-US" xlink:label="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of valuation assumptions</link:label>
    <link:label id="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Based Payment Award, Stock Options and Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="exas-20210930.xsd#exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_ee1b9516-36c3-48ad-95ef-907f70a14d7c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_6cf61597-b19b-453f-aab0-79cbd769bcea_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_a216e0f5-a3cc-464f-b3d1-a4ade099c01d_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition of PFS Genomics outstanding shares</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_609b88d5-091f-483d-95ec-d562587169d8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ConvertibleNotesPayableGross_48ebaf74-0501-4d07-a82b-49ca0337298f_terseLabel_en-US" xlink:label="lab_exas_ConvertibleNotesPayableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayableGross_label_en-US" xlink:label="lab_exas_ConvertibleNotesPayableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable Gross</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayableGross_documentation_en-US" xlink:label="lab_exas_ConvertibleNotesPayableGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount as of balance sheet date of convertible notes payable including debt issuance costs and debt discounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayableGross" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ConvertibleNotesPayableGross" xlink:to="lab_exas_ConvertibleNotesPayableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_58e1f310-c6bd-427e-8253-53fe0cb2c854_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock to fund the Company's 401(k) match</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_EmployeesWithQualifyingTerminationEventsMember_e2696a31-f9fb-48a4-a058-e5c81d2ff0e0_terseLabel_en-US" xlink:label="lab_exas_EmployeesWithQualifyingTerminationEventsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees with Qualifying Termination Events</link:label>
    <link:label id="lab_exas_EmployeesWithQualifyingTerminationEventsMember_label_en-US" xlink:label="lab_exas_EmployeesWithQualifyingTerminationEventsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees with Qualifying Termination Events [Member]</link:label>
    <link:label id="lab_exas_EmployeesWithQualifyingTerminationEventsMember_documentation_en-US" xlink:label="lab_exas_EmployeesWithQualifyingTerminationEventsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employees with Qualifying Termination Events</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeesWithQualifyingTerminationEventsMember" xlink:href="exas-20210930.xsd#exas_EmployeesWithQualifyingTerminationEventsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_EmployeesWithQualifyingTerminationEventsMember" xlink:to="lab_exas_EmployeesWithQualifyingTerminationEventsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_f863e2e0-9db2-4b5e-82f8-b57bced2a381_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_6a81da1f-8032-4cd8-bea8-eabdef7f1a6a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, right-of-use asset</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneAxis_8602d7dd-6ca3-4259-bc65-ac55de479bd9_terseLabel_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements Sales Milestone [Axis]</link:label>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneAxis_label_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements Sales Milestone [Axis]</link:label>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneAxis_documentation_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the ranges of sale milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAxis" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis" xlink:to="lab_exas_CollaborativeArrangementsSalesMilestoneAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_052d485a-7f08-4070-8aaf-530738a3f37c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_eb496733-a875-43d6-8789-1f518fe38155_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_580ee850-31c5-4565-884e-4c973bb5873f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_1393776b-f5ec-4abd-bfcf-1fee7ba45b34_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_a01f8001-e632-4759-874d-670b2951b0f0_terseLabel_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through acquisition (in dollars per share)</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed in Period Through Acquisitions, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed in Period Through Acquisitions, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" xlink:to="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_182906fe-a197-4be8-9ec9-8b8db3b7d490_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_SalesMilestoneRangeOneMember_b0334bf5-9008-4d40-a842-94324d07d37f_terseLabel_en-US" xlink:label="lab_exas_SalesMilestoneRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Range One</link:label>
    <link:label id="lab_exas_SalesMilestoneRangeOneMember_label_en-US" xlink:label="lab_exas_SalesMilestoneRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Range One [Member]</link:label>
    <link:label id="lab_exas_SalesMilestoneRangeOneMember_documentation_en-US" xlink:label="lab_exas_SalesMilestoneRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to the first sales milestone range.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeOneMember" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_SalesMilestoneRangeOneMember" xlink:to="lab_exas_SalesMilestoneRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained_fc3735f8-27d4-405c-8285-36881555335c_terseLabel_en-US" xlink:label="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of jobs required to create and maintain</link:label>
    <link:label id="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained_label_en-US" xlink:label="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Jobs Required to Created and Maintained</link:label>
    <link:label id="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained_documentation_en-US" xlink:label="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of jobs required to create and maintain.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfJobsRequiredToCreatedAndMaintained" xlink:href="exas-20210930.xsd#exas_NumberOfJobsRequiredToCreatedAndMaintained"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NumberOfJobsRequiredToCreatedAndMaintained" xlink:to="lab_exas_NumberOfJobsRequiredToCreatedAndMaintained" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_57b2c720-17b4-431e-8a19-77cef73011b2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a3f3d34b-56c8-4edf-aee9-de37874e9325_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_3c79adcb-9d30-4716-8360-b4055c9ea85a_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_01356055-0c87-45e1-b543-f3e5a854543c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NetProceedsFromFinancingArrangement_11fceda4-297a-48b9-a289-b741a4ca22b9_terseLabel_en-US" xlink:label="lab_exas_NetProceedsFromFinancingArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds received from financing arrangements</link:label>
    <link:label id="lab_exas_NetProceedsFromFinancingArrangement_label_en-US" xlink:label="lab_exas_NetProceedsFromFinancingArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Proceeds From Financing Arrangement</link:label>
    <link:label id="lab_exas_NetProceedsFromFinancingArrangement_documentation_en-US" xlink:label="lab_exas_NetProceedsFromFinancingArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the proceeds from issuance of loan receivable to investor.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NetProceedsFromFinancingArrangement" xlink:href="exas-20210930.xsd#exas_NetProceedsFromFinancingArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NetProceedsFromFinancingArrangement" xlink:to="lab_exas_NetProceedsFromFinancingArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_fa101150-9511-4eef-b2ad-14676d1ec0ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale investments, before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_55bd8b1f-6ffb-4063-a33c-954c98681b2c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_444a33b1-4455-4c30-a359-1d4af76fcc02_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation consideration assumed</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-based Compensation</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_67c3d8b5-e25c-4517-bcf5-89b30fbff44f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_3d2d55a4-c968-4e18-aa73-2ca7137a6e22_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_289fdc03-0d5e-4d98-a141-34bc3abddffa_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_6bc359e1-210c-4717-8cda-1620cdb53f87_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_3739b6f7-9662-4b93-9ade-2d98fe880b38_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment charge</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8bd2c33d-a0ee-4860-ae6f-258bf423d1fc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_04c0c80f-72cd-4add-9e60-270e17353b53_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_fece28b7-c8d1-401a-a4d1-579b443c8a16_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ec8b1f83-5364-4e7b-9ab2-291c57327f35_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_InterestExpenseDebtTableTextBlock_4ffd29ec-1aee-4c6a-b17e-c6e4f000b3ef_terseLabel_en-US" xlink:label="lab_exas_InterestExpenseDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense</link:label>
    <link:label id="lab_exas_InterestExpenseDebtTableTextBlock_label_en-US" xlink:label="lab_exas_InterestExpenseDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt [Table Text Block]</link:label>
    <link:label id="lab_exas_InterestExpenseDebtTableTextBlock_documentation_en-US" xlink:label="lab_exas_InterestExpenseDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the total debt interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InterestExpenseDebtTableTextBlock" xlink:href="exas-20210930.xsd#exas_InterestExpenseDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_InterestExpenseDebtTableTextBlock" xlink:to="lab_exas_InterestExpenseDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cba32941-9653-49f2-8a71-1ba53d70eb6e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_53ce8e6e-5684-426d-8f91-db487755d593_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_075a4197-edd3-402f-85c6-236873ca3b11_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of common stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_cce28f2c-54ec-4802-b648-da72f6f63049_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_EmployeeAndNonEmployeesStockOptionMember_94f1352f-4bb1-4e9d-8a01-6ee5fb8c92aa_verboseLabel_en-US" xlink:label="lab_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon exercise of stock options</link:label>
    <link:label id="lab_exas_EmployeeAndNonEmployeesStockOptionMember_920dcd65-362e-4399-98cb-a7710a8b93c8_terseLabel_en-US" xlink:label="lab_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Plan Shares</link:label>
    <link:label id="lab_exas_EmployeeAndNonEmployeesStockOptionMember_label_en-US" xlink:label="lab_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee And Non Employees Stock Option [Member]</link:label>
    <link:label id="lab_exas_EmployeeAndNonEmployeesStockOptionMember_documentation_en-US" xlink:label="lab_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize individuals, in addition to their regular compensation and benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:to="lab_exas_EmployeeAndNonEmployeesStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2ba25f69-87cc-4bdf-b083-4b30ffced76d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in amount of contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_777757ff-d62e-4ba0-a9fa-76c1c6606ca7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_66c2cace-a48c-45c9-8d2a-0651739b7373_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_22adaaee-6ea1-4f54-8246-e8cd00c41ae1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion rate, number of shares to be issued per $1,000 of principal amount (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_179b22db-7575-44fc-b222-ce071e2196ec_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ConvertibleNotesPayable2027Member_e8f241a2-9ee8-40df-bb62-c3ad54170d0a_terseLabel_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 Notes</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayable2027Member_label_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable2027 [Member]</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayable2027Member_documentation_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to convertible notes, maturing on 2027.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ConvertibleNotesPayable2027Member" xlink:to="lab_exas_ConvertibleNotesPayable2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_61c5f37e-b979-4276-95a1-545317eaa945_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_e4d0b62d-4089-47b2-947a-671f3c1ac2d2_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_09c1047d-dfa7-4bd9-9d62-6eddbc781650_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_262d0326-3596-461c-8905-08da4c4ccbff_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_54fa17e2-4b9d-4c48-ac97-dac56f32d903_terseLabel_en-US" xlink:label="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced, asset</link:label>
    <link:label id="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_label_en-US" xlink:label="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Asset</link:label>
    <link:label id="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_documentation_en-US" xlink:label="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" xlink:href="exas-20210930.xsd#exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" xlink:to="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_VariablePriceContractMember_e09e6771-96af-42fb-97cc-35456d571626_terseLabel_en-US" xlink:label="lab_exas_VariablePriceContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable consideration</link:label>
    <link:label id="lab_exas_VariablePriceContractMember_label_en-US" xlink:label="lab_exas_VariablePriceContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Price Contract [Member]</link:label>
    <link:label id="lab_exas_VariablePriceContractMember_documentation_en-US" xlink:label="lab_exas_VariablePriceContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Company estimates the amount of variable consideration using the expected value method, which represents the sum of probability-weighted amounts in a range of possible consideration amounts. When estimating the amount of variable consideration, the Company considers several factors, such as historical collections experience, patient insurance eligibility and payer reimbursement contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_VariablePriceContractMember" xlink:href="exas-20210930.xsd#exas_VariablePriceContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_VariablePriceContractMember" xlink:to="lab_exas_VariablePriceContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_2984cf4f-3c25-4d2f-b16f-547809a7b5c5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_20a1f626-a2ea-40b8-8c42-8c12686f7cdc_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueNetAssetLiability_label_en-US" xlink:label="lab_us-gaap_FairValueNetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetAssetLiability" xlink:to="lab_us-gaap_FairValueNetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_a4ab0b2f-cf67-4902-bfbd-0afc61c6e922_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_SharesIssuedUponAcquisitionMember_72a58383-c40c-4e94-95b7-691fc2523a30_terseLabel_en-US" xlink:label="lab_exas_SharesIssuedUponAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable in connection with acquisitions</link:label>
    <link:label id="lab_exas_SharesIssuedUponAcquisitionMember_label_en-US" xlink:label="lab_exas_SharesIssuedUponAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued Upon Acquisition [Member]</link:label>
    <link:label id="lab_exas_SharesIssuedUponAcquisitionMember_documentation_en-US" xlink:label="lab_exas_SharesIssuedUponAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued Upon Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SharesIssuedUponAcquisitionMember" xlink:href="exas-20210930.xsd#exas_SharesIssuedUponAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_SharesIssuedUponAcquisitionMember" xlink:to="lab_exas_SharesIssuedUponAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_84dec15e-59b1-4a30-85c2-24cc42ed9518_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_d963225e-9eae-410a-89a2-572828709063_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b14e15c6-8e5e-4270-a8b1-21133ddb8fc8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_7516a87c-6217-4b5b-8a8d-2f8b4c6bc29b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reclassifications</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_437d804a-e0c7-4781-9cb8-eceda61d8264_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AmortizationOfRefundableTaxCredits_b54c40f8-332d-47fc-9390-580846f6ea7a_terseLabel_en-US" xlink:label="lab_exas_AmortizationOfRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of tax credits</link:label>
    <link:label id="lab_exas_AmortizationOfRefundableTaxCredits_label_en-US" xlink:label="lab_exas_AmortizationOfRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Refundable Tax Credits</link:label>
    <link:label id="lab_exas_AmortizationOfRefundableTaxCredits_documentation_en-US" xlink:label="lab_exas_AmortizationOfRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amortization of the tax credits, representing a reduction of operating expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AmortizationOfRefundableTaxCredits" xlink:href="exas-20210930.xsd#exas_AmortizationOfRefundableTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AmortizationOfRefundableTaxCredits" xlink:to="lab_exas_AmortizationOfRefundableTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_add3a25c-2d8c-4f05-9500-27feee1f8883_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for business combination and asset acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_0602a611-20fe-4018-ba3a-5ea52bea66f9_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of 9,510,436 and 382,947 shares of common stock for business combinations and asset acquisition for 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RefundableTaxCreditReceived_932633d8-476c-4705-940d-e03cdc759347_terseLabel_en-US" xlink:label="lab_exas_RefundableTaxCreditReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable tax credit received</link:label>
    <link:label id="lab_exas_RefundableTaxCreditReceived_label_en-US" xlink:label="lab_exas_RefundableTaxCreditReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Tax Credit Received</link:label>
    <link:label id="lab_exas_RefundableTaxCreditReceived_documentation_en-US" xlink:label="lab_exas_RefundableTaxCreditReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of refundable tax credit received during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditReceived" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RefundableTaxCreditReceived" xlink:to="lab_exas_RefundableTaxCreditReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_22f09965-ae39-4edf-9439-8bb28bb031ee_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_ddcf9fac-2660-435e-a7f6-5c349b530bf2_terseLabel_en-US" xlink:label="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable tax credits available, contingent</link:label>
    <link:label id="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_label_en-US" xlink:label="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Tax Credits Available Contingent on Capital Investments and Creation of Full-time Positions</link:label>
    <link:label id="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_documentation_en-US" xlink:label="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the refundable tax credits available, that is contingent on the Company expending a specified dollar amount on capital investments and the creation of a specified number of full-time positions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" xlink:to="lab_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ThriveAndAshionMember_216fa134-ac9a-4de5-959a-0d659d59a85f_terseLabel_en-US" xlink:label="lab_exas_ThriveAndAshionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thrive and Ashion</link:label>
    <link:label id="lab_exas_ThriveAndAshionMember_label_en-US" xlink:label="lab_exas_ThriveAndAshionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thrive and Ashion [Member]</link:label>
    <link:label id="lab_exas_ThriveAndAshionMember_documentation_en-US" xlink:label="lab_exas_ThriveAndAshionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thrive and Ashion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveAndAshionMember" xlink:href="exas-20210930.xsd#exas_ThriveAndAshionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ThriveAndAshionMember" xlink:to="lab_exas_ThriveAndAshionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_eed5e3fc-79b0-4f86-9c43-c6c95c387a9a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated vesting compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Accelerated Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_eed635d2-2d5b-4b00-95d0-2c92c80aeadb_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_f10489d0-f7ac-4d05-b635-f4ef22db1041_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ServiceOrProductTypeDomain_a21a516a-9dc8-4d9a-8c0d-e6e965679053_terseLabel_en-US" xlink:label="lab_exas_ServiceOrProductTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service or Product Type [Domain]</link:label>
    <link:label id="lab_exas_ServiceOrProductTypeDomain_label_en-US" xlink:label="lab_exas_ServiceOrProductTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service or Product Type [Domain]</link:label>
    <link:label id="lab_exas_ServiceOrProductTypeDomain_documentation_en-US" xlink:label="lab_exas_ServiceOrProductTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service or Product Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeDomain" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ServiceOrProductTypeDomain" xlink:to="lab_exas_ServiceOrProductTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ae2d732f-5bb1-49f3-8c96-900ebf60a8d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef780d57-84dc-4555-86a7-0414745ba234_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments to acquire business, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_bed854b5-4771-4631-be6f-6c0d975b9d1c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a989aa61-417f-4c42-a21f-80f33e781e2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_14b36846-6c2b-4669-ad39-7e0903164dbe_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a700678d-a1f9-46fe-8ce9-0ba8ab69c9bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_6f265938-760c-4b8d-a29a-cf2f36e81729_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c6406f4e-0d48-4239-aa34-0865eb90df0b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_eb4fb45a-1cd8-476e-aac4-7072de20adda_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_d81f976e-2465-4a05-9b38-68e53427e12c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_92e8b0bb-98f9-47eb-9984-317571299568_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MARKETABLE SECURITIES</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_6a48a613-ecf6-412c-9d5c-d32045697af4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_5ae04bbc-9970-404d-b618-5fc39e13fbbd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount to be recognized at lease commencement for the lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_SalesMilestoneRangeTwoMember_e7291a5c-ca3c-4b66-ba18-f930446b0a97_terseLabel_en-US" xlink:label="lab_exas_SalesMilestoneRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Range Two</link:label>
    <link:label id="lab_exas_SalesMilestoneRangeTwoMember_label_en-US" xlink:label="lab_exas_SalesMilestoneRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Range Two [Member]</link:label>
    <link:label id="lab_exas_SalesMilestoneRangeTwoMember_documentation_en-US" xlink:label="lab_exas_SalesMilestoneRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to the second sales milestone range one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeTwoMember" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_SalesMilestoneRangeTwoMember" xlink:to="lab_exas_SalesMilestoneRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_SalesMilestoneRangeThreeMember_08f170c7-656d-42ce-a7ee-64cb2bdb57cf_terseLabel_en-US" xlink:label="lab_exas_SalesMilestoneRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Range Three</link:label>
    <link:label id="lab_exas_SalesMilestoneRangeThreeMember_label_en-US" xlink:label="lab_exas_SalesMilestoneRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Milestone Range Three [Member]</link:label>
    <link:label id="lab_exas_SalesMilestoneRangeThreeMember_documentation_en-US" xlink:label="lab_exas_SalesMilestoneRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to the third sales milestone range one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeThreeMember" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_SalesMilestoneRangeThreeMember" xlink:to="lab_exas_SalesMilestoneRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_cdcb5f27-d40a-4dd9-a278-0758f559d7d7_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value Authorized&#8212;400,000,000 shares issued and outstanding&#8212;172,242,798 and 159,423,410 shares at September&#160;30, 2021 and December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_20238cab-a8ec-4144-a79a-666d076ef65e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2cd43ed2-64b3-43c5-9dc3-b8d8690447b0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ad113c6c-a1a0-4ddc-bdf1-f108363c9f81_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_347ffb25-fb7f-479e-b6c9-3fe782fba601_negatedTerseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, less current portion</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent, Operating Lease Liability</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent, Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_f39a25c5-d302-43a7-8e06-af5fd747fb3a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_36accf64-a103-4285-8ce7-4c3378a44247_terseLabel_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_label_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember_7b9ad74a-0446-4165-91bf-64b824db538a_terseLabel_en-US" xlink:label="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and Other Performance-based Payments</link:label>
    <link:label id="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember_label_en-US" xlink:label="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and Other Performance-based Payments [Member]</link:label>
    <link:label id="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember_documentation_en-US" xlink:label="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue and Other Performance-based Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RevenueAndOtherPerformanceBasedPaymentsMember" xlink:href="exas-20210930.xsd#exas_RevenueAndOtherPerformanceBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RevenueAndOtherPerformanceBasedPaymentsMember" xlink:to="lab_exas_RevenueAndOtherPerformanceBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c8071699-81ab-4150-a633-063f4b8a98a4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period for recognition of cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_aa42ec57-52c5-49be-bbf4-1b2c06cd9a27_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_59ff0621-be3e-4f6d-b0fe-19c617eb3d73_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_af7f79e3-b963-4a73-aad5-c1350112707f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_8cb64d0b-6ee0-499d-a0f2-8841a1c32996_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon the release of performance share units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_723aab5c-d2af-43d4-8106-5d647ba2e46a_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Share Units</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_542e0f9f-7b42-4efa-a9c9-4a1d52356b24_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 14)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_ddf2c70b-976d-4dcc-af34-71dc30b99ea3_terseLabel_en-US" xlink:label="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Development and Other Milestone-based Payments</link:label>
    <link:label id="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_label_en-US" xlink:label="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Development and Other Milestone-based Payments [Member]</link:label>
    <link:label id="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_documentation_en-US" xlink:label="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Development and Other Milestone-based Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" xlink:href="exas-20210930.xsd#exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" xlink:to="lab_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2a4d9f84-3385-4e28-87a7-3766651b53bc_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_FacilityInLaJollaCAMember_6e58b91c-1c71-4fd0-b291-0c91aafe33b6_terseLabel_en-US" xlink:label="lab_exas_FacilityInLaJollaCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility in La Jolla, CA</link:label>
    <link:label id="lab_exas_FacilityInLaJollaCAMember_label_en-US" xlink:label="lab_exas_FacilityInLaJollaCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility in La Jolla, CA [Member]</link:label>
    <link:label id="lab_exas_FacilityInLaJollaCAMember_documentation_en-US" xlink:label="lab_exas_FacilityInLaJollaCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility in La Jolla, CA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FacilityInLaJollaCAMember" xlink:href="exas-20210930.xsd#exas_FacilityInLaJollaCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_FacilityInLaJollaCAMember" xlink:to="lab_exas_FacilityInLaJollaCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_f7064611-0ea7-46e3-ba2a-5b1e365954f3_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, at fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_22d6f486-c476-4b5b-a4e1-da416b5493d0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares of common stock to fund the Company's 401(k) matching contribution (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_e72b2185-3410-428d-ad63-8bf5e3a9001e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_2f9ec1ab-0bc2-453a-ab90-80626af0996b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon the release of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_596720fe-d5b5-40ee-8dd4-9a47467ffef1_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_736a78f1-d3d8-442c-805d-d518d0e80333_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based payment award, stock options, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_51c129fc-3e13-4740-92a2-674484dbaf5f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c8845f0b-ddcb-4783-bc23-c0e66c6f336c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_6b973640-04e2-410e-a27f-899a975115e3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_c4547e94-d8c9-4957-8fd4-e9130c69eb80_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_998f1e10-b34d-4481-aa34-e4912da1c2a0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from external customers by geographic areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_f398f2c5-7610-4f90-95c8-5717f2c1c349_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, liability, current, statement of financial position, extensible list</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_b82f3fa5-1d6d-487f-911d-825b4986c595_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_FDAApprovalMember_16b739f6-c8f9-4ce5-b712-fe710e5756eb_terseLabel_en-US" xlink:label="lab_exas_FDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval</link:label>
    <link:label id="lab_exas_FDAApprovalMember_label_en-US" xlink:label="lab_exas_FDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval [Member]</link:label>
    <link:label id="lab_exas_FDAApprovalMember_documentation_en-US" xlink:label="lab_exas_FDAApprovalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FDA Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FDAApprovalMember" xlink:href="exas-20210930.xsd#exas_FDAApprovalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_FDAApprovalMember" xlink:to="lab_exas_FDAApprovalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_63cdd3a0-1f7c-4b42-8ca2-d11146565102_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_97b4dba7-753c-467a-b143-3f8bb366bdbd_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_4f412b74-24d5-4f7b-9005-7c08a228624d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income (expense)</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_171e31ae-930a-4389-bec2-63abea22eecc_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsIncurred_543d6877-1deb-4dc4-b4ce-8cf462ce50b3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest incurred, accrued for as an interest reserve</link:label>
    <link:label id="lab_us-gaap_InterestCostsIncurred_label_en-US" xlink:label="lab_us-gaap_InterestCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsIncurred" xlink:to="lab_us-gaap_InterestCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_9f8aaf87-776b-4efb-9d0e-3b2edacb66eb_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interests issued or issuable to previous investors, vesting period</link:label>
    <link:label id="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_label_en-US" xlink:label="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Vesting Period</link:label>
    <link:label id="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_documentation_en-US" xlink:label="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" xlink:href="exas-20210930.xsd#exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" xlink:to="lab_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_695d1944-3ded-4d20-bda8-12b96ea272b7_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire productive assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_af34ef15-fc32-4cac-937c-c7d564d14160_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized gain on preferred stock investment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_55de8857-70ee-4ddd-abe8-72dffe5f759c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f3075b5-9423-45b5-bd65-98ae07819bcc_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_2813ab4e-916a-41ed-a938-422b39f2a6f5_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_bb0c1dd0-9c9b-40e0-87a4-5f872416cb30_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, equity interest issued or issuable (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_2f3c8230-4b69-4c32-8b06-00c2c5860ace_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_0a4cdd0b-ba3b-4abf-82ae-9ea20478420a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued to acquire productive assets, value</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b37084bc-517d-42c2-bd59-f9189dfc8578_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4e63f1c8-1c8d-4239-8d59-83b7ceaa9b7d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_IssuanceOfStockToFundMatchingContributions_acc65e4c-6bba-4cb3-9c3b-c525105b9360_terseLabel_en-US" xlink:label="lab_exas_IssuanceOfStockToFundMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of 162,606 and 136,559 shares of common stock to fund the Company&#8217;s 401(k) matching contribution for 2020 and 2019, respectively</link:label>
    <link:label id="lab_exas_IssuanceOfStockToFundMatchingContributions_label_en-US" xlink:label="lab_exas_IssuanceOfStockToFundMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance Of Stock To Fund Matching Contributions</link:label>
    <link:label id="lab_exas_IssuanceOfStockToFundMatchingContributions_documentation_en-US" xlink:label="lab_exas_IssuanceOfStockToFundMatchingContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock to fund the entity's 401(k) matching contribution.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IssuanceOfStockToFundMatchingContributions" xlink:href="exas-20210930.xsd#exas_IssuanceOfStockToFundMatchingContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_IssuanceOfStockToFundMatchingContributions" xlink:to="lab_exas_IssuanceOfStockToFundMatchingContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ServiceOrProductTypeAxis_f95be3b4-5ea0-474f-9040-e5d2588df6a3_terseLabel_en-US" xlink:label="lab_exas_ServiceOrProductTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service or Product Type [Axis]</link:label>
    <link:label id="lab_exas_ServiceOrProductTypeAxis_label_en-US" xlink:label="lab_exas_ServiceOrProductTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service or Product Type [Axis]</link:label>
    <link:label id="lab_exas_ServiceOrProductTypeAxis_documentation_en-US" xlink:label="lab_exas_ServiceOrProductTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service or Product Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeAxis" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ServiceOrProductTypeAxis" xlink:to="lab_exas_ServiceOrProductTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_InternationalSalesMember_5c2c3941-0cad-4b85-9bf3-4d88e82462d9_terseLabel_en-US" xlink:label="lab_exas_InternationalSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_exas_InternationalSalesMember_label_en-US" xlink:label="lab_exas_InternationalSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Sales [Member]</link:label>
    <link:label id="lab_exas_InternationalSalesMember_documentation_en-US" xlink:label="lab_exas_InternationalSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InternationalSalesMember" xlink:href="exas-20210930.xsd#exas_InternationalSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_InternationalSalesMember" xlink:to="lab_exas_InternationalSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_11ed7abb-ac0e-4bb6-8b2d-563900935a8d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_3f5cac3d-2532-46d2-811d-e217e941a678_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously held equity investment fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_9e3d3081-2f7e-49cb-a913-1686bc861c82_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_c5b053aa-6d98-4231-9a81-8a21dca1a31c_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_eb732bc6-0fff-4154-8a1f-bcf288f9cb57_terseLabel_en-US" xlink:label="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on short-term investments</link:label>
    <link:label id="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_label_en-US" xlink:label="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Amortization of Premium on Short Term Investments</link:label>
    <link:label id="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_documentation_en-US" xlink:label="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the period in the carrying amount of amortization of purchase premium on nonoperating securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" xlink:href="exas-20210930.xsd#exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" xlink:to="lab_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_1eb407f3-28f6-4d4c-b9f7-d1549bd6d55f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_fbf30683-55d2-4a90-818e-fadfab0b6b0a_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable upon conversion of convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_e331ceb8-9fa1-43e9-a27b-56697c8ef915_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_809030fe-d011-435d-a41a-814b750bc27a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_51590925-e370-45e5-b887-59a031fd002e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_94f4ce61-ce5d-4314-92af-919e2a6fbe02_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets and Liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets and Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_06d5b318-5f91-4c64-b43d-454f1a3e2e7b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9f997689-cf67-4bcc-96b3-9b4cfb27b021_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_bfa4d1ca-e6ef-4df6-b2a3-6d95d71c0ed3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3d57cdc0-c461-4045-b346-150e40c906a0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_27022c3f-4f4a-49dc-946b-3270417b3c84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7deea4d9-7869-4c8f-b8e2-7e99c8892f3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c4299b51-c59e-4a83-b1d6-bcbb4da854d7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cb2c9a27-6940-4cf0-8269-5d3178faab6e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6e98fdfa-b5e3-443f-b382-3da0fc78bc91_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_032c1703-3791-4f04-9c19-4a3816d27de3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_2ebbce36-0e3d-4cbc-aa05-9db1a5b4efaf_terseLabel_en-US" xlink:label="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Shares and RSUs</link:label>
    <link:label id="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards And Restricted Stock Units R S U [Member]</link:label>
    <link:label id="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_documentation_en-US" xlink:label="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the details relating to the restricted stock awards and restricted stock units (RSUs) as awarded by the entity to their employees as a form of incentive compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" xlink:href="exas-20210930.xsd#exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" xlink:to="lab_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_9f58dbed-96e7-44cb-8a99-a9ab9e92c57a_verboseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PFIZER PROMOTION AGREEMENT</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_e55bfddb-f5a3-4fd0-b885-bebdbca9d261_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e1095f28-689c-4a4a-be20-be836e423d63_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_09e3eb02-7a2a-41f1-92f9-6fd4bbc12a4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_37a97833-f404-4e47-a018-7cbe28cc7920_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_b04287c2-e66f-46ec-a4ea-08551f6510d5_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase price, as percentage of principal amount, if company undergoes change of control</link:label>
    <link:label id="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_label_en-US" xlink:label="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Repurchase Price Due to Change in Control as Percentage of Principal Amount</link:label>
    <link:label id="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_documentation_en-US" xlink:label="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the price at which the debt may be repurchased, as a percentage of the principal amount if the entity undergoes a change of control.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" xlink:href="exas-20210930.xsd#exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" xlink:to="lab_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AggregateConvertibleNotesMember_551c03f3-cba2-4063-a940-e07bc1e59001_terseLabel_en-US" xlink:label="lab_exas_AggregateConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes</link:label>
    <link:label id="lab_exas_AggregateConvertibleNotesMember_label_en-US" xlink:label="lab_exas_AggregateConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Convertible Notes [Member]</link:label>
    <link:label id="lab_exas_AggregateConvertibleNotesMember_documentation_en-US" xlink:label="lab_exas_AggregateConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the 2027 Notes and the 2025 Notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AggregateConvertibleNotesMember" xlink:href="exas-20210930.xsd#exas_AggregateConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AggregateConvertibleNotesMember" xlink:to="lab_exas_AggregateConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_81b9b63d-cad5-4270-ac54-a33bfa55f616_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_034dd850-33be-49c6-b061-f00c1e3452c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in privately held companies</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb2ca396-1f43-4df0-bdd6-6de7da0dc8aa_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_7db1837c-8207-4ac0-8936-e773a5b83c1f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3d87ff38-8a7b-4ac4-889a-b57acad0e471_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_80350712-b6e3-4c94-b047-e2c405424b7b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_53048257-154e-4a78-b0f0-bffb604095c3_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_ce88b2a8-a00a-4e68-b719-42f44e8d8077_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense related to items of other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3abc8ee6-0ffa-48af-a1e9-bfe2d9807baa_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_bf2804a6-4f76-4bcd-b15b-7175dfe05ef7_terseLabel_en-US" xlink:label="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before tax</link:label>
    <link:label id="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_label_en-US" xlink:label="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Income (Loss), Before Tax</link:label>
    <link:label id="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_documentation_en-US" xlink:label="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Income (Loss), Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionProFormaIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" xlink:to="lab_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e6d99493-4b78-4354-bb6a-4232a4392542_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneAmount_7c4275a3-7edc-41c3-a523-f4cae54ab233_terseLabel_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement sales milestone amount</link:label>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneAmount_label_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements Sales Milestone Amount</link:label>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneAmount_documentation_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of net sales of a licensed product considered as a milestone under the collaborative arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAmount" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAmount" xlink:to="lab_exas_CollaborativeArrangementsSalesMilestoneAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CouponInterestExpense_190cca6a-7188-4d94-be4b-e1d1593af3c3_terseLabel_en-US" xlink:label="lab_exas_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest expense</link:label>
    <link:label id="lab_exas_CouponInterestExpense_label_en-US" xlink:label="lab_exas_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:label id="lab_exas_CouponInterestExpense_documentation_en-US" xlink:label="lab_exas_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of coupon interest expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CouponInterestExpense" xlink:href="exas-20210930.xsd#exas_CouponInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CouponInterestExpense" xlink:to="lab_exas_CouponInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1d2c40bf-a4bf-4ee9-9486-f2a9bdf505bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_1b25227c-46b1-4f1b-b7ee-2fa332eb3529_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation consideration assumed and deemed compensatory</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation, Deemed Compensatory</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation, Deemed Compensatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_39f6128e-29b6-46ea-9f53-4e5225bfae4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c958c4a6-5b1d-49e5-b788-7f68fe924875_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_36cdff56-e475-4cfc-9134-2b4bf010edbb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_053df6a0-72ba-40a0-84fd-5d48061037a1_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_16a9a80f-38bc-4739-9e09-a2ab6c982be4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c2ac9543-6826-43c0-b62f-da0dbc69be41_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentRemainingAmortizationPeriod_ada2ec05-d88b-473b-9690-dbc7a21f0138_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentRemainingAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_exas_DebtInstrumentRemainingAmortizationPeriod_label_en-US" xlink:label="lab_exas_DebtInstrumentRemainingAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Remaining Amortization Period</link:label>
    <link:label id="lab_exas_DebtInstrumentRemainingAmortizationPeriod_documentation_en-US" xlink:label="lab_exas_DebtInstrumentRemainingAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amortization period for interest on debt instrument in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentRemainingAmortizationPeriod" xlink:href="exas-20210930.xsd#exas_DebtInstrumentRemainingAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentRemainingAmortizationPeriod" xlink:to="lab_exas_DebtInstrumentRemainingAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_8f82bb03-6fc0-4d5f-9d87-162dd8e1ba47_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_8cfb8368-f70f-464f-a642-19b2a0e5e51f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_57a57a3c-2084-4eda-bcd1-862072ba1c50_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_8b9cea6a-2a87-4560-8fea-d85d908803d3_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_34a5a243-71ff-4842-82e0-65ecfa8136c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities, value issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d6c17000-c802-4e88-b854-c6cf4a45159e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ebf350d-476e-416f-8f61-29519a3488a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ea99bdf4-069f-4672-9bca-c76c52ba60e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_d80120f5-9b0b-46f3-a919-13a28424f4ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_JuneNotesMember_236b1488-d64d-4b8d-b19b-89d31d23e232_terseLabel_en-US" xlink:label="lab_exas_JuneNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 2018 Notes</link:label>
    <link:label id="lab_exas_JuneNotesMember_label_en-US" xlink:label="lab_exas_JuneNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June Notes [Member]</link:label>
    <link:label id="lab_exas_JuneNotesMember_documentation_en-US" xlink:label="lab_exas_JuneNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the June Notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_JuneNotesMember" xlink:href="exas-20210930.xsd#exas_JuneNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_JuneNotesMember" xlink:to="lab_exas_JuneNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_b4f33135-7bbb-4c05-a166-683ff25a45ef_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_e6138a32-51fb-4f81-ae00-6990ded77996_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_894bae1f-ca45-4487-8683-232574ac0d68_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_855f2e25-3fc2-42b2-887b-2bee63e47e13_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1bf52663-cd23-4d71-a6c3-b18495191900_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_79862498-78f5-4c10-be68-ebf877a90c61_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_e7c35525-4ee2-4394-8912-d6cef1c3a079_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NumberOfAgreementsEntered_89c457ee-88ac-4ec6-936e-d5ad56039fd0_terseLabel_en-US" xlink:label="lab_exas_NumberOfAgreementsEntered" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of agreements</link:label>
    <link:label id="lab_exas_NumberOfAgreementsEntered_label_en-US" xlink:label="lab_exas_NumberOfAgreementsEntered" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Agreements Entered</link:label>
    <link:label id="lab_exas_NumberOfAgreementsEntered_documentation_en-US" xlink:label="lab_exas_NumberOfAgreementsEntered" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of agreements entered.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfAgreementsEntered" xlink:href="exas-20210930.xsd#exas_NumberOfAgreementsEntered"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NumberOfAgreementsEntered" xlink:to="lab_exas_NumberOfAgreementsEntered" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e8c6f029-e740-456c-9936-4646dff97297_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_5ba509d4-9c4a-4981-9706-8e12d1a52a21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8704592e-9f4a-4f79-b986-f8b251b3bf69_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_ef300991-8fcb-4351-ac9c-727bb2f734a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information related to our operating leases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_LICENSEAGREEMENTSAbstract_16c0c127-6b9b-4ce2-89d7-35c2d8afaa40_terseLabel_en-US" xlink:label="lab_exas_LICENSEAGREEMENTSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MAYO LICENSE AGREEMENT</link:label>
    <link:label id="lab_exas_LICENSEAGREEMENTSAbstract_label_en-US" xlink:label="lab_exas_LICENSEAGREEMENTSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LICENSE AGREEMENTS [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LICENSEAGREEMENTSAbstract" xlink:href="exas-20210930.xsd#exas_LICENSEAGREEMENTSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_LICENSEAGREEMENTSAbstract" xlink:to="lab_exas_LICENSEAGREEMENTSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_d67439a7-ef80-4f35-a4d3-205f0e82c21d_terseLabel_en-US" xlink:label="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which the capital investment expenditures must be incurred and the creation of full-time positions must be completed</link:label>
    <link:label id="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_label_en-US" xlink:label="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for Capital Investment Expenditures and Creation of Full-time Positions to Earn Refundable Tax Credits</link:label>
    <link:label id="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_documentation_en-US" xlink:label="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The period over which the capital investment expenditures must be incurred and the creation of full-time positions must be completed.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" xlink:href="exas-20210930.xsd#exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" xlink:to="lab_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_0500265c-9beb-4f80-bf02-66ce29c3be96_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on settlement of convertible notes</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_d8d14bff-aa13-41bb-84c1-70aa0ae701ba_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets Acquired</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_23e9d1e6-ad16-4a27-8c98-a52291c9d613_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest costs capitalized</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_56ba24e6-80a0-4661-a330-94751850c352_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_41447430-26b8-47b3-866a-ef808e327c93_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_9ee8af62-9264-4bd7-9844-ba665c9406f8_negatedTerseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f78fe77a-db1d-4acd-b81a-2433a944cd64_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_95a2f71c-5fe0-4773-93c3-24f4406fb214_terseLabel_en-US" xlink:label="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire productive assets (in shares)</link:label>
    <link:label id="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_label_en-US" xlink:label="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares</link:label>
    <link:label id="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_documentation_en-US" xlink:label="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:href="exas-20210930.xsd#exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:to="lab_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b3aee99c-512d-430f-b808-cd35916c21a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of amounts recognized in accumulated other comprehensive income (loss) (AOCI)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ArmuneBiosciencesAgreementMember_0486bd66-55d1-4407-a9ef-7f3980f31bd5_terseLabel_en-US" xlink:label="lab_exas_ArmuneBiosciencesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Armune Biosciences Agreement</link:label>
    <link:label id="lab_exas_ArmuneBiosciencesAgreementMember_label_en-US" xlink:label="lab_exas_ArmuneBiosciencesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Armune Biosciences Agreement [Member]</link:label>
    <link:label id="lab_exas_ArmuneBiosciencesAgreementMember_documentation_en-US" xlink:label="lab_exas_ArmuneBiosciencesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Armune Biosciences Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ArmuneBiosciencesAgreementMember" xlink:href="exas-20210930.xsd#exas_ArmuneBiosciencesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ArmuneBiosciencesAgreementMember" xlink:to="lab_exas_ArmuneBiosciencesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_2e32dae8-7f3c-48d6-996d-ae804da05568_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_b69d01a8-fe1f-4535-8fbf-0f3caa791136_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rates, minimum (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f9e12eea-7e5a-4c3c-94cc-c7d03e537264_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, less current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6d9a0e2f-1332-4001-b2cf-01a476c0b7ad_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_8c567969-6d5d-4a37-9482-4b4c0abc024b_terseLabel_en-US" xlink:label="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced, liability</link:label>
    <link:label id="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_label_en-US" xlink:label="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Liability</link:label>
    <link:label id="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_documentation_en-US" xlink:label="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:href="exas-20210930.xsd#exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:to="lab_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone_c6323f12-bfbb-40cb-afe5-bd488d2d29e1_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue milestone</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone_label_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Revenue Milestone</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone_documentation_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Revenue Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationRevenueMilestone" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationRevenueMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationContingentConsiderationRevenueMilestone" xlink:to="lab_exas_BusinessCombinationContingentConsiderationRevenueMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_67f7c282-db71-472d-ace3-97970219366e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7945c465-9a8f-4b57-a074-585aa5a57e68_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_05a71566-8fb6-4784-bf5f-43af7fc05912_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount issued and sold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_749dc6c3-5500-4796-9102-4323daeecd65_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_b23f5b7f-3607-4dc5-8fcc-84a7de6f3d8b_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_05b29ea5-df3b-4886-9253-d83b572dab99_negatedLabel_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement of contingent consideration</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_e15303a0-bcd7-4e03-ab6e-082b91e7f6c1_negatedTerseLabel_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in fair value</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_label_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss), Change in Fair Value</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_documentation_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss), Change in Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:to="lab_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_8f781d6a-d4c1-4731-8f5c-27cf69ba48f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AllocatedToConsiderationTransferredMember_3ed60105-f050-4e95-960f-ec955959538e_terseLabel_en-US" xlink:label="lab_exas_AllocatedToConsiderationTransferredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Consideration Transferred</link:label>
    <link:label id="lab_exas_AllocatedToConsiderationTransferredMember_label_en-US" xlink:label="lab_exas_AllocatedToConsiderationTransferredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Consideration Transferred [Member]</link:label>
    <link:label id="lab_exas_AllocatedToConsiderationTransferredMember_documentation_en-US" xlink:label="lab_exas_AllocatedToConsiderationTransferredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToConsiderationTransferredMember" xlink:href="exas-20210930.xsd#exas_AllocatedToConsiderationTransferredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AllocatedToConsiderationTransferredMember" xlink:to="lab_exas_AllocatedToConsiderationTransferredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d3b5d4e3-7b65-4847-bf80-6fc4531e9d29_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0d2f0dfd-a4ce-4cd6-8b7c-01ea43b03ea6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_b723350b-f4b6-4837-8fbe-537b0a259774_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_975f94cd-5f1e-43a4-8377-7a6d7ee8d14c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_0810942c-f9e6-4018-b613-f5c4222c6399_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_e14988ae-216d-4969-978c-3faafdb02af1_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Current</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_54bec725-8460-4088-8844-7ccfc7771a9d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_837aeb94-770a-4fb8-8ff9-9aaf91725431_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_e4aa1ee4-c60d-4115-889b-7c4c8cc816ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of recognized identified assets acquired and liabilities assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e4a905e3-6389-49c3-9686-219c518af621_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of employee stock purchase plan shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e61d5f3e-b97b-44ba-b941-785af09b1e4e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_2f502f7a-5897-48c9-b1e9-9f5bb6df0bb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_5efa6a76-7df0-4c25-a657-fe2318b26184_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_bfe9a762-e4fe-4494-9761-6b81a7908f48_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_8833ec82-46e6-44f4-bbe7-811d383a8714_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3f6c93eb-95b6-4577-8dc9-e84f943e07a7_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities_fa3c5bcd-4ad8-46ba-9980-0e6eb720720f_terseLabel_en-US" xlink:label="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:label id="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="exas-20210930.xsd#exas_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_exas_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_9e63e213-57f4-4f36-a697-45c49f7b75c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interests issued or issuable to previous investors</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ScheduleOfConvertibleNotesTable_7e85dcc8-318b-420e-95f1-28b23f93213f_terseLabel_en-US" xlink:label="lab_exas_ScheduleOfConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Convertible notes [Table]</link:label>
    <link:label id="lab_exas_ScheduleOfConvertibleNotesTable_label_en-US" xlink:label="lab_exas_ScheduleOfConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Convertible notes [Table]</link:label>
    <link:label id="lab_exas_ScheduleOfConvertibleNotesTable_documentation_en-US" xlink:label="lab_exas_ScheduleOfConvertibleNotesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table information pertaining to convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfConvertibleNotesTable" xlink:href="exas-20210930.xsd#exas_ScheduleOfConvertibleNotesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable" xlink:to="lab_exas_ScheduleOfConvertibleNotesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_593d1d3c-a26e-4410-9e7a-d91a1b7ac5a5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncome_af8ad613-d5a6-470b-8cb9-94ed152fba59_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating income</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncome_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncome" xlink:to="lab_us-gaap_OtherOperatingIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_42aa1c4a-089c-4de3-9dd0-ffd61bd71640_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense amortization term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_a95064c7-06dc-41d0-9769-cdbc6059058f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_847e3927-e8ae-450f-b184-2c02691d562a_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_56d82efd-ab90-461b-9c83-c5fa8188a90d_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d559f457-61d8-4542-a7f2-0bcd1a6906e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0dbe4ac2-eedf-45f3-ac40-e7c5470fd626_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_08078d87-f050-4a34-9d4e-15bde5479428_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6647a148-a4a9-41c8-a4e5-4d20e8494c0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_7036f1fe-5fa1-478a-9496-9af261197712_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c56a025f-0558-44b1-be23-616ee9a0dd4f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_ce978706-85f7-41ce-a66d-d6975ad14f52_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_dc1703f5-38e0-459e-97e8-cfe5bd1673ea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b65fe6c2-e563-435c-96bd-df620f7533e7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_beccb029-7b2e-4a37-8f76-7cad2ff01317_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_5197299b-6dcf-484d-ad1a-77d8b0f9c00b_verboseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon convertible notes settlement (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_59826946-3af4-4457-a67e-389f82671b01_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ca4d84a3-5d35-47f7-a924-316181445921_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_f040de00-cd3b-447f-9650-fcd0cf530956_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_caa6d19e-0bc9-4722-9065-8743b82ad145_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_caba4f75-3a2c-4e3b-82e6-31da2572c0af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from change in deferred tax asset valuation allowance resulting from merger</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_748a5231-9cda-4cc9-9002-330e22f4043a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionTextBlock_6f484028-3b26-4994-b2ef-7e2fae24fc04_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c26fb64b-79bd-4e92-81e5-e607a0793e01_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_cc739205-9b7b-488f-a6ec-25e6ac718b9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1428e8f7-79c5-4f13-ad90-5886ee6a8f68_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_d243acde-a5ec-42cb-b6ea-092f46e7c4b8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_951117de-a9d0-4a7d-9fac-bf8a2b1f5c4c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d17df5ef-228f-46dd-9b2a-4bc6604df6b5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d031e047-43d6-4e47-98d1-dfa760d2f60e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_37da1554-1340-43d3-8e77-45f0cb39161e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_a0a624bb-418a-4958-beaa-99daadce4f7d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_d3efc643-2081-4999-b049-6d59111b0933_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b6b127d8-c8e6-4033-a829-7bc57a716252_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_1ae3f6fd-b9c3-497b-a439-85bac553c0cd_terseLabel_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through acquisition (in dollars per share)</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_label_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Assumed in Period Through Acquisitions, Weighted Average Exercise Price</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Assumed in Period Through Acquisitions, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" xlink:to="lab_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4e45b9db-15c2-4dc8-8374-8297e8cf9831_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3c19876c-4c37-4a9b-804a-33fd69df0ebb_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_82ee473b-f2fc-4051-b548-b31847c01a5f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7798caed-ff0d-4c5c-a81e-79ef917ec771_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value per share of options granted during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6923265a-97ba-4b0c-b553-72a8210fa8f7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_321057af-6438-46e2-accb-c21daf4378d2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of outstanding performance share units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5aea946f-c163-47c0-a860-d19b4a499bf7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_c5a27c81-0d8c-4ffb-85c5-61f2cc43657b_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_8293c5ea-9bb1-4df1-bbee-faf21761115a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm_13948741-1cd7-476c-a3df-11794367d7dd_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest-only payment, period</link:label>
    <link:label id="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm_label_en-US" xlink:label="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Periodic Payment Interest Term</link:label>
    <link:label id="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm_documentation_en-US" xlink:label="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of the required periodic payments applied to interest in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentPeriodicPaymentInterestTerm" xlink:href="exas-20210930.xsd#exas_DebtInstrumentPeriodicPaymentInterestTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentPeriodicPaymentInterestTerm" xlink:to="lab_exas_DebtInstrumentPeriodicPaymentInterestTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6425afd9-1aca-4ca4-9ac0-ab6759f801d7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PrecisionOncologyMember_b7802f8a-321b-46b4-a20d-b0a06bbcff04_terseLabel_en-US" xlink:label="lab_exas_PrecisionOncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precision Oncology</link:label>
    <link:label id="lab_exas_PrecisionOncologyMember_label_en-US" xlink:label="lab_exas_PrecisionOncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precision Oncology [Member]</link:label>
    <link:label id="lab_exas_PrecisionOncologyMember_documentation_en-US" xlink:label="lab_exas_PrecisionOncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Precision Oncology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PrecisionOncologyMember" xlink:href="exas-20210930.xsd#exas_PrecisionOncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PrecisionOncologyMember" xlink:to="lab_exas_PrecisionOncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_8a39b92c-9a63-4d55-9cb0-4dc7bfe08ba2_terseLabel_en-US" xlink:label="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee based on incremental gross profits over specified baselines and royalties</link:label>
    <link:label id="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_label_en-US" xlink:label="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Fee Based on Incremental Gross Profits Over Specified Baselines and Royalties</link:label>
    <link:label id="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_documentation_en-US" xlink:label="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents service fee based on incremental gross profits over specified baselines and royalties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" xlink:href="exas-20210930.xsd#exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" xlink:to="lab_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_953909bb-af61-4591-a67b-10a8647bf13e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosures related to New Market Tax Credit</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_65a8dcd2-d849-4092-a521-cfb24cf837af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental share based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Plan Modification, Incremental Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_b6db4c4d-229d-4956-8428-252cf9fd114c_terseLabel_en-US" xlink:label="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of shares held for future issuance</link:label>
    <link:label id="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Shares Reserved For Future Issuance</link:label>
    <link:label id="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_documentation_en-US" xlink:label="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Shares Reserved For Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" xlink:to="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_c0bc5c60-4071-4909-a46b-a427fd122de6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_ef6968cd-93fb-43c7-966d-651242797424_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_c08d0a51-0884-4138-b0cf-05ed429dcb74_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9dcdfa4a-2829-4f5e-80e4-34fa36d21301_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_58223dff-0d23-44a1-9fd1-2fbb85d285e7_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_71e459e9-716a-483f-85e2-bbb1515abc72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_9e0b2f48-8aa3-43d3-b181-00675c3f0afa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for business combinations and asset acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_bd7477cf-aadf-4ac3-a748-f5bf9038a6f7_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a3ba2897-ec03-4315-9738-79304272c1f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_316e1fe4-fb84-4628-8a65-381d1f5aca8e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense related to issuance of stock options and restricted stock awards</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_95fb7d57-7797-4ad2-bc49-41e86503769a_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1307b64a-b39b-4a7b-9a79-0114e2ba431b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_7e031527-4f9a-4e0b-8fe0-40ecad06a5d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent payment obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_33d50c84-49d3-4ccd-9e7e-b0bc17792018_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_8ee597a3-6b67-4a26-b3f0-e43a95c2b405_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_74ee71e8-9e16-48c1-9557-cbcbe4b1a682_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, fair value</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_02c3138e-ca61-48d9-8bf9-abd8cdc92984_terseLabel_en-US" xlink:label="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="exas-20210930.xsd#exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_93522b84-5799-404a-963e-213ec87b818f_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived and indefinite-lived intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1043e26c-2ef5-43b1-a518-a71528fa66b1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_0228841a-ba27-4469-a570-8db05fdfecc6_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_599b45d0-23ee-45c9-b4e8-936fcf86a866_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_bf377ca8-a791-4d82-b3c5-e487bd4bdf9a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability, current</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_0af6645d-b4f7-4727-8a1b-fe923c07feba_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_2fc8dbaf-9337-475d-871e-c6bbf0951ac8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock to fund the Company's 401(k) match (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_183d833c-aef3-4d7b-81c7-b226eef81202_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss before tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_cf190ee5-822c-43e7-b074-640dbb8e831d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_6b51f364-0f1e-4433-adc5-cc04653e4abe_terseLabel_en-US" xlink:label="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial investment</link:label>
    <link:label id="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_label_en-US" xlink:label="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Own Investment to be Made in Construction Project</link:label>
    <link:label id="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_documentation_en-US" xlink:label="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum amount of own investment to be made in construction project.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MinimumOwnInvestmentToBeMadeInConstructionProject" xlink:href="exas-20210930.xsd#exas_MinimumOwnInvestmentToBeMadeInConstructionProject"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_MinimumOwnInvestmentToBeMadeInConstructionProject" xlink:to="lab_exas_MinimumOwnInvestmentToBeMadeInConstructionProject" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_bb62910b-ec54-470d-b8f5-d5472b4fa3a9_terseLabel_en-US" xlink:label="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of facilities receiving working capital and capital improvements from financing agreements</link:label>
    <link:label id="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_label_en-US" xlink:label="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Facilities Receiving Working Capital and Capital Improvements</link:label>
    <link:label id="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_documentation_en-US" xlink:label="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of facilities receiving working capital and capital improvements from financing agreements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" xlink:href="exas-20210930.xsd#exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" xlink:to="lab_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_bf18a992-7be6-47ad-b609-21795bb9c31e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_94bd5eb1-d14d-485b-b26d-89b88abbf76b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_cd273b87-eeb8-4ca6-9353-6916beaab4ae_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net, current portion</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_1ae52029-7dff-40df-98d0-781810f9602e_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in current portion of convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_eec440e2-96ef-4270-9184-94e9174053f3_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of available-for-sale securities in a continuous unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_93cb5989-4b71-4fbe-ad17-538d8011f4bf_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ac0467b1-3ee2-4d78-9f4e-1c54f46af66d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c10bf6b1-1eff-4706-b7df-9d5b5fe4e0e3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining useful life of finite-lived intangible asset (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLoansPayable_054f0a0e-e4bd-429a-8b8e-01211622558c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermLoansPayable_label_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="lab_us-gaap_LongTermLoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BiomatricaIncMember_7ba2b77f-696b-4798-bcdb-54662ea88a33_terseLabel_en-US" xlink:label="lab_exas_BiomatricaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biomatrica, Inc</link:label>
    <link:label id="lab_exas_BiomatricaIncMember_label_en-US" xlink:label="lab_exas_BiomatricaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biomatrica Inc [Member]</link:label>
    <link:label id="lab_exas_BiomatricaIncMember_documentation_en-US" xlink:label="lab_exas_BiomatricaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Biomatrica, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BiomatricaIncMember" xlink:href="exas-20210930.xsd#exas_BiomatricaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BiomatricaIncMember" xlink:to="lab_exas_BiomatricaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_bc481e4e-3fd5-4680-a4b5-0b81c485c00e_terseLabel_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_label_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Options, Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_1fcb3664-ae5a-4758-948d-9e37f90c9beb_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_cd763c35-ab4b-4cb4-9589-0797fe2d4a02_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c44e86d6-3736-4712-8a7d-cb455933345f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_5906b4c0-b2ac-465c-a757-2313881f3f37_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8890c1da-a5b9-47ee-ae9d-9aa951264a30_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ConvertibleNotesPayable2025Member_302ce96e-675a-4453-b2ad-0a067a864f80_terseLabel_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 notes</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayable2025Member_label_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable2025 [Member]</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayable2025Member_documentation_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to convertible notes, maturing on 2025.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ConvertibleNotesPayable2025Member" xlink:to="lab_exas_ConvertibleNotesPayable2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_376c79dc-3533-4b10-8824-7a99f3ede457_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense related to items of other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7e29836d-dd80-4417-9b49-fd1457f2e125_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_96d38e3b-25a7-4b1f-8167-06bad7197345_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_51a389dc-e433-488d-9abe-6e5da0083f8a_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_30f3ad86-a3ab-40a9-81ed-0ea305687596_terseLabel_en-US" xlink:label="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital investment expenditures over specified period, requirement to earn the refundable tax credits</link:label>
    <link:label id="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_label_en-US" xlink:label="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Investment Expenditures, Requirement for Refundable Tax Credits</link:label>
    <link:label id="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_documentation_en-US" xlink:label="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of expenditures in capital investments the Company is required to make over a specified period to earn the refundable tax credits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" xlink:href="exas-20210930.xsd#exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" xlink:to="lab_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_848ba06f-fc0f-43d5-b462-b6b711d476ae_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_81ebe4c5-fb7b-46a7-b9e6-8846867e379e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_becb2406-a4aa-40de-9b51-37404812a67d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8bf9f2ae-b3bd-4c8a-91ad-c9450bb867f3_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_e73ffced-0e5e-4708-8c39-44c1dcab440a_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_c163ba22-a96f-4b6d-9f28-67cd9f45f925_terseLabel_en-US" xlink:label="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Full-time positions that must be created over a specified time period to earn the refundable tax credits</link:label>
    <link:label id="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_label_en-US" xlink:label="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Full-time Positions Required to be Created to Earn Refundable Tax Credits</link:label>
    <link:label id="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_documentation_en-US" xlink:label="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the number of full-time positions that must be created over a specified time period to earn the refundable tax credits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" xlink:href="exas-20210930.xsd#exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" xlink:to="lab_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f58eb2a2-1e0b-4d42-a3fd-3f255f6c1300_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3fae7c72-518b-4640-9e4e-dd7be3eb1797_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3491c337-6b39-44e7-b5eb-10c2d7975e68_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ConvertibleNotesPayable2028Member_aa7064a2-9f4d-4c5c-9de4-33786f20aa27_terseLabel_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Notes</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayable2028Member_label_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable2028 [Member]</link:label>
    <link:label id="lab_exas_ConvertibleNotesPayable2028Member_documentation_en-US" xlink:label="lab_exas_ConvertibleNotesPayable2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ConvertibleNotesPayable2028Member" xlink:to="lab_exas_ConvertibleNotesPayable2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_091897b1-545d-4417-be5a-781582edfbe6_netLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_92b699b0-54f8-4703-89a1-54a8b1fddbb0_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_da0f667e-25a7-45f9-b8ed-45d3b1e6cc8d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_COVID19Member_98f8febc-5681-433f-a6c0-9e27cfc0e3a8_terseLabel_en-US" xlink:label="lab_exas_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19</link:label>
    <link:label id="lab_exas_COVID19Member_label_en-US" xlink:label="lab_exas_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_exas_COVID19Member_documentation_en-US" xlink:label="lab_exas_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_COVID19Member" xlink:href="exas-20210930.xsd#exas_COVID19Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_COVID19Member" xlink:to="lab_exas_COVID19Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_f04535ca-2af8-47b5-b621-dcd1a655c726_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Basis of Pricing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:to="lab_us-gaap_ContractWithCustomerBasisOfPricingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_bacea647-079b-4c6f-b76e-f2a612535121_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_db55444e-cad8-440b-9f3c-7bde6fdc52b8_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_17052a32-d0a8-483b-8a44-dbeda1252996_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_572788bd-94f9-4b36-a3f2-29731e417183_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_3633ef05-60e1-4edb-a1ac-68adcd5fe7f0_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net, less current portion</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_8db29ee2-3df6-4949-b317-8c893b42f209_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in convertible notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_ca6fa1a4-3d4a-44f1-9f01-74f32700a1d1_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_75764388-2fce-489e-a861-a1eb3d7efc3f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_c998d802-0505-40c2-b721-93c943ccb144_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_8f18c424-335f-4e1d-b4d1-63cfb669b26a_terseLabel_en-US" xlink:label="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CSM Coverage</link:label>
    <link:label id="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_label_en-US" xlink:label="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Center for Medicare And Medicaid Services (CMS) Coverage [Member]</link:label>
    <link:label id="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_documentation_en-US" xlink:label="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Center for Medicare And Medicaid Services (CMS) Coverage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" xlink:href="exas-20210930.xsd#exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" xlink:to="lab_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_f8c1ef1b-628d-41dc-9aa9-a55256060810_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_f97fb9f4-5d49-4f44-8ac3-fd2cae94b1e7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_27f3ec6a-f60d-4552-8e88-abb2ca143c2d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition IPR&amp;D expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_02614f8a-8aff-41ef-b367-3499a57f288c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_InvestmentIncomeExpenseNonoperating_b337c683-6541-4c6c-a428-ab602fe931de_terseLabel_en-US" xlink:label="lab_exas_InvestmentIncomeExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income (expense), net</link:label>
    <link:label id="lab_exas_InvestmentIncomeExpenseNonoperating_label_en-US" xlink:label="lab_exas_InvestmentIncomeExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income (Expense), Nonoperating</link:label>
    <link:label id="lab_exas_InvestmentIncomeExpenseNonoperating_documentation_en-US" xlink:label="lab_exas_InvestmentIncomeExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income (Expense), Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InvestmentIncomeExpenseNonoperating" xlink:href="exas-20210930.xsd#exas_InvestmentIncomeExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_InvestmentIncomeExpenseNonoperating" xlink:to="lab_exas_InvestmentIncomeExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_acbdf29f-eff4-48bd-97f4-4ab41ba0ac0a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_411f35af-79f5-4554-8772-3a404a8db9bf_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ComprehensiveIncomeLossBeforeTax_a72a2f45-f5b5-41ef-87ff-8f674d69ebe3_totalLabel_en-US" xlink:label="lab_exas_ComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss, before tax</link:label>
    <link:label id="lab_exas_ComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_exas_ComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (loss), Before Tax</link:label>
    <link:label id="lab_exas_ComprehensiveIncomeLossBeforeTax_documentation_en-US" xlink:label="lab_exas_ComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before tax, of comprehensive income (loss).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ComprehensiveIncomeLossBeforeTax" xlink:href="exas-20210930.xsd#exas_ComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ComprehensiveIncomeLossBeforeTax" xlink:to="lab_exas_ComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_c6a48a5c-b13f-4cef-8be2-74ccd2c6509a_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetUnderConstructionMember_7c1f11e4-861c-4bed-997b-9151db9944fe_terseLabel_en-US" xlink:label="lab_us-gaap_AssetUnderConstructionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets under construction</link:label>
    <link:label id="lab_us-gaap_AssetUnderConstructionMember_label_en-US" xlink:label="lab_us-gaap_AssetUnderConstructionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset under Construction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetUnderConstructionMember" xlink:to="lab_us-gaap_AssetUnderConstructionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_452fb58d-c559-48d7-bc60-add7fb59d40c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_0154290a-9589-4581-b554-bae84155c96d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_98e9b138-a6bc-4b14-a9b8-7c2e3e14c2a1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in net loss per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_871e0eab-0cda-4208-b8d8-0eaa29b158bc_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in amortization debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NewMarketTaxCreditAbstract_7d4b5982-b2be-4630-b3f1-60874e93b21a_terseLabel_en-US" xlink:label="lab_exas_NewMarketTaxCreditAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MARKET TAX CREDIT</link:label>
    <link:label id="lab_exas_NewMarketTaxCreditAbstract_label_en-US" xlink:label="lab_exas_NewMarketTaxCreditAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MARKET TAX CREDIT</link:label>
    <link:label id="lab_exas_NewMarketTaxCreditAbstract_documentation_en-US" xlink:label="lab_exas_NewMarketTaxCreditAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Market Tax Credit [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditAbstract" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NewMarketTaxCreditAbstract" xlink:to="lab_exas_NewMarketTaxCreditAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_f8fa783e-8aa5-47d5-91e5-7605b10e08fa_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Parts B &amp; C</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_6609d317-73a9-4953-beed-9c74c4ad9fe2_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ParadigmViomicsMember_c4fa80e7-e484-4df3-9ab8-a971ed22e045_terseLabel_en-US" xlink:label="lab_exas_ParadigmViomicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paradigm &amp; Viomics</link:label>
    <link:label id="lab_exas_ParadigmViomicsMember_label_en-US" xlink:label="lab_exas_ParadigmViomicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paradigm &amp; Viomics [Member]</link:label>
    <link:label id="lab_exas_ParadigmViomicsMember_documentation_en-US" xlink:label="lab_exas_ParadigmViomicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paradigm &amp; Viomics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ParadigmViomicsMember" xlink:to="lab_exas_ParadigmViomicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_ce943d23-23aa-4cb0-a1c4-7e2d36ba66af_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside of United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c20a2e08-785b-4985-9a10-a631f6b4ebfc_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2333bf9b-02ff-41d6-82a4-f8dcebfbe9fc_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_45053449-8e1e-4bee-bf77-793a1b92ff08_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived and indefinite-lived intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_78457f71-3a53-4b04-a9da-53b93e2c336a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales (exclusive of amortization of acquired intangible assets)</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_MRDProductRevenueMilestoneMember_e484fd96-5af1-49aa-abd6-14fbd0f36da9_terseLabel_en-US" xlink:label="lab_exas_MRDProductRevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRD Product Revenue Milestone</link:label>
    <link:label id="lab_exas_MRDProductRevenueMilestoneMember_label_en-US" xlink:label="lab_exas_MRDProductRevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRD Product Revenue Milestone [Member]</link:label>
    <link:label id="lab_exas_MRDProductRevenueMilestoneMember_documentation_en-US" xlink:label="lab_exas_MRDProductRevenueMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRD Product Revenue Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MRDProductRevenueMilestoneMember" xlink:href="exas-20210930.xsd#exas_MRDProductRevenueMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_MRDProductRevenueMilestoneMember" xlink:to="lab_exas_MRDProductRevenueMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c0dd9434-b1c6-45a2-9298-c0c3b4fec6c8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BuildingsAndLeaseholdImprovementsMember_a94121ad-f74e-4254-8ed8-13755a753a9f_terseLabel_en-US" xlink:label="lab_exas_BuildingsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold and building improvements</link:label>
    <link:label id="lab_exas_BuildingsAndLeaseholdImprovementsMember_label_en-US" xlink:label="lab_exas_BuildingsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings And Leasehold Improvements [Member]</link:label>
    <link:label id="lab_exas_BuildingsAndLeaseholdImprovementsMember_documentation_en-US" xlink:label="lab_exas_BuildingsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to buildings and leasehold improvements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BuildingsAndLeaseholdImprovementsMember" xlink:href="exas-20210930.xsd#exas_BuildingsAndLeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BuildingsAndLeaseholdImprovementsMember" xlink:to="lab_exas_BuildingsAndLeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_35a0fe2c-ee74-4dfa-99a9-652e64c2d6cd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_61bd4847-2c47-42f2-9b01-d6a66f316257_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible notes, net of tax (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_41440adf-3165-4d8b-bf31-4d5d07b8ad9b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_42fa8ed3-677e-4fc0-96a1-fc5054fa114c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_86ed62b5-a709-43a2-99cc-13a8c3e67489_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of restricted stock and restricted stock unit activity under the Stock Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock_9376860a-244b-489b-a8c9-8929e2fd25e1_terseLabel_en-US" xlink:label="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of allocation of transaction costs related to convertible debt</link:label>
    <link:label id="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Transaction Costs Related to Convertible Debt [Table Text Block]</link:label>
    <link:label id="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock_documentation_en-US" xlink:label="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Transaction Costs Related to Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" xlink:href="exas-20210930.xsd#exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" xlink:to="lab_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_ad804d85-daf8-4194-bc55-8365d4f70359_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0d1f5cd2-10a0-4061-81bc-ee2de83e0381_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_TaxIncrementFinancingLoanAgreementsMember_d54f22c3-1588-4e69-883b-7cc84361e3e0_terseLabel_en-US" xlink:label="lab_exas_TaxIncrementFinancingLoanAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Increment Financing</link:label>
    <link:label id="lab_exas_TaxIncrementFinancingLoanAgreementsMember_label_en-US" xlink:label="lab_exas_TaxIncrementFinancingLoanAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Increment Financing Loan Agreements [Member]</link:label>
    <link:label id="lab_exas_TaxIncrementFinancingLoanAgreementsMember_documentation_en-US" xlink:label="lab_exas_TaxIncrementFinancingLoanAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the tax increment financing loan agreement with the City of Madison, Wisconsin.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TaxIncrementFinancingLoanAgreementsMember" xlink:href="exas-20210930.xsd#exas_TaxIncrementFinancingLoanAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_TaxIncrementFinancingLoanAgreementsMember" xlink:to="lab_exas_TaxIncrementFinancingLoanAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_61487e82-b618-4bef-823e-41a42107b1be_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_33a033de-cfda-4840-8caf-3441582f7510_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, current portion</link:label>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_label_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Bank Loans and Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_c18d5a65-7afb-4a33-ab11-0d74d39e31f8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development (IPR&amp;D)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_765c1ed3-3653-4868-91b7-5771c0d42871_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NewMarketTaxCreditProgramMember_e81ce1ad-ef9a-4eab-8b9b-e86c65fa71ec_terseLabel_en-US" xlink:label="lab_exas_NewMarketTaxCreditProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Market Tax Credit Program</link:label>
    <link:label id="lab_exas_NewMarketTaxCreditProgramMember_label_en-US" xlink:label="lab_exas_NewMarketTaxCreditProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Market Tax Credit Program [Member]</link:label>
    <link:label id="lab_exas_NewMarketTaxCreditProgramMember_documentation_en-US" xlink:label="lab_exas_NewMarketTaxCreditProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information regarding the New Market Tax Credit program, pursuant to Section 45D of the Internal Revenue Code of 1986, as amended.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditProgramMember" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NewMarketTaxCreditProgramMember" xlink:to="lab_exas_NewMarketTaxCreditProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_37a87ae6-3731-43e7-80fb-006fa45fcffb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_58ca93d0-4215-4322-82e7-0599f91f2708_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of fair value measurements along with the level within the fair value hierarchy in which the fair value measurements fall</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_1b4cf0f2-b63f-46e1-9106-9182b898b5bd_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible notes, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_db7b0314-cb51-462b-a9bd-bf3cc0fd125c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3738d1e7-3f41-4830-949e-7f4ba5f6c3d4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_36faf055-1880-4993-b1da-382d1a85f582_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_86c3a647-cfe4-4d6e-b26c-7e1cb8cc1e90_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remaining three months)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_11419649-8eec-4174-8050-555de4955cb5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_183fece2-910b-4062-bd1f-67be966ec0c3_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_14510026-088b-4882-9e21-3215f8c910fa_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_db0dba75-3cd6-4e47-a293-407f09aca7e5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3bf7ba27-505b-4387-8f5d-e4fa5d9181e0_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_AllocatedToPreviousOwnershipInterestMember_dd74e985-7440-4029-8813-060e94d9acf1_terseLabel_en-US" xlink:label="lab_exas_AllocatedToPreviousOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Previous Ownership Interest</link:label>
    <link:label id="lab_exas_AllocatedToPreviousOwnershipInterestMember_label_en-US" xlink:label="lab_exas_AllocatedToPreviousOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Previous Ownership Interest [Member]</link:label>
    <link:label id="lab_exas_AllocatedToPreviousOwnershipInterestMember_documentation_en-US" xlink:label="lab_exas_AllocatedToPreviousOwnershipInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated to Previous Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToPreviousOwnershipInterestMember" xlink:href="exas-20210930.xsd#exas_AllocatedToPreviousOwnershipInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_AllocatedToPreviousOwnershipInterestMember" xlink:to="lab_exas_AllocatedToPreviousOwnershipInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PaymentsContingentOnMilestonesPayable_ecfa3454-e87c-44a7-9549-659c0a3a17d3_terseLabel_en-US" xlink:label="lab_exas_PaymentsContingentOnMilestonesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments contingent on milestones</link:label>
    <link:label id="lab_exas_PaymentsContingentOnMilestonesPayable_label_en-US" xlink:label="lab_exas_PaymentsContingentOnMilestonesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments Contingent on Milestones Payable</link:label>
    <link:label id="lab_exas_PaymentsContingentOnMilestonesPayable_documentation_en-US" xlink:label="lab_exas_PaymentsContingentOnMilestonesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents potential future payments still contingent upon achievement of milestones under a collaborative arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsContingentOnMilestonesPayable" xlink:href="exas-20210930.xsd#exas_PaymentsContingentOnMilestonesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PaymentsContingentOnMilestonesPayable" xlink:to="lab_exas_PaymentsContingentOnMilestonesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_cf0e29b1-51ee-41e5-9b47-6ac8d46bb5f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7c9de41a-5bfd-4bba-9004-8b3c20c761be_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_73956f1c-818a-4b6f-a365-753c0d7f0971_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation consideration assumed and allocated to consideration transferred</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation Allocated to Consideration Transferred</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation Allocated to Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_b223effe-2c68-446e-a9e0-f83db19825e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock issued in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_TARDISTechnologyMember_04d8bbfe-a782-4a35-b6a1-d0dd2e6b55cc_terseLabel_en-US" xlink:label="lab_exas_TARDISTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TARDIS Technology</link:label>
    <link:label id="lab_exas_TARDISTechnologyMember_label_en-US" xlink:label="lab_exas_TARDISTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TARDIS Technology [Member]</link:label>
    <link:label id="lab_exas_TARDISTechnologyMember_documentation_en-US" xlink:label="lab_exas_TARDISTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TARDIS Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TARDISTechnologyMember" xlink:href="exas-20210930.xsd#exas_TARDISTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_TARDISTechnologyMember" xlink:to="lab_exas_TARDISTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_d3d60d76-b461-465a-ad4b-a36eb32513f0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_04db860a-3a06-475c-9361-56628501e696_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_517eef28-9e4a-4d69-b4d7-cd1e49ae38f7_terseLabel_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed through acquisition (in shares)</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_label_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed During Period Through Acquisitions</link:label>
    <link:label id="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_documentation_en-US" xlink:label="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed During Period Through Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" xlink:to="lab_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_c57278f7-cdb9-4288-b8f2-1b7af66fdf3c_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_b96976f9-203e-4d55-83a5-3e7ba35ffbf7_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating assets</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Excluding Intangible Assets</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Excluding Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5c13c742-1663-4a72-8cdb-d37277366d33_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares not included in the computation of diluted net loss per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_767efa0e-0a6d-406c-a619-fe427f41b0c1_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_b99e52f7-c9ea-4506-b19e-337b851e7004_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_17880048-23d8-48a1-8870-00f7804150ac_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum liquidity covenant for construction loan</link:label>
    <link:label id="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_label_en-US" xlink:label="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Required, Minimum</link:label>
    <link:label id="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_documentation_en-US" xlink:label="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentCovenantLiquidityRequiredMinimum" xlink:href="exas-20210930.xsd#exas_DebtInstrumentCovenantLiquidityRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentCovenantLiquidityRequiredMinimum" xlink:to="lab_exas_DebtInstrumentCovenantLiquidityRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34e9ae04-9bb6-42f7-a478-835a55c473e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_e3342542-77c0-4d77-b022-422c89aa511b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_4fc212a7-f5b1-40d0-9f84-ffaed42a7b7c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_52f787e7-f24e-4bdb-b2b0-363a18215e51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_0fcdf890-074e-48c9-8c7b-36f0ae7d16d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_4d289a03-01d2-4b4c-a632-0d6d921c0e99_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, less current portion</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Noncurrent</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_851dc0b0-a3b5-40ac-a729-dd7cdee3f270_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_7efcb7e7-fe5e-45bb-bf65-a58e90cea22a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_5bcd0237-0797-4e4b-a117-bda970c08fde_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_96c4ead7-f3bb-4b2e-80f4-e80a075dddf0_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_LicenseAgreementFeesCommitment_a1f1f01e-f522-40b2-a33e-f010c62d4243_terseLabel_en-US" xlink:label="lab_exas_LicenseAgreementFeesCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License agreement fees commitment</link:label>
    <link:label id="lab_exas_LicenseAgreementFeesCommitment_label_en-US" xlink:label="lab_exas_LicenseAgreementFeesCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement Fees Commitment</link:label>
    <link:label id="lab_exas_LicenseAgreementFeesCommitment_documentation_en-US" xlink:label="lab_exas_LicenseAgreementFeesCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Agreement Fees Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LicenseAgreementFeesCommitment" xlink:href="exas-20210930.xsd#exas_LicenseAgreementFeesCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_LicenseAgreementFeesCommitment" xlink:to="lab_exas_LicenseAgreementFeesCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_fd2429a7-a934-4a3e-b4a3-31e11dc69755_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_e0c3043d-7785-4551-b8d5-16860018e4c8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_46e2772d-410f-4f8c-801c-d4c385f022f3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_746e0b47-bb38-459b-b5d9-8b1f664bbdc9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_168b3a0b-7ae1-4396-bde5-65dbc96e15d9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_ec1eae00-1887-4962-8636-5d75594f8378_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_GoodwillAcquiredAdjustment_742a30e3-1b5e-4fae-aa86-b6aabe6385a4_terseLabel_en-US" xlink:label="lab_exas_GoodwillAcquiredAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Genomic Health acquisition adjustment</link:label>
    <link:label id="lab_exas_GoodwillAcquiredAdjustment_label_en-US" xlink:label="lab_exas_GoodwillAcquiredAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired, Adjustment</link:label>
    <link:label id="lab_exas_GoodwillAcquiredAdjustment_documentation_en-US" xlink:label="lab_exas_GoodwillAcquiredAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_GoodwillAcquiredAdjustment" xlink:href="exas-20210930.xsd#exas_GoodwillAcquiredAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_GoodwillAcquiredAdjustment" xlink:to="lab_exas_GoodwillAcquiredAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_7eb9fb0f-7920-4315-9deb-19c27fdb9b1d_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_174ebe00-5311-4259-9734-c4027a08b154_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of estimated future amortization expense, intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4e5f42c7-e928-46e3-aec2-dfa02761e065_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_30f1e00f-f550-462e-a22c-9d9d6a61bea9_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_05db17b7-ca25-4c63-a633-14ba9f6a659a_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8859750a-3718-4686-80c7-eaae5e01f0f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5b41a9d8-8741-47fc-88a5-a9c30a48b8f6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_19c8d9bf-1e5b-4d95-a092-316486ec8f89_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gain) loss on equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_184f0675-3f68-4325-9123-ab9e4498478f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_954cdc5b-34e0-434a-8b6b-d5fbd3165497_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_f3738e0b-58de-4ed6-aafb-3f80812263cd_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Liabilities</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_0dc67197-61bc-4559-9361-dfd3e1a88a37_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_COVID19TestingMember_19ffa77f-2ecd-4229-bc26-fee6bb585b23_terseLabel_en-US" xlink:label="lab_exas_COVID19TestingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing</link:label>
    <link:label id="lab_exas_COVID19TestingMember_label_en-US" xlink:label="lab_exas_COVID19TestingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing [Member]</link:label>
    <link:label id="lab_exas_COVID19TestingMember_documentation_en-US" xlink:label="lab_exas_COVID19TestingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_COVID19TestingMember" xlink:href="exas-20210930.xsd#exas_COVID19TestingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_COVID19TestingMember" xlink:to="lab_exas_COVID19TestingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_7fe31ef1-db02-4239-a342-94e1ee99a7fa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_7c16d2c3-89e8-49f1-afca-64055abdafeb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_DebtInstrumentConvertibleTransactionCosts_7e80af52-9643-40ef-8d5a-6e9b81651ac3_terseLabel_en-US" xlink:label="lab_exas_DebtInstrumentConvertibleTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total transaction costs</link:label>
    <link:label id="lab_exas_DebtInstrumentConvertibleTransactionCosts_label_en-US" xlink:label="lab_exas_DebtInstrumentConvertibleTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Transaction Costs</link:label>
    <link:label id="lab_exas_DebtInstrumentConvertibleTransactionCosts_documentation_en-US" xlink:label="lab_exas_DebtInstrumentConvertibleTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The transaction costs of the liability and equity component of convertible debt which may be settled upon conversion.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentConvertibleTransactionCosts" xlink:href="exas-20210930.xsd#exas_DebtInstrumentConvertibleTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_DebtInstrumentConvertibleTransactionCosts" xlink:to="lab_exas_DebtInstrumentConvertibleTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_e7c863ec-170f-4724-afe1-ea9f07b8f333_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition, consideration transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_524480d7-f961-4041-982b-a115a31ec1ad_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7fa32186-72b1-4498-a199-181b7a38d491_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8ffc6490-b509-47a9-999b-a1ac1d8cfcda_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PfizerIncMember_f025af76-44a9-4e70-b8cc-ca2753adb47c_terseLabel_en-US" xlink:label="lab_exas_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Inc</link:label>
    <link:label id="lab_exas_PfizerIncMember_label_en-US" xlink:label="lab_exas_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Inc [Member]</link:label>
    <link:label id="lab_exas_PfizerIncMember_documentation_en-US" xlink:label="lab_exas_PfizerIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member represents information regarding Pfizer Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PfizerIncMember" xlink:href="exas-20210930.xsd#exas_PfizerIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PfizerIncMember" xlink:to="lab_exas_PfizerIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_edad8d0b-0fa3-4cd6-93c3-e9b574b55172_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_4ebdd9dc-f494-419a-a322-3164e2e2edc7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RegulatoryLiabilityAmortizationPeriod_af38c37b-8711-49e8-b5ae-33463fe17488_terseLabel_en-US" xlink:label="lab_us-gaap_RegulatoryLiabilityAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timeframe when amount will be repaid through property taxes</link:label>
    <link:label id="lab_us-gaap_RegulatoryLiabilityAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_RegulatoryLiabilityAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Liability, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RegulatoryLiabilityAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatoryLiabilityAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RegulatoryLiabilityAmortizationPeriod" xlink:to="lab_us-gaap_RegulatoryLiabilityAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_0bf62848-3a02-41a6-bfb3-67dd50c00c6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_934d8394-2b8b-4f1a-a1a2-9860cef980c0_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_5f7198d1-f503-479a-9c34-8e94d539c7de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_7597bc3e-559d-4370-a734-fd1421108238_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_66f189b8-8eef-4e0d-a0f5-9193f446d365_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4a1f1b16-2c45-4232-872a-c0800a5f88c3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b9ee3eac-2659-4f88-9854-36908e18cc4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3e39fb4f-e8ba-4c77-84db-3d027d661ec7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b56717cf-d98e-4abb-8db2-e3cdf9b294a7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_5b6bcb3b-2664-4911-978b-2c6c0d5d12b8_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_6db3a07b-2119-46db-8e08-82f5b83f79af_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_73bbda96-0a51-43e2-9737-9291b1d22e6d_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_d8779479-1de4-4089-b0cb-2b00160392a3_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_540f7b81-f24a-4533-ab63-c6181b576944_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities and sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_69cf3466-677b-400a-9b94-ad4adcb572a6_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_beae0b5b-4ea2-406b-a246-e9e7a0d49bd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CONVERTIBLENOTESAbstract_19187398-f689-4df2-ae63-559b34650f3c_terseLabel_en-US" xlink:label="lab_exas_CONVERTIBLENOTESAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONVERTIBLE NOTES.</link:label>
    <link:label id="lab_exas_CONVERTIBLENOTESAbstract_label_en-US" xlink:label="lab_exas_CONVERTIBLENOTESAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONVERTIBLE NOTES [Abstract]</link:label>
    <link:label id="lab_exas_CONVERTIBLENOTESAbstract_documentation_en-US" xlink:label="lab_exas_CONVERTIBLENOTESAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONVERTIBLE NOTES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CONVERTIBLENOTESAbstract" xlink:href="exas-20210930.xsd#exas_CONVERTIBLENOTESAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CONVERTIBLENOTESAbstract" xlink:to="lab_exas_CONVERTIBLENOTESAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_862d5c4e-cc65-4ca4-ac13-4c28376af930_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_157142ef-d0a9-4db0-a4e5-8508d1038d0b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_588117ea-d861-4a13-80a5-839c9cc4d18d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_86530793-6264-44e0-826d-2214c23cfa13_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_75642444-382f-429b-bfe9-5ab251fa9b41_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_e78003ad-7103-497d-bc52-4e44a014c13d_terseLabel_en-US" xlink:label="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-combination expense for acceleration of unvested equity</link:label>
    <link:label id="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_label_en-US" xlink:label="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Combination Expense for Acceleration of Unvested Equity</link:label>
    <link:label id="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_documentation_en-US" xlink:label="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-Combination Expense for Acceleration of Unvested Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:href="exas-20210930.xsd#exas_PostCombinationExpenseForAccelerationOfUnvestedEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:to="lab_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_940539f7-c718-400e-a958-631869069b0d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rates, maximum (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandImprovementsMember_e6506dd8-0f9a-41ce-844e-6774b52288c3_terseLabel_en-US" xlink:label="lab_us-gaap_LandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land improvements</link:label>
    <link:label id="lab_us-gaap_LandImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LandImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandImprovementsMember" xlink:to="lab_us-gaap_LandImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_6ac269c7-19de-4d4d-9d15-c5520da51c14_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_2a6e7468-b3c6-496d-aadc-d81888ff6b2c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_67c53ddf-fc4b-4fdf-a89a-71d845a7c84a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_953e7be0-4165-40e5-9ffc-9fe0c8587d21_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PromotionAgreementDisclosureAbstract_35547ba7-9753-42f4-939c-6255b19816df_terseLabel_en-US" xlink:label="lab_exas_PromotionAgreementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PFIZER PROMOTION AGREEMENT</link:label>
    <link:label id="lab_exas_PromotionAgreementDisclosureAbstract_label_en-US" xlink:label="lab_exas_PromotionAgreementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PFIZER PROMOTION AGREEMENT</link:label>
    <link:label id="lab_exas_PromotionAgreementDisclosureAbstract_documentation_en-US" xlink:label="lab_exas_PromotionAgreementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">n/a</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PromotionAgreementDisclosureAbstract" xlink:href="exas-20210930.xsd#exas_PromotionAgreementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PromotionAgreementDisclosureAbstract" xlink:to="lab_exas_PromotionAgreementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_41841d89-8d25-4d92-8bf0-f6a16a22ab16_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_31496904-10dd-4017-97f9-3e4ede038bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net-book value and estimated remaining life and finite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d1cba419-43a0-4a10-a818-5d693c6d2932_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b150f50c-920e-434f-9b95-6dba939cbbce_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_f1ee5458-ca77-494b-ab4d-a7c837ff2cb0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on available-for-sale investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_7289d711-98dc-4a5f-9f46-df366fb9266a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_58557b51-e472-4f80-baea-1b6168885962_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseOther_0c81b15e-b2ec-45e7-a6a9-ac3965bbfd69_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseOther_label_en-US" xlink:label="lab_us-gaap_InterestExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseOther" xlink:to="lab_us-gaap_InterestExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ConvertibleNotesTextBlock_6d90c1a5-8bfb-426a-85c5-1291374b9fca_terseLabel_en-US" xlink:label="lab_exas_ConvertibleNotesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONVERTIBLE NOTES</link:label>
    <link:label id="lab_exas_ConvertibleNotesTextBlock_label_en-US" xlink:label="lab_exas_ConvertibleNotesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes [Text Block]</link:label>
    <link:label id="lab_exas_ConvertibleNotesTextBlock_documentation_en-US" xlink:label="lab_exas_ConvertibleNotesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesTextBlock" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ConvertibleNotesTextBlock" xlink:to="lab_exas_ConvertibleNotesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_320182a6-3942-44d6-a06a-214845542a6b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of common stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_63324f38-9496-41cb-ba66-41e8a625abbf_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6aeb5d4b-c7e8-4a32-8220-9c5344419cad_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_4beae0b7-003e-466e-8d72-90bc1df11fe8_terseLabel_en-US" xlink:label="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses and accelerated vesting of awards</link:label>
    <link:label id="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_label_en-US" xlink:label="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Accelerated Vesting Of Awards</link:label>
    <link:label id="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_documentation_en-US" xlink:label="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Acquire Businesses And Accelerated Vesting Of Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" xlink:href="exas-20210930.xsd#exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" xlink:to="lab_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_b32e4468-1f90-43c6-b908-92f254f5af1a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_f4c170d5-cd9d-4078-9a5a-1e03a3f35e20_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated civil damages</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_5f68aab9-65e3-437f-9c26-3a17f6e4ea05_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_19374baa-44c9-4030-8205-b21b407e5fd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_4a61a669-11b0-4ea1-9a83-321e234af13e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash and cash equivalents, restricted cash and marketable securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_dd8d4512-37f3-4700-a34d-94cfccc54ccd_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use Assets</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a84be53f-ec7b-4f52-8a81-47d5b8a67852_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ece846a8-56bd-4540-ab27-964294d2ee83_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d7f152bd-b009-45cf-a027-7ed1252594c4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, right-of-use asset, statement of financial position, extensible list</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_14e583ca-902c-4956-9501-c27c7652fc64_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_b6896131-52e4-4620-994c-859e3bf6b4ef_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_02ce79aa-b30b-4d95-8144-31b3a26a4d57_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_3a227625-028c-4a5c-a69b-dd835403c820_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_bd2ea23e-e4c7-450a-9c56-9d5065e1c717_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_39674900-186a-449b-b916-bf2da75ca9d1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_33fe9c47-8a0c-477e-b4ac-1a5d6d1e69ed_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment_58980b6a-2c66-4798-93ef-70b68741cc63_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional cash consideration to be paid</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment_label_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Additional Payment</link:label>
    <link:label id="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment_documentation_en-US" xlink:label="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Additional Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationAdditionalPayment" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationAdditionalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationContingentConsiderationAdditionalPayment" xlink:to="lab_exas_BusinessCombinationContingentConsiderationAdditionalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_21c90416-b25b-449d-955b-4aefbfdcf012_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e99005f-1349-465d-8ac0-a4a55c5bf9d2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_79bc6a66-3914-4fe7-8dec-526b2f84a917_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_4c6b7130-be59-48cb-94be-595325b3e0b2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_dddfdc0f-73e0-43b8-b34e-321e41d788ca_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f9708a-247f-43b2-a0c1-dbc850eb86f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_04dc9319-8159-4874-96ba-e7260cb6066f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_5d5d7874-1807-4b35-b610-a17faa7d31ae_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_f552610e-bd4f-439f-a085-0085accfbcd6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of employee stock purchase plan shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_RefundableTaxCreditEarnedToDate_cc1785e0-b147-4988-9cb6-5da80d18ae51_terseLabel_en-US" xlink:label="lab_exas_RefundableTaxCreditEarnedToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable tax credits earned</link:label>
    <link:label id="lab_exas_RefundableTaxCreditEarnedToDate_label_en-US" xlink:label="lab_exas_RefundableTaxCreditEarnedToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refundable Tax Credit Earned to Date</link:label>
    <link:label id="lab_exas_RefundableTaxCreditEarnedToDate_documentation_en-US" xlink:label="lab_exas_RefundableTaxCreditEarnedToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of refundable tax credits earned, relating to capital investments and job creation, as of the end of the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditEarnedToDate" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditEarnedToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_RefundableTaxCreditEarnedToDate" xlink:to="lab_exas_RefundableTaxCreditEarnedToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_MeasurementInputPresentValueFactorMember_2c45291a-2d58-4a9a-8cfa-e63e3ec25dc8_terseLabel_en-US" xlink:label="lab_exas_MeasurementInputPresentValueFactorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Present-value Factor</link:label>
    <link:label id="lab_exas_MeasurementInputPresentValueFactorMember_label_en-US" xlink:label="lab_exas_MeasurementInputPresentValueFactorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Present-value Factor [Member]</link:label>
    <link:label id="lab_exas_MeasurementInputPresentValueFactorMember_documentation_en-US" xlink:label="lab_exas_MeasurementInputPresentValueFactorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Present-value Factor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MeasurementInputPresentValueFactorMember" xlink:href="exas-20210930.xsd#exas_MeasurementInputPresentValueFactorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_MeasurementInputPresentValueFactorMember" xlink:to="lab_exas_MeasurementInputPresentValueFactorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_efa8d52f-2cc9-401c-8ec5-6b904d1d3d04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_b4e2cdb1-b8a3-4b78-9e8f-4e5d7e58e973_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_ac807148-aa0e-407b-a245-82f82d0dd0de_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_685dbe0d-e6b4-4387-a2ac-2e80ce26bd79_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_JanuaryNotesMember_2c9fd1cd-06da-4f98-b69c-2149e1efd42c_terseLabel_en-US" xlink:label="lab_exas_JanuaryNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2018 Notes</link:label>
    <link:label id="lab_exas_JanuaryNotesMember_label_en-US" xlink:label="lab_exas_JanuaryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January Notes [Member]</link:label>
    <link:label id="lab_exas_JanuaryNotesMember_documentation_en-US" xlink:label="lab_exas_JanuaryNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the January Notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_JanuaryNotesMember" xlink:href="exas-20210930.xsd#exas_JanuaryNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_JanuaryNotesMember" xlink:to="lab_exas_JanuaryNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_ScreeningMember_bb258b67-36ed-40f3-9191-ab76d158ee22_terseLabel_en-US" xlink:label="lab_exas_ScreeningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Screening</link:label>
    <link:label id="lab_exas_ScreeningMember_label_en-US" xlink:label="lab_exas_ScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Screening [Member]</link:label>
    <link:label id="lab_exas_ScreeningMember_documentation_en-US" xlink:label="lab_exas_ScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Screening</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScreeningMember" xlink:href="exas-20210930.xsd#exas_ScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_ScreeningMember" xlink:to="lab_exas_ScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9ca1ed69-c09d-4146-9e25-14680914e87c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6e1801ca-103b-4fb4-86bf-db841c771661_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_0ac3b53c-eb96-4ca5-afe1-5692043e8254_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_6405ee4e-a7b6-444f-8f1d-a2084f003257_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_c86f39e2-c586-4d21-b854-c8d4b6212387_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Activities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:to="lab_us-gaap_CashFlowOperatingActivitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneDomain_3b6bd4b7-b2ea-49c0-bf69-3446af4c5705_terseLabel_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements Sales Milestone [Domain]</link:label>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneDomain_label_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements Sales Milestone [Domain]</link:label>
    <link:label id="lab_exas_CollaborativeArrangementsSalesMilestoneDomain_documentation_en-US" xlink:label="lab_exas_CollaborativeArrangementsSalesMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by range of sale milestones pertaining to the collaborative arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain" xlink:to="lab_exas_CollaborativeArrangementsSalesMilestoneDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_32cc8a6c-ab50-429d-80a2-d1e14cc8b3be_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_d77ca9d7-6bfa-47a4-abfe-646a70951c26_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_98bf5d31-563f-4c6e-81a2-a15c9578d2b3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_355dfed1-bbdc-4f63-921f-17e17a82e94a_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and money market</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7f06c132-e36d-48d6-bd37-22c7b385d035_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2dd12f03-b2ad-4e1d-90fe-f269fbc80574_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_455411fb-22f5-4027-942b-71e464abdb75_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Out Of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_97b96e41-eed7-45a3-bd14-68a28959ea35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f10c8cfe-3e65-4045-8fbf-d1d65982967d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_33a8e51d-ac2a-4290-8e2b-ce3e460d7613_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Discount and Issuance Costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9cd9cd2d-9a0a-4ea6-8f92-4f65be06c3ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a36be282-1df2-4d76-bef2-ddefb10bf7ec_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_441d722f-a9ee-4835-bf13-6709b6ebbf37_terseLabel_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_label_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:label id="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_documentation_en-US" xlink:label="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:to="lab_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_6655ede3-6817-40f2-810f-8d345b79cac3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds in connection with the Company&#8217;s employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_d2011232-7ea4-441f-a7df-514711bf90d7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_154d546c-b88c-4d88-a9c0-aa4a72ca9d3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_f59f2d22-2a40-40c4-a359-77b92eebacd1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6f338847-0f9d-44eb-a543-a36160e7c352_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_b7cf2b0d-7041-4d1f-a891-59775dbe91d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6decd0d8-d626-4ac8-a705-5228a4330190_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_NewMarketTaxCreditTextBlock_a37d68fa-39fd-449b-bb2d-483d0612b9fc_terseLabel_en-US" xlink:label="lab_exas_NewMarketTaxCreditTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MARKET TAX CREDIT</link:label>
    <link:label id="lab_exas_NewMarketTaxCreditTextBlock_label_en-US" xlink:label="lab_exas_NewMarketTaxCreditTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Market Tax Credit [Text Block]</link:label>
    <link:label id="lab_exas_NewMarketTaxCreditTextBlock_documentation_en-US" xlink:label="lab_exas_NewMarketTaxCreditTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure for the new market tax credit program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditTextBlock" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_NewMarketTaxCreditTextBlock" xlink:to="lab_exas_NewMarketTaxCreditTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9f020581-ca90-4838-8715-0f95f40615e0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_MAYOFoundationMember_2001d011-df10-4861-8f78-0a9fa6879072_terseLabel_en-US" xlink:label="lab_exas_MAYOFoundationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mayo</link:label>
    <link:label id="lab_exas_MAYOFoundationMember_label_en-US" xlink:label="lab_exas_MAYOFoundationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">M A Y O Foundation [Member]</link:label>
    <link:label id="lab_exas_MAYOFoundationMember_documentation_en-US" xlink:label="lab_exas_MAYOFoundationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the pertinent information about MAYO Foundation for Medical Education and Research (MAYO).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MAYOFoundationMember" xlink:href="exas-20210930.xsd#exas_MAYOFoundationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_MAYOFoundationMember" xlink:to="lab_exas_MAYOFoundationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_CompensationExpenseMember_6e8719d8-62a9-445c-a2c9-3c7ca2ccc684_terseLabel_en-US" xlink:label="lab_exas_CompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense</link:label>
    <link:label id="lab_exas_CompensationExpenseMember_label_en-US" xlink:label="lab_exas_CompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense [Member]</link:label>
    <link:label id="lab_exas_CompensationExpenseMember_documentation_en-US" xlink:label="lab_exas_CompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CompensationExpenseMember" xlink:href="exas-20210930.xsd#exas_CompensationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_CompensationExpenseMember" xlink:to="lab_exas_CompensationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_9b236000-c52b-4dbe-bc2d-ab05a3eaeeb2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_fe668deb-44f6-4fc9-9359-9094564a9303_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_17951e3d-ae71-4663-8a57-b48d15f9352a_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_6dd6beeb-4654-4753-ae47-faedc582a832_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_1ff8d6b1-9cdc-4e1d-b2a5-01d93ffed2af_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_c2079326-4a05-44dc-a6c7-d54bf9b1e742_negatedTerseLabel_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current portion</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_label_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current, Operating Lease Liability</link:label>
    <link:label id="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_documentation_en-US" xlink:label="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current, Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:to="lab_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_523fa50d-45df-49ac-9369-041d00a2e118_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt, amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_ff9630be-f80d-4be8-a583-0d5284a02cf1_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets under construction</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_7b708d99-4a99-4a7e-bf41-65885c9a8cbe_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_704f3aaf-ba67-4f78-a618-280487403ec4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_e7bfc136-8f07-48ab-9428-545df00f369f_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a7030418-c41c-42d9-b334-63560534e5c7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less, Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_58476da0-6181-4a66-b2fc-f5b9682e49f1_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_3b001c57-da42-4a6f-b463-26a157165749_terseLabel_en-US" xlink:label="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share conversion ratio (share per share)</link:label>
    <link:label id="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_label_en-US" xlink:label="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Issued Exchange Ratio</link:label>
    <link:label id="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_documentation_en-US" xlink:label="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Issued Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" xlink:to="lab_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_b5e45162-b46e-4de2-ab9f-dd427438a11e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_exas_PFSGenomicsMember_ef592110-58b4-4689-b699-f9e6b2be70c0_terseLabel_en-US" xlink:label="lab_exas_PFSGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PFS Genomics</link:label>
    <link:label id="lab_exas_PFSGenomicsMember_label_en-US" xlink:label="lab_exas_PFSGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PFS Genomics [Member]</link:label>
    <link:label id="lab_exas_PFSGenomicsMember_documentation_en-US" xlink:label="lab_exas_PFSGenomicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PFS Genomics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exas_PFSGenomicsMember" xlink:to="lab_exas_PFSGenomicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_23b27461-1e35-4f95-8b12-437a073a7a09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_bd39c4f8-80c5-4463-b646-023195ed3a6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based payment award, employee stock purchase plan, valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d23eedda-1c0a-47ad-9963-389dd8144494_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fdd8d383-3944-4afb-99bb-0275c93dba28_verboseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_55df43e3-5ab4-47c6-8295-0db3a0e6d2aa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4d0ff7f7-4afe-47c1-93f7-68dfe2385dd7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_79206085-581e-4b89-aa9b-91aa494c1779_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_8b4d7ad8-1866-4467-9893-c12234cf352f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>exas-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:62297662-2bfb-41ec-9bf7-9eb144772313,g:499e252f-fe94-4d47-8333-c3acba229b0e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exactsciences.com/role/CoverPage" xlink:type="simple" xlink:href="exas-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_92ed0e79-e648-45e2-b0a4-336adc7ed7aa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_DocumentType_92ed0e79-e648-45e2-b0a4-336adc7ed7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_cc1867ce-5c41-495a-9192-3e37ed55ccef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_DocumentQuarterlyReport_cc1867ce-5c41-495a-9192-3e37ed55ccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5f792c6b-eedb-4772-bcc2-2bace4d0b14c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_DocumentPeriodEndDate_5f792c6b-eedb-4772-bcc2-2bace4d0b14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_3f3c9981-f780-45fe-a023-932d4f18ac30" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_DocumentTransitionReport_3f3c9981-f780-45fe-a023-932d4f18ac30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_45be2e22-929b-466e-9076-37a9631860bb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityFileNumber_45be2e22-929b-466e-9076-37a9631860bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_97b092f9-b0f9-4ca0-bf74-e4161ac29813" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityRegistrantName_97b092f9-b0f9-4ca0-bf74-e4161ac29813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8d47ce45-73cf-4918-9e39-1a6ddd55644a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8d47ce45-73cf-4918-9e39-1a6ddd55644a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f4e71802-7b67-48bb-b46e-486e37dbfd46" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityTaxIdentificationNumber_f4e71802-7b67-48bb-b46e-486e37dbfd46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a091df40-b663-4557-ade1-ebf66e256c5b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityAddressAddressLine1_a091df40-b663-4557-ade1-ebf66e256c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d2bb0345-0627-46cc-8310-8f2e95067231" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityAddressCityOrTown_d2bb0345-0627-46cc-8310-8f2e95067231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_05b31e20-5cea-432d-8c10-0248fd1e7bff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityAddressStateOrProvince_05b31e20-5cea-432d-8c10-0248fd1e7bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b686b899-51a7-42dc-bda7-f429c25be876" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityAddressPostalZipCode_b686b899-51a7-42dc-bda7-f429c25be876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_8a3e4560-b8cb-4649-ada2-ccbad7ea8f30" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_CityAreaCode_8a3e4560-b8cb-4649-ada2-ccbad7ea8f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d5068f33-968b-45f8-884e-7ac5a57ff794" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_LocalPhoneNumber_d5068f33-968b-45f8-884e-7ac5a57ff794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9c53f417-5402-4acb-86b5-9f115167e490" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_Security12bTitle_9c53f417-5402-4acb-86b5-9f115167e490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_def87648-37bb-449a-8fcc-0e053dc8619f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_TradingSymbol_def87648-37bb-449a-8fcc-0e053dc8619f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e1ea32e3-2a9d-405d-a98e-cd6fd0675b8d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_SecurityExchangeName_e1ea32e3-2a9d-405d-a98e-cd6fd0675b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b58145a6-5a61-46fa-910e-9980ac171494" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityCurrentReportingStatus_b58145a6-5a61-46fa-910e-9980ac171494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_82f29155-d2fe-4345-bb20-afb01d9551ce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityInteractiveDataCurrent_82f29155-d2fe-4345-bb20-afb01d9551ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_64da270d-1045-4b49-ba49-daba9d4ef6e7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityFilerCategory_64da270d-1045-4b49-ba49-daba9d4ef6e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1f2381ab-ab16-45cc-a867-def835c6edeb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntitySmallBusiness_1f2381ab-ab16-45cc-a867-def835c6edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ed999940-26c2-43bb-9151-56ace2f07327" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityEmergingGrowthCompany_ed999940-26c2-43bb-9151-56ace2f07327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7df3deaa-f27e-464b-9f59-e835d843fe85" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityShellCompany_7df3deaa-f27e-464b-9f59-e835d843fe85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0e1f946e-fa38-4e61-9139-e31c94c496d8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0e1f946e-fa38-4e61-9139-e31c94c496d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_6a6e708b-9c54-40b7-bceb-b214bdf8ff07" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_DocumentFiscalYearFocus_6a6e708b-9c54-40b7-bceb-b214bdf8ff07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5fbba957-8c6b-4f29-b6c8-4721bf2f9955" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5fbba957-8c6b-4f29-b6c8-4721bf2f9955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_600b7d00-7ac3-4366-bbc4-8edcbc9fc88a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_EntityCentralIndexKey_600b7d00-7ac3-4366-bbc4-8edcbc9fc88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_5f0648b1-c04e-475c-bc53-d88e6629910f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_AmendmentFlag_5f0648b1-c04e-475c-bc53-d88e6629910f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bfff5d66-44ed-4c38-96a7-d1e73e6d707f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_da02d677-653e-43c0-8dcb-1250fa3bc6cf" xlink:to="loc_dei_CurrentFiscalYearEndDate_bfff5d66-44ed-4c38-96a7-d1e73e6d707f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_adfce67b-e3df-41c1-9c8c-88473d0d8390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9bf92785-6df8-4bfe-a333-10cfd7d63d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_adfce67b-e3df-41c1-9c8c-88473d0d8390" xlink:to="loc_us-gaap_AssetsAbstract_9bf92785-6df8-4bfe-a333-10cfd7d63d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bf92785-6df8-4bfe-a333-10cfd7d63d44" xlink:to="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af2aeb64-93d6-4753-9011-0df1c9fb2f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af2aeb64-93d6-4753-9011-0df1c9fb2f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_62dbe29b-5728-4824-ad0a-181b7ebac52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_62dbe29b-5728-4824-ad0a-181b7ebac52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e7fb84e6-d54f-4f15-92c1-a80782de6a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e7fb84e6-d54f-4f15-92c1-a80782de6a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dd0901a6-acc3-4850-a11a-77db3ea87e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:to="loc_us-gaap_InventoryNet_dd0901a6-acc3-4850-a11a-77db3ea87e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f94e9373-9127-41c0-800e-924a4cd52483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f94e9373-9127-41c0-800e-924a4cd52483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3424c10b-ed98-4841-a2d2-12d000b187c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_5f0e4a95-6432-4641-b48e-fd5c20fc1cd4" xlink:to="loc_us-gaap_AssetsCurrent_3424c10b-ed98-4841-a2d2-12d000b187c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bf92785-6df8-4bfe-a333-10cfd7d63d44" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_824b8ba3-8b02-469a-a747-dc4335e35508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_824b8ba3-8b02-469a-a747-dc4335e35508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a538300b-b4e0-4f69-8a8f-8192c447cf47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a538300b-b4e0-4f69-8a8f-8192c447cf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dc05dfd6-3156-4a29-9ec2-ad8bb07ebf80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:to="loc_us-gaap_Goodwill_dc05dfd6-3156-4a29-9ec2-ad8bb07ebf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dc018f6a-213f-4973-bb6a-590948f78af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dc018f6a-213f-4973-bb6a-590948f78af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_36870e56-41f6-484f-b950-265251e8d780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_8b4f0f3b-8d1d-4f5c-ae20-429ffcfe07da" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_36870e56-41f6-484f-b950-265251e8d780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_51ee14d9-3acd-4418-b723-bd64042b0a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9bf92785-6df8-4bfe-a333-10cfd7d63d44" xlink:to="loc_us-gaap_Assets_51ee14d9-3acd-4418-b723-bd64042b0a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_adfce67b-e3df-41c1-9c8c-88473d0d8390" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3d21192a-51a4-4486-978f-6cdd0cbf21b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_AccountsPayableCurrent_3d21192a-51a4-4486-978f-6cdd0cbf21b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_877df6fa-9606-438f-9e59-4e4ea6784f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_877df6fa-9606-438f-9e59-4e4ea6784f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_66138f64-1c57-4712-90ba-b222d4e2d53a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_66138f64-1c57-4712-90ba-b222d4e2d53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_ba65ca0e-8075-4f51-9a61-428bdb9a3558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_ba65ca0e-8075-4f51-9a61-428bdb9a3558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_e5c4f6d5-149b-43db-872e-2347bcb811f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_e5c4f6d5-149b-43db-872e-2347bcb811f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_95456cbb-5358-4f42-8497-5ab6113efcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_95456cbb-5358-4f42-8497-5ab6113efcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2af05de3-0be5-4856-a1a1-3edae56b5ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c1462cc3-b4d1-4595-aa28-3163190a3afe" xlink:to="loc_us-gaap_LiabilitiesCurrent_2af05de3-0be5-4856-a1a1-3edae56b5ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_63b05d46-8232-4d76-bffb-c6f945e6bf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_63b05d46-8232-4d76-bffb-c6f945e6bf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_7fc07f04-9081-41b0-8bfd-94843b2c0177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_63b05d46-8232-4d76-bffb-c6f945e6bf1c" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_7fc07f04-9081-41b0-8bfd-94843b2c0177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_34a04300-6e03-4b1e-b099-75126896c4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_63b05d46-8232-4d76-bffb-c6f945e6bf1c" xlink:to="loc_us-gaap_LongTermLoansPayable_34a04300-6e03-4b1e-b099-75126896c4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d87afb04-7c1c-4489-885b-10ffcb0f43d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_63b05d46-8232-4d76-bffb-c6f945e6bf1c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d87afb04-7c1c-4489-885b-10ffcb0f43d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_db600b5d-66ae-4071-95dd-cae114b2a128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_63b05d46-8232-4d76-bffb-c6f945e6bf1c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_db600b5d-66ae-4071-95dd-cae114b2a128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_01678489-71df-47eb-b533-a5cd90806907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:to="loc_us-gaap_Liabilities_01678489-71df-47eb-b533-a5cd90806907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d66f199e-3e79-4ba7-bbad-4357472f02be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d66f199e-3e79-4ba7-bbad-4357472f02be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_16952595-b342-4399-b148-7089c8aeec2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:to="loc_us-gaap_PreferredStockValue_16952595-b342-4399-b148-7089c8aeec2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_491abcd0-a947-4501-b234-db73e54bb092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:to="loc_us-gaap_CommonStockValue_491abcd0-a947-4501-b234-db73e54bb092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9bc8c8ef-f145-42a0-a801-32101b0a4182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_9bc8c8ef-f145-42a0-a801-32101b0a4182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66499b23-50ed-4370-98d8-754e5469efcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_66499b23-50ed-4370-98d8-754e5469efcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_77181b33-36d2-4855-9a73-9817910ece9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_77181b33-36d2-4855-9a73-9817910ece9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_583b7c3e-f327-4963-955f-d638aff310d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2dde6432-d941-4874-8ddb-069caa6c7e07" xlink:to="loc_us-gaap_StockholdersEquity_583b7c3e-f327-4963-955f-d638aff310d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_13efd7bc-0bbd-4562-9c38-252e867a1279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_944315da-4ac9-4ca2-8214-6b8a887b0bc0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_13efd7bc-0bbd-4562-9c38-252e867a1279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f450fcd3-ef89-48e4-8dcd-b81c6dca19b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f450fcd3-ef89-48e4-8dcd-b81c6dca19b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_e988e411-fc18-4024-a2f4-8c4ca5931eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_e988e411-fc18-4024-a2f4-8c4ca5931eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_9ccf2247-618d-463d-8abd-ec03f4813d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_PreferredStockSharesIssued_9ccf2247-618d-463d-8abd-ec03f4813d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7e5fec11-fbc0-4c01-b3a8-cb81fd4457a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7e5fec11-fbc0-4c01-b3a8-cb81fd4457a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_45cf79ec-c611-48ac-84b6-0a710d1a1563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_45cf79ec-c611-48ac-84b6-0a710d1a1563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7b541a98-1356-4d44-80e2-3240303f542b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7b541a98-1356-4d44-80e2-3240303f542b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d45264f7-67cd-43d9-8815-6a32fffe9659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_CommonStockSharesIssued_d45264f7-67cd-43d9-8815-6a32fffe9659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0444c665-d343-414c-9de9-bb3d9a146c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ac5f7147-96db-44d9-8f52-cb79bb9d77f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0444c665-d343-414c-9de9-bb3d9a146c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea93176c-2ec0-43db-a505-e8168a8a8d93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea93176c-2ec0-43db-a505-e8168a8a8d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_639bb374-98f4-4a39-8efb-0355c7529822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_CostOfRevenue_639bb374-98f4-4a39-8efb-0355c7529822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7b75f047-89b8-4c26-b3f0-c684d341d4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7b75f047-89b8-4c26-b3f0-c684d341d4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_c426b044-f744-4d47-a6a2-de585304bc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_SellingAndMarketingExpense_c426b044-f744-4d47-a6a2-de585304bc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f20bdb32-7b55-489f-ae3a-d7defb344897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f20bdb32-7b55-489f-ae3a-d7defb344897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5e298858-02e4-4b9c-9c68-29aeb17425a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5e298858-02e4-4b9c-9c68-29aeb17425a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c194fa2a-c071-418c-98c9-5548923a713d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_c194fa2a-c071-418c-98c9-5548923a713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6de2ed7f-fa6c-42e0-8a53-3a850deba495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2cb572cd-5214-41a1-8054-7cc06e5d790e" xlink:to="loc_us-gaap_CostsAndExpenses_6de2ed7f-fa6c-42e0-8a53-3a850deba495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncome_c3f0f5e5-d6f5-4100-908f-63379f7f1eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_OtherOperatingIncome_c3f0f5e5-d6f5-4100-908f-63379f7f1eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a0b7fad0-4c6b-452b-b09c-d7bd11bb9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_OperatingIncomeLoss_a0b7fad0-4c6b-452b-b09c-d7bd11bb9f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ba58281e-fa2b-4f59-83c9-bec520204e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ba58281e-fa2b-4f59-83c9-bec520204e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InvestmentIncomeExpenseNonoperating_5bcf2cc1-4d0f-4d5b-84a0-09634f838b6f" xlink:href="exas-20210930.xsd#exas_InvestmentIncomeExpenseNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ba58281e-fa2b-4f59-83c9-bec520204e81" xlink:to="loc_exas_InvestmentIncomeExpenseNonoperating_5bcf2cc1-4d0f-4d5b-84a0-09634f838b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ce58601b-8951-41f3-bdd6-18e6228839d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ba58281e-fa2b-4f59-83c9-bec520204e81" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ce58601b-8951-41f3-bdd6-18e6228839d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_30992c0c-c51d-47ad-9db0-fa9b38d3dd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_ba58281e-fa2b-4f59-83c9-bec520204e81" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_30992c0c-c51d-47ad-9db0-fa9b38d3dd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_066ac32a-a6b8-4636-ab4c-b40e6c2ad268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_066ac32a-a6b8-4636-ab4c-b40e6c2ad268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0b927b44-8992-4b0f-ad27-81ecef5404f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0b927b44-8992-4b0f-ad27-81ecef5404f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4a826ce5-8c16-4844-a581-cb9fa5253d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_NetIncomeLoss_4a826ce5-8c16-4844-a581-cb9fa5253d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fca19b2f-4990-46c0-8ffe-4c516f7f3212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_EarningsPerShareBasic_fca19b2f-4990-46c0-8ffe-4c516f7f3212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5c807e96-f328-4ce1-ad1e-26924d73b477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5c807e96-f328-4ce1-ad1e-26924d73b477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0ee6d6a-e82d-4e6e-a3c8-377ee3a8766f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0ee6d6a-e82d-4e6e-a3c8-377ee3a8766f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_711ff304-c9a5-4bc2-9ba6-c494689a47c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d4100362-589b-41d2-a914-94aa6f88f657" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_711ff304-c9a5-4bc2-9ba6-c494689a47c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_97a8347b-13b3-4147-bd81-3b67ee359b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76cd5782-9dbe-4a16-806d-1ec65ee0c830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_97a8347b-13b3-4147-bd81-3b67ee359b3c" xlink:to="loc_us-gaap_NetIncomeLoss_76cd5782-9dbe-4a16-806d-1ec65ee0c830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_67b01542-787b-43de-9907-399c445f0dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_97a8347b-13b3-4147-bd81-3b67ee359b3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_67b01542-787b-43de-9907-399c445f0dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_74cdafe5-9aab-4c62-881b-24fa284475eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_67b01542-787b-43de-9907-399c445f0dac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_74cdafe5-9aab-4c62-881b-24fa284475eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_872cf80b-2fb9-4326-a058-8849376afdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_67b01542-787b-43de-9907-399c445f0dac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_872cf80b-2fb9-4326-a058-8849376afdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ComprehensiveIncomeLossBeforeTax_752f39b8-d3b3-4e79-917e-7a75047ed945" xlink:href="exas-20210930.xsd#exas_ComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_97a8347b-13b3-4147-bd81-3b67ee359b3c" xlink:to="loc_exas_ComprehensiveIncomeLossBeforeTax_752f39b8-d3b3-4e79-917e-7a75047ed945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_46afcbd4-343a-40c2-af77-d9123308f1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_97a8347b-13b3-4147-bd81-3b67ee359b3c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_46afcbd4-343a-40c2-af77-d9123308f1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ddcaf99-0168-4aa0-851b-3874c7222a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_97a8347b-13b3-4147-bd81-3b67ee359b3c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_6ddcaf99-0168-4aa0-851b-3874c7222a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_863825c9-6d36-4753-bffd-cae09a11d2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_863825c9-6d36-4753-bffd-cae09a11d2de" xlink:to="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f9655555-1cb4-4f8c-97ee-e40c04a5cb3e" xlink:to="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_82b9a31f-3066-4910-bae5-ed8b71f62761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_CommonStockMember_82b9a31f-3066-4910-bae5-ed8b71f62761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a263ba04-094e-4672-8aa1-b08ef81eb36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a263ba04-094e-4672-8aa1-b08ef81eb36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_53f8f08f-94b0-483c-9358-f666d1606867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_53f8f08f-94b0-483c-9358-f666d1606867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_80ad239d-13ce-4f01-a47f-e369920dd42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d32a4f5d-1d59-4088-a143-905dfb5a7bed" xlink:to="loc_us-gaap_RetainedEarningsMember_80ad239d-13ce-4f01-a47f-e369920dd42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_58330c29-e9db-42ef-948f-e48be9feea7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_fb1d23d7-7eda-40bc-bd6e-c7d61eb2a410" xlink:to="loc_us-gaap_StatementLineItems_58330c29-e9db-42ef-948f-e48be9feea7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_58330c29-e9db-42ef-948f-e48be9feea7c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2e2e8d1b-57e1-4f86-99d9-f99267cb7652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2e2e8d1b-57e1-4f86-99d9-f99267cb7652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8f798b9e-5918-4def-bc4d-11933608f3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockholdersEquity_8f798b9e-5918-4def-bc4d-11933608f3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ee35f1b2-56de-49a3-acad-f71c9b5722a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ee35f1b2-56de-49a3-acad-f71c9b5722a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4bbf0711-67fa-42e3-a6b4-d6380060902a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4bbf0711-67fa-42e3-a6b4-d6380060902a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6746afc7-b354-4fb4-af31-704977b92bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6746afc7-b354-4fb4-af31-704977b92bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_73ca6e06-afb5-43ad-9f88-8c2cd1d963e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_73ca6e06-afb5-43ad-9f88-8c2cd1d963e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_3629cc3a-d5b7-4fce-a107-879274828dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_3629cc3a-d5b7-4fce-a107-879274828dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_c94f960d-681b-4546-9f61-38c8adffab02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_c94f960d-681b-4546-9f61-38c8adffab02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14ac64d8-4b68-4542-b7aa-5a75ce574001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_14ac64d8-4b68-4542-b7aa-5a75ce574001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6fde136a-db13-4512-b938-aea257cd48c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6fde136a-db13-4512-b938-aea257cd48c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_812beed0-8b31-4179-b61d-feb7718c3a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_812beed0-8b31-4179-b61d-feb7718c3a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fa4c2d9f-420b-4c82-9593-b1b589681fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_fa4c2d9f-420b-4c82-9593-b1b589681fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2ace3ead-882d-450c-9fe3-3f161e9d019c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2ace3ead-882d-450c-9fe3-3f161e9d019c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cd4e8302-3cc5-497d-a33d-78618bff82f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cd4e8302-3cc5-497d-a33d-78618bff82f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42ddf73b-912c-4f6a-8ff5-7d8c7df6e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_NetIncomeLoss_42ddf73b-912c-4f6a-8ff5-7d8c7df6e8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_afe367ba-e89b-4712-bb80-b40e7fd5aeab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_afe367ba-e89b-4712-bb80-b40e7fd5aeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_56fdf455-8a8a-46d2-9550-0573c608d789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_StockholdersEquity_56fdf455-8a8a-46d2-9550-0573c608d789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dd1a7c14-f72d-43e9-9996-c514febf29ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e5d6243-916d-4c10-9a63-100d69394f7b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dd1a7c14-f72d-43e9-9996-c514febf29ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ad5a7901-bcc5-4004-be24-63e3af81bf38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_baee149e-c28a-4aa6-bec6-4c63a02e38db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ad5a7901-bcc5-4004-be24-63e3af81bf38" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_baee149e-c28a-4aa6-bec6-4c63a02e38db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5d39a616-42f3-4959-a5bb-c2a88a854f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5d39a616-42f3-4959-a5bb-c2a88a854f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0f519e87-946c-4da2-9da8-3d0a2600ef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5d39a616-42f3-4959-a5bb-c2a88a854f16" xlink:to="loc_us-gaap_ProfitLoss_0f519e87-946c-4da2-9da8-3d0a2600ef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5d39a616-42f3-4959-a5bb-c2a88a854f16" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4b058a20-c5bf-46c0-8431-b35f95fae1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4b058a20-c5bf-46c0-8431-b35f95fae1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_4e234fd1-342c-4210-b036-24fe60634efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_4e234fd1-342c-4210-b036-24fe60634efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_6601d61a-991d-47a5-996f-53e9cec8a0c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_6601d61a-991d-47a5-996f-53e9cec8a0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2e7cd4a6-8886-42e1-82c6-917e1316aa52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2e7cd4a6-8886-42e1-82c6-917e1316aa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_56b04953-dc46-4cd9-b9b5-41584ed19668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_ShareBasedCompensation_56b04953-dc46-4cd9-b9b5-41584ed19668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_61e17176-73b6-4ab1-9bfe-5e13da03831c" xlink:href="exas-20210930.xsd#exas_PostCombinationExpenseForAccelerationOfUnvestedEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity_61e17176-73b6-4ab1-9bfe-5e13da03831c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_83bca430-5df5-48f2-947c-f1a3b0d4dc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_83bca430-5df5-48f2-947c-f1a3b0d4dc7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_28f6303b-097a-4465-a679-165ec379b41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_28f6303b-097a-4465-a679-165ec379b41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_88a08ada-ac8c-436f-b38e-1f1a09515a06" xlink:href="exas-20210930.xsd#exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities_88a08ada-ac8c-436f-b38e-1f1a09515a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_40073fda-b28d-48e9-8c36-c0d35cdc0eb6" xlink:href="exas-20210930.xsd#exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments_40073fda-b28d-48e9-8c36-c0d35cdc0eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_bdfa5cb4-7f80-4225-915b-9171bdc3a05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_bdfa5cb4-7f80-4225-915b-9171bdc3a05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1799c811-2481-4456-814f-c2bd88a9f418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1799c811-2481-4456-814f-c2bd88a9f418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_c976d21a-f4d1-42ff-9d25-a7bec47fb8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_c976d21a-f4d1-42ff-9d25-a7bec47fb8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_d6bbf455-3266-4bab-84f7-c4122bcc598d" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_d6bbf455-3266-4bab-84f7-c4122bcc598d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_3c153252-0f84-4f81-a835-4acd89189483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fc36d995-db91-43e6-9c87-0c209afea695" xlink:to="loc_us-gaap_OperatingLeaseExpense_3c153252-0f84-4f81-a835-4acd89189483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5d39a616-42f3-4959-a5bb-c2a88a854f16" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_21360808-e392-4a5a-8df0-1d24ba4c79e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_21360808-e392-4a5a-8df0-1d24ba4c79e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c6b62469-08b9-40df-9976-52fd18428ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c6b62469-08b9-40df-9976-52fd18428ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IncreaseDecreaseInOperatingLeaseLiabilities_6c004b31-4087-49b9-a404-eef0876138c7" xlink:href="exas-20210930.xsd#exas_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:to="loc_exas_IncreaseDecreaseInOperatingLeaseLiabilities_6c004b31-4087-49b9-a404-eef0876138c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_15de4ceb-d272-48f7-9dec-fc1067b7597a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_15de4ceb-d272-48f7-9dec-fc1067b7597a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_707df630-4cf1-4a4d-9c49-7f278131df4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d11f2c13-4264-4fd0-a51e-517199f7d4a3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_707df630-4cf1-4a4d-9c49-7f278131df4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f402a781-2f65-47fb-aa9d-9bb1c963c3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_5d39a616-42f3-4959-a5bb-c2a88a854f16" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f402a781-2f65-47fb-aa9d-9bb1c963c3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_aa670eed-1292-4120-b4b3-256af380bd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_aa670eed-1292-4120-b4b3-256af380bd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ac09e1ff-c99c-40a4-8719-b1ceee88655c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_ac09e1ff-c99c-40a4-8719-b1ceee88655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_81f8140f-c4e0-437f-8718-d7199c31c678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_81f8140f-c4e0-437f-8718-d7199c31c678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c5c0d1fb-ffe2-4c41-859a-96924164c9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c5c0d1fb-ffe2-4c41-859a-96924164c9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_13649e95-480a-40b0-ba10-00f2058f1b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_13649e95-480a-40b0-ba10-00f2058f1b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_b7afdf60-8617-4859-8b19-3e131f199cba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_b7afdf60-8617-4859-8b19-3e131f199cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2e57b6ac-aeab-409f-a196-49f0288d331d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2e57b6ac-aeab-409f-a196-49f0288d331d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_07dec56d-4580-4cdb-9104-17d185a9e4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_1ac0e6dc-fe35-432b-be9e-b16dc83ae9d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_07dec56d-4580-4cdb-9104-17d185a9e4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_444fd6bc-5a5d-4ba2-bf1d-54f1a4dee887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_444fd6bc-5a5d-4ba2-bf1d-54f1a4dee887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a2788bc9-066c-489b-b183-78e54ed630d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_a2788bc9-066c-489b-b183-78e54ed630d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_4fbc0f64-8269-4f51-aa32-8ef546662659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:to="loc_us-gaap_ProceedsFromStockPlans_4fbc0f64-8269-4f51-aa32-8ef546662659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_672798ce-f615-4f56-8936-c69214c5542a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_672798ce-f615-4f56-8936-c69214c5542a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_57cf55c8-cbe4-4b86-99c5-0d415f6b889b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_57cf55c8-cbe4-4b86-99c5-0d415f6b889b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16d5e74-3aa9-43eb-a91b-0ab843f447c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_67586a90-3398-4df3-a32f-181a97db5ec6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f16d5e74-3aa9-43eb-a91b-0ab843f447c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b06d8b15-e182-4251-a502-99eff5989d61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b06d8b15-e182-4251-a502-99eff5989d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c806ea3f-d327-480a-bb47-aad7758ae6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c806ea3f-d327-480a-bb47-aad7758ae6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71c237e9-cde1-4268-adfb-2ae4f94c0826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_71c237e9-cde1-4268-adfb-2ae4f94c0826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_91155a2b-95bb-40e7-842f-65aa7c564b12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_91155a2b-95bb-40e7-842f-65aa7c564b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_4f12ca76-cf6c-45e5-ba7c-79b26863b7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_4f12ca76-cf6c-45e5-ba7c-79b26863b7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_IssuanceOfStockToFundMatchingContributions_a34760df-14b7-4a0b-89d6-0d508d46a3a0" xlink:href="exas-20210930.xsd#exas_IssuanceOfStockToFundMatchingContributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:to="loc_exas_IssuanceOfStockToFundMatchingContributions_a34760df-14b7-4a0b-89d6-0d508d46a3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_80b46f8c-e977-42d1-80c2-0641111d220c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_80b46f8c-e977-42d1-80c2-0641111d220c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_dcae4db6-8600-4c61-a576-0826f8d9a97c" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_4560a409-efe9-4f4f-b8ef-e8def5763f48" xlink:to="loc_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_dcae4db6-8600-4c61-a576-0826f8d9a97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_07a63637-fd02-4f5a-bc6a-30a85b183c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7276fe81-ea3e-4f2d-ba07-8268e881f19e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_07a63637-fd02-4f5a-bc6a-30a85b183c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5ba5bab7-4b45-4f29-bdea-ae71103d2ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_07a63637-fd02-4f5a-bc6a-30a85b183c31" xlink:to="loc_us-gaap_InterestPaidNet_5ba5bab7-4b45-4f29-bdea-ae71103d2ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="exas-20210930.xsd#CondensedConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a3cfb5bd-8604-4a0b-a69f-b6f14b7afcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_c31a2f25-160c-4faa-96dc-34d8977a28d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a3cfb5bd-8604-4a0b-a69f-b6f14b7afcc8" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued_c31a2f25-160c-4faa-96dc-34d8977a28d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_20936c16-2862-4047-b64d-e1010166b4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a3cfb5bd-8604-4a0b-a69f-b6f14b7afcc8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_20936c16-2862-4047-b64d-e1010166b4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f4a714ae-53b5-4081-9b5b-3c82143a8068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_dcf34926-61ef-49b7-bde6-222b3ebdeed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f4a714ae-53b5-4081-9b5b-3c82143a8068" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_dcf34926-61ef-49b7-bde6-222b3ebdeed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_452207b8-376a-4d59-96ef-2ccb127ad6db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_e45c4228-7acb-4f70-9fef-3197004bd67f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_452207b8-376a-4d59-96ef-2ccb127ad6db" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_e45c4228-7acb-4f70-9fef-3197004bd67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_8e86853a-7c50-4352-a045-455cff3be318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_452207b8-376a-4d59-96ef-2ccb127ad6db" xlink:to="loc_us-gaap_UseOfEstimates_8e86853a-7c50-4352-a045-455cff3be318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_9d4a3479-5f13-484e-b0e7-bc0a02d77812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_452207b8-376a-4d59-96ef-2ccb127ad6db" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_9d4a3479-5f13-484e-b0e7-bc0a02d77812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_afa0367c-3fdf-4a89-abdb-9acf37918511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_452207b8-376a-4d59-96ef-2ccb127ad6db" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_afa0367c-3fdf-4a89-abdb-9acf37918511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_065fa6a5-6a75-4733-8555-49f883546bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_452207b8-376a-4d59-96ef-2ccb127ad6db" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_065fa6a5-6a75-4733-8555-49f883546bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f0eadac6-d486-4651-b362-c2092bf8ad93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3435972f-4558-4b42-ab0d-ff907740356d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f0eadac6-d486-4651-b362-c2092bf8ad93" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3435972f-4558-4b42-ab0d-ff907740356d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_90ba610b-471d-4409-968f-8b993f401fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_90ba610b-471d-4409-968f-8b993f401fdd" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ab4ab502-d9c9-4b61-9dc4-dda772501844" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_5a746ad6-8ff1-419e-8c95-ff20fd5fc4c4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ab4ab502-d9c9-4b61-9dc4-dda772501844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_fcafa693-4050-4828-a933-f6106d89ff18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_ab4ab502-d9c9-4b61-9dc4-dda772501844" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_fcafa693-4050-4828-a933-f6106d89ff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b094c848-eaac-49d8-866b-43e5648e29be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7a930936-9c8f-40ca-a6fe-2572f10057da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b094c848-eaac-49d8-866b-43e5648e29be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member_1f7f1ad3-fa6e-43c6-9f71-344e3984fe02" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b094c848-eaac-49d8-866b-43e5648e29be" xlink:to="loc_exas_ConvertibleNotesPayable2025Member_1f7f1ad3-fa6e-43c6-9f71-344e3984fe02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5fd01905-e825-4f64-b0e9-28a6ccc7ed19" xlink:to="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_94393617-601c-40f2-b239-f7c8528e7309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_94393617-601c-40f2-b239-f7c8528e7309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a5fb015e-f51d-4796-b23d-bdbbda929a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2bc77801-6235-42c0-8f6f-115358b790f7" xlink:to="loc_us-gaap_RetainedEarningsMember_a5fb015e-f51d-4796-b23d-bdbbda929a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1b659561-d886-4165-a5e8-14f9f4f4bc1f" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_03fa65d2-05dc-4c13-8759-d5bade9140b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_StockholdersEquity_03fa65d2-05dc-4c13-8759-d5bade9140b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_2d110fdf-8fbd-44ad-ad79-a29af65110d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_2d110fdf-8fbd-44ad-ad79-a29af65110d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a5cb8672-80d7-4aa7-8d98-5b77342a1489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a5cb8672-80d7-4aa7-8d98-5b77342a1489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38d17065-d742-409b-a8af-68d2f06200ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_38d17065-d742-409b-a8af-68d2f06200ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_0a11bc35-9f55-4c96-b5c1-82babc255bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_0a11bc35-9f55-4c96-b5c1-82babc255bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_018f5e6b-0e66-4e37-865e-bd7426b38c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_018f5e6b-0e66-4e37-865e-bd7426b38c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ad40b4e6-2196-42ab-b155-b3d7da1c4c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ad40b4e6-2196-42ab-b155-b3d7da1c4c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8626d7c0-5535-4953-b23d-9925c5c0f052" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8626d7c0-5535-4953-b23d-9925c5c0f052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3072dd46-e70c-4d0a-9f48-de202a359cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_EarningsPerShareBasic_3072dd46-e70c-4d0a-9f48-de202a359cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_104c94d6-021e-427a-9284-4be73556748e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_EarningsPerShareDiluted_104c94d6-021e-427a-9284-4be73556748e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8f2c18a6-8c24-4017-9ac1-ceeafc57f6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_8f2c18a6-8c24-4017-9ac1-ceeafc57f6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_34675378-4bd0-438c-a09d-85a101ad72e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_34675378-4bd0-438c-a09d-85a101ad72e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_d91ad599-19e4-4e7e-83b9-62208cf425bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_823ee4e4-5c57-410a-9c6d-69ce4ca42402" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_d91ad599-19e4-4e7e-83b9-62208cf425bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2aa335d8-5655-47bc-bb84-677659d52bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2aa335d8-5655-47bc-bb84-677659d52bb1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c71758a-02b0-4c14-90d1-6b18af27832c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SharesIssuedUponAcquisitionMember_a0c1a74c-14db-4c0d-bb6e-a482d7462bd1" xlink:href="exas-20210930.xsd#exas_SharesIssuedUponAcquisitionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_exas_SharesIssuedUponAcquisitionMember_a0c1a74c-14db-4c0d-bb6e-a482d7462bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember_154b51b2-4124-4e18-b9aa-a0e5025d86e2" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_exas_EmployeeAndNonEmployeesStockOptionMember_154b51b2-4124-4e18-b9aa-a0e5025d86e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_878665d0-ecd2-426f-acfb-283fc9e33d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_us-gaap_RestrictedStockMember_878665d0-ecd2-426f-acfb-283fc9e33d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_eb81a226-cc3f-4b98-9b49-8952b1e270d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_us-gaap_PerformanceSharesMember_eb81a226-cc3f-4b98-9b49-8952b1e270d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_fb17e467-e5d0-4f54-b00c-1a2513581acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab91b31-4614-4969-aac2-a0ff23f99702" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_fb17e467-e5d0-4f54-b00c-1a2513581acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6c9880f8-0bc2-4524-99ca-47f134358286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a8f00b51-3795-448d-a9e4-f2407c87a63f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6c9880f8-0bc2-4524-99ca-47f134358286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0bdb23b1-f8d5-497f-bcec-a0f668570d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6c9880f8-0bc2-4524-99ca-47f134358286" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0bdb23b1-f8d5-497f-bcec-a0f668570d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/REVENUE" xlink:type="simple" xlink:href="exas-20210930.xsd#REVENUE"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/REVENUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f1b2f80b-4816-46c5-a8e0-cbb8d5c00d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_82716652-e142-442e-a9c1-ea9b0265d668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f1b2f80b-4816-46c5-a8e0-cbb8d5c00d1c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_82716652-e142-442e-a9c1-ea9b0265d668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/REVENUETables" xlink:type="simple" xlink:href="exas-20210930.xsd#REVENUETables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/REVENUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87e21fe0-2173-4781-ae8c-fa6fce1e1ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8fe7b701-f36f-4510-bfd9-d437b2ad33fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_87e21fe0-2173-4781-ae8c-fa6fce1e1ef8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8fe7b701-f36f-4510-bfd9-d437b2ad33fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#REVENUEScheduleofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a42dd05-7ea1-408a-a56c-76e55e2615ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6a42dd05-7ea1-408a-a56c-76e55e2615ef" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:to="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:href="exas-20210930.xsd#exas_ServiceOrProductTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ServiceOrProductTypeAxis_4c8bbba3-6ce8-42a7-9833-beea848a7284" xlink:to="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScreeningMember_7c8d5ec3-23e2-44db-ac96-5632bd0dcd9e" xlink:href="exas-20210930.xsd#exas_ScreeningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:to="loc_exas_ScreeningMember_7c8d5ec3-23e2-44db-ac96-5632bd0dcd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PrecisionOncologyMember_712df447-2ee0-4aad-871c-ef4471957131" xlink:href="exas-20210930.xsd#exas_PrecisionOncologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:to="loc_exas_PrecisionOncologyMember_712df447-2ee0-4aad-871c-ef4471957131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_COVID19TestingMember_14a18d32-8e5b-4a8e-97b1-20fb64780fa0" xlink:href="exas-20210930.xsd#exas_COVID19TestingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ServiceOrProductTypeDomain_52666f30-05d4-4aa4-b8d4-e7404ce54bb1" xlink:to="loc_exas_COVID19TestingMember_14a18d32-8e5b-4a8e-97b1-20fb64780fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:to="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_db59d9d9-2d8e-45e4-8b03-b9c30de08581" xlink:to="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_6dbd38a7-c3ed-4f7b-8c9f-6be8b1c1b238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_us-gaap_ProductMember_6dbd38a7-c3ed-4f7b-8c9f-6be8b1c1b238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_ebb35ce5-bf9b-46d4-8ebe-fe21e87ea157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_us-gaap_ServiceMember_ebb35ce5-bf9b-46d4-8ebe-fe21e87ea157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InternationalSalesMember_96fd6ed6-a860-4c76-b692-30cf8ae2dfb4" xlink:href="exas-20210930.xsd#exas_InternationalSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_exas_InternationalSalesMember_96fd6ed6-a860-4c76-b692-30cf8ae2dfb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_c3733701-62f4-4d73-af3a-1daddd7d1a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e943e745-372e-4650-93ae-7e885775f605" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_c3733701-62f4-4d73-af3a-1daddd7d1a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_475561c1-6e96-4993-92a4-088c8b8edf83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac81dc3b-caf7-4794-a4f6-147ee74cdca5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_475561c1-6e96-4993-92a4-088c8b8edf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b5dde5d-45cf-4a60-9a88-8ad0c5c13b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_475561c1-6e96-4993-92a4-088c8b8edf83" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4b5dde5d-45cf-4a60-9a88-8ad0c5c13b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/REVENUENarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#REVENUENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/REVENUENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dec27e48-61fa-4400-93d9-02e7dcbb602d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dec27e48-61fa-4400-93d9-02e7dcbb602d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ae8981d5-9379-412c-9b6a-aafc671dcbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerBasisOfPricingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingAxis_1270f0dc-8562-4624-9a8b-9b0795e32e72" xlink:to="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ae8981d5-9379-412c-9b6a-aafc671dcbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_VariablePriceContractMember_0b971477-7b03-45d5-96af-cf83ca32b546" xlink:href="exas-20210930.xsd#exas_VariablePriceContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerBasisOfPricingDomain_ae8981d5-9379-412c-9b6a-aafc671dcbfe" xlink:to="loc_exas_VariablePriceContractMember_0b971477-7b03-45d5-96af-cf83ca32b546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_54f610de-88e4-40a0-a751-e2f986b290e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_90b7cb67-a218-49d5-a94d-b408de9c6471" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_54f610de-88e4-40a0-a751-e2f986b290e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_COVID19Member_17b977fb-0f7e-473a-88e2-45030657c815" xlink:href="exas-20210930.xsd#exas_COVID19Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_54f610de-88e4-40a0-a751-e2f986b290e0" xlink:to="loc_exas_COVID19Member_17b977fb-0f7e-473a-88e2-45030657c815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_497f451f-a434-469b-8814-643d659e8b0a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ad28b8f8-8b14-474a-8cb0-5dbef957c2e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice_ad28b8f8-8b14-474a-8cb0-5dbef957c2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a8453447-eeeb-423c-a79b-c09b3f7cdede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a8453447-eeeb-423c-a79b-c09b3f7cdede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3c611666-5b89-416f-963f-9c9e659e3014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e7431ef3-764a-4331-8c6d-7aeda9a18f63" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3c611666-5b89-416f-963f-9c9e659e3014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIES" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIES"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_6fb8697b-953e-4bcb-ba53-0f5223f7b6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_1aede710-b795-4e1a-9c14-dab2740c3c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_6fb8697b-953e-4bcb-ba53-0f5223f7b6cc" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_1aede710-b795-4e1a-9c14-dab2740c3c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESTables" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_35edce40-b03f-42a4-9a50-5d569d4f658f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_60587452-f38f-4270-810e-039d067bf628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_35edce40-b03f-42a4-9a50-5d569d4f658f" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_60587452-f38f-4270-810e-039d067bf628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_e46f85d6-69f6-460d-a928-cf75ac678eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_35edce40-b03f-42a4-9a50-5d569d4f658f" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_e46f85d6-69f6-460d-a928-cf75ac678eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_6ab59731-f6fb-4acf-822d-6a76ad3cd5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_35edce40-b03f-42a4-9a50-5d569d4f658f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_6ab59731-f6fb-4acf-822d-6a76ad3cd5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_56d516fd-f05b-4aa3-9725-9d8e653a20ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_35edce40-b03f-42a4-9a50-5d569d4f658f" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_56d516fd-f05b-4aa3-9725-9d8e653a20ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_db076e36-ae15-4903-b927-4303f5e4051c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_35edce40-b03f-42a4-9a50-5d569d4f658f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_db076e36-ae15-4903-b927-4303f5e4051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_0a6649b2-1467-4585-aaae-b31d1f1963d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_0a6649b2-1467-4585-aaae-b31d1f1963d5" xlink:to="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_94abc9a2-1cdf-4b38-824d-622627801bc0" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CashAndMoneyMarketMember_5dbd639f-9d66-4a18-bf5d-f89e6c494161" xlink:href="exas-20210930.xsd#exas_CashAndMoneyMarketMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:to="loc_exas_CashAndMoneyMarketMember_5dbd639f-9d66-4a18-bf5d-f89e6c494161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_3b95f410-743b-4513-8e3b-490a027fad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_3b95f410-743b-4513-8e3b-490a027fad2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedCashMember_08fd7aee-234c-46a8-8e0c-efff28eef637" xlink:href="exas-20210930.xsd#exas_RestrictedCashMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8751b43e-da95-481b-ae38-0a04cd7f644c" xlink:to="loc_exas_RestrictedCashMember_08fd7aee-234c-46a8-8e0c-efff28eef637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_86cbf448-05cf-4d7d-b731-38ece312daa6" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7a3bc6dc-da4f-4d5f-a3f6-93616989a2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7a3bc6dc-da4f-4d5f-a3f6-93616989a2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ec8da510-9b8c-4be2-8db6-dcf3d25b6117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9f002382-96a4-480f-9e6e-28cf29202aa0" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ec8da510-9b8c-4be2-8db6-dcf3d25b6117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_adf3c68b-9ce2-42dc-8f6d-ffb1c4795e1b" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5070bdd5-e8ea-40f6-865a-1f08a75ab06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5070bdd5-e8ea-40f6-865a-1f08a75ab06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2f12871a-1ac0-4598-a5ac-c7f7f9832044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2f12871a-1ac0-4598-a5ac-c7f7f9832044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_62cd86c9-6539-4561-9093-c5844ad3c267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_62cd86c9-6539-4561-9093-c5844ad3c267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_6953b16c-af7b-40b6-ab2e-de82485ecaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_MarketableSecurities_6953b16c-af7b-40b6-ab2e-de82485ecaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_be041511-3c01-4559-9c3f-bb9bfa249942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_3d054085-1c0b-4686-b81f-b6e9c269c413" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_be041511-3c01-4559-9c3f-bb9bfa249942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_d8d68054-9974-4980-b5a0-057848dda5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_d8d68054-9974-4980-b5a0-057848dda5d8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d54c45f7-9b05-4028-8548-3ed8116004fd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_34207ff8-7c0f-42aa-90f2-52214d113be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_34207ff8-7c0f-42aa-90f2-52214d113be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f00ebe53-42d0-430e-a7db-4877662f6463" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f00ebe53-42d0-430e-a7db-4877662f6463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_1be67557-c62f-486c-a3d0-7752c4b682c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_CertificatesOfDepositMember_1be67557-c62f-486c-a3d0-7752c4b682c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_555022f8-d36f-4802-8efe-b756c15798c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_CommercialPaperMember_555022f8-d36f-4802-8efe-b756c15798c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f697fe31-a9f3-4735-b7ec-95849d23050a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e7084aa-cbc5-4f3f-af84-009463530216" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f697fe31-a9f3-4735-b7ec-95849d23050a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0ff5ce52-ee4b-4efa-9e23-ffbb4b7224fc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_f0644239-4232-4ced-b341-cd0ad69d75e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_f0644239-4232-4ced-b341-cd0ad69d75e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_eb880d50-cc3a-4dd5-b4c4-04005e50b9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d80fc68a-0b40-4702-9748-410e350f4572" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_eb880d50-cc3a-4dd5-b4c4-04005e50b9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_716f9711-40ac-48a3-8d95-4bf6527cf959" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06359762-402e-4229-9e56-162e372baa88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_06359762-402e-4229-9e56-162e372baa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c9784b16-78db-49a4-b38a-ef3aaaea9bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c9784b16-78db-49a4-b38a-ef3aaaea9bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ebe175d-fe1b-4039-84c5-c8148af7064e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ebe175d-fe1b-4039-84c5-c8148af7064e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3f7d8fa0-78d2-412e-99a8-c04867e0ad94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4c98704-4247-4c9d-a2a3-bf8254f9685c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3f7d8fa0-78d2-412e-99a8-c04867e0ad94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_535ed8b1-1ac0-4622-bc8d-a04ec3c57cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_535ed8b1-1ac0-4622-bc8d-a04ec3c57cc2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2786d8a2-3588-44c2-bdf4-9293fce4439f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_ad76fba0-d7df-4dc1-818f-4c5dcdac01f5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2786d8a2-3588-44c2-bdf4-9293fce4439f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_b714cd5e-dd78-4282-9bfc-f123c1f7f925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_2786d8a2-3588-44c2-bdf4-9293fce4439f" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_b714cd5e-dd78-4282-9bfc-f123c1f7f925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ca39bb11-5c63-40bc-a418-a7bc94b212ee" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b615fff-1a0d-41f5-913b-1b5e23184c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b615fff-1a0d-41f5-913b-1b5e23184c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_1cc46085-adef-4f68-a484-2c8827ea9a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_1cc46085-adef-4f68-a484-2c8827ea9a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_7191d8b3-c41a-4a45-95f4-9df27bcd893f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_CertificatesOfDepositMember_7191d8b3-c41a-4a45-95f4-9df27bcd893f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_5a3b378f-833e-4dce-8832-b5fbb09556c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_5a3b378f-833e-4dce-8832-b5fbb09556c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_254ca6e6-1d09-46c7-ae99-aa084fb47942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e98626bd-f558-4df2-b119-e77aba814c3f" xlink:to="loc_us-gaap_CommercialPaperMember_254ca6e6-1d09-46c7-ae99-aa084fb47942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_9025b7f0-0d1c-4ad8-955e-a56898e630bf" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_ef5e9ee3-6a7b-4208-93e1-442cd857ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_ef5e9ee3-6a7b-4208-93e1-442cd857ef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_23cd6337-fcc5-4fb4-a893-5db94bf91a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_23cd6337-fcc5-4fb4-a893-5db94bf91a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_f60a7aed-77df-44d1-9c31-86a45178e735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_f60a7aed-77df-44d1-9c31-86a45178e735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_35b133df-ceb4-4f19-ad50-44422741fd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_9a37e7fc-658e-4d41-89b2-ef9f2a12a3a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_35b133df-ceb4-4f19-ad50-44422741fd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_cffdcc8e-c012-4f74-a0ad-48403cfae85d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_cffdcc8e-c012-4f74-a0ad-48403cfae85d" xlink:to="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7be1b207-dd4c-4b87-881f-405b53eaa79f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_4c323835-72d9-472e-90b2-7cf29f7afbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_4c323835-72d9-472e-90b2-7cf29f7afbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_b5e5f2d7-add9-4764-b1b0-92a0197301c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_CertificatesOfDepositMember_b5e5f2d7-add9-4764-b1b0-92a0197301c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_88f0b2b1-b6e5-4ac1-92d3-914ce58f9e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_88f0b2b1-b6e5-4ac1-92d3-914ce58f9e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6f3bd9f-23c0-4672-aa72-c7c14c995db0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9b997d92-861e-4126-9062-6ba1e50e9fc8" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6f3bd9f-23c0-4672-aa72-c7c14c995db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_68249dfe-b0de-447a-9415-6b8c8e3fcf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_3bb1d394-bcbc-47e3-a6d3-52eb4bbfea6f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_68249dfe-b0de-447a-9415-6b8c8e3fcf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e01a258c-9766-4e67-9515-828491ecb0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_68249dfe-b0de-447a-9415-6b8c8e3fcf63" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e01a258c-9766-4e67-9515-828491ecb0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_f1b882f1-fd8a-4116-8f09-2cab3c124753" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c3e5ea89-ca91-4f90-ac43-f6fc6d82089f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_c3e5ea89-ca91-4f90-ac43-f6fc6d82089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e8042b4e-3e7b-460e-aae1-bf17a4b449f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e8042b4e-3e7b-460e-aae1-bf17a4b449f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_da7f524b-0ccd-45f0-8fc7-c366b23fcf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_da7f524b-0ccd-45f0-8fc7-c366b23fcf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1efedd54-5c22-411d-b603-8abb13690bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_1efedd54-5c22-411d-b603-8abb13690bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_fbdaa6e0-5a41-4c62-95f3-2cdfe5dc5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_fbdaa6e0-5a41-4c62-95f3-2cdfe5dc5359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3e0303b-9727-432e-8948-31c0e871499d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_1da6cd3f-a0ae-4a88-9853-40daa26d3415" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_f3e0303b-9727-432e-8948-31c0e871499d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/MARKETABLESECURITIESNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#MARKETABLESECURITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/MARKETABLESECURITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_f0f71032-fca1-43b6-9a11-a85a8d239da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_d610185e-ef0f-428d-aa58-d72c060b5e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_f0f71032-fca1-43b6-9a11-a85a8d239da6" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_d610185e-ef0f-428d-aa58-d72c060b5e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INVENTORY" xlink:type="simple" xlink:href="exas-20210930.xsd#INVENTORY"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INVENTORY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c20a4a81-c508-4d38-ac0b-8fc9b4ffb0dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_d9741c25-fc9f-4809-a7fb-1577fd62f9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c20a4a81-c508-4d38-ac0b-8fc9b4ffb0dc" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_d9741c25-fc9f-4809-a7fb-1577fd62f9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INVENTORYTables" xlink:type="simple" xlink:href="exas-20210930.xsd#INVENTORYTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INVENTORYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_a9a23292-c2b0-48e4-a0f1-fa7959f167dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_861a3dd6-887e-451e-9c59-fd6730f79530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_a9a23292-c2b0-48e4-a0f1-fa7959f167dd" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_861a3dd6-887e-451e-9c59-fd6730f79530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INVENTORYDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_f6b1940c-97c5-4a9a-be95-c02ea6afd6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_587f6427-8d5e-430d-b183-dbca69a69602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f6b1940c-97c5-4a9a-be95-c02ea6afd6ec" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_587f6427-8d5e-430d-b183-dbca69a69602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InventoryFinishedAndSemiFinishedGoods_507ee7a8-a2c0-4d67-b97b-1affe9c8442a" xlink:href="exas-20210930.xsd#exas_InventoryFinishedAndSemiFinishedGoods"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f6b1940c-97c5-4a9a-be95-c02ea6afd6ec" xlink:to="loc_exas_InventoryFinishedAndSemiFinishedGoods_507ee7a8-a2c0-4d67-b97b-1affe9c8442a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f38bab1c-d6a0-43d4-8c74-dcefb09cca3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f6b1940c-97c5-4a9a-be95-c02ea6afd6ec" xlink:to="loc_us-gaap_InventoryNet_f38bab1c-d6a0-43d4-8c74-dcefb09cca3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8efe2b38-b300-409d-9745-8928f65bf540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_44e745af-6836-4a35-b034-1f51498b2163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8efe2b38-b300-409d-9745-8928f65bf540" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_44e745af-6836-4a35-b034-1f51498b2163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ebadaf90-d50d-4c92-b463-5d9302574960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e981b505-cff9-4203-83e6-f24035015703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ebadaf90-d50d-4c92-b463-5d9302574960" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_e981b505-cff9-4203-83e6-f24035015703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_60320b4f-1dbd-4240-aedf-87cb27092c19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_60320b4f-1dbd-4240-aedf-87cb27092c19" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:to="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2117624d-95f9-4c75-a3be-ddb16a967ce5" xlink:to="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_093c91ca-8932-4f4a-9c76-326c32068d3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:to="loc_srt_MinimumMember_093c91ca-8932-4f4a-9c76-326c32068d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8fb29ba7-e1fa-4102-99ba-2d4e7ad606d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_33e6723a-d3f3-437e-9faf-b8213f774719" xlink:to="loc_srt_MaximumMember_8fb29ba7-e1fa-4102-99ba-2d4e7ad606d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9dc48f77-471b-48b5-bddc-69ebadfe52f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_daf8e8c3-6140-434c-8a44-80a9a66f8b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_LandMember_daf8e8c3-6140-434c-8a44-80a9a66f8b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BuildingsAndLeaseholdImprovementsMember_9366f80a-54e5-498f-bf84-fd28955ca822" xlink:href="exas-20210930.xsd#exas_BuildingsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_exas_BuildingsAndLeaseholdImprovementsMember_9366f80a-54e5-498f-bf84-fd28955ca822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_511a52b8-9b68-4481-957e-2845eb0dd640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_LandImprovementsMember_511a52b8-9b68-4481-957e-2845eb0dd640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_6becece3-249b-4b15-9243-fe3570cd2bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_BuildingMember_6becece3-249b-4b15-9243-fe3570cd2bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_OfficeEquipmentAndComputerSoftwareMember_59ce9d26-dc86-4d70-beec-ec96d030b8fe" xlink:href="exas-20210930.xsd#exas_OfficeEquipmentAndComputerSoftwareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_exas_OfficeEquipmentAndComputerSoftwareMember_59ce9d26-dc86-4d70-beec-ec96d030b8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_fadd1266-2e46-430e-9264-13835be9ec03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_EquipmentMember_fadd1266-2e46-430e-9264-13835be9ec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d7d35e4a-6b70-4004-beab-87b71d4ed6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d7d35e4a-6b70-4004-beab-87b71d4ed6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_fb56a357-d394-4ebc-851d-7ba742bb8104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1d568348-f10b-4efa-9085-241f0b4f1574" xlink:to="loc_us-gaap_AssetUnderConstructionMember_fb56a357-d394-4ebc-851d-7ba742bb8104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_fe68be04-fd9b-485f-9895-674025e576ea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_29c67dac-1111-4bc7-9f54-7d1d4b9ef592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_29c67dac-1111-4bc7-9f54-7d1d4b9ef592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4e73336f-1b38-42e6-a67a-d4448e829873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4e73336f-1b38-42e6-a67a-d4448e829873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ed11828-696e-43fe-b3cd-fb5a6c476330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6ed11828-696e-43fe-b3cd-fb5a6c476330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a591dc46-55c0-46ef-875d-e0d4ba50b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c69d13f4-910d-4289-8fbc-7bcbbc6e209f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a591dc46-55c0-46ef-875d-e0d4ba50b27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PROPERTYPLANTANDEQUIPMENTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2cfd36c-4890-49cb-b096-8c947b6cf8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c2cfd36c-4890-49cb-b096-8c947b6cf8d2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_63ba4f63-c54b-4ac1-857e-78236c8a6eeb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetUnderConstructionMember_42f6f04d-e409-40e1-b3de-8a4cfd5165bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetUnderConstructionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_AssetUnderConstructionMember_42f6f04d-e409-40e1-b3de-8a4cfd5165bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_73c245b6-1511-4e99-944b-e66d6074e458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_EquipmentMember_73c245b6-1511-4e99-944b-e66d6074e458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BuildingsAndLeaseholdImprovementsMember_1c7f82a1-221a-4924-8ac7-8168d541fa50" xlink:href="exas-20210930.xsd#exas_BuildingsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_exas_BuildingsAndLeaseholdImprovementsMember_1c7f82a1-221a-4924-8ac7-8168d541fa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_a2b2a1cd-6feb-4459-9262-2ce9e8659942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_a2b2a1cd-6feb-4459-9262-2ce9e8659942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandImprovementsMember_db588228-7bc9-4d57-be2d-e73f5ee55bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e1d25da9-069a-412b-82df-e43037bb2397" xlink:to="loc_us-gaap_LandImprovementsMember_db588228-7bc9-4d57-be2d-e73f5ee55bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_97d6340f-f574-4766-9b44-37a0e6ab6140" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_560cb401-7240-4dfe-a56c-160e319e6bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_Depreciation_560cb401-7240-4dfe-a56c-160e319e6bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_818193a0-8ed7-4520-9aab-f081959634a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_818193a0-8ed7-4520-9aab-f081959634a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_60faa33e-1cd9-4f6d-91ee-e59840b019b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c9378ba8-3ef1-4569-80be-eee6a7f2165b" xlink:to="loc_us-gaap_ConstructionInProgressGross_60faa33e-1cd9-4f6d-91ee-e59840b019b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILL"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c34b760c-4703-4926-986f-b9c7127137c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d940320f-1a9f-4254-ab7f-8e1406ff98ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c34b760c-4703-4926-986f-b9c7127137c8" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d940320f-1a9f-4254-ab7f-8e1406ff98ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e4fa843-0a5c-4d51-bfae-2d150d94b511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_457e16ca-dc03-4dde-a4b4-9472c72f781f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e4fa843-0a5c-4d51-bfae-2d150d94b511" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_457e16ca-dc03-4dde-a4b4-9472c72f781f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_374d356d-e174-4eed-afc7-145c1dada8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e4fa843-0a5c-4d51-bfae-2d150d94b511" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_374d356d-e174-4eed-afc7-145c1dada8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3a56d803-7aa8-4333-aa33-8f6f505b1d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e4fa843-0a5c-4d51-bfae-2d150d94b511" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_3a56d803-7aa8-4333-aa33-8f6f505b1d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b3f462c-496b-41b5-b302-5507f031304a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8b3f462c-496b-41b5-b302-5507f031304a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_623948a2-f32f-415f-bff4-3aa038e24c87" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_64a24bb8-d5f0-4b26-baec-ea3a7a781c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_TradeNamesMember_64a24bb8-d5f0-4b26-baec-ea3a7a781c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_952dde4d-91ab-4e60-8ddf-798bec5e204a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_952dde4d-91ab-4e60-8ddf-798bec5e204a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_f34c2804-faf0-41f3-93e4-e7ded22d09f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_PatentsMember_f34c2804-faf0-41f3-93e4-e7ded22d09f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_5a44e481-98cd-466d-af57-bd66e1250e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_5a44e481-98cd-466d-af57-bd66e1250e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_08dff7ae-47e8-4ccb-9b30-aab906d5d906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_00c6494c-f955-4c9c-839c-0c72077aa4c0" xlink:to="loc_us-gaap_ServiceAgreementsMember_08dff7ae-47e8-4ccb-9b30-aab906d5d906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_4c6aa342-5ddb-4c46-bcc8-f613b58b6389" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7afebc09-5e59-4dfa-be6f-88bf9fef16f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7afebc09-5e59-4dfa-be6f-88bf9fef16f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_40e2ddb4-076e-4e99-a6db-08b83f09de3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_40e2ddb4-076e-4e99-a6db-08b83f09de3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fcd3ffbf-ccb3-4711-8897-d32d8d962703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_fcd3ffbf-ccb3-4711-8897-d32d8d962703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2551e062-c646-43c3-9583-e435a45f1aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2551e062-c646-43c3-9583-e435a45f1aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4681f475-382b-41ba-98bc-6687e8347d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_4681f475-382b-41ba-98bc-6687e8347d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8872e8e2-2e7e-41bf-8e79-487a7c289a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_8872e8e2-2e7e-41bf-8e79-487a7c289a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8588a4a-3d7b-441f-beaf-24b5e8876939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3747124d-a157-460e-97a5-5f8bace17ae9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b8588a4a-3d7b-441f-beaf-24b5e8876939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c09dd9fc-dea0-473d-8288-5d88b8c5d9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c09dd9fc-dea0-473d-8288-5d88b8c5d9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f49ed0b8-f392-48a1-aaba-4dca9f3c4043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f49ed0b8-f392-48a1-aaba-4dca9f3c4043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_51e51df6-0869-4cb7-a7d0-8cb2e81f2984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_51e51df6-0869-4cb7-a7d0-8cb2e81f2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b7f6f297-c78e-433e-9c7d-04b2319bd23e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b7f6f297-c78e-433e-9c7d-04b2319bd23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0946c839-0e40-406c-a591-af7747c70794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0946c839-0e40-406c-a591-af7747c70794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_f5ca326b-2001-4843-b060-2dd6d242eb74" xlink:href="exas-20210930.xsd#exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_f5ca326b-2001-4843-b060-2dd6d242eb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5bb7114d-109b-405b-981a-6abdcbe9e1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb8d8388-733e-432f-b26b-3753b07837e4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5bb7114d-109b-405b-981a-6abdcbe9e1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_afc99e8b-6f0f-4698-8197-96c7edf75527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_afc99e8b-6f0f-4698-8197-96c7edf75527" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b09f480f-f6e0-488c-ab3c-391b9593faca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1d1b8eb0-6228-44b7-9eea-01a71daf1eb9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b09f480f-f6e0-488c-ab3c-391b9593faca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_800643d3-e9b7-4dbe-8f29-c18cd6241866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b09f480f-f6e0-488c-ab3c-391b9593faca" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_800643d3-e9b7-4dbe-8f29-c18cd6241866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b210214-06b3-49a1-9ecb-5129f3ffbfd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4d7af28c-9695-4f15-933d-85dc37f0f337" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b210214-06b3-49a1-9ecb-5129f3ffbfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ArmuneBiosciencesAgreementMember_c3205072-4e6a-4b71-ba3e-2b484494b190" xlink:href="exas-20210930.xsd#exas_ArmuneBiosciencesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8b210214-06b3-49a1-9ecb-5129f3ffbfd9" xlink:to="loc_exas_ArmuneBiosciencesAgreementMember_c3205072-4e6a-4b71-ba3e-2b484494b190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e0d7d4fc-e1d8-40b6-8e68-421a91001c10" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2163ef5d-b2e7-40f9-99d9-3b6cf42db1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_2163ef5d-b2e7-40f9-99d9-3b6cf42db1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a361ff49-3d3b-4464-96a1-1edb6100fa91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a361ff49-3d3b-4464-96a1-1edb6100fa91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64e5b55f-a28f-41ce-ae79-b41ae6560a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_64e5b55f-a28f-41ce-ae79-b41ae6560a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66030d92-4690-4540-912c-a121bc2013e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_c2da1cda-52e4-4017-bfbc-8829a4be119d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66030d92-4690-4540-912c-a121bc2013e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd83ffec-25db-426f-a8b1-1f227b136e96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cd83ffec-25db-426f-a8b1-1f227b136e96" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e2041714-32ce-4eed-bcc7-6ab42638b17d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_d5d06729-061d-4289-9217-720feea7cfef" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_ParadigmViomicsMember_d5d06729-061d-4289-9217-720feea7cfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_GenomicHealthIncMember_2354fe6a-377e-4a21-a564-5282ec103cb4" xlink:href="exas-20210930.xsd#exas_GenomicHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_GenomicHealthIncMember_2354fe6a-377e-4a21-a564-5282ec103cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_19fd671a-db5c-40d8-81a6-f176b8679169" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_19fd671a-db5c-40d8-81a6-f176b8679169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_992f9eb4-f5c7-48ef-93f0-42d8b500ac76" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a9b562a-f3c9-4e20-b409-bb494690002b" xlink:to="loc_exas_AshionAnalyticsMember_992f9eb4-f5c7-48ef-93f0-42d8b500ac76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_fc6f9271-503f-4f29-9e6e-0f0e1e12d36b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_721fd2c4-bae4-425d-b318-f85fd0f6b3a2" xlink:to="loc_us-gaap_GoodwillLineItems_fc6f9271-503f-4f29-9e6e-0f0e1e12d36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_fc6f9271-503f-4f29-9e6e-0f0e1e12d36b" xlink:to="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_57ccb650-f9c8-416a-a459-0d0f1064dc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_us-gaap_Goodwill_57ccb650-f9c8-416a-a459-0d0f1064dc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dcf28143-0b54-49e1-a849-6f4bacad3f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dcf28143-0b54-49e1-a849-6f4bacad3f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_GoodwillAcquiredAdjustment_ae720ed8-2c0f-4800-8a2c-c34fdee04581" xlink:href="exas-20210930.xsd#exas_GoodwillAcquiredAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_exas_GoodwillAcquiredAdjustment_ae720ed8-2c0f-4800-8a2c-c34fdee04581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1312c43-7508-436c-a095-6f2eff18093c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_937ee723-9be8-4c7c-83de-1134ec9c7c39" xlink:to="loc_us-gaap_Goodwill_b1312c43-7508-436c-a095-6f2eff18093c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_27d8ad00-67f9-43b2-8475-3416c762111b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_50b630b5-5fe3-49a3-9e17-35b9bad90442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_27d8ad00-67f9-43b2-8475-3416c762111b" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_50b630b5-5fe3-49a3-9e17-35b9bad90442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cade1988-4892-4714-a36f-82fac45c6328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_02f49cbe-61ad-4bfb-a73b-2224c28e6211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cade1988-4892-4714-a36f-82fac45c6328" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_02f49cbe-61ad-4bfb-a73b-2224c28e6211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_ecf91148-bf1c-4e36-a1b9-479bda9794d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cade1988-4892-4714-a36f-82fac45c6328" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_ecf91148-bf1c-4e36-a1b9-479bda9794d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_58a43976-760a-4e73-926d-c3cb4a2f7869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_58a43976-760a-4e73-926d-c3cb4a2f7869" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6daedf5a-1410-48dd-868f-9c9537275697" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_98d517c8-2788-40b9-9929-c1395785672e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_98d517c8-2788-40b9-9929-c1395785672e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c6d1f29c-6bab-42e6-9023-5942f340d000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c6d1f29c-6bab-42e6-9023-5942f340d000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_30361b05-7ba8-4763-921c-5d1e5c6e4f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2b83958-d57e-43ee-8473-9b0a6ff57a05" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_30361b05-7ba8-4763-921c-5d1e5c6e4f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_47b55fda-b383-4ae2-8148-6b119774713e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_876c6273-f6d1-4a59-8a89-0f30ec24debf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_47b55fda-b383-4ae2-8148-6b119774713e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f0528c5a-23c8-491b-a8fc-871a9f72c3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_47b55fda-b383-4ae2-8148-6b119774713e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f0528c5a-23c8-491b-a8fc-871a9f72c3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_90457a82-58fe-437b-9527-03958643599a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_6bc02fac-4e71-4b1a-b9dc-2d97da214367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:to="loc_us-gaap_MoneyMarketFundsMember_6bc02fac-4e71-4b1a-b9dc-2d97da214367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedCashMember_fb055f99-59c6-4c90-bd3b-bb56d692085f" xlink:href="exas-20210930.xsd#exas_RestrictedCashMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:to="loc_exas_RestrictedCashMember_fb055f99-59c6-4c90-bd3b-bb56d692085f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b81976b-2b08-4307-8589-42bb8a0be0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e9214ad5-564b-4931-b33c-1437c5b64bfa" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_4b81976b-2b08-4307-8589-42bb8a0be0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_ed21d1fe-bfd6-4951-8326-5bb89da535e7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_e3a361bd-533e-4106-b45b-ce6765f627b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_e3a361bd-533e-4106-b45b-ce6765f627b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_c1f4dd4c-174f-4636-981d-52ab8465966d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_CertificatesOfDepositMember_c1f4dd4c-174f-4636-981d-52ab8465966d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b3a4840d-f1d9-4d4e-87ba-1d09668fa856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_CommercialPaperMember_b3a4840d-f1d9-4d4e-87ba-1d09668fa856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1abcc25c-c549-47cf-8b05-cb49ba51c40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_1abcc25c-c549-47cf-8b05-cb49ba51c40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_c7a759d2-3ed8-404b-b29b-f2dd3c39835a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_96e5262d-0da3-466e-93a3-1d957935debf" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_c7a759d2-3ed8-404b-b29b-f2dd3c39835a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_72e052e8-90a5-4cd5-a7a6-9168868b91e6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a09abc70-66bd-4ae8-8f66-fe932740936a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a09abc70-66bd-4ae8-8f66-fe932740936a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f23ab1c2-55a8-4da8-975a-ca56a8a2727a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f23ab1c2-55a8-4da8-975a-ca56a8a2727a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_50d5023a-be0b-45c5-93ca-df9f4f2e81df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_50d5023a-be0b-45c5-93ca-df9f4f2e81df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_3705a8bd-79b1-4959-9364-ec2f805d5417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecurityOwnedNotReadilyMarketableFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_SecurityOwnedNotReadilyMarketableFairValue_3705a8bd-79b1-4959-9364-ec2f805d5417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3e8fc267-7e27-4de5-9028-b5cb9612bc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_3e8fc267-7e27-4de5-9028-b5cb9612bc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetAssetLiability_f0465b42-5505-4e92-9134-ff30d0fb7f01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetAssetLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_fae7c05b-58a9-49bf-ae86-fe690ddece38" xlink:to="loc_us-gaap_FairValueNetAssetLiability_f0465b42-5505-4e92-9134-ff30d0fb7f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_767691b6-9c35-4578-92e0-2071428e5942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_767691b6-9c35-4578-92e0-2071428e5942" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_257dc960-95cd-45b2-b20c-54622d3a3b5e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveAndAshionMember_0e6b211b-cd2b-46be-ab11-74e31f01e0b8" xlink:href="exas-20210930.xsd#exas_ThriveAndAshionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:to="loc_exas_ThriveAndAshionMember_0e6b211b-cd2b-46be-ab11-74e31f01e0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BiomatricaIncMember_092f6edd-e6c2-46af-8578-a2b492f5db09" xlink:href="exas-20210930.xsd#exas_BiomatricaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0c1f6d6e-36f8-40f2-a666-5871d7e97d9a" xlink:to="loc_exas_BiomatricaIncMember_092f6edd-e6c2-46af-8578-a2b492f5db09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54c7959a-7457-45a1-a5b3-ab8387b67aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0571f8c2-ac0f-4a6e-b245-bc99697b467e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54c7959a-7457-45a1-a5b3-ab8387b67aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a1820e1f-aa9c-46b9-86ef-e320baad728c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_54c7959a-7457-45a1-a5b3-ab8387b67aca" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a1820e1f-aa9c-46b9-86ef-e320baad728c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_114b6d24-33f1-4f51-bfd0-419cce620e10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_42a94dc8-9da9-4cf8-a7d9-3e87be8fc2bf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_114b6d24-33f1-4f51-bfd0-419cce620e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f101fefd-5637-435e-a19d-1ff299c358f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_114b6d24-33f1-4f51-bfd0-419cce620e10" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f101fefd-5637-435e-a19d-1ff299c358f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1eea35a7-e370-47d5-9f38-d5025d7bdfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cb1ef9fa-a54e-4a4f-b40d-56f60e3fde93" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1eea35a7-e370-47d5-9f38-d5025d7bdfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_56463792-c82c-4596-b7d8-f000a0d4ac68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1eea35a7-e370-47d5-9f38-d5025d7bdfdd" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_56463792-c82c-4596-b7d8-f000a0d4ac68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_ee5e3e77-a752-4151-8232-df5661150f49" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_a2cba1b8-76a6-4fa5-8a9e-5a7dc8ae1d93" xlink:href="exas-20210930.xsd#exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:to="loc_exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember_a2cba1b8-76a6-4fa5-8a9e-5a7dc8ae1d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RevenueAndOtherPerformanceBasedPaymentsMember_fa3032ca-8875-4fc3-ae9a-974278a8c3ed" xlink:href="exas-20210930.xsd#exas_RevenueAndOtherPerformanceBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_06ca9252-214c-46c5-ae73-a98c70d50e4b" xlink:to="loc_exas_RevenueAndOtherPerformanceBasedPaymentsMember_fa3032ca-8875-4fc3-ae9a-974278a8c3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c661d43-1711-4323-8694-af687f43cfba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3d6baa0b-e56f-4df0-a11e-879e543cb8f9" xlink:to="loc_srt_RangeMember_0c661d43-1711-4323-8694-af687f43cfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_ced818be-543b-4a53-bd9a-e64e1b0ab3f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0c661d43-1711-4323-8694-af687f43cfba" xlink:to="loc_srt_WeightedAverageMember_ced818be-543b-4a53-bd9a-e64e1b0ab3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_a539adab-4a38-4d5e-9897-c64f55c86693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_cd36a4a3-52f2-4137-b44e-5adddca0d842" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_a539adab-4a38-4d5e-9897-c64f55c86693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_de0e48b4-0b55-41ba-a1d5-7c13fb0aa06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_a539adab-4a38-4d5e-9897-c64f55c86693" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_de0e48b4-0b55-41ba-a1d5-7c13fb0aa06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc6bd01f-6eb5-40da-be7a-6ce2b519c641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_de0e48b4-0b55-41ba-a1d5-7c13fb0aa06a" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc6bd01f-6eb5-40da-be7a-6ce2b519c641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_cde67302-4ace-4f4f-9598-fe6ac7b13426" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MeasurementInputProbabilityOfSuccessMember_0ae6a1f9-bc6b-4ca4-994b-875cd3471df9" xlink:href="exas-20210930.xsd#exas_MeasurementInputProbabilityOfSuccessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:to="loc_exas_MeasurementInputProbabilityOfSuccessMember_0ae6a1f9-bc6b-4ca4-994b-875cd3471df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MeasurementInputPresentValueFactorMember_503026dd-13ca-417d-b6e9-0a4b6702c3d6" xlink:href="exas-20210930.xsd#exas_MeasurementInputPresentValueFactorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1f26d344-5224-470f-89f1-8884fe28ef4d" xlink:to="loc_exas_MeasurementInputPresentValueFactorMember_503026dd-13ca-417d-b6e9-0a4b6702c3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_31fcfca1-8367-4caa-890d-a9ec687da8a3" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c532862-02fa-4b69-8489-1d408e95b12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_6c532862-02fa-4b69-8489-1d408e95b12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_79b11235-ff98-412c-ab43-f69be2843f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_79b11235-ff98-412c-ab43-f69be2843f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_87e7045a-52a5-4856-bd28-c89d0f375faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_87e7045a-52a5-4856-bd28-c89d0f375faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_912f14f6-6178-4fcf-9807-a5b1b1b9a8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_ccbf3155-dbf0-4437-a8a1-b344c9063973" xlink:to="loc_us-gaap_DerivativeNotionalAmount_912f14f6-6178-4fcf-9807-a5b1b1b9a8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a5015147-d08f-4add-9f00-9a7247cdbd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29201720-4232-434f-a9f5-1a9550612fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5015147-d08f-4add-9f00-9a7247cdbd1b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_29201720-4232-434f-a9f5-1a9550612fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_2599020c-7863-4cc4-9bf3-eafe689f40bd" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5015147-d08f-4add-9f00-9a7247cdbd1b" xlink:to="loc_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition_2599020c-7863-4cc4-9bf3-eafe689f40bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_be91926a-83cd-4651-896e-08917b6cde08" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5015147-d08f-4add-9f00-9a7247cdbd1b" xlink:to="loc_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue_be91926a-83cd-4651-896e-08917b6cde08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_80d33111-349e-48d6-a6c2-b52244d26369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5015147-d08f-4add-9f00-9a7247cdbd1b" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities_80d33111-349e-48d6-a6c2-b52244d26369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_33d9ace2-ce8f-4cb3-ace2-73e274e3f315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5015147-d08f-4add-9f00-9a7247cdbd1b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_33d9ace2-ce8f-4cb3-ace2-73e274e3f315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LONGTERMDEBT" xlink:type="simple" xlink:href="exas-20210930.xsd#LONGTERMDEBT"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/LONGTERMDEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b06c286d-f01f-4133-accc-8bd289202a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_853eb3c2-dba5-4565-83d4-17b8022c4b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b06c286d-f01f-4133-accc-8bd289202a2d" xlink:to="loc_us-gaap_LongTermDebtTextBlock_853eb3c2-dba5-4565-83d4-17b8022c4b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LONGTERMDEBTDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#LONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/LONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d90a8e8c-2b0c-4055-97c7-d7fba97d34ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d90a8e8c-2b0c-4055-97c7-d7fba97d34ea" xlink:to="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_3bce057c-eeea-4736-9214-c4b3dca36fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_9ca59d9d-d221-4a8d-837f-93b525c7b6b9" xlink:to="loc_us-gaap_CreditFacilityDomain_3bce057c-eeea-4736-9214-c4b3dca36fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_05db5ccc-c40f-49c8-acf8-531b5dfa4547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_3bce057c-eeea-4736-9214-c4b3dca36fc5" xlink:to="loc_us-gaap_LetterOfCreditMember_05db5ccc-c40f-49c8-acf8-531b5dfa4547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0bedcf8c-6d58-45a1-b155-79fb0543f30b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionLoansMember_565de808-80e1-4f5f-8632-93c47011c051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:to="loc_us-gaap_ConstructionLoansMember_565de808-80e1-4f5f-8632-93c47011c051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TaxIncrementFinancingLoanAgreementsMember_9cefac29-34cc-4814-9ab2-0284c2b2ff19" xlink:href="exas-20210930.xsd#exas_TaxIncrementFinancingLoanAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_46c57617-89ac-41a1-9493-737e16403ccf" xlink:to="loc_exas_TaxIncrementFinancingLoanAgreementsMember_9cefac29-34cc-4814-9ab2-0284c2b2ff19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e06ea348-4337-4019-bff9-b19b08d9a1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f44431a4-0f24-4433-9ce0-76bc429376b3" xlink:to="loc_us-gaap_VariableRateDomain_e06ea348-4337-4019-bff9-b19b08d9a1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_OneMonthLondonInterbankOfferRateMember_29c65e39-f02e-4b1e-8a39-6310d91fedf7" xlink:href="exas-20210930.xsd#exas_OneMonthLondonInterbankOfferRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e06ea348-4337-4019-bff9-b19b08d9a1ce" xlink:to="loc_exas_OneMonthLondonInterbankOfferRateMember_29c65e39-f02e-4b1e-8a39-6310d91fedf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fc9959a8-337e-44c4-b974-60b6669a0bcc" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_86bdfc17-3bce-424b-8e7f-94cdad78c679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_86bdfc17-3bce-424b-8e7f-94cdad78c679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_49b7b9b8-dda8-4853-bbf3-5efa8ffe30d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_49b7b9b8-dda8-4853-bbf3-5efa8ffe30d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentPeriodicPaymentInterestTerm_5338900d-1fb6-4b0c-9db0-417103efc863" xlink:href="exas-20210930.xsd#exas_DebtInstrumentPeriodicPaymentInterestTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_DebtInstrumentPeriodicPaymentInterestTerm_5338900d-1fb6-4b0c-9db0-417103efc863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentRemainingAmortizationPeriod_925c430d-e858-434c-bb0e-5bf7fdb72512" xlink:href="exas-20210930.xsd#exas_DebtInstrumentRemainingAmortizationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_DebtInstrumentRemainingAmortizationPeriod_925c430d-e858-434c-bb0e-5bf7fdb72512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6700e6c6-dbeb-457a-b360-7cc4781624f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6700e6c6-dbeb-457a-b360-7cc4781624f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_62f05084-4146-4e4a-ab93-5651f4018087" xlink:href="exas-20210930.xsd#exas_MinimumOwnInvestmentToBeMadeInConstructionProject"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_MinimumOwnInvestmentToBeMadeInConstructionProject_62f05084-4146-4e4a-ab93-5651f4018087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent_40886f85-2a91-4ae9-8826-ee152e3dc4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermConstructionLoanCurrentAndNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent_40886f85-2a91-4ae9-8826-ee152e3dc4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsIncurred_9fc2c66e-209b-41a3-8586-4ca419529523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsIncurred"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_InterestCostsIncurred_9fc2c66e-209b-41a3-8586-4ca419529523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_5356e9b2-a4a1-4c08-82f4-d9fd0b68185d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_InterestCostsCapitalized_5356e9b2-a4a1-4c08-82f4-d9fd0b68185d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_ad5482d0-3919-4e46-81fb-b062832e1bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_ad5482d0-3919-4e46-81fb-b062832e1bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_33e53d6d-fda1-46b6-91d8-84eb73ae1a0b" xlink:href="exas-20210930.xsd#exas_DebtInstrumentCovenantLiquidityRequiredMinimum"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_DebtInstrumentCovenantLiquidityRequiredMinimum_33e53d6d-fda1-46b6-91d8-84eb73ae1a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfAgreementsEntered_95790b68-847a-45c0-8277-4226216dd0e5" xlink:href="exas-20210930.xsd#exas_NumberOfAgreementsEntered"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_NumberOfAgreementsEntered_95790b68-847a-45c0-8277-4226216dd0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfJobsRequiredToCreatedAndMaintained_ecc7e6d8-1765-4e3d-81ed-d06a6a9359da" xlink:href="exas-20210930.xsd#exas_NumberOfJobsRequiredToCreatedAndMaintained"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_exas_NumberOfJobsRequiredToCreatedAndMaintained_ecc7e6d8-1765-4e3d-81ed-d06a6a9359da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_114db150-01b8-45ed-b3fe-131cc83d1dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_DebtInstrumentTerm_114db150-01b8-45ed-b3fe-131cc83d1dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RegulatoryLiabilityAmortizationPeriod_59492048-592f-4fe7-a969-1a0bd1b41a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RegulatoryLiabilityAmortizationPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c4cff761-b8d4-4df0-8d21-29e7c66dc4d6" xlink:to="loc_us-gaap_RegulatoryLiabilityAmortizationPeriod_59492048-592f-4fe7-a969-1a0bd1b41a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTES" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTES"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_CONVERTIBLENOTESAbstract_bdab67ba-e6cc-4149-9663-76779c408b4e" xlink:href="exas-20210930.xsd#exas_CONVERTIBLENOTESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesTextBlock_fe074810-b8b9-43f5-9f61-f84ade92957e" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CONVERTIBLENOTESAbstract_bdab67ba-e6cc-4149-9663-76779c408b4e" xlink:to="loc_exas_ConvertibleNotesTextBlock_fe074810-b8b9-43f5-9f61-f84ade92957e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESTables" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_CONVERTIBLENOTESAbstract_98b4df4a-b2a5-496c-a5c0-d935df382e8e" xlink:href="exas-20210930.xsd#exas_CONVERTIBLENOTESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_1f5f5284-5fc9-493f-baf4-1559d019d96c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CONVERTIBLENOTESAbstract_98b4df4a-b2a5-496c-a5c0-d935df382e8e" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_1f5f5284-5fc9-493f-baf4-1559d019d96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock_c4577006-87d3-42ed-92a3-799fd2c7bc73" xlink:href="exas-20210930.xsd#exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CONVERTIBLENOTESAbstract_98b4df4a-b2a5-496c-a5c0-d935df382e8e" xlink:to="loc_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock_c4577006-87d3-42ed-92a3-799fd2c7bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_InterestExpenseDebtTableTextBlock_b50b85df-5570-49c3-ae4c-a09186b79420" xlink:href="exas-20210930.xsd#exas_InterestExpenseDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CONVERTIBLENOTESAbstract_98b4df4a-b2a5-496c-a5c0-d935df382e8e" xlink:to="loc_exas_InterestExpenseDebtTableTextBlock_b50b85df-5570-49c3-ae4c-a09186b79420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESScheduleofConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_CONVERTIBLENOTESAbstract_2c44e9e6-c22d-4bb0-8610-c25d1b35fff9" xlink:href="exas-20210930.xsd#exas_CONVERTIBLENOTESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:href="exas-20210930.xsd#exas_ScheduleOfConvertibleNotesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CONVERTIBLENOTESAbstract_2c44e9e6-c22d-4bb0-8610-c25d1b35fff9" xlink:to="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d0a9f56-4797-473f-8564-32921570012b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f005bbd-aa88-4017-ad39-61adc029fea2" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d0a9f56-4797-473f-8564-32921570012b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_7995de6f-ff1f-4a7a-a2ef-a81d928b1b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3d0a9f56-4797-473f-8564-32921570012b" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_7995de6f-ff1f-4a7a-a2ef-a81d928b1b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:href="exas-20210930.xsd#exas_AggregateConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember_7995de6f-ff1f-4a7a-a2ef-a81d928b1b49" xlink:to="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member_c86b4abc-257c-4808-8167-8ad1d560593e" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:to="loc_exas_ConvertibleNotesPayable2028Member_c86b4abc-257c-4808-8167-8ad1d560593e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member_8bc59764-e589-4a5e-a63d-5a05cd989c6f" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:to="loc_exas_ConvertibleNotesPayable2027Member_8bc59764-e589-4a5e-a63d-5a05cd989c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member_2a160149-8fa2-4029-bdd7-c4cbf3def48a" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_882a86be-d0ee-4dd7-8727-64c1f516b365" xlink:to="loc_exas_ConvertibleNotesPayable2025Member_2a160149-8fa2-4029-bdd7-c4cbf3def48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_194bd5ac-a639-451e-8afe-728729f13e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_75b35011-892e-4252-882d-dc0b4472461d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_194bd5ac-a639-451e-8afe-728729f13e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9837ec25-9b29-49f6-a586-e3d965c2986e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_194bd5ac-a639-451e-8afe-728729f13e84" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9837ec25-9b29-49f6-a586-e3d965c2986e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_f1c96043-5786-4987-aff1-bd0f7ce89d70" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4d5c5ee1-7ef2-424a-86a7-87b3a9f6c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4d5c5ee1-7ef2-424a-86a7-87b3a9f6c70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f92d56c2-d060-4779-93c5-4f3f4a42adf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_3d44e4ab-17f7-4dd5-b6a0-2e25a9ce2ef6" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_f92d56c2-d060-4779-93c5-4f3f4a42adf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_3b7d9766-7206-46c3-a1c9-9e248a9fda47" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4922496f-8e78-4644-bb9c-7b3101e17c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4922496f-8e78-4644-bb9c-7b3101e17c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayableGross_e9484616-e057-4733-a96f-ce0f420d6a2a" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayableGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_exas_ConvertibleNotesPayableGross_e9484616-e057-4733-a96f-ce0f420d6a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4894070a-dbf5-4ff8-8740-07912278f6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_4894070a-dbf5-4ff8-8740-07912278f6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_e41cd0be-e97f-411e-a692-673d1c159c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_ConvertibleNotesPayable_e41cd0be-e97f-411e-a692-673d1c159c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fd0513d-e7ca-4ee5-a12b-e01f6e6ce2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2ae434a8-fbe5-4e77-a82f-b106e25f7c1b" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_1fd0513d-e7ca-4ee5-a12b-e01f6e6ce2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_CONVERTIBLENOTESAbstract_6358f5bb-b639-4bfd-81d9-92880e801608" xlink:href="exas-20210930.xsd#exas_CONVERTIBLENOTESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CONVERTIBLENOTESAbstract_6358f5bb-b639-4bfd-81d9-92880e801608" xlink:to="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:to="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0f9de16e-2912-41d2-9815-baf2c769765d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_99299173-ccd2-44d0-844a-d6e7316e45c3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0f9de16e-2912-41d2-9815-baf2c769765d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_b128302e-5c30-4453-9cbc-6aad0d5b6964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0f9de16e-2912-41d2-9815-baf2c769765d" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_b128302e-5c30-4453-9cbc-6aad0d5b6964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:href="exas-20210930.xsd#exas_AggregateConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember_b128302e-5c30-4453-9cbc-6aad0d5b6964" xlink:to="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_JanuaryNotesMember_876ae152-c54f-4d42-995d-5b88b6cfa876" xlink:href="exas-20210930.xsd#exas_JanuaryNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_JanuaryNotesMember_876ae152-c54f-4d42-995d-5b88b6cfa876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_JuneNotesMember_99fa140a-ce9b-4317-bc38-e8026d52af86" xlink:href="exas-20210930.xsd#exas_JuneNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_JuneNotesMember_99fa140a-ce9b-4317-bc38-e8026d52af86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2025Member_f21f24df-0a10-4663-ac92-29420a3746d7" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2025Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_ConvertibleNotesPayable2025Member_f21f24df-0a10-4663-ac92-29420a3746d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member_60157730-b8ef-4883-b80f-45e13ad55af2" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_ConvertibleNotesPayable2027Member_60157730-b8ef-4883-b80f-45e13ad55af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member_aefb389c-4d36-4c11-ab95-db08faa166ca" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_AggregateConvertibleNotesMember_8c7376b6-15bb-42e3-9627-66358b5367fe" xlink:to="loc_exas_ConvertibleNotesPayable2028Member_aefb389c-4d36-4c11-ab95-db08faa166ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_78a59a1d-4388-4445-a738-9cefeddb7d0e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b5180499-535b-46ba-abd7-a61f0c15fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b5180499-535b-46ba-abd7-a61f0c15fb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_68afac09-c7e8-4350-8154-326fde4b7423" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_68afac09-c7e8-4350-8154-326fde4b7423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3662768f-dc2c-4af3-9fee-686d23d38d49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3662768f-dc2c-4af3-9fee-686d23d38d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_0a8ebdcb-e31d-48a3-bf58-6e29274a0421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_0a8ebdcb-e31d-48a3-bf58-6e29274a0421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_a6e426c5-4c08-4848-92b2-9485f9470272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_a6e426c5-4c08-4848-92b2-9485f9470272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_17131fe5-b34b-4c11-98f7-d459536ed6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments_17131fe5-b34b-4c11-98f7-d459536ed6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_41d04474-8760-42ce-9f66-0127d656e819" xlink:href="exas-20210930.xsd#exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares_41d04474-8760-42ce-9f66-0127d656e819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_3f0c2340-171e-4f23-ac83-d8dc19d26970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_RepaymentsOfDebt_3f0c2340-171e-4f23-ac83-d8dc19d26970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_3ed74ca3-bbc9-41ce-b75d-aa4d7eab8ad6" xlink:href="exas-20210930.xsd#exas_DebtInstrumentConvertibleEquityComponentInterestAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued_3ed74ca3-bbc9-41ce-b75d-aa4d7eab8ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_66c275e0-ae6d-43d0-b539-1629e1687f36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_66c275e0-ae6d-43d0-b539-1629e1687f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentAmountSettledInExtinguishment_58b8a473-b9cb-40a7-9529-8e518aa9052d" xlink:href="exas-20210930.xsd#exas_DebtInstrumentAmountSettledInExtinguishment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_DebtInstrumentAmountSettledInExtinguishment_58b8a473-b9cb-40a7-9529-8e518aa9052d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c91946d9-6f9e-44a5-982a-182ce4fb107c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c91946d9-6f9e-44a5-982a-182ce4fb107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f609a790-50a3-4dd0-ac91-6fbadac40122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_f609a790-50a3-4dd0-ac91-6fbadac40122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_13f0f8ff-05b8-4712-8d86-d64f4aeba515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments_13f0f8ff-05b8-4712-8d86-d64f4aeba515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_f0dd8218-9619-41f5-a28e-b00c88618c67" xlink:href="exas-20210930.xsd#exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount_f0dd8218-9619-41f5-a28e-b00c88618c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_ed51260e-71aa-4e9f-951d-1ce68fda2b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_SharePrice_ed51260e-71aa-4e9f-951d-1ce68fda2b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_59445a9f-845c-4b0b-8bfc-41eba5002bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_59445a9f-845c-4b0b-8bfc-41eba5002bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_33e907ed-03c0-4e8e-a46c-3992668b4b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_33e907ed-03c0-4e8e-a46c-3992668b4b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_48813ae2-db85-4709-bfef-8f56769959cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ce7da131-85d5-4d96-9785-10ce13e2431b" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_48813ae2-db85-4709-bfef-8f56769959cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESScheduleofTransactionCostsDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_defd550b-cd61-49a9-8e3c-072f494bbccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:href="exas-20210930.xsd#exas_ScheduleOfConvertibleNotesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_defd550b-cd61-49a9-8e3c-072f494bbccd" xlink:to="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:to="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_432c4dd0-d0b0-4ccc-9884-d7183ed11c8b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_January2025NotesMember_e5445b7e-88a0-4c65-9698-cda739c34c23" xlink:href="exas-20210930.xsd#exas_January2025NotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_January2025NotesMember_e5445b7e-88a0-4c65-9698-cda739c34c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_June2025NotesMember_1136b78b-af4c-4702-9d6c-aa0c599beb83" xlink:href="exas-20210930.xsd#exas_June2025NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_June2025NotesMember_1136b78b-af4c-4702-9d6c-aa0c599beb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2027Member_447034e2-5fc4-47e3-961d-281ae44a247f" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_ConvertibleNotesPayable2027Member_447034e2-5fc4-47e3-961d-281ae44a247f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ConvertibleNotesPayable2028Member_3e756f82-f69f-43af-ab4c-de5fbab6cad3" xlink:href="exas-20210930.xsd#exas_ConvertibleNotesPayable2028Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_15fb523e-e4be-43f6-8180-9c7eae2eead9" xlink:to="loc_exas_ConvertibleNotesPayable2028Member_3e756f82-f69f-43af-ab4c-de5fbab6cad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4483401d-14fb-452c-873e-f93d853ba8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ScheduleOfConvertibleNotesTable_188691f6-6f4e-4af4-940f-327070bccfd4" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4483401d-14fb-452c-873e-f93d853ba8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DebtInstrumentConvertibleTransactionCosts_bbafb3c6-6f01-4b8c-a6d7-a087d7471134" xlink:href="exas-20210930.xsd#exas_DebtInstrumentConvertibleTransactionCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4483401d-14fb-452c-873e-f93d853ba8fe" xlink:to="loc_exas_DebtInstrumentConvertibleTransactionCosts_bbafb3c6-6f01-4b8c-a6d7-a087d7471134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#CONVERTIBLENOTESSummaryofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_d692cb9d-f18d-4af4-a88f-452dd06f9c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_d692cb9d-f18d-4af4-a88f-452dd06f9c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9c1746f4-757e-4b76-8cd5-9477abcc0252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9c1746f4-757e-4b76-8cd5-9477abcc0252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a412572-b247-4079-944e-caf543e59b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3a412572-b247-4079-944e-caf543e59b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CouponInterestExpense_26d5be44-4279-4698-9be5-1b0b96404b09" xlink:href="exas-20210930.xsd#exas_CouponInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_exas_CouponInterestExpense_26d5be44-4279-4698-9be5-1b0b96404b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_dc89ecb5-4f42-4ceb-943b-c0be67daa985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_us-gaap_InterestExpenseDebt_dc89ecb5-4f42-4ceb-943b-c0be67daa985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_691878ba-e223-467d-b920-61fa34a2cf1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_us-gaap_InterestExpenseOther_691878ba-e223-467d-b920-61fa34a2cf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_f4211db5-20c6-44d7-93f3-4c2bddc64f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b5311991-d41f-4d27-898a-c24ab8861fdb" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_f4211db5-20c6-44d7-93f3-4c2bddc64f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS" xlink:type="simple" xlink:href="exas-20210930.xsd#LICENSEANDCOLLABORATIONAGREEMENTS"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_LICENSEAGREEMENTSAbstract_9fe6a65b-64e1-47b4-a1e4-edbe8c2bd3b8" xlink:href="exas-20210930.xsd#exas_LICENSEAGREEMENTSAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LicensingAgreementDisclosureTextBlock_0ff92262-335a-43f4-83ae-621219a4ef8c" xlink:href="exas-20210930.xsd#exas_LicensingAgreementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_LICENSEAGREEMENTSAbstract_9fe6a65b-64e1-47b4-a1e4-edbe8c2bd3b8" xlink:to="loc_exas_LicensingAgreementDisclosureTextBlock_0ff92262-335a-43f4-83ae-621219a4ef8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_LICENSEAGREEMENTSAbstract_89ced6fe-b794-40e9-9555-f72a6dc7fef9" xlink:href="exas-20210930.xsd#exas_LICENSEAGREEMENTSAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_LICENSEAGREEMENTSAbstract_89ced6fe-b794-40e9-9555-f72a6dc7fef9" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1b5f4e05-9cfa-496c-8db0-1d3c25d10cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e7680e66-88d9-436a-bbea-3ae376d586ba" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1b5f4e05-9cfa-496c-8db0-1d3c25d10cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_a8948d61-e13c-4a3f-b2ce-ff7ec3bc62ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1b5f4e05-9cfa-496c-8db0-1d3c25d10cd3" xlink:to="loc_us-gaap_LicensingAgreementsMember_a8948d61-e13c-4a3f-b2ce-ff7ec3bc62ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cbdd944e-d9f7-4879-9d51-cb39be8a259f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e7116111-1343-456e-b769-8a6707d9255b" xlink:to="loc_dei_EntityDomain_cbdd944e-d9f7-4879-9d51-cb39be8a259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MAYOFoundationMember_ee45b212-fe9c-4ae6-848a-476349fa629c" xlink:href="exas-20210930.xsd#exas_MAYOFoundationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_cbdd944e-d9f7-4879-9d51-cb39be8a259f" xlink:to="loc_exas_MAYOFoundationMember_ee45b212-fe9c-4ae6-848a-476349fa629c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e04eb3a9-4a03-4d54-a2a0-d5fc5fb2324f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_263c89ac-4416-4341-ac71-99cdb16faaed" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e04eb3a9-4a03-4d54-a2a0-d5fc5fb2324f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MAYOFoundationMember_eb4c807b-1257-476f-9209-90d77e5f7c38" xlink:href="exas-20210930.xsd#exas_MAYOFoundationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e04eb3a9-4a03-4d54-a2a0-d5fc5fb2324f" xlink:to="loc_exas_MAYOFoundationMember_eb4c807b-1257-476f-9209-90d77e5f7c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_4ff887b0-e036-4f6c-8bdb-ac67a9b34e64" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LicenseAgreementFeesCommitment_0d1eae56-2171-4a52-8f48-e45e41a6608d" xlink:href="exas-20210930.xsd#exas_LicenseAgreementFeesCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:to="loc_exas_LicenseAgreementFeesCommitment_0d1eae56-2171-4a52-8f48-e45e41a6608d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_29770fae-b8cf-4c22-bc4e-000ce9aff839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_cdabbbfa-478b-44db-8136-ed08f0d9b25f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_29770fae-b8cf-4c22-bc4e-000ce9aff839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7f508db2-9d3e-4157-8117-35c42977aab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_7f508db2-9d3e-4157-8117-35c42977aab1" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_c281ba92-593c-4568-8ca8-afda75f8ee3c" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeOneMember_64a6c311-65f3-436b-a7cf-102efe1466c8" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:to="loc_exas_SalesMilestoneRangeOneMember_64a6c311-65f3-436b-a7cf-102efe1466c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeTwoMember_7df613ec-e977-4a5a-8484-1294b294f0f3" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:to="loc_exas_SalesMilestoneRangeTwoMember_7df613ec-e977-4a5a-8484-1294b294f0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeThreeMember_89a25eed-5b36-40a4-abcf-cfd837e74060" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_922d6037-8a88-4d9a-9510-391a50a28719" xlink:to="loc_exas_SalesMilestoneRangeThreeMember_89a25eed-5b36-40a4-abcf-cfd837e74060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62e3081b-7cee-496c-85c2-9ba0fad40158" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f987c38f-bfe3-4801-b9ee-4c2be8017ff3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62e3081b-7cee-496c-85c2-9ba0fad40158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_4594a00d-37e2-420c-b353-02c4edc54e4b" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_62e3081b-7cee-496c-85c2-9ba0fad40158" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_4594a00d-37e2-420c-b353-02c4edc54e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a982cf0d-d041-4382-b88a-0d661bed891b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8227553f-a890-45e8-b181-199977d334aa" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a982cf0d-d041-4382-b88a-0d661bed891b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_f2f5c762-f1fb-46ee-97a1-3aae27fa7544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a982cf0d-d041-4382-b88a-0d661bed891b" xlink:to="loc_us-gaap_LicensingAgreementsMember_f2f5c762-f1fb-46ee-97a1-3aae27fa7544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_696d2386-6d01-4d74-bcbe-64d7ac72ccf1" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsContingentOnMilestonesPayable_e83819ef-8119-41f1-920e-8438c941fd0c" xlink:href="exas-20210930.xsd#exas_PaymentsContingentOnMilestonesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:to="loc_exas_PaymentsContingentOnMilestonesPayable_e83819ef-8119-41f1-920e-8438c941fd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_48a23349-816e-4b2a-823a-49512fa8dc8f" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_a36dcd01-3b92-44bd-bd22-5a30e8e9b4ef" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_48a23349-816e-4b2a-823a-49512fa8dc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT" xlink:type="simple" xlink:href="exas-20210930.xsd#PFIZERPROMOTIONAGREEMENT"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_PromotionAgreementDisclosureAbstract_77284033-81c6-45c6-967e-66e121548ac4" xlink:href="exas-20210930.xsd#exas_PromotionAgreementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ee83b05d-d8ff-403f-be87-6ed3a63efa44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_PromotionAgreementDisclosureAbstract_77284033-81c6-45c6-967e-66e121548ac4" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_ee83b05d-d8ff-403f-be87-6ed3a63efa44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#PFIZERPROMOTIONAGREEMENTDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_PromotionAgreementDisclosureAbstract_e77734bd-b24f-4667-bdca-add73d78363c" xlink:href="exas-20210930.xsd#exas_PromotionAgreementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_PromotionAgreementDisclosureAbstract_e77734bd-b24f-4667-bdca-add73d78363c" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:to="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_93ce06a9-8a19-4b87-98c3-735a01c9b3b6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_422f677e-9992-4664-a510-95a5388a79c3" xlink:to="loc_dei_EntityDomain_93ce06a9-8a19-4b87-98c3-735a01c9b3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PfizerIncMember_7ada2000-debb-4ede-979b-66448e6e4bf4" xlink:href="exas-20210930.xsd#exas_PfizerIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_93ce06a9-8a19-4b87-98c3-735a01c9b3b6" xlink:to="loc_exas_PfizerIncMember_7ada2000-debb-4ede-979b-66448e6e4bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b853fd2d-7fdc-4ea2-96f6-74db7d25cc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ef0db40a-d130-4ebd-8c79-faabc5e42e81" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b853fd2d-7fdc-4ea2-96f6-74db7d25cc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember_4cf4134c-f644-4ada-8324-1e5055aacaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b853fd2d-7fdc-4ea2-96f6-74db7d25cc2b" xlink:to="loc_us-gaap_ManufacturedProductOtherMember_4cf4134c-f644-4ada-8324-1e5055aacaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_273dc708-27c0-4c0b-81ec-b82b4e12216c" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_9a26b87d-b3a2-45a0-9e43-d4fdc58bdd67" xlink:href="exas-20210930.xsd#exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:to="loc_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties_9a26b87d-b3a2-45a0-9e43-d4fdc58bdd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense_a9851f8e-74ac-416a-968b-bdd3d016cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f9041c78-3bc5-4579-903e-64a18eb03aa5" xlink:to="loc_us-gaap_MarketingExpense_a9851f8e-74ac-416a-968b-bdd3d016cad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f388f2fa-1f40-4a65-80dd-a0eadec1873e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5bcb837a-3ce2-4858-bda7-ac30b4f63224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f388f2fa-1f40-4a65-80dd-a0eadec1873e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5bcb837a-3ce2-4858-bda7-ac30b4f63224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3b1409aa-6fab-47cd-9f62-e52c369150ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a8ac5b4a-dba8-46a3-89cd-896cdcd34876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b1409aa-6fab-47cd-9f62-e52c369150ca" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a8ac5b4a-dba8-46a3-89cd-896cdcd34876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_77844f66-2d37-4234-bd87-8beed21ba09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b1409aa-6fab-47cd-9f62-e52c369150ca" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_77844f66-2d37-4234-bd87-8beed21ba09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7b271e42-6b71-4372-acdd-5163d0fbde3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7b271e42-6b71-4372-acdd-5163d0fbde3e" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_fe1473e2-ef74-4729-a3d8-cf61e4c88dc4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_d1a5327c-9539-400a-aa95-286120209e95" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:to="loc_exas_AshionAnalyticsMember_d1a5327c-9539-400a-aa95-286120209e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_623ab6bd-8c1d-4729-b6b6-db0f8facf3e1" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_623ab6bd-8c1d-4729-b6b6-db0f8facf3e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_dfc4b103-6239-4ee5-94a1-43849c8ef3b2" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_101ed99b-4bfa-4ac3-9ee5-7a8cc69c87b6" xlink:to="loc_exas_ParadigmViomicsMember_dfc4b103-6239-4ee5-94a1-43849c8ef3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:to="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_b96d084c-2113-405d-a8a0-dce716e35c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_856da2e9-11e5-40a6-bb2a-8cb1049c5bc6" xlink:to="loc_us-gaap_AssetAcquisitionDomain_b96d084c-2113-405d-a8a0-dce716e35c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TARDISTechnologyMember_0aa0de88-7179-4a3e-8cec-493a6a5fe482" xlink:href="exas-20210930.xsd#exas_TARDISTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_b96d084c-2113-405d-a8a0-dce716e35c72" xlink:to="loc_exas_TARDISTechnologyMember_0aa0de88-7179-4a3e-8cec-493a6a5fe482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_dc466618-364c-4e07-8bc3-07de0b529c87" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f2153d51-f6da-45b6-b8e5-05418d6cf387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_f2153d51-f6da-45b6-b8e5-05418d6cf387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_afd6ea65-55ca-4d06-b5db-7e7bfd1e45ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_afd6ea65-55ca-4d06-b5db-7e7bfd1e45ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_31f0cffe-2208-4568-a46c-312a4f7641d7" xlink:href="exas-20210930.xsd#exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_31f0cffe-2208-4568-a46c-312a4f7641d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_8bb4420a-0a2f-4f87-8e74-191f5b8e2144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_8bb4420a-0a2f-4f87-8e74-191f5b8e2144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e04808c2-95c3-44c5-a486-8fb82e48a744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e04808c2-95c3-44c5-a486-8fb82e48a744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1f720d61-be5e-4b5d-9f49-45754167bed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1f720d61-be5e-4b5d-9f49-45754167bed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d35e6f-901f-48d5-8205-cbd8658acf61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f9d35e6f-901f-48d5-8205-cbd8658acf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_be62fb59-7fc1-454a-a328-c2b3be71e139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_7ce5c02d-0068-43fe-863f-5680c2350148" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_be62fb59-7fc1-454a-a328-c2b3be71e139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYScheduleofOCIDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f4325331-addc-4cd7-ad62-29d1b3f0a8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f4325331-addc-4cd7-ad62-29d1b3f0a8e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9a18f55e-69a1-4acb-8217-3409328e5bd7" xlink:to="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ad65573-7d66-4403-ad80-2613c0576963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_4ad65573-7d66-4403-ad80-2613c0576963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_de96ee27-fd2a-49f3-815e-5675cebc7b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_de96ee27-fd2a-49f3-815e-5675cebc7b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d5febe82-d861-41d1-af2d-2fbd0d8c2fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_01aec9a2-94c6-4af5-be5c-5e6c00f72f02" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_d5febe82-d861-41d1-af2d-2fbd0d8c2fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_860e89c7-2b51-4495-96f5-98a71463e6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20284625-07eb-4b88-8d33-e7823869a707" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_860e89c7-2b51-4495-96f5-98a71463e6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_860e89c7-2b51-4495-96f5-98a71463e6bc" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_01d63e68-5366-4266-ab7c-aea099949b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_StockholdersEquity_01d63e68-5366-4266-ab7c-aea099949b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_78823277-498a-4808-91ac-5f9e173d352e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_78823277-498a-4808-91ac-5f9e173d352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_24160e05-df74-4f4e-9913-18110f3c8185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent_24160e05-df74-4f4e-9913-18110f3c8185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1e78cf8a-cb7a-4057-919b-8c24339d6390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1e78cf8a-cb7a-4057-919b-8c24339d6390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_27df58db-bf42-463d-9259-8835724f4abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_27df58db-bf42-463d-9259-8835724f4abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16ac6194-2f0a-4cd0-a396-174ce967827b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_d988db6d-559f-49a3-9529-cd37d6612219" xlink:to="loc_us-gaap_StockholdersEquity_16ac6194-2f0a-4cd0-a396-174ce967827b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d4330c8c-2bae-4d66-95aa-e266207bf34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d4330c8c-2bae-4d66-95aa-e266207bf34f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bad41ecf-2634-4365-a032-dd84d767ec7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_48643877-ffc0-44ef-b792-9705a1958b73" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bad41ecf-2634-4365-a032-dd84d767ec7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_a87ba4f5-4542-4c3f-ad23-f4196f1a84b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_bad41ecf-2634-4365-a032-dd84d767ec7f" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_a87ba4f5-4542-4c3f-ad23-f4196f1a84b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_af1182fa-e865-4667-a271-b14fc36b9183" xlink:to="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_68c65bf9-9f18-4e33-b36e-47aa24031b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_68c65bf9-9f18-4e33-b36e-47aa24031b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4b281882-ba9f-476c-abb8-0b6fdcbfc647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_920e417a-8c61-43b9-ba6d-82f2495f0139" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4b281882-ba9f-476c-abb8-0b6fdcbfc647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e4875c72-41a8-4347-8420-b7579215296c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_3de2d7bc-b794-478d-9e55-c7dfec60c96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_3de2d7bc-b794-478d-9e55-c7dfec60c96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1ad23cb1-8276-4696-bd41-c6ba62349aba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1ad23cb1-8276-4696-bd41-c6ba62349aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b05d9166-cb34-4db5-b740-68b13af50309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_96120f07-4b73-48e3-a37c-e8ae60e8fff1" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_b05d9166-cb34-4db5-b740-68b13af50309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8ca3cb6e-1109-4a67-9b7f-a5b86a5690dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f8b56806-2983-4831-b24d-660a5ef1ac2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8ca3cb6e-1109-4a67-9b7f-a5b86a5690dc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f8b56806-2983-4831-b24d-660a5ef1ac2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f898a5db-0e5a-4496-82b0-227e2649bca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_eccf4da4-83da-4ddb-a8e7-997b76b9c917" xlink:href="exas-20210930.xsd#exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f898a5db-0e5a-4496-82b0-227e2649bca2" xlink:to="loc_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_eccf4da4-83da-4ddb-a8e7-997b76b9c917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_84c723e7-d95f-43d1-9cad-d15f60ebf5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f898a5db-0e5a-4496-82b0-227e2649bca2" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_84c723e7-d95f-43d1-9cad-d15f60ebf5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_1e82f22a-2c0a-42d1-a786-bb82a0490456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f898a5db-0e5a-4496-82b0-227e2649bca2" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_1e82f22a-2c0a-42d1-a786-bb82a0490456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_76da31ce-e004-4c45-bb55-99a3ab2accb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f898a5db-0e5a-4496-82b0-227e2649bca2" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_76da31ce-e004-4c45-bb55-99a3ab2accb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a8b24d2-3e19-4e47-ad6b-07a96db91e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a8b24d2-3e19-4e47-ad6b-07a96db91e45" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3545ac0f-0952-4707-975e-d2d8bc8bd321" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember_6444e4b8-fd80-4016-9842-09c48201d73c" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:to="loc_exas_EmployeeAndNonEmployeesStockOptionMember_6444e4b8-fd80-4016-9842-09c48201d73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_074bd722-6a9a-4121-a13e-bb33f2f0900f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fcf6ac2-fc7f-44eb-8afb-92d7653fbad2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_074bd722-6a9a-4121-a13e-bb33f2f0900f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_637544f3-0f3b-42ba-8dc7-b79f70b71d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a720cc30-683d-4151-87af-d80faebef122" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_637544f3-0f3b-42ba-8dc7-b79f70b71d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_bbed7414-afd4-4830-a688-f5277c4fb5bd" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_637544f3-0f3b-42ba-8dc7-b79f70b71d3d" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_bbed7414-afd4-4830-a688-f5277c4fb5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_af02b9d8-df4c-4499-8ef1-92d488bae62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_94ec66cb-4c35-4e61-bc9d-09d6e3bd7639" xlink:to="loc_us-gaap_PlanNameDomain_af02b9d8-df4c-4499-8ef1-92d488bae62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_StockBasedCompensationPlansMember_65e9ab96-a72c-4079-b385-d44544b1f6aa" xlink:href="exas-20210930.xsd#exas_StockBasedCompensationPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_af02b9d8-df4c-4499-8ef1-92d488bae62d" xlink:to="loc_exas_StockBasedCompensationPlansMember_65e9ab96-a72c-4079-b385-d44544b1f6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d0769a58-aad5-4068-8cc3-bafc1c773596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ba9a6999-5afd-47f2-b696-7bef7d2a7870" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d0769a58-aad5-4068-8cc3-bafc1c773596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4abc2c2a-7f63-4a13-8c6b-0c00f3af38fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d0769a58-aad5-4068-8cc3-bafc1c773596" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_4abc2c2a-7f63-4a13-8c6b-0c00f3af38fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5095f432-7c8c-4075-a537-b9d0735d0a24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_be7f43ba-6ddf-4122-b310-f2338926cf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_be7f43ba-6ddf-4122-b310-f2338926cf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0014e3ae-d9c4-4a0c-ad83-8dd2b74e294f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0014e3ae-d9c4-4a0c-ad83-8dd2b74e294f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d541832-f150-4eb5-9312-b01281ab8f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d541832-f150-4eb5-9312-b01281ab8f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_5b8efa62-1de5-4283-b821-8b8eb6e98a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_5b8efa62-1de5-4283-b821-8b8eb6e98a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9659d109-a365-4a4e-bba6-6d1df3e92bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ShareBasedCompensation_9659d109-a365-4a4e-bba6-6d1df3e92bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_78b9a738-8e90-4a0f-8187-d7f5ab475e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_78b9a738-8e90-4a0f-8187-d7f5ab475e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9aa7460e-f856-4bb3-bc0a-aa445de34932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_346b6080-b7cb-40a5-b477-b96226bdae7d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9aa7460e-f856-4bb3-bc0a-aa445de34932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#STOCKBASEDCOMPENSATIONFairValueandActivityDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b0020b0-ac37-4815-b837-7cb457754a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5b0020b0-ac37-4815-b837-7cb457754a1c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_2334fa44-a62b-4b47-96ad-f43f637291fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_da2d0c18-cd05-4b11-9255-aec67bad6281" xlink:to="loc_us-gaap_PlanNameDomain_2334fa44-a62b-4b47-96ad-f43f637291fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_StockBasedCompensationPlansMember_194f1cc4-6b0a-4d79-ac53-10c899234508" xlink:href="exas-20210930.xsd#exas_StockBasedCompensationPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_2334fa44-a62b-4b47-96ad-f43f637291fa" xlink:to="loc_exas_StockBasedCompensationPlansMember_194f1cc4-6b0a-4d79-ac53-10c899234508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4d545def-1c57-4cf9-bbe6-39955c735366" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeeAndNonEmployeesStockOptionMember_1e9c1dd0-93c8-40e2-b4af-3bc7ad6ee5d2" xlink:href="exas-20210930.xsd#exas_EmployeeAndNonEmployeesStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_exas_EmployeeAndNonEmployeesStockOptionMember_1e9c1dd0-93c8-40e2-b4af-3bc7ad6ee5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_c9c89168-c8f6-49fa-a1d9-5c3a7fc13f14" xlink:href="exas-20210930.xsd#exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember_c9c89168-c8f6-49fa-a1d9-5c3a7fc13f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_799044a2-d348-41ea-bd7f-42d94045e4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_799044a2-d348-41ea-bd7f-42d94045e4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_34b667e2-75e5-4ec8-83a6-9df0b76bd2eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_us-gaap_PerformanceSharesMember_34b667e2-75e5-4ec8-83a6-9df0b76bd2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a7eae26a-14f4-4327-b4b8-c2c53e808a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_21460f40-d587-4e63-b0ae-61ce2049f1f4" xlink:to="loc_us-gaap_EmployeeStockMember_a7eae26a-14f4-4327-b4b8-c2c53e808a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c5fdc8e8-8da1-44d4-bd85-bc93a49c3c18" xlink:to="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_800344b5-d962-4aa8-8176-410d61938408" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:to="loc_srt_MinimumMember_800344b5-d962-4aa8-8176-410d61938408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4a7f013d-70be-4ab2-ae23-282f45aeaa14" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db1c3bce-ea29-435a-8568-c7e53b40df7c" xlink:to="loc_srt_MaximumMember_4a7f013d-70be-4ab2-ae23-282f45aeaa14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ff1aa310-4d31-4a3b-a970-78216bcd9d9f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_36d29e56-8846-499a-bd1c-8f1a30265e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_36d29e56-8846-499a-bd1c-8f1a30265e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d6892062-4012-48bb-b852-155863b073b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d6892062-4012-48bb-b852-155863b073b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a5a8a930-eda1-4129-b49b-f4fbafe24743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_a5a8a930-eda1-4129-b49b-f4fbafe24743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5f5362a0-60af-4cd0-be9f-f864a01b00f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5f5362a0-60af-4cd0-be9f-f864a01b00f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_9d721448-a946-4f77-9fb7-f2b427a59310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_9d721448-a946-4f77-9fb7-f2b427a59310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cdb86395-d9ac-4012-99a6-b9dc9d77bc44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_508138c2-68ff-4876-80e2-052aa7f991b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_cdb86395-d9ac-4012-99a6-b9dc9d77bc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ef9c7251-710f-4746-bdce-cbad78a89857" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ef9c7251-710f-4746-bdce-cbad78a89857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_597c8f34-9c7f-4c5a-a131-2ff6ace9c62f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_597c8f34-9c7f-4c5a-a131-2ff6ace9c62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_ad5b589f-b9f9-4028-b820-2f83ec7c34f6" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions_ad5b589f-b9f9-4028-b820-2f83ec7c34f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4773232-fb62-47d5-bf99-ffdc1f0d4114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b4773232-fb62-47d5-bf99-ffdc1f0d4114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8229f088-51bb-4708-9086-c898ba865a32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8229f088-51bb-4708-9086-c898ba865a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1c1872d6-c7ef-49b9-99a5-eb1a428ecdb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_452c9d8f-e79c-423b-b7e5-eadeba96f7bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1c1872d6-c7ef-49b9-99a5-eb1a428ecdb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_94895410-0ed8-4760-9115-8a1c155bf908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_94895410-0ed8-4760-9115-8a1c155bf908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b0fb4a9-1e09-44ff-8744-7c6ab800966a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b0fb4a9-1e09-44ff-8744-7c6ab800966a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6626eb3b-9a40-48ef-aac4-a7aa03244047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6626eb3b-9a40-48ef-aac4-a7aa03244047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bc9d883f-161d-44e9-b935-136ea72b2144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bc9d883f-161d-44e9-b935-136ea72b2144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_e0f8cef6-8a02-4a30-be4b-02bba016d1bd" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice_e0f8cef6-8a02-4a30-be4b-02bba016d1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a388422c-dbf1-4fcd-af53-23be7c1ec5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_a388422c-dbf1-4fcd-af53-23be7c1ec5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c0426886-b7db-427d-9ba8-fca31ed38559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c0426886-b7db-427d-9ba8-fca31ed38559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_611fb478-82c8-4ad3-a52f-c3464811e2a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0dcae4ed-48fe-4b52-88da-0db5dd8c7b22" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_611fb478-82c8-4ad3-a52f-c3464811e2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_98398a52-bc99-46d1-8694-aba5288b9a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_98398a52-bc99-46d1-8694-aba5288b9a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d26482b6-b2c3-4476-9301-930d0227beb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_d26482b6-b2c3-4476-9301-930d0227beb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a809a8c0-9c18-4af8-b2d9-380d592d6adc" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a809a8c0-9c18-4af8-b2d9-380d592d6adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dbe4bb95-ce80-4e22-a3a5-45b550c3c287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_a809a8c0-9c18-4af8-b2d9-380d592d6adc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dbe4bb95-ce80-4e22-a3a5-45b550c3c287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dd1a8b07-1481-4b72-b6ce-f3fbf0a99bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dd1a8b07-1481-4b72-b6ce-f3fbf0a99bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a5086402-2df2-4549-a41d-cd6f0072337f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a5086402-2df2-4549-a41d-cd6f0072337f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_11417408-46cc-4667-b27f-f3dda4ef57f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_11417408-46cc-4667-b27f-f3dda4ef57f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_11384a73-a2cb-4e50-8d64-d7d8b1a5f267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_11384a73-a2cb-4e50-8d64-d7d8b1a5f267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_454f0f6e-523e-4d5d-a86a-be8a4f03f05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_03f81543-8933-47cd-b3b4-466fa7c37ce7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_454f0f6e-523e-4d5d-a86a-be8a4f03f05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e2bd0239-4e64-4b87-89e6-3c0ad467fb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e2bd0239-4e64-4b87-89e6-3c0ad467fb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_79b66b33-0ca4-4927-b525-3ce11199c9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_79b66b33-0ca4-4927-b525-3ce11199c9a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81780f3d-caee-4cb4-a159-60de9653c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81780f3d-caee-4cb4-a159-60de9653c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_735185a6-79e1-46a3-9849-937b54bffda9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_735185a6-79e1-46a3-9849-937b54bffda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_fa19176f-dd3f-41c4-a09f-a312aff68eb3" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions_fa19176f-dd3f-41c4-a09f-a312aff68eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23b0ea87-34d7-40a0-89db-cf27cbe35eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_23b0ea87-34d7-40a0-89db-cf27cbe35eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ea43c96f-0ee9-49cd-ae7a-243eee03ad53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ea43c96f-0ee9-49cd-ae7a-243eee03ad53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7820b4b8-fe97-4782-928c-5ba1f08ee2a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_730640f2-22a8-48b3-a787-8ae19cf76d1c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7820b4b8-fe97-4782-928c-5ba1f08ee2a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_75e45f9f-eea1-47e4-9526-218c47adb94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_75e45f9f-eea1-47e4-9526-218c47adb94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_601857bd-74f7-4999-b76a-568522a19deb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_601857bd-74f7-4999-b76a-568522a19deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_397cefe1-1567-4377-b165-a7dbf34bd793" xlink:href="exas-20210930.xsd#exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue_397cefe1-1567-4377-b165-a7dbf34bd793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0128dd33-ad97-4bed-ac71-861a5682e44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0128dd33-ad97-4bed-ac71-861a5682e44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a93fe2f-0eff-45ee-b1b6-45d3e8332cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9a93fe2f-0eff-45ee-b1b6-45d3e8332cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7aecb443-b73f-4b8e-9027-445de26dcfcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b57efe35-3f85-4108-98da-46414ef483e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7aecb443-b73f-4b8e-9027-445de26dcfcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_83ff885b-f01d-48de-b1be-fd9c5b87ed34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_83ff885b-f01d-48de-b1be-fd9c5b87ed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_17b13a38-ceda-40bc-ba90-ad24e8e99828" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f9c2cea-b731-4b0e-8bb9-57d8e01d1eb4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_17b13a38-ceda-40bc-ba90-ad24e8e99828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="exas-20210930.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ac22c8d7-30bb-4c82-b33b-622f788d79d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0fa62d05-ae17-468f-b965-17e2900ebaca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ac22c8d7-30bb-4c82-b33b-622f788d79d6" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0fa62d05-ae17-468f-b965-17e2900ebaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="simple" xlink:href="exas-20210930.xsd#COMMITMENTSANDCONTINGENCIESTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80091fa1-1fd7-45ac-8edc-cece07ab54af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_58416246-09fc-4ca1-b19a-95d6b31f5cd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_80091fa1-1fd7-45ac-8edc-cece07ab54af" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_58416246-09fc-4ca1-b19a-95d6b31f5cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6c72ccd-0122-4370-9a38-05b6d8669ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6c72ccd-0122-4370-9a38-05b6d8669ef7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8c4f118-73fe-4716-8510-6537642f3825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2a4f5fb-d994-49bc-9725-22fa2cc57a34" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8c4f118-73fe-4716-8510-6537642f3825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_5e698e4d-b178-41df-82e9-da129259c64e" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c8c4f118-73fe-4716-8510-6537642f3825" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_5e698e4d-b178-41df-82e9-da129259c64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b42b91b7-164b-4f86-8a9c-0d5d3dd452fa" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowOperatingActivitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_7b1e19eb-6191-48e7-b872-9b71903b0688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:to="loc_us-gaap_OperatingLeasePayments_7b1e19eb-6191-48e7-b872-9b71903b0688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_5523728d-a614-4fc0-a7cf-3273957d8478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_5523728d-a614-4fc0-a7cf-3273957d8478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_248105d6-db1d-4ec5-b9c2-9e4710dc08d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowOperatingActivitiesLesseeAbstract_5daab6af-a657-402d-a212-8571be00ec13" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_248105d6-db1d-4ec5-b9c2-9e4710dc08d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7b67c9e6-2aec-4881-b53a-69b6b802c61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_7b67c9e6-2aec-4881-b53a-69b6b802c61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ef2616e1-d524-414d-82d8-00ea84552f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_64adfe77-2e95-494d-8683-29b7ed8e6f1c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ef2616e1-d524-414d-82d8-00ea84552f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4b356db5-8394-47b3-a798-54696b39c55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_4b356db5-8394-47b3-a798-54696b39c55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66f29438-df0d-4246-b110-8069666c168a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_66f29438-df0d-4246-b110-8069666c168a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f9455bbf-bf1c-4e68-978a-c56a9858a1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f9455bbf-bf1c-4e68-978a-c56a9858a1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ba3e1128-ece4-40aa-b218-403c1a23b586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_6bed28dc-2392-45e7-b15f-e095c16ed660" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ba3e1128-ece4-40aa-b218-403c1a23b586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c895c17-796a-41d6-88b6-5def8819caf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c895c17-796a-41d6-88b6-5def8819caf3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb47d7e-11da-46cc-b30a-dd86648a404a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d55e3360-27c0-400a-a3de-6d9be9edbc11" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb47d7e-11da-46cc-b30a-dd86648a404a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FacilityInLaJollaCAMember_10f33cf0-a0aa-4c68-96af-7ef83c25a1ef" xlink:href="exas-20210930.xsd#exas_FacilityInLaJollaCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1cb47d7e-11da-46cc-b30a-dd86648a404a" xlink:to="loc_exas_FacilityInLaJollaCAMember_10f33cf0-a0aa-4c68-96af-7ef83c25a1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:to="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_30e16a99-3f0a-4d55-88d5-6172926e151e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9ca30bb3-c382-41ce-b060-94b54ab6cfcb" xlink:to="loc_srt_LitigationCaseTypeDomain_30e16a99-3f0a-4d55-88d5-6172926e151e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_DOSRuleInvestigationMember_bb67b6c9-b316-4071-886e-eea4669b9ab2" xlink:href="exas-20210930.xsd#exas_DOSRuleInvestigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_30e16a99-3f0a-4d55-88d5-6172926e151e" xlink:to="loc_exas_DOSRuleInvestigationMember_bb67b6c9-b316-4071-886e-eea4669b9ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a4364186-7388-40c9-b91f-ba0c3e6c3eac" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8422672e-26f5-474e-8b0a-c315a83c57dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8422672e-26f5-474e-8b0a-c315a83c57dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_88f78c11-8884-4831-8161-c3693a778c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseLiability_88f78c11-8884-4831-8161-c3693a778c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d767ae2a-6f43-4540-8c6d-1ee67180f2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d767ae2a-6f43-4540-8c6d-1ee67180f2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3abaa8e6-5348-4897-87b9-8f5f05ba8b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3abaa8e6-5348-4897-87b9-8f5f05ba8b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_ed80a1e3-5238-4113-a82e-95f061dba384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_ed80a1e3-5238-4113-a82e-95f061dba384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7cb1ded6-d1d0-4e5f-8945-245d6ec7436c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_7cb1ded6-d1d0-4e5f-8945-245d6ec7436c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_ccd60e60-bffb-44b2-92da-bfc96d671de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiability_ccd60e60-bffb-44b2-92da-bfc96d671de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_b79f54a2-42dd-40d2-bc4f-012c28fb18e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_b79f54a2-42dd-40d2-bc4f-012c28fb18e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1f8247a5-b253-4cb3-a563-8805f70e0146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_1f8247a5-b253-4cb3-a563-8805f70e0146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8113ad43-3fb2-492e-adec-2185a02d3dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_8113ad43-3fb2-492e-adec-2185a02d3dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_77a94634-5966-48e2-af17-fe1308423c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_77a94634-5966-48e2-af17-fe1308423c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_8d9260cd-0343-4604-bce3-577592bbd32b" xlink:href="exas-20210930.xsd#exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset_8d9260cd-0343-4604-bce3-577592bbd32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_cadde35a-7319-40fa-8c3e-53d3f233f64e" xlink:href="exas-20210930.xsd#exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability_cadde35a-7319-40fa-8c3e-53d3f233f64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_423288de-263f-435e-956b-a2759d1fc2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_LitigationReserve_423288de-263f-435e-956b-a2759d1fc2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_43ecb68c-8eb0-4e9b-9e7e-06f8d12d770b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2fc49374-1e48-4b5e-8906-e1f3e5261ee9" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_43ecb68c-8eb0-4e9b-9e7e-06f8d12d770b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/NEWMARKETTAXCREDIT" xlink:type="simple" xlink:href="exas-20210930.xsd#NEWMARKETTAXCREDIT"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/NEWMARKETTAXCREDIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditAbstract_b37978d8-4dc7-4cd3-aff4-c85343edf531" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditTextBlock_5a313a37-47a9-4416-b3a0-29903062c5aa" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_NewMarketTaxCreditAbstract_b37978d8-4dc7-4cd3-aff4-c85343edf531" xlink:to="loc_exas_NewMarketTaxCreditTextBlock_5a313a37-47a9-4416-b3a0-29903062c5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#NEWMARKETTAXCREDITDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditAbstract_8391e182-33f3-4a5d-8c11-e346874a4ea5" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_NewMarketTaxCreditAbstract_8391e182-33f3-4a5d-8c11-e346874a4ea5" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:to="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_8f683a65-3af1-4b7e-84de-e920e76a2207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_0cc00180-ff53-489a-aaf9-b4b11c0216dc" xlink:to="loc_us-gaap_TransactionDomain_8f683a65-3af1-4b7e-84de-e920e76a2207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NewMarketTaxCreditProgramMember_205d889f-e1b2-436a-94ca-c1dd30396897" xlink:href="exas-20210930.xsd#exas_NewMarketTaxCreditProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_8f683a65-3af1-4b7e-84de-e920e76a2207" xlink:to="loc_exas_NewMarketTaxCreditProgramMember_205d889f-e1b2-436a-94ca-c1dd30396897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1f27b174-8c55-4acb-8572-13d3644e1ddb" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NetProceedsFromFinancingArrangement_05eca71d-3b66-4521-aa04-065a852a0fe7" xlink:href="exas-20210930.xsd#exas_NetProceedsFromFinancingArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:to="loc_exas_NetProceedsFromFinancingArrangement_05eca71d-3b66-4521-aa04-065a852a0fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_539b75d6-db89-4240-afd6-f538471463c9" xlink:href="exas-20210930.xsd#exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_78f6eae4-cdeb-4438-ae0b-4cd81b1407f2" xlink:to="loc_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements_539b75d6-db89-4240-afd6-f538471463c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS" xlink:type="simple" xlink:href="exas-20210930.xsd#WISCONSINECONOMICDEVELOPMENTTAXCREDITS"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_1799994d-8aae-4d73-8a10-570d716d2e3a" xlink:href="exas-20210930.xsd#exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock_9165fd05-9f8c-4a0e-90c6-0e2927c43f2d" xlink:href="exas-20210930.xsd#exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_1799994d-8aae-4d73-8a10-570d716d2e3a" xlink:to="loc_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock_9165fd05-9f8c-4a0e-90c6-0e2927c43f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_b182ffa4-cf56-4616-b563-93cd7f9e565c" xlink:href="exas-20210930.xsd#exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract_b182ffa4-cf56-4616-b563-93cd7f9e565c" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bababee2-2ba7-4f96-86f6-4419d41e8654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_e3e6330e-954e-4797-8307-4867a7643dc7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bababee2-2ba7-4f96-86f6-4419d41e8654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_20c859f8-d4f1-48a0-95d8-7b3725b6de60" xlink:href="exas-20210930.xsd#exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bababee2-2ba7-4f96-86f6-4419d41e8654" xlink:to="loc_exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember_20c859f8-d4f1-48a0-95d8-7b3725b6de60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_46e95745-2031-4663-8ea1-94ffefbf8a4a" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_d9752d82-b6fa-4338-a182-a5929a0d578e" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions_d9752d82-b6fa-4338-a182-a5929a0d578e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_33d6f054-e91d-4bf3-90e5-132935576c0a" xlink:href="exas-20210930.xsd#exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits_33d6f054-e91d-4bf3-90e5-132935576c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_ea202d58-6f57-4bc6-b97e-ef9884c335b0" xlink:href="exas-20210930.xsd#exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits_ea202d58-6f57-4bc6-b97e-ef9884c335b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_54a68e9b-8cd3-4340-b29a-a23c1702f8d5" xlink:href="exas-20210930.xsd#exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits_54a68e9b-8cd3-4340-b29a-a23c1702f8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditEarnedToDate_86463db5-9966-48d8-8d27-2a52474c8e1d" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditEarnedToDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditEarnedToDate_86463db5-9966-48d8-8d27-2a52474c8e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditReceived_759f599a-7341-4426-a76f-416e64aedba0" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditReceived_759f599a-7341-4426-a76f-416e64aedba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_RefundableTaxCreditReceivable_718a8e15-2f04-4f4e-903a-f7a4535f174f" xlink:href="exas-20210930.xsd#exas_RefundableTaxCreditReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_RefundableTaxCreditReceivable_718a8e15-2f04-4f4e-903a-f7a4535f174f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AmortizationOfRefundableTaxCredits_ffef112f-285e-4415-bbed-7c9a3706cb9f" xlink:href="exas-20210930.xsd#exas_AmortizationOfRefundableTaxCredits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_6a0885c7-a6d3-4fd7-8591-46c2a532af33" xlink:to="loc_exas_AmortizationOfRefundableTaxCredits_ffef112f-285e-4415-bbed-7c9a3706cb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONS"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_35a59010-12ea-48d8-bf73-eeee83e08e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a804cbb2-09c8-48e0-ab52-b5265ec02d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_35a59010-12ea-48d8-bf73-eeee83e08e73" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_a804cbb2-09c8-48e0-ab52-b5265ec02d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionTextBlock_051de610-ecc4-440e-83f9-ae20a97f11bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_35a59010-12ea-48d8-bf73-eeee83e08e73" xlink:to="loc_us-gaap_AssetAcquisitionTextBlock_051de610-ecc4-440e-83f9-ae20a97f11bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d67249e-dbab-453d-b080-cf85a36de0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e170a6b9-db62-462f-9c55-d1ccf5ff566e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d67249e-dbab-453d-b080-cf85a36de0e2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_e170a6b9-db62-462f-9c55-d1ccf5ff566e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_028104c1-d730-481e-bc9c-27c3668a74dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d67249e-dbab-453d-b080-cf85a36de0e2" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_028104c1-d730-481e-bc9c-27c3668a74dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_221c7ae7-4f6a-4490-92ee-a87fd5e712a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d67249e-dbab-453d-b080-cf85a36de0e2" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_221c7ae7-4f6a-4490-92ee-a87fd5e712a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_efcde22e-74df-4143-a08f-eca9487d5d30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3d67249e-dbab-453d-b080-cf85a36de0e2" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_efcde22e-74df-4143-a08f-eca9487d5d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_341ba80f-f2ea-429e-a4a9-5a7eb4d1dec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_341ba80f-f2ea-429e-a4a9-5a7eb4d1dec8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92e83665-2684-4601-aa35-3919dc5ad6f4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_c3f308e6-dc8e-466c-80e5-5d7605886537" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_AshionAnalyticsMember_c3f308e6-dc8e-466c-80e5-5d7605886537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_02f65c10-f04f-4494-b026-00ab19698df1" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_02f65c10-f04f-4494-b026-00ab19698df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_10e949f6-d17b-467e-b35d-aadfcce4d8fe" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_ParadigmViomicsMember_10e949f6-d17b-467e-b35d-aadfcce4d8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember_25c4a66a-abe6-4753-8330-6182c146cd86" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7ab9294f-62f8-4034-8498-70e3be77a16c" xlink:to="loc_exas_PFSGenomicsMember_25c4a66a-abe6-4753-8330-6182c146cd86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_f50e0028-67ed-4c61-bf68-6741f77dcf2c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CommercialLaunchMilestoneMember_d652d66c-552c-482b-92f6-847af4de6ac6" xlink:href="exas-20210930.xsd#exas_CommercialLaunchMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_CommercialLaunchMilestoneMember_d652d66c-552c-482b-92f6-847af4de6ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_MRDProductRevenueMilestoneMember_5b3dce41-f117-4657-8489-e3c0885c5057" xlink:href="exas-20210930.xsd#exas_MRDProductRevenueMilestoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_MRDProductRevenueMilestoneMember_5b3dce41-f117-4657-8489-e3c0885c5057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_FDAApprovalMember_fc2af115-bdad-46ec-8bd6-87562c80fea5" xlink:href="exas-20210930.xsd#exas_FDAApprovalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_FDAApprovalMember_fc2af115-bdad-46ec-8bd6-87562c80fea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_85c8f301-da4b-4cda-904f-493d2bdd5fc3" xlink:href="exas-20210930.xsd#exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember_85c8f301-da4b-4cda-904f-493d2bdd5fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToConsiderationTransferredMember_be78c489-8aa2-479b-b780-808ca5163834" xlink:href="exas-20210930.xsd#exas_AllocatedToConsiderationTransferredMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_AllocatedToConsiderationTransferredMember_be78c489-8aa2-479b-b780-808ca5163834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToPreviousOwnershipInterestMember_436b14c6-093f-4981-9393-97b4a25041ff" xlink:href="exas-20210930.xsd#exas_AllocatedToPreviousOwnershipInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_AllocatedToPreviousOwnershipInterestMember_436b14c6-093f-4981-9393-97b4a25041ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AllocatedToCompensationMember_4e14a38c-d7af-42db-a4ed-3e2da0cc1bb1" xlink:href="exas-20210930.xsd#exas_AllocatedToCompensationMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_AllocatedToCompensationMember_4e14a38c-d7af-42db-a4ed-3e2da0cc1bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CompensationExpenseMember_6358e49e-96e3-4505-af46-9da9db6136ab" xlink:href="exas-20210930.xsd#exas_CompensationExpenseMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_873cae39-4e23-46ae-8f08-99626473dbd5" xlink:to="loc_exas_CompensationExpenseMember_6358e49e-96e3-4505-af46-9da9db6136ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_54da8275-09f1-43d1-bb0b-0d04a7b943af" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d3f98d2-60d7-4dfd-ab3e-515618483212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d3f98d2-60d7-4dfd-ab3e-515618483212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeMember_5409cb7f-3c74-4f08-8a22-172664bbc19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bc7a061c-d5d7-4b59-b56e-60dc6b416334" xlink:to="loc_us-gaap_InvestmentIncomeMember_5409cb7f-3c74-4f08-8a22-172664bbc19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_869a4508-c5f3-4aea-a882-37d7d2c86729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_19563e47-1203-415f-8e17-d0aa60429745" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_869a4508-c5f3-4aea-a882-37d7d2c86729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7df086-8ca6-4110-87df-2a7d6b5c4a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_869a4508-c5f3-4aea-a882-37d7d2c86729" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7df086-8ca6-4110-87df-2a7d6b5c4a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_46ca8484-d9dc-4980-92e8-3c4d4aa6f361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8c7df086-8ca6-4110-87df-2a7d6b5c4a92" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_46ca8484-d9dc-4980-92e8-3c4d4aa6f361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e2a9810c-2d73-4d36-a70a-f1c6318bce6b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_b2243ba6-44bf-4f0a-ad08-01fe9c065c6b" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e2a9810c-2d73-4d36-a70a-f1c6318bce6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_3b0c3080-edeb-4b54-a399-a272e66bb52d" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e2a9810c-2d73-4d36-a70a-f1c6318bce6b" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_3b0c3080-edeb-4b54-a399-a272e66bb52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a2fff00-ff25-48c5-b5c1-ad0fe69b366f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_73b4ee85-95f2-4288-9ae3-4e2cc4f8e272" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a2fff00-ff25-48c5-b5c1-ad0fe69b366f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_EmployeesWithQualifyingTerminationEventsMember_873fd08e-99b2-463b-b3d5-cd6bc33fa9eb" xlink:href="exas-20210930.xsd#exas_EmployeesWithQualifyingTerminationEventsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_6a2fff00-ff25-48c5-b5c1-ad0fe69b366f" xlink:to="loc_exas_EmployeesWithQualifyingTerminationEventsMember_873fd08e-99b2-463b-b3d5-cd6bc33fa9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1817ae2d-0c4c-4aa2-9619-9104cefc56c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a9694bb5-a1da-4639-b1c7-f64ca4e8fe41" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1817ae2d-0c4c-4aa2-9619-9104cefc56c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3a6301dd-09fe-4610-83e5-a41f393be5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1817ae2d-0c4c-4aa2-9619-9104cefc56c9" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3a6301dd-09fe-4610-83e5-a41f393be5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a1a971b7-42f7-4132-a384-4e9c43d04869" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7ed81b52-7d4d-487b-ab86-5f2abfe81483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_7ed81b52-7d4d-487b-ab86-5f2abfe81483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d00981dc-a1c1-4d4f-bfde-b2391eac630d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_d00981dc-a1c1-4d4f-bfde-b2391eac630d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_f5a828e9-6ab1-463c-aa69-1c0c26cedd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_f5a828e9-6ab1-463c-aa69-1c0c26cedd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationAdditionalPayment_c1f1f144-a69a-439c-8bad-dbb901b18042" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationAdditionalPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationContingentConsiderationAdditionalPayment_c1f1f144-a69a-439c-8bad-dbb901b18042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3472eda2-91cb-41f6-8e40-0677b50c5957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3472eda2-91cb-41f6-8e40-0677b50c5957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationContingentConsiderationRevenueMilestone_71eb56d3-6a52-4668-b636-ddee6f8d6d68" xlink:href="exas-20210930.xsd#exas_BusinessCombinationContingentConsiderationRevenueMilestone"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationContingentConsiderationRevenueMilestone_71eb56d3-6a52-4668-b636-ddee6f8d6d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5f0d3168-bdbb-4208-b852-c14e49c7071a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_5f0d3168-bdbb-4208-b852-c14e49c7071a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f64ef704-f2da-4dd1-915a-566c32530514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f64ef704-f2da-4dd1-915a-566c32530514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6c85589e-56bb-4deb-bdb9-2d4e30b4b31f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6c85589e-56bb-4deb-bdb9-2d4e30b4b31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dffdfbaa-1d22-439b-a353-2efef9b4ca12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dffdfbaa-1d22-439b-a353-2efef9b4ca12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18f48534-bbd4-4710-b259-65b619c86856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_18f48534-bbd4-4710-b259-65b619c86856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_cba88286-86c9-40f0-aa17-d767e22f6d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_cba88286-86c9-40f0-aa17-d767e22f6d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_20d159f5-7b0c-4bae-b708-5cfcfb50d485" xlink:href="exas-20210930.xsd#exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards_20d159f5-7b0c-4bae-b708-5cfcfb50d485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_8dee9e4c-5f32-463a-8785-48d3f18ad99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_8dee9e4c-5f32-463a-8785-48d3f18ad99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3dc30683-188e-4832-a116-e3075cc90d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3dc30683-188e-4832-a116-e3075cc90d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8be657e8-d1b2-4015-8521-16ea4eed928a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_8be657e8-d1b2-4015-8521-16ea4eed928a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_326a98a8-bea0-4890-9160-3873433795c6" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation_326a98a8-bea0-4890-9160-3873433795c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_00bc94c3-0a31-4c82-8327-def927101388" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred_00bc94c3-0a31-4c82-8327-def927101388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_999ae443-747d-40d5-947b-85cbf2303f4f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory_999ae443-747d-40d5-947b-85cbf2303f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1ca8f1fc-0dad-4faf-92cd-c385f3bfb92d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost_1ca8f1fc-0dad-4faf-92cd-c385f3bfb92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_61a61240-e5d4-4002-b3d2-a2563acb5e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_61a61240-e5d4-4002-b3d2-a2563acb5e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_17b59ccf-3f4c-4418-8305-42e729300baa" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio_17b59ccf-3f4c-4418-8305-42e729300baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_56953dfa-6ad6-4360-8377-df3e28f630ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_56953dfa-6ad6-4360-8377-df3e28f630ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c5287794-016f-43f4-8288-bcc592c23725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_c5287794-016f-43f4-8288-bcc592c23725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_0c210cbd-f4ea-4d98-9c99-f768ae35e334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_0c210cbd-f4ea-4d98-9c99-f768ae35e334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f4a107a-7685-4718-90e5-9f1b10a963d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7f4a107a-7685-4718-90e5-9f1b10a963d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_635675b7-9966-4816-a1b0-afe6f2bfff4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_ShareBasedCompensation_635675b7-9966-4816-a1b0-afe6f2bfff4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsPeriodExpense_a1c584f4-4f01-4773-9367-c6d4218f20d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsPeriodExpense"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_PostemploymentBenefitsPeriodExpense_a1c584f4-4f01-4773-9367-c6d4218f20d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6d6ccfda-e66d-4621-a3d3-485e72155dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_6d6ccfda-e66d-4621-a3d3-485e72155dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_bc7212b0-a35f-4fae-afb9-0f2022ba0a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_bc7212b0-a35f-4fae-afb9-0f2022ba0a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_b35f8dcd-ffa9-45c1-99b5-f84398cd759d" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance_b35f8dcd-ffa9-45c1-99b5-f84398cd759d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_61947136-6dcc-45e1-9862-6ede0200de87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1_61947136-6dcc-45e1-9862-6ede0200de87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_379b5591-cd05-4db9-9151-09028a8fe505" xlink:href="exas-20210930.xsd#exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e186c1b5-d00c-4555-9125-8dc426633a11" xlink:to="loc_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod_379b5591-cd05-4db9-9151-09028a8fe505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2ad3eeec-f074-4780-94ae-b1bf0b6ceeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2ad3eeec-f074-4780-94ae-b1bf0b6ceeca" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7e06509-346e-4747-9d53-55af1ab2f155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6e6b9cc1-9517-4454-8c38-69b1ca5d46b6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7e06509-346e-4747-9d53-55af1ab2f155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_9423d9e1-e338-4839-b9e8-e2a8cceeb744" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e7e06509-346e-4747-9d53-55af1ab2f155" xlink:to="loc_exas_AshionAnalyticsMember_9423d9e1-e338-4839-b9e8-e2a8cceeb744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_875d93bc-345e-4619-b5b9-247af24f67cf" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_b1cb0e4a-cd54-4b8b-ac97-e044391abb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_b1cb0e4a-cd54-4b8b-ac97-e044391abb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8216c1d7-6309-4bba-8742-f7ecea683893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8216c1d7-6309-4bba-8742-f7ecea683893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_f9f0f537-60cd-4f07-9b60-26bd74f854b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_f9f0f537-60cd-4f07-9b60-26bd74f854b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d3676a1-892d-41e2-942e-056d843d815f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_9dc895f6-809d-46f6-98fa-31f9ced299ec" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3d3676a1-892d-41e2-942e-056d843d815f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7c110239-bc0a-4b78-b192-30159c665164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_7c110239-bc0a-4b78-b192-30159c665164" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fcfd34-a0f5-4f40-b18c-8bbb2e130e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5e086991-ee92-4149-b37d-90440e5e39d2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fcfd34-a0f5-4f40-b18c-8bbb2e130e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AshionAnalyticsMember_b2e1fa02-5518-4455-871a-d5ed5e9e929a" xlink:href="exas-20210930.xsd#exas_AshionAnalyticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f3fcfd34-a0f5-4f40-b18c-8bbb2e130e0b" xlink:to="loc_exas_AshionAnalyticsMember_b2e1fa02-5518-4455-871a-d5ed5e9e929a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2db15197-3504-4426-95a8-5781f489c269" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_061c1ac8-2d30-42f0-90be-09561a1e21a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_061c1ac8-2d30-42f0-90be-09561a1e21a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a654e3db-2303-468f-9591-464eb82338b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a654e3db-2303-468f-9591-464eb82338b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fd6b5fd6-8fce-4074-a137-97be0bab4c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fd6b5fd6-8fce-4074-a137-97be0bab4c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_583a2092-7ec6-4f06-8b21-553e34e57f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_583a2092-7ec6-4f06-8b21-553e34e57f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bfc406ca-df63-4546-ae5c-25e6a911106e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bfc406ca-df63-4546-ae5c-25e6a911106e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_4c88ae22-d7f6-4644-993a-6e0750631543" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_4c88ae22-d7f6-4644-993a-6e0750631543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_563e1ceb-6320-4f6a-913f-7cfe2d2f7b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_563e1ceb-6320-4f6a-913f-7cfe2d2f7b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_78e585c8-b338-487c-b924-ac9d4cf43bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_78e585c8-b338-487c-b924-ac9d4cf43bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a57f93b6-7b21-4087-9b5a-9425d2c57f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_a57f93b6-7b21-4087-9b5a-9425d2c57f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_64bc9e1b-aa9d-42ad-b1f7-d044c4d7e794" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_64bc9e1b-aa9d-42ad-b1f7-d044c4d7e794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_63429298-5516-4c5c-b0fc-5c5082f880f7" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_63429298-5516-4c5c-b0fc-5c5082f880f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7007e838-c6c7-4718-ac68-14f498b833ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_7007e838-c6c7-4718-ac68-14f498b833ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_d27bcd9c-17f1-4c00-b4d8-f4b240d53a33" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_d27bcd9c-17f1-4c00-b4d8-f4b240d53a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d490dde-195e-4dae-9234-a98d91f912d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3d490dde-195e-4dae-9234-a98d91f912d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c3ac7217-7a9d-4846-b7ea-5bafafde4324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c3ac7217-7a9d-4846-b7ea-5bafafde4324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97632de4-c5f0-4208-9fbb-f1df9efec0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_Goodwill_97632de4-c5f0-4208-9fbb-f1df9efec0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0fffb1f3-3eb9-4ade-aa76-55ed68e98480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a30fb3df-a917-4826-ae98-2c437eebcc7b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_0fffb1f3-3eb9-4ade-aa76-55ed68e98480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d80c50f2-a3d4-497e-9cfa-e434e074ce05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d80c50f2-a3d4-497e-9cfa-e434e074ce05" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d92989e5-67b3-46c2-b9bf-c09c5eaf649e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d1123e7-9393-456b-933a-1a7356ed6bf1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d92989e5-67b3-46c2-b9bf-c09c5eaf649e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_00907da7-7fbe-4f7f-b925-ae5ae203ce34" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d92989e5-67b3-46c2-b9bf-c09c5eaf649e" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_00907da7-7fbe-4f7f-b925-ae5ae203ce34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8e10cc0c-fd1e-4a2b-97d2-48ff6f38e910" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b08a336f-18c8-4343-940d-022179479e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_b08a336f-18c8-4343-940d-022179479e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_c287b915-b1e3-440f-9935-bda18fc7ffaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_c287b915-b1e3-440f-9935-bda18fc7ffaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_6596f431-53bc-438e-aec4-d68cadd5005e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_6596f431-53bc-438e-aec4-d68cadd5005e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards_4ee1a3d0-5741-4f96-93e6-817bf5e63eb6" xlink:href="exas-20210930.xsd#exas_BusinessCombinationFairValueOfReplacedEquityAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_exas_BusinessCombinationFairValueOfReplacedEquityAwards_4ee1a3d0-5741-4f96-93e6-817bf5e63eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_71c1fa95-2d7b-48c2-ac0d-d0fad34f81c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_71c1fa95-2d7b-48c2-ac0d-d0fad34f81c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c7d19944-f9f3-4029-884b-9b85df6800f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_6cf9c3f8-ebf4-4ab7-8aab-8cf13f06a716" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c7d19944-f9f3-4029-884b-9b85df6800f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_75393196-45b5-480a-bad8-4a8bdc8d719c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_75393196-45b5-480a-bad8-4a8bdc8d719c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4835de7-76f2-463c-acee-ee3afb47470b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_059e0500-0c96-4ffe-8c29-bdc1b73b4ad4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4835de7-76f2-463c-acee-ee3afb47470b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_459ef7d1-2378-4ef5-99cc-07ba08c3cde0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4835de7-76f2-463c-acee-ee3afb47470b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_459ef7d1-2378-4ef5-99cc-07ba08c3cde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_50d77ce9-660e-487a-994f-d404902aa8f5" xlink:to="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b83145a1-2f39-4ed8-b4b5-720ef03b10ef" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:to="loc_srt_MinimumMember_b83145a1-2f39-4ed8-b4b5-720ef03b10ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4278ce3b-cb13-4632-a132-b5aaac526636" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a52f85e6-3927-4f6f-938f-5d1342ffff1d" xlink:to="loc_srt_MaximumMember_4278ce3b-cb13-4632-a132-b5aaac526636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a3ab886-2c9b-49c7-87b8-910afe3e05e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_795536d0-9959-4d2c-a6bd-1eabef7c83a2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a3ab886-2c9b-49c7-87b8-910afe3e05e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_dae0f6f6-7d92-4d19-a372-f829e0ab7b64" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a3ab886-2c9b-49c7-87b8-910afe3e05e4" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_dae0f6f6-7d92-4d19-a372-f829e0ab7b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_bb1ba642-606c-4e39-a0d3-78d7720a7e5f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5b9456cf-083e-408c-bcd1-0fd2334b5934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_5b9456cf-083e-408c-bcd1-0fd2334b5934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3a4afe0d-1376-43f7-9206-e7da34756257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3a4afe0d-1376-43f7-9206-e7da34756257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f335df72-8f1f-4b42-a953-e51972071ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_f335df72-8f1f-4b42-a953-e51972071ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c4f52d5e-6569-4281-9e67-6c89eab0b06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_c4f52d5e-6569-4281-9e67-6c89eab0b06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_a6ac2910-4d75-4f05-9cff-f2c91137988e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_a6ac2910-4d75-4f05-9cff-f2c91137988e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bfb86e28-210f-4ca0-aa84-78f099ddbe15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bfb86e28-210f-4ca0-aa84-78f099ddbe15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c66542fb-1adf-4e22-8e7d-99a005a27d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a136e1c9-7acb-4953-b6dd-3df5d429549c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c66542fb-1adf-4e22-8e7d-99a005a27d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95603487-8c16-4655-982a-cb9a67ed10d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95603487-8c16-4655-982a-cb9a67ed10d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a9e3ec5-c328-4fc6-8faf-bf998fc09572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cdd4e99e-fbea-4537-84dc-68e1ca0639e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a9e3ec5-c328-4fc6-8faf-bf998fc09572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_bd5c0fc5-ef31-405a-985d-dd11fc848eaf" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7a9e3ec5-c328-4fc6-8faf-bf998fc09572" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_bd5c0fc5-ef31-405a-985d-dd11fc848eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_73f75834-d809-4a45-9f7f-acfd9f5aafdf" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_df6a1d13-dff4-4ecb-843c-c17a2d446542" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_df6a1d13-dff4-4ecb-843c-c17a2d446542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_00f78aa6-070e-4f3f-b5c5-bffa4bf40b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_00f78aa6-070e-4f3f-b5c5-bffa4bf40b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_fc512447-abce-4362-bc34-03709dd70085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_fc512447-abce-4362-bc34-03709dd70085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6888c4e8-679f-4780-8208-535dc3aee144" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_6888c4e8-679f-4780-8208-535dc3aee144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dc94f59-c12d-4908-906c-a95b92916196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8dc94f59-c12d-4908-906c-a95b92916196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_608e9f0a-1cf0-4d67-9b85-03d2dc76097c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_608e9f0a-1cf0-4d67-9b85-03d2dc76097c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5dfb05b8-3ddf-4d80-bf23-fb8ba25ea724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5dfb05b8-3ddf-4d80-bf23-fb8ba25ea724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_191e4657-0bf7-41ac-b157-665af9e1ea8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_191e4657-0bf7-41ac-b157-665af9e1ea8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_99453cb9-489d-439a-b01e-7c3c0d8e8bd1" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities_99453cb9-489d-439a-b01e-7c3c0d8e8bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_108e702c-8c1e-45bd-ae13-ebb3ecfebc7d" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability_108e702c-8c1e-45bd-ae13-ebb3ecfebc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_e73c54ca-5fcf-4935-9350-b2c7977e569b" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability_e73c54ca-5fcf-4935-9350-b2c7977e569b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f67d9f76-c34c-48dd-b837-69d8f3bfb0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_f67d9f76-c34c-48dd-b837-69d8f3bfb0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6e90f056-5c81-4540-9d17-d0d6d490f6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6e90f056-5c81-4540-9d17-d0d6d490f6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_dc3eee05-c48e-438c-9559-de69d756cf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_dc3eee05-c48e-438c-9559-de69d756cf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_68ca5e00-50bb-4efb-bfbc-2ef58b8c4841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_Goodwill_68ca5e00-50bb-4efb-bfbc-2ef58b8c4841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_324558f1-c9fc-4579-8819-f1ff92896860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_324558f1-c9fc-4579-8819-f1ff92896860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentDisclosureAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c622ad2c-812b-4d28-b801-390bfa37e8cb" xlink:to="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_836437b9-d318-4864-a3af-4041885761f2" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_836437b9-d318-4864-a3af-4041885761f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_80f365f9-4140-4879-8b12-bb7406756a30" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets_80f365f9-4140-4879-8b12-bb7406756a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_e3199096-0206-4ed6-bc6f-581d0c4ef1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_e3199096-0206-4ed6-bc6f-581d0c4ef1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_19810135-2d90-4495-b1f6-87b557269c03" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_19810135-2d90-4495-b1f6-87b557269c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_2c5ae7c1-eb32-483e-a330-9d7002152863" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets_2c5ae7c1-eb32-483e-a330-9d7002152863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_205cfc31-2319-4ffe-97c2-7cbedd94814d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_205cfc31-2319-4ffe-97c2-7cbedd94814d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_4f2be099-0d55-4fd2-965b-bbef143bb70f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_4f2be099-0d55-4fd2-965b-bbef143bb70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_9e6c66c9-bbec-43f1-bc55-342edeb85e86" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable_9e6c66c9-bbec-43f1-bc55-342edeb85e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_b2dadbf0-35c1-4ac0-abab-f5ddc6e6e3dc" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities_b2dadbf0-35c1-4ac0-abab-f5ddc6e6e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_4d99416c-9abc-4491-bf02-f40cdf5898e0" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent_4d99416c-9abc-4491-bf02-f40cdf5898e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_634ea05a-328d-4692-8a3c-2b7222abf180" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent_634ea05a-328d-4692-8a3c-2b7222abf180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_d2e1d772-26dc-4e61-9910-1b56dfe87966" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability_d2e1d772-26dc-4e61-9910-1b56dfe87966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_cb786bcb-abc1-4278-9c59-8480be0cd439" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_cb786bcb-abc1-4278-9c59-8480be0cd439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_bda300ed-d802-4a6a-9fc4-88f97e400e78" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_bda300ed-d802-4a6a-9fc4-88f97e400e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_55b8926c-8f31-4f75-bc49-b7c50ab5949b" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_55b8926c-8f31-4f75-bc49-b7c50ab5949b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_8d3908b0-46c7-4b2a-ac75-0fb4b3e44094" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_5075cabc-e3ea-46ac-aba3-b90e7040ab5b" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired_8d3908b0-46c7-4b2a-ac75-0fb4b3e44094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0347278a-6e99-4c4f-b5b1-df582bdcd815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0347278a-6e99-4c4f-b5b1-df582bdcd815" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d60e4b16-255e-4a1c-83b0-a425bfef05aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0a2e0b14-dd98-4a4a-ad3c-83b549285896" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d60e4b16-255e-4a1c-83b0-a425bfef05aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ThriveEarlierDetectionCorporationMember_fff3652e-3992-4f5a-8d41-71eb9238b582" xlink:href="exas-20210930.xsd#exas_ThriveEarlierDetectionCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d60e4b16-255e-4a1c-83b0-a425bfef05aa" xlink:to="loc_exas_ThriveEarlierDetectionCorporationMember_fff3652e-3992-4f5a-8d41-71eb9238b582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_d878dc78-9cd3-4a54-a872-8c51f783fd1d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_20270665-4ac9-407c-a411-ca40ddab6a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_20270665-4ac9-407c-a411-ca40ddab6a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_8837d088-4e1e-444c-a37d-aa850a645cc8" xlink:href="exas-20210930.xsd#exas_BusinessAcquisitionProFormaIncomeLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467513af-ad34-4f7d-9f75-26a10e1cc370" xlink:to="loc_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax_8837d088-4e1e-444c-a37d-aa850a645cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_053cb988-4573-4af9-8b21-69b97a3c2955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_053cb988-4573-4af9-8b21-69b97a3c2955" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44b30286-3172-4a2b-a634-a3c813107402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_511d0684-8009-44ed-8958-fa13c88b72fd" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44b30286-3172-4a2b-a634-a3c813107402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_ParadigmViomicsMember_748baf81-1c7a-4b6f-8b34-651b2f05ff9d" xlink:href="exas-20210930.xsd#exas_ParadigmViomicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_44b30286-3172-4a2b-a634-a3c813107402" xlink:to="loc_exas_ParadigmViomicsMember_748baf81-1c7a-4b6f-8b34-651b2f05ff9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_225c6162-96d0-4a66-883a-d87bdf51e6ea" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_dfc8c4ca-de91-4616-af77-f7ecdb37321f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets_dfc8c4ca-de91-4616-af77-f7ecdb37321f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5262fd15-8f9b-4317-8fd7-9ac193288c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_Goodwill_5262fd15-8f9b-4317-8fd7-9ac193288c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6afcac0d-14ab-4588-8bfb-c974091367f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_6afcac0d-14ab-4588-8bfb-c974091367f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_200b4d5e-ea0b-4927-bf6e-333a989c7cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_200b4d5e-ea0b-4927-bf6e-333a989c7cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f6625e86-d707-4f6b-9927-ef4ea725175e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f6625e86-d707-4f6b-9927-ef4ea725175e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentDisclosureAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3e95bd83-2071-4159-b94b-153660253ccc" xlink:to="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_36a04b61-a579-4eb6-a481-97d71d92dac8" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets_36a04b61-a579-4eb6-a481-97d71d92dac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_629f6e0f-0346-449d-8e6f-d22fd245cb55" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_629f6e0f-0346-449d-8e6f-d22fd245cb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_c0cad0c0-0bee-4b35-94e0-f85eeee37d11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_c0cad0c0-0bee-4b35-94e0-f85eeee37d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_b8924ae7-b5be-4b02-aa2f-48620b1d5aea" xlink:href="exas-20210930.xsd#exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities_b8924ae7-b5be-4b02-aa2f-48620b1d5aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_f0f9f7a6-d4ac-4d1c-9b0b-11425edfd541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAdjustmentDisclosureAbstract_ea21d5a4-e3b8-4861-a2df-fec606ec371e" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod_f0f9f7a6-d4ac-4d1c-9b0b-11425edfd541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3dcab571-8396-4066-921b-5b49ef1bc215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3dcab571-8396-4066-921b-5b49ef1bc215" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneAxis_fc14b605-4fc9-4f08-adf4-230a6eaf7bc7" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeOneMember_403c3e4e-8c38-46f8-af46-32060ffb718f" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:to="loc_exas_SalesMilestoneRangeOneMember_403c3e4e-8c38-46f8-af46-32060ffb718f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_SalesMilestoneRangeTwoMember_0e673c28-9786-4d05-921e-151c4d517897" xlink:href="exas-20210930.xsd#exas_SalesMilestoneRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_exas_CollaborativeArrangementsSalesMilestoneDomain_4f4a56c0-3287-4c85-8b9a-614d2bf9a222" xlink:to="loc_exas_SalesMilestoneRangeTwoMember_0e673c28-9786-4d05-921e-151c4d517897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_9382533b-9e36-4389-885b-60011bf67a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_7a66fbdf-3e47-440a-9ccf-c7dabc952237" xlink:to="loc_us-gaap_AssetAcquisitionDomain_9382533b-9e36-4389-885b-60011bf67a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_TARDISTechnologyMember_aa66ac9a-e7a3-4fd1-80e9-e0c0a3327e3a" xlink:href="exas-20210930.xsd#exas_TARDISTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_9382533b-9e36-4389-885b-60011bf67a96" xlink:to="loc_exas_TARDISTechnologyMember_aa66ac9a-e7a3-4fd1-80e9-e0c0a3327e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37d94f13-bdd7-4075-9dbd-9e27962a6b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6c74f24d-c33c-42a5-969a-0454cb1e4c29" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37d94f13-bdd7-4075-9dbd-9e27962a6b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember_067586bb-084c-4ca2-b3a6-937a87a22a35" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_37d94f13-bdd7-4075-9dbd-9e27962a6b32" xlink:to="loc_exas_PFSGenomicsMember_067586bb-084c-4ca2-b3a6-937a87a22a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_201a9898-ee48-495e-a953-a0883fdb312f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98e92e4a-cd65-4703-932d-279cc69b1277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_98e92e4a-cd65-4703-932d-279cc69b1277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c699a856-9994-4c8f-96bc-6f1747c1263c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_c699a856-9994-4c8f-96bc-6f1747c1263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_1b7e8588-0596-4419-a03e-b0760a0d792c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_1b7e8588-0596-4419-a03e-b0760a0d792c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7307e56d-e93f-4c95-ad84-1fd3a03a739f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7307e56d-e93f-4c95-ad84-1fd3a03a739f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_145443d2-9044-46fa-8688-bc404e84e8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_145443d2-9044-46fa-8688-bc404e84e8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_54597acd-9726-4515-ba2c-838c06b6a97d" xlink:href="exas-20210930.xsd#exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares_54597acd-9726-4515-ba2c-838c06b6a97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_13605954-7b50-4df4-a42e-addd0010056f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable_13605954-7b50-4df4-a42e-addd0010056f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PaymentsContingentOnMilestonesPayable_4c5a3213-5919-4c3b-be0a-56ec81baf5e4" xlink:href="exas-20210930.xsd#exas_PaymentsContingentOnMilestonesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_exas_PaymentsContingentOnMilestonesPayable_4c5a3213-5919-4c3b-be0a-56ec81baf5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_71bf12bb-98ca-4404-8382-075a548c5d33" xlink:href="exas-20210930.xsd#exas_CollaborativeArrangementsSalesMilestoneAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_06fd2149-fd68-446f-8ad5-ac19d082b952" xlink:to="loc_exas_CollaborativeArrangementsSalesMilestoneAmount_71bf12bb-98ca-4404-8382-075a548c5d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1adbe6c5-d7e7-41b4-a172-c388fbaae2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_1adbe6c5-d7e7-41b4-a172-c388fbaae2f5" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50b50163-97cf-4d50-8bb0-380f4b3f3f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b72f46d6-4def-4bc0-bd35-c9f279501e42" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50b50163-97cf-4d50-8bb0-380f4b3f3f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_PFSGenomicsMember_0d08c677-6069-4afc-a96b-13f9a3b10497" xlink:href="exas-20210930.xsd#exas_PFSGenomicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_50b50163-97cf-4d50-8bb0-380f4b3f3f51" xlink:to="loc_exas_PFSGenomicsMember_0d08c677-6069-4afc-a96b-13f9a3b10497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_857158fe-087a-4cb5-a60e-84fbb0698d47" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_91b74750-8932-4c91-99c5-555b112fc070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_91b74750-8932-4c91-99c5-555b112fc070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_9aba7353-2320-4d53-b7dd-b96b3c28bc63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_9aba7353-2320-4d53-b7dd-b96b3c28bc63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4e14d32e-3b99-4807-8783-0e3abb865aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_4e14d32e-3b99-4807-8783-0e3abb865aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_13d76436-cb34-4b13-bfa0-e0154c2d536f" xlink:href="exas-20210930.xsd#exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities_13d76436-cb34-4b13-bfa0-e0154c2d536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_128d2466-1819-4594-a0fb-c429df987f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f7cf6661-7268-47cf-b0cb-c40bdcd4535e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_128d2466-1819-4594-a0fb-c429df987f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="exas-20210930.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c8c047ab-90a3-48f3-8c37-9a2901d89aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0e24d6ca-566f-4a39-bef7-14c2899270af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c8c047ab-90a3-48f3-8c37-9a2901d89aa1" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0e24d6ca-566f-4a39-bef7-14c2899270af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="exas-20210930.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0eb242eb-904a-4ef0-aef5-68573db01538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_cdd68d25-1fc7-4ac5-9e40-84c5f1af3a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0eb242eb-904a-4ef0-aef5-68573db01538" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_cdd68d25-1fc7-4ac5-9e40-84c5f1af3a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#SEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cbea6abe-24b8-49a2-b14d-efabbe300c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cbea6abe-24b8-49a2-b14d-efabbe300c40" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:to="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_74fb158e-c092-4352-bce7-2f908141d92f" xlink:to="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_832c023e-22f0-4b64-bc00-7735a0f80cb7" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:to="loc_country_US_832c023e-22f0-4b64-bc00-7735a0f80cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_aab06f64-e9b0-4ccd-ae8e-dec2d5fdc504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c9795be1-ab1b-42c1-a086-885a73e2c58b" xlink:to="loc_us-gaap_NonUsMember_aab06f64-e9b0-4ccd-ae8e-dec2d5fdc504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_c39d360a-f882-4f84-a8b3-a2a405d1e443" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5b786de9-8ec3-4b1d-aa51-d3ca5d00ae69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5b786de9-8ec3-4b1d-aa51-d3ca5d00ae69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01eda3ba-5b48-48b2-a2a9-b5ccdfda7b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_fd3c3778-20cb-4fac-885d-63771f683d7a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_01eda3ba-5b48-48b2-a2a9-b5ccdfda7b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INCOMETAXES" xlink:type="simple" xlink:href="exas-20210930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7aec26fc-53c0-4b6b-a131-6968d92c8fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d7fbc285-1b42-4403-9888-79d40223592b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7aec26fc-53c0-4b6b-a131-6968d92c8fc2" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d7fbc285-1b42-4403-9888-79d40223592b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.exactsciences.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="exas-20210930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.exactsciences.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_92f9f7cf-d783-4a04-af90-eef862ef93e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_32b7e535-af66-49d4-9139-e26ca5fea466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_92f9f7cf-d783-4a04-af90-eef862ef93e5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_32b7e535-af66-49d4-9139-e26ca5fea466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9618838b-f458-4d6f-93e7-36f8fdb9ff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_92f9f7cf-d783-4a04-af90-eef862ef93e5" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9618838b-f458-4d6f-93e7-36f8fdb9ff1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_217b75df-af0a-4fab-8705-999c3d6d4315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_92f9f7cf-d783-4a04-af90-eef862ef93e5" xlink:to="loc_us-gaap_DeferredTaxLiabilities_217b75df-af0a-4fab-8705-999c3d6d4315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_dbcd2a61-d6a9-448b-9ddb-70363df16846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_92f9f7cf-d783-4a04-af90-eef862ef93e5" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_dbcd2a61-d6a9-448b-9ddb-70363df16846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>exas-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:exas="http://www.exactsciences.com/20210930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="exas-20210930.xsd" xlink:type="simple"/>
    <context id="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4345381fdd3249c7b09e4950af6f50d7_I20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2021-11-01</instant>
        </period>
    </context>
    <context id="icaadbb616eae41fa90b155f9198a61f3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i551c655f93e84ff688983bbc818b9b24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b879da246b14941a83322faaeed6793_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3a089c68d2054e71ae53dbe33acb46e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2d218d7eeae48b689178b021a2d9641_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d1a5e4e4fb3441dbfac2e16747f0f82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41f71ee0084e4eadb1fad7a7287abf77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i06acbbeed575445bb4555931be715a61_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i34c8dfbdd693442781c06071382283a0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i35f5f3b14daf4545b117801527f11480_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i094f6b20548e406aa1288c2f7bb503ce_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i01dccf0f1cd74d4b9ba6b84dc1db95d1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8ec01d6b22540e381cef4d704dbefdd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i037dafa9fcb1448595787e22be1373a3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if4239b36587d47b9b67ceb074d0de230_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id326b3d6f1254686955c693689f8d7d8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0baa301bd4a2483fb87ec3ff4678d7b3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i19d78ab3ef424e599d850c44805a1ce8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7570a7ca68604ab193ddcc503f407047_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6c13f47ff92f4d38a48f563ec039cca7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9a00307d8ec84b5e91e63fb7f9ff072e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic6d6c8e24a154e2298c770d5ede9849a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iae0e894a4a7f44789a730dae8d02a80e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1875021431d84ba4b5c921b34aa74aff_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i60304b507d2d47a4beae13dd19cd021e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9ed5f3ef270f4beca6bc7c118222f3e6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4f46968c2ac4412d8f9620137a8c6374_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ief7040c10b7747fcbcec17982a4d2f4e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i48f2732f724e456a9642ca5734eae6e1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if4e10d3514844641a53eb38bf634cf5b_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8c52981677ce4a888854fe6b6b0ffe08_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5a62efea1c4b4dad930fa573b6c99563_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4d558258814f4878ba1f82b61916b08e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64bfc16e556a449a831b1c4af0089d2e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3f2b2bb1c864e00920956c21f816e20_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i01c96c9ab7c14967920412b87f32b6c0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb5c4e6487434fdbb1a622f0080871e0_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0dfef23d60d041dcb2e5ff139b68bed4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i73256ccbde6a4a12845c25b8d6a836c2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if4ddaf31e8724905808d6d26fb1d3e98_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8f129d90bdeb408e8087ee20a8683ffc_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i01e9c8f772ad4932a0753e9678189d1b_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ieba75542757243c48c1903c54053e34f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib0912a5984f84bb28a27c9b48d9742d0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic0ad06284f6547c3a757c9097601bd0a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0c72990efe38423c885bc80777b5d195_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i96986827f84947af8d4abfe56c07628f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i35e6ccfede314e49b1285af649de49da_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id99a4512c1d64749be5a8a8315d2d519_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9ab125bbe3464831934cae09e63392a9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4c3768e6733343e298c844be52e6b227_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26c5d0a1031244da98e1f497d05696a9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0c26ea4630974c43a74423ba696c884d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie92f563c0ffb417f938fb6903a548c40_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ia53cf4692f7a499a8f9f2bb58f1edb6f_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic260e91a22f64d36ace033eed2e0ebe6_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic5fd31d1a4c54db49806dc7819602dcb_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="ic9d44e865abb4a51a5b5501e0a448a8d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5b178d75514549ce8ea66ebbd555a8f3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7670af9c955a4e8faf887308db05e979_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id444aec802554b8bb1365dce26fea270_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4d9018de7fac4dc190a8367b24291c0c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib05f381693e64b0dab8d73252c93ac05_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3905df4105f94399ab1bfd44d6526587_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaded02e3fc3944cb80ece4c9df2ccde3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2207747f21754338966e914ce4f44b7a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idcd243860e9749e797d0fa40c030a984_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:SharesIssuedUponAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b8fefa7fe2141829ad68e0d413c03d3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:SharesIssuedUponAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ied784b899fd94614a96d000bcd733b92_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iab5607dd7295462cb8c90861fc743def_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5ff017345e814e08bfa7d77cb58912c7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7b3a687e0214f13b567a2e97a426191_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie3a1712ede2942bc8705b2381ed4bde8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i137c30961fc947dda5c83f8077cb708d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib679c506439a443bb2d06e9eb73f7433_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7297a2895984854bde48ce5c1058f91_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2dcafd136a464463a18bf7d7a0aabc1b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8379dfc1c2554ffab184de397af796d4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic581a41a228c4ae7ae63d34ea421cced_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i54f0651ae9954de988ac49c1cec0c010_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1f57ca6a167a43b4bd33c0535aa347d5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id9fc6aab4d3f47f7afa8fdee107a4a60_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia505fd74c0704dd78a15cd07d6bec4f2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i667d454b548144cc8245d44ab0448111_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iccc3607a1c09473eb6ba098ff05bad78_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ff09f5adfd24b298edc56009dd65975_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i00444e24ec1241f3b7ce26b81f6319cb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c87ea0590d04f828df277e02be7dbce_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i063bc72fa7ab4cb6a8c9a466fe5aa116_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieec34b3d38ad47c3a8c65d21d6a37b56_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaa3ffbd8983c4f1ba70c98a0ab97ef7d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifcb4b44207d9466993c79d22ca6e06eb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:ScreeningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i04e1d778217746d0a4ed93e318426779_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9528b0d3873149b0baaa0af2498e1789_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i59324a5c86a042f18bd9bf5e533238e0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0871846c6e044d0289f2d41819e1fb31_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib39277e0ee7649f4a508d3e2c9863dd3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb79758603984bad872062ffd7af29a2_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd8d8fb26ece45a69d29c95350219e5e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia4915188f99d42a6b86eca6320118435_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4f7b5bb29d0e4ce08e610464b1b71b37_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i992eec5c1e0a4469b393b751d5eb9389_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i661a0097adc94c5c86868c8e52fb1c00_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2f52f7ff969c485b96ea18039cc813cd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">exas:InternationalSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i707df04e45c244bdb2753eb7ff65444b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i016c8264c60a431a8ecf3ae449c720c8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i53f4fa3ff2f042ec8152cfdd2a41b981_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id13f5ee7c3f641fc979fe7a4a3c4e208_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9955c3ab73c746da927a0a812a044811_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie52257ef670146a09f3d526496fbd69f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6a45ebc0ee824d3b8b9a76338253a1ae_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe7fefd1dd334af09a0b944eb61e0372_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:PrecisionOncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i42f37da1b5f84e8d9f2274f6ca39cf9e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie93b05b8539f41c1840428f39ff69a20_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2a76a46842ae4cf493ed92d239b12b86_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf18cbd6240143d7b12639b8d3688bda_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="exas:ServiceOrProductTypeAxis">exas:COVID19TestingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4090efeb29b94b56a6aad380d6c19370_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib8250c7f4f5e4113adb46384c985cf13_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i96884d3335c9474d85d0a0151047b3c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i248f0aaf5ff64f5aaee08b667c06b387_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerBasisOfPricingAxis">exas:VariablePriceContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia0cca153dbb14b2f99d14ed4101de2af_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">exas:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8d988dcef79447dcb20227b33fd68679_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">exas:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i11b42a57edea48f5924650bda9e8458a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">exas:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2cfebb799f1944df980320a2b810292b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:CashAndMoneyMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i056bbdc3f35d4f1c97c9eaf225f5e67d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:CashAndMoneyMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i13be9f7dfe5045bfa40c514789b1321c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i83467d26f5bd4aea9d91d6b5d120f225_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c8a7f6ee43e472892b140b9fd2a1a53_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id26cf57382b64fdab7bfd9aa29ea248c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb18575cb9a44b4daebf27decd1b5840_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia73e374a0bd147d2b769746796b11924_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i152dab5324a1480c9feaec96cfb9608b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib7d5f7437ec646d18e769f045a314e6a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i832a3ecaa8474916bdc09a1251d24703_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f7300a597044b329c0be127d20807ba_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1df2197ee3ca4faba476f8e618d26e98_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50e5244a5f34475e816a12b0991473e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i046c9bf82f9d4d84afc8bdb4fbc09ee4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2603c42ca166450aa67a6456c7aac5f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib565421c7a9e4cee80899653950911dd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifee71fa70c5840f2aa66cb1886e4e1e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if97c19b0ff2e426c8ff2e5e5c8c9ba5b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie5d1f9f305b34febb42e7ec0e7aea18f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2c709a9c228d4975bf362e7fbdbaf15d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1eea2a1fc8048b3886f462bacd90918_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1eaf3d04e6d54cb69c0bcb15abf59ad3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0f34accaeb4c4b69bd008a1a7025ae7c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i26037492e0b347dc8fb448751d76c11a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c7eb1cd63614c76a69d6c2265857e45_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:OfficeEquipmentAndComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i73857043c37b41f9baaed76bd0a2da45_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:OfficeEquipmentAndComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a9cb213c64b4411bef4a6f840992c57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:OfficeEquipmentAndComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i17efc5443e29495c96dd26eb9db272fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8206c44cfe3d480d87b647d39baa233b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib08e3529a89e4d289e1bef68ce7d0fcc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9e40593098e345db94df0524569e9818_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84d059ff1b2e4031ad7a352239b93fa2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if185d20192144383ad067c44e7be1c5a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id8e88e6baa0f4bb08fcee1ef175222e9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7428b7f6a341495982fc6f8d0cd2b254_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00a10169cbd94256abf1a671f2b87341_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i850e8485ac9b4874afcdcf9edc86f702_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetUnderConstructionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i397f9e5032ae4722a80dcb17bdcc41dc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if702705143d144ad941b197bde5db8a0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id4a88eba861f4e4192b519eeccb19ef6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2991de22736346499f93730cc6444632_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icb98b0ac54b84d199190275ac41818ce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i42836131dcd845d9b7d67c233c57a9e5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i23b0a3bd4a6c42c2898767451b09fa3b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie377b2d58e75450081174518661faffc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice576d710d154504bb423eb18f1ad591_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i09917a07a99c400e9b8821622e9f4348_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie999f144ca6d42a8945ed5489734beaf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib7453ee4e20e44478b0b8848dde011f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2500b0e4387f476185dd50c36f479490_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic730c612567f459fb5f4f0a35a23f7aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6157347e1860457c9ba2688f1f242d19_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3520dd0084974b7b9d074b11858f9955_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib02b8ec43328475895f430cbf7c3fe17_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18d3648998024a2caf8410e3d681a404_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ae3fe6eee984352a3ff41b1d601ab3a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8e3951d25ef84754a2744cec75114754_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0fde4bcaab504180ae894941003778cc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i890d82d4d1c74eb0bd114be1fd3387da_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8ff8b0693ba14e6a8ba588d8c68f9d36_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">exas:ArmuneBiosciencesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="icce105c6a6b64d718e4502a0b7aa92d7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">exas:ArmuneBiosciencesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6599b9ca619946ee95551b50bc36454a_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">exas:ArmuneBiosciencesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i501c7f9788854b61a82cd861d37a75db_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4920c4a12554781a0baa0e8b7a2a4ca_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:GenomicHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie6653408e966412f9580bd258009d9e9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7670aee13835456b9ef946cbf5090d2c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i076cccc3ea454a719579e19eb576403a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7735b48d36ff44b29b0a466a9b6c6a03_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i9eaa44b39d5645a9a0faf988680be02a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if36c23e4f0c64b8892c737ae997e1b21_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice75a7198c9c4189b63219eac0c1032e_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4330edc45cf84441a4cd9cf3d6dc4379_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iec3596c0cce347588c0c90b759253721_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i71ac0875363d44f48e9a998b50b03693_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id5b310b00e484dcf83114f26ed4d03ab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1edbf863623a4583b670e04195a560f2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f071db6d26f4417836a89ae4bf9dc13_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iae353c40c869427d99501cfd0e428d16_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i47e1dca476854604bbc32c5a07963ffa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia30980f5ef444b3490f4789bea8f12fb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2629689a88b443dc8d9888f5eef1bd71_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie5f1a09055054f3d8d1946791967fc77_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i29cb011245734390b34548e0994a1a0b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i556b2b7061a84128a4bcc29752f8e922_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0e1cdf0f1387456c89946289c26f60e8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic6d0406051014646b0970f3d9130bbb7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i108006d8fdb74103b198303365a9bc58_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic730ed990e6644239b3ae1d4cb5eb387_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iee052d8326c94ffda0d8f89f13146d06_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6f1f3c7b2e624156a85733d1e95e2f04_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6d569e7074a40b4b3e6f21fdc68efdc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iabdd7005af4546f38d23f679ee216c45_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i79793c0a6b4a40bfbc8f7bd09705a9e1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8c347bb18e4e44cd93e616e79b51eadc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iaab539435c7a481aaed99f701cafa053_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6179574a6404661adb02cdfd4ecac70_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f5eb5cb806f46a3a282ece9ae9e05a6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02062cfc353a43feb126d3f904610723_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0332bd716b34f80bbba08e250974a9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98e4418e3f444936ae782784aaf5154c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10f358e0fdb3422f93412305ec8ee504_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ae36a17c1b640618068686e33ff1802_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i456b35ed51ac45b18c17b51e6d86e854_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07629df4ca2c4cbf803a8e9b3e8c6908_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0802092f5404859b5da28c255e698c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70d1e5476c5e4d07af802800933a510b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">exas:RestrictedCashMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e245a53d37346bf907516b3ea304801_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31c943c8a77e42589005bd95b10382ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i672fb690c6e24a47821c2ddc8a90fabb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e24063fca9740369d367ba93027918e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1d60b555b44746d6b68f5fe0334c3ca9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c3a663e94eb4a27bd5c65ba03cacf87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i247aaad53c6245ccbbd5ec147d4988da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib403eea329ef416a8a24ac2287f97a62_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifd7d357017eb4157a5f470172d3e0487_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4dd8f93b52f5442291314fe4545a7ec8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i043e843eab1c434d95629465a45eab9a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43309733f4814ee09bbc83df1d2962fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c5970ee82644e25bb734b992dd63362_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8e8f57f6c664ec39d5d416a45042a81_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ee94b86157f48f68658ceb0b86089f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7735ebc6072e4844a77d8a37da54e9e3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveAndAshionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibd2c2b55dd8e4b4a8baccd8dfe9fabf8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:ProductDevelopmentAndOtherMilestoneBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">exas:MeasurementInputProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib3f1b003917c4eb2b6290a35759a68ab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:ProductDevelopmentAndOtherMilestoneBasedPaymentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">exas:MeasurementInputPresentValueFactorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i63f9bc02d95f4a8d88d901e1d36b8857_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:BiomatricaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:RevenueAndOtherPerformanceBasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0a1df4e2f14a42828145784edc81d152_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if7e54c98df5e425386007ce202a5cdaa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i423735ec2fa04dc998bc308ebb5ebaa2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i46c3a28bcdca48689179ee81c50f41d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i875166f2ce66407bbd9156c0c0b38938_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="if3202fd2c10d4c7398235b5e85235b84_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">exas:OneMonthLondonInterbankOfferRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="iadfa6d5584e64d8d96cf57f8ef06f8c5_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i37e094585ad64a8dbf6962da458f2b91_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i9f3368f21e3f45b08bdf3abf7718904a_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="iafe6aabe3c26422ba3568068ffeae6b5_I20171130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-30</instant>
        </period>
    </context>
    <context id="ib1c80baca1f84cf0b348fa500c7ac519_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0cd6211d49ce40f2a37e553096ffe101_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3bd705add894d9cbb688ee5e9a40dbf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i75e9cb3ad90c4a5d82d4288d4e770a53_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1d7390258e4a4b2ba37dcee40cdf5250_D20191201-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i797d752f32bf41b5a68518c097333f71_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConstructionLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">exas:TaxIncrementFinancingLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife7a525df7ca4926bdd7bd3c78f5a6bd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">exas:TaxIncrementFinancingLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i215a2290155b49189167351e504e7ec6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">exas:TaxIncrementFinancingLoanAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6a521727e1e2422195adff75e2af975a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib556532666a843ffaa7ac89ce011921f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if16b3c6f1e4a4d1489f70faed335b68d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibbba114462ea45e2925e5dd96d8f6ec2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i50e1ec8fda6643ce82eee56046acd62b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icfddf1183e2348268bfa21947a0c2519_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if11cabfe62874386b5321d2d3c18173d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7019a92c504448ceac52c088b3629b1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3877e40a0f249069cae9a5fc123fb01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9d10c4091ef4bb88a8442da98f2e144_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59d45eaa6f404347bac96339127fc805_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38025f781a304faeaa4d5be06d555c28_I20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:JanuaryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="ic2e12ba29e1148cc92200e3f802d478d_I20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-01-31</instant>
        </period>
    </context>
    <context id="i2f6e4612ba6042b3a41b0a3a22cc1a08_D20180101-20180131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-01-31</endDate>
        </period>
    </context>
    <context id="i130815bcac064cb9a769f10dde0d717f_I20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:JuneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-30</instant>
        </period>
    </context>
    <context id="i321e09355b9344bb8c1ddfb4873b74c4_D20180601-20180630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:JuneNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="i374446ae108740e8b3d011f480573480_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:AggregateConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i2cedb49083ec46b7819b0b36b95fd866_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:AggregateConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i8bfcc0d5558a40d4bbafe59948477390_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i7b1067f298de48eca8c19edda276d2ed_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="ida0a237027f04c40b0f9753f4982f052_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="i41663aac7c7a4e50bbe228b3f6df07a4_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5de4fa457232460eb415263a8948799a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:AggregateConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i124fcfaa5c2844ba9a7f3648437e97a4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:January2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icebfd363a27a407f91529aaa90ed0971_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:June2025NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibd02d60e985347cca760b9cee3c1553f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i11ab2964ac5a4d30ab3e51e81e533a19_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i558d42ab543b48d1bd82a3e120ac356d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1c6f646df40d4090b3421105d8392a38_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i25bccea148c24ef3b5882a544e0cc76f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i62e976ba77074ce9b9fe3a0c91204d9f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie533365c1c7a49cfa488f532fa22ddb8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i096f0478568e4ab3ba5831ff5cf0ff8b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">exas:ConvertibleNotesPayable2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i09b705cb560e427b94fb986c5efcc8fa_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:MAYOFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i7687d156b5064d39b98d15068b794c79_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4b58a8bac9c14347b1a5e677d4bd4071_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia4940cc012454056b02ad98f6edbda80_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i38df5143fb9f471eaadf9f61fcdb461a_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:MAYOFoundationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5315ee1596b6499d88299026c527248b_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i08569ff75b9f4fb89d6962ce95f8760d_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="ie431846077ce465aaa2deb9090c42f3d_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="id60aa524dd6844bfab317842fa27f753_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="i073a3afe3259475fa47b27b5734849c0_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="ib66de190a3114ea390108d37accaf4be_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id0e581abbb2e45fb9d0f5e111ecb424d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie75cea8f115f4394bd4c6369824b83e6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9f8d48835a0141b7a3d9e3c2af436ca5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">exas:PfizerIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-14</startDate>
            <endDate>2021-04-14</endDate>
        </period>
    </context>
    <context id="i5fa41ad8e71d4dd28f502802045906ae_I20210414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-14</instant>
        </period>
    </context>
    <context id="i376b181ad07a407cbb2ac71cfb91c79f_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-03</startDate>
            <endDate>2020-03-03</endDate>
        </period>
    </context>
    <context id="i440309922a2844d8b7f20c86821d414f_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i949e45cbfa8f4affa83a6c86d26dc895_D20200303-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-03</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if11e689b7b1c49b3a07b24b28aee69ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b6189b240ae4709b0cb6a53b24b5529_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibb78c2ffc7a24797b5f3efdbf143d558_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9728265290ae4d62bae3395eaa6b09a9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc090024fb42477da472a7b389554c39_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i032fd22b30fc4740afe82de8e068942e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i350ab28dcf6f4361a935ff5ed1b2d4e0_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="id526869db3114853b21ef6d57b0d6023_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1e5ec3803d9c47489d2b8976b93ba9cd_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i871bb8ae36f4481b94f202bc81915ae8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib2b935f915cf4d8284af4012ec5af1fc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i820542840d28423db7a2ed962f5b4151_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibed0ef19bdd64427a77d040d96302174_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i46963a5244634b8a9cb4bede92e87e7c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd69de72c3544263ada7167dc7802735_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0149388bcc174e008d48d4ce24ecd34b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4887ef5292e44700918959f6042a59c3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icecddaccecae455d8964c306f1d3197d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i92f3ebdda81e4395b4fdf88ad090c5ca_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i80e812e1e60a444187707448c6487230_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9f69879b003347d9ad2b403f9773eef5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:EmployeeAndNonEmployeesStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib4a70c95a2c047f2bdceaeba16fb36a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27d111df7c824f28b43805bf4020f417_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82ad627bc9d74b5d9d01292c752d08e0_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">exas:StockBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i980b2917c57c435eae9dc611d50ee893_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia6945ebb4ad9454887ade5b79a893636_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8e2d9caa00d941178a209e6942f90740_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">exas:RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0e95c6cd79cc4d7a935971ea5e1e6e8e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id1ead48ecd8c495a8083ab6bde044c3d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie99e0e805c704e9eb1ceeca30b976339_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i75a8ee4db1a042719bcde877f5d252ea_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i558be5b82da24f16af1d8a52684e9d6d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1f932abf713e4c43a93cd801959cce5e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91c9ab0eda5440bd9d65a69c85ab0eb7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i39ccbffede514c3292129dae5bcde954_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i26b0e97ffe0040889b3f8b090462e327_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">exas:FacilityInLaJollaCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icb129685ec824606a9235abe6526a5d3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">exas:DOSRuleInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0d998ca81b55400f81d638f38b49779c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">exas:DOSRuleInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">exas:NewMarketTaxCreditProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i107170d7fed64652982d166e0b941437_I20150331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-03-31</instant>
        </period>
    </context>
    <context id="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-03-31</endDate>
        </period>
    </context>
    <context id="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1bc1f54843b74a68949920da70be0d63_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9a07478702f74507bc6501dba1c86d9d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">exas:WisconsinEconomicDevelopmentTaxCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i233731ca43664d2c93c9d490bf6d67d5_I20210414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:CommercialLaunchMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-14</instant>
        </period>
    </context>
    <context id="i990575d7a2fe4594870c1692af08e8f6_I20210414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:AshionAnalyticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:MRDProductRevenueMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-14</instant>
        </period>
    </context>
    <context id="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="i70acbbc0dbc5483ab952ef2d524cf18b_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="ib2b131fa1d864ac79567f3577788ccc1_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:FDAApprovalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i55deacfe7ea94c7488107e4687d0d7e9_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:CenterForMedicareAndMedicaidServicesCMSCoverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i434a63ff04d349ca9dd0cd31f8dbd3fe_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i0a0e991fc3574513b998b53a404cbd4d_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:AllocatedToConsiderationTransferredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="ic720ba1718c741998617bf85bd1369ef_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:AllocatedToPreviousOwnershipInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i9e00c316ed7d4743b9ae72c32d1ea634_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:AllocatedToCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i72248a0ae06a4828857001f7eb06939a_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">exas:CompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="ib3b489bbf63f4c70a052049910386070_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="i1f2212887fcb4485932c6ca7b57bac3b_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="i37a4ec695a024e4e80da4d3494beed97_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="i9248689114b34d9bb59ac32e2ea4d2fe_I20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-05</instant>
        </period>
    </context>
    <context id="i739d95546ece4d0bb7484bec638b1ce3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InvestmentIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia1bb5f00a7bb444381ab380f445719b4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2de807b6ca3d4e4a86f20612c5808594_D20210106-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4af871727fe246d883797ebcafb803cf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie231f4fa3d2943ffbe7fe72b6feb6e16_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2208e7b3dafd4734ad1c448f7ee2ebd2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">exas:EmployeesWithQualifyingTerminationEventsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6b29593c68434f2699b1a75adf89a7cf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i836f2fc064cf4745a2df3a6dffded766_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">exas:ThriveEarlierDetectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i68687c83ee8c49eb85c072bb07c29656_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie959531369c94b0683d868dc39af4087_I20200303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-03</instant>
        </period>
    </context>
    <context id="i53102950ca084ca68b3b328343165ec8_D20200304-20210303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-04</startDate>
            <endDate>2021-03-03</endDate>
        </period>
    </context>
    <context id="i660d9c31964046fd8f0829d2e58f4405_I20210303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-03</instant>
        </period>
    </context>
    <context id="i236fa5e8e1614dad9327b02436f9e492_D20200303-20200303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:ParadigmViomicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-03</startDate>
            <endDate>2020-03-03</endDate>
        </period>
    </context>
    <context id="i5084f90d66dc4b7ebb62ead28ea222fe_D20200303-20200303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
        </entity>
        <period>
            <startDate>2020-03-03</startDate>
            <endDate>2020-03-03</endDate>
        </period>
    </context>
    <context id="i98ec76a50c654b3286dda25e4ae5e185_I20210503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:PFSGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-03</instant>
        </period>
    </context>
    <context id="i584d1f57791b47d7842344882f5499e3_I20210623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:PFSGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-23</instant>
        </period>
    </context>
    <context id="i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">exas:PFSGenomicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-23</startDate>
            <endDate>2021-06-23</endDate>
        </period>
    </context>
    <context id="i80ac638840f440a7904d59afcbea3cc5_I20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="ifabaf4b7e254465dbc76f19d64a783d8_I20210111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="i94f31a307e874ce8afdd82c892892230_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ice171bffc87a4afd95cc52b6534e2776_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">exas:TARDISTechnologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="exas:CollaborativeArrangementsSalesMilestoneAxis">exas:SalesMilestoneRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i0c8253dc31a74450a8053d46842c3eb1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7f486f15d984c8ab5076786cc04e07f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i11e90247f0d444a48ddf485761f1c6bc_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91c6bcdbe518418186b36093e716a0e5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6260119aed2d44219f06bcf7f78466ff_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5a40758325f4f10ba85a4d7f63cc106_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia01c094882504b1680c962a4508c16f1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0745308ee7374949b866802826027f90_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124140</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>exas:agreement</measure>
    </unit>
    <unit id="employee">
        <measure>exas:employee</measure>
    </unit>
    <unit id="facility">
        <measure>exas:facility</measure>
    </unit>
    <unit id="segment">
        <measure>exas:segment</measure>
    </unit>
    <dei:DocumentFiscalYearFocus
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV8zLTEtMS0xLTE_f3999791-f229-42d2-9ad2-e47748d2c94a">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV80LTEtMS0xLTE_3e8dde2d-b4e1-431e-9235-1dba81f0bd0b">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV81LTEtMS0xLTE_00357081-893f-4ded-8be2-b686b23378a4">0001124140</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGFibGU6ODI1MjBmZmU1ZDI0NGRhYjgwMzc1ZGE0Nzc3MTc1YzEvdGFibGVyYW5nZTo4MjUyMGZmZTVkMjQ0ZGFiODAzNzVkYTQ3NzcxNzVjMV82LTEtMS0xLTE_d2245361-1186-4f5c-8daf-43779e1a45b8">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80L2ZyYWc6N2RlMGZlZDcxZWFmNGNjNzlkOGQxNDExODZlZDIwNTgvdGV4dHJlZ2lvbjo3ZGUwZmVkNzFlYWY0Y2M3OWQ4ZDE0MTE4NmVkMjA1OF80Mg_bfae8c5f-0fb2-425f-8952-f57db9870ba9">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81OC9mcmFnOmNkODljMWIwZDEzNTRkYzU5ZWRiN2U2MDMwODA2YWViL3RleHRyZWdpb246Y2Q4OWMxYjBkMTM1NGRjNTllZGI3ZTYwMzA4MDZhZWJfMjQy_e181e8c0-7a3d-42ea-83d1-789d5ee50987"
      unitRef="number">0.1326</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81OC9mcmFnOmNkODljMWIwZDEzNTRkYzU5ZWRiN2U2MDMwODA2YWViL3RleHRyZWdpb246Y2Q4OWMxYjBkMTM1NGRjNTllZGI3ZTYwMzA4MDZhZWJfMjQ1_08f6b0ce-bc50-4c94-b93a-d7f05ab60dd6"
      unitRef="number">0.0896</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81OC9mcmFnOmNkODljMWIwZDEzNTRkYzU5ZWRiN2U2MDMwODA2YWViL3RleHRyZWdpb246Y2Q4OWMxYjBkMTM1NGRjNTllZGI3ZTYwMzA4MDZhZWJfMjQ4_9244d8e2-6708-44cf-94ac-96a946f5af23"
      unitRef="number">0.0821</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NA_a63abb75-8298-4289-82ca-d79cd14f64fc">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NQ_a7a5c01b-96cc-4030-a445-b85e4c06296f">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI1MA_7ed6786f-7aa1-4913-ad46-9c4fe5b019bf">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d">P4Y</exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod>
    <exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb">P4Y</exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMTk3L2ZyYWc6ZGM5YzdkYmIwMmNjNDZjNWE0YmJiNjMzZDdhNjgyNTUvdGV4dHJlZ2lvbjpkYzljN2RiYjAyY2M0NmM1YTRiYmI2MzNkN2E2ODI1NV8yMTk5MDIzMjU1NTU3_4d5562d8-8c6b-45a7-a707-cabb69d0386d"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:DocumentType
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU2_7eb2e827-9e03-4e6e-8fda-b9640b494cec">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU3_0b7927ad-a414-41af-989f-a4ba9e4241f8">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMTM_eae0c5ae-02bb-4cc8-8506-849211fc2b9b">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU4_dfc36e0f-46d4-4752-ae5d-3de2e3fa7501">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUy_5ba84d3a-0b5e-43b9-b489-68862060d8a1">001-35092</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDQ5_46017015-cd79-44d6-b473-5548a96a706a">EXACT SCIENCES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8wLTAtMS0xLTE_be028e2e-2831-401d-a1db-e4648621b539">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8wLTEtMS0xLTE_f946856f-94e2-4905-bfbe-698d11e514a6">02-0478229</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTAtMS0xLTEvdGV4dHJlZ2lvbjo5OTFiNDMzZmEyNTU0MDRkODhmMWZiYTFhOTg3ZmE0Ml80_63c20cd3-09b4-4d10-a699-92c850f71ea6">5505 Endeavor Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTAtMS0xLTEvdGV4dHJlZ2lvbjo5OTFiNDMzZmEyNTU0MDRkODhmMWZiYTFhOTg3ZmE0Ml84_dbf5f70f-06a4-4605-8e31-c2c009cb262a">Madison</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTAtMS0xLTEvdGV4dHJlZ2lvbjo5OTFiNDMzZmEyNTU0MDRkODhmMWZiYTFhOTg3ZmE0Ml8xMQ_b04baed5-4615-4a20-a0fe-e5d5b841b739">WI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODkzNTYyYjI0MGNhNGY4YjlmMWIzMjgwNWFiYTE5OTQvdGFibGVyYW5nZTo4OTM1NjJiMjQwY2E0ZjhiOWYxYjMyODA1YWJhMTk5NF8zLTEtMS0xLTE_524e47f0-0f02-4e63-a4e1-ce1b243a98e4">53719</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUz_79af6e8e-da5d-4d1c-8e92-f34aa33b10b1">608</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU0_7b0e0c56-a4a5-4d9e-b04a-2a82c5073dec">535-8815</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6MzExYzdhYjAyMjUzNDViNzg1MzZjYzQzOWI5Y2VhMDkvdGFibGVyYW5nZTozMTFjN2FiMDIyNTM0NWI3ODUzNmNjNDM5YjljZWEwOV8xLTAtMS0xLTE_eb54aad6-10af-40ad-9efa-9b72072f1619">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6MzExYzdhYjAyMjUzNDViNzg1MzZjYzQzOWI5Y2VhMDkvdGFibGVyYW5nZTozMTFjN2FiMDIyNTM0NWI3ODUzNmNjNDM5YjljZWEwOV8xLTItMS0xLTE_91ae4607-7e5d-4308-8fc2-406f579d664d">EXAS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6MzExYzdhYjAyMjUzNDViNzg1MzZjYzQzOWI5Y2VhMDkvdGFibGVyYW5nZTozMTFjN2FiMDIyNTM0NWI3ODUzNmNjNDM5YjljZWEwOV8xLTQtMS0xLTE_18d26a0e-943a-45a6-8f17-6a94d56291a8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDU1_149eacaa-9591-4a36-9a90-542f219f35e6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUw_f1a61bbd-5a2c-4877-bf4c-fa823172e612">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODk4NjM4NDFiNDMyNGQyMDk2YTEyNmZlNDk2YWVlZDQvdGFibGVyYW5nZTo4OTg2Mzg0MWI0MzI0ZDIwOTZhMTI2ZmU0OTZhZWVkNF8wLTAtMS0xLTE_332333ad-567c-46e3-91f5-1fd8866cde0a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODk4NjM4NDFiNDMyNGQyMDk2YTEyNmZlNDk2YWVlZDQvdGFibGVyYW5nZTo4OTg2Mzg0MWI0MzI0ZDIwOTZhMTI2ZmU0OTZhZWVkNF8xLTMtMS0xLTE_7675e349-7e0a-4543-b727-d450a1680939">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGFibGU6ODk4NjM4NDFiNDMyNGQyMDk2YTEyNmZlNDk2YWVlZDQvdGFibGVyYW5nZTo4OTg2Mzg0MWI0MzI0ZDIwOTZhMTI2ZmU0OTZhZWVkNF8yLTEtMS0xLTE_c8f897e7-467e-4f58-a87e-e27e54967b35">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDUx_273f14c6-1cb3-45f0-b741-8629b0f33314">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i4345381fdd3249c7b09e4950af6f50d7_I20211101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xL2ZyYWc6YTM1NjIyOTcxYzQ4NGE4M2E1OTZjYmUzNmY5M2Y3YjEvdGV4dHJlZ2lvbjphMzU2MjI5NzFjNDg0YTgzYTU5NmNiZTM2ZjkzZjdiMV8yMDA5_cb4d1ca2-3d8c-45b9-be5c-f08f114a9a7f"
      unitRef="shares">172318821</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMy0xLTEtMS0x_f52d52f6-c2d9-4528-bd4e-0fa8243eeb82"
      unitRef="usd">273779000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMy0zLTEtMS0x_08e9a446-371a-413c-8c45-b1056f4512f9"
      unitRef="usd">1491288000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNC0xLTEtMS0x_8697c8ab-0552-403a-be6b-f9ab48ad6065"
      unitRef="usd">944688000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNC0zLTEtMS0x_2738c95d-cc67-4cf0-a812-8aa0ee5921c8"
      unitRef="usd">348699000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNS0xLTEtMS0x_2777dae2-10bd-4b78-ba21-49bcbb527b92"
      unitRef="usd">249572000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNS0zLTEtMS0x_93e149a2-79fd-4d6f-8208-dd1ae1b56375"
      unitRef="usd">233185000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNi0xLTEtMS0x_930f744a-4856-4695-9c6f-18a99fc88e00"
      unitRef="usd">95167000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNi0zLTEtMS0x_0e9aedae-ca86-45e1-ab15-404ee908b5f8"
      unitRef="usd">92265000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNy0xLTEtMS0x_bff82d3b-8c28-4b3a-af6b-ae1fda1242b4"
      unitRef="usd">52385000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfNy0zLTEtMS0x_e32d3770-6e2f-4153-a741-4367d4072113"
      unitRef="usd">33157000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfOC0xLTEtMS0x_95c91bd5-ae6c-47a9-811b-4a47c1fb2abd"
      unitRef="usd">1615591000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfOC0zLTEtMS0x_c79cdc7a-2eea-4e8e-8cfc-2e5638500812"
      unitRef="usd">2198594000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTAtMS0xLTEtMQ_b9e9a0b4-0b7a-4543-bb80-72ef7be2a054"
      unitRef="usd">524200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTAtMy0xLTEtMQ_ee0c9769-02d7-472b-b50f-332dbc3abd56"
      unitRef="usd">451986000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTEtMS0xLTEtMQ_1340ee9b-fb1b-46d9-917d-031c0f984c0b"
      unitRef="usd">167911000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTEtMy0xLTEtMQ_2ab32944-fe16-405b-b8e1-707f1a1bfb47"
      unitRef="usd">125947000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTItMS0xLTEtMQ_7f2f7132-4d8b-4382-9496-7ecf07f5a545"
      unitRef="usd">2242535000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTItMy0xLTEtMQ_90bc7ddf-8bd5-4b79-9654-bbb3ab080dd8"
      unitRef="usd">1237672000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTMtMS0xLTEtMQ_23088bbf-3b03-441b-bb71-e3dc256a48c0"
      unitRef="usd">2044958000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTMtMy0xLTEtMQ_8ce40ab5-e3a0-4307-85da-d5fc342bb658"
      unitRef="usd">847123000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTQtMS0xLTEtMQ_8cf858a4-3647-4b1d-be00-e4a787c90760"
      unitRef="usd">59241000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTQtMy0xLTEtMQ_787e6c16-2256-40f3-9121-e37784c84436"
      unitRef="usd">63770000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTUtMS0xLTEtMQ_d014c4f8-b7ef-450e-ba28-dbb422fa4df5"
      unitRef="usd">6654436000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTUtMy0xLTEtMQ_a8bde2ed-30c1-415a-8ff8-e18929329d91"
      unitRef="usd">4925092000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTgtMS0xLTEtMQ_a8273ba5-b17c-486b-baa7-add1e1e1ae71"
      unitRef="usd">41717000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTgtMy0xLTEtMQ_15db7078-9eda-42fd-a808-4e013971f892"
      unitRef="usd">35709000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTktMS0xLTEtMQ_42847e61-b0e3-4b24-9c56-d46e0689ab68"
      unitRef="usd">304714000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMTktMy0xLTEtMQ_2f90a0b8-0991-4f50-aaaf-5cfe6c2a2017"
      unitRef="usd">233604000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjAtMS0xLTEtMQ_177d39ea-940f-4457-b7cc-059aae799add"
      unitRef="usd">19220000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjAtMy0xLTEtMQ_1bbc880f-91e8-4bab-a3c4-9cfc06e35876"
      unitRef="usd">11483000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjEtMS0xLTEtMQ_04379deb-0efb-4178-b680-787145877fae"
      unitRef="usd">1319000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjEtMy0xLTEtMQ_91e778e5-c290-49a2-a11e-ac46a513fe2f"
      unitRef="usd">1319000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjItMS0xLTEtMQ_a7b55e45-7a5c-41fc-aa9c-77925b69b2f9"
      unitRef="usd">313104000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjItMy0xLTEtMQ_5f226618-6c34-4b20-85a8-cd0ebe76bc3c"
      unitRef="usd">312716000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjMtMS0xLTEtMQ_2dc4b53b-c208-4da0-a3b6-d5c2b39aec9d"
      unitRef="usd">30157000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjMtMy0xLTEtMQ_3680e6c3-0ce9-4d05-ae6b-24ee7e4138f2"
      unitRef="usd">38265000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjQtMS0xLTEtMQ_a94c1a98-b066-4a63-8f8c-000813171927"
      unitRef="usd">710231000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjQtMy0xLTEtMQ_796e30b2-7c6c-433c-93ca-e970f3d63677"
      unitRef="usd">633096000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjYtMS0xLTEtMQ_6a45b7f1-aa7c-4ba2-9907-990935c45580"
      unitRef="usd">1865647000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjYtMy0xLTEtMQ_2e9d17c9-e04b-4792-8b54-ef58118a9c17"
      unitRef="usd">1861685000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjctMS0xLTEtMQ_ec5b56f4-7b9e-47a8-b62f-c00b768c07df"
      unitRef="usd">21438000</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjctMy0xLTEtMQ_c9ee753b-cd39-4944-9ac6-05f1fb35d3b0"
      unitRef="usd">22342000</us-gaap:LongTermLoansPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjgtMS0xLTEtMQ_4b39b1a3-a8be-4f23-807a-06180eddfed6"
      unitRef="usd">436580000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjgtMy0xLTEtMQ_b52d2d3b-b7c2-40c2-a0cd-d392b7f5586b"
      unitRef="usd">51342000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjktMS0xLTEtMQ_e18e05e3-0459-42e0-8e94-05d4e8737e28"
      unitRef="usd">162950000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMjktMy0xLTEtMQ_54529b53-ef24-412f-bfea-2f7a00752166"
      unitRef="usd">121075000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzAtMS0xLTEtMQ_1a6b2b78-31e9-438c-bdb5-9bc7e8c418fc"
      unitRef="usd">3196846000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzAtMy0xLTEtMQ_7be107be-0aec-4a94-9c06-911922cbcb15"
      unitRef="usd">2689540000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzEtMS0xLTEtMQ_50178a73-b658-4731-abab-5ee3a40cd82f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzEtMy0xLTEtMQ_b9c7d0ea-85df-4668-968e-0b74a0929874"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzIx_4729dc42-c72a-451e-927e-82f2f9c3f4c7"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzIx_b5e50a23-15ef-4d75-8a28-07bec760c034"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzQ1_6ddfc6b5-36fe-4fe8-84e4-035dfa32c65c"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1XzQ1_8c2ac30f-d145-40d9-9042-f91ed6a0ade3"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_2f22bd15-2d39-4ff1-a036-d5779de3364a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_36f0bd7b-cd10-4e87-8971-46184fa51ee4"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_c6842332-3c3b-4ea0-ae2c-1cb119a67d69"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMC0xLTEtMS90ZXh0cmVnaW9uOjhlNGI1OTlmOTA0YzRhNzc5OTMzZWU4MjkyODA2NDQ1Xzc4_e8808c23-1e55-4ca7-bca7-14b4fff035ad"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMS0xLTEtMQ_f010729d-dfad-457d-a575-46b5a0597a33"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzMtMy0xLTEtMQ_0e2b7e43-9296-4f87-9ed7-d4d991431c31"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzE4_ae545512-7843-4614-b8a9-69dccb228782"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzE4_ba07ba65-2c7a-4255-8da5-33f57161e74f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzQy_d136cd03-90af-4c99-8482-49ed4842fad7"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzQy_df49bc6e-75da-423a-945e-474bcb6997ef"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzc1_62b4f3fc-fe25-4102-acba-9145cdf6ea59"
      unitRef="shares">172242798</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzc1_8b741d5d-e934-4f02-8ddf-fd4669689147"
      unitRef="shares">172242798</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzgy_a27a92be-4a7c-4ed8-b2a6-5b17a98e4204"
      unitRef="shares">159423410</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMC0xLTEtMS90ZXh0cmVnaW9uOmE2YmQ5ODgxNTQ1MDQwNGRhZDkwZDlkNGVmMjgyNjczXzgy_a91465d9-2929-431f-9b78-aa122b1200d3"
      unitRef="shares">159423410</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMS0xLTEtMQ_ae3828cc-f74f-409b-bc2e-46dcc2ef98ad"
      unitRef="usd">1723000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzQtMy0xLTEtMQ_3aa4cf7e-7c23-43fc-8cc3-cd2efcbce51c"
      unitRef="usd">1595000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzUtMS0xLTEtMQ_d23ac330-f95a-4e29-92d8-a1a5af30b08f"
      unitRef="usd">5876644000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzUtMy0xLTEtMQ_93046777-359d-49c2-b55b-80675329c3b8"
      unitRef="usd">4279327000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzYtMS0xLTEtMQ_fd02b4e5-fdf3-4b5a-83ff-120a2ac96b40"
      unitRef="usd">133000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzYtMy0xLTEtMQ_b6c0e077-887b-4f85-84ba-2a0f373cc87b"
      unitRef="usd">526000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzctMS0xLTEtMQ_2d33a8f7-9bef-4bb8-be9b-f5b8b0d0f25e"
      unitRef="usd">-2420910000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzctMy0xLTEtMQ_cb2caab5-575f-4c7c-989c-8c67e4d24837"
      unitRef="usd">-2045896000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzgtMS0xLTEtMQ_59087cb5-afd9-40a6-bb40-cd3437439c06"
      unitRef="usd">3457590000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzgtMy0xLTEtMQ_1f138f15-20b9-44e8-8250-a946a15428af"
      unitRef="usd">2235552000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzktMS0xLTEtMQ_046e8c50-4ac9-49b8-890d-a4abb616af63"
      unitRef="usd">6654436000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xMy9mcmFnOmJhNzNjOTZkNzcwYjQxMGE4MWZiNWQxZDdhNGRkZjA5L3RhYmxlOjc4ZDNhYmZmZTZiYzQyMGZhMzkwNTIxZDVlODRiZThlL3RhYmxlcmFuZ2U6NzhkM2FiZmZlNmJjNDIwZmEzOTA1MjFkNWU4NGJlOGVfMzktMy0xLTEtMQ_51e83a2a-4d55-4523-b84e-c34eb32ca1b0"
      unitRef="usd">4925092000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi0xLTEtMS0x_910e3e84-c4a0-4f04-996e-17f88b175242"
      unitRef="usd">456379000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi0zLTEtMS0x_6bfccf7e-b357-4c58-8e60-c2e69e6ce784"
      unitRef="usd">408363000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi01LTEtMS0x_61d7356b-8ed5-4ee0-8c1e-ce00ea8b831c"
      unitRef="usd">1293275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMi03LTEtMS0x_4d57ed78-4591-49be-a01c-f9c75ce99c7b"
      unitRef="usd">1025052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS0xLTEtMS0x_c260cf2c-2c76-43b5-8ca8-21a17483f39c"
      unitRef="usd">115738000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS0zLTEtMS0x_84a85724-dd09-42c5-9860-9ce97a70b8bb"
      unitRef="usd">95061000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS01LTEtMS0x_584f82d6-5921-4c5a-9fcd-e2d1f204f94c"
      unitRef="usd">339699000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNS03LTEtMS0x_1dff9146-c916-45fe-b0ff-bc8c3317629f"
      unitRef="usd">254559000</us-gaap:CostOfRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi0xLTEtMS0x_149ba1fd-ea59-44ed-a550-ca7fdb8a3515"
      unitRef="usd">75356000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi0zLTEtMS0x_d214096d-3eec-44b9-85e8-07338b0f1aa7"
      unitRef="usd">31471000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi01LTEtMS0x_cf200368-93f2-475e-946e-5fa0e4402f5c"
      unitRef="usd">297158000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNi03LTEtMS0x_62ff423f-fada-46c8-9bd9-0065dfb90b48"
      unitRef="usd">107653000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy0xLTEtMS0x_7bf28736-e3b6-4ae4-ba41-cc269ed797b8"
      unitRef="usd">196617000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy0zLTEtMS0x_e01a69ae-ebad-4903-ada2-55202bc9d7dc"
      unitRef="usd">136481000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy01LTEtMS0x_81a388d2-34b6-4754-a176-accdd8992a1f"
      unitRef="usd">577585000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfNy03LTEtMS0x_6b8e149e-b25c-4fdb-a6bd-36fac90127b2"
      unitRef="usd">423092000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC0xLTEtMS0x_7e62c179-f8e9-4b82-9088-fcde9a612327"
      unitRef="usd">186541000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC0zLTEtMS0x_87384eff-367e-4546-a29f-ca07f770429f"
      unitRef="usd">115589000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC01LTEtMS0x_c2c674d9-e44a-4899-90e6-4908efec29df"
      unitRef="usd">621897000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOC03LTEtMS0x_360586bb-0cf6-4408-8611-814f80b42641"
      unitRef="usd">336265000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS0xLTEtMS0x_0b31d47f-da48-483b-b503-3fc59b2ad769"
      unitRef="usd">23940000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS0zLTEtMS0x_2f881637-adfb-41a9-bdd4-09f8ce04ccfe"
      unitRef="usd">23430000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS01LTEtMS0x_ab197447-d9af-4361-8c77-baf5980dd260"
      unitRef="usd">70954000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfOS03LTEtMS0x_2d201873-5026-4e83-9e52-70ec33608e05"
      unitRef="usd">70199000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMS0xLTEtMjY2_a31931cc-92ca-48ec-bb89-c48160ebd1f8"
      unitRef="usd">20210000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMy0xLTEtMjY2_b4aefd6b-aee9-4f03-a358-b8a1f44cce24"
      unitRef="usd">209666000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNS0xLTEtMjY2_126b0d9e-841f-44c2-a91f-5d02dc3e6a18"
      unitRef="usd">20210000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNy0xLTEtMjY2_6f1e0f95-94fa-4146-a6e5-5e6560a31347"
      unitRef="usd">209666000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:CostsAndExpenses
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMS0xLTEtMQ_60176d86-3fc4-4c3e-a83f-a14e58ea4f6c"
      unitRef="usd">618402000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtMy0xLTEtMQ_9cddff02-8e30-4813-9883-e45aabde1411"
      unitRef="usd">611698000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNS0xLTEtMQ_3035c30e-680f-48d2-8fa9-c30cf51bc6fb"
      unitRef="usd">1927503000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTAtNy0xLTEtMQ_15395e56-a7f1-4819-a9c9-b03139ee4a51"
      unitRef="usd">1401434000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherOperatingIncome
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItMS0xLTEtMQ_6c33dec3-9e33-43c6-99c3-e05e0601599c"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItMy0xLTEtMQ_cecce2eb-528e-4a83-a5d0-04df68e77bea"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItNS0xLTEtMQ_a6f1b107-56bc-4965-81e6-930a7fa057ff"
      unitRef="usd">0</us-gaap:OtherOperatingIncome>
    <us-gaap:OtherOperatingIncome
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTItNy0xLTEtMQ_7886bd71-0e86-4128-9b88-d9eac3e178f6"
      unitRef="usd">23665000</us-gaap:OtherOperatingIncome>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtMS0xLTEtMQ_48b33144-b4e6-44dc-8677-fafa4398dda6"
      unitRef="usd">-162023000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtMy0xLTEtMQ_5e290d06-d1ef-4191-a236-5445a089ad37"
      unitRef="usd">-203335000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtNS0xLTEtMQ_d675ed0f-8f9a-487e-9e9d-22185f67406c"
      unitRef="usd">-634228000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTMtNy0xLTEtMQ_2b4369c9-ccc5-458b-abba-067e5dc712a6"
      unitRef="usd">-352717000</us-gaap:OperatingIncomeLoss>
    <exas:InvestmentIncomeExpenseNonoperating
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtMS0xLTEtMQ_0522a94f-f458-4950-a9d5-98746f582e37"
      unitRef="usd">-4093000</exas:InvestmentIncomeExpenseNonoperating>
    <exas:InvestmentIncomeExpenseNonoperating
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtMy0xLTEtMQ_a6f6c130-2d18-491d-9645-824717b1d086"
      unitRef="usd">2523000</exas:InvestmentIncomeExpenseNonoperating>
    <exas:InvestmentIncomeExpenseNonoperating
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtNS0xLTEtMQ_ae1b2881-b4aa-4956-8171-84f12e0b11bc"
      unitRef="usd">30524000</exas:InvestmentIncomeExpenseNonoperating>
    <exas:InvestmentIncomeExpenseNonoperating
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTYtNy0xLTEtMQ_c1327de1-af0e-4634-b46c-68d00d6d11a8"
      unitRef="usd">5532000</exas:InvestmentIncomeExpenseNonoperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctMS0xLTEtMQ_e7824e4f-be34-4c1a-8286-f93003a41a81"
      unitRef="usd">-4680000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctMy0xLTEtMQ_b726c87b-5eab-4bf7-b60b-7ef64e36dabf"
      unitRef="usd">-4478000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctNS0xLTEtMQ_8a3edd55-d15a-43f4-8237-9423135bade1"
      unitRef="usd">-13948000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTctNy0xLTEtMQ_b8fb6c96-f9e9-4f30-9f7e-12619e5cfd5a"
      unitRef="usd">-63382000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtMS0xLTEtMQ_7d65c683-4def-4d48-af65-ffb6e278b2e2"
      unitRef="usd">-8773000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtMy0xLTEtMQ_6fbe277b-8e85-46fd-8044-334c8934e20b"
      unitRef="usd">-1955000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtNS0xLTEtMQ_782b3c29-5a1c-48ad-a0e0-1433c62414b5"
      unitRef="usd">16576000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMTgtNy0xLTEtMQ_3518816e-2b21-451a-95ae-825a698d794c"
      unitRef="usd">-57850000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtMS0xLTEtMQ_331bf4d8-4c91-48cf-b970-ad8a82d1e6e1"
      unitRef="usd">-170796000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtMy0xLTEtMQ_ca9cfbf6-01bb-419f-9391-3465cf5d7830"
      unitRef="usd">-205290000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtNS0xLTEtMQ_0031e5c9-826a-4360-b2f2-995e1b3a152f"
      unitRef="usd">-617652000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjAtNy0xLTEtMQ_4cf912b0-e285-4e82-a7da-3824ed00ea67"
      unitRef="usd">-410567000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItMS0xLTEtMQ_c2a3d349-0a44-4f83-bddc-7cea2a0267d8"
      unitRef="usd">-3858000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItMy0xLTEtMQ_b809f1b0-57d2-4376-b082-14397248f9f1"
      unitRef="usd">-2752000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItNS0xLTEtMQ_d4520d8a-3f3f-465f-87cb-750e7c68abfa"
      unitRef="usd">-242638000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjItNy0xLTEtMQ_50ea01a6-678c-4a05-b452-16d5fb9476f5"
      unitRef="usd">-5294000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtMS0xLTEtMQ_cb35a3ba-2d92-4b41-ad52-faa0c97e8d32"
      unitRef="usd">-166938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtMy0xLTEtMQ_a3846831-3fdd-4897-ae46-d87820c86c3e"
      unitRef="usd">-202538000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtNS0xLTEtMQ_997c8cd0-cff7-47a0-a8d6-73c9d9d352ed"
      unitRef="usd">-375014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjQtNy0xLTEtMQ_806ef33b-1d23-4f0a-8007-725aba3d255d"
      unitRef="usd">-405273000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMS0xLTEtMQ_c6786d09-ee94-4679-a830-a2e2522f2ec3"
      unitRef="usdPerShare">-0.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMS0xLTEtMQ_fcb0cf58-2d9e-47b1-9751-1b0ae5d574d1"
      unitRef="usdPerShare">-0.97</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMy0xLTEtMQ_7aac35e9-22a5-4ad8-b242-691175451a07"
      unitRef="usdPerShare">-1.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtMy0xLTEtMQ_b4d4425d-cfa4-4715-bc20-30dea812c703"
      unitRef="usdPerShare">-1.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNS0xLTEtMQ_4fb72e39-7a8c-4d6d-a89a-9a70e0d21d93"
      unitRef="usdPerShare">-2.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNS0xLTEtMQ_9dd1389b-f882-4a22-a96f-5b07c3d8d8dc"
      unitRef="usdPerShare">-2.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNy0xLTEtMQ_17b45bf9-2ad0-41f0-aaf3-33468e8dc28a"
      unitRef="usdPerShare">-2.71</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjYtNy0xLTEtMQ_fe225dc5-baa9-4c71-ba2d-5ff62713d6ac"
      unitRef="usdPerShare">-2.71</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMS0xLTEtMQ_0c399f13-5978-45af-ac3c-9dff62b54dec"
      unitRef="shares">171978000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMS0xLTEtMQ_928ee9c5-705b-4741-ad51-442a8647ca09"
      unitRef="shares">171978000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMy0xLTEtMQ_1e91f91a-f5d4-4c63-868b-41a578e3d09a"
      unitRef="shares">150155000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtMy0xLTEtMQ_2bd7d3af-6a56-44e6-a3c0-150e786647cf"
      unitRef="shares">150155000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNS0xLTEtMQ_08d978a3-731f-41e6-b770-c133bed1aadc"
      unitRef="shares">170978000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNS0xLTEtMQ_c7cee06b-0822-4704-81ee-48cc26974453"
      unitRef="shares">170978000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNy0xLTEtMQ_1692dc23-1143-4f30-9d9b-8cc80cd094ce"
      unitRef="shares">149346000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xNi9mcmFnOjY2MmY4NWNjNGQ5ZjRhNDNiZjExZDQwZDBkNDQ5OTMwL3RhYmxlOjZkY2UxZDE1MmQ1ZjRlYjM4ZmJiODEzNmMyMjRlYWI1L3RhYmxlcmFuZ2U6NmRjZTFkMTUyZDVmNGViMzhmYmI4MTM2YzIyNGVhYjVfMjgtNy0xLTEtMQ_a3064940-6100-4967-955e-d4a6059560d8"
      unitRef="shares">149346000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi0xLTEtMS0x_5972c2e1-ea4a-4354-8de8-c2cd4e867100"
      unitRef="usd">-166938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi0zLTEtMS0x_5d06adbe-ef31-445c-9569-dc7400de0bec"
      unitRef="usd">-202538000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi01LTEtMS0x_e273ca00-847b-4bed-ac02-d5f3d6d5138f"
      unitRef="usd">-375014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfMi03LTEtMS0x_0892e237-a6d3-4fcc-937c-c9ac6d06749f"
      unitRef="usd">-405273000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC0xLTEtMS0x_45a3498a-f9c6-4d6d-8448-c1d3bbca4011"
      unitRef="usd">66000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC0zLTEtMS0x_c3fe8f3f-2d19-4837-a68a-c034041aff5b"
      unitRef="usd">-405000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC01LTEtMS0x_e221c5fd-6c3d-4466-9ae3-7c3ce6e476ff"
      unitRef="usd">-563000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNC03LTEtMS0x_ff8edf18-5208-40c7-80d4-8918a6d93319"
      unitRef="usd">1159000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS0xLTEtMS0x_06f36e19-25e2-4fdc-853e-68960c60183b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS0zLTEtMS0x_c8474a02-3408-46d8-9f19-5c8c5210cb97"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS01LTEtMS0x_fb4e8ebb-d6a1-4c37-8c7d-2b100dce46d2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNS03LTEtMS0x_3b88b3da-c12d-44ce-afd5-eea3bd141a39"
      unitRef="usd">25000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <exas:ComprehensiveIncomeLossBeforeTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi0xLTEtMS0x_673c7681-a228-41e8-86fd-a65c2de225db"
      unitRef="usd">-166872000</exas:ComprehensiveIncomeLossBeforeTax>
    <exas:ComprehensiveIncomeLossBeforeTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi0zLTEtMS0x_556acb65-9a7a-42eb-ae80-cd3dda8c38d8"
      unitRef="usd">-202943000</exas:ComprehensiveIncomeLossBeforeTax>
    <exas:ComprehensiveIncomeLossBeforeTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi01LTEtMS0x_5cfd8529-546c-4d70-abdf-c2fce1b24e58"
      unitRef="usd">-375577000</exas:ComprehensiveIncomeLossBeforeTax>
    <exas:ComprehensiveIncomeLossBeforeTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNi03LTEtMS0x_7b47f698-f162-4b78-92de-643a161feefc"
      unitRef="usd">-404089000</exas:ComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy0xLTEtMS0x_7333849b-f421-4b7f-8ea3-de9682b11cfa"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy0zLTEtMS0x_c4ad724d-1413-4652-884e-90f4048292b9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy01LTEtMS0x_23c2e80c-4af9-497d-9f21-2f6ccf464440"
      unitRef="usd">-170000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfNy03LTEtMS0x_14811270-7045-4ff5-8fb3-576b867d56d1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC0xLTEtMS0x_f5534830-7826-4c65-8a26-385986cf21f8"
      unitRef="usd">-166872000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC0zLTEtMS0x_57dce947-5431-44fd-a454-b0ac51e6a302"
      unitRef="usd">-202943000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC01LTEtMS0x_b5e228fb-4816-459c-8cb4-d900b72f51bb"
      unitRef="usd">-375407000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8xOS9mcmFnOjhhMjdhMTYwY2Y1MDQ3YWRhN2FjODY3Zjc5NzExZmUzL3RhYmxlOmQzNmZiYzRhYTgwZTQ4MDk5YjVjYjM1MmFiYTBlZmE1L3RhYmxlcmFuZ2U6ZDM2ZmJjNGFhODBlNDgwOTliNWNiMzUyYWJhMGVmYTVfOC03LTEtMS0x_537b7514-7d53-4fdd-aede-8f2e2ebd937d"
      unitRef="usd">-404089000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMS0zLTEtMS0xL3RleHRyZWdpb246Yjg4ZGZjMjZmNmNkNDQ2M2E3ZTIwMjEwNzRjYmY2ZDRfNA_2b2eeeb8-e56f-401c-8039-c03fa289b37f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3a089c68d2054e71ae53dbe33acb46e3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi0xLTEtMS0x_178308bd-7f5d-4689-a584-1920b2ebb993"
      unitRef="shares">159423410</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3a089c68d2054e71ae53dbe33acb46e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi0zLTEtMS0x_d3c7747f-eb40-4af0-af63-de91a984b4af"
      unitRef="usd">1595000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic2d218d7eeae48b689178b021a2d9641_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi01LTEtMS0x_cf230bb1-f933-4a46-88af-53e86deb5813"
      unitRef="usd">4279327000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d1a5e4e4fb3441dbfac2e16747f0f82_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi03LTEtMS0x_ff6c37d6-60c4-4983-9042-88e78320a8e0"
      unitRef="usd">526000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41f71ee0084e4eadb1fad7a7287abf77_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi05LTEtMS0x_f9d1d21a-7d15-4fee-9432-9c850522f0f8"
      unitRef="usd">-2045896000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMi0xMS0xLTEtMQ_c60e5db4-5da0-439b-8a2e-9ca83a91da6c"
      unitRef="usd">2235552000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMy0xLTEtMS0x_8df259af-d6c5-4317-bf55-47f6e0a3b2c9"
      unitRef="shares">344</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMy01LTEtMS0x_67fb6231-b2a1-4289-8205-3b39f9d54b51"
      unitRef="usd">26000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMy0xMS0xLTEtMQ_c7246442-0a93-4a8d-ac27-7e55f6b02939"
      unitRef="usd">26000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC0xLTEtMS0x_62e05936-c5a1-45a4-997d-15cb4a53df83"
      unitRef="shares">967107</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC0zLTEtMS0x_68dbd0e8-e04d-43a9-90cc-1efacd5c85ba"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC01LTEtMS0x_9a39fdb1-1d20-4aee-b00e-8b7e0d048f6d"
      unitRef="usd">8749000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNC0xMS0xLTEtMQ_7027d726-a6ac-48b2-8bf7-11995c0da33b"
      unitRef="usd">8759000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS0xLTEtMS0x_dc968b31-baf3-467a-a355-12c062ccc6b3"
      unitRef="shares">162606</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS0zLTEtMS0x_c2f83e10-209b-4943-8389-16d9c840f7e9"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS01LTEtMS0x_93f594b5-5224-4aa4-94f8-2f6e656b86b5"
      unitRef="usd">22932000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNS0xMS0xLTEtMQ_143c00b7-713a-4353-99ce-15a42baac12d"
      unitRef="usd">22934000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi0xLTEtMS0x_e0cfad6d-2516-4dcf-9b47-ecad1b8bebe7"
      unitRef="shares">1355435</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi0zLTEtMS0x_814a9965-5b8c-4e35-906f-73e9d54345cf"
      unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi01LTEtMS0x_a0ec84a7-6386-4f2d-918b-da79fe83bc1b"
      unitRef="usd">158239000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNi0xMS0xLTEtMQ_c5949474-3ac9-4b24-9d35-3e807a82283a"
      unitRef="usd">158252000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy0xLTEtMS0x_de1c0726-a258-45f8-8294-9d62c803a515"
      unitRef="shares">9384410</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i34c8dfbdd693442781c06071382283a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy0zLTEtMS0x_9fa16f3b-dc0b-404a-a9d1-a8f7d2da933d"
      unitRef="usd">94000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i06acbbeed575445bb4555931be715a61_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy01LTEtMS0x_d454d425-f700-44dc-8439-277a71cfa1e3"
      unitRef="usd">1254704000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfNy0xMS0xLTEtMQ_0b1bd94d-710c-4fc4-82f4-eac336a3a225"
      unitRef="usd">1254798000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i35f5f3b14daf4545b117801527f11480_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOC05LTEtMS0x_16535c89-a06e-430c-a32c-32f0a56a88bc"
      unitRef="usd">-31164000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOC0xMS0xLTEtMQ_bd0831d9-c358-4b83-a0ee-63b7119e33e0"
      unitRef="usd">-31164000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i094f6b20548e406aa1288c2f7bb503ce_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOS03LTEtMS0x_8a7bd4cd-ccde-4563-aa61-b30f769bea70"
      unitRef="usd">-162000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8871b403bd4f4b078ec457ed2fe0e4a0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfOS0xMS0xLTEtMQ_9fcba27e-91a7-44d8-b167-d2960acd0c48"
      unitRef="usd">-162000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i01dccf0f1cd74d4b9ba6b84dc1db95d1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtMS0xLTEtMQ_ce8767c1-7b43-4fdb-80e7-aa5de6f3da29"
      unitRef="shares">171293312</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i01dccf0f1cd74d4b9ba6b84dc1db95d1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtMy0xLTEtMQ_7ab8ebcc-35ea-4135-aae9-6f677a61d8fc"
      unitRef="usd">1714000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8ec01d6b22540e381cef4d704dbefdd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtNS0xLTEtMQ_dfd488ae-bc59-4096-b543-9ccf01324634"
      unitRef="usd">5723977000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i037dafa9fcb1448595787e22be1373a3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtNy0xLTEtMQ_dbb97aae-2e98-4990-95f1-2b5d9f03e4aa"
      unitRef="usd">364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if4239b36587d47b9b67ceb074d0de230_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtOS0xLTEtMQ_afb7e520-8f2e-44d1-894a-2defc81ff505"
      unitRef="usd">-2077060000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id326b3d6f1254686955c693689f8d7d8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTAtMTEtMS0xLTE_d8cadfb4-78c2-4719-9585-e0c864068e6a"
      unitRef="usd">3648995000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTEtMS0xLTEtMQ_2d23ce99-bf4b-4526-b411-260e154ebfea"
      unitRef="shares">197</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTEtNS0xLTEtMQ_c154430f-ed9b-4656-bf40-e9ae7610f265"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTEtMTEtMS0xLTE_3e775822-1f89-4d2e-9466-c5f49f9f3dbb"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItMS0xLTEtMQ_ff7855d7-6b6b-487c-9c0d-91622a75704a"
      unitRef="shares">140478</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItMy0xLTEtMQ_a4635c99-4add-4663-a4a1-98192dbda977"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItNS0xLTEtMQ_6eba08c2-a9ba-4e34-951d-0e62283751e6"
      unitRef="usd">2857000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTItMTEtMS0xLTE_e0a91d02-36fd-450c-9301-063ec3d48fed"
      unitRef="usd">2858000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtMS0xLTEtMQ_cca7378d-f246-41e3-9bd6-91c54d70841f"
      unitRef="shares">121575</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtMy0xLTEtMQ_30470d4c-db35-4ac5-93d9-06d0ac0e7ec7"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtNS0xLTEtMQ_bf748b5e-1571-40f4-a4fe-20e6098a7434"
      unitRef="usd">56283000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTMtMTEtMS0xLTE_b87b62b7-b1fa-4bc5-b2c2-caf41e2013fa"
      unitRef="usd">56285000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtMS0xLTEtMQ_550beb61-6ff1-43b9-8a5e-8abe0bbb2ef6"
      unitRef="shares">126026</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtMy0xLTEtMQ_12bda5f8-55a8-4ed9-aec5-e19cdd5739c4"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtNS0xLTEtMQ_53074e79-0176-4419-9d6a-c5d5241528b1"
      unitRef="usd">16119000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTQtMTEtMS0xLTE_398e9a28-9cfc-4629-9c03-dcd2009d0540"
      unitRef="usd">16120000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtMS0xLTEtMQ_ca30cbb1-7064-4ccd-8670-5de8a3b6c777"
      unitRef="shares">173717</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i481655aa627e4f5e8afa1d10e4166266_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtMy0xLTEtMQ_9ab29389-0721-427a-88f4-b398af9c3b6a"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i3daf8f4ee6364c6ca9e19061d02919f5_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtNS0xLTEtMQ_7f38a83d-3a22-43ed-ae27-af511bd307ea"
      unitRef="usd">12036000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTUtMTEtMS0xLTE_09fdf85e-4748-4cb0-a898-c4f76e37f82a"
      unitRef="usd">12038000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="i0baa301bd4a2483fb87ec3ff4678d7b3_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTYtOS0xLTEtMQ_a0697525-1814-4229-973e-da5522419656"
      unitRef="usd">-176912000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTYtMTEtMS0xLTE_1c10746b-2e02-4885-9602-c818f0a7ab14"
      unitRef="usd">-176912000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i19d78ab3ef424e599d850c44805a1ce8_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTctNy0xLTEtMQ_19949b5d-9fae-40d0-878e-1b36fd665ecd"
      unitRef="usd">-297000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib55ef7b106ca4439a1e951eb72191194_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTctMTEtMS0xLTE_7cada29c-b5bc-4e6e-8db1-29ab24558399"
      unitRef="usd">-297000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7570a7ca68604ab193ddcc503f407047_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtMS0xLTEtMQ_81e260de-ab6d-4e86-9008-6c607786b270"
      unitRef="shares">171855305</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7570a7ca68604ab193ddcc503f407047_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtMy0xLTEtMQ_4eb038b2-808c-4355-8843-8f9bedd1d458"
      unitRef="usd">1720000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c13f47ff92f4d38a48f563ec039cca7_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtNS0xLTEtMQ_2ba2e2a1-ef4b-4acc-a85c-b9f446af2749"
      unitRef="usd">5811286000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9a00307d8ec84b5e91e63fb7f9ff072e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtNy0xLTEtMQ_b057de3c-3c1b-4999-b7ba-2e9010df6cfc"
      unitRef="usd">67000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic6d6c8e24a154e2298c770d5ede9849a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtOS0xLTEtMQ_8ad6ac54-ff83-4a07-b4b5-d68f8a37c578"
      unitRef="usd">-2253972000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae0e894a4a7f44789a730dae8d02a80e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTgtMTEtMS0xLTE_64892cc6-7cbd-43ff-8885-bb09aa8d754a"
      unitRef="usd">3559101000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMS0xLTEtMjY2MTY_a28455ea-fc1b-40cc-82d5-4765b151fb12"
      unitRef="shares">39</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktNS0xLTEtMjY2MTY_f3ba3824-e9a1-4091-bf65-66aa5a6060a0"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMTEtMS0xLTI2NjE2_0c72874e-3831-4299-aa99-b23bdbe2054b"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMS0xLTEtMzc5_ed00bb7f-2f3f-4d61-9544-6edefb22d920"
      unitRef="shares">100474</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMy0xLTEtMzc5_b11fd16f-d9ae-4754-b3d6-29f4401bc721"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktNS0xLTEtMzc5_c37db1ea-1c41-4202-a17c-a4f864053c2f"
      unitRef="usd">1754000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMTktMTEtMS0xLTM3OQ_ac45374e-4a57-4744-a282-3a8e91c79a5e"
      unitRef="usd">1755000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtMS0xLTEtMzc5_623b7e04-7bd7-43cc-9c27-046313737a6e"
      unitRef="shares">286980</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i79ea2753506242c9aa498b3f8139d288_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtMy0xLTEtMzc5_c30b98d2-c8e4-4e96-9454-712da55b80ef"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9f16fad59fa74eeb9d34f55e06f066c3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtNS0xLTEtMzc5_a2312d02-59cc-43fb-945a-15f1b08d84ed"
      unitRef="usd">63601000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjAtMTEtMS0xLTM3OQ_fe22fb11-4c91-4255-8d4b-dcaaffda583f"
      unitRef="usd">63603000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i1875021431d84ba4b5c921b34aa74aff_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjItOS0xLTEtMzc5_08d9654b-bf1e-4905-b141-1a800b7ab2d5"
      unitRef="usd">-166938000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjItMTEtMS0xLTM3OQ_b817f8dc-e422-4724-8b40-0f74e4b69cbd"
      unitRef="usd">-166938000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i60304b507d2d47a4beae13dd19cd021e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjMtNy0xLTEtMzc5_e23c0e04-0c40-4cb2-b063-a5535063689c"
      unitRef="usd">66000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjMtMTEtMS0xLTM3OQ_f5e216c5-8824-420f-8ef4-354dbbb82018"
      unitRef="usd">66000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9ed5f3ef270f4beca6bc7c118222f3e6_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtMS0xLTEtMzc5_cf73ac44-f39b-4b35-bee2-362b692ccd4d"
      unitRef="shares">172242798</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i9ed5f3ef270f4beca6bc7c118222f3e6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtMy0xLTEtMzc5_a8b5400a-cec4-4bd3-8854-2ad7b52ee6cf"
      unitRef="usd">1723000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f46968c2ac4412d8f9620137a8c6374_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtNS0xLTEtMzc5_7764787c-e8a7-4501-9bce-bfd47d5d974a"
      unitRef="usd">5876644000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief7040c10b7747fcbcec17982a4d2f4e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtNy0xLTEtMzc5_20a918d8-5a61-4efe-8cf2-8bbb0fb92f3e"
      unitRef="usd">133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48f2732f724e456a9642ca5734eae6e1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtOS0xLTEtMzc5_a08b548b-2c10-448e-8dcf-bafa3f77c140"
      unitRef="usd">-2420910000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjA4YTc5ODgyZmZhYzQyZDBiMGE3MGU1ZDNmZjJhOTBmL3RhYmxlcmFuZ2U6MDhhNzk4ODJmZmFjNDJkMGIwYTcwZTVkM2ZmMmE5MGZfMjQtMTEtMS0xLTM3OQ_15a24e0f-4d00-481b-bd23-023e8ca03fad"
      unitRef="usd">3457590000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMS0zLTEtMS0xL3RleHRyZWdpb246ZjdhZWYzOTk5ZjcwNDQwOThkMjNiYzc0ZTk3M2E3M2JfNA_859e9744-39db-45f8-aea8-58ef3c87490b"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8c52981677ce4a888854fe6b6b0ffe08_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi0xLTEtMS0x_cd6ecce8-76aa-4b70-ad2e-b80964ac2609"
      unitRef="shares">147625696</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8c52981677ce4a888854fe6b6b0ffe08_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi0zLTEtMS0x_e016f740-85d6-4330-96bd-454b5e22d034"
      unitRef="usd">1477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5a62efea1c4b4dad930fa573b6c99563_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi01LTEtMS0x_3fe85569-c68b-4d93-a668-da12ac3f8f0d"
      unitRef="usd">3178552000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d558258814f4878ba1f82b61916b08e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi03LTEtMS0x_1c3c901c-fb76-47f9-89e2-d171deace886"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i64bfc16e556a449a831b1c4af0089d2e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi05LTEtMS0x_68c49ab4-d069-42d5-8cf1-6785688763ee"
      unitRef="usd">-1222290000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib3f2b2bb1c864e00920956c21f816e20_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMi0xMS0xLTEtMQ_c26fb7ff-f176-4f22-887c-421b5c427449"
      unitRef="usd">1957639000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy0xLTEtMS0x_e182e08a-291f-4c8b-8a4b-d2b1a5cfd2b6"
      unitRef="shares">160286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy0zLTEtMS0x_0c4a0d37-a125-47b2-a278-b27cd57257b3"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy01LTEtMS0x_89e85d08-ebd3-4463-b938-5abad97bb114"
      unitRef="usd">4298000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMy0xMS0xLTEtMQ_2847b1e1-9180-4946-ac64-b596e11a714a"
      unitRef="usd">4300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC0xLTEtMS0x_73a3f11d-a137-480f-898b-5a71cdf7c621"
      unitRef="shares">136559</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC0zLTEtMS0x_2dbb703b-f81b-4d40-95f8-b67e1ccc3215"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC01LTEtMS0x_8baa105c-ff8e-4602-af66-989f5353d83f"
      unitRef="usd">12006000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNC0xMS0xLTEtMQ_b6a7cdc7-6bdc-4b96-b18c-be3583c442c5"
      unitRef="usd">12007000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS0xLTEtMS0x_fc99c7cc-7849-40e5-a02f-ba7f61b35549"
      unitRef="shares">1141376</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS0zLTEtMS0x_8527b9f6-aa46-4e96-9339-bf91ea775b7c"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS01LTEtMS0x_9b433732-1160-4a76-9b30-a53b7ebe6673"
      unitRef="usd">29549000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNS0xMS0xLTEtMQ_b1bef25b-e4fc-4092-b2a7-0499c4093af3"
      unitRef="usd">29560000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi0xLTEtMS0x_43eeee68-114e-442b-a1e8-df504669d35b"
      unitRef="shares">382947</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi0zLTEtMS0x_bd982de7-dde6-4ff2-81fb-46e043f42f3d"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i72c29d48b31c4264991df3e7086a9884_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi01LTEtMS0x_26149505-7ffa-4de4-a019-1cab7aa1f470"
      unitRef="usd">28593000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNi0xMS0xLTEtMQ_283b9efd-c2bf-4033-9d2b-192286a65036"
      unitRef="usd">28597000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i01c96c9ab7c14967920412b87f32b6c0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNy05LTEtMS0x_58139571-7731-4173-9289-371de77b5069"
      unitRef="usd">-134643000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfNy0xMS0xLTEtMQ_3f6831d4-b00a-4eae-9af6-100f241ef2b9"
      unitRef="usd">-134643000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifb5c4e6487434fdbb1a622f0080871e0_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOC03LTEtMS0x_41940b15-bcce-4b00-8a77-a8aab23b307e"
      unitRef="usd">-1617000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib9b17f6163dd4a929e7951727216de4a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOC0xMS0xLTEtMQ_4421107e-365c-4320-a2f4-08108e920773"
      unitRef="usd">-1617000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0dfef23d60d041dcb2e5ff139b68bed4_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS0xLTEtMS0x_cc8ec5e7-701d-42a1-b81f-54491a41511b"
      unitRef="shares">149446864</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0dfef23d60d041dcb2e5ff139b68bed4_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS0zLTEtMS0x_2ca04661-427f-4133-b34f-095bec8c0c92"
      unitRef="usd">1495000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73256ccbde6a4a12845c25b8d6a836c2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS01LTEtMS0x_48c0af79-a6ef-4719-aa77-fe0cb4addaab"
      unitRef="usd">3252998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if4ddaf31e8724905808d6d26fb1d3e98_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS03LTEtMS0x_1ab1354b-e51e-4123-ab4c-daa7a6ea9074"
      unitRef="usd">-1717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f129d90bdeb408e8087ee20a8683ffc_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS05LTEtMS0x_0f96324c-4344-4caa-948c-19e2a618879e"
      unitRef="usd">-1356933000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i01e9c8f772ad4932a0753e9678189d1b_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfOS0xMS0xLTEtMQ_fd8fdeeb-e268-4015-9b5f-58f28e67b823"
      unitRef="usd">1895843000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtMS0xLTEtMQ_d900d50f-3dbc-41e2-8c95-39f11633c50d"
      unitRef="shares">208434</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtMy0xLTEtMQ_3a1a5c3b-5073-4efa-bca1-0a0b84ebf95d"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtNS0xLTEtMQ_67989827-5d54-492c-bb05-6950df51c5d5"
      unitRef="usd">6636000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTAtMTEtMS0xLTE_96529842-8092-428e-b034-9b2790d1f60c"
      unitRef="usd">6638000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtMS0xLTEtMQ_ba62b858-6c1e-467d-87ed-c2e592e84f5f"
      unitRef="shares">157579</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtMy0xLTEtMQ_aa71be46-e2a1-40d8-ba9b-1fe2b9b81235"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtNS0xLTEtMQ_dd2762e1-efe0-42a4-ba5b-ae4436234c9b"
      unitRef="usd">40037000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTEtMTEtMS0xLTE_d5f73bd0-4958-4878-a331-b92e1229a624"
      unitRef="usd">40039000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItMS0xLTEtMQ_313407c7-ae03-422d-b472-b9a802ae4ccd"
      unitRef="shares">167921</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4b7d33ca9b7c40ea86149a0a554a31b7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItMy0xLTEtMQ_a009da2f-9094-47fe-9d25-b0176bcf08ab"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ibbf42b9079bc404c9a5cd3d45033f848_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItNS0xLTEtMQ_3132dc99-2097-4e92-9502-2bff95e0f9e0"
      unitRef="usd">9797000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTItMTEtMS0xLTE_79403497-a89f-4a5c-b99e-f8a0731b9d18"
      unitRef="usd">9799000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="ib0912a5984f84bb28a27c9b48d9742d0_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTMtOS0xLTEtMQ_30980b8a-2c8c-4ba3-875d-f0360364bc51"
      unitRef="usd">-68092000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTMtMTEtMS0xLTE_364d634e-daa0-4410-9b6a-d55bd486da13"
      unitRef="usd">-68092000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic0ad06284f6547c3a757c9097601bd0a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTQtNy0xLTEtMQ_7b4a1c87-0d9c-4404-b6c7-8f94d4a25065"
      unitRef="usd">3206000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ieba75542757243c48c1903c54053e34f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTQtMTEtMS0xLTE_3aec23bd-d260-489b-8852-aeca9b1b584c"
      unitRef="usd">3206000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0c72990efe38423c885bc80777b5d195_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtMS0xLTEtMQ_0932b8b5-0733-4e0c-bfd4-8a487f2b90d3"
      unitRef="shares">149980798</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0c72990efe38423c885bc80777b5d195_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtMy0xLTEtMQ_3b59cd38-7f5a-4d2e-906d-5fa89d8067d4"
      unitRef="usd">1501000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i96986827f84947af8d4abfe56c07628f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtNS0xLTEtMQ_11915756-8720-46d6-adad-49b3309ee936"
      unitRef="usd">3309468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i35e6ccfede314e49b1285af649de49da_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtNy0xLTEtMQ_0fb50e85-e2bd-4f41-a716-d5fd1185fec5"
      unitRef="usd">1489000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id99a4512c1d64749be5a8a8315d2d519_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtOS0xLTEtMQ_56b85d69-1094-4ba6-98e2-83c28c606ff4"
      unitRef="usd">-1425025000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ab125bbe3464831934cae09e63392a9_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTUtMTEtMS0xLTE_34b839a3-bba7-433d-9dc3-c255b72b2ff7"
      unitRef="usd">1887433000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtMS0xLTEtMzM4_917e73c6-1701-48b1-afbd-9a8545c2776a"
      unitRef="shares">140145</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtMy0xLTEtMzM4_30e8734c-db33-436a-8860-930c4788d4c3"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4c3768e6733343e298c844be52e6b227_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtNS0xLTEtMzM4_8f684902-432b-4036-bb14-e14eb52ec7e2"
      unitRef="usd">4469000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTYtMTEtMS0xLTMzOA_72a18406-8efc-447d-855d-949f98c84608"
      unitRef="usd">4470000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctMS0xLTEtMzM4_e515791c-d7d5-42b5-a23d-959541467568"
      unitRef="shares">249197</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctMy0xLTEtMzM4_81a9ac8f-584b-4e15-8f72-a61470236e4c"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4c3768e6733343e298c844be52e6b227_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctNS0xLTEtMzM4_87063394-352e-44e6-930f-f461d7308b8b"
      unitRef="usd">41474000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTctMTEtMS0xLTMzOA_97e99aa3-a2cb-4610-bf3d-f761fa06fadc"
      unitRef="usd">41476000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtMS0xLTEtMzM4_a8074cda-692c-4040-9efe-c6a4f2f4f390"
      unitRef="shares">3346</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i05930efe57f84bf4a1db4dcfa5b64510_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtMy0xLTEtMzM4_2b031a96-5a00-43b4-b434-d160e8b07b8e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4c3768e6733343e298c844be52e6b227_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtNS0xLTEtMzM4_f30562cd-60f9-40a8-bb11-f8b20407cb8c"
      unitRef="usd">249000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTgtMTEtMS0xLTMzOA_976252ed-15d0-4798-9bd4-01d6b42a88d9"
      unitRef="usd">250000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i26c5d0a1031244da98e1f497d05696a9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTktOS0xLTEtMzM4_b72ff91c-4aa0-45d4-a623-d56251133251"
      unitRef="usd">-202538000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMTktMTEtMS0xLTMzOA_f09d53e2-fa81-4ce9-a097-2de1de218a4c"
      unitRef="usd">-202538000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i0c26ea4630974c43a74423ba696c884d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjAtNy0xLTEtMzM4_ca5fc2f4-1e95-403f-ad7f-06539ef5316d"
      unitRef="usd">-405000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjAtMTEtMS0xLTMzOA_e6c86969-c5f8-4cee-8d43-8b20a7a0fa94"
      unitRef="usd">-405000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie92f563c0ffb417f938fb6903a548c40_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtMS0xLTEtMzM4_c727310a-ae10-4277-a805-02707fe2ab75"
      unitRef="shares">150373486</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie92f563c0ffb417f938fb6903a548c40_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtMy0xLTEtMzM4_f5a3a321-dac5-47fd-a2fe-6f000bf438b0"
      unitRef="usd">1505000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia53cf4692f7a499a8f9f2bb58f1edb6f_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtNS0xLTEtMzM4_7659bb6a-4a26-4226-9600-48ef1f44d116"
      unitRef="usd">3355660000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic260e91a22f64d36ace033eed2e0ebe6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtNy0xLTEtMzM4_70b77d08-bd64-47df-a4b5-96ab32e10af8"
      unitRef="usd">1084000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic5fd31d1a4c54db49806dc7819602dcb_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtOS0xLTEtMzM4_32d2b6da-6b42-4072-ad5c-f94e9f77a4cd"
      unitRef="usd">-1627563000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yMi9mcmFnOmY0MzgwMzlkOTNhMTQyZmQ5NzkzMThhMDQwZDcwNGE5L3RhYmxlOjNiNjc1OTY4ZGQ4ZDRiMDg5MDVmODM0MjRlMTExMDZhL3RhYmxlcmFuZ2U6M2I2NzU5NjhkZDhkNGIwODkwNWY4MzQyNGUxMTEwNmFfMjEtMTEtMS0xLTMzOA_a32ae2fd-bd90-4c1b-92ef-c90751c4f682"
      unitRef="usd">1730686000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMy0xLTEtMS0x_076f3e16-6b5a-485f-8d72-1219086b118c"
      unitRef="usd">-375014000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMy0zLTEtMS0x_ac9463b4-b019-455e-a176-39b0db7845a4"
      unitRef="usd">-405273000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNS0xLTEtMS0x_292877ab-4c1d-4dfe-9e1c-accdea28d13a"
      unitRef="usd">64267000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNS0zLTEtMS0x_fc5c99b6-80d7-47ce-8e9b-53b19cd41ed6"
      unitRef="usd">53345000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNi0xLTEtMS0x_73c6bde9-cd67-4228-9f3d-0ad6d56de43a"
      unitRef="usd">-928000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNi0zLTEtMS0x_a7440d49-5e24-4634-b001-270f66db4d6c"
      unitRef="usd">-930000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNy0xLTEtMS0x_c15aa2b3-a251-4e52-a972-5cba031b3554"
      unitRef="usd">-1937000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNy0zLTEtMS0x_114c8da9-d36f-41f0-afce-77bcaeea44c2"
      unitRef="usd">1183000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOC0xLTEtMS0x_55cc5924-66be-4ac4-89ca-7a7e157a850b"
      unitRef="usd">-248716000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOC0zLTEtMS0x_32e8bbf3-dcc8-49cd-9a96-d172963af2dd"
      unitRef="usd">-6161000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOS0xLTEtMS0x_524e53f2-2825-498e-95b3-6ea97c6651e6"
      unitRef="usd">197180000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfOS0zLTEtMS0x_fea5f8c9-a120-48cc-8d20-73034b2380e8"
      unitRef="usd">111075000</us-gaap:ShareBasedCompensation>
    <exas:PostCombinationExpenseForAccelerationOfUnvestedEquity
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTAtMS0xLTEtMQ_5260291e-b0f1-47c6-a0a6-cbc732673fe0"
      unitRef="usd">80960000</exas:PostCombinationExpenseForAccelerationOfUnvestedEquity>
    <exas:PostCombinationExpenseForAccelerationOfUnvestedEquity
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTAtMy0xLTEtMQ_469a8cf7-4240-4895-9f10-ec3b12170d4a"
      unitRef="usd">0</exas:PostCombinationExpenseForAccelerationOfUnvestedEquity>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTEtMS0xLTEtMQ_3c36f353-1b9e-4414-ad15-619262bc6edb"
      unitRef="usd">30500000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTEtMy0xLTEtMQ_66591f2e-ad46-440a-8403-ff5f3a1e50d3"
      unitRef="usd">0</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTItMS0xLTEtMQ_28a1bacd-7831-4f79-85c2-b6bbf13f8356"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTItMy0xLTEtMQ_805ca576-81f6-4932-80a3-54e639209db2"
      unitRef="usd">-50819000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <exas:AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTMtMS0xLTEtMQ_2579fac8-eb7d-4489-aba6-45a61c7e1db2"
      unitRef="usd">4948000</exas:AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities>
    <exas:AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTMtMy0xLTEtMQ_8dda291c-b8e4-4d02-912d-42f0fe3701ba"
      unitRef="usd">340000</exas:AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities>
    <exas:IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTQtMS0xLTEtMQ_af0e8a98-a6bf-41d1-b156-b3ae2edd650a"
      unitRef="usd">3265000</exas:IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments>
    <exas:IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTQtMy0xLTEtMQ_5cd7ae57-4c1e-4b01-9b6b-f5ddd51a8209"
      unitRef="usd">1040000</exas:IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTUtMS0xLTEtMQ_ee1f5e65-dd85-4225-a4d8-4eb51add3d77"
      unitRef="usd">70954000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTUtMy0xLTEtMQ_e1287b8c-5e8e-45e0-b3fb-bd6402534a73"
      unitRef="usd">70199000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMS0xLTEtMzAw_2c72588f-8e32-4458-915a-0393066782ba"
      unitRef="usd">20210000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMy0xLTEtMzAw_009edf92-8223-4b2b-8873-e7f337177b06"
      unitRef="usd">209666000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMS0xLTEtMQ_e38e8da9-5715-4b70-a796-2b78c8f2e260"
      unitRef="usd">85337000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTYtMy0xLTEtMQ_238be780-368d-43be-b844-1c1b74f70b54"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTctMS0xLTEtMQ_67285b77-2431-4075-ad66-8a4fca4c2526"
      unitRef="usd">-10986000</exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue>
    <exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTctMy0xLTEtMQ_8d9a73a3-7e2a-49cf-930f-01ab78381ca4"
      unitRef="usd">0</exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue>
    <us-gaap:OperatingLeaseExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTgtMS0xLTEtMQ_cfb03e15-05a5-42b8-b4ea-c59dd6d53ab9"
      unitRef="usd">18347000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMTgtMy0xLTEtMQ_19a270d1-206f-4de1-823a-714130f020d2"
      unitRef="usd">11041000</us-gaap:OperatingLeaseExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjAtMS0xLTEtMQ_4771484c-140c-4f46-a17a-3b571ab254af"
      unitRef="usd">14038000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjAtMy0xLTEtMQ_8b81ab37-48b0-4675-9ece-27b59f04b66f"
      unitRef="usd">73642000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjEtMS0xLTEtMQ_d4bf8689-6741-4cee-9d0f-12454b840a33"
      unitRef="usd">1091000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjEtMy0xLTEtMQ_14e5e587-a348-453d-b112-3fdd3643f5aa"
      unitRef="usd">18472000</us-gaap:IncreaseDecreaseInInventories>
    <exas:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjItMS0xLTEtMQ_4b55f8ca-9f75-4975-b766-aedba75b768c"
      unitRef="usd">-11834000</exas:IncreaseDecreaseInOperatingLeaseLiabilities>
    <exas:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjItMy0xLTEtMQ_a99b8183-366f-4d5c-9ccb-3de8cb16a670"
      unitRef="usd">-6135000</exas:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjMtMS0xLTEtMQ_4a5bc1bc-92a2-465d-b46d-e59d49c39986"
      unitRef="usd">64344000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjMtMy0xLTEtMQ_49b08561-876d-477a-9b1c-e8fa0a2833a9"
      unitRef="usd">-7608000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjQtMS0xLTEtMQ_8564ca60-3caa-4f27-9cdc-20d41c10cae1"
      unitRef="usd">20134000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjQtMy0xLTEtMQ_0351a4b4-e010-4055-aa7a-1bbed5b7c781"
      unitRef="usd">-35097000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjUtMS0xLTEtMQ_3b00b198-e73e-489e-b5ae-537dabb04e1d"
      unitRef="usd">-77664000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjUtMy0xLTEtMQ_ecc9db1b-a120-4e38-b045-1106d4cec57f"
      unitRef="usd">25078000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjctMS0xLTEtMQ_118985f6-9d36-4ef5-9ff7-b7e9a266c8a9"
      unitRef="usd">1021557000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjctMy0xLTEtMQ_5b971a61-0f82-416a-ae2c-1f34845e5e97"
      unitRef="usd">890012000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjgtMS0xLTEtMQ_dd5b0e45-5719-40bd-ba4a-75ece35a284e"
      unitRef="usd">424830000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjgtMy0xLTEtMQ_4d95f075-d585-479b-aa8e-dbe2e07823b2"
      unitRef="usd">559907000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjktMS0xLTEtMQ_72b66ee4-ea84-4afa-bdef-ba5af6c97ab1"
      unitRef="usd">76374000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMjktMy0xLTEtMQ_563438b6-9c5b-42e0-9f4f-62b31e8f3478"
      unitRef="usd">48371000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzAtMS0xLTEtMQ_1765fa03-9f3f-4369-8bf3-4e188ab1a221"
      unitRef="usd">415549000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzAtMy0xLTEtMQ_8ecde97d-d47f-4c28-aa4a-e0b4bbab0555"
      unitRef="usd">6658000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzEtMS0xLTEtMQ_f6ef8789-434e-47ce-a3e8-139323c25780"
      unitRef="usd">58073000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzEtMy0xLTEtMQ_4f40d902-2844-42ee-b438-1aec5fa290a8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzItMS0xLTEtMQ_1b7638d2-6c83-487c-a8a0-a9f1e98f74e0"
      unitRef="usd">13555000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzItMy0xLTEtMQ_192a05ec-a8b9-4cae-88a1-9994542841ee"
      unitRef="usd">10610000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzMtMS0xLTEtMQ_1beb0377-603f-4037-aee3-ae567976a332"
      unitRef="usd">244000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzMtMy0xLTEtMQ_6283a739-bab6-4052-bc7e-34d2d40653ee"
      unitRef="usd">-345000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzQtMS0xLTEtMQ_636ff13b-c383-405b-9399-dbc1671cb69f"
      unitRef="usd">-1160522000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzQtMy0xLTEtMQ_59f4b875-eb6d-4652-842b-d3a77a002277"
      unitRef="usd">-395399000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzYtMS0xLTEtMQ_dc0d39fd-e581-4456-8d8e-2d2fb86f6cbe"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzYtMy0xLTEtMQ_a7f73c7f-1f30-435d-bff7-db8370130efb"
      unitRef="usd">1125547000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzctMS0xLTEtMQ_bd185379-9bc4-4498-833e-104534479b91"
      unitRef="usd">13372000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzctMy0xLTEtMQ_0a726b13-c28e-4cb6-a0b6-6d59cd238d6e"
      unitRef="usd">15408000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzgtMS0xLTEtMQ_4b853cc2-3b5e-4972-b2f4-a3233339022a"
      unitRef="usd">12038000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzgtMy0xLTEtMQ_c569e94d-845f-48c8-bd9a-141503641ff4"
      unitRef="usd">9799000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzktMS0xLTEtMQ_6025e57c-1f78-49d6-b81b-732c849822e7"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfMzktMy0xLTEtMQ_0f36f5ea-15aa-4245-b28b-4ea4759c4f09"
      unitRef="usd">150054000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDAtMS0xLTEtMQ_075b1067-6789-4a4d-936f-fe1ca6bdeafd"
      unitRef="usd">-4742000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDAtMy0xLTEtMQ_9398e9e7-6dff-4728-929b-494436f9c4ab"
      unitRef="usd">-938000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDEtMS0xLTEtMQ_96499f26-9820-4c51-b080-7ed7ef6d0881"
      unitRef="usd">20668000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDEtMy0xLTEtMQ_945f615c-6d85-428d-b3a1-44f27ed075c2"
      unitRef="usd">999762000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDItMS0xLTEtMQ_3e448482-6c1f-4a45-bd85-c595a227317e"
      unitRef="usd">-1217518000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDItMy0xLTEtMQ_b2f7b079-46b6-42da-b57d-c8c252d8eb78"
      unitRef="usd">629441000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDMtMS0xLTEtMQ_c14e8ed4-673e-4e50-a880-f5d56283afca"
      unitRef="usd">1491594000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib3f2b2bb1c864e00920956c21f816e20_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDMtMy0xLTEtMQ_98f71d78-d497-4cbf-bf0f-a8d54204f62f"
      unitRef="usd">177528000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDQtMS0xLTEtMQ_0c834c04-57b1-4f0c-909b-180fadb52077"
      unitRef="usd">274076000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE2NzVjNTRmZGNiMTQ3ODdiZThhNjIzNDM2MzhiZjUzL3RhYmxlcmFuZ2U6MTY3NWM1NGZkY2IxNDc4N2JlOGE2MjM0MzYzOGJmNTNfNDQtMy0xLTEtMQ_6417a45f-eb10-4767-a43c-7e5e29381306"
      unitRef="usd">806969000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfMy0xLTEtMS0x_99ea1b8a-9c9a-4919-954f-90fc2a08a99b"
      unitRef="usd">21110000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfMy0zLTEtMS0x_38ea1ca8-3d4d-49ab-b406-db27c32b48bf"
      unitRef="usd">7209000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNC0xLTEtMS0x_77e0bd95-ed7e-4c2c-94b4-4ae773446d7c"
      unitRef="usd">-563000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNC0zLTEtMS0x_08111f94-6f8d-42e8-92ff-94c49b3022c1"
      unitRef="usd">1159000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0wLTEtMS0xL3RleHRyZWdpb246NDRlZDY0ODk3ZWU4NDI1MWFjM2VkMmM5ZjViZmVjYTNfMTY_b53d0d25-5fc7-4e9c-bbec-88e53cb13d22"
      unitRef="shares">162606</us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued>
    <us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0wLTEtMS0xL3RleHRyZWdpb246NDRlZDY0ODk3ZWU4NDI1MWFjM2VkMmM5ZjViZmVjYTNfMjM_1bc393c6-778a-42b8-a07c-a118a92b297f"
      unitRef="shares">136559</us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued>
    <exas:IssuanceOfStockToFundMatchingContributions
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0xLTEtMS0x_5d64032c-4fe1-4288-8714-a22ae217b176"
      unitRef="usd">22934000</exas:IssuanceOfStockToFundMatchingContributions>
    <exas:IssuanceOfStockToFundMatchingContributions
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNS0zLTEtMS0x_6ada2aca-5493-4f2f-8b62-0572dd54552d"
      unitRef="usd">12007000</exas:IssuanceOfStockToFundMatchingContributions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0wLTEtMS0xL3RleHRyZWdpb246ZDE4YzBjNDUzNmExNGZhMGI4YzQ2NDJhMjY4ZmY5MGFfMTY_acb2ec06-258f-49d6-bc25-d6780feb03ef"
      unitRef="shares">9510436</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0wLTEtMS0xL3RleHRyZWdpb246ZDE4YzBjNDUzNmExNGZhMGI4YzQ2NDJhMjY4ZmY5MGFfMjM_406f6f21-f02b-4fc0-8f4a-cb1663707a20"
      unitRef="shares">382947</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0xLTEtMS0x_9ca5023c-849f-44af-9b34-cfb3160d0332"
      unitRef="usd">1270918000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNi0zLTEtMS0x_937b6f3f-9b08-4831-b293-3c6b3eaa3d7f"
      unitRef="usd">28847000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNy0xLTEtMS0x_0823bb27-f8a9-48ca-b550-eda3a0a3cc6c"
      unitRef="usd">350348000</exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition>
    <exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfNy0zLTEtMS0x_264a0a5f-3bfc-41c3-bc32-290085f9ae91"
      unitRef="usd">0</exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition>
    <us-gaap:InterestPaidNet
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfOS0xLTEtMS0x_a257de4e-9721-4721-8785-653d24a105fe"
      unitRef="usd">10685000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8yNS9mcmFnOjQ0OWU0YjI0OWMzMzRhMmFhZWFhOTM3MWQ1ZjQzNzczL3RhYmxlOjE1NTYxZTNkNTliYTQyMzRhNmUyOTk5MjI5N2Y0Yjg5L3RhYmxlcmFuZ2U6MTU1NjFlM2Q1OWJhNDIzNGE2ZTI5OTkyMjk3ZjRiODlfOS0zLTEtMS0x_ca1f4731-83f8-4e01-8e35-7a4f179f1d8f"
      unitRef="usd">9239000</us-gaap:InterestPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjY_a231a143-30f5-4ecd-bff1-ce29419135c7">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exact Sciences Corporation (together with its subsidiaries, &#x201c;Exact,&#x201d; or the &#x201c;Company&#x201d;) was incorporated in February 1995. Exact is a leading global cancer diagnostics company. It has developed some of the most impactful brands in cancer screening and diagnostics, including Cologuard&#xae; and Oncotype DX&#xae;. Exact is currently working on the development of additional tests, with the goal of bringing new, innovative cancer tests to patients throughout the world.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements, which include the accounts of Exact Sciences Corporation and those of its wholly owned subsidiaries and variable interest entities, are unaudited and have been prepared on a basis substantially consistent with the Company&#x2019;s audited financial statements and notes as of and for the year ended December&#160;31, 2020 included in the Company&#x2019;s Annual Report on Form 10-K (the &#x201c;2020 Form 10-K&#x201d;). All intercompany transactions and balances have been eliminated upon consolidation. These condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and follow the requirements of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of adjustments of a normal and recurring nature) considered necessary for a fair statement of its financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet at December&#160;31, 2020 has been derived from audited financial statements, but does not contain all of the footnote disclosures from the 2020 Form 10-K. The results of the Company&#x2019;s operations for any interim period are not necessarily indicative of the results of the Company&#x2019;s operations for any other interim period or for a full fiscal year. The statements should be read in conjunction with the audited financial statements and related notes included in the 2020 Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company&#x2019;s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company&#x2019;s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The spread of the coronavirus (&#x201c;COVID-19&#x201d;) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic impacted the Company's revenues and operating results for the three and nine months ended September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ultimate impact of COVID-19 depends on factors beyond the Company&#x2019;s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2021, there were no changes to the Company&#x2019;s significant accounting policies as described in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, except as described in the Recently Adopted Accounting Pronouncements section below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, The Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (subtopic 470-20) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This update simplifies the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the update, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. This standard may be adopted through either a modified retrospective method of transition or a full retrospective method of transition. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted the standard on January 1, 2021 through application of the full retrospective method of transition. This method of adoption was applied to enhance comparability between the periods presented in the Company&#x2019;s financial statements. The Company applied the standard to convertible notes outstanding as of the date of the first offering of the Company&#x2019;s outstanding convertible notes as discussed in Note 9. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s convertible debt instruments will be accounted for as a single liability measured at its amortized cost. The notes are no longer bifurcated between debt and equity, rather accounted for entirely as debt at face value net of any discount or premium and issuance costs. Interest expense is comprised of (1) cash interest payments, (2) amortization of any debt discounts or premiums based on the original offering, and (3) amortization of any debt issuance costs. Gain or loss on extinguishment of convertible notes is calculated as the difference between the (i) fair value of the consideration transferred and (ii) the sum of the carrying value of the debt at the time of repurchase. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 1, 2019, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $260.2&#160;million, a decrease in accumulated deficit of $26.6&#160;million, and an increase to net deferred tax assets of $55.7&#160;million offset by a corresponding increase of $55.7&#160;million in the valuation allowance. As of January 1, 2020, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $227.8&#160;million, an increase in accumulated deficit of $102.6&#160;million, and an increase to the net deferred tax assets of $83.2&#160;million offset by a corresponding increase of $74.7&#160;million in the valuation allowance resulting in a net decrease of $8.5&#160;million in recorded deferred tax liabilities. As of December 31, 2020, the cumulative effect of adoption resulted in an increase in the net carrying amount of convertible notes, net, current portion of $57.3&#160;million and convertible notes, net, less current portion of $540.9&#160;million, a decrease in additional-paid-in-capital of $510.3&#160;million, an increase in accumulated deficit of $77.7&#160;million, and an increase to net deferred tax assets of $146.0&#160;million offset by a corresponding increase of $135.8&#160;million in the valuation allowance resulting in a net decrease of $10.2&#160;million in recorded deferred tax liabilities. For the three months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $19.1&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs, income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, decreased by $0.12 per share. For the nine months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $8.3&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs of $51.2&#160;million, which was offset by an increase in loss on extinguishment of $42.9&#160;million in connection with the extinguishment of $100.0&#160;million face value of 2025 Notes. Income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, increased by $0.04 per share.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share is the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive as a result of the Company&#x2019;s losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses for each period:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable in connection with acquisitions (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the release of restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the release of performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon conversion of convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;(1)During the third quarter of 2021, shares were issued related to holdback amounts on the previously closed acquisition of Viomics, Inc. (&#x201c;Viomics&#x201d;). The remaining issuable shares relate to the previously closed acquisition of Paradigm Diagnostics, Inc. (&#x201c;Paradigm&#x201d;).</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjc_7cd93f90-f42c-497c-bf8a-ffaf27256572">Basis of Presentation and Principles of ConsolidationThe accompanying condensed consolidated financial statements, which include the accounts of Exact Sciences Corporation and those of its wholly owned subsidiaries and variable interest entities, are unaudited and have been prepared on a basis substantially consistent with the Company&#x2019;s audited financial statements and notes as of and for the year ended December&#160;31, 2020 included in the Company&#x2019;s Annual Report on Form 10-K (the &#x201c;2020 Form 10-K&#x201d;). All intercompany transactions and balances have been eliminated upon consolidation. These condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and follow the requirements of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) for interim reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of adjustments of a normal and recurring nature) considered necessary for a fair statement of its financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet at December&#160;31, 2020 has been derived from audited financial statements, but does not contain all of the footnote disclosures from the 2020 Form 10-K. The results of the Company&#x2019;s operations for any interim period are not necessarily indicative of the results of the Company&#x2019;s operations for any other interim period or for a full fiscal year. The statements should be read in conjunction with the audited financial statements and related notes included in the 2020 Form 10-K.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMzA_90cb8a02-336a-4b7e-a5cf-48f4ffa05327">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company&#x2019;s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company&#x2019;s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The spread of the coronavirus (&#x201c;COVID-19&#x201d;) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic impacted the Company's revenues and operating results for the three and nine months ended September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ultimate impact of COVID-19 depends on factors beyond the Company&#x2019;s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjg_eb6cd40a-550c-467b-ba3b-7a00c915f29b">ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMzM_a893840a-97da-494e-b7e1-b60acbb81838">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, The Financial Accounting Standards Board issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt &#x2013; Debt with Conversion and Other Options (subtopic 470-20) and Derivatives and Hedging &#x2013; Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This update simplifies the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the update, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. This standard may be adopted through either a modified retrospective method of transition or a full retrospective method of transition. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted the standard on January 1, 2021 through application of the full retrospective method of transition. This method of adoption was applied to enhance comparability between the periods presented in the Company&#x2019;s financial statements. The Company applied the standard to convertible notes outstanding as of the date of the first offering of the Company&#x2019;s outstanding convertible notes as discussed in Note 9. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s convertible debt instruments will be accounted for as a single liability measured at its amortized cost. The notes are no longer bifurcated between debt and equity, rather accounted for entirely as debt at face value net of any discount or premium and issuance costs. Interest expense is comprised of (1) cash interest payments, (2) amortization of any debt discounts or premiums based on the original offering, and (3) amortization of any debt issuance costs. Gain or loss on extinguishment of convertible notes is calculated as the difference between the (i) fair value of the consideration transferred and (ii) the sum of the carrying value of the debt at the time of repurchase. &lt;/span&gt;&lt;/div&gt;As of January 1, 2019, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $260.2&#160;million, a decrease in accumulated deficit of $26.6&#160;million, and an increase to net deferred tax assets of $55.7&#160;million offset by a corresponding increase of $55.7&#160;million in the valuation allowance. As of January 1, 2020, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $227.8&#160;million, an increase in accumulated deficit of $102.6&#160;million, and an increase to the net deferred tax assets of $83.2&#160;million offset by a corresponding increase of $74.7&#160;million in the valuation allowance resulting in a net decrease of $8.5&#160;million in recorded deferred tax liabilities. As of December 31, 2020, the cumulative effect of adoption resulted in an increase in the net carrying amount of convertible notes, net, current portion of $57.3&#160;million and convertible notes, net, less current portion of $540.9&#160;million, a decrease in additional-paid-in-capital of $510.3&#160;million, an increase in accumulated deficit of $77.7&#160;million, and an increase to net deferred tax assets of $146.0&#160;million offset by a corresponding increase of $135.8&#160;million in the valuation allowance resulting in a net decrease of $10.2&#160;million in recorded deferred tax liabilities. For the three months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $19.1&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs, income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, decreased by $0.12 per share. For the nine months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $8.3&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs of $51.2&#160;million, which was offset by an increase in loss on extinguishment of $42.9&#160;million in connection with the extinguishment of $100.0&#160;million face value of 2025 Notes. Income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, increased by $0.04 per share.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="ic9d44e865abb4a51a5b5501e0a448a8d_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfNzk5NQ_32ec3580-909d-4183-ab84-19a0d759ca61"
      unitRef="usd">-260200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b178d75514549ce8ea66ebbd555a8f3_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODAzNg_77ffd746-b326-407c-83f4-45945c85c25c"
      unitRef="usd">26600000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i7670af9c955a4e8faf887308db05e979_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODA4Ng_82fd6b06-4655-4f37-be53-1275ac060e21"
      unitRef="usd">55700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i7670af9c955a4e8faf887308db05e979_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODEyNw_ebd1e9f5-88f0-41fc-8848-a9b4ee611e31"
      unitRef="usd">55700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:StockholdersEquity
      contextRef="id444aec802554b8bb1365dce26fea270_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODI3MQ_e3980d96-69ff-4627-a238-1cfd42ef5dea"
      unitRef="usd">-227800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d9018de7fac4dc190a8367b24291c0c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODMxMw_f465a344-b652-4cb1-9b83-95b7265ea4d9"
      unitRef="usd">-102600000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib05f381693e64b0dab8d73252c93ac05_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODM2Nw_97287778-238a-46b5-93f7-b89b25ce598c"
      unitRef="usd">83200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ib05f381693e64b0dab8d73252c93ac05_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODQwOA_7af3587c-6ad0-4650-aa35-c3b2f9b86186"
      unitRef="usd">74700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib05f381693e64b0dab8d73252c93ac05_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODQ2OQ_7d4d104a-ea36-48cd-8dd3-b41aec11f27d"
      unitRef="usd">-8500000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODY2Ng_d11ad513-2880-4301-a2a7-db0f540e0ccb"
      unitRef="usd">57300000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODcyMQ_aff4dba3-35be-40b5-9506-ad0be3bda335"
      unitRef="usd">540900000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:StockholdersEquity
      contextRef="i3905df4105f94399ab1bfd44d6526587_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODc2OQ_02f8c2b1-bcdd-45b9-89bb-588e31a4c8d4"
      unitRef="usd">-510300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaded02e3fc3944cb80ece4c9df2ccde3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODgxMQ_38944a19-6240-4a78-b5a5-a018710c393b"
      unitRef="usd">-77700000</us-gaap:StockholdersEquity>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODg2MQ_d15ce257-32b5-4a97-9340-115fccff2c78"
      unitRef="usd">146000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODkwMg_5678aa08-0b23-443e-b6cb-6d77c70bda67"
      unitRef="usd">135800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i91fe81e1e0f24ae69e9c251d911dacb4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfODk2Mw_ba1aeb5d-fb6a-44c2-a39b-78594d379ddd"
      unitRef="usd">-10200000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTEwMA_b89617f2-1289-4f3c-86f0-b7e9c57b14ee"
      unitRef="usd">19100000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTIyNg_32818f68-6528-4415-a000-70a943b1e7a8"
      unitRef="usd">1800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTI4NQ_1efcf78c-28c7-48a5-93f4-a87409ef8928"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2207747f21754338966e914ce4f44b7a_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTI4NQ_58df4bcf-cfda-4639-8218-0db60fda9c1f"
      unitRef="usdPerShare">0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTM5NQ_51defc1c-f925-40f4-9c2f-9af8daed824d"
      unitRef="usd">8300000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMzI5ODUzNDg5NDIzNg_6f87762f-97d2-43b5-b140-091009b0e809"
      unitRef="usd">-51200000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMzI5ODUzNDg5NDI1OA_ef280ede-7870-4aca-85cc-4acf4657f508"
      unitRef="usd">-42900000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMzI5ODUzNDg5NDI4MA_236163f1-1d2f-4113-a62a-ad13ecb4403f"
      unitRef="usd">100000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTY3OQ_94afd2e6-e244-4d20-a882-cb5b16edc1f1"
      unitRef="usd">-1800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTczOA_b3b4b3f9-ffc5-4022-a5b6-1f266a34c559"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7c1b2c2ed3064da595423f4a17c6edca_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfOTczOA_b80cbeb4-cff8-401c-82fc-977e06acf3d0"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMjk_d3517d26-646a-4683-a5a0-81cd4afaba4b">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share is the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive as a result of the Company&#x2019;s losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RleHRyZWdpb246NTYyMWY5OGZlMTg0NGUwZDhlMGM3M2JjY2E2OWQwYjVfMTAzMzI_f05af164-56f2-4232-94a7-5075b27f51b4">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses for each period:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable in connection with acquisitions (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the release of restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the release of performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon conversion of convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;(1)During the third quarter of 2021, shares were issued related to holdback amounts on the previously closed acquisition of Viomics, Inc. (&#x201c;Viomics&#x201d;). The remaining issuable shares relate to the previously closed acquisition of Paradigm Diagnostics, Inc. (&#x201c;Paradigm&#x201d;).</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idcd243860e9749e797d0fa40c030a984_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMi0yLTEtMS0x_10c756bd-0fef-47fd-97f4-41d3e6ae5a2b"
      unitRef="shares">45000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6b8fefa7fe2141829ad68e0d413c03d3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMi00LTEtMS0x_5a6d3ab1-611a-48ca-a717-92a4a2d8d791"
      unitRef="shares">157000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ied784b899fd94614a96d000bcd733b92_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMy0yLTEtMS0x_4c0e0e15-cbdb-417c-977e-d914a4d4b506"
      unitRef="shares">2380000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iab5607dd7295462cb8c90861fc743def_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfMy00LTEtMS0x_81431558-8e1c-438e-a15d-4bfa272b14ba"
      unitRef="shares">2429000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5ff017345e814e08bfa7d77cb58912c7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNC0yLTEtMS0x_0db3e27e-5098-4f4a-a5b3-cebcec41c62f"
      unitRef="shares">4306000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7b3a687e0214f13b567a2e97a426191_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNC00LTEtMS0x_18c15c39-0130-4f13-b7e2-bb69bdc07448"
      unitRef="shares">4035000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie3a1712ede2942bc8705b2381ed4bde8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNS0yLTEtMS0x_a7a3ae69-d534-48b2-aeba-1ddb3637f0b6"
      unitRef="shares">863000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i137c30961fc947dda5c83f8077cb708d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNS00LTEtMS0x_7e6def39-ff42-487e-8017-80172046ae32"
      unitRef="shares">619000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib679c506439a443bb2d06e9eb73f7433_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNi0yLTEtMS0x_0be87935-55a3-4125-9dc3-73db421f7b9f"
      unitRef="shares">20309000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id7297a2895984854bde48ce5c1058f91_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNi00LTEtMS0x_4f5d528c-f691-4e25-a549-e13bfd52587d"
      unitRef="shares">20309000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNy0yLTEtMS0x_248933f9-b6fe-435d-bc81-40d5819650ef"
      unitRef="shares">27903000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zMS9mcmFnOjU2MjFmOThmZTE4NDRlMGQ4ZTBjNzNiY2NhNjlkMGI1L3RhYmxlOjY4MjgxMzk3MGU4OTQ0MjFhMzM0ZGNhODI0NDA2YjI0L3RhYmxlcmFuZ2U6NjgyODEzOTcwZTg5NDQyMWEzMzRkY2E4MjQ0MDZiMjRfNy00LTEtMS0x_fdb37511-2249-43a8-8230-f3df4053f5e6"
      unitRef="shares">27549000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjI2NA_b63c8d04-aec7-4afa-8227-2bbed2c05d20">REVENUE The Company&#x2019;s revenue is primarily generated by its laboratory testing services utilizing its Cologuard, Oncotype DX, and COVID-19 tests. The services are completed upon release of a patient&#x2019;s test result to the ordering healthcare provider.  &lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s revenues disaggregated by revenue source:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Parts B &amp;amp; C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;151,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;419,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;280,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;280,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;214,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;784,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;565,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precision Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Parts B &amp;amp; C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;137,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;80,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Precision Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;412,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;322,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COVID-19 Testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Screening revenue primarily includes laboratory service revenue from the Cologuard test while Precision Oncology revenue primarily includes laboratory service revenue from global Oncotype DX products. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The downward adjustment to revenue from changes in transaction price was $0.2 million for the three months ended September 30, 2021 and revenue recognized from changes in transaction price was $0.5 million for the three months ended September 30, 2020. The downward adjustment to revenue from changes in transaction price was $13.2 million for the nine months ended September 30, 2021 and revenue recognized from changes in transaction price was $9.1 million for the nine months ended September 30, 2020. At each reporting period end, the Company conducts an analysis of the estimates used to calculate the transaction price to determine whether any new information available impacts those estimates made in prior reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue balances are reported in other current liabilities in the Company&#x2019;s condensed consolidated balance sheets and were $18.7&#160;million and $25.0&#160;million as of September&#160;30, 2021 and December&#160;31, 2020, respectively. As of September&#160;30, 2021, $17.8&#160;million of the Company&#x2019;s deferred revenue balance is a result of the billing terms pursuant to the existing COVID-19 laboratory service agreements (&#x201c;LSAs&#x201d;) with customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized for the three months ended September 30, 2021 and 2020, which was included in the deferred revenue balance at the beginning of each period, was $0.2&#160;million and $5,000, respectively. Of the $0.2&#160;million of revenue recognized for the three months ended September 30, 2021, which was included in the deferred revenue balance at the beginning of the period, $0.1&#160;million related to COVID-19 testing. Revenue recognized for the nine months ended September 30, 2021 and 2020, which was included in the deferred revenue balance at the beginning of each period, was $24.6&#160;million and $0.2&#160;million, respectively. Of the $24.6&#160;million of revenue recognized for the nine months ended September 30, 2021, which was included in the deferred revenue balance at the beginning of the period, $24.3&#160;million related to COVID-19 testing.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjI2NQ_0b730ac4-f870-4465-9c08-023485cce018">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s revenues disaggregated by revenue source:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Parts B &amp;amp; C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;151,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;419,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;280,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;280,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;214,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;784,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;565,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Precision Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Parts B &amp;amp; C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;137,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;80,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total Precision Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;145,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;412,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;322,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COVID-19 Testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dcafd136a464463a18bf7d7a0aabc1b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy0yLTEtMS0x_7e7fefa4-a6de-41bd-8267-ab638784bada"
      unitRef="usd">116088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8379dfc1c2554ffab184de397af796d4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy00LTEtMS0x_61b7c6c8-dc87-42c3-aafe-4fc82b66e502"
      unitRef="usd">98847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic581a41a228c4ae7ae63d34ea421cced_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy02LTEtMS0x_06def5b9-56de-4cc2-b1a6-1e3e30cdfd7c"
      unitRef="usd">329034000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54f0651ae9954de988ac49c1cec0c010_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMy04LTEtMS0x_3483a191-dd67-44e3-8b04-c4559035df4c"
      unitRef="usd">256589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f57ca6a167a43b4bd33c0535aa347d5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC0yLTEtMS0x_85cc4e24-6077-4a38-8c95-3e1ca9441715"
      unitRef="usd">151245000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9fc6aab4d3f47f7afa8fdee107a4a60_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC00LTEtMS0x_b2b4e8f4-727d-4bc2-9273-23999d9fa613"
      unitRef="usd">106002000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia505fd74c0704dd78a15cd07d6bec4f2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC02LTEtMS0x_ad46de51-8415-4bc5-83df-aa5aa1a35a06"
      unitRef="usd">419268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i667d454b548144cc8245d44ab0448111_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNC04LTEtMS0x_f4506c1a-9749-4245-8b42-c023f31a9005"
      unitRef="usd">280451000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccc3607a1c09473eb6ba098ff05bad78_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS0yLTEtMS0x_49e711a4-f726-4bab-96fa-62e6deaec3e5"
      unitRef="usd">13045000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ff09f5adfd24b298edc56009dd65975_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS00LTEtMS0x_9af83ed1-c77a-4229-83cb-f54dccf67cbf"
      unitRef="usd">9774000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00444e24ec1241f3b7ce26b81f6319cb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS02LTEtMS0x_ef4b237c-bcff-4478-9be1-12e362edd8d1"
      unitRef="usd">36341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c87ea0590d04f828df277e02be7dbce_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNS04LTEtMS0x_9c6b6635-6141-410d-b3f3-80c3528185df"
      unitRef="usd">28367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i063bc72fa7ab4cb6a8c9a466fe5aa116_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi0yLTEtMS0x_f013e12d-a83d-41ae-ad8c-469625237576"
      unitRef="usd">280378000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieec34b3d38ad47c3a8c65d21d6a37b56_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi00LTEtMS0x_df13a5df-ba93-4869-a54e-6d69218df7c0"
      unitRef="usd">214623000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa3ffbd8983c4f1ba70c98a0ab97ef7d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi02LTEtMS0x_97e9ec01-6099-41f1-a496-96de1c3ba096"
      unitRef="usd">784643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcb4b44207d9466993c79d22ca6e06eb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfNi04LTEtMS0x_0678a547-ac94-444c-a735-482fb53cde2e"
      unitRef="usd">565407000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04e1d778217746d0a4ed93e318426779_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC0yLTEtMS0x_849fc732-3697-4c4e-9ca8-3bab47e5572b"
      unitRef="usd">51607000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9528b0d3873149b0baaa0af2498e1789_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC00LTEtMS0x_33740e99-c5d6-47eb-857e-6a8446d9ad30"
      unitRef="usd">33945000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59324a5c86a042f18bd9bf5e533238e0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC02LTEtMS0x_e474f503-8f1b-439b-bfb2-d226d1d8b787"
      unitRef="usd">142428000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0871846c6e044d0289f2d41819e1fb31_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOC04LTEtMS0x_f9a59f7d-002c-47f8-a407-62a2292b2991"
      unitRef="usd">114973000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib39277e0ee7649f4a508d3e2c9863dd3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS0yLTEtMS0x_664e9bfb-b9ba-4f6a-b4ce-f6cc4bf9d9d4"
      unitRef="usd">42844000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb79758603984bad872062ffd7af29a2_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS00LTEtMS0x_84f4732b-0fcf-4476-b8ca-9cfb41b6ce24"
      unitRef="usd">37402000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd8d8fb26ece45a69d29c95350219e5e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS02LTEtMS0x_241c3398-c3d1-4f09-966a-49fee539eee6"
      unitRef="usd">145821000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4915188f99d42a6b86eca6320118435_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfOS04LTEtMS0x_f85ef790-da90-4f3d-b458-8d377b3c64dc"
      unitRef="usd">137212000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f7b5bb29d0e4ce08e610464b1b71b37_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtMi0xLTEtMQ_0de15209-1a61-4078-9bba-176b4bc0b5ac"
      unitRef="usd">27229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i992eec5c1e0a4469b393b751d5eb9389_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtNC0xLTEtMQ_2659b570-dcbb-45a8-9fb4-3beb308540c0"
      unitRef="usd">16243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i661a0097adc94c5c86868c8e52fb1c00_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtNi0xLTEtMQ_15012e52-2a4f-4854-9422-437ec1e578f4"
      unitRef="usd">80133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f52f7ff969c485b96ea18039cc813cd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTAtOC0xLTEtMQ_45fcc54b-48e3-42c3-900c-f329ca61a97b"
      unitRef="usd">56227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i707df04e45c244bdb2753eb7ff65444b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtMi0xLTEtMQ_05579ce4-59f1-4693-a679-7236a3106784"
      unitRef="usd">23732000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i016c8264c60a431a8ecf3ae449c720c8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtNC0xLTEtMQ_59a7fb8a-b2bb-4802-8210-4bf56cae9d61"
      unitRef="usd">3989000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53f4fa3ff2f042ec8152cfdd2a41b981_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtNi0xLTEtMQ_8a0730f7-53cd-4459-8994-4a464d1466df"
      unitRef="usd">44246000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id13f5ee7c3f641fc979fe7a4a3c4e208_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTEtOC0xLTEtMQ_f4931ef0-33f8-4a45-93e5-3b76745e05af"
      unitRef="usd">14493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9955c3ab73c746da927a0a812a044811_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItMi0xLTEtMQ_34fc7579-33a8-4be4-9f08-e412b9e3b4ca"
      unitRef="usd">145412000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie52257ef670146a09f3d526496fbd69f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItNC0xLTEtMQ_c3b89236-293b-462a-93bc-eee8149f370a"
      unitRef="usd">91579000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a45ebc0ee824d3b8b9a76338253a1ae_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItNi0xLTEtMQ_d429ecf8-6d40-419b-805a-82aae9c9e1f8"
      unitRef="usd">412628000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe7fefd1dd334af09a0b944eb61e0372_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTItOC0xLTEtMQ_3de5ae74-3c28-4509-ae6e-b46e40527dd5"
      unitRef="usd">322905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42f37da1b5f84e8d9f2274f6ca39cf9e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtMi0xLTEtMQ_b14d01eb-b543-4eb8-b477-fe077db727a0"
      unitRef="usd">30589000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie93b05b8539f41c1840428f39ff69a20_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtNC0xLTEtMQ_7b22961f-ec29-4aaa-8453-81865e66e37a"
      unitRef="usd">102161000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a76a46842ae4cf493ed92d239b12b86_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtNi0xLTEtMQ_243bc9dc-5cf5-4220-80ac-9bb8b0c0271d"
      unitRef="usd">96004000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf18cbd6240143d7b12639b8d3688bda_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTMtOC0xLTEtMQ_bd655adf-eba8-42de-ac2c-64df85f7a42a"
      unitRef="usd">136740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtMi0xLTEtMQ_1116e21b-55bc-4c14-91bf-95eb8378119a"
      unitRef="usd">456379000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtNC0xLTEtMQ_82e1603a-7ddd-4b7b-911a-ad5d0bedfbcf"
      unitRef="usd">408363000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtNi0xLTEtMQ_969e5f5f-7411-4b39-bfc0-2c909c0aa954"
      unitRef="usd">1293275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RhYmxlOjUzMWY4MjJkM2RmNTQyZWU4ZmNkMGE0OWM0MzU5YjdjL3RhYmxlcmFuZ2U6NTMxZjgyMmQzZGY1NDJlZThmY2QwYTQ5YzQzNTliN2NfMTQtOC0xLTEtMQ_08d7b94b-dc99-4191-baab-fd5a52b142ef"
      unitRef="usd">1025052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i4090efeb29b94b56a6aad380d6c19370_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfNjUy_f4d932cd-09d9-4116-8b45-8eca0be1af6c"
      unitRef="usd">-200000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="ib8250c7f4f5e4113adb46384c985cf13_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfNzI3_450bbbf7-b0a8-415a-b335-2a69f5a4f0a8"
      unitRef="usd">500000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i96884d3335c9474d85d0a0151047b3c5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfODE2_0320fe25-4f2d-4ab3-aa03-b386220a55bb"
      unitRef="usd">-13200000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
      contextRef="i248f0aaf5ff64f5aaee08b667c06b387_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfODkx_bbf6b7a1-2aac-41f4-8f0d-928ba4eb2ca6"
      unitRef="usd">9100000</us-gaap:ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTQyOA_ce4864cf-af4d-4b50-a9a4-8f8560349772"
      unitRef="usd">18700000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTQzNQ_f0048ea0-437e-492c-967b-2498eb5238ca"
      unitRef="usd">25000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia0cca153dbb14b2f99d14ed4101de2af_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTQ3OQ_f5e89775-9003-412a-bf37-f7fbaddd4a11"
      unitRef="usd">17800000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTc3Mg_e81f810b-a323-4b44-a5d3-644288eea821"
      unitRef="usd">200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTc3OQ_2bcb8e70-f715-44e7-8120-5a094bb1255c"
      unitRef="usd">5000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTgwNA_e81f810b-a323-4b44-a5d3-644288eea821"
      unitRef="usd">200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i8d988dcef79447dcb20227b33fd68679_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMTkyNA_05bd24d0-43e5-4bb0-bbc7-d8e15281012b"
      unitRef="usd">100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjA4MQ_e0468337-f011-41ff-abed-3fdf7429ca05"
      unitRef="usd">24600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjA4OA_b481fdfa-96d6-4cc7-859a-5ad2818acefd"
      unitRef="usd">200000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjExMw_e0468337-f011-41ff-abed-3fdf7429ca05"
      unitRef="usd">24600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i11b42a57edea48f5924650bda9e8458a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNC9mcmFnOjQ4ZTlkZDUwOWEyOTRmNjM4ZTliNDNiY2ZkZWZmNDgxL3RleHRyZWdpb246NDhlOWRkNTA5YTI5NGY2MzhlOWI0M2JjZmRlZmY0ODFfMjIzMw_6e68b430-e594-4a72-84cd-08f29790d880"
      unitRef="usd">24300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_0f7de33e-5a92-431b-8579-1573e4d6c238">MARKETABLE SECURITIES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in AOCI are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contractual underlying maturities of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due after one year through five&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;One year or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a loss of $4.5&#160;million and $1.9&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $33,000 and a loss of $0.3&#160;million for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses recorded are included in investment income (expense), net in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_460b9c45-5d6e-4882-94f1-519934e581f1">MARKETABLE SECURITIES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in AOCI are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contractual underlying maturities of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due after one year through five&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;One year or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a loss of $4.5&#160;million and $1.9&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $33,000 and a loss of $0.3&#160;million for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses recorded are included in investment income (expense), net in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_c384d141-2fee-4891-a462-a7a7af30f930">MARKETABLE SECURITIES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in AOCI are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contractual underlying maturities of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due after one year through five&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;One year or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a loss of $4.5&#160;million and $1.9&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $33,000 and a loss of $0.3&#160;million for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses recorded are included in investment income (expense), net in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_ee4969f4-43e3-47c1-b71e-3bdc7a110f5e">MARKETABLE SECURITIES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in AOCI are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contractual underlying maturities of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due after one year through five&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;One year or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a loss of $4.5&#160;million and $1.9&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $33,000 and a loss of $0.3&#160;million for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses recorded are included in investment income (expense), net in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxNg_efa067b1-920d-4dbe-bdf6-0f1e6bdce14e">MARKETABLE SECURITIES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in AOCI are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contractual underlying maturities of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due after one year through five&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;One year or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded a loss of $4.5&#160;million and $1.9&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $33,000 and a loss of $0.3&#160;million for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses recorded are included in investment income (expense), net in the Company&#x2019;s condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxOA_2b6baeec-7437-4da6-845d-a91d7a2e20f4">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxOA_f745b35c-d4ae-456c-88c7-6ddd8873bcac">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,491,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cash and cash equivalents, restricted cash and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2cfebb799f1944df980320a2b810292b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMi0yLTEtMS0x_c71efc7e-a2e5-455a-bbd1-594866245dbb"
      unitRef="usd">273779000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i056bbdc3f35d4f1c97c9eaf225f5e67d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMi00LTEtMS0x_d3d91e95-8c89-4563-8fb7-5e18b53fe64a"
      unitRef="usd">901294000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i13be9f7dfe5045bfa40c514789b1321c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMy0yLTEtMS0x_3b4425c9-2ffa-4139-b3db-07ba7a98a293"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMy00LTEtMS0x_8fc1e90e-122c-43f2-bf97-37fb2862a416"
      unitRef="usd">589994000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4c8a7f6ee43e472892b140b9fd2a1a53_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNC0yLTEtMS0x_a0186f3a-f501-42f2-a368-f9fd1b8ae9fa"
      unitRef="usd">297000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id26cf57382b64fdab7bfd9aa29ea248c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNC00LTEtMS0x_4486bcb2-aa63-46dd-b2f8-86500113e33e"
      unitRef="usd">306000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNS0yLTEtMS0x_3d85e641-3b17-4000-9f5e-2b2b98a5c5c2"
      unitRef="usd">274076000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNS00LTEtMS0x_9a6f69df-18fa-48af-84ff-a96e00542438"
      unitRef="usd">1491594000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icb18575cb9a44b4daebf27decd1b5840_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNy0yLTEtMS0x_e0a8d57d-14bc-43eb-8ddc-33e2a4cb417d"
      unitRef="usd">941620000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia73e374a0bd147d2b769746796b11924_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfNy00LTEtMS0x_8c714d7f-1f34-45c6-bc30-300089312a91"
      unitRef="usd">347178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOC0yLTEtMS0x_0429ce1e-7195-4fe9-b523-2745f1c612e2"
      unitRef="usd">3068000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOC00LTEtMS0x_c2983df1-fae4-4b19-8c79-3644910cc766"
      unitRef="usd">1521000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOS0yLTEtMS0x_e6e86ad3-f338-4768-905e-90fe0674a9d7"
      unitRef="usd">944688000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfOS00LTEtMS0x_e3bafb0b-845e-453c-8871-bb921a9da4b2"
      unitRef="usd">348699000</us-gaap:MarketableSecurities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMTAtMi0xLTEtMQ_f16b0c43-2c36-4087-83fb-78757d96d27d"
      unitRef="usd">1218764000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjBhNTI1OGUyNmJhNjRiNDJhNmNiYTM2YmY1ODk2YjU3L3RhYmxlcmFuZ2U6MGE1MjU4ZTI2YmE2NGI0MmE2Y2JhMzZiZjU4OTZiNTdfMTAtNC0xLTEtMQ_291c8e38-430f-4636-8189-a7c6e79ef15c"
      unitRef="usd">1840293000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgyMQ_bc73721b-b562-4622-ae38-d513f7be1dc4">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;941,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in accumulated other comprehensive income (loss) (&#x201c;AOCI&#x201d;) are reported before tax impact.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In&#160;thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses in Accumulated&lt;br/&gt;Other Comprehensive&lt;br/&gt;Income (Loss) (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Gains and losses in AOCI are reported before tax impact.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS0yLTEtMS0x_e62c6f58-30d2-43e6-b7a3-7216afc43d38"
      unitRef="usd">368662000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS00LTEtMS0x_f6af8f7e-c553-4503-965d-c0db0f8b2cc8"
      unitRef="usd">213000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS02LTEtMS0x_2d697a89-e1ab-4ee6-bfc5-b95474c229b3"
      unitRef="usd">43000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNS04LTEtMS0x_078f8300-ace1-4c53-9c03-7325fb5e5221"
      unitRef="usd">368832000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi0yLTEtMS0x_3ab74a8b-c5d8-4569-aa3d-ecc4a682b175"
      unitRef="usd">276146000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi00LTEtMS0x_81c3cd58-c994-483d-addc-258eb00e93e6"
      unitRef="usd">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi02LTEtMS0x_4f3ce667-2373-4f97-ab04-2e7c6b9bee10"
      unitRef="usd">84000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNi04LTEtMS0x_af50d4a9-c462-466e-bce9-c58178b8e3a9"
      unitRef="usd">276081000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy0yLTEtMS0x_ebc23680-8467-4a7c-b454-9ddfc1860686"
      unitRef="usd">175508000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy00LTEtMS0x_4be9203f-8cf7-4522-9aba-359319d45ddc"
      unitRef="usd">35000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy02LTEtMS0x_8a610ae5-8927-48c7-bb20-66cf2a89a4c5"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfNy04LTEtMS0x_3a3efc27-df34-48cf-bd69-c9122c2c8b76"
      unitRef="usd">175542000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC0yLTEtMS0x_a42cc00b-d73a-49d9-a64d-f403d58bc7b2"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC00LTEtMS0x_7e19544d-2c64-4597-9257-14bcb0298232"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC02LTEtMS0x_3a6cf887-bdeb-4280-b880-894acb964daa"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOC04LTEtMS0x_90e87fac-92d5-4c2e-8761-34b4623bb99a"
      unitRef="usd">10001000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS0yLTEtMS0x_806967fe-394f-489d-b2c1-0a5ee8616a2f"
      unitRef="usd">111171000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS00LTEtMS0x_5ac402eb-d87d-4b7b-860d-44216a89c6c2"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS02LTEtMS0x_e498c5d7-2bbe-4b21-ae1b-91c996cd4b2f"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfOS04LTEtMS0x_8ae58e50-21ce-461b-a415-f63df41ec200"
      unitRef="usd">111164000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtMi0xLTEtMQ_9e35607f-96f1-4676-86b4-5c1148184c5e"
      unitRef="usd">941487000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtNC0xLTEtMQ_76b6d7b9-91e0-4f20-8556-5a368c8d2518"
      unitRef="usd">279000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtNi0xLTEtMQ_537f4232-12fa-4a4d-bb60-9045a4ad5fe0"
      unitRef="usd">146000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjY3ZGJhYWU4YzRiMzQxNWU5MWQ5Y2Q2NTIzMzUwMWZlL3RhYmxlcmFuZ2U6NjdkYmFhZThjNGIzNDE1ZTkxZDljZDY1MjMzNTAxZmVfMTEtOC0xLTEtMQ_2a34fb54-f2c9-4f98-8e68-e69f87c06f22"
      unitRef="usd">941620000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi0yLTEtMS0x_9c0c3bd9-893f-412f-8c92-94427523f397"
      unitRef="usd">589986000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi00LTEtMS0x_403f6cef-5c34-4663-9a09-e04160d57ded"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi02LTEtMS0x_28dba6a7-0098-4d18-acd8-eb2884c88c83"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1df2197ee3ca4faba476f8e618d26e98_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMi04LTEtMS0x_ca80af7a-5ca3-4a14-a1e9-66d435f8d1b4"
      unitRef="usd">589994000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy0yLTEtMS0x_92afcd93-6c41-47dd-a0f7-fb055826c1a5"
      unitRef="usd">589986000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy00LTEtMS0x_64fe4220-33dc-4e4a-acc0-614a522f65c7"
      unitRef="usd">8000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy02LTEtMS0x_606f8f19-99c5-419e-b6a0-ac655b1f7fca"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i83467d26f5bd4aea9d91d6b5d120f225_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfMy04LTEtMS0x_4daaaa69-e845-4568-9b3c-b3d4c7d6d220"
      unitRef="usd">589994000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS0yLTEtMS0x_68c245e5-0cb0-4dda-9edd-c587d4123ff9"
      unitRef="usd">207119000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS00LTEtMS0x_ea87e509-b89c-4446-8d0c-b348386cc9fc"
      unitRef="usd">52000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS02LTEtMS0x_7a18285c-7d85-4e1f-953d-d564e7e50fde"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1f4d4a0058f9466f8ca49a60a0de3611_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNS04LTEtMS0x_83bc7bb1-f37f-4172-8cde-43e23d3d870c"
      unitRef="usd">207171000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi0yLTEtMS0x_481fe329-9a3f-4894-874c-43ce1e3bc213"
      unitRef="usd">7070000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi00LTEtMS0x_afac5aa5-3bb7-4190-a017-c55ac6905209"
      unitRef="usd">24000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi02LTEtMS0x_2800cd30-e9a9-4aa9-ac49-3545291dba97"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1b60e8a5e02741b591ad64aaa04ecb20_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNi04LTEtMS0x_7277973e-2eee-465c-99f4-6846ea41a2ed"
      unitRef="usd">7094000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy0yLTEtMS0x_fdaf901c-2fbe-40b4-9872-9d7c2d0b8317"
      unitRef="usd">132301000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy00LTEtMS0x_898eca5f-9834-4dff-afa0-eb709cd93456"
      unitRef="usd">612000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy02LTEtMS0x_b77e15ff-eba1-4671-a604-51a6f6e46133"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i50e5244a5f34475e816a12b0991473e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfNy04LTEtMS0x_c9a63577-6b9c-438e-9052-b1f0f999b3af"
      unitRef="usd">132913000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia73e374a0bd147d2b769746796b11924_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC0yLTEtMS0x_909db683-6e1c-4c58-a0df-e9285cf77a1e"
      unitRef="usd">346490000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia73e374a0bd147d2b769746796b11924_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC00LTEtMS0x_fe0408b2-2126-4369-ab23-ccff1f1e175e"
      unitRef="usd">688000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia73e374a0bd147d2b769746796b11924_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC02LTEtMS0x_68b517ce-582e-44a0-86eb-dd30333597a1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia73e374a0bd147d2b769746796b11924_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOC04LTEtMS0x_56b55002-71cf-4c54-b050-e79e7392f652"
      unitRef="usd">347178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS0yLTEtMS0x_55174a64-8e08-4789-b438-c37aefd9e2b8"
      unitRef="usd">936476000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS00LTEtMS0x_98c93bff-9d6e-4082-997e-9d3d202a8e5b"
      unitRef="usd">696000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS02LTEtMS0x_b107dca6-ddd4-41d1-9a2b-5e1e318393be"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOjNmZjE2ODEyMGFmNzRiNGZiMjU1NmExMzhhNzhkNmMzL3RhYmxlcmFuZ2U6M2ZmMTY4MTIwYWY3NGI0ZmIyNTU2YTEzOGE3OGQ2YzNfOS04LTEtMS0x_4c8bc821-8de0-486c-93ab-a9a75bb1f78a"
      unitRef="usd">937172000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgyMg_046c3989-8735-4b9f-9110-165137bd73d5">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes contractual underlying maturities of the Company&#x2019;s available-for-sale debt securities at September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due one year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Due after one year through five&#160;years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi0yLTEtMS0x_8863d461-7cc8-4810-99b8-defa21dae1f1"
      unitRef="usd">7049000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi00LTEtMS0x_1b413079-566b-4eab-8825-98c6a217e855"
      unitRef="usd">7067000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi02LTEtMS0x_bd439a0d-86d1-44c1-ace7-6251029dfa0e"
      unitRef="usd">269097000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNi04LTEtMS0x_8446acf2-b584-4655-a154-696c6395e4f0"
      unitRef="usd">269014000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy0yLTEtMS0x_1f2d134f-b646-4fda-90ba-1bb57bb9ec43"
      unitRef="usd">235977000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy00LTEtMS0x_f7a2f6fe-4756-48c3-a65a-bcc4649287dd"
      unitRef="usd">236101000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy02LTEtMS0x_19df5e2e-5dad-4512-acd9-5822616dab85"
      unitRef="usd">132685000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfNy04LTEtMS0x_edad1aee-2661-45e6-a0b7-5ad02b04f4c4"
      unitRef="usd">132731000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC0yLTEtMS0x_b4be9772-7a34-43c7-b969-b168c285d2ac"
      unitRef="usd">175508000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC00LTEtMS0x_efad0a45-aaed-4915-8607-c9b23ebbcfdb"
      unitRef="usd">175542000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC02LTEtMS0x_83570965-9c42-4eba-a298-1d4f6c98a456"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOC04LTEtMS0x_44311414-42e6-41d8-8217-1e7af65856d5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS0yLTEtMS0x_11093627-4b23-4af1-a772-d1f14f1f9a08"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS00LTEtMS0x_2baa2e76-22e8-4aec-bf5d-02277d9517c6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS02LTEtMS0x_6e8e2607-00e0-47ee-b8b3-3b0e655e07c3"
      unitRef="usd">111171000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfOS04LTEtMS0x_a1f0d5e1-c9a5-49cf-94af-cbb5a6d3a2f1"
      unitRef="usd">111164000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtMi0xLTEtMQ_25103347-fd44-4638-8993-42de7ae9a82c"
      unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtNC0xLTEtMQ_30c1ef34-9733-4235-9ab5-dfd253d2b0f4"
      unitRef="usd">10001000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtNi0xLTEtMQ_e6441e98-8d3f-429b-9645-c69649f9a79d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i832a3ecaa8474916bdc09a1251d24703_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTAtOC0xLTEtMQ_7a910748-b62b-4088-9c2c-7ad0cd3a5ffe"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItMi0xLTEtMQ_b7f61864-dfe0-4a56-9fb5-b1b484392994"
      unitRef="usd">428534000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItNC0xLTEtMQ_6b8e4e42-fccb-4f59-a1dc-ce9143dbcd44"
      unitRef="usd">428711000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItNi0xLTEtMQ_8b68596a-7e9d-41af-b866-931aa006f26d"
      unitRef="usd">512953000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmRlMDUzOWI5ZmY5ZjRmY2I5NWE1NGVlZmFmNmFlZjEzL3RhYmxlcmFuZ2U6ZGUwNTM5YjlmZjlmNGZjYjk1YTU0ZWVmYWY2YWVmMTNfMTItOC0xLTEtMQ_b23b46b5-5d2b-453c-bf2e-18d3cda34524"
      unitRef="usd">512909000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTgxOQ_72783cb8-1b9d-4a06-828e-f4362bce0648">&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt;text-indent:18pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;One year or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available-for-sale securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy0yLTEtMS0x_93bc9bda-59ec-410c-a66f-f2c7641edc5a"
      unitRef="usd">155043000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy00LTEtMS0x_f69a4bd7-8518-484b-a451-a8fe7750c86e"
      unitRef="usd">43000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy02LTEtMS0x_6b319ba8-eb5b-433c-978a-794c2fda68fe"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy04LTEtMS0x_f5a261a8-c874-4f9d-b1ab-d601c6920674"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy0xMC0xLTEtMQ_e1f70ad8-01b8-473b-8287-5327098e0f80"
      unitRef="usd">155043000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i152dab5324a1480c9feaec96cfb9608b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfMy0xMi0xLTEtMQ_0d68eec3-8ade-47fc-ae41-a9892a5a36e4"
      unitRef="usd">43000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC0yLTEtMS0x_d82dbdc6-a89d-4363-8bad-4f3372358940"
      unitRef="usd">15650000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC00LTEtMS0x_d470e3c6-86ae-4e95-9f0a-a47539535e7a"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC02LTEtMS0x_e30713bb-0495-4087-9511-5e85ca571b58"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC04LTEtMS0x_d69cb8ec-6fb8-4766-ab15-8c5db5689c62"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC0xMC0xLTEtMQ_29bb7718-fd71-4847-8ee4-e21831dfc2ff"
      unitRef="usd">15650000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib7d5f7437ec646d18e769f045a314e6a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNC0xMi0xLTEtMQ_d7c93ecc-d10e-49dc-98c9-4b41fd6766e4"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS0yLTEtMS0x_f37cdf79-678c-42cb-b8fc-a1651027125f"
      unitRef="usd">81478000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS00LTEtMS0x_6c38b288-a008-4b4d-80d4-dce521582585"
      unitRef="usd">18000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS02LTEtMS0x_5b4abc12-cf35-40e2-a85d-bc733bef3a27"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS04LTEtMS0x_12f45549-7dab-43e4-aa29-80b468a3c979"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS0xMC0xLTEtMQ_cedfefc9-3129-4c73-8f15-ebc0795cf456"
      unitRef="usd">81478000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3f7300a597044b329c0be127d20807ba_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNS0xMi0xLTEtMQ_d6052ec3-05f5-4a65-8d91-17828e1baf00"
      unitRef="usd">18000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi0yLTEtMS0x_92ab45aa-dda6-4614-bdfa-c705144b1017"
      unitRef="usd">259019000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi00LTEtMS0x_84829eb6-248c-40f2-aaa5-f35c1e342132"
      unitRef="usd">84000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi02LTEtMS0x_af2d6c5f-772a-45fe-9b09-17e685c66443"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi04LTEtMS0x_002a031c-4946-4949-974c-bd15c27b1630"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi0xMC0xLTEtMQ_7a8aeaad-81b1-40ce-a834-92a89e8b57f9"
      unitRef="usd">259019000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i6d3e77b7c21e4c13a2c8122467dfbc74_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfNi0xMi0xLTEtMQ_d71c9bc1-2c50-42f2-a1c6-81f371dbfc14"
      unitRef="usd">84000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC0yLTEtMS0x_12c839e9-af66-4fc3-b132-a0a02d7de2b1"
      unitRef="usd">511190000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC00LTEtMS0x_311ef9d9-575d-488e-ad5b-f1b90260d7f8"
      unitRef="usd">146000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC02LTEtMS0x_8129d31f-dbd6-4844-a1c5-a86d44750d5a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC04LTEtMS0x_28de6cac-7b5f-4d61-a959-6fa30bad6005"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC0xMC0xLTEtMQ_b7cd9197-7827-44ee-830f-9900968d96fd"
      unitRef="usd">511190000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RhYmxlOmJmNjUzNzljYjJlMTQyMTI5YjI4ODg3ZjA4NGQwYTc5L3RhYmxlcmFuZ2U6YmY2NTM3OWNiMmUxNDIxMjliMjg4ODdmMDg0ZDBhNzlfOC0xMi0xLTEtMQ_94648ad7-74b8-4cd0-ac96-7ae165d37650"
      unitRef="usd">146000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTU0NQ_16ca4911-92cf-4278-b9d9-a4d131dfda83"
      unitRef="usd">4500000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTU1Mg_c4b758d2-5625-4d85-a645-9d47d46f1a50"
      unitRef="usd">1900000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTYzNA_24e09a9c-5a5a-4ada-a0c9-29fd11de868d"
      unitRef="usd">33000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF8zNy9mcmFnOjcxMTc4MGEyYmU3YjQ1YWQ4YzNjMzkyMjY4NDg4ODE5L3RleHRyZWdpb246NzExNzgwYTJiZTdiNDVhZDhjM2MzOTIyNjg0ODg4MTlfMTY1MQ_397dbc13-d705-4c5e-b6d5-e0779e6e365a"
      unitRef="usd">-300000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RleHRyZWdpb246Y2FjNGI3NzQ1ZDZkNDlhNGJjZGViZWM3NzVlM2RkYzlfNTg_73da5953-e0ba-4a18-b450-209d7f6425af">INVENTORY&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Semi-finished and finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RleHRyZWdpb246Y2FjNGI3NzQ1ZDZkNDlhNGJjZGViZWM3NzVlM2RkYzlfNTk_3b0c6e0d-9070-412d-a228-5e7570eec85d">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Semi-finished and finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMS0yLTEtMS0x_300dc8d9-05a8-40d4-ac31-643326bddc70"
      unitRef="usd">47971000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMS00LTEtMS0x_e9d2d005-0e1b-44a4-8207-bc2131fd2aa6"
      unitRef="usd">43083000</us-gaap:InventoryRawMaterialsAndSupplies>
    <exas:InventoryFinishedAndSemiFinishedGoods
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMi0yLTEtMS0x_e1e74851-5223-48ca-99d3-559f3b4e3e22"
      unitRef="usd">47196000</exas:InventoryFinishedAndSemiFinishedGoods>
    <exas:InventoryFinishedAndSemiFinishedGoods
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMi00LTEtMS0x_50a06c85-4417-4c11-8156-49f8bffe2346"
      unitRef="usd">49182000</exas:InventoryFinishedAndSemiFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMy0yLTEtMS0x_af6b817e-f70a-4b6d-9f90-6bdde01d0c03"
      unitRef="usd">95167000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80MC9mcmFnOmNhYzRiNzc0NWQ2ZDQ5YTRiY2RlYmVjNzc1ZTNkZGM5L3RhYmxlOjJlZGZkNDJhOTU2YzQ3MWZhMWI2ZDRlMjA4NTUwOGUwL3RhYmxlcmFuZ2U6MmVkZmQ0MmE5NTZjNDcxZmExYjZkNGUyMDg1NTA4ZTBfMy00LTEtMS0x_3bddee4c-badf-4410-9086-2b9a7389a8eb"
      unitRef="usd">92265000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNjYy_bf69472f-860d-449f-8c6f-d098856769ac">PROPERTY, PLANT AND EQUIPMENT&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated useful lives of property, plant and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 - 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and computer software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under construction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Lesser of remaining lease term, building life, or estimated useful life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the three months ended September 30, 2021 and 2020 was $22.3 million and $19.7&#160;million, respectively. Depreciation expense for the nine months ended September 30, 2021 and 2020 was $64.3 million and $53.3&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;At September&#160;30, 2021, the Company had $64.2 million of assets under construction which consisted of $11.8 million in laboratory equipment, $40.6 million related to building and leasehold improvements, $11.6 million in capitalized costs related to software projects, and $0.2 million related to land improvements. Depreciation will begin on these assets once they are placed into service upon completion between 2021 and 2023.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNjYz_2718205a-0432-46cd-8e15-3c199965609e">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated useful lives of property, plant and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold and building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30 - 40 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and computer software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets under construction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137,538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Lesser of remaining lease term, building life, or estimated useful life.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i046c9bf82f9d4d84afc8bdb4fbc09ee4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMi00LTEtMS0x_a92c1d71-9ec9-4d28-8bff-343cf99d153d"
      unitRef="usd">4466000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2603c42ca166450aa67a6456c7aac5f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMi02LTEtMS0x_ba4896ad-e542-4574-b7f5-b22506ae7a1d"
      unitRef="usd">4466000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib565421c7a9e4cee80899653950911dd_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMy00LTEtMS0x_1f312172-bd31-4a4d-929b-1419345d1427"
      unitRef="usd">142025000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifee71fa70c5840f2aa66cb1886e4e1e9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMy02LTEtMS0x_6f342414-22ee-47a2-96f4-6c85f214b9f6"
      unitRef="usd">117865000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if97c19b0ff2e426c8ff2e5e5c8c9ba5b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNC0yLTEtMS0x_4d7ff02b-7997-4569-8a23-25a5468d273c">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie5d1f9f305b34febb42e7ec0e7aea18f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNC00LTEtMS0x_1da7ea96-1154-405f-b714-69720f11d5d1"
      unitRef="usd">4894000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2c709a9c228d4975bf362e7fbdbaf15d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNC02LTEtMS0x_587ee410-0103-4266-8426-44c5cca8a6a4"
      unitRef="usd">4864000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id1eea2a1fc8048b3886f462bacd90918_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS0yLTEtMS0xL3RleHRyZWdpb246MTY3OTA4ZDQzMTA5NDg1N2I2NTZjMjBmOGMxODMxZWRfNA_5a69329a-5f4d-4335-a4cb-232197c338b6">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1eaf3d04e6d54cb69c0bcb15abf59ad3_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS0yLTEtMS0xL3RleHRyZWdpb246MTY3OTA4ZDQzMTA5NDg1N2I2NTZjMjBmOGMxODMxZWRfOQ_a48150a8-ef4d-46bf-b880-25b5e62381de">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0f34accaeb4c4b69bd008a1a7025ae7c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS00LTEtMS0x_46d762ec-4990-4abe-ad35-54bf9f37bb93"
      unitRef="usd">201040000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i26037492e0b347dc8fb448751d76c11a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNS02LTEtMS0x_966f125a-bfe6-47d2-bf26-77a96a1a8762"
      unitRef="usd">200980000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i5c7eb1cd63614c76a69d6c2265857e45_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNi0yLTEtMS0x_92e4ffdd-d1e0-4fbe-996e-b851cd8f914e">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i73857043c37b41f9baaed76bd0a2da45_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNi00LTEtMS0x_dcd7563e-db8b-4bbc-bea7-b634f0e2623c"
      unitRef="usd">99889000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2a9cb213c64b4411bef4a6f840992c57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNi02LTEtMS0x_db919726-e652-49c5-8b2b-1066e0d54ac7"
      unitRef="usd">75417000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i17efc5443e29495c96dd26eb9db272fd_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy0yLTEtMS0xL3RleHRyZWdpb246NGQyZDc2Yzc4ZGZjNGQ3ODlkMGU1MjU0YTIwYzY1NTdfNA_2438ba25-e3aa-4935-88b8-9de1c7ca7a32">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8206c44cfe3d480d87b647d39baa233b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy0yLTEtMS0xL3RleHRyZWdpb246NGQyZDc2Yzc4ZGZjNGQ3ODlkMGU1MjU0YTIwYzY1NTdfOQ_29ef3db0-ad80-4da7-a75a-1f832ac7e20f">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib08e3529a89e4d289e1bef68ce7d0fcc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy00LTEtMS0x_a5ebff72-ea7a-42cb-9554-d9895c4bf2a2"
      unitRef="usd">175393000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9e40593098e345db94df0524569e9818_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfNy02LTEtMS0x_a11c75e3-812b-49e9-a740-364afa62d0ae"
      unitRef="usd">142110000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i84d059ff1b2e4031ad7a352239b93fa2_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC0yLTEtMS0xL3RleHRyZWdpb246MjMyNTIyMzNiNTE0NDc3Y2I1ZDRmOThhY2Y1Y2EyYmRfNA_f329d5eb-cd9b-4e72-8b60-61529efeb94c">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="if185d20192144383ad067c44e7be1c5a_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC0yLTEtMS0xL3RleHRyZWdpb246MjMyNTIyMzNiNTE0NDc3Y2I1ZDRmOThhY2Y1Y2EyYmRfOQ_2f741b8e-bfac-4131-b966-f0fd3e1de462">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id8e88e6baa0f4bb08fcee1ef175222e9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC00LTEtMS0x_8ef17c09-75ae-4e48-bfae-f4ef693a4a7f"
      unitRef="usd">27593000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7428b7f6a341495982fc6f8d0cd2b254_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOC02LTEtMS0x_9fb94222-dad6-4d59-81eb-ca347ad0dce2"
      unitRef="usd">24968000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i00a10169cbd94256abf1a671f2b87341_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOS00LTEtMS0x_abf4e376-faf1-439a-90d1-5aae5e26f7ec"
      unitRef="usd">64187000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i850e8485ac9b4874afcdcf9edc86f702_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfOS02LTEtMS0x_6b772146-50d6-4c8f-8e34-33155a4908a5"
      unitRef="usd">18854000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTAtNC0xLTEtMQ_c88b2c99-dc59-46d0-bc9b-8b37b2b54d9d"
      unitRef="usd">719487000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTAtNi0xLTEtMQ_5c7581d2-59f1-4d00-9a87-34b8e95998d0"
      unitRef="usd">589524000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTEtNC0xLTEtMQ_0ee31b72-64c6-4e6a-9211-487a8e745a08"
      unitRef="usd">195287000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTEtNi0xLTEtMQ_3da88ec4-1172-4688-9f80-c5f343db8eb7"
      unitRef="usd">137538000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTItNC0xLTEtMQ_6865e551-c7ab-42b1-8177-54100bc90864"
      unitRef="usd">524200000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RhYmxlOjNkODUyYmYwZmMwZTQ2MGJiZTA2NzUwYTY4YzA1OTVhL3RhYmxlcmFuZ2U6M2Q4NTJiZjBmYzBlNDYwYmJlMDY3NTBhNjhjMDU5NWFfMTItNi0xLTEtMQ_33cdd47a-2207-4620-9fba-7a98a861e555"
      unitRef="usd">451986000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMjQ5_c79f50bd-c64f-4ea1-be41-ce2c36d74042"
      unitRef="usd">22300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMjU2_212a4b0d-6d1d-4fea-b4cd-c1d52765edb2"
      unitRef="usd">19700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMzE3_e4206426-71f0-4254-9370-f106793f772e"
      unitRef="usd">64300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMzI0_49e9ae64-8475-45d1-9683-76c9b7287987"
      unitRef="usd">53300000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i00a10169cbd94256abf1a671f2b87341_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMzY1_5551bab3-5641-4f58-9d46-a26f8d7e1c93"
      unitRef="usd">64200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ib08e3529a89e4d289e1bef68ce7d0fcc_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNDE2_c5565cb7-cf2a-4b84-a82c-cde5004b9a5f"
      unitRef="usd">11800000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ib565421c7a9e4cee80899653950911dd_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNDQ0_4e7a71df-2a09-4b72-bfa5-361b0c1d9e37"
      unitRef="usd">40600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i397f9e5032ae4722a80dcb17bdcc41dc_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfNDk5_8adaa183-b8a2-4d0e-aa4e-63061c58f1a1"
      unitRef="usd">11600000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ie5d1f9f305b34febb42e7ec0e7aea18f_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80My9mcmFnOmNmN2UzNjZhMWFjZDQ4YjRiOWFjY2U3OTQxYjNlOTc4L3RleHRyZWdpb246Y2Y3ZTM2NmExYWNkNDhiNGI5YWNjZTc5NDFiM2U5NzhfMTA5OTUxMTYyODUyMg_8e9175fe-20e9-457d-923f-5199e9f9faf4"
      unitRef="usd">200000</us-gaap:ConstructionInProgressGross>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2OA_c8c0a654-c00b-412f-84ac-e9078cc76a1c">INTANGIBLE ASSETS AND GOODWILL&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the net-book-value and estimated remaining life of the Company&#x2019;s intangible assets as of September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the net-book-value and estimated remaining life of the Company&#x2019;s intangible assets as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Remaining Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,422)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;814,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(93,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;720,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the estimated future amortization expense associated with the Company&#x2019;s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s acquired intangible assets are being amortized on a straight-line basis over the estimated useful life. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021 and in connection with the preparation of the financial statements, the Company recorded a non-cash, pre-tax impairment loss of $20.2 million related to the supply agreement intangible asset that was initially recorded as part of the combination with Genomic Health due to lower than anticipated performance of the underlying product. The Company utilized the income approach to measure the fair value of the supply agreement, which involves significant unobservable inputs (Level 3 inputs). The impairment is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2020, the Company began discussions with Biocartis regarding the termination of its agreements with Biocartis related to the development of an in vitro diagnostic (&#x201c;IVD&#x201d;) version of the Oncotype DX Breast Recurrence Score&#xae; test. As a result, and in connection with the preparation of the financial statements included in the Company&#x2019;s Form 10-Q for the period ended September&#160;30, 2020, the Company recorded a non-cash, pre-tax impairment loss of $200.0 million related to the in-process research and development intangible asset that was initially recorded as part of the combination with Genomic Health. The impairment is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2020, the Company abandoned certain research and development assets acquired through an asset purchase agreement with Armune Biosciences, Inc. in 2017. These assets were expected to complement the Company&#x2019;s product pipeline and were expected to have alternative future uses at the time of acquisition; however, due to changes in strategic priorities and efforts during the third quarter of 2020, these assets are no longer expected to be utilized to advance the Company&#x2019;s product pipeline. As a result, and in connection with the preparation of the financial statements included in the Company&#x2019;s Form 10-Q for the period ended September&#160;30, 2020, the Company wrote-off the gross cost basis of the intangible asset of $12.2 million and accumulated amortization of $2.5 million as of September&#160;30, 2020. This write-off resulted in a non-cash, pre-tax impairment loss of $9.7 million, which is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of goodwill for the periods ended September&#160;30, 2021 and December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paradigm &amp;amp; Viomics acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Genomic Health acquisition adjustment (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thrive acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ashion Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company recognized a measurement period adjustment to goodwill related to an increase in Genomic Health&#x2019;s pre-acquisition deferred tax liability due to finalization of certain income-tax related items.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no impairment losses for the three and nine months ended September&#160;30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2OQ_53ce1cec-9dcd-42fe-acd9-4b8f07ad50c4">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the net-book-value and estimated remaining life of the Company&#x2019;s intangible assets as of September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(539)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,427)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155,404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;697,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;969,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;n/a&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174,350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,044,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the net-book-value and estimated remaining life of the Company&#x2019;s intangible assets as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Remaining Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net balance at&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(404)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,422)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;814,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(93,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;720,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,527)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;958,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if702705143d144ad941b197bde5db8a0_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi0yLTEtMS0x_7bcda72b-a7ed-47ae-9213-517b8f313f53">P14Y1M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi00LTEtMS0x_aa34ca28-fd5c-43b8-8de3-d0c3dd1c146b"
      unitRef="usd">100700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi02LTEtMS0x_070cf94e-c2a2-4994-8801-434df975b722"
      unitRef="usd">11980000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie767cb0f38b749b0b375b727bd0a8ee2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMi04LTEtMS0x_f700aac9-f68b-41a1-965d-20ec991ac017"
      unitRef="usd">88720000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id4a88eba861f4e4192b519eeccb19ef6_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy0yLTEtMS0x_3cbd0ead-b7af-4a13-b091-7b43cfa79f01">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2991de22736346499f93730cc6444632_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy00LTEtMS0x_403c8083-1986-4264-a698-9016c8de19a8"
      unitRef="usd">2700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2991de22736346499f93730cc6444632_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy02LTEtMS0x_a83bac04-c327-4d43-a346-10df3c8a81bd"
      unitRef="usd">539000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2991de22736346499f93730cc6444632_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfMy04LTEtMS0x_1fc4e9bd-4f73-4071-b68f-ca6b7e9d5bd2"
      unitRef="usd">2161000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="icb98b0ac54b84d199190275ac41818ce_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC0yLTEtMS0x_35083f2c-2b45-4c43-994f-111390b1f589">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i42836131dcd845d9b7d67c233c57a9e5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC00LTEtMS0x_20ecd967-a732-46db-951f-fc07300f68c0"
      unitRef="usd">10442000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i42836131dcd845d9b7d67c233c57a9e5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC02LTEtMS0x_e58931ee-7042-4715-81cd-eccc2c1a5469"
      unitRef="usd">6427000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i42836131dcd845d9b7d67c233c57a9e5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNC04LTEtMS0x_42bae61e-3674-437d-8a86-056dca659a1b"
      unitRef="usd">4015000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i23b0a3bd4a6c42c2898767451b09fa3b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS0yLTEtMS0x_79fddee0-5337-479f-9ff0-b16696a80c4c">P8Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS00LTEtMS0x_68079843-a108-43b3-aaac-eb4c9059a975"
      unitRef="usd">853171000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS02LTEtMS0x_9984777b-00e6-4c7d-bebe-8f3e217a7f99"
      unitRef="usd">155404000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie2e914ef8d1842a6a361e8a8382b7a83_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNS04LTEtMS0x_7b69f879-71e2-42a5-b430-cf75f2ae7194"
      unitRef="usd">697767000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie377b2d58e75450081174518661faffc_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi0yLTEtMS0x_6637daa5-82a3-45ce-a6f5-af83a4e1c1c9">P5Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi00LTEtMS0x_c20d8c8c-c5f6-4bb2-9704-0d67cb5def68"
      unitRef="usd">2295000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi02LTEtMS0x_e9171206-d7b1-4f99-9f48-bc5cd3462181"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i46a634464cd94fb0a4f71f6de31cbbdb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNi04LTEtMS0x_03b8ceb0-cd5a-4ea0-9722-1ff01429795c"
      unitRef="usd">2295000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNy00LTEtMS0x_ebf9da56-2945-4fe4-b9dc-f6550e7cff38"
      unitRef="usd">969308000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNy02LTEtMS0x_d7e37b2a-63f5-4904-b943-bd4b890446a9"
      unitRef="usd">174350000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfNy04LTEtMS0x_ec568fa3-0a3d-411b-9fc3-a26520967e7d"
      unitRef="usd">794958000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOC00LTEtMS0x_44bdcff1-5ab5-4136-b821-8ab096543ae8"
      unitRef="usd">1250000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOC04LTEtMS0x_b3bfd602-68c4-4e27-92bb-5aab1aaddfae"
      unitRef="usd">1250000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOS00LTEtMS0x_588e33b8-fcb0-4180-87e2-0f0ea2eca6e8"
      unitRef="usd">2219308000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOS02LTEtMS0x_e2ad6141-7c54-4a08-98af-270c2194e60a"
      unitRef="usd">174350000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjcxNTM5NTRmMzg2MTQ4MmNhOTBkMThlMzJkMzdhZmE1L3RhYmxlcmFuZ2U6NzE1Mzk1NGYzODYxNDgyY2E5MGQxOGUzMmQzN2FmYTVfOS04LTEtMS0x_9b2655bf-c9e2-473d-81ba-b74d7375b4ea"
      unitRef="usd">2044958000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ice576d710d154504bb423eb18f1ad591_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi0yLTEtMS0x_b7bc840e-051e-419b-9ff1-da2d2653a538">P14Y10M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i09917a07a99c400e9b8821622e9f4348_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi00LTEtMS0x_0b4befa1-da87-4625-bbc4-bb1349f45f9c"
      unitRef="usd">100700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i09917a07a99c400e9b8821622e9f4348_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi02LTEtMS0x_57d868bf-78ee-4981-a71b-66c51970da3c"
      unitRef="usd">7258000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i09917a07a99c400e9b8821622e9f4348_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMi04LTEtMS0x_f57fa1a9-186e-4347-99d5-3cb135a8822e"
      unitRef="usd">93442000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie999f144ca6d42a8945ed5489734beaf_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy0yLTEtMS0x_f77b552c-1e9d-486a-91ff-dc4ca1de223c">P12Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib7453ee4e20e44478b0b8848dde011f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy00LTEtMS0x_d31e6cc5-e292-4f35-ae26-e088bce93dce"
      unitRef="usd">2700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib7453ee4e20e44478b0b8848dde011f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy02LTEtMS0x_9b75624d-57eb-460b-b1ba-e9a6dd4f871d"
      unitRef="usd">404000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib7453ee4e20e44478b0b8848dde011f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfMy04LTEtMS0x_68985ad3-0052-4f95-bf09-dd3eaad1bdc3"
      unitRef="usd">2296000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i2500b0e4387f476185dd50c36f479490_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC0yLTEtMS0x_bb99e9f3-fea8-435c-ac26-f58a103d8c63">P3Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic730c612567f459fb5f4f0a35a23f7aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC00LTEtMS0x_75f9f4e7-dafe-4b41-a58b-54586bd053d4"
      unitRef="usd">10441000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic730c612567f459fb5f4f0a35a23f7aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC02LTEtMS0x_390a69cc-b71c-44ab-93a0-ce715aa38ced"
      unitRef="usd">5422000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic730c612567f459fb5f4f0a35a23f7aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNC04LTEtMS0x_f3f07f5f-2b38-434b-a045-7363e84e12da"
      unitRef="usd">5019000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6157347e1860457c9ba2688f1f242d19_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS0yLTEtMS0x_4b9b5f49-3156-4d3a-b74e-a79c6c3ffb49">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3520dd0084974b7b9d074b11858f9955_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS00LTEtMS0x_6db0e054-f49d-48b9-8fb0-1d9def2ff810"
      unitRef="usd">814171000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3520dd0084974b7b9d074b11858f9955_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS02LTEtMS0x_79a35ec1-aff0-49ec-a02d-97070a1de80d"
      unitRef="usd">93278000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3520dd0084974b7b9d074b11858f9955_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNS04LTEtMS0x_add9027d-caa3-4558-af13-73716804a7f8"
      unitRef="usd">720893000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib02b8ec43328475895f430cbf7c3fe17_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi0yLTEtMS0x_0c7632d6-e559-42d8-b81b-691b3fff5460">P6Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i18d3648998024a2caf8410e3d681a404_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi00LTEtMS0x_cea5a3e3-d51e-4cd6-8094-7d88a889853e"
      unitRef="usd">30000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i18d3648998024a2caf8410e3d681a404_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi02LTEtMS0x_88e7fce4-1c5d-463d-9483-2e51b5dceaf9"
      unitRef="usd">4527000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i18d3648998024a2caf8410e3d681a404_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNi04LTEtMS0x_6553af44-aa1d-45f8-963e-e8d53bea6f8b"
      unitRef="usd">25473000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNy00LTEtMS0x_05d37905-c3dc-41f0-9d1d-7fe9ecab8e09"
      unitRef="usd">958012000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNy02LTEtMS0x_dc339e18-c45c-443e-817e-3683ce79e1bc"
      unitRef="usd">110889000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNiY2U0NDA3MmYyYTRiNDI5NmNiMDMwOTczOTM0MDJkL3RhYmxlcmFuZ2U6M2JjZTQ0MDcyZjJhNGI0Mjk2Y2IwMzA5NzM5MzQwMmRfNy04LTEtMS0x_441a120a-981a-4817-9bb2-9a8b54d41396"
      unitRef="usd">847123000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2Ng_6ad346ac-8e01-4ed1-b092-511c20413c8b">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the estimated future amortization expense associated with the Company&#x2019;s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfMS0yLTEtMS0x_457d9a26-d7f3-4df3-b190-87200d05119c"
      unitRef="usd">23053000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfMi0yLTEtMS0x_b32b23be-c460-40af-bb94-8abeeb3d35db"
      unitRef="usd">92205000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfMy0yLTEtMS0x_85027660-ef10-45d8-8ff2-ae47c3c0319e"
      unitRef="usd">92202000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNC0yLTEtMS0x_d8b94f15-fae3-46ac-9c23-6138cdabb10e"
      unitRef="usd">91868000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNS0yLTEtMS0x_d344958c-1393-4ec3-80e6-d286c64b3977"
      unitRef="usd">90820000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <exas:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNi0yLTEtMS0x_9ee95cfb-43fa-4476-a158-7e5c1f6221cd"
      unitRef="usd">404810000</exas:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjI2OTcwYjBkZTY1NjRkNTJhN2ZhZjA5MjExZjk3OWNhL3RhYmxlcmFuZ2U6MjY5NzBiMGRlNjU2NGQ1MmE3ZmFmMDkyMTFmOTc5Y2FfNy0yLTEtMS0x_a1c334a1-0f49-4544-927e-d4f499fcd2e2"
      unitRef="usd">794958000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i7ae3fe6eee984352a3ff41b1d601ab3a_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMjAzNg_20e4c49c-b52e-4d8e-bb9d-70a60cc6f05a"
      unitRef="usd">20200000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i8e3951d25ef84754a2744cec75114754_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMjAzNg_cb94a5f5-d2d5-454b-9936-13543006351c"
      unitRef="usd">20200000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i0fde4bcaab504180ae894941003778cc_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDY1MA_749e3c9f-fdfc-40bf-a314-d9643ae09c0c"
      unitRef="usd">200000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i890d82d4d1c74eb0bd114be1fd3387da_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDY1MA_c4bc1fd6-3c1f-470b-974b-a48b0c5428e7"
      unitRef="usd">200000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8ff8b0693ba14e6a8ba588d8c68f9d36_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDc1OQ_de017243-2c49-4dba-8ab7-c91cb1433646"
      unitRef="usd">12200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8ff8b0693ba14e6a8ba588d8c68f9d36_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDc3OA_08d47590-0b7c-4227-a747-d8bf8b8af6f1"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="icce105c6a6b64d718e4502a0b7aa92d7_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDgxOA_99338ed3-2659-4ad1-aa03-004ce805c3d8"
      unitRef="usd">9700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i6599b9ca619946ee95551b50bc36454a_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA5OTUxMTYzMDgxOA_e2fda415-1f55-4619-b2a6-0a0076a01502"
      unitRef="usd">9700000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTA2Nw_d18a073d-6b23-4730-9466-5de12e0e058b">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the carrying amount of goodwill for the periods ended September&#160;30, 2021 and December&#160;31, 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paradigm &amp;amp; Viomics acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Genomic Health acquisition adjustment (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thrive acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ashion Acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company recognized a measurement period adjustment to goodwill related to an increase in Genomic Health&#x2019;s pre-acquisition deferred tax liability due to finalization of certain income-tax related items.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib3f2b2bb1c864e00920956c21f816e20_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfMS0yLTEtMS0x_9162c5d3-e79d-412b-9985-73b709a7d497"
      unitRef="usd">1203197000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i501c7f9788854b61a82cd861d37a75db_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfMi0yLTEtMS0x_a0df9799-3606-4c7d-93df-119ffceea00e"
      unitRef="usd">30431000</us-gaap:GoodwillAcquiredDuringPeriod>
    <exas:GoodwillAcquiredAdjustment
      contextRef="ib4920c4a12554781a0baa0e8b7a2a4ca_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfMy0yLTEtMS0x_090d023f-7418-4526-a456-c23dfadfa6e3"
      unitRef="usd">4044000</exas:GoodwillAcquiredAdjustment>
    <us-gaap:Goodwill
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNC0yLTEtMS0x_0101f7a2-fe5d-4590-aeaf-b71e7edbfad6"
      unitRef="usd">1237672000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNS0yLTEtMS0x_09ff5d37-ad97-4ac3-8b61-b98c38a49c4a"
      unitRef="usd">948105000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie6653408e966412f9580bd258009d9e9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNi0yLTEtMS0x_253268ef-a531-4b22-828a-ed7d386975a5"
      unitRef="usd">56758000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RhYmxlOjNhM2E4ZGIxNTlkYjRjNjViNmMxMmZlMjBiNTNkN2FhL3RhYmxlcmFuZ2U6M2EzYThkYjE1OWRiNGM2NWI2YzEyZmUyMGI1M2Q3YWFfNy0yLTEtMS0x_8dc95897-cb75-4ee9-b20d-8e516f832acd"
      unitRef="usd">2242535000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_131abee0-545d-4ce4-901b-672aecc3fc86"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_23cc76ea-24f7-4ab8-895c-cd69be1e07cb"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_921c9516-094e-49e6-9ce0-af7265b8b057"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80Ni9mcmFnOmFiNDVmMmVlZmQxYjQ4NDlhNzlkOTUwNjJiMjZkODZiL3RleHRyZWdpb246YWI0NWYyZWVmZDFiNDg0OWE3OWQ5NTA2MmIyNmQ4NmJfMTAxMQ_9c564678-0775-436d-9d1c-be24994dd942"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNjM3OQ_a5b5b6d7-bb8f-4bd7-b067-2f467cd582dd">FAIR VALUE MEASUREMENTS&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The three levels of the fair value hierarchy established are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Unobservable inputs that reflect the Company&#x2019;s assumptions about the assumptions that market participants would use in pricing the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value measurements as of September&#160;30, 2021 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active Markets&lt;br/&gt;for Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(361,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The equity securities held are classified as Level 2 as they are subject to a short-term lock-up restriction and have been discounted from the observable market prices of the similar unrestricted equity securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value measurements as of December&#160;31, 2020 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active Markets&lt;br/&gt;for Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes in valuation techniques or transfers between fair value measurement levels during the periods ended September&#160;30, 2021 and December&#160;31, 2020. The fair value of Level 2 instruments classified as cash equivalents and marketable debt securities are valued using a third-party pricing agency where the valuation is based on observable inputs including pricing for similar assets and other observable market factors. The Company&#x2019;s marketable equity security investment in Biocartis held as of December&#160;31, 2020 was classified as a Level 1 instrument prior to being sold in the first quarter of 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain regulatory and product revenue milestones being achieved. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within general and administrative expenses on the Company&#x2019;s condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of contingent consideration as of September&#160;30, 2021 and December&#160;31, 2020 was $363.6&#160;million and $2.5&#160;million, respectively, which was recorded in other long-term liabilities in the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance, September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The increase in the contingent consideration liability is due to the contingent consideration associated with the acquisitions of Ashion Analytics, LLC (&#x201c;Ashion&#x201d;) and Thrive Earlier Detection Corporation (&#x201c;Thrive&#x201d;). Refer to Note 17 for further information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This fair value measurement of contingent consideration is categorized as a Level 3 liability, as the measurement amount is based primarily on significant inputs not observable in the market. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the contingent consideration liability recorded related to regulatory and product development milestones associated with the Thrive and Ashion acquisitions was $361.3&#160;million as of September&#160;30, 2021. The Company evaluates the fair value of the regulatory and product development contingent consideration liabilities using the probability-weighted scenario based discounted cash flow model, which is consistent with the initial measurement of the expected contingent consideration liabilities. Probabilities of success are applied to each potential scenario and the resulting values are discounted using a rate that considers a present-value factor. The passage of time in addition to changes in projected milestone achievement timing, present-value factor, the degree of achievement if applicable, and probabilities of success may result in adjustments to the fair value measurement. The fair value measurements of contingent consideration for which a liability is recorded include significant unobservable inputs. As of September&#160;30, 2021, the fair value of the contingent consideration liability recorded related to regulatory and product development milestones was determined using a weighted average probability of success of 90.5% and a weighted average present-value factor of 2.0%. The projected fiscal year of payment range is from 2024 to 2027. Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the contingent consideration earnout liability related to certain revenue milestones associated with the Biomatrica acquisition was $2.3&#160;million as of September&#160;30, 2021. The revenue milestone associated with the Ashion acquisition is not expected to be achieved and therefore no liability has been recorded for this milestone. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Marketable Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021 and December&#160;31, 2020, the aggregate carrying amounts of the Company&#x2019;s non-marketable equity securities without readily determinable fair values were $22.7&#160;million and $29.1&#160;million, respectively, which are classified as a component of other long-term assets in the Company&#x2019;s condensed consolidated balance sheets. There have been no downward or upward adjustments made on these investments since initial recognition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021 and December&#160;31, 2020, the Company had open foreign currency forward contracts with notional amounts of $29.5&#160;million and $22.4&#160;million, respectively. The Company's foreign exchange derivative instruments are classified as Level 2 within the fair value hierarchy as they are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data. The fair value of the foreign currency forward contracts was zero at September&#160;30, 2021 and December&#160;31, 2020, and there were no gains or losses recorded for the three and nine months ended September&#160;30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNjM4MA_f2a3711d-4ca9-4219-b340-1869de883e57">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value measurements as of September&#160;30, 2021 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active Markets&lt;br/&gt;for Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363,647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;857,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;944,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(361,107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The equity securities held are classified as Level 2 as they are subject to a short-term lock-up restriction and have been discounted from the observable market prices of the similar unrestricted equity securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value measurements as of December&#160;31, 2020 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active Markets&lt;br/&gt;for Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant Other&lt;br/&gt;Observable Inputs&lt;br/&gt;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;903,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7670aee13835456b9ef946cbf5090d2c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi0yLTEtMS0x_b06e5f05-615b-420b-b56f-796740c4ccb8"
      unitRef="usd">273779000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i076cccc3ea454a719579e19eb576403a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi00LTEtMS0x_9d051123-9c59-438c-8fe4-dafe13044a7d"
      unitRef="usd">273779000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7735b48d36ff44b29b0a466a9b6c6a03_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi02LTEtMS0x_ef5a9149-046b-4589-ba86-cb0a7bfbaaec"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9eaa44b39d5645a9a0faf988680be02a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMi04LTEtMS0x_395f3b2a-b64e-4d3f-b26c-f25faaa3815d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if36c23e4f0c64b8892c737ae997e1b21_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC0yLTEtMS0x_4271bd5a-95d1-486a-bd10-fdbf53573df7"
      unitRef="usd">297000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ice75a7198c9c4189b63219eac0c1032e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC00LTEtMS0x_34854242-a310-4e4c-a233-98d32e51100c"
      unitRef="usd">297000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4330edc45cf84441a4cd9cf3d6dc4379_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC02LTEtMS0x_0a2117b7-9ff6-4500-9c30-6c3922209f8a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iec3596c0cce347588c0c90b759253721_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNC04LTEtMS0x_ff49cc8d-08d4-41ee-93dd-0f794d160eeb"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i71ac0875363d44f48e9a998b50b03693_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi0yLTEtMS0x_ebae1b06-0c0d-4ede-95f5-397aa6c3c5ca"
      unitRef="usd">368832000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5b310b00e484dcf83114f26ed4d03ab_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi00LTEtMS0x_7d08ea61-25b0-4ea7-8845-f0e7117fd287"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1edbf863623a4583b670e04195a560f2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi02LTEtMS0x_f369cce0-5aaf-43eb-a6b5-05f7e345483f"
      unitRef="usd">368832000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f071db6d26f4417836a89ae4bf9dc13_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNi04LTEtMS0x_bb626bd4-bb55-4e49-ade9-6326942c8616"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae353c40c869427d99501cfd0e428d16_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy0yLTEtMS0x_ee7f3cb2-bd15-44be-bc8e-09dd2a6ca295"
      unitRef="usd">175542000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i47e1dca476854604bbc32c5a07963ffa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy00LTEtMS0x_39504433-f07d-4315-96d8-0e79b7d4eb93"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia30980f5ef444b3490f4789bea8f12fb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy02LTEtMS0x_3fedd29d-9a4b-485e-9a28-14de3b7cb5a0"
      unitRef="usd">175542000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2629689a88b443dc8d9888f5eef1bd71_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfNy04LTEtMS0x_4e8f9805-307a-4c6e-b0f6-86bbffa8abcd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie5f1a09055054f3d8d1946791967fc77_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC0yLTEtMS0x_2c855bf9-dcc2-4ea9-90fc-b6b6f09c2750"
      unitRef="usd">10001000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29cb011245734390b34548e0994a1a0b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC00LTEtMS0x_18a2f283-0484-45d2-b364-045e19054a6d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i556b2b7061a84128a4bcc29752f8e922_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC02LTEtMS0x_b15c8586-e76f-4fbb-ba4f-c341c29069b7"
      unitRef="usd">10001000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e1cdf0f1387456c89946289c26f60e8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOC04LTEtMS0x_aed422d2-a404-451a-9981-634b66e40b27"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic6d0406051014646b0970f3d9130bbb7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS0yLTEtMS0x_452860b5-b8e5-4832-ad97-3ade55026fc9"
      unitRef="usd">276081000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i108006d8fdb74103b198303365a9bc58_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS00LTEtMS0x_23416ef5-9da2-4712-b042-9e2a09cbea4d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic730ed990e6644239b3ae1d4cb5eb387_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS02LTEtMS0x_7fbe3582-fa2c-4fc4-9d31-42861c5cf5a3"
      unitRef="usd">276081000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iee052d8326c94ffda0d8f89f13146d06_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfOS04LTEtMS0x_e7a1b06e-7758-4bee-9ee6-c8d9aae206c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f1f3c7b2e624156a85733d1e95e2f04_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtMi0xLTEtMQ_88829785-ab7f-45ab-bdce-2a682a053328"
      unitRef="usd">111164000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6d569e7074a40b4b3e6f21fdc68efdc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtNC0xLTEtMQ_d1ac569e-c9a5-424c-9c14-52f5c5ee90c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iabdd7005af4546f38d23f679ee216c45_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtNi0xLTEtMQ_b8eea1c4-5bfb-4f2e-a688-c1d3ebf0583e"
      unitRef="usd">111164000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i79793c0a6b4a40bfbc8f7bd09705a9e1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTAtOC0xLTEtMQ_bde68c07-df37-4c72-891b-4e9a66293401"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtMi0xLTEtMQ_4bafef81-6b09-4060-9f8f-84148ee12116"
      unitRef="usd">3068000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtNC0xLTEtMQ_fed21869-776c-47c7-b28e-c01f78629606"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtNi0xLTEtMQ_52748ce5-f542-4f92-b184-a45693bfc258"
      unitRef="usd">3068000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTEtOC0xLTEtMQ_a93148c6-89eb-456a-a6ed-a5522f09d6ac"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:SecurityOwnedNotReadilyMarketableFairValue
      contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItMi0xLTEtMjU0MjU_783f8ddd-434b-4d9c-a1eb-7e3c65cb7dc4"
      unitRef="usd">2540000</us-gaap:SecurityOwnedNotReadilyMarketableFairValue>
    <us-gaap:SecurityOwnedNotReadilyMarketableFairValue
      contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItNC0xLTEtMjU0MjU_21969dcb-0263-456b-b853-56163c187e44"
      unitRef="usd">0</us-gaap:SecurityOwnedNotReadilyMarketableFairValue>
    <us-gaap:SecurityOwnedNotReadilyMarketableFairValue
      contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItNi0xLTEtMjU0MjU_9c4e069f-ed10-444b-9876-6c61e91fcc43"
      unitRef="usd">0</us-gaap:SecurityOwnedNotReadilyMarketableFairValue>
    <us-gaap:SecurityOwnedNotReadilyMarketableFairValue
      contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTItOC0xLTEtMjU0MjU_7fbdeac9-d6ae-4c5e-9f56-b2ddfa11eda7"
      unitRef="usd">2540000</us-gaap:SecurityOwnedNotReadilyMarketableFairValue>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtMi0xLTEtMQ_0d01c6e9-07ea-46c9-80c1-c613642ba0ae"
      unitRef="usd">363647000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtNC0xLTEtMQ_b8d0bff5-bf28-4138-a46f-2b77e4809c80"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtNi0xLTEtMQ_417cb40e-0ee6-4155-a1f4-351806024327"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTMtOC0xLTEtMQ_f5e9ef68-fd91-4cca-a4b8-7081280ee3f0"
      unitRef="usd">363647000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtMi0xLTEtMQ_e70740cd-87c5-4f70-9c53-260b09614485"
      unitRef="usd">857657000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i645a1944eb1447bc9f67b05bcf8eae2b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtNC0xLTEtMQ_681bc1f9-2bb3-4741-852c-228682b5207a"
      unitRef="usd">274076000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i8c347bb18e4e44cd93e616e79b51eadc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtNi0xLTEtMQ_f30e4061-0c4d-4b33-8561-bb850c9c6a14"
      unitRef="usd">944688000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ia313dd0befc349d4a004a3b20ad7fd0a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjIyZWRhY2Y3MjA4ZDRiZTViYjM5ZjI2OWJmNTY4N2UxL3RhYmxlcmFuZ2U6MjJlZGFjZjcyMDhkNGJlNWJiMzlmMjY5YmY1Njg3ZTFfMTQtOC0xLTEtMQ_cd61b54a-ff15-4a9d-b83f-57e311a270d3"
      unitRef="usd">-361107000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iaab539435c7a481aaed99f701cafa053_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi0yLTEtMS0x_7ba5fe0b-bf33-4883-bf0d-2be21025216a"
      unitRef="usd">901294000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic6179574a6404661adb02cdfd4ecac70_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi00LTEtMS0x_57852b4a-18cb-479d-b16e-76c6861d27b0"
      unitRef="usd">901294000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0f5eb5cb806f46a3a282ece9ae9e05a6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi02LTEtMS0x_8f6ad36d-9c60-4ece-a2eb-cf8d0ab98a63"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i02062cfc353a43feb126d3f904610723_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMi04LTEtMS0x_5be94350-6aa2-443c-b013-4a9842c49b75"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic0332bd716b34f80bbba08e250974a9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy0yLTEtMS0x_bcbcb0b5-cbff-4112-9230-fe04ba1a091a"
      unitRef="usd">589994000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i98e4418e3f444936ae782784aaf5154c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy00LTEtMS0x_794ce6d6-bd4e-48f7-90a8-0f537a27ce81"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i10f358e0fdb3422f93412305ec8ee504_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy02LTEtMS0x_b48057f2-22ac-47df-9ba4-799f2da77ef1"
      unitRef="usd">589994000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0ae36a17c1b640618068686e33ff1802_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMy04LTEtMS0x_9f3917ff-cfd0-4653-864c-8d100c738e06"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i456b35ed51ac45b18c17b51e6d86e854_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC0yLTEtMS0x_605fbfcc-a5e0-4a40-9288-85dd54140a8e"
      unitRef="usd">306000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i07629df4ca2c4cbf803a8e9b3e8c6908_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC00LTEtMS0x_939b4594-fa81-4061-85aa-136bd400cee8"
      unitRef="usd">306000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie0802092f5404859b5da28c255e698c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC02LTEtMS0x_677e629a-2389-478a-89b0-75aa67231ed5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i70d1e5476c5e4d07af802800933a510b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNC04LTEtMS0x_75f4b997-542c-417e-95c8-e90612a1e6fc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9e245a53d37346bf907516b3ea304801_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi0yLTEtMS0x_d8cf4989-4340-44e5-8288-fa2af52824da"
      unitRef="usd">207171000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i31c943c8a77e42589005bd95b10382ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi00LTEtMS0x_ce89b2ad-6623-4e1d-bbe6-d555f6dae6a9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i672fb690c6e24a47821c2ddc8a90fabb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi02LTEtMS0x_d7c6bcae-78f7-4779-8a2b-63a09ec24b0c"
      unitRef="usd">207171000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8e24063fca9740369d367ba93027918e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNi04LTEtMS0x_97f1c7fd-eb08-4528-b6f8-0c4b325033ca"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1d60b555b44746d6b68f5fe0334c3ca9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy0yLTEtMS0x_31c9adc0-db9c-45ba-a1e5-de65c31921b0"
      unitRef="usd">132913000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c3a663e94eb4a27bd5c65ba03cacf87_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy00LTEtMS0x_27e2dace-8dec-4c3e-ade6-5f40f051d848"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i247aaad53c6245ccbbd5ec147d4988da_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy02LTEtMS0x_63a4525a-270a-4a4d-a5db-f264a41bf6e4"
      unitRef="usd">132913000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib403eea329ef416a8a24ac2287f97a62_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfNy04LTEtMS0x_c5724ff9-710e-40a6-b1a2-b722fa707805"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd7d357017eb4157a5f470172d3e0487_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC0yLTEtMS0x_f0faee91-b1fe-4b91-96da-eee08da48468"
      unitRef="usd">7094000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4dd8f93b52f5442291314fe4545a7ec8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC00LTEtMS0x_853ba83d-8f1f-4405-9f74-475d2232b70e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i043e843eab1c434d95629465a45eab9a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC02LTEtMS0x_2686416d-8ee8-41c0-8d6f-5770a2d123f9"
      unitRef="usd">7094000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43309733f4814ee09bbc83df1d2962fc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOC04LTEtMS0x_2b936902-c1c1-450e-bac1-2ea2a73b9559"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4c5970ee82644e25bb734b992dd63362_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS0yLTEtMS0x_00fbc04e-a8a6-4c61-bc9d-5f71e6146ce5"
      unitRef="usd">1521000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia8e8f57f6c664ec39d5d416a45042a81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS00LTEtMS0x_6f85a738-7f83-41b5-9b17-b50c2d147cd3"
      unitRef="usd">1521000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS02LTEtMS0x_7bbe420c-5312-440e-a6a8-3861875a6e59"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i2ee94b86157f48f68658ceb0b86089f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfOS04LTEtMS0x_485f300b-cf7c-4193-ac10-88f23895987d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i4c5970ee82644e25bb734b992dd63362_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtMi0xLTEtMQ_ca314894-77c6-4a84-9f01-f8606569b614"
      unitRef="usd">2477000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ia8e8f57f6c664ec39d5d416a45042a81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtNC0xLTEtMQ_bd3f7d2d-a6f9-4ced-b0b2-f95ef8b5c462"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtNi0xLTEtMQ_f9d24682-45ba-4e83-a1c7-d5a9b26f05f2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i2ee94b86157f48f68658ceb0b86089f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTEtOC0xLTEtMQ_0e154d64-1874-4ca7-a9f9-7b2b25160a07"
      unitRef="usd">2477000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i4c5970ee82644e25bb734b992dd63362_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItMi0xLTEtMQ_4ab53de2-d57a-461f-a5c9-d930803fdec9"
      unitRef="usd">1837816000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ia8e8f57f6c664ec39d5d416a45042a81_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItNC0xLTEtMQ_9fea2c1f-5544-4f59-95c4-994fd7a7699f"
      unitRef="usd">903121000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="ie1fea28a472e4c9e9cc9dbed926fe8bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItNi0xLTEtMQ_367093f6-2da5-467f-bdf8-af46b459168b"
      unitRef="usd">937172000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:FairValueNetAssetLiability
      contextRef="i2ee94b86157f48f68658ceb0b86089f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOmJlOGQ4Zjc3OTdjNTRkNTM4ZTE2M2U0ZDhhNjVlOTUwL3RhYmxlcmFuZ2U6YmU4ZDhmNzc5N2M1NGQ1MzhlMTYzZTRkOGE2NWU5NTBfMTItOC0xLTEtMQ_5dbf21d2-ef6e-42ef-b8f7-eb979d09e096"
      unitRef="usd">-2477000</us-gaap:FairValueNetAssetLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfMjg4OA_6615b8ef-a7ff-4c06-b90b-100cffc367b8"
      unitRef="usd">363600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfMjg5NQ_d3693199-9590-48e5-91a0-b8e6d19204ac"
      unitRef="usd">2500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNjM3Nw_3d09d587-d67c-41aa-9deb-0b175cdcd676">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balances of contingent consideration:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase price contingent consideration (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;350,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance, September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;(1)The increase in the contingent consideration liability is due to the contingent consideration associated with the acquisitions of Ashion Analytics, LLC (&#x201c;Ashion&#x201d;) and Thrive Earlier Detection Corporation (&#x201c;Thrive&#x201d;). Refer to Note 17 for further information.</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfMS0yLTEtMS0x_68abf171-98be-4a81-996c-d88e55df9d3d"
      unitRef="usd">2477000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfMi0yLTEtMS0x_3e2af4d3-2eec-4232-910d-8b1d9a097dd7"
      unitRef="usd">350348000</exas:BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition>
    <exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfMy0yLTEtMS0x_bcd16c9c-924d-48b4-9334-0aaf96744130"
      unitRef="usd">-10986000</exas:BusinessCombinationContingentConsiderationGainLossChangeInFairValue>
    <us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfNC0yLTEtMS0x_6ca34b8d-2686-4991-845c-dcd29869bdc3"
      unitRef="usd">164000</us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RhYmxlOjM1OTY1Y2IxYTc1NDQ4MGRhMDUzNWI0YzQ4ZDA3ZDIxL3RhYmxlcmFuZ2U6MzU5NjVjYjFhNzU0NDgwZGEwNTM1YjRjNDhkMDdkMjFfNS0yLTEtMS0x_cfa42e7f-f89d-4fb1-b417-8f2eaaa6a84c"
      unitRef="usd">363647000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7735ebc6072e4844a77d8a37da54e9e3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfMzc2OQ_c4c15050-9c65-4d1a-80b4-5416a08e7cf8"
      unitRef="usd">361300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ibd2c2b55dd8e4b4a8baccd8dfe9fabf8_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNDg0NA_b7730a62-c9b6-4d7e-aad9-6433d746f06f"
      unitRef="number">0.905</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ib3f1b003917c4eb2b6290a35759a68ab_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNDg5NA_4914fa2b-348d-4bb4-9419-9b4cbd55a3f7"
      unitRef="number">0.020</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i63f9bc02d95f4a8d88d901e1d36b8857_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTIxNA_48dbbe6c-f163-47de-b4f9-db9daa9a7f01"
      unitRef="usd">2300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i0a1df4e2f14a42828145784edc81d152_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTU2Mw_6edda2b9-1f69-49cc-81c0-9a0e16407d37"
      unitRef="usd">22700000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="if7e54c98df5e425386007ce202a5cdaa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTU3MA_83d1bafa-b047-488d-84cd-fc22460b9537"
      unitRef="usd">29100000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i423735ec2fa04dc998bc308ebb5ebaa2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTk0MQ_4002bc2d-863d-408b-a5c2-32c2d852108c"
      unitRef="usd">29500000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i46c3a28bcdca48689179ee81c50f41d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF80OS9mcmFnOjZiNmJjYjkwOWUxNTRjYTViMTQ3MjUyZjYxMDNjNWViL3RleHRyZWdpb246NmI2YmNiOTA5ZTE1NGNhNWIxNDcyNTJmNjEwM2M1ZWJfNTk0OA_65471b5e-4354-45e4-aac8-fcc3d768a656"
      unitRef="usd">22400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDI5Nw_5bf6b140-e6b9-4cdb-a197-38ac8b2a37a6">LONG-TERM DEBT&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Construction Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During December 2017, the Company entered into a loan agreement with Fifth Third Bank (formerly MB Financial Bank, N.A.) (the &#x201c;Construction Loan Agreement&#x201d;), which provides the Company with a non-revolving construction loan (the &#x201c;Construction Loan&#x201d;) of $25.6 million. The Company used the Construction Loan proceeds to finance the construction of an additional clinical laboratory and related facilities in Madison, Wisconsin. The Construction Loan is collateralized by the additional clinical laboratory and related facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Construction Loan Agreement, funds drawn will bear interest at a rate equal to the sum of the 1-month LIBOR rate plus 2.25 percent. Regular monthly payments are interest-only for the first 24 months, with further payments based on a 20-year amortization schedule. Amounts borrowed pursuant to the Construction Loan Agreement may be prepaid at any time without penalty. The maturity date of the Construction Loan Agreement is December 10, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2017, Fifth Third Bank, on behalf of the Company, issued an Irrevocable Standby Letter of Credit in the amount of $0.6 million in favor of the City of Madison, Wisconsin (the &#x201c;City Letter of Credit&#x201d;). The City Letter of Credit is deemed to have been issued pursuant to the Construction Loan Agreement. The amount of the City Letter of Credit will reduce, dollar for dollar, the amount available for borrowing under the Construction Loan Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a condition to Fifth Third Bank&#x2019;s initial advance of loan proceeds under the Construction Loan Agreement, the Company was required to first invest at least $16.4 million of its own cash into the construction project. The Company fulfilled its required initial investment and made its first draw on the Construction Loan in June 2018. In December 2019, the Company began making monthly payments towards the outstanding principal balance plus accrued interest. As of September&#160;30, 2021 and December&#160;31, 2020, the outstanding balance was $22.8 million and $23.8 million, respectively, from the Construction Loan, including $0.7 million of interest incurred, which is accrued for as an interest reserve and represents a portion of the loan balance. The Company capitalized the $0.7 million of interest to the construction project. The Company incurred approximately $0.2 million of debt issuance costs related to the Construction Loan, which are recorded as a direct deduction from the liability. The debt issuance costs are being amortized over the life of the Construction Loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of the Construction Loan approximates fair value due to the short maturity of this instrument. The Construction Loan is privately held with no public market for this debt and therefore is classified as a Level 3 fair value measurement. The change in the fair value during the three and nine months ended September&#160;30, 2021 was due to payments made on the loan resulting in a decrease in the liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Construction Loan Agreement was amended effective June 30, 2020 to include a financial covenant to maintain a minimum liquidity of $250&#160;million and remove the minimum tangible net worth covenant. As of September&#160;30, 2021, the Company is in compliance with the covenant included in the amended agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tax Increment Financing Loan Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into two separate Tax Increment Financing Loan Agreements (&#x201c;TIFs&#x201d;) in February 2019 and June 2019 with the City of Madison, Wisconsin. The TIFs provide for $4.6 million of financing in the aggregate. In return for the loans, the Company is obligated to create and maintain 500 full-time jobs over a five-year period, starting on the date of occupancy of the buildings constructed. In the event that the job creation goals are not met, the Company would be required to pay a penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records the earned financial incentives as the full-time equivalent positions are filled. The amount earned is recorded as a liability and amortized as a reduction of operating expenses over a two-year period, which is the timeframe when the TIFs will be repaid through property taxes.&lt;/span&gt;&lt;/div&gt;As of December 31, 2019, the Company had earned and received payment of the full $4.6 million from the City of Madison, and the corresponding liability became fully amortized in October 2020. In May 2021 the City of Madison confirmed that the Company had repaid the TIFs in full and released the Company from the loans and the related property lien.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i875166f2ce66407bbd9156c0c0b38938_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzA1_4f1ac2d7-0bcd-45dc-928c-22d1acf3a062"
      unitRef="usd">25600000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if3202fd2c10d4c7398235b5e85235b84_D20171201-20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNzA4_ea6d00cd-fad3-4a78-86cf-7cd7723a5b87"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <exas:DebtInstrumentPeriodicPaymentInterestTerm
      contextRef="iadfa6d5584e64d8d96cf57f8ef06f8c5_D20171201-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNzY5_991a733c-e811-418c-a482-fd2355f7b795">P24M</exas:DebtInstrumentPeriodicPaymentInterestTerm>
    <exas:DebtInstrumentRemainingAmortizationPeriod
      contextRef="i37e094585ad64a8dbf6962da458f2b91_D20171201-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDI5OA_24dfb51f-75a5-4f8b-a6ad-ad305fd1cfd4">P20Y</exas:DebtInstrumentRemainingAmortizationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9f3368f21e3f45b08bdf3abf7718904a_I20171130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTE0Mw_fee8f0c0-7e37-43f0-8639-67a1aae14924"
      unitRef="usd">600000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <exas:MinimumOwnInvestmentToBeMadeInConstructionProject
      contextRef="iafe6aabe3c26422ba3568068ffeae6b5_I20171130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTYyNg_e376e52b-2ebb-4f2b-b1c9-67a3a28a595e"
      unitRef="usd">16400000</exas:MinimumOwnInvestmentToBeMadeInConstructionProject>
    <us-gaap:LongtermConstructionLoanCurrentAndNoncurrent
      contextRef="ib1c80baca1f84cf0b348fa500c7ac519_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTk2Mw_79f40498-2068-47c3-8b5d-5c8592a16999"
      unitRef="usd">22800000</us-gaap:LongtermConstructionLoanCurrentAndNoncurrent>
    <us-gaap:LongtermConstructionLoanCurrentAndNoncurrent
      contextRef="i0cd6211d49ce40f2a37e553096ffe101_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMTk3MA_7c518d04-3c77-44e2-8a8b-d08a7ffe1b8b"
      unitRef="usd">23800000</us-gaap:LongtermConstructionLoanCurrentAndNoncurrent>
    <us-gaap:InterestCostsIncurred
      contextRef="id3bd705add894d9cbb688ee5e9a40dbf_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjAyNg_123df39c-169b-497d-8bc3-352e6fd921be"
      unitRef="usd">700000</us-gaap:InterestCostsIncurred>
    <us-gaap:InterestCostsIncurred
      contextRef="i75e9cb3ad90c4a5d82d4288d4e770a53_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjAyNg_dff608cd-fb14-4d1e-a33a-d160c942ca6d"
      unitRef="usd">700000</us-gaap:InterestCostsIncurred>
    <us-gaap:InterestCostsCapitalized
      contextRef="i1d7390258e4a4b2ba37dcee40cdf5250_D20191201-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjE2OQ_752839d9-0d80-442b-9aab-e45e06ffc813"
      unitRef="usd">700000</us-gaap:InterestCostsCapitalized>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="iafe6aabe3c26422ba3568068ffeae6b5_I20171130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjI0OA_f3aa151e-17dd-48a6-b856-4388641874bb"
      unitRef="usd">200000</us-gaap:DeferredFinanceCostsNet>
    <exas:DebtInstrumentCovenantLiquidityRequiredMinimum
      contextRef="i797d752f32bf41b5a68518c097333f71_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMjk4Mg_23bb994e-be61-4155-a0da-7fef5e73fe96"
      unitRef="usd">250000000</exas:DebtInstrumentCovenantLiquidityRequiredMinimum>
    <exas:NumberOfAgreementsEntered
      contextRef="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzE5NQ_a8e584f8-1121-483d-89df-a699ae071d94"
      unitRef="agreement">2</exas:NumberOfAgreementsEntered>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ife7a525df7ca4926bdd7bd3c78f5a6bd_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzM0NQ_50e7dcfd-4dd4-447c-99ba-a45560b85163"
      unitRef="usd">4600000</us-gaap:DebtInstrumentFaceAmount>
    <exas:NumberOfJobsRequiredToCreatedAndMaintained
      contextRef="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfMzQ1Mg_f5ec0675-e93f-4daa-b54e-459a230eaad5"
      unitRef="employee">500</exas:NumberOfJobsRequiredToCreatedAndMaintained>
    <us-gaap:DebtInstrumentTerm
      contextRef="i46e254ddb9e0433fa8c01d17b46c5d05_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDI5OQ_509eb210-8ad1-46a5-b5ed-2d5c7ad12a56">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:RegulatoryLiabilityAmortizationPeriod
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDMwMA_0d667748-a81b-4977-ba95-1a37210b4fec">P2Y</us-gaap:RegulatoryLiabilityAmortizationPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i215a2290155b49189167351e504e7ec6_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81Mi9mcmFnOjcwNGUxYTMxMTliODQ5NmE4YmRlZDdhMDIyZmVhYTU4L3RleHRyZWdpb246NzA0ZTFhMzExOWI4NDk2YThiZGVkN2EwMjJmZWFhNThfNDAzNw_10491c68-80f4-4e23-ada6-e7f0f0257568"
      unitRef="usd">4600000</us-gaap:DebtInstrumentFaceAmount>
    <exas:ConvertibleNotesTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3Nw_d7adf332-63eb-4195-8ce8-b216f8245b02">CONVERTIBLE NOTES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leveling&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Convertible notes - 1.000% (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leveling&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Convertible notes - 1.000% (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the Company&#x2019;s share price on the days leading up to September&#160;30, 2021 and December 31, 2020, holders of the 2025 Convertible Notes have the right to convert their debentures. As a result, the 2025 Convertible Notes are included within convertible notes, net, current portion on the condensed consolidated balance sheets. Some holders did convert their debentures, resulting in a decrease of the principal amount of the 2025 Convertible Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The fair values are based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Issuances and Settlements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2018, the Company issued and sold $690.0 million in aggregate principal amount of 1.0% Convertible Notes (the &#x201c;January 2025 Notes&#x201d;) with a maturity date of January 15, 2025. The January 2025 Notes accrue interest at a fixed rate of 1.0% per year, payable semi-annually in arrears on January 15 and July 15 of each year, beginning on July 15, 2018. The net proceeds from the issuance of the January 2025 Notes were approximately $671.1 million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2018, the Company issued and sold an additional $218.5 million in aggregate principal amount of 1.0% Convertible Notes (the &#x201c;June 2025 Notes&#x201d;). The June 2025 Notes were issued under the same indenture pursuant to which the Company previously issued the January 2025 Notes (the &#x201c;Indenture&#x201d;). The January 2025 Notes and the June 2025 Notes (collectively, the &#x201c;2025 Notes&#x201d;) have identical terms (including the same January 15, 2025 maturity date) and are treated as a single series of securities. The net proceeds from the issuance of the June 2025 Notes were approximately $225.3 million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, the Company issued and sold $747.5 million in aggregate principal amount of 0.375% Convertible Notes (the &#x201c;2027 Notes&#x201d;) with a maturity date of March 15, 2027. The 2027 Notes accrue interest at a fixed rate of 0.375% per year, payable semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2019. The net proceeds from the issuance of the 2027 Notes were approximately $729.5 million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilized a portion of the proceeds from the issuance of the 2027 Notes to settle a portion of the 2025 Notes in privately negotiated transactions. In March 2019, the Company used cash of $494.1 million and an aggregate of 2.2 million shares of the Company&#x2019;s common stock valued at $182.4 million for total consideration of $676.5 million to settle $493.4 million of the 2025 Notes, of which $0.7 million was used to pay off interest accrued on the 2025 Notes. The transaction resulted in a loss on settlement of convertible notes of $187.7 million, which is reflected in accumulated deficit in the Company&#x2019;s condensed consolidated balance sheets. The loss represents the difference between (i) the fair value of the consideration transferred and (ii) the carrying value of the debt at the time of repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company issued and sold $1.15 billion in aggregate principal amount of 0.375% Convertible Notes (the &#x201c;2028 Notes&#x201d; and, collectively with the 2025 Notes and the 2027 Notes, the &#x201c;Notes&#x201d;) with a maturity date of March 1, 2028. The 2028 Notes accrue interest at a fixed rate of 0.375% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2020. The net proceeds from the issuance of the 2028 Notes were approximately $1.13 billion, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company used $150.1 million of the proceeds from the issuance of the 2028 Notes to settle $100.0 million of the 2025 Notes, of which $0.1 million was used to pay off interest accrued on the 2025 Notes. The transaction resulted in a loss on settlement of convertible notes of $50.8 million, which is recorded in interest expense in the Company&#x2019;s condensed consolidated statement of operations. The loss represents the difference between (i) the fair value of the consideration transferred and (ii) the carrying value of the debt at the time of repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of Conversion Features&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Until the six-months immediately preceding the maturity date of the applicable series of Notes, each series of Notes is convertible only upon the occurrence of certain events and during certain periods, as set forth in the Indentures filed at the time of the original offerings. On or after the date that is six-months immediately preceding the maturity date of the applicable series of Notes until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert such Notes at any time. The Notes will be convertible into cash, shares of the Company&#x2019;s common stock (plus, if applicable, cash in lieu of any fractional share), or a combination of cash and shares of the Company&#x2019;s common stock, at the Company&#x2019;s election.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is the Company&#x2019;s intent and policy to settle all conversions through combination settlement. The initial conversion rate is&#160;13.26, 8.96, and 8.21 shares of common stock per&#160;$1,000&#160;principal amount for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively, which is equivalent to an initial conversion price of&#160;approximately $75.43,&#160;$111.66, and $121.84 per share of the Company&#x2019;s common stock for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively. The 2025 Notes, 2027 Notes, and 2028 Notes may be convertible in up to 4.2&#160;million, 6.7&#160;million, and 9.4&#160;million shares, respectively. The conversion rate is subject to adjustment upon the occurrence of certain specified events as set forth in the Indentures filed at the time of the original offerings but will not be adjusted for accrued and unpaid interest. In addition, holders of the Notes who convert their Notes in connection with a &#x201c;make-whole fundamental change&#x201d; (as defined in the Indenture), will, under certain circumstances, be entitled to an increase in the conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a &#x201c;fundamental change&#x201d; (as defined in the Indenture), holders of the Notes may require the Company to repurchase for cash all or part of their Notes at a repurchase price equal to&#160;100%&#160;of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the closing price of the Company&#x2019;s common stock of $95.45 on September&#160;30, 2021, the if-converted values on the Company&#x2019;s 2025 Notes exceed the principal amount by $83.6 million and the 2027 Notes and 2028 Notes do not exceed the principal amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ranking of Convertible Notes&lt;/span&gt;&lt;span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Notes are the Company&#x2019;s senior unsecured obligations and (i) rank senior in right of payment to all of its future indebtedness that is expressly subordinated in right of payment to the Notes; (ii) rank equal in right of payment to each outstanding series thereof and to all of the Company&#x2019;s future liabilities that are not so subordinated, unsecured indebtedness; (iii) are effectively junior to all of the Company&#x2019;s existing and future secured indebtedness and other secured obligations, to the extent of the value of the assets securing that indebtedness and other secured obligations; and (iv) are structurally subordinated to all indebtedness and other liabilities of the Company&#x2019;s subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Issuance costs are amortized to interest expense over the term of the Notes. The following table summarizes the original issuance costs at the time of issuance for each set of Notes:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on settlement of convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coupon interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense on convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective interest rates on the 2025 Notes, 2027 Notes, and 2028 Notes for the three months ended September&#160;30, 2021 and 2020 were 1.18%, 0.68%, and 0.64% and 1.18%, 0.68%, and 0.64%, respectively. The effective interest rates on the 2025 Notes, 2027 Notes, and 2028 Notes for the nine months ended September&#160;30, 2021 and 2020 were 1.18%, 0.67%, and 0.64% and 1.21%, 0.68%, and 0.63%, respectively. The remaining period over which the unamortized debt discount will be recognized as non-cash interest expense is 3.30, 5.46, and 6.42 years for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively.&lt;/span&gt;&lt;/div&gt;</exas:ConvertibleNotesTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3NA_ae64efdb-7c36-4cda-88d3-08731f7f9f12">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of September&#160;30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leveling&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,130,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,257)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;834,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Convertible notes - 1.000% (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;455,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Principal Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unamortized Debt Discount and Issuance Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leveling&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,526,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Convertible notes - 0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Convertible notes - 1.000% (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Based on the Company&#x2019;s share price on the days leading up to September&#160;30, 2021 and December 31, 2020, holders of the 2025 Convertible Notes have the right to convert their debentures. As a result, the 2025 Convertible Notes are included within convertible notes, net, current portion on the condensed consolidated balance sheets. Some holders did convert their debentures, resulting in a decrease of the principal amount of the 2025 Convertible Notes. &lt;/span&gt;&lt;/div&gt;(2)The fair values are based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement.</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6a521727e1e2422195adff75e2af975a_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi0wLTEtMS0xL3RleHRyZWdpb246YjNiODIxNGNjNDQzNDg1YThhZDY0M2ZkMWU5ODFkNGFfMjk_c5e42f2d-e09d-46a9-b940-4a5bc0179783"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <exas:ConvertibleNotesPayableGross
      contextRef="i6a521727e1e2422195adff75e2af975a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi0yLTEtMS0x_bdeb3b38-931e-4a10-823b-a7de6e33df26"
      unitRef="usd">1150000000</exas:ConvertibleNotesPayableGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i6a521727e1e2422195adff75e2af975a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi00LTEtMS0x_ccce53a0-050a-4ed6-bf98-8e3065deba42"
      unitRef="usd">19596000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i6a521727e1e2422195adff75e2af975a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi02LTEtMS0x_34e993ab-6ad8-4f54-b2f2-6d59e40003c5"
      unitRef="usd">1130404000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ib556532666a843ffaa7ac89ce011921f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMi04LTEtMS0x_c2c88ea7-2cbd-4bbc-b89c-401d4831efac"
      unitRef="usd">1222968000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy0wLTEtMS0xL3RleHRyZWdpb246NTU1NDFmNDZjMDU3NGI1MzkwNmQ1NGE4MzE2NzkyZDlfMjk_e9178604-d295-422b-86c7-07221805f526"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <exas:ConvertibleNotesPayableGross
      contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy0yLTEtMS0x_72297702-e6dc-45fc-bc13-26f59605d393"
      unitRef="usd">747500000</exas:ConvertibleNotesPayableGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy00LTEtMS0x_c4696128-6f43-4bc6-b4d7-08152668edd8"
      unitRef="usd">12257000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy02LTEtMS0x_a577ac22-4a8c-4394-bda8-2453d79ce216"
      unitRef="usd">735243000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="ibbba114462ea45e2925e5dd96d8f6ec2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfMy04LTEtMS0x_01546038-385d-4448-978e-9df31fa17589"
      unitRef="usd">834285000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC0wLTEtMS0xL3RleHRyZWdpb246MWViNzdjMGY4YWU5NGNmNTg5ODkwZWExYTUxZDg3ZWJfMjk_270fdd87-7f4f-4a05-85bd-4912054b8b81"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <exas:ConvertibleNotesPayableGross
      contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC0yLTEtMS0x_d0fbdf66-3f6b-4fb3-a3ed-fbbe85c2645a"
      unitRef="usd">315005000</exas:ConvertibleNotesPayableGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC00LTEtMS0x_0f00b3ae-c1fa-4020-ba88-cee8d821df18"
      unitRef="usd">1901000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC02LTEtMS0x_5e073693-756b-4563-adde-a4495f1c037d"
      unitRef="usd">313104000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="icfddf1183e2348268bfa21947a0c2519_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjk1NWMxODQyYTFhMDQ4Zjg4Y2YzYzUyZTAyYTcxYzdiL3RhYmxlcmFuZ2U6OTU1YzE4NDJhMWEwNDhmODhjZjNjNTJlMDJhNzFjN2JfNC04LTEtMS0x_4bc5fc02-55e5-444f-b953-1ebb829de77d"
      unitRef="usd">455204000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi0wLTEtMS0xL3RleHRyZWdpb246NzkxZjIwZjYyOGVlNDA3OTg4YjViNzNhMzZjNzVjNzlfMjk_c75a7bac-8b61-499b-8eb3-042748e5658d"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <exas:ConvertibleNotesPayableGross
      contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi0yLTEtMS0x_bfc74a95-4c46-463a-9ff4-ea2f9ad21fb5"
      unitRef="usd">1150000000</exas:ConvertibleNotesPayableGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi00LTEtMS0x_2d34c2f9-022e-4b03-a356-0f40fd8b1288"
      unitRef="usd">21878000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="ib1de8ddd92e7432c9ef925b25e3b0dc9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi02LTEtMS0x_cbb8ae2e-c3c3-464b-9a07-ac3d0f1a3da6"
      unitRef="usd">1128122000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="if11cabfe62874386b5321d2d3c18173d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMi04LTEtMS0x_e9709911-fe10-4c16-ae98-0da9f3905b6a"
      unitRef="usd">1526625000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy0wLTEtMS0xL3RleHRyZWdpb246MGU1ODdmMTk0NDEwNDEzNmE3ODlhOTRhY2Q2NDI2MGRfMjk_7bc2ccaa-34eb-42a3-af7a-f135ee4bd0a5"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <exas:ConvertibleNotesPayableGross
      contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy0yLTEtMS0x_5eab7c70-2679-4af9-9612-a1ddfaa60f83"
      unitRef="usd">747500000</exas:ConvertibleNotesPayableGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy00LTEtMS0x_7c84f74a-fd64-4477-b931-69a037fd5d54"
      unitRef="usd">13937000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i7019a92c504448ceac52c088b3629b1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy02LTEtMS0x_b2ff15f1-dffb-4d91-825c-07414907c018"
      unitRef="usd">733563000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="if3877e40a0f249069cae9a5fc123fb01_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfMy04LTEtMS0x_0f68f735-6575-4a3b-ba19-925b525f5688"
      unitRef="usd">992306000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC0wLTEtMS0xL3RleHRyZWdpb246OTIwNTdjMDc2ZGJjNDVlZGFjOTZmYmRlZWEzMzIzMWVfMjk_a7042f75-988d-4417-a568-c7b9ea2dae5d"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <exas:ConvertibleNotesPayableGross
      contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC0yLTEtMS0x_3d9cc925-3aa0-4c7a-9b10-786df7f995d8"
      unitRef="usd">315049000</exas:ConvertibleNotesPayableGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC00LTEtMS0x_a83cea98-b2b8-4eff-ab69-303453d5e42a"
      unitRef="usd">2333000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:ConvertibleNotesPayable
      contextRef="id9d10c4091ef4bb88a8442da98f2e144_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC02LTEtMS0x_9fa0625d-72f1-4130-9c33-fa19212fce7a"
      unitRef="usd">312716000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i59d45eaa6f404347bac96339127fc805_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjJlNjY2MDk3Y2E4ZTRhZWU5ODlmNGU1OTJjODFiYWE4L3RhYmxlcmFuZ2U6MmU2NjYwOTdjYThlNGFlZTk4OWY0ZTU5MmM4MWJhYThfNC04LTEtMS0x_842ce6b5-609a-4e2a-8aef-b9ff84e62ef9"
      unitRef="usd">601744000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i38025f781a304faeaa4d5be06d555c28_I20180131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODQy_dc6d05bb-a540-42ef-bc67-d1a633e619ae"
      unitRef="usd">690000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i38025f781a304faeaa4d5be06d555c28_I20180131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODc4_ab7878f2-94ab-4e92-879f-dfa22b32896e"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic2e12ba29e1148cc92200e3f802d478d_I20180131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTAyNg_d7f14ba4-8fdb-4631-966e-36d786116f02"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2f6e4612ba6042b3a41b0a3a22cc1a08_D20180101-20180131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTIyMA_aafa8a7b-4722-46d8-804f-e46737205e8e"
      unitRef="usd">671100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i130815bcac064cb9a769f10dde0d717f_I20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTM4Ng_06279e5d-9944-4126-9880-29edf01f5bb8"
      unitRef="usd">218500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i130815bcac064cb9a769f10dde0d717f_I20180630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTQyMg_4a1653f1-4ba4-4723-9cd4-7d9ad0d77ee7"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i321e09355b9344bb8c1ddfb4873b74c4_D20180601-20180630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMTg5NQ_18895944-051c-41d1-b70b-091feadc6280"
      unitRef="usd">225300000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i374446ae108740e8b3d011f480573480_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjA0OA_8b78f216-7c1d-4de4-bc81-9214d5eef76b"
      unitRef="usd">747500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i374446ae108740e8b3d011f480573480_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjA4NA_a30a4746-cc14-4317-8768-605680da9121"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i374446ae108740e8b3d011f480573480_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjIxNA_a30a4746-cc14-4317-8768-605680da9121"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i2cedb49083ec46b7819b0b36b95fd866_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjQwOA_23726a71-7c85-4a13-8c97-937da5baeb4c"
      unitRef="usd">729500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjcxNw_a92a622b-d22b-4517-a9a6-2276a8802a17"
      unitRef="usd">494100000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjc0MA_1de0e043-0334-463d-ba05-c06a2d9b46f2"
      unitRef="shares">2200000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
      contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjc5MA_280cb609-7566-497b-9d96-1eb09bb7c9eb"
      unitRef="usd">182400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments>
    <exas:RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares
      contextRef="ic4b646c92a0b4531bdfcd2c0097ff500_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjgyMA_49aba912-551f-4699-b4bb-8310bdfff623"
      unitRef="usd">676500000</exas:RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares>
    <us-gaap:RepaymentsOfDebt
      contextRef="i8bfcc0d5558a40d4bbafe59948477390_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjgzMw_f37a6084-7170-4f75-9f66-bebfade4a2e4"
      unitRef="usd">493400000</us-gaap:RepaymentsOfDebt>
    <exas:DebtInstrumentConvertibleEquityComponentInterestAccrued
      contextRef="i8bfcc0d5558a40d4bbafe59948477390_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjg2NA_13be7379-942c-4e5a-9e60-429c8b52d0d0"
      unitRef="usd">700000</exas:DebtInstrumentConvertibleEquityComponentInterestAccrued>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7b1067f298de48eca8c19edda276d2ed_D20190301-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMjk5Ng_dcbafecf-2e4d-49f1-b96f-c56d5ceeb55d"
      unitRef="usd">-187700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzMwNg_36ab4216-484d-40a2-87ae-12972a881a2b"
      unitRef="usd">1150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzM0Mg_f695a10d-19c7-4675-a78e-dcf6cad6b9f8"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5e969b5cee9e4e158859b31a3e2bb0f5_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzU0MQ_f695a10d-19c7-4675-a78e-dcf6cad6b9f8"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ida0a237027f04c40b0f9753f4982f052_D20200201-20200229"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzczMg_84189d5a-c92d-4db4-bf34-8fc1af8956ef"
      unitRef="usd">1130000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzg3Nw_8aaa4fa8-b5f1-4aa6-b035-49ad61c41cca"
      unitRef="usd">150100000</us-gaap:RepaymentsOfConvertibleDebt>
    <exas:DebtInstrumentAmountSettledInExtinguishment
      contextRef="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzk0Mg_0a691880-7a0f-4396-a3e4-431cf9c67841"
      unitRef="usd">100000000.0</exas:DebtInstrumentAmountSettledInExtinguishment>
    <exas:DebtInstrumentConvertibleEquityComponentInterestAccrued
      contextRef="i99583f786f534fe7a48d700d80f00a4c_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfMzk3Mw_057f81b3-3b82-4497-9dc8-0bdb4c571347"
      unitRef="usd">100000</exas:DebtInstrumentConvertibleEquityComponentInterestAccrued>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i41663aac7c7a4e50bbe228b3f6df07a4_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNDEwNQ_8abea08b-56eb-4870-b715-a0632a77af8a"
      unitRef="usd">-50800000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i50e1ec8fda6643ce82eee56046acd62b_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTUwMQ_a05b6c6c-80a5-4a86-9f6e-b61b9a3400a1"
      unitRef="usdPerShare">75.43</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="if16b3c6f1e4a4d1489f70faed335b68d_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTUwNQ_c357e03b-cf00-48fd-ab2a-a1fd99dffac8"
      unitRef="usdPerShare">111.66</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i6a521727e1e2422195adff75e2af975a_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTUxMw_7a98ab20-7cb7-4a01-94b1-c3696bddce1d"
      unitRef="usdPerShare">121.84</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTY4OQ_e256101e-fbb7-4d5a-a9db-17fe81cfa7e2"
      unitRef="shares">4200000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTY5Mw_909320ff-9488-4a82-ba87-8397fd3cc4ef"
      unitRef="shares">6700000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments
      contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNTcwMQ_182e2ae1-86ed-4df0-a602-de906df6329d"
      unitRef="shares">9400000</us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments>
    <exas:DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount
      contextRef="i5de4fa457232460eb415263a8948799a_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNjM4Ng_e1e3d4e7-0910-4208-9a7e-5f65c351bd4e"
      unitRef="number">100</exas:DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount>
    <us-gaap:SharePrice
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNjU0MQ_15672a6c-20ab-46d4-9d1a-5f81aac5c6d5"
      unitRef="usdPerShare">95.45</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal
      contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNjYwNg_6d7d5f79-1255-4c28-866f-3f5b4ba7f38c"
      unitRef="usd">83600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <exas:ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3NQ_e1304415-b731-4bbd-b10c-91cea10a1710">The following table summarizes the original issuance costs at the time of issuance for each set of Notes:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</exas:ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock>
    <exas:DebtInstrumentConvertibleTransactionCosts
      contextRef="i124fcfaa5c2844ba9a7f3648437e97a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfMS0yLTEtMS0x_ae88a4d5-b6c9-4af8-8c39-5c93343532d6"
      unitRef="usd">10284000</exas:DebtInstrumentConvertibleTransactionCosts>
    <exas:DebtInstrumentConvertibleTransactionCosts
      contextRef="icebfd363a27a407f91529aaa90ed0971_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfMi0yLTEtMS0x_f07e7330-3cdf-4aaf-895a-040a4f71051f"
      unitRef="usd">7362000</exas:DebtInstrumentConvertibleTransactionCosts>
    <exas:DebtInstrumentConvertibleTransactionCosts
      contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfMy0yLTEtMS0x_be1953a2-95f5-4fd7-99da-22ae60f795b2"
      unitRef="usd">14285000</exas:DebtInstrumentConvertibleTransactionCosts>
    <exas:DebtInstrumentConvertibleTransactionCosts
      contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjI0ZDc4NTA2YzViMDRjYjY5ZWU3Mjk0MmU3M2RlOTJkL3RhYmxlcmFuZ2U6MjRkNzg1MDZjNWIwNGNiNjllZTcyOTQyZTczZGU5MmRfNC0yLTEtMS0x_7ef18dde-6905-4791-8272-e518831b5189"
      unitRef="usd">24453000</exas:DebtInstrumentConvertibleTransactionCosts>
    <exas:InterestExpenseDebtTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODM3OQ_13f361bf-c58f-4cf1-99e6-2d5d6446e5e3">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense includes the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt issuance costs amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt discount amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on settlement of convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Coupon interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense on convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</exas:InterestExpenseDebtTableTextBlock>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi0yLTEtMS0x_c7174701-55bf-42b3-a049-e1b6b13cdc31"
      unitRef="usd">1444000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi00LTEtMS0x_41fb1cc6-adc7-420b-b08d-4e20603bc734"
      unitRef="usd">1443000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi02LTEtMS0x_befe4347-a8dc-4a01-a824-cbffa150c250"
      unitRef="usd">4284000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMi04LTEtMS0x_e27ada19-60d5-4e41-a95d-0026d1ca8532"
      unitRef="usd">3860000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy0yLTEtMS0x_472865d6-66b7-4b54-8f23-e6962694edb9"
      unitRef="usd">37000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy00LTEtMS0x_0e28cce2-c00b-4e3c-bae4-ba965770549f"
      unitRef="usd">37000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy02LTEtMS0x_0c3cb799-6041-403c-b5ca-ce082fa0796b"
      unitRef="usd">110000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfMy04LTEtMS0x_d2f221b9-413a-4b70-8483-862bc2c6cc2d"
      unitRef="usd">94000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC0yLTEtMS0x_5ee9c6f0-0e10-49ba-abce-11b96c0b0e36"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC00LTEtMS0x_30c4cbcf-b75f-48f1-af64-e369cb5677eb"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC02LTEtMS0x_ceeb8aa0-d108-4635-9245-18f276cf3fd4"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNC04LTEtMS0x_c11e7901-cf76-4971-970c-48059b6c3d63"
      unitRef="usd">-50819000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <exas:CouponInterestExpense
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS0yLTEtMS0x_5a457c08-61f6-4d1a-87cf-340f4e9fb691"
      unitRef="usd">2566000</exas:CouponInterestExpense>
    <exas:CouponInterestExpense
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS00LTEtMS0x_e478bb5b-fcae-414b-bbcd-9095b23b4b33"
      unitRef="usd">2567000</exas:CouponInterestExpense>
    <exas:CouponInterestExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS02LTEtMS0x_808d477d-edd2-4be2-abe0-95c5f6109983"
      unitRef="usd">7699000</exas:CouponInterestExpense>
    <exas:CouponInterestExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNS04LTEtMS0x_45e8aa47-c525-43a9-933d-15873a0450bb"
      unitRef="usd">7065000</exas:CouponInterestExpense>
    <us-gaap:InterestExpenseDebt
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi0yLTEtMS0x_c7357dce-f877-4c24-886a-eb7781888c6d"
      unitRef="usd">4047000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi00LTEtMS0x_26bf13aa-2462-4851-b563-faf4ad6f5835"
      unitRef="usd">4047000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi02LTEtMS0x_60391218-32ae-461b-9608-e941df8a5240"
      unitRef="usd">12093000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNi04LTEtMS0x_dc5ba4fd-bf1f-49b0-b9be-fe7811c0d12e"
      unitRef="usd">61838000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseOther
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy0yLTEtMS0x_d42618db-bb6c-4628-b321-eafd8d226ead"
      unitRef="usd">633000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy00LTEtMS0x_03d1dc22-49b5-4b5e-b010-2e09629afdca"
      unitRef="usd">431000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy02LTEtMS0x_8f44098d-c101-475b-9022-3e36e526957d"
      unitRef="usd">1855000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestExpenseOther
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfNy04LTEtMS0x_215b698d-369f-401d-b886-d2a96aa3cefb"
      unitRef="usd">1544000</us-gaap:InterestExpenseOther>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC0yLTEtMS0x_b93498cc-bd12-4b63-9e24-089f9392c922"
      unitRef="usd">-4680000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC00LTEtMS0x_57a19d47-40d9-4850-8535-9711ca0c563c"
      unitRef="usd">-4478000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC02LTEtMS0x_0553f15e-dd6a-40c0-9b56-fbc56d5a76bf"
      unitRef="usd">-13948000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RhYmxlOjYwMTJiNmNhNzE0MzRkNDlhYTlmNDEzMDk3OTQ0YWU4L3RhYmxlcmFuZ2U6NjAxMmI2Y2E3MTQzNGQ0OWFhOWY0MTMwOTc5NDRhZThfOC04LTEtMS0x_7ffff758-8d3b-4131-818f-2779e4d7256e"
      unitRef="usd">-63382000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ibd02d60e985347cca760b9cee3c1553f_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk3Mg_b8246562-7598-4af9-87c0-61185410b757"
      unitRef="number">0.0118</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i11ab2964ac5a4d30ab3e51e81e533a19_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk3Ng_5c972224-934b-4982-9b71-1597d8e0900b"
      unitRef="number">0.0068</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i558d42ab543b48d1bd82a3e120ac356d_D20210701-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk4NA_06e949f6-f203-4de3-afa8-1aea6e75b9ec"
      unitRef="number">0.0064</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i1c6f646df40d4090b3421105d8392a38_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk5MQ_57c4293e-3e05-4527-80c5-9c11da04f1f6"
      unitRef="number">0.0118</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i25bccea148c24ef3b5882a544e0cc76f_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfNzk5NQ_563585d1-63eb-4c81-813c-3c460dabe33f"
      unitRef="number">0.0068</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i62e976ba77074ce9b9fe3a0c91204d9f_D20200701-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODAwMw_04b4fe4f-c663-4978-bc02-88ab3309ff86"
      unitRef="number">0.0064</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODEzNQ_9c697fa6-5cdb-447c-a0cd-18f803cd706f"
      unitRef="number">0.0118</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODEzOQ_0d2c57f6-74c0-4c3d-b841-1123cb0dff16"
      unitRef="number">0.0067</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE0Nw_b1d22572-e9dc-45c6-8f59-30cfde73f433"
      unitRef="number">0.0064</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="if1829c1ca7704928b8a7a131034977d3_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE1NA_798b5c2c-546c-494e-8062-0eb6735b3127"
      unitRef="number">0.0121</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ie533365c1c7a49cfa488f532fa22ddb8_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE1OA_eab29878-5362-40f5-9b99-40f746cee048"
      unitRef="number">0.0068</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i096f0478568e4ab3ba5831ff5cf0ff8b_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODE2Ng_c9692e9b-a9b1-46d9-b777-2a0bef38501f"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="ia5462ab263a2442ea0afa18fbd5fcd3e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODI5Nw_cd6b4be7-6171-4149-9acf-9c59115671bc">P3Y3M18D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="icf4f7655fd804a66a9881becc9134f7c_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODMwMQ_e5926725-a9c4-426f-b19a-d398f8901d90">P5Y5M15D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="i0d980f0760d14e2cb3fdc196c55efe2b_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF81NS9mcmFnOmVhOGU5MjgxMzUxZTQ0ZDlhMDgyZWVlZDkxNGFjYzlmL3RleHRyZWdpb246ZWE4ZTkyODEzNTFlNDRkOWEwODJlZWVkOTE0YWNjOWZfODMwOQ_9b3e7db0-dbc7-45ea-adec-2ffc9fd3aa73">P6Y5M1D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <exas:LicensingAgreementDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQzMQ_b73aeb1f-783f-4e07-9c40-5e061b94776d">LICENSE AND COLLABORATION AGREEMENTS&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company licenses certain technologies that are, or may be, incorporated into its technology under several license agreements, as well as the rights to commercialize certain diagnostic tests through collaboration agreements. Generally, the license agreements require the Company to pay low single-digit royalties based on net revenues received using the technologies and may require minimum royalty amounts or maintenance fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Mayo&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June&#160;2009 the Company entered into a license agreement with Mayo Foundation for Medical Education and Research (&#x201c;Mayo&#x201d;). The Company&#x2019;s license agreement with Mayo was most recently amended and restated in September 2020. Under the license agreement, Mayo granted the Company an exclusive, worldwide license to certain Mayo patents and patent applications, as well as a non-exclusive, worldwide license with regard to certain Mayo know-how. The scope of the license covers any screening, surveillance or diagnostic test or tool for use in connection with any type of cancer, pre-cancer, disease or condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The licensed Mayo patents and patent applications contain both method and composition claims that relate to sample processing, analytical testing and data analysis associated with nucleic acid screening for cancers and other diseases. The jurisdictions covered by these patents and patent applications include the U.S., Australia, Canada, the European Union, China, Japan and Korea. Under the license agreement, the Company assumed the obligation and expense of prosecuting and maintaining the licensed Mayo patents and is obligated to make commercially reasonable efforts to bring to market products using the licensed Mayo intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant&#160;to the Company&#x2019;s&#160;agreement with Mayo,&#160;the Company is&#160;required to pay Mayo a low-single-digit royalty on the Company&#x2019;s net sales of current and future products using the licensed Mayo intellectual property&#160;each year during the term of the Mayo agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the most recent amendment, the Company agreed to pay Mayo an additional $6.3 million, payable in five equal annual installments through 2024. The annual installments are recorded in research and development expenses in the Company&#x2019;s condensed consolidated statements of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The license agreement will remain in effect, unless earlier terminated by the parties in accordance with the agreement, until the last of the licensed patents expires in 2038 (or later, if certain licensed patent applications are issued). However, if the Company is still using the licensed Mayo know-how or certain Mayo-provided biological specimens or their derivatives on such expiration date, the term shall continue until the earlier of the date the Company stops using such know-how and materials and the date that is five years after the last licensed patent expires. The license agreement contains customary termination provisions and permits Mayo to terminate the license agreement if the Company sues Mayo or its affiliates, other than any such suit claiming an uncured material breach by Mayo of the license agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to granting the Company a license to the covered Mayo intellectual property, Mayo provides the Company with product development and research and development assistance pursuant to the license agreement and other collaborative arrangements. In September 2020, Mayo also agreed to make available certain personnel to provide such assistance through January 2025. In connection with this collaboration, the Company incurred charges of $1.3 million and $0.9 million for the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $3.5&#160;million and $2.8 million for the nine months ended September 30, 2021 and 2020, respectively. The charges incurred in connection with this collaboration are recorded in research and development expenses in the Company&#x2019;s condensed consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Johns Hopkins University (&#x201c;JHU&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through the acquisition of Thrive, the Company acquired a worldwide exclusive license agreement with JHU for use of several JHU patents and licensed know-how. The license is designed to enable the Company to leverage JHU proprietary data in the development and commercialization of a blood-based, multi-cancer early detection test. The agreement terms include single-digit sales-based royalties and sales-based milestone payments of $10.0 million, $15.0 million, $20.0 million upon achieving calendar year licensed product revenue using JHU proprietary data of $0.50 billion, $1.00 billion, and $1.50 billion, respectively.&lt;/span&gt;&lt;/div&gt;</exas:LicensingAgreementDisclosureTextBlock>
    <exas:LicenseAgreementFeesCommitment
      contextRef="i09b705cb560e427b94fb986c5efcc8fa_I20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMjA3Mg_9d39adc5-84df-40be-aefc-5a0b5cb1361f"
      unitRef="usd">6300000</exas:LicenseAgreementFeesCommitment>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7687d156b5064d39b98d15068b794c79_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzU0OA_9fc136ce-d2ea-42ad-9635-75f09e4c3c33"
      unitRef="usd">1300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4b58a8bac9c14347b1a5e677d4bd4071_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzU1NQ_2b5d9ebf-1c11-4f7b-95ac-2e244b17f0bc"
      unitRef="usd">900000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia4940cc012454056b02ad98f6edbda80_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzYyMw_80d54e38-d6d3-4d11-9874-0f9133de2d55"
      unitRef="usd">3500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i38df5143fb9f471eaadf9f61fcdb461a_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfMzYzMA_681bc5d7-bd0e-47f0-9875-3149fd4cfebb"
      unitRef="usd">2800000</us-gaap:ResearchAndDevelopmentExpense>
    <exas:PaymentsContingentOnMilestonesPayable
      contextRef="i5315ee1596b6499d88299026c527248b_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDMwMg_3b91f3c4-f998-4563-8dac-b45816243fec"
      unitRef="usd">10000000</exas:PaymentsContingentOnMilestonesPayable>
    <exas:PaymentsContingentOnMilestonesPayable
      contextRef="i08569ff75b9f4fb89d6962ce95f8760d_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDMwNg_d191d699-c94f-4cd8-a6c1-e829b292733a"
      unitRef="usd">15000000</exas:PaymentsContingentOnMilestonesPayable>
    <exas:PaymentsContingentOnMilestonesPayable
      contextRef="ie431846077ce465aaa2deb9090c42f3d_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDMxMA_acbff61a-55a1-4a3d-8680-4f6e6f7b23c6"
      unitRef="usd">20000000</exas:PaymentsContingentOnMilestonesPayable>
    <exas:CollaborativeArrangementsSalesMilestoneAmount
      contextRef="id60aa524dd6844bfab317842fa27f753_D20210105-20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQwMQ_814813cb-643d-4677-bf9c-72bb4c95a641"
      unitRef="usd">500000000</exas:CollaborativeArrangementsSalesMilestoneAmount>
    <exas:CollaborativeArrangementsSalesMilestoneAmount
      contextRef="i073a3afe3259475fa47b27b5734849c0_D20210105-20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQwNQ_9b51fb87-995c-4750-b213-bbdd6dc7b6fe"
      unitRef="usd">1000000000</exas:CollaborativeArrangementsSalesMilestoneAmount>
    <exas:CollaborativeArrangementsSalesMilestoneAmount
      contextRef="ib66de190a3114ea390108d37accaf4be_D20210105-20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82MS9mcmFnOjA0M2QyY2E5ZjZmNTQ5YmM5NmJiNWM0ZTIxMDUyMzlhL3RleHRyZWdpb246MDQzZDJjYTlmNmY1NDliYzk2YmI1YzRlMjEwNTIzOWFfNDQxMw_1a5514f4-f861-4b57-877f-6aad3fd12ac3"
      unitRef="usd">1500000000</exas:CollaborativeArrangementsSalesMilestoneAmount>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMjE4MQ_c0cb22f0-8613-4fc3-bdff-3b50405c4209">PFIZER PROMOTION AGREEMENTIn August 2018, the Company entered into a Promotion Agreement (the &#x201c;Original Promotion Agreement&#x201d;) with Pfizer Inc. (&#x201c;Pfizer&#x201d;), which was amended and restated in October 2020 (the &#x201c;Restated Promotion Agreement&#x201d;). The Restated Promotion Agreement extends the relationship between the Company and Pfizer and restructures the manner in which the Company compensates Pfizer for promotion of the Cologuard test through a service fee, and provision of certain other sales and marketing services related to the Cologuard test. The Restated Promotion Agreement includes fixed and performance-related fees, some of which retroactively went into effect on April 1, 2020. All payments to Pfizer are recorded in sales and marketing expenses in the Company&#x2019;s condensed consolidated statements of operations. Under the Original Promotion Agreement, the service fee was calculated based on incremental gross profits over specified baselines during the term. Under the Restated Promotion Agreement, the service fee provides a fee-for-service model that includes certain fixed fees and performance-related bonuses. The performance-related bonuses are contingent upon the achievement of certain annual performance criteria with any applicable expense being recognized ratably upon achievement of the payment becoming probable. The Company incurred charges of $16.8&#160;million and $18.0&#160;million for the service fee for the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $63.6&#160;million and $39.7 million for the service fee for the nine months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $30.2 million and $15.8 million for promotion, sales and marketing services performed by Pfizer on behalf of the Company during the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $88.0&#160;million and $56.3 million for promotion, sales and marketing services performed by Pfizer on behalf of the Company during the nine months ended September 30, 2021 and 2020, respectively. During 2022, and contingent upon the achievement of certain Cologuard test revenue metrics during 2021, the Company will pay Pfizer a royalty based on a low single-digit royalty rate applied to actual 2022 Cologuard test revenues. The term of the Restated Promotion Agreement runs through December 31, 2022.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties
      contextRef="i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTM4MA_91fb215a-0f5e-43b8-b2ad-7ba807290b4e"
      unitRef="usd">16800000</exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties>
    <exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties
      contextRef="id0e581abbb2e45fb9d0f5e111ecb424d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTM4Nw_38f3895d-ece8-4eea-80f2-f723297c51b1"
      unitRef="usd">18000000</exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties>
    <exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties
      contextRef="ie75cea8f115f4394bd4c6369824b83e6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTQ3NQ_9cd05edf-b4a3-4cba-9a2b-864e765c76f4"
      unitRef="usd">63600000</exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties>
    <exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties
      contextRef="i9f8d48835a0141b7a3d9e3c2af436ca5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTQ4Mg_6ac37d30-5c32-4d44-bb85-b591c0e194a7"
      unitRef="usd">39700000</exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties>
    <us-gaap:MarketingExpense
      contextRef="i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTU3MA_1c4828dc-fa52-461e-8033-e39709203750"
      unitRef="usd">30200000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="id0e581abbb2e45fb9d0f5e111ecb424d_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTU3Nw_1943d2d1-58ba-46e6-9e19-3783cf1afae8"
      unitRef="usd">15800000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="ie75cea8f115f4394bd4c6369824b83e6_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTczNw_e3eaf8ee-7436-4896-ab04-1c2297369aff"
      unitRef="usd">88000000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="i9f8d48835a0141b7a3d9e3c2af436ca5_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82NC9mcmFnOjA3YWY2ZDI5MDI5MDRjYmFiYjRkZWNlNGMwZGUzYjEyL3RleHRyZWdpb246MDdhZjZkMjkwMjkwNGNiYWJiNGRlY2U0YzBkZTNiMTJfMTc0NA_bd39b233-cc82-4c5e-bc0d-dc5a8925b770"
      unitRef="usd">56300000</us-gaap:MarketingExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTg5MA_4f6af421-719b-4ba1-96a3-9ea8cf3bd340">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ashion Acquisition Stock Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2021 the Company completed its acquisition of Ashion. In connection with the acquisition, which is further described in Note 17, the Company issued 0.1&#160;million common shares that had a fair value of $16.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Thrive Acquisition Stock Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company completed its acquisition of Thrive. In connection with the acquisition, which is further described in Note 17, the Company issued 9.3&#160;million common shares that had a fair value of $1.19 billion.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Targeted Digital Sequencing (&#x201c;TARDIS&#x201d;) License Acquisition Stock Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company acquired a worldwide exclusive license to the TARDIS technology from The Translational Genomics Research Institute (&#x201c;TGen&#x201d;), which is further described in Note 17. As part of the consideration transferred, the Company issued 0.2&#160;million shares that had a fair value of $27.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Paradigm Diagnostics, Inc. and Viomics, Inc. Acquisition Stock Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the Company completed the acquisitions of Paradigm and Viomics. The purchase price for these acquisitions consisted of cash and stock with a fair value of $40.4 million. Of the $40.4 million purchase price, $32.2&#160;million is expected to be settled through the issuance of 0.4&#160;million shares of common stock. Of the $32.2&#160;million that will be settled through the issuance of common stock, $28.8&#160;million was issued as of September&#160;30, 2021, and the remainder was withheld and may become issuable as additional merger consideration subject to the terms and conditions of the acquisition agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount recognized in AOCI for the nine months ended September&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain (Loss)&lt;br/&gt;on Marketable&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period change in accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense related to items of other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in AOCI for the nine months ended September 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain (Loss)&lt;br/&gt;on Marketable&lt;br/&gt;Securities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period change in accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;There was no tax impact from the amounts recognized in AOCI for the three and nine months ended September&#160;30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from AOCI for the nine months ended September&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line Item in the&lt;br/&gt;Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about AOCI Components (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in value of available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and maturities of available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMjIy_d3d8d016-3ab1-482b-93d3-39ba468b9da5"
      unitRef="shares">100000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMjY0_0b6c75e1-15d9-44b1-9850-03f8b542cac6"
      unitRef="usd">16200000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i376b181ad07a407cbb2ac71cfb91c79f_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfNDYy_d1a3866c-2b2b-4cf3-987d-74dd045b5d7b"
      unitRef="shares">9300000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfNTA0_1a2bb007-bdf9-4d1d-be02-9eaf3508e374"
      unitRef="usd">1190000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <exas:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
      contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfODM4_32658dfc-544a-4358-a36c-c980add3c68e"
      unitRef="shares">200000</exas:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
      contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfODcz_83d69112-4740-43a7-9087-a5a46af2a59e"
      unitRef="usd">27300000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTE0NQ_bacaabba-2334-408f-ba6f-8d62554b8ab1"
      unitRef="usd">40400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTE1Ng_bacaabba-2334-408f-ba6f-8d62554b8ab1"
      unitRef="usd">40400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTE3NQ_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc"
      unitRef="usd">32200000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i440309922a2844d8b7f20c86821d414f_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTIyOA_2535c692-5c0d-42a7-85b8-6964ce5c226d"
      unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTI2Mg_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc"
      unitRef="usd">32200000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i949e45cbfa8f4affa83a6c86d26dc895_D20200303-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTMyNA_c8cea121-5732-449d-9a84-0931aaa0e99e"
      unitRef="usd">28800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTg4OQ_6b36eabd-929e-408a-9210-3f4fae146f5c">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount recognized in AOCI for the nine months ended September&#160;30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain (Loss)&lt;br/&gt;on Marketable&lt;br/&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period change in accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense related to items of other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amounts recognized in AOCI for the nine months ended September 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gain (Loss)&lt;br/&gt;on Marketable&lt;br/&gt;Securities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current period change in accumulated other comprehensive loss, before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;(1)There was no tax impact from the amounts recognized in AOCI for the three and nine months ended September&#160;30, 2020.</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="if11e689b7b1c49b3a07b24b28aee69ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMS0yLTEtMS0x_251e2276-0d25-4c9d-a542-3da207cd1123"
      unitRef="usd">526000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2d1a5e4e4fb3441dbfac2e16747f0f82_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMS00LTEtMS0x_4bd55d7d-8d50-4f4b-a9bc-4c2c8bd125a8"
      unitRef="usd">526000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMi0yLTEtMS0x_4e16378a-76d9-4840-889e-533fa0603fef"
      unitRef="usd">-292000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMi00LTEtMS0x_77e3be87-16d5-4dcf-8e47-faa4cc4351cf"
      unitRef="usd">-292000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMy0yLTEtMS0x_12125f9f-6b23-42ef-90b7-3635680e4674"
      unitRef="usd">271000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfMy00LTEtMS0x_4b4f3343-c297-4ad3-b130-9156d8736ea0"
      unitRef="usd">271000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="iefb25704ee824b2ab829d74b163646fd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNC0yLTEtMS0x_24e74b6e-bd24-4529-968e-e9be4e71476f"
      unitRef="usd">-563000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNC00LTEtMS0x_3754e330-0204-4e52-9f8d-166e6562126a"
      unitRef="usd">-563000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNS0yLTEtMS0x_4bee3881-af49-406e-94aa-096a7bbdec19"
      unitRef="usd">-170000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNS00LTEtMS0x_f1fad145-d3f0-4261-b599-f651f4f6f2be"
      unitRef="usd">-170000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
    <us-gaap:StockholdersEquity
      contextRef="i5b6189b240ae4709b0cb6a53b24b5529_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNi0yLTEtMS0x_6224d3ec-9e8c-4104-a14d-3d3710dfb4bf"
      unitRef="usd">133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief7040c10b7747fcbcec17982a4d2f4e_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOjBkNWY2NDY0YjEyMTQ5NDc4YjkxZTcyN2UyODU2NTZjL3RhYmxlcmFuZ2U6MGQ1ZjY0NjRiMTIxNDk0NzhiOTFlNzI3ZTI4NTY1NmNfNi00LTEtMS0x_13bad597-6b35-47ee-954e-730ccf2d397b"
      unitRef="usd">133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibb78c2ffc7a24797b5f3efdbf143d558_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMS0yLTEtMS0x_51c4a77c-7066-4166-bbc9-777d10746164"
      unitRef="usd">-25000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9728265290ae4d62bae3395eaa6b09a9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMS00LTEtMS0x_e7e5d1a3-eec7-4820-8af6-f5c230a1504f"
      unitRef="usd">-75000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4d558258814f4878ba1f82b61916b08e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMS02LTEtMS0x_845e3db4-644d-44d4-83c3-3dee16539f10"
      unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMi0yLTEtMS0x_a14d54bc-de06-4df3-bed0-ea7ff765a11c"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ifc090024fb42477da472a7b389554c39_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMi00LTEtMS0x_d8160b1d-9dd2-4e7f-ad8e-55827579b17b"
      unitRef="usd">1159000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMi02LTEtMS0x_8f7bfff9-a810-440f-a1dc-ea4be7bdbf7f"
      unitRef="usd">1159000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMy0yLTEtMS0x_aa7286ae-27b5-4848-a5b8-a5fe8caf982f"
      unitRef="usd">-25000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="ifc090024fb42477da472a7b389554c39_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMy00LTEtMS0x_18c6e2e0-8f4c-49fe-8fd9-50d7bc8932a9"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfMy02LTEtMS0x_63319e80-7113-4d17-a608-6592c18b33f6"
      unitRef="usd">-25000</us-gaap:ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="ic7814a5dec0946189abf692f559dd4dd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNC0yLTEtMS0x_61010fb1-4db2-4b58-80a3-2c556a2a1811"
      unitRef="usd">25000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="ifc090024fb42477da472a7b389554c39_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNC00LTEtMS0x_e47f45f0-8ac1-42d0-ac18-896a23f8c1ce"
      unitRef="usd">1159000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNC02LTEtMS0x_5401d135-ae8e-47d7-aed3-7fd15bb237b6"
      unitRef="usd">1184000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i032fd22b30fc4740afe82de8e068942e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNS0yLTEtMS0x_0d66d6bd-d39d-4a5f-9f96-01ef3ab097ce"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i350ab28dcf6f4361a935ff5ed1b2d4e0_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNS00LTEtMS0x_f20e923f-f33d-4069-b784-33a8cecba680"
      unitRef="usd">1084000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic260e91a22f64d36ace033eed2e0ebe6_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmU2MGMwZGY0M2NmZTQ5ZmZiOTI0NTg1ZTQ0NzYxY2U0L3RhYmxlcmFuZ2U6ZTYwYzBkZjQzY2ZlNDlmZmI5MjQ1ODVlNDQ3NjFjZTRfNS02LTEtMS0x_e52415b6-e092-4907-8990-a4b32ca96dac"
      unitRef="usd">1084000</us-gaap:StockholdersEquity>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RleHRyZWdpb246N2YxMTE0ZGIxNWNkNGE0Mzg5MjM1M2E1MDYxNTU5ZTFfMTg4OA_717dd838-47c7-4cbc-988f-88b4e8cc8a2f">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from AOCI for the nine months ended September&#160;30, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.970%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.161%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Affected Line Item in the&lt;br/&gt;Statements of Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Details about AOCI Components (In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in value of available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and maturities of available-for-sale investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="id526869db3114853b21ef6d57b0d6023_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfMy00LTEtMS0x_ef2f794c-3f5a-44fe-b33e-56bb83798618"
      unitRef="usd">-271000</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:InvestmentIncomeNonoperating
      contextRef="i1e5ec3803d9c47489d2b8976b93ba9cd_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfMy02LTEtMS0x_73edc913-7369-4c6f-a265-697d6fd0d975"
      unitRef="usd">0</us-gaap:InvestmentIncomeNonoperating>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i871bb8ae36f4481b94f202bc81915ae8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNC00LTEtMS0x_37f43c7f-f491-489e-9bf0-459d6cd23fb2"
      unitRef="usd">0</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib2b935f915cf4d8284af4012ec5af1fc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNC02LTEtMS0x_57abeb1c-9610-4ac7-b49f-97ab609c2ac6"
      unitRef="usd">-25000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="i820542840d28423db7a2ed962f5b4151_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNS00LTEtMS0x_2d84926d-ebf5-4bd2-8754-dbe70dfec84e"
      unitRef="usd">271000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
      contextRef="ibed0ef19bdd64427a77d040d96302174_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF82Ny9mcmFnOjdmMTExNGRiMTVjZDRhNDM4OTIzNTNhNTA2MTU1OWUxL3RhYmxlOmNkMjBhOWQzOTBhMzQ0ZTdhNjdjY2NjMTJlNGNmNjI4L3RhYmxlcmFuZ2U6Y2QyMGE5ZDM5MGEzNDRlN2E2N2NjY2MxMmU0Y2Y2MjhfNS02LTEtMS0x_b70de358-1c4b-4ee3-9dd5-c77a573aa0f3"
      unitRef="usd">-25000</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYyOA_95988f84-75d8-4977-b87a-3a13972aba6a">STOCK-BASED COMPENSATION&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains the 2010 Omnibus Long-Term Incentive Plan (As Amended and Restated Effective July 27, 2017), the 2019 Omnibus Long-Term Incentive Plan, the 2010 Employee Stock Purchase Plan, and the 2016 Inducement Award Plan (collectively, the &#x201c;Stock Plans&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records stock-based compensation expense in connection with the amortization of restricted stock and restricted stock unit awards (&#x201c;RSUs&#x201d;), stock purchase rights granted under the Company&#x2019;s employee stock purchase plan and stock options granted to employees, non-employee consultants and non-employee directors. The Company recorded $63.6 million and $41.5 million in stock-based compensation expense during the three months ended September 30, 2021 and 2020, respectively. The Company recorded $283.3 million and $111.1 million in stock-based compensation expense during the nine months ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, there was $401.6 million of expected total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under all equity compensation plans. The Company expects to recognize that cost over a weighted average period of 2.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the acquisition of Thrive, the Company accelerated the vesting of shares of previously unvested stock options and restricted stock units for employees with qualifying termination events. During the three months ended September 30, 2021, the Company accelerated 34,167 shares of previously unvested stock options and 24,865 shares of previously unvested restricted stock awards and restricted stock units and recorded $4.5 million of non-cash stock-based compensation for the accelerated awards. During the nine months ended September 30, 2021, the Company accelerated 138,163 shares of previously unvested stock options and 58,171 shares of previously unvested restricted stock awards and restricted stock units and recorded $19.0 million of non-cash stock-based compensation for the accelerated awards. As further discussed in Note 17, the Company also recorded $86.2 million in stock-based compensation related to accelerated vesting of awards held by Thrive employees in connection with the acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of each service-based option award on the date of grant using the Black-Scholes option-pricing model, which utilizes several key assumptions which are disclosed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Option Plan Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11% - 1.47%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25 - 6.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.19% - 77.51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company did not grant stock options under its 2010 Omnibus Long-Term Incentive Plan or 2019 Omnibus Long-Term Incentive Plan during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity under the Stock Plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Aggregate intrinsic value in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,231,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed through acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,208,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,816,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The weighted average grant date fair value of options granted during the nine months ended September&#160;30, 2020 was $58.57. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The total intrinsic value of options exercised during the nine months ended September&#160;30, 2021 and 2020 was $148.8 million and $29.0 million, respectively, determined as of the date of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received approximately $13.4 million and $15.4 million from stock option exercises during the nine months ended September&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock and Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock and restricted stock units is determined on the date of grant using the closing stock price on that day. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of restricted stock and restricted stock unit activity during the nine months ended September&#160;30, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted stock and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average Grant&lt;br/&gt;Date Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,968,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed through acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,582,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,306,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The fair value of restricted stock units vested and converted to shares of the Company&#x2019;s common stock was $114.4 million and $79.1 million during the nine months ended September&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The weighted average grant date fair value of the restricted stock units granted during the nine months ended September&#160;30, 2020 was $90.95.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Performance Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued performance-based equity awards to certain employees which vest upon the achievement of certain performance goals, including financial performance targets and operational milestones. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of performance share-based compensation arrangements granted under all equity compensation unit activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average Grant&lt;br/&gt;Date Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The performance share units listed above assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding performance share units as of September&#160;30, 2021 was 249,695. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The weighted average grant date fair value of the performance share units granted during the nine months ended September&#160;30, 2020 was $90.17.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of ESPP shares is based on the assumptions in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04% - 0.16%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12% - 0.20%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5 - 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5 - 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.38% - 68.51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.67% - 89.04%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;(1)The Company did not issue stock purchase rights under its 2010 Employee Stock Purchase Plan during the three months ended September&#160;30, 2021 and 2020, respectively.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNzEy_d19f2c8b-af04-4ba1-944d-4b95bdca86d1"
      unitRef="usd">63600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNzE5_db96fadc-79ca-4ae5-b055-1bbcad335487"
      unitRef="usd">41500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfODE1_73cf6077-35f1-4314-ad19-0e650ab688d5"
      unitRef="usd">283300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfODIy_636c0f47-09a5-4ae6-a3d2-ef6278ecd3a0"
      unitRef="usd">111100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfOTE3_b1a8b50e-e399-4e52-95f9-469f5d77afd0"
      unitRef="usd">401600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTE1MQ_34be96b3-8633-41f4-943f-d6a7abf9d920">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="icd69de72c3544263ada7167dc7802735_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTQwMA_41813b55-881e-49be-87d1-e2901965702c"
      unitRef="shares">34167</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="i0149388bcc174e008d48d4ce24ecd34b_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTQ1MQ_5e02b566-684d-448b-991f-82d257eff95d"
      unitRef="shares">24865</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ShareBasedCompensation
      contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTU0OA_d2a8a282-c0be-46a3-8135-a2e8263ce194"
      unitRef="usd">4500000</us-gaap:ShareBasedCompensation>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="icecddaccecae455d8964c306f1d3197d_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTY1NQ_ad81b946-6543-4086-870c-6297406ea2bb"
      unitRef="shares">138163</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
      contextRef="i92f3ebdda81e4395b4fdf88ad090c5ca_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTcwNg_dd9507d1-2b0b-46da-9f8f-7d7ce5aae445"
      unitRef="shares">58171</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber>
    <us-gaap:ShareBasedCompensation
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTgwMw_288a95cc-80d5-479f-ab11-236317dfbae2"
      unitRef="usd">19000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMTkzMA_a1b0204b-fd59-4aa9-9a63-b5c1c407ef05"
      unitRef="usd">86200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYzMA_5e294ecc-7833-4f84-a04f-0ac4b503bc4a">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of each service-based option award on the date of grant using the Black-Scholes option-pricing model, which utilizes several key assumptions which are disclosed in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Option Plan Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11% - 1.47%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25 - 6.15&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.19% - 77.51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The Company did not grant stock options under its 2010 Omnibus Long-Term Incentive Plan or 2019 Omnibus Long-Term Incentive Plan during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity under the Stock Plans is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value(2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Aggregate intrinsic value in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,231,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed through acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,393,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,208,355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest, September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,379,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,816,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The weighted average grant date fair value of options granted during the nine months ended September&#160;30, 2020 was $58.57. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The total intrinsic value of options exercised during the nine months ended September&#160;30, 2021 and 2020 was $148.8 million and $29.0 million, respectively, determined as of the date of exercise.&lt;/span&gt;&lt;/div&gt;</exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfMy04LTEtMS0xL3RleHRyZWdpb246MmZiY2RmYTE0ZGY0NGM4ZmI1YTFkZjRiZWFmNDIwOTlfNA_28e1ae33-3753-481c-a077-84f25ec2c436"
      unitRef="number">0.0011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfMy04LTEtMS0xL3RleHRyZWdpb246MmZiY2RmYTE0ZGY0NGM4ZmI1YTFkZjRiZWFmNDIwOTlfOQ_c5366da1-d97a-4cfd-b180-b681f6ba5f53"
      unitRef="number">0.0147</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i80e812e1e60a444187707448c6487230_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNC04LTEtMS0xL3RleHRyZWdpb246MzEyZWVhM2FjNDNmNDU2YmFhYmE1NGUwY2FiNGQ4MDJfNA_1a504138-1eb8-4db2-87e0-e32606828354">P0Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i9f69879b003347d9ad2b403f9773eef5_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNC04LTEtMS0xL3RleHRyZWdpb246MzEyZWVhM2FjNDNmNDU2YmFhYmE1NGUwY2FiNGQ4MDJfOQ_aa06d6bb-486f-4c15-8c2a-adc9a9064c64">P6Y1M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNS04LTEtMS0xL3RleHRyZWdpb246ZDc2ZDFhNmM2MmJjNGJhZmI4YTlkNWVhNDk1NzcyN2FfNA_76649f5d-2f3a-4c9f-b33a-593000b3c6f1"
      unitRef="number">0.4419</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNS04LTEtMS0xL3RleHRyZWdpb246ZDc2ZDFhNmM2MmJjNGJhZmI4YTlkNWVhNDk1NzcyN2FfOQ_1fad88c5-58b6-48d1-a147-b6b8e600b21b"
      unitRef="number">0.7751</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjg2MWE5MDg4OWY0ZTRkMmQ5YjcxOTcwNzZiZjI5YTRmL3RhYmxlcmFuZ2U6ODYxYTkwODg5ZjRlNGQyZDliNzE5NzA3NmJmMjlhNGZfNi04LTEtMS0x_31f577ad-2028-4ec7-953f-84cd03c296a7"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib4a70c95a2c047f2bdceaeba16fb36a9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMi0yLTEtMS0x_4a26ed6b-b56d-47b5-b393-c2969946c713"
      unitRef="shares">2231059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib4a70c95a2c047f2bdceaeba16fb36a9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMi00LTEtMS0x_07f8b319-98a6-4130-9844-404e428b8ef9"
      unitRef="usdPerShare">39.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i27d111df7c824f28b43805bf4020f417_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMi02LTEtMS0x_d99f8deb-6ab9-438d-a2f8-6409c8559266">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMy0yLTEtMS0x_36626cc2-c980-4c87-aa87-eff93c441522"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfMy00LTEtMS0x_1511bb35-f2f6-4cf0-bbb7-05a99099f64b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNC0yLTEtMS0x_0b35b83f-5c22-4d56-b5bf-706dd479eebd"
      unitRef="shares">1393748</exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions>
    <exas:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNC00LTEtMS0x_9f22b5f1-1a27-4b3d-bf4b-f5d5ec3008ab"
      unitRef="usdPerShare">5.51</exas:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNS0yLTEtMS0x_9fc899bb-f3c2-4856-8e8f-eb962a1b5e20"
      unitRef="shares">1208355</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNS00LTEtMS0x_9f5ddd85-f1d7-4221-bc7c-b3fad58f212a"
      unitRef="usdPerShare">11.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNi0yLTEtMS0x_3cdb8ec2-3f76-4fd2-92a2-a07361225765"
      unitRef="shares">36909</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNi00LTEtMS0x_0e2ac1ff-9b95-4b12-a44f-d506a2518d4d"
      unitRef="usdPerShare">62.85</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy0yLTEtMS0x_36642ee6-1390-4f5f-8335-06f51299370d"
      unitRef="shares">2379543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy00LTEtMS0x_9b8e17ce-c5f9-4e62-824d-037c2457067d"
      unitRef="usdPerShare">33.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy02LTEtMS0x_7a43c0b3-4d2b-40a1-9337-c37dbd90d5e3">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfNy04LTEtMS0x_ea5af069-f5b6-4064-ab3e-7e380780d1f1"
      unitRef="usd">147337000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC0yLTEtMS0x_0ef96152-1566-4b75-9f5e-97f5d1b83222"
      unitRef="shares">2379543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC00LTEtMS0x_24b35668-03c1-490d-a4b7-7d5f1d6a6f07"
      unitRef="usdPerShare">33.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC02LTEtMS0x_9adb8d0d-29c5-44ea-922c-fd6ebd588450">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOC04LTEtMS0x_560d59ef-f2a0-4371-8f26-a781ee7485d6"
      unitRef="usd">147337000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS0yLTEtMS0x_8bea02a2-9b89-47dc-bee1-16bca4e9e69b"
      unitRef="shares">1816492</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS00LTEtMS0x_ec067b61-6651-4241-b643-8e6ecd01a988"
      unitRef="usdPerShare">25.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS02LTEtMS0x_4476656f-0713-45f5-8606-3dd605a383b5">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i46963a5244634b8a9cb4bede92e87e7c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOmI4NjlkMWQ3ZTM1ZjQ3MTRhYWMwNmU2OTJlOGVhZmFiL3RhYmxlcmFuZ2U6Yjg2OWQxZDdlMzVmNDcxNGFhYzA2ZTY5MmU4ZWFmYWJfOS04LTEtMS0x_fb60f298-6339-4543-9634-453426d18511"
      unitRef="usd">127826000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjY1NA_18a88b94-7e8d-4db3-aa78-f7f625b36263"
      unitRef="usdPerShare">58.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i8876babe87d34d0d98910281d0e40c27_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjc0Nw_1e4d7c7a-aee8-4de7-96f1-187c140d2270"
      unitRef="usd">148800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i82ad627bc9d74b5d9d01292c752d08e0_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjc1NA_798e744d-e9e2-4439-bd0a-b32a812e4d6d"
      unitRef="usd">29000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjg0Ng_38bd8a34-be4a-4a27-a72f-6953d3358a48"
      unitRef="usd">13400000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMjg1Mw_ca073d31-e3ea-4d89-8a66-ee1ce794656e"
      unitRef="usd">15400000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYzNA_b2adcc49-e1bf-44a9-9a3a-566b86215883">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of restricted stock and restricted stock unit activity during the nine months ended September&#160;30, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted stock and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average Grant&lt;br/&gt;Date Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,968,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,084,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed through acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,582,760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(406,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,306,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The fair value of restricted stock units vested and converted to shares of the Company&#x2019;s common stock was $114.4 million and $79.1 million during the nine months ended September&#160;30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The weighted average grant date fair value of the restricted stock units granted during the nine months ended September&#160;30, 2020 was $90.95.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i980b2917c57c435eae9dc611d50ee893_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMS0yLTEtMS0x_19deb479-9fbc-4ac5-b368-e2c5419eda18"
      unitRef="shares">3968214</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i980b2917c57c435eae9dc611d50ee893_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMS00LTEtMS0x_dcf8d42e-fbe1-4050-83fc-b071731ef8b7"
      unitRef="usdPerShare">79.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMi0yLTEtMS0x_84dfb192-9fcf-486e-87de-7408160ffa03"
      unitRef="shares">2084705</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMi00LTEtMS0x_4eb9f185-16c0-4f19-9203-a5d9ed38a2e6"
      unitRef="usdPerShare">133.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMy0yLTEtMS0x_b8c4e975-6135-49b5-96cc-3fd41ea9c8a9"
      unitRef="shares">242123</exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions>
    <exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfMy00LTEtMS0x_58bbe70e-8a90-44b4-ac2e-0c07c6d88978"
      unitRef="usdPerShare">127.79</exas:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNC0yLTEtMS0x_28d08921-a2bb-4bb6-b875-3d68f9a25777"
      unitRef="shares">1582760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNC00LTEtMS0x_53c527c2-3751-4dd6-9c9a-536303ec50e7"
      unitRef="usdPerShare">72.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNS0yLTEtMS0x_dad7b905-514f-457a-af2a-743b72024179"
      unitRef="shares">406201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNS00LTEtMS0x_737160ed-c627-443a-a99b-a2cd95cf17c3"
      unitRef="usdPerShare">99.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia6945ebb4ad9454887ade5b79a893636_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNi0yLTEtMS0x_ac81d178-124b-41fd-aaea-be8f8b7d8e86"
      unitRef="shares">4306081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia6945ebb4ad9454887ade5b79a893636_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjI3ZmFmN2M4NzIyZjQ3M2Y5Y2ZlNDViZWE3YWVmZGU5L3RhYmxlcmFuZ2U6MjdmYWY3Yzg3MjJmNDczZjljZmU0NWJlYTdhZWZkZTlfNi00LTEtMS0x_c83f5fc8-ca3a-4e51-867b-9ab6469d1757"
      unitRef="usdPerShare">109.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i41d6aa411d3c4c30b25413ad079098c5_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMzM1NQ_52329d22-5e21-4026-9283-8087e56716fc"
      unitRef="usd">114400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i8e2d9caa00d941178a209e6942f90740_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMzM2Mg_5bd74847-1d94-4173-8724-ffffafe8df7a"
      unitRef="usd">79100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0e95c6cd79cc4d7a935971ea5e1e6e8e_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfMzUzMw_4a1c626a-8bc9-41cc-964c-ba7c1cbbd0d2"
      unitRef="usdPerShare">90.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYzMg_02f38bba-a2e6-4c1f-9fc4-6753f4d035d6">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of performance share-based compensation arrangements granted under all equity compensation unit activity is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average Grant&lt;br/&gt;Date Fair Value (2)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;618,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding, September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;The performance share units listed above assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding performance share units as of September&#160;30, 2021 was 249,695. &lt;/span&gt;&lt;/div&gt;(2)The weighted average grant date fair value of the performance share units granted during the nine months ended September&#160;30, 2020 was $90.17.</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id1ead48ecd8c495a8083ab6bde044c3d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMS0yLTEtMS0x_c3a25449-fb6c-438a-864d-3351954d8f91"
      unitRef="shares">618515</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id1ead48ecd8c495a8083ab6bde044c3d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMS00LTEtMS0x_5f2416b8-ba0f-4a19-9b8f-1491ff3bca92"
      unitRef="usdPerShare">93.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMi0yLTEtMS0x_d13fdc7b-4434-43a8-a972-c3b89c576b2b"
      unitRef="shares">253120</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMi00LTEtMS0x_414040da-2193-4715-bef3-98d115e27ffe"
      unitRef="usdPerShare">140.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMy0yLTEtMS0x_8e7eaaaf-d987-402b-a58c-549b211549c0"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfMy00LTEtMS0x_9bf233f7-ff3a-4329-b61c-8a2bdcfea35b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNC0yLTEtMS0x_8180257e-1b46-4091-a395-fc6a29169bfa"
      unitRef="shares">8991</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9f82e972f8e546a6a3fa135da0f610b3_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNC00LTEtMS0x_b23cd4d6-4303-4587-9a3b-38bfcfc7242f"
      unitRef="usdPerShare">68.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie99e0e805c704e9eb1ceeca30b976339_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNS0yLTEtMS0x_90af025f-0516-4345-9544-53270e5f8a57"
      unitRef="shares">862644</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie99e0e805c704e9eb1ceeca30b976339_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjMxZmQyOGRlMmRkODQ2MDc4MDNiZGZiZmUzYzczNTYxL3RhYmxlcmFuZ2U6MzFmZDI4ZGUyZGQ4NDYwNzgwM2JkZmJmZTNjNzM1NjFfNS00LTEtMS0x_2f38f4d1-b66c-4a38-9bd0-69786ccdefb0"
      unitRef="usdPerShare">107.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ie99e0e805c704e9eb1ceeca30b976339_I20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDM3OQ_a6e3a998-6fca-4735-851d-e15ed70785b3"
      unitRef="shares">249695</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i75a8ee4db1a042719bcde877f5d252ea_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDUwMA_6e701599-d746-4c2b-ab0d-c1926e53698b"
      unitRef="usdPerShare">90.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RleHRyZWdpb246MWRiMGYzMGY2OWRlNDRjNWEyODI0Yjc2NzQyNGFjOTNfNDYyOQ_b360ed4b-baa9-4c63-8efd-2d0e92d19c41">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of ESPP shares is based on the assumptions in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04% - 0.16%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.12% - 0.20%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5 - 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5 - 2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.38% - 68.51%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.67% - 89.04%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;______________&lt;/span&gt;&lt;/div&gt;(1)The Company did not issue stock purchase rights under its 2010 Employee Stock Purchase Plan during the three months ended September&#160;30, 2021 and 2020, respectively.</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy02LTEtMS0xL3RleHRyZWdpb246NzlhYTExMjQ4NWY2NDNiOWE2ZTFhZWNlYTI3ZGMxM2VfNA_09a0785b-5018-4b97-a0d0-9eae42f26121"
      unitRef="number">0.0004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy02LTEtMS0xL3RleHRyZWdpb246NzlhYTExMjQ4NWY2NDNiOWE2ZTFhZWNlYTI3ZGMxM2VfOQ_4187f3d3-4bd4-47ac-a34f-57f7575a9dcb"
      unitRef="number">0.0016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy04LTEtMS0xL3RleHRyZWdpb246Y2ViZjljZTZjMmFmNDhlNDhhYzllNmY0N2RiY2JjNzJfNA_0e11ba49-e102-4752-9f48-86d56487db78"
      unitRef="number">0.0012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfMy04LTEtMS0xL3RleHRyZWdpb246Y2ViZjljZTZjMmFmNDhlNDhhYzllNmY0N2RiY2JjNzJfOQ_68c68a8b-6162-4038-b66f-9c0fcbb98302"
      unitRef="number">0.0020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i558be5b82da24f16af1d8a52684e9d6d_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC02LTEtMS0xL3RleHRyZWdpb246YjdiNWE5ODgyNzY0NGU1MTgxM2I5NThmNjQ2MjFhNzZfNA_83261c1a-a5b9-4478-8d5c-aa30f94ac653">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1f932abf713e4c43a93cd801959cce5e_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC02LTEtMS0xL3RleHRyZWdpb246YjdiNWE5ODgyNzY0NGU1MTgxM2I5NThmNjQ2MjFhNzZfOQ_7bf95734-736d-4395-8593-bce783b099d1">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i91c9ab0eda5440bd9d65a69c85ab0eb7_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC04LTEtMS0xL3RleHRyZWdpb246YmRmMDZhMDAyMDRjNDdiMDgwMTQ1NWMzYTQ5MjVkZTNfNA_57c8ded7-50da-4b6c-9d8b-ebbb0bc9befa">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i39ccbffede514c3292129dae5bcde954_D20200101-20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNC04LTEtMS0xL3RleHRyZWdpb246YmRmMDZhMDAyMDRjNDdiMDgwMTQ1NWMzYTQ5MjVkZTNfOQ_2818c919-6b5c-4f18-bf17-6e98a8ea4e5a">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS02LTEtMS0xL3RleHRyZWdpb246YzkzNzZhM2NjNTg4NDM1YmIwODA2OTJjZDJjNWJkMDJfNA_d97468a3-e5bb-4d62-8ea4-f8dd40be5bb8"
      unitRef="number">0.4838</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS02LTEtMS0xL3RleHRyZWdpb246YzkzNzZhM2NjNTg4NDM1YmIwODA2OTJjZDJjNWJkMDJfOQ_b45c4797-559c-49bd-93a8-32035234a1c6"
      unitRef="number">0.6851</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS04LTEtMS0xL3RleHRyZWdpb246ODg5OTdkMDA2NmM3NDJhNjgzZmE2OTJjMDJlMTE3NWZfNA_1729d2fb-df6b-46a2-a819-df48706fde2b"
      unitRef="number">0.6367</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNS04LTEtMS0xL3RleHRyZWdpb246ODg5OTdkMDA2NmM3NDJhNjgzZmE2OTJjMDJlMTE3NWZfOQ_792988d4-c2ba-427e-9eda-9b0ee870ed2f"
      unitRef="number">0.8904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia8978266369d482f8d48c2cec45c2dff_D20210101-20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNi02LTEtMS0xL3RleHRyZWdpb246N2I2YWJhZWMwOTdiNDEyNmExZDYxNjBlMTY0Y2Q5MjZfNA_fd220cb5-b2c6-4908-a36c-c118c6b826e6"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6fd00fb314ef482db2159a4574c24919_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83MC9mcmFnOjFkYjBmMzBmNjlkZTQ0YzVhMjgyNGI3Njc0MjRhYzkzL3RhYmxlOjBjZjk0ODgxZTZjZjRlMDRhZDkxNTAwZWFjZDczNWJjL3RhYmxlcmFuZ2U6MGNmOTQ4ODFlNmNmNGUwNGFkOTE1MDBlYWNkNzM1YmNfNi04LTEtMS0xL3RleHRyZWdpb246MTNkNDQ0MzFmNDI4NGE0ZGFkMTAyYzk3ZDA0NzU3MWVfNA_8f85ac28-3f87-4840-a1a0-31e96bb0b69d"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0Ng_a56b6683-54b2-4d66-b90d-589a6cbcbbf6">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental disclosure of cash flow information related to the Company&#x2019;s cash and non-cash activities with its leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,835&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,827&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,805&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,480&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,662&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,296&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,420&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term - operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term - finance leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.86&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;For the nine months ended September&#160;30, 2021, this includes right-of-use assets acquired as part of the business combinations described in Note 17 of $39.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021 and December&#160;31, 2020, the Company&#x2019;s right-of-use assets from operating leases are $167.9 million and $125.9 million, respectively, which are reported in operating lease right-of-use assets in the Company&#x2019;s condensed consolidated balance sheets. As of September&#160;30, 2021, the Company has outstanding operating lease obligations of $182.2 million, of which $19.2 million is reported in operating lease liabilities, current portion and $163.0 million is reported in operating lease liabilities, less current portion in the Company&#x2019;s condensed consolidated balance sheets. As of December&#160;31, 2020, the Company had outstanding operating lease obligations of $132.6 million, of which $11.5 million is reported in operating lease liabilities, current portion and $121.1 million is reported in operating lease liabilities, less current portion in the Company&#x2019;s condensed consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#x2019;s rating for operating leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021 and December&#160;31, 2020, the Company&#x2019;s right-of-use assets from finance leases are $18.7 million and $18.6 million, respectively, which are reported in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NA_a63abb75-8298-4289-82ca-d79cd14f64fc"&gt;other long-term assets&lt;/span&gt;, net in the Company&#x2019;s condensed consolidated balance sheets. As of September&#160;30, 2021, the Company has outstanding finance lease obligations of $19.1 million, of which $5.9 million is reported in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NQ_a7a5c01b-96cc-4030-a445-b85e4c06296f"&gt;other current liabilities&lt;/span&gt; and $13.2 million is reported in &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI1MA_7ed6786f-7aa1-4913-ad46-9c4fe5b019bf"&gt;other long-term liabilities&lt;/span&gt; in the Company&#x2019;s condensed consolidated balance sheets. As of December&#160;31, 2020, the Company had outstanding finance lease obligations of $18.7 million, of which $4.7 million is reported in other current liabilities and $14.0 million is reported in other long-term liabilities in the Company&#x2019;s condensed consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#x2019;s rating for finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company executed a lease agreement for a new facility in La Jolla, California, which the Company is expecting to commence in the fourth quarter of 2021. The Company anticipates that it will recognize $22.9 million in operating lease right-of-use assets and $22.9 million in operating lease liabilities in the condensed consolidated balance sheet, respectively, upon commencement of the lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company&#x2019;s best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of the date of this Quarterly Report on Form 10-Q, amounts accrued for legal proceedings and regulatory matters were not material except for the amounts accrued related to the Medicare Date of Service Rule Investigation (the &#x201c;DOS Rule Investigation&#x201d;) discussed below. However, it is possible that in a particular quarter or annual period the Company&#x2019;s financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of, or development in, legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is currently responding to civil investigative demands and administrative subpoenas issued pursuant to the Health Insurance Portability and Accountability Act of 1996 by the United States Department of Justice (&#x201c;DOJ&#x201d;) concerning Genomic Health&#x2019;s compliance with the Medicare Date of Service billing regulations. The Company has been cooperating with these inquiries and has produced documents in response thereto.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2021, as part of ongoing discussions between the DOJ and the Company regarding the DOS Rule Investigation, the DOJ presented an estimate of civil damages in the amount of $48.2 million relating to alleged non-compliance with the Medicare Date of Service billing regulations from 2007 to 2020. The civil damages estimate does not include potential treble damages, civil or criminal penalties or other remedies that the DOJ could seek against the Company. Based on the Company&#x2019;s review and analysis of the DOJ presentation, civil damages estimate, and range of potential exposure, the Company recorded an accrual of approximately $10 million for the three and nine months ended September&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted above, litigation outcomes are difficult to predict, and the estimation of probable losses requires an analysis of multiple possible outcomes that often depend on judgments about potential actions by third parties. Accordingly, the recorded accrual of approximately $10 million for the three and nine months ended September&#160;30, 2021 is based on several factors, considerations, and judgments, and the ultimate resolution of this matter could result in a loss in excess of the recorded accrual.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 24, 2019, Niles Rosen M.D. filed a sealed ex parte qui tam lawsuit against the Company in the United States District Court for the Middle District of Florida, that alleged a violation of the Federal Anti-Kickback Statute and False Claims Act for offering gift cards to patients in exchange for returning the Cologuard screening test (the &#x201c;Qui Tam Suit&#x201d;). Dr. Rosen seeks on behalf of the U.S. government and himself an award of civil penalties, treble damages and fees and costs. On February 25, 2020, the Company received a civil investigative demand by the DOJ related to the Company&#x2019;s gift card program. The Company produced documents in response thereto. On March 25, 2021, the DOJ filed a notice of its election to decline intervention in the Qui Tam Suit. This election does not prevent Dr. Rosen from continuing the Qui Tam Suit. On April 12, 2021, Dr. Rosen filed an amended complaint against the Company, alleging violations of the Federal Anti-Kickback Statute and False Claims Act. The Company first learned of the Qui Tam Suit and the DOJ&#x2019;s election to decline intervention in July 2021.  The Company intends to vigorously defend itself against Dr. Rosen's claims and seek, among other things, the Company&#x2019;s attorneys' fees and costs incurred in defending this action. Although the Company denies Dr. Rosen's allegations and believes that it has meritorious defenses to his False Claims Act claims, neither the outcome of the litigation nor can a reasonable estimate or an estimated range of loss associated with the litigation be determined at this time.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adverse outcomes from the DOS Rule Investigation and the Qui Tam Suit could include the Company being required to pay treble damages, incur civil and criminal penalties, paying attorneys&#x2019; fees, entering into a corporate integrity agreement, being excluded from participation in government healthcare programs, including Medicare and Medicaid, and other adverse actions that could materially affect the Company&#x2019;s business, financial condition, and results of operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company's combination with Genomic Health, on June 22, 2020, Suzanne Flannery, a purported former stockholder of Genomic Health, filed a Verified Individual and Class Action Complaint in the Delaware Court of Chancery, captioned Flannery v. Genomic Health, Inc., et al., C.A. No. 2020-0492. Flannery amended her complaint on November 23, 2020. The amended complaint asserts individual and class action claims, including: (i) a violation of 8 Del. C. &#xa7; 203 by Genomic Health, Exact Sciences and a purported controlling group of former Genomic Health stockholders; (ii) conversion by Genomic Health, Exact Sciences and Spring Acquisition Corp.; (iii) breach of fiduciary duty by Genomic Health's former directors; (iv) breach of fiduciary duty by the purported controlling group; and (v) aiding and abetting breach of fiduciary duty against Exact Sciences, Spring Acquisition and Goldman Sachs &amp;amp; Co. LLC, Genomic Health's financial advisor in the combination. The amended complaint seeks, among other things, declaratory relief, unspecified monetary damages and attorneys' fees and costs. All defendants moved to dismiss the amended complaint. Oral argument on defendants&#x2019; motions to dismiss the amended complaint occurred in May 2021, and in September 2021 the case was officially dismissed by the court.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0Nw_7b119d2c-09f7-47f4-9e1e-2909f2787901">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental disclosure of cash flow information related to the Company&#x2019;s cash and non-cash activities with its leases are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,835&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,827&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;723&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,805&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash investing and financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,480&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,662&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,296&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,420&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term - operating leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.95&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term - finance leases (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.86&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;For the nine months ended September&#160;30, 2021, this includes right-of-use assets acquired as part of the business combinations described in Note 17 of $39.6 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMy0yLTEtMS0x_bc3a5851-921a-42d9-9dd3-1f685113918b"
      unitRef="usd">19835000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMy00LTEtMS0x_85f4808a-11e6-4c99-b0a9-6911fcffccf5"
      unitRef="usd">12827000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNC0yLTEtMS0x_75382ae0-495b-4112-812d-9eaa78204756"
      unitRef="usd">723000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNC00LTEtMS0x_fb39b5ec-b571-4e79-8e17-8c33bbd1fa7e"
      unitRef="usd">125000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNS0yLTEtMS0x_250f3e37-0497-48a5-88b3-e8bad323caac"
      unitRef="usd">3805000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNS00LTEtMS0x_dbcf8c2d-7a15-4235-85cd-987d0152d6e3"
      unitRef="usd">620000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNy0yLTEtMS0x_b1cdaa13-44eb-46b2-9b81-371dc3a37a2d"
      unitRef="usd">60480000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfNy00LTEtMS0x_a2bee913-19e7-4aa1-b513-20911d8d371e"
      unitRef="usd">13662000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOC0yLTEtMS0x_64c4a63c-fd39-4597-b7aa-8836d4bc8947"
      unitRef="usd">4296000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOC00LTEtMS0x_0db4cfb2-4853-487e-a7f9-7d4b1a858556"
      unitRef="usd">17420000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOS0yLTEtMS0x_f0a9b988-e18d-4f55-9a96-0bd00a0251a7">P8Y1M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfOS00LTEtMS0x_84bc52a6-ebbc-4c62-a4a1-4ddd8a8a8831">P8Y11M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTAtMi0xLTEtMQ_fd267518-04dc-4c03-be33-c3a577e7c03b">P3Y1M17D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTAtNC0xLTEtMQ_e9274acd-f0e8-4f83-91b4-9854fbb48d7c">P3Y10M9D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTEtMi0xLTEtMQ_112be9bd-632a-4d7e-9a85-1f5fbc726a0c"
      unitRef="number">0.0628</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTEtNC0xLTEtMQ_1dc5e1e5-e960-4eea-ad0f-09a2f8219110"
      unitRef="number">0.0683</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTItMi0xLTEtMQ_7b05fade-727b-4124-8a14-ba969fe8e27d"
      unitRef="number">0.0542</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="if4e10d3514844641a53eb38bf634cf5b_I20200930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RhYmxlOmM2NGIwZWNlYjQzNjQzN2Q4MTQzNzljODRkNTJlNmJlL3RhYmxlcmFuZ2U6YzY0YjBlY2ViNDM2NDM3ZDgxNDM3OWM4NGQ1MmU2YmVfMTItNC0xLTEtMQ_cbf32df5-2db8-49e7-9048-afb162362199"
      unitRef="number">0.0587</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMzMx_64f5ff75-91e5-44cd-9080-9efe37a4a5f1"
      unitRef="usd">39600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNDEy_f031430a-4a36-4ca5-bb52-aaa308000ac4"
      unitRef="usd">167900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNDE5_400d27fd-3984-49ed-8fb5-533f68c73167"
      unitRef="usd">125900000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNjIw_bcb342d3-2de9-4e4f-b5c9-23f8886b5675"
      unitRef="usd">182200000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNjMz_8c7c01fe-d6f7-4c1a-a5e0-48ce93f8bb51"
      unitRef="usd">19200000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNzAw_aa3fea45-2854-4ee7-87e8-e5dc98c9672b"
      unitRef="usd">163000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfODkz_63d3cea3-4f75-4429-b1cc-35258dca46a6"
      unitRef="usd">132600000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTA2_adba0d60-d8d9-4621-a08b-5f3ae4fd82a0"
      unitRef="usd">11500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTcz_fd087be6-1471-4d0a-a6f3-9979f239bf48"
      unitRef="usd">121100000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTM4OQ_c6d23b87-53e8-489b-8531-333d2de77cf2"
      unitRef="usd">18700000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTM5Ng_43cd97b6-857d-4759-9ca9-3b1f40d06054"
      unitRef="usd">18600000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiability
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTU4Nw_ce43d5c8-fcd8-444a-9f5a-43cace2d4918"
      unitRef="usd">19100000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTYwMA_9c3bba38-1818-4faf-b5e3-251953ac05c6"
      unitRef="usd">5900000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTY0OA_466f32d9-8bd0-495a-8954-dbc256c87959"
      unitRef="usd">13200000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTgxNw_44e5232b-e353-45e2-b62a-391c90ae1691"
      unitRef="usd">18700000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTgzMA_173f4334-2e1f-414f-bf20-bd7002a4dfdb"
      unitRef="usd">4700000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTg3OA_cc54f06e-de71-49c3-bd22-0a61442a4c68"
      unitRef="usd">14000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <exas:LesseeOperatingLeaseLeaseNotYetCommencedAsset
      contextRef="i26b0e97ffe0040889b3f8b090462e327_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMjM1Mg_df12070b-f1d8-4ef8-b13b-69bf0a9489cc"
      unitRef="usd">22900000</exas:LesseeOperatingLeaseLeaseNotYetCommencedAsset>
    <exas:LesseeOperatingLeaseLeaseNotYetCommencedLiability
      contextRef="i26b0e97ffe0040889b3f8b090462e327_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMjM5OA_4644097f-f459-4f66-becb-76599442ab2d"
      unitRef="usd">22900000</exas:LesseeOperatingLeaseLeaseNotYetCommencedLiability>
    <us-gaap:LitigationReserve
      contextRef="icb129685ec824606a9235abe6526a5d3_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfNTExOA_de28e0a0-4606-40d8-b50a-a45ab3482a92"
      unitRef="usd">48200000</us-gaap:LitigationReserve>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0d998ca81b55400f81d638f38b49779c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTA5OTUxMTYzODg2OQ_7c642901-7fb2-46f9-87d9-dbd402121e16"
      unitRef="usd">10000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i0d998ca81b55400f81d638f38b49779c_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfMTA5OTUxMTYzOTg1Nw_7c642901-7fb2-46f9-87d9-dbd402121e16"
      unitRef="usd">10000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <exas:NewMarketTaxCreditTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83Ni9mcmFnOjQ1YTNlZmY3NmU3MTRmNmU4ZTg2ZGUwYjgwZDk3MGNlL3RleHRyZWdpb246NDVhM2VmZjc2ZTcxNGY2ZThlODZkZTBiODBkOTcwY2VfMjI5Mg_5591fd68-ac9e-42e2-8de2-8c732bbae605">NEW MARKET TAX CREDIT&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2014, the Company received approximately $2.4 million in net proceeds from financing agreements related to working capital and capital improvements at one of its Madison, Wisconsin facilities.&#160;This financing arrangement was structured with an unrelated third-party financial institution (the &#x201c;Investor&#x201d;), an investment fund, and its majority owned community development entity in connection with the Company&#x2019;s participation in transactions qualified under the federal New Markets Tax Credit (&#x201c;NMTC&#x201d;) program, pursuant to Section 45D of the Internal Revenue Code of 1986, as amended. The Company is required to be in compliance through December 2021 with various regulations and contractual provisions that apply to the NMTC arrangement. Noncompliance with applicable requirements could result in the Investor&#x2019;s projected tax benefits not being realized and, therefore, require the Company to indemnify the Investor for any loss or recapture of NMTC related to the financing until such time as the recapture provisions have expired under the applicable statute of limitations. The Company does not anticipate any credit recapture will be required in connection with this financing arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Investor and its majority owned community development entity are considered Variable Interest Entities (&#x201c;VIEs&#x201d;) and the Company is the primary beneficiary of the VIEs. This conclusion was reached based on the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the ongoing activities of the VIEs &#x2014; collecting and remitting interest and fees and NMTC compliance &#x2014; were all considered in the initial design and are not expected to significantly affect performance throughout the life of the VIE;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;contractual arrangements obligate the Company to comply with NMTC rules and regulations and provide various other guarantees to the Investor and community development entity;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the Investor lacks a material interest in the underlying economics of the project; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;the Company is obligated to absorb losses of the VIEs.&lt;/span&gt;&lt;/div&gt;Because the Company is the primary beneficiary of the VIEs, they have been included in the consolidated financial statements. There are no other assets, liabilities or transactions in these VIEs outside of the financing transactions executed as part of the NMTC arrangement.</exas:NewMarketTaxCreditTextBlock>
    <exas:NetProceedsFromFinancingArrangement
      contextRef="ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83Ni9mcmFnOjQ1YTNlZmY3NmU3MTRmNmU4ZTg2ZGUwYjgwZDk3MGNlL3RleHRyZWdpb246NDVhM2VmZjc2ZTcxNGY2ZThlODZkZTBiODBkOTcwY2VfMTAy_581f0459-c9f5-4ffa-b228-742e4134ea7c"
      unitRef="usd">2400000</exas:NetProceedsFromFinancingArrangement>
    <exas:NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements
      contextRef="ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83Ni9mcmFnOjQ1YTNlZmY3NmU3MTRmNmU4ZTg2ZGUwYjgwZDk3MGNlL3RleHRyZWdpb246NDVhM2VmZjc2ZTcxNGY2ZThlODZkZTBiODBkOTcwY2VfMjAy_f639daec-c12f-44ec-908f-158fc2490be7"
      unitRef="facility">1</exas:NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements>
    <exas:WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyMw_df0370a1-c649-40b2-ae1e-af98b97988c1">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2015, the Company entered into an agreement with the Wisconsin Economic Development Corporation (&#x201c;WEDC&#x201d;) to earn $9.0 million in refundable tax credits on the condition that the Company expends $26.3 million in capital investments and establishes and maintains 758 full-time positions over a seven-year period. The tax credits earned are first applied against the tax liability otherwise due, and if there is no such liability present, the claim for tax credits will be reimbursed in cash to the Company. The maximum amount of the refundable tax credit to be earned for each year is fixed, and the Company earns the credits by meeting certain capital investment and job creation thresholds over the seven-year period. Should the Company earn and receive the job creation tax credits but not maintain those full-time positions through the end of the agreement, the Company may be required to pay those credits back to the WEDC.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records the earned tax credits as job creation and capital investments occur. The amount of tax credits earned is recorded as a liability and amortized as a reduction of operating expenses over the expected period of benefit. The tax credits earned from capital investment are recognized as an offset to depreciation expense over the expected life of the acquired capital assets. The tax credits earned related to job creation are recognized as an offset to operational expenses over the life of the agreement, as the Company is required to maintain the minimum level of full-time positions through the seven-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, the Company has earned all $9.0 million of the refundable tax credits and has received payment of $7.5 million from the WEDC. The unpaid portion is $1.5 million, which is reported in prepaid expenses and other current assets, reflecting when collection of the refundable tax credits is expected to occur. As of September&#160;30, 2021 and December&#160;31, 2020, the corresponding liability, which reflected when the expected benefit of tax credit amortization would reduce future operating expenses, has been fully amortized. &lt;/span&gt;&lt;/div&gt;During the three and nine months ended September&#160;30, 2020, the Company amortized $0.6 million and $1.7 million, respectively, of the tax credits earned as a reduction of operating expenses.</exas:WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock>
    <exas:RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions
      contextRef="i107170d7fed64652982d166e0b941437_I20150331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTk0_d4a4b67a-8b77-4298-a28b-1c2e8eb76359"
      unitRef="usd">9000000</exas:RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions>
    <exas:CapitalInvestmentExpendituresRequirementForRefundableTaxCredits
      contextRef="i107170d7fed64652982d166e0b941437_I20150331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjY1_c2c18206-6360-4415-b231-b2997080019f"
      unitRef="usd">26300000</exas:CapitalInvestmentExpendituresRequirementForRefundableTaxCredits>
    <exas:NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits
      contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMzIx_f654749e-22f1-4672-a545-4959466b7b5a"
      unitRef="employee">758</exas:NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits>
    <exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits
      contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyNA_9b841fb8-0d8d-4288-8790-a4f047e50c77">P7Y</exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits>
    <exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits
      contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyNQ_e12da41b-ff3a-44d1-bf2a-34d8c67c17a9">P7Y</exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits>
    <exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits
      contextRef="i1a090e02f3144c7683d65af3eaa99cf2_D20150101-20150331"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjIyNg_69c96266-56b9-41fa-b892-a2539f6717a6">P7Y</exas:PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits>
    <exas:RefundableTaxCreditEarnedToDate
      contextRef="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTY0OQ_73beba8a-0e0c-475c-a2f6-be95d2db0e15"
      unitRef="usd">9000000</exas:RefundableTaxCreditEarnedToDate>
    <exas:RefundableTaxCreditReceived
      contextRef="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTcxMA_95a92184-3bd4-4ecc-b1c8-0dd3267c967c"
      unitRef="usd">7500000</exas:RefundableTaxCreditReceived>
    <exas:RefundableTaxCreditReceivable
      contextRef="ie34ec6afb45d446cb6f0a5aace6595ab_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMTc1MA_a3a1546c-e36b-4fb4-b401-bfd710d2fcb1"
      unitRef="usd">1500000</exas:RefundableTaxCreditReceivable>
    <exas:AmortizationOfRefundableTaxCredits
      contextRef="i1bc1f54843b74a68949920da70be0d63_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjEzMw_7580e2e9-1e17-4742-96be-3c6e8a449374"
      unitRef="usd">600000</exas:AmortizationOfRefundableTaxCredits>
    <exas:AmortizationOfRefundableTaxCredits
      contextRef="i9a07478702f74507bc6501dba1c86d9d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83OS9mcmFnOmU3MGQ1NzcwNmZjNTQ4MjNhMGM3MjNmZTAzMmFhYTNiL3RleHRyZWdpb246ZTcwZDU3NzA2ZmM1NDgyM2EwYzcyM2ZlMDMyYWFhM2JfMjE0MA_28fdbc5b-1207-4767-85f0-66d60e8b5262"
      unitRef="usd">1700000</exas:AmortizationOfRefundableTaxCredits>
    <us-gaap:AssetAcquisitionTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDI_21c1a71a-5f3f-44aa-ad2f-c0ee767f6096">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ashion Analytics, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 14, 2021, the Company completed the acquisition (&#x201c;Ashion Acquisition&#x201d;) of all of the outstanding equity interests of Ashion from PMed Management, LLC (&#x201c;PMed&#x201d;), which is a subsidiary of TGen. The Ashion Acquisition provided the Company a Clinical Laboratory Improvement Amendments (&#x201c;CLIA&#x201d;) certified and College of American Pathologists (&#x201c;CAP&#x201d;) accredited sequencing lab based in Phoenix, Arizona. Ashion developed GEMExTra&#xae;, a comprehensive genomic cancer test, and provides access to whole exome, matched germline, and transcriptome sequencing capabilities. The Company has included the financial results of Ashion in the consolidated financial statements from the date of the combination.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The combination date fair value of the consideration transferred for Ashion was approximately $110.0 million, which consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the 125,444 common shares issued as part of consideration transferred was determined on the basis of the average of the high and low market price of the Company's shares on the acquisition date, which was $129.33. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration arrangement requires the Company to pay $20.0 million of additional cash consideration to PMed upon the Company&#x2019;s commercial launch, on or before the tenth anniversary of the Ashion Acquisition, of a test for minimal residual disease (&#x201c;MRD&#x201d;) detection and/or treatment (the &#x201c;Commercial Launch Milestone&#x201d;). The fair value of the Commercial Launch Milestone at the acquisition date was $19.0 million. The contingent consideration arrangement also requires the Company to pay $30.0 million of additional cash upon the Company&#x2019;s achievement, on or before the fifth anniversary of the Ashion Acquisition, of cumulative revenues from MRD products of $500.0 million (the &#x201c;MRD Product Revenue Milestone&#x201d;). No value was ascribed to the MRD Product Revenue Milestone based on probability assessments as of the acquisition date. The fair value of the Commercial Launch Milestone and MRD Product Revenue Milestone was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in Accounting Standards Codification (&#x201c;ASC&#x201d;) 820. The key assumptions are described in Note 7. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,313)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,241&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded $39.0 million of identifiable intangible assets related to the developed technology associated with GEMExTra. Developed technology represents purchased technology that had reached technological feasibility and for which Ashion had substantially completed development as of the date of combination. The fair value of the developed technology has been determined using the income approach multi-period excess earnings method, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, and required rate of return and tax rate. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 13 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the acquired workforce expertise, the capabilities in the advancement of creating and launching new products, including an MRD product, and expected sales force synergies related to the developed technology. The total goodwill related to this combination is deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the developed technology intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma impact and results of operations disclosures have not been included due to immateriality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, the Company incurred $1.6&#160;million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations, respectively. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thrive Earlier Detection Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 5, 2021, the Company completed the acquisition (&#x201c;Thrive Merger&#x201d;) of all of the outstanding capital stock of Thrive. Thrive, headquartered in Cambridge, Massachusetts, is a healthcare company dedicated to incorporating earlier cancer detection into routine medical care. The Company expects that combining Thrive's early-stage screening test, CancerSEEK, with the Company&#x2019;s scientific platform, clinical organization and commercial infrastructure will establish the Company as a leading competitor in blood-based, multi-cancer early detection. The Company has included the financial results of Thrive in the consolidated financial statements from the date of the combination.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The combination date fair value of the consideration transferred for Thrive was approximately $2.19 billion, which consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175,431&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,348&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of replaced equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Previously held equity investment fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued 9,323,266 common shares that had a fair value of $1.19 billion based on the average of the high and low market price of the Company's shares on the acquisition date, which was $127.79. Of the total consideration for common stock issued, $1.18 billion was allocated to the purchase consideration and $16.0 million was recorded as compensation within general and administrative expenses in the condensed consolidated statement of operations on the acquisition date due to accelerated vesting of legacy Thrive restricted stock awards (&#x201c;RSA&#x201d;) and RSU awards in connection with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid $590.2 million in cash on the acquisition date. Of the total consideration for cash, $585.0 million was allocated to the purchase consideration and $5.2 million was recorded as compensation within general and administrative expenses on the acquisition date due to accelerated vesting of legacy Thrive RSU and RSA awards that were cash-settled in connection with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration arrangement requires the Company to pay up to $450.0 million of additional cash consideration to Thrive&#x2019;s former shareholders upon the achievement of two discrete events, U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) approval and Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) coverage, for $150.0 million and up to $300.0 million, respectively. The fair value of the contingent consideration arrangement at the acquisition date was $352.0 million. The fair value of the contingent consideration was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. The key assumptions are described in Note 7. Of the total fair value of the contingent consideration, $331.3 million was allocated to the consideration transferred, $6.4 million was allocated to the Company&#x2019;s previous ownership interest in Thrive, and $14.3 million was deemed compensatory as participation is dependent on replaced unvested equity awards vesting which requires future service. Compensation expense related to the milestones could be up to $18.2 million undiscounted and will be recognized in the future once probable and payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company replaced unvested stock options, RSUs, and RSAs and vested stock options with a combination-date fair value of $197.0 million. Of the total consideration for replaced equity awards, $52.2 million was allocated to the consideration transferred and $144.8 million was deemed compensatory as it was attributable to post acquisition vesting. Of the total compensation related to replaced awards, $65.0 million was expensed on the acquisition date due to accelerated vesting of stock options in connection with the acquisition and $79.8 million relates to future services and will be expensed over the remaining service periods of the unvested stock options, RSUs, and RSAs on a straight-line basis. Including expense recognized for accelerated vesting of RSUs and RSAs described above, total expected stock-based compensation expense is $166.0 million, of which $86.2 million was recognized immediately to general and administrative expenses in the condensed consolidated statement of operations due to accelerated vesting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the stock options assumed by the Company was determined using the Black-Scholes option pricing model. The fair value of the RSA and RSUs assumed by the Company was determined based on the average of the high and low market price of the Company's shares on the acquisition date. The share conversion ratio of 0.06216 was applied to convert Thrive&#x2019;s outstanding equity awards for Thrive&#x2019;s common stock into equity awards for shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options assumed were based on the assumptions in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Option Plan Shares Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11% - 0.12%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26 - 1.57&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.54% - 71.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per share of options assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$109.74 - $124.89&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company previously held a preferred stock investment of $12.5 million in Thrive and recognized a gain of approximately $30.5 million on the transaction within investment income (expense), net on the Company&#x2019;s condensed consolidated statement of operations, which represented the adjustment of the Company&#x2019;s historical investment to the acquisition date fair value. The fair value of the Company&#x2019;s previous ownership in Thrive was determined based on the pro-rata share payout applied to the Company&#x2019;s interest combined with the fair value of the Company&#x2019;s share of the contingent consideration arrangement, as discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Allocation&lt;br/&gt;January 5, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allocation as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,977&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,977&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,222)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,222)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,218)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,080)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,622)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,622)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272,905)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272,905)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,947)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325,809)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,240,811&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238,949&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946,243&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D represents the fair value assigned to research and development assets that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying product and expected commercial release. The amounts capitalized are accounted for as indefinite-lived intangible assets, subject to impairment testing, until completion or abandonment of the research and development efforts associated with the projects. The Company recorded $1.25 billion of IPR&amp;amp;D related to a project associated with the development of an FDA approved blood-based, multi cancer screening test. The IPR&amp;amp;D asset was valued using the multiple-period excess earnings method approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, required rate of return and tax rate, as well as estimates of achievement probability and timing related to the royalty and milestone obligations due to JHU, as described in Note 10. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the research and development workforce expertise, next generation sequencing capabilities and expected synergies. The total goodwill related to this combination is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the IPR&amp;amp;D asset, as well as finalization of the pre-combination income tax returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net loss before tax of Thrive included in the Company&#x2019;s condensed consolidated statement of operations from the combination date of January 5, 2021 to September&#160;30, 2021 was $219.6 million. The net loss before tax of Thrive included in the Company&#x2019;s condensed consolidated statement of operations for the three months ended September 30, 2021 was $39.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma financial information for all periods presented above has been calculated after adjusting the results of Thrive to reflect the business combination accounting effects resulting from this combination. The Company incurred $86.2 million of stock-based compensation expense related to accelerated vesting in connection with the acquisition, $13.5 million of stock-based compensation expense related to accelerated vesting for employees with qualifying termination events, and $10.3 million of transaction costs incurred to execute the acquisition during the first quarter of 2021. These expenses are included in general and administrative expenses on the condensed consolidated statement of operations for the nine months ended September 30, 2021 and are reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a realized gain of $30.5 million during the first quarter of 2021 in investment income (expense), net on the Company&#x2019;s condensed consolidated statement of operations relating to the Company&#x2019;s pre-acquisition investment in Thrive. This gain has been reduced to $7.6&#160;million due to the Company&#x2019;s smaller ownership interest in Thrive on January 1, 2020, and is reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a remeasurement of contingent consideration of $10.5 million related to Thrive in general and administrative expenses in the condensed consolidated statement of operations for the nine months ended September 30, 2021. This expense is reflected in the nine months ended September 30, 2020 in the table above. The historical consolidated financial statements have been adjusted in the unaudited pro forma combined financial information to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The unaudited pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the combination had taken place as of January 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2021, the Company incurred $10.3 million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with acquisition-related severances, the Company recorded $4.5 million of expense related to vesting of previously unvested equity awards and $1.2 million of additional benefit charges for the three months ended September 30, 2021. The Company recorded $19.0 million of expense related to vesting of previously unvested equity awards and $3.9 million of additional benefit charges for the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Paradigm Diagnostics, Inc. and Viomics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2020, the Company acquired all of the outstanding capital stock of Paradigm and Viomics, two related party companies of one another headquartered in Phoenix, Arizona, in transactions that were deemed to be a single business combination in accordance with ASC 805, Business Combinations, (&#x201c;the Paradigm Acquisition&#x201d;). Paradigm provides comprehensive genomic-based profiling tests that assist in the diagnosis and therapy recommendations for late-stage cancer. Viomics provides a platform for identification of biomarkers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into this acquisition to enhance its product portfolio in cancer diagnostics and to enhance its capabilities for biomarker identification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair value of the consideration to be transferred for Paradigm and Viomics was $40.4 million, which consists of $32.2&#160;million payable in shares of the Company&#x2019;s common stock and $8.2&#160;million which was settled through a cash payment. Of the $32.2&#160;million to be settled through the issuance of common stock, $28.8&#160;million was issued as of September&#160;30, 2021, and the remaining $3.4&#160;million, which was withheld and may become payable as additional merger consideration, is included in other current liabilities in the condensed consolidated balance sheet as of September&#160;30, 2021. The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Allocation&lt;br/&gt;March 3, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Allocation&lt;br/&gt;March 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The measurement period adjustments primarily related to accounts receivable valuation and working capital adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of identifiable intangible assets has been determined using the income approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, weighted average cost of capital and tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology represents purchased technology that had reached technological feasibility and for which development had been completed as of the acquisition date. Fair value was determined using future discounted cash flows related to the projected income stream of the developed technology for a discrete projection period. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the assembled workforce, and expected synergies. The total goodwill related to this acquisition is not deductible for tax purposes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company agreed to issue to the previous investors in Viomics equity interests with an acquisition-date fair value of up to $8.4&#160;million in Viomics, vesting over 4 years based on certain retention arrangements. Payment is contingent upon continued employment with the Company over the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb"&gt;four&lt;/span&gt;&lt;/span&gt; year vesting period and is recognized as stock-based compensation expense in general and administrative expense in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Asset Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PFS Genomics Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 3, 2021, the Company acquired 90% of the outstanding capital stock of PFS Genomics Inc. (&#x201c;PFS&#x201d;). On June 23, 2021, the Company completed the acquisition of the remaining 10% interest in PFS. The Company paid cash of $33.6 million for 100% of the outstanding capital stock in PFS. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PFS is a healthcare company focused on personalizing treatment for breast cancer patients to improve outcomes and reduce unnecessary treatment. The Company expects this acquisition to expand its ability to help guide early-stage breast cancer treatment through individualized radiotherapy treatment decisions.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction was treated as an asset acquisition under GAAP because substantially all of the fair value of the gross assets acquired were deemed to be associated with the acquired technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets acquired and liabilities assumed were substantially comprised of the IPR&amp;amp;D asset as shown in the table below. The IPR&amp;amp;D asset acquired was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the total purchase price was allocated to the acquired net tangible and intangible assets based on their estimated fair values as of the closing date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition related costs were not material in this asset acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisition of PFS Genomics outstanding shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TARDIS License Agreement &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 11, 2021, the Company entered into a worldwide exclusive license to the proprietary TARDIS technology from TGen, an affiliate of City of Hope. Under the agreement, the Company acquired a royalty-free, worldwide exclusive license to proprietary TARDIS patents and know-how. The Company intends to develop and commercialize the TARDIS technology as a minimal residual disease test. The Company accounted for this transaction as an asset acquisition. In connection with the asset acquisition, the Company paid upfront fair value consideration of $52.3 million comprised of $25.0 million in cash and issuance of 0.2&#160;million shares of common stock valued at $27.3 million based on the average of the high and low market price of the Company&#x2019;s shares on the acquisition date. In addition, the Company is obligated to make milestone payments to TGen of $10.0 million and $35.0 million upon achieving cumulative product revenue related to MRD detection and/or treatment totaling $100.0 million and $250.0 million, respectively. These payments are contingent upon achievement of these cumulative revenues on or before December 31, 2030. The upfront consideration was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. The Company will record the sales milestones once achievement is deemed probable. No acquisition related costs were incurred in this asset acquisition during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:AssetAcquisitionTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNTE_6698e803-7468-4ffa-9151-fc83e242ff44">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ashion Analytics, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 14, 2021, the Company completed the acquisition (&#x201c;Ashion Acquisition&#x201d;) of all of the outstanding equity interests of Ashion from PMed Management, LLC (&#x201c;PMed&#x201d;), which is a subsidiary of TGen. The Ashion Acquisition provided the Company a Clinical Laboratory Improvement Amendments (&#x201c;CLIA&#x201d;) certified and College of American Pathologists (&#x201c;CAP&#x201d;) accredited sequencing lab based in Phoenix, Arizona. Ashion developed GEMExTra&#xae;, a comprehensive genomic cancer test, and provides access to whole exome, matched germline, and transcriptome sequencing capabilities. The Company has included the financial results of Ashion in the consolidated financial statements from the date of the combination.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The combination date fair value of the consideration transferred for Ashion was approximately $110.0 million, which consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the 125,444 common shares issued as part of consideration transferred was determined on the basis of the average of the high and low market price of the Company's shares on the acquisition date, which was $129.33. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration arrangement requires the Company to pay $20.0 million of additional cash consideration to PMed upon the Company&#x2019;s commercial launch, on or before the tenth anniversary of the Ashion Acquisition, of a test for minimal residual disease (&#x201c;MRD&#x201d;) detection and/or treatment (the &#x201c;Commercial Launch Milestone&#x201d;). The fair value of the Commercial Launch Milestone at the acquisition date was $19.0 million. The contingent consideration arrangement also requires the Company to pay $30.0 million of additional cash upon the Company&#x2019;s achievement, on or before the fifth anniversary of the Ashion Acquisition, of cumulative revenues from MRD products of $500.0 million (the &#x201c;MRD Product Revenue Milestone&#x201d;). No value was ascribed to the MRD Product Revenue Milestone based on probability assessments as of the acquisition date. The fair value of the Commercial Launch Milestone and MRD Product Revenue Milestone was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in Accounting Standards Codification (&#x201c;ASC&#x201d;) 820. The key assumptions are described in Note 7. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,313)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,241&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded $39.0 million of identifiable intangible assets related to the developed technology associated with GEMExTra. Developed technology represents purchased technology that had reached technological feasibility and for which Ashion had substantially completed development as of the date of combination. The fair value of the developed technology has been determined using the income approach multi-period excess earnings method, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, and required rate of return and tax rate. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 13 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the acquired workforce expertise, the capabilities in the advancement of creating and launching new products, including an MRD product, and expected sales force synergies related to the developed technology. The total goodwill related to this combination is deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the developed technology intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pro forma impact and results of operations disclosures have not been included due to immateriality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2021, the Company incurred $1.6&#160;million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations, respectively. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thrive Earlier Detection Corporation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 5, 2021, the Company completed the acquisition (&#x201c;Thrive Merger&#x201d;) of all of the outstanding capital stock of Thrive. Thrive, headquartered in Cambridge, Massachusetts, is a healthcare company dedicated to incorporating earlier cancer detection into routine medical care. The Company expects that combining Thrive's early-stage screening test, CancerSEEK, with the Company&#x2019;s scientific platform, clinical organization and commercial infrastructure will establish the Company as a leading competitor in blood-based, multi-cancer early detection. The Company has included the financial results of Thrive in the consolidated financial statements from the date of the combination.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The combination date fair value of the consideration transferred for Thrive was approximately $2.19 billion, which consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175,431&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,348&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of replaced equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Previously held equity investment fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company issued 9,323,266 common shares that had a fair value of $1.19 billion based on the average of the high and low market price of the Company's shares on the acquisition date, which was $127.79. Of the total consideration for common stock issued, $1.18 billion was allocated to the purchase consideration and $16.0 million was recorded as compensation within general and administrative expenses in the condensed consolidated statement of operations on the acquisition date due to accelerated vesting of legacy Thrive restricted stock awards (&#x201c;RSA&#x201d;) and RSU awards in connection with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid $590.2 million in cash on the acquisition date. Of the total consideration for cash, $585.0 million was allocated to the purchase consideration and $5.2 million was recorded as compensation within general and administrative expenses on the acquisition date due to accelerated vesting of legacy Thrive RSU and RSA awards that were cash-settled in connection with the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration arrangement requires the Company to pay up to $450.0 million of additional cash consideration to Thrive&#x2019;s former shareholders upon the achievement of two discrete events, U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) approval and Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;) coverage, for $150.0 million and up to $300.0 million, respectively. The fair value of the contingent consideration arrangement at the acquisition date was $352.0 million. The fair value of the contingent consideration was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. The key assumptions are described in Note 7. Of the total fair value of the contingent consideration, $331.3 million was allocated to the consideration transferred, $6.4 million was allocated to the Company&#x2019;s previous ownership interest in Thrive, and $14.3 million was deemed compensatory as participation is dependent on replaced unvested equity awards vesting which requires future service. Compensation expense related to the milestones could be up to $18.2 million undiscounted and will be recognized in the future once probable and payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company replaced unvested stock options, RSUs, and RSAs and vested stock options with a combination-date fair value of $197.0 million. Of the total consideration for replaced equity awards, $52.2 million was allocated to the consideration transferred and $144.8 million was deemed compensatory as it was attributable to post acquisition vesting. Of the total compensation related to replaced awards, $65.0 million was expensed on the acquisition date due to accelerated vesting of stock options in connection with the acquisition and $79.8 million relates to future services and will be expensed over the remaining service periods of the unvested stock options, RSUs, and RSAs on a straight-line basis. Including expense recognized for accelerated vesting of RSUs and RSAs described above, total expected stock-based compensation expense is $166.0 million, of which $86.2 million was recognized immediately to general and administrative expenses in the condensed consolidated statement of operations due to accelerated vesting. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the stock options assumed by the Company was determined using the Black-Scholes option pricing model. The fair value of the RSA and RSUs assumed by the Company was determined based on the average of the high and low market price of the Company's shares on the acquisition date. The share conversion ratio of 0.06216 was applied to convert Thrive&#x2019;s outstanding equity awards for Thrive&#x2019;s common stock into equity awards for shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options assumed were based on the assumptions in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Option Plan Shares Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11% - 0.12%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26 - 1.57&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.54% - 71.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per share of options assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$109.74 - $124.89&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company previously held a preferred stock investment of $12.5 million in Thrive and recognized a gain of approximately $30.5 million on the transaction within investment income (expense), net on the Company&#x2019;s condensed consolidated statement of operations, which represented the adjustment of the Company&#x2019;s historical investment to the acquisition date fair value. The fair value of the Company&#x2019;s previous ownership in Thrive was determined based on the pro-rata share payout applied to the Company&#x2019;s interest combined with the fair value of the Company&#x2019;s share of the contingent consideration arrangement, as discussed above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Allocation&lt;br/&gt;January 5, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allocation as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,977&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,977&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,222)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,222)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,218)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,080)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,622)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,622)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272,905)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272,905)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,947)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325,809)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,240,811&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238,949&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946,243&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D represents the fair value assigned to research and development assets that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying product and expected commercial release. The amounts capitalized are accounted for as indefinite-lived intangible assets, subject to impairment testing, until completion or abandonment of the research and development efforts associated with the projects. The Company recorded $1.25 billion of IPR&amp;amp;D related to a project associated with the development of an FDA approved blood-based, multi cancer screening test. The IPR&amp;amp;D asset was valued using the multiple-period excess earnings method approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, required rate of return and tax rate, as well as estimates of achievement probability and timing related to the royalty and milestone obligations due to JHU, as described in Note 10. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the research and development workforce expertise, next generation sequencing capabilities and expected synergies. The total goodwill related to this combination is not deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the IPR&amp;amp;D asset, as well as finalization of the pre-combination income tax returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net loss before tax of Thrive included in the Company&#x2019;s condensed consolidated statement of operations from the combination date of January 5, 2021 to September&#160;30, 2021 was $219.6 million. The net loss before tax of Thrive included in the Company&#x2019;s condensed consolidated statement of operations for the three months ended September 30, 2021 was $39.6 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited pro forma financial information for all periods presented above has been calculated after adjusting the results of Thrive to reflect the business combination accounting effects resulting from this combination. The Company incurred $86.2 million of stock-based compensation expense related to accelerated vesting in connection with the acquisition, $13.5 million of stock-based compensation expense related to accelerated vesting for employees with qualifying termination events, and $10.3 million of transaction costs incurred to execute the acquisition during the first quarter of 2021. These expenses are included in general and administrative expenses on the condensed consolidated statement of operations for the nine months ended September 30, 2021 and are reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a realized gain of $30.5 million during the first quarter of 2021 in investment income (expense), net on the Company&#x2019;s condensed consolidated statement of operations relating to the Company&#x2019;s pre-acquisition investment in Thrive. This gain has been reduced to $7.6&#160;million due to the Company&#x2019;s smaller ownership interest in Thrive on January 1, 2020, and is reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a remeasurement of contingent consideration of $10.5 million related to Thrive in general and administrative expenses in the condensed consolidated statement of operations for the nine months ended September 30, 2021. This expense is reflected in the nine months ended September 30, 2020 in the table above. The historical consolidated financial statements have been adjusted in the unaudited pro forma combined financial information to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The unaudited pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the combination had taken place as of January 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30, 2021, the Company incurred $10.3 million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with acquisition-related severances, the Company recorded $4.5 million of expense related to vesting of previously unvested equity awards and $1.2 million of additional benefit charges for the three months ended September 30, 2021. The Company recorded $19.0 million of expense related to vesting of previously unvested equity awards and $3.9 million of additional benefit charges for the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Paradigm Diagnostics, Inc. and Viomics, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2020, the Company acquired all of the outstanding capital stock of Paradigm and Viomics, two related party companies of one another headquartered in Phoenix, Arizona, in transactions that were deemed to be a single business combination in accordance with ASC 805, Business Combinations, (&#x201c;the Paradigm Acquisition&#x201d;). Paradigm provides comprehensive genomic-based profiling tests that assist in the diagnosis and therapy recommendations for late-stage cancer. Viomics provides a platform for identification of biomarkers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into this acquisition to enhance its product portfolio in cancer diagnostics and to enhance its capabilities for biomarker identification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The acquisition date fair value of the consideration to be transferred for Paradigm and Viomics was $40.4 million, which consists of $32.2&#160;million payable in shares of the Company&#x2019;s common stock and $8.2&#160;million which was settled through a cash payment. Of the $32.2&#160;million to be settled through the issuance of common stock, $28.8&#160;million was issued as of September&#160;30, 2021, and the remaining $3.4&#160;million, which was withheld and may become payable as additional merger consideration, is included in other current liabilities in the condensed consolidated balance sheet as of September&#160;30, 2021. The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Allocation&lt;br/&gt;March 3, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Allocation&lt;br/&gt;March 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The measurement period adjustments primarily related to accounts receivable valuation and working capital adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of identifiable intangible assets has been determined using the income approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, weighted average cost of capital and tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology represents purchased technology that had reached technological feasibility and for which development had been completed as of the acquisition date. Fair value was determined using future discounted cash flows related to the projected income stream of the developed technology for a discrete projection period. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the assembled workforce, and expected synergies. The total goodwill related to this acquisition is not deductible for tax purposes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company agreed to issue to the previous investors in Viomics equity interests with an acquisition-date fair value of up to $8.4&#160;million in Viomics, vesting over 4 years based on certain retention arrangements. Payment is contingent upon continued employment with the Company over the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb"&gt;four&lt;/span&gt;&lt;/span&gt; year vesting period and is recognized as stock-based compensation expense in general and administrative expense in the condensed consolidated statement of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Asset Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PFS Genomics Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 3, 2021, the Company acquired 90% of the outstanding capital stock of PFS Genomics Inc. (&#x201c;PFS&#x201d;). On June 23, 2021, the Company completed the acquisition of the remaining 10% interest in PFS. The Company paid cash of $33.6 million for 100% of the outstanding capital stock in PFS. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PFS is a healthcare company focused on personalizing treatment for breast cancer patients to improve outcomes and reduce unnecessary treatment. The Company expects this acquisition to expand its ability to help guide early-stage breast cancer treatment through individualized radiotherapy treatment decisions.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction was treated as an asset acquisition under GAAP because substantially all of the fair value of the gross assets acquired were deemed to be associated with the acquired technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets acquired and liabilities assumed were substantially comprised of the IPR&amp;amp;D asset as shown in the table below. The IPR&amp;amp;D asset acquired was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the total purchase price was allocated to the acquired net tangible and intangible assets based on their estimated fair values as of the closing date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition related costs were not material in this asset acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisition of PFS Genomics outstanding shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;TARDIS License Agreement &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 11, 2021, the Company entered into a worldwide exclusive license to the proprietary TARDIS technology from TGen, an affiliate of City of Hope. Under the agreement, the Company acquired a royalty-free, worldwide exclusive license to proprietary TARDIS patents and know-how. The Company intends to develop and commercialize the TARDIS technology as a minimal residual disease test. The Company accounted for this transaction as an asset acquisition. In connection with the asset acquisition, the Company paid upfront fair value consideration of $52.3 million comprised of $25.0 million in cash and issuance of 0.2&#160;million shares of common stock valued at $27.3 million based on the average of the high and low market price of the Company&#x2019;s shares on the acquisition date. In addition, the Company is obligated to make milestone payments to TGen of $10.0 million and $35.0 million upon achieving cumulative product revenue related to MRD detection and/or treatment totaling $100.0 million and $250.0 million, respectively. These payments are contingent upon achievement of these cumulative revenues on or before December 31, 2030. The upfront consideration was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. The Company will record the sales milestones once achievement is deemed probable. No acquisition related costs were incurred in this asset acquisition during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDk_02408839-2f61-4391-b160-51735b9ecfcb">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The combination date fair value of the consideration transferred for Ashion was approximately $110.0 million, which consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,224&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The combination date fair value of the consideration transferred for Thrive was approximately $2.19 billion, which consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,175,431&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,996&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331,348&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of replaced equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Previously held equity investment fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,034&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODk1_cf5159ea-833c-4b84-a64c-1ab86a3d49a2"
      unitRef="usd">110000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfMS0yLTEtMS0x_a144d927-bc18-47a0-9a43-7a5382c48774"
      unitRef="usd">74775000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfMi0yLTEtMS0x_ccd5687c-f432-4728-84c6-ffe0a018dc28"
      unitRef="usd">16224000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfMy0yLTEtMS0x_3e78c2a9-67e1-469c-b7f8-54f98b1c7e5b"
      unitRef="usd">19000000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc5ZjkyODUwM2YwOTRkNDBhNDY3ZTRmZmY5ZjA5MTQ0L3RhYmxlcmFuZ2U6NzlmOTI4NTAzZjA5NGQ0MGE0NjdlNGZmZjlmMDkxNDRfNC0yLTEtMS0x_ae91b779-b8d9-4475-ba13-22b47213851b"
      unitRef="usd">109999000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfOTU3_e5bd93b9-c1e3-4bec-85b2-5c28b410e44a"
      unitRef="shares">125444</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTE1Mw_3b725b6e-f6ca-4c56-bab5-5ac1dd95fbb7"
      unitRef="usdPerShare">129.33</us-gaap:SharesIssuedPricePerShare>
    <exas:BusinessCombinationContingentConsiderationAdditionalPayment
      contextRef="i233731ca43664d2c93c9d490bf6d67d5_I20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTIyNw_df79c089-6766-4f46-8478-defe8b1c785e"
      unitRef="usd">20000000.0</exas:BusinessCombinationContingentConsiderationAdditionalPayment>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i233731ca43664d2c93c9d490bf6d67d5_I20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU2MA_0e6a2bf0-5ed5-449e-8149-28bd777ff82e"
      unitRef="usd">19000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i990575d7a2fe4594870c1692af08e8f6_I20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTYzOA_685d204f-016b-4e0d-870a-fc340804b0df"
      unitRef="usd">30000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <exas:BusinessCombinationContingentConsiderationRevenueMilestone
      contextRef="i990575d7a2fe4594870c1692af08e8f6_I20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc5OA_24a1ad22-02b5-45aa-adb4-060968020d25"
      unitRef="usd">500000000.0</exas:BusinessCombinationContingentConsiderationRevenueMilestone>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDc_df766310-d0d8-4d38-b0fa-8c209ecde26a">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,474&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,811&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(343)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,313)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,241&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Allocation&lt;br/&gt;January 5, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allocation as of September&#160;30, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,748&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241,748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,939&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,977&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,977&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development (IPR&amp;amp;D)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total identifiable assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564,758&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,564,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,222)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,222)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,218)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,080)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,622)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,622)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272,905)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(272,905)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities assumed &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323,947)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325,809)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,240,811&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,862)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,238,949&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946,243&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,862&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,105&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,187,054&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Preliminary Allocation&lt;br/&gt;March 3, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Final Allocation&lt;br/&gt;March 3, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(760)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total purchase price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for acquisition of PFS Genomics outstanding shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets acquired and liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPR&amp;amp;D asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,074&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMS0yLTEtMS0x_ba32279f-9291-4c51-8a4c-245b579d96e7"
      unitRef="usd">2474000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMi0yLTEtMS0x_40956055-8d9a-40c3-be2b-1c8f7a00a894"
      unitRef="usd">2349000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMy0yLTEtMS0x_0541b508-ea33-47d1-9a1c-662546862f78"
      unitRef="usd">1811000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNC0yLTEtMS0x_7c9a9028-783a-44ce-be05-8fe380f70b23"
      unitRef="usd">425000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNS0yLTEtMS0x_942befb3-9f24-4a92-a5b4-877c9d395456"
      unitRef="usd">9947000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNi0yLTEtMS0x_2ac10a6f-7aca-4c6b-8296-982a33acefcb"
      unitRef="usd">548000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfNy0yLTEtMS0x_94438ed9-f755-49b6-b729-b976d1b95fac"
      unitRef="usd">39000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfOC0yLTEtMS0x_2ec4122f-d3d4-4724-bb76-193e88b5d3a9"
      unitRef="usd">56554000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTAtMi0xLTEtMQ_98540516-763d-4759-8def-f31822d999b5"
      unitRef="usd">1477000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTEtMi0xLTEtMQ_10092310-1b96-42a1-8028-f4ad29692962"
      unitRef="usd">1190000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTItMi0xLTEtMQ_0113894b-ab0a-4f77-b844-9b5c844dc18b"
      unitRef="usd">343000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTMtMi0xLTEtMQ_6540a601-c114-4248-b110-9ec04db2c1f8"
      unitRef="usd">98000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTQtMi0xLTEtMQ_0f34f8d7-639e-4a14-a430-85581e4561c3"
      unitRef="usd">205000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTUtMi0xLTEtMQ_2ea276bf-73cc-42c0-bdda-3ac2ddbc609c"
      unitRef="usd">3313000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTYtMi0xLTEtMQ_bb3ca788-a1a5-40d8-b98c-4a603a2cb62c"
      unitRef="usd">53241000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTgtMi0xLTEtMQ_76527105-dddb-4219-b1a5-bddfc9481c84"
      unitRef="usd">56758000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmYzYTAzNzViZTE1ZjRhMjdiNTNhODFkNzFlOTI3OTEyL3RhYmxlcmFuZ2U6ZjNhMDM3NWJlMTVmNGEyN2I1M2E4MWQ3MWU5Mjc5MTJfMTktMi0xLTEtMQ_05406cbc-a031-41d4-a653-235342d85d19"
      unitRef="usd">109999000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i5fa41ad8e71d4dd28f502802045906ae_I20210414"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjUyMA_9ac162b8-ba7a-433c-bbbc-df3d91b7a09b"
      unitRef="usd">39000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMzI1Mw_87224285-61c0-4458-b8f8-8d2462651578">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie6653408e966412f9580bd258009d9e9_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNDMyMg_81c316e6-80c1-4136-8ba7-bca449ccdf04"
      unitRef="usd">1600000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTQwNg_9a76361d-51aa-4204-b7a2-912820870f5b"
      unitRef="usd">2190000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfMS0yLTEtMS0x_34c39c67-f51f-4479-bd3a-944fc6e80645"
      unitRef="usd">1175431000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfMi0yLTEtMS0x_6102558c-ecad-49a3-b40c-2c6ec0f3a341"
      unitRef="usd">584996000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfMy0yLTEtMS0x_55999b82-9ba4-4349-b0d2-a4572813fae3"
      unitRef="usd">331348000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <exas:BusinessCombinationFairValueOfReplacedEquityAwards
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfNC0yLTEtMS0x_5df7880e-f7c4-40c1-8f37-41c3273e8bdc"
      unitRef="usd">52245000</exas:BusinessCombinationFairValueOfReplacedEquityAwards>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfNS0yLTEtMS0x_64041345-1e24-4858-aa6c-74100183814f"
      unitRef="usd">43034000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjA4NzQzYWU1NDEzNzRjN2Q4OTA3NGE0MzBlY2U4YWE5L3RhYmxlcmFuZ2U6MDg3NDNhZTU0MTM3NGM3ZDg5MDc0YTQzMGVjZThhYTlfNi0yLTEtMS0x_c6b17785-5b26-4ce7-91df-4594a7956643"
      unitRef="usd">2187054000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTQ2NQ_d9a1ee1e-e329-44ee-b2f8-b9b4efc85f53"
      unitRef="shares">9323266</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTUwNw_1a2bb007-bdf9-4d1d-be02-9eaf3508e374"
      unitRef="usd">1190000000</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTYyMw_736c09a7-cf49-47e8-a00d-cc5345c07dcc"
      unitRef="usdPerShare">127.79</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTY3OQ_6fdb2f29-279c-41a0-91af-3d8d6911795f"
      unitRef="usd">1180000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
      contextRef="i70acbbc0dbc5483ab952ef2d524cf18b_D20210105-20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNTczMA_078d9c88-be26-4e3a-9d75-0b42d3cb6fed"
      unitRef="usd">16000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
    <exas:PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjAyNw_d6c9bae6-d78e-4a8f-86b9-a0eaf4eac301"
      unitRef="usd">590200000</exas:PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjEwMA_8b00fe87-e25d-4f01-808a-8eb9a41dc99d"
      unitRef="usd">585000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i70acbbc0dbc5483ab952ef2d524cf18b_D20210105-20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjE1MQ_3fd51d05-36c9-4ad2-a408-d07f3b95df0c"
      unitRef="usd">5200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjQ0Nw_da8b9f08-8a3f-480f-beb6-0ada933175ff"
      unitRef="usd">450000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib2b131fa1d864ac79567f3577788ccc1_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjY3OA_7274cdad-ad94-4115-ba42-133f33b8b26a"
      unitRef="usd">150000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i55deacfe7ea94c7488107e4687d0d7e9_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjY5MQ_d7548152-f779-4819-8b65-11f8ac9dbd46"
      unitRef="usd">300000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i434a63ff04d349ca9dd0cd31f8dbd3fe_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNjc5Ng_76393d90-c249-42a9-a722-554f4dcb490b"
      unitRef="usd">352000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0a0e991fc3574513b998b53a404cbd4d_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzE4OA_ac9d2b78-f0f6-4f6f-bfea-8cde77c5423a"
      unitRef="usd">331300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ic720ba1718c741998617bf85bd1369ef_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzIzOQ_5cad8dc3-8c11-4e0d-bbb8-267ba5da7314"
      unitRef="usd">6400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i9e00c316ed7d4743b9ae72c32d1ea634_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzMxNg_bb7bdc6c-4435-4d9a-9947-c6b93c4d7dc2"
      unitRef="usd">14300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i72248a0ae06a4828857001f7eb06939a_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzUwOQ_c3ae78e7-ec17-4d64-ad78-0fdba6679543"
      unitRef="usd">18200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzcxMg_7980d842-f620-49b0-a331-9b19558c30c3"
      unitRef="usd">197000000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzc3MQ_92a8c785-532c-4393-8b9d-c7a4f650357c"
      unitRef="usd">52200000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzgyNQ_e37e1f39-db0f-408c-9c86-fe70a912f706"
      unitRef="usd">144800000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfNzk1OA_227b1689-7752-46f6-81dd-22e3ec998473"
      unitRef="usd">65000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODA4MQ_be092424-529c-4574-bc2b-784f0c4e86a1"
      unitRef="usd">79800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODM3Nw_65f46b59-b411-4d3e-981e-162d0328bc52"
      unitRef="usd">166000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODM5MA_a1b0204b-fd59-4aa9-9a63-b5c1c407ef05"
      unitRef="usd">86200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <exas:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfODg2OA_7d8269af-713c-4f3b-b027-ea2abd17f800"
      unitRef="number">0.06216</exas:BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDY_bf71f285-8978-40a0-b490-c6b3d7fa44ef">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options assumed were based on the assumptions in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Option Plan Shares Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11% - 0.12%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.26 - 1.57&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.54% - 71.00%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value per share of options assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$109.74 - $124.89&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMS0yLTEtMS0xL3RleHRyZWdpb246MGM0N2VlODI4MzYzNGUyZTg0YzQ1OTk5ZDcyZTBlMmVfNA_c92391af-f618-44ae-8c01-e84c4182bd11"
      unitRef="number">0.0011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMS0yLTEtMS0xL3RleHRyZWdpb246MGM0N2VlODI4MzYzNGUyZTg0YzQ1OTk5ZDcyZTBlMmVfOQ_c2da5270-8354-4b16-973c-6f1d9643405e"
      unitRef="number">0.0012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1f2212887fcb4485932c6ca7b57bac3b_D20210105-20210105"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMi0yLTEtMS0xL3RleHRyZWdpb246YTE0MjJhZjY5ZDhjNDk3NGE0OGEyMDI1Nzc4ZmRlYWNfNA_d3865607-b3d3-4db7-8d7d-23f476f94233">P1Y3M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i37a4ec695a024e4e80da4d3494beed97_D20210105-20210105"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMi0yLTEtMS0xL3RleHRyZWdpb246YTE0MjJhZjY5ZDhjNDk3NGE0OGEyMDI1Nzc4ZmRlYWNfOQ_3b423f4a-5a31-457f-8edb-57ab113b5edd">P1Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMy0yLTEtMS0xL3RleHRyZWdpb246Nzc3MzM3YTIzM2NjNGMwYmIwOTNlZDYyZjQzOGEzOTRfNA_0d998a18-15d6-41af-a2a0-5750ca1930d3"
      unitRef="number">0.6554</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfMy0yLTEtMS0xL3RleHRyZWdpb246Nzc3MzM3YTIzM2NjNGMwYmIwOTNlZDYyZjQzOGEzOTRfOQ_931821b7-d3eb-4c6f-8e70-75b18f08c87f"
      unitRef="number">0.7100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ib3b489bbf63f4c70a052049910386070_D20210105-20210105"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfNC0yLTEtMS0xL3RleHRyZWdpb246YzMyNWM3NWVlYmM2NGRmNmIxYjRiNDVlYWQ4ZDZmYzVfNA_d2651266-bb15-46b6-a9e8-7d0df2f8fb1b"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1f2212887fcb4485932c6ca7b57bac3b_D20210105-20210105"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfNS0yLTEtMS0xL3RleHRyZWdpb246NjJmNDVmZjk2ZjIzNGE0MGIxN2M2NDM1NjY2MjM1YzZfNA_93c8b00d-53fe-4a71-8bdd-b3e28f1234a5"
      unitRef="usdPerShare">109.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i37a4ec695a024e4e80da4d3494beed97_D20210105-20210105"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjc2MWQxZDY2YjgyOTRmOWQ5Mjg1YzA3MzEzNWQwYWVlL3RhYmxlcmFuZ2U6NzYxZDFkNjZiODI5NGY5ZDkyODVjMDczMTM1ZDBhZWVfNS0yLTEtMS0xL3RleHRyZWdpb246NjJmNDVmZjk2ZjIzNGE0MGIxN2M2NDM1NjY2MjM1YzZfOQ_6f33bb3a-420d-4413-b558-e59fd495b4c4"
      unitRef="usdPerShare">124.89</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="i9248689114b34d9bb59ac32e2ea4d2fe_I20210105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfOTE2Ng_8a7cb1b3-cfcf-497a-b036-bdf378b4536c"
      unitRef="usd">12500000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i739d95546ece4d0bb7484bec638b1ce3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfOTIxOA_7ba103c0-1901-4dcb-904b-df8cb19d9703"
      unitRef="usd">30500000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMS0yLTEtMS0x_07d0ffde-fbc8-45b8-84ce-55b07256e4f4"
      unitRef="usd">241748000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMS00LTEtMS0x_7959c382-8dba-4856-86ff-996757b6503b"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMS02LTEtMS0x_a6d92526-9f22-46e8-959e-2ffea9f90108"
      unitRef="usd">241748000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMi0yLTEtMS0x_76f70eba-9c65-4987-9f8e-07252d255837"
      unitRef="usd">3939000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMi00LTEtMS0x_06765495-0cb2-42ce-85ba-756598e1d66b"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMi02LTEtMS0x_59e9802b-ad55-4609-aef3-d1062b5c903d"
      unitRef="usd">3939000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMy0yLTEtMS0x_ada94f8e-3636-4cfa-9aaf-10fe55d03584"
      unitRef="usd">29977000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMy00LTEtMS0x_fe163426-8f90-4b65-bc1c-0a2aae86a4ca"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMy02LTEtMS0x_8ed2d7eb-e4f3-482a-96a8-ebdc00876265"
      unitRef="usd">29977000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNC0yLTEtMS0x_19482561-3fe8-40ca-b3e2-52a158411342"
      unitRef="usd">39027000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNC00LTEtMS0x_e2696d47-7bc5-41b8-87c9-5d5b976f96c6"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNC02LTEtMS0x_e23ded04-905f-4488-8c97-12fbfb7cd429"
      unitRef="usd">39027000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNS0yLTEtMS0x_ff9229ee-b011-479e-8969-df08983b3020"
      unitRef="usd">67000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNS00LTEtMS0x_c460b1ed-16c5-4021-ae25-8e9bf3418942"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNS02LTEtMS0x_a987cce5-6664-4332-b573-ca69c5adc820"
      unitRef="usd">67000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNi0yLTEtMS0x_a8d8767b-bcdb-4017-8ac0-f7dbd09b3278"
      unitRef="usd">1250000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNi00LTEtMS0x_8b5b3364-c297-4afe-8d2e-46608a80cfdd"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNi02LTEtMS0x_d3f15e00-9511-47cc-9b00-0a5cba4f4a92"
      unitRef="usd">1250000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNy0yLTEtMS0x_97c6e276-5b74-417d-a09c-cb852676b887"
      unitRef="usd">1564758000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNy00LTEtMS0x_c32b868c-2f4c-4bfe-bdad-bf43f731a95c"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfNy02LTEtMS0x_dd86a968-ad9e-4085-8a6a-600966e6d02a"
      unitRef="usd">1564758000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfOS0yLTEtMS0x_24ba94a9-5701-4298-9e69-a9683161f38a"
      unitRef="usd">3222000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfOS00LTEtMS0x_e667ed3a-4d5c-4a8c-bba0-717e0429d1ad"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfOS02LTEtMS0x_3d3b3fcd-e344-4d69-bf6f-470059fa590f"
      unitRef="usd">3222000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTAtMi0xLTEtMQ_1f1f938c-49ab-4057-92c2-297ceb92a502"
      unitRef="usd">6218000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTAtNC0xLTEtMQ_a460069d-7a58-4d54-a602-53964d656afe"
      unitRef="usd">-1862000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTAtNi0xLTEtMQ_e663d6bc-5c92-4a7f-8886-22769d407be4"
      unitRef="usd">8080000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTEtMi0xLTEtMQ_bca4b715-c5c1-4f32-9ad0-ae3e6146357e"
      unitRef="usd">2980000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTEtNC0xLTEtMQ_8aca44d2-dc3e-4e39-9b9b-303c569c525c"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTEtNi0xLTEtMQ_d398d72c-8d0d-44f4-bbb8-58e5135929a1"
      unitRef="usd">2980000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTItMi0xLTEtMQ_b26d1c1e-3f7b-40c4-8fae-b71d08fb7010"
      unitRef="usd">38622000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTItNC0xLTEtMQ_a43f2eb7-65a8-403f-8d9d-f7ec226a6cf2"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTItNi0xLTEtMQ_ad2127e5-9367-4d9b-a5de-d1fb3da6db4e"
      unitRef="usd">38622000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTMtMi0xLTEtMQ_2a1bc57a-6d43-4103-96bd-ef7a70c62c01"
      unitRef="usd">272905000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTMtNC0xLTEtMQ_03764e62-4de7-44eb-9e5f-186ca7f46fa6"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTMtNi0xLTEtMQ_74e82d3a-a9d9-4162-9387-d9d76c852b73"
      unitRef="usd">272905000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTQtMi0xLTEtMQ_84dc0f28-7b8d-466c-9902-e99ff3252a2f"
      unitRef="usd">323947000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTQtNC0xLTEtMQ_2b1d3d4e-dab1-49d9-b226-d8b1891e88af"
      unitRef="usd">-1862000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTQtNi0xLTEtMQ_c7a4587b-21c5-4916-bda9-9ea10dd9172b"
      unitRef="usd">325809000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTUtMi0xLTEtMQ_69abdd11-992f-4080-a543-032f2d6ea4e0"
      unitRef="usd">1240811000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTUtNC0xLTEtMQ_8b3b7a78-efd7-4fb2-b549-1e4e5cc097b0"
      unitRef="usd">-1862000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTUtNi0xLTEtMQ_54e298f8-f811-4182-82aa-32047941186e"
      unitRef="usd">1238949000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTctMi0xLTEtMQ_d1a528ad-61a9-4ad3-91ff-46c7c804a472"
      unitRef="usd">946243000</us-gaap:Goodwill>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTctNC0xLTEtMQ_2c978936-7760-483d-916f-013b40eca0dc"
      unitRef="usd">1862000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:Goodwill
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTctNi0xLTEtMQ_27a7c140-5f6c-4f4b-bf64-73ca860e57af"
      unitRef="usd">948105000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTgtMi0xLTEtMQ_7eed6723-e889-4cd3-968f-843034201428"
      unitRef="usd">2187054000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired
      contextRef="i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTgtNC0xLTEtMQ_0cabcac0-c54b-4c7f-a815-b333c04f9516"
      unitRef="usd">0</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ia1bb5f00a7bb444381ab380f445719b4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjJmZGY3OWY4ZTdhYTRjNGNiZWUzOWYxMzQwYmE1ZGRlL3RhYmxlcmFuZ2U6MmZkZjc5ZjhlN2FhNGM0Y2JlZTM5ZjEzNDBiYTVkZGVfMTgtNi0xLTEtMQ_866de75b-45f4-40b0-a430-65537b270081"
      unitRef="usd">2187054000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i191fdcd9bb59431e8d618ad7da3fd8ef_I20210105"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTAzNjQ_3fcc2902-70ce-49eb-9db7-39d02837c034"
      unitRef="usd">1250000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i2de807b6ca3d4e4a86f20612c5808594_D20210106-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTE4OTE_ff4f9ba0-2cd7-407e-8ecf-57e53dc1a7c6"
      unitRef="usd">-219600000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTIwMTc_cf995977-f296-4589-9059-572471b45dec"
      unitRef="usd">-39600000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDA_d116c2a0-98a6-4cab-8928-82cde0226d18">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170,797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224,860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(536,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(575,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi0yLTEtMS0x_b971cb79-a79c-416f-b465-fba7d3612e3f"
      unitRef="usd">456379000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i4af871727fe246d883797ebcafb803cf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi00LTEtMS0x_1db480bc-a7cf-41d3-9ada-44284fbce9e1"
      unitRef="usd">408363000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi02LTEtMS0x_dd632d9d-0c76-47c0-92f9-78bb1a01efe3"
      unitRef="usd">1293275000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ie231f4fa3d2943ffbe7fe72b6feb6e16_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMi04LTEtMS0x_0479f575-8284-4da8-ab56-298d7b9d05c6"
      unitRef="usd">1025052000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <exas:BusinessAcquisitionProFormaIncomeLossBeforeTax
      contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy0yLTEtMS0x_f2414629-61b4-44a0-bfd4-9865ffef86ef"
      unitRef="usd">-170797000</exas:BusinessAcquisitionProFormaIncomeLossBeforeTax>
    <exas:BusinessAcquisitionProFormaIncomeLossBeforeTax
      contextRef="i4af871727fe246d883797ebcafb803cf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy00LTEtMS0x_91aafe16-0776-40b8-beaf-f7824ab71bca"
      unitRef="usd">-224860000</exas:BusinessAcquisitionProFormaIncomeLossBeforeTax>
    <exas:BusinessAcquisitionProFormaIncomeLossBeforeTax
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy02LTEtMS0x_5798abb5-0cce-4eb9-9ab3-735f5c15a229"
      unitRef="usd">-536253000</exas:BusinessAcquisitionProFormaIncomeLossBeforeTax>
    <exas:BusinessAcquisitionProFormaIncomeLossBeforeTax
      contextRef="ie231f4fa3d2943ffbe7fe72b6feb6e16_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOjgxYjlkZTgyMDU4YTQ2Yzc4NDk0NDkyNWEyYmYxNDVhL3RhYmxlcmFuZ2U6ODFiOWRlODIwNThhNDZjNzg0OTQ0OTI1YTJiZjE0NWFfMy04LTEtMS0x_81cbc6b3-d74e-4b46-b374-75e626acff7e"
      unitRef="usd">-575981000</exas:BusinessAcquisitionProFormaIncomeLossBeforeTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="ib93f49e05a5248078f875a6dfb3cd21c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTI0NzY_a1b0204b-fd59-4aa9-9a63-b5c1c407ef05"
      unitRef="usd">86200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
      contextRef="i2208e7b3dafd4734ad1c448f7ee2ebd2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTI1ODI_6a1fb986-5793-4ea5-9f55-06b077db2a1b"
      unitRef="usd">13500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i6b29593c68434f2699b1a75adf89a7cf_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTI3MDY_c205ddc8-dc15-4631-a794-586b57145a03"
      unitRef="usd">10300000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i739d95546ece4d0bb7484bec638b1ce3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTMwNDM_7ba103c0-1901-4dcb-904b-df8cb19d9703"
      unitRef="usd">30500000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i836f2fc064cf4745a2df3a6dffded766_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTMyNjM_d4962a14-5ca9-432e-8ed7-fb54d3d83980"
      unitRef="usd">7600000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i836f2fc064cf4745a2df3a6dffded766_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTM0ODI_b430891c-452b-4a71-b287-b83c08043b89"
      unitRef="usd">10500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTA5OTUxMTY0OTAwMg_2e2ce333-73bb-47b9-beb7-dec1251635d4"
      unitRef="usd">10300000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ0ODQ_d2a8a282-c0be-46a3-8135-a2e8263ce194"
      unitRef="usd">4500000</us-gaap:ShareBasedCompensation>
    <us-gaap:PostemploymentBenefitsPeriodExpense
      contextRef="i4887ef5292e44700918959f6042a59c3_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ1NTg_5773c971-6880-4c84-8367-d2d0dbcb59d4"
      unitRef="usd">1200000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ2MjM_288a95cc-80d5-479f-ab11-236317dfbae2"
      unitRef="usd">19000000</us-gaap:ShareBasedCompensation>
    <us-gaap:PostemploymentBenefitsPeriodExpense
      contextRef="ibe6c3e93785e4618bdf37cfa436b21ac_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTQ2OTc_951949d9-7a00-4bfb-b862-6537f0d90252"
      unitRef="usd">3900000</us-gaap:PostemploymentBenefitsPeriodExpense>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU1Nzk_bacaabba-2334-408f-ba6f-8d62554b8ab1"
      unitRef="usd">40400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU2MDE_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc"
      unitRef="usd">32200000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU2NTY_a59c853b-1073-4a2d-ae3f-547930927f3b"
      unitRef="usd">8200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU3MDg_f7bdccb9-63ad-40d1-8aba-7c1ce3c04acc"
      unitRef="usd">32200000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i949e45cbfa8f4affa83a6c86d26dc895_D20200303-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU3NjM_c8cea121-5732-449d-9a84-0931aaa0e99e"
      unitRef="usd">28800000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <exas:BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance
      contextRef="i68687c83ee8c49eb85c072bb07c29656_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTU4MDU_2ca81f87-1083-4186-b153-b470750c8dc5"
      unitRef="usd">3400000</exas:BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets
      contextRef="ie959531369c94b0683d868dc39af4087_I20200303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMS0yLTEtMS0x_5dd4e9d4-8024-4d3d-9e20-4c1645de34c5"
      unitRef="usd">6133000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets
      contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMS00LTEtMS0x_39bafc06-a4f3-405f-8d7c-aba134f7eccc"
      unitRef="usd">-760000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets
      contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMS02LTEtMS0x_516cf305-9c04-4244-9f60-086ad70c3f3a"
      unitRef="usd">5373000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="ie959531369c94b0683d868dc39af4087_I20200303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMi0yLTEtMS0x_9475e4bf-7ec9-4b21-b9d6-2bf00f809fdc"
      unitRef="usd">29695000</us-gaap:Goodwill>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
      contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMi00LTEtMS0x_d3fa2811-18f9-4e4b-853e-38f9163130f2"
      unitRef="usd">736000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:Goodwill
      contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMi02LTEtMS0x_bb9df23a-3173-4eb7-a7ad-dc018b583712"
      unitRef="usd">30431000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ie959531369c94b0683d868dc39af4087_I20200303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMy0yLTEtMS0x_961e84a2-48e4-447d-a265-0f93e53f4e45"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMy00LTEtMS0x_1ba9ea6a-91ba-42c8-8c12-28b95d4610c2"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfMy02LTEtMS0x_2d21f0b1-9ef6-4046-8477-ac79281b5c47"
      unitRef="usd">7800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ie959531369c94b0683d868dc39af4087_I20200303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNC0yLTEtMS0x_da29598a-79bc-41b2-817d-3d67dcbdf337"
      unitRef="usd">3123000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities
      contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNC00LTEtMS0x_af22d89a-a3f9-48e5-bfdc-f8c6e48af261"
      unitRef="usd">80000</exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNC02LTEtMS0x_2990c717-ca51-4617-b973-2d061b31f642"
      unitRef="usd">3203000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie959531369c94b0683d868dc39af4087_I20200303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNS0yLTEtMS0x_462bd314-6505-40ef-83dc-79bc24cd5674"
      unitRef="usd">40505000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod
      contextRef="i53102950ca084ca68b3b328343165ec8_D20200304-20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNS00LTEtMS0x_883bdbfd-ee61-4497-84bb-ba4613d391ec"
      unitRef="usd">104000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i660d9c31964046fd8f0829d2e58f4405_I20210303"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmE2MTZhZDczOTgxNTQxNzlhOWI4ZTU3YTgwMTYwNWMwL3RhYmxlcmFuZ2U6YTYxNmFkNzM5ODE1NDE3OWE5YjhlNTdhODAxNjA1YzBfNS02LTEtMS0x_6a5620f1-da7d-4182-9398-a897ad3f8a71"
      unitRef="usd">40401000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i236fa5e8e1614dad9327b02436f9e492_D20200303-20200303"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTY5OTc_afa068b9-8c7f-497a-a112-10f2a9ebd80a">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1
      contextRef="i5084f90d66dc4b7ebb62ead28ea222fe_D20200303-20200303"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc0NjE_7be4a1c5-a7b8-45ff-bec0-963b6477ad63"
      unitRef="usd">8400000</us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1>
    <exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod
      contextRef="ic1d6e6f60daa492698b9cf6ccd560512_D20200303-20200303"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc0ODk_be290d9b-1b83-4c99-8517-2779a24af94d">P4Y</exas:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i98ec76a50c654b3286dda25e4ae5e185_I20210503"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc4NTI_7f587832-3fdd-4973-9494-88373cc57b4f"
      unitRef="number">0.90</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i584d1f57791b47d7842344882f5499e3_I20210623"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc5OTE_90ccc202-5956-4b3f-9034-6daee240f685"
      unitRef="number">0.10</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTgwMzY_79247e02-a68d-4089-9319-bc563d741ff5"
      unitRef="usd">33600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage
      contextRef="i584d1f57791b47d7842344882f5499e3_I20210623"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTgwNDM_7fcb1a8b-98a1-4069-b055-d7d9e47bbee4"
      unitRef="number">1</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfMi0yLTEtMS0x_c1829602-7071-46a9-971d-f1db2d5b18d6"
      unitRef="usd">33569000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i584d1f57791b47d7842344882f5499e3_I20210623"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNC0yLTEtMS0x_267140cc-6b40-478a-8521-f2f013331797"
      unitRef="usd">496000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i584d1f57791b47d7842344882f5499e3_I20210623"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNS0yLTEtMS0x_dcd71f07-d384-40fe-ade1-825ecb6c07e7"
      unitRef="usd">33074000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities
      contextRef="i584d1f57791b47d7842344882f5499e3_I20210623"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNi0yLTEtMS0x_d1451a63-2ef5-4665-8360-a4e2d9e69c33"
      unitRef="usd">-1000</exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i584d1f57791b47d7842344882f5499e3_I20210623"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RhYmxlOmQ4MjRmMzIxZTFhZDQwNzFiN2Q2ZmU2MmI2ZDQ3OTZjL3RhYmxlcmFuZ2U6ZDgyNGYzMjFlMWFkNDA3MWI3ZDZmZTYyYjZkNDc5NmNfNy0yLTEtMS0x_c9484aec-e507-4046-ac4c-472ba57eb03c"
      unitRef="usd">33569000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxMDA_d71eaa5e-6b89-44d4-952a-2636ba0322e7"
      unitRef="usd">52300000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxMTY_0700de9f-4f68-4155-9705-1f1a4be84a5b"
      unitRef="usd">25000000</us-gaap:PaymentsToAcquireProductiveAssets>
    <exas:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
      contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxNDM_32658dfc-544a-4358-a36c-c980add3c68e"
      unitRef="shares">200000</exas:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares>
    <us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
      contextRef="ie1bd95264b204940990e1c4da28702ab_D20210111-20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAxNzk_83d69112-4740-43a7-9087-a5a46af2a59e"
      unitRef="usd">27300000</us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable>
    <exas:PaymentsContingentOnMilestonesPayable
      contextRef="i80ac638840f440a7904d59afcbea3cc5_I20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAzNjE_18254b5d-6947-441b-9bf3-1dfd17cb15c5"
      unitRef="usd">10000000</exas:PaymentsContingentOnMilestonesPayable>
    <exas:PaymentsContingentOnMilestonesPayable
      contextRef="ifabaf4b7e254465dbc76f19d64a783d8_I20210111"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjAzNjg_f5dd57b4-ee78-4c2f-9f40-5ebfe6d17d10"
      unitRef="usd">35000000</exas:PaymentsContingentOnMilestonesPayable>
    <exas:CollaborativeArrangementsSalesMilestoneAmount
      contextRef="i94f31a307e874ce8afdd82c892892230_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjA0NjQ_d79fc603-c761-47dc-be7b-3bd960efea12"
      unitRef="usd">100000000</exas:CollaborativeArrangementsSalesMilestoneAmount>
    <exas:CollaborativeArrangementsSalesMilestoneAmount
      contextRef="ice171bffc87a4afd95cc52b6534e2776_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjA0NzE_aac68e12-6d0b-4b2f-9e87-955370a801e8"
      unitRef="usd">250000000</exas:CollaborativeArrangementsSalesMilestoneAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RleHRyZWdpb246OTdlNzljZTRlZTY0NDhlODk3OWRkZGZiOWRkYjg1MzdfMTAxMA_1af68960-51d0-4c4e-8a60-d05fa2c1197d">SEGMENT INFORMATIONManagement determined that the Company functions as a single operating segment, and thus reports as a single reportable segment. This operating segment is focused on the development and global commercialization of clinical laboratory services allowing healthcare providers and patients to make individualized treatment decisions. Management assessed the discrete financial information routinely reviewed by the Company's Chief Operating Decision Maker, its President and Chief Executive Officer, to monitor the Company's operating performance and support decisions regarding allocation of resources to its operations. Performance is continuously monitored at the consolidated level to timely identify deviations from expected results. &lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total revenue from customers by geographic region. Product revenues are attributed to countries based on ship-to location.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-lived assets located in countries outside of the United States are not significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RleHRyZWdpb246OTdlNzljZTRlZTY0NDhlODk3OWRkZGZiOWRkYjg1MzdfMTAxMQ_65a7c41a-5b05-4e3d-a3ee-929821b56ebe">&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total revenue from customers by geographic region. Product revenues are attributed to countries based on ship-to location.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;392,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,213,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside of United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;408,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,293,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c8253dc31a74450a8053d46842c3eb1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi0yLTEtMS0x_b8369c6a-1430-4103-9440-ba7ea0aae8c3"
      unitRef="usd">429150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7f486f15d984c8ab5076786cc04e07f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi00LTEtMS0x_743a0f20-4aa5-493c-baed-da4849428d0c"
      unitRef="usd">392120000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11e90247f0d444a48ddf485761f1c6bc_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi02LTEtMS0x_0ff96660-b880-411b-b3d3-4f0b7f76304d"
      unitRef="usd">1213142000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c6bcdbe518418186b36093e716a0e5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMi04LTEtMS0x_bc20878a-ab38-4863-bfcb-0bbbc3364627"
      unitRef="usd">968825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6260119aed2d44219f06bcf7f78466ff_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy0yLTEtMS0x_7e6d63e7-e189-497a-b349-f9049ef6fc7f"
      unitRef="usd">27229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5a40758325f4f10ba85a4d7f63cc106_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy00LTEtMS0x_66b7327b-fa95-4c89-b01c-1b0667bf68c4"
      unitRef="usd">16243000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia01c094882504b1680c962a4508c16f1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy02LTEtMS0x_9729bd36-7456-440b-aa84-561288f0f30c"
      unitRef="usd">80133000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0745308ee7374949b866802826027f90_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfMy04LTEtMS0x_b2e9ee4e-49b0-40f8-b801-1b808e8ce291"
      unitRef="usd">56227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC0yLTEtMS0x_cbbb52cc-0b14-48bf-8090-0b4d9849decc"
      unitRef="usd">456379000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC00LTEtMS0x_07f3d762-5259-48e4-9e65-94c825ea7274"
      unitRef="usd">408363000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC02LTEtMS0x_27408603-de79-455a-a095-dc68ab993a34"
      unitRef="usd">1293275000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84NS9mcmFnOjk3ZTc5Y2U0ZWU2NDQ4ZTg5NzlkZGRmYjlkZGI4NTM3L3RhYmxlOmVlNDc3ZmI1M2MxZDQ5NGFhMjlkMGExNjZhNTQzNTYwL3RhYmxlcmFuZ2U6ZWU0NzdmYjUzYzFkNDk0YWEyOWQwYTE2NmE1NDM1NjBfNC04LTEtMS0x_f22d0001-08b6-4a7e-961d-087affd5f107"
      unitRef="usd">1025052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMjAzNg_409ae580-3957-44fe-b1c4-c8e0cf9d655e">INCOME TAXES&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded an income tax benefit of $3.9 million and $2.8 million for the three months ended September 30, 2021 and 2020, respectively. The Company recorded an income tax benefit of $242.6 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. The Company&#x2019;s income tax expense recorded during the three months ended September 30, 2021 is primarily related to foreign tax expense, as well as the future limitations on and expiration of certain Federal and State deferred tax assets. The Company&#x2019;s income tax benefit recorded during the nine months ended September 30, 2021 is primarily related to an income tax benefit of $239.2 million recorded as a result of the change in the deferred tax asset valuation allowance resulting from the Thrive Merger. A deferred tax liability of approximately $32.7 million was recorded as of September&#160;30, 2021, which is included in other long-term liabilities on the Company&#x2019;s condensed consolidated balance sheet. The Company continues to maintain a full valuation allowance against its deferred tax assets based on management&#x2019;s determination that it is more likely than not the benefit will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had $17.7 million and $16.6 million of unrecognized tax benefits at September&#160;30, 2021 and December&#160;31, 2020, respectively. These amounts have been recorded as a reduction to the Company&#x2019;s deferred tax asset, if recognized they would not have an impact on the effective tax rate due to the existing valuation allowance. Certain of the Company's unrecognized tax benefits could change due to activities of various tax authorities, including possible settlement of audits, or through normal expiration of various statutes of limitations. The Company does not expect a material change in unrecognized tax benefits in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2021, due to the carryforward of unutilized net operating losses and research and development credits, the Company is subject to U.S. federal income tax examinations for the tax years 2001 through 2021, and to state income tax examinations for the tax years 2001 through 2021. No interest or penalties related to income taxes have been accrued or recognized as of September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5b879da246b14941a83322faaeed6793_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfNjk_f5fd7481-aca6-4543-ad4b-0ca6be8961c9"
      unitRef="usd">-3900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic9602c7129e04c0aad9873f767092c0f_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfODk_ddf095a9-9d37-4c48-bc02-6cbd5a664759"
      unitRef="usd">-2800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTcx_b2216c4b-22e3-43f8-86ab-065b342fc52b"
      unitRef="usd">-242600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0833fe01c7da40d7bef3192ab6a3518d_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTkx_50b69731-284c-481b-bf6e-cbc82fc003ed"
      unitRef="usd">-5300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfNTgy_534cb324-9872-4ddf-9457-6bbeba35774c"
      unitRef="usd">-239200000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfNzQy_e5e0b595-9839-4938-b536-064e1da29b47"
      unitRef="usd">32700000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="icaadbb616eae41fa90b155f9198a61f3_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTA4Mw_58cc5179-15f0-4b18-97af-0b0d19aaa887"
      unitRef="usd">17700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i551c655f93e84ff688983bbc818b9b24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84OC9mcmFnOjNjNzNkMzc2YWRmODQyMzFhZjE4MTRmMTUzMmFiNzQwL3RleHRyZWdpb246M2M3M2QzNzZhZGY4NDIzMWFmMTgxNGYxNTMyYWI3NDBfMTA5MA_738c9a32-63e9-482d-8375-c55a62be1442"
      unitRef="usd">16600000</us-gaap:UnrecognizedTaxBenefits>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139811019971096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXACT SCIENCES CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">02-0478229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5505 Endeavor Lane<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Madison<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">53719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">535-8815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EXAS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172,318,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001124140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905780248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 273,779<span></span>
</td>
<td class="nump">$ 1,491,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">944,688<span></span>
</td>
<td class="nump">348,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">249,572<span></span>
</td>
<td class="nump">233,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">95,167<span></span>
</td>
<td class="nump">92,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">52,385<span></span>
</td>
<td class="nump">33,157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,615,591<span></span>
</td>
<td class="nump">2,198,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">524,200<span></span>
</td>
<td class="nump">451,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">167,911<span></span>
</td>
<td class="nump">125,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,242,535<span></span>
</td>
<td class="nump">1,237,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,044,958<span></span>
</td>
<td class="nump">847,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets, net</a></td>
<td class="nump">59,241<span></span>
</td>
<td class="nump">63,770<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,654,436<span></span>
</td>
<td class="nump">4,925,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">41,717<span></span>
</td>
<td class="nump">35,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">304,714<span></span>
</td>
<td class="nump">233,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">19,220<span></span>
</td>
<td class="nump">11,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Debt, current portion</a></td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible notes, net, current portion</a></td>
<td class="nump">313,104<span></span>
</td>
<td class="nump">312,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">30,157<span></span>
</td>
<td class="nump">38,265<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">710,231<span></span>
</td>
<td class="nump">633,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes, net, less current portion</a></td>
<td class="nump">1,865,647<span></span>
</td>
<td class="nump">1,861,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Long-term debt, less current portion</a></td>
<td class="nump">21,438<span></span>
</td>
<td class="nump">22,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">436,580<span></span>
</td>
<td class="nump">51,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, less current portion</a></td>
<td class="nump">162,950<span></span>
</td>
<td class="nump">121,075<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,196,846<span></span>
</td>
<td class="nump">2,689,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value Authorized&#8212;5,000,000 shares issued and outstanding&#8212;no shares at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value Authorized&#8212;400,000,000 shares issued and outstanding&#8212;172,242,798 and 159,423,410 shares at September&#160;30, 2021 and December&#160;31, 2020</a></td>
<td class="nump">1,723<span></span>
</td>
<td class="nump">1,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,876,644<span></span>
</td>
<td class="nump">4,279,327<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(2,420,910)<span></span>
</td>
<td class="num">(2,045,896)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">3,457,590<span></span>
</td>
<td class="nump">2,235,552<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,654,436<span></span>
</td>
<td class="nump">$ 4,925,092<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810996960088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">172,242,798<span></span>
</td>
<td class="nump">159,423,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">172,242,798<span></span>
</td>
<td class="nump">159,423,410<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905883128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 456,379<span></span>
</td>
<td class="nump">$ 408,363<span></span>
</td>
<td class="nump">$ 1,293,275<span></span>
</td>
<td class="nump">$ 1,025,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales (exclusive of amortization of acquired intangible assets)</a></td>
<td class="nump">115,738<span></span>
</td>
<td class="nump">95,061<span></span>
</td>
<td class="nump">339,699<span></span>
</td>
<td class="nump">254,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">75,356<span></span>
</td>
<td class="nump">31,471<span></span>
</td>
<td class="nump">297,158<span></span>
</td>
<td class="nump">107,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">196,617<span></span>
</td>
<td class="nump">136,481<span></span>
</td>
<td class="nump">577,585<span></span>
</td>
<td class="nump">423,092<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">186,541<span></span>
</td>
<td class="nump">115,589<span></span>
</td>
<td class="nump">621,897<span></span>
</td>
<td class="nump">336,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">23,940<span></span>
</td>
<td class="nump">23,430<span></span>
</td>
<td class="nump">70,954<span></span>
</td>
<td class="nump">70,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charge</a></td>
<td class="nump">20,210<span></span>
</td>
<td class="nump">209,666<span></span>
</td>
<td class="nump">20,210<span></span>
</td>
<td class="nump">209,666<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">618,402<span></span>
</td>
<td class="nump">611,698<span></span>
</td>
<td class="nump">1,927,503<span></span>
</td>
<td class="nump">1,401,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncome', window );">Other operating income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">23,665<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(162,023)<span></span>
</td>
<td class="num">(203,335)<span></span>
</td>
<td class="num">(634,228)<span></span>
</td>
<td class="num">(352,717)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_InvestmentIncomeExpenseNonoperating', window );">Investment income (expense), net</a></td>
<td class="num">(4,093)<span></span>
</td>
<td class="nump">2,523<span></span>
</td>
<td class="nump">30,524<span></span>
</td>
<td class="nump">5,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense</a></td>
<td class="num">(4,680)<span></span>
</td>
<td class="num">(4,478)<span></span>
</td>
<td class="num">(13,948)<span></span>
</td>
<td class="num">(63,382)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(8,773)<span></span>
</td>
<td class="num">(1,955)<span></span>
</td>
<td class="nump">16,576<span></span>
</td>
<td class="num">(57,850)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before tax</a></td>
<td class="num">(170,796)<span></span>
</td>
<td class="num">(205,290)<span></span>
</td>
<td class="num">(617,652)<span></span>
</td>
<td class="num">(410,567)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">3,858<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
<td class="nump">242,638<span></span>
</td>
<td class="nump">5,294<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (166,938)<span></span>
</td>
<td class="num">$ (202,538)<span></span>
</td>
<td class="num">$ (375,014)<span></span>
</td>
<td class="num">$ (405,273)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in usd per share)</a></td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="num">$ (1.35)<span></span>
</td>
<td class="num">$ (2.19)<span></span>
</td>
<td class="num">$ (2.71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in usd per share)</a></td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="num">$ (1.35)<span></span>
</td>
<td class="num">$ (2.19)<span></span>
</td>
<td class="num">$ (2.71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">171,978<span></span>
</td>
<td class="nump">150,155<span></span>
</td>
<td class="nump">170,978<span></span>
</td>
<td class="nump">149,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">171,978<span></span>
</td>
<td class="nump">150,155<span></span>
</td>
<td class="nump">170,978<span></span>
</td>
<td class="nump">149,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_InvestmentIncomeExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income (Expense), Nonoperating</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_InvestmentIncomeExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908535640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (166,938)<span></span>
</td>
<td class="num">$ (202,538)<span></span>
</td>
<td class="num">$ (375,014)<span></span>
</td>
<td class="num">$ (405,273)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss), before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized gain (loss) on available-for-sale investments</a></td>
<td class="nump">66<span></span>
</td>
<td class="num">(405)<span></span>
</td>
<td class="num">(563)<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ComprehensiveIncomeLossBeforeTax', window );">Comprehensive loss, before tax</a></td>
<td class="num">(166,872)<span></span>
</td>
<td class="num">(202,943)<span></span>
</td>
<td class="num">(375,577)<span></span>
</td>
<td class="num">(404,089)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Income tax expense related to items of other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss, net of tax</a></td>
<td class="num">$ (166,872)<span></span>
</td>
<td class="num">$ (202,943)<span></span>
</td>
<td class="num">$ (375,407)<span></span>
</td>
<td class="num">$ (404,089)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, of comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906688680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit&#8203;</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,625,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,957,639<span></span>
</td>
<td class="nump">$ 1,477<span></span>
</td>
<td class="nump">$ 3,178,552<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (1,222,290)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">4,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock to fund the Company's 401(k) match (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock to fund the Company's 401(k) match</a></td>
<td class="nump">12,007<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">12,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards</a></td>
<td class="nump">29,560<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">29,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="nump">28,597<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">28,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(134,643)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134,643)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(1,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">1,895,843<span></span>
</td>
<td class="nump">$ 1,495<span></span>
</td>
<td class="nump">3,252,998<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="num">(1,356,933)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,446,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,625,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,957,639<span></span>
</td>
<td class="nump">$ 1,477<span></span>
</td>
<td class="nump">3,178,552<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(1,222,290)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="nump">382,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="nump">$ 28,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(405,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">1,730,686<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="nump">3,355,660<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="num">(1,627,563)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,373,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,446,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">1,895,843<span></span>
</td>
<td class="nump">$ 1,495<span></span>
</td>
<td class="nump">3,252,998<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
<td class="num">(1,356,933)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">6,638<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards</a></td>
<td class="nump">40,039<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">40,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of employee stock purchase plan shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of employee stock purchase plan shares</a></td>
<td class="nump">9,799<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">9,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(68,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,092)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">1,887,433<span></span>
</td>
<td class="nump">$ 1,501<span></span>
</td>
<td class="nump">3,309,468<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
<td class="num">(1,425,025)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,980,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">4,470<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">4,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards</a></td>
<td class="nump">41,476<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">41,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(202,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202,538)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(405)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2020</a></td>
<td class="nump">$ 1,730,686<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="nump">3,355,660<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
<td class="num">(1,627,563)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,373,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">159,423,410<span></span>
</td>
<td class="nump">159,423,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 2,235,552<span></span>
</td>
<td class="nump">$ 1,595<span></span>
</td>
<td class="nump">4,279,327<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="num">(2,045,896)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, net of tax (in shares)</a></td>
<td class="nump">344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible notes, net of tax</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">967,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">8,759<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">8,749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock to fund the Company's 401(k) match (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Issuance of common stock to fund the Company's 401(k) match</a></td>
<td class="nump">22,934<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">22,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,355,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards</a></td>
<td class="nump">158,252<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">158,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,384,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="nump">1,254,798<span></span>
</td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">1,254,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(31,164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 3,648,995<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="nump">5,723,977<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="num">(2,077,060)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,293,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">159,423,410<span></span>
</td>
<td class="nump">159,423,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 2,235,552<span></span>
</td>
<td class="nump">$ 1,595<span></span>
</td>
<td class="nump">4,279,327<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="num">(2,045,896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="nump">9,510,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="nump">$ 1,270,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(375,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 3,457,590<span></span>
</td>
<td class="nump">$ 1,723<span></span>
</td>
<td class="nump">5,876,644<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="num">(2,420,910)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">172,242,798<span></span>
</td>
<td class="nump">172,242,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,293,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 3,648,995<span></span>
</td>
<td class="nump">$ 1,714<span></span>
</td>
<td class="nump">5,723,977<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="num">(2,077,060)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, net of tax (in shares)</a></td>
<td class="nump">197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible notes, net of tax</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">2,858<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards</a></td>
<td class="nump">56,285<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">56,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="nump">16,120<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">16,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of employee stock purchase plan shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173,717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of employee stock purchase plan shares</a></td>
<td class="nump">12,038<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">12,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(176,912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(176,912)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 3,559,101<span></span>
</td>
<td class="nump">$ 1,720<span></span>
</td>
<td class="nump">5,811,286<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="num">(2,253,972)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,855,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, net of tax (in shares)</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible notes, net of tax</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of common stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of common stock options</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">286,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Compensation expense related to issuance of stock options and restricted stock awards</a></td>
<td class="nump">63,603<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">63,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(166,938)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166,938)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 3,457,590<span></span>
</td>
<td class="nump">$ 1,723<span></span>
</td>
<td class="nump">$ 5,876,644<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
<td class="num">$ (2,420,910)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (in shares) at Sep. 30, 2021</a></td>
<td class="nump">172,242,798<span></span>
</td>
<td class="nump">172,242,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904374264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906253208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (375,014)<span></span>
</td>
<td class="num">$ (405,273)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">64,267<span></span>
</td>
<td class="nump">53,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property, plant and equipment</a></td>
<td class="nump">928<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized (gain) loss on equity investments</a></td>
<td class="nump">1,937<span></span>
</td>
<td class="num">(1,183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="num">(248,716)<span></span>
</td>
<td class="num">(6,161)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">197,180<span></span>
</td>
<td class="nump">111,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity', window );">Post-combination expense for acceleration of unvested equity</a></td>
<td class="nump">80,960<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Realized gain on preferred stock investment</a></td>
<td class="num">(30,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities', window );">Amortization of deferred financing costs, convertible note debt discount and issuance costs, and other liabilities</a></td>
<td class="nump">4,948<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments', window );">Amortization of premium on short-term investments</a></td>
<td class="nump">3,265<span></span>
</td>
<td class="nump">1,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">70,954<span></span>
</td>
<td class="nump">70,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Intangible asset impairment charge</a></td>
<td class="nump">20,210<span></span>
</td>
<td class="nump">209,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">Asset acquisition IPR&amp;D expense</a></td>
<td class="nump">85,337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue', window );">Remeasurement of contingent consideration</a></td>
<td class="nump">10,986<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">18,347<span></span>
</td>
<td class="nump">11,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(14,038)<span></span>
</td>
<td class="num">(73,642)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="num">(1,091)<span></span>
</td>
<td class="num">(18,472)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(11,834)<span></span>
</td>
<td class="num">(6,135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">64,344<span></span>
</td>
<td class="num">(7,608)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(20,134)<span></span>
</td>
<td class="nump">35,097<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(77,664)<span></span>
</td>
<td class="nump">25,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(1,021,557)<span></span>
</td>
<td class="num">(890,012)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Maturities and sales of marketable securities</a></td>
<td class="nump">424,830<span></span>
</td>
<td class="nump">559,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(76,374)<span></span>
</td>
<td class="num">(48,371)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business combination, net of cash acquired</a></td>
<td class="num">(415,549)<span></span>
</td>
<td class="num">(6,658)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Asset acquisition</a></td>
<td class="num">(58,073)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Investments in privately held companies</a></td>
<td class="num">(13,555)<span></span>
</td>
<td class="num">(10,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(244)<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,160,522)<span></span>
</td>
<td class="num">(395,399)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,125,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of common stock options</a></td>
<td class="nump">13,372<span></span>
</td>
<td class="nump">15,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds in connection with the Company&#8217;s employee stock purchase plan</a></td>
<td class="nump">12,038<span></span>
</td>
<td class="nump">9,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payments on settlement of convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(150,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(4,742)<span></span>
</td>
<td class="num">(938)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">20,668<span></span>
</td>
<td class="nump">999,762<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="num">(1,217,518)<span></span>
</td>
<td class="nump">629,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">1,491,594<span></span>
</td>
<td class="nump">177,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">274,076<span></span>
</td>
<td class="nump">806,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Property, plant and equipment acquired but not paid</a></td>
<td class="nump">21,110<span></span>
</td>
<td class="nump">7,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Unrealized gain (loss) on available-for-sale investments, before tax</a></td>
<td class="num">(563)<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_IssuanceOfStockToFundMatchingContributions', window );">Issuance of 162,606 and 136,559 shares of common stock to fund the Company&#8217;s 401(k) matching contribution for 2020 and 2019, respectively</a></td>
<td class="nump">22,934<span></span>
</td>
<td class="nump">12,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of 9,510,436 and 382,947 shares of common stock for business combinations and asset acquisition for 2021 and 2020, respectively</a></td>
<td class="nump">1,270,918<span></span>
</td>
<td class="nump">28,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition', window );">Business combination contingent consideration liability</a></td>
<td class="nump">350,348<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">$ 10,685<span></span>
</td>
<td class="nump">$ 9,239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization (Deferred Amortization) of Deferred Financing Costs, Debt Discounts (Premiums) and Issuance Costs, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Increase Due to Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss), Change in Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying amount of amortization of purchase premium on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_IssuanceOfStockToFundMatchingContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock to fund the entity's 401(k) matching contribution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_IssuanceOfStockToFundMatchingContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_PostCombinationExpenseForAccelerationOfUnvestedEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Post-Combination Expense for Acceleration of Unvested Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_PostCombinationExpenseForAccelerationOfUnvestedEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810997800408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued', window );">Issuance of shares of common stock to fund the Company's 401(k) matching contribution (in shares)</a></td>
<td class="nump">162,606<span></span>
</td>
<td class="nump">136,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="nump">9,510,436<span></span>
</td>
<td class="nump">382,947<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued pursuant to the terms of a deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904271768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exact Sciences Corporation (together with its subsidiaries, &#8220;Exact,&#8221; or the &#8220;Company&#8221;) was incorporated in February 1995. Exact is a leading global cancer diagnostics company. It has developed some of the most impactful brands in cancer screening and diagnostics, including Cologuard&#174; and Oncotype DX&#174;. Exact is currently working on the development of additional tests, with the goal of bringing new, innovative cancer tests to patients throughout the world.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements, which include the accounts of Exact Sciences Corporation and those of its wholly owned subsidiaries and variable interest entities, are unaudited and have been prepared on a basis substantially consistent with the Company&#8217;s audited financial statements and notes as of and for the year ended December&#160;31, 2020 included in the Company&#8217;s Annual Report on Form 10-K (the &#8220;2020 Form 10-K&#8221;). All intercompany transactions and balances have been eliminated upon consolidation. These condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and follow the requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of adjustments of a normal and recurring nature) considered necessary for a fair statement of its financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet at December&#160;31, 2020 has been derived from audited financial statements, but does not contain all of the footnote disclosures from the 2020 Form 10-K. The results of the Company&#8217;s operations for any interim period are not necessarily indicative of the results of the Company&#8217;s operations for any other interim period or for a full fiscal year. The statements should be read in conjunction with the audited financial statements and related notes included in the 2020 Form 10-K. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company&#8217;s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company&#8217;s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2020 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of the coronavirus (&#8220;COVID-19&#8221;) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic impacted the Company's revenues and operating results for the three and nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of COVID-19 depends on factors beyond the Company&#8217;s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, there were no changes to the Company&#8217;s significant accounting policies as described in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2020, except as described in the Recently Adopted Accounting Pronouncements section below. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, The Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update simplifies the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the update, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. This standard may be adopted through either a modified retrospective method of transition or a full retrospective method of transition. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the standard on January 1, 2021 through application of the full retrospective method of transition. This method of adoption was applied to enhance comparability between the periods presented in the Company&#8217;s financial statements. The Company applied the standard to convertible notes outstanding as of the date of the first offering of the Company&#8217;s outstanding convertible notes as discussed in Note 9. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s convertible debt instruments will be accounted for as a single liability measured at its amortized cost. The notes are no longer bifurcated between debt and equity, rather accounted for entirely as debt at face value net of any discount or premium and issuance costs. Interest expense is comprised of (1) cash interest payments, (2) amortization of any debt discounts or premiums based on the original offering, and (3) amortization of any debt issuance costs. Gain or loss on extinguishment of convertible notes is calculated as the difference between the (i) fair value of the consideration transferred and (ii) the sum of the carrying value of the debt at the time of repurchase. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2019, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $260.2&#160;million, a decrease in accumulated deficit of $26.6&#160;million, and an increase to net deferred tax assets of $55.7&#160;million offset by a corresponding increase of $55.7&#160;million in the valuation allowance. As of January 1, 2020, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $227.8&#160;million, an increase in accumulated deficit of $102.6&#160;million, and an increase to the net deferred tax assets of $83.2&#160;million offset by a corresponding increase of $74.7&#160;million in the valuation allowance resulting in a net decrease of $8.5&#160;million in recorded deferred tax liabilities. As of December 31, 2020, the cumulative effect of adoption resulted in an increase in the net carrying amount of convertible notes, net, current portion of $57.3&#160;million and convertible notes, net, less current portion of $540.9&#160;million, a decrease in additional-paid-in-capital of $510.3&#160;million, an increase in accumulated deficit of $77.7&#160;million, and an increase to net deferred tax assets of $146.0&#160;million offset by a corresponding increase of $135.8&#160;million in the valuation allowance resulting in a net decrease of $10.2&#160;million in recorded deferred tax liabilities. For the three months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $19.1&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs, income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, decreased by $0.12 per share. For the nine months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $8.3&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs of $51.2&#160;million, which was offset by an increase in loss on extinguishment of $42.9&#160;million in connection with the extinguishment of $100.0&#160;million face value of 2025 Notes. Income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, increased by $0.04 per share.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share is the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive as a result of the Company&#8217;s losses.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses for each period:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable in connection with acquisitions (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the release of restricted stock awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the release of performance share units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon conversion of convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div>(1)During the third quarter of 2021, shares were issued related to holdback amounts on the previously closed acquisition of Viomics, Inc. (&#8220;Viomics&#8221;). The remaining issuable shares relate to the previously closed acquisition of Paradigm Diagnostics, Inc. (&#8220;Paradigm&#8221;).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902926360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE</a></td>
<td class="text">REVENUE The Company&#8217;s revenue is primarily generated by its laboratory testing services utilizing its Cologuard, Oncotype DX, and COVID-19 tests. The services are completed upon release of a patient&#8217;s test result to the ordering healthcare provider.  <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s revenues disaggregated by revenue source:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:18pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Screening</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Parts B &amp; C</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">419,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">280,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Screening</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">280,378&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">214,623&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">784,643&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">565,407&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precision Oncology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Parts B &amp; C</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Precision Oncology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145,412&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,579&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">412,628&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">322,905&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 Testing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,589&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,161&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,004&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,740&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Screening revenue primarily includes laboratory service revenue from the Cologuard test while Precision Oncology revenue primarily includes laboratory service revenue from global Oncotype DX products. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The downward adjustment to revenue from changes in transaction price was $0.2 million for the three months ended September 30, 2021 and revenue recognized from changes in transaction price was $0.5 million for the three months ended September 30, 2020. The downward adjustment to revenue from changes in transaction price was $13.2 million for the nine months ended September 30, 2021 and revenue recognized from changes in transaction price was $9.1 million for the nine months ended September 30, 2020. At each reporting period end, the Company conducts an analysis of the estimates used to calculate the transaction price to determine whether any new information available impacts those estimates made in prior reporting periods. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue balances are reported in other current liabilities in the Company&#8217;s condensed consolidated balance sheets and were $18.7&#160;million and $25.0&#160;million as of September&#160;30, 2021 and December&#160;31, 2020, respectively. As of September&#160;30, 2021, $17.8&#160;million of the Company&#8217;s deferred revenue balance is a result of the billing terms pursuant to the existing COVID-19 laboratory service agreements (&#8220;LSAs&#8221;) with customers. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized for the three months ended September 30, 2021 and 2020, which was included in the deferred revenue balance at the beginning of each period, was $0.2&#160;million and $5,000, respectively. Of the $0.2&#160;million of revenue recognized for the three months ended September 30, 2021, which was included in the deferred revenue balance at the beginning of the period, $0.1&#160;million related to COVID-19 testing. Revenue recognized for the nine months ended September 30, 2021 and 2020, which was included in the deferred revenue balance at the beginning of each period, was $24.6&#160;million and $0.2&#160;million, respectively. Of the $24.6&#160;million of revenue recognized for the nine months ended September 30, 2021, which was included in the deferred revenue balance at the beginning of the period, $24.3&#160;million related to COVID-19 testing.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902847400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">MARKETABLE SECURITIES</a></td>
<td class="text">MARKETABLE SECURITIES<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">274,076&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,491,594&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,688&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,699&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents, restricted cash and marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Gains and losses in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) are reported before tax impact.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,986&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,490&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,178&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Gains and losses in AOCI are reported before tax impact.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contractual underlying maturities of the Company&#8217;s available-for-sale debt securities at September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Due one year or less</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Due after one year through five&#160;years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,534&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:18pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less than one year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">One year or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates investments that are in an unrealized loss position for impairment as a result of credit loss. It was determined that no credit losses exist as of September&#160;30, 2021 and December&#160;31, 2020, because the change in market value for those securities in an unrealized loss position has resulted from fluctuating interest rates rather than a deterioration of the credit worthiness of the issuers. The realized gain recorded on available-for-sale debt securities was not material to the condensed consolidated statements of income for the three and nine months ended September&#160;30, 2021 and 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a loss of $4.5&#160;million and $1.9&#160;million from its equity securities for the three and nine months ended September&#160;30, 2021 as compared to a gain of $33,000 and a loss of $0.3&#160;million for the three and nine months ended September&#160;30, 2020.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses recorded are included in investment income (expense), net in the Company&#8217;s condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904731912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,971&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,083&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished and finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810901812184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated useful lives of property, plant and equipment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 - 40 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and computer software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719,487&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,524&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,986&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Lesser of remaining lease term, building life, or estimated useful life.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the three months ended September 30, 2021 and 2020 was $22.3 million and $19.7&#160;million, respectively. Depreciation expense for the nine months ended September 30, 2021 and 2020 was $64.3 million and $53.3&#160;million, respectively.</span></div>At September&#160;30, 2021, the Company had $64.2 million of assets under construction which consisted of $11.8 million in laboratory equipment, $40.6 million related to building and leasehold improvements, $11.6 million in capitalized costs related to software projects, and $0.2 million related to land improvements. Depreciation will begin on these assets once they are placed into service upon completion between 2021 and 2023.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904068440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS AND GOODWILL</a></td>
<td class="text">INTANGIBLE ASSETS AND GOODWILL<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net-book-value and estimated remaining life of the Company&#8217;s intangible assets as of September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,427)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969,308&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174,350)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174,350)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net-book-value and estimated remaining life of the Company&#8217;s intangible assets as of December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Remaining Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,422)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">814,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(93,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">720,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110,889)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the estimated future amortization expense associated with the Company&#8217;s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,053&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquired intangible assets are being amortized on a straight-line basis over the estimated useful life. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021 and in connection with the preparation of the financial statements, the Company recorded a non-cash, pre-tax impairment loss of $20.2 million related to the supply agreement intangible asset that was initially recorded as part of the combination with Genomic Health due to lower than anticipated performance of the underlying product. The Company utilized the income approach to measure the fair value of the supply agreement, which involves significant unobservable inputs (Level 3 inputs). The impairment is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company began discussions with Biocartis regarding the termination of its agreements with Biocartis related to the development of an in vitro diagnostic (&#8220;IVD&#8221;) version of the Oncotype DX Breast Recurrence Score&#174; test. As a result, and in connection with the preparation of the financial statements included in the Company&#8217;s Form 10-Q for the period ended September&#160;30, 2020, the Company recorded a non-cash, pre-tax impairment loss of $200.0 million related to the in-process research and development intangible asset that was initially recorded as part of the combination with Genomic Health. The impairment is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company abandoned certain research and development assets acquired through an asset purchase agreement with Armune Biosciences, Inc. in 2017. These assets were expected to complement the Company&#8217;s product pipeline and were expected to have alternative future uses at the time of acquisition; however, due to changes in strategic priorities and efforts during the third quarter of 2020, these assets are no longer expected to be utilized to advance the Company&#8217;s product pipeline. As a result, and in connection with the preparation of the financial statements included in the Company&#8217;s Form 10-Q for the period ended September&#160;30, 2020, the Company wrote-off the gross cost basis of the intangible asset of $12.2 million and accumulated amortization of $2.5 million as of September&#160;30, 2020. This write-off resulted in a non-cash, pre-tax impairment loss of $9.7 million, which is recorded in intangible asset impairment charge in the condensed consolidated statement of operations for the three and nine months ended September&#160;30, 2020.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the periods ended September&#160;30, 2021 and December&#160;31, 2020 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,197&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paradigm &amp; Viomics acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,431&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genomic Health acquisition adjustment (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237,672&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thrive acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,105&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ashion Acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company recognized a measurement period adjustment to goodwill related to an increase in Genomic Health&#8217;s pre-acquisition deferred tax liability due to finalization of certain income-tax related items.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no impairment losses for the three and nine months ended September&#160;30, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904862328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The three levels of the fair value hierarchy established are as follows:</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</span></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Unobservable inputs that reflect the Company&#8217;s assumptions about the assumptions that market participants would use in pricing the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value measurements as of September&#160;30, 2021 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active Markets<br/>for Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857,657&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,076&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,688&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361,107)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The equity securities held are classified as Level 2 as they are subject to a short-term lock-up restriction and have been discounted from the observable market prices of the similar unrestricted equity securities. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value measurements as of December&#160;31, 2020 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active Markets<br/>for Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,477)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,477)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,172&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,477)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in valuation techniques or transfers between fair value measurement levels during the periods ended September&#160;30, 2021 and December&#160;31, 2020. The fair value of Level 2 instruments classified as cash equivalents and marketable debt securities are valued using a third-party pricing agency where the valuation is based on observable inputs including pricing for similar assets and other observable market factors. The Company&#8217;s marketable equity security investment in Biocartis held as of December&#160;31, 2020 was classified as a Level 1 instrument prior to being sold in the first quarter of 2021.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s business combinations involve potential payment of future consideration that is contingent upon the achievement of certain regulatory and product revenue milestones being achieved. A liability is recorded for the estimated fair value of the contingent consideration on the acquisition date. The fair value of the contingent consideration is remeasured at each reporting period, and the change in fair value is recognized within general and administrative expenses on the Company&#8217;s condensed consolidated statements of operations. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of contingent consideration as of September&#160;30, 2021 and December&#160;31, 2020 was $363.6&#160;million and $2.5&#160;million, respectively, which was recorded in other long-term liabilities in the condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance, September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The increase in the contingent consideration liability is due to the contingent consideration associated with the acquisitions of Ashion Analytics, LLC (&#8220;Ashion&#8221;) and Thrive Earlier Detection Corporation (&#8220;Thrive&#8221;). Refer to Note 17 for further information. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This fair value measurement of contingent consideration is categorized as a Level 3 liability, as the measurement amount is based primarily on significant inputs not observable in the market. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration liability recorded related to regulatory and product development milestones associated with the Thrive and Ashion acquisitions was $361.3&#160;million as of September&#160;30, 2021. The Company evaluates the fair value of the regulatory and product development contingent consideration liabilities using the probability-weighted scenario based discounted cash flow model, which is consistent with the initial measurement of the expected contingent consideration liabilities. Probabilities of success are applied to each potential scenario and the resulting values are discounted using a rate that considers a present-value factor. The passage of time in addition to changes in projected milestone achievement timing, present-value factor, the degree of achievement if applicable, and probabilities of success may result in adjustments to the fair value measurement. The fair value measurements of contingent consideration for which a liability is recorded include significant unobservable inputs. As of September&#160;30, 2021, the fair value of the contingent consideration liability recorded related to regulatory and product development milestones was determined using a weighted average probability of success of 90.5% and a weighted average present-value factor of 2.0%. The projected fiscal year of payment range is from 2024 to 2027. Unobservable inputs were weighted by the relative fair value of the contingent consideration liability. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration earnout liability related to certain revenue milestones associated with the Biomatrica acquisition was $2.3&#160;million as of September&#160;30, 2021. The revenue milestone associated with the Ashion acquisition is not expected to be achieved and therefore no liability has been recorded for this milestone. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Marketable Equity Investments</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the aggregate carrying amounts of the Company&#8217;s non-marketable equity securities without readily determinable fair values were $22.7&#160;million and $29.1&#160;million, respectively, which are classified as a component of other long-term assets in the Company&#8217;s condensed consolidated balance sheets. There have been no downward or upward adjustments made on these investments since initial recognition. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company had open foreign currency forward contracts with notional amounts of $29.5&#160;million and $22.4&#160;million, respectively. The Company's foreign exchange derivative instruments are classified as Level 2 within the fair value hierarchy as they are valued using inputs that are observable in the market or can be derived principally from or corroborated by observable market data. The fair value of the foreign currency forward contracts was zero at September&#160;30, 2021 and December&#160;31, 2020, and there were no gains or losses recorded for the three and nine months ended September&#160;30, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904743544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text">LONG-TERM DEBT<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Construction Loan Agreement</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2017, the Company entered into a loan agreement with Fifth Third Bank (formerly MB Financial Bank, N.A.) (the &#8220;Construction Loan Agreement&#8221;), which provides the Company with a non-revolving construction loan (the &#8220;Construction Loan&#8221;) of $25.6 million. The Company used the Construction Loan proceeds to finance the construction of an additional clinical laboratory and related facilities in Madison, Wisconsin. The Construction Loan is collateralized by the additional clinical laboratory and related facilities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Construction Loan Agreement, funds drawn will bear interest at a rate equal to the sum of the 1-month LIBOR rate plus 2.25 percent. Regular monthly payments are interest-only for the first 24 months, with further payments based on a 20-year amortization schedule. Amounts borrowed pursuant to the Construction Loan Agreement may be prepaid at any time without penalty. The maturity date of the Construction Loan Agreement is December 10, 2022.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2017, Fifth Third Bank, on behalf of the Company, issued an Irrevocable Standby Letter of Credit in the amount of $0.6 million in favor of the City of Madison, Wisconsin (the &#8220;City Letter of Credit&#8221;). The City Letter of Credit is deemed to have been issued pursuant to the Construction Loan Agreement. The amount of the City Letter of Credit will reduce, dollar for dollar, the amount available for borrowing under the Construction Loan Agreement.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition to Fifth Third Bank&#8217;s initial advance of loan proceeds under the Construction Loan Agreement, the Company was required to first invest at least $16.4 million of its own cash into the construction project. The Company fulfilled its required initial investment and made its first draw on the Construction Loan in June 2018. In December 2019, the Company began making monthly payments towards the outstanding principal balance plus accrued interest. As of September&#160;30, 2021 and December&#160;31, 2020, the outstanding balance was $22.8 million and $23.8 million, respectively, from the Construction Loan, including $0.7 million of interest incurred, which is accrued for as an interest reserve and represents a portion of the loan balance. The Company capitalized the $0.7 million of interest to the construction project. The Company incurred approximately $0.2 million of debt issuance costs related to the Construction Loan, which are recorded as a direct deduction from the liability. The debt issuance costs are being amortized over the life of the Construction Loan.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Construction Loan approximates fair value due to the short maturity of this instrument. The Construction Loan is privately held with no public market for this debt and therefore is classified as a Level 3 fair value measurement. The change in the fair value during the three and nine months ended September&#160;30, 2021 was due to payments made on the loan resulting in a decrease in the liability.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Construction Loan Agreement was amended effective June 30, 2020 to include a financial covenant to maintain a minimum liquidity of $250&#160;million and remove the minimum tangible net worth covenant. As of September&#160;30, 2021, the Company is in compliance with the covenant included in the amended agreement. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Increment Financing Loan Agreements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into two separate Tax Increment Financing Loan Agreements (&#8220;TIFs&#8221;) in February 2019 and June 2019 with the City of Madison, Wisconsin. The TIFs provide for $4.6 million of financing in the aggregate. In return for the loans, the Company is obligated to create and maintain 500 full-time jobs over a five-year period, starting on the date of occupancy of the buildings constructed. In the event that the job creation goals are not met, the Company would be required to pay a penalty.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the earned financial incentives as the full-time equivalent positions are filled. The amount earned is recorded as a liability and amortized as a reduction of operating expenses over a two-year period, which is the timeframe when the TIFs will be repaid through property taxes.</span></div>As of December 31, 2019, the Company had earned and received payment of the full $4.6 million from the City of Madison, and the corresponding liability became fully amortized in October 2020. In May 2021 the City of Madison confirmed that the Company had repaid the TIFs in full and released the Company from the loans and the related property lien.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904279208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CONVERTIBLENOTESAbstract', window );"><strong>CONVERTIBLE NOTES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ConvertibleNotesTextBlock', window );">CONVERTIBLE NOTES</a></td>
<td class="text">CONVERTIBLE NOTES<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (2)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Discount and Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leveling</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,596)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130,404&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222,968&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Convertible notes - 1.000% (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of December&#160;31, 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (2)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Discount and Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leveling</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,878)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128,122&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526,625&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Convertible notes - 1.000% (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the Company&#8217;s share price on the days leading up to September&#160;30, 2021 and December 31, 2020, holders of the 2025 Convertible Notes have the right to convert their debentures. As a result, the 2025 Convertible Notes are included within convertible notes, net, current portion on the condensed consolidated balance sheets. Some holders did convert their debentures, resulting in a decrease of the principal amount of the 2025 Convertible Notes. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The fair values are based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuances and Settlements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the Company issued and sold $690.0 million in aggregate principal amount of 1.0% Convertible Notes (the &#8220;January 2025 Notes&#8221;) with a maturity date of January 15, 2025. The January 2025 Notes accrue interest at a fixed rate of 1.0% per year, payable semi-annually in arrears on January 15 and July 15 of each year, beginning on July 15, 2018. The net proceeds from the issuance of the January 2025 Notes were approximately $671.1 million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, the Company issued and sold an additional $218.5 million in aggregate principal amount of 1.0% Convertible Notes (the &#8220;June 2025 Notes&#8221;). The June 2025 Notes were issued under the same indenture pursuant to which the Company previously issued the January 2025 Notes (the &#8220;Indenture&#8221;). The January 2025 Notes and the June 2025 Notes (collectively, the &#8220;2025 Notes&#8221;) have identical terms (including the same January 15, 2025 maturity date) and are treated as a single series of securities. The net proceeds from the issuance of the June 2025 Notes were approximately $225.3 million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the Company issued and sold $747.5 million in aggregate principal amount of 0.375% Convertible Notes (the &#8220;2027 Notes&#8221;) with a maturity date of March 15, 2027. The 2027 Notes accrue interest at a fixed rate of 0.375% per year, payable semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2019. The net proceeds from the issuance of the 2027 Notes were approximately $729.5 million, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilized a portion of the proceeds from the issuance of the 2027 Notes to settle a portion of the 2025 Notes in privately negotiated transactions. In March 2019, the Company used cash of $494.1 million and an aggregate of 2.2 million shares of the Company&#8217;s common stock valued at $182.4 million for total consideration of $676.5 million to settle $493.4 million of the 2025 Notes, of which $0.7 million was used to pay off interest accrued on the 2025 Notes. The transaction resulted in a loss on settlement of convertible notes of $187.7 million, which is reflected in accumulated deficit in the Company&#8217;s condensed consolidated balance sheets. The loss represents the difference between (i) the fair value of the consideration transferred and (ii) the carrying value of the debt at the time of repurchase.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company issued and sold $1.15 billion in aggregate principal amount of 0.375% Convertible Notes (the &#8220;2028 Notes&#8221; and, collectively with the 2025 Notes and the 2027 Notes, the &#8220;Notes&#8221;) with a maturity date of March 1, 2028. The 2028 Notes accrue interest at a fixed rate of 0.375% per year, payable semi-annually in arrears on March 1 and September 1 of each year, beginning on September 1, 2020. The net proceeds from the issuance of the 2028 Notes were approximately $1.13 billion, after deducting underwriting discounts and commissions and the offering expenses payable by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company used $150.1 million of the proceeds from the issuance of the 2028 Notes to settle $100.0 million of the 2025 Notes, of which $0.1 million was used to pay off interest accrued on the 2025 Notes. The transaction resulted in a loss on settlement of convertible notes of $50.8 million, which is recorded in interest expense in the Company&#8217;s condensed consolidated statement of operations. The loss represents the difference between (i) the fair value of the consideration transferred and (ii) the carrying value of the debt at the time of repurchase.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Conversion Features</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the six-months immediately preceding the maturity date of the applicable series of Notes, each series of Notes is convertible only upon the occurrence of certain events and during certain periods, as set forth in the Indentures filed at the time of the original offerings. On or after the date that is six-months immediately preceding the maturity date of the applicable series of Notes until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert such Notes at any time. The Notes will be convertible into cash, shares of the Company&#8217;s common stock (plus, if applicable, cash in lieu of any fractional share), or a combination of cash and shares of the Company&#8217;s common stock, at the Company&#8217;s election.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company&#8217;s intent and policy to settle all conversions through combination settlement. The initial conversion rate is&#160;13.26, 8.96, and 8.21 shares of common stock per&#160;$1,000&#160;principal amount for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively, which is equivalent to an initial conversion price of&#160;approximately $75.43,&#160;$111.66, and $121.84 per share of the Company&#8217;s common stock for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively. The 2025 Notes, 2027 Notes, and 2028 Notes may be convertible in up to 4.2&#160;million, 6.7&#160;million, and 9.4&#160;million shares, respectively. The conversion rate is subject to adjustment upon the occurrence of certain specified events as set forth in the Indentures filed at the time of the original offerings but will not be adjusted for accrued and unpaid interest. In addition, holders of the Notes who convert their Notes in connection with a &#8220;make-whole fundamental change&#8221; (as defined in the Indenture), will, under certain circumstances, be entitled to an increase in the conversion rate.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a &#8220;fundamental change&#8221; (as defined in the Indenture), holders of the Notes may require the Company to repurchase for cash all or part of their Notes at a repurchase price equal to&#160;100%&#160;of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the closing price of the Company&#8217;s common stock of $95.45 on September&#160;30, 2021, the if-converted values on the Company&#8217;s 2025 Notes exceed the principal amount by $83.6 million and the 2027 Notes and 2028 Notes do not exceed the principal amount.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ranking of Convertible Notes</span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are the Company&#8217;s senior unsecured obligations and (i) rank senior in right of payment to all of its future indebtedness that is expressly subordinated in right of payment to the Notes; (ii) rank equal in right of payment to each outstanding series thereof and to all of the Company&#8217;s future liabilities that are not so subordinated, unsecured indebtedness; (iii) are effectively junior to all of the Company&#8217;s existing and future secured indebtedness and other secured obligations, to the extent of the value of the assets securing that indebtedness and other secured obligations; and (iv) are structurally subordinated to all indebtedness and other liabilities of the Company&#8217;s subsidiaries.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Issuance costs are amortized to interest expense over the term of the Notes. The following table summarizes the original issuance costs at the time of issuance for each set of Notes:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,284&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by the Company.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,284&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,860&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on settlement of convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coupon interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense on convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,047&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,047&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,093&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,838&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective interest rates on the 2025 Notes, 2027 Notes, and 2028 Notes for the three months ended September&#160;30, 2021 and 2020 were 1.18%, 0.68%, and 0.64% and 1.18%, 0.68%, and 0.64%, respectively. The effective interest rates on the 2025 Notes, 2027 Notes, and 2028 Notes for the nine months ended September&#160;30, 2021 and 2020 were 1.18%, 0.67%, and 0.64% and 1.21%, 0.68%, and 0.63%, respectively. The remaining period over which the unamortized debt discount will be recognized as non-cash interest expense is 3.30, 5.46, and 6.42 years for the 2025 Notes, 2027 Notes, and 2028 Notes, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CONVERTIBLENOTESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CONVERTIBLE NOTES</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CONVERTIBLENOTESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ConvertibleNotesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ConvertibleNotesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810903240776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSE AND COLLABORATION AGREEMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_LICENSEAGREEMENTSAbstract', window );"><strong>LICENSE AGREEMENTS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_LicensingAgreementDisclosureTextBlock', window );">LICENSE AND COLLABORATION AGREEMENTS</a></td>
<td class="text">LICENSE AND COLLABORATION AGREEMENTS<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company licenses certain technologies that are, or may be, incorporated into its technology under several license agreements, as well as the rights to commercialize certain diagnostic tests through collaboration agreements. Generally, the license agreements require the Company to pay low single-digit royalties based on net revenues received using the technologies and may require minimum royalty amounts or maintenance fees.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mayo</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June&#160;2009 the Company entered into a license agreement with Mayo Foundation for Medical Education and Research (&#8220;Mayo&#8221;). The Company&#8217;s license agreement with Mayo was most recently amended and restated in September 2020. Under the license agreement, Mayo granted the Company an exclusive, worldwide license to certain Mayo patents and patent applications, as well as a non-exclusive, worldwide license with regard to certain Mayo know-how. The scope of the license covers any screening, surveillance or diagnostic test or tool for use in connection with any type of cancer, pre-cancer, disease or condition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The licensed Mayo patents and patent applications contain both method and composition claims that relate to sample processing, analytical testing and data analysis associated with nucleic acid screening for cancers and other diseases. The jurisdictions covered by these patents and patent applications include the U.S., Australia, Canada, the European Union, China, Japan and Korea. Under the license agreement, the Company assumed the obligation and expense of prosecuting and maintaining the licensed Mayo patents and is obligated to make commercially reasonable efforts to bring to market products using the licensed Mayo intellectual property.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant&#160;to the Company&#8217;s&#160;agreement with Mayo,&#160;the Company is&#160;required to pay Mayo a low-single-digit royalty on the Company&#8217;s net sales of current and future products using the licensed Mayo intellectual property&#160;each year during the term of the Mayo agreement. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the most recent amendment, the Company agreed to pay Mayo an additional $6.3 million, payable in five equal annual installments through 2024. The annual installments are recorded in research and development expenses in the Company&#8217;s condensed consolidated statements of operations.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The license agreement will remain in effect, unless earlier terminated by the parties in accordance with the agreement, until the last of the licensed patents expires in 2038 (or later, if certain licensed patent applications are issued). However, if the Company is still using the licensed Mayo know-how or certain Mayo-provided biological specimens or their derivatives on such expiration date, the term shall continue until the earlier of the date the Company stops using such know-how and materials and the date that is five years after the last licensed patent expires. The license agreement contains customary termination provisions and permits Mayo to terminate the license agreement if the Company sues Mayo or its affiliates, other than any such suit claiming an uncured material breach by Mayo of the license agreement.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to granting the Company a license to the covered Mayo intellectual property, Mayo provides the Company with product development and research and development assistance pursuant to the license agreement and other collaborative arrangements. In September 2020, Mayo also agreed to make available certain personnel to provide such assistance through January 2025. In connection with this collaboration, the Company incurred charges of $1.3 million and $0.9 million for the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $3.5&#160;million and $2.8 million for the nine months ended September 30, 2021 and 2020, respectively. The charges incurred in connection with this collaboration are recorded in research and development expenses in the Company&#8217;s condensed consolidated statements of operations. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Johns Hopkins University (&#8220;JHU&#8221;)</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the acquisition of Thrive, the Company acquired a worldwide exclusive license agreement with JHU for use of several JHU patents and licensed know-how. The license is designed to enable the Company to leverage JHU proprietary data in the development and commercialization of a blood-based, multi-cancer early detection test. The agreement terms include single-digit sales-based royalties and sales-based milestone payments of $10.0 million, $15.0 million, $20.0 million upon achieving calendar year licensed product revenue using JHU proprietary data of $0.50 billion, $1.00 billion, and $1.50 billion, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_LICENSEAGREEMENTSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_LICENSEAGREEMENTSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_LicensingAgreementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the entire disclosure related to licensing agreement entered by an entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_LicensingAgreementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902973624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PFIZER PROMOTION AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PromotionAgreementDisclosureAbstract', window );"><strong>PFIZER PROMOTION AGREEMENT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">PFIZER PROMOTION AGREEMENT</a></td>
<td class="text">PFIZER PROMOTION AGREEMENTIn August 2018, the Company entered into a Promotion Agreement (the &#8220;Original Promotion Agreement&#8221;) with Pfizer Inc. (&#8220;Pfizer&#8221;), which was amended and restated in October 2020 (the &#8220;Restated Promotion Agreement&#8221;). The Restated Promotion Agreement extends the relationship between the Company and Pfizer and restructures the manner in which the Company compensates Pfizer for promotion of the Cologuard test through a service fee, and provision of certain other sales and marketing services related to the Cologuard test. The Restated Promotion Agreement includes fixed and performance-related fees, some of which retroactively went into effect on April 1, 2020. All payments to Pfizer are recorded in sales and marketing expenses in the Company&#8217;s condensed consolidated statements of operations. Under the Original Promotion Agreement, the service fee was calculated based on incremental gross profits over specified baselines during the term. Under the Restated Promotion Agreement, the service fee provides a fee-for-service model that includes certain fixed fees and performance-related bonuses. The performance-related bonuses are contingent upon the achievement of certain annual performance criteria with any applicable expense being recognized ratably upon achievement of the payment becoming probable. The Company incurred charges of $16.8&#160;million and $18.0&#160;million for the service fee for the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $63.6&#160;million and $39.7 million for the service fee for the nine months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $30.2 million and $15.8 million for promotion, sales and marketing services performed by Pfizer on behalf of the Company during the three months ended September 30, 2021 and 2020, respectively. The Company incurred charges of $88.0&#160;million and $56.3 million for promotion, sales and marketing services performed by Pfizer on behalf of the Company during the nine months ended September 30, 2021 and 2020, respectively. During 2022, and contingent upon the achievement of certain Cologuard test revenue metrics during 2021, the Company will pay Pfizer a royalty based on a low single-digit royalty rate applied to actual 2022 Cologuard test revenues. The term of the Restated Promotion Agreement runs through December 31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_PromotionAgreementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>n/a</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_PromotionAgreementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904389736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ashion Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021 the Company completed its acquisition of Ashion. In connection with the acquisition, which is further described in Note 17, the Company issued 0.1&#160;million common shares that had a fair value of $16.2 million.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Thrive Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company completed its acquisition of Thrive. In connection with the acquisition, which is further described in Note 17, the Company issued 9.3&#160;million common shares that had a fair value of $1.19 billion.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Targeted Digital Sequencing (&#8220;TARDIS&#8221;) License Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company acquired a worldwide exclusive license to the TARDIS technology from The Translational Genomics Research Institute (&#8220;TGen&#8221;), which is further described in Note 17. As part of the consideration transferred, the Company issued 0.2&#160;million shares that had a fair value of $27.3 million. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paradigm Diagnostics, Inc. and Viomics, Inc. Acquisition Stock Issuance</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the Company completed the acquisitions of Paradigm and Viomics. The purchase price for these acquisitions consisted of cash and stock with a fair value of $40.4 million. Of the $40.4 million purchase price, $32.2&#160;million is expected to be settled through the issuance of 0.4&#160;million shares of common stock. Of the $32.2&#160;million that will be settled through the issuance of common stock, $28.8&#160;million was issued as of September&#160;30, 2021, and the remainder was withheld and may become issuable as additional merger consideration subject to the terms and conditions of the acquisition agreements. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount recognized in AOCI for the nine months ended September&#160;30, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gain (Loss)<br/>on Marketable<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period change in accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense related to items of other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in AOCI for the nine months ended September 30, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gain (Loss)<br/>on Marketable<br/>Securities (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period change in accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">There was no tax impact from the amounts recognized in AOCI for the three and nine months ended September&#160;30, 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI for the nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the<br/>Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about AOCI Components (In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of available-for-sale investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902679400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Plans</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains the 2010 Omnibus Long-Term Incentive Plan (As Amended and Restated Effective July 27, 2017), the 2019 Omnibus Long-Term Incentive Plan, the 2010 Employee Stock Purchase Plan, and the 2016 Inducement Award Plan (collectively, the &#8220;Stock Plans&#8221;). </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records stock-based compensation expense in connection with the amortization of restricted stock and restricted stock unit awards (&#8220;RSUs&#8221;), stock purchase rights granted under the Company&#8217;s employee stock purchase plan and stock options granted to employees, non-employee consultants and non-employee directors. The Company recorded $63.6 million and $41.5 million in stock-based compensation expense during the three months ended September 30, 2021 and 2020, respectively. The Company recorded $283.3 million and $111.1 million in stock-based compensation expense during the nine months ended September 30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, there was $401.6 million of expected total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under all equity compensation plans. The Company expects to recognize that cost over a weighted average period of 2.8 years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Thrive, the Company accelerated the vesting of shares of previously unvested stock options and restricted stock units for employees with qualifying termination events. During the three months ended September 30, 2021, the Company accelerated 34,167 shares of previously unvested stock options and 24,865 shares of previously unvested restricted stock awards and restricted stock units and recorded $4.5 million of non-cash stock-based compensation for the accelerated awards. During the nine months ended September 30, 2021, the Company accelerated 138,163 shares of previously unvested stock options and 58,171 shares of previously unvested restricted stock awards and restricted stock units and recorded $19.0 million of non-cash stock-based compensation for the accelerated awards. As further discussed in Note 17, the Company also recorded $86.2 million in stock-based compensation related to accelerated vesting of awards held by Thrive employees in connection with the acquisition. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of each service-based option award on the date of grant using the Black-Scholes option-pricing model, which utilizes several key assumptions which are disclosed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Plan Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11% - 1.47%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 - 6.15</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.19% - 77.51%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company did not grant stock options under its 2010 Omnibus Long-Term Incentive Plan or 2019 Omnibus Long-Term Incentive Plan during the period. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under the Stock Plans is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Aggregate intrinsic value in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,231,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed through acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379,543&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.81&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379,543&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.81&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,337&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.17&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of options granted during the nine months ended September&#160;30, 2020 was $58.57. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The total intrinsic value of options exercised during the nine months ended September&#160;30, 2021 and 2020 was $148.8 million and $29.0 million, respectively, determined as of the date of exercise.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received approximately $13.4 million and $15.4 million from stock option exercises during the nine months ended September&#160;30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock and Restricted Stock Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock and restricted stock units is determined on the date of grant using the closing stock price on that day. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock and restricted stock unit activity during the nine months ended September&#160;30, 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted stock and restricted stock units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average Grant<br/>Date Fair Value (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,968,214&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed through acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,582,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,306,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The fair value of restricted stock units vested and converted to shares of the Company&#8217;s common stock was $114.4 million and $79.1 million during the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of the restricted stock units granted during the nine months ended September&#160;30, 2020 was $90.95.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Share Units</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued performance-based equity awards to certain employees which vest upon the achievement of certain performance goals, including financial performance targets and operational milestones. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of performance share-based compensation arrangements granted under all equity compensation unit activity is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance share units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average Grant<br/>Date Fair Value (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,515&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.22&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,644&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.49&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The performance share units listed above assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding performance share units as of September&#160;30, 2021 was 249,695. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of the performance share units granted during the nine months ended September&#160;30, 2020 was $90.17.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of ESPP shares is based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04% - 0.16%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12% - 0.20%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.38% - 68.51%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.67% - 89.04%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div>(1)The Company did not issue stock purchase rights under its 2010 Employee Stock Purchase Plan during the three months ended September&#160;30, 2021 and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902939928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental disclosure of cash flow information related to the Company&#8217;s cash and non-cash activities with its leases are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,835</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,827</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,805</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,480</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,662</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,296</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,420</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.95</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.86</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the nine months ended September&#160;30, 2021, this includes right-of-use assets acquired as part of the business combinations described in Note 17 of $39.6 million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company&#8217;s right-of-use assets from operating leases are $167.9 million and $125.9 million, respectively, which are reported in operating lease right-of-use assets in the Company&#8217;s condensed consolidated balance sheets. As of September&#160;30, 2021, the Company has outstanding operating lease obligations of $182.2 million, of which $19.2 million is reported in operating lease liabilities, current portion and $163.0 million is reported in operating lease liabilities, less current portion in the Company&#8217;s condensed consolidated balance sheets. As of December&#160;31, 2020, the Company had outstanding operating lease obligations of $132.6 million, of which $11.5 million is reported in operating lease liabilities, current portion and $121.1 million is reported in operating lease liabilities, less current portion in the Company&#8217;s condensed consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#8217;s rating for operating leases. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021 and December&#160;31, 2020, the Company&#8217;s right-of-use assets from finance leases are $18.7 million and $18.6 million, respectively, which are reported in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NA_a63abb75-8298-4289-82ca-d79cd14f64fc">other long-term assets</span>, net in the Company&#8217;s condensed consolidated balance sheets. As of September&#160;30, 2021, the Company has outstanding finance lease obligations of $19.1 million, of which $5.9 million is reported in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI0NQ_a7a5c01b-96cc-4030-a445-b85e4c06296f">other current liabilities</span> and $13.2 million is reported in <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF83My9mcmFnOmQxMGEyYTI5Zjk4NTRiNjQ4ZTQyNWM5NzljOGY1NjE2L3RleHRyZWdpb246ZDEwYTJhMjlmOTg1NGI2NDhlNDI1Yzk3OWM4ZjU2MTZfOTI1MA_7ed6786f-7aa1-4913-ad46-9c4fe5b019bf">other long-term liabilities</span> in the Company&#8217;s condensed consolidated balance sheets. As of December&#160;31, 2020, the Company had outstanding finance lease obligations of $18.7 million, of which $4.7 million is reported in other current liabilities and $14.0 million is reported in other long-term liabilities in the Company&#8217;s condensed consolidated balance sheets. The Company calculates its incremental borrowing rates for specific lease terms, used to discount future lease payments, as a function of the U.S. Treasury rate and an indicative Moody&#8217;s rating for finance leases. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company executed a lease agreement for a new facility in La Jolla, California, which the Company is expecting to commence in the fourth quarter of 2021. The Company anticipates that it will recognize $22.9 million in operating lease right-of-use assets and $22.9 million in operating lease liabilities in the condensed consolidated balance sheet, respectively, upon commencement of the lease. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company&#8217;s best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Quarterly Report on Form 10-Q, amounts accrued for legal proceedings and regulatory matters were not material except for the amounts accrued related to the Medicare Date of Service Rule Investigation (the &#8220;DOS Rule Investigation&#8221;) discussed below. However, it is possible that in a particular quarter or annual period the Company&#8217;s financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of, or development in, legal and/or regulatory proceedings, including as described below. Except for the proceedings discussed below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow or liquidity.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently responding to civil investigative demands and administrative subpoenas issued pursuant to the Health Insurance Portability and Accountability Act of 1996 by the United States Department of Justice (&#8220;DOJ&#8221;) concerning Genomic Health&#8217;s compliance with the Medicare Date of Service billing regulations. The Company has been cooperating with these inquiries and has produced documents in response thereto.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, as part of ongoing discussions between the DOJ and the Company regarding the DOS Rule Investigation, the DOJ presented an estimate of civil damages in the amount of $48.2 million relating to alleged non-compliance with the Medicare Date of Service billing regulations from 2007 to 2020. The civil damages estimate does not include potential treble damages, civil or criminal penalties or other remedies that the DOJ could seek against the Company. Based on the Company&#8217;s review and analysis of the DOJ presentation, civil damages estimate, and range of potential exposure, the Company recorded an accrual of approximately $10 million for the three and nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, litigation outcomes are difficult to predict, and the estimation of probable losses requires an analysis of multiple possible outcomes that often depend on judgments about potential actions by third parties. Accordingly, the recorded accrual of approximately $10 million for the three and nine months ended September&#160;30, 2021 is based on several factors, considerations, and judgments, and the ultimate resolution of this matter could result in a loss in excess of the recorded accrual.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 24, 2019, Niles Rosen M.D. filed a sealed ex parte qui tam lawsuit against the Company in the United States District Court for the Middle District of Florida, that alleged a violation of the Federal Anti-Kickback Statute and False Claims Act for offering gift cards to patients in exchange for returning the Cologuard screening test (the &#8220;Qui Tam Suit&#8221;). Dr. Rosen seeks on behalf of the U.S. government and himself an award of civil penalties, treble damages and fees and costs. On February 25, 2020, the Company received a civil investigative demand by the DOJ related to the Company&#8217;s gift card program. The Company produced documents in response thereto. On March 25, 2021, the DOJ filed a notice of its election to decline intervention in the Qui Tam Suit. This election does not prevent Dr. Rosen from continuing the Qui Tam Suit. On April 12, 2021, Dr. Rosen filed an amended complaint against the Company, alleging violations of the Federal Anti-Kickback Statute and False Claims Act. The Company first learned of the Qui Tam Suit and the DOJ&#8217;s election to decline intervention in July 2021.  The Company intends to vigorously defend itself against Dr. Rosen's claims and seek, among other things, the Company&#8217;s attorneys' fees and costs incurred in defending this action. Although the Company denies Dr. Rosen's allegations and believes that it has meritorious defenses to his False Claims Act claims, neither the outcome of the litigation nor can a reasonable estimate or an estimated range of loss associated with the litigation be determined at this time.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse outcomes from the DOS Rule Investigation and the Qui Tam Suit could include the Company being required to pay treble damages, incur civil and criminal penalties, paying attorneys&#8217; fees, entering into a corporate integrity agreement, being excluded from participation in government healthcare programs, including Medicare and Medicaid, and other adverse actions that could materially affect the Company&#8217;s business, financial condition, and results of operation.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company's combination with Genomic Health, on June 22, 2020, Suzanne Flannery, a purported former stockholder of Genomic Health, filed a Verified Individual and Class Action Complaint in the Delaware Court of Chancery, captioned Flannery v. Genomic Health, Inc., et al., C.A. No. 2020-0492. Flannery amended her complaint on November 23, 2020. The amended complaint asserts individual and class action claims, including: (i) a violation of 8 Del. C. &#167; 203 by Genomic Health, Exact Sciences and a purported controlling group of former Genomic Health stockholders; (ii) conversion by Genomic Health, Exact Sciences and Spring Acquisition Corp.; (iii) breach of fiduciary duty by Genomic Health's former directors; (iv) breach of fiduciary duty by the purported controlling group; and (v) aiding and abetting breach of fiduciary duty against Exact Sciences, Spring Acquisition and Goldman Sachs &amp; Co. LLC, Genomic Health's financial advisor in the combination. The amended complaint seeks, among other things, declaratory relief, unspecified monetary damages and attorneys' fees and costs. All defendants moved to dismiss the amended complaint. Oral argument on defendants&#8217; motions to dismiss the amended complaint occurred in May 2021, and in September 2021 the case was officially dismissed by the court.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904092248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NEW MARKET TAX CREDIT<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NewMarketTaxCreditAbstract', window );"><strong>NEW MARKET TAX CREDIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NewMarketTaxCreditTextBlock', window );">NEW MARKET TAX CREDIT</a></td>
<td class="text">NEW MARKET TAX CREDIT<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2014, the Company received approximately $2.4 million in net proceeds from financing agreements related to working capital and capital improvements at one of its Madison, Wisconsin facilities.&#160;This financing arrangement was structured with an unrelated third-party financial institution (the &#8220;Investor&#8221;), an investment fund, and its majority owned community development entity in connection with the Company&#8217;s participation in transactions qualified under the federal New Markets Tax Credit (&#8220;NMTC&#8221;) program, pursuant to Section 45D of the Internal Revenue Code of 1986, as amended. The Company is required to be in compliance through December 2021 with various regulations and contractual provisions that apply to the NMTC arrangement. Noncompliance with applicable requirements could result in the Investor&#8217;s projected tax benefits not being realized and, therefore, require the Company to indemnify the Investor for any loss or recapture of NMTC related to the financing until such time as the recapture provisions have expired under the applicable statute of limitations. The Company does not anticipate any credit recapture will be required in connection with this financing arrangement.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor and its majority owned community development entity are considered Variable Interest Entities (&#8220;VIEs&#8221;) and the Company is the primary beneficiary of the VIEs. This conclusion was reached based on the following:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing activities of the VIEs &#8212; collecting and remitting interest and fees and NMTC compliance &#8212; were all considered in the initial design and are not expected to significantly affect performance throughout the life of the VIE;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contractual arrangements obligate the Company to comply with NMTC rules and regulations and provide various other guarantees to the Investor and community development entity;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Investor lacks a material interest in the underlying economics of the project; and</span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company is obligated to absorb losses of the VIEs.</span></div>Because the Company is the primary beneficiary of the VIEs, they have been included in the consolidated financial statements. There are no other assets, liabilities or transactions in these VIEs outside of the financing transactions executed as part of the NMTC arrangement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NewMarketTaxCreditAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>New Market Tax Credit [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NewMarketTaxCreditAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NewMarketTaxCreditTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the new market tax credit program.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NewMarketTaxCreditTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902989256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract', window );"><strong>WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock', window );">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</a></td>
<td class="text">WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2015, the Company entered into an agreement with the Wisconsin Economic Development Corporation (&#8220;WEDC&#8221;) to earn $9.0 million in refundable tax credits on the condition that the Company expends $26.3 million in capital investments and establishes and maintains 758 full-time positions over a seven-year period. The tax credits earned are first applied against the tax liability otherwise due, and if there is no such liability present, the claim for tax credits will be reimbursed in cash to the Company. The maximum amount of the refundable tax credit to be earned for each year is fixed, and the Company earns the credits by meeting certain capital investment and job creation thresholds over the seven-year period. Should the Company earn and receive the job creation tax credits but not maintain those full-time positions through the end of the agreement, the Company may be required to pay those credits back to the WEDC.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the earned tax credits as job creation and capital investments occur. The amount of tax credits earned is recorded as a liability and amortized as a reduction of operating expenses over the expected period of benefit. The tax credits earned from capital investment are recognized as an offset to depreciation expense over the expected life of the acquired capital assets. The tax credits earned related to job creation are recognized as an offset to operational expenses over the life of the agreement, as the Company is required to maintain the minimum level of full-time positions through the seven-year period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the Company has earned all $9.0 million of the refundable tax credits and has received payment of $7.5 million from the WEDC. The unpaid portion is $1.5 million, which is reported in prepaid expenses and other current assets, reflecting when collection of the refundable tax credits is expected to occur. As of September&#160;30, 2021 and December&#160;31, 2020, the corresponding liability, which reflected when the expected benefit of tax credit amortization would reduce future operating expenses, has been fully amortized. </span></div>During the three and nine months ended September&#160;30, 2020, the Company amortized $0.6 million and $1.7 million, respectively, of the tax credits earned as a reduction of operating expenses.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Wisconsin Economic Development Tax Credit Disclosure [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure relating to the Wisconsin Economic Development Tax Credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902890664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</a></td>
<td class="text">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ashion Analytics, LLC</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2021, the Company completed the acquisition (&#8220;Ashion Acquisition&#8221;) of all of the outstanding equity interests of Ashion from PMed Management, LLC (&#8220;PMed&#8221;), which is a subsidiary of TGen. The Ashion Acquisition provided the Company a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;) certified and College of American Pathologists (&#8220;CAP&#8221;) accredited sequencing lab based in Phoenix, Arizona. Ashion developed GEMExTra&#174;, a comprehensive genomic cancer test, and provides access to whole exome, matched germline, and transcriptome sequencing capabilities. The Company has included the financial results of Ashion in the consolidated financial statements from the date of the combination.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Ashion was approximately $110.0 million, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,775</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,224</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,999</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the 125,444 common shares issued as part of consideration transferred was determined on the basis of the average of the high and low market price of the Company's shares on the acquisition date, which was $129.33. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration arrangement requires the Company to pay $20.0 million of additional cash consideration to PMed upon the Company&#8217;s commercial launch, on or before the tenth anniversary of the Ashion Acquisition, of a test for minimal residual disease (&#8220;MRD&#8221;) detection and/or treatment (the &#8220;Commercial Launch Milestone&#8221;). The fair value of the Commercial Launch Milestone at the acquisition date was $19.0 million. The contingent consideration arrangement also requires the Company to pay $30.0 million of additional cash upon the Company&#8217;s achievement, on or before the fifth anniversary of the Ashion Acquisition, of cumulative revenues from MRD products of $500.0 million (the &#8220;MRD Product Revenue Milestone&#8221;). No value was ascribed to the MRD Product Revenue Milestone based on probability assessments as of the acquisition date. The fair value of the Commercial Launch Milestone and MRD Product Revenue Milestone was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in Accounting Standards Codification (&#8220;ASC&#8221;) 820. The key assumptions are described in Note 7. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,947</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,554</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,313)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,241</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,758</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,999</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $39.0 million of identifiable intangible assets related to the developed technology associated with GEMExTra. Developed technology represents purchased technology that had reached technological feasibility and for which Ashion had substantially completed development as of the date of combination. The fair value of the developed technology has been determined using the income approach multi-period excess earnings method, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, and required rate of return and tax rate. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 13 years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the acquired workforce expertise, the capabilities in the advancement of creating and launching new products, including an MRD product, and expected sales force synergies related to the developed technology. The total goodwill related to this combination is deductible for tax purposes.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the developed technology intangible asset.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma impact and results of operations disclosures have not been included due to immateriality.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the Company incurred $1.6&#160;million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations, respectively. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thrive Earlier Detection Corporation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2021, the Company completed the acquisition (&#8220;Thrive Merger&#8221;) of all of the outstanding capital stock of Thrive. Thrive, headquartered in Cambridge, Massachusetts, is a healthcare company dedicated to incorporating earlier cancer detection into routine medical care. The Company expects that combining Thrive's early-stage screening test, CancerSEEK, with the Company&#8217;s scientific platform, clinical organization and commercial infrastructure will establish the Company as a leading competitor in blood-based, multi-cancer early detection. The Company has included the financial results of Thrive in the consolidated financial statements from the date of the combination.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Thrive was approximately $2.19 billion, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175,431</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,996</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,348</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of replaced equity awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,245</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously held equity investment fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,034</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued 9,323,266 common shares that had a fair value of $1.19 billion based on the average of the high and low market price of the Company's shares on the acquisition date, which was $127.79. Of the total consideration for common stock issued, $1.18 billion was allocated to the purchase consideration and $16.0 million was recorded as compensation within general and administrative expenses in the condensed consolidated statement of operations on the acquisition date due to accelerated vesting of legacy Thrive restricted stock awards (&#8220;RSA&#8221;) and RSU awards in connection with the acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $590.2 million in cash on the acquisition date. Of the total consideration for cash, $585.0 million was allocated to the purchase consideration and $5.2 million was recorded as compensation within general and administrative expenses on the acquisition date due to accelerated vesting of legacy Thrive RSU and RSA awards that were cash-settled in connection with the acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration arrangement requires the Company to pay up to $450.0 million of additional cash consideration to Thrive&#8217;s former shareholders upon the achievement of two discrete events, U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval and Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) coverage, for $150.0 million and up to $300.0 million, respectively. The fair value of the contingent consideration arrangement at the acquisition date was $352.0 million. The fair value of the contingent consideration was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. The key assumptions are described in Note 7. Of the total fair value of the contingent consideration, $331.3 million was allocated to the consideration transferred, $6.4 million was allocated to the Company&#8217;s previous ownership interest in Thrive, and $14.3 million was deemed compensatory as participation is dependent on replaced unvested equity awards vesting which requires future service. Compensation expense related to the milestones could be up to $18.2 million undiscounted and will be recognized in the future once probable and payable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company replaced unvested stock options, RSUs, and RSAs and vested stock options with a combination-date fair value of $197.0 million. Of the total consideration for replaced equity awards, $52.2 million was allocated to the consideration transferred and $144.8 million was deemed compensatory as it was attributable to post acquisition vesting. Of the total compensation related to replaced awards, $65.0 million was expensed on the acquisition date due to accelerated vesting of stock options in connection with the acquisition and $79.8 million relates to future services and will be expensed over the remaining service periods of the unvested stock options, RSUs, and RSAs on a straight-line basis. Including expense recognized for accelerated vesting of RSUs and RSAs described above, total expected stock-based compensation expense is $166.0 million, of which $86.2 million was recognized immediately to general and administrative expenses in the condensed consolidated statement of operations due to accelerated vesting. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the stock options assumed by the Company was determined using the Black-Scholes option pricing model. The fair value of the RSA and RSUs assumed by the Company was determined based on the average of the high and low market price of the Company's shares on the acquisition date. The share conversion ratio of 0.06216 was applied to convert Thrive&#8217;s outstanding equity awards for Thrive&#8217;s common stock into equity awards for shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options assumed were based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Plan Shares Assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11% - 0.12%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26 - 1.57</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.54% - 71.00%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share of options assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$109.74 - $124.89</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously held a preferred stock investment of $12.5 million in Thrive and recognized a gain of approximately $30.5 million on the transaction within investment income (expense), net on the Company&#8217;s condensed consolidated statement of operations, which represented the adjustment of the Company&#8217;s historical investment to the acquisition date fair value. The fair value of the Company&#8217;s previous ownership in Thrive was determined based on the pro-rata share payout applied to the Company&#8217;s interest combined with the fair value of the Company&#8217;s share of the contingent consideration arrangement, as discussed above.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>January 5, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allocation as of September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,748</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,977</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,977</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564,758</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564,758</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,222)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,222)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,218)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,080)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,622)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,622)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,905)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,905)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,947)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325,809)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238,949</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,105</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D represents the fair value assigned to research and development assets that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying product and expected commercial release. The amounts capitalized are accounted for as indefinite-lived intangible assets, subject to impairment testing, until completion or abandonment of the research and development efforts associated with the projects. The Company recorded $1.25 billion of IPR&amp;D related to a project associated with the development of an FDA approved blood-based, multi cancer screening test. The IPR&amp;D asset was valued using the multiple-period excess earnings method approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, required rate of return and tax rate, as well as estimates of achievement probability and timing related to the royalty and milestone obligations due to JHU, as described in Note 10. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the research and development workforce expertise, next generation sequencing capabilities and expected synergies. The total goodwill related to this combination is not deductible for tax purposes.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the IPR&amp;D asset, as well as finalization of the pre-combination income tax returns.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net loss before tax of Thrive included in the Company&#8217;s condensed consolidated statement of operations from the combination date of January 5, 2021 to September&#160;30, 2021 was $219.6 million. The net loss before tax of Thrive included in the Company&#8217;s condensed consolidated statement of operations for the three months ended September 30, 2021 was $39.6 million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,797)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information for all periods presented above has been calculated after adjusting the results of Thrive to reflect the business combination accounting effects resulting from this combination. The Company incurred $86.2 million of stock-based compensation expense related to accelerated vesting in connection with the acquisition, $13.5 million of stock-based compensation expense related to accelerated vesting for employees with qualifying termination events, and $10.3 million of transaction costs incurred to execute the acquisition during the first quarter of 2021. These expenses are included in general and administrative expenses on the condensed consolidated statement of operations for the nine months ended September 30, 2021 and are reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a realized gain of $30.5 million during the first quarter of 2021 in investment income (expense), net on the Company&#8217;s condensed consolidated statement of operations relating to the Company&#8217;s pre-acquisition investment in Thrive. This gain has been reduced to $7.6&#160;million due to the Company&#8217;s smaller ownership interest in Thrive on January 1, 2020, and is reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a remeasurement of contingent consideration of $10.5 million related to Thrive in general and administrative expenses in the condensed consolidated statement of operations for the nine months ended September 30, 2021. This expense is reflected in the nine months ended September 30, 2020 in the table above. The historical consolidated financial statements have been adjusted in the unaudited pro forma combined financial information to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The unaudited pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the combination had taken place as of January 1, 2020.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, the Company incurred $10.3 million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with acquisition-related severances, the Company recorded $4.5 million of expense related to vesting of previously unvested equity awards and $1.2 million of additional benefit charges for the three months ended September 30, 2021. The Company recorded $19.0 million of expense related to vesting of previously unvested equity awards and $3.9 million of additional benefit charges for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paradigm Diagnostics, Inc. and Viomics, Inc.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2020, the Company acquired all of the outstanding capital stock of Paradigm and Viomics, two related party companies of one another headquartered in Phoenix, Arizona, in transactions that were deemed to be a single business combination in accordance with ASC 805, Business Combinations, (&#8220;the Paradigm Acquisition&#8221;). Paradigm provides comprehensive genomic-based profiling tests that assist in the diagnosis and therapy recommendations for late-stage cancer. Viomics provides a platform for identification of biomarkers.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into this acquisition to enhance its product portfolio in cancer diagnostics and to enhance its capabilities for biomarker identification.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of the consideration to be transferred for Paradigm and Viomics was $40.4 million, which consists of $32.2&#160;million payable in shares of the Company&#8217;s common stock and $8.2&#160;million which was settled through a cash payment. Of the $32.2&#160;million to be settled through the issuance of common stock, $28.8&#160;million was issued as of September&#160;30, 2021, and the remaining $3.4&#160;million, which was withheld and may become payable as additional merger consideration, is included in other current liabilities in the condensed consolidated balance sheet as of September&#160;30, 2021. The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>March 3, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Allocation<br/>March 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(760)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measurement period adjustments primarily related to accounts receivable valuation and working capital adjustments.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of identifiable intangible assets has been determined using the income approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, weighted average cost of capital and tax rate.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology represents purchased technology that had reached technological feasibility and for which development had been completed as of the acquisition date. Fair value was determined using future discounted cash flows related to the projected income stream of the developed technology for a discrete projection period. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 15 years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the assembled workforce, and expected synergies. The total goodwill related to this acquisition is not deductible for tax purposes.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company agreed to issue to the previous investors in Viomics equity interests with an acquisition-date fair value of up to $8.4&#160;million in Viomics, vesting over 4 years based on certain retention arrangements. Payment is contingent upon continued employment with the Company over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb">four</span></span> year vesting period and is recognized as stock-based compensation expense in general and administrative expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Acquisitions</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PFS Genomics Inc. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 3, 2021, the Company acquired 90% of the outstanding capital stock of PFS Genomics Inc. (&#8220;PFS&#8221;). On June 23, 2021, the Company completed the acquisition of the remaining 10% interest in PFS. The Company paid cash of $33.6 million for 100% of the outstanding capital stock in PFS. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PFS is a healthcare company focused on personalizing treatment for breast cancer patients to improve outcomes and reduce unnecessary treatment. The Company expects this acquisition to expand its ability to help guide early-stage breast cancer treatment through individualized radiotherapy treatment decisions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was treated as an asset acquisition under GAAP because substantially all of the fair value of the gross assets acquired were deemed to be associated with the acquired technology.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets acquired and liabilities assumed were substantially comprised of the IPR&amp;D asset as shown in the table below. The IPR&amp;D asset acquired was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the total purchase price was allocated to the acquired net tangible and intangible assets based on their estimated fair values as of the closing date. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related costs were not material in this asset acquisition. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisition of PFS Genomics outstanding shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,074</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TARDIS License Agreement </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2021, the Company entered into a worldwide exclusive license to the proprietary TARDIS technology from TGen, an affiliate of City of Hope. Under the agreement, the Company acquired a royalty-free, worldwide exclusive license to proprietary TARDIS patents and know-how. The Company intends to develop and commercialize the TARDIS technology as a minimal residual disease test. The Company accounted for this transaction as an asset acquisition. In connection with the asset acquisition, the Company paid upfront fair value consideration of $52.3 million comprised of $25.0 million in cash and issuance of 0.2&#160;million shares of common stock valued at $27.3 million based on the average of the high and low market price of the Company&#8217;s shares on the acquisition date. In addition, the Company is obligated to make milestone payments to TGen of $10.0 million and $35.0 million upon achieving cumulative product revenue related to MRD detection and/or treatment totaling $100.0 million and $250.0 million, respectively. These payments are contingent upon achievement of these cumulative revenues on or before December 31, 2030. The upfront consideration was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. The Company will record the sales milestones once achievement is deemed probable. No acquisition related costs were incurred in this asset acquisition during the three and nine months ended September&#160;30, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionTextBlock', window );">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</a></td>
<td class="text">BUSINESS COMBINATIONS AND ASSET ACQUISITIONS<div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ashion Analytics, LLC</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2021, the Company completed the acquisition (&#8220;Ashion Acquisition&#8221;) of all of the outstanding equity interests of Ashion from PMed Management, LLC (&#8220;PMed&#8221;), which is a subsidiary of TGen. The Ashion Acquisition provided the Company a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;) certified and College of American Pathologists (&#8220;CAP&#8221;) accredited sequencing lab based in Phoenix, Arizona. Ashion developed GEMExTra&#174;, a comprehensive genomic cancer test, and provides access to whole exome, matched germline, and transcriptome sequencing capabilities. The Company has included the financial results of Ashion in the consolidated financial statements from the date of the combination.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Ashion was approximately $110.0 million, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,775</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,224</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,999</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the 125,444 common shares issued as part of consideration transferred was determined on the basis of the average of the high and low market price of the Company's shares on the acquisition date, which was $129.33. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration arrangement requires the Company to pay $20.0 million of additional cash consideration to PMed upon the Company&#8217;s commercial launch, on or before the tenth anniversary of the Ashion Acquisition, of a test for minimal residual disease (&#8220;MRD&#8221;) detection and/or treatment (the &#8220;Commercial Launch Milestone&#8221;). The fair value of the Commercial Launch Milestone at the acquisition date was $19.0 million. The contingent consideration arrangement also requires the Company to pay $30.0 million of additional cash upon the Company&#8217;s achievement, on or before the fifth anniversary of the Ashion Acquisition, of cumulative revenues from MRD products of $500.0 million (the &#8220;MRD Product Revenue Milestone&#8221;). No value was ascribed to the MRD Product Revenue Milestone based on probability assessments as of the acquisition date. The fair value of the Commercial Launch Milestone and MRD Product Revenue Milestone was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in Accounting Standards Codification (&#8220;ASC&#8221;) 820. The key assumptions are described in Note 7. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,947</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,554</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,313)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,241</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,758</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,999</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $39.0 million of identifiable intangible assets related to the developed technology associated with GEMExTra. Developed technology represents purchased technology that had reached technological feasibility and for which Ashion had substantially completed development as of the date of combination. The fair value of the developed technology has been determined using the income approach multi-period excess earnings method, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, and required rate of return and tax rate. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 13 years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the acquired workforce expertise, the capabilities in the advancement of creating and launching new products, including an MRD product, and expected sales force synergies related to the developed technology. The total goodwill related to this combination is deductible for tax purposes.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the developed technology intangible asset.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pro forma impact and results of operations disclosures have not been included due to immateriality.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2021, the Company incurred $1.6&#160;million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations, respectively. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thrive Earlier Detection Corporation</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2021, the Company completed the acquisition (&#8220;Thrive Merger&#8221;) of all of the outstanding capital stock of Thrive. Thrive, headquartered in Cambridge, Massachusetts, is a healthcare company dedicated to incorporating earlier cancer detection into routine medical care. The Company expects that combining Thrive's early-stage screening test, CancerSEEK, with the Company&#8217;s scientific platform, clinical organization and commercial infrastructure will establish the Company as a leading competitor in blood-based, multi-cancer early detection. The Company has included the financial results of Thrive in the consolidated financial statements from the date of the combination.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Thrive was approximately $2.19 billion, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175,431</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,996</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,348</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of replaced equity awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,245</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously held equity investment fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,034</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued 9,323,266 common shares that had a fair value of $1.19 billion based on the average of the high and low market price of the Company's shares on the acquisition date, which was $127.79. Of the total consideration for common stock issued, $1.18 billion was allocated to the purchase consideration and $16.0 million was recorded as compensation within general and administrative expenses in the condensed consolidated statement of operations on the acquisition date due to accelerated vesting of legacy Thrive restricted stock awards (&#8220;RSA&#8221;) and RSU awards in connection with the acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $590.2 million in cash on the acquisition date. Of the total consideration for cash, $585.0 million was allocated to the purchase consideration and $5.2 million was recorded as compensation within general and administrative expenses on the acquisition date due to accelerated vesting of legacy Thrive RSU and RSA awards that were cash-settled in connection with the acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration arrangement requires the Company to pay up to $450.0 million of additional cash consideration to Thrive&#8217;s former shareholders upon the achievement of two discrete events, U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval and Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) coverage, for $150.0 million and up to $300.0 million, respectively. The fair value of the contingent consideration arrangement at the acquisition date was $352.0 million. The fair value of the contingent consideration was estimated using a probability-weighted scenario based discounted cash flow model. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement as defined in ASC 820. The key assumptions are described in Note 7. Of the total fair value of the contingent consideration, $331.3 million was allocated to the consideration transferred, $6.4 million was allocated to the Company&#8217;s previous ownership interest in Thrive, and $14.3 million was deemed compensatory as participation is dependent on replaced unvested equity awards vesting which requires future service. Compensation expense related to the milestones could be up to $18.2 million undiscounted and will be recognized in the future once probable and payable.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company replaced unvested stock options, RSUs, and RSAs and vested stock options with a combination-date fair value of $197.0 million. Of the total consideration for replaced equity awards, $52.2 million was allocated to the consideration transferred and $144.8 million was deemed compensatory as it was attributable to post acquisition vesting. Of the total compensation related to replaced awards, $65.0 million was expensed on the acquisition date due to accelerated vesting of stock options in connection with the acquisition and $79.8 million relates to future services and will be expensed over the remaining service periods of the unvested stock options, RSUs, and RSAs on a straight-line basis. Including expense recognized for accelerated vesting of RSUs and RSAs described above, total expected stock-based compensation expense is $166.0 million, of which $86.2 million was recognized immediately to general and administrative expenses in the condensed consolidated statement of operations due to accelerated vesting. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the stock options assumed by the Company was determined using the Black-Scholes option pricing model. The fair value of the RSA and RSUs assumed by the Company was determined based on the average of the high and low market price of the Company's shares on the acquisition date. The share conversion ratio of 0.06216 was applied to convert Thrive&#8217;s outstanding equity awards for Thrive&#8217;s common stock into equity awards for shares of the Company&#8217;s common stock.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options assumed were based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Plan Shares Assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11% - 0.12%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26 - 1.57</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.54% - 71.00%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share of options assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$109.74 - $124.89</span></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously held a preferred stock investment of $12.5 million in Thrive and recognized a gain of approximately $30.5 million on the transaction within investment income (expense), net on the Company&#8217;s condensed consolidated statement of operations, which represented the adjustment of the Company&#8217;s historical investment to the acquisition date fair value. The fair value of the Company&#8217;s previous ownership in Thrive was determined based on the pro-rata share payout applied to the Company&#8217;s interest combined with the fair value of the Company&#8217;s share of the contingent consideration arrangement, as discussed above.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>January 5, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allocation as of September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,748</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,977</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,977</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564,758</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564,758</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,222)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,222)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,218)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,080)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,622)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,622)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,905)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,905)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,947)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325,809)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238,949</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,105</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D represents the fair value assigned to research and development assets that have not reached technological feasibility. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying product and expected commercial release. The amounts capitalized are accounted for as indefinite-lived intangible assets, subject to impairment testing, until completion or abandonment of the research and development efforts associated with the projects. The Company recorded $1.25 billion of IPR&amp;D related to a project associated with the development of an FDA approved blood-based, multi cancer screening test. The IPR&amp;D asset was valued using the multiple-period excess earnings method approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, required rate of return and tax rate, as well as estimates of achievement probability and timing related to the royalty and milestone obligations due to JHU, as described in Note 10. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the research and development workforce expertise, next generation sequencing capabilities and expected synergies. The total goodwill related to this combination is not deductible for tax purposes.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price allocation is preliminary and based upon estimates and assumptions that are subject to change within the measurement period as additional information for the estimates is obtained. The measurement period remains open pending the completion of valuation procedures related to certain acquired assets and liabilities assumed, primarily in connection with the IPR&amp;D asset, as well as finalization of the pre-combination income tax returns.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net loss before tax of Thrive included in the Company&#8217;s condensed consolidated statement of operations from the combination date of January 5, 2021 to September&#160;30, 2021 was $219.6 million. The net loss before tax of Thrive included in the Company&#8217;s condensed consolidated statement of operations for the three months ended September 30, 2021 was $39.6 million.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,797)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited pro forma financial information for all periods presented above has been calculated after adjusting the results of Thrive to reflect the business combination accounting effects resulting from this combination. The Company incurred $86.2 million of stock-based compensation expense related to accelerated vesting in connection with the acquisition, $13.5 million of stock-based compensation expense related to accelerated vesting for employees with qualifying termination events, and $10.3 million of transaction costs incurred to execute the acquisition during the first quarter of 2021. These expenses are included in general and administrative expenses on the condensed consolidated statement of operations for the nine months ended September 30, 2021 and are reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a realized gain of $30.5 million during the first quarter of 2021 in investment income (expense), net on the Company&#8217;s condensed consolidated statement of operations relating to the Company&#8217;s pre-acquisition investment in Thrive. This gain has been reduced to $7.6&#160;million due to the Company&#8217;s smaller ownership interest in Thrive on January 1, 2020, and is reflected in pro forma earnings for the nine months ended September 30, 2020 in the table above. The Company recorded a remeasurement of contingent consideration of $10.5 million related to Thrive in general and administrative expenses in the condensed consolidated statement of operations for the nine months ended September 30, 2021. This expense is reflected in the nine months ended September 30, 2020 in the table above. The historical consolidated financial statements have been adjusted in the unaudited pro forma combined financial information to give effect to pro forma events that are directly attributable to the business combination and factually supportable. The unaudited pro forma financial information is for informational purposes only and is not indicative of the results of operations that would have been achieved if the combination had taken place as of January 1, 2020.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2021, the Company incurred $10.3 million of acquisition-related costs recorded in general and administrative expenses in the condensed consolidated statement of operations. These costs include fees associated with financial, legal, accounting and other advisors incurred to complete the merger.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with acquisition-related severances, the Company recorded $4.5 million of expense related to vesting of previously unvested equity awards and $1.2 million of additional benefit charges for the three months ended September 30, 2021. The Company recorded $19.0 million of expense related to vesting of previously unvested equity awards and $3.9 million of additional benefit charges for the nine months ended September 30, 2021.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Paradigm Diagnostics, Inc. and Viomics, Inc.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2020, the Company acquired all of the outstanding capital stock of Paradigm and Viomics, two related party companies of one another headquartered in Phoenix, Arizona, in transactions that were deemed to be a single business combination in accordance with ASC 805, Business Combinations, (&#8220;the Paradigm Acquisition&#8221;). Paradigm provides comprehensive genomic-based profiling tests that assist in the diagnosis and therapy recommendations for late-stage cancer. Viomics provides a platform for identification of biomarkers.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into this acquisition to enhance its product portfolio in cancer diagnostics and to enhance its capabilities for biomarker identification.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition date fair value of the consideration to be transferred for Paradigm and Viomics was $40.4 million, which consists of $32.2&#160;million payable in shares of the Company&#8217;s common stock and $8.2&#160;million which was settled through a cash payment. Of the $32.2&#160;million to be settled through the issuance of common stock, $28.8&#160;million was issued as of September&#160;30, 2021, and the remaining $3.4&#160;million, which was withheld and may become payable as additional merger consideration, is included in other current liabilities in the condensed consolidated balance sheet as of September&#160;30, 2021. The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>March 3, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Allocation<br/>March 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(760)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measurement period adjustments primarily related to accounts receivable valuation and working capital adjustments.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of identifiable intangible assets has been determined using the income approach, which involves significant unobservable inputs (Level 3 inputs). These inputs include projected sales, margin, weighted average cost of capital and tax rate.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology represents purchased technology that had reached technological feasibility and for which development had been completed as of the acquisition date. Fair value was determined using future discounted cash flows related to the projected income stream of the developed technology for a discrete projection period. Cash flows were discounted to their present value as of the closing date. Developed technology is amortized on a straight-line basis over its estimated useful life of 15 years.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill, which is primarily attributed to the assembled workforce, and expected synergies. The total goodwill related to this acquisition is not deductible for tax purposes.  </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company agreed to issue to the previous investors in Viomics equity interests with an acquisition-date fair value of up to $8.4&#160;million in Viomics, vesting over 4 years based on certain retention arrangements. Payment is contingent upon continued employment with the Company over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMTc2MDc_be290d9b-1b83-4c99-8517-2779a24af94d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmZkOTQyZDljYWY2NjQ5MjViOTYxZmI0ZjhkOGY2ODVkL3NlYzpmZDk0MmQ5Y2FmNjY0OTI1Yjk2MWZiNGY4ZDhmNjg1ZF84Mi9mcmFnOjk4MTdkZmE2ZWUzMTRkN2ZhOGY1ZjcxMDUzNmQyNGU0L3RleHRyZWdpb246OTgxN2RmYTZlZTMxNGQ3ZmE4ZjVmNzEwNTM2ZDI0ZTRfMjEwNDQ_6f076965-3d7f-4189-abe5-ea96d0bf18bb">four</span></span> year vesting period and is recognized as stock-based compensation expense in general and administrative expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asset Acquisitions</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PFS Genomics Inc. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 3, 2021, the Company acquired 90% of the outstanding capital stock of PFS Genomics Inc. (&#8220;PFS&#8221;). On June 23, 2021, the Company completed the acquisition of the remaining 10% interest in PFS. The Company paid cash of $33.6 million for 100% of the outstanding capital stock in PFS. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PFS is a healthcare company focused on personalizing treatment for breast cancer patients to improve outcomes and reduce unnecessary treatment. The Company expects this acquisition to expand its ability to help guide early-stage breast cancer treatment through individualized radiotherapy treatment decisions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction was treated as an asset acquisition under GAAP because substantially all of the fair value of the gross assets acquired were deemed to be associated with the acquired technology.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets acquired and liabilities assumed were substantially comprised of the IPR&amp;D asset as shown in the table below. The IPR&amp;D asset acquired was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition in accordance with the accounting standards codification guidance for business combinations, whereby the total purchase price was allocated to the acquired net tangible and intangible assets based on their estimated fair values as of the closing date. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition related costs were not material in this asset acquisition. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisition of PFS Genomics outstanding shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,074</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">TARDIS License Agreement </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2021, the Company entered into a worldwide exclusive license to the proprietary TARDIS technology from TGen, an affiliate of City of Hope. Under the agreement, the Company acquired a royalty-free, worldwide exclusive license to proprietary TARDIS patents and know-how. The Company intends to develop and commercialize the TARDIS technology as a minimal residual disease test. The Company accounted for this transaction as an asset acquisition. In connection with the asset acquisition, the Company paid upfront fair value consideration of $52.3 million comprised of $25.0 million in cash and issuance of 0.2&#160;million shares of common stock valued at $27.3 million based on the average of the high and low market price of the Company&#8217;s shares on the acquisition date. In addition, the Company is obligated to make milestone payments to TGen of $10.0 million and $35.0 million upon achieving cumulative product revenue related to MRD detection and/or treatment totaling $100.0 million and $250.0 million, respectively. These payments are contingent upon achievement of these cumulative revenues on or before December 31, 2030. The upfront consideration was recorded to research and development expense in the condensed consolidated statement of operations immediately after acquisition as the asset was deemed to be incomplete and had no alternative future use at the time of acquisition. The Company will record the sales milestones once achievement is deemed probable. No acquisition related costs were incurred in this asset acquisition during the three and nine months ended September&#160;30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 15<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6911878&amp;loc=d3e8732-128492<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810903031448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATIONManagement determined that the Company functions as a single operating segment, and thus reports as a single reportable segment. This operating segment is focused on the development and global commercialization of clinical laboratory services allowing healthcare providers and patients to make individualized treatment decisions. Management assessed the discrete financial information routinely reviewed by the Company's Chief Operating Decision Maker, its President and Chief Executive Officer, to monitor the Company's operating performance and support decisions regarding allocation of resources to its operations. Performance is continuously monitored at the consolidated level to timely identify deviations from expected results. <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total revenue from customers by geographic region. Product revenues are attributed to countries based on ship-to location.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,150&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,120&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,142&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968,825&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets located in countries outside of the United States are not significant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904071208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax benefit of $3.9 million and $2.8 million for the three months ended September 30, 2021 and 2020, respectively. The Company recorded an income tax benefit of $242.6 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. The Company&#8217;s income tax expense recorded during the three months ended September 30, 2021 is primarily related to foreign tax expense, as well as the future limitations on and expiration of certain Federal and State deferred tax assets. The Company&#8217;s income tax benefit recorded during the nine months ended September 30, 2021 is primarily related to an income tax benefit of $239.2 million recorded as a result of the change in the deferred tax asset valuation allowance resulting from the Thrive Merger. A deferred tax liability of approximately $32.7 million was recorded as of September&#160;30, 2021, which is included in other long-term liabilities on the Company&#8217;s condensed consolidated balance sheet. The Company continues to maintain a full valuation allowance against its deferred tax assets based on management&#8217;s determination that it is more likely than not the benefit will not be realized.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had $17.7 million and $16.6 million of unrecognized tax benefits at September&#160;30, 2021 and December&#160;31, 2020, respectively. These amounts have been recorded as a reduction to the Company&#8217;s deferred tax asset, if recognized they would not have an impact on the effective tax rate due to the existing valuation allowance. Certain of the Company's unrecognized tax benefits could change due to activities of various tax authorities, including possible settlement of audits, or through normal expiration of various statutes of limitations. The Company does not expect a material change in unrecognized tax benefits in the next twelve months.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, due to the carryforward of unutilized net operating losses and research and development credits, the Company is subject to U.S. federal income tax examinations for the tax years 2001 through 2021, and to state income tax examinations for the tax years 2001 through 2021. No interest or penalties related to income taxes have been accrued or recognized as of September&#160;30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908671704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text">Basis of Presentation and Principles of ConsolidationThe accompanying condensed consolidated financial statements, which include the accounts of Exact Sciences Corporation and those of its wholly owned subsidiaries and variable interest entities, are unaudited and have been prepared on a basis substantially consistent with the Company&#8217;s audited financial statements and notes as of and for the year ended December&#160;31, 2020 included in the Company&#8217;s Annual Report on Form 10-K (the &#8220;2020 Form 10-K&#8221;). All intercompany transactions and balances have been eliminated upon consolidation. These condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and follow the requirements of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim reporting. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting only of adjustments of a normal and recurring nature) considered necessary for a fair statement of its financial position, operating results and cash flows for the periods presented. The condensed consolidated balance sheet at December&#160;31, 2020 has been derived from audited financial statements, but does not contain all of the footnote disclosures from the 2020 Form 10-K. The results of the Company&#8217;s operations for any interim period are not necessarily indicative of the results of the Company&#8217;s operations for any other interim period or for a full fiscal year. The statements should be read in conjunction with the audited financial statements and related notes included in the 2020 Form 10-K.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those that affect the Company&#8217;s financial statements materially and involve difficult, subjective or complex judgments by management, and actual results could differ from those estimates. These estimates include revenue recognition, valuation of intangible assets and goodwill, and accounting for income taxes among others. The Company&#8217;s critical accounting policies and estimates are explained further in the notes to the condensed consolidated financial statements in this Quarterly Report and the 2020 Form 10-K.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of the coronavirus (&#8220;COVID-19&#8221;) has affected many segments of the global economy, including the cancer screening and diagnostics industry. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of September&#160;30, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, equity investments, software, and the carrying value of the goodwill and other long-lived assets. The Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and related precautionary measures began to materially disrupt the Company's operations in March 2020 and may continue to disrupt the business for an unknown period of time. As a result, the pandemic impacted the Company's revenues and operating results for the three and nine months ended September&#160;30, 2021. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of COVID-19 depends on factors beyond the Company&#8217;s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the extent to which COVID-19 will negatively impact its financial results or liquidity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">ReclassificationsCertain prior year amounts have been reclassified to conform to the current year presentation in the condensed consolidated financial statements and accompanying notes to the condensed consolidated financial statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, The Financial Accounting Standards Board issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt &#8211; Debt with Conversion and Other Options (subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update simplifies the accounting for convertible debt instruments by removing the beneficial conversion and cash conversion separation models for convertible instruments. Under the update, the embedded conversion features are no longer separated from the host contract for convertible instruments with conversion features that are not required to be accounted for as derivatives or that do not result in substantial premiums accounted for as paid-in capital. The update also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and the treasury stock method will no longer be available. This standard may be adopted through either a modified retrospective method of transition or a full retrospective method of transition. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted the standard on January 1, 2021 through application of the full retrospective method of transition. This method of adoption was applied to enhance comparability between the periods presented in the Company&#8217;s financial statements. The Company applied the standard to convertible notes outstanding as of the date of the first offering of the Company&#8217;s outstanding convertible notes as discussed in Note 9. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s convertible debt instruments will be accounted for as a single liability measured at its amortized cost. The notes are no longer bifurcated between debt and equity, rather accounted for entirely as debt at face value net of any discount or premium and issuance costs. Interest expense is comprised of (1) cash interest payments, (2) amortization of any debt discounts or premiums based on the original offering, and (3) amortization of any debt issuance costs. Gain or loss on extinguishment of convertible notes is calculated as the difference between the (i) fair value of the consideration transferred and (ii) the sum of the carrying value of the debt at the time of repurchase. </span></div>As of January 1, 2019, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $260.2&#160;million, a decrease in accumulated deficit of $26.6&#160;million, and an increase to net deferred tax assets of $55.7&#160;million offset by a corresponding increase of $55.7&#160;million in the valuation allowance. As of January 1, 2020, the cumulative effect of adoption resulted in a decrease in additional-paid-in-capital of $227.8&#160;million, an increase in accumulated deficit of $102.6&#160;million, and an increase to the net deferred tax assets of $83.2&#160;million offset by a corresponding increase of $74.7&#160;million in the valuation allowance resulting in a net decrease of $8.5&#160;million in recorded deferred tax liabilities. As of December 31, 2020, the cumulative effect of adoption resulted in an increase in the net carrying amount of convertible notes, net, current portion of $57.3&#160;million and convertible notes, net, less current portion of $540.9&#160;million, a decrease in additional-paid-in-capital of $510.3&#160;million, an increase in accumulated deficit of $77.7&#160;million, and an increase to net deferred tax assets of $146.0&#160;million offset by a corresponding increase of $135.8&#160;million in the valuation allowance resulting in a net decrease of $10.2&#160;million in recorded deferred tax liabilities. For the three months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $19.1&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs, income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, decreased by $0.12 per share. For the nine months ended September 30, 2020, interest expense in the condensed consolidated statement of operations decreased by $8.3&#160;million as a result of a decrease in amortization of debt discounts, premiums, and issuance costs of $51.2&#160;million, which was offset by an increase in loss on extinguishment of $42.9&#160;million in connection with the extinguishment of $100.0&#160;million face value of 2025 Notes. Income tax benefit decreased by $1.8&#160;million and net loss per share, basic and diluted, increased by $0.04 per share.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per common share was determined by dividing net loss applicable to common stockholders by the weighted average common shares outstanding during the period. Basic and diluted net loss per share is the same because all outstanding common stock equivalents have been excluded, as they are anti-dilutive as a result of the Company&#8217;s losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904331752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially issuable common shares were not included in the computation of diluted net loss per share because they would have an anti-dilutive effect due to net losses for each period:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable in connection with acquisitions (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the release of restricted stock awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the release of performance share units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon conversion of convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,903&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div>(1)During the third quarter of 2021, shares were issued related to holdback amounts on the previously closed acquisition of Viomics, Inc. (&#8220;Viomics&#8221;). The remaining issuable shares relate to the previously closed acquisition of Paradigm Diagnostics, Inc. (&#8220;Paradigm&#8221;).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904179560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenue</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s revenues disaggregated by revenue source:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:18pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Screening</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Parts B &amp; C</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">419,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">280,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Screening</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">280,378&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">214,623&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">784,643&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">565,407&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Precision Oncology</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Parts B &amp; C</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,493&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Precision Oncology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145,412&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,579&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">412,628&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">322,905&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 Testing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,589&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,161&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,004&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,740&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904178664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of cash and cash equivalents</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">274,076&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,491,594&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,688&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,699&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents, restricted cash and marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of restricted cash and cash equivalents</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s cash, cash equivalents, restricted cash, and marketable securities at September&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">274,076&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,491,594&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,688&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,699&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cash and cash equivalents, restricted cash and marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840,293&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of available-for-sale securities</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities at September&#160;30, 2021 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,487&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">941,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Gains and losses in accumulated other comprehensive income (loss) (&#8220;AOCI&#8221;) are reported before tax impact.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities at December&#160;31, 2020 consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In&#160;thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1) </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses in Accumulated<br/>Other Comprehensive<br/>Income (Loss) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,986&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346,490&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,178&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936,476&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,172&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Gains and losses in AOCI are reported before tax impact.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of contractual maturities of available-for-sale investments</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes contractual underlying maturities of the Company&#8217;s available-for-sale debt securities at September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.527%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Due one year or less</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Due after one year through five&#160;years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,534&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428,711&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of gross unrealized losses and fair values of investments in an unrealized loss position</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the gross unrealized losses and fair values of available-for-sale debt securities in an unrealized loss position as of September&#160;30, 2021, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.414%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt;text-indent:18pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Less than one year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">One year or greater</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Unrealized Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total available-for-sale securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904057048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,971&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,083&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Semi-finished and finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,167&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,265&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810903025720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property, plant and equipment, net</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated useful lives of property, plant and equipment are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 - 40 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and computer software</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under construction</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719,487&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,524&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,538)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524,200&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,986&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Lesser of remaining lease term, building life, or estimated useful life.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906291000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of net-book value and estimated remaining life and finite lived intangible assets</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net-book-value and estimated remaining life of the Company&#8217;s intangible assets as of September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,427)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">969,308&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174,350)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219,308&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174,350)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,044,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net-book-value and estimated remaining life of the Company&#8217;s intangible assets as of December&#160;31, 2020:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Remaining Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December&#160;31, 2020</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,258)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,422)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">814,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(93,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">720,893&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">958,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110,889)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of estimated future amortization expense, intangible assets</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2021, the estimated future amortization expense associated with the Company&#8217;s finite-lived intangible assets for each of the five succeeding fiscal years is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,053&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,868&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of carrying amount of goodwill</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the carrying amount of goodwill for the periods ended September&#160;30, 2021 and December&#160;31, 2020 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,197&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paradigm &amp; Viomics acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,431&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Genomic Health acquisition adjustment (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,044&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237,672&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thrive acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,105&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ashion Acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242,535&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company recognized a measurement period adjustment to goodwill related to an increase in Genomic Health&#8217;s pre-acquisition deferred tax liability due to finalization of certain income-tax related items.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904237144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of fair value measurements along with the level within the fair value hierarchy in which the fair value measurements fall</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value measurements as of September&#160;30, 2021 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active Markets<br/>for Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273,779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">857,657&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,076&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">944,688&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361,107)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The equity securities held are classified as Level 2 as they are subject to a short-term lock-up restriction and have been discounted from the observable market prices of the similar unrestricted equity securities. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value measurements as of December&#160;31, 2020 along with the level within the fair value hierarchy in which the fair value measurements, in their entirety, fall.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active Markets<br/>for Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant Other<br/>Observable Inputs<br/>(Level&#160;2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agency securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,477)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,477)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">903,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,172&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,477)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of fair value of contingent consideration</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balances of contingent consideration:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,477&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase price contingent consideration (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,986&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance, September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,647&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div>(1)The increase in the contingent consideration liability is due to the contingent consideration associated with the acquisitions of Ashion Analytics, LLC (&#8220;Ashion&#8221;) and Thrive Earlier Detection Corporation (&#8220;Thrive&#8221;). Refer to Note 17 for further information.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810907579304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CONVERTIBLENOTESAbstract', window );"><strong>CONVERTIBLE NOTES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of convertible note obligations included in the condensed consolidated balance sheets</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of September&#160;30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (2)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Discount and Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leveling</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,596)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130,404&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222,968&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,257)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Convertible notes - 1.000% (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,901)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note obligations included in the condensed consolidated balance sheet consisted of the following as of December&#160;31, 2020:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value (2)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unamortized Debt Discount and Issuance Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leveling</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,878)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128,122&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,526,625&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Convertible notes - 0.375%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,937)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Convertible notes - 1.000% (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Based on the Company&#8217;s share price on the days leading up to September&#160;30, 2021 and December 31, 2020, holders of the 2025 Convertible Notes have the right to convert their debentures. As a result, the 2025 Convertible Notes are included within convertible notes, net, current portion on the condensed consolidated balance sheets. Some holders did convert their debentures, resulting in a decrease of the principal amount of the 2025 Convertible Notes. </span></div>(2)The fair values are based on observable market prices for this debt, which is traded in active markets and therefore is classified as a Level 2 fair value measurement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock', window );">Schedule of allocation of transaction costs related to convertible debt</a></td>
<td class="text">The following table summarizes the original issuance costs at the time of issuance for each set of Notes:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2025 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,284&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_InterestExpenseDebtTableTextBlock', window );">Schedule of interest expense</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,443&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,284&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,860&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on settlement of convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Coupon interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense on convertible notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,047&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,047&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,093&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,838&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,544&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,680&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,478&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CONVERTIBLENOTESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CONVERTIBLE NOTES</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CONVERTIBLENOTESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_InterestExpenseDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total debt interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_InterestExpenseDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Allocation of Transaction Costs Related to Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904134552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of amounts recognized in accumulated other comprehensive income (loss) (AOCI)</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount recognized in AOCI for the nine months ended September&#160;30, 2021 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gain (Loss)<br/>on Marketable<br/>Securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period change in accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(563)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense related to items of other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts recognized in AOCI for the nine months ended September 30, 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gain (Loss)<br/>on Marketable<br/>Securities (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period change in accumulated other comprehensive loss, before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div>(1)There was no tax impact from the amounts recognized in AOCI for the three and nine months ended September&#160;30, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Schedule of amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI for the nine months ended September&#160;30, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.970%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.161%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Affected Line Item in the<br/>Statements of Operations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Details about AOCI Components (In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of available-for-sale investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and maturities of available-for-sale investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909268504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of valuation assumptions</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of each service-based option award on the date of grant using the Black-Scholes option-pricing model, which utilizes several key assumptions which are disclosed in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Plan Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11% - 1.47%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 - 6.15</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.19% - 77.51%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Company did not grant stock options under its 2010 Omnibus Long-Term Incentive Plan or 2019 Omnibus Long-Term Incentive Plan during the period. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under the Stock Plans is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term(Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value(2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Aggregate intrinsic value in thousands)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,231,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed through acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,393,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,208,355)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379,543&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.81&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest, September&#160;30, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,379,543&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.81&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,337&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,816,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.17&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,826&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of options granted during the nine months ended September&#160;30, 2020 was $58.57. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The total intrinsic value of options exercised during the nine months ended September&#160;30, 2021 and 2020 was $148.8 million and $29.0 million, respectively, determined as of the date of exercise.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of restricted stock and restricted stock unit activity under the Stock Plans</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of restricted stock and restricted stock unit activity during the nine months ended September&#160;30, 2021 is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted stock and restricted stock units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average Grant<br/>Date Fair Value (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,968,214&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.50&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,084,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed through acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,582,760)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,201)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,306,081&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The fair value of restricted stock units vested and converted to shares of the Company&#8217;s common stock was $114.4 million and $79.1 million during the nine months ended September&#160;30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The weighted average grant date fair value of the restricted stock units granted during the nine months ended September&#160;30, 2020 was $90.95.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Share-based payment arrangement, performance shares, activity</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of performance share-based compensation arrangements granted under all equity compensation unit activity is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance share units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average Grant<br/>Date Fair Value (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">618,515&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.22&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,991)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding, September 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,644&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.49&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The performance share units listed above assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding performance share units as of September&#160;30, 2021 was 249,695. </span></div>(2)The weighted average grant date fair value of the performance share units granted during the nine months ended September&#160;30, 2020 was $90.17.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of share-based payment award, employee stock purchase plan, valuation assumptions</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of ESPP shares is based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04% - 0.16%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.12% - 0.20%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.38% - 68.51%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.67% - 89.04%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________</span></div>(1)The Company did not issue stock purchase rights under its 2010 Employee Stock Purchase Plan during the three months ended September&#160;30, 2021 and 2020, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904188184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental disclosure of cash flow information related to our operating leases</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental disclosure of cash flow information related to the Company&#8217;s cash and non-cash activities with its leases are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,835</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,827</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance cash flows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,805</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities (1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,480</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,662</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,296</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,420</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - operating leases (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.14</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.95</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term - finance leases (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.86</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the nine months ended September&#160;30, 2021, this includes right-of-use assets acquired as part of the business combinations described in Note 17 of $39.6 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909064424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of business acquisitions, by acquisition</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Ashion was approximately $110.0 million, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,775</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,224</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,999</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination date fair value of the consideration transferred for Thrive was approximately $2.19 billion, which consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175,431</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,996</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,348</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of replaced equity awards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,245</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Previously held equity investment fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,034</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of recognized identified assets acquired and liabilities assumed</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,474</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,811</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,947</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,554</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(343)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,313)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net identifiable assets acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,241</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,758</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,999</span></td></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>January 5, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allocation as of September&#160;30, 2021</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,748</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241,748</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,977</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,977</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development (IPR&amp;D)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564,758</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,564,758</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,222)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,222)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,218)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,080)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, less current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,622)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,622)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,905)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(272,905)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities assumed </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323,947)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325,809)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net identifiable assets acquired </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,862)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,238,949</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946,243</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,862</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,105</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,187,054</span></td></tr></table></div>The purchase price was allocated to the underlying assets acquired and liabilities assumed based upon their estimated fair values as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Preliminary Allocation<br/>March 3, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Final Allocation<br/>March 3, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,133&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(760)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,373&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,800&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,505&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,401&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed: </span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consideration</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for acquisition of PFS Genomics outstanding shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets acquired and liabilities assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,074</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,569</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of share-based payment award, stock options, valuation assumptions</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options assumed were based on the assumptions in the following table:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Plan Shares Assumed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11% - 0.12%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.26 - 1.57</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.54% - 71.00%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value per share of options assumed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$109.74 - $124.89</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business acquisition, pro forma information</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following unaudited pro forma financial information summarizes the combined results of operations for the Company and Thrive, as though the companies were combined as of the beginning of January 1, 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.537%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170,797)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224,860)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(575,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904846984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from external customers by geographic areas</a></td>
<td class="text"><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total revenue from customers by geographic region. Product revenues are attributed to countries based on ship-to location.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429,150&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,120&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,142&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968,825&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside of United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,133&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">408,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025,052&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906003544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent Accounting Pronouncements (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,457,590<span></span>
</td>
<td class="nump">$ 1,730,686<span></span>
</td>
<td class="nump">$ 3,457,590<span></span>
</td>
<td class="nump">$ 1,730,686<span></span>
</td>
<td class="nump">$ 3,559,101<span></span>
</td>
<td class="nump">$ 3,648,995<span></span>
</td>
<td class="nump">$ 2,235,552<span></span>
</td>
<td class="nump">$ 1,887,433<span></span>
</td>
<td class="nump">$ 1,895,843<span></span>
</td>
<td class="nump">$ 1,957,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Increase in current portion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Increase in convertible notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,865,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,680)<span></span>
</td>
<td class="num">(4,478)<span></span>
</td>
<td class="num">(13,948)<span></span>
</td>
<td class="num">(63,382)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,858)<span></span>
</td>
<td class="num">$ (2,752)<span></span>
</td>
<td class="num">$ (242,638)<span></span>
</td>
<td class="num">$ (5,294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increase (decrease) in net loss per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="num">$ (1.35)<span></span>
</td>
<td class="num">$ (2.19)<span></span>
</td>
<td class="num">$ (2.71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increase (decrease) in net loss per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.97)<span></span>
</td>
<td class="num">$ (1.35)<span></span>
</td>
<td class="num">$ (2.19)<span></span>
</td>
<td class="num">$ (2.71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of convertible notes</a></td>
<td class="nump">$ 50,800<span></span>
</td>
<td class="nump">$ 187,700<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,876,644<span></span>
</td>
<td class="nump">3,355,660<span></span>
</td>
<td class="nump">5,876,644<span></span>
</td>
<td class="nump">3,355,660<span></span>
</td>
<td class="nump">5,811,286<span></span>
</td>
<td class="nump">5,723,977<span></span>
</td>
<td class="nump">4,279,327<span></span>
</td>
<td class="nump">3,309,468<span></span>
</td>
<td class="nump">3,252,998<span></span>
</td>
<td class="nump">3,178,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Accumulated Deficit&#8203;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,420,910)<span></span>
</td>
<td class="num">(1,627,563)<span></span>
</td>
<td class="num">$ (2,420,910)<span></span>
</td>
<td class="num">(1,627,563)<span></span>
</td>
<td class="num">$ (2,253,972)<span></span>
</td>
<td class="num">$ (2,077,060)<span></span>
</td>
<td class="num">(2,045,896)<span></span>
</td>
<td class="num">$ (1,425,025)<span></span>
</td>
<td class="num">$ (1,356,933)<span></span>
</td>
<td class="num">(1,222,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member', window );">2025 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,200<span></span>
</td>
<td class="nump">$ 55,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,700<span></span>
</td>
<td class="nump">55,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Increase in current portion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Increase in convertible notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increase (decrease) in net loss per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increase (decrease) in net loss per share (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Decrease in amortization debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(510,300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(227,800)<span></span>
</td>
<td class="num">(260,200)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit&#8203;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (77,700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (102,600)<span></span>
</td>
<td class="nump">$ 26,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908820040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Common shares not included in the computation of diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="nump">27,903<span></span>
</td>
<td class="nump">27,549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=exas_SharesIssuedUponAcquisitionMember', window );">Shares issuable in connection with acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Common shares not included in the computation of diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=exas_EmployeeAndNonEmployeesStockOptionMember', window );">Shares issuable upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Common shares not included in the computation of diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="nump">2,380<span></span>
</td>
<td class="nump">2,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Shares issuable upon the release of restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Common shares not included in the computation of diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="nump">4,306<span></span>
</td>
<td class="nump">4,035<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Shares issuable upon the release of performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Common shares not included in the computation of diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="nump">863<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember', window );">Shares issuable upon conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Common shares not included in the computation of diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect</a></td>
<td class="nump">20,309<span></span>
</td>
<td class="nump">20,309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=exas_SharesIssuedUponAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=exas_SharesIssuedUponAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=exas_EmployeeAndNonEmployeesStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=exas_EmployeeAndNonEmployeesStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908467240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">$ 456,379<span></span>
</td>
<td class="nump">$ 408,363<span></span>
</td>
<td class="nump">$ 1,293,275<span></span>
</td>
<td class="nump">$ 1,025,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_ScreeningMember', window );">Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">280,378<span></span>
</td>
<td class="nump">214,623<span></span>
</td>
<td class="nump">784,643<span></span>
</td>
<td class="nump">565,407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_ScreeningMember', window );">Screening | Medicare Parts B &amp; C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">116,088<span></span>
</td>
<td class="nump">98,847<span></span>
</td>
<td class="nump">329,034<span></span>
</td>
<td class="nump">256,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_ScreeningMember', window );">Screening | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">151,245<span></span>
</td>
<td class="nump">106,002<span></span>
</td>
<td class="nump">419,268<span></span>
</td>
<td class="nump">280,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_ScreeningMember', window );">Screening | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">13,045<span></span>
</td>
<td class="nump">9,774<span></span>
</td>
<td class="nump">36,341<span></span>
</td>
<td class="nump">28,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember', window );">Precision Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">145,412<span></span>
</td>
<td class="nump">91,579<span></span>
</td>
<td class="nump">412,628<span></span>
</td>
<td class="nump">322,905<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember', window );">Precision Oncology | Medicare Parts B &amp; C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">51,607<span></span>
</td>
<td class="nump">33,945<span></span>
</td>
<td class="nump">142,428<span></span>
</td>
<td class="nump">114,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember', window );">Precision Oncology | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">42,844<span></span>
</td>
<td class="nump">37,402<span></span>
</td>
<td class="nump">145,821<span></span>
</td>
<td class="nump">137,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember', window );">Precision Oncology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">27,229<span></span>
</td>
<td class="nump">16,243<span></span>
</td>
<td class="nump">80,133<span></span>
</td>
<td class="nump">56,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember', window );">Precision Oncology | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">23,732<span></span>
</td>
<td class="nump">3,989<span></span>
</td>
<td class="nump">44,246<span></span>
</td>
<td class="nump">14,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceOrProductTypeAxis=exas_COVID19TestingMember', window );">COVID-19 Testing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue recognized</a></td>
<td class="nump">$ 30,589<span></span>
</td>
<td class="nump">$ 102,161<span></span>
</td>
<td class="nump">$ 96,004<span></span>
</td>
<td class="nump">$ 136,740<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ServiceOrProductTypeAxis=exas_ScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ServiceOrProductTypeAxis=exas_ScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ServiceOrProductTypeAxis=exas_PrecisionOncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=exas_InternationalSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=exas_InternationalSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ServiceOrProductTypeAxis=exas_COVID19TestingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ServiceOrProductTypeAxis=exas_COVID19TestingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810907150856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue, revenue recognized during period</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">24,600<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=exas_COVID19Member', window );">COVID-19</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">17,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue, revenue recognized during period</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=exas_VariablePriceContractMember', window );">Variable consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice', window );">Revenue recognized (downward adjustments) from changes in transaction prices</a></td>
<td class="num">$ (200)<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="num">$ (13,200)<span></span>
</td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=exas_COVID19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=exas_COVID19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerBasisOfPricingAxis=exas_VariablePriceContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerBasisOfPricingAxis=exas_VariablePriceContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905768648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Schedule of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 274,076<span></span>
</td>
<td class="nump">$ 1,491,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">941,620<span></span>
</td>
<td class="nump">937,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total marketable securities</a></td>
<td class="nump">944,688<span></span>
</td>
<td class="nump">348,699<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total cash and cash equivalents, restricted cash and marketable securities</a></td>
<td class="nump">1,218,764<span></span>
</td>
<td class="nump">1,840,293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">589,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">941,620<span></span>
</td>
<td class="nump">347,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=exas_CashAndMoneyMarketMember', window );">Cash and money market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">273,779<span></span>
</td>
<td class="nump">901,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=exas_RestrictedCashMember', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 297<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=exas_CashAndMoneyMarketMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=exas_CashAndMoneyMarketMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=exas_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=exas_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905821336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Schedule of Available For Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 941,487<span></span>
</td>
<td class="nump">$ 936,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="num">(146)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">941,620<span></span>
</td>
<td class="nump">937,172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">346,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">941,620<span></span>
</td>
<td class="nump">347,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">368,662<span></span>
</td>
<td class="nump">132,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">368,832<span></span>
</td>
<td class="nump">132,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">276,146<span></span>
</td>
<td class="nump">207,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="num">(84)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">276,081<span></span>
</td>
<td class="nump">207,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">175,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">175,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset backed securities | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">111,171<span></span>
</td>
<td class="nump">7,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 111,164<span></span>
</td>
<td class="nump">$ 7,094<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810990277016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Schedule of Underlying Maturities of AFS Securities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Cost</a></td>
<td class="nump">$ 428,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">428,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Cost</a></td>
<td class="nump">512,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">512,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Cost</a></td>
<td class="nump">7,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">7,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Cost</a></td>
<td class="nump">269,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">269,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Cost</a></td>
<td class="nump">235,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">236,101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Cost</a></td>
<td class="nump">132,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">132,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Cost</a></td>
<td class="nump">175,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">175,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Cost</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities | Asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Cost</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Cost</a></td>
<td class="nump">111,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">111,164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember', window );">Marketable securities | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Available-for-sale securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in one year or less, Cost</a></td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less, Fair Value</a></td>
<td class="nump">10,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years, Cost</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years, Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906082888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Schedule of Gross Unrealized Losses And Fair Value of Available For Sale Securities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="nump">$ 511,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="nump">511,190<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bonds | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="nump">155,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="nump">155,043<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="nump">15,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="nump">15,650<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset backed securities | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="nump">81,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="nump">81,478<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government agency securities | Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="nump">259,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months</a></td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total fair value of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="nump">259,019<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position</a></td>
<td class="num">$ (84)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906727576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MARKETABLE SECURITIES - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Equity securities, realized gain (loss)</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="num">$ (300)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904417864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Raw materials</a></td>
<td class="nump">$ 47,971<span></span>
</td>
<td class="nump">$ 43,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_InventoryFinishedAndSemiFinishedGoods', window );">Semi-finished and finished goods</a></td>
<td class="nump">47,196<span></span>
</td>
<td class="nump">49,182<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 95,167<span></span>
</td>
<td class="nump">$ 92,265<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_InventoryFinishedAndSemiFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise/goods and merchandise/goods expected to be completed within one year of operating cycle that are expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_InventoryFinishedAndSemiFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810907122232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT - Schedule of Estimated Useful Lives (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 719,487<span></span>
</td>
<td class="nump">$ 589,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(195,287)<span></span>
</td>
<td class="num">(137,538)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">524,200<span></span>
</td>
<td class="nump">451,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">4,466<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_BuildingsAndLeaseholdImprovementsMember', window );">Leasehold and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 142,025<span></span>
</td>
<td class="nump">117,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 4,894<span></span>
</td>
<td class="nump">4,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 201,040<span></span>
</td>
<td class="nump">200,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_OfficeEquipmentAndComputerSoftwareMember', window );">Computer equipment and computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 99,889<span></span>
</td>
<td class="nump">75,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">175,393<span></span>
</td>
<td class="nump">142,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">27,593<span></span>
</td>
<td class="nump">24,968<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember', window );">Assets under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 64,187<span></span>
</td>
<td class="nump">$ 18,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_BuildingsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_BuildingsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_OfficeEquipmentAndComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_OfficeEquipmentAndComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906080456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 22,300<span></span>
</td>
<td class="nump">$ 19,700<span></span>
</td>
<td class="nump">$ 64,300<span></span>
</td>
<td class="nump">$ 53,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">719,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">719,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 589,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember', window );">Assets under construction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">64,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,854<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">175,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Assets under construction</a></td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_BuildingsAndLeaseholdImprovementsMember', window );">Leasehold and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">142,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Assets under construction</a></td>
<td class="nump">40,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Assets under construction</a></td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember', window );">Land improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">4,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Assets under construction</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetUnderConstructionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_BuildingsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_BuildingsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810907460664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 969,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(174,350)<span></span>
</td>
<td class="num">$ (110,889)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">794,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Finite-lived and indefinite-lived intangible assets, gross</a></td>
<td class="nump">2,219,308<span></span>
</td>
<td class="nump">958,012<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Finite-lived and indefinite-lived intangible assets, net</a></td>
<td class="nump">$ 2,044,958<span></span>
</td>
<td class="nump">$ 847,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">14 years 1 month 6 days<span></span>
</td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 100,700<span></span>
</td>
<td class="nump">$ 100,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(11,980)<span></span>
</td>
<td class="num">(7,258)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">$ 88,720<span></span>
</td>
<td class="nump">$ 93,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(539)<span></span>
</td>
<td class="num">(404)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">$ 2,161<span></span>
</td>
<td class="nump">$ 2,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 10,442<span></span>
</td>
<td class="nump">$ 10,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(6,427)<span></span>
</td>
<td class="num">(5,422)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">$ 4,015<span></span>
</td>
<td class="nump">$ 5,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Acquired developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 853,171<span></span>
</td>
<td class="nump">$ 814,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="num">(155,404)<span></span>
</td>
<td class="num">(93,278)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">$ 697,767<span></span>
</td>
<td class="nump">$ 720,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 2,295<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,527)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">$ 2,295<span></span>
</td>
<td class="nump">$ 25,473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908997096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL - Schedule of Future Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2021 (remaining three months)</a></td>
<td class="nump">$ 23,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">92,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">92,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">91,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">90,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">404,810<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">$ 794,958<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904889320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="nump">$ 969,308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 969,308,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="nump">174,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">174,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,889,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets, finite-lived</a></td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">$ 20,200,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development | Armune Biosciences Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=exas_ArmuneBiosciencesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=exas_ArmuneBiosciencesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908585320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS AND GOODWILL - Schedule of Changes in Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Recognized Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 1,237,672<span></span>
</td>
<td class="nump">$ 1,203,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,242,535<span></span>
</td>
<td class="nump">1,237,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember', window );">Paradigm &amp; Viomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Recognized Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_GenomicHealthIncMember', window );">Merger Agreement with Genomic Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Recognized Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_GoodwillAcquiredAdjustment', window );">Genomic Health acquisition adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Recognized Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">948,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">948,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember', window );">Ashion Analytics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Recognized Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">$ 56,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_GoodwillAcquiredAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Acquired, Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_GoodwillAcquiredAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_GenomicHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_GenomicHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905391192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Schedule of Fair Value (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 274,076<span></span>
</td>
<td class="nump">$ 1,491,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">941,620<span></span>
</td>
<td class="nump">937,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=exas_RestrictedCashMember', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityOwnedNotReadilyMarketableFairValue', window );">Non-marketable securities</a></td>
<td class="nump">2,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="num">(363,647)<span></span>
</td>
<td class="num">(2,477)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">857,657<span></span>
</td>
<td class="nump">1,837,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">368,832<span></span>
</td>
<td class="nump">132,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">175,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">276,081<span></span>
</td>
<td class="nump">207,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">111,164<span></span>
</td>
<td class="nump">7,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Cash and money market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">273,779<span></span>
</td>
<td class="nump">901,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityOwnedNotReadilyMarketableFairValue', window );">Non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">274,076<span></span>
</td>
<td class="nump">903,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Cash and money market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">273,779<span></span>
</td>
<td class="nump">901,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityOwnedNotReadilyMarketableFairValue', window );">Non-marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="nump">944,688<span></span>
</td>
<td class="nump">937,172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">368,832<span></span>
</td>
<td class="nump">132,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">175,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">10,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">276,081<span></span>
</td>
<td class="nump">207,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">111,164<span></span>
</td>
<td class="nump">7,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Cash and money market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityOwnedNotReadilyMarketableFairValue', window );">Non-marketable securities</a></td>
<td class="nump">2,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Contingent consideration</a></td>
<td class="num">(363,647)<span></span>
</td>
<td class="num">(2,477)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetAssetLiability', window );">Total</a></td>
<td class="num">(361,107)<span></span>
</td>
<td class="num">(2,477)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Asset backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Cash and money market</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | U.S. government agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash, cash equivalents, and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset after deduction of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedNotReadilyMarketableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the not readily marketable security or category which has been determined by management based upon fair value methods, including pricing of similar securities and valuation techniques and is included in the schedule of financial condition or the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 820<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35710923&amp;loc=d3e45360-110995<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedNotReadilyMarketableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=exas_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=exas_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906278280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 363,647<span></span>
</td>
<td class="nump">$ 2,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember', window );">Product Development and Other Milestone-based Payments | Weighted Average | Measurement Input, Probability of Success</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember', window );">Product Development and Other Milestone-based Payments | Weighted Average | Measurement Input, Present-value Factor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration liability, measurement input</a></td>
<td class="nump">0.020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 29,500<span></span>
</td>
<td class="nump">22,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment owned, at fair value</a></td>
<td class="nump">22,700<span></span>
</td>
<td class="nump">$ 29,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveAndAshionMember', window );">Thrive and Ashion | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">361,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_BiomatricaIncMember', window );">Biomatrica, Inc | Revenue and Other Performance-based Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=exas_MeasurementInputProbabilityOfSuccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=exas_MeasurementInputProbabilityOfSuccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=exas_MeasurementInputPresentValueFactorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=exas_MeasurementInputPresentValueFactorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveAndAshionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveAndAshionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_BiomatricaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_BiomatricaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_RevenueAndOtherPerformanceBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_RevenueAndOtherPerformanceBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909068920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - Fair Value of Contingent Consideration (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Beginning balance</a></td>
<td class="nump">$ 2,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition', window );">Purchase price contingent consideration</a></td>
<td class="nump">350,348<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue', window );">Changes in fair value</a></td>
<td class="nump">10,986<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities', window );">Payments</a></td>
<td class="num">(164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Ending balance</a></td>
<td class="nump">$ 363,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration Arrangements, Increase Due to Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss), Change in Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810914370072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LONG-TERM DEBT (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>employee </div>
<div>agreement</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RegulatoryLiabilityAmortizationPeriod', window );">Timeframe when amount will be repaid through property taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoansMember', window );">Construction Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentRemainingAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_MinimumOwnInvestmentToBeMadeInConstructionProject', window );">Initial investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent', window );">Amount drawn from loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,800,000<span></span>
</td>
<td class="nump">$ 23,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsIncurred', window );">Interest incurred, accrued for as an interest reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest costs capitalized</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentCovenantLiquidityRequiredMinimum', window );">Minimum liquidity covenant for construction loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoansMember', window );">Construction Loan Agreement | 1-month LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=exas_TaxIncrementFinancingLoanAgreementsMember', window );">Tax Increment Financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NumberOfAgreementsEntered', window );">Number of agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NumberOfJobsRequiredToCreatedAndMaintained', window );">Number of jobs required to create and maintain | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">City Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentPeriodicPaymentInterestTerm', window );">Interest-only payment, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">City Letter of Credit | Construction Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentCovenantLiquidityRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentCovenantLiquidityRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentPeriodicPaymentInterestTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of the required periodic payments applied to interest in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentPeriodicPaymentInterestTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentRemainingAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for interest on debt instrument in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentRemainingAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_MinimumOwnInvestmentToBeMadeInConstructionProject">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount of own investment to be made in construction project.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_MinimumOwnInvestmentToBeMadeInConstructionProject</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NumberOfAgreementsEntered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of agreements entered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NumberOfAgreementsEntered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NumberOfJobsRequiredToCreatedAndMaintained">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of jobs required to create and maintain.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NumberOfJobsRequiredToCreatedAndMaintained</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total interest costs incurred during the period and either capitalized or charged against earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermConstructionLoanCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the current and noncurrent portions of a long-term real estate loan with an initial maturity beyond one year or beyond the normal operating cycle, if longer, to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan. The rate is normally higher than the prime rate, and there is usually an origination fee. The effective yield on these loans tends to be high, and the lender has a security interest in the real property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermConstructionLoanCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatoryLiabilityAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period for the recovery of regulatory liability, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatoryLiabilityAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConstructionLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=exas_OneMonthLondonInterbankOfferRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=exas_OneMonthLondonInterbankOfferRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=exas_TaxIncrementFinancingLoanAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=exas_TaxIncrementFinancingLoanAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908480616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONVERTIBLE NOTES - Schedule of Convertible Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_AggregateConvertibleNotesMember', window );">Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon interest rate</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ConvertibleNotesPayableGross', window );">Principal Amount</a></td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="nump">$ 1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Debt Discount and Issuance Costs</a></td>
<td class="num">(19,596)<span></span>
</td>
<td class="num">(21,878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Net Carrying Amount</a></td>
<td class="nump">1,130,404<span></span>
</td>
<td class="nump">1,128,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member', window );">2028 Notes | Level 2 | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible notes, fair value</a></td>
<td class="nump">$ 1,222,968<span></span>
</td>
<td class="nump">$ 1,526,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon interest rate</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ConvertibleNotesPayableGross', window );">Principal Amount</a></td>
<td class="nump">$ 747,500<span></span>
</td>
<td class="nump">$ 747,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Debt Discount and Issuance Costs</a></td>
<td class="num">(12,257)<span></span>
</td>
<td class="num">(13,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Net Carrying Amount</a></td>
<td class="nump">735,243<span></span>
</td>
<td class="nump">733,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member', window );">2027 Notes | Level 2 | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible notes, fair value</a></td>
<td class="nump">$ 834,285<span></span>
</td>
<td class="nump">$ 992,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member', window );">2025 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Coupon interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ConvertibleNotesPayableGross', window );">Principal Amount</a></td>
<td class="nump">$ 315,005<span></span>
</td>
<td class="nump">$ 315,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized Debt Discount and Issuance Costs</a></td>
<td class="num">(1,901)<span></span>
</td>
<td class="num">(2,333)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Net Carrying Amount</a></td>
<td class="nump">313,104<span></span>
</td>
<td class="nump">312,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member', window );">2025 notes | Level 2 | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible notes, fair value</a></td>
<td class="nump">$ 455,204<span></span>
</td>
<td class="nump">$ 601,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ConvertibleNotesPayableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount as of balance sheet date of convertible notes payable including debt issuance costs and debt discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ConvertibleNotesPayableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_AggregateConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_AggregateConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905473928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES - Additional information (Details)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,125,547,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of debt in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">150,054,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of convertible notes</a></td>
<td class="nump">$ 50,800,000<span></span>
</td>
<td class="nump">$ 187,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">50,819,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Market price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 95.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 671,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_AggregateConvertibleNotesMember', window );">Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 747,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 729,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount', window );">Repurchase price, as percentage of principal amount, if company undergoes change of control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_JanuaryNotesMember', window );">January 2018 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_JuneNotesMember', window );">June 2018 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member', window );">2025 notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of debt in cash</a></td>
<td class="nump">150,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued', window );">Amount used to pay off interest accrued</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentAmountSettledInExtinguishment', window );">Amount of debt extinguished</a></td>
<td class="nump">100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate, number of shares to be issued per $1,000 of principal amount (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Convertible debt, if-converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">If-converted value of debt in excess of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.18%<span></span>
</td>
<td class="nump">1.18%<span></span>
</td>
<td class="nump">1.18%<span></span>
</td>
<td class="nump">1.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Interest expense amortization term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Repayments of debt in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Issuance of common stock upon convertible notes settlement (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments', window );">Conversion of convertible securities, value issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 676,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate, number of shares to be issued per $1,000 of principal amount (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Convertible debt, if-converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
<td class="nump">0.67%<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Interest expense amortization term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 5 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Amount issued and sold</a></td>
<td class="nump">$ 1,150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Fixed interest rate (as a percent)</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.375%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Net proceeds from issuance</a></td>
<td class="nump">$ 1,130,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate, number of shares to be issued per $1,000 of principal amount (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments', window );">Convertible debt, if-converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.64%<span></span>
</td>
<td class="nump">0.64%<span></span>
</td>
<td class="nump">0.64%<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Interest expense amortization term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 5 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentAmountSettledInExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, Amount Settled In Extinguishment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentAmountSettledInExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentConvertibleEquityComponentInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents amount used to pay off interest accrued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentConvertibleEquityComponentInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the price at which the debt may be repurchased, as a percentage of the principal amount if the entity undergoes a change of control.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total consideration for repayments of convertible debt by way of cash and shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_AggregateConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_AggregateConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_JanuaryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_JanuaryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_JuneNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_JuneNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909311688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES - Schedule of Transaction Costs (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_January2025NotesMember', window );">January 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentConvertibleTransactionCosts', window );">Total transaction costs</a></td>
<td class="nump">$ 10,284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_June2025NotesMember', window );">June 2025 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentConvertibleTransactionCosts', window );">Total transaction costs</a></td>
<td class="nump">7,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member', window );">2027 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentConvertibleTransactionCosts', window );">Total transaction costs</a></td>
<td class="nump">14,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_DebtInstrumentConvertibleTransactionCosts', window );">Total transaction costs</a></td>
<td class="nump">$ 24,453<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_DebtInstrumentConvertibleTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The transaction costs of the liability and equity component of convertible debt which may be settled upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_DebtInstrumentConvertibleTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_January2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_January2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_June2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_June2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=exas_ConvertibleNotesPayable2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905757768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONVERTIBLE NOTES - Summary of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Debt issuance costs amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,444<span></span>
</td>
<td class="nump">$ 1,443<span></span>
</td>
<td class="nump">$ 4,284<span></span>
</td>
<td class="nump">$ 3,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Debt discount amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on settlement of convertible notes</a></td>
<td class="nump">$ 50,800<span></span>
</td>
<td class="nump">$ 187,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CouponInterestExpense', window );">Coupon interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,566<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
<td class="nump">7,699<span></span>
</td>
<td class="nump">7,065<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense on convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,047<span></span>
</td>
<td class="nump">4,047<span></span>
</td>
<td class="nump">12,093<span></span>
</td>
<td class="nump">61,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Other interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">1,855<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Total interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,680<span></span>
</td>
<td class="nump">$ 4,478<span></span>
</td>
<td class="nump">$ 13,948<span></span>
</td>
<td class="nump">$ 63,382<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CouponInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of coupon interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CouponInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909649432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSE AND COLLABORATION AGREEMENTS - Mayo (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 75,356<span></span>
</td>
<td class="nump">$ 31,471<span></span>
</td>
<td class="nump">$ 297,158<span></span>
</td>
<td class="nump">$ 107,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements | Mayo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_LicenseAgreementFeesCommitment', window );">License agreement fees commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember', window );">Licensing Agreements | Mayo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_LicenseAgreementFeesCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License Agreement Fees Commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_LicenseAgreementFeesCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=exas_MAYOFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=exas_MAYOFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=exas_MAYOFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=exas_MAYOFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139811013473528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LICENSE AND COLLABORATION AGREEMENTS - John Hopkins University (Details) - Thrive - Licensing Agreements<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 05, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeOneMember', window );">Sales Milestone Range One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PaymentsContingentOnMilestonesPayable', window );">Payments contingent on milestones</a></td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAmount', window );">Collaborative arrangement sales milestone amount</a></td>
<td class="nump">500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeTwoMember', window );">Sales Milestone Range Two</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PaymentsContingentOnMilestonesPayable', window );">Payments contingent on milestones</a></td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAmount', window );">Collaborative arrangement sales milestone amount</a></td>
<td class="nump">1,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeThreeMember', window );">Sales Milestone Range Three</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PaymentsContingentOnMilestonesPayable', window );">Payments contingent on milestones</a></td>
<td class="nump">20.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAmount', window );">Collaborative arrangement sales milestone amount</a></td>
<td class="nump">$ 1,500.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of net sales of a licensed product considered as a milestone under the collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_PaymentsContingentOnMilestonesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents potential future payments still contingent upon achievement of milestones under a collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_PaymentsContingentOnMilestonesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902764376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PFIZER PROMOTION AGREEMENT (Details) - Pfizer Inc - Cologuard promotion agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties', window );">Service fee based on incremental gross profits over specified baselines and royalties</a></td>
<td class="nump">$ 16.8<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="nump">$ 63.6<span></span>
</td>
<td class="nump">$ 39.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Charges for promotion, sales and marketing</a></td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">$ 15.8<span></span>
</td>
<td class="nump">$ 88.0<span></span>
</td>
<td class="nump">$ 56.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents service fee based on incremental gross profits over specified baselines and royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=exas_PfizerIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=exas_PfizerIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_ManufacturedProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_ManufacturedProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810907657016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">19 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 14, 2021</div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
<th class="th"><div>Jan. 05, 2021</div></th>
<th class="th"><div>Mar. 03, 2020</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock for business combinations and asset acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,510,436<span></span>
</td>
<td class="nump">382,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,120<span></span>
</td>
<td class="nump">$ 1,254,798<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 28,597<span></span>
</td>
<td class="nump">$ 1,270,918<span></span>
</td>
<td class="nump">$ 28,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember', window );">TARDIS Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Payments to acquire productive assets (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Stock issued to acquire productive assets, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember', window );">Ashion Analytics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable (in shares)</a></td>
<td class="nump">125,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Fair value of stock issued in acquisition</a></td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">109,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="nump">$ 16,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,323,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Fair value of stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,187,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,175,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember', window );">Paradigm &amp; Viomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904913320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of OCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 2,235,552<span></span>
</td>
<td class="nump">$ 1,957,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive loss before reclassifications</a></td>
<td class="num">(292)<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(271)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Net current period change in accumulated other comprehensive loss, before tax</a></td>
<td class="num">(563)<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax expense related to items of other comprehensive income</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">3,457,590<span></span>
</td>
<td class="nump">1,730,686<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gain (Loss) on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">526<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive loss before reclassifications</a></td>
<td class="num">(292)<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="num">(271)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Net current period change in accumulated other comprehensive loss, before tax</a></td>
<td class="num">(563)<span></span>
</td>
<td class="nump">1,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">526<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">1,084<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive loss before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Net current period change in accumulated other comprehensive loss, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908767592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of amounts reclassified from AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="num">$ (186,541)<span></span>
</td>
<td class="num">$ (115,589)<span></span>
</td>
<td class="num">$ (621,897)<span></span>
</td>
<td class="num">$ (336,265)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification Out Of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Total reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification Out Of Accumulated Other Comprehensive Income | Unrealized Gain (Loss) on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNonoperating', window );">Investment income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification Out Of Accumulated Other Comprehensive Income | Foreign Currency Translation Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909092408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 05, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,500<span></span>
</td>
<td class="nump">$ 283,300<span></span>
</td>
<td class="nump">$ 111,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Noncash stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,180<span></span>
</td>
<td class="nump">111,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400<span></span>
</td>
<td class="nump">$ 15,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=exas_StockBasedCompensationPlansMember', window );">Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">401,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 401,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period for recognition of cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Noncash stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated vesting compensation expense</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated vesting compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember', window );">Option Plan Shares | Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Accelerated vesting (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units | Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Stock-based compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber', window );">Accelerated vesting (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=exas_StockBasedCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=exas_StockBasedCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810914341880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Fair Value and Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember', window );">Option Plan Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rates, minimum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.11%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rates, maximum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.47%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.19%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share of options granted during the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember', window );">Option Plan Shares | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember', window );">Option Plan Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember', window );">Restricted Shares and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Shares, RSUs, and Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at the beginning of the period (in shares)</a></td>
<td class="nump">3,968,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">2,084,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions', window );">Assumed through acquisition (in shares)</a></td>
<td class="nump">242,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares)</a></td>
<td class="num">(1,582,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(406,201)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at the end of the period (in shares)</a></td>
<td class="nump">4,306,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,968,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 79.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">133.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue', window );">Assumed through acquisition (in dollars per share)</a></td>
<td class="nump">127.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share)</a></td>
<td class="nump">72.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">99.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 109.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of equity instruments other than options vested in period</a></td>
<td class="nump">$ 114,400<span></span>
</td>
<td class="nump">$ 79,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Shares, RSUs, and Performance Share Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at the beginning of the period (in shares)</a></td>
<td class="nump">618,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">253,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(8,991)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at the end of the period (in shares)</a></td>
<td class="nump">862,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">618,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 93.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">140.96<span></span>
</td>
<td class="nump">$ 90.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">68.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 107.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of outstanding performance share units (in shares)</a></td>
<td class="nump">249,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rates, minimum (as a percent)</a></td>
<td class="nump">0.04%<span></span>
</td>
<td class="nump">0.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rates, maximum (as a percent)</a></td>
<td class="nump">0.16%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum (as a percent)</a></td>
<td class="nump">48.38%<span></span>
</td>
<td class="nump">63.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum (as a percent)</a></td>
<td class="nump">68.51%<span></span>
</td>
<td class="nump">89.04%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=exas_StockBasedCompensationPlansMember', window );">Stock Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning of the period (in shares)</a></td>
<td class="nump">2,231,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions', window );">Assumed through acquisition (in shares)</a></td>
<td class="nump">1,393,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(1,208,355)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(36,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end of the period (in shares)</a></td>
<td class="nump">2,379,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,231,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at end of period (in shares)</a></td>
<td class="nump">2,379,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end of the period (in shares)</a></td>
<td class="nump">1,816,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 39.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice', window );">Assumed through acquisition (in dollars per share)</a></td>
<td class="nump">5.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">11.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">62.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">33.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and expected to vest at end of period (in dollars per share)</a></td>
<td class="nump">33.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 25.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vest at end of period</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at the end of the period</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at the end of the period</a></td>
<td class="nump">$ 147,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at end of period</a></td>
<td class="nump">147,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at the end of the period</a></td>
<td class="nump">127,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="nump">$ 148,800<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed During Period Through Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed in Period Through Acquisitions, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Assumed in Period Through Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangements by Share-based Payment Award, Options, Assumed in Period Through Acquisitions, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=exas_EmployeeAndNonEmployeesStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=exas_StockBasedCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=exas_StockBasedCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909928632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Supplemental Disclosure of Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 19,835<span></span>
</td>
<td class="nump">$ 12,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">723<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance cash flows from finance leases</a></td>
<td class="nump">3,805<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">60,480<span></span>
</td>
<td class="nump">13,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for new finance lease liabilities</a></td>
<td class="nump">$ 4,296<span></span>
</td>
<td class="nump">$ 17,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average lease term remaining</a></td>
<td class="text">8 years 1 month 20 days<span></span>
</td>
<td class="text">8 years 11 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance lease, weighted average remaining lease term</a></td>
<td class="text">3 years 1 month 17 days<span></span>
</td>
<td class="text">3 years 10 months 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate</a></td>
<td class="nump">6.28%<span></span>
</td>
<td class="nump">6.83%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate</a></td>
<td class="nump">5.42%<span></span>
</td>
<td class="nump">5.87%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 39,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingActivitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingActivitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810992234440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 167,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Additional amount to be recognized at lease commencement for the lease liability</a></td>
<td class="nump">182,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">19,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">162,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease, right-of-use asset</a></td>
<td class="nump">$ 18,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance lease, right-of-use asset, statement of financial position, extensible list</a></td>
<td class="text">Other long-term assets, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liability</a></td>
<td class="nump">$ 19,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liability, current</a></td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance lease, liability, current, statement of financial position, extensible list</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liability, noncurrent</a></td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance lease, liability, noncurrent, statement of financial position, extensible list</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=exas_DOSRuleInvestigationMember', window );">DOS Rule Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated civil damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss Contingency Accrual</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_FacilityInLaJollaCAMember', window );">Facility in La Jolla, CA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset', window );">Operating lease not yet commenced, asset</a></td>
<td class="nump">22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability', window );">Operating lease not yet commenced, liability</a></td>
<td class="nump">$ 22,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not yet Commenced, Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not yet Commenced, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=exas_DOSRuleInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=exas_DOSRuleInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_FacilityInLaJollaCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=exas_FacilityInLaJollaCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904130232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NEW MARKET TAX CREDIT (Details) - New Market Tax Credit Program<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($) </div>
<div>facility</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Disclosures related to New Market Tax Credit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NetProceedsFromFinancingArrangement', window );">Net proceeds received from financing arrangements | $</a></td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements', window );">Number of facilities receiving working capital and capital improvements from financing agreements | facility</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NetProceedsFromFinancingArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the proceeds from issuance of loan receivable to investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NetProceedsFromFinancingArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of facilities receiving working capital and capital improvements from financing agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=exas_NewMarketTaxCreditProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=exas_NewMarketTaxCreditProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810904747160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>WISCONSIN ECONOMIC DEVELOPMENT TAX CREDIT (Details) - Wisconsin Economic Development Tax Credit Agreement<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2015 </div>
<div>USD ($) </div>
<div>employee</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions', window );">Refundable tax credits available, contingent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits', window );">Capital investment expenditures over specified period, requirement to earn the refundable tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits', window );">Full-time positions that must be created over a specified time period to earn the refundable tax credits | employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits', window );">Period over which the capital investment expenditures must be incurred and the creation of full-time positions must be completed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_RefundableTaxCreditEarnedToDate', window );">Refundable tax credits earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_RefundableTaxCreditReceived', window );">Refundable tax credit received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_RefundableTaxCreditReceivable', window );">Refundable tax credit receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_AmortizationOfRefundableTaxCredits', window );">Amortization of tax credits</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_AmortizationOfRefundableTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amortization of the tax credits, representing a reduction of operating expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_AmortizationOfRefundableTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditures in capital investments the Company is required to make over a specified period to earn the refundable tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of full-time positions that must be created over a specified time period to earn the refundable tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period over which the capital investment expenditures must be incurred and the creation of full-time positions must be completed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_RefundableTaxCreditEarnedToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of refundable tax credits earned, relating to capital investments and job creation, as of the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_RefundableTaxCreditEarnedToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_RefundableTaxCreditReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of refundable tax credit receivable as of the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_RefundableTaxCreditReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_RefundableTaxCreditReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of refundable tax credit received during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_RefundableTaxCreditReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the refundable tax credits available, that is contingent on the Company expending a specified dollar amount on capital investments and the creation of a specified number of full-time positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810895350008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Business Combinations Textual (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="3">9 Months Ended</th>
<th class="th" colspan="1">19 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 14, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 05, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 03, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,647<span></span>
</td>
<td class="nump">$ 363,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business combination, equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash payments to acquire business, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,120<span></span>
</td>
<td class="nump">$ 1,254,798<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 28,597<span></span>
</td>
<td class="nump">1,270,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1', window );">Equity interests issued or issuable to previous investors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment owned, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business combination, equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in amount of contingent consideration liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember', window );">Investment Income | Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business combination, equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember', window );">Ashion Analytics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Fair value of stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember', window );">Ashion Analytics | Commercial Launch Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationContingentConsiderationAdditionalPayment', window );">Additional cash consideration to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember', window );">Ashion Analytics | MRD Product Revenue Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationContingentConsiderationRevenueMilestone', window );">Revenue milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,187,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business acquisition, equity interest issued or issuable (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,323,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued, price per share (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Fair value of stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,175,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards', window );">Payments to acquire businesses and accelerated vesting of awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">584,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation', window );">Compensation consideration assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred', window );">Compensation consideration assumed and allocated to consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory', window );">Compensation consideration assumed and deemed compensatory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated vesting compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio', window );">Share conversion ratio (share per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.06216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Business combination, pro forma loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsPeriodExpense', window );">Additional benefit charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | Employees with Qualifying Termination Events</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated vesting compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Incremental share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost', window );">Accelerated vesting compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | FDA Approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | CSM Coverage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | Allocated to Consideration Transferred | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | Allocated to Previous Ownership Interest | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | Allocated to Compensation | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive | Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent payment obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember', window );">Paradigm &amp; Viomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash payments to acquire business, net of cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock for business combination and asset acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance', window );">Amount of shares held for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod', window );">Equity interests issued or issuable to previous investors, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember', window );">Paradigm &amp; Viomics | Acquired developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted-average remaining useful life of finite-lived intangible asset (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember', window );">PFS Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 33,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">$ 33,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Issued Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Shares Reserved For Future Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationContingentConsiderationAdditionalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Additional Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationContingentConsiderationAdditionalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationContingentConsiderationRevenueMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Revenue Milestone</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationContingentConsiderationRevenueMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation Allocated to Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation, Deemed Compensatory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Businesses And Accelerated Vesting Of Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period expense related to postemployment benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InvestmentIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_CommercialLaunchMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_CommercialLaunchMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_MRDProductRevenueMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_MRDProductRevenueMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=exas_EmployeesWithQualifyingTerminationEventsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=exas_EmployeesWithQualifyingTerminationEventsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_FDAApprovalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_FDAApprovalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_AllocatedToConsiderationTransferredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_AllocatedToConsiderationTransferredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_AllocatedToPreviousOwnershipInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_AllocatedToPreviousOwnershipInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_AllocatedToCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_AllocatedToCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=exas_CompensationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=exas_CompensationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909210408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Schedule of Consideration Transferred for Ashion Analytics (Details) - Ashion Analytics<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 14, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">$ 74,775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="nump">16,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">19,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 109,999<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810905278072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, Ashion Analytics (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Apr. 14, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,242,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,237,672<span></span>
</td>
<td class="nump">$ 1,203,197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember', window );">Ashion Analytics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,190)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability', window );">Operating lease liabilities, current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(343)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability', window );">Operating lease liabilities, less current portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,313)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908244424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Consideration Transferred, Thrive (Details) - Thrive<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jan. 05, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued</a></td>
<td class="nump">$ 1,175,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash</a></td>
<td class="nump">584,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">331,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationFairValueOfReplacedEquityAwards', window );">Fair value of replaced equity awards</a></td>
<td class="nump">52,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Previously held equity investment fair value</a></td>
<td class="nump">43,034<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 2,187,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationFairValueOfReplacedEquityAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Fair value of Replaced Equity Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationFairValueOfReplacedEquityAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139811025381032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Assumptions on Fair Value of Options Assumed (Details) - Options - Thrive<br></strong></div></th>
<th class="th">
<div>Jan. 05, 2021 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rates, minimum (as a percent)</a></td>
<td class="nump">0.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rates, maximum (as a percent)</a></td>
<td class="nump">0.12%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum (as a percent)</a></td>
<td class="nump">65.54%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum (as a percent)</a></td>
<td class="nump">71.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">1 year 3 months 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share of options granted during the period (in dollars per share)</a></td>
<td class="nump">$ 109.74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">1 year 6 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value per share of options granted during the period (in dollars per share)</a></td>
<td class="nump">$ 124.89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810906577512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed, Thrive (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jan. 05, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,242,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,237,672<span></span>
</td>
<td class="nump">$ 1,203,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentDisclosureAbstract', window );"><strong>Fair Value, Adjustment Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets', window );">Total identifiable assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(1,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent', window );">Operating lease liabilities, current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent', window );">Operating lease liabilities, less current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability', window );">Deferred tax liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities', window );">Total liabilities assumed</a></td>
<td class="num">(1,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired', window );">Net identifiable assets acquired</a></td>
<td class="num">(1,862)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired', window );">Net assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember', window );">Thrive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">241,748<span></span>
</td>
<td class="nump">$ 241,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,939<span></span>
</td>
<td class="nump">3,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">29,977<span></span>
</td>
<td class="nump">29,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">39,027<span></span>
</td>
<td class="nump">39,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">1,250,000<span></span>
</td>
<td class="nump">1,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total identifiable assets acquired</a></td>
<td class="nump">1,564,758<span></span>
</td>
<td class="nump">1,564,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(3,222)<span></span>
</td>
<td class="num">(3,222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(8,080)<span></span>
</td>
<td class="num">(6,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability', window );">Operating lease liabilities, current portion</a></td>
<td class="num">(2,980)<span></span>
</td>
<td class="num">(2,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability', window );">Operating lease liabilities, less current portion</a></td>
<td class="num">(38,622)<span></span>
</td>
<td class="num">(38,622)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="num">(272,905)<span></span>
</td>
<td class="num">(272,905)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="num">(325,809)<span></span>
</td>
<td class="num">(323,947)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="nump">1,238,949<span></span>
</td>
<td class="nump">1,240,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">948,105<span></span>
</td>
<td class="nump">946,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">$ 2,187,054<span></span>
</td>
<td class="nump">$ 2,187,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Long-term Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent, Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810907493160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Pro Forma Thrive Information (Details) - Thrive - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenues</a></td>
<td class="nump">$ 456,379<span></span>
</td>
<td class="nump">$ 408,363<span></span>
</td>
<td class="nump">$ 1,293,275<span></span>
</td>
<td class="nump">$ 1,025,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax', window );">Net loss before tax</a></td>
<td class="num">$ (170,797)<span></span>
</td>
<td class="num">$ (224,860)<span></span>
</td>
<td class="num">$ (536,253)<span></span>
</td>
<td class="num">$ (575,981)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessAcquisitionProFormaIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Pro Forma Income (Loss), Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessAcquisitionProFormaIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810914268184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed From Paradigm Diagnostics Acquisition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Mar. 03, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 03, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,242,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,237,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,203,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentDisclosureAbstract', window );"><strong>Fair Value, Adjustment Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets', window );">Net operating assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="nump">1,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Developed technology</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities', window );">Net operating liabilities</a></td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember', window );">Paradigm &amp; Viomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets', window );">Net operating assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Net operating liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentDisclosureAbstract', window );"><strong>Fair Value, Adjustment Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets', window );">Net operating assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities', window );">Net operating liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Excluding Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_ParadigmViomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810908451976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details) - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 23, 2021</div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>May 03, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember', window );">PFS Genomics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Percent of equity acquired</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">$ 33,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage', window );">Equity interest in acquiree after subsequent acquisition</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember', window );">TARDIS Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Payments to acquire productive assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares', window );">Payments to acquire productive assets (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable', window );">Stock issued to acquire productive assets, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeOneMember', window );">Sales Milestone Range One | TARDIS Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PaymentsContingentOnMilestonesPayable', window );">Payments contingent on milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAmount', window );">Collaborative arrangement sales milestone amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeTwoMember', window );">Sales Milestone Range Two | TARDIS Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_PaymentsContingentOnMilestonesPayable', window );">Payments contingent on milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_CollaborativeArrangementsSalesMilestoneAmount', window );">Collaborative arrangement sales milestone amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of net sales of a licensed product considered as a milestone under the collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_PaymentsContingentOnMilestonesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents potential future payments still contingent upon achievement of milestones under a collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_PaymentsContingentOnMilestonesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123362884&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123385561&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_CollaborativeArrangementsSalesMilestoneAxis=exas_SalesMilestoneRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810902955864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, PFS Genomics (Details) - PFS Genomics<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jun. 23, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Cash paid for acquisition of PFS Genomics outstanding shares</a></td>
<td class="nump">$ 33,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="nump">33,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities', window );">Other assets and liabilities</a></td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="nump">$ 33,569<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets and Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>exas_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=exas_PFSGenomicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139810909837608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 456,379<span></span>
</td>
<td class="nump">$ 408,363<span></span>
</td>
<td class="nump">$ 1,293,275<span></span>
</td>
<td class="nump">$ 1,025,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">429,150<span></span>
</td>
<td class="nump">392,120<span></span>
</td>
<td class="nump">1,213,142<span></span>
</td>
<td class="nump">968,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Outside of United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 27,229<span></span>
</td>
<td class="nump">$ 16,243<span></span>
</td>
<td class="nump">$ 80,133<span></span>
</td>
<td class="nump">$ 56,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139811000788744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax expense (benefit)</a></td>
<td class="num">$ (3,858)<span></span>
</td>
<td class="num">$ (2,752)<span></span>
</td>
<td class="num">$ (242,638)<span></span>
</td>
<td class="num">$ (5,294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Tax benefit from change in deferred tax asset valuation allowance resulting from merger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="nump">32,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>101
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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ML:U7G&B9Y#MC"ZFUC/+#M>"^4.8!N+^44A].S ^4FZNC_P!02P,$%     @
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M8V_@H9RNR8[IS^+P,VT"2HR^E6#*_J)#@\4>6NV4%E4C#!Y4):^?Y+DAXD0
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MM8!YGDH#@.]K(?1Q80RT_Q F_P!02P,$%     @ ,XEB4[H'_HM2#   :5(
M !@   !X;"]W;W)K<VAE971S+W-H965T-BYX;6S-G&USVS82Q[\*Q]>Y)C-U
M1#P#/<<SC2Q/<W.]RS3MW6M:HBU.)%(5J3CY]@=2M" ""T"1;3E]T4C6 EH\
M_OZ[ '5Q7ZT_U?,\;Y(ORT59OSV;-\WJY]&HGL[S95:_J59YJ3^YK=;+K-%O
MUW>C>K7.LUE7:+D8X33EHV56E&>7%]W?/JPO+ZI-LRC*_,,ZJ3?+9;;^^BY?
M5/=OS]#9PQ]^+^[F3?N'T>7%*KO+/^;-GZL/:_UNM*ME5BSSLBZJ,EGGMV_/
M?D$_7Z.T*]&9_+?([^N]UTG;EINJ^M2^>3][>Y:V+N6+?-JT=63ZG\_Y.%\L
MVJJT(W_UM9[MOK0MN/_ZH?;KKO6Z-3=9G8^KQ?^*63-_>R;/DEE^FVT6S>_5
M_:]YWR+6UC>M%G7W_^2^MTW/DNFF;JIE7UA[L"S*[;_9E[XG]@H@XBF ^P+X
MT *D+T"L EAX"M"^ +4*4.XIP/H"S/X&Y"G ^P*\Z_MM9W4]?94UV>7%NKI/
MUJVUKJU]T0U75UIW<%&V4^MCL]:?%KI<<SFNRIF>*/DLT:_J:E',LD:_^=CH
M?_0,:NJDNM7OJNFG>;68Y>LZF?RU*9JOR7GRY\>KY-4/KY,?DJ),_IA7FSHK
M9_7%J-%NM96/IKT+[[8N8(\+?U1-M@"*C</%QM5RJ:=FYQM0^BI<^I?9K&BG
M=K9(/F3%[/Q]F8RS50%[,HG4-9UNEIM%UW'_:>;Y6O?E4B_T>;L"/^?)^W):
M+?/DU;^JNGX-5']]>/57^6TQ+9J__TWBE/QC6-=(#_UN_/%N_'%7.?54_BY;
M9.54.Z?'L)YGZ[Q^G62-_I[IFX2@GQ*<(@6-S;96UM7:;E^?+Q$5'#.N^,7H
M,^ 0V3E$P@[E=T59%N6=WC"VKAW@SKMMG7S?'<4$)VKGS-9MP(X*,32Z<HT(
M$I(Q/+2;N';G*$V'1M>0$=;_J13N)[KK)]J5))Y^TI-*HZ36(Z<[IWOUNEV'
M^TOUQWZM!J8)VWT;"X[*Y$N^GA;ZV_1N,-TNO+K]IJ1:M:NHWI\_T'1A[G3A
M*9:>N<)W7O%'>07-%.YX0HD]:&/N#)HU]E= -5A)N#EBUQP1;,[[NMYT,]YN
M3E,EMYMRENB]I=M:LO+KCW5"4_3JTVL-@V8ZC_6_</N?<,84[+#<.2R?RV%H
M:*3KI%9(UNH<2W<)6V,#U^.9:VK75A5L:]L,O9]GG1[*O[2O<ZVMMMNR;F^Q
MUQ?#I:&IJ WK9EU,6]OMA]E]MIY%EXUR6X(H(L+3%I0:ZJ>G;PV(_M1I E:,
MVPNN-QN,JCVL<%74,X?1G@)"Q\UB+=R3FTVMS>NZ_>2F*#/3"5E=:^6?3?46
M6W=2(C:8O1O[_A.)%16>!AB$HS##O[D!L/_@\+F<QY(I>TWV9OO#1^W1@VLB
MGL8;N8#">N'?NA$++:Q [XGSG>>(4$Z)!>D##(?N&4HC&G1OJP>G SU8]'IP
MX=&#[_HZA^YP9/7Z)&HV]-FP'D5@7\XL_?5;MG[07S@%/08 +Q63=D^/>\.A
M E/,GBQN=00SK/8(VW>!:WB.A-U3UZ 9T6*5^ ;82! 4UB > 1WKL3%R%83N
M"$JYY-3CD]$1*"PDCA7U") )856/C%1 8:UPG*Y' .U!80\9NLH>N=( EO:
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M287OW( 8OA-Y CU!#+;)X[ =W?J Q#9-$?4,#C7LI6'V'J,GJ(M.2H6=H:9
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MAG#\"!&E7*J0W$KA9G$:@#,BMD5BE.'<@]HP&PY3V_51@%9X5WMSK\&9@$F
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M0.E9;6E,OM9%D?AI]1:21T8UK)>WI+_2$&93? 8^[NDM>U3]9,7./V$,V+0
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M.&FI0F;4F_.P')V%BLUNI<+-9,6=&6^DP(Y0'B9P*#*BESC/()ANW<*LD&]
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M1L& R>8ML>EHL3+O=U.AM2A-<\E3U(%$@/FY$'K=H0VZ!]VK/P%02P,$%
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MG2 9G]$J)*_"Y.Q''#4-GA,@5(=R;,H=^Y3I$?S]YF=KNT *39KFE6CFC6D
M;OH"*/65\]H5G+K1 2'?:_\"A]251S[C"PTXPJ !1RU.6!N)"%5WC:&YQMYK
M;!.%[><M'9.3(!B&=#MS;@<-O3KQT^'X(''(7]6@G3]\]P-ZBNK?LH^B[]GC
M\%7R'?M[%YM[-#\JE&L[)175OJUU-TIZ:3^(9]W\>57OIO@MD^NR5E27@DR]
MX3@>@.PF8[?1HK'3:"4TS3:[W-#'!$JC0.\+(?1A8PCZSY/I/U!+ P04
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M_,TY>_7V[?G'B]>O3T86.FCG*&WEG37RP@?DS=A/JK1KPUZ6F<ANGQ_!ML[
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MXZ] M&OPY9DA_X7B"M @6KR UO*#S.1J7WG'(S&>3Z+Y_++SC34\?M[Z]N&
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M:.I,KW8\. 7DP=^I=RC.6V^G9,JN^1T<BC%XCW]1I;Y;O^9SY=]N:9;[=X0
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M^?3$0IGN1U-M^)3KLFJ:JN#;M9* \_0!WJ\J,.U^T 3]L><7_P%02P,$%
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MM\*+LQ-K5F!9FM#X(K@:M(F<U)R4C][24TEZ_FS^[NJ/RUN8W]Y<WWRZNOD
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M0RPDQ0GX'7U8/M_< SX6GDN%ZCO"H;?6B:JGT51F[[,Y:!$T.&KCV^ZD_!I
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M6'PH =TP9'9 &D]/(G&)L<Z)CP:9+"[B\QA-+^=#!0?,Q@=UPTY5@#XM:EF
M.E^[!IUT2SFUR+/1.:AM(6UP5V-[JG"ALPRA[WZ%SF]R\/],1J&7!VR28JU-
M+H<G2V]4QKX]11KL_E.GGQ.9?N;]FG#(]$;F0/(S/[90<^,C)1H9";66-",
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M*Y(= C<6-8RC>P:5-)\*4#HSMCQHZZN*:_.4WFIP.H345C'+@\ $F =N0#K
M.TAN.I)N4+)WQ'_C6C4S  JS<1*R_K(,/LZZW_AGK.1C"$'9MF_R2,S[/%K?
M*[AM<F.#HVW6DL!OX4.0+W$%:4[\0Q;8]PPI]_[]6;3%RJ[,@1W:H0%TC[^Z
M>KTOW9B8;N^OU.OIT)K.WBRUN$4DFC(\,(:0.T\$V!7W-6!JKWGHO'S07IAU
M]Y"YT,Z%PXL-!4&NB/%(NVS\(50YD-'B>F$"5'Y%F#!I3P(NY&U[F%/RA7ZP
MXZ&.'4C/%:_I50X:ASWRAAU4QXQ3PI5XVXN$>X-7-Y&'2WY!E6"T*6O_%F=W
MM7L']M2_^MG?[E^@!2,&*:17\!98.HF/#W?\D]+V2VTJ?A$T,8A P1_1B5")
M= -^7QB,S^$+;="]&?SR?U!+ P04    "  SB6)3-LKPH'$%  !]#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6RE5UMOVS84_BN$-PP=X/FB.&U:
M)P%R*Q8,"8HD2_=*2Y3$AB)5DK+C_?I]YTA6Y*+M0_:01+R<^_<=GAQOG'\*
MI5)1/%?&AI-1&6/]83H-::DJ&2:N5A8GN?.5C%CZ8AIJKV3&0I69)K/9VVDE
MM1V='O/>)W]Z[)IHM%6?O A-54F_/5?&;4Y&\]%NXTX79:2-Z>EQ+0MUK^+?
M]2>/U;37DNE*V:"=%5[E)Z.S^8?S!=WG"X]:;<+@6U D*^>>:'&=G8QFY) R
M*HVD0>+/6ETH8T@1W/C:Z1SU)DEP^+W3_I%C1RPK&=2%,Y]U%LN3T=%(9"J7
MC8EW;O.GZN(Y)'VI,X%_BTU[-TE&(FU"=%4G# \J;=N_\KG+PT#@:/8#@:03
M2-COUA![>2FC/#WV;B,\W88V^N!061K.:4M%N8\>IQIR\?3VZK.X.;O[Z^I!
M/)S](R[NKBZO'XZG$:KIPC3MU)RW:I(?J'DO;IR-91!7-E/9OOP4+O5^)3N_
MSI.?*KQ7]40<S,8BF27SG^@[Z.,\8'T'KX]S3^^BU[M@O8O_F[]7J!&7C=>V
M$+%4(G>-CZ7XVD@?E1<N1V+FBS&?7;BJEG8+CJ0*$,^$K&OOGC4PJ\Q6_)I,
M%H".,<0";84%U7&>*I4%D7M7B5Q;:5,R)0NO%#@7 [09R&<B.B86G::RUE$:
M(6W6?^L*NM:=C(S"647>::QN9*:#LV/Q68?4@<=6Y#+51D>MPD0\E#H,37LO
M;<&*Q$8&$:)OTMAXN+#1"%U:T=C>J5+[[(\:R=CN5) O-D0=&Z;[&\K,;[\<
M)<EL>6W7"DSRO)PO?Q^3,LV;;"YO;#;FJ,CM2GYQ7D.QVUB82EU5-9;6F5JC
MB=4L@A_:0DB(S'8MAOT<5(3LS=\M@R!'=:IK&;L:1,0:)$L%*JK1N88M^('B
M<KT5OA#2+?K:C?1/"HX]R&=Q@7SH*-YTD=W>/%SLHJ*B%EY68U$W/C027J)V
M]YUOB\-+J@OIOK: D(7R.P1D&W(WXZ+-WQ^]11Y01\0('E.-7N"E"1-?&^U;
M4*Q4&WU5&XW\*ZCVKBE*<0D85BO$0=1M<[*67KN&Y(O&R#9J!A&:AD<:D #R
M?JT#'\420 *( 5X8(I<ISB%")N+6V8'M%B&0T*E<&;5SM$5EZAJ382N@4W/R
M.0<OD&A+Y-T7I(IB0YI7RJJ<P&!=Q(+PB2?/Z'^)7006Z,#SX;P:[VSM41%N
M:V2PLCK?[MD#D;V@&\:%(/ -TLJ:8$X%X# 'Q&,D] QI@#F#YS,%R/ P4J'H
MPHN&00I+N59"/==<K1=8#5(4H@15V*S1%;C,9=DO>>94FP* J<6O8N?3%H4O
MEC=H+X2('B#?)<:/^-X:[5/T&B)*.,$]!I'B[B, QU$RUJ$6#U/DOM-3Y_'Z
M*O34(9-Q'^NTK+VF4:6# WH,OCL2D7C7PV W-0V/*=2X !2,3AD/"QGZ8=>_
M#>8?Q/VA;4IOE[SM;.$X&32<M/X-]//5>;*$!<-C#-VT!&74BU=Z%QYMYTJU
MM&(8#=BQ4[/!72%1J4&F.CYH))9::*:"+BQKH912[8&BCAA.T"%:50H\@)PR
MSW$B:N5Y.APT 8Q_K!9]30TB6O;!#YD_0 +"7QE=$,Z^H1.'LVV1U-*D,5VX
MWW85I@$ZVJ[K."*K*/!TPFW*4<>L/<#]#%W+O9KU8D:F3[ HZ)WU[?O35:-+
M*O/.;*E0"@&[2J=]?;M^LV3C0_4#".YRP:F7J^#\BOO&/DHFWQMCIH.1L%*^
MX,&76Z&-[738[_:S]5D[4KY<;P=S/#\%7E9A5 [1V>3=X4CX=MAM%]'5/&"N
M7,2XRI\E_C]0GB[@/'<N[A9DH/^/X_0_4$L#!!0    ( #.)8E/9?(@/-@4
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MK[#^!$H&L4SWD]-_A)R=A O"M>!W6B?MD&PIED\B65ALBCA &Q; O>-)P;4
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M!U_H\4"))]0;DMUSE*F52E$\ AC3]-68J_ <QBEA1<F]5N9 /W:#2^@7I6W
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M8\%5,86L+J>>4&7QE>+KD()5-7S&#?,IV*IE4%JX3^AT:,2PBC598:@=;R!
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M9S>,_Q//;H#N-@M4EV5^L7F8PI.RA;7 U8'9PM+R7H&[HK8QHPJNF$Y7VJE
MF'+D2F-EY\A*Y;4E-<>MQ4+26R!FUEZ1JE>G<FV0;"-%^*J.S^3MD*.39O6<
M1&/XP6S6L0)3I/G4=S0P5,A9Y78;&Z0K;EFF1;9[1*ID-Z]OV8_*I):65_.@
M?1JWPZ>9#[\[S*?9Z;X\Y?/U;67TPYA_+6 )>:VC=N^G+\,EQH!R 2X[\@BC
MM.R*5'L@T?;TK? F,I4[/&1BIF.<7==V^F4:%N9@-7 &4DJ9DHXJS]\CZQR^
M83FFLNUQEX\*8E&=#):/(!@H(J4NO,70+.BMA*.,0/NE[*]KSWV+J_%E2](
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MPK57\W81;!VOPW,;<+F.CR6^9LBQ -X7UH;-@AWTWT<7?P%02P,$%     @
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MT=>7]Q];G[G-X%B;4E7N&V9;?$[%#4(^5/T@="AB5.'+,B1"(CQ7O,QQ<8/
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M0]LYN5A8M9#Q(\03NZ7S5J%/PH;K>>%6LE'C!.^?4_9%)9.G)0HS/=ZM3B_
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M!>VM@M=VJ\![NCP%QS3 -FVK19Y3'=C1\IPC\L9$+(#D4]"#FZ]%LB(IS:6
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M?B2 QHPO&4<JF##<#XWO^.A=WU8(L!S\[;O.8+,<.C8\GMZ?PIRM*,^Q=96
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M6!"/![0:4E3#>/ S']3MM,G$RJC&=KLCGRH]@O_>/>W>KI!24[9Y%=I98QM
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M&;XXJ;(,N#Z3"'@U815LWK!7?P)02P,$%     @ ,XEB4\ARVN5=!0  I@X
M !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&ULU5=[;]LV$/\J!Z\=$D"S
M)5(OIXF!O(JE:-.@2;L_AF&@I7,L5!(UDHJ;??H=*5E-',=(@6'  D=\WH_W
M/O)P)=57O40T\*TJ:WTT6AK3'$PF.EMB)?18-EC3RD*J2A@:JMN);A2*W!%5
MY83Y?CRI1%&/9H=N[DK-#F5KRJ+&*P6ZK2JA[D^PE*NC43!:3WPJ;I?&3DQF
MAXVXQ6LTGYLK1:/)@)(7%=:ZD#4H7!R-CH.#D]CN=QN^%+C2#_I@)9E+^=4.
M+O*CD6\9PA(S8Q$$-7=XBF5I@8B-OWK,T7"D)7S87Z._=;*3+'.A\526OQ6Y
M61Z-TA'DN!!M:3[)U:_8RQ-9O$R6VGUAU>_U1Y"UVLBJ)R8.JJ+N6O&MU\-+
M"%A/P!S?W4&.RS-AQ.Q0R14HNYO0;,>)ZJB)N:*V1KDVBE8+HC.STX^77\X_
MW5R<O#^'RX\WY]>P=R/F)>K]PXDA?+MKDO58)QT6>P9K"A]D;98:SNL<\\?T
M$^)K8(ZMF3MA.P&OL1D#]SU@/@MVX/%!6.[P^(N%_?UXKHTBU_AC!WPXP(<.
M/GR.78J8O"T1Y (R6=^A,@6I$FII:&Y>%K?">J*&HL[*EE1$'3!+M)MS\G.:
MH)Z699$+0X.Y*$6=(3CKZFWVV,F/C><#W8@,CT84L!K5'8YFI_\V8VZIT':>
MY+94"UE2K!?U+0AMY\B,!JLYJL&6!_!6% J^B+)%V&/[L'=A#Y2M%G6N]^%*
M$2=%(THXKF1;&_A<BTH2UW_3*6<X-W!6Z,RM$ %<:-TZADZE-AHNB:E3H=2]
M9:$'Z)OW>(>EG28N4MC4A89?P!_S)'H-KR#P@LCW?-^G_EXP]:)IO-]-DQ2A
M'[H^8\R;QBDP"YCL DS"Q(L(;"]@'HN2?4AXY+&00\I#CZ51!Q%MA0C&Q,9K
M(MT''D3$4T1];^J[,?<"8B:,"(U:]@3@/S#P&6:]?0-G7_]_9U\6>&F2]O9E
M*?TSUX]8[,4L^B'[<F_*G7VY%\4<IE/F<3_^$?N&4^+(XYS;,?.2((;8#[PD
MM/;]\]&?(SH1UH*R,^FIK!I1W__\4\J"Y(TF&PJ%T*B"]-=OR<6]AI)*N-54
MVX"16V+4:?Z)93U8RC)'I=>^\$2H2R?44MRA6U>V+-H3^HQH)\DU<IQC;5I*
M2V,XUB"HP&LJI-XN3"O'X,"KPBS)B3?SK/:@1H+)6J7H &BL5Y'8\@<R[1BN
M986#H'F1/\N\U_-M%4G<"%K*Z&ZD<:V>9O!TT7GH3K6-84<9BH8R%+VX# D*
MU$QT&J"#E:BUZ*Y#F0LEA:53P'?[.&9(0+.MWNP\>'N]N7F4+XR]6_0W0 IV
M[70AR4>*FE14K..\8TXX?8.A2Z#E?EBEJRB@R):@T>G3J>Y@,\>\$W5+U\Q.
MTYT#443[E&M#>-?6^' A\7C<AW@W$?0YV6:1;H:%7ACQ7?:)!_O$+[9/41LD
M51G ;XWURVU*WXFV7>D7&[#KL-&/T_<!W"P5XJ-KVT8FN*3C=JUO*-TE#ILG
M'O1</M\T;9?M.\^TB38,P[[EU(;.2J^ >VG< ^1#07A(RA/["P(?IB&\EUK;
M0">W,"56V$7;DPP!+C6R-T]:*@=I,*6H;!M"V30-,$KGL?LFY##Q=$I?/X[@
M1AKKNYO;Y9;D1(+Y8=)_*;/[4PXQE1Z>PD>RC'J*$G,.(0](,VD4V8)$>GKF
M0*NV./5=&R:I52>5HM!V8N[QE&UUWLF#MT.%ZM:]D#0X77?/B&%V>(0==V^/
M[]N[%]P'H2B.;659$*D_3BA=J.Y5U V,;-Q+9"X-O6M<=TE5")7=0.L+24KJ
M!_: X6DZ^P=02P,$%     @ ,XEB4U$Z#]4(!   ,@L  !D   !X;"]W;W)K
M<VAE971S+W-H965T,S@N>&ULK58-;]LV$/TK!RW8;""-/ASG:[8!Q\E68VV3
MQLF&81@&6CI;7"G2)2D[V:_OD9(5)TO<I)L!4R1U]_AX?#Q=;Z7T)Y,C6K@M
MA#3](+=V<1*&)LVQ8&9/+5#2FYG2!;,TU//0+#2RS#L5(DRBZ" L&)?!H.?G
M+O6@ITHKN,1+#:8L"J;O3E&H53^(@_7$%9_GUDV$@]Z"S7&"]F9QJ6D4-B@9
M+U :KB1HG/6#87QRVG7VWN!7CBNST0>WDZE2G]Q@G/6#R!%"@:EU"(P>2QRA
M$ Z(:'RN,8-F2>>XV5^C_^3W3GN9,H,C)7[CF<W[P5$ &<Y8*>R56KW%>C^>
M8*J$\2VL:MLH@+0T5A6U,S$HN*R>[+:.PTL<DMHA\;RKA3S+,V;9H*?5"K2S
M)C37\5OUWD2.2W<H$ZOI+2<_.YA<7XQ^>7OQ[NS\:O(#G'^\&5__#JUK-A5H
MVKW0TA+.,$QKN-,*+GD&[AC>*VES ^<RP^RA?TC4&G[)FM]ILA5P@HL]Z$2[
MD$1)O 6OT^RWX_$ZS^"=?RZYO8,_AE-C-4GBSRV8^PWFOL?<?XXCW92L% AJ
M!JQ0I;2&])JJN>3_8 ;<:2\MBU(P2T-E<]20JH(N4>[4O40RH3%"2RACVM :
M7HS&3P9_.X_K'.OU'RWO\( N,-#2(,D+BNJ4T)T24(PM%E-BM0XTK% 3EB$G
M0=?6G$!K+,E;E8;)C"C>2,H PN,/-_9VR@23*7E:.,.TQHP]9@0[T$T.ZO;B
MB2"XS<,4B2<Z_H(9PV<\9>[V&F@EQTF[;H?W0:ZM:.V95L57 ^W7:"6'<;MN
M/U#>2TNMD8*V0,U5!FG.Y!Q?<FP.;7=-V;);:'4/.NVZ'5=GZJ;QEG*H<;NJ
ML*P"3A$W3C!;Y! ?1OZ_$=4GCFH'XDZG;N\5\%B!KY5 ]%4)4%*DE"=?+X7X
MF-BVDF[;/0ZK1QQ%[6\0Q???'25Q\B/$NW'WN&[_HSB2;H-*W?]7'@38,#W:
MWWJN[KJL>=#9[D9DOW[^]>"W)8%UFP36_98$]LKP/4AB3V6OK21<]7%B%BS%
M?D"@!O42@\'SA_GZG$:R?4;9P]F,B@3R>N=PQN3HCM<!?W 3FY^T1\!G:!D7
M!MB4"IZ*TXB"HB0ZUH]NC&?A&8P:#2V9**NX+PG(?7;?T*;>&";<ZR4:6WBH
M"4T8OP6J1$K-+4?S K=QTV^.ITY&[5V0).Z=.@_>JVU]KRO9IW? LK_+&N-G
ME*B9\#Q81N4(=U]15U=M7IIK9<GFW[?U?BTR>DJVX48=4Z">^VK-D,Q( U5)
MT\PV!>&PJH/NS:MJ\CW3<TYK"IR1:[1W2.+35856#:Q:^*IHJBS56+Z;4U&+
MVAG0^YE2=CUP"S1E\N +4$L#!!0    ( #.)8E-FYDZQ#P<  .X3   9
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M& !ULHN45+@P^_;"HE5KU#1<"5DX9+(N] BM;3.Z2HR1Z,S!3??V/8K21&B
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MF$)R'8I1"I,X3-(4,M;$&-:G=^FSL2$=3YT43\+T.AVR3=-0C#,OQR(+XTS
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M^>62N2+"&4!\OXA%'U+<9 /L7J([^Q=02P,$%     @ ,XEB4U%TRKC# P
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M!<MWQ]"[&RG6U3GKBY!2I-7EBD=SGI<"]7PAA'R[*3MH_ADP^!=02P,$%
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MN-<6SNO4EZ]3O^Z&+R#2<-P&?Y'+H"ZBP/(%Q_BH)$DB("'V;\'7: 5/P#:
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M[9]0%M0S^5*>2?N+MF6LYZ!T+17/2[!FD+-B=Z6_2R$: !R< ) 20,X%^"7
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MT/<7G*N7$[,A5^^G3OX'4$L#!!0    ( #.)8E.@4&46R00  !@@   9
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;-6:76_;-A2&_PIA]*(%DDBD9,<N
M; /.1[>@&1#$27<Q[(*6:)N()'HD9;?#?OQ(61&5223B#8FUFU@?)/6^A^1Y
M?*R,=XP_B34A$GQ/DTQ,>FLI-Y\]3T1KDF)QQC8D4W>6C*=8JE.^\L2&$QP7
MG=+$0[X_\%),L]YT7%R[X],QRV5",W+'@<C3%/,?%R1ANTD/]IXOW-/56NH+
MWG2\P2LR)_)Q<\?5F5>-$M.49(*R#'"RG/1F\/-%Z.L.18MOE.Q$[1AH*PO&
MGO3)33SI^5H124@D]1!8?6S))4D2/9+2\4<Y:*]ZINY8/WX>_4MA7IE98$$N
M6?(KC>5ZTAOV0$R6.$_D/=O]3$I#?3U>Q!)1_ 6[LJW? U$N)$O+SDI!2K/]
M)_Y>!J+6 4%+!U1V0(7N_8,*E5=8XNF8LQW@NK4:31\45HO>2AS-]*S,)5=W
MJ>HGI[_,[K]>/\PN;J_!_/KR\?[FX>9Z#D[!7$U_G"<$L"7XB3,AP&.F9CVA
M?Y(8W*IS(L LB\$73#GXAI.\:#G;8IK@A>JF0@;F6!W,291S*JEJ__&*2'5?
M? (? ,W PYKE F>Q&'M2.=%ZO*A4?;%7C2RJYV1S!@+_!" ?P<?Y%?CXX=/+
M43P5ARH8J H&*H8-;,' _$E)7+R4_=NM:@9N)$G%[XZ'!-5#@N(AH>4A#TSB
M!"QUW+;/<<//<3M5^^Q4Z+@)(T#%"H.(99)FN0H9R,U,)'IF-DS08HFKSB A
MZHI<XPS('4FV!*2JX[HUQGN=@T*GWKW;:1]"./+'WK;%7UCY"U_A;U6LF7\H
M55Z.9G8ONE\S>PK#0;O5?F6U[[1Z11:RIOVDQ=K):[R< (A*Z3I "<M6A+>9
MZ#=,6"9K4#D8',^!&BV*\C1/L"S;MWD:O-;3>>7I_$@;K$W^>4.^:Q,-*P_#
M+FRB-D/# S;*J+(S<MJY9'S#N%H&8,%4P@=_@5JJ-;H=V17Z!FC^VR5Q6.,F
M_)^D\5)H?<9@O^^'0?N<04-#B+JP" _VBYHKU&K64!FZL?SNN;S4\XK$!PUZ
MH9N]'4CGL E:FRV#6>CF[/MF=-BDK',_&=9"-VR/F-1AD[+V/6- "]VDO21<
MTB6-U((H],>DT/!OTKL!(QR^87HWP()N8G4HO8]:EN.@;]E4R' 2^5U8C8?:
M+56__/YA\6I@C=RP?O?DCII,MDU8K3AUX[@#R1TUT6NS9<"+CE4/MSIH4M>U
MFPQY42>JWE9+;:6MQ8]!+G(C=Z9T2[# T9.24!-Z>&I'AH]H\':I'1EJH6/5
MAP?GNF;Q.(3A^= R>8:1J!/5X\%VVTI+FUE#:N0F]?OG]B:0+>DC,# .W##N
M0&X/FN"UV3+<#8Y5)+<Z:$+7L9T" ]Z@$W5PJZ666M>V98+:+]!NY#Z>S<_
MBFT)SU*228!7)(M^_+<T'QA4!N$;_LIN"!8<JV@\^'?V9D&)^B,?CBSS:( 9
M=**@/-AO2[$Y#"UF#;8#-[;?/<\'33K;$J(A<^ F<Q?R?)/"-EN&P<&QJN56
M!TT N_93:"@<=J(D;GT]Y3=>QC7WC%=[SZO?F:M,NJ*94'MSJ7KY9^<J)'S_
M&GI_(MFF>/6[8%*RM#A<$QP3KANH^TO&Y/.)?IM<_3/ ]&]02P,$%     @
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MH8V=N&%A?BDH;8)9GPNA-Q,KT/ZDDC]02P,$%     @ ,XEB4]3VOEY5 @
MI 4  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULC51=3]LP%/TK5L0#
M2(-\-2U%;21H-XV',=0"TS3MP4UN&PO'SFRW@7^_:R=$A:757A)?^YYSS[G^
MF-12/>L"P)"7D@L]]0ICJBO?UUD!)=47L@*!*VNI2FHP5!M?5PIH[D E]Z,@
M&/HE9<)+)V[N7J43N36<";A71&_+DJK7&^"RGGJA]S:Q8)O"V D_G51T TLP
MC]6]PLCO6')6@M!,"J)@/?6NPZM98O-=PA.#6N^-B76RDO+9!K?YU NL(."0
M&<M \;>#&7!NB5#&GY;3ZTI:X/[XC?V+\XY>5E3#3/(?+#?%U+OT2 YKNN5F
M(>NOT/IQ C/)M?N2NLD=)![)MMK(L@6C@I*)YD]?VC[L <+! 4#4 J+_!<0M
M('9&&V7.UIP:FDZ4K(FRV<AF!ZXW#HUNF+"[N#0*5QGB3'I[]_3Y[N'[XB<Y
MG8.AC.LS<DX>EW-R>G)&3@@3Y*&06TU%KB>^P8H6YV<M^TW#'AU@7T)U0>+@
M$XF"*.R!SX[#YY A/'3PX#W<1Y^=V:@S&SF^^)!9L0-AI'HE<Z8S+O56 ?EU
MO=)&X7'Z?:1"W%6(787!@0H+6N/N&%",\MY^-?"A@]L;MDL'H_$(>[/;;TM/
M5AQ<QEW6.VV#3MO@J+8EE.Q\S03#TY(3W%#2!1LI^[>W84S>R0W'PP]R>[+&
MX674+S?IY"9'Y3Y(0SF>OW;+^M0E_[1IG(3#T0=U/5E1-$P^J//W[I!]O[Y1
MM6%"$PYKQ 47(Z11S9O0!$96[EJMI,%+ZH8%/J.@; *NKZ4T;X&]J=W#G/X%
M4$L#!!0    ( #.)8E-0,YN*)04  &L;   9    >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;+69:V^C.!2&_XH5S8<9J5/P!0*C-%)Z&>U([6RVEUWM1Q><
M!@W@C&V:5MH?OX903 -QTIGRI05RSLGKE\-C$T_67/R02\84>,K27)Z,EDJM
MOCB.C)8LH_*8KUBN/UEPD5&E3\6#(U>"T;A*RE('N:[O9#3)1]-)=6TNIA->
MJ#3)V5P 6609%<^G+.7KDQ$<O5RX3AZ6JKS@3"<K^L!NF+I;S84^<YHJ<9*Q
M7"8\!X(M3D8S^.7,<\N$*N+OA*UEZQB40[GG_$=Y\BT^&;FE(I:R2)4EJ/[W
MR,Y8FI:5M(Z?==%1\YUE8OOXI?K7:O!Z,/=4LC.>_I/$:GDR"D8@9@M:I.J:
MK_]@]8"\LE[$4UG]!>LZUAV!J)"*9W6R5I E^>8_?:J-:"7H.OT)J$Y VPED
M1P*N$W UT(VR:ECG5-'I1/ U$&6TKE8>5-Y4V7HT25[>QALE]*>)SE/3^?6?
M\XOKVW^/P/QR]OT6S+Z?@XN_[K[-KR[TV6=PH_LF+E(&^ )<2)5HXU@,[B1;
M%"FXU'= @H_G3-$DE9]T^-W-.?CXX1/X )(<W"YY(6D>RXFCM-3R"YVHEG6Z
MD85VR K!%<_54H*+/&;QZWQ'#[$9)WH9YRFR%KQAJV. W2. 7 1[])S9T\]9
MI--AE>Y:Y.#&=ES5P[ML%_I!%.KY"*Q2FBN@70+L9Y&L]!.B+/5)4Y]4]<FO
MU#\"5(&(2]5W7S9U_:INR8#'Z1B&)!A/G,>V7=TP+P@]1)JP5[*]1K9GE3V+
MHB(KTJK'8J:Y%"6T?-K[A&XJ>2T%GZ%6T%':%X?''@[ZI?J-5/]W',Y9K[M^
M1XSV3"-W2W,WC'@P#/Q^R>-&\M@J^5)KM/16T)0)!NG=L*D?#M2[8=<VXOM;
MWNX)>B49N@:CKMU;IN>2)4_C2NY]D:1QDC^ )%L)_LA*Y=)B#6SA&@YB/D3F
M&]! ]M>%VU" NKF1MW4'ZKCV+8!P'/C>CIM@H KQW@8_V'*#4DB&L=Q0#]JQ
MUS.Q+EBOP_8ZT //C KKL W?X&\!SM8'?J</2!"2[2[H@5S@[YA H&$<M$/N
MM'[TK"88U,%A6 <-[.!0M*L+MVU&+G3)]F0"N\33,TX8N/U6(\,\9&?>&<]6
MA6+"Z*W41R^7)5^H-17,MGPSX$/#@ \9\"$[^ Y^"O?4P7L?0F2(ANQ$^_7N
MJ NWNR,,@R#<:HXZK-T<8X_ \8[>,-!$]@7H);WG@BHNG@^[2X:5R!NF#PSX
MT%#@0UVD0;W2#/&VZ3UQ!$&XZXDT\$-V^'TM1)ZH0K!*]")Y*H^MG6A(B(8A
M(3(D1$.1$/40;NQU;>\)(Z&_XT4 &PYB.P=G4C(E0:%?5876F$LEBJC[VO*Z
MN@$?'@9\V( /#[7BP]T5GT]@YQ6L)PP&@;=CKL>MEV@[':^2/,F*#/P'#IGU
ML8$7'F;%APW%\#NM^/;4P>[>R08;\&$[^(R=;Z0W-H#"XV&<-9S"P3LY:Z^S
M?Q;'AFS83C9C[)L!30R%B#O,3TJ&1 2^C[5[ZNRWEAAV$3N[KNC3&Q! #%K(
M0#_0M7ZALZ^0#G?37H?L1P Q7")VGA@[WX@ 8BA#_&&<-9 A]E70X<[:Z\ #
MG#5<(G:>&&??S@ #&A(.XJUG*./9USH'>[NGCLU;I[6=D3'Q4.WR2+T(*7*U
MV=EHKC8[2;-J_\0QX9MMJ"LJ'I)<@I0M=*I[/-;M+S8[.YL3Q5?5YL@]5XIG
MU>&24;V0*P/TYPO.U<M)^07-_MKT?U!+ P04    "  SB6)3O*L,= @$  #$
M$0  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6RU6%F/FSH8_2L6ZD,K
MS1VP63-*(F6RZ%;J3--9[E4?G> DJ("I;2:=?U\;& B!$+KD)<'FG,_?QC%X
MN*?L&]\1(L"/*(SY2-L)D=SH.E_O2(3Y-4U(+.]L*(NPD$.VU7G""/8S4A3J
MR# </<)!K(V'V=R2C8<T%6$0DR4#/(TBS%YO24CW(PUJ;Q,/P78GU(0^'B9X
M2QZ)>$Z63([TTHH?1"3F 8T!(YN1-H$W"V0J0H;X+R![?G -5"@K2K^IP4=_
MI!G*(Q*2M5 FL/Q[(5,2ALJ2].-[850KUU3$P^LWZXLL>!G,"G,RI>'_@2]V
M(\W3@$\V. W% ]W_2XJ ;&5O34.>_8)]CG5=#:Q3+FA4D*4'41#G__A'D8@#
M@K333D % 1T3K!,$LR"8?5>P"H+5=P6[(-A]"4Y!<++<Y\G*,CW# H^'C.X!
M4VAI35UDY<K8,L%!K#KK43!Y-Y \,5X^?%[.'YZ^7H'EI\G]$YC<S\#\R_/'
MY=U<COX!]Y@QK(H/WL^(P$'(/\C9Y\<9>/_N W@'@A@\[6C*<>SSH2ZD1\JN
MOBY6O\U71R=6-\$=C<6.@WGL$[^%/^OF#SKXNLQ$F0[TEHY;U&GPD237P#2N
M #(0;/%GVI]NM(7S9ZO/_VSU13=]1M:2#MOHM5R:96N9F3WS5&LQJ7],O%Z!
M),2Q +)% /F>!HD4)M%AWRKM6YE]ZZ2_4DO7 58*U=9Z.=O)V$I@7\8(F8:,
M[.6PH$T4'+C'J%D3Y5@-6_,FRC8/4;4P[3),NS/,SC1> 2S FG+1EH#<KGW@
MC@L'EN<>Q=8/MK";P7D#&UGMT3EE=$YG=!/.B> @E<\ODX'$7+!TW:QHS;9;
MVG8OTH!>:=^[4&6\1LH="S8*TPNU:**@Y]DGRC(H0QMTAO8)KZC4?<I>>V4,
M&M5V8URD)O!@0X,7JDIAN)9*US8'YE%=>N(6;3@+07A"$""J0D1_XZ$IHD)-
M+Z#74+BSL+JOU28 S>Y.(O*];T=#/RO$*@U"/XBW((@21E^(J@GO*GNU&4#K
M,HU5Z3"\E!##IL3*1C"0?5R#?KA%&PZZGF.?*%8EQO"OJ'$1E=/PPC*<9F.=
M@]5]K<0=NIV^3FF4I$+ZR>E&[#$C746N)!UZEVFC2EEAM[3^6HX'+95NR?$Y
M6/UEN%)K9)S9!F3X/1]55"DT@A?),:H$$G4+Y.\_JJ@I@Y8WL([RW0NU*%!.
M#>6<V)E1I:BH6U%_J8$*6[6WX$;[G 'E?NH''YD18=OL.(!+!])8Y!\%Y6QY
MY##)/K2/YF_AS12VS,_@S3P_4*C,Y^<;=YAM@YB#D&SD4L:U*Q//\B.#?"!H
MDGWBKJB0'\S9Y8Y@F1\%D/<WE(JW@5J@/+@9_P102P,$%     @ ,XEB4W1Z
M0Q_:!0  HQP  !D   !X;"]W;W)K<VAE971S+W-H965T-34N>&ULO5G;;MLX
M$/T5PNA#"]252.H:. :<I.T&2-.@3K8/BWU@)-H6*HFN2"5-OWZI2T3;HF@G
MN^L^-)(],SPSY)E#FI-'5OS@*TH%^)6E.3\=K818GU@6CU8T(_P#6]-<?K-@
M14:$?"V6%E\7E,2U4Y9:R+8]*R-)/II.ZL]NBNF$E2)-<GI3 %YF&2F>SFC*
M'D]'</3\P;=DN1+5!]9TLB9+.J?B;GU3R#>KBQ(G&<UYPG)0T,7I: 9/SG%8
M.=06?R;TD6\\@RJ5>\9^5"^7\>G(KA#1E$:B"D'DGP=Z3M.TBB1Q_&R#CKHQ
M*\?-Y^?HG^KD93+WA--SEGY/8K$Z'04C$-,%*5/QC3W^0=N$W"I>Q%)>_P\>
M6UM[!**2"Y:USA)!EN3-7_*K+<2& W(''%#K@'8=_ $'W#K@.M$&69W6!1%D
M.BG8(R@J:QFM>JAK4WO+;)*\FL:Y*.2WB?03T\OKV]GUY\NSJX]@-I]_O)V#
MV?4%^/SUZ\7WRZLK, 9SN7#B,J6 +<"G)$\$!5>R\#&XS 7)E\F]_&K&.14<
M7,M5=T92DD>4 Y+'X'M=1&D[>Z"%7!3@CM-%F=8!.'A[005)4OY.CG(WOP!O
MW[P#;T"2@]L5*[GTYQ-+R!0KH%;4IG/6I(,&T@G!%Y:+%0<?\YC&&O]SLS]$
MA@"6K&U78/1<X#-DC#BGZP\ V^\!LA'4 3*[7]!(NL/:W3; P=U\XSH>'HC7
M3.%X: K_NI+VX%+0C/]M&,WI1G/JT1SS:&D]6J)&(_5H[\&R8%P[RTU8KPY;
M=:*':>B%V XFUH,&CMO!<8UPKBCG)V 61656IJ1:F"1CA4A^DZJEZ' T\=P-
M'&/H.]BU.R#-)+H]O&,([2 (]8"]#K!G!*PF2!8KIT('T>M!]$,G= =*Y7<C
M^WM&'J\+)HG,9;/FE!31JJ9T3!]DZU_+1JX%X_? 0.3:\I\>3="A"0Y?1Q6,
M1+)S\=K%%?1 (@2W5E<SJ7T[658;(GTN89=+^-_G,C#W86_9(=O9FOPFD[Y=
MX/@087TFT%;B81MSN2U(3$%.,FIH%G!#B^ 1FA-$:CQDA/^L3V/2ZE-!JYU/
MDB]!V2A5FBQJY3/.#W@K1>M)<H2_TRJ6&01T&E\ 059)#_! 3)YT"_?\X$AV
M$XH#Y&B";5=+*0?$_T\S;^-N+C]HV[Z]VT3WVVTC5RH$S3+T\K[?!MQN_# ,
M>I U=CX::KY0"14T*]4AC1_V12<(?-2#V#<+L>,,=#&HI F:M>F\WIS20I(F
MK>O(5\G:N-*4]D#_&'U J0LTR\N1^H 9A-QZUKY:XA_F"L)GWL-@+^^57L$7
M"-:+>*^1)PWK]UAM[[J5-"&S-+V<\VW +2Z[.-R!J[-R;&< KI(^!/\UX=L0
M6Y6"'MP%J+%"H3< 4&DE,HO+C:QA+DPK"BDE0<<XA"#5_Y&Y_Q^'WWM X&%Z
M'^8)@H[=:!^[D5(:9%::5[,;]74%VINZTN:F-X,#ZU')#S++SROXW3\IC3T'
M^;N -6:N@P;T$BE10_M.5 <PW.\5R[&ANXNP;^7:<."HB90*(K.*S**?95+0
M[HPGGP2-5CE+V?+)M-:4DJ#P"+S'2@.P60..P_L]((*6O8YQ3][,[)Y0H:Z%
M;-=&"0XV"\ZK>8_[^A*X&/J[.J2S@\ZFW39RI438K$0O9WX;<'LW[[J;LMUB
MUAB&&/D#^WF\\:N;^>QT"/EQ__CCA;[O[38HC9W<]0?AP&D>*YG$9IV9E^MU
M^@3(LJ TVR/V6 D,=H]!>B4,V"P,1R*]&81[D&2W\VD.Y;6AO#:4J4A*C+!9
MC%[/_K[VR-WEKD)IK/#PKX!8210V2]0KJ-__$6_W *(Q&3ONQKY@&ZQ2.VP^
M-QW$><WA1U-.C97K^+N$MS:N@>3!?%G?CG$0L3(7S8U0]VEW S>K[YTL9=Y<
MWWTAQ3+).4CI0KK:'WQ9G:*Y$6M>!%O7ETKW3 B6U8\K2F):5 ;R^P5CXOFE
M&J"[EYS^ U!+ P04    "  SB6)3HY/M'JD"  #$!@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6R%E5UOVC 4AO_*4;2+5NJ:8 B$"I"@M!U2UU8-
M72^F71AR(%8=F]E.Z?;K9QN:L1'*3>*O\S[O<>R3WEJJ%YTC&G@KN-#](#=F
M=1&&>IYC0?6Y7*&P,PNI"FIL5RU#O5)(,Q]4\)!$43LL*!/!H.?''M2@)TO#
MF< '!;HL"JI^C9#+=3]H!.\#CVR9&S<0#GHKNL04S=/J0=E>6*EDK$"AF12@
M<-$/AHV+4=>M]PN^,5SKG3:X3&92OKC.).L'D3.$'.?&*5#[>L5+Y-P)61L_
MMYI!A72!N^UW]6N?N\UE1C5>2O[,,I/W@R2 #!>TY.91KK_@-I_8Z<TEU_X)
MZ^W:*(!YJ8TLML'60<'$YDW?MONP$T :!P+(-H!XWQN0=SFFA@YZ2JY!N=56
MS35\JC[:FF/"?934*#O+;)P93.ZFP[N;R>CV"H9I>C5-87@WAIO[^_'SY/86
M/D-JCT%6<@2Y@.O2E IA6$AEV&_JM_7JS9X/C7 R1D,9UZ?P"9B :2Y+346F
M>Z&Q-ATLG&\MC3:6R %+*:[.H1F= 8E(XRD=P\FGTW]50IMDE2FI,B5>MGE
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MJN>;N?W-H'(+[/Q"2O/><:6O^G$-_@!02P,$%     @ ,XEB4^CQ\[J= P
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M^!&:A$+#%_%,5K_HV,1Z#HI*J7C>@+6"G++ZG_QH"M$#:)YA@-\ _.> \0E
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M5(BR=Y<3Q7/;_M9<Z69JAZE^[D"8#?K[AG-UF!B!^@$=_ 502P,$%     @
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MK[JN*FWWVH"!:$G,=0QL5_?#7SND<2")@8V^* D\Y_#XV/G%I+=E_$>VI%2
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M(7<G@JWRAV83)@1+\L,E)3/*58'\?,[D,(H3]1RN?!0\^!]02P,$%     @
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M'WM2/+YG3CMYS!A8OMYZOT@&KP:SP(*,F?\7=:5WVNEU@$N6./+E ]M<DFQ
M"4&'^2+Y!IO,5N\ )Q*2!1E8,0AHF/[B']E$E #0K &@#(#: HP,8+0%F!G
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MV)RN$W7'-U]8"<C5\4*>R/POVA2V/AB':ZEX6CI#!6F<%?_I<]F(+0>(T^Y
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MJ9KK"8B^QGD:ZH@]K:@.66^$#PSJ_*L,K/KF!$\JU8D">BRBQE,9-;3W55!
MR2-**A*@>1K$Q?6SM=8R1_FBO"Y,])#I:#%+HBA(,]/4.G2U)E%J*C*;IW-/
M.IXX'3_9G"'&&;(C$-&_T;=J/4"C98"+Z5'AB UU,1NV2#1QEN50OBH]D/;A
M@TU1M"RC)J3+4!O#4+4/:;5XH0X,;#$_[I :..*!=!PRI+ I7C5%N!I:1!B:
M!:^@3$-'#!/L5@>8-"R%U@-<9&NW=S]!\P9KV ?'MV7^4VG[4]G+C4K+K4<\
M5=5?J]0/RK0,MX@+SYQUGN6ZDX(205Z"XD'-PS@N?M! >4>.*ONTW9Q)W9'7
MP 7UN228V8%!#/T(3+]_U##K$X!; H@KF7"]#@&&6 0FUD4QYXLINDB3]7RA
MMU%_K\,L+-=#GRC2%L4()K1#DX$<@=/*6[VITSNQ_E&A+0$GV)-$<+=#@J$A
M@1&FMX2/*AQR9UA; W,Y<7&'! ,^T@.^]O0MLH/=)J[74L>HRUUIU-7[AO:%
M\ PW>"4P7C?Q_:*.[^641U=%/F$VB-""-[PE,"1W7/"#4H5)W6<S51"^T[7N
M#'0)#-WFPA\HI#*(24,)IM21'5(,H F<*?8A8* \WR*/"$?X=GW4<)S"'-_"
MP3 QM<4M,8(XI&.LJ.$UA7F]S86!8G!;C.\[?L?2HH;=M"?;'$J(@3I):Z9C
MUW<:/*]88;FN>T701BT!IOX7D_=K#Y2>@_FKW@#KY$'/SCC/4**]2K5K.A%\
MVPL\Z=Q"WPOM8N6MU:VJ6]YT"S/FNMMN75JN$SYV.T()-:&$PJ&DF?_DR?1W
M;X9#38B@WG^7K=1@G,(5@YUY=5D;;$X3WW7\KGEB*$]ARN^>,E)#92K_E[DJ
M-0RF,(./EZO6'34C.<?2PQWCS@R&&8SA@:DJ:^?*Q*.8=*PC9M#+8/0.S0I9
M.U?NZMN0EL&D'9P.LG9.?")]OR,99 :.K*?2>H1DD+739<D)9^P=WRW7@3.H
M4=B%*[L'XXH9,K*=D^?#4\&ZSRVB48>0CG$Q;&5'9NND-KB=;#%-5_XNJ#$K
MA'%'H8L9"#,8PGOD9+7%(>O2\)K!6?0^Z1BSY-%<.EW;5F88SG9F^"'I6-W;
M=CHF'.:_7Z[MZX!9Z1G>>S#OOZ^7#UI@47EM.+9J!,&J-+LN@F ?>SQ+5& ^
M[\H&/!,5/#@J7"]74?*JM)@BMX*.B0SL/7+< RA#<:^GL''X$=2DIPO7<=F?
MMG2LMQTFT'&!9RCO]>2[AY]>37JZT&*YW<F^=@0\$_$:9XEP?#GLX&O28YU)
MATJ[@W!#3AT.'NQY)BAY<% Z[-!LTF-= [=U:E9["#>4?GN";WMH8I@'Q[!=
M#]PF/?8L)VZU2SNWV_;(A$.OYZ!S"X:#CIX\$]X\N(Z_*Q:YB30<CC0[G)-,
M>DQQZ]%3?22^3]-METQ8XKN$I4$G5MP$*'[< ,5-@.)P%-CI3L"F2-74>B/V
M:+GMD E&'"9^57$I#@]!>X;['*ZX]#[EPAL/>< D.]Z6O^YH*[DB%+M>1^F5
M&T1R&$T#]_Q\<&K/#<LXS+(##J9JRTTYF/I4L([R+S<,Y'"*?_VBPT,XH C!
MVU68$TQ<2;V.C%<86@J84X-K$:*=<Y]0[KL=LT(8N D8;L<H1@C+B285OL?>
M5YMM%T*36QB,"KBH\ZLJ'A>E/;7A7E+6E NW:I<&NF,Y"WWGSK9*@V31A^1R
MR@4/D=I_L-L5'2PQ9W[')E$8OHH=2SIO*P3=I.$4JN4(PUSQ?ZCEB'8MA_HZ
M>>X8$$-U<>Q:CFC3NP.>HO%8'LSMXQSIU9UL54H\G;=WJ#-H%WW/XS4I.E"+
M[?03.YTP,T@7,-+W*2$)RUDG)X[L8+LT;)<[/[)R2 E)6HY!BQ/C]Z?_]74#
M%X,T@4+"@6)GP@YTRW*@NNW6MEX3$20<$0:S=J#.]D$I\3J+K]*$! D_!-B"
M[JTJ7M H)LVEWL*DP31?!Q&ZUSD\]/2L@;R$D^C&K+2Z";?VZD?71+V_0MSR
MZ%H]#V%+O'=C($U0D7!0V65J6IV&S0]R>ENZ"3&RKS+3/TNMDF&S[.T10_=-
M<_]#AM)$)"G .;O/0\2R\8 W'%&&<-,Z)++];  3E'8M41-5)!Q5#IY>[?T#
M),PW$<;OJ[7L-WG\]F8"$R$)[Q!D8H0/QXC[)->L"C>38O,$R-LS'NHM6[#*
MPI8;*&7KX0[+=<1W6P]WC!OO02U5.B_?)\O0-%G'>?62S^;7S3MK%^6;6N]^
MG^#/E]6;9\9,]2+<MR#5N6N&(O6H3;I.D8BFU;MEU9<\695O6STD>9XLRX\+
M%<Q46ER@__Z8)/G;EZ*#S1M^Y_\!4$L#!!0    ( #.)8E-L!>82" 0  &@.
M   9    >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;+U7;7/:.!#^*QJFG6EG
M&OP&QF2 F80D5SY ,H7>?1:VC#6U)9\D(/GWMY*-(6 ,;>_N"UCV[NIYGI6T
MVL&6BQ\R(42AURQE<MA*E,IO+4N&"<FP;/.<,/@2<Y%A!4.QLF0N"(Z,4Y9:
MKFW[5H8I:XT&YMV+& WX6J64D1>!Y#K+L'B[)RG?#EM.:_?B&UTE2K^P1H,<
MK\B<J._YBX"1546):$:8I)PA0>)AZ\ZY'3N^=C 6?U*RE0?/2%-9<OY##R;1
ML&5K1"0EH=(A,/QMR)BDJ8X$./XN@[:J.;7CX?,N^I,A#V266)(Q3_^BD4J&
MK:"%(A+C=:J^\>U74A+JZG@A3Z7Y1=O2UFZA<"T5STIG0)!15OSCUU*( P>W
M<\;!+1W<8P?_C(-7.GB&:(',T'K "H\&@F^1T-8033\8;8PWL*%,IW&N!'RE
MX*=&X^?I=+*8/LX6<W0W>T#CY]EB,OOC<3:>/,[1#9JO\SPED#>%4_1 99AR
MN18$\1B-L4S0$ZP#-&'%>M)Y^?1 %*:I_ S.W^</Z-.'S^@#H@PM$KZ6F$5R
M8"D KJ>WPA+D?0'2/0.RCZ:<J42B1Q:1Z+V_!80KUNZ.];W;&'!.\C;R["_(
MM5VG!L_X>G>[ 8Y7)<$S\;QS2=!*YIA&"'1$..-KIB1H%J9KX*O%4PE!&<%:
M>IT++7\*0X)2BI<TI8H2>=N I%,AZ1@DG3-(GG,B((]LA4*-*8;L2A0+GB%>
M?3$3UV:QB.V;V/K\V(R<?N!U!];F4-L:*S=P>Y75.^#="GCW%X''E&$6D@;8
M1>3N :">ZQV!/K5QW&X]9+^"[#="?BJ!_3Q@_P2,%]C',I\:^7JQUB'N58A[
MC>MTQMF-04O9ADBC-FSH$K 9Z4/YXF(,JNF"1H%,3;GA\<T:%CJ6DL"FX$LX
M75BQ*<AKF&"V(F;7,*@81VOT<'/4R1B<*F1W OM(QU,KQ_-]MU[)?D6M_^]2
M>[<H+A'KG^RPCMOWCWB=&CF]SKD5XMC[>F)?N1$-U"]H:RHIT,(;^++:45!$
M9' /T#<-,*ZM"<T3!>B-8"&1@S)='. L1A%^J]-C?&VD,A0\N36QW@MR4&"=
MJ[;Y.3DJ#0Z$J96C>1KO2 ZG=UZ.*R/9.SGZ%]5P]VJXO[D\(KADZ *(P([4
M"M$\@]]V@X^UM"_Y!=[')H[[:NYXOY7QRPR;XW?;';>>X26_H-?(<']+<)JO
M"8M$P.6[*=2^;CO=_Z.F./NJZS27W?^ZJI33'QZL7M^WCP]6Z^#.GA&Q,JV,
M1&9A%!?9ZFW5+MV9)N'H_;UNHTPOL ]3]&!3+%:428 =0TB[W8-,B**M*0:*
MYZ8S6'(%?89Y3* 5)$(;P/>8<[4;Z FJYG+T#U!+ P04    "  SB6)3\*#9
MFE\$  "-$   &0   'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6RUF%MSVC@4
M@/^*ANE#.T-B2YB+.\!,"NDNG=PFI.W#SCX(6X"FML1*(B3[Z_?(=FP#MDFS
M[0M8^)RC[URD(S'<2?5#KQDSZ"F.A!ZUUL9L/CJ.#M8LIOI<;IB -TNI8FI@
MJ%:.WBA&PT0ICASBNCTGIERTQL/DMSLU'LJMB;A@=PKI;1Q3]?R)17(W:N'6
MRP_W?+4V]@=G/-S0%9LS\W5SIV#DY%9"'C.AN11(L>6H=8$_3DFBD$A\XVRG
M2\_(NK*0\H<=S,)1R[5$+&*!L28H?#VR"8LB:PDX_LF,MO(YK6+Y^<7ZY\1Y
M<&9!-9O(Z#L/S7K4&K10R)9T&YE[N?N390YUK;U 1CKY1+M,UFVA8*N-C#-E
M((BY2+_I4Q:(D@(9U"B03($<*&"O1J&3*71>J^!E"EX2F=25) Y3:NAXJ.0.
M*2L-UNQ#$LQ$&]SGPN9];A2\Y:!GQI/;Z^O9P_7ES<,<7=Q,T>3VYF%V\\?E
MS61V.4=GZ"(,N4T0C=!,I&5FT_5^R@SED?X (E_G4_3^W0?T#G&!'M9RJZD(
M]= Q@&<G<8(,Y5.*0FI0YFQSCCIN&Q&7X KU2;/ZEZUH5)\VJT]9 .HX47?W
MU1V(:1Y8D@>6)/8Z-?:NF-:,M=$5@ZILHRG3@>*;)'A_78$LFAD6Z[\;9NKD
M,W62F;R:F6XW3$%6Q I%=BZD;*F?R>79%@84*$QE,E*CO<2HW1T>Q[C7]S&$
M[K$<M0HQTO6]?BZVQ^SES%XC<ZFL:"RWPB CT0+862!7@O_+0D1-YD\@8]AH
M @8?!D$)(K-FV:N(TP6/N'FN<C EZ);)!P3VPP,'*\0ZI%<2VW.PFSO8_:FD
MY*1M6-5*@2M5R-UC%I^00^(**>P-.M7 O1RX]U9@(44#<^^8ID?\[B%TA1C!
M;K];3=W/J?N-U)^YH% :*7.[HO2KB/O')3WH']5%OZ)\:LMBD/,._A]O&VE#
M35KK<HF6B3R'9;*1.EDQ;<2>C.V[B\@F25=ZV QQ"PM(H4B*U9EA*L[V",CS
M8;CV7/1S%_W7N]B\0OWC1/CX*!%^12+Z=8G ;M'XW+=P-J[/S&29N.L? 6=2
M96*O'KC4J?'/U,XQ\:^IG1,4:?%D,^80G.F&TL%%T\3D;4EIWH,RJ[W]3?PX
M,15BGEN;F:(!X^8.7)^9 OL7)>?$4>!@9;\R/477QLUM>WH[1_=;X)N)1Z8-
M7R6GP2;31;_$W=]\7L)%J\/-O>X2T.$@"X>,@#_R"(4TACM.U2EIDEDJEXPW
M(+4E4_0MW-RXKJ36:"*%[;APN'E&%T&@MC2J3'I%PW+KR[;H1?A$,Z)!4J;V
MW'Y%T1<91;2-)A=-,2ZZ /9_<SY)L963YJW\\.PBI$'/<&=^.3F&[?K# #G>
MK GQZX)+BMV:G-@G3S,U]L;,?.\$EU.Z^MF+^C55*RXT3+H$/?>\#XZI].Z;
M#HS<)+?!A31PMTP>UXR&3%D!>+^4TKP,[ 4S_P=B_!]02P,$%     @ ,XEB
M4X#"68R  @  @@4  !D   !X;"]W;W)K<VAE971S+W-H965T-S<N>&UL?519
MC]HP$/XKHV@?=J660( >JQ")J^JJ8H58MMM7DTP2:WVDMCE6ZH^O[824KH"7
M^,C,=XP]CO=2O>H2T<"!,Z%'06E,=1^&.BV1$]V1%0K[)Y>*$V.7J@AUI9!D
M/HFS,.IV/X6<4!$DL=];JB266\.HP*4"O>6<J+<),KD?!;W@N+&B16G<1IC$
M%2GP"<USM51V%;8H&>4H-)4"%.:C8-R[GPQ=O _X27&O3^;@G&RD?'6+AVP4
M=)T@9)@:AT#LL,,I,N: K(S?#6;04KK$T_D1_9OW;KULB,:I9"\T,^4H^!)
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MK.PO'(NYG@/A7FF1%&!2D/ TO[*7HA!G@*9_ = L ,WW@,$%0*L M*[]0KL
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M>AU[NZ.&%Z690.\W0NC3@_E V4*/_P%02P,$%     @ ,XEB4VT.43L*#
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M[8X]0)LQU]HHAY=1&H:W=>M5H+1M1FF^!5&.)U-7'W;9F@V/+0#<-I/7_:P
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M$Y3=@.NEE.9M8IMX>(+3/U!+ P04    "  SB6)39":J\E8$  !"#P  &0
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M50AB"5?-A%V$";PY0\UXIMZ2X6[N"&Y32><P\C71&P9_T9#.:M+H&=*/K.A
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M69(?KBD)*=<!ZOZ2,?E\H@N4;[1&_P%02P,$%     @ ,XEB4Q4<UF+D @
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MU-_%/.3;'VW<PW,3'57$HW]1X;!6W#;VT6E3=6:.8'UHP-X0*C7_C43)>_#
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M ^H9>Y&(5?X+^_)=SX$H4UHD)1@9)#PMGO2Y3,01@'1; 'X)\-\*"$I \%9
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MP/_70NB7B;GZ5Q^3XW\ 4$L#!!0    ( #.)8E-,@%)"N0(  %P&   9
M>&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;(V5;4_;,!#'OXH531-(0-JD#X.U
ME?HPMDQ0*@+;BVDOW.3:6#AQL)V6??N=G304D79[T_CI[O^[L^\ZV KYI!(
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M5!$":(S*;2/E=*$DK3PTC+IA9>=,B#MXE']D>]KK;&?OJIV3;=,:JIM.QG5
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MKX9Y P:6!S+]V5KCNXU7R,MU@.WI2Q6"S12O1&RF^%H#XE\W8"2)?[>Q/,#
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
M  @ ,XEB4_]YROE$!@  .SL   \   !X;"]W;W)K8F]O:RYX;6S%FUUSFT84
MAO_*CFZ:SM25A?AR)LX,DE8J$PE40$[3FPP6R&:"P ,X:?+KNR"[WDW0.[TY
MX4H68/2P7\^>W<.;+V7UZ;8L/[%_CGE17X_NF^;A]7A<[^_38US_7CZDA3AS
M**MCW(BOU=VX?JC2.*GOT[0YYF/M\M(<'^.L&+U]\WRO;366OY1-NF^RLA '
MVP,W6?JE?CG??F6?LSJ[S?*L^7H]ZO[.TQ$[9D5VS+ZER?7H<L3J^_++'V65
M?2N+)L[#?57F^?5H<CIQDU9-MO_A<-A"1O%MW1UIXML@%B#7(_-2W/"05773
M7='=/Q:,GU-Q\>G;8U,NL[Q)JT7<I*NJ?'S(BKOV-N(IQM)C=.7P_'DJQ-?5
M_RG&\G#(]NFBW#\>TZ(YE6.5YBU@4=]G#_6(%?$QO1[-R\]IQ;;Q7=H^E/@5
M-SD]8"/(I.*J7F?B1.4F'2,E3Y&D19TF3/Q5EWF6"(Z$S>(\+O8IDR U *D-
M"/E1DR"G '(Z"&38XHA_E2!U *D/"*F4I $@C2$AIQ*D"2#-(2%U"=("D-:0
MD(8$:0-(>TA(4X*\ I!7M)#A;K-Q@@_,7[+077GNTIT[7L2<^=S?>9$K#^:7
M:#2_I,4,^ WW=ES&@7(AMHLHLG<\<F9KSD(^WP5NY/)0AD-2F1!;Q?5$645^
M\$$&0@*9$!MD&_A;'D0??F/;==>XO 7C?^[<[49PRI!((!-B@[A>Y'@KMZU2
M)PQY%':8*]]?O'?7:YD2&61"K)"EXP;LQEGO.-MP)]P%O"U#I>DA=TR(Y;'V
MO=5%Q(,-6_"94K5(%A-J6_BB1P115[>>'ZD]%0EB0FR(M3OG7LB[EC;WUVMG
MY@=.Y/H><U8!5T8[I(@)L2.V2_=O'C#1C3?^"]UWG5=#>M"(]1!&_OS='_YZ
MP8/PEVYLB>313T.NT(A=T;%=S)R0MY6\V8H:[^I8YH,Q"'40XF\V;M0-(T\-
M47C?6W%OKCI-0PK1B!7B\??L)%T6.7^Q>< 7KM+ZD#HT8G6\=T-1:*'K,2X^
M_8T[%\/?#5_[G>"46!.Y0R-VQVPG$'D8MJUPYGI=(SQ5>2<\&1,Y1"-V2,A7
M7;&YWM(/-C]T%202C5@DKB>*CK<M4.T9R"$:L4/@!%Z)?#7D$&W(.$.)?:=(
M)-.?$V>P5U$L?KC^5>9"$ID.$7#T4B*53']6Y-%+!M>PA@Q!V"L9$YED.F@0
M(IMDBDPR'28*>:YU&1.99$J]E/7]O+^W62*A3(F%TC=O[85$AIE2&^;,!/8)
M5,9$AID2&P;.8Y4NKB/#Z,2&@;,PQ=<Z$HY.';7\. OK:Y@ZTHU.K!L\IY"7
MJG7D'IW8/1A37JS6X0X*L7N>ISX7+!1W2Q[SE)4'MLCJ^.ZN2N]D3.0>G=@]
M+YA>7%5QNQW*7BW2)LYRM64B\^C$YNF?KOU7LC(FTH].K!^(J8Y%2$ ZL8 P
MIAP[Z$A .K& ,*8\'!E(0 :Q@,YA/G4G&1,)R" 6D!1+]/1N WG'(/8.#B8N
M9$SD'6/(F$?=$T?>,8:,>51,N'=/[!V,*0]"!C*/06P>C*D,0L@\!OE*&L*4
MYT0&,H]!;)YS@>[3H"YC(O,8Q.8YC]D-ZG)B"3*/26R>\YC+.*ODU0T3F<<D
M-H^ZB=FK'Q/IQR3?L/E^64.9LLN82#\F==Y8#Z:3)%E[89PKM8WT8U)GCJ'2
M5/1C(OV8U+EC?9B/QV-<?6W#-!D3)H]1)P"@'6VU-)%^3&+]8$PE$P_IQR36
MS_F-]VY4DC&1?DSJO9V^5<R7^%Q.&43ZL09($I ZNXR)]&/]C'R!<YA*%[*0
MA2SJQ;=SJ\*GBI<QD84LZL6W\YCMI$/&1!:RR"V$%J_ED-)"%K+(+00PU;:)
M+&016Z@W6Z1W(F?!)&9B"\&\$;4TD84L8@OA'0M9EA:RD$5LH7[,OC57&UG(
M'F3_IV_-U486LHDMA"M=7D>PD85L8@MA3.5% &0AF]A"&%-^%<!&%K*)+80Q
M+1D36<@>,I'MHRUC(@O9Q!;"F%<R)K*036PA/"#)P[L-7Z:ASD+HVY#N,;J-
M'&03.TA.$.RENT+JN>K4,^XNKM^^2=)#5J2))^Y<B^/[.-]O*]9^M'>::+K1
M9H4?'O-\+H[YQ;J,D^=W/Y_?6WW[+U!+ P04    "  SB6)3YN*DT* "   %
M-0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I-;N) $(;AJR ?
M(*:KNJN:4<AJ-ME&N8!%FA\%L&5[E.3V@\@"/FL6LXG\K5#;HORN'J.F'U_*
ML1D/[7G8'[IA\7DZGH=UM1_'[E==#YM].37#0]N5\^7.MNU/S7A9]KNZ:S;O
MS:[4LEQ:W=_/J)X>[V<N7K^Z\C\3V^WVL"F_V\V?4SF/_QA<?[3]^[ O9:P6
MKTV_*^.ZJC^/M\M#??T(#Y?)U>+Y;5WUSV^AJN<.$@B2^8,4@G3^H A!<?Z@
M!$%I_B"#()L_R"'(YP_*$)3G#UI!T&K^H+!$&9<$21.L";0.R'4@\#H@V(%
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MXWCXQ_'+,^VK=GC)SY8_V-S^!%!+ 0(4 Q0    ( #.)8E,'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ ,XEB4YC]4*GM    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ ,XEB4YE<G",0!@  G"<  !,
M     ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  SB6)3
M-";] CT%  !H%0  &               @($,"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ ,XEB4]8=N0KQ!@  ?QP  !@
M     ("!?PT  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    (
M #.)8E,F<!PJV@(  )L)   8              " @:84  !X;"]W;W)K<VAE
M971S+W-H965T,RYX;6Q02P$"% ,4    "  SB6)3 GF*YF8&  "-&@  &
M            @(&V%P  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#
M%     @ ,XEB4U-K%G"F P  +0P  !@              ("!4AX  'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( #.)8E.Z!_Z+4@P  &E2
M   8              " @2XB  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"% ,4    "  SB6)3<BR_2SH"   _!0  &               @(&V+@
M>&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ,XEB4_5.6RC?
M"0  $RD  !@              ("!)C$  'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;%!+ 0(4 Q0    ( #.)8E/;IVZ3I@(  %8&   8              "
M@3L[  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    "  SB6)3
MYSJJ%7T0  #>,   &0              @($7/@  >&PO=V]R:W-H965T<R]S
M:&5E=#$P+GAM;%!+ 0(4 Q0    ( #.)8E.]XD=%/@8  /L0   9
M      " @<M.  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%
M  @ ,XEB4[6@&BQ_!P  W!4  !D              ("!0%4  'AL+W=O<FMS
M:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    "  SB6)3AE BIVH"   <!0
M&0              @('V7   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+
M 0(4 Q0    ( #.)8E,Z!JTQU0,  *H(   9              " @9=?  !X
M;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ ,XEB4PZ,\A^V
M"   KQ@  !D              ("!HV,  'AL+W=O<FMS:&5E=',O<VAE970Q
M-2YX;6Q02P$"% ,4    "  SB6)31W'$:RT,   ()0  &0
M@(&0;   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( #.)
M8E/"6Y8S(P@  )L4   9              " @?1X  !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&UL4$L! A0#%     @ ,XEB4TTE!U:*#0   BT  !D
M         ("!3H$  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4
M    "  SB6)3]L%/<:0(  "L%@  &0              @($/CP  >&PO=V]R
M:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( #.)8E.K:+)!"04  .X-
M   9              " @>J7  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL
M4$L! A0#%     @ ,XEB4R/Q"CD[!@  -A$  !D              ("!*IT
M 'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    "  SB6)3-Z_5
MH(8)  #('0  &0              @(&<HP  >&PO=V]R:W-H965T<R]S:&5E
M=#(R+GAM;%!+ 0(4 Q0    ( #.)8E-*Q_8QT0\  "4L   9
M  " @5FM  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @
M,XEB4S;*\*!Q!0  ?0P  !D              ("!8;T  'AL+W=O<FMS:&5E
M=',O<VAE970R-"YX;6Q02P$"% ,4    "  SB6)3V7R(#S8%   J#0  &0
M            @($)PP  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4
M Q0    ( #.)8E.UA:OE7QT  #?*   9              " @7;(  !X;"]W
M;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ ,XEB4W!+Z+M6!
M,PD  !D              ("!#.8  'AL+W=O<FMS:&5E=',O<VAE970R-RYX
M;6Q02P$"% ,4    "  SB6)3]K!\:1<%   K#0  &0              @(&9
MZ@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( #.)8E-:
M">K,20T  .0D   9              " @>?O  !X;"]W;W)K<VAE971S+W-H
M965T,CDN>&UL4$L! A0#%     @ ,XEB4PL_B@LT P  /0<  !D
M     ("!9_T  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #.)8E/./;\U\P4  !L/   9              "
M@1$2 0!X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ ,XEB
M4Y6,@;I'!0  SPX  !D              ("!.Q@! 'AL+W=O<FMS:&5E=',O
M<VAE970S-BYX;6Q02P$"% ,4    "  SB6)3R'+:Y5T%  "F#@  &0
M        @(&Y'0$ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0
M   ( #.)8E-1.@_5" 0  #(+   9              " @4TC 0!X;"]W;W)K
M<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ ,XEB4V;F3K$/!P  [A,
M !D              ("!C"<! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q0
M2P$"% ,4    "  SB6)3[<19:=P#   )"0  &0              @('2+@$
M>&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( #.)8E/6MC"(
M P@   ,6   9              " @>4R 0!X;"]W;W)K<VAE971S+W-H965T
M-#$N>&UL4$L! A0#%     @ ,XEB4_XM7.SQ @  )P8  !D
M ("!'SL! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    "  S
MB6)3<E^*Y]D'  !0)P  &0              @(%'/@$ >&PO=V]R:W-H965T
M<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( #.)8E-1=,JXPP,  *L0   9
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M970T."YX;6Q02P$"% ,4    "  SB6)3+_I0;4@$  !;%0  &0
M    @('B7 $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    (
M #.)8E.@4&46R00  !@@   9              " @6%A 0!X;"]W;W)K<VAE
M971S+W-H965T-3 N>&UL4$L! A0#%     @ ,XEB4S8*=YZ- @  L 8  !D
M             ("!868! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"
M% ,4    "  SB6)3U/:^7E4"  "D!0  &0              @($E:0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( #.)8E-0,YN*)04
M &L;   9              " @;%K 0!X;"]W;W)K<VAE971S+W-H965T-3,N
M>&UL4$L! A0#%     @ ,XEB4[RK#'0(!   Q!$  !D              ("!
M#7$! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4    "  SB6)3
M='I#']H%  "C'   &0              @(%,=0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4U+GAM;%!+ 0(4 Q0    ( #.)8E.CD^T>J0(  ,0&   9
M      " @5U[ 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%
M  @ ,XEB4^CQ\[J= P  Z0T  !D              ("!/7X! 'AL+W=O<FMS
M:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    "  SB6)3UD+_GW@#  !S"P
M&0              @($1@@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+
M 0(4 Q0    ( #.)8E/3:L@LL0@  *M"   9              " @<"% 0!X
M;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ ,XEB4V9A7)ST
M P  T@X  !D              ("!J(X! 'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6Q02P$"% ,4    "  SB6)3[&P:5,T"  !,!P  &0
M@('3D@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( #.)
M8E.*.;'/]P0  + 3   9              " @=>5 0!X;"]W;W)K<VAE971S
M+W-H965T-C(N>&UL4$L! A0#%     @ ,XEB4Q<B\0R@!   %A8  !D
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M=#8W+GAM;%!+ 0(4 Q0    ( #.)8E/UP<=AX0(  &T)   9
M  " @:RR 0!X;"]W;W)K<VAE971S+W-H965T-C@N>&UL4$L! A0#%     @
M,XEB4WG[J%D- P  ,P@  !D              ("!Q+4! 'AL+W=O<FMS:&5E
M=',O<VAE970V.2YX;6Q02P$"% ,4    "  SB6)3G(0( ^T$    %@  &0
M            @($(N0$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4
M Q0    ( #.)8E/A-A;#J00  '83   9              " @2R^ 0!X;"]W
M;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ ,XEB4]=[<\N2 P
M,0P  !D              ("!#,,! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX
M;6Q02P$"% ,4    "  SB6)3UA"Z[3,$  !@$0  &0              @('5
MQ@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( #.)8E-:
M$'=$R D  .TW   9              " @3_+ 0!X;"]W;W)K<VAE971S+W-H
M965T-S0N>&UL4$L! A0#%     @ ,XEB4VP%YA((!   : X  !D
M     ("!/M4! 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #.)8E-Q^P)Z<@(  (X%   9              "
M@?GP 0!X;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ ,XEB
M4V0FJO)6!   0@\  !D              ("!HO,! 'AL+W=O<FMS:&5E=',O
M<VAE970X,2YX;6Q02P$"% ,4    "  SB6)30@BFM] "  "U!@  &0
M        @($O^ $ >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0
M   ( #.)8E,6G1NK4P,  "0+   9              " @3;[ 0!X;"]W;W)K
M<VAE971S+W-H965T.#,N>&UL4$L! A0#%     @ ,XEB4V;(FZCL!0  W1H
M !D              ("!P/X! 'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6Q0
M2P$"% ,4    "  SB6)3%1S68N0"  #5!P  &0              @('C! (
M>&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+ 0(4 Q0    ( #.)8E,CPD"/
M5@0  $<0   9              " @?X' @!X;"]W;W)K<VAE971S+W-H965T
M.#8N>&UL4$L! A0#%     @ ,XEB4[QF%[\-!   6 X  !D
M ("!BPP" 'AL+W=O<FMS:&5E=',O<VAE970X-RYX;6Q02P$"% ,4    "  S
MB6)33(!20KD"  !<!@  &0              @('/$ ( >&PO=V]R:W-H965T
M<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( #.)8E,##2#8- ,  +D*   9
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M @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  SB6)3YN*DT* "   %-0
M&@              @ $Z)0( >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  SB6)3PH ,:SH"  !H,P  $P              @ $2* (
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     8@!B .4:  !]*@(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>459</ContextCount>
  <ElementCount>533</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>118</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Stockholders Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1008009 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106102 - Disclosure - REVENUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/REVENUE</Role>
      <ShortName>REVENUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIES</Role>
      <ShortName>MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2117104 - Disclosure - INVENTORY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INVENTORY</Role>
      <ShortName>INVENTORY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2120105 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - INTANGIBLE ASSETS AND GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2130107 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - LONG-TERM DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/LONGTERMDEBT</Role>
      <ShortName>LONG-TERM DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - CONVERTIBLE NOTES</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.exactsciences.com/role/CONVERTIBLENOTES</Role>
      <ShortName>CONVERTIBLE NOTES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2143110 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS</Role>
      <ShortName>LICENSE AND COLLABORATION AGREEMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2146111 - Disclosure - PFIZER PROMOTION AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT</Role>
      <ShortName>PFIZER PROMOTION AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2148112 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2153113 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2157114 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2161115 - Disclosure - NEW MARKET TAX CREDIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/NEWMARKETTAXCREDIT</Role>
      <ShortName>NEW MARKET TAX CREDIT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2163116 - Disclosure - WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS</Role>
      <ShortName>WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2165117 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2177118 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2180119 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - REVENUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/REVENUETables</Role>
      <ShortName>REVENUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/REVENUE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2311303 - Disclosure - MARKETABLE SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIESTables</Role>
      <ShortName>MARKETABLE SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/MARKETABLESECURITIES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2318304 - Disclosure - INVENTORY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INVENTORYTables</Role>
      <ShortName>INVENTORY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/INVENTORY</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2321305 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2338308 - Disclosure - CONVERTIBLE NOTES (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.exactsciences.com/role/CONVERTIBLENOTESTables</Role>
      <ShortName>CONVERTIBLE NOTES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/CONVERTIBLENOTES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2349309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2354310 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2358311 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESTables</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2366312 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2378313 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent Accounting Pronouncements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent Accounting Pronouncements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - REVENUE - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails</Role>
      <ShortName>REVENUE - Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - REVENUE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/REVENUENarrativeDetails</Role>
      <ShortName>REVENUE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - MARKETABLE SECURITIES - Schedule of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Schedule of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - MARKETABLE SECURITIES - Schedule of Available For Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Schedule of Available For Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - MARKETABLE SECURITIES - Schedule of Underlying Maturities of AFS Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Schedule of Underlying Maturities of AFS Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - MARKETABLE SECURITIES - Schedule of Gross Unrealized Losses And Fair Value of Available For Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Schedule of Gross Unrealized Losses And Fair Value of Available For Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - MARKETABLE SECURITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/MARKETABLESECURITIESNarrativeDetails</Role>
      <ShortName>MARKETABLE SECURITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - INVENTORY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INVENTORYDetails</Role>
      <ShortName>INVENTORY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/INVENTORYTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Schedule of Estimated Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT - Schedule of Estimated Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL - Schedule of Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Changes in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails</Role>
      <ShortName>INTANGIBLE ASSETS AND GOODWILL - Schedule of Changes in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Schedule of Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - FAIR VALUE MEASUREMENTS - Fair Value of Contingent Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - Fair Value of Contingent Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - LONG-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/LONGTERMDEBTDetails</Role>
      <ShortName>LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/LONGTERMDEBT</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - CONVERTIBLE NOTES - Schedule of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails</Role>
      <ShortName>CONVERTIBLE NOTES - Schedule of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - CONVERTIBLE NOTES - Additional information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails</Role>
      <ShortName>CONVERTIBLE NOTES - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - CONVERTIBLE NOTES - Schedule of Transaction Costs (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails</Role>
      <ShortName>CONVERTIBLE NOTES - Schedule of Transaction Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2442424 - Disclosure - CONVERTIBLE NOTES - Summary of Interest Expense (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails</Role>
      <ShortName>CONVERTIBLE NOTES - Summary of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2444425 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS - Mayo (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails</Role>
      <ShortName>LICENSE AND COLLABORATION AGREEMENTS - Mayo (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2445426 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS - John Hopkins University (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails</Role>
      <ShortName>LICENSE AND COLLABORATION AGREEMENTS - John Hopkins University (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - PFIZER PROMOTION AGREEMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails</Role>
      <ShortName>PFIZER PROMOTION AGREEMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of OCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of OCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2452430 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of amounts reclassified from AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of amounts reclassified from AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - STOCK-BASED COMPENSATION - Fair Value and Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Fair Value and Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2459433 - Disclosure - COMMITMENTS AND CONTINGENCIES - Supplemental Disclosure of Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Supplemental Disclosure of Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2460434 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2462435 - Disclosure - NEW MARKET TAX CREDIT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails</Role>
      <ShortName>NEW MARKET TAX CREDIT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/NEWMARKETTAXCREDIT</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2464436 - Disclosure - WISCONSIN ECONOMIC DEVELOPMENT TAX CREDIT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails</Role>
      <ShortName>WISCONSIN ECONOMIC DEVELOPMENT TAX CREDIT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2467437 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Business Combinations Textual (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Business Combinations Textual (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2468438 - Disclosure - BUSINESS COMBINATIONS - Schedule of Consideration Transferred for Ashion Analytics (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Schedule of Consideration Transferred for Ashion Analytics (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2469439 - Disclosure - BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, Ashion Analytics (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, Ashion Analytics (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2470440 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Consideration Transferred, Thrive (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Consideration Transferred, Thrive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2471441 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Assumptions on Fair Value of Options Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Assumptions on Fair Value of Options Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2472442 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed, Thrive (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed, Thrive (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2473443 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Pro Forma Thrive Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Pro Forma Thrive Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2474444 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed From Paradigm Diagnostics Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed From Paradigm Diagnostics Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2475445 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails</Role>
      <ShortName>BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2476446 - Disclosure - BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, PFS Genomics (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails</Role>
      <ShortName>BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, PFS Genomics (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2479447 - Disclosure - SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails</Role>
      <ShortName>SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="exas-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2481448 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exactsciences.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.exactsciences.com/role/INCOMETAXES</ParentRole>
      <Position>90</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="exas-20210930.htm">exas-20210930.htm</File>
    <File>exas-20210930.xsd</File>
    <File>exas-20210930_cal.xml</File>
    <File>exas-20210930_def.xml</File>
    <File>exas-20210930_lab.xml</File>
    <File>exas-20210930_pre.xml</File>
    <File>exas-20210930xexx311.htm</File>
    <File>exas-20210930xexx312.htm</File>
    <File>exas-20210930xexx321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>107
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exas-20210930.htm": {
   "axisCustom": 2,
   "axisStandard": 37,
   "contextCount": 459,
   "dts": {
    "calculationLink": {
     "local": [
      "exas-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "exas-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "exas-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "exas-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exas-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "exas-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 752,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://www.exactsciences.com/20210930": 2,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 14
   },
   "keyCustom": 84,
   "keyStandard": 449,
   "memberCustom": 55,
   "memberStandard": 56,
   "nsprefix": "exas",
   "nsuri": "http://www.exactsciences.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.exactsciences.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106102 - Disclosure - REVENUE",
     "role": "http://www.exactsciences.com/role/REVENUE",
     "shortName": "REVENUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - MARKETABLE SECURITIES",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIES",
     "shortName": "MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117104 - Disclosure - INVENTORY",
     "role": "http://www.exactsciences.com/role/INVENTORY",
     "shortName": "INVENTORY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120105 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "role": "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - INTANGIBLE ASSETS AND GOODWILL",
     "role": "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130107 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - LONG-TERM DEBT",
     "role": "http://www.exactsciences.com/role/LONGTERMDEBT",
     "shortName": "LONG-TERM DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:ConvertibleNotesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - CONVERTIBLE NOTES",
     "role": "http://www.exactsciences.com/role/CONVERTIBLENOTES",
     "shortName": "CONVERTIBLE NOTES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:ConvertibleNotesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:LicensingAgreementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143110 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS",
     "role": "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS",
     "shortName": "LICENSE AND COLLABORATION AGREEMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:LicensingAgreementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146111 - Disclosure - PFIZER PROMOTION AGREEMENT",
     "role": "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT",
     "shortName": "PFIZER PROMOTION AGREEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2148112 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.exactsciences.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153113 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157114 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:NewMarketTaxCreditTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161115 - Disclosure - NEW MARKET TAX CREDIT",
     "role": "http://www.exactsciences.com/role/NEWMARKETTAXCREDIT",
     "shortName": "NEW MARKET TAX CREDIT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:NewMarketTaxCreditTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163116 - Disclosure - WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS",
     "role": "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS",
     "shortName": "WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AssetAcquisitionTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2165117 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AssetAcquisitionTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2177118 - Disclosure - SEGMENT INFORMATION",
     "role": "http://www.exactsciences.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2180119 - Disclosure - INCOME TAXES",
     "role": "http://www.exactsciences.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - REVENUE (Tables)",
     "role": "http://www.exactsciences.com/role/REVENUETables",
     "shortName": "REVENUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311303 - Disclosure - MARKETABLE SECURITIES (Tables)",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIESTables",
     "shortName": "MARKETABLE SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318304 - Disclosure - INVENTORY (Tables)",
     "role": "http://www.exactsciences.com/role/INVENTORYTables",
     "shortName": "INVENTORY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321305 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "role": "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Tables)",
     "role": "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338308 - Disclosure - CONVERTIBLE NOTES (Tables)",
     "role": "http://www.exactsciences.com/role/CONVERTIBLENOTESTables",
     "shortName": "CONVERTIBLE NOTES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2349309 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354310 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358311 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
     "role": "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESTables",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2366312 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Tables)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2378313 - Disclosure - SEGMENT INFORMATION (Tables)",
     "role": "http://www.exactsciences.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent Accounting Pronouncements (Details)",
     "role": "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Recent Accounting Pronouncements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "if1829c1ca7704928b8a7a131034977d3_D20200101-20200930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ExtinguishmentOfDebtAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Share (Details)",
     "role": "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - REVENUE - Schedule of Disaggregation of Revenue (Details)",
     "role": "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
     "shortName": "REVENUE - Schedule of Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i063bc72fa7ab4cb6a8c9a466fe5aa116_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - REVENUE - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/REVENUENarrativeDetails",
     "shortName": "REVENUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i551c655f93e84ff688983bbc818b9b24_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - MARKETABLE SECURITIES - Schedule of Cash and Cash Equivalents (Details)",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails",
     "shortName": "MARKETABLE SECURITIES - Schedule of Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - MARKETABLE SECURITIES - Schedule of Available For Sale Securities (Details)",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
     "shortName": "MARKETABLE SECURITIES - Schedule of Available For Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - MARKETABLE SECURITIES - Schedule of Underlying Maturities of AFS Securities (Details)",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails",
     "shortName": "MARKETABLE SECURITIES - Schedule of Underlying Maturities of AFS Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - MARKETABLE SECURITIES - Schedule of Gross Unrealized Losses And Fair Value of Available For Sale Securities (Details)",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
     "shortName": "MARKETABLE SECURITIES - Schedule of Gross Unrealized Losses And Fair Value of Available For Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - MARKETABLE SECURITIES - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/MARKETABLESECURITIESNarrativeDetails",
     "shortName": "MARKETABLE SECURITIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - INVENTORY (Details)",
     "role": "http://www.exactsciences.com/role/INVENTORYDetails",
     "shortName": "INVENTORY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Schedule of Estimated Useful Lives (Details)",
     "role": "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT - Schedule of Estimated Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details)",
     "role": "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL - Schedule of Finite Lived Intangible Assets Net Balances and Weighted Average Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Future Amortization Expense (Details)",
     "role": "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL - Schedule of Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i551c655f93e84ff688983bbc818b9b24_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - INTANGIBLE ASSETS AND GOODWILL - Schedule of Changes in Goodwill (Details)",
     "role": "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails",
     "shortName": "INTANGIBLE ASSETS AND GOODWILL - Schedule of Changes in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i501c7f9788854b61a82cd861d37a75db_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - FAIR VALUE MEASUREMENTS - Schedule of Fair Value (Details)",
     "role": "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Schedule of Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i0c34b3f6b5c24b7d80a7a7f2df067218_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i8c52981677ce4a888854fe6b6b0ffe08_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders Equity",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ia57a67045add45f5bfdd49dc22aafc20_D20200101-20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ibd2c2b55dd8e4b4a8baccd8dfe9fabf8_I20210930",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i551c655f93e84ff688983bbc818b9b24_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - FAIR VALUE MEASUREMENTS - Fair Value of Contingent Consideration (Details)",
     "role": "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - Fair Value of Contingent Consideration (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentForContingentConsiderationLiabilityInvestingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RegulatoryLiabilityAmortizationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - LONG-TERM DEBT (Details)",
     "role": "http://www.exactsciences.com/role/LONGTERMDEBTDetails",
     "shortName": "LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RegulatoryLiabilityAmortizationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ic2e12ba29e1148cc92200e3f802d478d_I20180131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - CONVERTIBLE NOTES - Schedule of Convertible Notes (Details)",
     "role": "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
     "shortName": "CONVERTIBLE NOTES - Schedule of Convertible Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i6a521727e1e2422195adff75e2af975a_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "exas:ConvertibleNotesPayableGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - CONVERTIBLE NOTES - Additional information (Details)",
     "role": "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
     "shortName": "CONVERTIBLE NOTES - Additional information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i2f6e4612ba6042b3a41b0a3a22cc1a08_D20180101-20180131",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i124fcfaa5c2844ba9a7f3648437e97a4_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "exas:DebtInstrumentConvertibleTransactionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - CONVERTIBLE NOTES - Schedule of Transaction Costs (Details)",
     "role": "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails",
     "shortName": "CONVERTIBLE NOTES - Schedule of Transaction Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i124fcfaa5c2844ba9a7f3648437e97a4_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "exas:DebtInstrumentConvertibleTransactionCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "exas:InterestExpenseDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442424 - Disclosure - CONVERTIBLE NOTES - Summary of Interest Expense (Details)",
     "role": "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails",
     "shortName": "CONVERTIBLE NOTES - Summary of Interest Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "exas:InterestExpenseDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444425 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS - Mayo (Details)",
     "role": "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
     "shortName": "LICENSE AND COLLABORATION AGREEMENTS - Mayo (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i7687d156b5064d39b98d15068b794c79_D20210701-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5315ee1596b6499d88299026c527248b_I20210105",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:PaymentsContingentOnMilestonesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445426 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS - John Hopkins University (Details)",
     "role": "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
     "shortName": "LICENSE AND COLLABORATION AGREEMENTS - John Hopkins University (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5315ee1596b6499d88299026c527248b_I20210105",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:PaymentsContingentOnMilestonesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - PFIZER PROMOTION AGREEMENT (Details)",
     "role": "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails",
     "shortName": "PFIZER PROMOTION AGREEMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i8e0332de952445d6b53e10c7c7e4f4e9_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Stockholders Equity (Parenthetical)",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical",
     "shortName": "Condensed Consolidated Statements of Stockholders Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "if4e10d3514844641a53eb38bf634cf5b_I20200930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i440309922a2844d8b7f20c86821d414f_D20200301-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i440309922a2844d8b7f20c86821d414f_D20200301-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i551c655f93e84ff688983bbc818b9b24_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of OCI (Details)",
     "role": "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of OCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452430 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of amounts reclassified from AOCI (Details)",
     "role": "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of amounts reclassified from AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i820542840d28423db7a2ed962f5b4151_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "role": "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - STOCK-BASED COMPENSATION - Fair Value and Activity (Details)",
     "role": "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION - Fair Value and Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "exas:ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i008216fc7bbe415ead370d27f4b5bfab_D20200101-20200930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459433 - Disclosure - COMMITMENTS AND CONTINGENCIES - Supplemental Disclosure of Cash Flow Information (Details)",
     "role": "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Supplemental Disclosure of Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460434 - Disclosure - COMMITMENTS AND CONTINGENCIES - Additional Information (Details)",
     "role": "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:NetProceedsFromFinancingArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462435 - Disclosure - NEW MARKET TAX CREDIT (Details)",
     "role": "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails",
     "shortName": "NEW MARKET TAX CREDIT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ida4a9519c1e4408091bedf0bdee07f94_D20141001-20141231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:NetProceedsFromFinancingArrangement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i107170d7fed64652982d166e0b941437_I20150331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464436 - Disclosure - WISCONSIN ECONOMIC DEVELOPMENT TAX CREDIT (Details)",
     "role": "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails",
     "shortName": "WISCONSIN ECONOMIC DEVELOPMENT TAX CREDIT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i107170d7fed64652982d166e0b941437_I20150331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "exas:RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467437 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Business Combinations Textual (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Business Combinations Textual (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5084f90d66dc4b7ebb62ead28ea222fe_D20200303-20200303",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468438 - Disclosure - BUSINESS COMBINATIONS - Schedule of Consideration Transferred for Ashion Analytics (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails",
     "shortName": "BUSINESS COMBINATIONS - Schedule of Consideration Transferred for Ashion Analytics (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i6bd0bbe9d38b4e39930c371323fae2c2_D20210414-20210414",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469439 - Disclosure - BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, Ashion Analytics (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
     "shortName": "BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, Ashion Analytics (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5fa41ad8e71d4dd28f502802045906ae_I20210414",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470440 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Consideration Transferred, Thrive (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Consideration Transferred, Thrive (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ic0cb2c2ce07444aba1874a982cbc3831_D20210105-20210105",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ib3b489bbf63f4c70a052049910386070_D20210105-20210105",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471441 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Assumptions on Fair Value of Options Assumed (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Assumptions on Fair Value of Options Assumed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "ib3b489bbf63f4c70a052049910386070_D20210105-20210105",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472442 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed, Thrive (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed, Thrive (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i4adc81b8f9854589bb5aca129a63c7df_D20210106-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "exas:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i4887ef5292e44700918959f6042a59c3_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473443 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Pro Forma Thrive Information (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Pro Forma Thrive Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i4887ef5292e44700918959f6042a59c3_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "icaadbb616eae41fa90b155f9198a61f3_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474444 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed From Paradigm Diagnostics Acquisition (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Schedule of Assets Acquired and Liabilities Assumed From Paradigm Diagnostics Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i660d9c31964046fd8f0829d2e58f4405_I20210303",
      "decimals": "-3",
      "lang": "en-US",
      "name": "exas:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i584d1f57791b47d7842344882f5499e3_I20210623",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2475445 - Disclosure - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
     "shortName": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i584d1f57791b47d7842344882f5499e3_I20210623",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i2f21018f47a64a1cacc7aaca37a154da_D20210623-20210623",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476446 - Disclosure - BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, PFS Genomics (Details)",
     "role": "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails",
     "shortName": "BUSINESS COMBINATIONS - Schedule of Assets Acquired and Liabilities Assumed, PFS Genomics (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i584d1f57791b47d7842344882f5499e3_I20210623",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2479447 - Disclosure - SEGMENT INFORMATION (Details)",
     "role": "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails",
     "shortName": "SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i0c8253dc31a74450a8053d46842c3eb1_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1008009 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)",
     "role": "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCompensationArrangementWithIndividualSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i5b879da246b14941a83322faaeed6793_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2481448 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.exactsciences.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "exas-20210930.htm",
      "contextRef": "i98a34e6c264d4e53a51b12f553ebf243_D20210101-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 118,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r734"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.exactsciences.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exas_AggregateConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the 2027 Notes and the 2025 Notes.",
        "label": "Aggregate Convertible Notes [Member]",
        "terseLabel": "Notes"
       }
      }
     },
     "localname": "AggregateConvertibleNotesMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_AllocatedToCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated to Compensation",
        "label": "Allocated to Compensation [Member]",
        "terseLabel": "Allocated to Compensation"
       }
      }
     },
     "localname": "AllocatedToCompensationMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_AllocatedToConsiderationTransferredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated to Consideration Transferred",
        "label": "Allocated to Consideration Transferred [Member]",
        "terseLabel": "Allocated to Consideration Transferred"
       }
      }
     },
     "localname": "AllocatedToConsiderationTransferredMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_AllocatedToPreviousOwnershipInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated to Previous Ownership Interest",
        "label": "Allocated to Previous Ownership Interest [Member]",
        "terseLabel": "Allocated to Previous Ownership Interest"
       }
      }
     },
     "localname": "AllocatedToPreviousOwnershipInterestMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization (Deferred Amortization) of Deferred Financing Costs, Debt Discounts (Premiums) and Issuance Costs, Other Liabilities",
        "label": "Amortization (Deferred Amortization) of Deferred Financing Costs, Debt Discounts (Premiums) and Issuance Costs, Other Liabilities",
        "terseLabel": "Amortization of deferred financing costs, convertible note debt discount and issuance costs, and other liabilities"
       }
      }
     },
     "localname": "AmortizationDeferredAmortizationOfDeferredFinancingCostsDebtDiscountsPremiumsAndIssuanceCostsOtherLiabilities",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_AmortizationOfRefundableTaxCredits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amortization of the tax credits, representing a reduction of operating expenses.",
        "label": "Amortization of Refundable Tax Credits",
        "terseLabel": "Amortization of tax credits"
       }
      }
     },
     "localname": "AmortizationOfRefundableTaxCredits",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_ArmuneBiosciencesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Armune Biosciences Agreement",
        "label": "Armune Biosciences Agreement [Member]",
        "terseLabel": "Armune Biosciences Agreement"
       }
      }
     },
     "localname": "ArmuneBiosciencesAgreementMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_AshionAnalyticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ashion Analytics",
        "label": "Ashion Analytics [Member]",
        "terseLabel": "Ashion Analytics"
       }
      }
     },
     "localname": "AshionAnalyticsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares",
        "label": "Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares",
        "terseLabel": "Payments to acquire productive assets (in shares)"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "exas_BiomatricaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Biomatrica, Inc.",
        "label": "Biomatrica Inc [Member]",
        "terseLabel": "Biomatrica, Inc"
       }
      }
     },
     "localname": "BiomatricaIncMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_BuildingsAndLeaseholdImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to buildings and leasehold improvements.",
        "label": "Buildings And Leasehold Improvements [Member]",
        "terseLabel": "Leasehold and building improvements"
       }
      }
     },
     "localname": "BuildingsAndLeaseholdImprovementsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Issued Exchange Ratio",
        "label": "Business Acquisition Equity Interest Issued Or Issuable Number Of Shares Issued Exchange Ratio",
        "terseLabel": "Share conversion ratio (share per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableNumberOfSharesIssuedExchangeRatio",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "exas_BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Shares Reserved For Future Issuance",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Shares Reserved For Future Issuance",
        "terseLabel": "Amount of shares held for future issuance"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableSharesReservedForFutureIssuance",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessAcquisitionProFormaIncomeLossBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Pro Forma Income (Loss), Before Tax",
        "label": "Business Acquisition, Pro Forma Income (Loss), Before Tax",
        "terseLabel": "Net loss before tax"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaIncomeLossBeforeTax",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Vesting Period",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Vesting Period",
        "terseLabel": "Equity interests issued or issuable to previous investors, vesting period"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombinationVestingPeriod",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "exas_BusinessCombinationContingentConsiderationAdditionalPayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Additional Payment",
        "label": "Business Combination, Contingent Consideration, Additional Payment",
        "terseLabel": "Additional cash consideration to be paid"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAdditionalPayment",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Increase Due to Acquisition",
        "label": "Business Combination, Contingent Consideration Arrangements, Increase Due to Acquisition",
        "terseLabel": "Purchase price contingent consideration",
        "verboseLabel": "Business combination contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsIncreaseDueToAcquisition",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationContingentConsiderationGainLossChangeInFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss), Change in Fair Value",
        "label": "Business Combination, Contingent Consideration, Gain (Loss), Change in Fair Value",
        "negatedLabel": "Remeasurement of contingent consideration",
        "negatedTerseLabel": "Changes in fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossChangeInFairValue",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationContingentConsiderationRevenueMilestone": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Revenue Milestone",
        "label": "Business Combination, Contingent Consideration, Revenue Milestone",
        "terseLabel": "Revenue milestone"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationRevenueMilestone",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationFairValueOfReplacedEquityAwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Fair value of Replaced Equity Awards",
        "label": "Business Combination, Fair value of Replaced Equity Awards",
        "terseLabel": "Fair value of replaced equity awards"
       }
      }
     },
     "localname": "BusinessCombinationFairValueOfReplacedEquityAwards",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayable",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccruedLiabilities",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liability",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiability",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets Acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Assets Acquired",
        "terseLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetAssetsAcquired",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired",
        "terseLabel": "Net identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Assets",
        "terseLabel": "Net operating assets",
        "verboseLabel": "Total identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingAssets",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Current",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Current",
        "terseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesCurrent",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Noncurrent",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities, Noncurrent",
        "terseLabel": "Operating lease liabilities, less current portion"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilitiesNoncurrent",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Liabilities",
        "negatedTerseLabel": "Net operating liabilities",
        "terseLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLiabilities",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Long-term Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Long-term Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLongTermAssets",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Current Assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Prepaid Expenses and Other Current Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPrepaidExpensesAndOtherCurrentAssets",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accrued Liabilities",
        "negatedTerseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccruedLiabilities",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Excluding Intangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Excluding Intangible Assets",
        "terseLabel": "Net operating assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsExcludingIntangibleAssets",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current, Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current, Operating Lease Liability",
        "negatedTerseLabel": "Operating lease liabilities, current portion"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentOperatingLeaseLiability",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent, Operating Lease Liability",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent, Operating Lease Liability",
        "negatedTerseLabel": "Operating lease liabilities, less current portion"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentOperatingLeaseLiability",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets and Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets and Liabilities",
        "terseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsAndLiabilities",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-based Compensation",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-based Compensation",
        "terseLabel": "Compensation consideration assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensation",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation Allocated to Consideration Transferred",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation Allocated to Consideration Transferred",
        "terseLabel": "Compensation consideration assumed and allocated to consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationAllocatedToConsiderationTransferred",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation, Deemed Compensatory",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Share-Based Compensation, Deemed Compensatory",
        "terseLabel": "Compensation consideration assumed and deemed compensatory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedShareBasedCompensationDeemedCompensatory",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_CONVERTIBLENOTESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CONVERTIBLE NOTES",
        "label": "CONVERTIBLE NOTES [Abstract]",
        "terseLabel": "CONVERTIBLE NOTES."
       }
      }
     },
     "localname": "CONVERTIBLENOTESAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "xbrltype": "stringItemType"
    },
    "exas_COVID19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19",
        "label": "COVID-19 [Member]",
        "terseLabel": "COVID-19"
       }
      }
     },
     "localname": "COVID19Member",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_COVID19TestingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing",
        "label": "COVID-19 Testing [Member]",
        "terseLabel": "COVID-19 Testing"
       }
      }
     },
     "localname": "COVID19TestingMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_CapitalInvestmentExpendituresRequirementForRefundableTaxCredits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expenditures in capital investments the Company is required to make over a specified period to earn the refundable tax credits.",
        "label": "Capital Investment Expenditures, Requirement for Refundable Tax Credits",
        "terseLabel": "Capital investment expenditures over specified period, requirement to earn the refundable tax credits"
       }
      }
     },
     "localname": "CapitalInvestmentExpendituresRequirementForRefundableTaxCredits",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_CashAndMoneyMarketMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding cash and money market balances.",
        "label": "Cash And Money Market [Member]",
        "terseLabel": "Cash and money market"
       }
      }
     },
     "localname": "CashAndMoneyMarketMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_CenterForMedicareAndMedicaidServicesCMSCoverageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Center for Medicare And Medicaid Services (CMS) Coverage",
        "label": "Center for Medicare And Medicaid Services (CMS) Coverage [Member]",
        "terseLabel": "CSM Coverage"
       }
      }
     },
     "localname": "CenterForMedicareAndMedicaidServicesCMSCoverageMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_CollaborativeArrangementsSalesMilestoneAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of net sales of a licensed product considered as a milestone under the collaborative arrangement.",
        "label": "Collaborative Arrangements Sales Milestone Amount",
        "terseLabel": "Collaborative arrangement sales milestone amount"
       }
      }
     },
     "localname": "CollaborativeArrangementsSalesMilestoneAmount",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_CollaborativeArrangementsSalesMilestoneAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the ranges of sale milestones.",
        "label": "Collaborative Arrangements Sales Milestone [Axis]",
        "terseLabel": "Collaborative Arrangements Sales Milestone [Axis]"
       }
      }
     },
     "localname": "CollaborativeArrangementsSalesMilestoneAxis",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "exas_CollaborativeArrangementsSalesMilestoneDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of sale milestones pertaining to the collaborative arrangement.",
        "label": "Collaborative Arrangements Sales Milestone [Domain]",
        "terseLabel": "Collaborative Arrangements Sales Milestone [Domain]"
       }
      }
     },
     "localname": "CollaborativeArrangementsSalesMilestoneDomain",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_CommercialLaunchMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Launch Milestone",
        "label": "Commercial Launch Milestone [Member]",
        "terseLabel": "Commercial Launch Milestone"
       }
      }
     },
     "localname": "CommercialLaunchMilestoneMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_CompensationExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Compensation Expense",
        "label": "Compensation Expense [Member]",
        "terseLabel": "Compensation Expense"
       }
      }
     },
     "localname": "CompensationExpenseMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, of comprehensive income (loss).",
        "label": "Comprehensive Income (loss), Before Tax",
        "totalLabel": "Comprehensive loss, before tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_ConvertibleNotesPayable2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to convertible notes, maturing on 2025.",
        "label": "Convertible Notes Payable2025 [Member]",
        "terseLabel": "2025 notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable2025Member",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ConvertibleNotesPayable2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to convertible notes, maturing on 2027.",
        "label": "Convertible Notes Payable2027 [Member]",
        "terseLabel": "2027 Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable2027Member",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ConvertibleNotesPayable2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes Payable2028",
        "label": "Convertible Notes Payable2028 [Member]",
        "terseLabel": "2028 Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayable2028Member",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ConvertibleNotesPayableGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount as of balance sheet date of convertible notes payable including debt issuance costs and debt discounts.",
        "label": "Convertible Notes Payable Gross",
        "terseLabel": "Principal Amount"
       }
      }
     },
     "localname": "ConvertibleNotesPayableGross",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_ConvertibleNotesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of convertible notes.",
        "label": "Convertible Notes [Text Block]",
        "terseLabel": "CONVERTIBLE NOTES"
       }
      }
     },
     "localname": "ConvertibleNotesTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "exas_CouponInterestExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of coupon interest expense.",
        "label": "Coupon Interest Expense",
        "terseLabel": "Coupon interest expense"
       }
      }
     },
     "localname": "CouponInterestExpense",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_DOSRuleInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DOS Rule Investigation",
        "label": "DOS Rule Investigation [Member]",
        "terseLabel": "DOS Rule Investigation"
       }
      }
     },
     "localname": "DOSRuleInvestigationMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_DebtInstrumentAmountSettledInExtinguishment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, Amount Settled In Extinguishment",
        "label": "Debt instrument, Amount Settled In Extinguishment",
        "terseLabel": "Amount of debt extinguished"
       }
      }
     },
     "localname": "DebtInstrumentAmountSettledInExtinguishment",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_DebtInstrumentConvertibleEquityComponentInterestAccrued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents amount used to pay off interest accrued.",
        "label": "Debt Instrument, Convertible, Equity Component, Interest Accrued",
        "terseLabel": "Amount used to pay off interest accrued"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleEquityComponentInterestAccrued",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_DebtInstrumentConvertibleTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The transaction costs of the liability and equity component of convertible debt which may be settled upon conversion.",
        "label": "Debt Instrument Convertible Transaction Costs",
        "terseLabel": "Total transaction costs"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleTransactionCosts",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_DebtInstrumentCovenantLiquidityRequiredMinimum": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Required, Minimum",
        "terseLabel": "Minimum liquidity covenant for construction loan"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRequiredMinimum",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_DebtInstrumentPeriodicPaymentInterestTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of the required periodic payments applied to interest in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument Periodic Payment Interest Term",
        "terseLabel": "Interest-only payment, period"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentInterestTerm",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "exas_DebtInstrumentRemainingAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period for interest on debt instrument in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument Remaining Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "DebtInstrumentRemainingAmortizationPeriod",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "exas_DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the price at which the debt may be repurchased, as a percentage of the principal amount if the entity undergoes a change of control.",
        "label": "Debt Instrument Repurchase Price Due to Change in Control as Percentage of Principal Amount",
        "terseLabel": "Repurchase price, as percentage of principal amount, if company undergoes change of control"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasePriceDueToChangeInControlAsPercentageOfPrincipalAmount",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "exas_EmployeeAndNonEmployeesStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize individuals, in addition to their regular compensation and benefits.",
        "label": "Employee And Non Employees Stock Option [Member]",
        "terseLabel": "Option Plan Shares",
        "verboseLabel": "Shares issuable upon exercise of stock options"
       }
      }
     },
     "localname": "EmployeeAndNonEmployeesStockOptionMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_EmployeesWithQualifyingTerminationEventsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employees with Qualifying Termination Events",
        "label": "Employees with Qualifying Termination Events [Member]",
        "terseLabel": "Employees with Qualifying Termination Events"
       }
      }
     },
     "localname": "EmployeesWithQualifyingTerminationEventsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_FDAApprovalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FDA Approval",
        "label": "FDA Approval [Member]",
        "terseLabel": "FDA Approval"
       }
      }
     },
     "localname": "FDAApprovalMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_FacilityInLaJollaCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility in La Jolla, CA",
        "label": "Facility in La Jolla, CA [Member]",
        "terseLabel": "Facility in La Jolla, CA"
       }
      }
     },
     "localname": "FacilityInLaJollaCAMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_GenomicHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Genomic Health, Inc.",
        "label": "Genomic Health Inc [Member]",
        "terseLabel": "Merger Agreement with Genomic Health, Inc."
       }
      }
     },
     "localname": "GenomicHealthIncMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_GoodwillAcquiredAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill, Acquired, Adjustment",
        "label": "Goodwill, Acquired, Adjustment",
        "terseLabel": "Genomic Health acquisition adjustment"
       }
      }
     },
     "localname": "GoodwillAcquiredAdjustment",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying amount of amortization of purchase premium on nonoperating securities.",
        "label": "Increase (Decrease) in Amortization of Premium on Short Term Investments",
        "terseLabel": "Amortization of premium on short-term investments"
       }
      }
     },
     "localname": "IncreaseDecreaseInAmortizationOfPremiumOnShortTermInvestments",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Operating Lease Liabilities",
        "label": "Increase (Decrease) in Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_InterestExpenseDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total debt interest expense.",
        "label": "Interest Expense, Debt [Table Text Block]",
        "terseLabel": "Schedule of interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtTableTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "exas_InternationalSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Sales",
        "label": "International Sales [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalSalesMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_InventoryFinishedAndSemiFinishedGoods": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/INVENTORYDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise/goods and merchandise/goods expected to be completed within one year of operating cycle that are expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished and Semi Finished Goods",
        "terseLabel": "Semi-finished and finished goods"
       }
      }
     },
     "localname": "InventoryFinishedAndSemiFinishedGoods",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_InvestmentIncomeExpenseNonoperating": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income (Expense), Nonoperating",
        "label": "Investment Income (Expense), Nonoperating",
        "terseLabel": "Investment income (expense), net"
       }
      }
     },
     "localname": "InvestmentIncomeExpenseNonoperating",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_IssuanceOfStockToFundMatchingContributions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock to fund the entity's 401(k) matching contribution.",
        "label": "Issuance Of Stock To Fund Matching Contributions",
        "terseLabel": "Issuance of 162,606 and 136,559 shares of common stock to fund the Company\u2019s 401(k) matching contribution for 2020 and 2019, respectively"
       }
      }
     },
     "localname": "IssuanceOfStockToFundMatchingContributions",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_January2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2025 Notes",
        "label": "January 2025 Notes [Member]",
        "terseLabel": "January 2025 Notes"
       }
      }
     },
     "localname": "January2025NotesMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_JanuaryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the January Notes.",
        "label": "January Notes [Member]",
        "terseLabel": "January 2018 Notes"
       }
      }
     },
     "localname": "JanuaryNotesMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_June2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 2025 Notes",
        "label": "June 2025 Notes [Member]",
        "terseLabel": "June 2025 Notes"
       }
      }
     },
     "localname": "June2025NotesMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_JuneNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the June Notes.",
        "label": "June Notes [Member]",
        "terseLabel": "June 2018 Notes"
       }
      }
     },
     "localname": "JuneNotesMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_LICENSEAGREEMENTSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LICENSE AGREEMENTS [Abstract]",
        "terseLabel": "MAYO LICENSE AGREEMENT"
       }
      }
     },
     "localname": "LICENSEAGREEMENTSAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "xbrltype": "stringItemType"
    },
    "exas_LesseeOperatingLeaseLeaseNotYetCommencedAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not yet Commenced, Asset",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Asset",
        "terseLabel": "Operating lease not yet commenced, asset"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedAsset",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_LesseeOperatingLeaseLeaseNotYetCommencedLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not yet Commenced, Liability",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Liability",
        "terseLabel": "Operating lease not yet commenced, liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedLiability",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_LicenseAgreementFeesCommitment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Agreement Fees Commitment",
        "label": "License Agreement Fees Commitment",
        "terseLabel": "License agreement fees commitment"
       }
      }
     },
     "localname": "LicenseAgreementFeesCommitment",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_LicensingAgreementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the entire disclosure related to licensing agreement entered by an entity during the period.",
        "label": "Licensing Agreement Disclosure [Text Block]",
        "terseLabel": "LICENSE AND COLLABORATION AGREEMENTS"
       }
      }
     },
     "localname": "LicensingAgreementDisclosureTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "exas_MAYOFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the pertinent information about MAYO Foundation for Medical Education and Research (MAYO).",
        "label": "M A Y O Foundation [Member]",
        "terseLabel": "Mayo"
       }
      }
     },
     "localname": "MAYOFoundationMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_MRDProductRevenueMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MRD Product Revenue Milestone",
        "label": "MRD Product Revenue Milestone [Member]",
        "terseLabel": "MRD Product Revenue Milestone"
       }
      }
     },
     "localname": "MRDProductRevenueMilestoneMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_MeasurementInputPresentValueFactorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Present-value Factor",
        "label": "Measurement Input, Present-value Factor [Member]",
        "terseLabel": "Measurement Input, Present-value Factor"
       }
      }
     },
     "localname": "MeasurementInputPresentValueFactorMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_MeasurementInputProbabilityOfSuccessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability of Success",
        "label": "Measurement Input, Probability of Success [Member]",
        "terseLabel": "Measurement Input, Probability of Success"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfSuccessMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_MinimumOwnInvestmentToBeMadeInConstructionProject": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount of own investment to be made in construction project.",
        "label": "Minimum Own Investment to be Made in Construction Project",
        "terseLabel": "Initial investment"
       }
      }
     },
     "localname": "MinimumOwnInvestmentToBeMadeInConstructionProject",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_NetProceedsFromFinancingArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the proceeds from issuance of loan receivable to investor.",
        "label": "Net Proceeds From Financing Arrangement",
        "terseLabel": "Net proceeds received from financing arrangements"
       }
      }
     },
     "localname": "NetProceedsFromFinancingArrangement",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_NewMarketTaxCreditAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Market Tax Credit [Abstract]",
        "label": "NEW MARKET TAX CREDIT",
        "terseLabel": "NEW MARKET TAX CREDIT"
       }
      }
     },
     "localname": "NewMarketTaxCreditAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "xbrltype": "stringItemType"
    },
    "exas_NewMarketTaxCreditProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information regarding the New Market Tax Credit program, pursuant to Section 45D of the Internal Revenue Code of 1986, as amended.",
        "label": "New Market Tax Credit Program [Member]",
        "terseLabel": "New Market Tax Credit Program"
       }
      }
     },
     "localname": "NewMarketTaxCreditProgramMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_NewMarketTaxCreditTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the new market tax credit program.",
        "label": "New Market Tax Credit [Text Block]",
        "terseLabel": "NEW MARKET TAX CREDIT"
       }
      }
     },
     "localname": "NewMarketTaxCreditTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDIT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "exas_NumberOfAgreementsEntered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of agreements entered.",
        "label": "Number of Agreements Entered",
        "terseLabel": "Number of agreements"
       }
      }
     },
     "localname": "NumberOfAgreementsEntered",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "exas_NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of facilities receiving working capital and capital improvements from financing agreements.",
        "label": "Number Of Facilities Receiving Working Capital and Capital Improvements",
        "terseLabel": "Number of facilities receiving working capital and capital improvements from financing agreements"
       }
      }
     },
     "localname": "NumberOfFacilitiesReceivingWorkingCapitalAndCapitalImprovements",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "exas_NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of full-time positions that must be created over a specified time period to earn the refundable tax credits.",
        "label": "Number of Full-time Positions Required to be Created to Earn Refundable Tax Credits",
        "terseLabel": "Full-time positions that must be created over a specified time period to earn the refundable tax credits"
       }
      }
     },
     "localname": "NumberOfFullTimePositionsRequiredToBeCreatedToEarnRefundableTaxCredits",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "exas_NumberOfJobsRequiredToCreatedAndMaintained": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of jobs required to create and maintain.",
        "label": "Number of Jobs Required to Created and Maintained",
        "terseLabel": "Number of jobs required to create and maintain"
       }
      }
     },
     "localname": "NumberOfJobsRequiredToCreatedAndMaintained",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "exas_OfficeEquipmentAndComputerSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information relating to office equipment and computer software.",
        "label": "Office Equipment And Computer Software [Member]",
        "terseLabel": "Computer equipment and computer software"
       }
      }
     },
     "localname": "OfficeEquipmentAndComputerSoftwareMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_OneMonthLondonInterbankOfferRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the one-month London interbank market.",
        "label": "One Month London Interbank Offer Rate [Member]",
        "terseLabel": "1-month LIBOR"
       }
      }
     },
     "localname": "OneMonthLondonInterbankOfferRateMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_PFSGenomicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PFS Genomics",
        "label": "PFS Genomics [Member]",
        "terseLabel": "PFS Genomics"
       }
      }
     },
     "localname": "PFSGenomicsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ParadigmViomicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paradigm &amp; Viomics",
        "label": "Paradigm &amp; Viomics [Member]",
        "terseLabel": "Paradigm &amp; Viomics"
       }
      }
     },
     "localname": "ParadigmViomicsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_PaymentsContingentOnMilestonesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents potential future payments still contingent upon achievement of milestones under a collaborative arrangement.",
        "label": "Payments Contingent on Milestones Payable",
        "terseLabel": "Payments contingent on milestones"
       }
      }
     },
     "localname": "PaymentsContingentOnMilestonesPayable",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Acquire Businesses And Accelerated Vesting Of Awards",
        "label": "Payments To Acquire Businesses And Accelerated Vesting Of Awards",
        "terseLabel": "Payments to acquire businesses and accelerated vesting of awards"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesAndAcceleratedVestingOfAwards",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period over which the capital investment expenditures must be incurred and the creation of full-time positions must be completed.",
        "label": "Period for Capital Investment Expenditures and Creation of Full-time Positions to Earn Refundable Tax Credits",
        "terseLabel": "Period over which the capital investment expenditures must be incurred and the creation of full-time positions must be completed"
       }
      }
     },
     "localname": "PeriodForCapitalInvestmentExpendituresAndCreationOfFullTimePositionsToEarnRefundableTaxCredits",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "exas_PfizerIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member represents information regarding Pfizer Inc.",
        "label": "Pfizer Inc [Member]",
        "terseLabel": "Pfizer Inc"
       }
      }
     },
     "localname": "PfizerIncMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_PostCombinationExpenseForAccelerationOfUnvestedEquity": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Post-Combination Expense for Acceleration of Unvested Equity",
        "label": "Post-Combination Expense for Acceleration of Unvested Equity",
        "terseLabel": "Post-combination expense for acceleration of unvested equity"
       }
      }
     },
     "localname": "PostCombinationExpenseForAccelerationOfUnvestedEquity",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_PrecisionOncologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Precision Oncology",
        "label": "Precision Oncology [Member]",
        "terseLabel": "Precision Oncology"
       }
      }
     },
     "localname": "PrecisionOncologyMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ProductDevelopmentAndOtherMilestoneBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Development and Other Milestone-based Payments",
        "label": "Product Development and Other Milestone-based Payments [Member]",
        "terseLabel": "Product Development and Other Milestone-based Payments"
       }
      }
     },
     "localname": "ProductDevelopmentAndOtherMilestoneBasedPaymentsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_PromotionAgreementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "n/a",
        "label": "PFIZER PROMOTION AGREEMENT",
        "terseLabel": "PFIZER PROMOTION AGREEMENT"
       }
      }
     },
     "localname": "PromotionAgreementDisclosureAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "xbrltype": "stringItemType"
    },
    "exas_RefundableTaxCreditEarnedToDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of refundable tax credits earned, relating to capital investments and job creation, as of the end of the reporting period.",
        "label": "Refundable Tax Credit Earned to Date",
        "terseLabel": "Refundable tax credits earned"
       }
      }
     },
     "localname": "RefundableTaxCreditEarnedToDate",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_RefundableTaxCreditReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of refundable tax credit receivable as of the end of the reporting period.",
        "label": "Refundable Tax Credit Receivable",
        "terseLabel": "Refundable tax credit receivable"
       }
      }
     },
     "localname": "RefundableTaxCreditReceivable",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_RefundableTaxCreditReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of refundable tax credit received during the reporting period.",
        "label": "Refundable Tax Credit Received",
        "terseLabel": "Refundable tax credit received"
       }
      }
     },
     "localname": "RefundableTaxCreditReceived",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the refundable tax credits available, that is contingent on the Company expending a specified dollar amount on capital investments and the creation of a specified number of full-time positions.",
        "label": "Refundable Tax Credits Available Contingent on Capital Investments and Creation of Full-time Positions",
        "terseLabel": "Refundable tax credits available, contingent"
       }
      }
     },
     "localname": "RefundableTaxCreditsAvailableContingentOnCapitalInvestmentsAndCreationOfFullTimePositions",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total consideration for repayments of convertible debt by way of cash and shares.",
        "label": "Repayments Of Convertible Debt In Cash And By Issuance Of Shares",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebtInCashAndByIssuanceOfShares",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_RestrictedCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash",
        "label": "Restricted Cash [Member]",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_RestrictedStockAwardsAndRestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the details relating to the restricted stock awards and restricted stock units (RSUs) as awarded by the entity to their employees as a form of incentive compensation.",
        "label": "Restricted Stock Awards And Restricted Stock Units R S U [Member]",
        "terseLabel": "Restricted Shares and RSUs"
       }
      }
     },
     "localname": "RestrictedStockAwardsAndRestrictedStockUnitsRSUMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_RevenueAndOtherPerformanceBasedPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue and Other Performance-based Payments",
        "label": "Revenue and Other Performance-based Payments [Member]",
        "terseLabel": "Revenue and Other Performance-based Payments"
       }
      }
     },
     "localname": "RevenueAndOtherPerformanceBasedPaymentsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_SalesMilestoneRangeOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the first sales milestone range.",
        "label": "Sales Milestone Range One [Member]",
        "terseLabel": "Sales Milestone Range One"
       }
      }
     },
     "localname": "SalesMilestoneRangeOneMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_SalesMilestoneRangeThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the third sales milestone range one.",
        "label": "Sales Milestone Range Three [Member]",
        "terseLabel": "Sales Milestone Range Three"
       }
      }
     },
     "localname": "SalesMilestoneRangeThreeMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_SalesMilestoneRangeTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to the second sales milestone range one.",
        "label": "Sales Milestone Range Two [Member]",
        "terseLabel": "Sales Milestone Range Two"
       }
      }
     },
     "localname": "SalesMilestoneRangeTwoMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Allocation of Transaction Costs Related to Convertible Debt",
        "label": "Schedule of Allocation of Transaction Costs Related to Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of allocation of transaction costs related to convertible debt"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfTransactionCostsRelatedToConvertibleDebtTableTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "exas_ScheduleOfConvertibleNotesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table information pertaining to convertible notes.",
        "label": "Schedule of Convertible notes [Table]",
        "terseLabel": "Schedule of Convertible notes [Table]"
       }
      }
     },
     "localname": "ScheduleOfConvertibleNotesTable",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "exas_ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share Based Payment Award, Stock Options and Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsAndEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "exas_ScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Screening",
        "label": "Screening [Member]",
        "terseLabel": "Screening"
       }
      }
     },
     "localname": "ScreeningMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents service fee based on incremental gross profits over specified baselines and royalties.",
        "label": "Service Fee Based on Incremental Gross Profits Over Specified Baselines and Royalties",
        "terseLabel": "Service fee based on incremental gross profits over specified baselines and royalties"
       }
      }
     },
     "localname": "ServiceFeeBasedOnIncrementalGrossProfitsOverSpecifiedBaselinesAndRoyalties",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "exas_ServiceOrProductTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service or Product Type",
        "label": "Service or Product Type [Axis]",
        "terseLabel": "Service or Product Type [Axis]"
       }
      }
     },
     "localname": "ServiceOrProductTypeAxis",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "exas_ServiceOrProductTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service or Product Type",
        "label": "Service or Product Type [Domain]",
        "terseLabel": "Service or Product Type [Domain]"
       }
      }
     },
     "localname": "ServiceOrProductTypeDomain",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed During Period Through Acquisitions",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed During Period Through Acquisitions",
        "terseLabel": "Assumed through acquisition (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedDuringPeriodThroughAcquisitions",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed in Period Through Acquisitions, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Assumed in Period Through Acquisitions, Weighted Average Grant Date Fair Value",
        "terseLabel": "Assumed through acquisition (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Assumed in Period Through Acquisitions",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Assumed in Period Through Acquisitions",
        "terseLabel": "Assumed through acquisition (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitions",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Options, Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "exas_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "exas_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Assumed in Period Through Acquisitions, Weighted Average Exercise Price",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Assumed in Period Through Acquisitions, Weighted Average Exercise Price",
        "terseLabel": "Assumed through acquisition (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInPeriodThroughAcquisitionsWeightedAverageExercisePrice",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "exas_SharesIssuedUponAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Issued Upon Acquisition",
        "label": "Shares Issued Upon Acquisition [Member]",
        "terseLabel": "Shares issuable in connection with acquisitions"
       }
      }
     },
     "localname": "SharesIssuedUponAcquisitionMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_StockBasedCompensationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company maintains the 2010 Omnibus Long-Term Incentive Plan (As Amended and Restated Effective July 27, 2017), the 2010 Employee Stock Purchase Plan, the 2015 Inducement Award Plan, the 2016 Inducement Award Plan and the 2000 Stock Option and Incentive Plan (collectively, the \"Stock Plans\").",
        "label": "Stock Based Compensation Plans [Member]",
        "terseLabel": "Stock Plans"
       }
      }
     },
     "localname": "StockBasedCompensationPlansMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_TARDISTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TARDIS Technology",
        "label": "TARDIS Technology [Member]",
        "terseLabel": "TARDIS Technology"
       }
      }
     },
     "localname": "TARDISTechnologyMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_TaxIncrementFinancingLoanAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the tax increment financing loan agreement with the City of Madison, Wisconsin.",
        "label": "Tax Increment Financing Loan Agreements [Member]",
        "terseLabel": "Tax Increment Financing"
       }
      }
     },
     "localname": "TaxIncrementFinancingLoanAgreementsMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ThriveAndAshionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Thrive and Ashion",
        "label": "Thrive and Ashion [Member]",
        "terseLabel": "Thrive and Ashion"
       }
      }
     },
     "localname": "ThriveAndAshionMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_ThriveEarlierDetectionCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Thrive Earlier Detection Corporation",
        "label": "Thrive Earlier Detection Corporation [Member]",
        "terseLabel": "Thrive"
       }
      }
     },
     "localname": "ThriveEarlierDetectionCorporationMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails",
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_VariablePriceContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company estimates the amount of variable consideration using the expected value method, which represents the sum of probability-weighted amounts in a range of possible consideration amounts. When estimating the amount of variable consideration, the Company considers several factors, such as historical collections experience, patient insurance eligibility and payer reimbursement contracts.",
        "label": "Variable Price Contract [Member]",
        "terseLabel": "Variable consideration"
       }
      }
     },
     "localname": "VariablePriceContractMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wisconsin Economic Development Tax Credit Disclosure [Abstract]",
        "label": "WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS [Abstract]",
        "terseLabel": "WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS"
       }
      }
     },
     "localname": "WISCONSINECONOMICDEVELOPMENTTAXCREDITSAbstract",
     "nsuri": "http://www.exactsciences.com/20210930",
     "xbrltype": "stringItemType"
    },
    "exas_WisconsinEconomicDevelopmentTaxCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information relating to the agreement with the Wisconsin Economic Development Corporation.",
        "label": "Wisconsin Economic Development Tax Credit Agreement [Member]",
        "terseLabel": "Wisconsin Economic Development Tax Credit Agreement"
       }
      }
     },
     "localname": "WisconsinEconomicDevelopmentTaxCreditAgreementMember",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "exas_WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure relating to the Wisconsin Economic Development Tax Credit.",
        "label": "Wisconsin Economic Development Tax Credit Disclosure [Text Block]",
        "verboseLabel": "WISCONSIN ECONOMIC DEVELOPMENT TAX CREDITS"
       }
      }
     },
     "localname": "WisconsinEconomicDevelopmentTaxCreditDisclosureTextBlock",
     "nsuri": "http://www.exactsciences.com/20210930",
     "presentation": [
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r59",
      "r61",
      "r128",
      "r129",
      "r299",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r135",
      "r143",
      "r149",
      "r230",
      "r422",
      "r423",
      "r424",
      "r444",
      "r445",
      "r531",
      "r534",
      "r536",
      "r537",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r135",
      "r143",
      "r149",
      "r230",
      "r422",
      "r423",
      "r424",
      "r444",
      "r445",
      "r531",
      "r534",
      "r536",
      "r537",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r135",
      "r143",
      "r149",
      "r230",
      "r422",
      "r423",
      "r424",
      "r444",
      "r445",
      "r531",
      "r534",
      "r536",
      "r537",
      "r737"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r298",
      "r327",
      "r383",
      "r385",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r630",
      "r681",
      "r684",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r298",
      "r327",
      "r383",
      "r385",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r630",
      "r681",
      "r684",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r191",
      "r361",
      "r365",
      "r632",
      "r680",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r191",
      "r361",
      "r365",
      "r632",
      "r680",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r298",
      "r327",
      "r373",
      "r383",
      "r385",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r630",
      "r681",
      "r684",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r298",
      "r327",
      "r373",
      "r383",
      "r385",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r630",
      "r681",
      "r684",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r60",
      "r61",
      "r128",
      "r129",
      "r299",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r192",
      "r193",
      "r361",
      "r366",
      "r683",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r192",
      "r193",
      "r361",
      "r366",
      "r683",
      "r705",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r198",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r606",
      "r608",
      "r611",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r25",
      "r199",
      "r200"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r271"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r71",
      "r78",
      "r79",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Marketable Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r68",
      "r70",
      "r71",
      "r667",
      "r692",
      "r696"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r78",
      "r79",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r67",
      "r71",
      "r78",
      "r79",
      "r80",
      "r132",
      "r133",
      "r134",
      "r508",
      "r687",
      "r688",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r63",
      "r71",
      "r78",
      "r79",
      "r80",
      "r508",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted-average remaining useful life of finite-lived intangible asset (in years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r422",
      "r423",
      "r424",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r387",
      "r412",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r94",
      "r112",
      "r311",
      "r576"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Debt discount amortization"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r88",
      "r112",
      "r311",
      "r578"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Debt issuance costs amortization"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r112",
      "r311",
      "r320",
      "r321",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "negatedLabel": "Decrease in amortization debt discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r112",
      "r256",
      "r263"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Common shares not included in the computation of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails",
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r491",
      "r492",
      "r493",
      "r494"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Asset acquisition, consideration transferred"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": {
     "auth_ref": [
      "r491",
      "r492",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.",
        "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable",
        "terseLabel": "Stock issued to acquire productive assets, value"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionTextBlock": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for asset acquisition.",
        "label": "Asset Acquisition [Text Block]",
        "terseLabel": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS"
       }
      }
     },
     "localname": "AssetAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r213",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetUnderConstructionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset in process of being built.",
        "label": "Asset under Construction [Member]",
        "terseLabel": "Assets under construction"
       }
      }
     },
     "localname": "AssetUnderConstructionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r123",
      "r177",
      "r181",
      "r187",
      "r226",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r502",
      "r509",
      "r555",
      "r597",
      "r599",
      "r642",
      "r664"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r58",
      "r123",
      "r226",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r502",
      "r509",
      "r555",
      "r597",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Long-term Assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gains in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Losses in Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r206",
      "r238"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r212"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years, Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r210",
      "r212",
      "r659"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r211"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less, Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r210",
      "r211",
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less, Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r204",
      "r207",
      "r238",
      "r646"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated Fair Value",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r389",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r520",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r382",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r382",
      "r384",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r486"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Fair value of stock issued in acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Business acquisition, equity interest issued or issuable (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business acquisition, pro forma information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Total revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r479",
      "r480",
      "r483"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase price",
        "totalLabel": "Total purchase price",
        "verboseLabel": "Cash paid for acquisition of PFS Genomics outstanding shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r479",
      "r480"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Common stock issued",
        "verboseLabel": "Common stock issued"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1": {
     "auth_ref": [
      "r459",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to,  instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination",
        "terseLabel": "Equity interests issued or issuable to previous investors"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingEquityInterestInAcquireeHeldPriorToCombination1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r477",
      "r479",
      "r480",
      "r485"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r111",
      "r489"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in amount of contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Contingent payment obligations"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r478",
      "r481",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r478",
      "r482"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "negatedLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration liability, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS COMBINATIONS AND ASSET ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "negatedTerseLabel": "Business combination, pro forma loss"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Developed technology",
        "verboseLabel": "In-process research and development (IPR&amp;D)"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in income that would have been recognized in previous periods if the adjustments to provisional amounts were recognized as of the acquisition date.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments Related to Previous Period",
        "negatedTotalLabel": "Total purchase price"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedTerseLabel": "Accounts payable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other",
        "negatedTerseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "In-process research and development (IPR&amp;D)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "In-process research and development (IPR&amp;D)",
        "verboseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      },
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedTerseLabel": "Net operating liabilities",
        "negatedTotalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net identifiable assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r460"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Previously held equity investment fair value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage",
        "terseLabel": "Equity interest in acquiree after subsequent acquisition"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Percent of equity acquired"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r461"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "negatedTerseLabel": "Realized gain on preferred stock investment",
        "terseLabel": "Business combination, equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r37",
      "r114"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "Total cash and cash equivalents, restricted cash and marketable securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r108",
      "r114",
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r108",
      "r566"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing activities:",
        "verboseLabel": "Non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashFlowOperatingActivitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Operating Activities, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowOperatingActivitiesLesseeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r496",
      "r497",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "verboseLabel": "PFIZER PROMOTION AGREEMENT"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "verboseLabel": "Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails",
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r53",
      "r279",
      "r648",
      "r671"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 14)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r280",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.01 par value Authorized\u2014400,000,000 shares issued and outstanding\u2014172,242,798 and 159,423,410 shares at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r74",
      "r76",
      "r77",
      "r85",
      "r653",
      "r675"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss, net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r257",
      "r261",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Computer software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r120",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r270"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Assets under construction"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionLoansMember": {
     "auth_ref": [
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A borrowing arrangement which provides the entity constructing a facility (such as a building and a landfill) with funds to effect construction, generally on a draw down, or as needed, basis.",
        "label": "Construction Loans [Member]",
        "terseLabel": "Construction Loan Agreement"
       }
      }
     },
     "localname": "ConstructionLoansMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingAxis": {
     "auth_ref": [
      "r361",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer.",
        "label": "Contract with Customer, Basis of Pricing [Axis]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerBasisOfPricingDomain": {
     "auth_ref": [
      "r361",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts.",
        "label": "Contract with Customer, Basis of Pricing [Domain]",
        "terseLabel": "Contract with Customer, Basis of Pricing [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerBasisOfPricingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice": {
     "auth_ref": [
      "r351"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in revenue recognized for cumulative catch-up adjustment from change in estimate of transaction price which (increases) decreases obligation to transfer good or service to customer for which consideration from customer has been received or is due. Includes, but is not limited to, change in assessment of whether estimate of variable consideration is constrained.",
        "label": "Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price",
        "terseLabel": "Revenue recognized (downward adjustments) from changes in transaction prices"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r349",
      "r350",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Deferred revenue, revenue recognized during period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r116",
      "r117",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "verboseLabel": "Issuance of common stock upon convertible notes settlement (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Convertible notes, fair value"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of convertible note obligations included in the condensed consolidated balance sheets"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Convertible notes, net, less current portion",
        "verboseLabel": "Increase in convertible notes, net"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r22",
      "r644",
      "r665",
      "r698"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Current",
        "terseLabel": "Convertible notes, net, current portion",
        "verboseLabel": "Increase in current portion of convertible notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r20",
      "r643",
      "r663",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes",
        "verboseLabel": "Shares issuable upon conversion of convertible notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r91",
      "r123",
      "r226",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r555"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales (exclusive of amortization of acquired intangible assets)"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r122",
      "r130",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r318",
      "r319",
      "r320",
      "r321",
      "r579",
      "r643",
      "r644",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r297",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "verboseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r50",
      "r297",
      "r342",
      "r343",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion rate, number of shares to be issued per $1,000 of principal amount (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.",
        "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal",
        "terseLabel": "If-converted value of debt in excess of principal amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": {
     "auth_ref": [
      "r50",
      "r297",
      "r342",
      "r343",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.",
        "label": "Debt Instrument, Convertible, Number of Equity Instruments",
        "terseLabel": "Convertible debt, if-converted (in shares)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period",
        "terseLabel": "Interest expense amortization term"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r295",
      "r318",
      "r319",
      "r577",
      "r579",
      "r580"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount",
        "verboseLabel": "Amount issued and sold"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r49",
      "r308",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r49",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "netLabel": "Coupon interest rate",
        "verboseLabel": "Fixed interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails",
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r51",
      "r122",
      "r130",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r318",
      "r319",
      "r320",
      "r321",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofTransactionCostsDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r51",
      "r122",
      "r130",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r318",
      "r319",
      "r320",
      "r321",
      "r342",
      "r344",
      "r345",
      "r346",
      "r576",
      "r577",
      "r579",
      "r580",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r302",
      "r313",
      "r318",
      "r319",
      "r578"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Unamortized Debt Discount and Issuance Costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r218",
      "r242",
      "r245"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r218",
      "r242"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "Debt securities, available-for-sale, continuous unrealized loss position, 12 months of longer, accumulated loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r218",
      "r242",
      "r245"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Total fair value of available-for-sale securities in a continuous unrealized loss position for less than twelve months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r218",
      "r242"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position for less than twelve months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r216",
      "r239",
      "r245"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Total fair value of available-for-sale securities in a continuous unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r217",
      "r240"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total gross unrealized losses of available-for-sale securities in a continuous unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r215",
      "r241",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of gross unrealized losses and fair values of investments in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued pursuant to the terms of a deferred compensation arrangement.",
        "label": "Deferred Compensation Arrangement with Individual, Shares Issued",
        "terseLabel": "Issuance of shares of common stock to fund the Company's 401(k) matching contribution (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r40",
      "r302",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs, net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r124",
      "r441",
      "r448",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r431",
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r432",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Deferred tax liabilities, net"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r112",
      "r269"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r112",
      "r175"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r61",
      "r521",
      "r522",
      "r524",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Acquired developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails",
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r361",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails",
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r382",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r86",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r150",
      "r152",
      "r154",
      "r155",
      "r156",
      "r159",
      "r160",
      "r537",
      "r538",
      "r654",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Increase (decrease) in net loss per share (in usd per share)",
        "verboseLabel": "Net loss per share - basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r86",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r152",
      "r154",
      "r155",
      "r156",
      "r159",
      "r160",
      "r537",
      "r538",
      "r654",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Increase (decrease) in net loss per share (in usd per share)",
        "verboseLabel": "Net loss per share - diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period for recognition of cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r78",
      "r79",
      "r80",
      "r132",
      "r133",
      "r134",
      "r137",
      "r146",
      "r148",
      "r161",
      "r230",
      "r341",
      "r347",
      "r422",
      "r423",
      "r424",
      "r444",
      "r445",
      "r536",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r687",
      "r688",
      "r689",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r550"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r224",
      "r677"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Equity securities, realized gain (loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r224",
      "r677"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Unrealized (gain) loss on equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r304",
      "r318",
      "r319",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt, amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAdjustmentDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Adjustment Disclosure [Abstract]",
        "terseLabel": "Fair Value, Adjustment Disclosure [Abstract]"
       }
      }
     },
     "localname": "FairValueAdjustmentDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r539",
      "r540",
      "r541",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of fair value measurements along with the level within the fair value hierarchy in which the fair value measurements fall"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r539",
      "r553",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r304",
      "r318",
      "r319",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r540",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r304",
      "r318",
      "r319",
      "r539",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r539",
      "r540",
      "r543",
      "r544",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r304",
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r304",
      "r374",
      "r375",
      "r380",
      "r381",
      "r540",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r304",
      "r318",
      "r319",
      "r374",
      "r375",
      "r380",
      "r381",
      "r540",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r304",
      "r318",
      "r319",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r540",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r304",
      "r318",
      "r319",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r603",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r539",
      "r540",
      "r543",
      "r544",
      "r545",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Fair Value, Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r546",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of asset after deduction of liability.",
        "label": "Fair Value, Net Asset (Liability)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FairValueNetAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r586",
      "r589"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r582",
      "r593"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Finance lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liability, current"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance lease, liability, current, statement of financial position, extensible list"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liability, noncurrent"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance lease, liability, noncurrent, statement of financial position, extensible list"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r585",
      "r589"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Finance cash flows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease, right-of-use asset"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance lease, right-of-use asset, statement of financial position, extensible list"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r592",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance lease, weighted average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r591",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance lease, weighted average remaining lease term"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r213",
      "r214",
      "r221",
      "r222",
      "r223",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r241",
      "r243",
      "r244",
      "r245",
      "r312",
      "r339",
      "r527",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted-average remaining useful life of finite-lived intangible asset (in years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r262"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      },
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: Accumulated amortization",
        "terseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2021 (remaining three months)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r257",
      "r259",
      "r262",
      "r266",
      "r633",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r262",
      "r637"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r257",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r262",
      "r633"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Intangibles, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property, plant and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r112",
      "r322",
      "r323"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": -1.0
      },
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on settlement of convertible notes"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedTerseLabel": "General and administrative",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative Expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r247",
      "r249",
      "r599",
      "r641"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "INTANGIBLE ASSETS AND GOODWILL"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILL"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r112",
      "r248",
      "r251",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Impairment losses"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Recognized Goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r112",
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Impairment of intangible assets, finite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r112",
      "r267"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Intangible asset impairment charge"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r177",
      "r180",
      "r183",
      "r186",
      "r189",
      "r638",
      "r650",
      "r656",
      "r678"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Net loss before tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r382",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r273",
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r435",
      "r437",
      "r440",
      "r446",
      "r451",
      "r455",
      "r456",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r126",
      "r147",
      "r148",
      "r176",
      "r433",
      "r447",
      "r453",
      "r679"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit",
        "terseLabel": "Tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/INCOMETAXESDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "negatedTerseLabel": "Tax benefit from change in deferred tax asset valuation allowance resulting from merger"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Finite-lived and indefinite-lived intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r255",
      "r260"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Finite-lived and indefinite-lived intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r575"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Interest costs capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestCostsIncurred": {
     "auth_ref": [
      "r575"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total interest costs incurred during the period and either capitalized or charged against earnings.",
        "label": "Interest Costs Incurred",
        "terseLabel": "Interest incurred, accrued for as an interest reserve"
       }
      }
     },
     "localname": "InterestCostsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r94",
      "r309",
      "r317",
      "r320",
      "r321"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Total interest expense on convertible notes"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense classified as other.",
        "label": "Interest Expense, Other",
        "terseLabel": "Other interest expense"
       }
      }
     },
     "localname": "InterestExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r655"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedTotalLabel": "Total interest expense",
        "terseLabel": "Interest income (expense)",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESSummaryofInterestExpenseDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r106",
      "r109",
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORY"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INVENTORY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r57",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/INVENTORYDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/INVENTORYDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.",
        "label": "Inventory, Raw Materials and Supplies, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSupplies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing investment income.",
        "label": "Investment Income [Member]",
        "terseLabel": "Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeNonoperating": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.",
        "label": "Investment Income, Nonoperating",
        "terseLabel": "Investment income (expense), net"
       }
      }
     },
     "localname": "InvestmentIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r697",
      "r699",
      "r700"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Investment owned, at fair value"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of contractual maturities of available-for-sale investments"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandImprovementsMember": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to real estate held.",
        "label": "Land Improvements [Member]",
        "terseLabel": "Land improvements"
       }
      }
     },
     "localname": "LandImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "City Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r123",
      "r182",
      "r226",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r503",
      "r509",
      "r510",
      "r555",
      "r597",
      "r598"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r123",
      "r226",
      "r555",
      "r599",
      "r645",
      "r669"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r123",
      "r226",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r503",
      "r509",
      "r510",
      "r555",
      "r597",
      "r598",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licensing Agreements"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r53",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Estimated civil damages"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "LONG-TERM DEBT"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermLoansPayable": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans Payable, Noncurrent",
        "terseLabel": "Long-term debt, less current portion"
       }
      }
     },
     "localname": "LongTermLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermConstructionLoanCurrentAndNoncurrent": {
     "auth_ref": [
      "r44",
      "r647",
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the current and noncurrent portions of a long-term real estate loan with an initial maturity beyond one year or beyond the normal operating cycle, if longer, to finance building costs. The funds are disbursed as needed or in accordance with a prearranged plan; generally, a portion of the funds is disbursed at inception and the remainder as construction progresses. The money is repaid on completion of the project (generally one to seven years), usually from the proceeds of a mortgage loan. The rate is normally higher than the prime rate, and there is usually an origination fee. The effective yield on these loans tends to be high, and the lender has a security interest in the real property.",
        "label": "Long-term Construction Loan",
        "terseLabel": "Amount drawn from loan"
       }
      }
     },
     "localname": "LongtermConstructionLoanCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r51",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss Contingency Accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ManufacturedProductOtherMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by labor or machinery, classified as other.",
        "label": "Manufactured Product, Other [Member]",
        "terseLabel": "Cologuard promotion agreement"
       }
      }
     },
     "localname": "ManufacturedProductOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r649"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Total marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r10",
      "r46"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketingExpense": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.",
        "label": "Marketing Expense",
        "terseLabel": "Charges for promotion, sales and marketing"
       }
      }
     },
     "localname": "MarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Cash and money market"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r108",
      "r110",
      "r113"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r72",
      "r75",
      "r80",
      "r83",
      "r113",
      "r123",
      "r136",
      "r141",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r153",
      "r177",
      "r180",
      "r183",
      "r186",
      "r189",
      "r226",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r538",
      "r555",
      "r651",
      "r673"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "exas_ComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r140",
      "r143",
      "r149",
      "r159",
      "r202",
      "r203",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r283",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r442",
      "r443",
      "r444",
      "r445",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r595",
      "r634",
      "r635",
      "r636",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Outside of United States"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r116",
      "r117",
      "r118"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Property, plant and equipment acquired but not paid"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive loss before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r177",
      "r180",
      "r183",
      "r186",
      "r189"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Additional amount to be recognized at lease commencement for the lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current portion",
        "verboseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, less current portion",
        "verboseLabel": "Operating lease liability, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r587",
      "r589"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r592",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease, weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r591",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease, weighted average lease term remaining"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets, net"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r62",
      "r68",
      "r564",
      "r565",
      "r567"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "exas_ComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Foreign currency adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r64",
      "r65",
      "r68"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Unrealized gain (loss) on available-for-sale investments, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r500",
      "r501",
      "r507"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent",
        "totalLabel": "Net current period change in accumulated other comprehensive loss, before tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]",
        "verboseLabel": "Other comprehensive income (loss), before tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r73",
      "r76",
      "r500",
      "r501",
      "r507"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r69",
      "r78",
      "r84",
      "r433",
      "r452",
      "r454",
      "r568",
      "r571",
      "r574",
      "r652",
      "r674"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedLabel": "Income tax expense related to items of other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": {
     "auth_ref": [
      "r500",
      "r501",
      "r507"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent",
        "negatedTerseLabel": "Income tax expense related to items of other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r64",
      "r68",
      "r219"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "exas_ComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Unrealized gain (loss) on available-for-sale investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r47",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingIncome": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Operating Income",
        "terseLabel": "Other operating income"
       }
      }
     },
     "localname": "OtherOperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities": {
     "auth_ref": [
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.",
        "label": "Payment for Contingent Consideration Liability, Investing Activities",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSFairValueofContingentConsiderationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r96",
      "r100"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r97",
      "r484"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Business combination, net of cash acquired",
        "terseLabel": "Cash payments to acquire business, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r205"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedTerseLabel": "Investments in privately held companies"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "negatedTerseLabel": "Asset acquisition"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r98",
      "r491",
      "r492",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Payments to acquire productive assets"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Shares issuable upon the release of performance share units",
        "verboseLabel": "Performance Share Units"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r389",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CONVERTIBLENOTESScheduleofConvertibleNotesDetails",
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsPeriodExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period expense related to postemployment benefits.",
        "label": "Postemployment Benefits, Period Expense",
        "terseLabel": "Additional benefit charges"
       }
      }
     },
     "localname": "PostemploymentBenefitsPeriodExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value Authorized\u20145,000,000 shares issued and outstanding\u2014no shares at September\u00a030, 2021 and December\u00a031, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r11",
      "r35",
      "r36"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Net proceeds from issuance",
        "verboseLabel": "Proceeds from issuance of convertible notes, net"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r101",
      "r417"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercise of common stock options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r103",
      "r105"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Maturities and sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r101",
      "r417"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds in connection with the Company\u2019s employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Medicare Parts B &amp; C"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r72",
      "r75",
      "r80",
      "r107",
      "r123",
      "r136",
      "r147",
      "r148",
      "r177",
      "r180",
      "r183",
      "r186",
      "r189",
      "r226",
      "r284",
      "r285",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r500",
      "r505",
      "r506",
      "r516",
      "r517",
      "r538",
      "r555",
      "r656"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r274",
      "r707",
      "r708",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY, PLANT AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r270"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r272",
      "r599",
      "r660",
      "r670"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESAdditionalInformationDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated Useful Life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, before Tax, Attributable to Parent",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive loss"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": {
     "auth_ref": [
      "r71",
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent",
        "negatedTerseLabel": "Total reclassifications"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification Out Of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Schedule of amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r179",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RegulatoryLiabilityAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period for the recovery of regulatory liability, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Regulatory Liability, Amortization Period",
        "terseLabel": "Timeframe when amount will be repaid through property taxes"
       }
      }
     },
     "localname": "RegulatoryLiabilityAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedLabel": "Payments on settlement of convertible notes",
        "verboseLabel": "Repayments of debt in cash"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r429",
      "r631",
      "r721"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "Asset acquisition IPR&amp;D expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Shares issuable upon the release of restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r347",
      "r425",
      "r599",
      "r668",
      "r691",
      "r696"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r132",
      "r133",
      "r134",
      "r137",
      "r146",
      "r148",
      "r230",
      "r422",
      "r423",
      "r424",
      "r444",
      "r445",
      "r536",
      "r687",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit\u200b"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r173",
      "r174",
      "r179",
      "r184",
      "r185",
      "r191",
      "r192",
      "r196",
      "r360",
      "r361",
      "r632"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue recognized",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations",
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails",
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r364",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Revenue from external customers by geographic areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r590",
      "r594"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new finance lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r590",
      "r594"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESSupplementalDisclosureofCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r71",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of amounts recognized in accumulated other comprehensive income (loss) (AOCI)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of potentially issuable common shares not included in the computation of diluted net loss per share because they would have an anti-dilutive effect"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Available-for-sale securities"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of available-for-sale securities"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of fair value of contingent consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssetAcquisitionsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedFromParadigmDiagnosticsAcquisitionDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofAssetsAcquiredandLiabilitiesAssumedThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofConsiderationTransferredThriveDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSScheduleofProFormaThriveInformationDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedAshionAnalyticsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofAssetsAcquiredandLiabilitiesAssumedPFSGenomicsDetails",
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSScheduleofConsiderationTransferredforAshionAnalyticsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of business acquisitions, by acquisition"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental disclosure of cash flow information related to our operating leases"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/COMMITMENTSANDCONTINGENCIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails",
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r257",
      "r261",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLNarrativeDetails",
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r257",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of net-book value and estimated remaining life and finite lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r252",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r252",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r32",
      "r33",
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INVENTORYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTNarrativeDetails",
      "http://www.exactsciences.com/role/PROPERTYPLANTANDEQUIPMENTScheduleofEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of recognized identified assets acquired and liabilities assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r17",
      "r119",
      "r640",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of restricted cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r389",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of share-based payment award, employee stock purchase plan, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of share-based payment award, stock options, valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of restricted stock and restricted stock unit activity under the Stock Plans"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]",
        "terseLabel": "Schedule of Subsidiary or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r502",
      "r503",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of estimated future amortization expense, intangible assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecurityOwnedNotReadilyMarketableFairValue": {
     "auth_ref": [
      "r639"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FairValueNetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the not readily marketable security or category which has been determined by management based upon fair value methods, including pricing of similar securities and valuation techniques and is included in the schedule of financial condition or the balance sheet.",
        "label": "Security Owned Not Readily Marketable, Fair Value",
        "terseLabel": "Non-marketable securities"
       }
      }
     },
     "localname": "SecurityOwnedNotReadilyMarketableFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r169",
      "r171",
      "r172",
      "r177",
      "r178",
      "r183",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r195",
      "r196",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Supply agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Commercial"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUEScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Noncash stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost.",
        "label": "Share-based Payment Arrangement, Accelerated Cost",
        "terseLabel": "Accelerated vesting compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at the end of the period (in shares)",
        "periodStartLabel": "Outstanding at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Shares, RSUs, and Performance Share Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at the end of the period (in dollars per share)",
        "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of equity instruments other than options vested in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Valuation assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rates, maximum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rates, minimum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r392",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "terseLabel": "Number of outstanding performance share units (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at the end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at the end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value per share of options granted during the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding at the end of the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r393",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end of the period (in shares)",
        "periodStartLabel": "Outstanding at the beginning of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at the end of the period (in dollars per share)",
        "periodStartLabel": "Outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at end of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest at end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": {
     "auth_ref": [
      "r413"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.",
        "label": "Share-based Payment Arrangement, Plan Modification, Incremental Cost",
        "terseLabel": "Incremental share based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r386",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.",
        "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "terseLabel": "Share-based payment arrangement, performance shares, activity"
       }
      }
     },
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Market price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number",
        "terseLabel": "Accelerated vesting (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r409",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSAssumptionsonFairValueofOptionsAssumedDetails",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable at the end of the period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end of the period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vest at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Shares issued, price per share (in usd per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r41",
      "r672"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Short-term Bank Loans and Notes Payable",
        "terseLabel": "Debt, current portion"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r701",
      "r702",
      "r703",
      "r704"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofCashandCashEquivalentsDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r55",
      "r78",
      "r79",
      "r80",
      "r132",
      "r133",
      "r134",
      "r137",
      "r146",
      "r148",
      "r161",
      "r230",
      "r341",
      "r347",
      "r422",
      "r423",
      "r424",
      "r444",
      "r445",
      "r536",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r687",
      "r688",
      "r689",
      "r739"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofamountsreclassifiedfromAOCIDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r161",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r23",
      "r24",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock for business combinations and asset acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlowsParenthetical",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r54",
      "r306",
      "r341",
      "r342",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible notes, net of tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Shares, Employee Benefit Plan",
        "terseLabel": "Issuance of common stock to fund the Company's 401(k) match (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r23",
      "r24",
      "r341",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchase of employee stock purchase plan shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r341",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Compensation expense related to issuance of stock options and restricted stock awards (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r341",
      "r347",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of common stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKBASEDCOMPENSATIONFairValueandActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r55",
      "r341",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock for business combination and asset acquisition",
        "verboseLabel": "Issuance of 9,510,436 and 382,947 shares of common stock for business combinations and asset acquisition for 2021 and 2020, respectively"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/BUSINESSCOMBINATIONSANDASSETACQUISITIONSBusinessCombinationsTextualDetails",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r55",
      "r341",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible notes, net of tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of stock issued during the period upon the conversion of convertible securities, net of adjustments (for example, to additional paid in capital) including the write-off of an equity component recognized to record the convertible debt instrument as two separate components - a debt component and an equity component. This item is meant to disclose the value of shares issued on conversion of convertible securities that were recorded as two separate (debt and equity) components.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments",
        "terseLabel": "Conversion of convertible securities, value issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CONVERTIBLENOTESAdditionalinformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.",
        "label": "Stock Issued During Period, Value, Employee Benefit Plan",
        "terseLabel": "Issuance of common stock to fund the Company's 401(k) match"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r23",
      "r24",
      "r341",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Purchase of employee stock purchase plan shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r347",
      "r388",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Compensation expense related to issuance of stock options and restricted stock awards"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r55",
      "r341",
      "r347"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of common stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r123",
      "r201",
      "r226",
      "r555",
      "r599"
     ],
     "calculation": {
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Stockholders' equity",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYScheduleofOCIDetails",
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRecentAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r121",
      "r326",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r340",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INTANGIBLEASSETSANDGOODWILLScheduleofFiniteLivedIntangibleAssetsNetBalancesandWeightedAverageUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r213",
      "r214",
      "r221",
      "r222",
      "r223",
      "r312",
      "r339",
      "r527",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSJohnHopkinsUniversityDetails",
      "http://www.exactsciences.com/role/LICENSEANDCOLLABORATIONAGREEMENTSMayoDetails",
      "http://www.exactsciences.com/role/PFIZERPROMOTIONAGREEMENTDetails",
      "http://www.exactsciences.com/role/WISCONSINECONOMICDEVELOPMENTTAXCREDITDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r127",
      "r374",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/FAIRVALUEMEASUREMENTSScheduleofFairValueDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofGrossUnrealizedLossesAndFairValueofAvailableForSaleSecuritiesDetails",
      "http://www.exactsciences.com/role/MARKETABLESECURITIESScheduleofUnderlyingMaturitiesofAFSSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r430",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/REVENUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Disclosures related to New Market Tax Credit"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/NEWMARKETTAXCREDITDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/LONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r151",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r150",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.exactsciences.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20,22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=SL65897772-128472"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4),(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "820",
   "Subparagraph": "(c)",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r722": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r723": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r724": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r725": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r726": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r727": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r728": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r729": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r730": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r731": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r732": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r733": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r734": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>108
<FILENAME>0001124140-21-000097-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001124140-21-000097-xbrl.zip
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MHU9C#?M@(0-$L-37G_M<6O106RAG*P,&LGKLO;GWZVJ!7(/#;&-*58"R_B]
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M6F$_9R2&HS936T@^NZ)),5-)I3$2.8T]FC#7X1O.D'!9G[W48G-(H99>[*T
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MXW4/WW^2_=E45)K.7\KRNY,ICV6BK$FQZO^\4$\1DL604"Q*"2F"\2.H:3I
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M\=5%<*Z0#['O/JA!B226<-V8,!1<BJW9%*ID6X;:5!-#;A2,J8EJL#C\/'-
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MNG^5XK^+AL5R/JDJ#U;$_G$Z62X>/OIQ&SD%&GVD!:<: ""I(+09 [9HP%'
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MHZ->]YMM/UE]>I 1PT*$:'V**EK#O>):$ZPBEUH%'%0T3T=%5N$=L?>ZVVM
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MXC'KQQ9\8SAN \$?CA5LQ,%^=VP<Z]6_QOA3\[LGP\N9"48(+J.//&#G%->
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M=@;=V@V.]KH"LW$G6^!D841-;L+^IX G!20>2',,&97_TE+^.W>":=B.W:M
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MK5"+/XYRJ?>P45ZW.F'N1S5-MJII*AF)1^41(SFM#\6TT@E5%X!AN5D):NZ
M5>/U(2XE30-S2'NJ$7?,(IND0Q#1I& )Y=3E\4VTSN8JIBEYB46D%\62IV[)
M%ZPC,K!CI3"2D2;$B6#(*DX09U(%CA4E^;!*SDZ(>P<*\YJ=,'-..;:[ ]N>
M!KL8+<)803JY5(X^7I'^- %K-ILA!9KN"$V;XU451GA#7!# *J1'7%F#-"$.
M<<N5)\E1ZT(N]))$U(4A4XJ))C:.!<IQ/&.#G\W.23'XNQO\!1?QROC@E44T
M1HMXU!'BB^3A5R$AD,!8Y\ZYM Y@#0;/%\7@G]9)ONLM\FVWLX<&L7=XKP-=
M4SQT]V#7>&[[8N]ZW2.XG9-Z[:AM,_WLA.I8U]$A8-W=2V^>1?9]1HFNH8#>
M9?% =+Q^)IR2C;_E*8/ME<H/5?[H_1=GHK'8<80=N"0N.$/.:8P4C4FY2"T6
M58Z+URG&<Y20+WMHBT@ABQ5/TXI/SJTX1NR-D@9A&A0$D=0A)W!"C-'@/(,0
M4LBE92Y(W6@Y1U;\W+;5-D'[[0#NO-:.MA]KU1*A;D+'\$O94)L#GG$NH;=9
M0!_RG6ZFC_U8$?X"4;>"J/5QHD$8QS$:AY++V2T9##)$!809\3@9S3UV2\M$
MJKHA]\YRE=VT^37CF1"-8L93->,+ID&M8]1PCE(D$G$L@&GH2)#"*A%+7')<
M@1E343?\R6ZE+0#3>-/MAN^M=KND+1Z53IR)H4#.K2!G8YPYJ$23(HPB'C0P
M!Z8I,MQ(I*)/@#K""I[/%M0IIW7!YJEJL"0I%I$[%)N]J\U>T 0 4Z]"2$CG
MK6WN%+!]*3ARSC'KL,8AZ+RK39FJR_N?ZBLIB7N<"!K8SEXKMR\9)B#*0>/'
MIPT70AEN-#;C8/V';Q_G=2WP="=X:HQ3"LJPULXEQ!QFB',"48Q3!$46/!72
M<NUQIA28\[H1\]1=J:0C%I%2%'M^"'N^H!O:1XZM$V# %D.(@!72(E@41/*,
M4\!K 71#<U4'0<Z1-3^WK,1P1F7[O(SFOHSC600]L]GWN#AMT.QV?"GRNP,D
MO1^G&-HG+;3EB$FN( (B ;F(,8K<*JV\P4H"Q1"F3OFTBGI+RF(.K7<VVQW%
M>J=AO1>$ DPT2D\DHC1W%L")(4-H#A"4TMQKSIE<6I:Y,_0\545--7FQ& >&
MKJ^:^-T#WU@._1RZ7D_X\$\&@F=X'*I@[JTP]^,X8PJ8<,^31D[%A+C ,?>!
MTPADQRE-EH<D '/K4O ZP.^4PKC)C&'.6_47.'M&<#;#PUX%SFX+9Q<4TFH7
M(HT!,>Q)/G-ND4Z ;I%H0PVC)ABRM,SKAHHZ-M-J;/FP</:T9G9=/Z[M[<;*
MWQMO-[8WUK=J*\VUVM;VYNK_^]_-MVOK'[:J.9GJ56W]_<>-[9W[C/,:DQ,#
M883N<=Z!N_]$MTGC\@>XQ>=P O!LH-O;EG6M=M64O!P"?"K9Z?.NVT?V)#>&
MO4\$_]2XUG6/^&08U4R;A[\;*E<Y1W\7AK4W'C!:315S-@]%4AYQ+1T$C%8A
MT%$2X7]M5)EAD;HB3[#]9T&C)XI&,VV#7M#H?FAT$>\1$9S"2B,3@T6<IH"L
MQAKQB DSBB2=QQ@P45>XC%9Y5)+7.XZAUKY@\*78\;&)49;(6$A5T.@N:/1U
MG!MQJKF*DB"'(T,<W 8R7D@4N(Q8:F.=S).>, =R=.\>0Z6^<7Y->%9LHICP
M=$QX[*AE,MABIQ$VAB">!$;6VH2$3U%Z:D%J:CA31>)Y,N'GEC;ZN:G#&+.H
MG_<S/>KVLEA*E>,<=7<X@ZN3 E9W *N#2WVDB%*!F6B1X3@ASH5"3GF/L##6
M1F4,*._2,C%U2N>I8*J4.RXBW2AF/%TS'DMB9%%IL&!#8AYY8!VRS.?8(7DL
M(Q-:23!C4N?ZWN<H2A+CS@:Y%MU@.MSB6<1 ,^$66_L@ANW8._S;=KZ^[<*3
MK71"LSN(9SG6@DNWPJ5+W:,P9\J$Z!".R2%.\HQ8F=M4:D4X@))*-N;SY(S<
M.[=:DAGS:\@S81?%D*=NR&.-(4A42D>!/#4852-C+2$16<^E%82E2-/\&?)4
M4QILSLG%:K=3W4ZN]NIDM:_.9Y94QGS1C3$IC6-3B8'N E&7^DU9Y82(7"!E
MA0>ND3RRUGBDE*'"2? SR2PM,\+JY/YYUY++F%\[G@G;*'8\73N^H!HB42HE
MT4AZQO,6*$9:6(U\P-%%)9UG/MLQK2M2FF(_=E.(,W91ZC+FA6%4<BE;NO>$
MI,M]IX+G3C 'T4^N# L6(\N<1$%XZIBQT9N0JS+F; YER6,L(K,H]CLE^[V@
M%$QJ'(%.(.RC ?O%U=A&ARB/40$2,YURC:>>QO3Z>4U?+$9;B&G1B:MGX? +
M<<LCU@L-53.A&@6E[HE2EUI/6<,]L48CAZ5$W$J&=-(>X3Q;DA%%#%5+RXK@
M.CB8Z<^7_*6!+%!RX_G:_$SH2;'Y^]O\6,,J(R/#CB+E\QAIQCPRS%L4C<*)
M!<FD4KEA%:MC,ZUDQT/;_',X4'XQ4K8<*7^"M<$W[:6U8[]?-M3FBH..B2H;
M92X *)O^=W9..^.$5%HNG$H$69L/:CM+D3%8Y7\,$YX+H7'>]-=2U.7]QT:5
M/;7Y->59[ZD54YZ&*8\=2HHF$.4-BI@[Q)6A2#O!44Q"$Z*M\?E04C9E4I=Z
MGH8Q/;=MM0MF&:IJX:E1CF>1H9]-VFL$3E6180&GNX"3'^<9T0LG9.)(.1,!
MG&RN$J8)>8R=DMIC%=+2,B5USLI,ER=LO+/)7Q7CG8+Q7C +;V)4U=YX8 ;Q
M/&/66"\1%HDDQT1@+L]DHG7&I]4L<^[VUA: 5OP\PF5*&VQ/&Y >I5ZG3(*X
M(RQ=:C+''3..6(:L=L I$F5(8V41ED3C&$**02XM<R;K0I>3S4_8AA^E9J?8
M\-UM^():.$$#!?Z06Q)0Q#'\8[$/"(@&=2H)H:5;6A9D&M2B9"P>II%*25_,
M'^&XO@U#P:P[8M:E!FZ1Z(A%9 AS >$0C1CI:#B$0X%'K9B*-$_0EK1NQ+UY
M1TEFS*\I/V9'E6+*=S?EL8-(7%#C!$,Q48XXH0FY%"VB25F,E:!$YJ8JE-3A
MESDRY6=8-ES*A1>!>(P%2 67;H-+IY=[MEGI(/[1B)%\FH%ICUQP AGG5=2>
M$YWR <DZ,;*N^:)4#99*X:=&3HJYW\/<QTJ$7208_D'81H^X-;FM&Y;($&(H
M]<X#4B\MT[K4IB[XM'*9I4AX&E6DAX>MP6',LXEL)U0F"/<>.QY,HO9'KFVJ
M$?[G-*N&'\;C_^BW7G9:[?]9&O2.X]6JK?.G7.F$U?%G+,8^@;%?:I@F,%':
M*H:<%!IQQ0BRN9NCB)%9CGW0N<_2%1N?FVKQAW%!1?\>5O_&4N[&JX AR-4B
M),2EU,A(#;['*6ZQH48K?J/^/:TQD]=C^M:@Z[_N=]O@'/OG8R7_<]P:G-SM
M],>D=/8QKS%K7QU:W\ZN/;H$RN]_24BU&?)(DG_7BRGV>C%S)]"!>NV_?H5V
M[V)O:]_VXE3B[(WFZY]1[_QN*H5\9WN;O:V!'<3PR;:/X\6WCW@W+E X 10V
M!HW5$11N&;S[[WWL#S]U[&=SO'FPWVZ^V2";V^U#^"S>.?T S^'%YG;C=!>N
MT3CX>K*YMD*;:^_)OT\W?GSABIK@.45>48NX(!$9JB("_TV3\2QQKW[M+V_0
MH+N%;D6#%DZ#G(@"6\H0$1%<<5 ":4LURK&@5Q)[S, 5XQ?XZEGP*W^H'=E>
M[5N6:VWE>+#?[0'NA<I]T5<WZF _R[\_/?6[1>K@LFY6BMB_N/&BDX^BD^_)
M%QE"\M()Q&3*5551(\TC1Y@!7;2,@FKX7Z#:M1IU#Y=8-&KA-4I[:CW#"07"
M!>(X&&0PN$V0?PS28ALB6UH6=>!V^?\G@+JADM5:_7Z>%YCS+MWC07\ /P"1
MO!/F34E#4^M'#.@T]KJ3*.=&=?]%,1]%,3W_ CR-ND $HE5=>\K'8#'+/=]4
M;FG/F.3VME W)>=9%&F1% E<)79!Y0,2!*-<!(2T401Q24 )+$0&D2^$(FU>
MP&C1IL?2)B\UIXQ1Q#QSH$VY%66D'A'O"#%6JB#-(S&PHDT+ITU1:PP,#&+,
M*(!]>:N0R_\0[@!6$M!Z&Y:6.]W?TZ[)B9D=U+;BT2 >NM@;[DTR7*]E#:O(
MVEKTXR^1ZB5\GEL-K6^EVO"AZG<FM> J0U2L]K96>['-ES#!.4&((&H.B L5
MD!4*+!!B:XN%499!U',6K,Q/:6&I$I[+0IQBMP]JMQ?;HSA2IR)GR% C(2@$
M+F]B4"CP8 SAC'@0U!S:[:QW9N=S!R]7"G0[]]F^F]KFR_!6RL[+].ST_<VL
M^'"=[L"S;J[M_6ANOR>-M???X3[W80V^PYI];;[Y=-@XV#MI'OC3?Y^N\R\V
M"@Z2IDAI,'6(TSERVAHD3?#>4:J5IG?:NYO:[F]1GSE6'V>Q<E8*1+VRB%.(
MK'2P C&6A"*21,73[#?N9K/-,J:898]E+A3R_<F70)CT 0-KP39!E&\,TEQ3
MQ(&[<,TIQ""_JD5XQ'W@HD[SJ$Z)&^=E1$J$C&_,(L-%;MS%G7?2&!4!W_AP
MPV[1-^UNJZ EK?G8&NK)%TD=3RQYE"(5B!-,D?4.U)1PX4,"E1"/E22_K3Z5
MW;O'527M%"=!!!1-GD:80)5T" FEP*4T4H-*Y<:IBM8IIW5EKC8HO IV&=X6
MPML6,'ML#=P[^6*ILH;F)E95%^X8-'+42B0<@1=TY!0_UOYQ ;,%4R5 *RF"
M0=30?'*8)&3R06)K":6.4(P# S 3I@ZLK@Y^<WYW]9Y%[[(9#5 XM]++^P/E
MK.Z$YCDVPBLR3;4'XJDX1-K8..0\!>B6P<-_$\@MY#;KBK(Y:EA6>@[.Y:Y>
ML=L'MMNQ :'6<I]41"H7P_ <.H(5,^0#&*UW/H) L]T*4T8C/)X%KL!MYR6W
M[=J1;074ZM2\/6H-;+MT%'Q4"G$AF'<@EXW.ZE J8PA5P.E6X/1QG%0$RJQG
M#*-DA(4 $*B[H1 %6F*%30P[K%,^(J&5K$O.YZCLH)0++2*Q*-8\?6N^H!J
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MP,(IL@9^$@'3X%F4EA0'_PSL?;99AV+OL[3W<0<O$XDX&8$,3T#H<_]"*Z-
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M\Q,UYT>JKBKF/"US'G/..CD)9 NX=35$@6%DDHJ(4$E,%#X%87.599WIJSF
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M<R:WW.F9NS7XKP=Z^/EVYPM0OP?*66:>W-&+O[^4.G-,6.8LHL% I.TX03:
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M5B;.BEV<!W0HP4KK@.OH@D663:JGA@V\#Q>\_0G2-62OC.R%$)W,RJ%7H(1
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MTV?>V5B[7B<$3$Z#0U6 S47M9N\M2[D-/WW0&.Y1)*\!?!T OQ#*(R$+E)D
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M__4?ZLW;<GWE.O=?'_RQ6Z[MUT^!O7G]A]P5S\O__S/O/?W-*I=<G;\C7?2
M*EN@1!:435D&:] QO[5='-;+#:_O+RYRLT>^/&J#[AG[BRX@MV+?.WSKHZI9
M^R>-3VCR<<"[@C6VAH*UQUF29H,2SG)M3$A(UM:$_)RTUY[EG)BMW,T=%Y*W
MDK0^,/KH-&NC,/IO(>I4GF$+1A,!>L. HDC@+7,:*0C-W-8V1S/40@VU6[G
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M2SE)BT*&\I3[8)DQQJO(G3KMEK]B,4>;R[LVGOK78L4&<U)XZQ4P(VLG61;
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MFIF:F9J9-LA,R_0 $SH4/46<22X0(SF;>$9G(E/::7(WT,-M!.?=2N,_SON
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M#7+ \NB"BRP#%ZC06V0D95>^Z7HR(JZ=ESTT?=&0O *2%^)6A863L@8*+UM
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M.'9IQM(Z'F2L_J]."H;38+Q-4G)#A3- @QU/.N@DM0B'0)@.LNAG!^U5AGG
MSW_]8C?FU_?B,LR*Y(-+H+I2 K?_9_/50>OMJYWMO5?;;UNO]M_\M?]F\V!G
M?V_IAP[S#%*<.Q+ ;P7-;':6WX[@/_5)75B,[%K_D4OV+OWS_+1Y JA>-8T<
M'??/X%IAV$) (NQ9Z,"C_7P56EQ&O@SQ5\,>/%@!Z"FZ%IL #]BUI\/XZ_B7
MWT)G>-JUY[]V>F68Y4N_S0-KQO$+!J'<KWI["C_KN(*@.I!3W[E^>[V\=<'
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M];^PYNY35KTM5_RU ^2[XV]0!_?@.+:L]]51@)SUW^N/X'X6"#L,KP.#/QH
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MVGK6K?5DDILPG*A(U>]WF.4CPW4,1< 6344MK:WA<<R'M4:+U"K3LR++\!S
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MA&5[ F7+L<Y;T8U*4ALAO[7*'V6?!9R^SW$P'(?J2G?'UGZ]\?S3\,R-^J<
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M;_-RW.\"" ZKT-BD')]\83L.>]\^B;W7AXQ&SX3&R& 3$">:(>LT1\18')0
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M'EML?L3R7$*6_TRK7[QL>'E-]U\?JL #P=RB:)G,'18#TB$PY#@!ZDA(HBH
MO*PO:J\R(SJYH,4@5(QD:G1FBHV,Z?(DL8']*&&>9T-C8S?9>JM2IJ_<$VSG
M3[8G.=+EJ'>U\W@;$38D14TBB3A1H-C21..I(,$0$JQW/(LP"/'=D._5=.PE
M&O^7/<^[(*^JH;]@P84K'1T&0FP0A"&J-8 >PP3(M54(W.PD.([8>P?NG5IG
MUTAN2<];(";=THYXM63E/_W>T4$<G,S*S L6%G\.GIA-B0=G&6+"1<1Q)E$"
M2P3VTD7F@F5,@+!PO+ZH<\NB(/.].>O,8!$2SRVM#&?&6$<<N(D\@'L@P;HO
M%I/&'[NKB&1#B&G2GH(7EG?S$!?.(&#8#@FM(R.6>QTXB C!UP'*0SCK%LPJ
MII$ESPP'7U%C,*'<FY"H]R&R1C@>3#B.O@)^, W3;HE!DG(P-A;<,2>L0!83
MK0B&56%@;)2ZCF$_Y([$H]B9QD^_2D0HB$@@X(Q3H1"C8%VX-0K\=! 60D3R
M/H&B*KVV0;A<QX_NJ#^J:#2.^E4R\NG+[M&AD$I;BS7"CC+$.8O(2>^0#$IY
MA8&'2 4RPL1U >%'\M1_7&X:3_U>A8?N?CET%CQR)P)*+E>-Y9XBRXQ#2@O#
M U,FA) #QM<& F_FJO\Q5S;K^\45<'NFHOPXO_B[9XWGJE_/E!0;2VK(\'<;
M4:44*\55HD0)SL!>2QD-X<"2$N=.V;JEIEK44O-V6#?.IJY$=;MZY!<MHP?;
M7W8W#QW,.X%%0(1JD[?E/=(RX7R$V'BA'.$Q]^LUZ^0ZIWQ:R*NJM3[G=%W(
M&9]/0V]/DM#;5V3"MV=*I=;G]4:K(W4U,-8"]WLU_!<L=#OG>T>'C&J2,X41
M>,H:@)%D7HXQ4MB")^U(5#8SKVMM:BD-&*LBFM/#<NW2[\+7953+D;KV+03F
MKSAXFR]SOX)#+XK&=GW(;WR[K6JD$]' +T\T^-[K0Q*33TI[1+57B&M;-L\X
MLEIQ;&+2IK0?7;[UR_UW_$M?/:%#XLXGY%.N12&909H28,_!20PO&4_2V@9>
M)Y<9SZ47I@H]I38W*!NU!,Q&>>*HIS$P+'FPP@A.088M45[&X.UUS<(;9G-'
M6=S-:<K@]0"6$(^2H;F  8 (^$()&9MTL#%HRLL^V;6[#0]%;&Z=IGAWL?H1
M)V]SYA'W4WV*I'?T*C_"9B]LC1_VQ<K;[K<=L;_U[MO>UI$HG>F/#F722LDL
M;"I0!)1&(&#2&&%#8%T<CAJ;')J^/D.^*G'[I9PHG@29YJ/5B\]7WD:Z$M$4
MX-E;I3 '(^NT598P@ADW2@7V0-*5#XD._U.*H._WMN>>8#_E.BB-6%5B1?8W
M#V.B&L<0D=(J![6]15IXGW_+R6DJ"0SDB-/K]L3J<OZ]>*%QT9-+T"T$YRI9
MV2Q9!(W$5!+#P;VG3!+)$D$D !IQ0ABRDEID V'1.\XQ2SD$A:^-<<\<9@>Y
M@ 44I?A .:A^?^[Y$]FXQD^_2*'>L_W7AX;;%&B4*%+.$0\4@Q^F*?)..)+7
M@R1RSW[ZV+#]L)]^1PFB,P+4.'S?DQ#_#2R28XX[E@Q*R6>232FRPDE$$I72
M,NZ%,#_DKC_:,C9QEVHA-?8N.@Z>>]*PD. W:9H\$%@5L01^P0+.GCOFM_+<
MKR@A^J@U1"^N=E,R=/?CI\/ ! ''1"+)\\:4S"=XA<5($Q\ \JVSW*U$"= ]
M,"K9>6C!^K;* J]@(:1B2.;M(["1DUQSL-1^^U)*"HUR7;)>91?AL3JA:E5?
M?ZFNNU6W2QE_?28K*'^M-*DO=\[5<#['@3V*<[>:KSXUTPYPW 3P]XL&^PJS
MGFOXE H[H(B3TGJEG>Q<9:OI"$MA)6"6<;YF<OPZ[KU5E0$Z;U6%\$8=5&Z>
MLXXOQ&:NJJ=5-=BZIL/+PX+06W\<PUDW[J=-&/UX\-/>R]OUD_XQZ)_DX9^-
MZF#+1?1ZT;CU;><P86$3D1P)F2@"0D 14%2%!%;"47!_B;O4_2%ZC)7$F$LE
M.4O:2<FCTL$(0AU1Y'8XMRR8<5#Z,N<,DJK'0:ZP4_4 *S'&C /SBCWI77>Q
MV["?"EP)8"[6Z[$N%UW\4EJ\%6VUO0M:69\%"&>39+E*":M":=8?UWCRZR6P
MWOC7J(Q]4N]J -B%8%*[]G08?QW_\EOH#$^[]OS73J],3?G2;_.KE2MKE01K
MH'5UV9JR=M7;TWI0Z[BJ"34:P+]A?.?Z[?7RUB^C</D]1=:-,0O?QNOD!]\3
M;/%-O_?-[PV6D'5)5FFPE-[HLK^45:M6#H0C2]/_M\;6IJ7"0K8VO^(6*9HZ
MOMZ/?-1<^B@]_9H_?$4]M0MR5XG<?2.%OHXA%;F>VQ^;Z-LMYNZ*I^S&=$FW
MGO(9?]HIQ5W/X!)A^//<0]Y9+FH(&O5/L[2?CEIEW[ U?J:5DH7,3VXP.S=\
MY)<W>?@V^N.L_W0TZ)_U JI'Z'T$R_C;=R;E>S/R>$IW/06ID*4B%A.^<<6>
M@O7 [*M*E<-<KO0FPK=HVJX5.WI_4X];5RS (#_[4JW PK!:Q?DNUA;Q =P5
M+7$TBINHC HX68X]9M@:S:]T9&9"Z^S2QO#=G)D+FS5L-7V:X_<G7[O[']_S
MW8]'7W>_?6*[?[[C,$X,USC>_;:+/_RY=[R_M8/WMC;I^X\[>/P=N-?9!_I.
MPOW/][>VO^T?^"\?#O+&S6OPB[;!WWGS"7P@N"Y<:^M#9_?CF[3;P>?_.=@>
M[;[%7P\)]DI(%Q!.,2&N4D!&Y9I;)+ H;126NK4-ON@8\$5=O$?8*MJ#;ZX[
M#1P\ 1Q(IT%NK$J1$IYW;FV0.N+ "0-$N'ZWMH&#98 #/($#865@UA$D";&Y
M+(!%5A&%#+7<TJ"#,GFO3BPZ[[9L>'!K>I7*_U::0IV=EC2>./"=NAU)B8]6
M]12&/\2>+LS*#\'E%3/[+"$Q!J6YT\;D^M:2<&MD@/$Y'Q1CSM ;,*3;Y-4U
M>/G8>'D^0Y^XQQ%'(I!WP0%I4M5>)PH&%IX'[@26X/6UF5Z4&7-CQ+P:F1Z4
M)35J?W.UMTY(K$)0U @NJ7?:&ZPE25YQ%F*Z 1-JU'ZYU7Y*DS3AC BAD8[$
M(_"'([)$!,1=LE111[C+%1[;G"[*H7P*M?_16-/*DZ&\0S6(W?%1Z'S.8=#Q
MU:F-3(WLE]SS\:GC2L\>(D5*F"C&103]B5B#LJA\ MX);0CUJF%&JPV1>Z]F
MF!$.CD4*5$A@HQ%/W.:</H9\=#YZ3KRD:6V#MQE>5.?TMK[DBL:/GKW:!^68
ME5I%T&F>" .BI"R-1EE.)3&D848KK_939D2T)\(S@S!A&.7ESD4 *').&A<\
M5ISGPR5MS.XKI-R$B>Z/&9W&05&U?+JP2M?)JMW$C!X\9L0L483&$*GAU'FM
ML'"4:1(#=R'J9E=M^5'P[0SYL<JR7#<)!<$XXMI19*.SB.2&89*IA)U<V]!R
MT:GA)BCT//2:,.49SGT-O>$J!"N\9DGC[/0HK$.S/;8*>CUE-RK*$!/+!Y4X
M!;T&]T:#2UM^4,REC8RN;0"I72*]?K%1GZJX\[!.2;Y4ZKD)]SPP^#FIC!=8
M<F8LY\PY&K",)CK%DN+LZC,/C=^W.L@XFT>$7=3*,(&$L QQ0@4RP3.D6'"<
MDJ2<23G]L0WF<(D<OT;O'R+>0XVR5!MA--<B.S!<^R@\P4*G)M[S#/1^RHAX
M$D%0[5&2AB >0>^MX 9%PER"=X3.?4263N_O&O"Y2=KZ0WI.==Y4?4J)P2R$
M_EFF-F,P>-%9B3]TVK)!H-5!H-D4',JU8;EXA),I(LY$0,YKP"(<A"9&"APS
M\U!M@^\KW')OVK="L9H&<;Z'.%B#"$9,O H6!$^YF!@QU#IIF2 W"O0TB+/<
MB#/E/"DXI@2!I:3 =#BS&FG*,$HL)(X%2R+*@CA A)X+XA3"]$LY(GU%68SZ
M#B@'ALJ!]KD3[N@)C[@?SOWO^_4;+E6968U'_->%85?:#(XWE9@:'+3F1AHK
ME;?2!IIX$$';BQ4.B(@\)@K>>B3<.NVL#H8;#^:589]-Z-7WN;XRPOQ]E&4.
M<-%%10*G6%GC=4Z6YBHY!SQM;:,<\;NT%%>\4JWEXT_Y;W.R(-<9+VM_Y?3\
MZ+1>/TU;T\(JH^/.(+3^[YD=C.*@+JQ'VG-%&W)H-(:\UUNJ%8_ZK5S2)>--
MW36Q%/\L55H&\7.G?S;LGK=\MY]KJ,T<P,P7_[O3/^GX83N7[%MO_91KI%#\
M6_UJ^8O\]O-ZZZ!L+9_83J_T)!F'9NM!50,9MRR^]IY_V8$-G:.3UE;''O7Z
MP]'E 8P_,AG!382H=8M*/[5Z;_S+#7[9N/R]LFPYYY\&XVT"-3!4N+SWXWC2
M(5>J%^&0\;7;W.RQ2R']1']N/7 =FS?Q<P0TJ%A*;Y3MXC^=T?&KLR$\>QPL
M2W6:O5=C5I(92/?3AZUW7_;_V3[?/W@#G]G-KW7VMC(K^?#IPS\?3O:VCKY>
MJDZS==S=_^?-I[V#3?'^8$? />CNM_S:#L[5:3Z<O.E^.(%Q;/V1=C_NT+W-
M0R>9UP%S9&.N7&^3!6Y!%:( !8%Z+ +%%R&5^I"D)PPSXCEQTG&'G<AMW5,2
MS/F+Q6G>;/^]O?=NNW79 *Y<U:NKP?/Z"9F?0.E%I-9JK\"&:2JL429X&U3(
M/W/_OX,K:D(-*D'.E:I.!T#3!_!XK:/8RZ7?JPI;'4#5K@5J9D?]P7EK%(>E
M/Q,\Z^>.ATD  M_M?"OP")]\!7-V!!@>VJW]GN^/SD]C:^M_JIK?K_;_WME"
MQ)1K#"MPG5PFY^GD CS=F.];]KYF<GILZQ2F!M9I,O!\C7&]JQJ "WO, SF.
MMCLZ]OF2IX/^YPZ\O-YJ+;:^EV2E7AY.UU4NGG/:KT#\UP+XX*],:^;\/_-E
MDFKIPM.O6 <D]FRT^"N+Y'*N^L.22&IN5C!'/F=^'@^F+/,H(C>(]A.R"4;_
MJ^U^L>?#M5_FGQL>NKZX!%]@X?S<_-%3>CBV5$81<N>I(CJ_@G<3!_E3,!R[
M-&-I'0^RA?NOZTVX C@H5 :4*UNP7''N7[_8Q2IQ22:?R+AO_\_FJX/6VU<[
MVWNOMM\"IKSY:__-YL'._M[2#[T4B<Y@]6K2?>/5;/>-NJ& [;;>COMP#&]M
MSI;@.7]ZU[-GH0./]/-5<'&EM;O>>BV-+2]7_#6W2>[X&V#F5F=HCXX&\6A2
M6*XFCX]9_'5^$/NI'D*!@!=-5E\?8J<8MIZC5#H)<"F0\;G-)64\MQ2(F.CG
M4!FQ*B<(3NJP5!>]JD!H30:'N6W+6%PJ$CBFB</^V<#'E:Y6R,4Z-GJ%"@"N
M5+7"9K /5@=2W'L=R*N ZK$*0UZ\]9(4N*N!,[>-W>V7YFK;EYNKW4==Q><R
M5WNY#]T-I^I9U-FD2U]G<YG%9?4*;R[Y;.)&^!KA6P[A>\%E8,N$O/5 &_)&
MX8.>RKBG";W+]9LQKO 8[^F8>$G 44NND;LQ=,HVT%]V,!JV?F_]+WMR^EOK
MU4.<!;_S.=%EFKT26OGONYSTNT5NUE)E1EYNQ$B#MRD0)BV7G$MFB79)!66Q
MM<X35X=?U?TD8E^365#E1\(D;^8V(L,8#NS7I4F"_,$(;IT$^>[;[C\Y$?+?
MGW8I?#Z/\Y]W'#[U:??/;;S_SR[>_?9.O/\8/EY*@CS8_?KAX]$YC//;AS_?
MD[VM?W<_'!R?O*>OO[P_@+%_>_UM+]^;[LU7/E11Y<J_'%D9(N+$!:2I5,@Z
MR72N@&F#7=L@1+:Q7M39<86/N3>0]4PA2S-E0N[X3H7@*5E'- ^1&663,C+P
M.I-;W4\F=P-9#PY9T[QM29SRTFL4O%:(4\^0M?G,2/*:.BFCP'1MP^BVYG>N
M;]T@5H-8CX187FAB.;&4:L]M5#9*%AB/EE,"GDZXW]-N#6(].&+1Z:GZ7&Y$
M.(-$(5G>4^2(E8A$%AGV(07EUS88-6W,+K?4;2"K@:SEA"Q@5E@*8J,Q MB5
MT=IZ;H!T18\](-7]'I=K(.O!(8M/((MQ#6Z^(2@$\ 8YCPQIASGR7 B#F0B)
M V11(=M"/\,R22L1VWO5/SG)[4%L=T6*(#W-7LXMSB#<$/=($N44'I'*<N:X
M"XQY+)BPEG$51!,/6R7<FZMWG?,=>:0<2:SRP1VFD?9&(!:)MX9SHHC(G9-(
MF]Y;-[7G70'IN2A],,E+:QT/+!_?5#99G4*,H.>66XF;B-***?TTHN2HXU$G
MCA15N?L'^&>&*H8H,\; NEM)&"@]EFV,::/T+TCIK< "O'/N0:]Y"$I;(GS
M*D@7/4_WW 6L4?H'5_II4,8&+D,4!&E.1%9Z@30+"5D+-(Y8('.YYQ<GIDWE
MG7>^&J5?(:674@4NN!-<$\Z]UT#U N<6_%]XA=QSY<-&Z1]<Z:=AC<0%EIY8
ME-M>(PX+B[3C%'E,66+$&HR!WE.-VUR0)5+ZEY2RM#\ZCH,5Z57Q7"#/>\_
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MX883JQFC-%D;8Y#*-(6M5\QZO)Z-N!)"9*3$(2&<1]P3C@QQ"1D1G69*$V+
M>G AV^R^TWWNJ&!+WK^D@=@&8F].T(W$U"M"3<3<8VN#T8HE)14VU.,FH7+E
M('8FAJMI!)1D%JD0 N)..8!88I$-(F 70W(^'U'#NLWD?17>:2"V@=@&8N<.
MNFC+>)2>@E_,HV!6$$=H$KGJ1Z*<-4'AE8/8*8LUTD211$**$P(0RPQRR6-$
MO<$FVU,C^-H&:5/#VE3=<S)9 [(-R#8@6_?^8RQ%3+P*EN.@7$R,&&J=M$P0
MW5226SF0G0DT8PT+:KA#P1N3D_P)<M8ZE(*P@CK":<R'KMN8BC86]WR>\(E
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M<FY%8IPK$361EE"'C2$<@,**A:'V!#=_6BH%FPPF'M'D@."PX\AH19$)RM.
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MF2+B2@#*M6?(2F&1\YY+;JA6(624RU52RJL4E!=[S/*"?F:/(28D$6E$(MB
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M7!^E_"6==_BP]GZM<3" )O6KTB[V(/;]R6.ERWR>CM5;\)L,+"KEE*<D<D]
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M!*:DP,_"%%N%6_PVSFL+_@V=_];/>M0Z[@%<_.1W/]&8;-7%A?T%7G<V/%/
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M Y;(9Q#)8('<5AR_8PGPLDCN+6>T-\1N^\.W9GOO)#L1F@>?=#1$B11!\8E
M*$(%9"A+2! #PCO,DDU\91W_2.B86QS=O!3FV>."BO\5;FFX"")Y WX#<174
M_:G ,NC[;"J,)XUJ<76MAT=V^GG%Q>%_';AX? 3WY))$DX O>,[X:XS]<W8
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MJY)^]EQ1O*8-6R'C_93VZ-^.CHXZ)Y7=[\=XV.S6WZ9+[S!U.GK.&-5<"6W
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MT$9'SHF.+''.#9,V*DV5YM8F003W#7-945V>Q7N4X3[*()$+/"*NDT(&6XW
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MN?!MJ1(VAWS]'KQG?%9C:M]7Y?@J!<W#18!$K?AWG+BJ0LD(G/YR5E(#X56
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M;%)+]#_)&BQ0]?E*?+BJ2WA939\/^>6WS RY4FGS;'8R?RIF(VC/()%B54C
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MMQ4JY]$P\^I9_0TS/PDSS[P!#'ONG4_(*9%RAUF";)(< 0\;[X14*KJ&F5\
M,R\YI:)AYA_&S#-7 ="IT]9B% C6B$LFD*%<(*(35=(GE@)OF/D%,/,2W 5#
MF"]\NE?J0,/:2V;MF5/!$Q*5@?WRH%^!TJT(,@I[D-A8&"<]"Y*]>BWPFB9F
MA3C[)20)O.F7'K*+K5F:#(%GY$BXK9Y>M;\+E5<:)+L/DLV7<Q>Y$ZP'_422
M!$B6^RIJ!08(XSCQ:)*3AKQZ3=>$O-K5KHEH_#0,_&,.K#0,O"P&GKD,(E?:
M.>%0\C8B3KA#SOF #,YU?)GCCK&*@9L<@I^8@7_,&8R&@9?%P#,W@<8Z<*4"
MBB%0Q%VDR+J(D1%>) D[933+[06D^6Y3HF'@U67@'W.LH&'@93'PS!G 1=36
M<H6\H )Q9@TRC 5$!*A0%G.!G<L,C.5WE]-OD@SNQ7Y[_5'I.KS8I;6W>HD&
MWW6,[%D#WX^M#')-R=8&^>Z#?)<+@C"A@H\H::40]Y0CK:5%T2FEB=;:RY /
MC6+^W;;'\SHTVG#^ZC@=&LY?&N?/O Y4ND28M0A@&XP6+0AR0C(@J<1MD$EH
M)AK.;SA_)2I&-)S_W9P_<U=(S RA1"-&L[]1$H< QC6*H+J%I*V@'+]Z3>@:
M;%K#^@WK/VWYA(;UOYOUYXY2>.$L3P&![$\YU1@C9QQH_Q&T?>)Q(#2^>BW)
MFF;ZF;#^DC(BRKO5BGM#=NNV6*N5&/%RD7#I9146P*[L=X-V]T&[^4H*@5,)
M\BB'4Z4'18=JY!@E*-H4=*!41AL [=BR6@JNBI;3\/9JN#8:WEXV;\]576"!
M!$]I5F)$KI(2D0.5$]&(C:0&.-S;5Z\Y(PUO-[R]4LZ+AO$?P/ASR1:)<VPT
M$'/>'JZ$0P8##K#(9!14&J%"+NJKQ;)BM0WK_T2L_Z3.BX;U'\#Z,^\%)<+)
MS/I,FH0X)@$YK24*U!II+?,QY<HM:^+[NQ?\(-9_N2D<3]BRIN["R6#/0G^<
M\T?*?C9E@)>Q.#^-H%B";^<A1_XF$F.[Y_NGL98;[=CXO.\C-7;GRVLXP[C1
MWB,72,[.E0R92#G"VB3#P)8WE.9 M]1+KA3\G:ST/*JF-V#:@.D/<:8U8/IT
M8#ISNPEEB0E<@?8=3,X:PDB+7!9!$>(M]D(RG\&4JR7'#QLP;<"T =-E>2\;
M,'TZ,)VK1 M;EHB(* 1I 5$]1L8)B9(#' W"*NG2J]>$K1G>H&F#I@V:KJA#
MN$'3IT/3F7=898^M$AKIP%RN%4R0)CHAJI2)/"@J9,YM8VM,TY\"38OS^)\C
M"R^$OT/G[]>3:;7'I\ W_O5_PY>329S:P5&G5T9#Z 34.KT0>\ TNN#K#^94
M6KS#Q[$%2QEA&_Z.,R_QP(YBJ2X\@M^![T2KG<_XK>7/:O+9]D+^MZ[^G;FO
M7#XZ'L38.H57'P];$6886A_BV2B>NCBH]IGA\B R>0)NG<-K6S>B!O"RRX&;
M2\#A J9!XFC  .+*>Q#7V!D@#.9)%NS?<!#R143(F:W;O>%H,,[UO2;X\!X6
M8G,\ %KY"Q:X'Z;X@.CS!(AN_)_W\'TX<Y3+@T];_&#O\\4N@$)[[X\N,/;G
MW4];Y[N;?W;A7AC_%H!$^V3WTT%J?_W,=HX.G8;[A*1(":,1M\GD<C<824*T
MX 0[)10H3>ODJLKT7VOWW&)"K*-&<NN%Y8%AZU@4)&H"6C<#0[C9XN5O<?OH
M4'BC**4<&<8!R8VFH!<K@H@P*NB(#<;NU6N\+J_=XLS3]]MF(73@(/$%9X[K
M0%S0U+(( &4] TV\V>:E;S-O;QQB&0TW">P=BAGB(3)DD]6(V&AE5,*9Z,LV
M7XWF_M<#=IEXF227(8&6QX&&'..4$"R"9J#N,?T-'V2SR_??9;'S[E HSZEA
M$;&(!>*"*J2Q%\AX0H+%/)$DEX775#C0S"SAVE,.>KP3&CA9<!ZQ]TI^R\W<
M;/$#MK@-6RR9T"(0)%D$O/8Z:][,(^:YQ,&Z"!;6,O%:TFB4=%8IK+B/QID4
MF<7> &+S8)IM7O(V[VYNG.^<'V+N>(H\(2\ERR53-7(>4Z0UZ$4,FY2TO FO
MUUJPI&>5EM^]6&\]@MK? ]OB\;5^0!,)J@*5S%+.:;089!:8F2Z(Y .+WW"^
M-K1W;]J#:]X=&B^-2E8BX0- #-A;"!@^Y$K<&C,?%)9I65+$)YZ4%"(%C;F5
MTAJMB8L>\(7!+[[9XN5O\>Z[0QRH%PK40<!T#%*$Y>P^#EH_H<P['%(B%;Q<
MK4?P("F"@]$X8;#: ^&1>L=2\,1(+T1,D;IFFY>^S;A]?NA(H%0HBJ()'O1!
M+Y%.PB"&?0I1L<1SM<NE:?V): JJIL_* C=4.VV5)8Q@!@),!?8-]VZSR_??
M90*VG3+:"4\] G$)NVQX!*U?4H2CDXH)QP@M7AIZ]7S.O?$Z.V.8%+#)RG+C
MD^4:*(K19"D-P>EFBY>_Q;L;AS'[QC0H@8+E C(X@4WGC,F?%&QZC)CK96K]
MV,B$N=)"ZLA!XW16:$92$CYA4#U=L\U+WV;:/CKT1AJPMQRRQA'$93#(*:40
MM3B'RK3 I#+NKIZBO5;K'\13VP%=_:AU5A:XU?\[#EKGQQU_7-3X,>Q2::4)
M"GR +6J%NH]FZ[S3[;9<?H+O'_7*!7;8@A<B;X?'5XL$=H83"JOC(4O0Y.<B
M?&@8_:]A/+B(=G [;;V9E2I\/YG]I#OH?-_0BN+(BZ.S;0%Z@0_2<1<5DD21
M7 7;(&-]0L8+0XB0BCC_ZC5;9W@QRK5VZS8_2)MOMOD1MGGG?.?=812&2D4%
MP(GGB%.9D"/&HL ,F'(&DV#PJ]=BG<NKVSPG,Z[=Z@=I],U6/\I6@T%G'(LJ
M.(R"\PHT_6B1!7F,:$K>I,"L5:#IRW5.%[>ZE7=@YMFYFR-H0=A,8_G3P'BF
ME4YO7#;FNM!X'<:_+3K^^K_=X)^O+S\Z/ZAL;PJ&TV"\35*"J2&<D20YGG30
M26H1#B5Y-7_3C6]_]%"\NC84_PO!_[B5OQZ4>#A7M?I?'0^"&5AEXV@02\?@
MS#/=_G \B'OPEM^[??_Y:7F%[DQXY60#[]!W%_MT2QR<')RV]^#^TQW1/OVS
MT_ZT@P_VMK_L;'Z\V/G:/5[DE9W-=U\/-O\\*>DNI_NDO=GM['_]3/=/X;U?
MWW=W3K;.VWO;7W<__9':<"W HE/,1D<24IHEQ"-6(/@X1B)B29SA2LDZ<0DH
M.(:-#%A.2*JLMS8IPC7@F^"4ZFS[2%!K*"B\$737,UA]0*WXZO6_MM]LM3]L
MM3;:FZTWN__ZU\;ON^\W]K9WVZV-M^^WMG:VVGL?KF207"+U!2:J=NK;P[@\
M; _J8ZX]B3478*DYK1*(>&>BH@#:R;YZ(&\^1>;*F_XIO/FBU2V4#<_V(!5
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MQN5>6.S\')M2IYM=%\.UVA\!$^Q5_JJ\),,Q6'+%6U*9[+"\8*O%V?*TLBX
M%[K:HECP?\ULK&=H8FW/K*.\UL4[.:'XJ5$U[XC,/TQ\-C?;J+6SLV:&X:7'
M%?:O3=]+*G/M7+U>G[;#80>4XXP?9[75/QG.59*8N9[F@AA S'8 \SN:A#&V
M%_VW]:B!(?ISEF1QP]B_;:=;%(X)M\,\A]EAV2W69C71BJ#FACHQ*OZT("V
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M?4F=LX@RQA''.B%G94)@'E$AN-,VG\O@>)W? BB[E=;34,1SIPC2/EH&12Q
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MSY/N&+:./3)=KW\@'6#V[W3S7%_TUOXYO6Y8=#FX .2]<G]NO_00'H\I\EF
M#M#IYM3R#F2)[\9OP73TRLPE 4X!U><_&L"6C#AE=1""*<*-$C@8%J2304CN
MCC)@S;RD:B<D[Z/6E%<@U)O3YSM[#),T^>@D.%?Q+B?!G?_=>K^??'V_NU-_
MO_,U>;_WY:^]+UO[NWOUE9]ZO=.'P?J=N.$N]NIR\56N4>1Q51\:;=VV#=U,
MOO;AC>FJD+>H%+PJZ_SM6UL/7 .6]/LBN%@H28)2TNE,!)GJ>(FM!+76<8P%
MT9E6;*3YEVK%$OKG7!\0NC?H[X6)\HI775WF7+0/,_FS"9; RU3YF_Z_OUP<
M?G=GAC!1)P>_X+?IX<?=7_7O]1_UCSMI[?(8YEG#-;*#:]L'O^K[W_CA_H=0
MVS]F>UM'&<Z<DU0BEL4"0]98I*0,2$K#O+16:A+6$@]VT5EDQ^[ WTX$/K_
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M+RSUBF:2^]@SW+A ,QLTH\(0K.UR;R@J&3M#2\?GM?,C GRON+5(IHXCEJF
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MCEU\WJ8B,P(C(3A&C#",C& 422^\=2G62LJU3<(W\+)NGU\)\MYEC"4N^44
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M[9V+>FOGU^'VP:_ZZ9\@K _2 Q+W+-<H@R,DM88C0ZP  S*52%-AD<586F&
MN+RXN@WB0TS(BO^?W81\BF;(%0(\$@)<J;+7]N%[VY_3V."@OKW+ZA]WTD,8
MI[:_=0%SI8?;6VG]\ANM?<_3OF207%LB$0VQB;)D*=)8IXABKT2\ P?9<C<$
M>(W- N:N8*^K5KNZ2UQ<Z_'&VHVS)?%B4(263FD=F G$9%IJ$HC+O"#*X*N>
M<W,IO>GGQ$E09Q@C,7XGPTK20&!Z0LM42RY*%72^$/C++ U^WVV]>9MBM;^(
MV[I]D;B&2]J=?M( /([5^6+9R[-AV<N\%4@OR0O8)K&$.(R3)M<6R9PH+M[/
MRVC=HKHX3C38N%$DK2==WXO2H/'3-R\6E(E>4#CZSB58Y\LM;O[+=/^Y.3]0
MOI\WU^JE:[=Z^G.5>\7L][+/S./6)P62:C7Z>5G<K;9[GQ_2L6_;AN]M-WJV
MV>D-NJM3<O2B%.NMS[]J'W<N#O9W.8AJ5M__TH!G,1#O%_7O-5Z_;)["<W#]
M=(?,BM;#[9WS@_U/H (T050?8U #2)$M!,\%T;KWO<8.3[^1VOYA@+FD]>,C
MS8410E+$F2'Q"E$@HU*'N%1:6&.-"6*N 0(<"V"B89)CENH@#<XP35UFN9'.
MV-F2H^_W:K7=_=I.??]KLE7?3M[OU?=W0>S7W^_N?+T^>FAQCX(;GS\]7Y]I
MJXC'!.B1&9E)"K3E<]5!I"(U*UK[]]\>0*PWMQ]/4M#WO>Z=?&AVSK\.SLZ:
MN0*MFV.>6;%BO<_!.>='F<%8.6)1J@(HIEE@2'GL$5'P!LEDIE+\,HOO3AXZ
MR./AJ<<JO!;H(@E &$FC75AFD2OS-@<Q9:Z3R]E2E.<Z>?9'K_A1E*A NJCX
M1Q2HC3X <7+>B/V38B.FG-R3V!Y$]\KZO;T77;<WPQM*O?GJLH\U64*JZK*K
M6D+U62L*WF[5O^W&0N&= 0SA;I7=^T9+3585.I^Q0N<]=V3E[HVC.IF<:9@Z
M* V);L%2^[%4OVT.(MZ4-?M;H & GC%LNY@K!$FSH4V,GP!=X=US7SA7%2M?
M06[&WIF/?9#:QV-E%M3-;J>5=$:?-*=-KR6&'MYE5U]H ^_1-I&[$5%V]^:_
M*W4%-NBYM268Y./[+T3OU%=U1-BYXZ"\Y.J-+J[HRS33BWNK5HV 27Z>%UX[
M_7Q9C_\GGUEM'_Z.W]_^\J.^_ZE9;WUJSMY;'5P>I >G?S9C&9WZ-HRS7:.'
MV\>_\DZI8-;7/W[&M=8W<M#Z.Y;AN1@UTC86#DQRC!3!,5C,*:2<HPA'+RO&
M5.'84!"K=4GG6ZA6V%%AQX.P(Y64!I]BFSG-4A<O7RA61!NA*<?2W7!W7F''
M,V!'.L(.R0.3J=0(8Q^;D2J%3*H5$@KC8$.P-G# #K(NR7PH]&,4]R_@@*XX
M'ERMFX6\UZ%_B&;V2!$]0^B9P=H7#3Y+4%RF\:5H5>ES=!D6"RQ19J_][]+$
MNZCPY@YX4W\_H:MDG$JB?8J8X@8QC F2F+A8'%EGDJ0LB_?L&:'+450J5GI*
M.5ZQTN.STEAT!T.5X=XBPS.,F,\4DAYG2%I*C7$XZ,Q'T7V#SK]4M\JJR^V2
M)A]#:C]2*N=KA)JG=3=,XM!?W4;;-LYTL[(<[@,_7R<D.>%IH)YF*&4JQKMJ
MCJ0T%'EIM*.$6JWMVB9=E^G3.!TJ!GLB65[QT -Y:"S"G;%!6E!_,XTY8H3&
MXH<6M&&9N11SXH2G:YMB007L5]Q7;S'UUX<A.8WV3U DH^D=(W4*P9W_:Q2J
M\^S7;RL]QEN[1OL27Z-.0(->WH#=]WM)Q_0U?#&_T/6_[$E,OLEO?-OPS)G;
MM<F+W60R5;.27:] .<RI8R]\Z\6\*M_?*PECM[U3DL6'3G?:YUQ9KO<2>U,7
M5M@ZK3%%C/E8?L,0I(S$B&;86:IIIHD#L9>N,WF#Y*OX;Q5UQXK_5I'_QFJG
M)L9[!?R'E0?3#5@1&0[_)*G"V$D'?!@]1W1=B/G.0(]WZ?,:E8DIQ]*D*K$J
M.NIKA;'54R,F;>@*Q.X#8GN3-TF"6:8%M2@XJA#C*D,FTQI)285CQDK%LK5-
MMD[4?"?#BOG>F@Y1,=\2F&^L0:3.,!MB(J;DH,;+S".=!84RX#RL)9<\7N/B
M;)TMW7?UP'*7S\$YW_-_>(<TS$J#=M#U+2#1L8LA;^&&YN)Z']K5[6FJBZXL
M4BW,/K5:.V,$%K$;,PY:I09S'A0&A4'@0(]V[]R*:-H^&1[V5G'67X9'G7^X
M$LTA7@+83-XTA50KHZ1$'D0'8J##(:650*EQ::I3PK$&22\W,+LR1[OBFH=Q
M36 >IPYD-Y.,"89U5*.I-$%0D /<Y%QSM^8K%=<\!M=,1':"#LR)%K$#CT7,
M"H(T TN?.>>DAO]*BB/7J+F./&_N;NFV\GDZ2N1E]%Q]63CS"-)Y4O.O4&89
M\>/[6_U:(_V5(\WG6/E09&#4H92YB#,I1<93BF)22I;Y#-XP:YMT ].E2.>*
M:YY$.E=<\PA<4W\_XAJO2,:T=2BD7H).*RE2V#"D)&?!&"9=%J.G-J18KG1^
M#=9SK/02$[,3T!_] K/Y4;7^.^9[+4QO6UETN66YU+M(Z6OZ&%QK 6R7AQQK
MFO[EN[%VP@J5-GT1@+,S*:8Q)L;'OC:"$@U&0.PHH"5'./!@;$:$3@%PQ :9
M[\!4UL";X:K[Q NM>-;C/RKD>&3DN(NF4B'',R+'A*J"G>4>>XZ\$BEBWFND
M71I0JC0)DF"%<1J10\[G;+U1Y'B3/I-9K>P)$V&O0]8%6_LJD75).MDU=E^%
MJP_&U=U)C2PS*0_:>921+*;"$H:DQ@P9K80*7GJ2N;5-OL'F8[#NB*O7!%V]
M*%RM<&-E-;(*-QX7-R;T,6L")2YP1)R1B,403I4RB70P6! J0"-3$3?D?,&.
M-XH;KZ*1QEVJ]:_NDB82:)[^\8N;2'SH=/.JCNU87O8V31?6X>N-457(7M'L
M828H6-O_&S2Z,(;N)6>ZF]>)C \Q@QX\IM<#$&X9P,R\CP\ :\]V&Z:((:YW
M0'_&6?S%?]XAYLYX8:E7-)/<,X&E<8%F-FA&A2%8VYL"7OF3Q^V+EXG]]Z['
M7KNLQ;#5P$/(.%+1I&8L9GNF,D7*!T\SS30/>&V3JHWYJ-4$&*()+S:N;ZGS
M(DJW;_4B?5_7U63;V\F/\'K9YV11X?9%'+BP4F9>M?TN7'4_L^J.S#3-*#.L
M]6;9)7;<.PHIQ8RF&C%-8WTRS9$QG""M-06V25-MV=HF%MF&NI)?<G*ZRZ%S
MCJV(ITR]9"$(*96DQE@)J*I@&85.C G%U:$O_]#Y$4"&(UEPB"K)HH;KD R&
M(TXI'(;-*)QW7MGFFD.?;HBTGIR?-.Q)SOY=?];I]@M9.YOKNPA(RJ+/<\TB
M.A%$>S[:D^V\=G'>6L+H9N[VZIUX^/%&<BW03:%9<@*Z0F?0[_6!7N.49B?7
M,:!8EQK#'96#9X"Q2M[73W?/CXPUE!%'P5KS"C'/ C+<*D1HD%(*PT46"RQ*
MLC'OYAG3,AQW0< OY=#?#[K=24/_[9U][?((H,JF.'CD1.R\8[%&FL?:=]*"
MHAXD2#(<"_-><_0)&!K7 =9$1N%Z8HM-3^+7[R/WGI-@ZIVV?>LT<[EU?@1Z
M3?":<40D9_&V+4,R\Q)Y[JR25HF,Q&+.@F[,)];<BVB:N34Z0SG+D'FW4.!!
MY+G'$GG/H,15(F]O^\?ED:".6J\I8M'.98PH9+"UB'+"I;.:"1V3PRBYQL:]
MI\A[SD-_ZR)O;W^+'($ T:D3*7+2@;HC"$8ZE0;Q0$&F!">)3N'L\<9\4;AG
M$7G/23"5R .:L9='P:4R,UX@S&(A4P?6OA:!(J4R%0A5)C 9S3V\@5=6Y$UV
M!H:CM(/8:+"7]PMLM&UWV*30=+K=SGF<5C?_/):)B%9J(S3L1*X)S''0*_H4
MCL(JPJ ?>QL67SHK2^^M1_^RAL_:!:677N9O&U]A2MV\3=%%$9 1&4/'53I0
M\Z)1G-0Z'3?A0BMV*TYHUFFVD<P['*_LV5UZ^1C9R&(QC[-.KQ&_\RYOO0B/
M'7<K_,=TF\G229F.?Z(-[/>@?_5/KG)O3K7;6A&')\4SFSCQYTEW?!=U[)&!
M@_N!=(#9O]/-<WW16_OG]+IAT>7@(E;<O6I_;K_T$![OTB6?!2!CIYM3R[N\
M*7;\%DQ'K\Q<DI-N% C_<8NNU6N;>5O9R&RQ5W/DPW_]4V]>>4$W1Y//U*=W
MYW^WWN\G7]_O[M3?[WQ-WN]]^6OOR];^[EY]Y:<>[\1Z$0[?C^#X_20<%^$'
M#4#8KWUXHU6<R>TO3%=EG;]]:^N!:\"2?E\$%PN[3-_8-7JFR[1DVJO L0>+
MGA%J9!H,H318"OJ9BY77JBNDB2NDF:3/E;Q FHR^J6X2RMO6_1K;^WQDA8LT
MGB%.8Z*55 9)3C&BE *M^RRS@43_Z\9\M,QJWQ]59[[PS'G]^(A1ZU1F!)QT
MYA#+N$(@SQ6B!@>6.@!%SO(SO\[_<)OKHRG<B^F4J/$+G30<0..[-[/I>9OY
MK2,MJ#8FXT@2!8Q&I()75B.7*>LP"X(%N[;9 >SM)LU.^QCE2?4%TI:R;CUI
M^_[SW;=-U^I;]=NVZRM:O3W._\;JYT?6,^JXE2A8!T3(F$:@ZF@$B*"M)XXI
M+/,;EZL]":M\V;;PS-^ZW[&V?W!>VSI2%D2LIA)A$+.(!1TO6CU%A&/%J;8I
MMR*&Q5X3)S+C0ZK0?8CNGX]TIKE-L4%*6(M82E.D&>/(Q&A#FPJB1!BB^]"S
M-E_M=#5O)!=R5>6<C8R5[FT=,2%BP#F(<^/ROFT:2<49<L82+JS,%%?Q.N<.
MM]@59Q6<A0&W,N]$)D5 6:S#S&)99NV8 (V5!<]-BI4)\WK3 MYZKCO;I:E-
M3VXV56I3;?_X%ZA-C'E.*#'(TUC.DWN"C" :486M2K7'0N$;C.15OK"MU*;%
M1W\)\(,S&ABE#!&/ V(XQJ<%DB+CLC0EFKG@S-HFN\X],GOU=I42L/I^E$KZ
M3]$'!>EO+6<A%1ZV+U[.@I8-I$$(2D'_8@P(Q(IH4;&[A"-=+<NJ6]C1+>RT
MWWGV#O9%>.@GC\/_\G80STR7FZ>/NSX_D'RUNNB6H&W.?I$,_JV33YUF4Z\G
M[W6S =]I-_30#S>IC@!Q^5^YIPXV#H[*=EHP*FQ<24JA,^CV3Y+_&VB@OVX\
MFV@R3-.*;O<;L:5=?LETHOM ,<DY$"^0K>T<MV')=\(M(DSJ51:"3U.6 FJ9
M&.R9JI0)XBG)'F2U^%^Z]^[?OM?S?B:N)/Y1[_0/?/]]N0?NC;N#3VNX=GSD
M I!CEAH4<'0*^2"1P=0@ 9IUJA63RMJU34*N=0W<+E?@KA)N=2BETH6!6GAN
M[C*6PI&@P+A"+ B!C+<&98(K%26>B5>D=Z:6!4+N-D)M]AYB< ;##R$N1\]2
MV.1/N9.4>*8K[G_[8Q#!-=T'-+[['?UJ";4H'KHN:C<PV,]2P]76=@<^ZBR]
M?J%;6-^-Z;%P1G'I9]V.]3Z:SL7WN_XXZBD=T!%:Q:Y$,1;/%!8<3W@HD9R/
M6DE,'XXZQ* =],].MXA$&?2!)GR4A3"ZR=^+0\=!="M77(9DTHFA;_!S$V^R
M=*_3AB^#=.[U 3F ^C:2[R<-^'5O &)VP;)<N:RN#TV@RH7*FH'11B,.'SR:
M5SZ#7..*CRA77'@8BNV,.D(^YQY\>@&J%Z!C-WX1SDLW8;+YM7R^--L?P(:.
M5QC/)!\V/B0J3;M 'G%C;-2AUI-V9WY>\,W&:%XPK6[>OPD^S=\H>CK%>,$X
M?#FM<BO6DT;^R/7AAK:T\_"WU5$BE.,WVJ#LPBG"O ?MLRZ<N\T+$0!&YYID
M?%!.%C.D,$$E0ZTG[H:)5*&!H$R!%1?)3]UM= :]J#O!#^'+15YZ1!XSZ,.2
MHPW6BB$E0%;Y/E_D(S7:/SO-GW&"0[J*NV*;NM$JSJ?5:?N^AJDXW=+'/M^<
MR1^&2(GKR9EOZV8.:_#Y691U4:TM?_,'K .(J!WG 0!6+A7FT.F6ORC> <VY
MX)$XT!^C1X#:?98KC7%Q\#Y8$>5P&N"Q$?++PLE- Q"U%^/?@ZX). )[G5<^
MB7L=<_&+P.&X4!U/,Y[Y> C3<?D4XE5OB=->=^'T>OUB$T;D/#R>R<>-']3S
M\*BXHS/L_L]<V3UO *6,*.VL$_D\1B^5C QCYK/J#9KY$G52MA6#+X\J")SE
M8@=H<^,%HNC6:"?=B!D!O3X76CIL]Y?<8$Q VGT 32?!*?J\/LN .9G>&E3/
M@0]S=AA"2<[99X7],4;*\>AYR&IA_\6/:Y%W(UELES/^"N (^Y]\&0 [[Q9M
MB0O79_);_$$$1)+^L;WW=<%7\@_Q'[_GIN6@%[4 XYN=\XWDOSOG_J?OKD?(
MCX ^!*A"#$1BR(DX&K?=L5D#5-5N1S0$O:/1<0N!.8RBY*+JD0?9KI=4EA]'
MJ;. ,A(AK7>2!)C0D&B;C?\;-%PTSL 2;KH"[T:8K!U,N>?C*X!K6V)3%%/-
M$F\GY14\,T;V%K;R>IR\@R4W.V>Y1M-HKX\Q\9_3[#D%BV.DTY,U-,I]W)D^
MW4D*F=GS:?\VO-7P/X>68/QDM(:AG"U%34G!$].+I#=/D/E D7)*GQ+L$J!F
M,?%C +U>+MY[)_F^1@H]T3F:C BUW-W$YWL;F>)^1SEYC"\1-?:G[?[Q=D8E
MN5/L:'0!-'XVFL-&X<>%G\5Y>+HK51D'TJ[1ZW>+CWH#<]8!*0;2OM>+C'\V
MZ/8&.FI>!>?_MP<)=P+\VQMT<]7\+X"FTES*!]RRN7=H^-:6S;41K)2(7)#[
M@MJY!,ZC4WO)=A0._:'Z_FG0BSB>_#8"C$\C=(#3!<F8MZ+XZ-N=5L.6LYEP
MC;7.P+B(TSIO]$^NARH3#93H]RI(-M+'M"<DQL08[Z.-,;9@AN/VHDB,=6V&
MSMSX;2!T-P #,G$=.\C=8850C@<2'6E1_>EW-I*7Z,#:'G1SDH(-ZOG(:+-N
MI/7)^CZ=]G$G?KU$E_P*S/C^>=S.. 2<ZT@K'UL0Q[KKA@]9+"K61[\NM1^?
M.Q$G-=F"XH>*6JFWC/7B.UVY&TR4D-Q;"09T*K0BE&OC!2="<S>\<A</NG+_
M=V.XN"^%C?%FO0[U_9U?>UM'SA/I4YVBN.6(I4XBPV,B%(.]ITP2.(:U32:O
MNV0O4FP*" 2A[(]]E"9M]%"$* PNDJ99'#E>N128,4UT(W)T'?A7E&)E@:P)
M];;?]5'\ES]9+T>(%G*W$0V0YK0U45P41+=]U,G'\CBR0J&$]+S_,9*A$WRU
MD?RIHWCO++Y.Z/J?#7]>>N-U\Z+7&*FC$VQ6,M_B9:X7:N:\"N]_@<8&EMWZ
M#)\/3=MVH5]&91^TB#. SU_Y@"#%[L*FJ5-*6BVQX1S *TCL!)6!2L-4EBE[
MA>=0W(U-0?=\GR</'/NVO=@J)K[5?Z^[W0MX\V_='+Q=UJWM;_&]_6^_:OL'
MEWO;QV3O\U%F!2,JQ2C+FV.*H)#,G$+.. ;'0;#',?7YFKNRH;K:/^GZPHES
MZ[IT+_*.:"O'BL@8IO,3F*8YD@PC8SA7G:,;*-H\N5)6^E'61^*TY,KR\FW*
MUQ0+]/F\&%_N-IOD]U94[,^:$TZ@T2-SK.D$8&K@GJBL1R@Y';CC0L.!R0[Z
M$TQ?G&*OT/8:73?T,VSDJF$NX*/W=MK)5<' ZX.!^-WSYX6!:!F9H?3K15<"
M$-G(.QBO&AIN;!S&H4=T/6:HD<D[9:H73IK"H5)*X$DGU;S'=!'!+RA?6&43
MWS6;F%39Q%4V<95-7&43+SN;>#G9P<7B3Z-C*URL"FCNM9-/ Q"BA$5!B=5Z
M4F\T8?@O';#VDMK&]D82X(T8HM3S.K[POW)%SB>@/R9]W4J:^KPW:/07F9Q#
MK\N,IR^Z&4%5A6\-NF-G=*WA'/#\Z%-@_@^P"4!_ZZ6WN+3?=?*ST6GJL?SU
MR0?O<I&^!4>'_J=A?\3"[?GS!F6$V0=0\F!>Q55>=$;F53WB-6JT[(_CO1G8
M_BYG@3,8>^BT\V7MYOS[7=\?%(['8I'-SO$ ?@1:'F@DQ?OQGG?RIN,S[-(^
M[-)7V**A!W,CV>YNE%L<K?5>U$J,/]'-,!4G=PS:?[>=NT1SSR),W3=#KK&?
MQ\>.G%PC#\'ZC#LA_UWPY8O\FGHC@3/_X VH'=V+A/!%X>R@GGC0).)67^TW
M'KIQHW=@YEIHUK<PVMYHAAQW=6O:P7I;=RE,O*:[]F0X:SSV @Z)%.RFZ+&!
MG8D!CC[>QT<RB>&*WD;RAY'[T;G6GBQP,WE(<6J-B9^.7#=@8,6?39Q=[@,J
MX6)(%--#P8RWSKJP@9@,9SSQ\V+.<)JM0GG-G5+QPG<1+ZT7]!^?,R+_WOWI
M?_H$0J,+3VMZW6U[-QQT<BDC);ATQ.?'>IOM_30 ZZVPQ*>>&+_7+MCM9^.X
MT^T,>O!%YT.T*^'L<D(O=V&T9?_5&U[&Q^E$ULGO/V.1O-PM!JIX?@FVB 9!
M0>_ ZBYZ_S7#$-$G%R]-\CC<8@+%839ZI0T+%FNS?](9'$]'60)V1Q?<Y.SR
M(RJ/)F>1J7NS1C^_'8@UR6$N>81"_KQ>(7GC ^=@JEAOS )NE$N<NG++XU?&
M[H%V]!M&BAH'LO@)IWAWTD?N9L(Z=*_7 0$?/QBY1">&-GX<; -4VR\V"(;R
M][G'6$EAN%5>*8X\'J.HFL67$".FF.*4P@8<.GJG;U$++W+9!B&7-!=S#N"<
M'$O<S8ETS@^\'G^7WY0.:;JD\IRRUY-<OXJ? Y-U(H9WNF>=// B<MUQ-[^B
M&X8:KY?3 D$7)^R*11?7Z3'\M^3C"5ETDE^VY9[R$LZG[IU';O0X^>(?#5=8
MT067#F]NAPZBG#>*79N\/2_N=1<&4Y7A'NN+KWR+6(?Y:]\;;W?[G;.5\@/N
MQBO'=KL$V1%3EMOQ7U,-,XJ/I^]#UZ->4:AW9"CFOPXN-0P)JE7\JQO%2KS;
M+3,1H@/,1UNY8W^<=)JNN-6;'74H;/^.RVK RUW8^Y\--RA#M@"^>CEZQ7F]
M'PFU4MAN@ZYP'NFC4/^BC7<2+V*Z>=#86?Q1M#?*^24_-^:>O]NV&T#E42.$
MO]]O;&TD=5 /X@)1"A;EQOC70]&:I]^,9M*)'45^YGZBA-#UB?N;!:*X!Z>7
M2XFI-=I\C:4S<@C2(R9XE_S6^'U6495QZ1LPWR0ZIX!;24JC$C6[O)U?,&SR
MU39B/&MY.S]Q1E'AZ':*&ZG8F^@LCET>W/10D^?8^P.FU,@OSR/WY8A^JT=_
M/<NA9"LV;RG<1G!PW;.-?#P8,/I20"6+<X#= 5Z,T7$#0)BYX?^K-YRF _S+
M?6]QD)_7CY''J5R]^#_R2?X&@P#*Y)@8M\OX?G[K=^7 0]5B>L'KBU8;!_P(
M>PCLG'R%T7K)_],M>.Y[(+E___O]^H)5CE )H*[1 [$[BFX>\>M5Y);; XNU
MFJABQ?BY&%33C8I%6$\&[3))!P:9"T[,M^(JM2<J-<U2W\EC_EJ=GZ/$GE:C
MUROORV<F"#IM5#0!, =%K$9[8HRA&&IU2F2_8;"D8\>J5TU?#.,'VOD;(U]N
MX<+--S"&C9_'&B7QYJ,0%.43_,@@L1%7[N)1O?U-T.:_3/>?"_Q0N9O@9K^6
M6%OE*/3?,/^][(8VU3YG^G9%24V9%Y8(YICG5'-L, D\]L@+A-&%/94FDB]@
MLF#$_?#]??WK?;RSZN_#V'\V :F>^9*DWB@O24X_XX/]>O.P=4#KK6^TMO^E
M!7^SP_UC<OCQV_G!Z?$YC$MK'^O-V4N2^O;?)S7R=^OPU)+#??L+G@%_GS3W
MM@]_'.[_V=C;_A/68,\/R-^A=KK+:\='G"L<G)!(6^41(YX@Z>(?-J/$&.U%
MRF?KU8E,8YE)H6V6LLPKR0VAE@LN7.! >6N@Y8,LC?[%[L"O;=9WOB>UK2__
ML[.?[&_];_+^R\[V[OY<EZ0ILE[H";OYN=/SQ#C5&E9@-?<,$V52GPJ12I]R
MXW3(7DI=O8F@IT6Y<YA=Y3^Y]R6FTTPKCI7%GK%4I@H;[T)JG/=I%A2+;(89
M3G,V@Q?W2_@M.;+_5Q&9V?L NG_IZ6T?;W5S [&U2AF_3\ZC^UL71USBD,;,
M)ZL"1RP$C0PA$F7 K P#&NHL)LMML&NSGV(=KS("=JJ,8A'R6EICO4E7VGFG
M^R-^"IS<Z _USO)UHP5C_2Q_ _;3E:0US!]=+GWMUC],$5@L6!*)[#SF_OCV
M-'WE"0![X4,Q$S!@O^3\ 4O[7JSP?;&HK;8K7^U.K&Y$>^E;H[U3H+T@J'+:
M6V1!R"+&X)5*94"8RV )4ZGQ@**@^<W37ND$K6G0D*)=_#TF;+?!=![F%,=@
MC$+@YR[/"7(<<WZN;?5 BMB8FE.ZAO)4JQ&AQN .%!T&%Q.:;]2N&_W!7.1_
MX4#I=(>^\/4B]SN^620^#]JELZ"1)SN==G)W1>>\72B.K4C8%U.Q\='96.1'
M7V,MCYP'<YZ-/JRU-_1% *PW"VTZO[@L$+]TKD994J@NO024EZ307D8ARO7:
M_OM1C'+I&%F?BIO^6LZ-\>VA[VXWNFJB<^=+="X/XG2=+P*EI2ARZ NE>=I?
MV^A-N9&,+U8_BFGLGW1S=^6P=DVA0>=[,LR-F@QF+(P"L*S*[+'(?(W>V#D#
M8@S$5^G<C^N<I)!H?+=GXRGC+QJV3&S()UH@U6R 1+$'8Y(HCJC;.2WR)?JP
MS<:W?8C$$)WP0Q<:G-)E[CQWZ\7] &"17Q\^:TH8P[2C M%J-\+%U/.*)'OX
MQBC-S4?_0YF!EB]SYEYCS"$#H+EFD5<77:#QH,JXCG*$B2W,,Q?\K[/\M,9D
M-;%%O=)1'UVQ,2]M413ZZ!YBG)B?3]X65#A^<IZD;_R80!8RQE7\_E)3($:'
M>A_HR/-0RB @^.[?P"+YN>3<&6_T=N+WHK-_R.Q_[^[T1LP^&\#>Z)79-2 L
M8_I<3L"%\Z%D^_CS\J(I9C,T![E#)D)M[K#(,YXG8G5#I]G,BW.\N_)TIMKX
M<K9"[8WS;1)_K$J+8\PV>-R+_"*ES$Z(Z/^S..") \I%%B9_P!$UFV4QC<*W
M#"S:+_WK!7U,7;/FR#$!B,-A\F0[W6Q.DEH)@8V8(JJC.Z;7."Y<3KK,S"L*
M>108%#^,!5ETGN!3>LC/?#=7Q"9P/P9B%M<WP4^LZ(^*>I9%/9/2<@(]>\-:
M;W,B**>'BP)]"]$R:/JIO,R1),Y%!V@!0TE=> %CI &<N_>C5/@IR+L.WZIS
M7RIJC/:]J>V/WO]G[]V;VDB6?=&OHO ^9Y_9$2I6O1\S^SJ",8P/ZXZ$'WA\
M\3]$O1ID"XDM"6/X]#>KNB6U)%["V.;1:X4'D/I179WYJ\RLS%_6:Q)G>%"I
M=9G\EK?J4JE4BA+7JZ63D9/CUW?N8]^\LMN]LMK*/%70#*@I 7;DICGQ]<6Y
M2<C]_H1<UB3D-@FY34)NDY#['0FY=]+M'PIKE^^,W+S3\6=%@K.^IU@QU.0X
M0BY$KY*+PGQ?N288\QC<>"88.920O(_L5$SS<#(_6WN!ABOEXM;C8>4-QI5#
ME"B.>V'F4LP#" OGS&D-YW7@EP:.+EE6OS_X\)U;M.:!;]'*G[!%.PL4;U=&
MZ];<I9CMVF[!0?U<U?M0]F]WWT^+W#ZPSNNWI'OAS[K'GSYW]][RSN?N4>=U
MA\'/XT][FQ>=X[^.]O>ZO94BMSU_]FGK ^M>;-)/QQW2W3H\[]#ML_T+#S\_
M]3M;G?/]CW\==>B_T_[M>>?L(!28*6P)\B!2B&-'D8TD@C5CM#/*:.W)\KZH
M\M)BBP$R,.91:5L02P)--09&%H5=WK_]N//^U6[W_4ZWM0T_=SL[KUI;V_]L
M_[W[IK/=K>_IOK_#IN[-@UD<O&?&<F\,$=9P1:SQ&B2-I!X3M%",/\9-W9S_
MO+BG*Q;W=/,:F2$W^0V#&E?K;*MAOL$R59Q637-RVE1EA<WBB!^WM^:;!G#A
ME(&]UCXQP8HH'%01@^124*-I(%)&[ PGG&6V3"(PN_OV,-P';,9D_LUT?[SY
MU?;ZZ:-9">QD=S#=NYMMYHS3AAY8]ND9=HN_3OO]]/[>5,[.^,%L*O]TX-C[
M@@\"M]Q)99%V2B&>&D19JATBGD8=G9(LM9 PUW)(IR*)Z<O)>R7E9L!X&C>>
M)<7.>2+FW,,G.?_^8<G:B@AMYV'VTL;&^-U\(^FOX>@RL7R^$O5YGQQXZ@&!
ML42228PX)P(YR@C\QQB%-<;$%"]>4KG!KA6I68;!7(]SA!'^@-GNC8^JL.5Q
MRN!+6917YQ[$XY/^\#S&93FRV(!Y3 M&./=*:A:DL 6+UAKC"YIS#T1EGZP*
M5,X]N"R_8!E@*H$)>\,_8\:A].LV(.RULO.KTPQ^NNQ<['P[**3@BIN(*"T(
MXE*!$2.X2*UM#)?2*2?LBY=*Z%71*6#:4=X$G8:Q '^^)O^B=9V1>B<A6,XX
M":>CRS).WF2^/P"):_'D^M7I.DEY7O(!9FYW\\ XS<%7T@@''5(O0XVT,JGE
M59%2 07V"IS<Q*TP0.=@QBP;HA4)8[FI75^KJJ*SY)J69EC>&$^?U(K@T@E3
M/_6\]%_/>N"6AM.*=:A7E'D R:4&#[=DO)V=4+$7E19=SM8ORTYKPYAOF_>.
MW>EH7&V<)Y[ Q:K&\@F.[;?>\>GQ$I7PI<MQE:%1/6>Z;TY*3Y/4RMOPWV)H
MKVPBI\/+Z,!TA.Z\=1QCWGB<LB>O8G5)7C%TZ2Q;+?WP\*D(H%++=,E&,9^*
M8KX]B(0&RXE#1<$L+/N!I&XU%C$>M)?*$V7-K13S?4FVN2R$U1YESFC-7RY*
M5TV%IMS*4\L CAZ"CEZV0$P3E#)1T6!6<EJK2JL/HV)Y7JF<RY>?W3V5O%:J
MFMRJQYK)LDRDGJ>HQ([Z9-OQXHM82 ZMF6ZYQ&):;3+#JE7\S2EE4U::M*LY
M1\^<CG \'$W*G*MQ+B\-I[/&+G-6S.Q5Y*VT*=+,TA<J#M[$UEPF=%VY$I1E
MU9<@VRC.FX^4XTBW+\9Q4E8@ \JG M8TJFH@EXRCGA-A?250LPS;'!*]<F2U
M=+#%N;]^9+,*Q)(*;VF&%@8TE_\JH^R*C+^:BL%:U!ODM:B?@@VYV.D&C6O@
M_ZG _^&!--Y(*B42TAF4&H(BIPV8[U0P4TCPV*V\#?P_0K1<LZ_UU- $.V^=
MJ$=D/'II"\=%X%QZ)PMLA;4^2F&$==_?C^828=[.8]T;)BK2YQO52,U6WQXH
MYJ*SVB* )9]:UWL0[B*UH#$BT.!P).*&2-EUYOF<MGE6ME,U,5N7)OB72,J[
M:M#/6$K\M]3K6EA#B>:(N< 1O B/'/')70V,@AEL9"K241OB&H+!*=U#-A^S
M$7 Z.+$]$(AD_)1=^QZ)0*2/GK-(I#;"EEDB8-I19-(A#J\!.8Z3>Q04P8$6
MWJ46KM>(Q+3-S%*W1C TLUC,C+DYN<6TQ^=T<[UJ"I0IXX\RAWQ_RIIS/2C-
M>OB5!E]EQE^[Y.5A7->N&,S[6E> F8$_?<IJK*G*YZCB9Y\-H3+:%YV'J5=0
M,5!4M1V)RVG:%'+5-6C/^?23F7H^]RR6N7JO3;I[(";(Y3NJ-^^0UO8>UZ<S
M76+KFKMF:VWF.$\*P35G3G$KM>'&4!RLPB[B(,LD 8Q5F22 OP>D-FM2LELT
M&S<+1OSV1>?L0 F-(XT&D4@4F#B<(B-=1,S+J"WGABD0&KPAKUZ\UFVS:"Q6
M7&D%GI[B BOG)7AUP5E8-&4PH7K_I'G_/_C]8UBIJ"Z"\\*AU)43WK]42(L"
M(RF#Q%$[025-*]5UO<87FR)6B\ME@?9;Q&\N2<VZ#R+U[\O-TO2!YV:I'YN;
M-:4>SPUL:PPU#R3_BG=F]=%?>&<O?/ETO$T_??QPT=E[]Z5+/QTE8O%/G\%8
MW_IPT3U^>]Y]_0$OZ\[NWN&W+GUWO+_WJ?]IK_.M^_HM@^OP3Y__.>Y>;)]U
M]T"#MF"L>^^2[IQUMW8.*/'$PBJ+1,%2B;2UR()QASR.$32ID-C(Y1PFPV"!
M)L)K#RA(5; 16U*D5K.!P*3CY02L'_Q*_ZP8S5[-"8(>7'[=KWF_>]L'4AH=
M-69(<:E+^@6PK @JO&:1<EH4G"^_7^L\K&V6VD)0KCQ BPE,VA01\U+C%8*4
M/S^\W^ENOT\IXIT_=[HY1?Q]:[.[U=I\_WY[K[7YZNV'G?<[^>/5%+NU4^YN
M%K_%QRD444+A@$T0'#OC% B89!C,-F(M45<9HC=/P^)]G%),*\JH@/N(8"U7
M3(%7[3D%;:+LIM2^7P2]4_5IU?3G@?;1S5?\/06_>_Y6(<ZC]#(W4X>.2<^#
M]_3WWZ\>YI/=Q#-=$>'RR\*SN3HREFP2U;9,Q;XV392<3L3\JUG:9&H6TN]/
M+9Z4HSZQI8>;-DPFY[.RO.P[5Q?*L9XW';ACQP[L8;7I I,[NV/Z<LY2,8L#
MV-0;;]P+TR3]O=>Q(G-;'>*TE'-Q4]6V7L$$]<#@;?UMW;!B=*M1GK0V$^=#
MN7TW'<VKOW<VYQWP(MC3F:4BTRT.,S%V?KB,0/!ZW]C)4:*G[HWKU]A\,Z]9
M]Z59&!./[O^<QC*/OV]=57G>@VL<#>.@]ZW=VASU+H8#NS%]PJK"%(YZO=W9
M_K8WLF#W*/Y'.W.-PG/$([ BTW;Q846-YS/!8V;';M=K7'-CT:2XB>T&!IP"
M#L/CV$XEE;D,_C".CI,T5?D1J<S CWHGDT1_6QLW0/FLAF&U>=^L7*)6M "3
M7^,(K1[LMN44\TCAO%/K$KM?:V45^('FP_LT5Z?]N%M,D; FA.,_SQMCL3(6
MOQQ@RK'6S"!8/PGBS!#DP&9'@B@&+D?TA5]9%97BSF(J61$U)PQK0AP+3O-H
M*75VQ9AX')"\MRBRI2@7MC=J?4V]B^9276N.4VI@$3-G8\IDJA0G,5?<G>M,
MNH"=BV"::,<C,R#AGBG"*"MLI)Y6&L )1]-?ED,1-YK3K^J/L3=_"O)00@\_
M72-VM[Z0 U\((DRT2#/F$0>91E9RCXAU&NS$P(U-@0>"K]E=FRZ.65+&DSF!
M_#6T)2__>U(QWU25T"-X-R@%Q^W)./X^_>6/U.V\;\]_[PVR .>3_EC4J51S
M_34MB/ :JX+&K&'EU_-*X0U<5@M/1O O3.]<?;V1O_K7)*Q^I\6&,.+*K_$&
MN>-W3/,[G7G=8 G9D/1V _I7GHAR,F"^TPOZ?UZP%TO4$+_3DV\MLE@OFLKK
MEZ>\G.W[AC)]D_F?7^EO.SG5['2<NAG/JTBK";CFV7!ZLA?K'WK#U*5,M$1.
M/ BHF@$P<F)1_%&)>>(9QXF<H)7-C%::H#\>Q'S?O'3D"7]EQT>WF.8KY^&J
M^;^O^<.MQS"+_^O**:3W)TH*OLI34I^*41K%@YJ+GV@ML+7Z/+XI4T'&>\/-
M,EEP:EO$\>O1<#S?N6"/TWPXVC_^UM_][%,[R//=K0]G';I_MIO.V?KSJ+NU
MS\!4./YTO _?;XK.WMO9.7"OTT_T@^Q>I':0.[R[MWF1C@&3 W=>;^/NY]#O
MOOYT_.ES_[BS]>5;=PN,\/?X_.^][0G\_'9@">?!4(6<)QIQ93$REC.DK&":
M>JY5VO-2O*W4Z@;]@NJL#<=%_M_C@MSA\7'J79D8_5N]\1A\DSLA\-*CWV(%
MO-7T36%F:1H;H+DUT*SALVSGL-:4G'"\DZ5A<Q#2+PMY/PTFW0*3>C5,\CX(
MJ95'!6<4,(EJI+F7J"A2(WJB@Z<:W"'9IG25[/G[,&G)-'H<F#0M_EZ,$OP(
MT_"N<]@ TT\$IK_G3#([55.U!HO6P:+S&A:QJ+2GUB"I8BK)-1XY56@D>"(6
M(5Y%X0"+3!ODLK&/]H:I?N?D=.2/4H^8DU'/QQ]A(-UT7N675;$I!N@3AJ<I
MTI4]L\:!O>>):MS;GP;NI('R-:"\^ZKNZD9#G%(&.1T,XEP)Y"QAB%('-B9A
M6I $Y=BTC3&WP/)_Y3AX/4^ZGGYR_>[3 ^UUF':C5C>?KM2;\9$%W^=^56>Y
MI\EM=:>VNWJI9[8[FCIF4Z:2]WGTY;</A7?DY^\_[7U@!V##!,.<09Y$AKB+
M'J6>4DB H^4XP9%S"YI!19OS2]KK^"HJDN>S"HO4:0>OWKQ,.Y:U?K8589*S
MX]Z,!]C""F(/9[)X!-*:LQ#ZP[/6<>X#4IH9TP/F?3FK\507K:>SI$W6Z7Y9
M&L*UVZ1OXBA+RI*8B\)R8H..B@0> M6%P%1CFEH486EC556T)-UT)6F@)H1O
MTG/,;_=,);*SMTTZ9P?,*2J<C*B0WB+NA02T=@()ZTD(1A3.J2239H.M,BG=
M7,32<$G?A4N:-US2#9=TPR7=<$E_!Y?TI2G2-Z96+R6#<<RBD992L#6Y\U%[
M!<M"X:*5A=+!796*?6-J]?)]@E#14APT+.S!)2I9AI7T*2;DX/:/*\WL\D#Q
M0J.YBMYDD?:D8OI9)YN,,J88\98S0*! O6'>A-0HKY!!JB N-X_F262Y9.UR
MO[AZB 4/>3.4%)NV7VT5/]N$LL[>SGDW\2$KX[%.<4LI$2^X1)HKC5*;Z!RW
MU +6+GI=1EE.Z9[-:TG"MF3*#\OD[=.3RLA>;O.7/(,XRIC6MZ<#?]1.YOAP
MU'*Y55Q9' =O*YGT@UYJB5XC75_-Y,X%=38G,.>\QTRY4^80ESWA0V\<4^!Q
MFFO=>;<UR[5.?H:?DC3]*U.L1UMR&M5;([Z:#_GO/.16I]=/G68&<7JI,K=Y
MU4^^YM161?RZ[(7<['[<LUY='W*Z3+6FVPGGSUBE/M#.Y@&.L."X B,1@T \
M\71JP@T"'SDHI8I"TYBV JY1J5)R;@7$\-Z&]X;&QF"A1%"6%A'\4ZX5]D0:
M:@NL(YB$C=3\"*G9O]C=/$CF-M@.!<(DT5]$'!#,OD6%9ZGC+W<X%.!9K0O$
M5T*N]4>]^+6JI%D!VZ)7K 6V_O3XM/1Y019S;]2J[ *0-96/I/KE\;H,/=\K
MC6O:!E53UQD6/V.)] (DDG)+;* 48>H QT2NU'4<X52BFR)8@8H7+P6^5B3K
M2V:2A3>E+,PZZ%ZR:':'U7*9ZQ12!9&;-W6]]AKS/IP@<FY&B)C2_\85-?8\
M7KBTPMYIL1Z$&P:4'@%^S7468/^,<U?*^N@J<SP5=H$SEGH(5@\14GN"T\$D
M\QV"(A<YD#D,L5^U(JT-]1B,F=.2:ST5O<UFH=:!LM4;G)Q6;7F'#KR#S#DT
MK:&J J0EJVUN-UQQ\*8*NK\S42%;N$N.QQ8Y&-M+:)"'FA[N?:KFLXD)\]4P
MY'LO%@:^GS=0 %>IG/0O,;^DT^.3DOPP$32&.'WQ</WD$;?4<K#N9U5IO9MQ
M1>XD]RR7\N6J_G&59)JRN6K)%)OI46+(<9/G7<#EDWLA)2,8!7"-$0],(X<+
MB\ OQB;Z$*E<Z5@B-75<1E840G-PQ+5G$MQPYW5(O.?L\19PS4IL6E4]S>DQ
M#!@N4O'&SH!BKMMSO,H2-R=!S7L;M5Y0MI2ZJQR(=1@C7S3U/DV]SWW4^]"F
MWN<7($VJ]ZD(IN&7Y!D"DBP$B9LBH*8(Z&=F2=UM#_S[DZ-6+;>T0MW"=DLJ
M!%]LSW7G::13'>]?[.]M7G0O_NE]VMN&X]X==3Z'7G>O>[2[]=>7[L5??;@W
MV]W;/E].I_J4^-2V.JS[\=_]SAY8?*^WS[MTAW3H-N]\?,LZ'S_ <WK1V?OW
M8N60LXQ290IDJ"%I@YX@;;E'E LGE E&1O7B)6US==])^H\K,;9DD"D]J2F[
M<1+7IG"H :=%<"I):\LCY_S!#42M!5'U0B*.C9!8"*2#L8ACSY"+-'7WTX5*
MO3:UX0FB&+]-ON?3K2/*$)7:0 P2"5)3.-0 TP(PS22C0:)UD*A>1H0%)TY@
MC:)E#'$5"#*6>"0E%5QJ20N52AK;FI#&6'IS6V+WQH1ZJ$CUDZRD2E*V2T&!
MXW>3E)3?-6"U!E@M%,HH;ZR!%XV4SKWL? 2S"8,5542F<:&P2QRDG-XW(<0C
M-)K>C!)M=VK><-*W5=_'%)G+O<8;0^JAPM,O,J2FTO(FR4H5ASI9R%9LL.H6
M6%6/0AE.72P<0Z:@''&;>JX)QY%6@&*!&<&%?/'2M U?9>U_=H;5[JS%0#^G
M26;M1\,"G8YC8U(]<,RZ/O?ISI@TDXF_DTB\2T^U6WP8Q\:(6A^8ZK$G:CW!
M5A9(V5R_)AW2U$AD- 47T/J8*&Y?"K[:R_W9&5%;,R;K2?1'@\28W02A'BP.
M_;(@U,0.#GNS@[.GMW=D!Z^'PY#:QC=0M0Y4G2_84)SI& PJE!"(&R>14]0@
M9Y0,Q!F0%?_B)6LX;NB<XZ97D][E'*Y?R'CSK/,QUIR*)A_CEX-Z8V2NC=R[
M]4@=C9X32@L46&JWJ\ %=DY)1 R+6CL1F#5@9,JV$+=+PEAB0""BS!K]=?;7
MO5_C.2Q1LVR3$WO>I)K<$7=_>\K 6^VBU+^H9.9-*3(-)J^SU;NW.>GT\+>,
MRV\/C!8<"R*1DBP *@N#=(@%*AC1E 9CC!-ILY>KU9CD?ST[[Q\$;Y0(HVI%
M#XWS_YCQZMY#E)6$U+YHT&DM=-JNHQ-(BZ&I= L\>XDXM03IM-E;<!NHD0;^
MI69#;6)6G?WO1*=':$HM;YG44*H]RT8Y29VU[\BXW9A9CWCSI#*C%O=05JD/
M&I2Z#4KMU%$*$\*TX0Y9ARWBA5+(:<X1F$X>?@9/M$N$=*O<?\_/@MI=2(UK
M[*C' T@_Q[7+\M& T5I@U*F#D01_SDI,D">$@\G$-7($+"@3?6*%HYX4^L5+
ML[J5V]A+"_92/S49;HRFQX51]VXT=8<#W]A-]P=5;Q?LIH(EFE>%)#,1<0MX
M93G#2 NA2>1"$L\2[]]J[N[SLYO*G=Q+R#::@OJFH/ZQ@?4OVDAH@G)WA>T/
M==BFT5(E78$4\QXE,F+D0K"(64]#<%YBDU)PVHS<N\/["(W,;IPT"3@/$+^;
M!)S'!M^@20ULKP7;^W78=HYYJ[1&EEB!>.+"<T8#@%N)F:7>20JP+5B;\MO5
M]3;Y-T]A?9JF)#>QC2< MTU^^9UP\K".DTH*J@@6*( Q"^8M,<@EQ 0;M_"&
M:^(USWF*2C3U,-F\O0^+]GXB$DT3U9\S48TU_#.MX2FJ-U;QO:#]EX48M.!8
M>N>1Q8P@#B\?62D8HDPP3H,6@9B?U6CU ;%$3_MWC%+KMA##6CT3[JA+M^G@
M\1-*\IY=IX7/'\X[FP?&>B*I Z?0*HLX8QXY!WH1"A92+V*+34IBN:YC3*()
M7PAU]6:3/K41<E?*>2>%<$DU;3ITZ'OYL+/>Y*CU>KNS_6UO9#=:EQ7?UOL$
M3)NY+WP_.;*3UI$-<*!-?/KS[](RU2JB'?>F71H&(?=J*KNM5FU&TJGC4S>&
M1YGT;+]_GCI%G?1C&E\U_FD[@HHF/3=+RKUD9W)[56>'2R< 'J'E8AS4V\V6
M;1O2*;T!7!<F].1D-(0':AV?]B<]= *Z/DPT5#[M6T<[&L#QX]9QG!P-P[1_
M;&_P==C_"DA1;\IP.ECHQ9 [-/PV[;=0_EUVD1K/OH8A]$]#3#TD/D>?&T>
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M71@MN$B9EL)Z2VBB;/,J%+/-.5FC [H:O%;3*Z\BDGXS&G[M):(MV]\9E)>
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MB\[[&@&S"(%'$SA*^[,H%5PC$VE*&2>2BQ 93RZR;!/6M!UJ //) >8Z))>
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MU]0=#_X6A;ZM6XGAF9%MIIZ#D:"193R:?']*,:"38B$F/77*^A^Q2$W6P=L
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MM1;/6J_:LC]-;J$=K;4=)KJ!DYBI"Z+1C!P_\0/'LATG"*S4=<*0VQ(3/6O
MQ'O%1/?=R>M/H1'',=RW[H:NIP-C2/70L!W=2QCGEF/@!'0,YJ_!1&4CHX0$
MO!(^"(4]<Y9)!^J6XVRM%&!O!JGC,P^M*1;'/F,QLWUFND["R(XA[-#7H<DP
M[/@^<.7T_.C;GY_\T')\#KC"O #'0(+*%MIFJ$>QZX$6YYAIBB/6[/%J=RTU
M[)C<3'O&+AJK]F,=5?P_-;".SE,#,Q$(<GQX!&(MCDP61'H8,!,0Q /<,%Q7
M3_PDY(X?19P[R$QN)-<4EU'J7%<OVYCO_U *&TI<=+%J$\ZFBTG,2DX"%%EA
M6L2U-,_!/J@PB2W[1O')DC,*U!)51/ O8*8QSODK@7\N,HJ?H?MR-B_![L:[
MP6"3\#N7Z+K%V7HY1]<VSFYJWM=GQ<)=7*TZ@>'5\!W93NBVE@$W^'3"IW/M
MM 8NJ(&Q-;T '1Q#E_T=MKM7<UQ!;\[.LJ3&\\%Y<?(]S3MD\\[>B$:KGHWT
M&!KV/EH%Y.-'@23Y)L87Z%Z%O8M.:K+INC"FV8O:+P<'[W%Z)0-$U"I@8T!B
MF#J)<8?I5-'>:M #:*JJ5N,:%)SD?":\ZQ&%*HHXHXTT'J/FYVT(<E\#2M>=
M6DD7T[]>9 )E1N0OKO3M^P]_9[/YBT,%K$JK)L5YKOP,8G1DQ*?%N2#CE0<V
MA9<P,DR#MW![W4#YK3P9P'W@: A;1)84A&,/OQ %U0W)N'H'+[(F(9<VA1'[
MO "4@[?DPLLBH^Z(EVPA+@"@AUOHK+)LPZ_)#%KYI(-<$IZ.-?9QGN:\$&]]
M3@$RV$0[1A,S\CH/2G0TVD=8!!=6+S8_L@F1>_/;=@2U'6/I6CO_G93M.+I3
MKB/K_Z(3^)^SZ3F[J)[]W#\W'%J^W+-A]4WW<_VCI^F]'5T ($':(6QY+B;4
MPJ]@.VQG]J)-2M2 _Y:E2>A821BSU/.<T'*CT#/3R$F#)$#[+/GD Y\BO@%T
M\PJ59QI*R%9'X/; T,7)1W)"OOZ_@U<GVL=7;U\?OWK]47OU[L/[=Q\.3MZ^
M.][YK1\7"T[JV:N&G[[J\E.<C)B#4)QJ'Q5GW=[#N@/G_/'WG('Y T?Z:1V[
M6#]2.>6N&8>&Z[DAH*D=^&[@\I YH0/66Q \V_!<R'@4!CSP<4*9:3N,^P:W
M<$Q\''NNZ5Z/USX^9^VE(<0JB8M2+)9\:5E./R@3&N_=49Y438M&YA K$XS8
M)92J2 ^B>D[/D.T@C5M4-Y1U6V&:"2@DT840JVOJ>M>/ZVX4#,QT:9-;UN:Z
M-(''*Z9TK\U2VT-ML&/X-_DUF-$I,_8PIP;/7R+9D[J55:M*^?+)UY+"-::,
M[\6-43XOS6@GDU<,1J]GF/7TC4OEL9D>NR%!2R)F'Z<P<[>?+'4-%?WY-DBW
M3X/< W?LANX]C!NW ^=^QHU?;T/#N/%M1D;W?KH#LY8?M8BUY\B_US;F=W2I
MMX/>)1U._%V'%,:)*&)$2?+]4&,OF-EU#U<35MY/S\5;-V':\;K+FS:<\K>L
MZ=KQBLK;AAIO75IY=:AQO^LE?W../G^8'7U[^_6ODS>3OPY_.S_^]B8[MGZS
M_IK];AW-WEKPF?WNY*_/R_62?QV>PKO^_';T^<WTZ(\W7XX/#^RC/][:?QW^
M-?OKY,^+/S__!9_%[O'LN#_F*S8#*_0,2_<-'[M)L5 /?3/14S.)K,2-S"#Q
M,$8Y<KUP)0K5HY,'ZO3TJ(SWX'I:\V,+ST% @H"\U^;"6]Z;$@2[W7MPFV*,
M&R497*MWR8V["R+0X0M,2P"C%]V'@UC80BSTF@A;GF\Z1ASK7N08NN,'3 ]<
MR]13*S5,V[9-/_2?O73"U<R5^Y )>\%SEN*.NR(#!O:S"YU/G\K$AP=B5=VN
M=DF<^&9J^'IB!X[N&"G76<)-/;!<'D=>;/C<)PW6\%<+R6['K?980R($[-;E
M/M18AN]2<]JJ_]N->1=Z\.%O5U4;WIA)$4[(W^7?8;/F!V).7?,Z,1W79)ZM
M6SQUP;SV7#VP/4-G#K>2D'MA;-O/7JYV(OKIR9G6QYTV 1))AS;*N^CGO-.+
MNKZ'=%]:*^^=:OK]M)M[(/[>G4$:AT[@,![KW 4-E,:-L=B)P6*V(N;Z/#+L
M> OW:=/*;4/:YJYD,&Q98WIR\.'P[4?MURRFO-H#;#1"F;.7)ZT]?C(&5OPQ
MN/WR0C/-=45_E&A&;:VP]QPVGIF".9=0 YTI$.D9!\5:G+IMA34O,[[ =\I[
MZ3:]*HN9=O(+ST>4GIZF0*O8/ 7S%+'8 /[\9S'G8^UWRE.G3 YUFQO*7IE6
M%A=LNKC04_CAZ*H]KMG?G%&"))D)7_+B7)^H7&NU&):VY0EE]\E$:OIQ7,QF
MO,2</KASVMWJB3&C2L-"<F!SF))-]1#8RHMC/LN"5TO5&<OI85G5R_'?D-<_
MUMY2QX9<MA!K$\>6?]F_10JRUG, "U:=M/G^<3<2M6W)'C>C)'0MSXDLPPD=
M(PP-;L9.PJS -RP6R3B::9JZ^LLM2O9(!'3RL#8%T9YNN=[G WC7P:?$-SEC
M+M>]* AUQTD<':#$=,NSO8@9MF6A(\&UQJMS59IRO5[YPN[BA&QK4IT44C5X
M7Q;4V>I,:@Q/&QE._OQD^(:1\##5G=0+=,=T73WT#5<W4Y,Y$<X==Z-G+RUW
MO%J;UR!#EHN*7M%MHZHI_;1M"+B*%B)#XU$P@YP)UV452Y6?V"T,=4O\"^HO
M'^4QGC *876G;7END*2Q[CH.TQW;#71F>[$>AX$!)I =>P%_]M(86U>TMQ)8
M03U009[B!U3?28(HP2J@W>4S=X103QN5OGWY%-B)%V(C2L?'<)S-?#TT E]G
M+G,\EEK,#0&5+/\RT=1-/6^ZZ\K\X0GHO,(+7)QC*]XOH!/)7H]I5Q^B2>K^
MBZK!R7Q#\UC0MM#*7U6HL&-J! :]2J"?L2\<MXB=!7/0CJ5@PJ]0#=Y6C )E
MQ9X=!(Z!/=Z9'QI.XH8LC2/.L%&(M+YOP2.5Z'S5M -[EQ^I_5?P[5-'V&_8
MVL\,+->)W$3W0@?L8L>,]#!*;=U,TL3TX\AT8VJ3<9GX1'S<!O8IBUB*G2%A
M:<=SDRCVO=0,$\]A/@ZX&F#_$+ __92Z28(=>73.?5"=8BO5PQ38ELNCE'L
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M$E\X0R>1OH#K@&LDJ#,P:S'0!HP.E!9\KW#-SPI4"@"/HJP@MVFY&A!;CQ,
M%UU!_G<RL*7G45G E*[^IBB$)^FPK$^U@P3LAXS<JJ0FR:.].6Q/!ELYJ$]K
M.)1EF,Z()$3+S^BT$8_93,1_TJRLA*.=K'5XD2ZV@8H+GK)WM:L'Z=_C6'NW
MNEJ&,?GS3A02A0JH2"5Z2=$% UH+^3\<5Z;)HX0Y%=ZM8@I*_EYJ&W@3[_*X
M6%S,.8F1'4V:NY3L_B">AX%M. UI?GH\!?0&N&<BTRI6;O(9+TG90/=GN4"/
MCG"2I24PH1)]S26Y3I"#B[((4'ZK:=M-0$5L\;%3GA<S>#=H,DR$%=37Q!E)
MQ15^>.$ZH]Q-=,*2(HQY%0(G^ZJKQ%FIV38NN\]PN)Q?C 1?EBIX1DIP^\Z*
M3Z6/DP('!4B, K4=@?(-H(7Z++4LD<XV9:<8]M#P=LG'IWY[^'^2D6$*&]X;
MG(8T+/$2/!.Z$ZJ%R&I:"'<6-4XME,70:][0>;-V\$'_MZ\=U_&4UY5V2&RK
MPS=':-5DH,4EDE,2J1)E)F?X9O0Y(Q$V*TM6M8=(#,+^7;PHL%F$3-_%>\R+
MFHXIG?\B."9Q$3]K+O/HX/V]:( >-GV\VNVQZH7#'HVZ34\O-X $4 KOS,G1
MHVJM[UFNOQ+4=D*!ST94=:^UD5D"(YMZ=Z:5;)XE(S(M2C[!$!^6'M:SHA29
M#U-*SV YG\J,HBP1>AN;7W1(%?&YL6-%;$)B]PCCL@PQ&]-/2IZ6Y-F_&,EJ
M*IGTI>3S/@J@M[T8XC]4..D?3;=28B;O951X#^GZ#]Z1.Q@,+-9QXLXE4!\!
M47S7!I= 7P),90D;:?]B> J*K&1?M==U6<PYZ[097>J4(]^$C7H)/Q-4S+*H
M[F?$5*U/2&9O).LW*OH=4 @Q-*[9VY3>G104O"DH!6R-N@<8O9+:=.E+AP#!
MM@$"9P@0# &"W10#[[,YZ0089FXKIP];O_$><OYWE*FXH1!<952(G/VXEK4G
M\B?*\]W+AN+Y!%VEE&V?+>5^8DI3DJ!J+AT]PH!'Q5SET"OG5&/"D"=A<2'S
MX.AA0BJIBVCS8J[2AYI4MF9ED@?$V&4S =H!J2U294=?P[QJA5GC>B W+69Y
MB*7/&/F"J4DO6!6DB(VT:%H4R:A-[TBG-6I/LJ1]RI5E3IF@;1I*]XH[O1BH
M,T,,&A<E%>%!T, 3F5ZX*L"(4K(:/]VB8T:UYA4FSXEV$7^(B,>\+JNZR:-O
M"BI[R4_/-Z*N[)^NXY"&YZZSA+GZ(Z(NZ;S>?:?&;I6=^J)W6Z:#EH7PXI)J
MA&#[J-P\CVE5-+B!-5$KR$"%"3-R78E\E55-J+'XNZ4@\82A[@];HK ;^89;
M<]$,I;F(9:H75*E0"6>JS'P[H!;9<!FPU)2?DN#X!3T>!6DHN'[;C07?ITI0
M/[8>E"/.1:LX])'EI])!S(!2$6$3'9W+JNR!$MHOL/" Z$%P+IYL\#$VQCR0
M9 X0Z-!?74E6B&FBDFW #\$LFEQ(KTSKTAQK)T6;F"FRVKKE-)ALUNZEYSTE
M=RPY3*65U^5K/(<C33N:KVF0H[PQVAQC@T]0%?2*M80ZV%9_H3K^CU]_?ZV_
M$O<E,L46V4P69C:Y3'+/,U5(L49]SK!3S9>\.!<\ZUQ59'<*8MX<'C3>VP9+
MV;0JFG MN8Y%+BX3'%CZ798<T2@-5B,# Y^[/SYW1 @D^=QKAI'0PX9(E-?B
MZ-7KP\9;@<[<K@*U-GWKP5PM?RQG""CNN GE1AJ>1OKK@=G]BP$_ HU!-AWD
MG8"NJ%IH8KU(.;*+Y6LIUMNKZJ5OR&L3/U87AS['3B)]K'HG<148:'=,&=T;
M-WT@U(H+#5A6U=M7PVF)F+! G\43K.FEBIE95G7J)C5J:2@8CBX93H^#C(3W
M (-GPH<B6*]DH? BTY"%5Y20"[9\U48DNYFL%0;@A/\I+YJ"PJ: H,<%VBH"
MF;M!VEP*R)("0^&RMO-,FOZB$EB49,PBU/+%/?QWU?'#TVLHP[X5.=U2T%&K
MN'9+$I8=^ZNN_%8@U)5(@FS"L[)6HR ^W8.C9-B"W@08&Z$T,+I[9'3_Y(#D
M!:CJ4[ ]0,J!\9213O#C8_(OR2EVZ?K@JEZ]>O0[,7?L3M;(O?NNL;LR--F3
M>YM$1\<\%K'^@JJ?.'$L[%0H/<1GQ-. .P&7:]SC;#J?,#WEBP($PX)GK6P[
M>-/&+U!KJZG25@/444[6,?U#YKY0A@9R4XSOH=N7V@F>-9:QB"-2DIX(/4IG
M,9Q%RB8]+>&/!)W83<J"5,*Q#\VB*4 A5X04,HTXT;OBIO$"SV5Y^-M.T@!J
M 6L4?.6S)LUX"(AMJ:7]2J!><M\@&#'-B&H6JDE;:S+GO 2 85XO?$CQ:<"+
MW>('KY3.L&SM$MT(88/_?%R/ 9E]>,](!:@N:H'U7T+MT$6 N\+H(KFSI+\.
MU,DSZBBC!<%_];Y&,D>2!L(+_/_"*I<8E2G\2@070;T#'B1UL2:S 8-):_E1
MI=XH]BG42]%4!176#OW)(C7@.;U8:<*!G8@BRT1SW/YN89>AT=\E+B=4+G%V
M6AKY3H.*5.K"SE@V%5[PG/($9IEH&(Y9$1$_S41VA416F=7W'Y%(B@=>TVER
M5U2Y+9%\;Y2[(R#&&34VJ[($W4N'H/FCVZBQ8#]<8L ^JB!?,D$[]7U$C&U\
M513[$C$@N9RT^4/(A43&4-6&.;"Q2X:M>UMS%'[4-I\H0:1G?('KGI"K"O,%
MLU,$@_:1RNHH(M \?/#A\.W'3LI"/,F)P8TO-<%5*30E6Y-91(7WPOV-[Y!)
M30EY_^/E;$-EORO-1>8?5C/D3ZH[- 9Q*3>"O&RJ<*WD6-Z,5*J\::J"E9B1
M1C%(T=^%HM,4+CLM<E1C,BHF;MSSI" PR:!ZTFJ7*./92UE+LH0:1^A@@-\^
M)I*/-($_?98]@5]@^*0N67RAB<9HF ,&^#$KICPF0PW[@A=YU53["OI.)'W+
MG/N<%RSY7)]A6:O*@U'Y:S*+K%$TY4X:ST@]QY^:AJ&GQ3113O29:'IT4:C@
MEM0H21J0GP,;^TQ%*ZH6_5I;ON^?D&$RT<< ))+PV^2Q4!F:*!/E65,!,Y.!
M),J,D-QMY?12D57RD(JHFPA6+ZJ6HDK?5(E*;4"IS92*0-&X;N$+]J\Y%>>[
M01[0BT'.W8.<ZT@M[:-H[4-:33?U4:4T/;I]BER8H@"H(-4Q9>*D]9KN1-W.
M3]C$ NMP.J5<_3B7"AAWCSQOCOP&53S1C6ZDJL> ]J:4K+IFX:(;P)8U%2K[
M5IF)G1!X9U>=(';7V8D\#:T73.Q6I+0=X>Q(DD$7@-2,2\MKFCB&QK!H;*AT
M &H:$)<%7)!J[M(-EP-T3DLVJU3G)L*%#$$T$TV5R ;_8Y)ARZN.:2*=I+UI
M/+)))HEVRFX@*,O.E01PW*^:XM!BSL42$VXXKNH$P*:JF&0Y/UINHTF3!EA-
MFMR#XK)4#.H9T6EA(7K!='JXX,'W$#4^;#APD\,J\K\K49[7I;F+!AE&*/B%
M_D9IU^W$" 19IV-TV_!1#NS#/IO4!@/53!%%G0@O#:XFQ;1",WP9B/6LZ":K
M=+H):7.5'Q3U76@MH:^4>M"IFTK5IM*T#>PB-[L4,>@DL$!=<MGZ1"&YG'>
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M@0.2G9*OJ^39+,)R1]J3&+&#G?B66L1<HF3*?!KA-E^O-_04V 3;Q^>H;JB
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MJ/W"\P)NAD:7'['-6,D:',$G?W MY=M2-(AK_&#;R_,>ZSE^UZX[PK?BJ&&
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M.(AINHYHFITJL%'F/1$31\_D/JJ1!YJXB9*G4Q0EF*8BO?^*C(#W9FDFTCV
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MN#=WZJ[2T>RF%952/PE^4C6CUU"7C*5LOHC*F KID);CW;+F:8*FP1W2%!2
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M6GQ]:,EL&[2P/FSI2D!8HI2ED/19)V)R>K)T1,PWPUH.5<<?)I!>;WI,Y2A
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MZV1=VMLKA)@K7;DN-V,U%DG2#4E($1IGL>Y,L!E1+1LD!G0ZV"YWYJXX=KZ
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M&WK/MVKR.Y/04 3^P[LL8G>[[Q?"[8@F"ZR:ZX56T))H[IR%M8>? @$GX-G
MKJV\6(C8*V,3A RYCX%D8A!!I@7N\M1UEKQ033\94L7]H'&<HBX)H18G9X4B
MUXM32QN<\F8?CX/[V(%3FM[Q^DX-M->^\%TRQV=!D!S'_CN3S\@"T0\,6/%
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M&PA<JOULNM3=]7TEK1(5C'9)!,$*1$=;,!E&A 5F-$"Q/@EI.QYXWD[8J [
M6^.EAW#&$$C#\N.+H_GOG0+H\Z?O,'"^F:-&-]3JTZ\T/'B#R]5BFHB,TX8(
MEW]PX9-K;Y+PLJBM/)_A^O_T_3H9\_Q+^@BS#_B&F'E>"J;5!&QQOG9+D 44
MTR4BBR 2;4QA1'( 'CLU'=LIGPWB_TK"Z\7\\Y1D_.3K>P+(P>S%= :S5#/R
MY.U\7@^/$$#+&:5CW-2KJ39%5L]]&9 N$()''W*? [/-:1R5V1TOWF](1?0
M0<NJ_9OH.R^HN4!?=*AY"(&A$(+I5+OZ0LG,60[.\)A][M-+<W,:QY!)^'E
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M[+F!'LY>J#I3C4<U!_O@ZY B06]T_3_@*=93;$>^N$4DX[#$5- IRE:;0+?
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M'P*-'S43.CN#W8[8NS[Q,6F@B94;K#/O<3J;#-,,\W?EK:TS1F<&F#(A$Z9
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M$S'1/Y)&5#WNR#5X42NNH=26I2QB;'-F]#V.Q\?^!G;N\6!H/D\=EC),>#%
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M"ZTW]O9 =(Q1!.M5@N*UIG?1)W"2_F#)"F9M"*I1Y]2]$-O=[9WW4FOKD-9
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M&1/*-K? >AW&QN62PK3F;M9_U2Y+7\)Q+:AP2=Q%JL<@,!]BL@R,B>1\D:W
M%5/MY:6P-$=(TZAX4E>(.TBYW9DB;Q1::L)C@[/"@R\T$]0=I5?CR0="^:$:
M8VZO%QAGE]\-BI A\B1 Z^! 9?K#6QT@D7,87!!6V#9ZZXKP*<NM"8L-]FKJ
MNS#[=HGGU9>WPX%F63/"!1%9!*5334!+Y'867U01Z'@N392U#,U35M'&[#3(
ME#Y'\^WPKQ'2N&?O,>3A\;??PN1/<F*JXA?F&TC+2-0TB9)GQ&GHM7NDI, 5
MDRB.Z=I[M$WB?W>,3UE=C9AL< Z[",N>CT_B<!3.HN.:'OF)%O':]7J8SW,D
M%[;\]IS,54^0);J2A+%@4=0K-DAO"Q,.*(*.WG 1$VM34>7^F)^R)K?$=(,&
M+!<V?(NSN1DO  X*4T;'6CI=,UT[H GP7%+,7V1-5HJV--+@:DQ/66,],=6@
M"TL?-EJ<1B.K_5'I%0BU?&#6$&PP-!KCG''1<VQS][.W(6RM?,?^Z7*K[.]+
MWLG%Z)]]N_CR/X<TV4_2T;<W]>KL6<7V'# 7"I"XXO52;LY (RK@D]>2@B5M
M?*-N'IWP[2HK94?:6:7@_CAL4:%A >W<+B??[01=X%VTB.@ MFU1D'7@[J@D
M2 />5TFK&6D[5UH6T4FO:V. >LXK$<$I6_-I63"E:!M8FQ+K>Z"PN^J [)O
MUN&JI;!>CSZ?SJ9S"_#%D:++FMOD0%@WO^Q?:YS.BTH08.NTH1F^K8QN@MIA
MN-$_G:N$LR$7+>K-+H$F%O<\3>9%^ 0FUNX2 DT-ER5HKT21BL(=UJB'T&I0
M3TTF]^%B2[.)/(<FF30\4C!L8SV?L$;6E+($.G/4R: JKE%)V=6@GII,[L-%
MBS;GEXOP%3.\FN"_3G&4OLU78&=-,H+&6DC2H(+VX(+SP(IDF(3*&-L<'74
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MX/[%X6 "?TY.KJ>4_.=?QO"E_+(MX#]?^\&9_P9'?_;'O>1YHJ5=8TP4_8S
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M5I79J\)+%T5DC3(1\%L?8 3_6L3'+X]]G2&OS27?XJ9Q1\3<HFI QCK1J>9
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M"IJ2D',@4H8RO#YY_#,ZG?#(35"_6N! K>#M)?X8!EM/+UA*U-SZ"L9E51H
M29X2D31Q$J+,J#X>N<V!V2[1<)#V;VOR?XP-4Q,;:VQT+%LNC5<D<(4V?"S)
M:DH+=/JHRH8"9;)^4L7F]+\>O%72Z6-DVBK(?. +6#3R?$*/463<3Z5#:\\G
MB&4&N_*4)Y%B':]L!6&O $L;:N$Q2%QED*QCJAGOI!:2**=UJ?3DQ&=F2 8F
MJ)5<1%G??]N*A5<%O$J:71*!W*X[ZTQ$"Y&-\L_9</)/F!P/OWTK%UCI-G*>
M'-<T)D)%"85I*M$8*%ZM,<KQ$)+@"VT/G[BC7>NQAP&<RN)>@HSM[NV;DOK
MC? I0>DN8P1S:"IF3VP40)1((G,A<M,;_+4?_0H1LIG8EZ!DZP#U1Q3UE^FU
M\06,8?0#>KAG<5N&0W)=)L8*50)=.A#/$;>)Y<A3G8%<CT@Y#&"T(^DENM\Z
MXOQQ.!X?#P<%J8C*GT<QCF[\]='DV(]&/_'%V=A0*2 &;2.Q$$J8R07BP "A
M.MO$>#*&UNF6VXB\ \-(ZQI9@INM ]+/9==Z*;1D5N-^9DM*?70D.)9)\!2W
M-8W_]W7"S"\@@WTK9+0D\WW)8/\\&N(I.?E9.@%/C@;3T<;?9X,W[P9Y)*5
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MY?DON"ZM=X:CDK=Q]W6LIYE#OT!HHE,LT@;DT6I.-"2@G-($MLMN)*TR=P#
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MW'#0.@2U.'_GI=1,MJV@38HEUY%NB]9S8?VJ/RFKX720^C_ZZ<9?3Y%N1)
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M1N_Y7UO.WPYZ/AJD^0B1GN5,1Y8,P6/#(2O!$VLD)]E !*^ML$Y4744M,'%
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M0E$L\-$:CK57][P91J3+.'U =U;ZS6+^.2^NO]9(XO7Z*/A<8XVS$C472EG
M$$E):02$*!4P:9E/R3+FVB16CZ+>>0\TI,,(S4=WUO#;$:AO:Q;MZ_*/Y?H_
MG1GG7%39@;&^@+*.@:LCV[34*4K,F:MNYNQX,I\ E:>,\CA-4G?7M-Y+#Q-^
MUPJZ%+TJVM.S3210O@X=K$YO]#IXX;GAOFTK_V:JG0#;ITF#<7JO[JS@JZLU
MUOFWBR_URVN\^G!Q_]_.#'/9%X; 8QVSF8Q=-0:E^RF)%*UAWK;M"#."DF?N
M-Z=&@]JP(55=:Z13"4P'!S+5VIY$]U<H0D()+J#0&>T1#(4^<WI8H!L4<34P
MKS>_$>/\YHIL;?RZBL]SS[,RV@(MM07%,4+@]*4Q&HO//*-KZZ\=1<TSX4>@
MQ_=[P4[& B6]%C??3/B8>:^TC'6FLJL3X*5'"(QGL%%&EEQV(?'1K<[OY3P!
MZDX-S>^)ZB9#U/66_-:6OONQKS-.SRK+ZO+'VC];AP28N80<@LRQY!!M&IVT
M/Y;Y3."F*']/9C\9,C_8QD]IFJV,6D4$72*]M>I@+_H?/;A$M-[:K(T/H_/Y
M6;'/E&Z-]2,1G$F%.5_D]9Q0_'/S%BK&)E^L@2A5I*LH)4)"TG/))U=D(+LB
MC3;N;6#=3H#S$R7"(UR?5+AR4R^3/2M,&]#1<;J9% .?N(7$DDF*OF=2FT:N
MC10ZLWI0R!^A\MY-+0>]I/+U+$69<V8:HG(UJ.HB>*T]I$R;T]9NS(TZ5PZL
MR)FZ@T#\"&7WCC7^.I^G_UQ<7L[JD%"=&0/-0JAEW 'H[(\@<M$N.!)/M9D3
M=2?!"9%DIT5]!-U#1=CNY'^2M5(HK5WA$'VA-X.V==8>]U!X*5XX;YQITZ*A
MD4(GQ+TI0/X(E?<.DSVT>DS_>[.\KDE'+RZ6M678S2+_%);7"XS7,\VLCD@[
M+,N,H Q&P( 2@F?9,L4PZ#8Q@D[BG1#-AH?C$=+L'*!ZRF7P9C'_<E$KNO#R
MU569+SZM_O1510$OUP&%BZL/KZ[BO):27&]HM\Z%KO_8S(=VTBAI UW8DCNR
MGHP"E%A ,<6=T];PLI40W]TK-+BTX_.O 4V>\0H=%N*AR^R&5?#;K.7E7=KR
MS]\F!;$BC2X>%"?[2;EZT <N( 2KF*$G*4IV $9WD?W,[W'A;S 78FB-G\I7
MSI)[S[P!5N>XJ)P,A&@*:,<3B_12YXV[)#16\)2VPI2Y,6#Z;X,=_TR>,_>.
M,RXUB.1IKRNO(?!B:G6RUE88'YD\P%$_M7SVHSKD!X1\P)3?%HK6N^NW^=6'
M.L]HK9V(&K.-''*0=5*WS/14D]4+;!F15@MG#D+H[T4]L[@IN./DZ>ZAX$,6
M,BG&="Q1U@Z:W-^VAO4V"K QY)2\<ER-YN8?1J538O>T\!\PB[?EY;/>LJJ(
MD)GWP)*NXX62 &]T(&."'E%*DDW!RB$?&.>SN#&H(R3:[J'9=@JQSR8:$WU5
M)=8QGYP>_J2C5"*G')S.SAR K@?/$#\JNNX#Z@CIMOMIMIU+'$3"% H#J>EA
MI#"RNN8!BDXIFFRR3/$PC#UX;OBQD78?:$?(K!W,)-W0<>UYG*GDO>(F@J](
MD%%*6[0P 46QF(IVWFUW_#^ '^)[N<^<'@_V(;-LQ]3U(==X9J3*R#2"%"X1
M+%Z 0QE!!"N$P%"XFQ3+'T0_$WU4\(?,LFV@[B-YQ%]G261>VR2#,*DV3S8<
M?)TKRX,VJ61GO3G$T_DQ6<]L;@OOD)FU37?KQF,K!NM,B*&V+Z+'EK .?-0>
MG'*,C-V8E/0'/9O/+^FQX!TRR[:!?G_DZZ>S^&8AH60L)TB.'E(*#8(O48%S
MQ=NLZ%O6'8#'/Q3Z3.B1 !\RP[B!HO=9TUH'YP79!:Y(VJW%:@A1>0@VZKKJ
M7NU>:3F ?&>^#@_CD!G#;?;@UKYS27KF J-UCA94$ @824-6@@HR*\7\SHT
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MY=LZE/<+O%K>MLKF,Y+'H],&O/<*5'2%3)T0P11NE8U<&-DVS[V+E*=-L&'
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M ]=0XM4+4#Y-*?]7 +F: Y[C.N#F<24IM@ Z'^1.Y8-(0I!2I<]<@PY^/"_
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M1[]7)QI?N2H(TOQ1]5%W%W)9PUU"$ P852F%V*DRT>6ZA@L/"TXPZM_D[[
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ME9=?T#S5(6+7<MUT5?+'0K[B* X<CB#AG@=1F'"8,)% G_B<Q3B.26!5'>O
M>'-[X2MQSYHFZ2V1P9]*:*"EMN2 0YB;,<* 2([,#\>":$T9AM ,2B"'QIR4
M3@P!>$TNIE_K1S5#;L=\Y(+G\H]W^'M[]]7'-'(<UX.)AU5?!BY@DO 8AD(X
MR(D2*H2P.&.93O*9'K4TPJH^8YOSEA<[MIO [&:$.1,K_J7/7C8/A%1\V WW
MZ:TT*/U/(/:D,\AT9G@]"4TX\LG+&.B@ANML=2_)_+'29R%8E#@L3*"(!(5(
M^M<0^QA!Z8F'">/<P2@^4?&"/>+.S6'?W[#W9.GG^PS<+T3@=&8[R4PU1&IY
M]2Q<;YZ%\_D]"R<K0'#D,_&7+SM@^6R<LMA AZDF+#&P3XJ_:F&!#D1'+"?0
M-6J_%?7YHVHB^Y]5O*2XDJ_CZC[=>$8+CX7$Q<2!(0^E)^%1!DE D'1=J4=C
MM7WG6VW/=P\W-T^@+:V.+6\6-^E&<"OOP!!TL[7H<%".?6#Y"L6MJ(-1IATF
M@Z[:#@PYZ8K+3/W7JR7#;YU^Q^ZU:)H-[Q[PZM<L8]_2Y7(1QS0*4>!#QXL(
M1%3^%(N(0C<FR,-N&++$JEK)I-+/C?T,&GJ 'Z^^?/WO^/'IGS]:9LQ,^UQX
M*O,?)0%,(C>&R&5J01P%T$'<1X32.&31XIGG)/O+/QEM+<;<U=7/@-K6Y?1A
ME2VS^Q/NZ1Y^ *;?WAW4J'_-G=XW$WVS9BHE#*#!89[[OL;FF^T6\&$-_K*[
MP<;&&7-CV%R(GBNS>O!/J5P9\NOT^>V0?_#T_J&4\DG2Q_?\]X*+]?(Z%7Q!
M$^I'.!+0Y2I3C(8(DE"$,*%R]990G&!JU9K@&&'FYM<T@D)<22J]&Q4%H[9Z
MUEIHL)12JY6*T-K"I5+WS9I/%Q!_D6Z1;;+P488U7!M.9*ZQ5X[-%/.I;8@]
MTTJC#*BU 94Z0.DSX.IR %2'77L>(]"T*],!H'NS;AWBGCW.[_XW7JUQ_B)M
M$GS.2MY$3\?,\3WJA) Z3@"1HXK (*&:0')7,K'G"V:T]NP88VY,6DL)E)A
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MQ[3042.J^^D7+E^65;D0OO2W C^"1*@C+SD/PX1S EV>>*$3>J[ KLT.H*T
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MQNI'];_AU5I@6LI5#?N29VQ-2QUT76_/TH &(A )]#B*(,+,@5AP F,1N5Y
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M"V'BA@@*'KN1%Y.$6I+0GD'FQCV5C* 1LN>:<B^<AF1Q)$AC<X0M/O;$T '
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M,!FV.4/GB-/V:S!1_DT+!Z,O]2.1B^SQ,:WJ;.I.L3H/@J^H'&M?L1+7C5G
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M0O,AY\8GC<321U(RZT,<WDAM1R8&>)M1RK HCDPL6P"_; #<" S^5"(#+?.
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MZ0JL"[;]RT]V3NQ^I%F,PS#@"#H$>Q")Q(68N!0&<8@2Y+D>#:WB:X_&>9K
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M[].5VDI5+Z[ZH))&[_SK'7_;?;SI'I'$P0EV!88.P@2B*'!AXOI<_BJ8)Q=
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MV;^OJ\*M>XI->1Q%./ $%-0+('+B"&(<^# */.8DB*J ?:LJ.2:CSHWEE=!
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M"1IB3@3UKBM**'9\/_*2V"A+Y.!(<WOE-_$(X-PBE.@PH 8[ET/!-/*[WTY
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M:\MP+TQ"[+M0)(*H+68$L1/$D <T=IDGA,,=8R?5;NRY\>!&^BI#=2L_:"D
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M4'<+YW5.TC>OK'Y3\T8AX]D"SZL76=?[7BU /E=-YA9+9P?JY@BVGZ0;/&?
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M$=7K&*298-0+H<<B#A'+Y!?L(XD=(C3$A#$AK)R_I@./[>/^[9?[7\#C1G2
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M6-)&B%F$_,1CGE'Q<K/AQD8=2C*@1;5P[Y\'U2!BPBE4/;-%0]82+-"0MDN
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MPBS,/!BE7HIB$7.<F)>'/#_>V%BC*;%:W15YT%)4"V^U <X&'G^WZ/5,(?O
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M][I\MCH-9-,(A2Q.DP3ZC!-5RQU!(K?WTFH6* [D/M\CEN73CHPR9N+5 DX
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MQ,<105Q@HR),W448FS6_%194I5:4W2?%M<EDZ389[?P[#,0]DVT379VF66H
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M^&\[$[]1TJK1:A\3:N$DO][$7L=[KK]:@%?@CZ></E4.=?D*/.,W0)03O0:
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MOWVR#ZXT;&?L4\SN]<(^>?%E-7C&C"L+?3;R1?W#[5(\EY-8IF$L<P)2A',
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MR[-U6_K.$K'34'WBW+/"VI .IIKV8$-\$]+[94W_>MJLQ^E/7;'SG+WK2,3
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M2 [-P-B4>TV^LL2\32$>\G6PVP;&+.2>MP[#%J":KZ#-?-#F/J!O0?O"&H'
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MM\O@32R##9_^,TD'%8G7#6P8R@?=P085QNX6-NSB;GM8N5CJF>Q\Q99WBYI
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MU)7VX .Z*;S;YQ>E<;4JO9.WLZ5ZI8IU<SBE;HNEF!:O@D\HSV&>,PD(X1)
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M;)JT?A/+._E ?MY7)\'7R^6BH"LS N%A?D],,1U".&01)X"D%"O310A !.8
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MJA!VUQA4"1QA</?#/W:9>_2];C'^JY@_+LC+4\'(M#'VJ<0R)@+01+>^8X@
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MVV<-9ZPZ<K=EL[K>VW4TBA2+A=Y%](G3 _G9RK13V\TD24DH1<R $+E)AR,
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M7&=!.%:8=?[&]Z_-O5_H&5/+MWOUPBW5%9_4M69:Z$39B00)GH LSP6 DH4
M9R0"DJ5A"B6)(NB4PS@(U6-3@0VA5\&+)M6$@$1#[/L5[QZ7NIOR'(TLAU+
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M_%'RA6!Z9>"NM@Q*N!<"]I9?+WU<YU+4?,/66WD$80BABO.B>2Z22!];Y()
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M57P+A<,._@60#+9//RO D[$.K,2S>K1660&S7?* ^O5W-?3K9<X.1U];[2<
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M^7(^)ZM"3T9 H8UWS.&VZ0++:8=?8/N>7.P5KE<&:QW*TN0J$UH97>9,>YQ
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M(X8#Y:8\/ I GG0!'ST6K]I>1UTI=%YNK"J06;6W.ML5.S1[ /^YI/J^:IN
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M]/R6/7V[9;_=:[\IBLU3N4NOEY"LS*U\"J<Y(Z'@:0Y9D"M&"U$*<Q$E4/V
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M=NWDZ=ZA;+<G=*R8N%R)V??%[0]F)+?5/_6>?;5#%$>,89(R2&@20!3E'.*
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MMLG*VJ\VK\L\EU!OC0?OSD'=(5C!'3//80P.!@P<X. .S6'H0X=G=)3K5RO
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M_.O0](6U*L7J9<;$<8,_+Q<O90ZBMJTPQ5N;?]?1[)^7ZW^(]4[^99IRP7C
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MZB\MK"BSS8$GE5B;+?@NBL8=YC$N[ ;14@>;[KGO<,K"+SC',EU/G!$FV\1
MZYI5]5IN4Z#>"Y)68H7I-J;N#H+&;0([-M:.UU$'4+M^E:BV"TH3R:S(61E
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M0MGB:H-FQVNC_*0A.&208B15)T::;>-Q[4C@\='OO:^Y:-'OA.44D@E 7B^
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MR7&]TQ9VY;%=8N 07=U22W2 X#JP) \FY= JR;%(L$91B"LE!U>[3-N .?C
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M'N]^K'KM0\7Q.(7;NC8Z=I&?WI<S0D!,CM#/%":9M$VIW;V.<0NW/1,ZVL*
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MU?6 PWL*&Z)&742V%,-M6#$*(H\,O B,>RL93VW:)!Q;C_(T:J*.PN! :NL
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M8Q$!D2)G6T3U!WO.\YB^S+')Z<-N"NH <G<OR<ZT82DJTKVM#4A4G:,>M$G
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MAB\W^22,):.\2E"\UG7>4 (GZ0]&,2JSY&*IU.8V>TM"I\5E,\ ,!^;>VNL
MG!^7(6,E_R;UR*@@5(P.LBX,5!2TB$/MI!9DL,$ZGGB;>Y#[E'0+K_W5OAA1
M!QU@Z/GEZF+Q!9?O\7RMG]7GV=<?[66UR!GKT \>:BLDP\#E7,!Z%S%I%*U<
MX$>(FO88Z9#(&DLS'8#L7;BXDR!9I$K"U:9'H:X07B1XB0K04HPG1&:^-$K:
MN4O&M&<_AP32[M+O #HO\!N>+[[6?A7I\WQQOOCT_7T]//C1N#@HA>MVQ2YE
M4,;4$]*:<IN-02XT0]OFYNL)PJ;-J3\DO,;44 > ^X#+;[.$)Y^6^%-:-W.Y
M%!L0E$5'(DH1/ 7L$$+TS&2=Z<\VQQ\/$S1M;OTA 3:&1CH UB,B>_,C>T[6
M:4IUSEK@M$24J6UM;="@BXLA(2=VVQRR#:&NEV3[J0XS=E-3U]"[T[S/AH(Q
M,0\:=:U;*0$BF@+.Q>(+%F[*H:'72VO%\3$Q&'0[*JAKT%UG]"J&%,5$!<S6
M;F>U8#@86J_,12<+\QEE.K2MZR!]?T*P[:"8OH%VIS/?W62+LY*R+"46(*=!
MUE%@G%:1KZV917;9&V$;]>S?GM9NX]3F8!Q#>?MV26P-T-J33VC-D1D!Y"+7
M40:)(G+M9*U!I=A)%QY"HP$ C]+5;03;''C;*F6T1HF[0^SU/&/9S-'+O]+Y
M9>V^<'-'?::,XT59#=*)]?5SH/@\)C#&430EE<VVS475MI1V&^>. \.FBNM@
M<W[0P_B5*^>L0(<"!%JL7-5*!TM>KK/!)N%\\&W.A(?1-^ULG0. <'0E=6$3
M?S'KO_(4G78NJ  RV]KW@Y<Z\:6 4%$C,6R\;!/U#J%NVCD\!X?=W@KJNF/Q
M@5,HS^X=JG>9H4I$'FV.ZGT!_\A2_3\'@,FF^H'FR<E/O?C0ZMQ*$),D$L?H
MLI/.@:W5ZZIF,45A(DBK963628MMYG =-)'XL3C^5^V\QWHK1-M7/<Q?I7#^
M7QB69XGYG'U)D#$P"NQE!B=(<#H[%UW2V><V)2(C$'],J<?;('*;\YH6>NX@
MA-F.Y;=D9#[^&\^_X>^+^<7GU5E1'C.+#HKT@GSEP.L-90"54_!%)L74X<\:
MGZ;[F.KU#@?HO;1[=%BNJ_7COQ=GFJ/FN1A@SE"XEZ*%8#,#ER(%A+P([]IL
M83N1>TQ5?8=#[BZZ/$[ $@+Q+-IBB!<+R;HJ6)*N3S8#4U%([F,6LLW<H1T)
MGO:TO6O0;JW/HX3MJ\7E\HQY99*3'AC6[GS,)*@3FR 4:Y5-EEG?BZ&M]$Y[
M-M\S:+?6YM0=T3>S6+E*]^Y@3PJ]]@>?1:<@JRR)*DX^D)(0F6$@<C99*('1
MWD/MAB[I>Q Q[0E]>R@>5$E]&]!Z/:MCM)RK#(2@2$M+1_".!S AYA31(X\'
M/RH8>F?>[,"^"X.XK7:.]<Q^C#F#VSS^( >K!YDUN!U,0TG>HXM@"BN@C'?@
M./F!WB2+N5BM19LJ[U[[,"#+-JN2 'EVM+BB 8>F3D/FP7,R[HFWGD+X=^K#
ML V^]NC#L(W6^MY^?ZG0YIE'AY&!J5,/E(HD/,1 " J6YU X-AHZ\7?LP[ 5
M3O;HP["-TOK&XX/U1I'YHEP=N&"00B_G*/2*,H'T/'KM90FI3>GRW[8/PU:
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MC2Y,AE#7R?W<&'#8!+6Q=-,!WMXMEFO57/Q@[@$NKPUV1HH+7%3 HB9WGL=
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M)S!9NZO>]+'F!5A?(M.* GK6+AZZ3\VTERYC[TQ[R[M#S%POI=K-R!INP?E
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MOC5UV]3KCGZ0/Q5:=I%O!_'OQN[):'/@DH/361,OWH"W3@-GB5"/@K;8_M+
M#I1Q,?:QVVY2[PX\=P9N1\T=4]Z#ECK6>2!U0E^V$ PO+'%=HK8'0$_WP\ZW
M4??08>?;R'YG#)$1C(O#YQ :%TI(S$.R6$?::@:.Z]J]Q92,*EK5:&C=R#F$
MAY_P,AK21M-/%]A[MUPDQ+QZ19*\=TU_)@VY!,85R$G0=AX*.0D%$8PS6<@L
M76[45^D1HOK,\MH'76-IH(/M\#U^O9KCOOHI8WS-"@L.8TX14%:7P04*(HIV
M8%!X855@2K3)?GZ$J#Y3N/8!TU@:Z,(V73&P6G=W_G"Q2']^^$R"7=4\1\S\
M+!A4PM0"DSH!4CE%KJ>( KQRNGAE*8!MDZCZ.%U]IF_M ZH1]= %KM8\7%'_
MXG(YFW^Z&F>S3DF[R^N=!?0!$WWR8H8UL?:TG.3_OKP:U+TZXY;$6E!#E"I>
MQ;O>%0M9:4^!-&:3VE3JCLI&IS/5]T#M=%J>^@SLD4W@]?QY6'T^F>=GWV_2
MQ6E-KY?SF>*9*645.%OK]T3".NG%$/*$S48;='Q8<^K=WM_I3/4=$'@H)73F
M\5UYK!1B"ZD8T()!4$74FP4G(;N<N,_"^$:M,>Y3TNE ]9%\NZUE/;5-NC]/
M]\>">/FOR]G%]^>++U\7\SO1]4E*2[+<9Q*S5:FZJK&.D>&T'J+5M1FRRA9#
M="$/NQ/>D8!.QZKO:I4.H88.S-)O839?O5FL5K@ZG;_\ZX)V_\O9ZG/E^7KM
M&).$U<@@H*DGV)E!U-(#-\(C-\X6V<9K>Y*T7L>P[V&YQE7'OJ5J8QNSJV/G
M#WAQ<8[Y]3W^SK2CQ:$LK1Q/H;=BP8+7PH-#S5T(GFF1=S!@C[ZTUV'LXUBM
M\>3=@:7::)!O0Y3W57/\+'GNE<D>3/&TVZN@*0(1 ;@C)U&5R)EM,]1N,(F]
M#G<?[>A_+/4<!^[>+6<DH+-BF _6,]",]G^5R30'8I;XC"&'I"@R.40]^",D
M]CH@OBWN=E!/%Z=O&UE[>UGS1T[+E2MZ^Y'5&:=(I[A2@.DZT]QR 2X[ ]FH
MH@+&H+D^+ 0WTMKKD/D66!Q'87U%IA1D7R[3Y[#"]?IZ<8D?%\\_A_DG?#TG
MUB_HS2>KVPO?TT(?FZ?9UW!^G7U06,Y.< ?>\!HI%0U!. J7&$O.&>Z2&9:Z
M.BY=O<ZH'\<E/*C6.MB]UX>%:U;/,&LN#$.P/-2Z>5_(W^49*$0WKN0@H@I-
M;.,M#<.P=5R7![L)N -H;+36KV^.H3%?MVE^^5?"U>K.8CC37BD=B$.G= (5
M60072YTD7VTV8R(VNLO:A^IA\#N*FX.#*[$[P-[-KKI[;7<F)7IF,0.3B=$R
M).,<E$D@O1?&N*BB;'.Q,(R^82 \JON&!HKI#FYWEM9[K$6\Q-=-=ZV3JW9;
M:R5>\<K/E'-<!A20(TE16>8A%J2E5K2QQGOMTX$/88:0/0R<1W&+<7@U'E6S
MH=MAUQ^78;ZB?T-O63>$:S+->]-+#C'->Q"#>_8>NHNVVV95/_K49"Q9:]I?
M4S8<E _UF%DF8%84Y56,*;7KL/$K/4V'?W,*@SPO!DQ16%-1%7C%"DAAF67$
M:<GJ*2#U._Q[1$5O-?U[&ZEVMWFN>Z@H*=+ZU#&S2-M_2@F\<PJRY4YBYCRY
M0]1)=3[]>RL]/]VB:!NA=P>;.QU3UL4X0B*@BB0620)RW#'PR2)MSX@AMZDP
M.)H615MI>FB+HFW$/O7Q['6/BUJ\?K> %34%N=$B.!>J7(P&;[PC QVL]$FJ
M=+\0ZO%.(?>>WQ,.=E7< YU"]I'BY$"XG.-]^CF7)EH7@0QJJGZ\ )\I]@R!
M)>U]Q.@&HN#7A_=4QS8*!/:4W]3Z?[I/@2(&I**H3I>DB)MU43O/(!P/J%00
MRAYRMO*!+IS'P,:XLNT7*3<]"B1:;8H34(PO)*A0($1: 1E)@B&:%/(PNS%.
M#X@#70>W1<HNLNW.-[T]G%+*2<7J/8\J$906"9PE@14OL],R!G>_3=W?L?_#
M@8.;W<0_M;W9>!9Y_XCJ+,90HDQ54J1X%5V=M%I;$S!GLU66]N-AARB#7]F3
M([NC=@?EK^\EZN,ZXKW\\H5<^46YN9%Y^==7G*]PS />)U[1\'AW&^;:'NY&
M+3GWGD-6O'92%!:<=P&24"'6G)"2VQULC7>X>_/4N]<@I^75;![F:3;_=+58
MLO$B19^A<)>O+'APKG;X$CDS4WQ2;7A]C*KI3=>>J+B_UXVF@@[<II]YN1'6
MG:%$9SYQJ\@C *LM>071DHN9LB;7P-I 3@&%HFWRAI\D;?K(OBFP]E5&!^AZ
MNF!(!L6%M@(B19Z@6!TVJLC[3*%H)5'[Z-NXY^/4;S4]&Q@97>,J8_KJK>>+
MRZ^+^3T'XZQVR8VH%"A!Y*MZ"NKKI",>6?1&,179L.KW!Q\__3' 2* 828(=
MV)A?/$P"<D[.8XIU6)X2H!)& K*,D%A$8W,(WK4I-'B F.G[R(QL1_85> >C
MY>ZQ<'KQN;;']=Q9%P.@$))P;S-$+QB0,()40:3"VVQ%#U$S?1^7MJC97N0=
MF9K7<PI\\9J3.J&30,]Y)O@+EDP=0&/!RT(<)1%S3D85TR9Y?Q-%TS=A:02?
MO42_]W#4>P:HQ3'1F]?/7[[]\/+D[8OGIV_>G#P[?7_R\?7IVY/?WK]\^?O+
MMQ\_['(P]/1#QSL*VI*!,:8*WKSRQRM^0,X7-,'H"$8A!V4C1>,<%6".Z"I"
M9!PV5G#C*_9R8=_,$N&8'/&33TO$ZHG?+IN/))EG],D_SU@I7@@C0$H=ZB6/
M B<#@A%<<!\4%I>&,3'D=1-F7XVCQY]<W/$EW/4A\Y.+[_?P?;''"?-6SS^@
M3=G(5EOSXGS";$IMHN,I7F)( ;/6&HH5P>1D"Y9AP>;HYN5' =R=.[]S^OUB
M23KXAB?+9:VJ7%?YGLSSVP5MJP__^LZ%S/4U81U [FQD@*P.!B@F@8LY0DC&
M!A^EPD:SY,;GI4M;MPVH?JEWG%;='?CH'^ESI^4.1^OT2[3&,30&G,N>#+P)
M$",&(",OK<G:F=C&07^0G&EO1*;&R&)LA76 NE^%%QZ6UTW"7M1%(=/@4R&'
MPU>!99(?SS()G3E+]Q.7QKI4V8[0:9$Z C3NW[ TU%,',/S5V[UA)#BO7"UZ
M02YK!WI9(-:FI*583#(F(TII KB-)$T+K:9 6+30RH3PRC@[>X.?POG+^<7L
MXOOU*N3<<,Z!2R5!:5/]%>/!!6.9S5YH_5BJP0K3__5I\>W_T*.OL$1?K"&T
M!L\#+YSVLK>3/7-?14R,H2NJKU-74\QY?;N8?;&@7+ULS)I#BM)34!^$]H]9
MI*<!=/=MTQB;O=6U&$%V4V=5_G[R7Z>O%I?SO!;W3<$**AT%%U"P3I@+2+NY
M<F18K9'*EV"$'W:D]=#3IU/V[DI:C"FQ"56^6E[4:^5Z6D_BNOA><]77N!=&
M)N<#D:XXF3NI.%DZR\'[E",W)00<5&--+[CC?-!W]QV/311,F\_1R08RBGHF
MAM=MD[ ?_M1]EJY7(#*%408*$@*K/16U@B "@ZQ+TB4**=0@IW<0Y@:3-8UY
M&D?SB]9JZ'.WBBHY9B/4[*AJ<0MXP<B<LVPMZF*3'':+U,]NU5"#3V]E6XBS
M@Z!Z!(/]YK973@XQQAI"UG)-I<A>.T[F&S-SA64?A6X3AX_)Q;19<)ULI9/#
M8VI3>76L<6L[7B&NGB^^?)FM1RV=L<PQH#8@..TF*F@!KB@'Y,>BXL$8YH8U
MS'_\/=,>(TVG_%\ON4?11 ?V]CVID BH@Y5>X#<\7WRM7/S(3O76LA(H:G:I
MU"P? 3%1D,482^@#+639IM7(HV1->SHU.0K'5]V(+<XGR;/XC\7G^3\67_^<
MS5=_S&?K5N\7WULF7CSZP@-F8@QG?*2RO]?S;W@]W>_D_'R=5WKW1S>WZK9H
M,G-UG&66"(J3Y^DXMR!U4A68(<0V<VN'T==AGH?Q=3BQ,V!RK;S-5M%RC0B&
MOJ0(4:14VDCL[Y+GT1"A!\C[V$;]4[NB&YG^$,YQ]?N,_KA8S*_..Y)P/ 8O
M0/MZYZ:- Y>"@U!RL+HX1#GLZ'F+E_[M$CZV L?B )HZ$@1>GZ=X(;)ADA9X
M<*YVS VU%ST#Z7G0+ AG!XYHW>JU$V:[-5/[#MC:00=3H^MG!MY7QD[G>'V<
M9E0P27(.1M>Z!VDB!$L.-F>"2.7*F#3L=/*QM_2/G5W4NF@AXP[!\O'?BVM&
M;"Z&2TR Y%'4LX!0KQ$5<.%5I/\75H9US'KL+1/V.)H.++O)N$>PD-YO<.]\
M$!HQ@X[U8)0%!2$2[E/)3EJTBAFV,UQNWS/-W>S4@-E1SCW>[A?OZJU-J>WW
MR3XZ<@JC1UQ7X2%]9\M]LS+%[?XQI8?MXF&/HIZCN=TW B4C5Q%LJJRL4S)U
MHO Y!E9"5HQK-QKFCO5V?RO-[W2[OXT:IM[MR.32NGL9EN<S7+[ "[QN-+?\
MNEZ2/VZHE?8J,):!;*\ )5B"*+4$)I+"G+3"^WVT-FQ[ U]X##D 6^EYT5CH
M'5Q3/5R<X(2P6LL"P7E&P2LZB-QQX-Z3,YBE5*&W0J-CRGG;95<<3V$=H&[;
MNH7@G4B%%E5FB@0FG8#H7 "6C>$1L_.\44? XR\TV@H:>Q8:;:.G#F"XN:2E
MB**3-0(*KRUA#>T5W@:"1P@H; E6JS;5P7^30J.M@#"XT&@;K70 KU$3&H(T
M.=7M0D9/?H6*&6(6 G20#!WZJ/!_4^Z.:B>?#!Y3QR_OPO<UGW46-BUS^O)T
M_N-0Z::'_QDZZ;BO8Q#YU1!L7O-K$1Q9D^3I^\R&W7 .>MW?* %O*R@LFNIE
M:J0-O;"[&KNN7!#D#GGBS-2VM"* $[+6R6HN2G YN:$36[9X[=\HZ6YGY+73
M4]=]CMZ]>OW_OGS_[OWI[Z<_I9_MDEJW\5GC9<T-(W>,7D7O"*>+]1+XM=_5
M;::1%4XQ*0D&M6>>IC^\L;3W&N2":T))&C:^8LC;6OF"#_7Q0C*QD6ERGETI
M0"P6B.@L&,PR&(DE- H^MB!RPIOTT<$QU#';5U>=9P-O6MY[Y/L^]<CVMJE9
M.[5!*$1KK5QO@T(1.HRQM"&F "%G*[-UT@S,TCN$B6H0'@GB,EGF0-A4)SJR
MFH6/":(3Y MP(;AI,Z#^[Y)\VP9J!\B[W4;SG?6$44(48VFO\+YZL<8H"#4[
MPNN@I7/!^O18%D";GC#'E%:[E>X?Z0FSC2)ZZ@GC94)FZE3V4"/D2.Z =TF"
ME3HPGGR4T>P%H)==]H392EV;>L)L([NI3Q?>E=G_U"*(=),Q%W*@ES#(&",H
MS/5XVD?R.95R:%#%,C @^?G!G72"V4HUBY'DU,$Q_H;^?87EJ%B S"49.:2=
MUR7KH800DT8ET+6I*]K]BOR8$L=VV4/&4U@'J-OVQBTZ+4L6&6S)B=@+@@+>
M8L"J'&T6.B7QOU?D8T!CSROR;?34 0Q_#_/+0AQ0J)$I#LF7Z6)=^G>3[92*
MXE(E**:.6B+##DX*!1PUTSJ$% IK@KK'Z3JNR_*M(+%HII\.T#;J;43Q3/%D
M'4A:Q*!T[5S'9+V;#=QA9#*$-N.S#GYC?DRY;_ML[)/!8^I(XP,NO\T2OD)\
M%E:83^?D3"_7O(7SWY:+U8J6?IE=K$Z_X?+#5TRS,L-</TI/PRJ=]XOOX?QB
MAJLS'X0AUSU#E&1G%+GNX%%)R(J,CW8Q9V,'!2GCT?0WNGO?"E2+Z37<@<W_
M/2S_Q)IO<--@I4[9X\4A[7^UGQ\W@;9#%X$(EYF1>0CYL>.3?7R*GRGY&]W,
M[X++4134]?W[AX^GS__O?YR^>?'R_8>7_\\?KS_^URZ77 \\9;Q[K:=('*G]
MS,M_7=9CO)O+A"*=*Z($X$71)AV,!L=RAL P9$S<6=EFB.3/=.Q]HW6Q2']^
M7IS30EU=/?GMX@(?NL;5,44G;0"9:M6&TX[0'"R$)%E4Q4@A&DT#&DKBM)OD
M'OCXY;*IB5*.S,ZL?>&=KM0W/JNES7F(W#:61T:NF \!3 D1E$T9?#$"4(LD
MC>>:I3:51R-;GA^!TTE*EU\NS^O@S75@_GSQA=3SN6:X?\.K.:!UFOE:PK?0
M#RXD'56 '(,#98($YTD6SIN44Y;*V38^T)Z$=V6EML'2YBOQ]@KLP E_C^D\
MK%845:2UMDXO+P9Q?H]K:YTBPVQ 9&E!":G(8CL++B)FP6-@OLTA]#CT3^OP
MCXC>"=1Y9!OPVWHD6T.G/;+;!CRUY:;\. MMMF<;A>6H!)A8F_!**\@;(\=/
M<T.A7XD9CR,P^&'=/US&U2S/PO+[Z?+J';_CQ>=%OFIMB%<KXBPG98SA%#X;
M54_H65T#20*S&5G4PB=G&V_'@PCM:OO=!BN;M]_Q%=3!=OOL<E6/[58GB3A:
MS=8*6O>Y0*XH="(C7ZPBFR\\!)D=I&)(DLFY?#^E?22<;2"HE]2T!B!8C*^1
M3H%5OUSB30,,SCAF[\FC6'?'IE@:/*(&&UQ*IHKHT>2T<2'V$VG3@FT4  P
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M,Y9M7( [2Z4A1&T4+A0FB&0'N:A4$U0>'-GIZH JYV) (X:YXEIZU=A=GH\
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M4O'Z#M2,NSNO29@?$!X-6./WBWE"S,LZ#>]V@//Z+URD*=$]\2%891A"<=J
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M+#D@B/K^_)9_#\#8"Q@[#<#81DIC0^_^P-UUM< C8W=O1BHD3WX(-^0*NV*
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MN>!T=4$<N;X G1"^,.= \QB)"<R!9\Y (B\Q!F=T&&@TYP#$'.D3<KO.TKZ
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M:H($[Y0'+VW4*I:2PTB-=#U1>*03(DY)(_> W-%FGI]ERJ:#__9DZX=&M)?
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MH_XN&7?U@*J83]$6D,G6X47D0;@@!' KC%$Q)NZ':<5]^#SCOF0/!ZD>N-\
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M23FPM]B?V(['*MZ?;3.Q'*.N>X1-T/6UWCB(1AK(&=$4ETTVKF>C>/\,XR:
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M$$1-\5&E,%#+^W[G[O:DSXX6IP>09D/8[9#!>/"!F+RB*SY,N"O*::D@QJQ
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M 70G4F2)Q0O+&9=NYZ*)PY/336^.)Q'7#F>W LKIJ]8KI+OWYD_FBQ\3[WU
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M7^*T"01LKPG^4A-F^'G]<#ERQO7EVFDBN[!>TO"N/->3R2>VJ,"9#4#<T+4
MDKC#D.16>.0L>"/S,,5^!R*PF[K\*CG:8?'1P#WR2$+.2&VLCK8N6"6'SW$#
M@4<&H: I(I9"MN& +X'=0'D\>=4>N=\ AM[/E\2)^AJS?G[$&9;I:OD>%]-Y
MOJK?"3QII\IZ[1LGM; 2O#06DLE*<%<$RT.M#WKV<-W0=3S9QZ'DT@+4'J]-
M?(O5/H?EEZM\T,1DDU+) ="8#,H0/H+,DA1*HQ5<ZUR&26=L<\INX#N>#-[@
MDFH A1]7\_3/RW>W5Q<+\@<N=>JR&>S6F,.Z1%-P42VWU'5A2$"RX=$#([T2
M(@86V#"/!UU/V&W2U!$FR8:0T-&]]5\^$'\@H2Z^8Z;0\,W%JFZEJ]^F\&\2
MB6;B)D5Z)7CB<.)U8KJ&XI3T+F6K?;<E+7V?K!LLCR=G-;[X&K":6[0AGLW2
M^44FM7WL_>Y_XGD=(3=?U,JGZQ_')X9["KFD 9-3%0X22YP18# C(Z(RND-.
MNNJ5N&Y*<3S)KU9QT8J9'XX?FY:QRSMQ(BT9#>TYI%Q3A'78@N>:0.Z9<,$5
MU/>=E*WF;PUV\&[Z<#QYN.:%WYMB_(__^$EDQ+I_KK^U_D[]MSY@^6_UU[]]
M.+OS\XE-:;5,4Z0K</G?T_SKY6?\]K>/9V]??_SX\MV?OYV]??'I[-W;CU=#
MR.?E,1Z6^>+%\DN%S"R<_UA-T_(5KL+T?'F7YN64PFA\3@GZ/L)_W##D/JLV
M)_D)T&,P!_]:X2Q3)-O_()]97I=XWE*Q%W&Y6A"-$Q&R1,0$A=DZB* NDU6U
MUY7'PJ))]*V#M40]<<Z]0\UMY^@[J[.7,8&D6Z[N5? 0=9V?HVPH0A5CTS %
M;-N>M(VQ\ .@[:=8=$@1-N37W^9;75]CT$2?:E"BN06EM *7I /C(T]!9V7B
ML"-A[AUH7, -BX+GYQAM+9)&D;7Q;:ZVJUID1C-/3#+$)*LL^*PE:!T*#U$4
MKH>MSGGT:&V8M[T T %4NTMC["CKGF>SV4KDE9#94W2(DKBB7%VYY=$!BN 2
M6?EHE>H4"SWXX]O#Q![RF_?*S#:MS4U YW-R7M<)W,S7# 5]Y5T)9!:*3YB%
M]P/5H>Z]XFFP!Z&Q;[3=A-, T)X=L$*V.#)4@8)R,M JN@@A>0O(E)*>-#'J
M86J,^AEY,\J+RU88V';BS38":0!@?0[\<X*;Q+,%(^EB4#'683]*0+&8,!@G
MG1]]Q5@O@QW'>3C?![9CB?FX$'ZK)_ALEB[63?'%%U:T)&I9JNV.C!R=:!@(
M$[-5Q6D5#U;DO,6Y&]X+=2 <[RO,XX(NG\@LC36!@_.":.,H@+QJ!*9-=DIF
MQ_7!1I;OM^!QG.Z2 \%R.T'M#L+:OCIJ'N7NQ(7PT,2%0^53=C_*H?(J/3%K
MG/R*39PS44/VQ (Y!-9!Y%Z 9%S[9(SFYF!79$OY%9$CUYQ\?ZD9A0)*D$71
MP8&VCA?E?!)FH&'/IYQ?V09M>^=7MA%A0P[#_;=<C<P9[SD@$J<45\0]:3-X
M"DH9:I1^H)+ZT\BO;(6"COF5;432*++NO@@765+)4D$@%YM\:\5(+UW=D!FC
M0"X9LOCO_,J. -@ZO[*---K,K]1CEL $:,U=S3]I<)8'R!KI?YZ8YKO-%CG*
M_,I6\GL^O[(-,]NT-C>!6I"L1)D+!%\3DXZL<4#O0"0E+6),R1[,T!QK?J7G
M&VTWX30$M#[F!Z[;E&;K]]/OX;PF"2;,\,1#(O*S9*!$863>(X7Z7AL>*/+G
MX6 307JDJSGCN2/^!MSXN2<83DTUZO/K;'7Y-^FG(#&%_DT2E]$*98Y0QV:"
M,JZ0'2*?2!F%T0DI73Q8RJAWZAK.)36C)GT X\24I0[7FJT'S99LHJ9_@"L)
M0=5ZTL"E!6\CN7\AJC1P2-4K.0VGI%I1A]U$?V+XOV,3WB_P6YA>S2"@O[]>
MG7WYO8EV,@A&T;/%9&HZC]@5"=!:2Y0*M2WJ8"U\PY/;<.ZL%?T9!CHGIE_O
M%_-ON%C]J-L)5QL?]5LM:IK$DA0S*4 NABY=K:H8=0*AT9!D.6=FF%$^!R&O
MD_Z,,]RM%?WI!QICOR?VR9%WW]8I_-GG/S L\</T\Y?5N_*WY>9?G:CD7$ A
M(-MBJG.JP'L9P""SFAG)M;H7OQQ@(\339^ZD!N,,;=M%#5J6^(E='&>$D]GG
MZ?5?7M^GG[Z$V>_S>?[7]/Q\HHU$GC""D8+1K6H">"X+V%109%%LU.V'\\^2
MV4F#QIDPU\I%TB]4=M:C[[B(\P8U:6-+K$/M='(0+[M>;(+HA:H%XUFEHF1,
MPZ;E^Z.EDTZ,,Q>O%9W80>B]E?^U ?M->';[&RG5::G+]^''.B\5*/#R,AJP
M-1A3S-4"71UJ@:3.(M%WS;"-P <ALY.RC#/'KQ5EZ1<JX\^>[MU-)78L+NY4
MN4^,BLDCCQ!"K6 6(4/DQ4)F2B65+5K?K2-UV'-VRQZ.,TBPB0AD3]&>(-@W
MUN!N:'8]27MBI!)>D)BTYA23)4U7*BL)=-+,B>(<*_;@P'_ZS-V4X'ARZ"V+
M?'R%.,P-N0ZR)I8QBXY<RV22O9PJ'Y)QP%51WD4G96K_$?<1XKIIS;]3ZOOB
M8GR-Z=V>O)U?-@$^;E*RL#%EGX#;4M<?,P9190=%15&7O,H@#_^6^^RQNZG$
M\:35&Q?\^)HQA,VX[6K*K#S+&8'[.GHC!P0O:B&R=]GSXKG(O/G[8^MPX]?.
MF^\J_[VUH<EGJK>XFB09ZKAW"W8=<#EE(%H,H&,HH6144ARLIW$?0KJA_]?.
M>F\K[P9>9:_3*-X:*>AXD'2I1<7,@2\Q0N&Y>#I;8F&885-;)</X\>23]^+P
M\29\K\A]5$%8*27R(D%B]* "71 A6$/Q-V;CB*O*L98,XG,$=</M+Y/%[57^
M1S>UXL7;5R\^?GS]Z<7+__S;V<>SCD.O/WU93+]CSU,K^CC*L%,K>F?6.%,K
MLF-)LR+J^B@%REOR<U,)0%>]0F95PH$6+C4^M<(A9RFQ!"5S\O^#B.!M%F2&
M2C%%DJKS80S]24^MV 9M^T\%WT*$#;DL]SOD;>9<2+3@I:\UIX;(D#( #U9J
M0]=.+,.^1!SWU(JM4-!Q:L4V(FD467?[['--(GG48&RL?69)0/2Q0&(^:0S%
M*#]LMN3(IE9L!8"MIU9L(XVQJ\PO'9K787$^Q07Y-9@J02_GBV_S2^=G,WJ!
M,<]L#A9LB:2&Q99:[Z5K^7Q P61"V:TJH^,'MH>;/60\'YCA;=JHFTC0I.*3
M+ XPUL6[(5IP(41PJ7!9F F6'VPQQO6ICFS61<_WX&[":0AH?<P CLP%*4T!
M[I(#\F$E>,4R,"&X]<IZ=*,/&^UEU/,X%3A;(6O 4<_;B+F)(OUGQ[,GX6ST
M7$/D2+>/8J6V[]!O<^"N)%M*&&876"_S\L>I;-D'C;T*Y+B,Z$,#J(WVIBC)
M0=?E%HHN'W)+DH)L7 HY:\;TP8JS3F.:^(%,Y;["'#M:>8#4-V&Z6&\Y?U<^
MX+?SD*XNA!?_"HN\G"A$'F1FH*WBY$=[0Z$>&G#<QJ+12+R_E*U[/=0SG]WP
MJ(-=\'8(";1I&S^N\-LM-CZV?O::$7QB>>(E> TBVT@^.H6'(9'+D5D)6:KB
M>!IF:'(?IV]XQ$#/=G)8P;8)YL='^B>;N?=*0?&%G!@F/#BG*,Z,3N=B'&-E
M]"4AW< Y3J'&@2[Q[01U$EGL=0;_V_IIY-9],R_O+O]LD^ _0 Y[NX,</H.]
M!Z-&VKJ@I9><7 *EHR9[R@+$D"E*#R[FY++E?M@U@XWFKV/D,1@EP#!#7CE*
M#X%E"9988@4+%@?:@W/2^>MMT+9W_GH;$3;@*JR]]4_TE]<9,J8],HK]@*7*
MKE*0KC&Z9XA-/%H95<C#^ )WCG%DN>JM)#[OB_T-8.?C%V+H;V&)F12Q#JK;
MR(B<EL^X?CG[[<?-W]F\IJTIOB%[ENN\KK?AZU6*+2@G=48+UA0!RLA$KC8B
M(,I08EW6.]#<T"&H&1?)>X#KOA4<6](-H/TU>93S'X@?5_/TSTO/:I.T5<39
M0LXY"&GI5L&BP?N4@-D8F$LR91RFZNS1(XUL04='RWP(T8V(P>5B-?E0N7>Y
M?871Q9+0@S$,ZQ2>0(=6!;)BRC,1@BN=JC_II]["&OWN/L[N?.R19<YWN95W
M9W,+V-A .FA1G$8#T@M;AY,5\-(5T)E+)0K]A^=^T3&FS=E#9/>%O@/_1A;[
MG]/9].O%UZL].4YRI0/9LD)@5T@13E04\!#:L3 9.?W2F^#O?/3(HM]%</,^
MN#BV^,-?MPZNA'4)9804>:U-DZ).71<0=0@A:6&,[%1NU4W\MS]ZG)NA-_'O
MS,4&G-)'2UV]UM)D1N9/$XJS(&_)Q P<Z6<4F^H$\>;*SP=+PA\TI.]#)(TB
MZVXQ+ \R1.<,B.0C*)\L.!L=>,Y"04G!)@Z;.#JV\O-M +!U^?DVTAB[H*-K
M-70.R$I=9FYS73.9.:FAM **$QY9B#;>7\Y\VN7G6\EXE_+S;1C>IHVZR<O2
MM6V0)P\VI,HL+2&:G$'FHK,27JN!<TP[EY\/5APT]CVXFW : -JS+UJ//6A=
M)V-OI6@_3)?_?$-*?55Q\B&L<!.#3'3T2IM4@#E95R>Y!#%E0EG)0DJ*0_S]
MAIM#O7[W1&%S)G9'3&[[0#X&0'X)Q;F,WB8R*+H"&7E3TAI0LECP@AE FX-4
M5ANAAUFG=2@*&ZZQ;UMQ=@!(*XH3G^=+[,*7ND8L70[P^\HG14J="WEUKO "
M*M+U'JK,L"Y5%LSR4@8:DC 830W7^.^M'..#H!5UZ,M,7''B[_-S^C%UC.;M
M&S:IHD76"$8;"M.%X^#16##)>8K4662F4_YDW)OD21H;;E%HYB[I#R2_B/IL
M[ME@0A*>,U#9ZKJ<4M=A,06*2)[3W>N=&Z9+[' T-MPIT;KZ[ "24U6?5]/O
MTXRS7/DRB24Z@\*!X(RNXQ08A. 46%>8]SE'Y,,,]!J<M(8[-YI3EITA<<PZ
MLFE2^)W^XFIY-GN/B^D\_P/K[DK,+[[C(GS&]3=?$5>NN3=)QF@E2@0>,K&G
M;K5T%,N!]X$Q'83-O+&7LMT(;7EAXQCZ<P"X]*9-;8P O3LL-3PT)'6$::!;
MGVK,P:#[L7"<'BNO#9/*67"I;ADRFGPL)P*DZ(.QF#G+P[R(-MYC966QVDD%
MV;$Z#%@17^J<K9!*]D6'4/*_>ZP&1=O>/5;;B+ !U^BQ@I"4LT+O$4K$ $I+
MXI[*"8RC6S4P(ST..R[@N&>$;H6"CD5:VXBD463=+1FQP:/$I"%)"B54209<
M"05B\=Z5Q+RVARL$/((BK:T L'61UC;2.)8BK9AU8H5HPB+K+MNZQM;I##ES
M7I)3#D-YSGT\I2*MK62\2Y'6-@QOTT;=A)#)"!%J):3C(M::2 ?156/B62Q!
M6G1IF&[/$YH1VO,]N)MP&@):+XLHP_(+?:..!OH>SFO+XB07$WCF$G*I<UXP
M1;H99(+$;1!9J?J^<*AXJD>ZFC.G.^)OR*VD^X'AU%3C<B'EY=]\O\!O89KK
M _9L6;MVU_M:+[\W8:Q8%X(!9FLW7I%T"6JZMV(I0<6B6.0'&X<V/+D-%V@U
MHTB#0.?$].O]8OX-%ZL?M?]]M3$[W^KS]X1\/BZ4LA!B(J9((R FNO>9M,SG
M;!ES!]OZTS]Y#==PM:(__4!C[,"R3X[<78O\H6:!WI6_+3?_ZL0XYY)"!\;Z
M LHZ!JXN0=12YR0#(E?=&H@.=^:&:[-V48.6)7YB%\?Z_KS9&+YAB,O)JZ(]
MN:8B@_)U!6AMY@E>1R\\-]P/NX5C,-(:+L-JY<+8'Q(GIB-GLXQE.INN\(_I
M]_K;59A]GE[_NQ/#'/K" O!4%^9F8]?C5>D>S2(G:YBW!QM,.121#5=DM:(W
M?<+DQ#1HPP&=2V0Z.I"YUM-DNF=C$1)*=#$(C<$>P8[Y+?1AG JK5O1A!Z$W
ML&A^@*>+V]](:7XQ6RW?AQ_K9WCN.2JC+9!H+"@>$D1.OS5&A^*18W##IC(.
M0F8G97&_M++T"Y7M]<A?ZM$,/X?+=J_6@G9BQ^+BSEJ:B?=*RU27LSM/+JGT
M 2+C"#;)Q+)#%S,_>*#^\SD[H=\?#?I;D^P)8GUC#.Z^6ES]M1\33HZD955J
MJ>YWU#%#0"X!8Y28"L9D\\%Q__29NR4,V:^K!#V*_ 05XN8UXC$&H95)JQ1
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M7'/Y;?+A9.*DB$Q(\M."=IH*C2(=, ;62AU8<2SB0Z3G>8Z_GLZ^_+9\XC5
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M$I?M[#0A+VXYM_X97T3C5^+._@!02P,$%     @ -(EB4Y&WDE4S"   K2<
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M87,M,C R,3 Y,S!X97AX,S(Q+FAT;>U9ZW/:1A#_WK_B@J>)/8.>"+"!>(8
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M3FQ\Y^]CLS?#QW\ 4$L! A0#%     @ -(EB4^Z5J$.+1P, E;<D !$
M         ( !     &5X87,M,C R,3 Y,S N:'1M4$L! A0#%     @ -(EB
M4PR@K_#5'   !54! !$              ( !ND<# &5X87,M,C R,3 Y,S N
M>'-D4$L! A0#%     @ -(EB4SC;2*WX*P  AM,! !4              ( !
MOF0# &5X87,M,C R,3 Y,S!?8V%L+GAM;%!+ 0(4 Q0    ( #2)8E-]W&.?
M]K<  #2#"  5              "  >F0 P!E>&%S+3(P,C$P.3,P7V1E9BYX
M;6Q02P$"% ,4    "  TB6)3?;::_R=_ 0#:LP\ %0              @ $2
M200 97AA<RTR,#(Q,#DS,%]L86(N>&UL4$L! A0#%     @ -(EB4_LW8 XN
M]   MH4+ !4              ( !;,@% &5X87,M,C R,3 Y,S!?<')E+GAM
M;%!+ 0(4 Q0    ( #2)8E.CY]2 & @  &TG   8              "  <V\
M!@!E>&%S+3(P,C$P.3,P>&5X>#,Q,2YH=&U02P$"% ,4    "  TB6)3D;>2
M53,(  "M)P  &               @ $;Q08 97AA<RTR,#(Q,#DS,'AE>'@S
M,3(N:'1M4$L! A0#%     @ -(EB4QB3:1)I!0  =!X  !@
M ( !A,T& &5X87,M,C R,3 Y,S!X97AX,S(Q+FAT;5!+!08     "0 ) %P"
(   CTP8    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
